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IN VIVO MATURATION OF HUMAN EMBRYONIC 
STEM CELL-DERIVED PANCREATIC PRECURSOR 
CELLS TO FUNCTIONAL ISLET-LIKE CELLS 
CAPABLE OF TREATING STZ-INDUCED 
DIABETES
Bruin, Jennifer E.1, Riedel, Michael J.1, Mojibian, Majid1, Xu, Jean2, 
Gauvin, Rebecca2, Narayan, Kavitha2, Karanu, Francis2, Rezania, 
Alireza2, Kieffer, Timothy J.1
1Cellular and Physiological Sciences, University of British Columbia, 
Vancouver, BC, Canada, 2BetaLogics Venture, Contocor Research & 
Development, Skillman, NJ, USA
We have developed a protocol to differentiate human embryonic stem cells 
(hESCs) in vitro into pancreatic precursor cells that can be further differenti-
ated in vivo towards mature pancreatic cell types following transplanta-
tion. Following a 4-stage, 14-day differentiation, hESC-derived cells were 
transplanted into the kidney capsule of streptozotocin (STZ)-treated diabetic 
SCID-Beige mice. Euglycemia was maintained in diabetic animals with sub-
cutaneous, slow-release insulin pellets for the first 12 - 16 weeks post-trans-
plant. After this time STZ-treated mice remained normoglycemic without an 
insulin pellet replacement, likely due to graft-derived C-peptide. Follow-
ing transplantation, fed human C-peptide levels in diabetic mice steadily 
increased from 0.077 ± 0.01 to 1.99 ± 0.3 ng/mL between 4 and 30 weeks. 
Furthermore, engrafted cells were capable of secreting human C-peptide in 
response to both meal and glucose challenges by 30 weeks post-transplant. 
An arginine challenge stimulated significant secretion of glucagon and GLP-
1, in addition to mild release of insulin. Maturation of hESC-derived pancre-
atic precursor cells was characterized by immunocytochemistry prior to and 
at several timepoints following transplantation. Prior to transplant, hESC-
derived cell clusters contained a mixture of scattered cells expressing insulin 
alone, glucagon alone, or both hormones. At 4 weeks post-transplant, 
engrafted cells maintained a similar hormone expression pattern to the pre-
transplant clusters, but in distinct islet-like endocrine clusters. By 12 weeks, 
the majority of endocrine cells in kidney grafts expressed either insulin or 
glucagon (but not both hormones), and displayed an architecture resembling 
mature adult human pancreatic islets. Furthermore, insulin/Pdx1 co-positive 
cells were observed near duct-like structures immunopositive for CK19 (a 
ductal marker), suggesting the possibility of ongoing islet neogenesis. In the 
islet-like endocrine clusters, insulin-expressing and glucagon-expressing cells 
exhibited transcription factor profiles similar to endogenous human beta 
and alpha cells, respectively. Taken together, these data demonstrate that 
hESCs can differentiate in vivo into a mixed population of mature pancreatic 
endocrine cells, capable of maintaining normoglycemia in STZ-treated mice 
without tumour formation.
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SMALL MOLECULES INDUCE EFFICIENT 
DIFFERENTIATION INTO INSULIN-PRODUCING 
CELLS FROM HUMAN INDUCED PLURIPOTENT 
STEM CELLS
Kunisada, Yuya, Tsubooka-Yamazoe, Noriko, Shoji, Masanobu, 
Hosoya, Masaki
Frontier Research Laboratories, Pharmaceutical Research Division, Takeda 
Pharmaceutical Company Limited, Tsukuba, Ibaraki, Japan
Human induced pluripotent stem (hiPS) cells have potential uses for drug 
discovery and cell therapy, including generation of pancreatic β-cells for 
diabetes research and treatment. There have already been several reports 
on the generation of insulin-producing cells from hiPS cells or hES cells in 
vitro, but there are still many challenges to overcome, including the low and 
variable differentiation efficiency of the current protocols for different hiPS 
or hES cell lines. To realize the full potential of hiPS or hES cells in the field 
of diabetes, it is necessary to be able to generate insulin-producing cells in 
an efficient and reproducible manner. Here, we report a novel protocol for 
generating insulin-producing cells from hiPS cells. We screened for small 
molecules that induced pancreatic differentiation from definitive endoderm 
and found that combined treatment with the compounds could induce 
efficient differentiation of pancreatic progenitor cells. Expression of the 
pancreatic progenitor markers Pdx1 and Ngn3 was increased at this step and 
Pdx1-positive cells were emerged. Next, we screened for small molecules 
that could induce insulin-producing cells from Pdx1-positive cells. Several 
compounds were found to induce the differentiation of insulin-producing 
cells. By combined treatment with these compounds, a larger number of the 
cells became insulin positive. With this protocol, all five hiPS cell lines that 
we examined showed differentiation into insulin-producing cells at a similar 
level of efficiency. They were also positive for antibodies to various islet-
enriched transcription factors, including Pdx1, NeuroD1, Islet-1, PAX6, and 
Nkx2.2. Other pancreatic endocrine cells (expressing glucagon, somatosta-
tin, and ghrelin) were also generated under the same conditions. More-
over, the differentiated cells could secrete human c-peptide in response to 
potassium chloride, tolbutamide (a KATP channel blocker), (-)-Bay K8644 (a 
L-type Ca2+ channel agonist), carbachol (a muscarinic agonist), and IBMX 
(a phosphodiesterase inhibitor). This differentiation protocol may contribute 
to drug discovery and cell therapy for diabetes.
Poster Board Number: 1006
IMPROVEMENT IN PANCREATIC ISLET 
FUNCTION AFTER CO-CULTURE WITH ADULT 
HUMAN PANCREATIC MESENCHYMAL STEM 
CELLS IS CELL CONTACT DEPENDENT
Yeung, Telford, Seeberger, Karen, Lyon, James, Korbutt, Gregory
University of Alberta, Edmonton, AB, Canada
Background: Islet transplantation offers metabolic benefits for type 1 dia-
betics, but recipients progressively lose insulin independence as a result of 
reduced islet function and/or destruction. Consequently, activating cellular 
repair may be a strategy to mitigate the resulting loss and dysfunction of 
islets. Bone marrow mesenchymal stem cells (BM-MSCs), which have been 
utilized in rodent islet transplantation, are an attractive solution due to 
their capacity to induce repair in various tissues. The expansion of a MSC 
population from the human pancreas led us to believe pancreatic MSCs 
(pMSCs) may possess similar regenerative properties. As therapeutic doses 
of MSCs exceed the natural frequency of these cells, we hypothesize that an 
expanded population of pancreatic MSCs may be beneficial for human islet 
function and survival. Methods: Mesenchymal stem cells from bone marrow 
and pancreas were characterized for CD29, CD34, CD45, CD73, CD90 and 
CD105 expression. To assess the regenerative capacity of these MSCs, five 
hundred human islet equivalents from donor pancreata were cultured in 
direct contact with MSCs by aggregating the islets with 0.5, 1.0, 1.5 or 3.0 
x 106 pMSCs or BM-MSCs over a 72 hr culture period. For a non-contact 
culture system, human islets were alginate microencapsulated to prevent 
contact with MSCs and then were co-cultured on a proliferating pMSC 
monolayer for 72 hr. Controls included islets cultured without MSCs for 72 
hr. After 72 hr, all conditions were characterized for glucose responsiveness 
as well as cellular insulin and DNA contents. Results: Immunophenotyping 
for surface antigen expression confirmed that pMSCs are similar to conven-
tional BM-MSCs (>95% CD29, CD73, CD90 and CD105 expression along 
with <5% CD34 and CD45 expression). After direct contact co-culture, 
both pMSCs and BM-MSCs improved glucose responsiveness in contrast 
to islets cultured alone. Moreover, these effects were observed in a dose 
response manner; and the most favorable effect based on stimulation index 
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(SI), the ratio of insulin release at high glucose compared to low glucose, 
was observed with 500 islet equivalents cultured in direct contact with 1.0 
x 106 pMSCs (SIco-culture = 2.73 ± 0.31 vs. SIislets alone = 1.50 ± 0.29, 
n=6) or 1.0 x 106 BM-MSCs (SIco-culture = 2.53 ± 0.37 vs. SIislets alone = 
1.78 ± 0.14, n=2). However, in the non-contact culture model, no beneficial 
effect on human islet function was observed (SIco-culture = 2.45 ± 0.50 vs. 
SIislets alone = 2.37 ± 0.52, n=4). In all conditions, co-culture (direct and 
non-direct) had no adverse or beneficial effects on cellular insulin and DNA 
content. Conclusions: Improved glucose responsiveness from co-cultured 
islets is cell contact and MSC dose dependent, suggesting that this improve-
ment is mediated by cell to cell interactions or is a function of trophic factor 
secretion. Preliminary data also demonstrate that pMSCs and BM-MSCs are 
equivalent in their regenerative capacity for islet function because they likely 
secrete similar trophic factors including vascular endothelial growth factor 
and hepatocyte growth factor. As MSC aggregates improved β-cell function 
from isolated human islets, MSC-islet composites are expected to improve 
transplant success by reducing the marginal mass of transplanted islets to 
reverse diabetes or by prolonging graft function.
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TREATMENT OF TYPE 1 DIABETES WITH 
INSULIN PRODUCING CELLS DERIVED FROM 
HUMAN AND MOUSE EMBRYONIC STEM 
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Li, Mira, Whiteley, Jennifer, Chua, Shawn, Rogers, Ian
Samuel Lunenfeld Research Institute, Toronto, ON, Canada
Type 1 diabetes affects approximately 1.3 million in the US alone and is 
the most common metabolic disease in children. People with diabetes are 
required to constantly monitor their glucose and take daily injections of 
insulin. Even with strict compliance patients eventually develop complica-
tions including nephropathy and retinopathy. Current long-term treatments 
include transplanting patients with islet cells isolated from donor cadavers. 
This method requires finding at least two cadaver sources per patient and is 
reserved for those with advanced complications. As a result less than 10% 
of islet cell transplants are successful and they are eventually rejected within 
1-5 years. Differentiating stem cells to become glucose responsive insulin 
secreting cells is a potential therapy for type 1 diabetics. We have shown 
that human embryonic stem (ES) cells can differentiate into insulin producing 
cells in vitro and have the ability to reverse the symptoms of type 1 diabetes 
when transplanted into STZ-treated mice. Cells were positive for pro-insulin 
as detected using a human specific antibody to pro-insulin and this response 
increased with the addition of glucose into the medium. We have differenti-
ated ES cells into pancreatic precursors by adapting a modified Novacell 
protocol. In vitro results revealed expression of critical islet transcription 
factors including nkx6.1, pdx and mafA cells. We have transplanted them 
into STZ treated-NOD/SCID mice to determine the efficiency of engraft-
ment, survival rate and insulin secretion rate. Diabetic animals were also able 
to regulate and maintain normal levels of glucose. Upon removal of the cells 
the diabetic symptoms returned including high blood glucose.
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Ambasta, Rashmi K.1, Arivarasan, A.1, Shaha, Harshit1, Kumar, 
Pravir2
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Diabetes is a rapidly growing health burden to the global society irrespective 
of race and region. However, researchers are involved in the exploration of 
effective clinical therapy for diabetes. Currently either regular medication or 
injections are only the solution to reduce the severity of diabetes. Moreover, 
stem cell transplantation has been tried to rejuvenate the atrophied pan-
creatic cells but this therapy has their own limitations in terms of identifica-
tion and maintenance of specific stem cell markers in cell culture condition. 
Therefore, cell therapy using bone marrow (BM)-derived mononuclear cells 
(BMNCs) can be one of the best treatment options as it can differentiate 
into stem cell and also is capable of regenerating damaged pancreatic islet 
cells. We aim to investigate diabetes cure using BMNCs transplantation 
and antioxidant rich cocktail derived from natural products in a murine 
model. We are reporting for the first time that intravenous transplanta-
tion of BMNCs supplemented with anti-oxidant cocktail is a better way of 
transplantation therapy than the BMNCs transplantation alone. Interestingly, 
in this study, we have found the translocation of intravenously injected 
DiI stained BMNCs into the damaged pancreas and kidney. However we 
are further investigating the fate of DiI stained BMNCs in other organs. 
Surprisingly, one time administration of transplanted BMNCs conjugated 
with antioxidant cocktails to the pancreas attenuates the high blood sugar 
level to the normal range within a short period of time that consistently lasts 
for months after transplantation. Also, the health and longevity of the mice 
after transplantation were observed reasonable and no further complications 
have been seen. Hence, we conclude that allogenic murine bone marrow 
mononuclear cell transplantation supplemented with antioxidant cocktail has 
the potential to cure diabetes.
Poster Board Number: 1012
PANCREATIC DEVELOPMENTAL 
INTERMEDIATES DEMARCATED BY 
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A thorough understanding of developmental pathways is essential for 
both developing and assessing the veracity of protocols for directing the 
differentiation of embryonic stem cells (ESCs) and induced pluripotent stem 
cells (iPSCs) to specific cell fates. During mouse development, pancreatic 
endocrine cells form as the result of a sequential process that involves at 
least four developmental intermediates including 1) definitive endoderm, 2) 
the primitive gut tube, 3) pre-pancreatic endoderm, and 4) islet progenitor 
cells. These developmental intermediates are distinguished by the expres-
sion of stage-specific transcription factors. Prior studies to compare the gene 
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expression profiles of these progenitor cells relied on both DNA microar-
rays for profiling and manual dissection methods for cell isolation, both of 
which diminish the value of the data obtained. To overcome the issue of cell 
purity, we have developed a series of fluorescently-tagged reporter alleles 
in mice (Sox17GFP-Cre, Pdx1Cerulean, Ptf1aCitrine, and Insm1GFP-Cre) 
that can be used to obtain genetically defined progenitor cell populations by 
fluorescence-activated cell sorting (FACS). Moreover, we have used these 
cell populations to perform RNA-seq to better quantify key aspects of the 
temporal, spatial and transcription factor-dependent gene expression in 
pancreatic or pre-pancreatic progenitor cells. Analysis of the data obtained 
to date has revealed multiple, stage-specific gene expression clusters thereby 
suggesting the involvement of additional transcription factors, cell-surface 
receptors and signaling pathways in key stages of pancreas development. 
Based on the quality of the results being generated, this strategy promises to 
provide a much higher resolution than currently exists for gene expression 
dynamics during early pancreas development.
Poster Board Number: 1014
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1Chemical Engineering, Université Laval, Québec, QC, Canada, 2Michael 
Smith Laboratories & Department of Chemical and Biological Engineering, 
University of British Columbia, Vancouver, BC, Canada, 3Polymer Institute, 
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Recent years have seen the development of more efficient methods to 
differentiate embryonic stem cells into insulin-producing cells. One major 
hurdle that remains for the use of these cells to treat diabetes is the antici-
pated requirement for immune suppression or immune isolation of these 
cells. We have recently developed a scaleable emulsion-based process to 
encapsulate pancreatic cells in alginate beads. The objective of the current 
work was to examine the immune protection conferred by these novel emul-
sion-generated beads. Compared to a standard extrusion-based process, 
the novel emulsion-based process allowed to generate alginate beads with 
higher in vitro stability and higher volumetric exclusion of antibody-sized 
dextrans. When βTC3 cells were transplanted into streptozotocin-induced 
allogeneic diabetic mice, a significant decrease in the blood glucose levels 
was seen within 2 days with the emulsion beads but not until >16 days with 
the extrusion beads. This was correlated with higher in vivo / in vitro DNA 
yields and lower graft-specific plasma immunoglobulin levels. These results 
suggest that the novel emulsion-generated alginate beads could provide 
improved graft immunoprotection. The emulsion process could be applied to 
other stem cell types to either manipulate their fate or to protect them from 
immune rejection in transplantation applications.
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Type I diabetes mellitus is a devastating disease due mainly to impaired 
insulin production by β-cells, which can only be cured by transplatation 
of new β-cells. In the present study, we report the efficient generation of 
insulin-secreting cells from two cell sources: Multipotent adult progenitor 
cells (MAPC) derived from rat bone marrow and Extraembryonic endoderm 
Precursor (Xen-P) cell lines obtained directly from rat under MAPC condi-
tions. MAPC as well as Xen-P cells isolated from Blastocysts under MAPC 
conditions have the potential to differentiate in vitro to cells with endothe-
lial, smooth muscle, hepatocyte-like and neuroprogenitor cell-like cells. The 
three step differentiation protocol designed in this study towards pancreatic 
lineage involves initial endoderm commitment, pancreatic epithelial expan-
sion and later cell maturation. After 21 days of differentiation, 20-25% of 
the differentiated cells expressed Pdx1 and there was a significant upregula-
tion of insulin gene expression. The glucose responsiveness of these cells 
was demonstrated by combined incubation with glucose and the Calcium 
channel blocker, Nifedipine, or incubation with the insulin agonist, Carba-
chol. As a proof of therapeutic significance, we demonstrate that implanta-
tion of ±5x105 MAPC and Xen-P cell-derived insulin producing cells under 
the kidney capsule reverts streptozotocin-induced hyperglycemia in nude 
mice, with normalization of the glucose tolerance test. Hyperglycemia 
recurred following graft removal. Analysis of the graft demonstrated expres-
sion of critical beta-cell transcription factors as well as insulin and C-Peptide. 
The ability of MAPC isolated from BM or its physiological equivalent isolated 
from balstocyst, to differentiate to β-cell like cells may serve as a useful tool 
to gain insight into signals that govern β-cell differentiation. This proto-
col could also serve to differentiate other pluripotent stem cells yielding a 
renewable source of islets for diabetes cell-replacement therapies.
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NGN3 PROGRAMMING OF ENDOCRINE 
PANCREAS DIFFERENTIATION
Gibson, Jason D., Chung, Kyung-min, Nelson, Craig E.
Molecular and Cell Biology, University of Connecticut, Storrs, CT, USA
The ability to generate therapeutic cell types from stem cells is at the heart 
of many envisioned procedures in the promising field of regenerative medi-
cine. Extensive research investigating endoderm development and pancreatic 
organogenesis has resulted in a comprehensive understanding of key signal-
ing events driving pancreas development, detailed transcriptional profiles of 
pancreatic progenitor cells, and the developmental trajectories of hormone-
producing cells in the endocrine pancreas. Exploiting this knowledge, many 
labs have shown stepwise guided differentiation of embryonic stem (ES) cells 
can effectively generate pancreas-like lineages, including insulin-producing 
beta-like (β) cells. However, these cells have not proven robust in trans-
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plantation or functional characterization assays, suggesting that while they 
express many β-cell markers, they lack critical pancreatic functions. A better 
understanding of the transcriptional regulatory network guiding cell type 
specification will help identify how these critical functions are controlled and 
help improve the directed differentiation of β-cells from stem cells. In these 
studies, we examine the role of enhanced neurogenin 3 (Ngn3) expression 
in promoting ES cell differentiation to endocrine pancreas cell types.The 
transcription factor Ngn3 is a crucial regulator of endocrine cell specification 
and is required for promoting pancreatic islet maturation including the de-
velopment of insulin-producing β-cells and the maintenance of islet function 
within the mature pancreas. Our research has shown that Ngn3 can direct 
ES cell differentiation toward the endocrine pancreas lineage, and highlights 
the importance of timed induction of this protein for proper islet differ-
entiation. Our present data indicates that definitive endoderm progenitor 
populations derived from ES cells are responsive to Ngn3 signaling through-
out stepwise directed differentiation protocols but earlier stages of ES cell 
differentiation are less receptive to Ngn3 activity. Studies pursued using an 
inducible transgenic system will provide a tractable experimental platform 
to study cellular cross-talk between Ngn3-positive and Ngn3-negative cells 
during pancreas differentiation.
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The absolute or relative lack of insulin secreting pancreatic β cells plays the 
central role in the development of diabetes Type 1 and Type 2, respectively. 
The discovery of the insulin hormone, its isolation and synthetic produc-
tion have impacted the clinical course of the disease dramatically. Treat-
ment with synthetic insulin however requires tight monitoring of glucose 
levels and precisely coordinated insulin injections. Many laboratories have 
thus established research projects to generate β cells from human pluripo-
tent stem cells. Such β cells could be used for cell replacement therapies, 
for drug discovery efforts and to study the basic biology of the islets of 
langerhans. However current differentiation protocols are limited to inef-
ficient methods that yield immature β cells in a heterogeneous gemisch of 
other islet and other non-pancreatic cells. To overcome these limitations 
we established a screening platform for small molecules that could comple-
ment or replace current methods. While many labs, including ours, are very 
efficient in generating PDX1pos pancreatic progenitors, a major obstacle is 
the subsequent differentiation into hormone positive, functionally mature 
cells. We consequently focused on this stage of pancreatic differentiation. 
To do so we first employed a serum free differentiation protocol to generate 
definitive endoderm progenitors from multiple human induced pluripotent 
stem cell lines (iPSCs). These progenitors were subsequently specified to 
pancreatic progenitors using retinoic acid, Dorsomorphin, FGF10 and inhibi-
tors of the sonic hedgehog pathway. After 15 days of differentiation these 
cells were passaged and allowed to mature until day 35, at which about 5% 
of the cells expressed C-PEPTIDE, as determined by flow cytometry. In a 
C-PEPTIDE ELISA these cells responded to glucose, albeit at various levels, 
indicating their immature status. To address these restrictions we began to 
establish a small molecule screen for inducers of mature and functional β 
cells. We assumed that our induction of PDX1 progenitors was efficient and 
provided a suitable starting material for these studies. We plated pancreatic 
progenitors in 384-well plates and exposed them to a subset of our chemical 
library at two different time points (3000 compounds, all at 10uM). After 
a single treatment cells were further cultured and analyzed for the expres-
sion of C-PEPTIDE by immunocytochemistry using an MDS automated 
confocal imaging platform. We then established a custom image analysis 
algorithm that is capable of detecting C-PEPTIDEpos cells with a sensitivity 
of 82% and a specificity of 87%, which is en par with trained individuals. 
To this date we used this platform to validate our approach and a handful 
of candidate compounds have been identified that increase C-PEPTIDEpos 
cells above the median. Their ability to routinely increase the frequency and 
maturity of C-PEPTIDEpos cells is currently being evaluated. SUMMARY: We 
established a small molecule screen to increase the number and function of 
iPSCs derived β cells. Assay validation with a subset of our chemical library 
was successful and a few selected compounds will be tested in secondary 
assays, while the results from this pilot experiment will help us to improve 
the current assay.
LIVER CELLS
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Generating functional hepatocytes from human embryonic stem (hES) 
cells remains a major challenge due to inefficient differentiation protocols, 
characterised by low yields, cellular heterogeneity and lack of functional 
attributes typical of primary hepatocytes. Here we describe the discovery of 
several highly efficient serum-free hepatic differentiation protocols using a 
Combinatorial Cell Culture technology called CombiCultTM. 3,375 pathways 
designed to mimic human embryonic liver development were screened using 
this high throughput technology. hES cells were cultured on microcarrier 
beads and shuffled through 3,375 combinations of cell culture conditions, 
containing growth factors and/or small molecules over 21 day period. As the 
beads pass through each of the culture conditions they are marked with a 
unique set of tags, enabling identification of the cell culture history for each 
of the beads bearing hepatic cells. Albumin and/or CYP3A4 expression was 
used as a marker to identify successful hepatic differentiation. Through this 
method, a number of highly efficient protocols were identified and subse-
quently validated in a monolayer culture system and characterised at cellular 
and functional levels. These hES-derived hepatic cells exhibit the morphol-
ogy, marker expression, and function of authentic hepatic cells, promising to 
be a valuable tool for regenerative medicine and drug discovery applications.
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Non-alcoholic fatty liver disease comprises a broad spectrum of disease 
states ranging from simple steatosis (S) to steatohepatitis (SH). In contrast 
to S which has a good prognosis and can be cured relatively easily, SH is as-
sociated with alterations of a variety of cellular functions including increased 
cellular stress that lead to serious hepatocyte injury and may result in liver 
cirrhosis and development of a lethal cancer - hepatocellular carcinoma. 
The major unsolved question is what genetic background and molecular 
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mechanisms result in the development of SH followed by cirrhosis and 
cancer as compared to other individuals who develop only steatosis. So far 
one of the biggest obstacles impeding studying the susceptibility to SH and 
its progression to hepatocellular carcinoma is the lack of a simplified in vitro 
system which would allow reproducible testing of the influence of various 
genetic and environmental factors on the etiology of this lethal disease. The 
generation of patient-specific iPS cells followed by their differentiation into 
hepatocytes enables the analysis of steatosis and steatohepatitis in a repro-
ducible, standarized and high throughput manner. The main goals of our 
study are the generation of a system level dataset to enable the studying of 
the molecular mechanisms underlying the etiology of both diseases followed 
by the development of a computational model quantitatively explaining 
the response of S and SH hepatocytes towards various stimuli mimicking 
key aspects of environmental exposures potentially increasing the risk of 
developing SH (high doses of fatty acids, glucose, insulin, reactive oxygen 
species). The entire dataset will be comprised of transcript, protein and 
metabolic profiling of iPS-derived hepatocytes obtained from 15 patients-
specific fibroblasts cell lines. The main biological question to be addressed 
is the comparison of lipid metabolic pathways between S, SH and non-liver 
disease iPS-derived hepatocytes with a special emphasis on the relationship 
between fatty acid metabolism, insulin resistance and intra-hepatic triglycer-
ides content. Another key question is whether iPS-derived hepatocytes from 
obese patients have the inherited ability to develop the known features of 
the cellular pathology, such as the accumulation of intracellular triglycerides. 
Here we present initial results on dermal fibroblast derivation and charac-
terisation of iPS cells from both steatosis and non-liver disease patients as 
controls. Followed by the differentiation into hepatocytes, then compara-
tive transcriptome and reverse phase protein array-based analysis of insulin 
signalling and drug metabolism pathways. This initial dataset provides the 
foundation to address the influence of genetic background and also identify 
both novel biomarkers for metabolic risk and unique targets for therapy.
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Human induced pluripotent stem cells (hiPSC) hold great potential for use in 
regenerative medicine, novel drug development, and disease progression/
developmental studies. One of the key concerns for employing iPSC for 
these applications is their ability to be fully differentiated. The differentiation 
of the hiPSC line, IMR90-4, was initiated by first directing the cells towards 
a very pure population of definitive endoderm, then further towards he-
patocytes. The metabolic function of hiPSC-derived hepatocytes (hiH) was 
characterized by the expression of metabolizing enzymes, and metabolic 
profiling of the drug bufuralol (BF). The differentiated hiPSC showed 84% of 
cells positive for albumin, indicating a highly efficient process for generating 
a relatively homogenous population of hepatocytes. Metabolizing enzymes, 
phase I enzymes, such as CYP 1A1, 2C9, 2C19, 2D6, 3A4, 7A1, and phase 
II enzymes, such as GSTA1-1, GSTP1-1, UGT1A1, 1A3, 1A10, UGT2B7, 
were expressed in hiH, as determined by Western blot and RT-PCR. More-
over, transporters, phase III proteins such as MRP1 and OATP2 were also ex-
pressed in hiH, as determined by immunochemistry. Some important nuclear 
regulators, critical in regulating the expression of metabolizing enzymes, 
including CAR, AhR, CPR, and PXR, were expressed in hiH, as assessed by 
immunochemistry. The cellular uptake and excretion of Indocyanine Green 
(ICG) is a unique characteristic of hepatocytes, and it was observed in our 
hiH in a very high percentage of cells. The excretion of ICG began 1 hour 
after the removal of ICG, and most of the ICG was excreted within 3.5 
hours, and it almost completely disappeared by 24 hours, indicating that 
a functional biotransforming system was generated by our hiH. To further 
assess the biotransformation system, we employed ultraperformance liquid 
chromatography-tandem mass spectrometry technology for BF metabolic 
profiling and metabolism. Predictive multiple reaction monitoring (MRM) is 
the most sensitive approach in metabolite identification. With the evidence 
of the same MRM transitions, LC retention time, MS/MS fragmentation 
patterns, and time-course effects of these secondary metabolites, we found 
4 secondary metabolites of BF from 2 different oxidations, dehydrogena-
tion, ketone formation, or potential methylation in the phase I stage, and 3 
secondary metabolites of BF from glucuonidation, conjugations of glucose 
and glutathione in the phase II stage, in both hiH and freshly isolated human 
primary hepatocytes (hPH). Thus, we have successfully identified seven 
major metabolic pathways of BF in hiH, which are the same as those in hPH. 
This is the first time that hiH have been shown to develop full metabolic 
function as do the hPH. After transplantation in MPSVII SCID mice, Fah-/-/
Rag2-/-/Il2rg-/- mice and NOD/SCID mice through splenic injection, our 
hiH engrafted in mouse livers and human liver-specific protein products were 
detected in the mouse livers and in the mouse serum 2-4 weeks after trans-
plantation. These results demonstrate that functioning patient-or disease-
specific hepatocytes could be generated for cell-based therapeutics, as well 
as for pharmacology and toxicology studies.
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Amyloidosis refers to a group of rare diseases of systemic extracellular 
deposition of misfolded fibrillar proteins, which leads to organ failure and 
death. The most common form of familial amyloidosis (AF) across the globe 
is due to diverse mutations in serum transthyretin (TTR). Familial transthyre-
tin amyloidosis (ATTR) is a lethal, autosomal dominant disease mediated by 
more than 100 distinct mutations in the transthyretin gene. Predominantly 
synthesized in the liver, mutant TTR protein deposits in multiple extra-
hepatic tissues, including the peripheral nervous system, heart, and the 
gastrointestinal tract disrupting organ function. ATTR represents a tremen-
dous unmet medical need with significant morbidity and mortality. Liver 
transplantation is the only proven treatment option, yet only about one third 
of patients are candidates for this invasive procedure. As with most amyloid 
diseases, the detailed molecular mechanisms involved in the development 
of ATTR are not fully understood, in part due to the lack of an appropri-
ate model and the inability to study the disease in the appropriate cell 
lineage with the appropriate genetic background. The recent discovery that 
pluripotent cells similar to embryonic stem (ES) cells can be generated by 
reprogramming somatic fibroblasts provides an unprecedented opportunity 
to model human disease and to develop regenerative therapies for genetic 
diseases. Like ES cells, the broad differentiation repertoire of these so called 
induced Pluripotent Stem Cells (iPSC) highlights their potential to form any 
desired somatic cell type, including hepatocytes. In contrast to ES cells, iPSC 
are genetically identical to the individual from whom they are derived, rais-
ing the prospect of utilizing iPSC for autologous cell-based therapies without 
risk of rejection. Diseases that affect the liver represent excellent targets for 
iPSC-based studies. A critical issue concerning the use of human iPSC, how-
ever, is whether they can generate terminally mature progeny with normal 
function. This point is highlighted in the study of liver specification when 
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one wishes to recapitulate in vivo ontogeny in an in vitro system in which 
the sequential development of primitive and definitive characteristics are 
accompanied by the appropriate, stage-specific expression of hepatic genes. 
We have developed a novel, excisable polycistronic vector (STEMCCA) for 
the generation of ‘clinical grade’ human iPSC free of exogenous transgenes. 
Using this technology, we have created the first known ATTR-disease 
specific human iPSC lines and demonstrate the efficient derivation of defini-
tive endoderm and liver-specified progeny from these cells. Our directed 
differentiation protocol allows us to direct greater than 65% of our human 
iPSC-derived endoderm progenitors into hepatocyte progenitors, defined as 
cells co-expressing alpha fetoprotein (AFP), Foxa1, HNF4A, and albumin. 
Importantly for the recapitulation of the ATTR disease phenotype, both 
normal and mutant forms of TTR are also detectable using a combination of 
isoelectric focusing (IEF) and mass spectrometric (MS) analyses. Lastly, we 
demonstrate small molecule inhibition of aberrant TTR production further 
validating the value of IPSC-based disease modeling. The long-term goals of 
this work are to better understand the molecular mechanisms underlying the 
pathogenesis of hereditary amyloidosis and to develop novel therapies for 
the treatment of the disease.
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HIGH PURITY SCALABLE PRODUCTION OF 
HEPATOCYTES FROM HUMAN EMBRYONIC 
STEM CELLS
Poole, Aleksandra J., Nistor, Gabriel, Fredrickson, Craig, Airriess, 
Chris, Keirstead, Hans
California Stem Cell, Inc., Irvine, CA, USA
There is significant demand for human hepatocytes for use in high through-
put drug screening, drug development and predictive toxicology. Human 
embryonic stem cell (hESC)-derived hepatocytes present several advantages 
over primary cell hepatocytes of human cadaveric origin currently on the 
market. In addition to the ability to produce cells on demand and in virtually 
unlimited quantities, hESC-derived hepatocytes present a relevant model 
for human ADME/toxicology studies. We have developed a fast, scalable 
method to directly differentiate hESCs into the high purity hepatocytes using 
well-defined media, with minimal animal components, resulting in mature 
functional hepatocytes within twenty-four days. The cells express appropri-
ate immunocytochemical markers and possess functional activities of mature 
hepatocytes, such a glycogen storage, albumin production and indocyanine 
green dye uptake. In addition, the induction of CYP activity is comparable 
to that of human primary hepatocytes. California Stem Cell’s hESC-derived 
hepatocytes will be available in 96-well and 384-well plate formats that are 
suitable for high throughput screening assays for drug development and 
predictive toxicology.
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HUMAN STEM/PROGENITOR CELL-DERIVED 
HEPATOCYTES PROVIDES ROBUST MODEL FOR 
DRUG METABOLISM
Roach, Marsha L.1, Malavarca, Richard1, Cacace, Angela2, Reid, Lola 
M.3
1GigaCyte, LLC, Branford, CT, USA, 2Applied Genomics, Bristol-Myers 
Squibb, Wallingford, CT, USA, 3School of Medicine Cell & Molecular 
Physiology, University of North Carolina, Chapel Hill, NC, USA
Human hepatocytes are used routinely throughout Drug discovery for drug 
metabolism studies, transporter studies and toxicity screens. The quality and 
availability of the gold standard, primary fresh and cryopreserved human 
hepatocytes is highly variable and the supply is limited. This results in the 
need to employ other hepatic models such as established human hepa-
toma cell lines, HepaRG and HepG2, that are more scalable and subcellular 
fractions, microsomes, to offer the opportunity of having many human 
models that cover most hepatic functions. Animal hepatocytes are more 
readily available and physiologically relevant, but are often not predictive of 
findings in humans. Consequently, since a single model doesn’t possess all 
the functions of in vivo hepatocytes, multiple hepatic model systems have 
become necessary. However, due to the limitations of the many different he-
patic models, there is still a need to develop a better model system that has 
more complete hepatic function. Here we provide data to demonstrate that 
human stem/progenitor cell-derived hepatocytes may offer a better model 
system to meet that need. We have developed a hepatic model system that 
includes human stem/progenitor cells, novel formulations of lineage stage 
specific media for expansion and differentiation of stem/progenitor cells 
and maintenance of mature hepatocytes as well as biomatrix isolated from 
decellularized liver. Human stem/progenitor cells differentiate into mature 
hepatocytes within a few days and maintain functions for months. Primary 
hepatocytes plated on the biomatrix in maintenance media maintain func-
tion longer than when plated on collagen I. This data will demonstrate that 
our pre-clinical reproducible, scalable hepatic model will provide hepatocytes 
that are more functional, more physiologically relevant and more predictive 
of clinical outcome than current models, therefore reducing attrition of drugs 
that enter the clinic.
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A FEEDER-FREE AND SERUM-FREE 
PRODUCTION OF MULTI-FUNCTIONAL 
MATURE HEPATOCYTES WITH ELECTRON 
MICROSCOPICALLY VALID MORPHOLOGIES: 
TOWARDS AN ESTABLISHMENT OF THE 
GLOBAL STANDARD FOR HUMAN ES/IPS-
BASED DRUG DISCOVERY TOOLS
Saeki, Kumiko1, Nakamura, Naoko1, Matsuyama, Satoko1, Nishio, 
Miwako1, Saeki, Koichi2, Hasegawa, Mamoru2, Akutsu, Hidenori3, 
Umezawa, Akihiro3, Yuo, Akira1
1Department of Disease Control, Research Institute, National Center for 
Global Health and Medicine, Tokyo, Japan, 2DNAVEC Corporation, Ibaraki, 
Japan, 3Department of Reproductive Biology, National Research Institute 
for Child Health and Development, Tokyo, Japan
<OBJECTIVES> Hepatotoxicity is a common cause of failure in drug dis-
covery. It is thus particularly important to understand the metabolism and 
hepatotoxicity of the drugs in the early phase of pharmaceutical develop-
ment. Although primary human hepatocytes and purified human liver 
microsomes have been providing excellent systems, they suffer from lot 
variation, high cost and expansion incapability. To provide more serviceable 
systems, we performed hepatic differentiation of human ES/iPS cells under a 
feeder-free and serum-free condition. <METHODS> One line of human ES 
cells (khES-1), four lines of retroviral vector-based iPS cells (253G1, 201B7, 
#25 and #40) and one line of Sendai virus vector-based, transgene-free iPS 
cells (SeV5) were subjected to a 5-tired differentiation system* mimicking in 
vivo hepatic development: Step 1 (Day 0); endoderm induction (first half) 
by Activin A and Wnt-3A, Step 2 (Day 1); endoderm induction (second half) 
by Activin A, Step 3 (Day 2 ~ 6); hepatic initiation by FGF-2, BMP-4 and 
SHH, Step 4 (Day 7 ~ 11); hepatic maturation (first half) by HGF, FGF-2 and 
BMP-4, Step 5 (Day 12 ~ 30); hepatic maturation (second half) by OSM 
and dexamethasone. Maturation of human ES/iPS-derived hepatocytes was 
evaluated by message and protein expressions, glycogen storage, indocya-
nine green (ICG)-uptaking/releasing capacities, cytochrome P450 (Cyp) 
activities and electron microscopic (EM) observations. <RESULTS> In the 
human ES-derived and all iPS-derived cells, the expressions of α-fetoprotein, 
albumin, α1 anti-trypsin were confirmed by RT-PCR, Western blotting and 
immunostaining. Majority of the cells (> 80 %) were positive for PAS-
staining (glycogen storage), and one third of the cells demonstrated ICG-
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uptaking/releasing capacities. Several fold Increments in Cyp 3A4 activities 
were detected in the human ES-derived and all iPS-derived hepatocytes 
compared to their immature counterparts. Moreover, Cyp 3A4 activities 
were significantly induced by drug treatments (high dose dexamethasone 
and rifampicin). EM observation further confirmed the maturation of ES/iPS-
derived hepatocytes: they showed rich microvillous projections characteristic 
to “Space of Disse”, hepatocyte-specific, rosset-forming glycogen granules 
called “α-particles” and “bile canaliculi” surrounded with tight junctions 
(proximal) and desmosomes (distal). Interesting, minor bile duct components 
with low-height microvilli on lumenal sides and basement membranes on 
the opposite sides were also detected. <DISCUSSSION> Our method has 
enabled the production of multi-functional mature hepatocytes with electron 
microscopically valid morphologies from human ES/iPS cells. Our system can 
be applied to wide varieties of human iPS lines including Sendai virus vector-
based, transgene-free iPS cells. Existence of minor bile duct components 
suggests co-generation of hepatic stem cells. Currently, we are establishing 
a feasible method for the assessment of hepatotoxicity of the drugs by mea-
suring concentrations of liver-specific enzymes in culture supernatants. Our 
method will greatly contribute to an establishment of the global standard for 
human ES/iPS-derived drug discovery tools. <Acknowledgements> Authors 
greatly thank Professor Yamanaka at Center for iPS Cell Research and Ap-
plication, Kyoto University, Japan, for generously providing the hiPSC lines 
(253G1 and 201B7).  
* This system is currently Japanese patent pending (Tokugan 2011-019103).
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HEPATIC PROGENITORS CAN BE PURIFIED 
UPON DIFFERENTIATION OF HUMAN 
EMBRYONIC STEM CELLS
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1INSERM U972, Le Kremlin Bicetre, France, 2INSERM U972, Paris, France, 
3IFR89 Université Paris-Sud 11, Villejuif, France, 4Vectalys, Toulouse, 
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Kingdom
Hepatocyte transplantation is now an alternative to liver transplantation for 
the treatment of liver metabolic diseases. However this approach is restricted 
by the lack of donors and the limited number of hepatocytes since these 
cells are difficult to cryopreserve and cannot be expanded in vitro. Isolation 
and amplification of hepatic progenitors should provide an alternative solu-
tion. Generation of hepatocyte-like cells from human embryonic stem (hES) 
cells have already been reported using undefined matrices and animal prod-
ucts in diverse culture conditions, all of which generating mixed cell popula-
tions. Recently we developed chemically defined differentiation conditions, 
which recapitulate key stages of liver development, to generate hepatic pro-
genitors representing about 60% of the cell population. We then developed 
a purification approach by fluorescent activated cell sorting (FACS) using a 
self inactivated lentivector encoding eGFP driven by the human Apolipopro-
tein A-II hepatic specific promoter (APOA-II). Furthermore, we designed a 
novel strategy to prevent vectors integration into the genomic DNA. Condi-
tions yielding to transduction of 70% of undifferentiated cells at MOI 30 
with an EF1α-eGFP vector were used. Southern blot analyses demonstrated 
that the genomic DNA from transduced cells was devoid of provirus DNA 
under our conditions. To insure the specificity of APOA-II-eGFP, its expres-
sion was followed along hES cells differentiation. While eGFP expression was 
detected in less than 1% of cells at day 3, and in about 2% of cells at day 8, 
it rose to 18% at day 14 and reached 35-39% at day 16 of differentiation, 
which was in correlation with endogenous APOA-II expression. Transduced 
cells were then purified at day 16 by FACS, yielding 99% of eGFP posi-
tive cells. Hepatic progenitor markers such as cytokeratine-19 (CK19) and 
α-fetoprotein (AFP) were found co-expressed in most of cells as assessed 
by immunocytochemistry, demonstrating that sorted cells were bipotential 
hepatic progenitors. Quantification by quantitative PCR and flow cytometry 
analysis as well as phenotypic characterization of differentiated sorted cells is 
currently performed. 
Our data indicate that hepatic progenitors can be purified using the APOA-II 
hepatic specific promoter carried by lentivectors and suggest a potential use 
of these progenitors for clinical applications.
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HIGH HEPATIC POTENTIALS IN MINI-SCALED 
FLOW-CULTURE SYSTEM OF MURINE OR 
HUMAN ES/IPS CELL-DERIVED HEPATIC 
TISSUE CONSISTING OF HEPATOCYTES AND 
ENDOTHELIAL CELLS
Tagawa, Yoh-ichi, Ahn, Sungho, Tamai, Miho
Tokyo Institute of Technology, Yokohama-shi, Japan
Hepatocyte has multiple specific functions in a cell, different from other cells 
having a single specific function. In order to establish an in vitro hepato-
cyte culture or artificial liver system being similar to the in vivo liver, it is 
necessary to maintain all of the multiple functions. However, it has been still 
developing materials, medium conditions, and apparatuses for the culture 
of the primary hepatocytes. On the other hand, there are so many reports 
that hepatocytes were obtained from the differentiation of ES or iPS cells. 
However, it is clear to be difficult to maintain the multiple hepatic functions 
in the single culture of ES or iPS cell-derived hepatocytes because it has been 
still difficult to culture primary hepatocytes for a long period. We consider 
that ES cells and iPS cells give promises in constructing in vitro liver models. 
Our purpose is to establish a micro-sized flow-culture system of murine or 
human ES/iPS cell-derived hepatic tissue being close to in vivo liver. An in 
vitro system for liver organogenesis from murine ES/iPS cells was established 
in our previous studies. These hepatic tissues consisted of hepatocytes and 
endothelial cells, which had higher hepatic function than that of primary cul-
tures of murine embryo and adult hepatocytes. The result indicated that he-
patic tissue reconstruction including parenchymal cells, as hepatocytes, and 
non-parenchymal cells, as endothelial cells, should be necessary for main-
taining hepatic functions in vitro. In the case of human liver tissue, firstly, 
immortalized human umbilical vein endothelial cells, HUVECs, were culture 
on some biomaterials to form the tube network structure. Several differen-
tiation stage cells from the human iPS cells on the hepatic lineage induced 
by addition of specific growth factors were co-cultured on the immortal-
ized HUVEC tube network. In the above culture, hepatic lineage cells were 
migrated to the network to form hepatic sinusoid-like structure. This human 
iPS cell-derived sinusoidal culture had much higher hepatic functions such 
as ammonia metabolism and cytochrome P450 activities compared to those 
of single culture of human iPS cell-derived hepatocytes. Human ES cells are 
trying to be differentiated by same way now. We also invented mini-scaled 
flow-culture system in which pH and dissolved oxygen concentration could 
be monitored. These murine or human ES/iPS cell-derived hepatic tissues 
were cultured and used for drug metabolism assays in this flow culture 
system. These hepatic tissues could have higher hepatic potentials in the 
culture for a long period. In future, we expect that our hepatic tissue culture 
system could be useful as an application of evaluating drug metabolism and 
hepatotoxicity in the development of new drugs and chemicals.
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ALTERNATIVE MOUSE PLURIPOTENT STEM 
CELLS AS A SOURCE OF HEPATIC CELLS
Loya, Komal1, Eggenschwiler, Reto 1, Sgodda, Malte 1, Ko, Kinarm 2, 
Schöler, Hans R.2, Cantz, Tobias 1, 2
1Hannover Medical School, Excellence-Cluster REBIRTH, JRG Stem Cell 
Biology, 2Max Planck Institute for Molecular Biomedicine, Münster
Recently there have been scientific reports that have described the genera-
tion of pluripotent stem cells from the mammalian germ-line. Parthenoge-
netic activation of female oocytes can give rise to blastocysts, whose inner 
cell mass can be isolated and propagated as parthenogenetic embryonic 
stem cells (pESCs). Murine testis-derived pluripotent germ-line stem (gP-
SCs) cells, obtained from adult mouse testes through culture of unipotent 
spermatogonial stem cells under ES cell conditions, has also been recently 
described. The pESCs and gPSCs show expression of pluripotency markers, 
at levels comparable to embryonic stem cells (ESCs). In our present study 
we investigate the hepatic differentiation potential of these alternative 
sources of pluripotent stem cells. We have previously reported the use of 
an embryoid body formation-based protocol to derive hepatic progenitors 
from the gPSCs and the pESCs. However, this protocol lacked efficiency in 
generating higher number of hepatic cells with a mature phenotype that 
were suitable for further transplantation experiments. We have also previ-
ously reported a cytokine based differentiation protocol which mimics the 
in vivo embryonic development of the liver. Modification of this cytokine-
based protocol was able to generate higher numbers of hepatocyte-like 
cells, with expression of hepatic markers comparable to Hepa 1-6 cells. 
Activin A treatment of pESCs and gPSCs grown as a monolayer in serum-
free differentiation (SFD) medium, initiated the induction of early endoderm. 
Further treatment of the cells with Bone Morphogenic Protein 4 (BMP4) 
and basic Fibroblast Growth Factor (bFGF) directed the cells towards the 
definitive endoderm. The cells were then cultured in Hepatocyte Culture 
Medium (HCM) along with Oncostatin M (OSM) and human Hepatocyte 
Growth Factor (hHGF), in order to induce hepatic cell maturation. Albumin 
producing cells were selected using an Albumin-Neomycin vector and then 
transplanted into the FAH knockout mouse to check for engraftment and 
proliferation. Our study hence provides an insight into the use of germ-line 
derived hepatocytes for cell therapy in treatment of liver disorders.
Poster Board Number: 1042
ISOLATION AND CHARACTERIZATION OF A 
UNIQUE MOUSE GALLBLADDER STEM CELL 
POPULATION
Manohar, Rohan R.1, Guzik, Lynda1, Stolz, Donna2, LaFramboise, 
William3, Lagasse, Eric1
1Pathology, McGowan Institute for Regenerative Medicine, Pittsburgh, PA, 
USA, 2Cell Biology and Physiology, University of Pittsburgh, Pittsburgh, PA, 
USA, 3Pathology, University of Pittsburgh, Pittsburgh, PA, USA
The identification and characterization of biliary stem cells has great impor-
tance for basic biology and cell-based therapy. The biliary tree is divided 
into intra- and extrahepatic systems. The latter consists of the gallblad-
der, cystic duct, common bile duct and pancreatic duct. Recent data have 
shown that intra- and extrahepatic biliary systems develop from separate 
progenitors implying that adult intra- and extrahepatic bile duct cells would 
be different. However, there are few reports regarding their similarities 
or differences. In addition, there is currently a paucity of data regarding 
extrahepatic bile duct stem cells. Here we report the identification and 
characterization of an EpCAM+CD49fhi sub-population of gallbladder cells 
with stem cell characteristics. We also show that these gallbladder stem cells 
have a unique phenotypic and expression profile compared to intrahepatic 
bile duct cells. Limiting Dilution Analyses from primary gallbladder indicate 
that EpCAM+CD49fhi cells are enriched in colony forming cells or stem 
cells compared to EpCAM+CD49flo cells (Exp1: 1/15 and 1/71; Exp2: 
1/4 and 1/62). These data were confirmed by index sorts where ~92% 
of the single-cell derived colonies originated from EpCAM+CD49fhi cells. 
EpCAM+CD49fhi cells expand in vitro long-term (>passage 20) and exhibit 
single cell clonogenic expansion. We developed a matrigel differentiation 
assay in which EpCAM+CD49fhi cells exhibit organotypic morphogenesis 
recapitulating both ultrastructure and transport functions of primary gall-
bladder. We also observed similar morphogenesis when EpCAM+CD49fhi 
cells were injected into the subcutaneous space of recipient mice. These data 
demonstrate that EpCAM+CD49fhi cells possess stem cell characteristics 
of self-renewal and lineage commitment. We found expression of CD49f, 
CD49e, CD81, CD26, CD54 and CD166 to be different between primary 
intrahepatic and gallbladder cells by flow cytometry, indicating that they 
might be different. The transcriptomes of these cells were compared to ex-
panded EpCAM+CD49fhi cells by cDNA microarrays. We found differences 
in the expression of key genes such as cytochrome P450, mucin3, solute 
carrier family, aquaporin1, interferon-regulated genes and IL-18. These data 
indicate that EpCAM+CD49fhi cells and intrahepatic bile duct cells have 
distinct transcriptomes and might have different functions. This is the first 
study to prospectively isolate and characterize stem cells from the adult 
mouse gallbladder. Furthermore, a major obstacle to studying intrahepatic 
bile duct cells has been a lack of appropriate expansion assays for the cells. 
The in vitro expansion assay and matrigel-based morphogenesis assay serve 
as technically facile and interchangeable tools to study bile duct biology. We 
postulate that these assays are generalizable for the study of bile duct biol-
ogy, and would have large impact on the etiology of diseases such as biliary 
atresia.
Poster Board Number: 1044
PROSPECTIVE ISOLATION AND EXPANSION OF 
HEPATOBLASTS DURING EARLY-FETAL LIVER 
DEVELOPMENT IN MICE
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As the initial event of liver development, stem cells or progenitor cells in the 
liver bud, called hepatoblasts, proliferate and migrate into septum transver-
sum mesenchyme at around embryonic day 9 (E9) in mice. Hepatoblasts 
are considered as somatic stem/progenitor cells in the fetal livers, because 
they have dual capacities of high proliferative potential and multi-lineage 
differentiation into both hepatocytes (hepatic parenchymal cells) and cho-
langiocytes. Several groups have analyzed hepatoblasts derived from mouse 
E11.5 to E14.5 mid-fetal livers. Previously, we have shown that a sorted 
individual cell derived from mid-fetal liver gives rise to a relatively large 
colony in the growth factor-supplemented culture on extracellular matrix-
coated dishes. Dlk, E-cadherin, Liv2, CD13, and CD133 were identified as 
cell surface markers for mid-fetal hepatoblasts. This conventional culture 
system and the reclone-sorting culture have demonstrated that hepatoblasts 
in mid-fetal livers have self-renewal capacity and bi-potency to differenti-
ate. In contrast to mid-fetal hepatoblasts, few studies have been done with 
epithelial cells found in early-fetal (E9.5 and 10.5) liver buds. The charac-
teristics of these cells remain largely unknown, because no suitable culture 
system has been established. In this study, we found that cells expressing 
CD13, Dlk, and Liv2 exist during early- to mid-fetal liver development. 
Single CD13+Dlk+ cells purified from embryonic day 11.5 and 13.5 mouse 
mid-fetal livers, but not those purified from embryonic day 9.5 and 10.5 
mouse early-fetal livers, formed individual large colonies in the conventional 
culture on collagen type-I coated dishes. Thus, we established a new co-
culture system using mouse embryonic fibroblasts (MEF) as feeder cells for 
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in vitro analysis of these cells. When E9.5 and E10.5 CD13+Dlk+ cells were 
co-cultured with MEF, several large colonies formed and consisted of both 
albumin-positive hepatocytic cells and cytokeratin 19-positive cholangi-
ocytic cells, indicating that early-fetal CD13+Dlk+ cells can function as fetal 
hepatoblasts. Interestingly, when E9.5 CD13+Dlk+ cells were cultured on 
collagen type I, small and large colonies were detected only when MEF-
conditioned media were used. Fresh medium not conditioned with MEF 
did not support colony formation on collagen-coated dishes. These data 
suggest that expansion of early-fetal hepatoblasts was partly supported by 
soluble factors derived from MEF. Inhibition of Rock or non-muscle myosin II 
(the downstream component of Rock) signaling was necessary for effective 
expansion of E9.5 CD13+Dlk+ cells. In sorted CD13+Dlk+ cells, expression 
of the hepatic marker genes albumin and α-fetoprotein was increased during 
fetal liver development. Expression of cytokeratin19 and Sox17, endodermal 
progenitor cell markers, was highest at embryonic day 9.5 but decreased 
dramatically thereafter. Collectively, our study indicated that CD13 and Dlk 
are expressed on hepatoblasts during early- to mid-fetal liver development 
and that expansion of early-fetal hepatoblasts requires the interaction with 
mesenchymal cells and the inhibition of Rock-myosin II signal pathway.
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FUNCTIONAL IMPROVEMENT OF 
HEPATOCYTES CULTURED ON NANOFIBER-
BASED 3D (NANEXTM) SCAFFOLD
Wang, Hong, Fischer, Stephen E., Zhao, Yukang, Sakthivel, 
Ramasamy
R&D, Arteriocyte, Inc., Cleveland, OH, USA
Hepatocyte in primary culture expresses various differentiated liver-specific 
functions in vitro for a certain period of time. However, it is generally rec-
ognized that human hepatocytes cultured in conventional 2D plastic culture 
dishes (TCPS) retain most of their functions only for a short period of time. 
A large-scale high-density hepatocyte culture, which maintains long-term 
albumin secretion, is expected to have many clinical and industrial applica-
tions, including a bio-artificial liver. In the present study, we evaluated the 
functional improvement of human hepatocytes cultured on nanofiber-based 
3D (NANEXTM) scaffold. We assessed the proliferation, albumin secretion, 
and changes in cell morphology of the hepatic cell line HepG2 on NAN-
EXTM surface. The results indicated that the human HepG2 cells cultured 
on nanofiber surface showed slower proliferation with increased albumin 
production for the first week. The Scanning Electron Microscope (SEM) 
analysis of HepG2 cells cultured on NANEXTM surface showed a tight ag-
gregate of cells indicating an enhanced cell attachment in nanofiber surface 
as compared to 2D TCPS culture. Hepatocytes also exhibited polarized 
shape morphology when cultured in 3D nanofiber while cells spread more 
completely on TCPS 2D culture and developed flattened cell morphology. 
Taken together, our preliminary results indicate that nanofiber-based hepa-
tocyte cultures exhibit better in vivo-like response than cells cultured in 2D. 
Our data suggest that the NANEXTM culture system may be a promising 
approach for several potential applications involving hepatocytes such as 
primary hepatocyte and liver stem cell ex vivo expansion, cell-based drug 
screening, toxicity testing, and/or liver regeneration.
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A NOVEL MARKER FOR ENDODERMAL 
PROGENITOR CELLS IN TISSUE REPAIR AND 
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Analysis of tissue renewal and regeneration depends critically on the avail-
ability of markers for prospective isolation of stem and progenitor cells. 
Using the monoclonal antibody GCTM-5, we have identified a novel cell 
surface marker whose expression appears to be restricted to human tis-
sues of endodermal origin. This large glycoconjugate is found on putative 
progenitor cells in the liver and the pancreas, and in intestinal metaplasia of 
the esophagus, GCTM-5 marks cells that appear to be progenitors in the 
development of metaplasia. GCTM-5pos cells isolated from adult liver were 
successfully expanded and passaged in vitro. GCTM-5 expression is retained 
through multiple passages and subsets of cells co-express liver progenitor 
markers N-CAM and EpCAM as well as hepatocyte (albumin) and biliary 
markers (CK19), suggesting a liver progenitor phenotype. By qPCR, cultured 
GCTM-5pos cells co-express albumin, 1-anti-trypsin, Hnf1, and Hnf6. In 
normal neonatal liver, GCTM-5 expression is restricted to a subset of biliary 
epithelial cells and cells within the canal of Hering where hepatic progeni-
tor cells are purported to reside. In contast, livers from patients with biliary 
atresia exhibit a marked increase in GCTM-5pos cells within the expand-
ing ductular reactive cells. Among the GCTM-5pos population are distinct 
groups of cells that are CK19pos, N-CAMpos, and EpCAMpos. GCTM-5pos 
cells also co-stain with Ki-67. Some GCTM-5pos cells are also CK19pos and 
albuminpos, suggesting a bipotential progenitor phenotype. The GCTM-5 
antigen is a useful marker in studies of embryonic stem cell differentiation 
and renewal, repair, and regeneration in tissues of endodermal origin.
LUNG CELLS
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THERAPEUTIC POTENTIAL OF HUMAN CORD 
BLOOD-DERIVED ENDOTHELIAL COLONY 
FORMING CELLS IN NEONATAL OXYGEN-
INDUCED LUNG INJURY
Alphonse, Rajesh1, Vadivel, Arul1, Waszak, Paul1, Coltan, Lavinia2, 
Fung, Moses1, Eaton, Farah1, Marshall, Thuraya1, Yoder, Merv C.3, 
Thebaud, Bernard1
1Department of Pediatrics, Cardiovascular Research Center and 
Pulmonary Research Group, University of Alberta, Edmonton, AB, 
Canada, 2Department of Physiology, Cardiovascular Research Center 
and Pulmonary Research Group, University of Alberta, Edmonton, AB, 
Canada, 3Department of Pediatrics, Indiana University School of Medicine, 
Indianapolis, IN, USA
INTRODUCTION: Bronchopulmonary dysplasia (BPD) and emphysema 
are life-threatening lung diseases characterized by either impaired alveolar 
development or alveolar destruction. Both conditions lack effective therapy. 
There is growing evidence that angiogenic growth factors actively support 
alveolar growth and maintenance throughout postnatal life. However, the 
likely role of vascular progenitor cells (endothelial progenitor cells, EPCs) 
in lung growth and maintenance is unknown. OBJECTIVES: In this study, 
we examine the role of endothelial colony forming cells (ECFCs), an EPC 
subtype capable of self-renewal and de novo vessel formation, in lung de-
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velopment and repair. We hypothesize that ECFC-driven angiogenesis con-
tributes to normal lung alveolar growth and ECFC supplementation restores 
disrupted alveolar development in hyperoxia-induced BPD. METHODS: In 
vitro, we assessed the proliferative, clonogenic and vessel forming potentials 
of lung ECFCs isolated from newborn rats housed in 95% O2 (BPD model) 
vs. room air controls. In vivo, the therapeutic potential of human umbilical 
cord blood (hUCB) ECFCs was assessed in immunocompromised Rag-/- 
mice exposed to 85% O2 from Postnatal day-(P) 6 to 14 and sacrificed 
at P-28. RESULTS: ECFCs isolated from hyperoxic lungs proliferated less 
rapidly when cultured in vitro for 3 weeks. More strikingly, ECFCs from the 
hyperoxic group showed decreased clonogenic capacity and formed fewer 
endothelial networks in matrigel. Intra-jugular administration of hUCB-
ECFCs after established lung injury restored lung function and alveolar 
structure in hyperoxia-exposed mouse pups. ECFC therapy also attenuated 
pulmonary hypertension, a co-morbidity commonly associated with severe 
BPD. CONCLUSION: Impaired ECFC function in hyperoxia-exposed rat pups 
contributes to arrested alveolar growth in BPD. hUCB-derived ECFC may 
offer a new therapeutic avenue for lung diseases characterized by alveolar 
injury.
Poster Board Number: 1052
DIRECTED DIFFERENTIATION OF MOUSE ES 
CELLS INTO PRIMORDIAL NKX2.1+ LUNG AND 
THYROID PROGENITOR CELLS
Longmire, Tyler1, Hawkins, Finn1, Murphy, George2, Mostoslavsky, 
Gustavo2, Kotton, Darrell2
1Boston University School of Medicine, Boston, MA, USA, 2Center for 
Regenerative Medicine (CReM), Boston University School of Medicine, 
Boston, MA, USA
RATIONALE: During normal embryological development, a small population 
of foregut endoderm cells are lineage specified into lung progenitors that 
then give rise to the entire post-natal adult lung epithelium. The transcrip-
tion factor Nkx2.1 is the earliest marker of these progenitors at gestational 
day ~E9 of mouse development. Nkx2.1 expression is also seen in devel-
oping thyroid and forebrain. Little is known about the identity and gene 
programs involved in lineage specification and differentiation of the lung 
progenitor cells. We aimed to recapitulate normal early anterior foregut 
endoderm development in vitro and purify primordial lung and thyroid pro-
genitors, identified by Nkx2.1 expression, to better understand lung/thyroid 
development. METHODS: We developed a reporter ES cell line by targeting 
a cDNA encoding the GFP reporter gene into the Nkx2.1 locus by homolo-
gous recombination. These ESCs were differentiated efficiently to definitive 
endoderm using Acivin A-supplemented serum-free media. To attempt to 
recapitulate anterior and ventral endodermal patterning we used a combina-
tion of growth factors and TGFb/BMP inhibitors, resulting in the emergence 
of GFP-positive cells after 9 days in culture. GFP-positive cells were sorted 
by FACS and either analyzed by quantitative real-time PCR or re-plated and 
cultured in various media followed by qRT PCR for markers of lung epithelial 
cells. RESULTS: The reporter line was faithful and specific based on qRT-PCR 
evidence of endogenous Ttf1 mRNA expression solely in the FACS purified 
positive GFP fraction. Fluorescence microscopy revealed clusters of GFP+ 
cells of varying morphology, including epithelial-like structures from day 9 
onwards. These cells expressed the endodermal marker Foxa2 and did not 
express neurectodermal markers above baseline undifferentiated stem cells. 
With further culture expansion and FGF2+10 growth factor stimulation, 
purified TTF1-GFP+ cells were lung and thyroid competent as evidenced by 
upregulation of markers SPC, SPB, CC10, FoxJ1, & CFTR suggesting a lung-
like phenotype, and Thyroglobulin, Pax8 & TSHR suggesting a thyroid-like 
phenotype. CONCLUSIONS: Our in-vitro system yields a purified population 
of Ttf-1 positive endodermal cells of a molecular phenotype and differentia-
tion repertoire reminiscent of primordial lung and thyroid progenitors.
Poster Board Number: 1054
RECRUITMENT OF p63-EXPRESSING DEEP 
AIRWAY STEM CELLS FOR LUNG REPAIR 
FOLLOWING H1N1 INFLUENZA INFECTION IN 
MICE
Kumar, Pooja A.1, Yamamoto, Yusuke2, Tay, Seok Wei3, Hu, 
Yuanyu2, Sun, Yan4, Limmon, Gino5, Chow, Vincent6, Crum, 
Christopher7, Chen, Jianzhu5, Xian, Wa8, McKeon, Frank2
1Stem Cell and Developmental Biology, Genome Institute of Singapore/ 
Singapore MIT Alliance Graduate Program, Singapore, Singapore, 2Stem 
Cell and Developmental Biology, Genome Institute of Singapore, Singapore, 
Singapore, 3Institute of Medical Biology, Singapore, Singapore, 4Department 
of Cell Biology, Harvard Medical School, Boston, MA, USA, 5Infectious 
Diseases, Singapore MIT Alliance for Research and Technology, Singapore, 
Singapore, 6Department of Microbiology, Yong Loo Lin School of Medicine, 
National University of Singapore, Singapore, Singapore, 7Department of 
Pathology, Brigham and Women’s Hospital, Boston, MA, USA, 8Institute of 
Medical Biology, Singapore, Singapore
The extent of lung repair following catastrophic damage and the potential 
role of adult stem cells in such processes remains obscure. Here we employ a 
murine-adapted H1N1 influenza virus related to that of the 1918 pandemic 
to introduce widespread but survivable damage to all regions of the mouse 
airways. We find that p63-expressing stem cells in the bronchiolar epithe-
lium undergo massive proliferation after infection followed by a concerted 
radiation to interbronchiolar regions of alveolar ablation. Once there, these 
cells proliferate into discrete, Krt5+ pods and initiate the expression of mark-
ers typical of type 1 pneumocytes. Gene expression profiles of lung contain-
ing these pods suggest that they participate in a process of reconstituting 
the alveolar-capillary network eradicated by viral infection. The dynamics 
of this p63-expressing stem cell in lung repair mirrors recent findings that 
pedigrees of human deep airway stem cells assemble alveoli-like structures 
in vitro and suggests new therapeutic avenues to acute and chronic airway 
disease.
Poster Board Number: 1056
MODULATION OF K-RASG12V 
TRANSFORMATION BY P38ALPHA IN MOUSE 
LUNG PROGENITOR/STEM CELLS AND THEIR 
ROLE IN LUNG TUMOUR DEVELOPMENT
Voisset, Edwige, Oeztuerk-Winder, Feride, Ventura, Juan-Jose
University of Cambridge, Wellcome Trust Centre for Stem Cell Research, 
Cambridge, United Kingdom
Bronchioalveolar stem cells are expanded in the premalignant lesions of K-
Ras-induced lung tumorigenesis. For this reason, bronchioalveolar stem cells 
have been proposed as the likely cell of origin in lung adenocarcinoma. We 
have previously shown that p38alpha attenuates K-Ras-induced lung cancer 
and transformation of bronchioalveolar stem cells; in absence of p38alpha, 
mice expressing the K-Ras oncogene show earlier initiation and progression 
to malignant stages of lung cancer. To define the mechanisms mediating 
p38alpha repression of lung tumorigenesis, we have isolated putative lung 
stem cells with the signature SPC+/CC10+/Sca1+/CD31-/CD34-/CD45-. 
These lung cells have been infected with retroviral constructs carrying a 
wild-type (WT) or oncogenic form of K-Ras. The oncogenic form of K-Ras 
(K-RasG12) is the most common K-Ras mutation found in both human and 
mouse lung adenocarcinoma. In addition these cells have been also infected 
to express a dominant negative mutant that blocks the p38alpha pathway. 
These cells maintain the profile signature of the wild-type lung stem cells. 
From a functional point of view, the K-RasG12V cells grow faster than the 
K-RasWT cells due to an accelerated G1-S phase transition induced by K-
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RasG12V. This increased proliferation is potentiated in absence of p38alpha 
activity. In vitro transformation of lung stem cells expressing K-RasG12V has 
been tested for their capacity to form more and bigger colonies in soft agar. 
This cell anchorage-independent proliferation is increased under deficient 
p38alpha pathway. We are also assessing the role of differentiation on 
K-RasG12V transformation and how K-Ras expression may influence the ca-
pacity of the lung stem cells to differentiate. Our studies are complemented 
with an in vivo model of K-RasG12D-induced lung tumorigenesis. We are 
using a TetOn system with a lung specific Sftpc-Tg activator that induces 
Cre activation after Doxycycline administration activating the K-RasG12D 
oncogene while deleting p38alpha-lox alleles. We are studying the specific 
role of cells with active Sftpc promoter (AT2 and lung stem cells) in the 
initiation and progression of lung cancer and the mechanisms involved.
Poster Board Number: 1058
HUMAN FETAL MESENCHYMAL STEM CELLS 
FOR THE TREATMENT OF A MURINE MODEL 
OF SMOKE-INDUCED ACUTE LUNG INJURY
Yeo, Julie SL1, Chong, Mark1, Chen, Jianzhu2, Limmon, Gino1, Lu, 
Jia3, Choolani, Mahesh A.1, Chan, Jerry KY1
1Obstetrics and Gynaecology, National University of Singapore, Singapore, 
Singapore, 2Interdisciplinary Research Group in Infectious Diseases, 
Singapore-Massachusetts Institute of Technology Alliance in Research 
and Technology, Singapore, Singapore, 3Combat Care Lab, DSO National 
Laboratories, Singapore, Singapore
Introduction: Acute lung injury (ALI) can be complicated with the develop-
ment of acute respiratory distress syndrome (ARDS), brought about by 
aggressive inflammatory responses in the alveolar system. Current treatment 
for ALI/ARDS is empiric with mortality rates of up to 40% despite advances 
with supportive treatment, necessitating alternative treatment modalities. 
There is mounting evidence that MSC may be able to alleviate this inflam-
matory response in different models of lung injury. Here we develop a mu-
rine model of smoke-induced ALI and investigated the ability of fetal MSC 
(fMSC) to ameliorate the lung injury. Methods: fMSC were isolated from 
fetal bone marrow and characterised. Global gene expression of fMSC was 
studied using microarray studies, where fMSC were first subjected to TNF-a 
stimulation to represent tissue injury. fMSC and endothelial cells co-culture 
systems were employed to study effects on vascular formation and stabilisa-
tion. Finally, a murine model of ALI via smoke inhalation was developed. 
Results: TNF-a stimulation of fMSC resulted in 170 genes differentially regu-
lated. In particular, inflammatory pathway genes like C1 inhibitor (5-fold), 
IL-28RA (4-fold), phospholipase A2, group X and prostacyclin synthase 
(3-fold) were up regulated, where as chemokine (C-C motif) ligand 2, IL-8 
and IL-9R were down regulated more than two-fold. These results highlight 
the immunomodulatory response of fMSCs in vitro that could facilitate the 
amelioration of lung injury. Endothelial cells seeded on to fMSC monolay-
ers exhibit network structures implicating the potential for tissue repair 
following vascular permeability in an injured lung. NOD/SCID mice exposed 
to smoke inhalation results in acute lung injury due to severe inflammatory 
response shown by the presence of neutrophils in histological lung sections. 
The effect of fMSC on this ALI model will be discussed. Conclusion: A 
murine model of ALI due to smoke inhalation has been developed. Together 
with the in vitro studies that demonstrate the immunomodulatory and tissue 
regenerative properties of fMSC, there is much potential for fMSCs to be 
used as treatment for ALI.
Poster Board Number: 1060
POLYETHYLENEIMINE (PEI)-MEDIATED 
TRANSIENT AND STABLE IN VIVO GENE 
DELIVERY IN LUNG PROGENITOR CELLS, AND 
ITS APPLICATIONS FOR ACUTE LUNG INJURY 
(ALI) TREATMENT AND TUMOR GROWTH 
INHIBITION
Lin, Erh-Hsuan1, Chang, Hsiang-Yi2, Hu, Huei-Sin1, Wu, Cheng-
Wen1
1National Yang-Ming University, Taipei, Taiwan, 2Institute of BioMedical 
Sciences, Academia Sinica, Taipei, Taiwan
Polyethyleneimine (PEI) is a cationic polymer that is effective for DNA 
complex and gene transfer. Systemic administration of PEI/DNA complex 
in mice mediates gene delivery in lung. The gene expression is efficient and 
can be detected in 6 hours post-delivery, but then it reduces and vanishes 
rapidly in the following days. Transgene expression is localized to the alveo-
lar region with the 2 types of alveolar epithelial cells (AECs) as major target. 
Plasmid DNA incorporating a transposon system, such as Sleeping-Beauty 
(SB) or piggyBac (PB), can address the problem of transient duration and 
induce a long-term transgene expression in mouse lung after PEI-mediated 
delivery. We have found that the stabilization of transposon-conveyed gene 
expression in lung actually arose from the multiplication of a small number 
of transposon-integrated alveolar progenitor cells, which proliferated both 
under normal conditions and in response to local injury for epithelia repair, 
and may play a role in long-term homeostatic maintenance in alveoli. In this 
report, we show that the transposon-labeled progenitor cells can be isolated 
and cultured ex vivo. In addition, the PEI-mediated transient gene delivery is 
applicable to acute lung injury (ALI) treatment. Following the ALI induced by 
intratracheal instillation of lipopolysaccharide (LPS), systemic delivery of PEI/
DNA expressing β2-adrenergic receptor (β2AR), a prototypical G protein-
coupled receptor that regulates several key proteins needed for alveolar epi-
thelial ion and fluid transport, efficiently reduced the lung wet-to-dry ratio 
and bronchoalveolar lavage protein levels and cellularity in 24 hours without 
remarkable inflammation or other adverse effects. On the other hand, the 
stable delivery of tumor suppressor genes, such as p27VP22 and soluble 
FLT-1, in alveolar progenitor cells, significantly inhibited the local tumor 
growth through bystander effect and prolonged the survival of treated mice. 
The data presented here suggest that PEI-mediated in vivo gene delivery in 
lung progenitor cells can serve as a versatile tool for treatment of acute and 
chronic lung diseases, and may also provide a promising platform for future 
research in lung biology and tissue regeneration.
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CARDIAC CELLS
Poster Board Number: 1062
HUMAN CARDIAC STEM CELLS – THERE IS 
A POOL OF AUTOLOGOUS RESIDENT C-KIT+ 
PROGENITORS IN THE LEFT AND RIGHT 
ATRIUM
Arsalan, Mani1, Garbade, Jens2, Woitek, Felix3, Adams, Volker3, 
Linke, Axel3, Dhein, Stefan2, Walther, Thomas1, Mohr, Friedrich-
Wilhelm2
1Cardiac Surgery, Kerckhoff Clinic, Bad Nauheim, Germany, 2Cardiac 
Surgery, Heart Center Leipzig, Leipzig, Germany, 3Cardiology, Heart Center 
Leipzig, Leipzig, Germany
Objectives: The existence of resident human cardiac stem cells (hCSC) in the 
adult myocardium and their regenerative capacity is not fully defined. The 
aim of this study was to identify hCSC in patients undergoing heart surgery 
by Flow Cytometry. Furthermore we wanted to investigate if there are dif-
ferences in the distribution of these cells in different compartments of the 
human heart. Methods: Tissue samples from the appendage of the right atri-
um (RA), left atrium (LA) and from the left ventricle (LV) were taken during 
cardiac surgery. The samples were digested and the mononuclear cells were 
isolated and marked for the stem cell marker c-kit and hematopoietic lineage 
markers (CD3, CD11b, CD19 and CD45). Quantitative and qualitative cell 
characteristics were analyzed by Flow Cytometry. Furthermore immunohis-
tology was performed. Results: Human cardiac stem cells, positive for c-kit 
and negative for hematopoietic lineage markers could be isolated from the 
RA, LA and LV. There is no significant quantitative difference of c-kitpos/
linageneg cells (RA 4.80±1.76% vs. LA 4.99±1.69% of isolated MNCs, 
P=0.922) between the atria. There is a significant difference of c-kitpos/
linageneg cells between the atria and the left ventricle (atria 4.90±1.29% vs. 
LV 0.62±0.14% of isolated MNCs P=0.035). The immunohistology showed 
c-kitpos/linneg cells in all compartments and confirmed the distributional 
pattern shown by Flow Cytometry. Conclusion: We could detect c-kitpos/li-
nageneg cell populations in the heart of patients undergoing cardiac surgery. 
There is no difference in the distribution between RV and LV, but we showed 
a higher concentration in both atria compared to the LV. 
Explanting tissue samples from the atria and isolating, promoting and 
transplanting the hCSCs might be an endogenous source for regeneration of 
heart failure.
Poster Board Number: 1064
A UNIVERSAL SYSTEM FOR HIGHLY EFFICIENT 
CARDIAC DIFFERENTIATION OF HUMAN 
INDUCED PLURIPOTENT STEM CELLS THAT 
ELIMINATES INTERLINE VARIABILITY
Burridge, Paul W.1, Thomson, Susan2, Millrod, Michal A.1, 
Weinberg, Seth2, Tung, Leslie2, Zambidis, Elias T.1
1Institute for Cell Engineering, Johns Hopkins University, Baltimore, MD, 
USA, 2Biomedical Engineering, Johns Hopkins University, Baltimore, MD, 
USA
The production of cardiomyocytes from human induced pluripotent stem 
cells (hiPSC) holds great promise for patient-specific cardiotoxicity drug test-
ing, disease modeling, and cardiac regeneration. However, existing protocols 
for the differentiation of hiPSC to the cardiac lineage are inefficient and 
highly variable. We describe a highly efficient system for differentiation of 
human embryonic stem cells (hESC) and hiPSC to the cardiac lineage. This 
system eliminated the variability in cardiac differentiation capacity of a vari-
ety of human pluripotent stem cells (hPSC), including hiPSC generated using 
non-viral, non-integrating methods. We systematically and rigorously opti-
mized >45 experimental variables to develop a universal cardiac differentia-
tion system that produced contracting human embryoid bodies (hEB) with 
an improved efficiency of 94.7±2.4% in an accelerated nine days from four 
hESC and seven hiPSC lines tested, including hiPSC derived from neonatal 
CD34+ cord blood cells and adult fibroblasts using non-integrating episomal 
plasmids. This cost-effective differentiation method employed forced ag-
gregation hEB formation in a chemically defined medium, along with staged 
exposure to physiological (5%) oxygen, and optimized concentrations of 
mesodermal morphogens BMP4 and FGF2, polyvinyl alcohol, serum, and 
insulin. The contracting hEB derived using these methods were composed 
of high percentages (64-89%) of cardiac troponin I+ cells that displayed 
ultrastructural properties of functional cardiomyocytes and uniform elec-
trophysiological profiles responsive to cardioactive drugs. This efficient and 
cost effective, universal system for cardiac differentiation of hiPSC allows the 
potentially unlimited production of functional cardiomyocytes suitable for 
application to hPSC-based drug development, cardiac disease modeling, and 
the future generation of clinically-safe human cardiac cells for regenerative 
medicine.
Poster Board Number: 1066
TRANSDIFFERENTIATION OF HUMAN 
MESENCHYMAL STEM CELLS INTO 
CARDIOMYOCYTES USING MYOCARDIUM 
TISSUE OBTAINED FROM DECEASED PATIENTS
Bustamante, Milán F.1, López, Elena1, Perán, Macarena2, Marchal, 
Juan Antonio3, Rodríguez-Serrano, Fernando1, Álvarez, Pablo1, 
Aránega, Antonia1
1Instituto de Biopatologia y Medicina Regenerativa (IBIMER), Granada, 
Spain, 2Facultad de Ciencias Experimentales y de la Salud, Universidad 
de Jaén, Jaén, Spain, 3Instituto de Biopatologia y Medicina Regenerativa 
(IBIMER), Dep.de Embriología y Anatomía Humana, Universidad de 
Granada, Granada, Spain
The increase of life expectancy has led to a high percentage of aging popu-
lation in the developed world and consequently, the high incidence of de-
generative and cardiovascular diseases. Regenerative medicine is presented 
as a promising tool for the treatment of cardiovascular diseases through the 
cardiac regeneration. The ventricular remodelling is the natural process of 
resolution of Acute Myocardial Infarction (AMI), which causes apoptosis and 
necrosis with scar formation, progressive ventricular dilatation and heart fail-
ure ending in death. A current therapeutic strategy is to increase the number 
of human functional heart muscle through the transplantation of several 
adult stem cell types. The use of human Mesenchymal Stem Cells (hMSCs) 
represents an attractive alternative because of their capacity for prolifera-
tion, easy collection and its immunological and paracrine properties, which 
could include the activation of different mechanisms against cell damage. 
They are multipotent cells that are present in many adult tissues, including 
bone marrow and adipose, etc., that in response to specific culture condi-
tions, these cells can give rise to multiple mesenchyme-derived cell types. 
This type of cross-lineage differentiation, also known as transdifferentiation, 
is a process whereby one cell type committed to and progressing along a 
specific developmental lineage switches into another cell type of a differ-
ent lineage through genetic reprogramming. This phenomenon implies that 
adult stem cells maintain the multidifferentiation potentials even after being 
exposed to certain inductive factors. The aim of this study was to develop an 
experimental model of cardiac regeneration consisting in obtain an optimum 
number of transdifferentiated hMSCs into cardiomyocytes, using techniques 
such as cell extract, co-culture and conditioned medium. For this purpose, 
we used hMSCs obtained from lipoaspirates and cardiomyocytes isolated 
from left ventricular samples of deceased patients (with dates of death less 
than 48 hours). We used several strategies to induce cardiac differentia-
tion consisting in: (i) a protein pool developed and introduced into hMSCs 
through membrane cell permebilization (cell extract method), (ii) a co-
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culture method using transwells with both cell types and (iii) the addition of 
conditioned medium collected from the adult cardiomyocytes isolated to the 
hMSCs (conditioned medium method). After two weeks of culture for each 
method, morphological studies were conducted and genetic determinations 
by RT-PCR were performed. We evaluated the expression of cardiomyocyte 
differentiation factors: GATA-4, Mef2c and Troponin C, induction factors 
such as BMP-2. Moreover, immunocytochemistry assays were performed for 
the expression of proteins such as desmin, α-actin, troponin I and C in the 
treated cells. Our results showed that hMSCs obtained from lipoaspirates 
can be reprogrammed into cardiomyocytes through the transdifferentiation 
methods tested. We conclude that heart tissue obtained from deceased pa-
tients can be a valuable source of cardiomyocytes for use in methods of cell 
reprogramming. This study elucidates the first insight that hMSCs with self 
renewal potential possess the capability to serve as a functional cardiomyo-
cyte precursor through the appropriate paracrine input and cross-talk with 
the cardiac milieu.
Poster Board Number: 1068
IDENTIFICATION AND CHARACTERIZATION OF 
NOVEL AND SPECIFIC MARKERS FOR CELLS 
OF THE HUMAN CARDIOVASCULAR LINEAGE
Dubois, Nicole, Craft, April, Keller, Gordon
McEwen Centre for Regenerative Medicine, University Health Network, 
Toronto, ON, Canada
The potential of embryonic stem (ES) cells and induced pluripotent stem 
(iPS) cells to generate cells of the cardiovascular lineage in culture provides 
a powerful model system for investigating the cellular interactions and 
molecular regulators that govern the specification, commitment and matura-
tion of these lineages. Studies in mouse and human have identified a Flk-1/
KDR-positive cardiovascular progenitor that gives rise to cells of the cardiac, 
vascular smooth muscle and endothelial cell lineages. When plated in mono-
layer cultures, these Flk-1/KDR+ cells can differentiate to generate popula-
tions consisting of greater than 50% contracting cardiomyocytes. While the 
mechanisms regulating the early differentiation steps of the cardiovascular 
lineage are rather well defined and relatively easy to monitor, the pathways 
that control the differentiation and maturation of the progenitor population 
into the distinct cell types of the adult heart (atrial and ventricular myocytes, 
cardiac conduction system, heart valves) are largely unknown. One major 
limitation in defining and characterizing the pathways that regulate fate 
choice and cell maturation within the cardiovascular lineage is the paucity 
of markers to monitor the emergence of the individual cell types and to 
enable their isolation from mixed cultures. Various studies have reported cell 
type specific reporters or purification based on mitochondrial dye up-take, 
however, none of these approaches have proven to be applicable to a broad 
range of human ES and iPS cells or to be efficient in consistently obtaining 
highly enriched cardiomyocyte populations. Using high throughput flow cy-
tometric analysis we have identified a novel cell surface marker that is specif-
ically expressed on hESC/iPSC-derived and fetal cardiomyocytes. Cell sorting 
using an antibody against this marker allows for enrichment of cardiomyo-
cytes from human ESC/iPSCPS differentiation cultures, resulting in popula-
tions consisting of greater than 95% cardiac TroponinT-positive cells. When 
subjected to gene expression analysis, these sorted cells express high levels 
of cardiac-specific markers such as NKX2.5, MYH6, MYH7, MYL2, MYL7 
and are devoid of markers characteristic for the non-myocyte cell types of 
the cardiovascular lineage including smooth muscle cells and fibroblasts. 
The non-myocyte markers are, however, expressed in the antibody-negative 
fraction. When plated in culture, the sorted cells give rise to contracting 
monolayers or aggregates that maintain their high cardiomyocyte content 
over time. CONCLUSION: We have successfully identified a novel marker of 
developing cardiac lineage cells that can be used to isolate cardiomyocytes 
from hESC/iPSC-derived populations with high efficiency and specificity. This 
novel and widely applicable tool will be invaluable for the generation of pure 
cardiomyocyte populations for future strategies in regenerative medicine as 
well as drug testing approaches for human PSC-derived cardiomyocytes. 
Furthermore, being able to monitor and isolate cardiomyocytes during PSC 
differentiation will open new possibilities to understand and characterize the 
pathways and molecular regulators involved in the formation of the human 
heart in healthy and diseased patients.
Poster Board Number: 1070
AUTOMATED FUNCTIONAL CELLULAR 
ANALYSES OF HUMAN IPS-DERIVED 
CARDIOMYOCYTES FOR CARDIOVASCULAR 
RESEARCH, TOXICITY AND DRUG DISCOVERY
Hesley, Jayne1, Callamaras, Nick1, Jiang, Xin1, Crittenden, Carole1, 
Cromwell, Evan F.1, Anson, Blake D.2, Sirenko, Oksana1
1Molecular Devices, Sunnyvale, CA, USA, 2Cellular Dynamics International, 
Madison, WI, USA
Human induced pluripotent stem cells (iPSC) are an ideal source of func-
tionally relevant, terminally differentiated cells for use in research, drug 
discovery, and toxicity testing. They are available as pure populations that 
can be supplied in the quantities required for drug discovery and screening 
campaigns. iPSC-derived cardiomyocytes are attractive because they express 
ion channels and demonstrate beating and action potentials similar to 
primary cardiac cells. Human cardiomyocytes derived from stem cell sources 
can greatly accelerate the discovery of cardiac drugs and safety pharmacol-
ogy by offering more clinically relevant human culture models than presently 
available. An emerging application for iPS-derived cardiomyocytes is for use 
as a model human system for testing toxicity and cardioprotective effects of 
drug candidates and developing drugs. Here we described methods that can 
be used to simultaneously monitor cell viability and mitochondria integrity in 
an automated fashion using high-content imaging. We have used iPS-de-
rived cardiomyocytes to determine IC50s of several cardiotoxic compounds 
(Doxazosin, Imatinib, Antimycin A, Terfenadine, Verapamil). A combina-
tion of cell scoring and granularity algorithms was used for analysis of the 
impact of compounds at the sub-cellular level. This method also evaluates 
the cardioprotective effect of other compounds (sphingosine phosphate) 
against cytotoxic damage. Since iPSC-derived cardiomyocytes demonstrate 
spontaneous beating similar to primary cardiac cells, we demonstrate an 
assay for measuring the impact of pharmacological compounds on the rate 
and magnitude of cells beating in 96 or 384 well microplates. We have 
developed a protocol that enables automatic determination of beat rate and 
magnitude of iPS-derived cardiomyocytes from time-lapse images of live 
cardiomyocytes, allowing measurement of the effect of compounds such 
as epinephrine and caffeine. In addition, iPSC-derived cardiomyocytes have 
been evaluated for their potential in ion channel drug discovery. Prelimi-
nary studies have demonstrated functional K and Ca channels using an 
automated patch clamp instrument which could then be used for screening 
prospective drugs.
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SECONDARY SPHERE FORMATION 
ENHANCES THE FUNCTIONALITY OF CARDIAC 
PROGENITOR CELLS FROM MURINE AND 
HUMAN CARDIAC EXPLANTS
Lee, Ho-Jae, Cho, Hyun-Jai, Youn, Seock-Won, Chung, Yeon-Ju, 
Yoon, Chang-Hwan, Yang, Han-Mo, Hur, Jin, Lee, Sae-Won, Lee, 
Eun Ju, Kwon, Yoo-Wook, Park, Myoung Hee, Park, Young-Bae, 
Kim, Hyo-Soo
Department of Laboratory Medicine, Seoul National University Hospital, 
Seoul National University College of Medicine, Seoul, Korea, Seoul, Korea, 
Republic of
Objective: We investigated a new strategy that enhances cellular potency 
and provides an enriched source of cardiac progenitor cells. Background: Re-
cent studies suggest that resident cardiac stem/progenitor cells could be an 
optimal cell source for repairing a damaged heart. However, cardiac progeni-
tor cells are difficult to maintain in terms of purity and multipotency when 
propagated in attached 2-dimensional culture systems in vitro. Methods: 
We applied the repeated sphere formation strategy (that is, cardiac explant 
; migrating cells out of explant ; primary cardiosphere (CS) formation ; 
cardiosphere-derived cells (CDCs) in adherent culture condition ; secondary 
CS formation by 3-dimensional culture). Results: Murine CSs were gener-
ated from cardiac explants of C57BL/6 mice. Cells in secondary CS showed 
a higher potency and differentiation potentials. Furthermore, when trans-
planted into the infarcted myocardium, secondary CSs engrafted robustly, 
improved LV dysfunction, and reduced infarct sizes more than CDCs did. In 
addition to the cardiovascular differentiation of transplanted secondary CSs, 
paracrine effects, such as robust VEGF secretion, were found to enhance 
neovascularization in the infarcted myocardium. Regarding the molecular 
mechanisms involved, ERK/E-selectin and ERK/Sp1/VEGF auto-paracrine 
loop were responsible for sphere initiation and maturation, respectively. 
When we applied this strategy to adult human cardiac tissues, secondary CS 
was readily generated, and cellular characteristics and molecular pathways of 
sphere formation were similar to murine findings. Conclusion: These results 
provide a simple and reproducible strategy for enhancing cellular potency for 
cardiac repair. Furthermore, this strategy may be applicable to other types of 
stem/progenitor cells for cell-based therapy.
Poster Board Number: 1074
ANTHRACYCLINE INDUCED CELLULAR 
DAMAGE DURING HUMAN PLURIPOTENT 
STEM CELL CARDIAC DIFFERENTIATION
Mahmut, Naila1, Uribe, Katherina2, Kinnear, Caroline2, Mital, 
Seema1
1Department of Pediatrics, Hospital for Sick Children, Toronto, ON, Canada, 
2Hospital for Sick Children, Toronto, ON, Canada
Backround: Anthracycline (ANTs) mediated cardiotoxicity is a leading cause 
of late complications in cancer survivors. The mechanisms of cardiotoxic-
ity of ANTs have been studied in vivo and in vitro in animal models. We 
investigated the role of oxidative stress and DNA damage in mediating 
ANT-induced cardiotoxicity using human pluripotent stem cell-cardiac 
cells (hPSC-CCs). Methods: The hPSC-CCs were treated at stage T15 with 
doxorubicin (DOXO, 0.1, 0.5, and 1 µM/L) with or without the antioxidant, 
ascorbic acid (AA, 200 µM/L) for 48hrs. The effect of DOXO on the follow-
ing was measured: 1) 8-OH-deoxyguanosine (8-OH-dG), marker of reactive 
oxygen species (ROS) by Elisa assay; 2) Phosphorylation of p53 at ser6, as 
a marker of DNA damage by immunofluorescence staining, and 3) beating 
rate of contracting embryonic bodies (EBs). Results: DOXO treatment of 
hPSC-CCs for 48 hours resulted in: 1) increase in 8-OH-dG levels which was 
attenuated by co-treatment with ascorbic acid (9.3±2.1 and 4.3±3.3 ng/
ml in DOXO and DOXO+AA groups compared to control 3.8±2.3 ng/ml, 
p<0.05) 2) increase in phospho-p53 at ser6 in DOXO group compared to 
control; and 3) a dose-dependent reduction in contractile rate of EBs (40 ± 
2.1% in 0.1, 12±1.4% in 0.5, and 1.3±1.1% in 1 µM/L concentration ex-
posure of DOXO, vs 96±2.4 % control p<0.05). This was not altered by AA. 
Conclusion: ANT administration induced significant increase in ROS, DNA 
damage and contractile dysfunction in hPSC-CCs. Antioxidant administra-
tion reduced the ROS levels but did not prevent DNA damage or contractile 
dysfunction. The hPSC-CCs may serve as a useful in vitro cellular model to 
study the mechanisms of ANT-mediated cardiotoxicity and screen for newer 
cardioprotective agents. 
Poster Board Number: 1076
DEVELOPMENT OF DELAYED 
AFTERDEPOLARIZATIONS ACTIVITY IN HUMAN 
IPS CARDIOMYOCYTES
Medei, Emiliano, Doss, Michael Xavier, Sicouri, Serge, Wu, 
Yuesheng, Treat, Jackie Treat, Antzelevitch, Charlie
Masonic Medical Research Laboratory, Utica, NY, USA
Background: Human induced pluripotent stem cell (hiPS)-derived cardio-
myocytes exhibit diverse electrophysiological and pharmacological proper-
ties. One of the goals of hiPS cardiomyocyte development is to have avail-
able a human model suitable for safety pharmacology. The present study 
tests the hypothesis that agents known to induce delayed (DAD) afterde-
polarizations do so in hiPS cardiomyocytes. Method: Embryoid bodies (EBs) 
were made from a human iPS cell line reprogrammed with Oct4, Nanog, 
Lin28 and Sox2 using a serum free differentiation protocol supplemented 
with growth factors for selective cardiac differentiation. Beating clusters 
were micro-dissected from EBs ranging between 70 and 80 days of maturity 
and plated on gelatin coated dishes. Standard microelectrode techniques 
were used to record action potentials (AP) from electrically stimulated EB 
clusters superfused with HEPES-Tyrode’s solution (KCl=4 mM; 37°C) before 
and after exposure to 2.5-5.0 µM ouabain (n= 6). Results: The effects of 
ouabain were examined using a pulse train of 10 beats at cycle lengths (CLs) 
of 1000, 800, 500 and 300 ms followed by a pause. Ouabain (2.5-5 µM) re-
duced phase 4 depolarization and induced DADs in 3/6 and DADs-induced 
triggered activity in 1/6 preparations. DAD amplitude increased progressive-
ly as CL was reduced, consistent with the characteristics of DADs observed 
in native cardiomyocytes. Conclusion: Our data indicate that cardiomyocyte 
clusters derived from hiPS generate DAD-induced triggered activity consis-
tent with their toxicological effects in the clinic.
Poster Board Number: 1078
QUICK INDUCTION OF FUNCTIONAL 
MATURATION IN CARDIOMYOCYTES DERIVED 
FROM HUMAN ES AND IPS CELLS
Otsuji, Tomomi G.1, Kurose, Yuko2, Suemori, Hirofumi1, Nakatsuji, 
Norio3, Tada, Masako4
1Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan, 
2Stem Cell and Drug Discovery Institute, Kyoto, Japan, 3Institute for 
Integrated Cell-Material Sciences, Kyoto University, Kyoto, Japan, 
4Chromosome Engineering Research Center, Tottori University, Tottori, 
Japan
Cardiomyocytes derived from human embryonic stem cells (hESCs) and hu-
man induced pluripotent stem cells (hiPSCs) are considered a promising cell 
source for repairing cardiac dysfunction or for drug discovery and develop-
ment. Most recent research has focused on efficient cardiac-cell induction 
procedures which convert pluripotent stem cells into contractile cardiomyo-
cytes. Unfortunately, the resulting cells are often functionally insufficient 
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as adult cardiomyocytes and generally possess properties more similar to 
those of fetal cardiomyocytes. In order to reproduce the developmental 
process seen in hearts during culturing of hESC/hiPSC-derived cardiac cells, 
additional steps designed to promote their full maturity need to be taken. 
We previously showed that the combination of short-term spheroid cultur-
ing following periodic re-plating of hESC-derived cardiomyocyte colonies 
produced cells which maintained their contractility for over a year, resulting 
in a cell-autonomous functional increase in cardiac gene expression and 
electrophysiological properties. Here, we found that spheroid culturing acti-
vated the chromatin structure of hESC-derived cardiomyocytes. Moreover, 
direct modification of the chromatin structure with a specific compound en-
hanced the cardiac gene expression in the premature cardiac cells obtained 
from both hES and hiPS cells within a few days under the adherent culture 
conditions. In the extracellular multielectrode recordings, premature cardiac 
colonies often exhibited arrhythmia, but with this treatment, most of them 
showed dose-dependent Na+-K+ interval prolongation in response to a 
HERG channel blocker. This suggests that proper chromatin regulation is es-
sential for the stem cell-derived cardiomyocytes to acquire full functionality. 
Our one-step pretreatment of a cardiomyocyte colony within each electrode 
chamber will greatly contribute to the accuracy of cell toxicity tests on the 
basis of the Na+-K+ interval prolongation in the drug discovery process.
Poster Board Number: 1080
APPLICATION OF HUMAN EMBRYONIC 
DERIVED CARDIOMYOCYTES IN TOXICITY 
TESTING
Steel, Daniella M.1, Dahlenborg, Kerstin1, Englund, Mikael C.O.2, 
Sartipy, Peter1
1Cellartis AB, Gothenburg, Sweden, 2Cellartis AB, Dundee, United Kingdom
The lack of readily available human cardiac tissue has hindered progress 
in safety pharmacology and drug discovery. Human embryonic stem cell 
(hESC) derived cardiomyocytes are a potential source of relevant cells to 
substitute for ex vivo material. These cardiomyocytes have been character-
ised at the genetic, molecular and functional level, and demonstrate typical 
cardiac characteristics. We now address the application of these cells in 
assessing new chemical entities for cardiotoxicity. hESC derived cardiomyo-
cytes were seeded as single cells, or maintained as 3D structures, and were 
exposed to compounds with documented adverse cardiac events. Toxicity 
was measured by several parameters, including cell viability and release of 
the cardiac specific biomarker cardiac troponin t (cTnT). Doxorubicin, an 
anthracycline, is one of the most widely used antitumor drugs with several 
potential mechanisms underlying the cardiotoxic effects. Doxorubicin caused 
a dose dependent decrease in viability and increase in cTnT release. Interest-
ingly, these effects were also time-dependent, and sensitivity was affected 
by proliferative capacity. Metformin, a commonly prescribed drug for use 
by type II diabetics, had dual effects, with no decrease in cell death at low 
doses but reduced cell viability only at high concentrations. This pattern 
was closely reflected by the release of cTnT. Toxicity testing was performed 
using serum free and serum containing media, and in 96- or 384-well plates, 
to assess transferability to high throughput systems. The viability of hESC 
derived cardiomyocytes was not affected by the absence of serum during 
the test period, nor by the constrained environment of the 384-well plate. In 
summary, hESC derived cardiomyocytes responded to cardiotoxic com-
pounds with a sensitivity comparable to that reported in literature in formats 
suitable for large scale screening campaigns. hESC derived cardiomyocytes 
have a potential to provide human cardiac material for toxicity testing. 
Frontloading of hESC derived cardiomyocytes in screening new chemical 
entities for adverse cardio events could provide more relevant information 
during the early stages of compound development.
Poster Board Number: 1082
ILK INDUCES STRESS IN MOUSE HEART 
AND PROMOTES EXPANSION OF RESIDENT 
CARDIAC STEM CELLS
Traister, Alexandra1, Aafaqi, Shabana1, Lu, Mingliang1, Arab, Sara1, 
Dai, Xiaojing1, Hannigan, Greg2, Coles, John G.1
1Physiology and Experimental Medicine, The Hospital for Sick Children, 
Toronto, ON, Canada, 2Medicine, Monash University, Melbourne, Australia
Background: We have previously reported that Integrin Linked Kinase (ILK), 
which has been implicated as a cardioprotective target, causes the in vitro 
expansion of cardiac c-kit + tissue-resident progenitor cells in human fetal 
heart. However, the effect of ILK on expansion of other cardiac progenitor 
cells remains obscure. Methods and Results: To investigate the role of ILK 
in expansion of resident stem cells we used transgenic mice with cardiac re-
stricted expression of constitutively active ILK (S343D) or activation resistant 
mutant ILK (ILK-R211A). We isolated sca-1+ cells from hearts of ILK-S343D 
and ILK R211A transgenic mice using magnetic cell sorting technique. The 
percentage of Sca1+ cardiac progenitor cells was significantly increased in 
both ILK over-expressed hearts of transgenic mice, with the highest increase 
(3-4 fold) in R211A mice as compared that of littermate control mice. RT-
PCR analysis of Sca 1- cells isolated from hearts of ILK S343 and ILK R211A 
mice expressed markedly higher levels of cardiac progenitor cell-marker 
Isl-1, as compared to expression levels of Isl-1 in Sca-1- cells isolated from 
hearts of littermate controls. Moreover, transgenic mice with cardiac-specific 
ILK overexpression were shown to have increased myocardial Isl-1 protein 
expression level with the highest expression levels in R211A mice. Microar-
ray analysis revealed induction of a robust heat-shock response. Further-
more, ILK immunoprecipitation show specific binding of ILK with consti-
tutively active heat shock protein 70 (Hsc-70) in both ILK wild type and 
ILK mutants over-expressed in the hearts of transgenic mice. Conclusion: 
Cardiac-specific upregulation of ILK expression induces stress conditions in 
mouse heart with specific binding of ILK with Hsc-70, and promotes expan-
sion of various resident cardiac stem cells, such as c-kit+-, Sca1+- and Isl-1+ 
-expressing cells.
Poster Board Number: 1084
LACK OF POLYCOMB PROTEIN RYBP/DEDAF 
IN MOUSE EMBRYONIC STEM CELLS IMPAIRS 
CARDIAC DIFFERENTIATION
Ujhelly, Olga1, Dinnyes, Andras2, Pirity, Melinda1
1Biotalentum Ltd, Godollo, Hungary, 2Biotalentum Ltd., Szent Istvan 
University, Godollo, Hungary, Godollo, Hungary
Polycomb protein Rybp/DEDAF (Rybp (Ring1 and YY1-Binding Protein; 
also known as DEDAF; UniGene Mm.321633; MGI:1929059) has been 
implicated in transcriptional regulation, apoptotic signaling and as a gene 
with important function in central nervous system development. Earlier, we 
have proven that RYBP plays important role in neural tube formation and 
development of the eye. However the precise molecular functions of Rybp/
DEDAF and its role during organogenesis remained still unclear. In pres-
ent study, we investigated the role of RYBP during heart development. To 
gain further support for the early embryonic expression pattern of Rybp in 
the embryonic heart, we determined the Rybp protein expression profile 
throughout heart development by utilizing anti-Rybp antibody on embryon-
ic sections. Rybp was shown to be readily detectable in the developing heart 
from day 7.5 of embryonic development (E7.5). Prominent Rybp expression 
persisted during all embryonic stages examined and RYBP marked differenti-
ated cell types of the heart suggesting its involvement in heart development. 
This prompted us to investigate the role of RYBP in the regulation of cardiac 
lineage commitment in a stem-cell model system. In order to investigate the 
function of RYBP during cardiac differentiation, we utilized RYBP null embry-
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onic stem cells (ESCs) and differentiated them towards cardiac lineages. We 
used the hanging drop method to generate embryoid bodies (EBs) as com-
mon intermediate during the in vitro differentiation of pluripotent stem ESCs 
into specialized cell types. We found although EBs could be derived from 
the RYBP null ESCs but consequent cardiac development was affected in the 
absence of RYBP. Furthermore, normally ESCs form rhythmically beating car-
diomyocytes in 6-14 days when EBs plated on gelatin coated surfaces. How-
ever no beating colonies were observed from the mutant cells. Analysis of 
cardiac markers revealed a down-regulation of terminal cardiac markers (e.g. 
cardiac troponinT (cTnT) in the mutants, assessed by immunohistochemistry 
and qRT-PCR. Importantly, forced expression of Rybp (by a lentiviral vector) 
in Rybp-deficient ESCs was able to rescue the mutant phenotype. In sum-
mary, this is a first attempt to understand the basis for Rybp’s integral role in 
the development of the heart. Our results showed that Rybp is expressed in 
the heart during mouse embryonic development and that in the absence of 
RYBP cells show defect in cardiac differentiation. Currently gene expression 
profile analysis is being performed to reveal the genetic network RYBP may 
affect. These findings are likely to place RYBP in processes of cardiac differ-
entiation and have implications for the understanding of heart diseases.
Poster Board Number: 1086
IDENTIFICATION OF GENES THAT REGULATE 
CARDIOMYOGENESIS IN MOUSE PLURIPOTENT 
EMBRYONIC CELLS
Yasuda, Satoshi1, Hasegawa, Tetsuya2, Hosono, Tetsuji3, Satoh, 
Mitsutoshi2, Yamaguchi, Teruhide4, Suzuki, Kazuhiro1, Sato, Yoji1
1Division of Cellular and Gene Therapy Products, National Institute of 
Health Sciences, Tokyo, Japan, 2Faculty of Pharmaceutical Sciences, Toho 
University, Chiba, Japan, 3Laboratory of Medicinal Microbiology, Yokohama 
College of Pharmacy, Kanagawa, Japan, 4Division of Biological Chemistry 
and Biologicals, National Institute of Health Sciences, Tokyo, Japan
The application of pluriopotent stem cells to cardiac repair holds great 
promise for stem cell-based therapy. An understanding of the mechanism 
underlying the cardiac differentiation of pluripotent stem cells is necessary 
for the effective generation and expansion of cardiomyocytes as cell therapy 
products. Here we have identified genes that modulate the cardiac differ-
entiation of embryonal carcinoma (EC) cells and embryonic stem (ES) cells. 
We isolated P19CL6 cell sublines that possess distinct properties in cardio-
myogenesis and extracted 24 cardiomyogenesis-related candidate (CMR) 
genes correlated with EC cell cardiomyogenesis by transcriptome analysis. 
Knockdown of the CMR genes by RNA interference (RNAi) revealed that 
19 CMR genes influence spontaneous contraction or transcript levels of 
cardiac marker genes in P19CL6 cells. We further performed knockdown of 
the CMR genes by RNAi in mouse ES cells and induced in vitro cardiac dif-
ferentiation. Three CMR genes were finally shown to modulate the cardiac 
differentiation of both EC cells and ES cells. We found that CMR2 is the 
most potent regulator of cardiomyogenesis in our identified CMR genes. 
Depletion of CMR2 attenuated the expression of early cardiac transcription 
factor Nkx2.5 without affecting transcript levels of pluripotency and early 
mesoderm marker genes during ES cell differentiation. Activation of Wnt/β-
catenin signaling enhanced the expression of both CMR2 and Nkx2.5 in ES 
cells during embryoid body formation. Our findings indicate that CMR2 is 
a novel regulator of cardiomyogenesis in pluripotent embryonic cells, which 
links Wnt/β-catenin signaling to Nkx2.5 expression.
Poster Board Number: 1088
INVESTIGATING THE MECHANISM OF MURINE 
ATRIAL BI-POTENCY
Harmon, Andrew, WIlliams, Star, Nakano, Atsushi
Molecular, Cell and Developmental Biology, University of California, Los 
Angeles, Los Angeles, CA, USA
Within the developing heart, a subset of Isl1-postive cardiac progenitors 
display multi-potency and are capable of giving rise to cardiac, smooth 
muscle and endothelial cells. While these progenitors lose their ability to dif-
ferentiate into endothelial cells early during heart development, the cardiac 
and smooth muscle lineages stay closely related until late cardiogenesis. One 
specific fraction of these progenitors is the cells of the posterior second heart 
field, which have already committed to the atrial lineage, but retain smooth 
muscle bi-potency until mid-gestation. The question of what molecular 
mechanism regulates the bi-potency of these cells and what developmental 
purposes this plasticity may serve remain largely unanswered. We hypoth-
esize that that the cardiac-smooth muscle bi-potency of atrial progenitors is 
regulated by a Myocardin dependant pathway and is critical for the forma-
tion of functional heart-vessel junctions such as between the in-flow tract 
and atria of the heart. Using the atrial-specific sarcolipin (Sln)-Cre knock-in 
mouse line, in combination with an adenoviral myocardin over-expression 
system, we have shown that the over-expression of myocardin is capable 
of enhancing the smooth muscle differentiation of cultured atrial progeni-
tor cells. Chimeric analysis shows that myocardin-null ES cells give little 
contribution to the smooth muscle layer within the cardiac inflow tract while 
preferentially contributing to the atrial myocardium, suggesting myocar-
din is required for the smooth muscle differentiation of atrial progenitors. 
Furthermore, we have begun to analyze this requirement in vivo using the 
Sln-Cre line to conditionally knock out the myocardin gene within the atrial 
chambers of the heart.
Poster Board Number: 1090
MHC6 ANTISENSE RNA EXPRESSION IN 
MURINE EMBRYONIC STEM CELLS LEADS TO 
LOSS OF THE CARDIOGENESIS PHENOTYPE
Wagh, Vilas, Doss, Michael, Niemann, Rabea, Maganathan, 
Kesavan, Jagtap, Smita, Gaspar, John, Gajewski, Martin, Winkler, 
Johannes, Hescheler, Juergen, Sachinidis, Agapios
Institute for Neurophysiology, Cologne, Germany
Global transcriptomic analysis of murine embryonic stem cell derived car-
diomyocytes led to the identification of Mhc6, the cellular role of which has 
not yet been reported till date despite of its higher abundance specifically in 
heart and brain. Functional analysis of this transcript in Zebrafish model with 
morpholino mediated knockdown showed severe abnormalities of the heart 
and blood vasculatures such as enlarged ventricles, atria and stagnancy of 
blood in blood vessels and eventually caused embryonic lethality with 100% 
percent. shRNA mediated constitutive knockdown of Mhc6 in embryonic 
stem cells and differentiating embryoid bodies showed complete abroga-
tion cardiomyogenesis and null expression of canonical cardiac markers such 
as Troponin T and alpha-myosin heavy chain. Cellular localization studies 
indicated the nuclear/membrane localization of this protein and subsequent 
microarray analysis showed its functional role in mesoderm development 
and cardiomyogenesis. Here we report that the novel transcript Mhc6 is a 
critical component of cardiomyogenesis in vivo and in vitro.
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LONG QT SYNDROME SPECIFIC CARDIAC 
CELL MODELS GENERATED USING INDUCED 
PLURIPOTENT STEM CELL TECHNOLOGY
Lahti, Anna L.1, Kujala, Ville J.1, Chapman, Hugh2, Koivisto, Ari-
Pekka2, Pekkanen-Mattila, Mari1, Hyttinen, Jari3, Kontula, Kimmo4, 
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Olli1, Aalto-Setälä, Katriina7
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Finland, 2Department of In vitro Pharmacology, Orion Pharma, Orion 
Corporation, Turku, Finland, 3Department of Biomedical Engineering, 
Tampere University of Technology, Tampere, Finland, 4Department of 
Medicine, University of Helsinki, Helsinki, Finland, 5Gladstone Institute of 
Cardiovascular Disease, San Francisco, and Department of Medicine and 
Cellular, University of California, San Fransisco, CA, USA, 6Institute for iPS 
Cell Research and Application (CiRA), Institute for integrated Cell-Material 
Science, Kyoto University, Kyoto, Japan, 7IBT, Institute of Biomedical 
Technology, Heart Center, Tampere University Hospital, University of 
Tampere, Tampere, Finland
Cell culture is an ideal environment to carry out biological and biomedical 
research but unfortunately, not all human cells can be maintained in vitro. 
Cardiomyocytes, for example, tend to dedifferentiate and stop beating rela-
tively fast in cell culture conditions. Pluripotent human stem cells are capable 
to proliferate indefinitely or alternatively differentiate into any cell type of 
human body. Induced pluripotent stem (iPS) cells can be generated by re-
programming already differentiated cells into a pluripotent state by activat-
ing certain pluripotency genes. iPS cell technology thereby provides a way to 
study patient and disease specific cell lines. Here we introduce functional cell 
models for long QT syndrome (LQTS) type 1 (LQT1) and 2 (LQT2). LQTS 
can be seen in ECG of a patient as prolonged QT interval and the syndrome 
is known to increase the risk of ventricular arrhythmias and sudden death. 
The most common subtypes of the disease are due to mutations in KCNQ1 
and HERG genes. Both of these genes code subunits of certain voltage-
gated potassium channels that are responsible for re-polarization of cardiac 
action potential and maintenance of normal cardiac rhythm. The disease 
phenotype is also present in the LQTS-specific cardiomyocytes differentiated 
from iPS cells that were derived from skin fibroblasts of patients with LQTS. 
The phenotype is seen as prolonged cardiac action potential duration (APD) 
using patch clamp-technique as well as longer field potential duration (FPD) 
measured with micro electrode array (MEA). We have been able to generate 
cardiac cell models for both LQT1 (carrying mutation in KCNQ1) and LQT2 
(carrying defective HERG). These human cardiac models for LQTS provide 
optimal platforms to study the basic pathology of the different subtypes of 
the syndrome and their responsiveness to different drugs. There are huge 
advantages compared to previous models that have used non-cardiac cells 
or animals since the intracellular environment is similar to real human heart. 
The models might also be used to safely design an optimal medication for 
the patients.
Poster Board Number: 1094
USING HUMAN INDUCED PLURIPOTENT STEM 
CELLS TO INVESTIGATE CARDIAC PHENOTYPES 
IN PATIENTS WITH TIMOTHY SYNDROME
Yazawa, Masayuki1, Hsueh, Brian1, Jia, Xiaolin1, Pasca, Anca M.1, 
Bernstein, Jonathan A.2, Hallmayer, Joachim3, Dolmetsch, Ricardo 
E.1
1Neurobiology, Stanford University School of Medicine, Stanford, CA, USA, 
2Pediatrics, Stanford University School of Medicine, Stanford, CA, USA, 
3Psychiatry & Behavioral Science, Stanford University School of Medicine, 
Stanford, CA, USA
Prolonged QT interval, the electrical manifestation of repolarization in 
ventricular myocytes, is a major cause of cardiac arrhythmia and sudden 
death. Long QT syndrome (LQTS) can have a genetic basis or be induced 
by drug exposure or physiological stress. A missense mutation in the L-type 
calcium channel, Cav1.2, causes LQTS and arrhythmia in patients with 
Timothy syndrome. To examine how the TS mutation affects electrical 
activity and contractility in human cardiomyocytes, we developed a human 
model of Timothy syndrome by reprogramming human skin cells from TS 
patients to generate pluripotent stem cells and by differentiating these cells 
into cardiomyocytes. Using electrophysiological recordings and live cell 
imaging, we found that significant defects in rhythmicity, electrical activity 
and calcium signaling in Timothy syndrome cardiomyocytes, likely reflect-
ing the cardiac phenotypes that are observed in the patients. To rescue the 
cellular phenotypes of Timothy syndrome patient-derived cardiomyocytes, 
we tested clinically-used blockers and chemical compounds that can alter 
the calcium channel function, and found that roscovitine, a compound that 
increases the voltage-dependent inactivation of Cav1.2, restored the electri-
cal and calcium signaling properties of cardiomyocytes derived from Timothy 
syndrome. This study opens new avenues for studying molecular and cellular 
mechanisms of genetic cardiac arrhythmia in human and for developing new 
drugs to treat these diseases.
Poster Board Number: 1096
PARATHYROID HORMONE IS A DIRECT DPP-
IV INHIBITOR AND THEREFORE INCREASES 
HOMING TO THE ISCHEMIC MYOCARDIUM VIA 
THE SDF-1/CXCR4-AXIS
Brunner, Stefan, Huber, Bruno C., Theiss, Hans D., Segeth, 
Alexander, Nathan, Petra, Franz, Wolfgang-Michael
Cardiology, LMU Munich - Großhadern, Munich, Germany
Aims: Parathyroid hormone (PTH) has been shown to induce stem cell pro-
liferation in the bone marrow (BM) niche and to promote stem cell mobiliza-
tion into peripheral blood. Moreover, PTH treatment after myocardial infarc-
tion improved survival and myocardial function associated with enhanced 
homing of bone marrow-derived stem cells (BMCs). To unravel the molecu-
lar mechanisms of PTH mediated stem cell trafficking, we analyzed wildtyp 
(wt) and GFP-transgenic mice after myocardial infarction with respect to the 
pivotal SDF-1/CXCR4 axis. Methods and Results: WT and GFP-transgenic 
mice (C57BL/6J) were infarcted by coronary artery ligation and PTH (80 μg/
kg/d) was injected for 5 days afterwards. Number of BMCs was analyzed by 
flow cytometry. SDF-1 protein levels and activity of dipeptidylpeptidase IV 
(DPP-IV) were investigated by ELISA and activity assay. Functional analy-
ses were performed at day 30 after MI. PTH treated animals revealed an 
enhanced homing of CXCR4+ BMCs associated with an increased protein 
level of the corresponding homing factor SDF-1 in ischemic myocardium. In 
vitro and in vivo, PTH inhibited the activity of DPP-IV, which cleaves and 
inactivates SDF-1. Functionally, PTH significantly improved myocardial func-
tion after MI. Both, stem cell homing as well as functional recovery were 
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reversed by the CXCR4 antagonist AMD3100. Conclusion: In summary, 
PTH is a direct DPP-IV inhibitor leading to an increased cardiac SDF-1 level, 
which enhances recruitment of CXCR4+ BMCs into ischemic myocardium 
associated with attenuated ischemic cardiomyopathy. Since PTH is already 
clinically used our findings may have direct impact on the initiation of stud-
ies in patients with ischemic disorders.
Poster Board Number: 1098
INCREASED NUMBER OF CD133 POSITIVE 
CARDIAC PROGENITOR CELLS IN THE HEARTS 
OF PATIENTS WITH CONGENITAL HEART 
DISEASE: IN VITRO AND IN VIVO ASSESSMENT 
OF DIFFERENTIATION AND FUNCTIONALITY
Ghazizadeh, Zaniar1, Fattahi, Seyedeh Faranak2, Fonoudi, 
Hananeh1, Namiri, Mehrnaz1, Kiani, Sahar1, Aghdami, Nasser1
1Department of Stem Cells and Developmental Biology, Royan Institute for 
Stem Cell Biology and Technology, ACECR, Tehran, Iran, Islamic Republic 
of, 2Department of Molecular Systems Biology, Royan Institute for Stem 
Cell Biology and Technology, ACECR, Tehran, Iran, Islamic Republic of
Since the late 90s, there has been several observations indicating that hu-
man cardiac cells divide after myocardial infarction; thereafter a considerable 
effort have been made to discover and characterize resident cardiac progeni-
tor cells suitable for cardiac regeneration. Yet, no feasible method is devel-
oped for cardiac progenitor separation based on the expression of a specific 
surface antigen. In addition, none of the candidate antigens were proved to 
mark all progenitor populations residing in the heart. This work focuses on 
isolation and characterization of the progenitors present in tissue samples 
obtained from patients with atrial septal defect, ventricular septal defect and 
tetralogy of fallot. The assumption is that in these patients, general hypox-
emia and structural defect in heart recruits and/or stimulates progenitors 
proliferation. In contrast to the previous reports on the inability of CD133+ 
hematopoietic stem cells in differentiating towards fully functional Cardio-
myocytes, our results show that CD133 antigen is one of the surface mark-
ers of cardiac progenitor cells and the CD133 positive (CD133+) cells can 
form mature cardiomyocytes. Heart biopsies (100-300 mg) were obtained, 
with informed consent, from patients during their heart surgery. After 
enzymatic digestion of tissue samples, flow cytometric analysis revealed the 
presence of significant level of CD133+ cells in patients’ samples (23.33 ± 
8.88%). The Colony Forming Unit (CFU) assay confirmed that these cardiac 
resident CD133+ cells had the ability to generate hematopoietic lineages. 
Two different approaches were taken in order to examine the ability of the 
isolated CD133+ cells to differentiate towards cardiomyocytes. In the first 
method, the cells resulted from enzymatic tissue digestion were incubated 
for four days and then the expression level of CD133 antigen along with 
ISL-1 and MEF2C transcription factors were evaluated by flow cytometry 
during this period. During the first day, most of CD133+ cells were also ISL-
1 positive with CD133/MEF2C double positive cells comprising only a small 
proportion of CD133+ cells. Interestingly, the reverse trend was observed on 
the fourth day. In the second method, the cells were incubated with CD133 
conjugated microbeads and then CD133+ cells were sorted using a MACS 
device. The sorted cells were expanded subsequently. CD133+ cells were 
differentiated by adding 5-azacytidine for 3 days to culture medium. During 
the next 28 days, the expression profile of cardiac specific genes was deter-
mined by RT-PCR in different stages of differentiation. To confirm the data 
obtained by RT-PCR, immunofluorescence staining for myosin heavy chain, 
alpha cardiac actin, ISL-1, MEF2C and Nkx2.5 markers were also performed 
on differentiated cells. Electrophysiological recordings verified the functional-
ity of differentiated cells. In order to get a better insight about the in vivo 
functionality of CD133+ cells, these cells were expanded and transplanted 
to rat infarct models. After six weeks, cardiac repair was evaluated using 
echocardiography and immunohistochemistry to evaluate the differentiation 
potential of CD133+ progenitor cells in rat heart. These studies revealed 
promising potential of CD133+ cells as a source for cardiac regeneration.
Poster Board Number: 1100
CARDIOMYOGENIC POTENTIAL OF 
CARDIOSPHERE-DERIVED CELLS
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Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
The heart is no longer considered a post-mitotic organ since it has been 
demonstrated that cardiomyocyte renewal occurs during our entire lifespan. 
The cells responsible for heart regeneration are the cardiac stem cells. The 
objective of this work was to study the in vitro properties of human cardio-
sphere-derived cells (CDCs), one of the cardiac stem cell types described 
so far, and their ability to differentiate into cardiomyocytes. CDCs were 
obtained from human atrial myocardial tissue discarded after cardiac surgery 
by enzymatic digestion with Collagenase type II (0.4%). Ten to fifteen days 
after isolation, small round phase-bright cells (PBC) appeared on top of the 
fibroblast-like cells. PBC were collected and placed in a non-adherent plate 
for 2 days where they formed cardiospheres, which were then transferred 
to adherent plates, giving rise to CDCs. These cells are adherent to plastic 
and present a spindle-shaped morphology. Surface molecule expression 
was studied by flow cytometry. CDCs were positive for the mesenchy-
mal stem cell (MSCs) markers CD105, CD90 and CD73 and negative for 
CD34, CD45, CD31 and all the hematopoietic lineage markers. Since CDCs 
expressed the core mesenchymal molecules found in bone marrow (BM) 
MSCs, we performed experiments to test their ability to differentiate in 
osteogenic and adipogenic lineages, a well-known property of BM MSCs. 
CDCs were unable to differentiate into these lineages. No numeric chromo-
some abnormalities were found in CDCs cultivated in vitro for 2 passages 
and these cells had a population doubling time of approximately 53.14 ± 
5.63 hours. CDCs were then co-cultured for 72 hours with neonatal ven-
tricular myocytes isolated from transgenic mice with the green fluorescent 
protein (GFP) gene under the control of the β-actin promoter. We detected 
the expression of connexin 43, troponin T, myosin light chain 2a and myosin 
heavy chain by RT-PCR, suggesting that these cells can be differentiated into 
cardiomyocytes. In conclusion, CDCs are cells of mesenchymal origin, adher-
ent to plastic and immunophenotipically similar to BM-MSCs. However, their 
differentiation properties are quite different, as BM-MSCs differentiate in 
osteogenic, adipogenic and chondrogenic lineages, while CDCs differentiate 
into the cardiac lineage. It still remains to be defined if CDCs can differenti-
ate into the other cell types found in the heart and if these cells have the 
ability to generate cardiomyocytes in vivo.
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TO PROTECT HEART FROM ISCHEMIA/
REPERFUSION INJURY THROUGH VE-CADHERIN 
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1Seoul National University Hospital, Seoul, Korea, Republic of, 2Seoul 
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Rationale: Early reperfusion after myocardial ischemia that is essential for 
tissue salvage also causes myocardial and vascular injury. Cardioprotec-
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tion during reperfusion therapy is an essential component in treatment of 
myocardial infarction. Angiopoietin-1 has been known as an endothelial 
specific-angiogenic factor. The effects of angiopoietin-1 on cardiomyocytes 
and vascular cells under reperfusion condition have not been investigated. 
Objective: We propose a protective mechanism whereby angiopoietin-1 
increases the integrity of the endothelial lining and it exerts a direct survival 
effect on cardiomyocytes under myocardial ischemia followed by reperfu-
sion. Methods and Results: Firstly, we found that angiopoietin-1 prevented 
vascular leakage through regulating VE-cadherin phosphorylation. The 
membrane expression of VE-cadherin was markedly decreased on hypoxia/
reoxygenation, which was recovered by angiopoietin-1. Interestingly, these 
effects were mediated by the facilitated binding between tyrosine phos-
phatase and VE-cadherin, leading to its de-phosphorylation. siRNA against 
tyrosine phosphatase abolished the effect of angiopoietin-1 on VE-cadherin 
de-phosphorylation, and thereby decreased levels of membrane-localized 
VE-cadherin. Secondly, we found angiopoietin-1 prevented cardiomyocytes 
death although they lack angiopoietin-1 receptor Tie2. Angiopoietin-1 
increased cardiomyocytes survival through integrin-β1, leading to decrease 
of active caspase-9 and then reduction of active caspase-3. Neutralizing an-
tibody against integrin-β1 blocked these protective effects of angiopoietin-1 
on cardiomyocytes. In a mouse myocardial ischemia/reperfusion model, 
angiopoietin-1 enhanced cardiac function; reduction of left ventricular 
end-systolic dimension (LVESD) and left ventricular end diastolic dimension 
(LVEDD) with the increase of ejection fraction (EF) and fractional shortening 
(FS). Conclusion: Our findings suggest the novel cardioprotective mecha-
nisms of angiopoietin-1 which are achieved by reductions in both vascular 
leakage and cardiomyocyte death after ischemia/reperfusion. 
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ADULT CARDIAC STEM CELLS POTENTIAL FOR 
CARDIAC TRANSPLANT PATIENTS
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Myocardial infarction is the leading cause of death among people in indus-
trialized nations. Although the heart has some ability to regenerate after 
infarction, myocardial restoration is inadequate. In several studies, patients 
with coronary disease who received autologous bone marrow cells by 
intracoronary injection show significant 3.7% (range: 1.9-5.4%) increases in 
LV ejection fraction, decreases in LV end-systolic volume of -4.8 ml (range: 
-1.4 to -8.2 ml) and reductions in infarct size of 5.5% (-1.9 to -9.1%), 
without experiencing arrhythmias. Bone marrow cells appear to release 
biologically active factors that limit myocardial damage. Unfortunately, bone 
marrow cells from patients with chronic diseases propagate poorly and can 
die prematurely. In the present study we have identified a sub-population of 
adult human cardiac stem cells (HACSCs) that can be utilized for restoration 
of myocardium. Over the past decade, the ability to culture and differentiate 
human adult cardiac stem cells (HACSCs) has offered researchers a novel 
therapeutic that may, for the first time, repair regions of the damaged heart. 
Studies of cardiac development in lower organisms have led to identification 
of the transforming growth factor-β superfamily (eg, activin A and bone 
morphogenic protein 4) and the Wnt/β-catenin pathway as key inducers of 
mesoderm and cardiovascular differentiation. These factors act in a context-
specific manner (eg, Wnt/β-catenin is required initially to form mesoderm 
but must be antagonized thereafter to make cardiac muscle). Different lines 
of HACSCs produce different levels of agonists and antagonists for these 
pathways, but with careful optimization, highly enriched populations of 
immature cardiomyocytes can be generated. These cardiomyocytes survive 
transplantation to infarcted hearts of experimental animals, where they 
create new human myocardial tissue and improve heart function. The grafts 
generated by HACSCs transplantation have been small, however, leading 
to an exploration of tissue engineering as an alternate strategy. Engineered 
tissue generated from preparations of adult human cardiomyocytes survives 
after transplantation may be because of recruitment of resident Cardiac stem 
cell signaling pathways. Creation of pre-organized vascular networks in the 
tissue markedly enhances survival, with human capillaries anastomosed to 
the host coronary circulation. Thus, pathways controlling formation of the 
human cardiovascular system are emerging, yielding the building blocks for 
tissue regeneration that may address the root causes of heart failure.
ENDOTHELIAL CELLS/HEMANGIOBLASTS
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A precise identification of human adult hemangioblast with a clear-cut 
definition of characterizing molecular markers is still lacking. To possibly 
identify circulating precursors endowed with the hemangioblast develop-
mental potentials, we established a new ex-vivo long-term culture model 
aimed to support the concomitant differentiation of hematopoietic and 
endothelial cell lineage. We identified a peripheral blood population lacking 
the expression of CD34, lineage markers, CD45 and CD133 (CD34-Lin-
CD45-CD133- cells) endowed with the ability to differentiate after 6-week 
culture into both hematopoietic and endothelial lineages. We demonstrated 
the bilineage potentiality of CD34-Lin-CD45-CD133-cells at the single cell 
level, and showed that CD34- Lin-CD45-CD133- cells transplanted in NOD/
SCID mice reconstitute the hematopoietic tissue and generate functional 
endothelial cells that contribute to new vessel formation during tumour an-
giogenesis, thus confirming the bilineage potentiality of these cells in vivo. 
Further molecular and functional characterization will aid the comprehension 
of the possible physiologic role of CD34-Lin-CD45-CD133- cells in blood 
and blood vessel maintenance and repair in adult life.
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Callery, Elizabeth1, Rana, Amer1, Geti, Imbisaat2, Ormiston, Mark1, 
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University of Cambridge, Cambridge, United Kingdom, 2Dept. Surgery 
& The Anne McLaren Laboratory for Regenerative Medicine, University 
of Cambridge, Cambridge, United Kingdom, 3Dept. Surgery; The Anne 
McLaren LRM & Cambridge Cardiovascular Consortium, University of 
Cambridge, Cambridge, United Kingdom
Idiopathic pulmonary arterial hypertension (PAH) is a debilitating condition 
asscociated with extensive remodelling of the pulmonary vasculature, which 
causes increased pulmonary vascular resistance and eventually right heart 
failure. The life-expectancy of a patient diagnosed with idiopathic PAH is 
less than three years, during which time increasing lung dysfunction severely 
impinges upon quality of life. At the cellular level, morphological aberrations 
are apparent in both the endothelial and smooth muscle layers of the small 
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peripheral arteries in the lungs of PAH patients. Dysregulated cell prolifera-
tion leads to increased muscularisation of these vessels and ultimately oc-
clusion of the lumen. At the molecular level, autosomal dominant mutations 
in the type II BMP receptor, BMPR2, have been detected in the majority of 
cases of familial PAH. Mutations in this gene have also been detected in pa-
tients with non-inherited, sporadic PAH, implicating dysregulated BMP sig-
nalling as a crucial factor in the development of this pulmonary pathology. 
Mechanistic analysis of the molecular basis of PAH is hindered by the limited 
supply of patient-derived endothelial and smooth muscle cells, and further 
exacerbated by the poor proliferative capacity of these cell populations. 
To overcome this constraint, we are generating iPS cell lines from patients 
harbouring a variety of mutations in BMPR2. We have already established 
iPS cell lines from both a PAH patient with the null mutation W9X and from 
their asymptomatic cousin, who also possesses this mutant allele. We are 
currently characterising the differentiation potential of these cell lines in 
both embryoid bodies and in chemically defined adherent culture conditions. 
As BMP signalling is important in ventral mesoderm specification, we will 
assess the potential of PAH mutant iPS cells to adopt this fate in response to 
ligand stimulation. We are particularly interested in determining the ability 
of PAH iPS cells to acquire endothelial and smooth muscle identities, since 
PAH is attributed to abnormalities in these cell types. To investigate this, we 
isolate CD34+ve PAH cells and direct their differentiation into endothelial 
and smooth muscle lineages, assessing functionality by a range of assays, 
including expression of differentiation markers and the ability of endothelial 
cells to form networks in vitro.
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Most solid tumors eventually require the formation of neo-vasculature for 
continued growth and metastases. This dependence on angiogenesis has 
been exploited in anti-cancer therapies with monoclonal antibodies, small 
molecule inhibitors, and cell-based approaches. Among the latter strategies 
is a so-called Trojan horse approach that includes ex vivo derivation and 
“arming” of tumor-homing cells followed by their systemic delivery and 
release of a toxic payload at the tumor. As a first step toward such a Trojan 
horse approach, we have established a highly efficient process for the deri-
vation of endothelial progenitor cells (EPCs) from human embryonic stem 
cells (hESCs). Our process to date has reproducibly provided high cell yields 
(>4x10^8 cells) and purities (approaching 99%) within 2-3 weeks of culture 
initiation. These cells display phenotypic (morphology, cell surface antigen, 
and gene expression) and functional vascular endothelial cell characteristics 
(tube formation in vitro and incorporation into both normal and tumor 
neo-vasculature in vivo). Our derivation process has been applied to 5 inde-
pendent hESC lines, including H1 (WA01) and H9 (WA09), as well as 3 of 
our GMP-compliant hESC lines (ESI 017, ESI 035 and ESI 051). The process 
uses a chemically-defined medium with sequential additions of recombinant 
human cytokines and signaling inhibitors, incorporates an optional immuno-
magnetic sorting step for CD31 or other characteristic markers, and is scal-
able to clinical demands. It does not involve feeder cells, serum, or xenoge-
neic components. Furthermore, our EPCs can be cryopreserved and banked, 
and are recovered with high efficiencies and the preservation of endothelial 
phenotypic characteristics.
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Endothelial dysfunction with resulting atherosclerosis is a fundamental cause 
for vascular injury in cardiovascular patients. Increasing evidence suggests 
that circulating endothelial progenitor cells (EPCs) monitor the health of the 
endothelium and are recruited into a site of vascular injury or tissue ischemia 
to orchestrate the initiation of the angiogenic response. Endothelial colony 
forming cells (ECFCs) are subtype of EPCs with robust clonal proliferative 
potential that display intrinsic in vivo vessel forming ability. However, ECFCs 
are rare in number (1/107-108 peripheral blood mononuclear cells) and 
their number tends to decline with age or develop replicative senescence. 
In elderly patients and subjects with cardiovascular disease, these cells may 
become prone to replicative senescence lacking proliferative potential, thus, 
rendering them impotent for vascular repair. Thus, generation of patient-
specific induced pluripotent stem (iPS) cells from cardiovascular patients 
and then deriving autologous ECFCs from the iPS cells for repair of their 
own damaged blood vessels may be a viable treatment solution. Directed 
differentiation of fibroblast-derived human iPS cells generates autologous 
endothelial cells that have not yet been fully characterized. It is unclear 
whether human iPS cell-derived endothelial cells possess a robust prolifera-
tive potential and in vivo vessel forming ability as displayed by umbilical 
cord blood- or adult peripheral blood-derived ECFCs. Further, factors and 
mechanisms that control the differentiation of human PS (human iPS and 
human ES) cells into endothelial cells with ECFC properties are completely 
unknown. Therefore, we sought to develop an endothelial differentiation 
protocol that would allow us to derive and isolate endothelial cells with an 
ECFC phenotype and function. Endothelial lineage differentiation was initi-
ated by growing human pluripotent cell-derived embryoid bodies (EBs) in 
suspension culture for 4 days and seeding them on gelatin or matrigel coat-
ed dishes for another 10 days. On day 14, cells were harvested and sorted 
using antibodies that recognize endothelial antigens CD31, CD144, CD146, 
and NRP-1. Sorted cells were subsequently cultured in endothelial growth 
(EGM-2) media supplemented with TGFβ inhibitor (10 μM SB431542) for 
2 weeks. These cells formed a homogenous monolayer with characteristic 
cobblestone appearance, exhibited clonal proliferative potential at a single 
cell level, and demonstrated angiogenic behavior by forming capillary like 
structures when cultured in matrigel. These cells also formed capillary like 
structures in cellular collagen gels implanted into the flanks of NOD/SCID 
mice and we are currently verifying these implants for their presence of 
humanized blood vessels. Thus, human pluripotent stem cells may be dif-
ferentiated into cells with ECFC properties, leading the way for pre-clinical 
studies of their function.
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HUMAN UMBILICAL CORD BLOOD ALDH-
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A PRO-ANGIOGENIC PARACRINE 
MICROENVIRONMENT
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Canada
Angiogenesis is a critical process for tissue repair and regeneration. Under-
standing the role of somatic progenitor cells in angiogenesis is integral to the 
development of effective revascularization therapies. Human umbilical cord 
blood (UCB) represents a readily available allogeneic source of functional 
pro-angiogenic progenitor cells for the development of cell-based strate-
gies to treat ischemic disease. Human UCB cells can be purified by high 
aldehyde dehydrogenase (ALDH) activity, a conserved function in multiple 
progenitor cell lineages. Fluorescence-activated cell sorting accrues clini-
cally applicable cell populations with high (ALDHhi=0.4±0.1%) versus low 
(ALDHlo=41.2±3.6%) ALDH activity (n=10). Whereas UCB ALDHlo cells are 
devoid of progenitor cell function in vitro, ALDHhi cells were highly enriched 
for hematopoietic (1 in 4 cells, n=4) and endothelial (1 in 5x104 cells, n=4) 
colony forming cells. While mature endothelial cells (ECs) plated in growth 
factor-free media rapidly die, supplementation with ALDHhi cells in transwell 
inserts promotes EC survival and expansion without cell contact (n=3, 
p<0.05). Furthermore, in direct co-culture, human UCB ALDHhi cells aug-
ment the tubule forming capacity of mature ECs plated on matrigel (n=6, 
p<0.05). In vivo, the vascular regenerative capacity of UCB ALDH-purified 
cells was assessed by tail-vein transplantation into NOD/SCID mice with 
acute hindlimb ischemia induced by unilateral femoral artery ligation and 
excision. Laser Doppler perfusion imaging was used to track the recovery of 
blood flow indicated by the perfusion ratio (PR) of the ischemic versus non-
ischemic limb. Mice transplanted with UCB ALDHhi cells showed signifi-
cantly improved recovery of limb perfusion by day 14 post-transplantation 
(PR=0.58±0.07, n=7) compared to mice injected with saline vehicle control 
(PR=0.28±0.03, n=6, p<0.01). Mice transplanted with ALDHhi cells showed 
specific recruitment to the ischemic hindlimb 3 and 7 days after transplanta-
tion as detected by flow cytometry and histochemistry for human cells in 
muscle sections. Notably, this robust recovery of blood flow to the ischemic 
limb was maintained stably despite diminished engraftment of human 
cells by 28 days post-transplantation (n=6, p<0.01). Sublethal irradiation 
(275cGy) of recipient mice to enhance engraftment of human UCB ALDHhi 
cells was less effective and only supported a transient recovery of blood 
flow compared to saline controls, as initial cell recruitment was diverted 
to the bone marrow. Although significantly improved perfusion was not 
maintained in irradiated mice, ischemic limbs of ALDHhi-transplanted mice 
also showed increased capillary densities compared to all other treatments 
at day 28 (P<0.01) quantified by enumeration of von Willebrand factor+ 
blood vessels, confirming the pro-angiogenic potential of UCB ALDHhi cells 
in vivo. Collectively, these findings show that human UCB-derived ALDHhi 
cells can actively recruit to areas of ischemic injury where they promote a 
pro-angiogenic microenvironment by paracrine support of ECs, accelerating 
the recovery of blood flow and enhancing endogenous revascularization. As 
a readily available population of pro-angiogenic cells, UCB ALDHhi mixed 
progenitor cells may prove useful in the development of allogeneic cell-
based clinical therapies for ischemic disease.
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It has been shown that the shear stress plays a critical role in promoting en-
dothelial cell (EC) differentiation from embryonic stem cell (ESC)-derived EC. 
However, the underlying mechanisms mediating shear stress effect in this 
process have yet to be investigated. It has been reported that the glycoca-
lyx component heparan sulfate proteoglycan (HSPG) mediates shear stress 
mechanotransduction in mature EC. In this study, we investigated whether 
cell surface HSPG plays a role in shear stress modulation of EC phenotype. 
ESC-derived endothelial cells were subjected to shear stress (5 dyn/cm2) for 
8 hours with or without heparinase III (Hep III) that digest heparan sulfate. 
Immunostaining showed that ESC-derived EC surfaces contain abundant 
HSPG, which could be cleaved by Hep III. We observed that shear stress 
significantly increased the expression of the vascular endothelial cell-specific 
markers genes (vWF, VE-cadherin, PECAM-1). The effect of shear stress on 
expression of tight junction genes (ZO-1, OCLD, CLD5) was also evaluated. 
Shear stress increased the expression of ZO-1 and CLD5, while it didn’t alter 
the expression of OCLD. Shear stress increased expression of vasodilatory 
gene (eNOS, COX-2) expression, while it decreased the expression of the 
vasoconstrictive gene ET1. After reduction of HSPG with Hep III, the shear 
stress-induced expression of vWF, VE-cadherin, ZO-1, eNOS, and COX-2, 
were abolished, suggesting that shear stress-induced expression of these 
genes depends on HSPG. These findings indicate for the first time that HSPG 
is a mechanosensor mediating shear stress-induced EC maturation from 
ESC-derived EC cells.
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Endothelial progenitor cells (EPCs) are central to the formation of new 
vessels that occurs during tissue repair and are attractive candidates for 
regenerative cell therapies. However, current knowledge regarding their 
immuno-phenotype and reservoirs is inadequate and controversial. We 
sought to quantitate the respective roles of skin-resident and bone marrow-
derived putative EPCs during wound healing to determine hierarchy and 
origin of the cells participating. Excisional wounds were generated on 
C57BL/6 mice and collected daily from day 1 to 5 after wounding. All 
tissues were analysed using 5-colour flow cytometry for CD45, CD11b, 
CD34, CD31 and VEGFR2. Unbiased analyses were performed to establish 
hierarchy. Absolute number modifications in each compartment (wound, 
blood, bone marrow) were calculated and considered for potential exchange 
between compartments. Here, we propose a cell population defined as 
CD34+CD45loCD31loVEGFR2lo that exists as an omnipresent EPC. In skin 
wounds these putative EPCs proliferated from day 1 and exhibited peak 
expansion on day 4 of healing. Within this expanded pool, a population of 
CD34+CD45loCD31hiVEGFR2hi cells appeared from day 2 and increased 
3 fold in absolute number between day 4 and 5 post wounding, suggest-
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ing terminal differentiation of progenitors. The contribution of EPCs or 
terminally differentiated cells from bone marrow or the circulating blood was 
quantitatively small and occurred later than this initial local response. We 
propose that putative EPCs exist in local rather than distant pools and prolif-
erate to give rise to the neovascularisation. These data challenge the current 
paradigm for EPC recruitment during wound healing and provide invaluable 
insight into a useful but poorly understood tissue progenitor population.
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Members of the bone morphogenetic protein (BMP) family have been 
implicated in the development and maintenance of vascular systems. While 
members of the BMP2/4 and osteogenic protein-1 groups signal via activin 
receptor-like kinases (ALK)-2, 3, and 6, BMP9 and 10 have been reported 
to bind to ALK-1 in endothelial cells. However, the roles of BMP9/ALK-
1 signaling in the regulation of endothelial cells have not yet been fully 
elucidated. Here, we examined the effects of BMP9 on the proliferation of 
endothelial cells using various systems. Vascular tube formation from ex 
vivo allantoic explants of mouse embryos was promoted by BMP9. BMP9, 
as well as BMP4 and 6, also induced the proliferation of in vitro-cultured 
mouse embryonic stem cell-derived endothelial cells (MESEC) by inducing 
the expression of vascular endothelial growth factor receptor 2 and Tie2, a 
receptor for Angiopoietin-1. Decrease in ALK-1 expression and expression 
of constitutively active ALK-1 in MESEC abrogated and mimicked the effects 
of BMP9 on the proliferation of MESEC, respectively, suggesting that BMP9 
promotes their proliferation via ALK-1. Furthermore, in vivo angiogenesis 
was promoted by BMP9 in a Matrigel plug assay and a BxPC3 human pan-
creatic cancer xenograft model. Furthermore, we found that BMP9 inhibited 
in vivo lymphangiogenesis in a BxPC3 human pancreatic cancer xenograft 
model. These findings suggest that BMP9 signaling activates the endothe-
lium tested in the present study via ALK-1.
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In type 2 diabetes the impairment of vascular repair processes and an-
giogenesis due to endothelial progenitor cell (EPC) dysfunction can be 
improved after strict glycemic control. We established an in vitro vessel 
formation assay of EPCs by using CFSE staining system in order to study the 
effects of hyperglycemic conditions. This system quantifies the vessel form-
ing capacity of CFSE-labeled EPCs cultured in hyperglycemic conditions, with 
good glycemic control (189.5 mg/dl of D-glucose) or poor glycemic control 
(295.5 mg/dl of D-glucose) compared to normal glycemic condition (100 
mg/dl of D-glucose) when co-culturing with human umbilical vein endothe-
lial cells (HUVECs). From three independent experiments, we found that the 
in vitro vessel forming capacity was impaired in EPCs cultured in hyperglyce-
mic conditions compared to normal glycemic conditions (43.40 ± 0.77% for 
good glycemic condition, 34.70 ± 0.70% for poor glycemic condition and 
50.78 ± 2.07% for normal glycemic conditions; p < 0.01). We studied the 
gene expression profiles of 15 candidate genes involving in vessel formation 
and found that there was a lower gene expression level only for angiopoi-
etin1 whereas there was a higher gene expression level for VECAM1 in EPCs 
cultured in hyperglycemic conditions compared to normal glycemic condi-
tion. The results were validated by coculturing EPCs in hyperglycemic condi-
tions with recombinant angiopoietin1 which showed a significant increase in 
vessel forming capacity of EPCs in hyperglycemic condition (35.33 ± 1.98% 
to 48.76 ± 2.67%, p< 0.05). In contrast, angiopoietin2 (a competitive 
inhibitor of angiopoietin1) was shown to inhibit the vessel forming capacity 
of EPCs cultured in normal glycemic condition (51.83 ± 1.32% to 41.28 
± 0.63% , p< 0.01). We conclude that in vitro vessel forming capacity of 
EPCs in hyperglycemic condition is impaired and angiopoietin1 may play an 
important role in the vessel forming capacity of EPCs.
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Aims Most previous studies on the role of SCF in EPC-mediated neovas-
cularization have focused on the EPC mobilization and homing process. 
However, the direct effects of SCF on neovascularization activity of EPCs 
have not been characterized. We sought to determine whether SCF regu-
lates the neovascularization ability of EPCs by comparing its roles in mature 
endothelial cells. Methods and Results In vitro and in vivo assays revealed 
that SCF substantially increased the neovascularization activity of human 
EPCs through the SCF receptor c-Kit. Notably, the SCF-induced increase 
in neovascularization activity was substantially greater in EPCs than that in 
HUVECs. SCF-induced phosphorylation of c-Kit and its downstream signal-
ing molecules was consistently found to be more potent and longer-lasting 
in EPCs than in HUVECs. This high responsiveness of EPCs to SCF was 
explained by the finding that the cell-surface expression of c-Kit is far higher 
in EPCs than in HUVECs. A c-Kit promoter assay revealed that the increased 
expression of c-Kit in EPCs could be attributed to the greater expression of 
Scl, LMO2, and GATA2. Conclusion In addition to its documented role in the 
mobilization and recruitment of EPCs, our findings show that SCF directly 
enhances the neovascularization activity of EPCs. Furthermore, the pres-
ent study provides further evidence that EPCs exhibit differentially greater 
responsiveness to hypoxia-inducible cytokines including SCF than mature 
endothelial cells, suggesting that EPCs in ischemic tissues function differently 
from mature endothelial cells, although they exhibit very similar phenotypes.
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TRANSPLANTATION OF AUTOLOGOUS 
ENDOTHELIAL PROGENITOR CELLS IMPROVES 
PULMONARY ENDOTHELIAL FUNCTION 
AND GAS EXCHANGE IN RABBITS WITH 
ENDOTOXIN-INDUCED ACUTE LUNG INJURY
Lam, Chen-Fuh
Department of Anesthesiology, National Cheng Kung University Medical 
College and Hospital, Tainan, Taiwan
Background. Circulating endothelial progenitor cells (EPCs) have been 
therapeutically applied to aid vascular repair and myocardial regeneration. 
The number of circulating EPCs also provides invaluable outcome prediction 
for fatal diseases such as acute lung injury (ALI) or acute respiratory distress 
syndrome (ARDS). However, evidence for the therapeutic potential of 
EPCs in subjects with ALI/ADRS is limited. Methods. Circulating EPCs were 
obtained from rabbits using Ficoll centrifugation. One week after culturing 
EPCs in endothelial growth medium-2, ALI was induced in rabbits by intra-
tracheal instillation of lipopolysaccharide (LPS, 500 µg/kg). Autologous EPCs 
or saline were administered intravenously following induction of ALI and 
animals were sacrificed 2 days later. Pulmonary artery endothelial function 
and gas exchange were determined. Degrees of lung injury were assessed 
by alveolocapillary permeability, lung hemoglobin content and myeloper-
oxidase (MPO) activity. Results. Compared with controls, partial pressure 
of oxygen in arterial blood was significantly elevated and pulmonary artery 
endothelium-dependent relaxation response was restored in rabbits receiv-
ing EPC transplantation. Lung water, Evan’s blue and bronchoalveolar lavage 
protein contents were significantly reduced in EPC transplanted group, 
indicating a better preservation of the alveolocapillary membrane. Transplan-
tation of EPCs decreased lung hemoglobin level. Furthermore, expressions 
of CD11b and MPO activity were also suppressed following administration 
of EPCs. Conclusions. Transplantation of EPCs restored pulmonary endothe-
lial function, preserved integrity of alveolocapillary barrier and suppressed 
lung inflammatory response, thereby improving pulmonary gas exchange in 
rabbits with intratracheal LPS-induced ALI. Transplantation of EPCs can be a 
novel cell-based, endothelium-targeted therapeutic strategy for prevention 
and treatment of ALI/ARDS.
Poster Board Number: 1130
WHAT’S THE ORIGIN OF AN OUTGROWTH 
ENDOTHELIAL PROGENITOR CELL?
Tura, Olga
University of Edinburgh, Edinburgh, United Kingdom
Background: The observation that peripheral blood contains a population 
of cells capable of forming endothelial cells in vitro and contributing to 
angiogenesis in vivo suggested the presence of a circulating endothelial 
progenitor cell (EPC). A decade of research has sought to identify the origin 
and phenotype of EPC and to harness their potential for cardiovascular 
regeneration. Whilst this concept is clearly important, ambiguity regarding 
the precise definition of an EPC has hampered progress in this field. Of the 
populations identified so far, endothelial outgrowth cells (EOC) most closely 
fulfil the criteria of an EPC, but their origin and circulating precursor have 
not been identified. Methods and Results: Using enrichment and depletion 
strategies to isolate cell fractions based on the expression of stem cell and 
endothelial markers, we provide evidence that EOC potential is associated 
with the CD34+CD133-CD146+ cell fraction. Mature endothelial cells are 
also defined as CD34+CD133-CD146+ cells. We have further investigated 
the origin of EOC and compared them to mature human umbilical vein 
endothelial cells (HUVEC). We report that EOC are identical to mature 
HUVECs by morphology, surface antigen expression, immunohistochemistry, 
RT-PCR, proliferation and functional assessments. In vivo data show that 
early passage EOC and HUVEC implanted in a mouse model of angiogenesis 
gave substantial blood vessel formation incorporating cells of human origin. 
On the other hand, our results showed that whilst EOC can be readily 
isolated from umbilical cord and peripheral blood they cannot be isolated 
from bone marrow or G-CSF mobilised blood raising the possibility that the 
precursors of EOC are derived from an alternative stem cell niche outside the 
bone marrow. Indeed, BM-derived outgrowth cells were positive for mes-
enchymal markers, negative for endothelial markers and they did not form 
blood vessels in vivo. Conclusion: Our study demonstrated the similar, if not 
identical, nature of EOC to mature endothelial cells and questions the source 
of these cells. The site of origin of EOC is presently unknown but the current 
literature suggests that human circulating endothelial progenitors appear 
to be bone marrow (BM) derived. In our study, BM had negligible numbers 
of CD34+CD133-CD146+ cells and lacked the potential to generate EOC 
colonies. We therefore conclude that bone marrow is not a source of EOC.
Poster Board Number: 1132
ROLE OF EPC IN VASCULARISED BONE TISSUE 
ENGINEERING
Liu, Yuchun1, Teoh, Swee-Hin2, Chong, Mark3, Kamm, Roger D.4, 
Zhang, Zhiyong2, Choolani, Mahesh A3, Chan, Jerry3
1Obstetrics and Gynaecology, National University of Singapore, Singapore, 
Singapore, 2Mechanical Engineering, National University of Singapore, 
Singapore, Singapore, 3Obstetrics and Gynaecology, National University 
Hospital System, Singapore, Singapore, 4Mechanical and Biological 
Engineering, Massachusetts Institute of Technology, Boston, MA, USA
Clinical translation of bone tissue engineering approaches for fracture repair 
has been hampered by the lack of adequate vascularization required for 
maintaining cell survival and skeletal regeneration. Here, we investigated 
the vasculogenic and osteogenic contributions of umbilical cord blood 
derived endothelial progenitor cells (EPC) when cocultured with human fetal 
mesenchymal stem cell (hfMSC) in both in vitro and in vivo paradigms for 
the generation of vascularised bone grafts. It is hypothesised that the addi-
tion of EPC to osteogenic-primed hfMSC constructs will lead to enhanced 
vascularisation and osteogenesis, eventually accelerating fracture healing. 
Coculture of EPC enhanced hfMSC osteogenic differentiation, resulting 
in earlier induction of ALP (Day 7 versus Day 10) and increased calcium 
deposition (1.9X; p<0.001) compared to hfMSC alone. This effect was 
observed only in bone inductive medium, but not in basal medium, suggest-
ing that EPC does not induce osteogenic programming by itself. Instead, 
the soluble factors secreted by EPC was found to be responsible for this 
observed osteogenic enhancement, which led to 1.8-2.2X higher ALP levels 
and 1.4-1.5X increase in extracellular calcium deposition (p<0.01) when 
hfMSC were cultured in EPC conditioned media (EPCCM) compared to bone 
media culture. Protein analysis of the EPCCM revealed a wide spectrum of 
secreted proteins containing pro-inflammatory cytokines, angiogenic fac-
tors and bone-related proteins such as Angiogenin, Angiopoietin-2, BMPs 
and TGF-βs. To observe the cellular distribution in coculture, cells were 
dual fluorescent-labelled by lentiviral vectors. Islet formation by EPC and 
subsequent development into vessel-like structures over time was observed 
only in coculture with hfMSC but not in EPC monoculture alone. Translation 
of the coculture from two-dimensional monolayer into three-dimensional 
scaffold constructs also supported an extensive EPC-derived vessel-like 
network within the microarchitecture of the scaffold in vitro. To investigate 
the performance of EPC/hfMSC coculture in vivo, cellular-scaffold con-
structs were implanted subcutaneously in immunodeficient mice. Microfil 
perfusion revealed extensive vascularisation penetration into the scaffolds, 
with the presence of human specific CD31+ lumenal-like structures on Week 
3 in EPC/hfMSC-constructs only. This was accompanied by an increase in 
ectopic bone formation on Week 8 in the EPC/hfMSC constructs as com-
pared to the hfMSC alone, suggesting the importance of vascularisation in 
aiding bone formation. This study highlighted the potency of umbilical cord 
blood-EPC as a potential vasculogenic and osteogenic-enhancing cell source 
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for stem cell therapy in bone tissue engineering applications. Evidence of its 
mechanistic influence via its secreted paracrine modulators also suggests the 
possibility of use of its soluble factors as a therapeutic off-the-shelf biologics 
strategy for bone repair.
Poster Board Number: 1134
EFFECT OF IONIZING RADIATION INDUCED 
DAMAGE OF ENDOTHELIAL PROGENITOR 
CELLS IN VASCULAR REGENERATION
Lee, Mi-Ok1, Song, Seun-Hyun1, Kwon, Sang-Mo2, Cha, Hyukjin1
1CHA University, Seoul, Korea, Republic of, 2Pusan National University, 
Pusan, Korea, Republic of
Accumulated studies have revealed that roles of stress signalings, and 
subsequent stress response in stem/progenitor cells, is responsible for 
retarded regeneration or degenerative disease. As ionizing radiation (IR), 
which sensitizes diverse types of stem/progenitor cells, has been reported to 
induce cardio-circulatory diseases, we hypothesized that IR induced vascular 
abnormality is associated to defect of stem/progenitor cells that are respon-
sible for vascular homeostasis, mainly endothelial progenitor cells (EPCs). 
Herein, we used the irradiated mouse model to mimic the IR effect on 
vasculorigenesis. Mouse EPCs isolated from irradiated mice and human EPCs 
exposed to IR were used for functional analysis and gene expression study. 
We showed the evidence that EPCs were depleted and their function for 
vasculorigenesis in vitro and in vivo was significantly reduced by a single IR 
exposure. Such IR mediated stress responses in EPCs, upregulating p21Cip1 
and downregulating vascular endothelial growth factor (VEGF) is mediated 
by p53 transcriptional activity. These results suggest that suppression of p53 
would be clinically applicable to minimize the functional defect of EPCs in 
order to prevent onset of vascular diseases from radio-therapy or radiation 
exposure. Conclusion: These studies provide a novel insight into addressing 
the mechanism of IR induced vascular damage.
Poster Board Number: 1136
IDENTIFICATION OF A NOVEL MICRORNA 
REGULATING ANGIOGENIC RESPONSES
Doi, Kent1, Matsunaga, Taichi2, Yamamizu, Kohei2, Miyamoto, 
Susumu1, Yamashita, Jun K.2
1Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto, 
Japan, 2Laboratory of Stem Cell Differentiation, Stem Cell Research Center, 
Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan
MicroRNAs are a class of small RNAs that regulate target gene expression on 
the post-transcriptional level. Several microRNAs, such as mir-126 or miR-
221/222 have been reported to control angiogenesis. We previously devel-
oped a novel embryonic stem (ES) cell differentiation system that exhibits 
vascular cell differentiation and early vascular development using vascular 
endothelial growth factor (VEGF) receptor-2 (VEGFR2/Flk1)-positive cells as 
common progenitors. With the use of this system, we have been elucidating 
various cellular and molecular mechanisms of vascular cell differentiation, 
such as enhancement of EC differentiation from Flk1+ cells with protein 
kinase A activation and arterial EC specification through direct interaction 
of Notch and β-catenin signaling downstream of cAMP. In this study, to 
elucidate roles of microRNAs in EC differentiation and vascular formation, 
we screened microRNAs specifically expressed during EC differentiation with 
the use of our ES cell differentiation system. Then, we identified a microRNA 
(mir-X) that is expressed in vascular ECs from ES cells, more predominantly 
in arterial ECs than venous ECs. Mir-X is expressed also in the dorsal aorta of 
mouse embryo and in human EC lines. Over-expression of mir-X in human 
EC lines showed an inhibitory effect on angiogenic responses such as EC 
migration or tube formation. Mir-X is, thus, supposed to be an endogenous 
regulator of angiogenesis, suggesting its great possibility for clinical applica-
tion in the treatment of cancer or ischemic diseases.
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GENETIC ENGINEERING OF ENDOTHELIAL 
PROGENITOR CELLS WITH ENDOTHELIAL 
NITRIC OXIDE SYNTHASE IMPROVES 
ANGIOGENESIS IN RABBITS WITH HINDLIMB 
ISCHEMIA
Kaur, Savneet1, Harikrishnan, VS2, Shenoy, Sachin J.2, 
Radhakrishnan, NS3, Uruno, Akira4, Sugawara, Akira4, Kartha, 
Chandrasekharan C.5
1School of Biotechnology, Gautam Buddha University, Greater Noida, India, 
2Biomedical Technology Wing, Sree Chitra Tirunal Institute of Medical 
Sciences and Technology, Kerala, India, 3Sree Chitra Tirunal Institute 
for Medical Sciences and Technology, Kerala, India, 4Tohoku University 
Graduate School of Medicine, Sendai, Japan, 5Rajiv Gandhi Center for 
Biotechnology, Kerala, India
Background: The present study explored the effect of endothelial nitric 
oxide synthase (eNOS) gene transfer on the angiogenic potential of ex vivo 
expanded endothelial progenitor cells (EPCs) in a rabbit model of hindlimb 
ischemia. Methods: Rabbit peripheral blood EPCs were cultured and 
transfected with mammalian expression vector pcDNA3.1-eNOS containing 
full-length human eNOS gene. Ischemia was induced in the right hind limb 
of three groups of rabbits by ligation of the distal external iliac artery and 
excision of the common and superficial femoral arteries. In one group of ani-
mals, ten days after the surgery, autologous eNOS-EPCs were transplanted 
intramuscularly in the ischemic limb. Two other groups received an equiva-
lent number of unmodified EPCs or phosphate buffered saline (PBS) respec-
tively. Results: Two weeks after cell transplantation, the in vivo expression 
of eNOS was detected in limb tissue sections of eNOS-EPCs treated animals. 
Animals treated with eNOS-EPCs had a significant reduction in ischemic 
muscle necrosis and inflammation, augmentation in the capillary density 
(P< 0.05) and angiographic scores demonstrating distal arterial reconstitu-
tion and enhanced angiogenesis in comparison to animals transplanted with 
EPCs or PBS (P< 0.05). Conclusion: We conclude that modification of EPCs 
by eNOS constitutes an effective strategy to improve the efficacy of EPCs 
for therapeutic angiogenesis.
Poster Board Number: 1140
THE ROLE OF MESENCHYMAL STEM CELL 
CONDITIONED MEDIUM ON THE MIGRATION 
AND PROLIFERATION OF ENDOTHELIAL 
PROGENITOR CELLS
Supokawej, Aungkura1, Witchayaporn, Kamprom2, Kheolamai, 
Pakpoom3, U-pratya, Yaowalak4, Manochantr, Sirikul3, 
Tantrawatpan, Chairat3, Issaragrisil, Surapol4
1Department of Clinical Microscopy, Faculty of Medical Technology, 
Mahidol University, Bangkok, Thailand, 2Department of Immunology, 
Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, 
Thailand, 3Division of Cell Biology, Department of Pre-clinical Sciences, 
Faculty of Medicine, Thammasat University, Pathumthani, Thailand, 
4Division of Hematology, Department of Medicine, Faculty of Medicine 
Siriraj Hospital, Mahidol University, Bangkok, Thailand
Mesenchymal stem cells (MSCs) are multipotent stem cells, which have been 
regarded as potential cell sources for tissue replacement therapy. Although 
the ability of MSCs in restoring the damaged tissue by direct differentiation 
to generate specific cell types is still controversial, their role as a source of 
pro-angiogenic and anti-inflammatory cytokines is well established. There 
are several reports showing the positive effects of MSC-derived cytokines 
in ameliorating the symptom of ischemic heart disease and cerebrovascular 
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disease in animal models. Recently, endothelial progenitor cells (EPCs) have 
been identified as an important regulator of vascular homeostasis and the 
major contributor of postnatal neovascularization. According to this, there 
might be an interaction between MSC-derived angiogenic cytokines and 
EPC function, which results in the neovascularization of ischemic tissues. 
In this study, the effect of cytokines secreted from bone marrow-derived 
MSCs (BM-MSCs) on the proliferation, migration and invasion of EPCs were 
investigated using an in vitro model. To investigate the effect of BM-MSCs 
on EPC proliferation, the conditioned medium from passage 4 of MSCs was 
collected and used for EPC culture. The results showed that the conditioned 
medium from BM-MSCs can enhance the proliferation of cultured EPCs 
compared with controls. In addition, the BM-MSCs were co-cultured with 
EPCs through the transwell system to assess their paracrine effects on EPC 
migration and invasion. The result showed that BM-MSCs can induce higher 
levels of EPC migration and invasion compared with controls. In conclu-
sion, this study demonstrated that the factors secreted by BM-MSCs play an 
important role in the proliferation, migration and invasion of EPCs.
EPIDERMAL CELLS
Poster Board Number: 1142
FEEDER LAYERS COMPARISON FOR THE 
PRESERVATION OF THE PROLIFERATIVE 
CAPACITY OF HUMAN EPITHELIAL STEM CELLS 
GROWN IN VITRO
Bisson, Francis1, Paquet, Claudie1, Larouche, Danielle1, Guérin, 
Sylvain L.2, Germain, Lucie1
1Centre LOEX de l’Université Laval, Centre de recherche FRSQ du CHA de 
Québec, Département de chirurgie, Faculté de Médecine, Université Laval, 
Quebec, QC, Canada, 2LOEX/CUO-Recherche, Centre de recherche FRSQ 
du CHA de Québec, Département d’ophtalmologie, Faculté de Médecine, 
Université Laval, Quebec, QC, Canada
INTRODUCTION: Epidermal cell sheets grown in vitro are used as skin sub-
stitutes in the treatment of severe burn wounds. Using a lethally irradiated 
fibroblast feeder layer allows for a better lifetime survival of human epithelial 
stem cells grown in vitro. Our team has already shown that mouse feeder 
layer mediated survival of keratinocytes (skin epithelial cells) comes in part 
from the stabilisation of the positive transcription factor Sp1 in keratino-
cytes. The goal of this project was to analyse the influence of co-culturing a 
human fibroblast feeder layers on the proliferation and differentiation of skin 
keratinocytes and determine whether it enhances the quality of epidermal 
cell cultures. 
METHODS: Keratinocytes were cultured either alone or in the presence of a 
lethally irradiated feeder layer (mouse or human) for about twenty passages 
or until differentiation. Proteins, RNA and cell extracts were obtained at each 
passages. Sp1 expression levels were analysed at each passage by Western 
Blot. RESULTS: Both human and mouse feeder layers had similar influences 
on keratinocytes growth and differentiation as revealed by the number of 
passages reached by these cells before they became differentiated and by 
their corresponding levels of Sp1 expression. Keratinocytes were cultured 
up to passage 18, both with human and mouse fibroblast feeder layer, 
without major degradation of Sp1, as opposed to keratinocytes cultured 
alone that only reached passage 8 before entering terminal differentiation. 
Furthermore, Sp1 level started to decline at higher passages with human 
feeder layers as compared to mouse feeder layers in 4 out of 6 cell lines. 
CONCLUSION: Human feeder layers promote proliferation of keratinocytes 
and stabilize expression of Sp1. Studying the mechanisms by which feeder 
layers promote cell proliferation will allow us to enhance the quality of tissue 
grafts, such as those from both the skin and the cornea that are used in the 
treatment of burn wounds.
Poster Board Number: 1144
FIBROBLAST DIFFERENTIATION FROM 
HUMAN INDUCED PLURIPOTENT STEM CELLS 
IS LINKED TO EPIGENETIC REGULATION 
OF PDGFR-B AND ACQUISITION OF 
MESENCHYMAL FUNCTION
Hewitt, Kyle J., Shamis, Yulia, Margvelashvili, Mariam, Knight, 
Elana, Smith, Avi, Garlick, Jonathan
Tufts University, Boston, MA, USA
Advances in human induced pluripotent stem (hiPS) cell biology have raised 
new questions regarding the effect of reprogramming on the phenotype 
and function of a variety of cell types differentiated from them. We recently 
derived cells from hiPS showing characteristic properties of stromal fibro-
blasts (iPDK) that were similar to human embryonic stem cell- (hES) derived 
fibroblasts (EDK), and contributed to normal skin development and repair in 
an in vitro 3D tissue. The goal of the current study was to characterize the 
epigenetic profile and associated functional properties hiPS-derived cells dur-
ing their differentiation to compare them to input fibroblasts initially used for 
reprogramming. We performed a detailed methylation analysis to compare 
iPDK cells to input fibroblasts, and showed that iPDK cells shared many of 
the same CpG methylation sites as the original fibroblasts, and were distinct 
from hiPS and hES cells. Specifically, our analysis revealed that the promoter 
for platelet-derived growth factor-β (PDGFRβ), an important receptor in 
fibroblast lineage commitment and function, was demethylated following 
differentiation, and PDGFRβ gene expression was concomitantly increased in 
differentiated fibroblasts. Following knockdown of PDGFRβ receptor using 
shRNA, iPDK and EDK exhibited a phenotypic shift towards a mesenchymal 
phenotype, including downregulation of cytoskeletal genes such as alpha-
smooth muscle actin and cytokeratin 18, as well as a decrease in expression 
of extracellular matrix proteins such as Type I Collagen and Tenascin C. We 
are currently studying the effects of PDGFRβ knockdown in a 3D tissue 
context to determine the importance of this receptor on the regenerative 
potential of iPDK cells. Our findings implicate the loss of methylation of 
the PDGFRB promoter during differentiation of hIPS cells as an important 
regulatory step in the commitment of fibroblast-like iPDK cells that may 
influence their phenotype and function.
Poster Board Number: 1146
DSG3 SAFEGUARDS MOUSE BULGE STEM 
CELL QUIESCENCE AND ITS LOSS RESULTS 
IN NICHE REPAIR AT THE EXPENSE OF HAIR 
FOLLICLE REGENERATION
Schulze, Katja, Galichet, Arnaud, Zyman, Hillard, Suter, Maja M., 
Müller, Eliane J.
Institute for Animal Pathology, Molecular Dermatology, University of Berne, 
Berne, Switzerland
The stem cell (SC) niche is considered to govern SC homeostasis and repair. 
Cell-cell and cell-matrix adhesion is important in epithelial tissue remodel-
ing through both structural and signaling-dependent mechanisms. Recent 
discussions about the contribution of cadherin-mediated niche adhesion in 
hematopoietic SC homeostasis and the proposition to eliminate quiescent 
cancer SC by targeting cadherins, emphasize an important role of cadherins 
in the SC niche. In skin, limited knowledge is available on mechanisms of SC 
activation during repair and specifically following loss of cadherin-mediated 
niche adhesion. Pemphigus vulgaris (PV) is a severe autoimmune blistering 
disease in human and animal, characterized by circulating antibodies against 
the desmosomal cadherin desmoglein 3 (Dsg3). We utilized a PV mouse 
model, in which a function disrupting mouse monoclonal anti-Dsg3 anti-
body (AK23) targets desmosomal adhesion, which results in blister formation 
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by interfering with intracellular signaling events. Upon AK23 injection into 
eight-week-old C57Bl/6J mice, adhesion of telogen HF bulge SC is disrupted 
between the inner K6pos bulge layer, believed to maintain quiescence, and 
the outer CD34pos cell layer, which participates in HF renewal. Timecourse 
studies revealed that 24 hours after AK23 injection a prominent SC activa-
tion is induced. This is characterized by progressive loss of label retaining 
cells in K5-tTA;tetO-H2BGFP mice and increased SC proliferation. Con-
comitant downregulation of the quiescence marker NFATc1, reduced CD34 
expression and downregulation of the bulge “stemness signature” (Sox9, 
Lhx2, Tcf4, Lgr5) further indicated profound alterations in SC homeostasis. 
We uncovered that BMP2/4 mRNA levels started to decrease from 24 hours 
onwards, correlating with PI3K/Akt activation. In vivo experiments using 
a dual PI3K/mTOR inhibitor (NVP-BEZ235) identified PI3K/Akt signal-
ing to be involved in the late proliferative process, but early proliferation 
taking place around 24 hours after AK23 injection occurs prior to PI3K/
Akt activation. Furthermore, PI3K/Akt signaling is not involved in loss of 
the “stemness signature.” Instead, we discovered that Wnt-mediated Shh 
activation which usually parallels reduced BMP signaling and is a prerequisite 
for HF regeneration, is suppressed upon disruption of niche adhesion. We 
propose that these collective processes favor niche repair at the expense of 
HF regeneration. Indeed, SC are not lost in the long-term, although clonal 
efficiency is transiently reduced. Keratinocytes isolated from AK23 treated 
CAG-EGFP mice are able to replenish all skin lineages in single cell graft-
ings. This suggests that SC activation did not result in irreversible commit-
ment which is underscored by studies using K1-15-CrePR1;R26R mice to 
trace bulge-derived SC. No significant upward migration of activated bulge 
SC was observed upon disruption of niche adhesion. Furthermore, AK23 
injected mice are able to enter anagen upon hair plucking. In summary 
we demonstrate in a mouse model for PV, that Dsg3 holds an important 
function in SC homeostasis by safeguarding quiescence. We further identify 
BMP/Wnt/Shh signaling as a switch board governing niche repair by receiv-
ing signals from early effectors upon disruption of niche adhesion. Therefore 
our work provides novel insights into cadherin-mediated SC activation and 
repair mechanisms.
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NOTCH SIGNALING IN EPIDERMAL AND HAIR 
CYCLE HOMEOSTASIS
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Notch signaling regulates a variety of processes such as differentiation, 
proliferation, apoptosis, and cell fate choice. Ligand binding leads to 
conformational changes in the Notch receptor and leads to NICD release 
from the membrane. NICD translocates into the nucleus and binds to Rbpj 
and Mastermind, thereby activating downstream target genes. Protein 
O-fucose transferase-1 (Pofut1), which catalyzes O-fucose modification of 
Notch receptor extracellular domain, is required for efficient ligand-receptor 
binding and subsequent signal transduction. Although Notch signaling plays 
an important role in regulating early-stage differentiation of the epidermis 
and complete maturation of hair follicles, how Notch signaling participates 
in epidermal and postnatal hair cycle homeostasis is less studied. Here, we 
conditionally inactivated Notch signaling by deletion of Rbpj and Pofut1 
using Tgfb3-Cre which induces gene recombination in hair follicle lineages 
and suprabasal layer of the epidermis. Both Rbpj and Pofut1 conditional 
inactivation resulted in defects in the granular layer and reactive epider-
mal hyperplasia. We are currently investigating gene expression levels of 
proteases and protease inhibitors which involved in filaggrin processing in 
the mutant epidermis. Disruption of Pofut in hair follicle lineages resulted in 
aberrant telogen morphology, a delay in anagen re-entry, and dysregulation 
of proliferation and apoptosis during the hair cycle transition. Moreover, 
increased DNA double stand break signals were detected in Pofut1-deficent 
hair follicles. To investigate the mechanism underlying the DNA damage 
response in Pofut1-deficient hair follicles, bulge stem cells from control and 
Pofut1-deficient mice were isolated and their colony forming ability was 
compared. Furthermore, examination of cell proliferation by BrdU staining 
and DNA damage by γ-H2AX staining were also carried out and results were 
compared between control and Pofut1-defeicint bulge stem cells. Our data 
suggest that Notch signaling plays a role in late-stage epidermal differentia-
tion and postnatal hair cycle homeostasis.
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THE BULGE AREA OF THE HAIR FOLLICLE 
IS THE MAJOR SOURCE OF HAIR FOLLICLE 
PLURIPOTENT STEM CELLS
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Nestin-expressing cells of both the bulge area (BA) and dermal papilla (DP) 
have been previously shown to be multipotent and be able to form hair 
follicle cells as well as neural and other non-follicle cell types. The objective 
of the present study was to determine the major source of nestin-expressing 
stem cells in the hair follicle and to compare the ability of the nestin-express-
ing stem cells from the BA and DP to repair spinal cord injury. Transgenic 
mice in which the nestin promoter drives GFP (ND-GFP) were used in order 
to observe nestin expression in the BA and DP. The expression of nestin in 
the DP depended on the phase of the hair follicle. Nestin-expressing DP 
cells were found in early and middle anagen. The BA had nestin expression 
throughout the hair cycle and to a greater extent than the DP. Nestin-
expressing cells from both regions had essentially identical morphology with 
very long processes extending from them as shown by two-photon confocal 
microscopy. Nestin-expressing cells from both areas differentiated into neu-
ronal cells at high frequency in vitro. Matrices of cells from both the BA and 
DP were formed by culturing them on Gelfoam® which were used to repair 
the injured spinal cord in nude mice. Both nestin-expressing DP and BA cells 
differentiated into neuronal and glial cells after transplantation to the injured 
spinal cord and enhanced injury repair and locomotor recovery within four 
weeks with the BA being the greater and more constant source.
Poster Board Number: 1152
DYNAMICS BETWEEN STEM CELLS, NICHE 
AND PROGENY IN THE HAIR FOLLICLE
Hsu, Ya-Chieh, Pasolli, H. Amalia, Fuchs, Elaine
Rockefeller University, New York, NY, USA
Here, we exploit the hair follicle to define the point at which stem cells 
become irreversibly committed along a differentiation lineage. Employing 
histone and nucleotide double-pulse-chase and lineage tracing, we show 
that the early SC descendents en route to becoming transit-amplifying cells 
retain stemness and slow-cycling properties and home back to the bulge 
niche when hair growth stops. These become the primary SCs for the next 
hair cycle, while initial bulge SCs become reserves for injury. Proliferating 
descendents further en route irreversibly lose their stemness, although they 
retain many SC markers and survive, unlike their transit-amplifying progeny. 
Remarkably, these progeny also home back to the bulge. Combining purifi-
cation and gene expression analysis with differential ablation and functional 
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experiments, we define critical functions for these non-SC niche residents, 
and unveil the intriguing concept that an irreversibly committed cell in an SC 
lineage can become an essential contributor to the niche microenvironment.
Poster Board Number: 1154
LHX2 OPERATES AS A SWITCHBOARD 
REGULATOR OF STEM CELL ACTIVITY DURING 
SKIN RESPONSE TO INJURY
Mardaryev, Andrei1, Meier, Natalia2, Poterlowicz, Krzysztof1, 
Sharov, Andrey3, Sharova, Tatyana3, Werner, Sabine4, Paus, Ralf5, 
Botchkarev, Vladimir6
1Centre for Skin Sciences, University of Bradford, Bradford, United 
Kingdom, 2Dermatology, University of Luebeck, Luebeck, Germany, 
3Dermatology, Boston University, Boston, MA, USA, 4Cell Biology, Swiss 
Federal Institute of Technology, Zuerich, Switzerland, 5Dermatology, 
University of Luebeck/University of Manchester, Luebeck/Manchester, 
Germany, 6Dermatology, Boston University/University of Bradford, Boston, 
MA, USA
The Lhx2 transcription factor plays essential roles in the morphogenesis and 
patterning of ectodermal derivatives, as well as in controlling the activity 
of epithelial stem cells in the skin. We demonstrate here that in mouse and 
human hair follicles (HFs), Lhx2+ cells residing in the stem cell-enriched epi-
thelial HF compartments (bulge, secondary hair germ, infundibulum/outer 
root sheath) represent the vast majority of cells that proliferate in response 
to skin injury. In heterozygous Lhx2 knockout (+/-) mice, the wound heal-
ing process is significantly retarded, while anagen onset in the HFs located 
closely to the wound edge is accelerated compared to wild-type mice. In 
Lhx2 -/- mice, expression of the genes encoding selected stem cell markers 
(Sox9, Tcf4, Cd34) was decreased, while expression of Lgr5 increased versus 
wild-type controls. Lhx2 co-localized with Sox9, Tcf4 and Cd34 in the bulge 
keratinocytes, and the number of Sox9+, Tcf4+ and Cd34+ cells seen in the 
infundibulum/bulge of the HFs closely adjacent to the wound decreased 
in the Lhx2 +/- mice versus wild-type controls. Furthermore, Chip-on-chip 
and Chip-qPCR analyses using lysates from primary mouse keratinocytes 
revealed Sox9, Tcf4 and Lgr5 as direct Lhx2 targets. Thus, our data strongly 
suggest that Lhx2 promotes re-epithelization during wound healing via posi-
tive regulation of Sox9 and Tcf4, while it simultaneously inhibits HF cycling 
via negative regulation of Lgr5. Thus, Lhx2 operates as a switchboard 
regulator of epithelial stem cell activity in the HF during the response of the 
skin to injury.
INTESTINAL/GUT CELLS
Poster Board Number: 1156
DIRECTED DIFFERENTIATION OF HUMAN 
PLURIPOTENT STEM CELLS INTO PROXIMAL 
INTESTINAL TISSUE
Howell, Jonathan C.1, Spence, Jason R.2, McCracken, Kyle2, 
Mayhew, Christopher N.2, Wells, James M.2
1Division of Endocrinology, Cincinnati Children’s Hospital Medical 
Center and University of Cincinnati, Cincinnati, OH, USA, 2Division of 
Developmental Biology, Cincinnati Children’s Hospital Medical Center and 
University of Cincinnati, Cincinnati, OH, USA
Human pluripotent stem cells (PSCs), including embryonic stem cells and 
induced pluripotent stem cells, have a well-established capacity for dif-
ferentiating into tissues derived from all three germ layers. In the endoderm, 
advancements in the study of foregut and hindgut organogenesis have 
permitted the establishment of protocols for the directed differentiation of 
PSCs into specific endoderm organ cell types. Recently, an in vitro culture 
system was described by our group in which three-dimensional intestinal 
tissue is robustly derived from PSCs. In this system, PSCs are differentiated 
into definitive endoderm (DE) with ActivinA, after which WNT3A and FGF4 
induce posterior endoderm patterning and hindgut morphogenesis by 48 to 
96 hours. Intestinal organoids emerge from culture, are able to be expanded 
in pro-intestinal conditions, and consist of mesenchyme surrounding polar-
ized intestinal epithelium with specified intestinal cell types including Paneth, 
goblet, enteroendocrine, and LGR5+ cells. Although this tissue is clearly 
intestinal, we have not yet determined the proximal-distal nature of these 
organoids. Based upon the presence of crypt-like proliferative zones and 
villus-like structures within mature organoids, we hypothesized that they 
are proximal intestine. To investigate this we have analyzed tissue from our 
WNT/FGF cultures using proximal and distal intestinal markers. Expression 
of the distal small intestine marker GATA6 was absent and expression of 
both GATA4 and KLF5, known to be present in developing proximal intes-
tine, was increased nearly 4-fold compared to control cells exposed to no 
growth factors. Additionally, emerging organoids express increased levels of 
HoxC5 and HoxC9 compared to controls. To investigate if we could alter the 
proximal-distal fate of intestinal tissue we included the factor BMP2 to the 
WNT3A/FGF4 condition. BMP signaling is known to be critical to intestinal 
morphogenesis and thought to play a role in proximal-distal development 
of the gut. Organoid production still occurred but was decreased by 80% 
in the presence of BMP2. Whereas expression of GATA4, GATA6, and KLF5 
was absent, expression of the distal intestinal markers HoxA13 and HoxD13 
was significantly increased with addition of BMP2 compared to both 
control and WNT/FGF alone. We also analyzed for the presence of specific 
enteroendocrine cells, which are normally present in discrete, proximal-distal 
segments of the gut. Intestinal organoids cultured long-term for 4 months 
were positive for chromograninA and the duodenal region-specific hor-
mones glucose-dependent insulinotropic peptide (GIP) and cholecystokinin. 
However, they were negative for glucagon-like peptide 1 (GLP1), ghrelin, 
peptide YY (PYY) and somatostatin. Taken together these data suggest 
that our culture conditions promote a proximal hindgut fate as indicated by 
region-specific gene expression, and mature intestinal organoids are similar 
to fetal duodenal tissue by morphology and region-specific enteroendocrine 
hormone expression. Furthermore, addition of BMP2 may induce a more 
posterior gut pattern compared to WNT3A and FGF4 alone. Ongoing stud-
ies are aimed at further characterization of the regulation of patterning in 
organoid development and at factors capable of inducing more proximal or 
more distal intestinal tissue.
Poster Board Number: 1158
PREGNANCY ASSOCIATED PROGENITOR CELLS 
ENGRAFT IN THE MATERNAL MURINE SMALL 
INTESTINE AND DISPLAY A HEMATOPOIETIC 
PHENOTYPE
Sasajala, Piriya, Udolph, Gerald
Institute for Medical Biology, ASTAR, Singapore, Singapore
Cells of fetal origin known as Pregnancy Associated Progenitor Cells (PAPCs) 
are known to migrate to the mother during parturition and survive for 
long term. This phenomenon of fetal cell microchimerism has been widely 
studied in the mammalian system and PAPCs are shown to exhibit multi-
lineage potential. Clusters of PAPCs were reported in the studies of human 
small intestine and we sought to characterize intestinal PAPCs in a murine 
model in more detail. We studied the presence of GFP labeled PAPCs in the 
maternal intestine pre- and postnatally. PAPCs were detected in the intes-
tine in 42-60% of mothers; earliest at postpartum day 10 with long term 
engraftment up to 7 months postpartum. PAPCs were located in the lamina 
propria and at the periphery of the Peyer’s patches in a non-specific manner 
throughout the entire length of the small intestine. PAPCs did not proliferate 
in the intestine and were identified to be of hematopoietic nature as judged 
by the expression of B and T lymphoid specific markers such as CD19, IgA, 
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CD4, and CD8 and the myeloid marker, CD11b. PAPCs expressing the 
hematopoietic markers CD34+ and CD45+ were also found in the maternal 
peripheral blood at timepoint P0 and P40 thus suggesting the presence of 
a long term hematopoietic progenitor pool in mothers. A subset of PAPCs 
in the maternal peripheral blood as well as in the small intestine expresses 
α4β7 integrin which is involved in specific homing to intestinal lymphoid 
tissues and other major lymphoid organs that express mucosal addressin 
cell adhesion molecule-1 (MAdCAM-1). Our current research focuses on 
identifying the mechanisms of PAPC migration to the mother and to specific 
organs such as the small intestine.
Poster Board Number: 1160
THE ROLE OF β-CATENIN AND 
EOMESODERMIN IN THE ESTABLISHMENT 
OF MOUSE PROGENITOR AND STEM CELL 
LINEAGES DURING INTESTINAL ENDODERMAL 
DEVELOPMENT
Silva, Rita, Rossant, Janet
Hospital for Sick Children, Toronto, ON, Canada
Many disorders, including various types of cancer, are a direct result of the 
impaired development of the primitive gut tube, which is derived from the 
endodermal germ layer. Although the canonical Wnt pathway is central for 
many developmental processes, few studies have examined Wnt and its 
key player, β-catenin, in early endoderm specification. Most of the present 
insight comes from adult epithelial studies, which poses severe limitations to 
the understanding of gastrointestinal pathologies. Similarly, Eomesodermin, 
a crucial gene in trophectoderm development, has only recently been impli-
cated in definitive endoderm specification. Importantly, many of the genes 
that, in articulation with Eomesodermin, orchestrate trophectoderm lineage 
establishment in the early embryo, including Nodal, Cdx2, Fgf4 and Ascl2, 
will later prove decisive in initiating posterior endodermal fates and intestinal 
identity. Furthermore, an interaction between β-catenin and Eomesoder-
min was reported in progenitor populations of the developing brain cortex. 
However, the extent and nature of this interaction during the establishment 
of the intestinal lineage remain unknown. In order to determine the role of 
β-catenin and Eomesodermin in the regional specification of gut endoderm 
progenitors, we designed a novel approach combining Cre-mediated muta-
genesis and experimental explants. To overcome the embryonic lethality of 
both β-catenin and Eomesodermin mutant embryos, we crossed mice with 
conditional (floxed) β-catenin stabilized, β-catenin null and Eomesodermin 
null alleles, with the inducible Cre-driver mouse line, Claudin-6CreERT2, 
which is specific to the endodermal compartment. Also, by tuning the 
tamoxifen dosage, mosaic recombination will be enabled by the CreERT2 
system, and used for clonal studies. At present, we are conducting an 
exhaustive phenotypical analysis, employing several techniques including 
antibody staining, confocal imaging and whole-mount in situ hybridization, 
in conjunction with biochemical studies and the establishment of in vitro 
organoid cultures from mutant and control mice. The present study will be 
instrumental in disclosing the transcription factor networks and mechanisms 
involved in endoderm and intestinal progenitor establishment. This knowl-
edge is absolutely critical to a better understanding of the ontogeny of vari-
ous gut diseases, and will encourage the development of novel therapeutics, 
considerably improving human health.
Poster Board Number: 1162
THE MAMMALIAN INTESTINE CONTAINS 
SEPARATE NEURAL CREST AND PANCREAS 
DERIVED STEM CELLS
Brokhman, Irina, Arntfield, Margot, Smukler, Simon, Razavi, Rozita, 
van der Kooy, Derek
University of Toronto, Toronto, ON, Canada
Adult stem cells are found amongst differentiated cells in a tissue or organ; 
they are capable of self-renewal and are thought to be limited to produce 
only the differentiated cell types of their tissue of origin. Currently, two types 
of stem cells are identified in the adult mouse gut: first, Lgr5 positive crypt 
based gut stem cells that generate all epithelial lineages, and second, enteric 
neural crest stem cells (NCSC) that persist in the gut muscle and can be 
cultured as clonal spheres and give rise to neurons, glia and smooth muscle 
cells among others. Here we report clonal isolation of sphere forming cells 
from the external muscle layer (EML) of the adult small intestine. Most of 
these clonal spheres co-expressed a combination of NCSC markers and gen-
erated differentiated neural crest progeny. Surprisingly, a smaller, separate 
population of clonal spheres produced pancreatic cell type progeny upon 
differentiation. Using Pdx1 (an early marker of the pancreatic and duodenal 
lineages) Cre x Roza Yfp transgenic mice we observed the clonal formation 
of Yfp -expressing spheres. The differentiation of FACS-sorted Yfp+ (Pdx1 
lineage derived) precursor derived spheres revealed that the progeny of 
these spheres had became a variety of differentiated pancreatic cell types 
expressing endocrine (Pdx-1, c-peptide) and exocrine-(amylase) markers 
as well as a neuronal cell type marker (b3-tubulin+ cells), whereas clonal 
spheres derived from Yfp- cells did not give rise to any pancreatic progeny. 
Immunolabeling of a whole adult duodenum and ileum tissue indicated the 
existence of the Yfp-positive (Pdx1 lineage derived) network, correspond-
ing to portions of the enteric nervous system. Additionally, whole duodenal 
and ileal tissue was co-stained for Map2 (a marker of neuronal cells) and 
Yfp protein using immunofluorescent techniques. Co-expression of the both 
markers was found in a minority of the Yfp+ cells of the enteric plexus (and 
thus are Pdx1-derived neurons), and the majority of cells expressed only 
Map2 (and presumably are neural crest derived neurons). Some of the cells 
in the EML of duodenum and ileum expressed only Yfp, and may be the 
Pdx1-derived stem cells that formed clonal spheres in vitro. Analysis of early 
transgenic embryos revealed that Pdx1 progeny migrate from developing 
pancreas and duodenum at E11.5 and contribute to enteric neural system. 
These results provide evidence that the enteric nervous system arises form 
both the neural crest and the endoderm. In the adult animals both neural 
crest and pancreatic stem cells are present in the external muscle layer of the 
gut. Identification of progenitor cells derived from gut adult tissue as a novel 
intrinsic source of pancreatic precursor cells has implications as potential 
expandable source for replacement therapy for diabetes.
Poster Board Number: 1164
REGULATION OF INTESTINAL REGENERATION 
BY INSULIN/NOTCH SIGNALING INTERACTIONS
Kapuria, Subir, Karpac, Jason, Jasper, Heinrich
Department of Biology, University of Rochester, Rochester, NY, USA
Pluripotent intestinal stem cells (ISCs) are critical for the maintenance of the 
adult posterior midgut. ISC proliferation is dynamically regulated in response 
to various environmental challenges and can be controlled by signals ema-
nating from surrounding enterocytes (ECs) and/or visceral muscle cells, as 
well as by systemic growth regulators such as insulin-like peptides. ISCs di-
vide asymmetrically, producing a new stem cell and a partially differentiated 
enteroblast (EB). Notch activation in EBs promotes their differentiation into 
either the absorptive ECs or into secretory cells known as enteroendocrine 
cell (EEs). While insulin/IGF signaling (IIS) activity in ISCs promotes their pro-
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liferation, we find that the same pathway also regulates endoreplication and 
growth of differentiating EBs, and influences lipid and glycogen metabolism 
in terminally differentiated ECs. The cellular response to IIS activation thus 
changes in the ISC lineage as cells progress toward terminal differentiation. 
How these different responses to IIS activation are achieved, and how the 
response of ISCs, EB and ECs changes during the commitment and differen-
tiation process, remains unexplored. Our preliminary results suggest a critical 
role for the Tuberous Sclerosis Complex (TSC) in diversifying the response 
of the ISC lineage to insulin signaling. TSC is an inhibitory component of 
TOR signaling, and TOR is required downstream of the insulin receptor to 
promote cell growth. Our results suggest that Tor signaling regulates growth 
of EBs, but does not influence proliferation of ISCs. We observe high levels 
of TSC2 expression in ISCs, and a transient reduction of TSC2 in EBs during 
the commitment and differentiation process, suggesting that the differential 
expression of this protein determines the specific response of ISCs and EBs 
to IIS activation. Our data further indicate that this transient repression of 
TSC2 expression is caused by elevated Notch signaling activity in EBs. The 
molecular mechanism of this interaction is currently under investigation.
EPITHELIAL CELLS (NOT SKIN)
Poster Board Number: 1166
CD93 AND CD31 AS POSSIBLE CANDIDATE 
MARKERS FOR HUMAN ENDOMETRIAL STEM/
PROGENITOR CELLS
Miyazaki, Kaoru, Kajitani, Takashi, Masuda, Hirotaka, Hamatani, 
Toshio, Oda, Hideyuki, Yamasaki, Akiko, Nishikawa-Uchida, Sayaka, 
Uchida, Hiroshi, Yoshimura, Yasunori, Maruyama, Tetsuo
Department of Obstetrics and Gynecology, School of Medicine, Keio 
University, Tokyo, Japan
The human uterine endometrium undergoes cyclical regeneration through-
out a woman’s reproductive life. Its high regenerative capacity suggests the 
existence of endometrial stem/progenitor cells. Recently several endometrial 
cell subpopulations have been emerged as candidate endometrial stem/
progenitor cells including clonogenic endometrial cells and endometrial side 
population cells (ESP) which possess a Hoechst 33342 low-fluorescence 
profile. In particular, several groups including us have demonstrated that 
human ESP, but not endometrial main population cells (EMP), exhibit stem 
cell-like properties including self-renewal, dormancy, and potential for dif-
ferentiation into a variety of endometrial cell components and that at least 
some ESP are localized to endometrial vascular endothelial walls. However, 
side population-based cell isolation is limited in terms of extreme expensive-
ness of keeping and using ultraviolet laser-equipped flow cytometry, cell 
damage caused by UV exposure, and toxicity of Hoechst dye. Therefore, 
to facilitate possible future clinical use, identification of surface markers is 
needed to permit selection of the endometrial stem cell population. The 
objective of this study was to search for genes associated with the surface 
phenotype and stem cell function of ESP. For this purpose, we isolated 
ESP and EMP from human endometria and compared the gene expression 
profiles between ESP and EMP using HG-U133A&B Affymetrix GeneChip 
platform. Microarray analysis revealed that 117 genes (143 probe sets) and 
40 genes (51 probe sets) were up-regulated and down-regulated in ESP, 
respectively, as compared to those in EMP. The up-regulated genes of ESP 
contained many vascular endothelial-associated genes including CD31, vas-
cular endothelial growth factor receptor 2, CD34, thrombomodulin, vascular 
endothelial-cadherin, and CD93. In addition, ESP preferentially expressed 
transcription factors such as hematopoietically-expressed homeobox protein 
and GATA-binding protein 3. The up-regulation of these genes was further 
confirmed by qPCR. We focused on CD 93 and CD31, because CD93 
distinguishes a rare human stem cell population with both hematopoietic 
and hepatic potential, and also CD31+ESP still show stem cell-like properties 
(unpublished observation). We performed immunohistochemical studies us-
ing human endometrium and found that CD93+CD31+cells were preferen-
tially localized to endothelial walls, whose distribution was similar to that of 
ESP. These results implicate CD93 and CD31 as possible candidate markers 
for human endometrial stem/progenitor cells.
Poster Board Number: 1168
HUMAN SOLID ORGAN CANCERS CONTAIN 
STEM-LIKE LABEL RETAINING CANCER CELLS 
THAT UNDERGO ASYMMETRIC CELL DIVISION 
AND HAVE SUPERIOR TUMOR INITIATING 
CAPACITY
Xin, Hong-Wu, Danielle, Hari M., Mullinax, John E., Ambe, Chenwi 
M., Satyajit, Ray, Koizumi, Tomotake, Wiegand, Gordon W., 
Anderson, Andrew J., Langan, Russell C., Avital, Itzhak
NCI/NIH, Bethesda, MD, USA
Label-retaining cells (LRC) were identified in several tissue types and have 
been proposed to represent adult tissue stem cells. Cancers develop in all tis-
sue types where LRC were detected. LRC are hypothesized to result from ei-
ther slow-cycling or asymmetric-cell-division with non-random chromosomal 
cosegregation (ACD-NRCC). However, the stem-cell nature and whether 
LRC undergo ACD-NRCC remains highly controversial. LRC are identi-
fied by exposing cells during development to nucleotide analogues such as 
Bromodeoxyuridine (BrdU) or 3H-thymine-deoxyribose (3H-TdR). During 
a chase period, where nucleotide analogous are no longer available to the 
cells, the DNA labels are diluted with each subsequent cell division, and 
theoretically will become undetectable after 4-5 cell divisions. Surprisingly, 
several investigators found that there is a subpopulation of cells that retain 
the DNA labels over a prolonged period of time. These cells are called LRC. 
In several studies, LRC were associated with populations of cells comprised 
or highly enriched with adult tissue stem cells. However, other investigators 
questioned the stem cell nature of LRC. The mechanism by which LRC are 
generated continues to be debated. It has been proposed that LRC are the 
result of either relative quiescence/slow-cycling or ACD-NRCC. The major 
obstacle for testing LRC and these hypotheses is that currently detection 
of LRC is done on fixed tissue. Here we show that we developed a unique 
method allowing isolating live LRC. This method allowed us, for the first 
time, to test the stem cell nature of LRC and the hypotheses regarding their 
mode of generation. Using this novel method for isolation of live label-
retaining-cancer-cells (LRCC), we provide evidence that a subpopulation 
of LRCC is not quiescent, actively dividing (10-16% in active mitosis), and 
express stem-cells and pluripotency associated genes. Using fluorescence-la-
beled nucleotide analog and real-time confocal-microscopy cinematography, 
we show directly that LRCC undergo live asymmetric non-random chro-
mosomal cosegregation label-retaining cell division for the first time. Using 
gene expression analysis we propose pathway-map containing driver genes 
of LRCC. Finally, in large blinded study, we show that LRCC have greater 
tumor initiating capacity than non-LRCC in-vivo. Additionally, we show that 
liver cancer derived LRCC are resistant to Nexavar. Based on our data and 
the fact that LRC are ubiquitous, LRCC might represent a novel population 
of universal stem-like cancer cells. LRCC has the potential to provide innova-
tive targets for the treatment of cancer and novel mechanistic insight into 
the biology of cancer.
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P63 PROMOTES QUIESCENCE IN HUMAN 
AND MOUSE MAMMARY STEM CELLS VIA 
GLOBAL SUPPRESSION OF RNA POLYMERASE 
II ACTIVITY AND SELECTIVE EXPRESSION OF 
ANTI-PROLIFERATIVE P53 TARGETS
Hutchinson, Justine A.1, DiRenzo, James2
1Program in Experimental Molecular Medicine, Dartmouth College, 
Hanover, NH, USA, 2Pharmacology and Toxicology, Dartmouth College, 
Hanover, NH, USA
Mammary stem cells survive mammary gland involution and permit cyclical 
epithelial regeneration. Recently it was reported that a variety of adult stem 
cells display diminished phosphorylation at Serine 2 of the RNA Polymerase 
II carboxy-terminal domain, a post-translation modification associated with 
productive mRNA elongation. We had observed changes in expression 
levels of so-called housekeeping genes in models of quiescent mammary 
stem cells, suggesting a role for the suppression of Pol II activity. Analysis of 
RNA Pol II in a hTERT immortalized model of human mammary stem cells 
revealed sharp declines in the phosphorylation at S2 at time points corre-
sponding to reversible cell cycle arrest. Both the reduced S2 phosphorylation 
and cell cycle exit are P53-independent. ChIP analysis demonstrated stalled 
polymerases as a functional consequence of reduced CTD phosphoryla-
tion. In an immortalized mouse mammary progenitor-like cell line, ectopic 
expression of ΔNp63α, the predominant TP63 isoform in mammary stem 
cells, induced a quiescent state characterized by prolonged G1, reduced S2 
phosphorylation, and reduced total RNA levels. Additionally, we observed 
that both spontaneous quiescence and quiescence induced by ectopic 
ΔNp63α were characterized by enhanced expression of anti-proliferative 
P53 target genes. These findings suggest a mechanism enabling stem cell 
resistance to differentiation and apoptosis by blocking elongation of a large 
subset of genes. To what degree human breast cancer stem cells share the 
features of quiescence is an open question with important implications for 
targeted therapies.
Poster Board Number: 1172
CHARACTERIZATION OF EPITHELIAL STEM 
CELLS IN THE MOUSE INCISOR USING GENE 
EXPRESSION PROFILING
Seidel, Kerstin1, Azimi, Saeed1, Oldham, Michael C.2, Klein, Ophir 
D.1
1Orofacial Sciences, Program in Craniofacial and Mesenchymal Biology, 
University of California, San Francisco, San Francisco, CA, USA, 2Neurology, 
University of California, San Francisco, San Francisco, CA, USA
Rodents have a highly specialized dentition with incisors that grow continu-
ously due to the presence of adult stem cells at their proximal end. These 
stem cells ensure generation of all required differentiated cell types, both 
epithelial and mesenchymal, throughout the animal’s life. The mouse incisor 
provides a good model system to study stem cells for two reasons. First, 
the generation of distinct cell lineages from adult stem cells in the incisor 
appears to be controlled by mechanisms shared with several other systems. 
Second, owing to its unidirectional growth, the progeny at progressively 
increasing stages of maturity are arrayed in a linear fashion, such that 
stage-specific effects of genetic and biochemical perturbations are readily 
identifiable. Using a combination of antibody staining, lineage tracing and 
pharmacological approaches, we previously showed that a subset of the epi-
thelial stem cells in the mouse incisor is Gli1-positive and requires Hedgehog 
(Hh) signaling for proper generation of progeny. Whereas these stem cells 
give rise to multiple epithelial cell lineages, Hh signaling is required specifi-
cally for generation of only one of the cell types, the enamel-producing 
ameloblasts. In the studies reported here, we performed microarray analysis 
to obtain genome-wide expression profiles of the stem cell-containing proxi-
mal incisor region. Samples were obtained from wild-type mice treated with 
either a small molecule Hh-Antagonist or a biologically inactive control. The 
most differentially expressed genes between these two groups (fold change 
greater than 2, false discovery rate less than 0.1) were identified as candi-
date genes downstream of Hh signaling that potentially could be involved in 
regulation of lineage-specific progenitors. First, we selected those differen-
tially expressed genes that had been reported to be expressed in stem cells 
or the niche in other systems, and we are studying the spatial expression 
patterns of those genes in the incisor in more detail. Second, using a more 
holistic approach, we also analyzed gene co-expression network organiza-
tion in the microarray data. This approach revealed a number of large gene 
co-expression modules that are likely to relate to distinct biological processes 
that are active in this region during development. Previous work has shown 
that gene co-expression modules identified in heterogeneous tissues are 
often driven by discrete cell types; therefore, we are currently investigating 
whether identified modules are enriched with known markers of incisor cell 
types. The identification of such modules will provide a wealth of new bio-
marker information and enhance our understanding of the cellular diversity 
that is present in this region. Together, these experiments are enabling us 
to delve deeper into the molecular basis for generation of cell type specific 
progenitors from the Hh-responsive stem cells by delineating the signaling 
pathways involved in this process. Additionally, these studies should point 
us to novel markers that allow discrimination between different cell types 
in the incisor stem cell niche. The results of these studies will facilitate our 
studies of adult stem cells and will further our understanding of how lineage 
decisions are directed.
Poster Board Number: 1174
OVARIAN GRANULOSA CELLS: A NOVEL 
CELL SOURCE WITH OSTEO-REGENERATIVE 
POTENTIAL
Mattioli, Mauro1, Berardinelli, Paolo1, Martignani, Eugenio2, 
Barboni, Barbara1
1Biomedical Sciences, University of Teramo, Teramo, Italy, 2Morfofisiologia 
Veterinaria, University of Torino, Torino, Italy
Granulosa cells (GC) have recently been shown to express stemness mark-
ers and be capable of differentiating into cell types not present within the 
follicles. Since ovarian follicles are in continuous dynamic evolution we have 
undertaken this research in the pig model to identify the phase of follicular 
dynamics from which GC with the best stemness properties and highest 
regenerative potential can be retrieved. Prepubertal gilts were treated with 
1200 IU equine chorionic gonadotropin (eCG) to induce follicle growth fol-
lowed 60 h later by 500 IU human chorionic gonadotropin (hCG) to trigger 
follicle luteinisation eventually leading to ovulation in 40h. GC from growing 
follicles (GGC) were isolated from the ovaries of gilts ovariectomized 50h 
after eCG, while GC from luteinizing follicles (LGC) were obtained from 
ovaries removed 30h after hCG. GC were expanded in vitro for 3 successive 
passages in αMEM based growth medium. Cell plasticity was assessed by 
culturing GC for 4 weeks in osteogenic medium (αMEM supplemented with 
50 µM ascorbic acid, 10 mM β-glicerol phosphate, 0.2 µM dexamethasone). 
Stemness markers (Nanog, SOx2 and TERT) GC markers (FSH receptors, 
inhibin, estradiol and progesterone production) were evaluated immediately 
after cell isolation, at the end of the expansion in vitro and after osteogenic 
differentiation. Osteogenic differentiation in vitro was assessed by evaluat-
ing extracellular matrix mineralisation (Calcein deposition, Alizarin red stain-
ing) and the expression of bone related genes (osteocalcin, Runx2). Cultured 
on poly(DL-lactide-co-glycolide) (PLGA) scaffolds for 2 weeks in osteogenic 
medium, GG, traceable by the membrane dye PKH26, were implanted s.c. in 
the dorsal region of SCID mice to confirm their osteo-regenerative poten-
tial in vivo. Immediately after isolation both GGC and LGC cells showed a 
diffused expression of Sox2, Nanog and TERT. Expansion in vitro caused 
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in both cell types a progressive disappearance of granulosa cell characters; 
expression of FSH receptors was barely detectable after three passages, ste-
roid production dropped to 1/10 of the initial levels and inhibin positive cells 
were totally absent at the end of the expansion. By contrast, expansion did 
not substantially modify the expression of stemness markers both in GGC 
and LGC. Extracellular matrix mineralisation was clearly recorded in LGC 
cultured for two weeks in osteogenic medium, while it was totally absent in 
the same cells cultured in growth medium. Matrix mineralisation was much 
lighter in GGC, becoming clearly detectable only after 4 weeks of culture. 
RT-PCR showed that osteocalcin and Runx2 expression were upregulated 
while stemness markers were down regulated by osteogenic medium in both 
cell types although LGC underwent wider changes. Implants retrieved 8 
weeks after transplantation showed viable GC surrounding the several nod-
ules of calcifications recorded. Similar osteogenic effect was induced by GGC 
and LGC while no bone formation was observed in the control scaffolds 
without cells. These data confirm the stemness properties of GC, show that 
in vitro expansion cause a progressive de-differentiation of granulosa cells 
without affecting their staminality and demonstrate that both GGC and LGC 
have ostegenic potential, luteinizing cells being the more efficient. Trans-
planted in SCID mice GC can directly participate in new bone formation thus 
confirming their therapeutic potential.
Poster Board Number: 1176
SUPPRESSION OF THE IMMUNE SYSTEM BY 
OVARIAN CANCER CELLS
Di, Jiabo1, Duiveman-de Boer, Tjitske1, Figdor, Carl G.1, Massuger, 
Leon F A G2, Torensma, Ruurd1
1Department of Tumorimmunology, Radboud University Nijmegen Medical 
Centre, Nijmegen, Netherlands, 2Department of Obstetrics & Gynaecology, 
Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands
Ovarian cancer is a devastating disease with only 30% 5-year survival de-
spite cytotherapy, extensive surgery and Paclitaxel treatment. Reoccurrence 
of the disease is in most cases again in the abdomen. Recurrence of disease 
has been explained by the resistance of cancer stem cells to standard thera-
pies. Ovarian cancer creates an immune suppressive microenvironment by 
recruiting Tregulatory cells from the circulation. This immune suppression ap-
peared to be more extended than anticipated. Lymphocytes collected from 
the ascites were non responsive to full activation signals in several patients. 
Removal of suppressive Tregulatory cells and myeloid derived suppressor 
cells by flow-sorting did not improve the reactivity of the ascites derived 
lymphocytes. Ascites fluid itself was able to suppress lymphocyte reactivity. 
Lymphocytes obtained from the blood of the same patient were normally 
responsive. We assume that circulating responsive lymphocytes migrate into 
the abdomen and become non-responsive in time. This opens the possibility 
to induce an immune response to cancer stem cells after treatment. Immune 
therapy directed to cancer stem cells could add to the armamentarium to 
fight this tumor. Sphere like clusters of tumor cells were observed when 
tumor cells were cultured under floating conditions in serumfree medium as 
was used for other epithelial cancers. Therefore, m-RNA of ovarian cancer 
stem cells was transfected into dendritic cells and experiments are under 
way to determine DC induced immunity. Transfected dendritic cells matured 
normally after incubation with maturation cytokines. Presently, we investi-
gate if transfected DCs are able to activate a CTL response to ovarian cancer 
stem cells.
EYE OR RETINAL CELLS
Poster Board Number: 1178
ERG EVALUATION OF RETINAL FUNCTION 
AFTER STEM CELL TRANSPLANTATION
Kabiel, Mostafa A.1, Ma, Jian1, Tucker, Budd A.2, Young, Michael J.1
1Ophthalmology, Schepens Eye Research Institute, Harvard Medical School, 
Boston, MA, USA, 2Ophthalmology, University of Iowa Carver College of 
Medicine, Iowa City, IA, USA
Purpose: To determine if human retinal progenitor cells (hRPCs) can improve 
retinal function upon transplantation in an animal model of retinal degen-
eration (C3H SCID mice) and to determine the effect of different oxygen 
concentrations on the hRPCs in terms of growth and functional outcome. 
Methods: hRPCs were grown under high oxygen (20%) and low oxygen 
(3%) conditions. Characterization of cells was done at specific points (P2, 
P6, P10). hRPCs were transplanted into the subretinal space of C3H SCID 
mice, then ERG was performed after 3 weeks. Animals were fixed on a 
specially designed heated stage, ERG contact lens electrodes were placed on 
the cornea, and mice were moved into a Ganzfeld stimulator. ERG responses 
of the treated eyes were compared with the untreated eyes as a control. 
Animals were then euthanized and immunohistochemical staining was done 
to assess the morphology of the transplanted cells in vivo. Results: ERG 
recordings showed a statistically significant improvement in the treated eyes 
compared to the untreated eyes. This improvement could be traced after 
injection of different passages of cells up to P15. Although Low oxygen con-
dition (3%) was found to promote hRPCs expansion, it had no significant 
effect on ERG improvement. Immunohistochemical studies of treated eyes 
showed that hRPCs had the ability to differentiate within the host tissues 
and to express some photoreceptor markers as CRX, Recoverin and Cone 
Opsin. Some cells showed evidence of integration through expression of 
Synaptophysin, which is an indicator of synapse function. Conclusion: hRPCs 
transplantation could be a potential tool for improving retinal function in the 
setting of retinal degenerative disorders. We can also conclude that using 
low oxygen concentration in culture promotes hRPCs expansion.
Poster Board Number: 1180
ADULT HUMAN RPE CAN BE ACTIVATED INTO 
A MULTIPOTENT STEM CELL THAT PRODUCES 
RPE AND MESENCHYMAL DERIVATIVES
Salero, Enrique, Blenkinsop, Timothy A., Corneo, Barbara, Harris, 
Ashley, Stern, Jeffrey H., Temple, Sally
New York Neural Stem Cell Institute, Rensselaer, NY, USA
The retinal pigment epithelium (RPE) forms a single layer of highly special-
ized cells performing many functions needed for a functioning neural retina. 
In normal conditions, RPE remain non-proliferative throughout adult life. 
In lower vertebrates during retinal injury, RPE cells can re-enter the mitotic 
phase and produce progeny capable of regenerating all cells of the retina 
and in some cases also the lens. Retinal stem cells, as defined by their ability 
to self-renew in vitro and differentiate into retinal neurons and glia, have 
been identified in the ciliary epithelium and iris pigmented epithelium of 
adult rodents and human. However, until now, there has been no evidence 
for a stem-like cell from the adult RPE. We hypothesized that similar to its 
corresponding lower vertebrate equivalent, the adult human RPE retains 
dormant properties of early neuroepithelial cells that can be activated if 
removed from its normal environment. To test our hypothesis, we isolated 
RPE cells from adult human cadaver eyes. When cultured in vitro, RPE cells 
exhibit two characteristic morphologies: epithelial pigmented “cobblestone” 
cells or fusiform cells with low pigmentation. These cells proliferate actively 
and self-renew over many passages, and they express markers associated 
with the stem cell state, including SSEA-4, c-Myc and KLF4. To determine 
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their plasticity, both RPE culture types were examined for their potential 
to form neural progeny as well as mesoderm and endoderm by inductive 
treatments for neural, osteogenic, chondrogenic, myogenic, adipogenic and 
hepatic lineages. We found that under appropriate culture conditions RPE 
cells are highly proliferative and are able to differentiate into an unexpect-
edly wide repertoire of progeny, including bone, cartilage, muscle and adi-
pocytes, but not endoderm. To rigorously prove multipotency, we performed 
clonal experiments in which single primary RPE cells were clonally expanded 
then split into five differentiation conditions; such clonal analyses showed 
that RPE clones can differentiate into multiple lineages. This multipotency 
observed in human RPE can be generalized across mammalian species, 
as RPE derived from cow eyes showed the same capabilities. This study 
establishes the human RPE to be a unique source of multipotent stem cells, 
RPESCs that are distinct from neural stem cells. Moreover, these cells can be 
obtained from patients, offering the possibility of autologous transplantation 
therapy. Patient-matched stem cell lines derived from RPE biopsies could be 
a unique source of multipotent CNS-derived stem cells for the study of cell 
fate choice and could be used to generate specific cell types, including RPE, 
for autologous or allogeneic cell replacement therapy.
Poster Board Number: 1182
ADULT HUMAN CIRCULATING ANGIOGENIC 
CELLS (CACS) ARE NOT ENDOTHELIAL 
PROGENITOR CELLS (EPCS) BUT REPRESENT A 
TYPE OF M2 MACROPHAGE THAT FACILITATES 
ANGIOGENESIS THROUGH IL8
O’Neill, Christina L., Medina, Reinhold J., O Doherty, Michelle T., 
Guduric-Fuchs, Jasenka, Knott, Henry, Gardiner, Tom, Stitt, Alan W.
Centre for Vision and Vascular Science, Queens University Belfast, Belfast, 
United Kingdom
EPCs promote angiogenesis and facilitate vascular repair. Recent clinical 
trials have demonstrated the feasibility, safety, and effectiveness of EPCs for 
treatment of various ischaemic diseases. However, results from such trials 
have been inconsistent. This is due to the heterogeneous mix of cells used 
as the term EPC has been applied to a broad range of blood-derived cells 
that display some endothelial markers and enhance angiogenesis. We have 
previously characterised two EPC subsets in vitro, CACs and Outgrowth 
endothelial cells (OECs). Although OECs are the only EPC subset with true 
progenitor and endothelial characteristics, CACs may still play an important 
role angiogenesis indirectly, as they have been shown to modulate vascular 
repair through the release of paracrine factors. The purpose of this study 
was to characterise the molecular phenotype of CACs, examine their role 
in angiogenesis, and elucidate molecular mechanisms responsible for CACs 
pro-angiogenic effects. Despite being widely referred to as EPCs, we reveal 
CACs to be cells lacking any endothelial characteristics; they do not directly 
incorporate into retinal microvascular tubes in vitro or a vascular network 
in vivo, however they significantly induced endothelial tube formation 
(p<0.001) and enhanced vascular repair in a murine model of ischaemic 
retinopathy (p<0.001) compared to respective controls. Our data highlights 
CAC-derived interleukin 8 (IL-8) as one of the key cytokines responsible 
for their pro-angiogenic function, as blocking IL-8 but not VEGF prevented 
CAC-induced angiogenesis. Furthermore we demonstrate that extracellular 
IL-8 is capable of transactivating VEGFR2 and induces the phosphorylation 
of ERKs in mature endothelial cells. Analysis of CACs transcriptome and 
immunophenotype suggests that they closely resemble M2 macrophages, as 
they express typical M2 markers such as CD163, CD204, CD206 and IL-10. 
Our findings unequivocally demonstrate a role for CACs in angiogenesis, 
highlight IL-8 as a key paracrine factor involved and reveal for the first time 
CACs to represent M2 macrophages with anti-inflammatory and pro-angio-
genic properties.
Poster Board Number: 1184
CHARACTERIZATION OF HUMAN ORAL 
MUCOSAL EPITHELIAL CELLS FOR FUTURE 
USE AS AN ALTERNATIVE SOURCE OF 
AUTOLOGOUS STEM CELLS FOR THE 
TREATMENT OF OCULAR SURFACE DISEASE
Alatza, Argyro
Ocular Biology and Therapeutics, Institute of Ophthalmology, UCL, 
London, United Kingdom
Introduction: Corneal structural integrity and transparency is necessary and 
critical for vision. The epithelium is the outermost layer of the cornea and its 
homeostasis relies on limbal epithelial stem cells (LESC) that are located at 
the basal layer of the limbus. LESC give rise to transit amplifying cells (TAC) 
in order to replenish suprabasal epithelium that is lost during normal eye 
blinking. Loss of LESC because of injury or disease results in cornea damage 
and can lead to blindness. Cultured LESC therapy can be used to treat LESC 
deficiency using autologous cells (from the healthy eye) or allogeneic donor 
cells. However, limited donor tissue supply, and importantly the need for 
systemic immunosuppression with the use of allogeneic LESCs, points to the 
need for an alternative solution. Oral mucosal epithelial cells (OMEC) have 
been used as an alternative cell source for treatment of LESC deficiency. 
However, post-operative follow up of the patients reveals susceptibility to 
undesirable vascularization of the peripheral cornea. Aim: To compare the 
characteristics of cultured human OMEC with those of limbal epithelial 
cells (LEC) in order to optimize OMEC culture conditions prior to grafting 
for the treatment of ocular surface failure. Methods: OMEC were isolated 
from 3mm punch biopsies of buccal mucosa from healthy volunteers. LEC 
were obtained from human cadaveric donor corneas. OMEC and LEC were 
cultured in presence of growth arrested 3T3 fibroblasts and fed with OMEC/
LEC medium respectively every other day. For both cell types, nucleus/cyto-
plasm (N/C) ratio and colony forming efficiency assays were performed. Im-
munocytochemistry was used for investigation of ABCG2, CK12, CK19, p75, 
pax6 and p63alpha expression. Results: Small colonies of OMEC and LEC 
were observed within 5 days of isolation. Primary (P0) human OMEC had 
a significantly higher N/C ratio (0.3483±0.01744) compared to that of pri-
mary LEC (0.2806±0.01414) (n=5, ±SEM, p< 0.05, two-tailed t-test). There 
was no significant alteration of the mean N/C ratio across different pas-
sages of OMEC (P0, P1, P2). Colony forming efficiency assays showed no 
significant difference between the two cell populations. Immunocytochem-
istry revealed the expression of nuclear p63alpha, cytosolic / membranous 
ABCG2 and CK19 by both cell types. OMEC did not express p75 and pax6. 
CK12 and pax6 expression was apparent in LEC. Conclusion: Primary OMEC 
have higher N/C compared to LEC in primary culture, however CFE assays 
demonstrated no significant difference in the proliferative capacity between 
the two cell types. This demonstrates the possible similar proportion of stem 
cell progenitors among the two populations. OMEC remain relatively undif-
ferentiated across passages which allows the manipulation and use of OMEC 
for longer periods, an advantage for therapeutic use. Both cell types express 
p63alpha and ABCG2, demonstrating the possible presence of progeni-
tor cells in both populations. Overall, the present study demonstrated the 
phenotypic characteristic of OMEC and their differences to LEC. According 
to these results it is possible to use pax 6 as a marker for detecting possible 
transdifferentiation of OMEC into corneal epithelial cells when altering the 
culture conditions since pax6 is used as a marker for normal corneal epithe-
lial differentiation.
33
Friday Poster Abstractswww.isscr.org
Friday Poster Abstracts
Poster Board Number: 1186
OPTIMIZATION OF RETINAL DIFFERENTIATION 
OF HUMAN PLURIPOTENT STEM 
CELLS BY MEANS OF MANIPULATING 
MICROENVIRONMENTAL OXYGEN TENSION
Bae, Daekyeong, Mondragon-Teran, Paul, Hernandez, Diana, 
Ruban, Ludmila, Veriatch, Farlan
Biochemical Engineering, University College London, London, United 
Kingdom
Human pluripotent stem cells have the ability to differentiate into almost all 
types of cells in the body including retinal cells which raises hope for treating 
currently incurable ocular diseases such as Retinitis pigmentosa. Despite en-
couraging evidences of generating retinal cell types from human embryonic 
(hES) and induced pluripotent (iPS) stem cells, they all seem to suffer from 
one major pitfall; the low yield of differentiated cells. We sought to over-
come the differentiation inefficiency by manipulating oxygen tension during 
differentiation protocol. Current differentiation protocols are performed at 
20% O2 which is significantly higher than the O2 tension experienced by 
the developing mammalian (rabbit 8.7% and monkey 1.5%) and human 
embryo (~3%). In this study, we examined the effect of mimicking the 
physiological O2 tension on retinal differentiation of hES and iPS cells. Our 
results have shown upregulation of early eye field genes, Lhx2 and Six3 
under lowered O2 compared to normal O2 after 3 days of differentiating 
cells as EBs in suspension. Upon attachment of EBs, the expression of retinal 
progenitor cell (RPC) markers, Pax6 and Chx10, as well as the early eye field 
genes was markedly increased when pluripotent stem cells were induced 
to differentiate under hypoxic condition. In addition, RPCs generated from 
both hES and iPS under normal and lowered O2 further differentiated into 
cells expressing Crx, a marker for photoreceptor precursor cells upon treat-
ment of RA and taurine. These studies reveal the oxygen tension is a key 
element of the microenvironment during the retinal neural differentiation of 
pluripotent stem cells.
Poster Board Number: 1188
SPECIFICATION OF THE EARLY EYE FIELD 
FROM HUMAN EMBRYONIC STEM CELLS
Buchholz, David E., Leach, Lyndsay L., Clegg, Dennis O.
Molecular, Cellular and Developmental Biology, University of California, 
Santa Barbara, Santa Barbara, CA, USA
Several protocols have been published that efficiently drive human embry-
onic stem cells(hESC’s) into retinal progenitors. These progenitors can be 
further differentiated into all cell types of the eye, including photoreceptors 
and retinal pigmented epithelium (RPE), but the precise molecular signaling 
pathways involved in ocular differentiation are poorly defined. To visualize 
early eye field differentiation from the pluripotent state, we have developed 
fluorescent reporter hESC lines under control of the Rax and Mitf promot-
ers. Rax is expressed at the earliest stages of eye field specification. Mitf is 
first expressed throughout the early optic vesicle and is later restricted to the 
RPE, making it an ideal reporter for both early eye and RPE development. 
The most efficient protocol to induce ocular specification makes use of the 
soluble factors noggin, Dkk-1, IGF-1 and bFGF, giving rise to ~80% retinal 
progenitors as defined by Chx10 expression. From previous studies, it is 
known that these factors modulate BMP, Wnt, IGF and FGF signaling path-
ways. We have further characterized the roles of these pathways through 
loss of function experiments that utilize small molecule inhibition and RNA 
interference. Preliminary results show that the phosphoinositide 3-kinase 
(PI3K) pathway is necessary for initial neural induction prior to specification 
of the early eye field. These studies provide new insights into the mecha-
nisms of early and late retinal differentiation from human embryonic stem 
cells, which may one day be used to treat degenerative ocular diseases such 
as age-related macular degeneration.
Poster Board Number: 1190
CHARACTERIZATION OF HUMAN LIMBAL 
STEM CELLS USING ACOUSTIC FOCUSING 
CYTOMETRY
Langsdorf, Chris, Knollman, Paul, Bailey, Matthew, Dubbels, 
Bradley, Kuninger, David, Bradford, Jolene
Molecular Probes, part of Life Technologies, Eugene, OR, USA
Limbal stem cells (LSCs) are found at the periphery of the cornea in the 
limbus and function to maintain and renew the corneal epithelium. Ex vivo 
expansion and transplantation of LSCs has been proposed as a treatment 
for various corneal diseases and injuries. In the present study we have 
developed a method to identify and characterize LSCs derived from primary 
human limbal tissue. Experimentation was focused on a model system com-
posed of human corneal epithelial cells enzymatically released from normal 
corneal-scleral buttons and expanded in KSFM growth medium. Cells of 
various passage number were harvested and analyzed using multicolor 
acoustic-focusing cytometry. Previous work has demonstrated that stem cells 
specifically pump out the cell-permeant DNA-binding dye Vybrant® Dye-
Cycle™ Violet via ABCG2-mediated efflux. This property enables the use 
of side-population technique to identify a sub-population of putative LSCs. 
The ABCG2 inhibitor Fumitremorgan C was shown to block the appearance 
of the corneal cell side-population. A549 human lung adenocarcinoma cells, 
which overexpress the ABCG2 transporter, were used to verify the action 
and inhibition of ABCG2. The LSC subpopulation was generally less than 
three percent of total cells, requiring analysis of large numbers of cells to 
generate statistically significant data. The extremely tight sample focusing 
provided by acoustic focusing cytometry enabled very high throughput 
while maintaining data integrity.
Poster Board Number: 1192
HYPOXIA INCREASES THE YIELD OF RETINAL 
CELL TYPES DIFFERENTIATING FROM MOUSE 
EMBRYONIC STEM CELLS AND IMPROVES THE 
MODELING OF RETINOGENESIS IN VITRO
Garita-Hernandez, Marcela1, Massalini, Simone1, Díez-LLobet, 
Andrea1, Krishna, Abhay1, Erceg, Slaven2, Bhattacharya, Shom S.2
1Cabimer, Seville, Spain, 2Cabimer and Medical Genome Project, Seville, 
Spain
Retinal diseases affect more than 2 million individuals worldwide. Retinitis 
pigmentosa (RP) and age-related macular degeneration (AMD) are the 
leading causes of permanent blindness and they are characterized by the 
progressive dysfunction and death of the light sensing photoreceptor cells 
of the retina. Due to the limited capacity of regeneration of the mammalian 
retina the scientific community has invested significant efforts in trying to 
obtain photoreceptors from embryonic stem cells (ESC). These represent an 
unlimited source of retinal cells, but it has not yet been possible to achieve 
specific populations, such as photoreceptors, efficiently enough to allow 
them to be used safely in the future as Cell Therapy of RP or AMD. The aim 
of our work is to study the possibility of obtaining a high yield of photo-
receptors from directed differentiation by recapitulating development. We 
are therefore presenting a protocol of differentiation, involving hypoxia and 
taking into account extrinsic and intrinsic cues. These include niche-specific 
conditions as well as the manipulation of the signaling pathways involved 
in retinal development. Our protocol involves the directed differentiation 
of reporter cell lines generated from mESC, using a small molecule based-
protocol in a chemically defined medium, as well as the control of the 
microenvironment, focusing particularly on controlling the oxygen tension. 
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Our results show that hypoxia promotes and improves the differentiation of 
embryonic stem cells towards photoreceptors. Expression of Rhodopsin and 
Recoverin is increased under hypoxia condition, as shown by the techniques 
of immunofluorescence and qPCR. Furthermore, our protocol achieves 
the expression of various transcription factors associated with the different 
retinal phenotypes occurring during retinogenesis, in a temporal fashion, 
that corresponds with the known mammalian cues of retinal development. 
We have found expression of early eye-field development markers, as 
well as mature RPE and photoreceptor markers, such as Rx1, Otx2, Pax6, 
Chx10, MIFT, Crx, Nrl, Rhodopsin, Recoverin and RPE65 in these cells. We 
believe our results will support the hypothesis that hypoxia is necessary to 
induce the efficient differentiation of embryonic stem cells towards retinal 
phenotypes. Purification of these specific retinal progenitors will allow us to 
define conditions to expand a homogenous population that will be further 
differentiated into fully mature photoreceptors.
Poster Board Number: 1194
NEW INDUCTION METHOD OF 
PHOTORECEPTORS FROM MOUSE 
PLURIPOTENT STEM CELLS
Okamoto, Satoshi, Takahashi, Masayo
Laboratory for Retinal Regeneration, Riken Center for Developmental 
Biology, Kobe, Japan
Retinitis pigmentosa is a major cause of visual loss. In the patient’s retina 
of this disease, photoreceptors that convert light signals into electric signals 
degenerate initially because of his/her gene mutation. There is no clinical 
treatment for it now. Cell therapy is one possible solution for this disease. 
Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) are 
promising candidate sources for cell therapy. We previously succeeded in 
generating retinal cells including photoreceptors from mouse, monkey and 
human ESCs / iPSCs. However, with the previous method we could not 
obtain photoreceptors in high efficiency even after long time culture. In 
this study we improved the method for photoreceptor differentiation from 
pluripotent stem cells. First, we used Rx-GFP knocked-in mouse ESCs to 
obtained retinal progenitors and cultured them in various media containing 
protein or chemical factors involved in cellular signal pathways. We found 
that a chemical inhibitor of intracellular signal promoted retinal progenitor 
generation. Moreover we produced a mouse iPSC line from Nrl-GFP trans-
genic mouse to investigate photoreceptor differentiation. GFP-positive cells 
induced from the iPSC line expressed rod photoreceptor markers, rhodopsin 
and recoverin. By using this iPSC line, we confirmed that the induction 
method with the cell signaling inhibitor generated photoreceptors more 
efficiently than previous methods. This new induction method might bring 
photoreceptor transplantation closer to clinical therapy.
Poster Board Number: 1196
GENERATION OF STRATIFIED SQUAMOUS 
EPITHELIAL CELLS FROM MOUSE INDUCED 
PLURIPOTENT STEM CELLS
Yoshida, Satoru1, Yasuda, Miyuki1, Miyashita, Hideyuki1, Yoshida, 
Tetsu1, Tsubota, Kazuo1, Okano, Hideyuki2, Shimmura, Shigeto1
1Department of Ophthalmology, Keio University School of Medicine, 
Tokyo, Japan, 2Department of Physiology, Keio University School of 
Medicine, Tokyo, Japan
In regenerative medicine of damaged corneal epithelium, in addition to 
the transplantation of donor cornea, a method to transplant the cultivated 
corneal epithelial sheet, which engineered using corneal epithelial stem cells 
isolated from limbal area of the cornea, has been established. Regenera-
tive medicine using such donor-derived cells and tissues, somatic stem cells 
and ES cells include problems such as immunological rejection and ethical 
objection. Application of induced pluripotent stem (iPS) cells to regenera-
tive medicine is expected to bypass these problems. To apply iPS cells to 
corneal epithelial disorders, we examined differentiation of mouse iPS cells 
into corneal epithelial cells. To promote epithelial differentiation, we use 
SDIA (Stromal cell-derived inducing activity) method. Mouse iPS cells were 
cultured on Mitomycin C-treated PA6 feeder cells with use of BMP-4 and 
serum stimulation. We found the derivation of epithelial colonies, which 
include the epithelial cells positive for an early ectodermal marker K18 and 
stratified epithelial markers K14 and p63. Clusters of the cells positive for 
corneal epithelial marker K12 were also found in K14-positive colonies. 
Based on the expression of K14, we found the derivation of epithelial cells 
was most effective when BMP was added during culture days 3-5. After 
several subcultures, we obtained K14-positive clones. Stratified epithelial 
sheets were engineered from an iPS-derived K14-positive epithelial clone by 
air-exposed culture with feeder cells in SHEM, on culture insert. In the result-
ing 3D sheet, along with the progression of differentiation by air-exposed 
culture, the expression of K18 was down-regulated and the expression of 
epidermal keratinocytes marker K10 was up-regulated instead. The expres-
sion of p63 at a high level was found in basal layer and that expression 
was down-regulated in suprabasal layers. The expression of K15, a stem 
cell marker for stratified epithelial cells, was found in basal layer as well. 
E-cadherin expression was found throughout the sheet. K12-positive cells 
disappeared during subcultures. To examine differentiation on mouse cornea 
further, cells labeled with Venus or mRFP were transplanted on denuded 
mouse cornea. The cell transplanted eyes were excised after engraftment 
and cultured ex vivo. Proliferation of the transplanted cells onto denuded 
mouse cornea was found ex vivo when cultured in serum containing-
medium. Expression patterns of those differentiation markers in stratified 
epithelium formed on the denuded cornea were quite similar with that in the 
cultivated sheet on culture insert. Even though the expression of corneal epi-
thelial marker K12 was not recovered, these results suggest that the culture 
method is available to produce epithelial cells from iPS cells, which can be 
engineered to produce polarized stratified cell sheets.
Poster Board Number: 1198
MODELING THE ZEBRAFISH CMZ, A LIFELONG 
RETINAL STEM CELL NICHE
Mattocks, Michael, Tropepe, Vincent
Cell and Systems Biology, University of Toronto, Toronto, ON, Canada
Zebrafish eyes are notable for their active retinal stem cell (RSC) niches, 
present throughout the life of the organism. These proliferative niches 
confer the zebrafish’s remarkable ability to expand and repair the neural 
retina even in adulthood. The circumferential marginal zone (CMZ) is the 
primary source of new neurons added to the zebrafish retina. Interestingly, 
a CMZ-like region is present and may be active in the adult primate retina. 
While the zebrafish CMZ has been characterized developmentally, little is 
known about its function in the juvenile or adult animal. Furthermore, no 
model exists to describe the three-dimensional ontogeny of the CMZ or 
its contributions to the retina. In order to more fully elucidate the function 
and comparative traits of the vertebrate CMZ, we present a working model 
of CMZ ontogeny in zebrafish. We have mapped the proliferating cells 
originating from the CMZ from the initial formation of the CMZ in develop-
ment to adulthood, demonstrating previously unreported complexity in the 
3-dimensional ontogeny of this population. We have also measured the 
changing activity of the CMZ, including the frequency, number and position 
of cells contributed to the retina, and their lineage commitment. Combining 
these data with morphological measurements and measures of cell turnover, 
we have constructed a mathematical model describing the changing activity 
of the CMZ and its function in building the neural retina over time. This 
model may have significant implications for the understanding of the regula-
tion and function of adult neurogenesis in the retina, and will assist us in 
determining the mechanisms by which the activity of the CMZ is maintained 
throughout life.
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THE ROLE OF DMBX1 GENES DURING 
RETINAL PROGENITOR CELL CYCLE EXIT AND 
DIFFERENTIATION
Wong, Loksum, Tropepe, Vincent
Department of Cell and Systems Biology, University of Toronto, Toronto, 
ON, Canada
Neurogenesis during vertebrate retinal development is a highly conserved 
process. In some vertebrates, such as teleost fish, new retinal neurons are 
generated throughout life under homeostatic conditions or as a regenerative 
response to retinal damage. There are two populations of retinal progenitor 
cells (RPCs) that exist in the mature fish retina: RPCs in the ciliary marginal 
zone at the far periphery of the retina and RPCs scattered among cells of 
the inner nuclear layer (INL). During zebrafish development, most RPCs exit 
the cell cycle and differentiate between 2 and 3 days post-fertilization (dpf). 
We previously found that the transcription factor called diencephalon/mes-
encephalon homeobox1 (dmbx1), is an important regulator of this process. 
The dmbx1 gene belongs to a family of paired-type homeobox genes, which 
includes crx, vsx/chx10 and otx genes, and is represented by two paralogs 
in the zebrafish genome, dmbx1a and dmbx1b. Loss of function of dmbx1 
by morpholino-based gene knockdown causes widespread defects in retinal 
growth and differentiation. We find that although RPCs progress through 
all phases of the cell cycle, they do so at a rate that is ~5-fold slower than 
wildtype RPCs. Thus, at 3 dpf when the vast majority of RPCs have differ-
entiated in the wildtype retina, the loss of dmbx1 prevents cells from exiting 
the cell cycle at the right time. Using cell transplantation, we show that this 
RPC defect in dmbx1 knockdown embryos is cell-autonomous. Further-
more, while RPCs with reduced levels of dmbx1 are capable of expressing 
the cell cycle inhibitor cdkn1c, they are incapable of down regulating cyclin 
D1, suggesting that the normal function of dmbx1 is to repress cyclin D1 
expression. Consistent with this hypothesis, over-expression of dmbx1 
prematurely represses cyclin D1 expression in the retina. Thus, these results 
demonstrated that dmbx1 is a key regulator for controlling the proper tim-
ing of RPC cell cycle exit. We are currently investigating which subtypes of 
neurons dmbx1 genes are expressing in the INL. Further insight into the role 
of dmbx1 in regulating the cell cycle and differentiation of RPCs will aid in 
our understanding of the mechanism that ensures the persistent, life-long 
neurogenesis in the zebrafish retina.
Poster Board Number: 1202
AUTOLOGOUS BONE MARROW DERIVED 
STEM CELLS TRANSPLANTATION FOR 
HEREDITARY RETINAL DYSTROPHY
Siqueira, Rubens C.1, Jorge, Rodrigo1, Mesias, Andre1, Scott, Ingrid2, 
Voltarelli, Julio C.3
1Ophthalmology, São Paulo University, São José do Rio Preto -SP, Brazil, 
2Ophthalmology, Penn State College of Medicine, Hershey, Pennsylvania, 
PA, USA, 3Department of Internal Medicine, São Paulo University, São José 
do Rio Preto -SP, Brazil
Purpose: To evaluate the short-term (10 months) safety of a single intravitre-
al injection of autologous bone marrow stem cells (ABMSC) in patients with 
Retinitis Pigmentosa (RP) or cone-rod dystrophy. Methods: A prospective, 
phase I, nonrandomized, open-label study was carried out. The study was 
approved by the local and National Institutional Review Board (ClinicalTrials.
gov Identifier: NCT01068561).Five patients with RP were included, age-
gender: 31-F; 35-M; 23-F; 33-M; and 35-M. Evaluations were performed at 
baseline, and 1, 7, 13, 18, 22, and 40 weeks after intravitreal injection of 10 
x 106 autologous bone marrow stem cells (0.1 ml). Patients presented best-
corrected ETDRS visual acuity (BCVA) of 20/200 or worse at baseline. In 
addition to comprehensive ophthalmological examination, patients yielded: 
standard full field electroretinography (ERG - ISCEV Standard); kinetic visual 
field (Goldman); fluorescein and indocyanine-green angiography; and opti-
cal coherence tomography (OCT). Results: No adverse side effect due to the 
injection was observed. A slightly improvement on BCVA (1 line) was mea-
sured in 4 patients 1 week after injection and kept during follow-up. Three 
patients showed undetectable ERG responses in all visits, while one patient 
showed residual responses for dark-adapted standard flash stimulus (a-wave 
amplitude around 35 µV), which was kept recordable during the entire 
follow-up. One patient showed a small response (a-wave amplitude around 
20 µV) recordable only at weeks 7, 13, 22 and 40. Visual fields showed no 
reduction on visible area (Goldman Standard V5e) for any patient, at any 
visit. No other changes were observed on OCT or fluorescein and indocya-
nine green angiograms. Conclusions: Intravitreal injection of ABMSC in eyes 
with advanced tapetoretinal dystrophies was followed by absence of detect-
able structural or functional retinal worsening over a period of 10 months. 
Further studies are required to investigate the role, if any, of bone marrow 
stem cell therapy for the management of retinal dystrophies.
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PLURIPOTENCY AND TRANSGENESIS OF 
BOVINE ES-LIKE CELLS
Saito, Shigeo1,2,3,4, Wang, Shin-Wei1,2,3,4,5, Huang, Yu-Chang1,2,3,4, Wu, 
Den-Chyang2,4,5, Murayama, Yoshinobu6, Omata, Sadao6 and Yokoyama, 
Kazunari-K.1,2,3,4,7
1Center of Excellence for Environmental Medicine, 2Cancer Center, 
3Graduate Institute of Medicine, 4Kaohsiung Medical University and 
5Kaohsiung Medical University Hospital, San Ming District, 807 Kaohsiung, 
Taiwan; 6College of Engineering, Nihon University, Koriyama, Fukushima, 
Japan, 7Department of Molecular Preventive Medicine, Graduate School of 
Medicine, The University of Tokyo, Tokyo, Japan.
Isolation and characterization of ES cells (ESCs) lines from domestic animals 
have great potential for studying the regenerating medicine and would 
represent a useful tool for developing therapeutic reagents for tissue repair 
and regeneration. For example, ESCs from domestic animals would be 
useful for improving genetic traits and developing the animals for disease 
resistance as well as production of pharmaceutical protein. Since mouse 
ESCs were first established nearly 30 years ago, only monkey, human and 
rat ESCs have been established to date. Although several efforts were made 
to establish ESCs in domestic animals, the pluripotent cells which differenti-
ate to all three germ layers have not been generated so far. Another type of 
induced pluripotent stem cells (iPSCs) have been generated from mouse, rat, 
human, monkey and porcine somatic cells by forced expression of several 
combinations of transcription factors (Oct 4, c-Myc, Klf4 and Sox2). In view 
of the probable significant contribution of ESCs to manipulate the genome 
and generate the transgenic offspring to replace various tissues and organs 
in xenotransplantation, it seems to be appropriate to use ESC-technology 
to genetic modification of domestic animals. We established immortalized 
bovine ES-like cells with a normal karyotype that exhibited similar charac-
teristics to those of murine ESCs which express Oct 4, STAT-3, SSEA-1 and 
alkaline phosphatase (AP). We also confirmed the pluripotent activity of 
these cells which were able to differentiate in vitro to neural progenitors 
and endothelial or hematopoietic lineages using a combination of FGF, EGF 
and PDGF or FGF, SCF and oncostatin M in serum-free MEMα medium, 
respectively. In addition, to avoid the immune surveillance by NK cells, we 
generated bovine ES-like cells that expressed HLA-B-EGFP, and found that 
they gave rise to ocular cells. Those differentiated cells were exhibited the 
markers of retinal stromal cells, pigment epithelial cells and crystalline lens. 
Furthermore, bovine ES-like cells transfected with EGFP were incorporated 
into both the inner cell mass and the trophectodermal cells to develop the 
blastocysts in vitro. Taken together, our findings provide possible evidence 
for the targeted genetic manipulation of the bovine genome to produce the 
cloned donor animals for regenerative therapy.
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TRANSLATIONAL RESEARCH IN STEM CELL 
BIOLOGY: HOW CAN BIOETHICISTS HELP?
Robert, Jason S.
School of Life Sciences, Arizona State University, Tempe, AZ, USA
Failures to translate preclinical research with non-human animals into thera-
peutics that work in humans are legion. For every successful attempt, there 
are hundreds if not thousands of failures. While the failures are expected 
- humans are, after all, different from non-human animals in all sorts of 
relevant ways - researchers and research institutions, including funders, have 
been seeking ways to improve translational success rates and so reduce the 
absolute number and the relative proportion of failures. What is missing 
from the growing literature assessing epistemological and methodological 
dimensions of stem cell research with non-human animals is an evaluation 
of the ethical and other non-scientific values at stake in debates about how 
to maximize knowledge translation from preclinical to clinical contexts. This 
presentation summarizes two of the central contributions bioethicists can 
make to these increasingly important debates: (1) bioethicists can provide 
a moral assessment of the scope and nature of failures of translation from 
preclinical to clinical contexts; and (2) bioethicists can engage debates about 
the justification of research with non-human animals, debates that involve 
animal rights and animal welfare considerations as well as the required evi-
dence base for proper risk-benefit assessment in the transition from preclini-
cal to human subjects research in biomedicine. These two contributions are 
critical not only to the moral evaluation of translational research efforts, but 
also to any attempt to engage in upstream ‘benchside consultation.’
Poster Board Number: 1208
ETHICAL AND SOCIAL ISSUES ON HUMAN 
PLURIPOTENT STEM CELL RESEARCH: 
EXTRACTS FROM DELIBERATIVE MEETINGS OF 
STAKEHOLDERS AT KYOTO UNIVERSITY
Yamamoto, Natsuko, Iwae, Sosuke, Kawakami, Masahiro, Kato, 
Kazuto
Kyoto University, Kyoto, Japan
With the progress of human pluripotent stem cell (hPSC) science, the ethical 
and regulatory environment encountered by laboratory-based scientists 
has become more complex. To better understand the current status, we 
convened two meetings at the Center for iPS cell Research and Applica-
tion (CiRA) at Kyoto University, and collected the opinions of stakeholders 
concerning the ethical, legal and social issues surrounding hPSC research. 
At the first meeting in 2009, 18 scientists working at the CiRA expressed 
their opinions on the environment surrounding the study of patient-derived 
induced pluripotent stem cells (iPSC). They presented many topics that 
are important but have not yet been properly deliberated, including the 
handling and storing of patients’ cells and data, disclosure of the data to the 
donor patients and the publication of research conducted using patient-
derived iPSC. They also discussed the points that need prompt measures. 
We held a second meeting in 2010 to discuss a particularly controversial 
issue - deriving gametes from hPSC - which seemed timely because the cor-
responding Japanese governmental guidelines were revised in May, 2010, to 
allow conditional germ cell production from hPSC. More than 12 stake-
holders working at Kyoto University (most of whom worked at the CiRA) 
in the fields of hPSC research, developmental biology of animal gametes, 
intellectual property management, research strategy and public relations 
attended this meeting. In this report, we describe the issues encountered by 
stakeholders at the CiRA in relation to the environment surrounding hPSC 
research and their suggestions for addressing some of these issues.
Poster Board Number: 1210
AN UNDERGRADUATE CURRICULUM 
IN HUMAN DEVELOPMENTAL AND 
REGENERATIVE BIOLOGY
Anderson, William J., Eggan, Kevin C., Melton, Douglas A.
Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 
USA
Human Developmental and Regenerative Biology (HDRB) is an integrated 
life science concentration (major) at Harvard College that educates students 
on how human beings develop from a fertilized egg, are maintained and 
repaired throughout adulthood, and age till life’s end. Students are given 
a broad liberal education in modern life sciences by studying important 
biological principles of general relevance within the specific rubric of the de-
veloping and regenerating body. By adding an explicit and heavy emphasis 
on hands-on research opportunities in all four undergraduate years, HDRB 
has engaged and retained students with an interest in research while taking 
advantage of Harvard’s unique strengths as a teaching college and research 
university.
Poster Board Number: 1212
ACCESS TO AND USE OF HESC LINES BY STEM 
CELL SCIENTISTS
Levine, Aaron D.
School of Public Policy and Institute of Bioenginnering and Bioscience, 
Georgia Tech, Atlanta, GA, USA
The potential of human embryonic stem cells (hESCs) to differentiate into 
many different cell types has inspired hope that these cells will lead to a new 
era of regenerative medicine. Yet at the same time, ethical controversy sur-
rounding the derivation of these cells has inspired countless policy debates 
and led to a heterogeneous and uncertain policy environment. The unusual 
policy environment facing hESC scientists could plausibly affect the develop-
ment of this field in many ways. This project focuses on one such potential 
impact - scientists’ ability to acquire hESC lines for their research and their 
choice to use specific hESC lines. Drawing on data collected from approxi-
mately two hundred hESC scientists in the United States in a recent survey, 
this study identifies challenges scientists face when acquiring hESCs. In all, 
nearly 40% of hESC scientists surveyed reported that they faced an exces-
sive delay acquiring one or more hESC lines and more than 25% reported 
that they were unable to acquire a hESC line that they wanted to study. 
Scientists’ free-text descriptions of the difficulties they faced acquiring hESC 
lines suggest that prolonged negotiations over material transfer agreements 
and atypical levels of internal bureaucracy, driven by the contentious nature 
of the field, account for many of the problems scientists have acquiring 
hESCs. Analysis of the hESC lines that scientists use in their research indi-
cated that a small number of different lines accounted for a large majority of 
all cell lines in use. In addition, scientists typically indicated they used only a 
small number of hESC lines in their research. More than 50% of hESC scien-
tists reported that they used only one or two hESC lines and more than 75% 
of hESC scientists indicated that they used no more than three hESC lines in 
their labs. These results highlight the challenges hESC scientists face as they 
acquire cell lines for their research and suggest the development of hESC 
research may be hindered by an overreliance on a small number of cell lines 
and a shortage of labs equipped to conduct comparative hESC research.
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STEM CELL RESEARCH IN THE US AND 
UK: THE EFFECTS OF INTERNATIONAL 
COLLABORATIONS AND POLICY DISPARITIES 
ON RESEARCH
Luo, Jingyuan1, Flynn, Jesse M.2, Matthews, Kirstin RW1
1Baker Institute for Public Policy, Rice University, Houston, TX, USA, 2Policy 
and Global Affairs Division, The National Academies, Washington, DC, 
USA
Stem cell research is being conducted today in an increasingly global envi-
ronment. Research articles resulting from multi-nation collaborations in all 
sciences have nearly doubled over the past ten year to 180,783 (account-
ing for over 20% of total publications). While it is generally assumed that 
international collaboration enhances the quality of research, this phenom-
enon has not been well examined. Stem cell research is unique in that it is a 
research area that faces policy disparities yet also often generates cross-
border collaborations. Thus, studying international collaborations in stem cell 
research elucidates the role of existing international networks in promoting 
quality research, as well as the effects of disparate national policies on col-
laboration. This study examined the impact of collaboration on publication 
significance in the United States and the United Kingdom, two world leaders 
in stem cell research with differing policies. We reviewed publications by US 
and UK authors from 2008, along with their citation rates and the political 
factors that may contribute to the frequency of international collaborations. 
Our data, consistent with previous research on all sciences, found that UK 
researchers collaborate with international partners significantly more than 
US scientists. Fifty-three percent of total UK stem cell publications were the 
result of international collaborations versus 27% of total US stem cell publi-
cations. We also demonstrated that international collaborations significantly 
increase an article’s impact, which was measured using citation rates. For US 
authors this was most apparent when the American was the corresponding 
author. The United States was the top collaborator for UK-authored articles, 
with Germany, Italy, the Netherlands, and France rounding out the top 
five. Four of the top collaborators with the United States – Germany, UK, 
Canada, and China – were consistent with previous studies on all science 
publications (including natural sciences, engineering and social sciences). 
Our results illustrate that collaborations across national borders had a posi-
tive effect on citation rates. The data also suggest that national stem cell 
policy differences and regulatory mechanisms driving international stem 
cell research in the US and UK did not affect the frequency of international 
collaborations, or even the countries with which the US and UK most often 
collaborated. Geographical and traditional collaborative relationships were 
the predominate considerations in establishing international collaborations.
Poster Board Number: 1216
PRODUCTION AND QUALITY SYSTEMS AT THE 
MASSACHUSETTS HUMAN STEM CELL BANK
Shi, Meng-jiao, Ji, Lan, Boyer-Boiteau, Anne, Zhang, Chuanyou, 
Laning, Joseph
UMass Human Stem Cell Bank & Registry, University of Massachusetts 
Medical School, Shrewsbury, MA, USA
Advancement of the field of stem cell biology and regenerative medicine will 
depend on sustained efforts in a number of areas including but not limited 
to; (1) derivation and distribution systems, (2) streamlined materials transfer 
and licensing pathways, (3) regulatory agency influences and standardiza-
tion of testing methods, and (4) development of effective information 
channels. The Massachusetts Human Stem Cell Bank seeks to develop and 
implement systems to influence these functional areas and facilitate growth 
in the field wherever possible. Funded by the Massachusetts Life Sciences 
Center, the Massachusetts Human Stem Cell Bank is located at University of 
Massachusetts Medical School and is a repository for human ES and iPS cell 
lines that are derived in laboratories worldwide. The Bank is equipped with a 
full spectrum of “state-of-the-art” equipment and employs comprehensive 
Standard Operating Procedures (SOPs) for cell culture, quality characteriza-
tion, cryopreservation and distribution to both academic researchers and 
commercial operations throughout the world. We also provide training 
on hESC and iPS cell culture and cryopreservation techniques. The Bank 
currently distributes five hESC lines and two iPS lines and is in the pro-
cess of acquiring more hESC and iPSC lines derived from either healthy or 
disease-specific host source material. To ensure the differentiation potential 
of the banked lines, the Bank currently performs in vitro lineage differentia-
tion assays for some lines while testing the embryoid body (EB) formation 
potential for all the distributed cell lines. In addition, the Bank implements 
rigorous quality control systems to ensure that cells distributed are of the 
highest quality. To meet the needs of this rapidly evolving field, the bank is 
also engaged in testing and refining emerging techniques. For example, the 
Bank has successfully cultured both hES and iPS cells feeder-free for more 
than ten passages without changing the karyotype and pluripotent potential 
of these cells as measured by EB formation and analysis of gene expression 
profiles by Reverse Transcriptase Quantitative Polymerase Chain Reaction 
(RT-QPCR) & ICC assays. In addition, we have completed shipping studies 
to ensure optimal recovery upon receipt. Our cell line Catalog, cell culture 
and characterization SOPs, cell deposit & request documentation can all be 
found at our Website: http://www.umassmed.edu/MHSCB/index.aspx.
Poster Board Number: 1218
EVOLUTION OF STEM CELL RESEARCH 2004-
2009: A CITATION ANALYSIS PERSPECTIVE
Strotmann, Andreas, Zhao, Dangzhi
University of Alberta, Edmonton, AB, Canada
This study examines the development of the international stem cell (SC) re-
search field from 2004 to 2009 by analyzing the evolution of its intellectual 
structure and key researchers during this time. Methodology: We perform 
author citation and cocitation analyses for three 2-year slices of this 6-year 
period based on a nearly complete and highly cleaned dataset of the stem 
cell literature (including cited references) compiled from the PubMed and 
Scopus databases. For each time slice, a set of key researchers was identified 
as the 200 most highly cited during that time period, using automatic author 
name disambiguation to work around the extreme author name ambiguity 
problems in this field - a first in the field of scientometrics. Based on their 
co-citation patterns with other researchers, these researchers are grouped 
into specialties using the Factor Analysis statistical procedure, and the inter-
relationships between researchers and specialties are visualized using the 
Pajek network analysis program. The research specialties that these authors 
represent are manually inferred from the topics of their highly cited publica-
tions. Preliminary Results: The main separation into subfields of the stem cell 
research field appears to be fairly stable over the six years, but some major 
development trends and revolutions during this time are identifiable, as are 
some interesting details. The main subfields we identified throughout are (1) 
embryonic and pluripotent SCs (biology, molecular biology, and biotechnol-
ogy); (2) neural stem cells, especially adult neurogenesis; (3) medical stem 
cell research and applications, ranging from cancer to regenerative medicine; 
and (4) a number of foundational cell biology areas that stem cell research 
appears to draw upon. Major revolutions that we can identify from this 
analysis include (a) the apparently complete failure of an initially strong 
attempt to unify the field under the banner of stem cell plasticity; (b) the 
emergence of the cancer stem cell concept; and (c) the recent induced pluri-
potent stem cell breakthrough. More gradual trends within the field are not 
as clearly identifiable, but there are a few observations that merit mention. 
(a) While early attempts to rally the field around the concept of SC plasticity 
apparently failed, there does appear to be a gradual trend both towards 
improved cohesion in research tools and methods and towards a deepening 
understanding of a common nature of stem cells. (b) While haematopoietic 
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SCs continue to play a major role in both research and medical practice, the 
interest in their study for their own sake appears to be fading. Among the 
interesting details that this analysis suggests, we mention (a) the merging 
of the myocardial repair specialty into the vascular growth area rather than 
with the muscle stem cell field, indicating perhaps a greater promise in con-
sidering the heart as a rather large blood vessel than as a muscle when treat-
ing heart attacks; (b) the evolution of a mesenchymal SC specialty towards 
a focus on cytotherapy; and (c) the recent appearance of a small and vague 
specialty concerned with the biotechnology surrounding knockout mice at 
around the same time that the Nobel Prize went to the discoverers of this 
important biomedical research tool. Conclusions: In all, we observe a rapid 
evolution of stem cell research within a relatively stable framework. There 
are signs that the field is maturing and evolving towards a cohesive view of 
its subject matter.
Poster Board Number: 1220
SURVEY OF 1,200 HUMAN ES AND IPS CELL 
LINES
Smith, Kelly P., Luong, Mai, Laning, Joseph
UMass Human Stem Cell Bank and Registry, University of Massachusetts 
Medical School, Shrewsbury, MA, USA
Since the first derivation of human embryonic cell (hESC) lines in 1998, 
progress in this field has been rapid and has resulted in the derivation of 
more than 1,200 cell lines. Furthermore, the advent of induced pluripotent 
stem cell (iPSC) technology has transformed the stem cell landscape. To 
assess the current state of the pluripotent stem cell field, we have surveyed 
1,200 hESC and induced pluripotent stem cell (iPSC) lines using information 
compiled at the International Stem Cell Registry (http://www.umassmed.
edu/iscr). Validated unpublished information, as well as data from over 
1,600 published studies was analyzed. Parameters in this study include: 
genetic disorders, genetic manipulation, genomic stability, gender, feeder 
and feeder-free culture conditions, and differentiation protocols. The results 
from this study provide an informative timeline for overcoming obstacles to 
regenerative medicine, and suggest intriguing questions for future experi-
ments.
MUSCLE CELLS
Poster Board Number: 1222
TRANSDIFFERENTIATION BY BACTERIAL 
MEDIATED MYOD PROTEIN DELIVERY
Bichsel, Candace1, Hamazaki, Takashi2, Chang, Lung-Ji1, Terada, 
Naohiro2, Jin, Shouguang1
1Molecular Genetics & Microbiology, University of Florida, Gainesville, FL, 
USA, 2Pathology, University of Florida, Gainesville, FL, USA
Forced exogenous gene expression has been well characterized as an 
effective method for directing both cellular differentiation and dediffer-
entiation. However, transgene expression is not amenable for therapeutic 
application due to the potential for insertional mutagenesis. Protein based 
techniques provide a safe alternative, but current protein delivery methods 
are quite limited by labor-intensive purification processes, low protein yield 
and inefficient intracellular targeting. Such limitations may be overcome by 
using a naturally occurring bacterial protein injection system. Pseudomonas 
aeruginosa utilizes a Type III Secretion System to inject bacterial proteins 
directly into the eukaryotic cell cytoplasm. Our previous studies describe 
the ability of this system to easily deliver a high quantity of protein to both 
differentiated and pluripotent cells using a genetically attenuated strain. 
Utilizing Cre recombinase as a reporter, we demonstrate high frequency loxP 
mediated recombination in the chromosome of the recipient cells, suggest-
ing the protein is not only efficiently targeted to the nucleus, but also retains 
its biological function. MyoD is a key muscle regulatory factor, the over-
expression of which is able to induce transdifferentiation of numerous cell 
types, such as fibroblasts, into functional myocytes. Here we demonstrate 
transient injection of MyoD protein by P. aeruginosa is sufficient to induce 
myogenic conversion of mouse embryonic fibroblasts. In addition to clear 
morphological changes, muscle specific gene expression has been observed 
by immunostaining as well as RT-PCR. These studies serve as a founda-
tion for the bacterial delivery of transcription factors to efficiently modulate 
concentration-dependent and temporal activation of gene expression to 
direct cell fate without jeopardizing genomic integrity.
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MOUSE MODEL TO UNDERSTAND THE ROLE 
OF DUX4 IN FSHD
Dandapat, Abhijit1, Bosnakovski, Darko1, Baltgalvis, Kristen2, 
Hartweck, Lynn1, Lonetree, Cara-lin1, Nash, Nardina1, Lowe, Dawn2, 
Kyba, Michael1
1Lillehei Heart Institute, University of Minnesota, Minneapolis, MN, USA, 
2Physical Medicine & Rehabilitation, University of Minnesota, Minneapolis, 
MN, USA
FSHD is an autosomal dominant disease that affects 1:20000 individu-
als. Mapping studies have associated the disease with a reduced number 
(1-10) of the D4Z4 macrosatellite repeats from the usual ~100. These 
repeats lie adjacent to the telomeres and are usually present in a highly 
silenced epigenetic state. It is not clear which genes are affected or how 
DNA methylation patterns affect the disease. Within the D4Z4 repeat is 
an ORF encoding a putative transcription factor named Dux4, containing 
two homeodomains. Although the function of Dux4 is unknown, the Dux4 
homeodomains are similar to those of Pax7, a protein known to be involved 
in muscle development, proliferation and differentiation. We have previ-
ously reported that Dux4 is toxic when misexpressed at high levels in many 
cell types, and blocks differentiation of myoblasts when expressed at low 
levels, and competes with Pax7 for regulation of myogenic target genes. 
To model Dux4 function in vivo, we made a Dux4-inducible mES cell line 
by inserting a doxycycline-inducible Dux4 allele (iDux4+3’UTR) onto the X 
chromosome at a euchromatic region (HPRT). High-level induction of the 
Dux4 was toxic to mES cells but low-level Dux4 resulted in altered differ-
entiation. When iDux4+3’UTR mice where generated and bred, this allele 
demonstrated leaky phenotypes in females, and male-specific lethality. Rare 
live-born males were small and underdeveloped with abnormal skin and 
defective sperm development and showed changes to muscle fibers, but 
no overt muscle degeneration. However, mice died within 1 month, well 
before the stage degeneration usually begins in FSHD. Dux4 protein could 
be induced and observed in cultured primary cells, and we are evaluating 
pups and embryos for Dux4 expression in vivo. Dux4 carrier females were 
smaller and displayed the skin phenotype in transverse stripes. We hypoth-
esize that the 3’ UTR contains an enhancer which drives leaky expression in 
some embryonic cell types and that X chromosome inactivation combined 
with selective survival of XDUX4-inactive cells protects the females from the 
lethality. To test for selectively biased X inactivation, we crossed Dux4 carrier 
females with XGFP males. Upon FACS analysis of the GFP+ cells in XGFP/ 
X+ vs. XGFP/ XDux4 female progeny, we found that the latter had an el-
evated frequency of GFP positive cells in most tissues, including the satellite 
cell compartment of skeletal muscle, confirming our hypothesis of selective 
XDUX4 inactivation. This mouse model suggests that Dux4 is a dominant 
lethal gene even when expressed at very low levels and can cause a variety 
of developmental defects in EBs and in embryo development.
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MYOSTATIN DEPENDENT MUSCLE 
REGENERATION IN EXPERIMENTALLY INDUCED 
DIABETES
Jeong, Jaemin, Conboy, Michael J., Conboy, Irina M.
QB3, Berkeley, CA, USA
Insulin insufficiency following the depletion of insulin producing pancreatic 
β-cells or peripheral insulin resistance cause diabetes mellitus, a severe meta-
bolic disorder that affects many organ systems and results in poor wound 
healing. In this work, we studied the direct influence of acute insulin insuf-
ficiency and deregulated glucose metabolism on the regenerative potential 
of skeletal muscle stem cells (satellite cells). Our results establish that in an 
animal model of type 1 diabetes, muscle stem cells fail to activate within 
72 hours of high glucose blood levels, and repair of young muscle instantly 
deteriorates, resembling that of old tissue. Furthermore, our data demon-
strate that this deleterious effect of insulin insufficiency on organ stem cells 
is direct and caused by a significantly increased TGF beta receptor signaling 
in satellite cells. Importantly, this work establishes that the increase of TGF 
beta receptor signaling and poor regenerative capacity can be restored to 
healthy levels in muscle stem cells in vivo by the administration of follistatin 
or an Alk5 inhibitor. Notably, transient Alk5 inhibitor treatment does not 
reduce the levels of blood glucose in insulin depleted mice, i.e. does not cure 
diabetes itself, but rather restores satellite cell responses through a TGF-beta 
signaled cell-cycle halt by CDK inhibitors. Summarily, the regenerative re-
sponses of muscle stem cells rapidly fail without insulin due to increased TGF 
beta receptor signaling; even a brief lack of insulin and perturbed glucose 
metabolism have immediate negative consequences for tissue maintenance 
and repair, and follistatin or Alk5 inhibition is predicted to rescue tissue 
regeneration in the presence of diabetes.
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ABERRANT GENE EXPRESSION IN 
FACIOSCAPULOHUMERAL MUSCULAR 
DYSTROPHY INDUCED PLURIPOTENT STEM 
CELLS
Lock, Leslie F.1, Winokur, Sara T.2, Stocksdale, Jennifer2, Hazim, 
Roni3, Bengtsson, Ulla2, Martin, Jorge2, Ibrahim, Abdulrahman2
1Biological Chemistry and Developmental and Cell Biology, University 
of California, Irvine, Irvine, CA, USA, 2Biological Chemistry, University 
of California, Irvine, Irvine, CA, USA, 3Developmental and Cell Biology, 
University of California, Irvine, Irvine, CA, USA
Facioscapulohumeral (FSH) muscular dystrophy is a common autosomal 
dominant neuromuscular disease for which there is no effective treatment. 
FSH is associated with heterochromatin loss and a gain-of-function mutation 
on human chromosome 4q. The mutation creates a polyadenylation site that 
stabilizes transcripts of DUX4, a double homeobox gene of unknown func-
tion. Previous studies suggested that DUX4 may be toxic and/or a transcrip-
tional activator. Our goal is to determine the relationship between DUX4 
expression and the pathology observed in FSH. In this study, we established 
an in vitro model of FSH using human induced pluripotent stem (iPS) cells. 
We used the model to determine: 1. the expression of DUX4 in FSH and 
control embryonic and adult cells and 2. the changes in gene expression 
associated with DUX4 expression. iPS cells were isolated from control and 
FSH skin and muscle biopsy tissue using retroviral vectors to express OCT4, 
SOX2, KLF4, and c-MYC. Both fibroblast- and myoblast-derived iPS cells 
express typical stem cell markers, have normal karyotypes, and form tera-
tomas containing differentiated cells from all three embryonic germ layers. 
To determine whether DUX4 is expressed in FSH-iPS cells, we performed 
RT-PCR and SYBR green quantitative PCR using probes specific to the DUX4 
transcript produced from the mutant allele. DUX4 transcripts were detected 
in all FSH-iPS cell lines but absent in most control iPS cell lines and human 
embryonic stem cells. Expression of DUX4 in pluripotent cells was correlated 
with 4q haplotypes containing the polyadenylation signal. To determine 
whether DUX4 alters gene expression in FSH-iPS cells, we performed 
microarray analysis (Affymetrix). Gene expression was largely similar in FSH- 
and control-iPS cells prior to differentiation with several notable exceptions. 
Our results suggest that DUX4 is aberrantly expressed in FSH pluripotent 
cells of the embryo and adult somatic cells and may reflect a pathogenic role 
in early development or renewable stem cell populations such as satellite 
cells in mature muscle.
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DERIVED CD133 POSITIVE STEM CELL DEFINE 
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In the muscle there exist different stem cell populations that are able to 
participate in muscle regeneration. How muscle stem cells balance their 
self-renewal capacity and their ability to differentiate are central questions 
in stem cell research. Moreover, recent findings supported the notion that 
heterogeneity is a hallmark of stem cells. It is known that these cell popula-
tions express a variety of surface markers including CD29, CD56, CD44, 
CD90, CD105, STRO1. Here we have focused our attention on the so-called 
MDSCs (Muscle Derived Stem Cells) that can be rather considered as satel-
lite precursors. In the past our group focused its attention on a stem cell 
population expressing CD133 antigens on its surface. The analysis of mus-
cle-derived CD133 positive cells showed that they have been characterized 
for their regenerative potential in vivo, as well as their ability to repopulate 
the satellite cell niche. However, we found in the CD133 positive MDSCs a 
phenotypic heterogeneity in the presence of some surface antigens: in the 
same cell population we found an oscillation of expression of endothelial, 
myogenic and mesenchymal markers. Based on these assumptions we sorted 
some cell subpopulations obtained from muscles of healthy orthopedic 
patients: mesenchimal like cells (133pos 73pos 44pos 29pos 34neg 45neg); 
endothelial like cells (133pos 90pos 146pos 31pos 45neg) and myogenic like 
cells (133pos 56pos 45neg 34pos or neg). These subpopulation of sorted 
CD133 were cloned and analyzed for their capacity to proliferate and differ-
entiate into the endothelial and myogenic lineages. In these experiments we 
found stem cell properties in the mesenchymal like CD133 positive clones. 
In fact these cells possess clonogenic potential and well differentiate into 
endothelial and myogenic cells. In conclusion, our study showed that muscle 
derived CD133 positive cells represent a heterogeneous population of mes-
enchymal, myogenic and endothelial progenitors. Further experiments are 
needed in order to understand whether CD133 purification could be useful 
for clinical applications in muscular dystrophies.
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THE LIN28/LET-7 AXIS REGULATES EMBRYONIC 
AND ADULT GLUCOSE METABOLISM IN 
MAMMALS
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The let-7 family of tumor suppressor microRNAs repress oncogene transla-
tion and promote differentiation in embryonic stem cells. The RNA-binding 
proteins Lin28A and Lin28B block the processing of let-7 family members to 
promote pluripotency and malignancy. Here we demonstrate an unexpected 
role for Lin28a/b and let-7 in regulating embryonic and adult glucose me-
tabolism in mammals. Loss of Lin28a in E10.5 mouse embryos and inducible 
overexpression of let-7 in mouse embryonic stem cells reduce both glycolytic 
flux and NADH levels, as shown by metabolomics. In contrast, overexpres-
sion of Lin28a in adult myoblast cells increases glycolytic flux and NADH 
levels. When overexpressed in transgenic mice, both Lin28a and LIN28B 
promote a metabolic state with high glucose uptake and high insulin sen-
sitivity that resists obesity-induced diabetes, by activating the PI3K-mTOR 
pathway. Overexpression of let-7, on the other hand, leads to impaired 
glucose uptake, due to let-7-mediated repression of the PI3K-mTOR path-
way. In vitro and in vivo, the enhanced glucose uptake and insulin-sensitive 
phenotype conferred by Lin28a is abrogated by the mTORC1 inhibitor 
rapamycin. In addition to interactions with the PI3K-mTOR pathway, let-7 
targets numerous genes associated with fasting glucose and type-2 diabetes, 
based on human genome-wide association studies. Furthermore, mRNA 
transcripts associated with the Lin28a RNA-binding protein in embryonic 
stem cells are also significantly enriched for glycolysis enzymes. These data 
establish the Lin28/let-7 pathway as a central regulator of both embryonic 
and adult mammalian glucose metabolism, with implications for the theory 
of fetal origins of metabolic disease (Barker’s hypothesis), and the Warburg 
effect in cancer.
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CHARACTERIZATION OF ROLE OF BAF60C 
IN TGF-β MEDIATED SMOOTH MUSCLE 
INDUCTION IN RODENT BONE MARROW 
DERIVED ADULT STEM CELLS
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Smooth muscle cells (SMC) occur in two varieties: vascular SMC in blood 
vessels and visceral SMC lining the visceral organs. The main function is to 
regulate blood pressure (vascular) and movement (visceral). Developmen-
tally, SMC can be derived from multiple sources: neural crest, local mesen-
chymal tissue, splanchnic mesoderm, as well as derived by transdifferentia-
tion of endothelial cells in blood vessels. Development of SMC is critical 
for the viability of embryo. In the adult, there are many diseases associated 
with SMC dysfunction, such as asthma atherosclerosis, obstructive bladder 
disease, gastrointestinal and reproductive disorders. SMC are a unique type 
of cells that have the ability to phenotypically remodel during injury and 
disease. However, there is very little known regarding the genes, specifically 
transcription factors (TFs), and signal pathways necessary for SMC develop-
ment and / or that regulate remodeling of SMC during injury and in disease 
conditions. Moreover the lack of proper model systems to study SMC 
development in vivo (as underdeveloped SMC leads to embryo lethality) has 
impaired our advancement in understanding SMC development. The aim of 
this study is to use adult bone marrow derived stem cells as model to iden-
tify genes involved in smooth muscle generation. We differentiated rat Mul-
tipotent adult progenitor cells (MAPC) towards smooth muscle using TGF-β 
and PDGF-BB, following which we preformed a temporal genome-wide 
transcriptional analysis to identify novel regulators of smooth muscle genes. 
We identified, among others, Baf60c as a transcription factor that regulates 
certain smooth muscle genes. Baf60c or Smarcd3 is a SWI/SNF chromatin 
remodeling complex protein shown to be important in cardiac and skeletal 
muscle genesis. Lickert et al. in 2004 had demonstrated that silencing of 
Smarcd3 expression leads to defects in developing heart. Ochi et al. had 
shown that morpholino mediated knock down of Smarcd3 leads to delay in 
onset of skeletal myogenesis. We here demonstrate that Smarcd3 is a target 
of Smad mediated TGF-β signaling. In addition, inhibition of Smarcd3 leads 
to a decrease in TGF-β mediated smooth muscle gene induction. Recently, 
Takeuchi et al. (2009) demonstrated that Baf60c in association with cardiac 
specific factors could differentiate mouse mesoderm to heart tissue. Similarly, 
we observed that Smarcd3 was sufficient to induce SMC genes including 
smooth muscle actin (SMA) in rat MAPC in serum and cytokine free condi-
tions, albeit with lower efficiency. We are currently characterizing the associ-
ated proteins that aid Smarcd3 in inducing a SMC fate in rat MAPC.
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MUSCLE CELL DIFFERENTIATION
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Guangxiu1
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The proliferation and differentiation of smooth muscle cells (SMCs) play 
critical roles in vascular diseases. Since myocardin is a key factor in smooth 
muscle differentiation, in this experiment we were looking for transcrip-
tion factors (TFs) or co-activators in smooth muscle differentiation signal-
ing pathway by screening the proteins that could bind and interact with 
myocardin. By studying the function of the protein candidates, we may 
discover new molecular mechanisms of smooth muscle differentiation. After 
screening of 1,070 transcription factors by luciferase assay and real-time 
PCR, we discovered that a list of 11 TF candidates, such as zbtb43, rxra, 
rai14, maged1, foxo3a, could increase luciferase activity by interacting with 
myocardin and also could be highly expressed in mouse aorta and human 
SMCs in a mRNA level. We successfully constructed the Myc-Tag expression 
plasmids of some of the TF candidates and further confirmed by co-immu-
noprecipitated assay (co-IP) that myocardin could bind with 4 TFs (RAI14, 
MAGED1, ZBTB43 and FOXO3A). Moreover, the expression level of above 
4 TFs was significantly upregulated during the process of mouse embryonic 
stem cells differentiating into SMCs induced by 10-5M all trans-retinoic acid. 
All these data suggested that these newly discovered TFs might play an im-
portant role in the SMC differentiation signaling pathway though interacting 
with myocardin.
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ADULT SKELETAL MYOGENESIS IN A RAT 
MODEL OF AMYOTROPHIC LATERAL 
SCLEROSIS
Warita, Hitoshi, Mizuno, Hideki, Suzuki, Naoki, Itoyama, Yasuto, 
Aoki, Masashi
Neurology, Tohoku University Graduate School of Medicine, Sendai, Japan
Objective: Considering the future development of neuromuscular recon-
struction therapy in amyotrophic lateral sclerosis (ALS), we investigated 
a temporal profile of endogenous myogenesis in skeletal muscles of a rat 
model of ALS. Background: ALS is a progressive and fatal neurodegenerative 
disease characterized by adult-onset loss of motoneurons without effec-
tive treatment to date. Axonal retraction from innervating skeletal muscles 
has been reported as an early pathology in ALS patients and in transgenic 
(Tg) mice with ALS-linked mutant SOD1 genes. Methods: We examined 
endogenous myogenesis in hindlimb skeletal muscles of His46Arg mutant 
SOD1 Tg rats at pre-symptomatic, early symptomatic, and late symptomatic 
stages (n=4-5) with their age-matched non-transgenic littermates (non-
Tg). Continuous administration of bromodeoxyuridine for 7 days labelled 
newborn cells in vivo. After the administration, we performed multiple 
immunofluorescence using various myogenic markers including MyoD, 
neonatal myosin heavy chain, and neural cell adhesion molecules in cryosec-
tions of femoral quadriceps and anterior tibial muscles. For quantification, 
we captured digital images of the immunofluorescence under confocal laser-
scanning microscopy. Results: In contrast to non-Tg, the Tg rats showed a 
significant increase of myogenesis with a distinct expression of the myogenic 
proteins, progressive neurogenic myopathology, and axonal retraction from 
neuromuscular junction. The myogenic response in Tg rats peaked at the 
early stage of disease, followed by decrease at the later stage. Furthermore, 
chondroitin sulfate was accumulated progressively in the interstitial space 
in Tg rats. Conclusions: The present results revealed an intrinsic regenera-
tive response against the chronic denervative amyotrophy in the ALS-like 
disease. The response, however, does not persist sufficiently throughout the 
disease. In addition to motoneuron restoration, promoting myogenesis and 
reinnervation to skeletal muscles could be needed for inhibiting amyotrophy 
and neuromuscular reconstruction.
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BIODEGRADABLE L LACTIDE E 
CAPROLACTONE COPOLYMER SCAFFOLD 
SUPPORTS MYOBLAST GROWTH AND 
DIFFERENTIATION
Bandyopadhyay, Balaji, Shah, Viru, Viswanathan, Chandra, Ghosh, 
Deepa
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Skeletal muscle regeneration involves the activation of satellite cells to 
myoblasts, followed by their proliferation and fusion to form multinucleated 
myotubes and myofibers. The potential of in vitro proliferated myoblasts 
to treat various diseases and tissue defects can be exploited using tissue 
engineering principles. With an aim to develop a biocompatible and biode-
gradable scaffold that supports myoblasts growth and differentiation, we 
have developed a scaffold with 85/15 L-lactide/ε-caprolactone copolymer 
(PLC) using a phase inversion combined with particulate leaching method. 
Biodegradability studies indicated that the highly porous scaffold retained 
its integrity for 5 months in vitro and had undergone complete degrada-
tion within nine months in vivo. The scaffold supported human myoblasts 
attachment and its proliferation. The myoblasts seeded on the PLC scaffold 
differentiated and fused to form multinucleated myotubes in vitro. Histo-
logical and molecular analyses of the PLC scaffolds loaded with GFP labeled 
myoblasts and implanted ectopically under the skin in SCID mice indicated 
the presence of multinucleated myotubes. Our results suggest PLC scaffolds 
loaded with myoblasts can be used for skeletal muscle engineering or muscle 
repair.
NEURAL CELLS
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It is possible to induce hESC to undergo mDA neuronal differentiation by 
simple exposure to feeder cell lines, particularly the mouse PA6 stromal 
cell line; this effect is known as SDIA. We have previously identified four 
factors highly expressed by PA6 cells which are able to mimic SDIA. These 
were stromal cell-derived factor 1 (SDF-1/CXCL12), pleiotrophin (PTN), 
insulin-like growth factor 2 (IGF2), and ephrin B1 (EFNB1), termed SPIE. 
All four factors are required for efficient mDA differentiation. SPIE-induced 
mDA neurons generated action potentials and formed functional synaptic 
connections. In the present study, we examined differences between hESC 
lines in their responses to SPIE, and compared these to mDA differentiation 
of the same hESC lines using the differentiation method reported by Yan et 
al. Five hESC lines were used, BG01, BG02, BG03, ES02, and ES04, as well 
as BG01V2 which differs from BG01 in that it has a trisomy at chromosome 
17. BG01V2 and BG03 rapidly formed large numbers of mDA neurons in 
response to SPIE, while BG02, ES02, and ES04 did not respond effectively. In 
BG02, SPIE produced small numbers of neurons positive for tyrosine hydrox-
ylase, but lacking the mesencephalic marker MSX1. SPIE also did not induce 
mDA differentiation of various mouse neural progenitor cell lines or Ntera2 
cells. The Yan et al. technique for mDA neuron differentiation from hESC 
involves an initial embryonic body formation phase, followed by isolation of 
neural rosettes and treatment with SHH and FGF8. In contrast to the SPIE 
technique, the Yan et al. technique is effective for all hESC lines. BG01V2 
and BG03 differentiated into mDA neurons in a period of 16 days, although 
BG03 differentiated less effectively than BG01V2. All other hESC lines 
required 45 days for mDA differentiation. We examined the possibility that 
differences in WNT signaling were responsible for the differences between 
hESC lines in mDA neuron differentiation. Using Western blotting, canonical 
and noncanonical signaling inhibitors (Dkk-1 and SP600125 respectively), 
and a chromatin immunoprecipitation (ChIP) assay, we examined the role 
of WNT at various differentiation stages. Noncanonical WNT signaling 
promoted the neuroectodermal fate through inhibition of hESC self-renewal 
while canonical WNT stimulated both neuroepithelial cell proliferation and 
mDA differentiation. Inhibition of WNT signaling reversed the accelerated 
differentiation of both BG01V2 and BG03. Because LMX1a is regulated by 
the β-catenin pathway and modulates expression of transcription factors 
required for mDA differentiation, we performed a ChIP assay. Binding of 
β-catenin to the promoter of LMX1a was greater for the rapidly-differenti-
ating lines BGO3 and BGO1V2, as compared to the other lines. Therefore, 
differences in WNT signaling can account for the differences between hESC 
in their propensity to undergo rapid mDA differentiation. These data also 
confirm the role of canonical WNT signaling in mDA differentiation.
ISSCR 9th Annual Meeting
42
www.isscr.org
Friday Poster Abstracts
Poster Board Number: 1244
INHIBITION OF NOTCH SIGNALING PREVENTS 
NEURAL OVERGROWTH AFTER THE 
TRANSPLANTATION OF NEURAL PROGENITORS 
DERIVED FROM HUMAN INDUCED 
PLURIPOTENT STEM CELLS
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When transplanted, pluripotent stem cell-derived neurons survived and 
contributed to functional recovery in animal models of Parkinson’s dis-
ease; however, their transplantation has always been accompanied by a 
risk of tumor formation. Removal of undifferentiated cells from the donor 
population with fluorescence-activated cell sorting (FACS) was successful in 
preventing tumorigenesis; however, immature neural progenitors in the graft 
often continued dividing instead of terminally differentiating into mature 
dopaminergic neurons. Such unpredictable growth of the graft, referred 
to as neural overgrowth, could pose a safety risk over time. Notch signal-
ing pathway plays a role in maintaining the multipotency and proliferative 
capacity of neural progenitors. Gamma secretase is a protease complex 
responsible for notch signal transduction by cleaving notch intracellular 
domain upon binding of the ligands to the notch receptor. In this study, we 
investigated if a transient notch inhibition in human induced pluripotent 
stem cell (iPSC)-derived neural progenitors with gamma secretase inhibitors 
(GSIs) could control the growth of the grafts after transplantation. We first 
evaluated if GSIs could suppress the growth of the graft consisting of highly 
proliferative immature progenitors. Dopaminergic progenitor cells were 
generated after the 22 days of differentiation via the serum-free culture of 
embryoid body-like aggregates quick (SFEBq) method. Quantitative PCR, 
immunocytochemical and cell cycle analyses were used to assess the prolif-
eration and maturation of those progenitors in vitro. A 4-day treatment with 
GSIs significantly reduced dividing population, and promoted the transition 
from PAX6-positive neural progenitors into MAP2AB-positive neurons. 
Next, they were transplanted into the striatum of NOD-SCID mice. Positive 
Nestin, NCAM and Tubβ3 stainings in the grafts indicated the neural and 
almost neuronal identities of the transplanted cells in animals of all groups. 
At 8 weeks post-transplantation, we observed prominent neural overgrowth 
with numerous neural rosettes in all animals of the control group (n=7). On 
the other hand, grafts pre-treated with GSIs were significantly smaller in 
volume compared to control. Such difference most likely to have reflected 
the reduced proliferative capacity of the transplants pre-treated with GSIs, 
as confirmed by a significant reduction in PAX6-positive and Ki67-positive 
populations at the time of sacrifice. Furthermore, stronger Tubβ3 staining in-
dicated the promotion of neuronal maturation by GSIs. These results suggest 
that a transient notch inhibition with GSIs could be combined with other 
strategies such as FACS to optimize the safety of cell replacement therapies 
with iPSCs.
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INTRODUCTION: Skin-derived precursor cells (SKPs) have been thoroughly 
studied since their discovery by Toma et al. a decade ago. These multipotent 
stem cells offer a great alternative to other more controversial sources of 
stem cells and their capacity to differentiate into mature neurons, highlights 
their therapeutic potential for a variety of neurological diseases, such as 
Parkinson’s disease (PD). One aspect of PD is the extensive loss of dop-
amine (DA) neurons in the substancia nigra pars compacta, inducing a lack 
of DA secretion in the striatum. OBJECTIVE: The purpose of this study was 
to determine whether adult human SKPs could fully develop into functional 
dopaminergic-like neurons, a subset of cells particularly targeted in PD. 
METHODS: Skin samples used in these experiments were obtained from 
breast reductive surgery, and fully informed consent was obtained for each 
patient. Cells were extracted from skin biopsies using enzymatic digestion 
and cultured as floating spheres in a proliferation medium containing epi-
dermal growth factor, leukemia inhibitory factor and basic fibroblast growth 
factor2. After a month of purification/proliferation in suspension, spheres 
were triturated and seeded on poly-d-lysine/laminin coated culture flask and 
cover slips. Differentiation process was divided in three stages depending 
on the cocktail of morphogens and neurotrophins used. Differentiated cells 
were analyzed regarding their generic and dopaminergic specific neuronal 
markers using immunofluorescence and flow cytometry techniques. PCR 
was used to analyze the expression of Nurr-1, a dopaminergic phenotype 
triggering gene. ELISA assessment of the secretion by the differentiated cells 
of brain-derived neurotrophic factor (BDNF), glial cell-derived neurotrophic 
factor (GDNF) and DA was also performed. RESULTS: Immunofluorescence 
and flow cytometry analyses showed that dopaminergic-induced cells 
express tyrosine hydroxylase (TH), a key enzyme in DA production (33% 
after 21 days of differentiation - D21). Cell imaging results also showed 
the expression of VMAT2 and DAT, two receptors respectively responsible 
for vesicular transport of DA to the synapse and re-uptake of DA. We also 
demonstrated that differentiated adult human SKPs secrete BDNF (~440 
pg/ml at D21) as well as GDNF (~1800 pg/ml at D21), two important 
neurotrophins promoting neuronal cell survival. Finally, DA release (~12 ng/
ml at D21) and Nurr-1 expression was also observed. CONCLUSION: The 
present study demonstrates that adult human SKPs can differentiate into 
dopaminergic-like neurons expressing several specific markers of this system. 
In addition, these cells secrete similar amounts of BDNF, GDNF and DA com-
pared to dopamineric neurons. These cells could prove to be an autologous 
cell therapy option for the treatment of Parkinson’s disease. 
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PARKINSON’S DISEASE PATIENT SPECIFIC IPS 
CELL-DERIVED NEURAL CELLS DEMONSTRATE 
GENOTYPE-SPECIFIC VULNERABILITIES IN 
VITRO
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T., Perez-Torres, E., Clark, L., Moskowitz, C., Andrabi, S., Xie, Z., 
Guardia Laguarta, C., Mazzulli, J., Chen, L., Volpicelli-Daley, L., 
Romero, N., Jiang, H., Carrillo-Reid, L
NINDS PD iPS Cell Research Consortium and collaborating institutions, 
Belmont, MA, USA
The greatest risk factor for Parkinson’s disease (PD) is age but genetic and 
epigenetic sources of cellular stress can accelerate the age of disease onset. 
While kindreds and genome sequencing technology can estimate an indi-
vidual’s risk for developing PD, human cell models are required to under-
stand the complex biological consequences of an authentic genetic risk load 
and develop treatments. As a new genetic tool to study PD, we generated 
iPS cell lines from 6 patients with SNCA, LRRK2 or PINK1 mutations and 2 
healthy individuals. Next, we developed a comparative multiple hit model of 
PD by administering a dose range of PD associated toxins to iPS cell-derived 
neural cells. Cytotoxicity assays showed that LRRK2 R1441C patient neural 
cells are more vulnerable to valinomycin and MPP+ than neural cells derived 
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from healthy individual iPS cells. Meanwhile, SNCA triplication patient neu-
ral cells were solely vulnerable to MPP+ and PINK1 p.Q456X patient neural 
cells to valinomycin alone. Furthermore, flow cytometry and immunocy-
tochemistry indicated that a subtoxic dose of valinomycin but not MPP+, 
6-OHDA or hydrogen peroxide increased the levels of mitochondrial super-
oxide and cell death of PINK1 p.Q456X patient neural cells. Interestingly, 
the concentration of valinomycin was 10-fold less than previously described 
to induce cellular stress in the same patients’ fibroblasts. These data suggest 
that cellular reprogramming technology can provide a biologically-relevant 
cellular context for studying the genetic risks for PD.
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SYNERGISTIC EFFECT OF PITX3 
OVEREXPRESSION AND GDNF INDUCTION 
IN DOPAMINERGIC PROGRAMMING OF 
NT2, A HUMAN PLURIPOTENT EMBRYONIC 
CARCINOMA CELL LINE
Momen Dizghandi, Hassan1, Gardaneh, Mossa1, Safi, Mojtaba2, 
abasi, Mozhgan2, Massumi, Mohammad2
1Molecular Genetics, NIGEB, Tehran, Iran, Islamic Republic of, 2Animal and 
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Cell replacement strategies are sought to replenish dying neurons by fresh 
and functional ones obtained from differentiation of potential sources 
ranging from stem cells to dopaminergic precursors. Human Nteratocar-
cinoma cell line NT2 expresses dopamine signals and, owing to its safety 
profile, has been applied for clinical transplantation. We have established a 
Pitx3-expressing NT2 cell line mediated by lentiviral transduction that stably 
overexpresses the dopaminergic transcription factor, as tested via RT-PCR 
analysis and monitored by GFP reporter expression. The engineered NT2 
cells were cultured in a defined medium supplemented with 5% SR serum 
that induces embroid bodies (EB) formation. These structures gained sharp 
and defined borders following retinoic acid treatment. Next, we cultured 
these EB-differentiating cells in the presence of conditioned medium taken 
from various cell lines over-secreting neurotrophic factor GDNF. This step 
accelerated neuronal morphology of the cells. We also found that the EBs 
formed from our NT2 clones can differentiate better when trypsinized to 
grow as single cells. Currently, we are determining the neuronal fate of the 
differentiated cells using specific markers that assist identifying dopaminergic 
neurons. Our findings indicate that GDNF and Pitx3 act in synergy to induce 
neuronal differentiation.
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One of the most remarkable forms of structural plasticity in the adult brain 
is the generation of new functional neurons from adult neural precur-
sors cells (NPCs). There is accumulating evidence that neurogenesis in the 
adult hippocampus contributes to brain physiology and disease, but its 
precise physiological role remains elusive. Conceptually, this process can be 
divided into four steps: (i) proliferation; (ii) neuronal fate determination; (iii) 
survival and maturation of new neurons; and (iv) functional integration of 
new neurons into the pre-existing neuronal network. Here we describe the 
development of phenotypic in vitro screening assays using human embry-
onic stem cell derived NPCs as a cellular model to investigate neurogenesis. 
Using expression profiling of differentiating cells and exposure of NPCs to 
bioactive small molecules, we can demonstrate that neurogenesis relevant 
signaling pathways are active in this in vitro cell model. These experiments 
demonstrate that this human NPC model represents a neuronal relevant 
transcriptional and biological state, which can unleash the identification 
of a plethora of targets spanning the druggable genome. Thus, unbiased 
High-Throughput Screenings (HTS) in combination with image based High 
Content Analysis (HCA) may represent a powerful tool to identify new ac-
tive CNS compounds/targets in regenerative medicine, which may ultimately 
elucidate novel mechanisms modulating adult neurogenesis.
Poster Board Number: 1254
DISRUPTION OF AUTOPHAGY IN A HUMAN 
NEURONAL MODEL OF NIEMANN PICK TYPE C
Ordonez, Paulina, Kidwell, Chelsea, Roberts, Elizabeth, Goldstein, 
Lawrence S.B.
University of California, San Diego, San Diego, CA, USA
Niemann Pick type C (NPC1) is an incurable, progressive and invariably fatal 
pediatric dementia caused by mutations of NPC1, a lysosomal membrane 
protein with a putative role in cholesterol transport. The disease is of 
tremendous basic science and public health interest due to the intriguing 
parallels in cellular pathology it shares with Alzheimer’s disease (AD), sug-
gesting a common underlying mechanism. Our knowledge of the mecha-
nisms leading to neuronal dysfunction in NPC1 is limited by the difficulty 
of obtaining live human neurons from affected children. To overcome this 
difficulty we generated neurons with decreased function of NPC1 from 
HUES9 human embryonic stem cells (hESC). NPC1 knockdown neurons 
replicate hallmark phenotypes of NPC1 with accumulation of cholesterol and 
an abnormal pattern of lysosomal staining. Furthermore, we have described 
a new phenotype of mitochondrial accumulation not previously reported 
in NPC1. We tested the hypothesis that abnormal cholesterol processing 
leads to deficient clearance of mitochondria by the autophagic pathway. 
Contrary to prior reports, we found that NPC1 fibroblasts and neurons not 
only have increased activation of autophagy, but also abnormal autophagic 
flow leading to accumulation of partially degraded mitochondria. These 
abnormal phenotypes were rescued by treatment with the autophagy inhibi-
tor 3-methyladenine (3MA), and by amelioration of lysosomal cholesterol 
accumulation with cyclodextrin. Our data suggest a previously unrecognized 
connection between abnormal cholesterol processing, autophagy defects, 
and mitochondrial accumulation in NPC1, and reveals a potential new target 
for the development of new therapies.
Poster Board Number: 1256
NEURAL STEM CELLS FROM DENTAL PAPILLA 
TISSUE OF HUMAN IMMATURE THIRD MOLAR 
TOOTH
KIM, Byung-Chul
Maxillofacial Biomedical Engeering, Kyung Hee University, Seoul, Korea, 
Republic of
INTORODUCTION: In developmental biology, it is well known that tooth 
development is mediated by the interaction between neural crest-derived 
mesenchyme and epithelial. During tooth development, nerve is also devel-
oped within the pulp tissue through root accompanied with the develop-
ment of enamel, pulp and ligament structure. Recently, various dental stem 
cells have been identified in dental tissues such as pulp, ligament, follicle and 
papilla, and their multi-differentiation including neural differentiation was 
reported. Regarding the developmental process of dental tissue, the origin of 
neural crest-derived ectomesenchyme and the neural differentiation activity 
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of dental stem cell, it could be hypothesized that neural stem cell can reside 
in immature soft dental tissue such as papilla tissue. In this study, there-
fore, the presence of neural stem cells was characterized in the histological 
section of the human third molar teeth, and neural stem cells were isolated 
and expanded, and neural differentiation of the isolated neural stem cells 
was studied. MATERIALS AND METHODS: Neural stem cells were isolated 
from human dental papilla tissues (KHUSD IRB# 0908-01) by anti-human 
PS-NCAM antibody and MACS, and characterized by immunocytochemical 
staining, DNA microarray analysis, flow cytometric analysis and real time-
PCR. Neural differentiation and dopaminergic neuronal differentiation was 
evaluated under proper culture conditions and characterized. RESULTS AND 
DISCUSSION: A specific cell population expressing neural stem cell markers 
such as nestin and PS-NCAM was identified within dental papilla tissues of 
third molar teeth by immunocytochemial staining. During passage of the 
isolated dental papilla tissue-derived cells, a certain cell population with 
round morphology demonstrated the characteristics of neural stem cell by 
expressing several neural stem cell markers; CD133, Nestin, Sox-2, and Sox-
9. The neural differentiation of those neural stem cells was induced under 
a differentiation culture condition containing neurotrophic factors such as 
NGF, β-mercaptoethanol, laminin and etc. Their neural differentiation activ-
ity was also confirmed in coculture with human astrocytes by the positive 
expression of βIII tubulin and GFAP. Interestingly, at passage 4, approxi-
mately 23 % of cell population was PS-NCAM positive. Dopaminergic neu-
rons could be generated from the PS-NCAM positive cells in the presence of 
shh and FGF 8. CONCLUSION: This research showed the isolation of neural 
stem cells from dental papilla tissues of human third molar tooth and their 
neural differentiation capacity including differentiation to dopaminergic neu-
ron, suggesting that dental papillar tissue can be used as a neural stem cell 
source for stem cell biology and cell therapy. ACKNOWLEDGEMENT: This 
research was supported by grant No. 20090065530 and 20100003398 from 
the Basic Research Program of the Korea Science & Engineering Foundation, 
and also by the National Agenda Project from Korea Research Council of 
Fundamental Science and Technology. 
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MAGNETIC ENRICHMENT OF TRA-1-
60+ HUMAN PLURIPOTENT STEM CELLS 
FACILITATES NEURAL SPECIFICATION
Schreiner, Claudia, Kurtz, Annett, Bosio, Andreas, Knoebel, 
Sebastian M.
Miltenyi Biotec GmbH, Bergisch-Gladbach, Germany
Human pluripotent stem cells constitute an invaluable source for the gen-
eration of defined cell types, which may be used for basic research, drug 
compound screening or ultimatively, regenerative medicine. The specifica-
tion of neural cell lineages has become relatively convenient after replac-
ing traditional embryoid body/neurosphere induction paradigms with 2D 
differentiation protocols, which are based on inhibition of SMAD signaling. 
These protocols give rise to PAX6+ multipotential neuroepithelial (NE) cells 
as well as AP2+ neural crest (NC) cells within 5-10 days after induction. 
However, as intermediate step, pluripotent stem cells that are cultivated 
on mouse embryonic feeder cells are usually transfered to Matrigel and 
expanded in conditioned medium (CM) before neural differentiation is 
initiated. Quality and density of the cells in the Matrigel culture are critical 
parameters that bias the preferential differentiation fate towards NE or NC 
cells. In order to optimize neural differentation towards either cell type, we 
have developed a magnetic selection protocol to standardize quality and cell 
number of truly pluripotent stem cells selected for neural differentiation. Our 
newly developed method uses magnetic enrichment of TRA-1-60 positive 
pluripotent stem cells that are immediately transfered to neural induction 
conditions. At the same time, defined cell densities can be adjusted in order 
to control differentiation fate towards NE or NC cells. The magnetic enrich-
ment therefore circumvents the need for pre-expansion of pluripotent stem 
cells in less defined CM conditions before neural induction, saving 3 days of 
preparation, and more importantly, leads to predictable differentiation results 
using defined and homogeneous cell populations.
Poster Board Number: 1260
DISC1 REGULATES SURVIVAL OF HUMAN 
BRAIN DERIVED NEURAL PROGENITOR CELLS 
VIA MODULATION OF GSK3β/β-CATENIN 
SIGNALING
Kobayashi, Nao R.1, Lim, Edwin KH2, Lomas, Tracey1, Crook, Jeremy 
M.1
1Stem Cell Medicine, O’Brien Institute, Fitzroy, Australia, 2Institute of 
Medical Biology, Singapore, Singapore
Disrupted-in-schizophrenia 1 (DISC1) is a risk factor for major mental ill-
ness, including schizophrenia. We and others have implicated DISC1 in key 
neurodevelopmental processes including neuronal and neural progenitor 
cell (NPC) migration, dendrite formation and axon termination. In this study 
we have further examined the role of DISC1 in human neurogenesis using 
established human subventricular zone (SVZ) and hippocampal (HP) derived 
NPC lines with constitutive expression of DISC1 targeting shRNA. DISC1 
loss-of-function caused a decreased SVZ- and HP-NPC number and con-
comitant reduction in the diameter of neurospheres compared to controls. 
The effect of DISC1 appears to be mediated by activation of GSK3β with 
ensuing down-regulation of active β-catenin. This is consistent with DISC1 
loss-off-function increasing caspase-3/7 activity in SVZ- and HP-NPCs. 
Importantly, inhibition of GSK3β normalizes NPC number and neurosphere 
diameter caused by DISC1 loss-of-function. Collectively, our observations 
implicate DISC1 in cell survival via GSK3β, canonical Wnt/β-catenin signal-
ing, and mitochondrial-mediated intrinsic apoptosis. The results provide a 
framework for understanding how aberrant DISC1 signaling may contribute 
to the etiology of psychiatric disorders.
Poster Board Number: 1262
IDENTIFICATION OF CD81’S FUNCTION IN 
HUMAN NEURAL STEM CELL MIGRATION
Lee, Soo Youn, Lee, Jin-Sung, Yang, Jae Won, choi, Jeong Woo, An, 
Jeung Hee
Sogang University, Seoul, Korea, Republic of
The tetraspanin superfamily (or TM4SF) includes CD81, CD9, CD37, CD53, 
CD63, CD82 and CD151. Tetraspanin proteins have been implicated in 
many cellular activities, including adhesion, migration, and proliferation, 
however their exact function is unknown. Specifically, CD81 (TAPA-1) has 
been involved in cell migration. But mechanisms are poorly defined in any 
of stem cells. We describe a novel mechanism whereby the CD81 can affect 
cell motility and induce migration onto ECM substrates in HNSC. RT-PCR 
and Western-blot analysis confirmed CD81 expression in HNSC. Immuno-
precipitation analysis confirmed CD81 interactions with MMP-9 and integrin 
beta 1 in HNSC. Also, the expression of the CD81, MMP-9 and integrin 
beta1 correlated with the HNSC migration. These results demonstrate that 
CD81 is key receptor in HNSC migration. The shRNA-mediated CD81 
downregulation effectively reduced MMP-9 binding to the cell surface, 
which inhibited the migration of HNSC. Also, Western-blot results show that 
CD81 stimulates the activity of ERK/MAPKinase in HNSC. Linked with this 
event, we observed an increase in CD81-associated phosphatidylinositol 
3 - kinases activity and mTOR. Our results demonstrate that CD81 as a cell 
surface binding partner for MMP-9, regulating cell migration and adhesion 
via intergrin beta1 modulation of tetraspanin/integrin signaling complex. 
Also, it is well established that CD81 play key roles in cell migration in HNSC 
cell migration.
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DIRECT GENERATION OF NEUROSPHERE-LIKE 
CELLS FROM HUMAN DERMAL FIBROBLASTS
Moon, Jangsup, Lee, Soon-Tae, Chu, Kon, Jung, Keun-Hwa, Song, 
Young-Mi, Park, Hyun, Jeon, Daejong, Kim, Seung U., Kim, Manho, 
Lee, Sang Kun, Roh, Jae-Kyu
Neurology, Seoul National University Hospital, Seoul, Korea, Republic of
Neural stem cell (NSC) transplantation replaces damaged brain cells and 
provides disease-modifying effects in many neurological disorders. However, 
there has been no efficient way to obtain autologous NSCs in patients. 
Given that ectopic factors can reprogram somatic cells to be pluripotent, we 
attempted to generate human NSC-like cells by reprograming human fibro-
blasts. Fibroblasts were transfected with NSC line-derived cellular extracts 
and grown in neurosphere culture conditions. The cells were then analyzed 
for NSC characteristics, including neurosphere formation, gene expression 
patterns, and ability to differentiate. The obtained induced neurosphere-
like cells (iNS), which formed daughter neurospheres after serial passaging, 
expressed neural stem cell markers, and had demethylated SOX2 regulatory 
regions, all characteristics of human NSCs. The iNS had gene expression 
patterns that were a combination of the patterns of NSCs and fibroblasts, 
but they could be differentiated to express neuroglial markers and neuronal 
sodium channels. These results show for the first time that iNS can be di-
rectly generated from human fibroblasts. Further studies on their application 
in neurological diseases are warranted.
Poster Board Number: 1266
A CELL-FREE EXTRACT FROM HUMAN 
ADIPOSE STEM CELLS PROTECTS MICE 
AGAINST EPILEPSY
Moon, Jangsup1, Sunwoo, Junsang1, Jeon, Daejong2, Chu, Kon1, 
Lee, Soon-Tae1, Jung, Keun-Hwa1, Lee, Sang Kun1, Roh, Jae-Kyu1
1Department of Neurology, Seoul National University Hospital, Seoul, 
Korea, Republic of, 2Department of Bio and Brain Engineering, Korea 
Advanced Institute of Science and Technology (KAIST), Daejeon, Korea, 
Republic of
Purpose: Stem cell-based therapies are being considered for various neuro-
logical diseases, such as epilepsy. Recent studies have suggested that some 
effects of transplanted stem cells are due to bystander effects that modulate 
the host environment, rather than direct effects of cell replacement. The 
extract from human adipose stem cells (ASCs) secreting multiple growth 
factors including cytokines and chemokines may be a potential source of 
bystander effects for the treatment of epilepsy, in which inflammation is 
thought to play an important role. Here, we investigated the effects of a 
cytosolic extract of ASCs (ASCs-E) in a mouse model of epilepsy. Methods: 
ASCs-E, boiled ASCs-E, or fibroblast-extract (fibroblast-E) was intraperito-
neally administrated to C57BL/6 mice 15 min before pilocarpine-induced 
status epilepticus (SE) or during chronic epileptic stage. Blood-brain barrier 
(BBB) leakage was evaluated by measuring Evans blue dye extravasation. 
Spontaneous recurrent seizure (SRS) was investigated by long-term video-
EEG monitoring. The mice performed elevated plus maze, open-field, light/
dark transition, and novel object recognition tasks. Results: Acute application 
of ASCs-E before SE led to earlier attenuation of seizure spike activities after 
treatment with diazepam, reduction of BBB leakage, and inhibition of the 
development of epilepsy. ASCs-E treatment (for 7 days) during the chronic 
epileptic stage suppressed SRS and reduced abnormal epileptic behavioral 
phenotypes. However, neither boiled ASCs-E nor fibroblast-E had any effects 
in the experimental epilepsy model. Conclusions: Our results demonstrate 
that ASCs-E prevents or inhibits epileptogenesis and SRS in mice. They also 
suggest a stem cell-based, noninvasive therapy for the treatment of epilepsy.
Poster Board Number: 1268
HISTOLOGICAL PATTERNS OF SURVIVAL, FATE 
AND MIGRATION IN THE INJURED SPINAL 
CORD AFTER TRANSPLANTATION OF HUMAN 
NEURAL STEM CELLS AT DOSES RANGING 
FROM 10,000 TO 500,000 CELLS
Piltti, Katja M.1, Funes, Gabriella M.1, Avakian, Sabrina N.1, Uchida, 
Nobuko2, Cummings, Brian J.3, Anderson, Aileen J.4
1Sue and Bill Gross Stem Cell Center, University of California, Irvine, 
Irvine, CA, USA, 2StemCells Inc, Palo Alto, CA, USA, 3Physical & Medical 
Rehabilitation, University of California, Irvine, Irvine, CA, USA, 4Anatomy 
& Neurobiology, University of California, Irvine, Irvine, CA, USA
We have previously shown that human central nervous system derived 
stem cells (hCNS-SCs) promote locomotor recovery after spinal cord injury 
(SCI) by integrating into host tissue, and that the majority of the hCNS-SCs 
differentiated into oligodendrocytes when 75,000 cells were transplanted 
into the spinal cord 9 or 30 days post-SCI. In these studies, the total number 
of surviving cells was positively correlated with improvements in functional 
recovery. However, the capacity of the injured spinal cord niche to accom-
modate donor cells and provide sites and cues for cell differentiation and/
or integration may be limited. In this study, we investigated the association 
between cell dose, i.e. the number of transplanted hCNS-SCs, and engraft-
ment, survival, or differentiation by transplanting 10,000, 100,000, 250,000, 
or 500,000 cells into the spinal cords of immunodeficient NOD-scid mice 
after moderate (50kD) mid-thoracic (T9) contusion SCI at an early chronic 
stage 30 days post-injury. At 16 weeks post-transplantation, unbiased 
stereological quantification of hCNS-SCs using a human-specific cytoplas-
mic marker (SC121) demonstrated that the number of engrafted cells was 
positively correlated with the transplanted cell dose in each group (Pearson 
r = 0.79, two-tailed p < 0.0001); that is, a linear relationship was observed 
between initial transplant dose and the estimated total number of surviving 
cells determined at 16 weeks post-transplantation. Engraftment and survival 
was observed across all dose cohorts, however the ratio of surviving cells 
relative to the initial cell dose was noted to be significantly higher in the 
low dose group when compared to the other dose cohorts (1-way ANOVA, 
Tukey’s test p <0.05). hCNS-SCs transplanted at all doses showed normal 
migration from the injection sites into the parenchyma. Quantification of 
hCNS-SC differentiation revealed that the majority of cells differentiated into 
SC121+/Olig2+ oligodendrocytes/oligoprogenitors, regardless of the dose 
group, and that the total number of SC121+/Olig2+ cells was greater in 
higher dose than lower dose groups. However, the proportion of SC121+/
Olig2+ cells varied from 82%7 in the 10,000 cell dose group, to 56%4 in 
the 500,000 cell dose group when normalized to the total number of surviv-
ing SC121+ cells. Statistical analysis revealed that the number of engrafted 
SC121+ cells and SC121+/Olig2+ cells exhibited a negative correlation 
(Pearson r = -0.62, two-tailed p = 0.002). In contrast, no correlation was 
found between the number of engrafted SC121+ cells and number of either 
SC121+/DCX+ neural progenitors (7%1.2) or SC123+ human astrocytes 
(151.5), suggesting the effect of cell dose on fate was lineage specific. Ad-
ditionally, the number of SC121+ cells not labeled by any of these 3 lineage 
markers exhibited a positive correlation with the number of engrafted 
SC121+ cells (Pearson r = 0.6, two-tailed p = 0.003), suggesting increasing 
cell dose may alter the kinetics of differentiation. No aberrant histological 
findings were observed in any transplanted spinal cords, regardless of dose. 
These preliminary data suggest a possible correlation between cell dose and/
or fate/differentiation kinetics in the injured spinal cord, but overall, similar 
patterns of survival, fate, and migration were observed in the injured spinal 
cord at transplantation doses ranging from 10,000 to 500,000 cells.
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DIFFERENTIATION OF HUMAN 
PARTHENOGENETIC STEM CELLS INTO NEURAL 
STEM CELLS IN VITRO
Semechkin, Ruslan1, Isaev, Dmitry1, Abramihina, Tatiana1, Turovets, 
Nikolay1, Zogovic-Kapsalis, Tatiana1, West, Richard A.2, Mueller, 
Albrecht3, Semechkin, Andrey1
1International Stem Cell Corporation, Oceanside, CA, USA, 2Department 
of Biological Sciences, Western Michigan University, Kalamazoo, MI, USA, 
3University of Wurzburg, Wurzburg, Germany
Unfertilized human oocytes can be artificially activated by appropriate 
chemical stimuli to develop into parthenogenetic blastocysts, the inner cell 
mass of which can be isolated and expanded as stem cell lines. Human 
parthenogenetic stem cells (hpSC) are similar to human embryonic stem cells 
(hESC) in their proliferation capacity and multilineage in vitro differentiation. 
The hpSC can be either heterozygous or homozygous depending on the 
way the genome forms from only the maternal chromosome set. Homozy-
gous hpSC could be useful as a source of cells for use in transplantations 
as the set of HLA genes in hpSC may make differentiated derivatives less 
susceptible to immune rejection. Furthermore, if the HLA type is com-
mon, differentiated derivatives will match many millions of individuals. In 
addition to these immunogenetic advantages, as parthenogenesis does not 
involve the destruction of a viable human embryo, the use of hpSC does not 
raise the same ethical concerns as conventional hESC. Together these two 
advantages make hpSC a very promising and potentially unlimited source 
of numerous differentiated somatic cell lines including multipotent neural 
stem cells (NSC). In this study we derive NSC from hpSC using an approach 
based on the adherent model with modifications. Primary neural induction 
was provoked immediately in the colonies of hpSC grown in the absence 
of feeder cells for 5 days by replacing the culture medium with another one 
containing bFGF in higher concentration and no serum. After seven days 
under such conditions rosettes of neuroepithelial cells formed, recapitulat-
ing the neural tube of a developing embryo. The rosettes generated in this 
way expressed specific set of neuroepithelial markers including PAX6, SOX1, 
NES (Nestin), MSI1 (Musashi-1), and did not express pluripotency marker 
OCT4 (POU5F1). These rosettes were isolated, disaggregated into single 
cell suspension and then propagated as an adherent culture. These human 
parthenogenetic NSC (hpNSC) were passaged every 4-5 days enzymatically 
with a 1:2 split rate for more than 15 passages. Reverse transcriptase real-
time quantitative PCR (qRT-PCR) revealed the expression of specific neural 
markers NES (Nestin), SOX2 and MSI1 (Musashi-1) in the hpNSC which was 
also confirmed by immunocytochemical staining of corresponding proteins. 
The expression of OCT4 was not detected at RNA and protein levels. The 
cells keep uniform morphology up to at least 15 passages and do not show 
constantly increasing levels of ectomesenchymal markers SNAI1 and FOXD3 
as detected by qRT-PCR. In order to produce neurons and glia cells, we 
allowed the low density-seeded hpNSC to spontaneously differentiate in cul-
ture medium without growth factors for three weeks. After this time most of 
the differentiated cells have acquired specific neuron morphology and were 
positive for anti-Tuj1 (Tubulin beta III) labeled antibodies. The expression of 
neuronal markers TUBB3 (Tubulin beta III) and MAP2 as well as glial mark-
ers FOXO4 and GFAP was detected in these differentiated cells by qRT-PCR. 
Thus, in this study we demonstrated that human multipotent NSC are stable 
to long-term passaging can be derived from pluripotent hpSC followed by 
differentiation into neurons and glia.
Poster Board Number: 1272
INTRAARTERIAL DELIVERY OF HUMAN 
EMBRYONIC-DERIVED NEURAL STEM CELLS 
YIELDS FUNCTIONAL RECOVERY AND GREATER 
MYELINATION FOLLOWING HYPOXIC-
ISCHEMIC STROKE IN NEONATAL RATS
Smith, Tenille, Rosenblum, Sahar, Wang, Nancy, Birk, Harjus, 
Guzman, Raphael
Neurosurgery, Stanford University, Palo Alto, CA, USA
Perinatal hypoxic-ischemic insults are a significant cause of neonatal en-
cephalopathy, developmental delays, epilepsy, and cerebral palsy. Studies 
have shown that demyelination and periventricular leukomalacia are com-
mon pathological changes seen in infants following hypoxia-ischemia (HI). 
While many studies have evaluated the effect of human embryonic-derived 
neural stem cells (hNSCs) on neurogenesis, angiogenesis and immuno-
modulation, the impact of hNSC treatment on myelination has not been 
adequately characterized. Using a neonatal rat model, we investigated the 
effect of hNSC treatment on remyelination and functional recovery follow-
ing hypoxia-ischemia. Neonatal Wistar rat pups underwent left common 
carotid artery ligation followed by placement in a hypoxia chamber with 
8% oxygen at 37C on post-natal day 7 (P7). Stroke size was evaluated on 
P9 using T2-weighted MRI. On P10, the neonates underwent intraarte-
rial injection of either 500,000 fLuc/eGFP transduced hNSCs suspended in 
0.9% saline or 0.9% saline only. In vivo bioluminescence images utilizing 
luciferin were obtained 1, 2, 3, 4, 7 and 10 days after injection. BrdU was 
administered intraperitoneally for 6 days following treatment to assess cell 
proliferation. Immunohistochemistry stains to evaluate hNSC survival and 
differentiation were done on stroke-size matched brains in addition to stains 
for Olig2, NG2 and CNP. Myelination was evaluated using luxol fast blue 
(LFB) and myelin basic protein (MBP) staining 10 days and 30 days post-
treatment. RT-qPCR was performed on hNSCs and the stroked hemisphere 
of neonates from both treatment groups. Functional recovery was assessed 
using the elevated open-arm task and novel object recognition task at P30. 
Bioluminescence imaging demonstrated significant homing of hNSCs to the 
stroked hemisphere 1 day (p=0.001), 2 days (p=0.002), 3 days (p=0.002), 4 
days (p<0.0001), and 7 days (p=0.001) following transplant. Iba-1-/GFAP- 
hNPCs were localized to the corpus callosum and cortex of cell-treated 
animals 3 days, 10 days, and 30 days after treatment. Counts of BrdU+ cells 
indicated a significant increase in cell proliferation around the lateral ven-
tricle (p=0.036) and in the corpus callosum (p=0.020) of cell-treated animals 
compared to saline-treated animals. Cell-treated neonates also showed an 
increase in Olig2+ and NG2+ cells in the striatum 3 and 10 days post-
treatment. LFB and MBP staining demonstrated greater myelination 10 days 
and 30 days after treatment in the corpus callosum (p=0.022, p=0.049) and 
striatum (p=0.017, p=0.001) of cell-treated animals. Increased expression 
of mRNA associated with cell proliferation (TGF1, p53, Stat3) and immu-
nomodulation (IL-10, ApoE, Hsp1) were seen in the stroked hemisphere of 
cell-treated animals. Neonates transplanted with hNPCs demonstrated bet-
ter performance on the elevated open arm task (p=0.050) and novel object 
recognition task (p=0.016). Intraarterial hNSC delivery following hypoxia-
ischemia in neonatal rats resulted in early hNSC homing to the injured brain 
with engraftment seen up to 30 days following treatment. Behavioral per-
formance on the elevated open arm task and novel object recognition task 
suggest cell-treated animals have reduced levels of anxiety and improved 
working memory compared to saline-treated animals. Functional recovery 
may be mediated by improved myelination and stimulation of oligodendro-
cyte-lineage cell proliferation in the corpus callosum and striatum.
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HUMAN EMBRYONIC STEM CELLS CULTURED 
ONTO A MEF-DERIVED ORGANIZED MATRIX 
FORM SYMMETRIC EMBRYOID BODIES PRONE 
TO THE NEURAL PHENOTYPE
Stelling, Mariana P.1, Lages, Yury V m1, Mourão, Paulo A.2, Rehen, 
Stevens K.1
1Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, 
Rio de Janeiro, Brazil, 2Instituto de Bioquímica Médica, Universidade 
Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Human embryonic stem (hES) cells have been exhaustingly cultured on 
mouse embryonic fibroblast (MEF) feeder layers. Although this approach 
maintains hES cells pluripotency and proliferative properties for long-term 
periods, embryoid bodies (EBs) derived from this system are morphologically 
irregular, varying in size and symmetry. Here we describe a strategy for the 
formation of symmetric EBs by culturing hES cells on ECM coats without 
the requirement of MEF feeder layers. This system abolishes feeder-stem 
cell contact, maintaining the organized characteristic of feeder-produced 
matrices, which differs from unorganized matrix systems, such as matrigel. 
ECM was obtained from MEFs by chemical treatment. H9 cells cultured onto 
plates previously coated with MEF-derived ECM (MEF-ECM) were compared 
with H9 cells cultured on mitomycin C-inactivated MEFs (control) for 100 
days. Cells were analyzed for the expression of pluripotency markers reveal-
ing that H9s cultured on either control MEFs or MEF-ECM expressed similar 
levels of Oct-4, SOX-2, TRA-1-60 and SSEA-4. EBs derived from MEF-ECM 
H9 cells were smaller (136 ± 32 µm) compared to control embryoid bodies 
(202 ± 65 µm) and more symmetric, with a longer/shorter diameter ratio 
closer to 1 (1.14 ± 0.13) when compared to the control group (1.33 ± 0.28). 
In addition, when stimulated to the neural phenotype, MEF-ECM derived 
EBs presented higher levels of the neural markers SOX-2 and β-III tubulin 
compared to the control EBs. In conclusion, we show here that hES cells 
differentiation dynamics can be altered by changing colony substrate to a 
MEF-ECM coat, and this alteration leads to a change in EB morphology and 
specific lineage differentiation.
Poster Board Number: 1276
FROM HUMAN EMBRYONIC STEM CELLS 
TO SYMPATHETIC NEURONES: A MODEL 
FOR UNDERSTANDING NEUROBLASTOMA 
PATHOGENESIS
Carr-Wilkinson, Jane1, Lako, Majlinda2, Herbert, Mary2, Tweddle, 
Deborah A.3
1North East Stem Cell Institute and Northern Institute for Cancer Research, 
Newcastle University, Newcastle Upon Tyne, United Kingdom, 2North East 
Stem Cell Institute, Newcastle University, Newcastle Upon Tyne, United 
Kingdom, 3Northern Institute for Cancer Research, Newcastle University, 
Newcastle Upon Tyne, United Kingdom
Background and Aims: Neuroblastoma is an embryonal tumour originating 
from neural crest cells which give rise to the sympathetic nervous system 
(SNS). Our aim is to differentiate human embryonic stem cells along neural 
crest and autonomic lineages to sympathetic neurons, providing a model to 
increase our understanding of the pathogenesis of neural crest derived ma-
lignancies, including neuroblastoma, as well as the potential of cell replace-
ment for neurological disease. Results: Using the stromal-derived activity 
(SDIA) of mouse PA6 we induced differentiation of H9 and Ncl-14 - clinical 
grade hESC into neural crest and autonomic progenitors. Expression of 
neural crest specifier genes by RT-PCR including, Snail, Slug, Sox-9, and the 
noradrenergic marker, dHAND were increased at days 7 and 14 of PA6 co-
culture, subsequently decreasing by day 21. Following 21 days of co-culture 
extensive neuronal differentiation was observed by Immunofluorescence 
with high expression of the neuronal markers NCAM, Phox2b, peripherin 
and tyrosine hydroxylase. The addition of BMP4 (5nM) at days 5-9 of co-
culture led to an increase in Peripherin expression by RT-PCR. FACS sorting 
for the NC stem cell marker p75 enriched for cells expressing p75, periph-
erin, dopamine beta-hydroxylase and tyrosine hydroxylase indicative of 
sympathetic neuronal differentiation. Conclusions: Our data shows a model 
of normal SNS development which can be used to understand more about 
neural crest pathogenesis.
Poster Board Number: 1278
FUNCTIONAL ASSAYS IN HUMAN EMBRYONIC 
STEM CELL DERIVED NEURAL CREST CELLS TO 
DETECT NEURODEVELOPMENTAL TOXICANTS
Zimmer, Bastian1, Lee, Gabsang2, Kadereit, Suzanne1, Studer, 
Lorenz2, Leist, Marcel1
1University of Konstanz, Konstanz, Germany, 2Memorial Sloan-Kettering 
Cancer Center, New York, NY, USA
Proper neural development consists of several tightly regulated processes 
including for example cell differentiation, neurite outgrowth and migration. 
The latter has a particularly important role in the development of the PNS. 
Neural crest cells (NCC) emerge from the neural tube and migrate through-
out the body along distinct paths to give rise to multiple cell types including 
neural and non-neural cells. To study potentially adverse effects of different 
compounds on the migratory potential of neural precursors, we used human 
embryonic stem cells (hESC) differentiated into NCC. We were able to keep 
the cells in a neural crest progenitor state, which allowed the expansion 
and freezing of the cells. Furthermore, the NCC could be differentiated into 
peripheral neurons and Schwann cells, which confirmed their functional po-
tential, while marker expression indicated the expected phenotype. To study 
the migratory potential of these cells and the effects of compounds on the 
migration capacity, we used the classical scratch assay which has been used 
successfully in many studies in different laboratories. A scratch was created 
within the confluent monolayer of NCC and the cell migration was analyzed 
in the presence and absence of compounds known to inhibit cell migration. 
Various negative controls and known developmental neurotoxicants like e.g. 
CH3HgCl were tested. LIVE cell imaging experiments demonstrated that 
the cells repopulate the scratch via migration, independent of cell division. 
We also showed that compounds which inhibit actin polymerization, inhibit 
the migration of these cells at concentrations that do not affect general cell 
viability or cell division, while negative control compounds had no effect on 
the migratory potential of the cells. In addition to the classical scratch assay 
and manual counting, we used actin-GFP transfected cells to investigate the 
effects of compounds on the actin cytoskeleton in real time using LIVE cell 
imaging. A second very important aspect in neurodevelopment is neurite 
outgrowth. Once the neural progenitor cells have reached their correct 
destination after the migration phase, proper establishment of the neurite 
network is essential for full functionality of the neurons. We found that the 
NCC, once differentiation was initiated, start forming multiple projections, 
which later in the differentiation process develop into neurites, which are 
at least 3 times longer than the diameter of the cell. The formation of these 
initial cell processes was decreased upon treatment with the potent protein 
kinase C inhibitor bisindolylmaleimide 1, in a concentration dependent man-
ner, without affecting general viability of the cells. The system presented 
here is suitable for high throughput, high content image analysis which 
allows the investigation of effects of different chemicals on the migration 
of NCC and on the initial process formation, leading to neurite outgrowth 
of NCC differentiating into peripheral neurons. We therefore believe that 
our human based in-vitro test system is a powerful tool to detect potential 
neurodevelopmental toxicants that affect early events during neural devel-
opment e.g. migration of NCC and later events like neurite outgrowth of 
NCC differentiating towards peripheral neurons. As lentiviral transduction of 
these cells can be achieved with a high efficency (≥ 95%) the system allows 
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functional analysis of the mode of action and specific pathways involved in 
the toxic effects of different chemicals.
Poster Board Number: 1280
NATURALLY SECRETED AMYLOID β 
OLIGOMERS DERIVED FROM APPSW 
EXPRESSEING CELLS DISTURB PROLIFERATION, 
INDUCE GLIOGENESIS AND ATTENUATE 
MIGRATION OF HUMAN NEURAL STEM CELLS
Park, Kook In1, Lee, Ilshin2, Jung, Kwangsoo2, Kim, Il-Sun2
1Department of Pediatrics and BK21 Project for Medical Science, Yonsei 
University College of Medicine, Seoul, Korea, Republic of, 2BK21 Project 
for Medical Science, Yonsei University College of Medicine, Seoul, Korea, 
Republic of
Neural stem cells (NSCs) derived from developing and adult brain are 
defined by their ability to self-renew, to differentiate into cells of all glial 
and neuronal lineages throughout the neuraxis, and to populate develop-
ing or degenerating CNS regions. Alzheimer’s disease (AD) is an inexorable 
neurodegenerative disease which neuropathologically reveals extracellular 
accumulations of amyloid beta (Aβ) and intracellular inclusion of hyperphos-
phorylated tau in the brain. Recent studies suggest that especially, soluble 
Aβ oligomers have a main deteriorative role in the synaptic and neuronal 
function of AD. To understand neuronal loss and the cognitive impairment 
in AD, a number of studies have performed to investigate whether Aβ 
could regulate the proliferation and differentiation of NSCs. However, it still 
remains controversial. In order to investigate the effects of Aβ oligomers on 
NSCs, we prepared Swedish mutated amyloid precursor protein (APPsw) 
expressing SK-N-MC cells using lentiviral vectors and confirmed that these 
cells secreted Aβ oligomers into the culture media. Human neural stem/
progenitor cells (hNSCs) were isolated from telencephalic tissue of a fetal 
cadaver at 13 weeks of gestation and cultured as neurospheres. When natu-
rally secreted Aβ oligomers generated from APPsw expressing SK-N-MC 
cells were directly administered to hNSCs under the proliferative condition, 
hNSCs showed the decrease in cell division via the induction of a senescence 
but not apoptosis. Under the differentiation condition, Aβ oligomers secret-
ed from cells remarkably induced gliogenesis of hNSCs at the level of both 
mRNAs and proteins. In addition, hNSCs little migrated across the mem-
brane of the trans-well in Boyden chamber when hNSCs were co-cultured 
with APPsw expressing SK-N-MC cells rather than co-cultured with naive 
cells. The results provide that naturally secreted Aβ oligomers produced from 
APPsw expressing SK-N-MC cells adversely regulate proliferation, enhance 
glial differentiation, and debilitate migration of hNSCs in vitro. These find-
ings suggest that the pathologic microenvironments of brain in AD may 
negatively regulate the homeostatic functions of NSCs in CNS which may 
cause the cognitive impairment and neural dysfunction in AD.
Poster Board Number: 1282
LONG-TERM SURVIVAL AND MIGRATION 
OF ALLOGENEIC HUMAN CENTRAL 
NERVOUS SYSTEM STEM CELLS FOLLOWING 
INTRACEREBRAL TRANSPLANTATION IN 
NEURONAL CEROID LIPOFUSCINOSIS
Jacobs, Yakop1, Selden, N2, Al-Uzri, A2, Koch, T2, Vogel, H3, Huhn, 
S1, Uchida, N1, Dalma-Weiszhausz, D1, Tsukamoto, A1, Steiner, R2
1StemCells, Inc., Palo Alto, CA, USA, 2OHSU, Portland, OR, USA, 3Stanford 
University, Stanford, CA, USA
Neuronal Ceroid Lipofuscinoses (NCL), also known as Batten Disease, is a 
rare and fatal lysosomal storage disorder that primarily affects the central 
nervous system. The infantile (INCL) and late-infantile (LINCL) subtypes 
result from inherited mutations that produce defective or deficient palmitoyl-
protein thioesterase 1 (PPT1) and tripeptidyl peptidase I (TPP-I) lysosomal 
enzymes, respectively. In vivo cross-correction of an affected host by human 
central nervous system stem cells (HuCNS-SC®) transplantation formed the 
rationale for a Phase I clinical trial in which unmodified donor cells supply 
the deficient lysosomal enzymes. The Phase I dose-escalation trial involved 
both intracerebral and intraventricular transplantation of purified HuCNS-SC 
cells into six patients with advanced INCL or LINCL, followed by 12 months 
of immunosuppression. To date, three patients have expired secondary to 
natural progression of the disease during either the Phase I study or separate 
four year long-term follow-up (LTFU) investigation. Post-mortem examina-
tion of the entire brain from all three patients was conducted to assess for 
adverse histological changes as well as the presence of donor cell engraft-
ment. One female patient with INCL in the low-dose cohort, still receiving 
immunosuppression, expired 11 months post-transplant during the Phase 
I study. Two other patients, both with LINCL, expired during the ongoing 
LTFU investigation; one male patient in the low-dose cohort at 2.5 years 
post-transplant and one male patient in the high-dose cohort at 3.5 years 
post-transplant (each received 12 months of immunosuppression as per pro-
tocol). Post-mortem examination revealed expected disease-related changes 
in all patients. No evidence of cellular atypia, cyst formation, neoplasm, or 
inflammatory reaction to HuCNS-SC transplantation was found. Evidence 
of donor cell engraftment was assessed by differences in genomic DNA 
sequences between the donor cells and the recipient by PCR-based analysis. 
The results show that HuCNS-SC can engraft and survive in the NCL host 
well after immunosuppression has been discontinued. Additional details 
regarding donor cell quantification and migration in individual patients 
will be presented. This report is the first to demonstrate long-term survival 
of a purified population of allogeneic neural stem cells following human 
transplantation. The postmortem results showing no adverse histological 
changes combined with HuCNS-SC survival supports allogeneic cell therapy 
for neurological disorders.
Poster Board Number: 1284
TRANSCRIPTIONAL PROFILING OF COFACTOR 
PROTEINS BY REST/NRSF IN NEURONAL STEM 
CELL USING PROTEOMICS ANALYSIS
An, Jeung Hee, Yang, Jae Won, Lee, Soo Yoon, Lee, Jin Sung, Choi, 
Jeong Woo
Chemical & Biomolecular Engineering, Sogang University, Seoul, Korea, 
Republic of
Repressor element-1 silencing transcription factor/neuron-restrictive factor 
(REST/NESF) is known to be a major transcriptional repressor of neuroge-
neous. For REST/NRSF-dependent promoter repression to occur, REST/NRSF 
must interact with several cellular cofactors, including Co-REST, N-CoR, 
mSin3A, and the histon deacetylase complex. However, despite the variety 
of interesting findings turned up thus far cofactors for the tight regulation 
of REST/NRSF activity remain to be identified. In present study, we have 
investigated to identify of a cofactors binding in around REST/NRSF in F3 
human neuronal stem cell. Using monoclonal anti NRSF and gold shell with 
magnetic nanobeads pull -down assay, 2-D electrophoresis and LC/mass 
spectrophotometry analysis, a total 20 specific binding proteins showed 
significant change in their expression in F3 cells. These proteins were catego-
rized by their function, those included transcription factor and metabolism 
related protein. To support the proteomic results, the presence of three 
candidate proteins, HIS1, HIS2 and HIS3, were further characterized in this 
study. The binding of these proteins with the NRSF were verified using chro-
matinimmunoprecipitation and immunoprecipitation analysis. These data 
suggest that these specifically interacting cofactors may play an important 
role in neuron cell specific expression of the neuronal stem cell. Also, these 
newly identified NRSF binding proteins provide a number of clues and 
potential links to understanding the mechanisms regulating the transcription 
of neurogenesis.
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HUMAN AND MOUSE NEURAL STEM CELL 
CHEMOKINE RECEPTOR AND LIGAND 
EXPRESSION DIFFERENCES AND THEIR 
IMPLICATIONS FOR NEUROREGENERATIVE 
MEDICINE
Wang, Nancy1, Smith, Tenille1, Rosenblum, Sahar1, Chua, Josh1, 
Auriat, Angela1, Guzman, Raphael2
1Stanford, Palo Alto, CA, USA, 2Neurosurgery, Stanford, Palo Alto, CA, USA
Introduction: Recent studies demonstrate the potential of intravascular stem 
cell therapies for the treatment of many CNS disorders, including stroke. 
Success of intravascular stem cell therapies hinges on neural stem cell (NSC) 
targeted homing and subsequent intraparenchymal migration to injured 
area, processes reliant on NSC expression of chemokines and their receptors. 
As these therapies come closer to clinical trials, it is essential to understand 
the interspecies differences of chemotaxis related receptor and ligand ex-
pression to expedite the transition from rodent research to human applica-
tion. Here we use RT-qPCR to compare human neural stem cell (hNSC) and 
mouse neural stem cell (mNSC) chemokine receptor and ligand expression at 
basal levels. Furthermore, we compare hNSCs and mNSCs after exposure to 
MCP-1 to test the response of NSCs to a chemokine shown to be upregu-
lated in the microenvironment of the ischemic brain. Finally, we explore the 
implication of these differences on cell migration. Methods: Human and 
mouse cells were grown as monolayers in their respective growth media. In 
pretreated cell groups, MCP-1 (20ng/mL) was introduced to cell media 1 
hour prior to RNA extraction. RT-qPCR was performed on extracted RNA 
using microarray technology for chemokine receptors and ligands. The Boy-
den chamber migration assay was used to determine migration to SDF-1 at 
concentrations 0ng/mL, 100ng/mL, 500ng/mL, 1000ng/mL, and 1500ng/
mL. Results: Analysis of baseline expression demonstrated that 18% of ana-
lyzed factors were different between hNPCs and mNPCs (p<0.001). The five 
factors with the largest fold regulation difference between hNSCs and mN-
SCs are CCL2, CCL7, CXCL12, CMLKR1, and CXCR4. After treatment with 
MCP-1 there was a 1.61% change in factor expression between human and 
mouse chemokine. Of the mRNA transcripts upregulated above 3 fold regu-
lation, ligands accounted for 6 of 6 factors in mNPCs and 1 of 1 in hNPCs. 
Of the mRNA transcripts downregulated below -3 fold regulation, recep-
tors accounted for 5 of 5 factors in mNPCs and 1 of 3 in hNPCs. Migration 
of hNSCs compared to mNSCs in response to SDF-1 was greater by 2.46 
fold (p< 0.01), consistent with the greater expression of CXCR4 on hNSCs 
than mNSCs. Conclusion: Baseline chemokine receptor and ligand expres-
sion between human and mouse NSCs was significantly different, possibly 
resulting in interspecies differences in NSC response to the ischemic brain 
microenvironment. In the context of cell therapy for stroke, the implications 
of interspecies distinctions should be strongly considered when conclusions 
drawn from rodent research are translated to human treatment.
Poster Board Number: 1288
ENRICHMENT OF MURINE NEURAL STEM 
CELLS FOR TRANSPLANTATION IN LYSOSOMAL 
STORAGE DISEASE MODEL
Chaubey, Sushma1, Wolfe, John H.2
1Department of Pediatrics, Division of Neurology, The Children’s Hospital 
of Philadelphia, Philadelphia, PA, USA, 2W. F. Goodman Center for 
Comparative Medical Genetics, School of Veterinary Medicine, University 
of Pennsylvania, Philadelphia, PA, USA
Neural stem cells (NSCs) are potential vehicles for delivery of therapeutic 
agents in the diseased CNS. Our lab has previously shown that it is possible 
to deliver a therapeutic agent directly to the mouse brain by transplantation 
of immortalized C17.2 NSCs, which integrate into the CNS in a cytoarchi-
tecturally appropriate manner. While C17.2 and similar clonal cell lines have 
been very useful for certain experiments, they were selected for robust 
engraftment properties, and thus are not representative of the heteroge-
neous populations of autologous NSCs that would be used for ex vivo gene 
therapy. The biology of C17.2 cells also differs significantly from primary 
neural stem cells, particularly in that primary murine NSCs exhibit much 
more limited migration ability. Since only a limited number of cells can be 
transplanted into the brain, enrichment for the most ‘stem-like’ cells in the 
donor population may increase engraftment. To test this, we selected NSCs 
at an early stem cell stage using the cell surface marker CD15 (Lewis X). A 
‘gentle FACS’ procedure (low sheath pressure, larger nozzle size, and low 
events/sec) was used to increase post-sorting viability and yield. Approxi-
mately 6% of adult mouse SVZ cells were CD15+ and selection resulted in 
a 15-fold enrichment. The phenotype was relatively stable in culture, with 
70% remaining CD15+ after 10 passages. The sorted cells differentiated into 
the three major neural lineages (oligodendrocytes, astrocytes and neurons). 
Although more donor cells were seen in transplants of enriched cells than 
with unsorted cells, they still exhibited limited migration. Cells were detected 
near the lateral ventricles, in the cortex, in the perimeter of the hippocampus 
and in the region surrounding third ventricle. We also analyzed the CD15+ 
population in the SVZ of a mouse model of a neurogenetic disease, the lyso-
somal storage disorder mucopolysaccharidosis type VII (MPS VII). Recent 
work from our lab on canine MPS VII NSCs and on the transcriptome of 
normal vs MPS VII mouse brain regions, suggest that developmental defects 
are present in MPS VII NSCs and are influenced by the diseased microen-
vironment. Significantly more CD15+ cells were present in the forebrain 
of MPS VII mice than unaffected controls at two months of age (p<0.026) 
which increased further by four months (p<0.0143). The MPS VII mouse 
brain has progressively increasing numbers of degenerating neurons with 
age, thus the corresponding increase in NSCs in the diseased brain may be 
due to a compensatory response to replace depleted mature cells.
Poster Board Number: 1290
A NOVEL LONG-LIVED 
IMMUNODEFICIENT MOUSE MODEL OF 
MUCOPOLYSACCHARIDOSES TYPE 1 SUITABLE 
FOR PRECLINICAL TRIALS OF STEM CELL 
COMBINATORIAL THERAPY
Schwartz, Philip H.1, Rangel, Anthony D.1, Stover, Alexander E.1, 
Cooper, Jonathan D.2, Wong, Andrew M.S.2, Nethercott, Hubert E.1, 
Dickson, Patricia I.3, Kan, Shih-hsin3, Gulsen, Gultekin4, Yan, Kevin4, 
Brick, David J.1
1Neuroscience, Children’s Hospital of Orange County Research Institute, 
Orange, CA, USA, 2Neuroscience, King’s College London, London, United 
Kingdom, 3Pediatrics, Harbor-UCLA Medical Center, Torrance, CA, USA, 
4Radiology, Physics and Biomedical Engineering, University of California, 
Irvine, Irvine, CA, USA
Mucopolysaccharidosis type 1 (MPS-1, Hurler Syndrome), a lysosomal stor-
age disorder (LSD), is an inherited deficiency of the lysosomal glycosamino-
glycan (GAG)-degrading enzyme α-L-iduronidase (IDUA) in which GAG 
accumulation causes progressive multi-system organ dysfunction, neuro-
logical impairment, and death. Current MPS-1 mouse models, based on a 
NOD/SCID (NS) immunodeficient background, are short-lived, providing a 
very narrow window to assess the long-term efficacy of therapeutic inter-
vention. These mice also develop thymic lymphomas, making assessment 
of potential tumorigenicity of human stem cell transplantation problematic. 
Neural stem cell (NSC) transplantation, in combination with hematopoietic 
stem cell (HSC) transplantation, may provide a robust treatment for these 
patients by providing enzyme to the central nervous system (CNS) as well 
as the periphery. We therefore developed a new MPS-1 model by breeding 
MPS-1 NS mice with the recently developed NOD/SCID/Il2rγ (NSG) mouse. 
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This model is long-lived and tumor-free, and engrafts significantly better 
than the NS-based model. NSG MPS-1 mice exhibit the phenotypic features 
of MPS-1 including coarsened fur and facial features, reduced/abnormal 
gait, kyphosis, and corneal clouding. We examined tissue IDUA and GAG 
accumulation, skeletal abnormalities, tissue pathology, and engraftment of 
human neural stem cells (NSCs) and human HSCs in this new MPS-1 model. 
IDUA was undetectable in all tissues examined while GAG levels were dra-
matically higher in most tissues. MPS-1 brain showed a significant inflam-
matory response and prominent gliosis compared to normal brain. NSCs 
and HSCs were found to readily engraft in this long-lived mouse model with 
human cells detectable for at least one year post-transplantation. This new 
model, therefore, is suitable for preclinical testing of combination stem cell 
therapies aimed at providing multimodal (peripheral and CNS) treatment 
for LSDs such as MPS-1 and provides a platform to move novel stem cell 
therapies toward Phase 1 clinical trials.
Poster Board Number: 1292
EXPANSION OF MURINE EMBRYONIC 
CORTICAL STEM CELLS USING DOXYCYCLINE 
INDUCIBLE N-MYC EXPRESSION
Desai, Ridham, Faiz, Maryam, Wijesinghe, Dishan, Park, Jin Gyoon, 
Nagy, Andras
Mount Sinai Hospital, Toronto, ON, Canada
Large-scale source of neural stem cells hold great potential for the treatment 
of disorders involving extensive cellular damage like spinal-cord injuries 
and also for other neurodegenerative disorders like Parkinson’s disease & 
Ischemic cerebral stroke. Besides its therapeutic potential, such cells would 
also serve as ex-vivo model for studying complex molecular pathways gov-
erning neural cell fate choices. Here we report the establishment of a novel 
transgenic system utilizing doxycycline inducible N-myc expression that 
allows for a million-fold expansion of cortical stem/progenitors isolated from 
E12.5 mouse embryos within a span of 25 days in culture. When these cells 
are propagated in presence of doxycycline, N-myc expression is induced and 
they undergo rapid proliferation while maintaining the expression of neural 
stem cell markers. After prolonged in vitro expansion, upon doxycycline 
withdrawal from the culture media, N-myc expression is turned off and the 
cells differentiate normally into neurons and glia. The ability of expanded 
progenitors to form neurons even after 25 days of culture as opposed to 
wild-type cells that generally lose the neurogenic potential within 6-8 days, 
suggests that doxycycline induced N-myc expression effectively ‘locks’ the 
cells in an undifferentiated state and aids rapid proliferation by triggering 
the cell-cycle progression. Furthermore, normal diploid G-band karyotype 
confirms the chromosomal stability and genomic integrity of the expanded 
cells. Currently engraftment assays involving transplantation of these cells 
into the brain of adult mice is being performed to determine their in-vivo 
differentiation potential into various neural cell types. Furthermore, we also 
performed differential gene expression analysis between the N-myc induced 
and the non-induced cell populations to determine the genetic networks 
that get activated in response to N-myc expression.
Poster Board Number: 1294
FUNCTIONAL IMPROVEMENT OF CEREBELLAR 
DEGENERATION AFTER INTRA-CEREBELLAR 
TRANSPLANTATION OF HUMAN FETAL NEURAL 
STEM CELLS INTO SPINOCEREBELLAR ATAXIA 
TYPE 3 MICE
Fan, Yiping1, Iizuka, Akira2, Takayama, Kiyohiko2, Murakami, 
Matsuka2, Choolani, Mahesh1, HIRAI, Hirokazu2, Chan, Jerry1
1National University of Singapore, Singapore, Singapore, 2Gunma University 
Graduate School of Medicine, Gunma, Japan
Introduction: Spinocerebellar ataxia types 1, 2, 3, 6, and 7 are examples 
of polyglutamine diseases which are caused by an abnormal expansion of 
repetitive CAG bases, which encode for the amino acid, glutamine. In par-
ticular, spinocerebellar ataxia type 3 (SCA3) which is associated with beyond 
50 glutamine repeats, is characterised by progressive neuronal degenera-
tion, cerebellar ataxia and variable findings associated with dystonic-rigid 
extrapyramidal syndrome, peripheral neuropathy and/ or amyotrophy. Em-
ploying SCA3 mice as a model of cerebellar degeneration, we hypothesised 
that intracerebellar human fetal neural stem cell (hfNSC) transplantation 
will result in improvement of the clinical phenotype. Methods: Multipotent 
regionally-derived cerebellum (C) and subventricular zone (S) hfNSC (15 
week gestation) were cultured as neurospheres (NS). Xenogeneic trans-
plantation of 105 C-hfNSC (n=6) and S-hfNSC (n=8) were injected into the 
cerebellum of P22-P28 SCA3 mice under cyclosporine immunosuppression. 
At D8 and D53 post injection, rotorod studies at accelerating speed of 0 to 
40RPM in 3min as well as steady speeds of 5 and 7RPM were performed. 
Mice were euthanised at both time-points for patch clamp analysis of 
electrophysiological properties. Results: Transplantation of S and C-hfNSC 
resulted in an improvement in accelerating rotarod latency (time taken to 
fall) of 26.9% and 38.5% over controls at D8. Improvements of 21.6% and 
28.2% over controls at D53 were observed for steady-speed rotarod latency 
at 5RPM. Improvements of 32.7% and 24.0% were observed over controls 
at D8 and 0% and 51.1% at D53, respectively when the SCA3 mice were 
subjected to rotarod turning at 7RPM. Multi-innervation of Purkinje cells by 
climbing fibres indicates the receipt of both proper and improper signals by 
the Purkinje cells and patch-clamp analysis conducted at D8 demonstrated a 
threefold improvement in reduction of multi-innervated Purkinje cells; from 
60% in the control to 20% in hfNSC injected SCA3 mice. However, these 
differences were transient and were not observed at D56 time-point (ratio of 
40%, 57.1% and 44.4%, respectively). Conclusion: Our data suggest func-
tional improvement of cerebellar degeneration in SCA3 mice post xenoge-
neic hfNSC transplantation, alluding to the utility of hfNSC for the treatment 
of polyglutamine-related neurodegenerative disorders. Further optimisation 
of the cell source, dosage, monitoring outcomes and therapeutic window 
may be required to ascertain the true efficacy of intra-cerebellar transplanta-
tion of hfNSC into SCA3 mice.
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NOVEL ROLES OF WNT/β-CATENIN SIGNALING 
IN MURINE CORTICAL NEURAL PRECURSOR 
FATE AND LAMINAR IDENTITY CONTROL 
REVEALED IN THE ABSENCE OF ADHESION 
DEFECTS
Draganova, Kalina1, Valenta, Tomas2, Miescher, Iris1, Civenni, 
Gianluca1, Basler, Konrad2, Sommer, Lukas1
1Institute of Anatomy, University of Zurich, Zurich, Switzerland, 2Institute of 
Molecular Life Sciences, University of Zurich, Zurich, Switzerland
The size and the complexity of the developing brain are determined by 
the exquisite balance between self-renewal and differentiation of neural 
stem cells (NSC). Among multiple signaling cascades active in the devel-
oping forebrain, the canonical Wnt pathway was shown to regulate NSC 
proliferation, fate choice and dorso-ventral specification. The transducer of 
Wnt signals, β-catenin, interacts with TCF/LEF family members, but it also 
participates in adherens junctions as a bridging component. Thus, experi-
mental overexpression and downregulation of β-catenin cannot distinguish 
between its signaling and adhesion functions. Combining a dorsal forebrain 
conditional inactivation approach with different β-catenin mutant alleles, we 
identify here the contribution of β-catenin transcriptional activity as opposed 
to adhesion in the development of the cerebral cortex. In agreement with 
previous reports, Wnt/β-catenin signaling ablation causes premature NSC 
cell cycle exit, which leads to microcephaly in the absence of ectopic BMP 
signaling. Similarly, inactivation of canonical Wnt signaling at the midline 
leads to a shortened hippocampal primordium and a dorsolaterally shifted 
hem. Contrary to published data, however, we do not observe a role of Wnt 
signaling in the dorso-ventral patterning of neural precursors and proper 
cortical layering, but, interestingly, in the control of laminar identity and 
sequential fate switch by NSCs.
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NEUROPROTECTION OF GRAFTED 
OLIGODENDROCYTE PROGENITORS IN A 
MOUSE MODEL OF EXCITOTOXICITY
Espinosa-Jeffrey, Araceli M., Hirose, Megumi, Zhao, Paul M., 
Taniguchi, Alana, de Vellis, Jean S.
IDDRC, University of Califonia Los Angeles, Los Angeles, CA, USA
Background: One of the major problems of the premature neonate is the 
extensive white matter loss that is a major cause of childhood neurological 
disability, especially, periventricular leukomalacia (PVL). PVL is now recog-
nized as the most important cause of cerebral palsy and mental retardation 
occurring at a high incidence in preterm (<32 gestational weeks) babies. 
Various studies have shown that in PVL lack of healthy OL leads to myelin 
deficiency and ventriculomegaly (enlargement of ventricles) conditions. 
When a premature infant is born, clinicians take preventive precautions to 
insure survival but, a potential treatment to reduce or prevent white matter 
loss does not exist at the present time. In the developing brain, oligodendro-
cytes (OL) maturation occurs perinatally, and immature OL are particularly 
vulnerable to insults. Myelinogenesis and myelin maintenance depend on 
the presence of healthy OL in adequate numbers. We previously identified 
a specific combination of two trophic factors, namely TS1 that promoted 
endogenous OL regeneration and CNS remyelination in the postnatal, as 
well as, the adult rodent brain. We recently described that a single injection 
of two trophic factors, namely TS1 partially alleviates white matter injury 
(WMI) in a mouse model of glutamate excitotoxicity (GME), by conferring 
neuroprotection to endogenous nestin-expressing progenitors and OL pro-
genitors present in the brain at the time of the insult. TS1 also stimulated the 
generation of new OL progenitors that were able synthetize myelin reducing 
the enormous white matter loss found in control mice. Because endogenous 
neural progenitors might not be enough to overcome vetriculomegaly, 
cell replacement therapies may need to be used to enhance the extent of 
recovery of white matter in PVL. Thus, here we investigated if grafted OL 
progenitors would survive in the excytotoxic brain to further myelinate CNS 
axons. Methods: The periventricular white matter lesion was produced by a 
single injection of NMDA into the floor of the CC above the lateral ventricle 
(LV). Five conditions were studied in a comparative manner: Saline, NMDA, 
NMDA+TS1 and NMDA+TS1+OLP and NMDA+OLP were stereotaxically 
injected simultaneously into p4 mouse pups. For ventricular measurements, 
the area of ipsilateral “IL” vs. contralateral “CL” ventricles was compared. 
These values were also compared against saline injection. Brains were exam-
ined at various time points (7 to 35 days) after treatment. Each treatment 
was performed in triplicates. Cell populations were evaluated for neural 
commitment or uncommitted by the expression of specific OL markers and 
nestin. Cell proliferation was evaluated with the antibody Ki67. Results: 
Out of all treatments a reduction of ventriculomegaly was found in the 
presence of TS1 with an increased myelination with respect to mice treated 
with NMDA alone. Moreover, in the absence of TS1, OLP did not survive 
the excitotoxic insult while in mice that received NMDA+TS1+OLP, grafted 
cells survived and migrated to white matter areas. Conclusion: PVL appears 
to be treatable, both by neuroprotection of endogenous progenitors, as 
well as with a combinatorial therapy in which cell grafts and trophic factors 
would be administered together to counteract the effects of excitotoxicity. 
This work was funded in part by a pilot grant from the American Multiple 
Sclerosis Society and by NIHD-0657 grant.
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HIGH EFFICIENCY MYELINATION OF THE 
HYPOMYELINATED SHIVERER MOUSE BRAIN 
USING HUMAN IPS CELL-DERIVED GLIAL 
PROGENITOR CELLS
Wang, Su1, Bates, Janna M.1, Li, Xiaojie1, Schanz, Steven J.1, 
Chandler-Militello, Devin1, Gee, Lucy E.1, Maherali, Nimet2, 
Hochedlinger, Konrad2, Studer, Lorenz3, Windrem, Martha S.1, 
Goldman, Steven A.4
1Center for Translational Neuromedicine and Department of Neurology, 
University of Rochester Medical Center, Rochester, NY, USA, 2Harvard 
Stem Cell Institute, Boston, MA, USA, 3Developmental Biology Program, 
Sloan-Kettering Institute, New York, NY, USA, 4Center for Translational 
Neuromedicine and Department of Neurology and Neurosurgery, University 
of Rochester Medical Center, Rochester, NY, USA
We have previously described techniques for the identification, isolation, 
molecular characterization, and transplantation of glial progenitor cells 
derived from the fetal human brain. Neonatal engraftment by these cells 
permits the widespread myelination of congenitally dysmyelinated shiverer 
mouse brain, and can rescue both the neurological phenotype and lifespan 
of these animals. Yet the possibility of immune rejection of allogeneic grafts 
has hindered the clinical development of this approach. To address this issue, 
we investigated the use of human induced pluripotent stem cells (hiPS cells) 
as a source from which new glial progenitor cells (GPCs) and their derived 
oligodendrocytes (OLs) might be generated. We developed a high-efficiency 
strategy by which to differentiate hiPS cells into GPCs, that are in turn 
able to mature into both astrocytes and myelinogenic OLs, in vitro and in 
vivo. Using this protocol, we have successfully generated and validated a 
population of olig2+/PDGFRα+/Nxk2.2+/sox10+ human GPCs. Using this 
protocol, we found that the efficiencies of GPC induction from hiPSCs (KØ4 
cells, K. Hochedlinger, keratinocyte-derived; C27 cells, L. Studer, fibroblast-
derived) were similar to that of human embryonic stem cells (hESCs; WA09), 
in that their otherwise unsorted yields of olig2+/Nkx2.2+GPC colonies 
were 63% (KØ4) and 79% (hES WA09), respectively. hiPSC-derived 
GPCs, as well as their oligodendrocytic and astrocytic progeny, could then 
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be differentially isolated using FACS directed at glial lineage markers that 
included A2B5, CD140a/ PDGFRα, CD9, O4, and GLT1. In addition, these 
hiPSC-derived GPCs could be differentiated into mature MBP+ OLs and 
GFAP+ astrocytes in culture. Importantly, these hiPS-GPCs readily matured 
into myelinogenic oligodendrocytes in vivo, and efficiently myelinated the 
forebrains of myelin-deficient shiverer mice by 12-13 weeks after neonatal 
graft. Of note, no tumor formation was noted from these grafts as long as 
3 months after transplant. These results demonstrate that high efficiency in 
vivo oligodendrocytic differentiation and myelination can be achieved from 
human iPS cells, suggesting the potential utility of iPS-derived autografts in 
treating acquired disorders of myelin.
Poster Board Number: 2002
DIRECT INDUCTION OF SAFE NEURAL STEM 
CELLS FROM ADULT MOUSE FIBROBLASTS
Matsui, Takeshi, Ohno, Soichiro, Yoshida, Kenji, Matsuzaki, Yumi, 
Akamatsu, Wado, Okano, Hideyuki
Physiology, Keio University, School of Medicine, Tokyo, Japan
Induced pluripotent stem (iPS) cells give rise to neural stem cells (NSCs), 
which are applicable for therapeutic transplantation in treatment of neural 
diseases. However, generation of patient-specific NSCs from iPS cells re-
quires a careful selection of safe iPS clones without teratoma formation. This 
precludes autograft transplantation for acute neural injuries which requires 
cell transplantation before their conditions are chronically fixed. We sought 
to determine whether direct induction of NSCs from partially reprogrammed 
somatic cells is able to generate safer cells rapidly. After 14 days of serum-
free culture of mouse fibroblasts partially reprogrammed by several retrovial 
vectors including Oct3/4, they generated mature neurospheres which give 
rise to neurons, astrocytes, and oligodendrocytes while primary neuro-
spheres derived from ES and iPS cells generated mostly neurons. Further, by 
optimizing culture conditions, these neurospheres contained Nanog-positive 
cells less than 0.01%. To evaluate the safety and engraftment of these 
neurospheres, they were transplanted into mouse striatum. Teratomas were 
observed in less than 10% of transplanted animals while more than 80% 
of clonal-iPS-derived neurospheres induced from adult mouse fibroblasts 
generated teratomas. These results suggest that NSCs derived from partially 
reprogrammed fibroblasts can differentiate more rapidly compared to ES/
iPS-derived NSCs. We propose that the direct induction without generation 
of iPS clones facilitiate quick and safe induction of NSCs for cell therapy.
Poster Board Number: 2004
MOUSE NEURAL PRECURSOR CELLS EXPRESS 
TROPHINS FOLLOWING TRANSPLANTATION 
BUT REMYELINATION IS THE KEY MECHANISM 
BY WHICH THEY AUGMENT FUNCTIONAL 
RECOVERY FOLLOWING RODENT SPINAL 
CORD INJURY
Hawryluk, Gregory W J1, Spano, Stefania2, Chew, Derek2, Wang, 
Shelly2, Fehlings, Michael G.1
1Genetics and Development, Neurosurgery, University of Toronto, Toronto, 
ON, Canada, 2University of Toronto, Toronto, ON, Canada
Background: Though myelination has been demonstrated following neural 
precursor cell (NPC) transplantation, the mechanism(s) by which NPCs 
enhance functional recovery from spinal cord injury (SCI) is unclear. NPCs 
have also been postulated to elaborate trophins following transplantation 
which could lead to tissue sparing or other beneficial effects. Methods: Two 
weeks following clip compression SCI at the T7 bony level, rats underwent 
cellular or control transplantation. Transplants included wild-type mouse 
NPCs, NPCs derived from shiverer mice unable to produce central myelin, 
freeze-thaw killed dead NPCs or cell suspension media. In most experimen-
tal groups animals also received minocycline, cyclosporin and peri-lesional 
infusion of trophins via an osmotic mini-pump. Hind-leg motor function 
was assessed weekly for 6 additional weeks according to the BBB scale. 
qPCR for trophin expression was performed on NPCs and host cord isolated 
by FACS sorting 1w post-transplant. Hematoxylin-eosin/luxol fast blue 
staining was used to assess grey and white matter, cyst and lesional tissue. 
Axonal preservation was assessed using Fluorogold retrograde tracing. As 
well, tissue bearing cells was stained for the axonal marker NF200 and the 
myelin marker MBP. Transplanted cells expressed the eYFP gene facilitating 
their identification. Confocal microscopy was used to assess the relationship 
between transplanted cells and axons, as well as their ability to make MBP. 
Results: Animals transplanted with wild-type NPCs showed significantly 
greater functional recovery than any other group. Animals transplanted 
with shiverer NPCs performed worse on functional testing than even injured 
and untreated animals, suggesting harm. Confocal microscopy confirmed 
that wild-type NPCs ensheath axons and form MBP. Shiverer NPCs also 
appeared to ensheath axons but did not produce MBP. NPCs isolated post-
transplant expressed all four neurotrophins, CNTF, EGF, and bFGF at higher 
levels than host tissue. Our transplantation protocol is associated with grey, 
white matter and oligodendrocyte sparing however this was attributable to 
pharmacotherapy and trophin infusion. Trophin infusion was associated with 
an increase in cyst and lesional tissue volume as well as inflammatory cell 
numbers and reduced functional recovery. No experimental therapy led to 
preservation of axons. Discussion: Our results suggest that remyelination by 
NPCs plays a dominant role in enhancing functional recovery. Shiverer NPCs 
may prevent remyelination by endogenous cells capable of myelin formation 
leading to harm. The mere presence of transplanted cells did not lead to a 
functional benefit suggesting that the trophins they produce are without a 
functional effect. Indeed, the tissue sparing seen in our protocol is attribut-
able instead to the pharmacotherapy and trophin infusion. The trophin 
pump, with its tip 1cm rostral to the epicenter, was associated with undesir-
able histological changes and impaired functional recovery. Conclusions: 
These results suggest that remyelination by NPCs is their most important 
contributor to functional recovery following SCI. Though NPC transplanta-
tion may have other effects, they do not appear to contribute to functional 
recovery in our transplantation paradigm. Though these findings may be 
specific to our protocol, these findings may lead to strategies to augment 
functional recovery associated with cellular transplantation for SCI. 
Poster Board Number: 2006
MCL-1 PROMOTES NEURAL PRECURSOR CELL 
CYCLE EXIT AND DIFFERENTIATION IN THE 
MOUSE EMBRYONIC BRAIN
Hasan, S M Mahmudul1, Sheen, Ashley2, Langevin, Lisa Marie3, 
Xiong, Jieying1, Furlong, Michael1, Day, Kristine1, Schuurmans, 
Carol3, Opferman, Joseph T.4, Vanderluit, Jacqueline1
1Neuroscience, Faculty of Medicine, Memorial University of Newfoundland, 
St. John’s, NL, Canada, 2Biology, Acadia University, Wolfville, NS, Canada, 
3Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada, 4St. 
Jude Children’s Research Hospital, Memphis, TN, USA
Neural precursor cell (NPC) proliferation and apoptosis are key regula-
tory aspects of mammalian nervous system development. Although recent 
studies suggested these two processes to be interrelated, the molecular 
mechanisms behind this remain undefined. Here we show that myeloid cell 
leukemia-1 (Mcl-1), a Bcl-2 family member that is essential for the survival 
of NPCs also causes premature terminal mitosis in NPCs. In utero electropo-
ration of Mcl-1 in E13.5 mouse embryonic brains show that within 48 hours, 
the majority of NPCs transfected with Mcl-1 have migrated into the post 
mitotic cortical plate, whereas control transfected NPCs are still within the 
proliferating ventricular/subventricular zones. Analysis of proliferation by 
proliferating cell nuclear antigen (PCNA) immunohistochemistry reveal a 
2-fold reduction in proliferating NPCs in the Mcl-1 treated brains. Immu-
nohistochemistry for Tbr1, a marker for newborn neurons, reveal a 50% 
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increase in differentiated neurons in Mcl1 treated brains. BrdU birthdating 
demonstrates that Mcl-1 overexpression results in a greater cohort of new-
born neurons. Mcl-1 transfected NPCs gave rise to neurons in deeper layers 
of the cortex than control transfected NPCs confirming an earlier birthdate. 
Similarly, transfection of Mcl-1 in NPCs in vitro, promotes cell cycle exit. Fi-
nally, we found an increase in Cdk inhibitor p27kip1 protein, a key promoter 
of cell cycle exit with Mcl-1 overexpression and a concomitant decrease in 
p27kip1 in Mcl-1 conditional knockout NPCs, suggesting that Mcl-1 may 
stabilize p27kip1 protein to promote NPC differentiation. In summary, these 
results identify a novel function for Mcl-1 in promoting terminal mitosis of 
NPCs by influencing the cell cycle regulatory machinery.
Poster Board Number: 2008
DERIVATION OF HIGH PURITY 
OLIGODENDROCYTE PROGENITOR CELLS 
FROM MOUSE EMBRYONIC STEM CELLS
Hatch, Maya N., Keirstead, Hans S.*
Reeve-Irvine Research Center, Sue and Bill Gross Stem Cell Research 
Center, Department of Anatomy & Neurobiology, School of Medicine, 2111 
Gillespie Neuroscience Research Facility, University of California at Irvine, 
Irvine, CA, 92697-4292
Mouse embryonic stem cells (mESCs) demonstrate remarkable proliferative 
and developmental capacities. The derivation of mESC lines from normal and 
transgenic mice, including non-viable breeds, and their subsequent differen-
tiation into high purity cell populations would permit novel developmental 
studies, screening assays and transplant-based research. Here we present a 
novel method for obtaining oligodendrocyte progenitor cells (OPCs) in high 
purity from mESCs. Our differentiation protocol benefits from a decade of 
developmental stem cell research and underscores important differences in 
culturing methods such as plating surfaces, media composition and culturing 
duration that can influence derivation purity. Overall, this differentiation 
protocol provides a means of generating high purity rodent OPCs for use 
in studies of oligodendroglial lineage development, screening assays for 
compounds that affect the oligodendroglial lineage, and OPC replacement 
strategies. Indeed, we are currently using this protocol for the differentiation 
of OPCs from mutant shiverer and wild-type matched mESCs for future use 
in various rodent-based diseased models. 
Poster Board Number: 2010
DYSTROGLYCAN REGULATES THE 
ORGANIZATION AND GLIOGENIC CAPACITY OF 
THE MOUSE NEURAL STEM CELL NICHE
McClenahan, Freyja K.1, Colognato, Holly2
1Program in Neuroscience, Stony Brook University, Stony Brook, NY, USA, 
2Department of Pharmacological Sciences, Stony Brook University, Stony 
Brook, NY, USA
The subventricular zone (SVZ) is a specialized microenvironment surround-
ing the lateral ventricles of the vertebrate forebrain. Arising perinatally from 
the neuroepithelium, the SVZ niche harbors neural stem and progenitor cells 
(NSCs/NPCs) that produce glia and olfactory interneurons throughout life. 
Recently, investigations into the architecture and cellular arrangement of the 
adult SVZ have demonstrated the importance of extracellular matrix (ECM) 
proteins in the maintenance of the niche. In particular, activated stem cells 
are often found in close proximity to laminin-rich blood vessel basal laminar 
and fractone-associated ECM structures. Our preliminary observations 
indicate that an organized laminin-rich SVZ ECM has been established by 
birth and may have a role in regulating the principal wave of gliogenesis that 
occurs within the first two postnatal weeks. The laminin receptor dystrogly-
can (DAG), with established roles in adhesion, ECM reorganization, cellular 
polarity and proliferation, is a good candidate receptor for the transduc-
tion of laminin signaling in SVZ cells. Here, we tested the possibility that 
dystroglycan has a role in early postnatal subventricular zone architecture, 
proliferation and gliogenesis. We utilized the Cre/loxP approach to generate 
mice in which dystroglycan is deleted at the neural stem cell stage (DAG 
CNS KO). Dystroglycan-deficient radial glia, the resident stem cells at birth, 
appear disorganized and fail to form apical endfoot associations with laminin 
structures at the ventricular surface. Normally, wild-type Sox2+ neural stem 
and progenitor cells become less proliferative in the first few postnatal days, 
however DAG KO Sox2+ cells retain their earlier proliferative capacity. DAG 
KO Sox2+ nuclei are also found in an aberrant distribution, such that they 
proliferate closer to the ventricular surface than WT Sox2+ cells. The corpus 
callosa of early postnatal DAG KO mice contain more oligodendrocyte 
precursor cells (OPCs) than those of WT littermates, with a higher propor-
tion of OPCs co-expressing the NSC markers Nestin and Sox2, as well as 
fewer mature oligodendrocytes. Together these findings suggest that loss 
of dystroglycan contributes to a developmental delay in oligodendrocyte 
lineage cells. In support of this, neurosphere differentiation assays reveal 
that NPCs isolated from DAG KO mice produce more OPCs but fewer post-
mitotic and myelinating oligodendrocytes. In vivo, this delay in oligoden-
drocyte differentiation in turn leads to delayed myelination of the corpus 
callosum. In summary, we report that dystroglycan-laminin interactions in 
the perinatal ‘gliogenic’ SVZ are important for stem and/or progenitor cell 
organization and gliogenic capacity. Ongoing studies are addressing if and 
how dystroglycan-mediated cytoskeletal reorganization contributes to the 
rate and symmetry of neural stem and progenitor cell division to maintain 
the fine balance between self-renewal of the neural stem cell niche and the 
production of more lineage-restricted progenitors.
Poster Board Number: 2012
ADULT RAT MESENCHYMAL STEM CELLS 
DERIVED SOLUBLE FACTORS PRIME 
PROLIFERATING NEURAL PROGENITORS INTO 
AN OLIGODENDROCYTE FATE
Rivera, Francisco J.1, Dechant, Franz-Xaver2, Steffenhagen, Carolin1, 
Furtner, Tanja1, Aigner, Ludwig1
1Institute of Molecular Regenerative Medicine, Paracelsus Medical 
University Salzburg, Salzburg, Austria, 2Department of Neurology, 
University of Regensburg, Regensburg, Germany
Oligodendrogenesis encompasses lineage specification of neural progenitors 
(NPCs), differentiation into oligodendrocytes, which ultimately culminates 
in the myelination of central nervous system axons. Each individual process 
must be tightly regulated by extracellular and cell-intrinsic mechanisms, 
whose identities are barely known. We had previously demonstrated that 
soluble factors derived from rat mesenchymal stem cells (MSCs) induce 
oligodendrogenesis in differentiating adult NPCs. However, since lineage 
specification typically occurs in proliferating progenitors and not during 
differentiation, we investigated if soluble factors derived from MSCs are 
able to prime proliferating NPCs (as neurospheres) to the oligodendroglial 
fate. Therefore, we analyzed the effects of conditioned media derived 
from MSCs (MSC-CM) on adult rat derived neurosphere cell morphology, 
proliferation, cell-specific marker expression profile, response to growth 
factor withdrawal, and the expression of astroglial and oligodendroglial fate 
determinants. While MSC-CM did not affect the proliferation rate of NPCs, 
it induced the formation of cellular processes and adherence of neurosphere 
cells. Even though the expression profile of the progenitor and precursor 
markers Nestin, GFAP, A2B5, NG2, O4, and DCX in neurosphere cells was 
not affected by MSC-CM, the formation of MBP positive oligodendrocytes 
after growth factor withdrawal was boosted by the MSC-CM pre-treatment. 
Moreover, in proliferating neurospheres, the presence of MSC-CM reduced 
the anti-oligodendrogenic determinant Id2, thus increasing the relative 
proportion of the pro-oligodendrogenic factor Olig2 expression. Finally, 
when MSC-CM pre-treated neurospheres were exposed to an astrogenic 
milieu, the proportion of MBP-expressing oligodendrocytes was increased 
compared to non pre-treated neurospheres, indicating that the MSC-CM 
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priming effect involved a strong oligodendrocyte lineage commitment. In 
summary, soluble factors derived from MSCs prime proliferating progeni-
tors towards oligodendrogenic fate. The present findings underscore the 
potential use of MSCs in cell therapies for remyelination such as in multiple 
sclerosis and spinal cord injury. Moreover, they urge the identification of the 
oligodendrogenic activity(ies) derived from MSCs in order to develop novel 
molecular therapies for demyelinating diseases.
Poster Board Number: 2014
EPIDERMAL GROWTH FACTOR STIMULATION 
OF ADULT RAT NEURAL STEM CELLS REVEALS 
UNIQUE CELLULAR PHENOTYPES, STRUCTURAL 
REORGANIZATION AND NEOANGIOGENESIS
Lindberg, Olle R.1, Brederlau, Anke1, Nannmark, Ulf2, Jansson, 
Axel1, Cooper-Kuhn, Christiana1, Kuhn, H. Georg1
1Center for Brain Repair and Rehabilitation, Institute of Neuroscience and 
Physiology, Gothenburg, Sweden, 2The Electron Microscopy Unit, Institute 
of Biomedicine, Gothenburg, Sweden
Objective: To study the ultrastructural and phenotypic characteristics of 
Epidermal Growth Factor (EGF) stimulated adult rat neural stem cells and 
subventricular zone neurogenic niche in the context of early tumor develop-
ment. Background: The highly proliferative neural stem cell population in 
the brain, which shows several glial characteristics, could be a likely source 
of glial tumors in both the immature and adult CNS. Brain tumors are the 
most common type of solid tumor in children and are very hard to treat 
due to the inherent risk of damaging healthy brain tissue and normal brain 
function. The activity of several growth factors, important for neural stem 
cell proliferation, has been demonstrated to be altered in both experimental 
models and clinical cases of brain tumors. Epidermal growth factor (EGF) is a 
potent mitogen with widespread effects on neural stem cells. It is known to 
stimulate proliferation and inhibit neuronal maturation of neural stem cells. 
The specific effects of EGF on the fate determination of rat neural stem cells 
in vivo is poorly studied, in spite of EGF being widely used to stimulate stem 
cell proliferation in vitro. Upon EGF infusion, profound structural reorganiza-
tion is observed and hyperplasias are formed from the subventricular zone. 
The hyperplasias show certain unique characteristics not seen in the control 
SVZ, both in terms of cellular phenotype and the surrounding niche. Results: 
Apart from confirming previous results, showing the retention of EGF stimu-
lated cells in a stem cell/glial like state, we characterize, in detail, the cell 
population stimulated by EGF infusion. A large subset of the EGF stimulated 
proliferating cells is expressing Sox2 or Olig2, with a significant portion of 
these cells being co-labeled, not observed in the control SVZ. Other mark-
ers such as GFAP, nestin, vimentin, NG2, and DCX were also analyzed. We 
show an increase in stem cell activity in the lateral ventricle walls upon EGF 
stimulation; inducing hyperplasia formation enriched for stem cells and halt-
ing normal differentiation from early stem cell stages. We observe structural 
reorganization, breakdown of the ependymal cell layer, and absence of 
junctional complexes in hyperproliferative zones. Occasionally, these zones 
exhibit signs of hypoxia, microglial activation, and neoangiogenesis. Char-
acterizing the EGF-responsive stem cell population and elucidating its role in 
neoplastic growth and restructuring of the subventricular zone neurogenic 
niche could prove useful in increasing the understanding in early stages of 
tumor development and cancer transformation in neural stem cells.
Poster Board Number: 2016
THE ANTI-COAGULANT FACTOR PROTEIN 
S AND ITS STRUCTURAL HOMOLOG 
GAS6 REGULATE NEURAL STEM CELL 
PROLIFERATION IN THE SUBVENTRICULAR 
ZONE OF ADULT RODENTS
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Lyon 1, Lyon, France, 3CNRS-UMR 6008, University of Poitiers, Poitiers, 
France, 4IIBB-IDIBAPS-CSIC, Instituto de Investigaciones Biomédicas de 
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Vitamin K-dependent proteins (VKDP) are a family of secreted proteins 
mainly known for their role in coagulation. VKDP share a post-translational 
modification catalyzed by an enzyme that requires vitamin K, necessary 
for their secretion and/or activity. VKDP production is blocked by warfa-
rin, a vitamin K antagonist that is a widely used anticoagulant. Recently, 
two vitamin K-dependent proteins, Gas-6 and protein S, have identified 
as ligands for the TAM tyrosine kinase receptors (Tyro 3, Axl, Mer) which 
regulate normal development and tumorigenesis, especially in the brain. 
Given the emerging pleioptropic functions of VKDP and TAM receptors, we 
assessed possible regulatory roles of these mechanisms over proliferation 
and stemness of neural stem cells in the adult mammalian brain. We focused 
our study on a major brain germinative center, the subventricular zone (SVZ) 
bordering the lateral ventricles. We demonstrate that the suppression of 
functional VKDP production, in vitro, by exposure of subventricular zone 
(SVZ) neural stem cell cultures to warfarin or in vivo by its intracerebroven-
tricular injection to mice, leads to a substantial increase in SVZ neural stem 
cells proliferation which is reversed by either vitamin K or endogenous VKDP, 
suggesting that VKDP constitutively inhibit neural stem cells proliferation. 
We further identify protein S and Gas6 as the two only VKDP produced by 
SVZ cells. We demonstrate that the anti-coagulant factor protein S inhibits 
while neutralization of endogenously produced protein S enhances SVZ cells 
proliferation, implying that protein S is a constitutive inhibitor of SVZ cells 
proliferation. Further, our data show that in Gas6 knock-out mice, loss of 
Gas-6 reduces SVZ neural stem cells pool. By identifying protein S and Gas6 
as novel regulators of neural stem cells, our study opens new insights in the 
regulation of stem cells activity by vascular determinants and suggests new 
perspectives for the pharmacological use of the anti-coagulant warfarin.
Poster Board Number: 2018
A ROLE FOR THE REDOX/FYN/C-CBL 
PATHWAY IN MODULATING OXIDANT-
INDUCED CELL CYCLE ARREST IN RODENT 
OLIGODENDROCYTE PRECURSOR CELLS
Folts, Christopher, Noble, Mark
Biomedical Genetics, University of Rochester School of Medicine & 
Dentistry, Rochester, NY, USA
Proper myelination of the central nervous system requires the tightly regu-
lated time- and region-specific generation of oligodendrocytes from precur-
sor cells, a process that involves timely cell cycle exit and the execution of 
a differentiation program. Previous work from our laboratory has identified 
a molecular pathway – termed the Redox/Fyn/c-Cbl pathway – that inte-
grates environmental cues and the balance between differentiation and self-
renewal in rodent oligodendrocyte/type II astrocyte (O-2A) progenitor cells, 
a biological decision which we have previously demonstrated is regulated by 
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the intracellular redox state. The present work describes a role for this path-
way in modulating cell cycle exit in response to oxidizing, pro-differentiation 
signals in O-2A progenitor cells. We also describe the involvement of this 
pathway in modulating cell cycle exit induced by chemical pro-oxidants that 
appear to mimic the anti-mitotic effects of physiological, pro-differentiation 
signaling molecules.
Poster Board Number: 2020
STEM CELL TRANSPLANTATION STRATEGIES 
FOR REPAIR OF THE DYSMYELINATED CNS
Ruff, Crystal A., Wang, Jian, Ye, Hui, Zhang, Liang, Fehlings, 
Michael G.
University Health Network, Toronto, ON, Canada
Neural stem and progenitor cells (NSPCs) show great potential for cellular 
replacement in models of cortical and sub-cortical injury and dysmyelination. 
NSPCs derived from the sub-ventricular zone of yellow fluorescent protein 
transgenic animals and grown in spheres were injected bilaterally into the 
anterior and posterior aspects of the anlagen of the corpus callosum and 
also into the anlagen of the cerebellar peduncle. Animals were injected, 
using a pulled glass needle, on P0, P7 (equivalent to human birth) and P21 
(equivalent to ~2 years human age) in a shiverer mouse model of dysmyeli-
nation and survived for 4 days, 14 days or 45 days. These cells integrated 
both anatomically and functionally into the local white matter, as well as the 
periventricular areas. Transplanted aNPCs did not become GFAP+ astrocytes, 
but preferentially became MBP+, Olig2+ oligodendrocytes that interacted 
with NF200+ axons. Trans callosal stimulation showed that MBP+ trans-
planted cells were capable of restoring a fast action potential, corresponding 
to the presence of functionally myelinated fibres, in the corpus callosum 
of transplanted shiverer animals. This evidence indicates that aNPCs are 
capable of restoring myelin conduction in brain white matter tracts, thereby 
illustrating their translational potential for other CNS demyelinating or dys-
myelinating diseases.
Poster Board Number: 2022
LABEL FREE ISOLATION OF NEURONAL AND 
GLIAL PROGENITORS
Nourse, Jamison L.1, Prieto, Javier L.2, Lu, Jente1, Dickson, Amanda 
R.1, Lee, Abraham P.2, Flanagan, Lisa A.1
1Pathology and Laboratory Medicine, University of California, Irvine, Irvine, 
CA, USA, 2Biomedical Engineering, University of California, Irvine, Irvine, 
CA, USA
Generation of differentiated neurons and astrocytes from neural stem/
progenitor cells (NSPCs) of the developing cerebral cortex occurs via the 
production of progenitors biased to either neuronal or glial fates. Despite de-
velopmental studies documenting these progenitors, a precise description of 
the cellular characteristics that discriminate them is lacking, partly due to lim-
itations in available markers for each specific cell type. We have previously 
shown dielectrophoresis (DEP), which is a label free technique for character-
izing cells, distinguishes both human and mouse neuronal progenitors from 
their glial counterparts. Progenitor cell dielectric properties shift as the cells 
lose neurogenic potential over time in culture and a specific measure of the 
membrane properties of the cells, membrane capacitance, is clearly linked to 
cell fate potential. DEP has been used successfully in other contexts to sort 
distinct cell populations and our studies have shown exposure to DEP forces 
necessary for cell sorting does not harm human or mouse NSPCs. We there-
fore used DEP frequencies to isolate cells from a mixed population of NSPCs 
and found that cells isolated at lower frequencies generated astrocytes while 
those collected at higher frequencies formed neurons. These results show 
that dielectric properties define specific progenitor cell populations and these 
properties can be used for their isolation. Specific dielectric properties can be 
added to the list of characteristics that distinguish neurogenic from gliogenic 
progenitors and isolation of these progenitors by DEP can provide purified 
populations of cells for further analysis and determination of discrete cellular 
properties.
Poster Board Number: 2024
SYNDECAN-1 IN THE FOREBRAIN GERMINAL 
NICHE INSTRUCTS THE APICAL TO BASAL 
PROGENITOR TRANSITION BY INHIBITING THE 
NOTCH PATHWAY
Wang, Qingjie, Yang, Landi, Temple, Sally
Neural Stem Cell Institute, Rensselaer, NY, USA
Two major classes of dorsal neural progenitor cells contribute to mam-
malian cerebral cortical neurogenesis. Apical cells in the ventricular zone 
(VZ) are the principle progenitor cells for the cortex. They directly generate 
neurons and also produce a secondary set of transit amplifying precursors, 
the basal progenitor cells, that move up to the sub ventricular zone (SVZ). 
The mechanisms underlying lineage progression from apical to basal fates 
are still largely unknown, and in particular, the environmental regulators 
that stimulate this important transition are being actively sought. This is 
an important topic because it has relevance to stem cell-transit amplifying 
transitions in other tissues. Syndecan-1 is a transmembrane proteoglycan 
involved in cell-matrix interactions and it influences the activity of a number 
of different signaling pathways. The extracellular domain of Syndecan-1 can 
be cleaved and the shed form of Syndecan-1 is biological active. Here we 
report that Syndecan-1 is highly expressed in the germinal zone of the de-
veloping cortex. In cultured forebrain cortical progenitor cells, we found that 
Syndecan-1 is necessary for production of basal progenitor cells, acting both 
cell and non-cell autonomously. In the embryonic cortex in vivo, Syndecan-1 
knockdown via in utero electroporation leads to depletion of both apical and 
basal progenitor cells, and to premature neuronal differentiation, while over-
expression increases progenitor proliferation. We found that over-expression 
of Syndecan-1 promotes the switch from apical to basal progenitor cell fates 
and disorganizes the VZ/SVZ structure. The extracellular integrin-binding 
domain, amino acids 67-121, is essential for the over-expression phenotype. 
In analysis of how Syndecan-1 elicits the apical-basal transition, we discov-
ered that exogenous Syndecan-1 inhibits Notch signaling and up-regulates 
Neurogenin-2 leading to increased expression of Tbr2, a key determinant 
of the basal progenitor fate. Thus Syndecan-1, which is expressed by both 
progenitor cells and endothelial cells in the ventricular zone niche, is a critical 
environmental factor capable of instructing stem cells to change to the tran-
sit amplifying state. As Syndecan-1 is present in other germinal zones and 
is up-regulated in several tumors, it will be important to examine whether it 
plays a similar role in this pathological context.
Poster Board Number: 2026
TIGHT REGULATION OF TRANSGENE 
EXPRESSION IN NEURAL PROGENITOR CELLS 
WITH A MIFEPRISTONE-INDUCIBLE SELF-
INACTIVATING LENTIVIRAL DELIVERY SYSTEM
Grunseich, Christopher1, Shi, Yijun1, Fischbeck, Kenneth H.1, 
Pierson, Tyler M.2
1Neurogenetics, NIH/NINDS, Bethesda, MD, USA, 2Neurogenetics, NIH/
NINDS/Undiagnosed Diseases Program, Bethesda, MD, USA
An important tool for studying stem cells is the ability to regulate expression 
of target genes. We have developed a mifepristone (MFP) inducible system 
for regulated expression of target genes in neural progenitor cells (NPCs). 
Potential uses include in vitro or in vivo applications for gene/cell therapy. 
As MFP readily penetrates the blood-brain barrier, this system is particularly 
amendable for use in the CNS. Components of the system were packaged 
into self-inactivating (SIN) lentiviral vectors for ex vivo delivery to NPCs. 
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Several different target transgenes including fluorescent markers, antibiotic 
resistance genes, and therapeutic proteins were placed into these vectors 
and specific strategies were used for selecting NPCs with robust MFP-in-
ducible transgene expression with minimal background. Our system consists 
of two separate components, a Switch vector and a Target vector. Several 
variants of each of these vectors were produced. Switch vectors express a 
chimeric nuclear receptor (SWITCH) consisting of the GAL4 DNA-binding 
domain, an NFkB transactivation domain, and a truncated progesterone re-
ceptor ligand-binding domain. When activated by MFP, the SWITCH protein 
binds to GAL4 response elements (UAS) and initiates transcription of down-
stream target transgenes. Autoinducible SWITCH vectors were produced us-
ing promoters consisting of the rat nestin enhancer linked to UAS sequences 
and a thymidine kinase minimal (TK) promoter. These nestin promoters were 
active in murine and human NPCs (and HEK293T cells). Internal ribosome 
entry sites were used to link SWITCH expression to selectable markers such 
as the hygromycin-resistance or eGFP genes. Target vectors were developed 
with different inducible promoters and target genes. MFP-inducible promot-
ers contained UAS sequences linked to a TK promoter. Numerous target loci 
were created using combinations of antibiotic resistance genes, MdsRED, 
eGFP, luciferase, receptor tyrosine kinases (RTKs), and/or neurotrophins. 
Specific selective strategies utilizing FACS or antibiotic selection were used to 
enrich for cells with robust MFP-inducible target transgene expression and 
minimal background expression. Switch and Target vectors were delivered 
to cells in a stepwise manner. Murine and human cells were infected with 
Switch vectors first and selected by antibiotic resistance or FACS. SWITCH 
expression was robust and was downregulated upon NPC differentiation. 
Switch-expressing cells were then infected with Target vectors containing 
selectable markers. Dual-infected cells were exposed to MFP or vehicle. 
Initially, the fidelity and inducibility of the system was evaluated using 
fluorescent marker target transgenes. In the absence of MFP there was no 
expression of these transgenes; while MFP exposure induced robust expres-
sion. Other Target loci with transgenes encoding receptor tyrosine kinases 
or neurotrophins linked to antibiotic resistance genes also showed very tight 
control of transgene expression in vitro. In vivo analysis of the MFP-induc-
ible NPC system is ongoing. Rodents will undergo CNS transplantation with 
NPCs capable of inducible expression of target transgenes. Initial analysis 
will look at NPCs inducibly expressing fluorescent markers and/or luciferase. 
Rodents will be treated with placebo or MFP for set periods of time and 
expression of target transgenes will be evaluated by fluorescent microscopy, 
immunohistochemistry, or bioluminescence.
Poster Board Number: 2028
DIFFERENTIAL REGULATION OF RETINOIC 
ACID SIGNALING IN ADULT SPINAL CORD 
NEURAL PROGENITORS
Leung, Carly1, Chan, Sherwin CL1, Tsang, Sze Lan1, Wu, Wutian2, 
Sham, Mai Har1
1Dept of Biochemistry, University of Hong Kong, Hong Kong SAR, China, 
2Dept of Anatomy, University of Hong Kong, Hong Kong SAR, China
Neural stem cells from the adult subventricular zone (SVZ) are highly 
heterogeneous, with their position of origin being a key factor in deter-
mining the neuronal subtype they can give rise to. Whether this diversity 
extends to other regions in the adult CNS has not been demonstrated. In 
vitro studies with directed neuronal differentiation of ES cells suggest that 
subtype specification may be regulated by the intrinsic positional identity of 
the ES-derived cell, since altering the positional identity leads to correspond-
ing changes in motor neuron subtype. This limited plasticity suggests the 
position identity of the original stem cell source is a critical factor for the 
generation of the desired neuronal subtype. The adult spinal cord consists 
of endogenous stem/progenitor cells which are activated upon injury, with 
potential for repair in CNS diseases and spinal cord injury. However, our 
knowledge and understanding of these cells are limited. Our research is 
aimed at understanding the properties of endogenous progenitor cells in the 
adult spinal cord and how they can be utilized for neuronal regeneration. 
In this study, we identified multiple subpopulations of spinal cord progeni-
tor cells (SCPCs) based on their position along the anterior/posterior (A/P) 
axis of the adult spinal cord. These subpopulations can be distinguished by 
the expression of distinct combinatorial Hox genes in a manner reminiscent 
of their expression in the developing neural tube. Moreover, different pro-
genitor subpopulations display varying cellular properties, such as a higher 
neurogenic potential and higher neurosphere-forming ability observed in 
lumbar-derived progenitor cells. We further demonstrate that axial-derived 
SCPCs are differentially responsive to the neurogenic agent retinoic acid 
(RA). In the presence of RA, neurogenesis was increased by two-fold 
during differentiation of cervical-derived spheres, while no increase was 
observed for lumbar-derived cells. Expression profile analysis of RA signaling 
components revealed that the RA degrading enzyme cyp26b1, absent in 
cervical SCPCs but highly expressed in lumbar SCPCs, is likely to regulate 
RA signaling in these SCPC populations. Our study suggests that different 
niche factor regimens are required for site-specific neuronal regeneration of 
endogenous SCPCs from distinct spatial regions.
Poster Board Number: 2030
TRANSPLANTATINON OF NEURAL STEM CELLS 
IMPROVES OUTCOME FROM SPINAL CORD 
INJURY IN AGED MICE
Takano, Morito1, Takahashi, Yuichiro1, Yasuda, Akimasa1, Nori, 
Satoshi1, Tsuji, Osahiko1, Toyama, Yoshiaki1, Okano, Hideyuki2, 
Nakamura, Masaya1
1Orthopaedics Surgery, Keio University, Tokyo, Japan, 2Physiology, Keio 
University, Tokyo, Japan
Neural stem cells (NSCs) transplantation have a role in restoring locomotor 
function after spinal cord injury (SCI), but how aging might affect the spinal 
cord’s receptivity to such transplants is unknown. In the present study, we 
compared the effect of NSCs transplantation for SCI in between young adult 
(2-month-old) and aged (15-month-old) mice. After inducing contusive SCI 
by IH impactor (70kDyn), NSCs derived from CAG-ffluc-venus Tg mice were 
transplanted into the injured spinal cords 9 days after SCI. Behavioral analy-
sis using BMS score and bioimaging of the grafted cells were performed until 
6 weeks after SCI. The aged mice showed severer neurological deficit com-
pared to the young adult mice in consistence with the larger lesion site and 
less spared myelination area after SCI. The aged mice, however, exhibited 
the higher survival rates of NSCs compared to the young adult mice, result-
ing in similar functional recovery to the young adult mice. RT-RCR of the 
injured spinal cords at 2 weeks after SCI revealed a lower gene expression 
of sema3a and higher gene expression of HGF in the aged mice, suggest-
ing that the favorable microenvironment of the injured spinal cord in the 
aged mice might support the survival of the grafted NSCs and the axonal 
regrowth. Taken together, advanced age did not reduce beneficial effects of 
NSCs transplantation for SCI.
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A NONVIRAL IPSC MODEL FOR THE STUDY OF 
ALZHEIMER’S DISEASE
Machairaki, Vasiliki1, Ryu, Jiwon1, Peters, Ann2, Burridge, Paul W.2, 
Park, Tea Soon2, Zambidis, Elias T.3, Koliatsos, Vassilis E.4
1Pathology, Division of Neuropathology, Johns Hopkins University School 
of Medicine, Baltimore, MD, USA, 2Institute for Cell Engineering, Stem 
Cell Program, Johns Hopkins University School of Medicine, Baltimore, 
MD, USA, 3Department of Oncology, Division of Pediatric Oncology, Johns 
Hopkins University School Of Medicine, Baltimore, MD, USA, 4Pathology, 
Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, 
USA
Alzheimer’s disease (AD) is the most common age-associated dementia. In 
these studies we generated nonviral, nonintegrated human induced pluripo-
tent stem cell (hiPSC) lines for in vitro and in vivo modeling of neurons and 
glial cells harboring specific AD mutations. This AD stem cell model provides 
unique opportunities for diagnostic and drug testing strategies. We describe 
the derivation of AD hiPSC lines derived with nonintegrated episomal con-
structs from fibroblasts of patients carrying familial AD mutations, as well as 
from healthy age-matched control fibroblasts. The two AD patient fibroblast 
donors included one 56-year old male and one 56-year old female, both 
carrying the missense mutation Ala246Glu (A246E) in the presenilin 1 (PS1) 
gene (Catalog No.AG06840 and AG06848; Coriell Institute for Medical 
Research, Camden, NJ). PS1 mutations are the most common cause of 
early-onset familial AD. Reprogramming was achieved with nonintegrating 
oriP/EBNA1-based episomal vectors for the transient expression of OCT4, 
SOX2, KLF4, LIN28, NANOG, c-Myc and SV40LT transgenes. AD-affected 
hiPSC were characterized for their pluripotency by teratoma analysis, cytol-
ogy, expression of human ES markers, karyotype analysis, and methylation/
demethylation profiling. hiPSC from AD and healthy subjects were differ-
entiated into neural cells with a Noggin induction protocol to demonstrate 
AD pathogenesis, including differential expression and cleavage of APP, and 
impairment of neurogenesis and neurite outgrowth. Neuronal differentia-
tion of AD-PS1 precursors was characterized via qRT-PCR and immunocy-
tochemical procedures for neuroepithelial/neural markers (e.g., Pax6, Sox1, 
nestin, musashi) as well as neuronal markers at various stages of maturation 
(doublecortin, βIII tubulin [TUJ1], MAP-2). Neuronal differentiation of PS1/
A246E precursors was measured with semiquantitative ICC and flow cytom-
etry and was compared to precursors from control hESC. We also examined 
the differential expression of APP and the levels of Aβ40 and Aβ42 in dif-
ferentiated hiPSC using quantitative anti-Aβ enzyme-linked immunosorbent 
assay (ELISA) from AD-derived neurons and controls. These studies provide 
a valuable foundation for characterizing the pathologic development of AD 
neural precursors.
Poster Board Number: 2034
NEURONAL DIFFERENTIATION OF NON-VIRAL 
DOWN SYNDROME IPS CELLS REVEALS 
KNOWN AND NOVEL DISEASE PHENOTYPES
Sun, Jane1, Briggs, James1, Ovchinnikov, Dmitry1, Chung, Tung-
Liang1, Limnios, Jason1, Kao, li-Pin1, Titmarsh, Drew1, Thakar, Nilay1, 
Shepherd, Jill Lauren2, Grimmond, Sean Michael2, Wolvetang, Ernst 
Jurgen1
1Australian Institute for Bioengineering and Nanotechnology, University 
of Queensland, Brisbane, Australia, 2Institute for Molecular Bioscience, 
University of Queensland, Brisbane, Australia
Down syndrome (DS, trisomy 21) affects both pre- and post-natal brain 
development and neuronal function. Because Down syndrome research has 
heavily relied on cells derived from 20 week old fetal brains or mouse model 
systems little is known about the effect of trisomy 21 on early human brain 
development. We therefore generated DS and control hiPS cells from pri-
mary fibroblasts using episomal vectors and, following extensive character-
ization, differentiated these cells into neurons and glial cells. We show that 
although DS iPS and control iPS transcriptomes are highly similar and closely 
resemble human embryonic stem cell, DS-hIPS display over-expression of 68 
chromosome 21 genes as well as differential expression of 1200 non-chro-
mosome 21 genes. We correlate these expression data with genome wide 
methylation comparisons between control anbd Down syndrome iPS cells. 
Upon stepwise neuronal differentiation of DS IPS over-expression of addi-
tional chromosome 21 genes, such as APP, DYRK1a and SOD1, is observed, 
revealing for the first time cell type dependent activation of specific chromo-
some 21 genes in DS. Importantly, neuronal cultures derived from DS iPS 
derived neurospheres display increased spontaneous and hydrogen peroxide 
induced cell death, shorter neurite extensions and increased glial differentia-
tion over time in culture, phenotypes previously also observed in primary 
human fetal derived DS neurons. We however also identify deregulation of 
Notch and Hedgehog signalling at specific temporal windows of early Down 
syndrome neurogenesis not previously identified in primary foetal derived 
neuronal cultures. We conclude that non-viral DS iPS cell derived neurons 
recapitulate known features of DS brain pathologies but can also be used to 
identify novel DS associated phenotypes.
Poster Board Number: 2036
PATIENT-SPECIFIC INDUCED NEURONS 
DIRECTLY FROM REPROGRAMMED 
FIBROBLASTS FUNCTION IN THE ANIMAL 
BRAIN
Zhu, Jianhong1, Zhang, Helen2
1National Key Lab for Medical Neurobiology, Dept of Neurosurgery, Fudan 
University Huanshan Hosp, Shanghai, China, 2Department of Genetics, 
Harvard Medical School, Boston, MA, USA
Regenerative medicine aims to create healthy and functional cells of the 
same type to replace diseased or damaged tissues. Here, we show that a 
combination of three transcription factors Ascl1, Myt1l and Sox2 is capable 
of converting human fibroblasts from the scalp of patients with traumatic 
brain injury (TBI) to neurons directly. 28 days after gene transduction, 
fluorescence-activated cell sorting (FACS) was performed using PSA-NCAM, 
a marker for immature neurons or neuronal progenitors. The percentage 
of PSA-NCAM+ cells was 7.62%. By further cultured, these sorted cells 
expressed the pan-neuronal markers Tuj1 and synapsin. To explore whether 
these cells possessed the characteristics of functional neurons, we analyzed 
the electrophysiological properties. Patch-clamp recordings demonstrated 
that, these cells expressed the voltage-gated ion channels, such as fast inac-
tivating inward (Na+-channels) and outward currents (K+-channels). These 
cells generated spontaneous action potentials as early as 35 days after trans-
duction albeit few spikes may indicate them more like less mature neurons. 
Three weeks after transplantation into the brain of NOD/SCID mouse, hu-
man iN cells were immunostained with markers of various types of neuron. 
We observed voltage-gated sodium and potassium channels. Both excitatory 
and inhibitory spontaneous postsynaptic currents (EPSCs and IPSCs) had be 
detected, suggesting iN cells formed functional postsynaptic compartments 
and receive synaptic inputs from host neurons. To test the potential for 
nerve regeneration with iN cells, we evaluated the effectiveness of iN cells 
transplantation as a treatment for TBI. Adult male NOD/SCID mice received 
a weight-drop injury as previous method to induce brain trauma. Five days 
after injury, iN cells were injected into the injured cortex. Open field BBB 
scoring showed significant differences between iN cells and either human 
fibroblast or vehicle transplanted controls (n=10, p<0.05). These cells were 
integrated into the mouse brain and promote locomotor function recovery. 
Generation of iN cells from patient-derived fibroblasts heralds immense 
hope in the neural regenerative medicine field.
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ABERRANT PURINERGIC SIGNALING IN IPS 
CELLS DEFICIENT IN HPRT EXPRESSION
Mastrangelo, Lina, Friedmann, Theodore
University of California San Diego, La Jolla, CA, USA
Lesch-Nyhan disease (LND) is an X-linked genetic disorder associated 
with mutations of the hypoxanthine guanine phosphoribosyltransferase 
(HPRT) gene leading to purine metabolic abnormalities and neurobehavioral 
manifestations including dystonia and compulsive self-injurious behavior. 
Although available evidence has identified a role for purinergic signaling in 
neuronal differentiation and brain development, mechanisms linking HPRT 
deficiency, purinergic pathways and neural dysfunction have not been well 
defined. In this study, we have used lentivirus vectors expressing shRNA 
targeted to the HPRT gene to produce HPRT-deficient human induced pluri-
potent stem (iPS) cells. In HPRT knockdown cells, real-time PCR analyses 
revealed severely decreased mRNA levels of the purinergic P2Y1 receptor 
compared to control cells and fluorescence-activated cell sorting (FACS) 
analyses confirmed a decreased cell surface expression of P2Y1. Exposure 
of cells to the P2Y1 blocker MRS2179 and the P2Y1 agonist ATP revealed 
dysregulated expression of phosphorylated CREB and ERK1/2 in HPRT 
knockdown cells. Additional studies of in vitro differentiation of normal and 
HPRT-deficient iPS cells may clarify a role of HPRT in purinergic mechanisms 
of the central nervous system and in the development of LND and other 
neurodevelopmental and neurodegenerative diseases.
Poster Board Number: 2040
THE EXPRESSION AND ROLE OF MACROPHAGE 
MIGRATION INHIBITORY FACTOR IN NEURAL 
STEM/PROGENITOR CELLS
Ohta, Shigeki1, Okano, Hideyuki2, Kawakami, Yutaka1, Toda, 
Masahiro3
1Division of Cellular Signaling, Institute for Advanced Medical Research, 
Keio University School of Medicine, Tokyo, Japan, 2Department of 
Physiology, Keio University School of Medicine, Tokyo, Japan, 3Department 
of Neurosurgery, Keio University School of Medicine, Tokyo, Japan
In previous studies, we demonstrated that mouse dendritic cells (DCs) can 
increase the number of neural stem/progenitor cells (NSPCs) in vitro and 
in vivo. In this study, we identified macrophage migration inhibitory factor 
(MIF) that is secreted from DCs and NSPCs as a novel factor that can sup-
port the proliferation and/or survival of murine NSPCs in vitro, although the 
function of MIF in the normal brain remains largely unknown. It was previ-
ously shown that in macrophages, MIF can bind to a receptor complex of 
CD74 and CD44. In the present study, we observed a CD74/CD44 double-
positive cell population in mouse ganglionic eminence (GE)-derived neuro-
spheres using flow cytometry technique in vitro. Interestingly, secretion of 
MIF from neurospheres was also confirmed by ELISA. We further found the 
expression of CD74 in GE of E14 mouse brain, suggesting the functional 
role of MIF in vivo. Exogenous addition of MIF to NSPCs increased the 
number of primary and secondary neurospheres in the presence of EGF and 
FGF2 and did not affect the differentiation potential of NSPCs. In contrast, 
retrovirally expressed MIF shRNAi suppressed the secondary neurosphere 
formations and cell proliferation, and increased the caspase3/7 activity in 
neurospheres. Moreover, we found that in neurospheres MIF increases the 
phosphorylation of Akt, Erk, and Stat3 (Ser727) which are known as factors 
supporting the cell survival, proliferation and/or maintenance of NSPCs. The 
cell surface expression of GLUT1 was also increased with AMPK activation 
by MIF treatment in neurospheres, showing that MIF may contribute to the 
cell proliferation and/or survival through glucose uptake. These results sug-
gest that MIF can cause proliferation and maintain NSPCs utilizing multiple-
signaling pathways synergistically in an autocrine manner and may be a 
new therapeutic factor for neural degenerative disorders through NSPCs 
activation.
Poster Board Number: 2042
NEURAL STEM CELLS SURVIVE, MIGRATE 
AND ENGRAFT OPTIMALLY WHEN DELIVERED 
INTRA-ARTERIALLY AT 3 DAYS AFTER HYPOXIC-
ISCHEMIC STROKE
Rosenblum, Sahar1, Wang, Nancy1, Chua, Joshua1, Birk, Harjus1, 
Sung, Hotaik1, Guzman, Raphael2
1Stanford University, Stanford, CA, USA, 2Neurosurgery, Stanford University, 
Stanford, CA, USA
Intro: Minimally invasive intra-arterial (IA) neural progenitor cell (NPC) 
transplantation is a promising avenue for stem cell therapy after stroke. 
However, the effects of timing of transplantation on cell survival remain 
unknown in this specific model. Methods: Mouse NPC’s (5x105 in 5µl 
saline) harboring a reporter gene construct containing renilla luciferase were 
delivered to the brain via the carotid artery at 5 distinct time points after 
hypoxic-ischemic (HI) stroke. These groups were assigned as the 6 hours, 
24 hours, 3, 7 and 14 days post-HI transplantation groups. Cell engraftment 
was monitored by in-vivo bioluminescence imaging (BLI) for luciferase activ-
ity, performed 6 hours, 4 days, and 7 days after IA injection. Stroked brain 
homogenates were analyzed using RT-qPCR for the chemokines CCL2 and 
SDF-1, and adhesion molecule VCAM-1. In-vitro Boyden Chamber migra-
tion and quantitative RT-qPCR was also used to characterize C17.2 NPCs. 
Results: BLI at 6 hours after transplantation revealed a significantly higher 
luciferase signal in the 3 days post-HI transplantation group as compared to 
the 6 hours (P=0.015), 7 days (P=0.015), and 14 days (P=0.016) post-HI 
transplantation groups. This trend continued at 4 days after transplanta-
tion. At 7 days after transplantation, the 3 days post-HI transplantation 
group was statistically significant to all other groups (P<0.05). Moreover, 
the percent of baseline luciferase signal was higher in the 3 days post-HI 
transplantation group. Histological cell counting of NPCs at 7 days after 
transplantation revealed the 3 days post-HI transplantation group was sta-
tistically significant when compared to all other groups (P<0.05). Phenotypi-
cally, NSCs in the 3 days post HI-transplantation group expressed nestin at 
close to 93% and GFAP at 2%. A greater percentage of cells in the 6 and 
24 hours post-HI transplantation groups expressed GFAP with close to 8% 
and 5% respectively. These two acute time points of transplantation also 
demonstrated a higher percentage of transplanted NPCs immuno-positive 
for Iba-1. Non-transplanted stroked brain homogenates from the 3 days 
post-HI transplantation group revealed upregulation of chemokines SDF-1 
and CCL2 at 7.4 and 1216 fold upregulation respectively. The adhesion mol-
ecule VCAM-1 was upregulated by 5.4 fold. Micro-array analysis revealed 
high expression of integrins beta-1 and alpha-4 (together comprising the 
VCAM-1 ligand, VLA-4) Additionally, cells expressed CXCR4 and CXCR7 
(receptors for SDF-1) and CCR4 (receptor for CCL2) but not CCR2 or CCR5. 
Boyden Chamber migration assay revealed NSCs migrate to both MCP-1 
and SDF-1 in a dose dependent manner. Conclusion: Transplanted NPC sur-
vival is optimal when delivered 3 days after HI as demonstrated by BLI and 
histological findings. In vivo, upregulation of adhesion molecule VCAM-1 
and chemokines CCL2 and SDF-1 in correspondence with in-vitro expres-
sion of their ligands VLA-4 and receptors CCR4, CXCR4, CXCR7, elucidate a 
possible mechanism for increased transplanted NSC migration. This assertion 
is supported by in-vitro migration of NPCs to potent chemotaxic factors 
SDF-1 and MCP-1. Additionally, transplantation at 6 hours and 24 hours 
after stroke revealed greater percent of transplanted NPC’s phagocytosed 
by activated microglia, as assessed by GFP/Iba-1 double positive cell counts. 
These data suggest a possible mechanism for significantly higher survival, 
migration and engraftment of NPCs transplanted at 3 days after HI.
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SIMULATED MICROGRAVITY INCREASES CELL 
MIGRATION AND NEUROPROTECTIVE EFFECT 
AFTER BONE MARROW STROMAL CELL 
TRANSPLANTATION SPINAL CORD INJURY
Kawahara, Yumi1, Takeda, Masaaki1, Mitsuhara, Takafumi1, 
Manabe, Tomotaka2, Matsumoto, Masaya2, Takahashi, Tetsuya1, 
Kurisu, Kaoru1, Matsumoto, Masayasu1, Yuge, Louis2
1Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, 
Japan, 2Graduate School of Health Sciences, Hiroshima University, 
Hiroshima, Japan
The 3D-clinostat, simulated microgravity machine, is a multi-directional 
gravity device, by controlled rotation of two axes, and makes 10-3 G aver-
age over time (patented: undifferentiated pluripotent stem cell proliferation/
differentiation regulation method and system, Japanese patent, publication 
number P2001-197182A, date of filing June. 28, 2001, P2003-9852A, date 
of filing January. 14, 2003, and overseas patents, WO2004/061092 A1 PCT 
[U.S.A., Canada, China, and Korea], P/E [Italy, U.K., Sweden, Germany, and 
France], 2004). We reported simulated microgravity inhibited cell differen-
tiation such as myoblasts, osteoblasts, and stem cells. Bone marrow stromal 
cells (BMSCs) represent one of the potential sources of cell therapy after 
central nerve disorders. In the present study, we investigated the migration 
property and neuroprotective effect of rat BMSCs cultured in simulated 
microgravity using spinal cord injury model rats. Rat BMSCs were isolated 
from Fisher F344 rats and harvested in 1G condition. After BMSCs were 
proliferated, the cells were divided into two different gravity conditions: 
normal 1G (group 1G) and simulated microgravity using the 3D-clinostat 
(group CL). After 7 days culture, BMSCs were labeled with PKH-26. Spinal 
cord injury was induced by weighing drop method in adult female Fisher 
F344 rats. Immediately after injury, rats were received BMSCs of group 1G 
or CL through the caudal vein. Non-treated rats were injected PBS only as 
a control. Functional recovery was examined by Basso-Beattie-Bresnahan 
scale and inclined plane score at 1 to 7, 14, and 21 days. Spinal cords were 
removed 21 days after injury and immunocytochemically examined. Oct-4 
and CXCR4 expressions were higher cells in group CL than in group 1G 
before cell transplantation. Locomotor function of group CL cells received 
rats showed more gradual improvement than non-treated and group 1G 
cells received rats, and a marked statistically significant difference after 4 
days. In group CL cells received rats, the cavity rate of the injured space 
was smaller compared to group 1G cells received rats. PKH-26 positive cells 
mainly existed in and around the injured space, and they were observed 
easier in group CL cells received rats than in group 1G. PKH-26 positive cells 
were expressed glial fibrillary acidic protein (GFAP) rather than neurofila-
ment. Moreover, in group CL cells received rats, the rate of Bax, apoptosis 
invitation marker, positive cells were significantly lower and that of Bcl-2 and 
Survivin, apoptosis inhibition markers, positive cells were higher compared 
to group 1G cells received rats. Our findings indicate that transplanted BM-
SCs migrate to the injury site, and mainly differentiate into astrocytes after 
cell transplantation in acute phase. As a result, BMSCs cultured in simulated 
microgravity facilitate functional recovery from spinal cord injury by increas-
ing cell migration and neuroprotective effect.
Poster Board Number: 2046
OPTIMIZED NEURONAL CULTURE MEDIA FOR 
ELECTROPHYSIOLOGY APPLICATIONS
Kaur, Navjot, Vemuri, Mohan
Life Technologies, Frederick, MD, USA
Primary neural cells offer an indispensible tool for dissecting basic cell 
biology with prospective applications in cell therapy and drug discovery. 
Utilization of their potential largely relies on optimal culture conditions that 
preserves it functional properties. In particular, electrophysiological proper-
ties of neurons are known to diminish under suboptimal culture conditions. 
It is through electrical activity that neurons communicate with each other as 
well as with muscle and other end organs. Electrophysiology is the funda-
mental technique to assess such electrical activities to study the functions 
and dysfunctions in cultured neurons. Neurons are usually cultured in serum-
free systems which include basal medium such as Neurobasal® supple-
mented with B-27® and GlutaMAX-I®. Neurons cultured in such media 
show lower electrophysiological spike rates relative to media supplemented 
with serum. We have developed an optimized medium Neurobasal Electro® 
and a supplement B-27 Electro® which promote higher spike rates by a 
mechanism involving greater sysnoptogenesis that is reflected by increased 
immunocytochemical marker expression of pre-synaptic Synaptophysin and 
post synaptic PSD-95. The immunoreactive GABA and NMDA puncta also 
increased 2.8- fold and 1.6-fold respectively (n=3, p<0.05) over the period 
of three week. Primary rat neurons cultured in Neurobasal Electro® and 
B-27® Electro produced higher spike rates on multielectrode arrays. The rate 
of cell survival was indistinguishable at day 4 between Neurobasal®/B-27® 
and Neurobasal Electro®/B-27® Electro assessed by Live/Dead® cell viabil-
ity assay (n=3, 98.0 ± 0.8 vs. 97.2 ± 1.6). These results show that this media 
system is an improvement to Neurobasal®/B-27® for cultured networks 
with an increased density of synapses and transmitter receptors. Neurobasal 
Electro® and B-27® Electro will render better electrophysiological studies, 
besides normal functional studies enabling improved screening applications.
Poster Board Number: 2048
DEVELOPING AN IPSC-DERIVED NEURONAL 
MODEL OF AUTISM BASED ON NEUROLIGIN 
SIGNALING
Kim, Ji-Eun, O’Sullivan, Matthew, Hwang, Minju, Ghosh, Anirvan
Biology, University of California, San Diego, La Jolla, CA, USA
We have previously described a protocol to direct the differentiation of hu-
man induced pluripotent stem cells (iPSCs) into forebrain neurons by expos-
ing them to developmentally relevant signals. Human iPSC-derived neurons 
(or “iPS-neurons”) mature into electrophysiologically functional neurons and 
display a range of characteristics typical of forebrain neurons. Their matura-
tion is facilitated by co-culturing with postnatal rat glia. Human iPS-neurons 
may be applied in studies investigating molecular mechanisms of human 
neurodevelopmental diseases such as autism. For example, we can use 
them in an artificial synapse formation assay where the cultured iPS-derived 
neurons are co-cultured with HEK293T cells that have been transfected with 
synapse-inducing molecules such as the Neuroligins. Human iPS-neurons 
are able to efficiently form Neuroligin-induced synapses onto HEK293T cells. 
The synapse-inducing ability autism-linked mutants of Neuroligin4 (NLGN4) 
can be directly compared in the same assay. NLGN4 overexpression in 
iPS-neurons resulted in enhanced density of presynaptic structures in three-
week-old neurons. We are in the process of testing whether this enhance-
ment correlates to an increase in synaptic activity of these neurons. These 
experiments provide further evidence that human iPS-neurons are a robust 
experimental system to investigate the effects of human disease-related 
mutations in neuronal synapse formation and function.
Poster Board Number: 2050
GENERATION OF IPS CELLS IN SPINAL BULBAR 
MUSCULAR ATROPHY (KENNEDY’S DISEASE)
Grunseich, Christopher, Perkins, Kristen, Harmison, George, 
Fischbeck, Kenneth
NINDS, NIH, Bethesda, MD, USA
Our understanding of the pathogenic mechanisms of motor neuron disease 
has been limited by the absence of model systems that can adequately 
recapitulate disease features as they occur in vivo. Spinal bulbar muscular 
ISSCR 9th Annual Meeting
60
www.isscr.org
Friday Poster Abstracts
atrophy (SBMA), also known as Kennedy’s disease, is caused by a CAG 
repeat expansion in the androgen receptor gene on the X chromosome, 
which results in a androgen-dependent toxic gain of function in the mutant 
protein. The length of the CAG repeat correlates inversely with the age of 
disease onset, with longer repeats associated with earlier onset. The iPS cell 
system provides a unique opportunity in which stem cells can be generated 
from adult patients with motor neuron disease, and then differentiated into 
disease-relevant progeny such as neurons and glia. We have generated iPS 
cells from patients with spinal bulbar muscular atrophy (SBMA) in order to 
generate neurons and other cells that can then be manipulated and studied 
in vivo to better understand the disease mechanism. The differentiated 
SBMA iPS cells will be cultured with and without the presence of dihydrotes-
tosterone (DHT) to determine if a phenotype is affected by ligand activation. 
The identification of a phenotype with the iPS cell system will allow us to 
develop assays to test candidate therapeutics and screen for new com-
pounds with therapeutic potential.
Poster Board Number: 2052
COMPARISON OF ADULT CANINE 
SKIN-DERIVED AND BRAIN-DERIVED 
NEUROPRECURSORS IN VITRO
Lowe, Aileen K.1, Sidhu, Kuldip S.2, Sachdev, Perminder S.3, 
Valenzuela, Michael J.4
1Regenerative Neuroscience Group, University of New South Wales, Sydney, 
Australia, 2Stem Cell Laboratory, Faculty of Medicine, University of New 
South Wales, Sydney, Australia, 3Neuropsychiatric Institute, Prince of Wales 
Hospital, Sydney, Australia, 4Brain & Ageing Research Program, University 
of New South Wales, Sydney, Australia
BACKGROUND: Neuroprecursors have been isolated from the brains of 
several mammalian species, including the domestic dog (Canis familiaris). 
Recent work has indicated neuroprecursors can also be successfully isolated 
from adult canine skin. Skin and the major cell types of the brain all arise 
from the embryonic ectoderm. Apart from this shared lineage, the similari-
ties between skin-derived and brain-derived neuroprecursors remain unclear. 
AIM: To compare the proliferation capacity and differentiation potential 
of skin-derived and brain-derived neuroprecursors under in vitro culture 
conditions. METHODS: Periventricular regions were dissected from fresh 
post mortem canine brain within 4 hours of death. Following enzymatic 
dissociation, cells were transferred to neurosphere and then to adherent 
culture for analysis (NeuroCult Media, Stem Cell Technologies). Fresh excess 
canine skin tissue was obtained following routine veterinary surgery. Skin 
derived precursors were isolated and propagated according to our protocol 
adapted from Toma et al. Proliferative potential was quantified using the 
5-ethynyl-2’-deoxyuridine (EDU, Invitrogen) assay. Spontaneous differen-
tiation towards neuronal lineages was induced by removal of the mitogens 
from culture medium and by the addition of 10ng /mL of Brain Derived 
Neurotrophic Factor (BDNF). Gene and protein expression for various 
neuronal markers were carried out using PCR and immunocytochemical 
staining respectively. RESULTS: Under neurosphere and adherent culture 
conditions, both canine skin and brain-derived neuroprecursors are mor-
phologically similar. Immunocytochemical and PCR analysis of proliferating 
cultures revealed expression of neural stem cell markers Nestin, NCAM and 
CD133. EDU proliferation assays revealed comparable proliferation rates of 
skin and brain-derived neuroprecursors until the second passage. Signifi-
cant decreases (p<0.05) in the proliferation rates of skin-derived (32.63%) 
compared to brain-derived (74.64%) neuroprecursors were observed after 
the third passage. Immunocytochemical staining of spontaneously differenti-
ated cultures from both tissue sources indicated expression of more mature 
neuronal markers βIII tubulin, MAP2 and NSE. However, a higher density of 
glial marker GFAP positive cells in brain-derived cultures (>90%) than skin-
derived (<1%) was observed. Additionally, expression of GABAergic marker 
GAD67 was limited to skin-derived samples. These immunocytochemical 
findings were corroborated by PCR analysis. CONCLUSIONS: Similarities 
between canine skin and brain-derived neuroprecursors were found in terms 
of morphology and neural stem cell-like markers based on gene and protein 
expression. However, skin-derived neuroprecursors exhibited significantly 
decreased proliferation rates following third passage, whilst spontaneous dif-
ferentiation suggest a preferential committal to the GABAergic lineage and 
decreased capacity for glial differentiation. Further research is in progress to 
better understand both molecular and functional properties of adult skin-
derived and brain-derived canine neuroprecursors.
Poster Board Number: 2054
MODELING PRIMATE NEURAL DEVELOPMENT 
USING INDUCED PLURIPOTENT STEM CELLS 
(IPSC)
Marchetto, Maria1, Kerman, Bilal1, Paquola, Apua2, Gage, Fred1, 
Muotri, Alysson2
1Salk Institute, La Jolla, CA, USA, 2Department of Pediatrics/Rady 
Children’s Hospital San Diego, Department of Cellular & Molecular 
Medicine, University of California, San Diego, La Jolla, CA, USA
New genomic tools provide us with high-resolution information about the 
alterations that may have resulted in the evolution of our own species. 
However, all information available to date for comparative studies between 
humans and our closest relatives come from DNA/RNA samples extracted 
from preserved (post-mortem) tissues. These samples don’t always fairly 
represent the distinctive traits of live cell behavior. The identification of dif-
ferences in genetic makeup between related species needs to be translated 
into phenotypic divergence. It is likely that some of these alterations will be 
subtle, impacting specific cell types at precise time points during develop-
ment. Pluripotent stem cells can differentiate into several cell types of the 
body, recapitulating early stages of an organism’s development. In this study, 
we characterize induced pluripotent stem cells (iPSC) derived from somatic 
cells of humans, bonobos and chimpanzee’s individuals. Bonobo’s and chim-
panzee’s iPSC behave similarly to human cells regarding self-renew capacity 
and pluripotency potential. Using a neural differentiation protocol we show 
that all species were able to generate electrophysiologically active neurons. 
Moreover, we demonstrate that human cells can recapitulate differences 
from bonobo and chimpanzee such as specific transcriptional and biochemi-
cal modifications, caused by genomic mutations that occurred after the split 
of the human lineage. This approach provides a unique biological resource 
to elucidate the phenotypic differences between human and apes at specific 
time points during cellular speciation. Our culture model could bring new 
insights to human adaptation, with potential consequences to biomedical 
research and basic biology of the species.
Poster Board Number: 2056
MODULATION OF SPREADING AND 
MIGRATION OF ASTROCYTES GENERATED 
FROM NEURAL STEM/PROGENITOR CELLS ON 
ELASTIC HYDROGELS
Mori, Hideki, HARA, Masayuki
Graduate School of Science, Osaka Prefecture University, Osaka, Japan
Background: The mechanical properties of cell-scaffold materials affect some 
cell behavior, the differentiation pathway of somatic stem cells and the 
motility of fibroblasts. The scaffold designing taken account of their proper-
ties are essential for controlled behavior of stem cells in tissue engineering 
applications. We investigated the cell motility and spreading of the dif-
ferentiated cells generated from mouse cerebral neural stem/progenitor cells 
(NSPC) formed neurosphere on type I collagen gels and polyacrylamide gels 
with storage elastic modulus (G’) from 100-2000 Pa. Methods: The stiffness 
of collagen gels were adjusted by carbodiimide cross-linking technique. 
Polyacrylamide gels were prepared with acrylamide/bis-acrylamide mixture, 
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containing 10% acrylamide and bis concentrations ranging from 0.26 to 
0.03%. After gelation, type I collagen molecules were bound on the surface 
of polyacrylamide gels by photoactivated crosslinker. NSPC which formed 
small neurosphere by serum-free culture for three days, were induced dif-
ferentiation in the medium containing 1% fetal bovine serum on respective 
collagen gels and polyacrylamide gels. Cell differentiation was evaluated by 
immunofluorescence staining with anti-tubulinβIII (neuronal marker) and 
anti-GFAP antibodies (astrocytic marker). The cell motility and spreading 
were by image analysis based on cell area and boundary length. Real-time 
RT-PCR analysis was performed on differentiated cells to evaluate changes 
in Rho family gene (Cdc42, Rac1, RhoA) expression. Results: In every gel 
conditions, the ratio of neurons were 5-10%, astrocytes were 90-95%. We 
could not observe the significant effect on cell differentiation lineage. How-
ever, spread area of astrocytes generated from neurosphere-formed NSPC 
was more extensive on harder gels (G’ > 1000 Pa) in both hydrogels. The 
expression level of cdc42 and Rac1 also were higher on harder gels. Neurons 
generated from neurosphere-formed NSPC migrated on all hydrogels. 
Conclusion: The stiffness of hydrogels (G’ > 1000 Pa) is important for the 
migration and spreading of astrocytes from neurosphere.
Poster Board Number: 2058
DRONC CASPASE EXERTS A NON-APOPTOTIC 
FUNCTION TO SUPPRESS PHOSPHO NUMB-
INDUCED EXCESS NEURAL STEM CELLS IN 
DROSOPHILA
Ouyang, Yingshi1, Petritsch, Claudia2, Wen, Hong3, Jan, Lily4, Jan, 
Yuh Nung4, Lu, Bingwei5
1Pittsburgh Development Center, Magee-Women’s Research Institute, Ob-
Gyn-Repro Sci., University of Pittsburgh School of Medicine, Pittsburgh, 
PA, USA, 2Department of Neurological Surgery, University of California, 
San Francisco, San Francisco, CA, USA, 3Department of Biochemistry 
and Molecular Biology, University of Texas M. D. Anderson Cancer 
Center, Houston, TX, USA, 4Department of Physiology, Biochemistry and 
Biophysics, Howard Hughes Medical Institute, University of California, San 
Francisco, San Francisco, CA, USA, 5Department of Pathology, Stanford 
University, Stanford, CA, USA
Drosophila neural stem cells, or called neuroblasts, have been instrumen-
tal for investigating mechanisms by which an appropriate balance of stem 
cell self-renewal versus differentiation is accomplished. Drosophila Numb 
protein controls this process through its predominant inheritance by the 
differentiating daughter cell. How Numb restricts the proliferation and self-
renewal potentials of the recipient cell remains enigmatic. Here we show 
that phosphorylation at conserved sites regulates the tumor suppressor 
activity of Numb. Enforced expression of a phospho-mimetic form of Numb 
(Numb-TS4D), or genetic manipulation boosting phospho-Numb level, 
attenuates endogenous Numb activity and causes ectopic neuroblast forma-
tion. This effect on neural stem cell (NSC) homeostasis occurs only in type II 
neuroblast lineage. The prominent brain tumor-like phenotype induced by 
Numb-TS4D provides an excellent system to identify novel molecules con-
trolling NSC homeostasis. We identify that Dronc caspase is a novel binding 
partner of Numb, and demonstrate that overexpression of Dronc suppresses 
Numb-TS4D effects in a non-apoptotic, and possibly non-catalytic manner. 
Conversely, depletion of Dronc activity enhances the over-proliferation phe-
notype upon impairment of Numb function. This result indicates that normal 
Numb-Dronc interaction is very important for NSC homeostasis. Our find-
ings reveal a molecular mechanism regulating Numb activity and implicate 
a novel role for Dronc caspase in regulating NSC homeostasis. Dr. Ouyang 
conducted his work when he was at Stanford University.
Poster Board Number: 2060
A ROLE FOR THE SNAIL TRANSCRIPTION 
FACTOR IN THE SURVIVAL AND MAINTENANCE 
OF DEVELOPING RADIAL PRECURSOR CELLS
Zander, Mark A.1, Burns, Sarah E.1, Gridley, Thomas2, Kaplan, David 
R.1, Miller, Freda D.1
1Developmental Biology, The Hospital for Sick Children, Toronto, ON, 
Canada, 2The Jackson Laboratory, Bar Harbor, ME, USA
The transcriptional repressor Snail has been implicated in the development 
of stem cells in both Drosophila and C. elegans, regulating survival in C. 
elegans, and self-renewal versus differentiation in Drosophila. In mammals, 
Snail has been shown to regulate the epethelial to mesenchymal transition 
(EMT) during development and in cancer, a process that has been implicated 
in regulating stem cell states. We have therefore asked whether Snail might 
play a role in regulating the biology of neural stem cells, focusing upon the 
developing cortex. We show that Snail is expressed in the embryonic cortex, 
where it is enriched in radial precursors and in newly-born cortical neurons. 
Acute genetic knockdown of Snail in developing cortical precursors in vivo 
results in cellular apoptosis, specifically within Pax6-positive radial precur-
sors. This apoptotic phenotype can be rescued by coincident knockdown of 
p53, indicating that Snail normally supports precursor survival by inhibiting a 
p53-dependent apoptotic pathway. However, while p53 knockdown rescues 
the apoptosis, it does not fully rescue the Snail knockdown phenotype 
suggesting that Snail plays other roles in radial precursors. In support of this 
idea, overexpression of Snail within cortical precursor cells in vivo resulted in 
an increase in the proportion of Pax6 radial precursors, suggesting that Snail 
also regulates self-renewal in a p53-independent fashion.
Poster Board Number: 2062
A COMBINATORIAL APPROACH FOR 
DEVELOPMENT OF SYNTHETIC SURFACES FOR 
STEM CELL CULTURE
Zhou, Yue, Pai, Sadashiva K., Baker, Wendy A., Dolley Sonneville, 
Paula J., Melkoumian, Zara, Weber, David M., Fadeev, Andrei G., 
Petzold, Odessa N., Faris, Ronald A., Pal, Santona
Science & Technology, Corning Inc., Corning, NY, USA
Development of scalable, reproducible, and regulatory-friendly synthetic 
surfaces for stem cell culture has been a challenge for cell therapy applica-
tions. Combinatorial chemistry and parallel screening approaches have been 
used to identify biological and biomimetic surfaces to culture stem cells with 
varying success. Here, we report a combinatorial approach that enabled the 
identification and validation of an optimized synthetic surface for long term 
culture of neuronal progenitor stem cells in chemically defined media. A vari-
ety of acrylate based formulations were polymerized in 96-well microplates. 
Adhesion peptides from extra cellular matrix proteins were conjugated 
to the acrylate surfaces through carboxyl groups to provide biospecific 
binding epitopes for the library. ReNcell VM human neural progenitor 
cells (Millipore) were propagated on the library using serum free medium. 
Cell proliferation was evaluated either by luminescence ATP (Promega) or 
CyQUANT (Life Technologies) assays. Neurons in the differentiated cultures 
were identified using β-Tubulin-III immunochemical assay (Millipore). Pas-
sage studies were done in coated and gamma sterilized 6 well plates. In the 
screen “hits” were identified based on proliferation data. Of these, the P75 
surface enabled differentiation into neurons similar to the Laminin protein 
standard. Multi-passage study was done to further validate the surface. 
P75 performance was comparable to Laminin for up to 9 passages based 
on doubling time, and fold of expansion. Cells retained normal karyotype, 
expression of phenotypic markers, and ability to differentiate into neurons 
after long-term passaging. We have developed an efficient process for gen-
erating combinatorial libraries of biomimetic materials in microplate formats. 
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The library can be tuned to provide a broad range of chemical structure, 
mechanical and surface properties. It can also be functionalized with a 
range of peptide epitopes or other molecules at varying densities to further 
modulate cell specific attributes of adhesion, release etc. Here, we used this 
strategy to identify the most optimal synthetic surface for the culture of 
ReNcell. Laminin is a well established culture surface for ReNcells and other 
neuronal cell lines. Thus, we expected Laminin-based adhesion epitopes to 
be successful in this screening against neuronal cells. However, none of the 
tested laminin peptide containing surfaces was found to be a hit. Interest-
ingly, all our “hits” contained RGD epitopes; although not all RGD epitopes 
were equivalent in culture performance. In addition, the identified hit P75 
is identical to the surface that was previously reported by us for long term 
culture of human embryonic stem cells and recently commercialized as Corn-
ing® Synthemax™ Surface. In conclusion, our combinatorial approach has 
been very powerful in successfully identifying optimal synthetic surfaces for 
various cell culture applications.
CANCER CELLS
Poster Board Number: 2066
NK-92 INFUSIONS IMPROVE SURVIVAL IN 
NOD/SCID GAMMA NULL MICE BEARING 
ACUTE MYELOID LEUKEMIA XENOGRAFTS
Williams, Brent A., Wang, Xing-Hua, Keating, Armand
Cell Therapy Program, Princess Margaret Hospital, Toronto, ON, Canada
Introduction: Survival with acute myeloid leukemia (AML) remains poor 
particularly for high risk patients who lack a matched stem cell donor. NK-92 
is a human permanent natural killer (NK) cell line in a phase I clinical trial for 
relapsed and refractory hematologic malignancies. Irradiation of NK-92 pre-
vents proliferation and tumour formation in patients. We recently showed 
that NK-92 targets leukemic stem cells (LSCs) in the cell line KG1 and in 
five primary AML samples using a clonogenic assay. Here, we establish a 
leukemia xenograft model in NOD/SCID gamma null mice to evaluate the 
therapeutic efficacy of NK-92 and the impact of irradiation of NK-92 on in 
vivo cytotoxicity. Methods: 3.2x106 primary AML cells were injected via tail 
vein into NOD/SCID gamma null mice irradiated with 325 cGy and main-
tained on Baytril. 10-20x106 NK-92 (+/- irradiation with 1000 cGy) were 
infused via tail vein every 5-7 days to a total of 30x106 or 60x106 cells in 
two separate experiments. Mice were monitored for leukemia and sacrificed 
at humane endpoints. Autopsies were performed on select mice from each 
cohort, including flow cytometry of bone marrow (BM) and splenocytes to 
determine leukemic burden. Flow cytometry staining panel was designed to 
detect primary AML cells (class I HLA A, B, C) including the leukemic stem 
cell fraction (CD34, CD38) and NK-92 (CD56). Kaplan Meier survival curves 
were generated to compare survival in control and treatment groups. Re-
sults: In the pilot, NSG mice infused with AML developed signs of leukemia 
at day 50 including weight loss and decreased activity and died or required 
sacrifice by day 60. Autopsy revealed enlarged spleens and pale fragile 
bones relative to controls. Treatment of AML-infused NSG mice receiving 
10x106 non-irradiated NK-92 weekly x3 increased median survival from 60 
to 85 days (log rank test p<0.01). One mouse of 10 survived long-term to 7 
months age and on sacrifice had no evidence of splenomegaly or detectable 
leukemia in BM or splenocytes by flow cytometry. Two mice infused with 
non-irradiated NK-92 weekly developed signs and symptoms of leukemia 
at day 90 requiring sacrifice with evidence of NK-92 in the spleen and BM. 
In a follow-up experiment, total dose was doubled to 60x106 with intent 
to use 20x106 cells per infusion. Three of 25 mice infused with 20x106 
NK-92 had transient acute reactions and minimal activity with apparent 
recovery after 10 minutes. Further doses of NK-92 were reduced to 10x106 
to complete the total 60x106 dose. All mice with AML developed weight 
loss and decreased activity requiring sacrifice between day 50-60 as with the 
pilot study. At day 65 survival assessment revealed: non-irradiated NK-92 
only (3/5), irradiated NK-92 only (3/5), AML only (0/5), AML + irradiated 
NK-92 (2/10), AML + non-irradiated NK-92 (1/5). Mice with AML infusions 
developed splenomegaly and had near 100% BM engraftment of human 
leukemia cells. Summary and conclusion: We show that NK-92 enhances 
survival in mice bearing primary human AML and is potentially curative. 
Individual doses of 10x106 are tolerated well by tail vein, but 20x106 leads 
to acute stress and possibly early mortality, most likely due to the high cell 
burden. There is no difference in survival between non-irradiated and ir-
radiated NK-92 in the ongoing experiment and is of relevance because only 
irradiated cells are currently used in patients. We also report for the first time 
engraftment of NK-92 in an animal model indicating the high degree of 
permissiveness of NSG mice irradiated with 325 cGy.
Poster Board Number: 2068
NOTCH SIGNALING IS UPREGULATED IN THE 
CHRONIC PHASE OF CHRONIC MYELOID 
LEUKEMIA
Aljedai, Abdullah H.1, Buckle, AM2
1Clinical Lab Sciences- Blood transfusion and hematological disorders 
research group, King Saud University, Riyadh, Saudi Arabia, 2Faculty of Life 
Sciences, University Of Manchester, Manchester, United Kingdom
Notch signalling is critical for haemopoietic stem cell self-renewal and surviv-
al. Chronic Myeloid Leukaemia (CML) is a stem cell disease characterised by 
the presence of the Philadelphia (Ph) chromosome, and subsequent expres-
sion of the BCR-ABL oncogene. The well established role for Notch signal-
ling in human T-cell acute lymphoblastic leukaemia (T-ALL) and the reported 
interaction between Notch and ABL in different developmental contexts in 
Drosophila raise the possibility that Notch signalling may be dysregulated 
in CML. Therefore, the aim of the study was to investigate whether Notch 
signalling is altered in CML and to study possible crosstalk between Notch 
signalling pathway and BCR-ABL in CML. The gene expression patterns of 
all four human Notch genes and the Notch target gene HES1 were studied 
in CD34+ stem and progenitor cells isolated from CML patients. Poly-A PCR 
followed by real time PCR analysis was used to quantitate gene expression 
levels in comparison with levels in equivalent populations isolated from nor-
mal bone marrow (NBM). The expression of Notch1 receptor protein levels 
expressed on the cell surface was also investigated by flow cytometry. Re-
sults showed an up-regulation of Notch1 and Notch2 genes and the target 
gene Hes1 on the most primitive CD34+ Thy+ subset of CML CD34+ cells 
as compared with NBM. In addition, Notch1 receptor protein was expressed 
in distinct lymphoid and myeloid progenitors within the CD34+ population 
of CML cells. These results suggest that Notch signalling may be highly 
activated in CML primitive progenitors. To investigate the possible crosstalk 
between Notch and ABL in vitro human cell line model systems were as-
sessed as possible models to study the interactions between Notch and ABL 
signalling and the FACS based P-crkl assay was optimised as a rapid method 
to assess ABL activity. The data showed that K562 and ALL-SIL cell lines are 
sufficient model systems to investigate the cross-talk between the Notch 
and ABL signalling pathways. The imatinib induced inhibition of ABL activ-
ity in K562 and ALL-SIL cells resulted in significant up-regulation of Notch 
activity as assessed by Hes1 expression. Similarly, GSI inhibition of Notch 
signalling in K562 cells resulted in hyperactivation of ABL kinase activity as 
assessed by P-crkl levels. The antagonistic relationship between Notch and 
ABL signalling observed in cell lines were further confirmed in CD34+ cells 
from chronic CML patients. Treatment of CD34+ CML cells with imatinib 
led to significant up-regulation of Notch activity whereas inhibition of Notch 
signalling with GSI in CD34+ CML cells resulted in increased ABL activity. 
It can be concluded therefore, that Notch signalling may be dysregulated 
in the chronic phase of CML. In addition, the data presented in this project 
demonstrate for the first time the cross-talk between Notch signalling and 
ABL signalling in cell line model systems as well as in primary CD34+ CML 
cells. Future work is required to address the possible mechanisms that under-
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lie the findings observed here and to investigate the biological consequences 
of the interplay between Notch and ABL signalling in CML.
Poster Board Number: 2070
EFFECTS OF RESVERATROL ON HL-60 
LEUKEMIA AND RAJI LYMPHOMA CELLS: A 
MOLECULAR AND IMMUNOHISTOCHEMICAL 
STUDY
Ergin, Kemal1, Bozkurt, Gökay2, Aktaş, Safiye3
1Histology and Embryology, Adnan Menderes University, Aydın, Turkey, 
2Genetics, Adnan Menderes University, Aydın, Turkey, 3Basic Oncology, 9 
Eylül University, İzmir, Turkey
Introduction: Resveratrol is a polifenolic compound found in grapes, red 
wine, peanuts and huckleberries. In previous studies Resveratrol’s antioxi-
dant, anticancer, cell protective and proapoptototic characteristics were 
shown. The aim of our study was to demonstrate the microRNA profile 
and to determine the apoptosis ratio by immunohistochemical methods in 
promyelocytic leucemia HL-60 and lymphoma Raji cell lines after resveratrol 
administration. Method: Routine cell culture technics for HL60 and Raji cells 
were done: cultured, passaged, treated Resveratrol and counted vital cells. 
Then, total was RNA isolated and continued with microarray for microRNA 
profile and with IHC-Apoptag (TUNEL) for apoptosis ratio. Results: We 
determined the increases and decreases of microRNA’s after resveratrol 
administration. Besides we found a twofold higher apoptosis ratio in resvera-
trol administrated HL-60 group compared to control group. No statistical 
significance was found between control raji and resveratrol administrated raji 
groups but a tendency of increasing was found in resveratrol administrated 
group. Conclusion: Further microRNA analysis is needed in leukemia and 
lymphoma because of its therapeutic potential.
Poster Board Number: 2072
TRANSCRIPTION FACTOR BCL11A DUALITY 
IN NORMAL AND LEUKEMIC STEM CELL 
FORMATION
Ortiz, Mariaestela1, Huntly, Brian2, Keller, Jonathan3, Liu, Pentao4
1The Anne McLaren Laboratory for Regenerative Medicine, University 
of Cambridge and Wellcome Trust Sanger Institute, Cambridge, United 
Kingdom, 2Cambridge Institute for Medical Research, Wellcome Trust, 
Cambridge, United Kingdom, 3SAIC-Frederick, National Cancer Institute, 
Frederick, MD, USA, 4Wellcome Trust Sanger Institute, Cambridge, United 
Kingdom
The biological and genetic differences of normal haematopoietic stem cells 
(HSC) and leukaemia stem cells (LSC) are not well known. Likewise how a 
normal HSC converts to LSC is poorly understood. We aimed to find essen-
tial differences between HSC and LSC by studying the roles of B-cell leukae-
mia/lymphoma 11a (Bcl11a) a tumour suppressor with dual function during 
normal and abnormal haematopoiesis. Bcl11a/Evi9/CTIP1 is a transcription 
factor that is activated in patients with a rare translocation involving the IG 
locus and is found as a retroviral insertion in the BXH2 mice leukaemia. We 
demonstrated that deletion of Bcl11a in mice is lethal, it blocks early B cell 
development, causes abnormal T cell development, does not affect myeloid 
or erythroid development, and results in leukaemia when transplanted into 
lethally irradiated mice. Therefore, to identify similarities or differences 
between HSC and LSC during self-renewal, survival, differentiation, and 
proliferation we derived Bcl11a-/- LSC lines from mice transplanted with 
Bcl11a-/- foetal liver cells and by co-cultures with OP9 stromal cells. These 
LSC lines showed high expression of stem cell surface markers (c-Kit and 
Sca-1), T cell markers (CD4 and CD8), B cell markers (B220 and CD43), very 
low expression of myeloid (Gr1 and Mac-1) and erythroid markers (TER119E 
and CD71) by flow cytometry. Additionally, the Bcl11a-/- LSC showed Side 
Population by Hoechst and stem cell renewal ability by single cell assays, 
which are both characteristics of HSC. They also gave rise to myeloid and 
erythroid colonies when assayed by colony formation assays (CFU-C). To 
establish the gene expression differences between HSC and Bcl11a-/--LSC 
we performed microarray assays and we began to compile differentially 
expressed genes; we also performed comparative genome hybridization, and 
FISH to determine chromosome integrity. To determine the stem cell ability 
in vivo we transplanted very low cell numbers (50 cells) of double and single 
positive Sca-1+ and c-Kit+ sorted cells. Our preliminary results indicate 
that as little as 50-sorted Sca1+/c-Kit+ cells cause leukaemia at 6 months 
post transplantation. In addition, we determined that Notch inhibitors and 
rapamycin could inhibit the growth of Bcl11a-/--LSC. We believe that our 
studies will identify key differences and similarities between HSC and LSC, 
which are now lacking. These key findings will shed light to understand 
how normal HSC convert to LSC, which is needed to develop therapies that 
target distinctively the LSC from the HSC.
Poster Board Number: 2074
IDENTIFICATION OF T-LYMPHOCYTIC 
LEUKEMIA-INITIATING STEM CELLS RESIDING 
IN PATIENTS WITH ACUTE MYELOID LEUKEMIC 
DISEASE
Risueño, Ruth M.1, Campbell, Clinton J. V.1, Levadoux-Martin, 
Marilyne1, Xenocostas, Anargyros2, Leber, Brian3, Bhatia, Mickie1
1McMaster University, Stem Cell and Cancer Research Institute, Hamilton, 
ON, Canada, 2McMaster University, London Health Sciences Centre, 
London, ON, Canada, 3Department of Medicine, McMaster University, 
Hamilton, ON, Canada
Xenotransplantation of acute myeloid leukemia (AML) into immunodeficient 
mice has been critical for understanding leukemogenesis in vivo and defin-
ing self-renewing leukemia-initiating cell subfractions (LICs). Although AML-
engraftment capacity is considered an inherent property of LICs, substrains 
of NOD/SCID mice that possess additional deletions such as the IL2Rγcnull 
(NSG) have been described as a more sensitive recipient to assay human LIC 
function. Using 21 AML-patient samples, 43% demonstrated no detectable 
engraftment in NS and were categorized as AMLs devoid of LICs. However, 
33% of AML patients lacking AML-LICs were capable of engrafting NSG 
recipients, but produced a monoclonal T-cell proliferative disorder similar 
to T-ALL. These grafts demonstrated self-renewal capacity as measured by 
in vivo serial passage and were restricted to CD34-positive fraction, and 
were defined as LICs. Molecular analysis for translocations in MLL genes 
indicated that these AML patient-derived LICs all expressed the MLL-AFX1 
fusion product. Our results reveal that the in vivo human vs. xenograft 
host microenvironment dictates the developmental capacity of human LICs 
residing in patients diagnosed with AML harboring MLL mutations. These 
findings have implications both for the basic biology of CSC function, and 
for the use of in vivo models of the leukemogenic process in preclinical or 
diagnostic studies.
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BMP2 SENSITIZES INTRATUMORAL 
GLIOBLASTOMA HUMAN STEM CELLS TO 
TEMOZOLOMIDE BY AFFECTING HIF-1α 
STABILITY
Persano, Luca1, Pistollato, Francesca1, Rampazzo, Elena1, Della 
Puppa, Alessandro2, Abbadi, Sara1, Frasson, Chiara1, Volpin, 
Francesco1, Basso, Giuseppe1
1Dept of Paediatrics, University of Padova, Padova, Italy, 2Dept of 
Neurosurgery, University of Padova, Padova, Italy
Glioblastoma multiforme (GBM) is the most common malignant tumour 
occurring in the central nervous system (CNS), actually treated by surgical 
removal followed by radio- and Temozolomide (TMZ)-based chemotherapy. 
We recently showed that GBM tumor mass, concentrically sampled through 
image guided surgery, is characterized by a central and partially necrotic 
core, with a high HIF-1α expression, that positively correlate with tumor 
aggressiveness and cancer stem cell maintenance, and enriched in immature 
CD133+, Nestin+ and MGMT+ cells that result to be resistant to TMZ in 
vitro treatment. We and others recently reported on the role of BMPs in 
promoting astro-glial differentiation and in reducing cell growth in GBM-
derived cells, considering BMPs treatment a promising therapeutic approach 
for brain cancer. Since we demonstrated that more differentiated cells in 
the GBM mass expressed low levels of MGMT and were hence sensitive to 
TMZ treatment, our aim was to investigate whether a pro-differentiating 
treatment, based on BMP2 administration, would increase resistant hypoxic 
primary GBM derived cells sensitivity to TMZ. Here we show that TMZ alone 
was able to reduce the number of CD133+ and Nestin+ cells by promoting 
GBM cell differentiation, as shown by the increase in CD24+ and β-III-
tubulin+ cells, majorly in the peripheral areas of the tumour and confirmed 
that more undifferentiated cells (i.e. cancer stem cells) were resistant to TMZ 
treatment. Confirming our hypothesis, BMP2 was able to sensitize resistant 
hypoxic GBM cells to TMZ treatment since BMP2 and TMZ combination 
therapy induced strong apoptosis and differentiation in vitro compared to 
BMP2 or TMZ alone. As down-regulation of HIF-1α occurred following 
BMP2/TMZ treatment and considering the previously described correla-
tion existing between hypoxia and MGMT expression, we tested whether 
MGMT expression was dependent on HIF-1α expression and found that 
down-modulation of HIF-1α signalling was able to partially ablate MGMT 
expression, thus providing a possible sensitization mechanism of GBM cells 
given by BMP2 administration. In conclusion in this work we show that 
BMP2 is able to induce a strong differentiation program in GBM derived 
stem cells, inhibit HIF-1α signalling and suppress MGMT expression, thus 
sensitizing more resistant GBM derived cancer stem cells to TMZ treatment.
Poster Board Number: 2078
ONCOGENIC VARIANT EGFRVIII DEFINES 
A CANCER STEM CELL POPULATION IN 
GLIOBLASTOMA MULTIFORME
Del Vecchio, Catherine A., Mitra, Siddhartha S., Emlet, David R., 
Han, Shuang-Yin, Gupta, Puja, Yan, Zhang, Söderström, Kalle, 
Holgado-Madruga, Marina, Skirboll, Stephen S., Wong, Albert J.
Stanford University, Stanford, CA, USA
Glioblastoma multiforme (GBM) is the most common and deadly primary 
brain tumor. Median survival is only 14 months, with tumor recurrence in 
>90% of cases. Research suggests cancer stem cell (CSC) or tumor initiat-
ing populations exist in GBM that mediate tumor initiation, local invasion, 
and recurrence. Putative CSCs have been identified via cell surface markers 
CD133 and CD15, but targeting is complicated by their expression in normal 
non-cancerous tissue. Here we report evidence that a naturally occurring 
tumor-specific variant of the epidermal growth factor receptor (EGFR), called 
EGFRvIII, is a novel CSC marker in GBM. EGFRvIII is an exon2-7 deletion 
mutant lacking part of the extracellular ligand binding domain, rendering 
it ligand independent and constitutively active. Found in 15-60% of GBM, 
EGFRvIII can be the result of either a genomic rearrangement or alternative 
splicing, and the rearrangement is often associated with amplification of 
the EGFR locus. We found EGFRvIII expressed in 40% of GBM by immu-
nohistochemistry (IHC). Expression was highly correlated with EGFR locus 
amplification, assessed by fluorescence in situ hybridization (FISH), and the 
EGFRvIII genomic rearrangement, determined by long-range PCR. Interest-
ingly, EGFRvIII expression is sporadic and restricted to sub-regions within 
the tumor, often displaying perivascular clustering. To better understand the 
contribution of this minority population to tumorigenesis and CSC pheno-
types, we performed flow cytometry analysis and sorting. Flow cytometry 
revealed a higher percentage of EGFRvIII positive tumors (71%), with 
1-25% of the cells being positive in each case. Because EGFRvIII expression 
can be sporadic, IHC may present a sampling bias that has lead to an overall 
underestimation of the prevalence of EGFRvIII. To understand the func-
tional relevance of EGFRvIII, we sought to devise a method of maintaining 
EGFRvIII expression in vitro. EGFRvIII gene and protein expression is lost 
when cells are grown under standard serum-culture techniques, but can 
be maintained when primary GBM are cultured as neurospheres. Impor-
tantly, EGFRvIII expression in spheres can be maintained for greater than 10 
passages, and EGFRvIII is lost when spheres are exposed to differentiating 
conditions. Furthermore, EGFRvIII is frequently expressed in the putative 
CSC CD133+ population of GBM. Flow cytometry demonstrates EGFRvIII 
expression in 81% (13/16) of primary GBMs expressing CD133, and there is 
a significant enrichment for cells expressing both proteins. Notably, cells that 
express both EGFRvIII and CD133 display greater self-renewal, as shown 
through limiting dilution sphere forming assays, and increased tumorigenic-
ity when compared to either the single positive or double negative popula-
tions. Tumor formation was observed in 80% (15/18) of mice injected in-
tracranially with 1000 EGFRvIII+/CD133+ cells, as compared to 25% (5/18) 
and 33% (4/12) of mice injected with EGFRvIII-CD133+ or EGFRvIII+/
CD133- populations, and as many as 100,000 EGFRvIII-CD133- cells could 
not form tumors. Finally, we created a bispecific antibody that targets cells 
expressing both EGFRvIII and CD133 and found that antibody-mediated 
cell killing of this population leads to a significant decrease in the sphere and 
tumor forming capacity of GBM sphere lines. Together our data suggests 
that EGFRvIII is expressed in the CSC population of GBM, and targeting of 
this receptor represents an excellent therapeutic strategy.
Poster Board Number: 2080
MIR-338-3P MEDIATES NOTCH-REGULATED 
SELF-RENEWAL IN GLIOBLASTOMA STEM 
CELLS
Hervey-J umper, Shawn1, He, Xiaobing1, Zhu, Thant1, Piccirillo, 
Sara2, Watts, Colin2, Vescovi, Angelo3, Heth, Jason1, Muraszko, 
Karin1, Fan, Xing1
1Neurosurgery, University of Michigan, Ann Arbor, MI, USA, 2Clinical 
Neurosciences, University of Cambridge, Cambridge, United Kingdom, 
3Biotechnology and Biosciences, University of Milan Bicocca, Milan, Italy
Glioblastoma (GBM) is the most common malignant brain tumor in human 
with extremely poor prognosis and new treatment for this deadly disease 
is desperately needed. Cancer stem cells (CSCs) have been prospectively 
isolated from many types of cancer, including GBM. Finding genes or signal 
pathways that regulate GBM CSCs may help develop novel therapeutic 
strategy. We have demonstrated recently that Notch pathway blockade by 
gamma-secretase inhibitor (GSI) depletes GBM CSCs and prevents tumor 
propagation both in vitro and in vivo. In the current study, we found that 
miR-338 was down-regulated by GSI treatment in GBM CSCs. When we 
introduced miR-338-3p into GBM neurospheres by lentivirus, we found that 
miR338 decreases clonogenesis of GBM neurospheres and nestin-positive 
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population, indicating that CSC population was reduced. Furthermore, we 
found miR-338 reduces GBM neurosphere growth through decreased prolif-
eration and induced apoptosis. In addition, we found that over-expression of 
miR-338-3p is associated with better survival in GBM patients. Interestingly, 
miR-338-3p was expressed at a lower level in the core of tumor whereas 
at a higher level in the peripheral region. miR-338-3p also prevents GBM 
neurosphere migration by Boden chamber assay. Furthermore, we found 
that miR-338-3p reduces HDAC expression at protein level. Finally, we 
found that miR-338-3p has no growth-inhibition effect on normal human 
neural stem cells, suggesting that miR-338-3p may spare normal stem cells 
when it was used to target GBM CSCs. Taken together, our data suggest 
that miR-338-3p medicates Notch-regulated GBM CSC self-renewal and 
migration through HDAC protein, indicating that miR-338-3p can be used 
to target CSCs in GBM.
Poster Board Number: 2082
HYPOXIA AND WNT PATHWAY CO-OPERATION 
PROMOTES PRIMARY GLIOBLASTOMA 
DERIVED STEM CELLS REPROGRAMMING 
TOWARD NEURONAL FATE
Rampazzo, Elena1, Persano, Luca1, Tiso, Natascia2, Moro, Enrico2, 
Argenton, Francesco2, Basso, Giuseppe1, Della Puppa, Alessandro3
1Pediatric, University of Padova, Padova, Italy, 2University of Padova, 
Padova, Italy, 3Neurosurgery, University of Padova, Padova, Italy
The definition of tumour niche signals involved in brain tumours stem cell 
maintenance is crucial to understand the processes of glioblastoma onset, 
progression and relapse. In this study we treated primary glioblastoma 
(GBM) derived cells, constantly maintained in a hypoxic microenvironment, 
with exogenous Wnt3a molecules and we evaluated the phenotypic repro-
gramming effects of Wnt pathway activation in the undifferentiated GBM 
cells both in our hypoxic in vitro conditions and in cells acutely exposed 
to environmental 20% O2. We found that exogenous Wnt3a promotes 
phenotypic reprogramming of GBM derived cells toward a neuronal fate. 
Indeed, we found an increase in β-III tubulin positive cells after Wnt3a treat-
ment with a parallel decrease of Nestin and GFAP positive cells. Moreover, 
we found that hypoxia enhances the activation of the pro-neurogenic Wnt 
pathway target genes and that Wnt3a promotes neuronal differentiation 
majorly in GBM stem cells (CD133+) under hypoxic conditions. The mecha-
nism that regulates GBM stem cells differentiation involves a Wnt-mediated 
suppression of Notch pathway activity. Moreover, Notch1 suppression under 
hypoxia significantly contributes to GBM stem cells neuronal differentia-
tion and cell cycle block. In this study we point to Wnt signalling activation 
as a new potential molecular strategy to be used, possibly in combination 
therapy, in order to promote GBM differentiation, tumour cell growth inhibi-
tion and eventually cancer cell death.
Poster Board Number: 2084
DECREASE OF NEUTROPHIL INFILTRATIONS 
AND NECROSIS FOLLOWING SUBCUTANEOUS 
XENOGRAFTING OF CANCER STEM-LIKE 
CELLS DERIVED BY SPHEROID CULTURE FROM 
U87MG GLIOBLASTOMA CELL LINE
Su, I-Chang1, Kuo, Ying-Ju2, Tu, Yong-Kwang3, Ling, Qing-Dong4
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National Taiwan University Hospital, Taipei, Taiwan, 4Cathay Medical 
Research Institute, Taipei Cathay General Hospital, Taipei, Taiwan
Recent neuro-oncological studies revealed that a small subset of cells derived 
from glioblastoma(GBM), has specific characteristics of cancer stem-like cells 
such as cancer re-initiation and chemo-resistance. Several literatures showed 
that GBM cells were capable of forming tumor neurospheres in vitro in 
serum-free neuronal stem cell media. Compared to GBM cells cultured in 
serum-contained media, cancer cells not only expressed stemness markers, 
such as CD133, site-specific embryogenic antigen-1 (SSEA-1), or Nanog 
within neurospheres, but also possessed higher tumor re-initiation capabili-
ties as demonstrated by nude mice xenotransplantation. The detailed histo-
pathological observations in the xenografts, however, haven’t been fully ad-
dressed. In our study, we generated neurospheres from U87MG, which was 
a representative cell line of GBM, by using the methods of neurospheroid 
culture in serum-free media containing epidermal growth factor (EGF) and 
basic fibroblast growth factor (FGF). Both cells from serum-contained cul-
tures and serum-free neurospheres were then injected into nude mice flanks 
for subcutaneous xenografting. The histopathological observations were 
processed for comparison of different origins. There were marked differences 
in the xenografts derived by both different culture cells. Tumors derived by 
the xenografting of the serum-contained cultured cells demonstrated bigger 
size and higher growth rate compared to the xenografting of the cells from 
the neurospheres. Pathologically, extensive necrosis and neutrophil infiltra-
tions were obvious. Tumors derived by serum-free neurospheres grew slowly 
in size, but they were infiltrated by little number of neutrophils with nearly 
absence of necrosis. In both xenografts, CD133 and SSEA-1 were positively 
stained in neutrophils but not among tumor cells. In summary, our results 
indicate the histopathological differences between the subcutaneous tumors 
derived from cancer cells and cancer stem-like cells of GBM neurospheres. 
The tumors of the cell xenograftings from neurospheres show dramatically 
more tolerable to hypoxia, which in turn resulted in less inflammatory cell 
infiltration and necrosis. In addition, the utility of CD133 and SSEA-1 as 
surface markers for deriving cancer stem cells by sorting from tumors should 
be carefully identified since neutrophils also express both markers.
Poster Board Number: 2086
TGFβ REGULATES HUMAN BREAST TUMOUR 
INITIATING CELL NUMBERS VIA NEDD9-
MEDIATED SMAD AND SRF COORDINATED 
REGULATION OF GENE EXPRESSION
Bruna, Alejandra1, Greenwood, Wendy1, Teschendorff, Andrew2, 
Miranda-Saavedra, Diego3, Stingl, John1, Caldas, Carlos1
1Cambridge Research Institute, Cambridge, United Kingdom, 2UCL Cancer 
Institute, University College London, London, United Kingdom, 3WPI 
Immunology Frontier Research Center (IFReC),Osaka University, Osaka, 
Japan
Human breast tumours contain a subset of cells responsible for tumour 
propagation and metastasis known as breast tumour-initiating cells (BTICs). 
We show here that TGFβ increases or decreases BTIC number in a cell-con-
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text dependent manner. In normal mammary epithelium TGFβ has similar 
contrasting effects in distinct epithelial cell subpopulations. A TGFβ synex-
pression signature (TβSC-A), derived from cell lines with TGFβ-induced BTIC 
activity, is significantly enriched in gene sets derived from stem cells. This 
signature is predictive of worse clinical outcome in breast cancer patients. 
NEDD9, a top gene in TβSC-A, mediates the TGFβ-induced BTIC activity. 
NEDD9, through a positive feedback loop, links TGFβ/Smads and Rho-actin-
SRF signals to converge at regulatory regions to regulate TβSC-A genes and 
increase BTIC number. We propose that combined targeting of Rho-actin-
SRF and TGFβ pathways could represent a new strategy to eliminate BTICs.
Poster Board Number: 2088
NEUROPILIN-1 IS ESSENTIAL FOR 
MAMMOSPHERE FORMATION BY HUMAN 
BREAST CANCER STEM CELLS
Prud’homme, Gerald J., Glinka, Yelena, Mohammed, Nada
Laboratory Medicine, St. Michael’s Hospital and University of Toronto, 
Toronto, ON, Canada
Neuropilin-1 (Nrp1) is a multifunctional transmembrane protein, which acts 
as a coreceptor for several mediators including VEGF, class 3 semaphorins, 
TGF-beta, hepatocyte growth factor (HGF) and platelet-derived growth fac-
tor. TGF-beta acts on breast cancer stem cells and promotes mammosphere 
formation. We have recently shown that Nrp1 can capture and activate 
latent TGF-beta-1 (LAP-TGF-beta-1) on the membrane of cancer cells, and 
acts as a coreceptor for TGF-beta by augmenting canonical Smad2/3 signal-
ing. Since Nrp1 acts as a coreceptor for several growth factors potentially 
relevant to cancer stem cells (CSCs), including TGF-beta, we hypothesized 
that it plays an important role in CSC biology. We examined Nrp1 in breast 
cancer cells lines by flow cytometry, and found that it was frequently co-
expressed with other stem cells markers. We observed that an aryl hydro-
carbon receptor agonist drug, tranilast, which inhibited breast CSCs also 
markedly suppressed Nrp1 expression. To examine the role of Nrp1 more 
specifically, we performed Nrp1 knockdown with siRNA. Knockdown se-
verely interfered with mammosphere formation, such that there were much 
fewer spheres and they were small. Cell survival was moderately decreased 
by knockdown. Several mechanisms might account for these findings, and 
we are currently examining how Nrp1 alters the response of CSCs to growth 
factors. Because CSCs exhibit enhanced NF-kB signalling, we examined this 
pathway. Without knockdown of Nrp1 this pathway was indeed activated, 
but in cells with knockdown NF-kB signaling was not detectable above 
background. We conclude that Nrp1 is expressed by breast CSCs, enhances 
NF-kB signaling and is essential for mammosphere formation.
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GENERATION AND MOLECULAR PROFILING 
OF BREAST EPITHELIAL CELLS WITH CANCER 
STEM CELL PROPERTIES
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Stem cell hypothesis of cancer predicts that most of the cancers originate 
in normal stem/progenitor cells. However, the molecular mechanisms that 
govern the tumorigenic conversion of these cells remain elusive due to lack 
of suitable model system. In this study, we have generated an immortalized 
mammosphere-derived breast epithelial cell line (NBLE) which retains stem 
cell properties. We observed that the CD44+/CD24- fraction of NBLE cells 
show deregulated Notch, Wnt and Hedgehog pathways, exhibit Epithelial-
Mesenchymal Transition (EMT), over-express stemness related genes and 
generate adenocarcinomas in immunocompromised mice and thus resemble 
breast cancer stem cells. These cells harbor chromosomal aberrations such 
as X-chromosome deletion and gain of chromosomes 8, 20 and 22 which 
is commonly observed in naturally occurring breast cancers. Molecular 
profiling showed that the tumorigenic NBLE cells exhibit gene expression 
profile similar to CD44+/CD24- fraction from primary breast cancer samples. 
Further, microRNA profiling showed significant down-regulation of miRNAs 
such as miR200a/b/c, miR205, miR141 and miR421. Down regulation of 
these miRNAs has been previously shown to result in induction of EMT and 
increased levels of stem cell markers such as Bmi1. The transformed NBLE 
cells showed activated DNA damage response which has been shown to 
convert normal human mammary epithelial cells into tumorigenic cells. Thus, 
deregulated self-renewal pathways, induction of EMT, triggering of DNA 
damage response and karyotypic alterations are the likely contributors for 
the transformation of these mammosphere-derived NBLE cells. Thus, the 
NBLE cells provide a novel experimental system to understand the molecular 
changes associated with the transformation of mammary stem/progenitor 
cells and can be used for screening drugs targeted against breast cancer 
stem cells.
Poster Board Number: 2092
PODOCALYXIN IS A KEY REGULATOR OF 
BREAST CANCER PROGRESSION AND 
METASTASIS
Snyder, Kim A.1, Hughes, Michael R.1, Turvey, Michelle2, Graves, 
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1Biomedical Research Centre, University of British Columbia, Vancouver, 
BC, Canada, 2School of Molecular & Biomedical Science, University of 
Adelaide, Adelaide, Australia, 3Department of Cellular and Physiological 
Sciences, University of British Columbia, Vancouver, BC, Canada
Recently, we found that podocalyxin (Podxl), a CD34-sialomucin nor-
mally expressed on hematopoietic progenitors and vascular endothelia, 
is upregulated on a subset of primary breast tumors associated with poor 
clinical outcome. To determine whether podocalyxin directly regulates breast 
cancer cell behavior, we ectopically expressed podcalyxin in the human 
breast cancer cell line, MCF7. MCF7 cells express low levels of podocalyxin 
and make well-polarized epithelial monolayers in vitro, relatively normal 
mammospheres in 3D culture, and, are non-metastatic. Upon ectopic ex-
pression of podocalyxin, MCF7 “bulge apically”, produce apical and lateral 
microvilli, are less adhesive in vitro, and are delayed in targeting integrins 
to the basolateral surface. In addition, podocalyxin enhances solid tumor 
expansion in MCF7 subcutaneous xenografts (RAG2-/- mice). In contrast 
to MCF7, MDA.231 cells express high levels of endogenous podocalyxin, 
exhibit poorly polarized monolayer and mammosphere architecture in vitro 
and form “metastatic” lung tumors in vivo. Using Podxl-targeted shRNA 
vectors, we show that expression of podocalyxin is required for MDA.231 
motility in vitro and in vivo. The impaired motility phenotype of Podxl-de-
ficient MDA.231 cells was as robust as Cxcr4- and Ccr7-deficient MDA.231 
lines. Both CXCR4 and CCR7 have key roles in the motility of breast cancer 
cells and we have previously found that podocalyxin enhances CXCR4-me-
diated chemotaxis in hematopoietic cells. Thus, up-regulation of podocalyxin 
may be a key event in tumor progression and likely endows cells with an 
enhanced ability to sense chemokines and metastasize to peripheral sites.
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INVOLVEMENT OF THE NERVE GROWTH 
FACTOR ON THE BALANCE BETWEEN 
PROLIFERATION AND QUIESCENCE IN BREAST 
CANCER STEM CELLS
Tomellini, Elisa1, Touil, Yasmine2, Polakowska, Renata2, Le Bourhis, 
Xuefen1
1Villeneuve d’Ascq, INSERM U908, University of Lille, France, 2IRCL, 
INSERM U837, University of Lille, France
Despite advances in early detection of cancers, disease relapse still occurs 
in a not insignificant percentage (20-30 %) of patients with early stage of 
breast cancer. This may be explained by the cancer stem cell hypothesis, 
which postulates that tumors are hierarchically organized and originated 
from a small subpopulation of cells, the so called ‘cancer stem cells’ (CSCs). 
These undifferentiated and mainly quiescent cells are posited to drive 
tumorigenesis through long term self renewal and the ability to differenti-
ate into the tumor bulk population, contributing to tumor maintenance, 
metastasis, relapse and drug resistance. Nerve Growth Factor (NGF), the 
first discovered neurotrophic factor, has been shown to be synthesized 
and released by breast cancer cells, on which it acts as a potent activator 
of both the survival and proliferation. NGF exerts its effects through two 
membrane receptors: p75NTR, that belongs to the tumor necrosis factor 
(TNF)-receptor family and that it’s the common receptor of all neurotro-
phines and pro-neurotrophines, and the tyrosine kinase receptor TrkA. Given 
the role of NGF in breast cancer development, the project aims to assess 
the potential involvement of NGF on breast CSCs biology, and to determine 
the underlying molecular mechanism. The study has been performed on the 
luminal MCF-7 and the basal-like MDA-MB-231 breast cancer cell lines. Cell 
culture in non-adherent conditions showed that both cell lines are able to 
form spheres for several generations. NGF does not modify the percentage 
of sphere forming units, which reflects indirectly the number of stem cells in 
the original culture. In contrast, NGF increased about 50% of mammosphere 
size upon 2 weeks of culturing. The increased sphere size resulted from 
enhanced proliferation of cells within spheres. 
To further understand how NGF exerts this proliferative effect we first 
established MCF-7 and MDA-MB-231 cell lines overexpressing the recep-
tors p75NTR or TrkA. We observed that the p75NTR overexpression per 
se increased the percentage of ALDEFLUOR positive population, although 
the involvement in NGF-mediated proliferation remains to be described. 
p75NTR is already considered as a marker for progenitor cells in melanoma, 
in esophageal and corneal epithelial cells, and this result suggests the 
involvement of the receptor in the activation of the breast cancer stem cells 
compartment. On the other hand, although TrkA overexpression per se did 
not seem to influence mammosphere formation, NGF strongly increased the 
number of sphere forming units in TrkA overexpressing cells. We conclude 
that NGF through its receptors seems to regulate the stem cell compartment 
either by the activation of quiescent cells or by increasing the size of the 
CSC compartment.
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INVOLVEMENT OF OCT-4 IN HUMAN 
EPITHELIAL TUMORS
Lim, Bobae, Kim, Sol, Kim, Jungho
Department of Life Science, Sogang University, Seoul, Korea, Republic of
Characterization of EWS-Oct-4 translocation fusion product in bone and 
soft-tissue tumors revealed a chimeric gene resulting from an in-frame fu-
sion between EWS exons one to six and Oct-4 exons one to four. Recently, 
an alternative form of the fusion protein between the EWS and Oct-4 
genes, named as EWS-Oct-4B, was reported in two types of epithelial 
tumors, a hidradenoma of the skin and a mucoepidermoid carcinoma of the 
salivary glands. As the N-terminal and POU domains of the EWS-Oct-4 and 
EWS-Oct-4B proteins are not structurally identical we decided to investigate 
the functional consequences of the EWS-Oct-4B fusion. We found that this 
new chimeric gene encodes a nuclear protein that binds DNA with the same 
sequence specificity as the parental Oct-4 protein, or the fusion EWS-Oct-4 
protein. We show that the nuclear localization signal of EWS-Oct-4B is 
dependent on the POU DNA binding domain, and we identified a cluster of 
basic amino acids, 269RKRKR273, in the POU domain that specifically medi-
ates the nuclear localization of EWS-Oct-4B. Comparison of the transactiva-
tion properties of EWS-Oct-4B and EWS-Oct-4 indicated that EWS-Oct-4B 
is a less potent transcriptional activator of a reporter construct carrying Oct-
4 binding sites. Deletion analysis of the functional domains of EWS-Oct-4B 
revealed that the EWS N-terminal domain (NTD)B, POU, and C-terminal 
domain (CTD) are necessary for its full transactivation potential. Despite its 
reduced activity as a transcriptional activator, EWS-Oct-4B regulated the 
expression of fgf-4 (fibroblast growth factor-4) and nanog, which are potent 
mitogens, as well as Oct-4 downstream target genes whose promoters con-
tain potential Oct-4 binding sites. Finally, ectopic expression of EWS-Oct-
4B in Oct-4-null ZHBTc4 ES cells resulted in increased tumorigenic growth 
potential in nude mice. These results suggest that the oncogenic effect of 
the t(6;22) translocation is due to the EWS-Oct-4B chimeric protein and 
that alternative fusion of the EWS amino terminal domain to the Oct-4 DNA 
binding domain produces another transforming chimeric product in human 
epithelial tumors.
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MIMG, HHMI, Broad Stem Cell Research Center, University of California, 
Los Angeles, Los Angeles, CA, USA, 5Obstetrics and Gynecology, Broad 
Stem Cell Research Center, University of California, Los Angeles, Los 
Angeles, CA, USA
Endometrial carcinoma, the most common gynecologic cancer in the U.S., 
is a hormonally sensitive tumor arising from the endometrial epithelia lining 
the uterine cavity. Despite an increase in both incidence and mortality in 
recent years, there is a dearth of meaningful basic and translational research 
looking at the pathogenesis of this disease. The cell of origin for endometrial 
carcinoma is unknown. We hypothesize that adult uterine epithelial stem 
cells may be the most efficient target for initiation of this tumor. Epithelial 
stem cells must exist in the endometrial lining. During reproductive years, 
the uterine lining sheds and re-grows on a monthly basis. With menopause 
the endometrium undergoes atrophy but retains the capacity to proliferate 
with the administration of estrogen hormone replacement therapy. These 
clinical observations suggest that uterine epithelial stem cells may be resilient 
to hormonal deprivation. The identity, location and characteristics of endo-
metrial epithelial stem cells remain unknown. To identify these stem cells 
we have recently established in vitro and in vivo assays to measure growth 
and self-renewal capacity of isolated and dissociated uterine epithelial cells 
(UtE). Murine UtE single cells, isolated by FACS, grew as hollow spheres in 
a 3-dimensional matrix. The histology and marker expression profile of UtE 
spheres were similar to native endometrial epithelial glands. The number of 
spheres generated was linear with respect to input cells suggesting clonal 
growth. Clonality was further supported when only single color spheres 
were obtained from mixtures of GFP- and DsRed-labeled UtE cells. UtE 
spheres had the capacity to self-renew demonstrated by serial passaging 
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of dissociated sphere cells. FACS sorted single UtE could also regenerate in 
vivo in combination with inductive stroma in the sub-renal capsule space 
and gave rise to functional endometrial-like glands. Titration experiments 
revealed that approximately 1 in 1000 UtE cells were capable of gland for-
mation in vivo. Withdrawal of hormones from uterine epithelium, achieved 
surgically by ovariectomy, increased in vitro and in vivo regenerative activity 
5-fold and 10-fold respectively. We demonstrate that uterine epithelial 
stem cells exist and are resilient to hormonal deprivation. Endometrial 
carcinoma is a disease commonly diagnosed in post menopausal women. 
Biologic hormonal deprivation with the onset of menopause may enrich for 
uterine epithelial stem cells, a potential target for cancer initiation. In future 
experiments, the cancer initiating capacity of uterine epithelium enriched for 
stem cells will be assessed using our in vivo regeneration system, previously 
shown to be an efficient model for studying endometrial cancer.
Poster Board Number: 2100
CISPLATIN INDUCED DNA DAMAGE 
INCREASES THE STEM LIKE CANCER CELLS IN 
HUMAN NON SMALL CELL LUNG CANCER
Liu, Yu-Peng1, Lu, Pei-Jung2, Hsiao, Michael1
1Genomics Research Center, Academia Sinica, Taipei City, Taiwan, 2Institute 
of Clinical Medicine, National Cheng Kung University, Tainan City, Taiwan
Cancer stem cell hypothesis suggests that the side population of cancer cells 
exhibits stemness and drug resistant properties and mediates tumor initiation 
and tumor recurrence. Although the origin of cancer stem cells remains in 
debate, accumulating evidences demonstrates that the stem-like cancer 
cells can be induced by several cell stress, including inflammation, hypoxia, 
and DNA damage. Cisplatin, an anti-cancer drug used as first-line chemo-
therapy, induces apoptosis by causing DNA damage in lung cancer cells. 
However, cisplatin is not effective in non-small cell lung cancers (NSCLCs) 
because of the low response rate and high recurrence rate, although the 
mechanism is not clear. Thus, we hypothesize that cisplatin-induced DNA 
damage may induce stem-like cancer cells in NSCLC and increase the risks of 
drug resistance and tumor relapses. CD133 is discussed as a putative marker 
for cancer stem/tumor-initiating cell populations in epithelial tumors. So 
far, isolation of CD133+ side population from cancer cells depends on the 
antibody-based sorting techniques, which may not avoid of the non-specific 
binding effect. By transducing the human NSCLC cell lines, H460 and 
A549, with lentivirus carrying CD133 promoter-driven GFP reporter gene, 
1.8% and 13.3% of GFP+ cells were distinguishable from H460 and A549 
cell lines respectively. Comparing with GFP- cells, the GFP+ cells expressed 
higher protein and mRNA levels of CD133, also referred as CD133+ cells. 
These CD133+ cells were able to expand and to growth as tumor sphere 
in serum-free culture condition, suggesting the self-renewal capacity. In 
addition, the CD133+ cells also expressed the stemness genes, including 
Oct4, Nanog, and Sox2. The higher tumorigenic and metastatic potentials 
of the CD133+ cells were demonstrated by their greater soft agar-colony 
forming and migration ability. To test the effect of cisplatin on induction of 
stem-like cancer cells, H460, A549, and H1299 lung cancer cell lines were 
treated with 10 μM of cisplatin for 24h, which was sufficient to induce DNA 
damage. We found that treatment of cisplatin resulted in the increase of 
CD133+ cells from 1.8% to 49.5%, 13.3% to 32.8%, and 6.4% to 31.8% 
in H460, A549, and H1299 cell lines respectively. This increase of CD133+ 
cells did not due to the selection of the exiting CD133+ in the cultures, 
because the limited cell death was observed after treatment. Our ongoing 
study is focusing on the regulatory mechanisms that mediate the induc-
tion of stem-like cancer cells by cisplatin. Together, our study suggests that 
cisplatin is able to induce stem-like cancer cells in lung cancer, which may 
increase the risks of cross-drug resistance and tumor recurrence. The new 
compounds specifically targeting stem-like cancer cells are necessary to be 
included in the chemotherapy protocol for lung cancer.
Poster Board Number: 2102
MIR-145 ATTENUATION PROMOTES SELF-
RENEWALING AND METASTATIC PROPERTY IN 
LUNG ADENOCARCINOMA
Chiou, Shih-Hwa
Dept of Medical Research & Education, Taipei Veterans General Hospital, 
Taipei, Taiwan
MiR145, a tumor suppressive micro RNA, has been reported being involved 
in tumor growth and metastasis in several types of cancer, as well as regulat-
ing stemness genes in embryonic stem cells. However, the roles of miR145 
in self-renewal and tumor-initiation of malignant lung adenocarcinoma 
(LAC) are still undetermined. In the current report, we showed that low level 
of miR145, accompanied with high level of Oct4 and Sox2, was found in 
metastatic and recurrent LAC patient specimens. We further demonstrated 
Oct4 and Sox2 as direct targets of miR145 in LAC. Forced overexpression 
of miR145 or silencing of Oct4/Sox2 in LAC-derived lung CD133+ cells 
decreased their stemness properties, repressed epithelial-mesenchymal 
transdifferentiation (EMT) through inhibiting mesenchymal-favored and 
enhancing epithelial-favored markers, and reduced primary cancer stem cell 
(CSC) population and in vivo tumor-initiating ability. Our results suggested 
miR145 as a potential switch regulating lung CSC-like properties, in which it 
negatively regulated EMT, a fundamental measurement of CSC characteris-
tic, through inhibiting Oct4/Sox2/Fascin1. Targeting miR145 in LAC should 
be warranted in treating metastatic or recurrent LAC in the future.
Poster Board Number: 2104
IDENTIFICATION OF TUMORIGENIC 
CELLS IN KRASG12D INDUCED LUNG 
ADENOCARCINOMA
Cho, Huan-Chieh1, Yu, John2
1Academia Sinica, Taipei, Taiwan, 2Genomics Research Center, Academia 
Sinica, Taipei, Taiwan
Lung adenocarcinomas are one of the most lethal human malignancies that 
arise from the bronchiolar and alveolar epithelia. To investigate the cellular 
origin of this cancer, we report a novel strategy using FACS fractionation 
that could highly enrich bronchiolar ciliated, Clara, and alveolar type II cells 
in respective cell fractions to help dissect this unresolved issue. It was shown 
that bronchiolar Clara and alveolar type II cells were susceptible to oncogen-
ic KrasG12D-induced transformation, whereas bronchiolar ciliated cells were 
not. EpCAM+MHCII- cells, which represent a bronchiolar origin, were more 
enriched in tumorigenic cells than EpCAM+MHCII+ cells, which represent an 
alveolar origin. In addition, secondary tumors derived from EpCAM+MHCII- 
cells showed phenotypic diversity of tumor locations and capable differentia-
tion of an alveolar lineage compared to those derived from EpCAM+MHCII+ 
cells. High ERK1/2 activation and in vitro colony-forming ability were ob-
served in EpCAM+MHCII- cells, in contrast to EpCAM+MHCII+ cells which 
had greater Sprouty-2 expression. These results suggest that bronchiolar 
Clara cells are the origin of cells and tumorigenesis for lung neoplasia after 
KrasG12D activation.
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Poster Board Number: 2106
A NOVEL PROTEIN IN HUMAN BRAIN TUMOR 
SUPPORTS HUMAN NEURAL STEM CELL 
MIGRATION THROUGH PI3-KINASE PATHWAY
Jeon, Jeong Yong1, Cho, Kyung Gi1, Jo, Soo Young2, Lee, Young 
Sik2, Lee, Myung Ae1
1School of Medicine, Institute for Medical Sciences, Ajou University, 
Suwon, Korea, Republic of, 2Division of Molecular Life Science, Hanyang 
University, Ansan, Korea, Republic of
Many in vivo studies demonstrated a migration tendency of neural stem cell 
toward glioma. Stem cells from various lineages have become attractive ve-
hicles to improve therapeutic gene delivery to brain tumors. However, little is 
known about the chemoattractive molecules to neural stem cells. To identify 
genes related to the tropism of human neural stem cells (NSCs) toward brain 
glioma, we compared the gene expression profile of human brain tumor 
with human normal brain tissues using micorarray analysis. Microarray 
analysis revealed that 150 secreted genes are up- or down-regulated in hu-
man brain tumor tissues, which were known to participate in tumor growth, 
inflammation, cell motility and apoptosis. The most differentially expressed 
secreted gene in this analysis is chemoattractant molecule 1 (CM1). Real-
time PCR and immunocytochemical analysis detected CM1 gene expression 
in the brain tumor sample with a range of 3- to 7-fold elevation over normal 
brain. Then, in vitro migration assay with Boyden chamber assay showed 
that CM1 (~2-fold) attracted human NSCs more powerful than VEGF 
(1.25-fold), known chemoattract, do. While inhibition of ERK, Well known 
downstream signaling pathway, by PD98059 block CM1-meidated NSC 
migration by 25%, that of doublecortin (DCX) pathway, neural stem cell mi-
gration pathway, with roscovitin inhibited by half. These results demonstrate 
that CM1 participates in NSCs tropism toward brain tumor through ERK and 
DCX pathway.
Poster Board Number: 2108
HUMAN NEURAL STEM CELL-NANOPARTICLE 
HYBRIDS FOR TARGETED DELIVERY OF 
DIAGNOSTIC AND THERAPEUTIC COMPOUNDS 
TO INTRACRANIAL GLIOMA
Mooney, Rachael G., Tirughana, Revathiswari, Valenzuela, Valerie, 
Aboody, Karen S.
Neurosciences, City of Hope, Duarte, CA, USA
Brain tumors are difficult to treat because of our inability to accurately detect 
and selectively eliminate cancer cells. Despite the identification of effective 
diagnostic and tumor-toxic compounds, carriers are needed that selectively 
target these compounds to tumors so that healthy tissue remains undam-
aged. Neural stem cells (NSCs) exhibit tumor tropism and can provide the 
required tumor-specificity. Here we show that nanoparticles containing 
either small molecule chemotherapeutics or magnetic resonance imaging 
agents can be coupled to NSCs via a stable avidin-biotin linkage without 
impairing NSC tumor tropism. Using established methods, HB1.F3 NSCs 
were biotinylated by modifying cell-surface sialic acid residues. NSC viability 
was not affected by this process (p>0.05). Fluorescence activated cell sort-
ing (FACS) results demonstrate biotinylation efficiencies of 85±9% when 
cells are labeled with FITC-conjugated avidin. Chromogenic and fluorescent 
immunostaining results confirm efficient NSC biotinylation. Biotinylated 
cells were incubated with streptavidin-conjugated nanoparticles (diam-
eter=300 nm) which resulted in the stable addition of an average of 15 ± 8 
nanoparticles/cell. A lower level of nanoparticle adsorption to unmodified 
control NSCs was also observed (2±1 nanoparticles/cell). NSC-nanoparticle 
hybrids maintained unimpaired in vitro tropism towards tumor conditioned 
media (p>0.05) as assessed using boyden-chamber chemotaxis assays. In 
vivo studies also demonstrate that human-nestin positive NSC-nanoparticle 
hybrids that were injected intravenously into mice with firefly luciferace-
expressing intracranial GL261 glioma are able to cross the blood brain barrier 
and target brain tumors. Diagnostic and therapeutic efficacy studies for 
NSC-nanoparticle hybrids are underway. This research establishes proof-
of-principle evidence that NSC-nanoparticle hybrids can deliver diagnostic 
and therapeutic payloads to tumors. This approach has great potential to 
improve the detection specificity of any diagnostic agent and the therapeutic 
index of any chemotherapeutic drug.
Poster Board Number: 2110
REPROGRAMMING MOUSE BRAIN TUMOUR 
STEM CELLS WITH DEFINED FACTORS
DiLabio, Julia1, Ward, Ryan J.1, Lee, Lilian1, Clarke, Ian D.1, Pollard, 
Steven M.2, Ellis, James1, Dirks, Peter B.1
1Hospital for Sick Children, University of Toronto, Toronto, ON, Canada, 
2University College London Cancer Institute, London, United Kingdom
The ability to reprogram somatic cells to generate induced pluripotent stem 
(iPS) cells has provided a tool for studying the epigenetic state of cells. This 
may be particularly interesting in the study of cancer, which results from a 
combination of genetic and epigenetic aberrations. Glioblastoma (GBM) is 
the most common and aggressive type of malignant brain tumour occurring 
in adults. The direct reprogramming of brain tumour stem cells (BTSCs) to 
generate iPS cells has not been reported to date, and may provide insights 
pertaining to the genetic and epigenetic aberrations occurring in brain 
cancer. We hypothesize that the epigenetic program of BTSCs can be reset 
by direct reprogramming with the Yamanaka Factors (Oct4, Klf4, Sox2, and 
c-Myc) to generate iPS cells, allowing us to study the role of epigenetics in 
glioma progression. We also hypothesize that neural stem cells (NSCs) gen-
erated from the tumour-derived iPS cells may have an altered tumourigenic 
potential. BTSCs derived from a CNS-specific p53-deficient mouse model 
of glioma were grown as adherent cell lines in serum-free media with EGF 
and FGF. These cells endogenously express Klf4, Sox2, and c-Myc, but fail 
to express pluripotency-associated genes, such as Nanog, Oct4, and Rex1. 
Mouse glioma BTSCs and normal NSCs were infected with retroviruses en-
coding Oct4, Klf4, Sox2, and c-Myc and cultured on feeders with serum and 
LIF to generate iPS cells. Ectopic expression of the four factors in BTSCs and 
normal NSCs generated colonies with typical iPS morphology. Colonies were 
sub-cloned and characterized by RT-PCR, which revealed the activation of 
endogenous expression of the pluripotency factors Nanog, Oct4, and Rex1 
in reprogrammed clones. Dual inhibition (2i) of MAPK/Erk signaling and 
GSK3, which has been shown to promote full reprogramming, enhanced 
the expression of Nanog in a glioma-derived iPS cell line. Teratoma assays 
were carried out to assess the pluripotency status of the iPS cell lines in vivo, 
and intracranial injections were performed to determine the tumourigenicity 
of the iPS cell lines. This study will aid in elucidating the relative contribu-
tion of genetics and epigenetics to the neoplastic phenotype of glioma. By 
investigating the aberrant changes in the epigenetic program of BTSCs that 
promote tumourigenesis, we may identify novel genes or signaling pathways 
that are altered in glioma, which could be targeted by new chemotherapeu-
tic agents interfering with chromatin modification.
Poster Board Number: 2112
LACTOBACILLUS CASEI INHIBIT THE GROWTH 
IN HUH7 CELL LINE
Dae-Jong, Han1, Kim, Jong Bin2
1Clinical Research Institute of SNUH, Seoul, Korea, Republic of, 2Institute 
for Biomedical Research, Seoul National University Hospital, Seoul, Korea, 
Republic of
Lactobacillus casei are known as lactic acid bacteria (LAB) that are widely 
used in dairy fermentations, and have many useful effects such as protec-
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tion, enhancement of biotherapeutic activities in our body. L. casei also have 
anti-cancer effect for proliferation in many cancers. However, there are not 
known to effect of L. casei in liver cancer. To investigate effect of L. casei 
about relationship with growth and cancer stem cell. Effect of growth and 
cancer stem cells observed in liver cancer cell line huh7. Effect of growth 
investigated through cell counting using trypan blue staining, and effect 
of cancer stem cells through analysis of side population cells (SP), which 
is known as cancer stem cells in liver cancer. To observe effect of L. casei 
about relationship with growth and SP cells in huh7 cells, lysate of L. casei 
treated to huh7 cells, investigated in growth rate, cell cycle, apoptosis, and 
Side Population(SP). L. casei induced 23% inhibition of growth compared 
untreated cells (control) to treated cells in huh7 cells. Inhibition of growth is 
caused by induction of cell cycle arrest and apoptosis. Huh7 cells increased 
3% G2/M phase after lysate of L. casei treatment. Lysate of L. casei induced 
5% cell death through Annexin V staining. In contrast to effect of growth, 
lysate of L.casei induced a 0.5% increase of SP cells. These results showed 
that L. casei induced inhibition of growth through induction of G2/M phase 
arrest and cell death but not target cancer stem cells. In conclusion, although 
L. casei is useful effect of inhibition of growth, these treated carefully in 
respect to targeting of cancer stem cells.
Poster Board Number: 2114
SSEA-4 EXPRESSION IS NOT ASSOCIATED 
WITH SIDE POPULATION OF HUH7 HEPATIC 
CARCINOMA CELLS
Park, Seo Young1, Kim, Jong Bin2, Yang, Man Gil2, Kim, Jong-Hoon1
1Korea university, Seoul, Korea, Republic of, 2Seoul National University 
Hospital, Seoul, Korea, Republic of
Stage-specific embryonic antigen 4 (SSEA-4), one of markers of human 
embryonic stem cells, is known to be expressed in adult stem cells, such as 
mesenchymal stem cells, neural stem cells, and fetal liver progenitor cells. 
Although the expression of SSEA4 was recently detected in cancer cells and 
proposed as a marker of cancer stem cells, its role in liver cancer is largely 
unknown. In this study, we examined the expression of SSEA-4 in side 
population (SP) cells of a liver cancer cell line, huh7 cells and investigated its 
role in proliferation, drug resistance, invasion, and migration. Approximately 
3% of the huh 7 cell population expressed SSEA-4, as determined by FACS 
analysis. Both SSEA4high and SSEA4low/- cells sorted from total huh7 cells 
maintained their phenotype in culture up to 30 days. Interestingly, side pop-
ulation cells were detected mainly in SSEA4low/- cells but not in SSEA4high 
cells. SSEA4high cells showed a decreased in proliferation by 24% compared 
to SSEA4 low/- cells. Moreover, the migrating ability of SSEA4high cells was 
significantly decreased compared to SSEA4low/- cells. Significant differ-
ences in invasive ability and drug resistance were not found between two 
cell populations. In conclusion, these results suggest that SSEA-4 may have 
a tumor suppressor effect and could be used as a potential indicator of liver 
cancer progression.
Poster Board Number: 2116
HDAC3 INDUCES EPITHELIAL-MESENCHYMAL 
TRANSITION AND STEM-LIKE PROPERTY 
IN HEAD AND NECK SQUAMOUS CELL 
CARCINOMA
Wu, Min-Zu
Institute of Biochemistry and Molecular Biology, National Yang-Ming 
University, Taipei, Taiwan
The epithelial-to-mesenchymal transition (EMT), one important process for 
cancer metastasis, which allow carcinoma cells for acquiring mesenchymal-
like properties to promote cell migration and invasiveness. Recently, EMT 
also has been demonstrated to generate cells with stem-like properties in 
either human mammary epithelial cells or head and neck squamous cell 
carcinoma (HNSCC). But little is known about whether chromatin modifica-
tion and modifier regulate EMT and EMT-induced tumor-initiating capability. 
Here, we show that histone deacetylase 3 (HDAC3), activated by hypoxia 
directly, is essential to induce EMT and metastasis phenotypes in vitro and in 
vivo. HDAC3 cooperates with EMT regulator-Snail and histone methyltrans-
ferase and causes specific histone modification changes, leading to repres-
sion of epithelial genes and activation of mesenchymal genes. We addition-
ally demonstrate that overexpression of HDAC3 increases the subpopulation 
of HNSCC cells expressing putative tumour-initiating cell markers, suggest-
ing the role of HDAC3 in EMT-induced tumor-initiating capability. These 
results suggest the important role of chromatin modifier in promotion of 
EMT and tumor-initiating capability and also highlight the potential use of 
epigenetic inhibitors in clinical treatment.
Poster Board Number: 2118
TARGETING OF HEAD AND NECK CANCER 
STEM CELLS USING SALINOMYCIN
Kuo, Selena, Blair, Katherine J., Kiang, Alan, Abhold, Eric, Rahimy, 
Elham, Ongkeko, Weg
University of California, San Diego, La Jolla, CA, USA
Cancer stem cells are believed to play a crucial role in cancer recurrence due 
to their resistance to conventional chemotherapy and capacity for self-re-
newal. Gupta and colleagues recently reported that salinomycin, a livestock 
antibiotic, selectively targets breast cancer stem cells. In our study we 
sought to determine the effect of salinomycin on head and neck squamous 
cell carcinoma (HNSCC) stem cells. We observed that salinomycin inhibits 
self-renewal capacity in HNSCC stem cells, as shown by a dose-dependent 
decrease in sphere formation. In addition, treatment with salinomycin re-
sulted in a decrease in mRNA expression of the stem cell markers CD44 and 
BMI-1, both of which are critical for maintaining tumorigenicity in HNSCC. 
In combination with the chemotherapeutic agents cisplatin and doxorubicin, 
salinomycin synergistically killed HNSCC cancer stem cells more effectively 
compared to either drug alone, as demonstrated by MTS assays. High-
throughput analysis revealed a set of differentially expressed microRNAs in 
salinomycin-treated HNSCC stem cells, warranting further investigation into 
the possibility of microRNA-mediated pathways that are regulated by salino-
mycin. Taken together, our findings indicate promise for using salinomycin 
as a novel treatment for HNSCC.
Poster Board Number: 2120
CANCER STEM CELL SELF-RENEWAL IS 
ADDICTED TO MYC ONCOGENE
Das, Bikul, Felsher, Dean
Medical Oncology, Stanford University, Stanford, CA, USA
Background: Cancer cells are addicted to oncogene for survival and growth. 
Whether, cancer stem cells (CSCs) are also addicted to oncogene for growth 
and self-renewal is not yet known. Here, we used a conditional MYC model 
of murine T-cell lymphoma to systematically relate the dependency of cancer 
stem cells to MYC oncogene for self-renewal and tumorigenicity. Methods: 
The primary Myc-induced T- cell lymphoma tumors were dissociated and 
flow-cytometry sorting was performed to isolate CSCs by flow cytometry. 
The sorted cells were injected to congenic mice intravenously and tumor 
formation was monitored. Results: We isolated a rare fraction (~ 0.01%) of 
CSC cells using flow-cytometry for SP-sorting of primary tumors. While only 
100 cells of CSC fraction developed disseminated lymphoma in congenic 
mice (intravenous injection), 106 of the non-sorting primary cells formed 
only rare tumors (1/25 mice at 6 months). When, the CSC fraction was 
re-injected to congenic mice, rapidly growing disseminated tumors were 
found in liver, spleen and mesenteric lymph nodes suggesting that the rare 
fraction suggesting they were maintained in the secondary tumors. In vitro 
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clonogenic assay using methylcellulose media demonstrated that the CSC 
fraction was 5x103 fold clonogenic (p<0.001). Recent studies suggest that 
MYC is involved in inducing an embryonic stem cell (ESC)- like gene signa-
ture in aggressive cancer. We found that inhibition of MYC expression both 
In vitro and in vivo appeared to suppress the CSC fraction. Conclusion: We 
conclude that CSCs are dependent on MYC oncogene for both growth and 
self-renewal.
Poster Board Number: 2122
LY294002 INDUCES APOPTOSIS AND 
NEURONAL DIFFERENTIATION IN MDB 
CANCER STEM CELLS
Frasson, Chiara, Rampazzo, Elena, Persano, Luca, Pistollato, 
Francesca, Beggio, Giacomo, Basso, Giuseppe
University of Padova, Padova, Italy
Medulloblastoma (MDB) is the most common cancerous brain malignancy 
of childhood, with only a 60% of 5-year overall survival. In the last years re-
markable advances have been made trying to understand the pathogenesis 
and genetic alterations involved in MDB, although outcome for this type of 
tumour is still poor. The PTEN/PI3K/Akt/mTOR signalling pathway, crucial 
in many aspects of cell growth, survival and proliferation and involved in 
the pathogenesis of different human malignancies, could be implicated in 
the molecular pathogenesis of MDB too and represents a novel therapeutic 
target in this disease. Moreover it is currently thought that MDB arises from 
cerebellar stem cells that have been prevented from dividing and differ-
entiating into normal cell and that are considered responsible for tumour 
relapse. We previously found that the treatment with LY294002, a specific 
inhibitor of the PI3K/Akt/mTOR signaling pathway, promoted a block of cell 
cycle at G1 phase, followed by apoptosis, in MDB cell lines in a time depen-
dent manner. Moreover, LY294002 treated cells formed less colonies than 
control. The Side Population (SP) cells, isolated by FACS, displayed a higher 
in vitro clonogenicity in soft agar compared to non-SP cells in all MDB cell 
lines tested and, importantly, SP cell fraction resulted to be more sensitive 
to LY294002 treatment. Here we have investigated the in vitro effect of 
the PI3K specific inhibitor, in primary MDB-derived cells and we found that 
LY294002 treatment impair cell proliferation, with a block of cell cycle at G1 
phase followed by apoptosis. We observed that reduced cell proliferation, 
after LY294002 treatment, was characterized by neuronal differentiation, 
as shown by the increase of β-III-tubulin+ and the concomitant decrease of 
Nestin+ MDB-derived cells. We also analyzed the expression of CD133, a 
stem cell marker, and we found that LY294002 treatment caused a decrease 
in the percentage of CD133 positive cells in a time dependent manner and 
that CD133 negative cells are not affected by the treatment. Moreover we 
found that sorted CD133+ cells were more sensitive, compared to CD133- 
cells, to LY294002 treatment, as shown by the increase of Annexin+ cells. 
These preliminary results suggest that PTEN/PI3K/Akt/mTOR signaling 
pathway could be critical for MDB stem-like cells maintenance and that 
it could be selectively targeted for inhibiting cancer stem-like cells for im-
proved treatment.
Poster Board Number: 2124
TARGETING SIDE POPULATION CELLS IN 
AGGRESSIVE FIBROMATOSIS
Ghanbari Azarnier, Ronak, Wei, Qingxia, Sato, Shingo, Nadesan, 
Puviindran, Alman, Benjamin
Developmental and Stem Cell Biology, Sickkids Hospital, Toronto, ON, 
Canada
Aggressive fibromatosis (AF) is a locally invasive, benign soft-tissue tumor, 
composed of fibroblast-like cells that arise from musculoskeletal structures. 
Despite their tendency to infiltrate into surrounding normal tissues, they do 
not metastasize to distant sites. These lesions can occur either sporadically 
or as part of preneoplastic conditions. AF tumors harbor mutations activat-
ing beta-catenin mediated signaling, and genetically modified mice that 
exhibit beta-catenin protein elevation develop AF tumors. Evidence from 
mice shows that AF is derived from mesenchymal progenitor cells contain-
ing a mutation activating beta-catenin mediated signaling. Mesenchymal 
neoplasms contain a subpopulation of cells that exclude Hoechst 33342 dye 
(Side Population, or SP cells) that are enriched for tumor initiating poten-
tial, and as such have stem cell like properties. Using expression profiling, 
we examined SP and non-SP cells from human AF tumors. Analysis of the 
expression profiles using the ingenuity expression analysis program showed 
that the Hedgehog (Hh) signaling pathway is differently regulated in side 
population (SP) compared to non-side population (NSP) cells from human 
AF samples. Since the Hh signaling can maintain mesenchymal progenitors 
in a less differentiated state, we examined the role of Hh signaling blockade 
in this tumor type. Apc1638N mice harbor a germ line mutation in the Apc 
gene, and develop large numbers of AF tumors. We treated Apc1638N mice 
with triparanol (which blocks Hh signaling), or a carrier as a control. We 
found that triparanol treatment decreased Hh signaling in the tumors, and 
resulted in a 25% decrease in the tumor volume in treated mice compared 
to control mice (P<0.013). This data shows that targeting Hh signaling in AF 
has the potential to developed into a therapeutic approach to treating AF, 
and raises the possibility that targeting SP cells could be used to treat select 
neoplasms.
Poster Board Number: 2126
THERAPEUTIC POTENTIAL OF SILYMARIN IN 
CANCER STEM CELLS
Gharagozloo, Marjan, Mirzaei, Hamid Reza
Department of Immunology, Isfahan University of Medical Sciences, 
ISFAHAN, Iran, Islamic Republic of
Silymarin, a flavonolignan complex isolated from milk thistle (Silybum 
marianum L. Gaertn), has a strong antioxidant activity and exhibits anti-
carcinogenic, anti-inflammatory, and cytoprotective effects. Although the 
anti-carcinogenic effects of silymarin on various types of cancers have been 
previously documented, the effect of silymarin on cancer stem cells (CSCs) 
is largely unknown. Recently, several studies have been shown that a grow-
ing tumor is a heterogeneous mix of mostly differentiated cancer cells and 
CSCs, a rare population that have stem cell-like properties and exhibits more 
resistance to conventional therapies. Since restricted oxygen conditions 
increase the CSC fraction and promote acquisition of a stem-like state, CSCs 
are critically dependant on the hypoxia-inducible factors (HIFs) for survival, 
self-renewal, and tumor growth. Mammalian target of Rapamycin (mTOR) 
is a regulator of HIF expression and activity; therefore, the inhibition of 
HIF-mediated gene expression is considered to be related to the antitumor 
activity of mTOR inhibitors in some cancers. Moreover, it has been shown 
that mTOR-inhibitors suppress the expression of CD133, a stemness marker 
of CSCs, suggesting a role for mTOR in the regulation of CD133 expres-
sion. Taking into consideration that silibinin, the major active constituent 
of silymarin, was found to inhibit HIF-1α and mTOR, silymarin could be 
considered as a novel potential therapeutic strategy targeting CSCs. Novel 
mechanisms of anti-carcinogenic effects of silymarin on CSCs is currently 
under investigation in our institution.
Poster Board Number: 2128
A NOVEL PLURIPOTENCY-RELATED ONCOGENE 
NETWORK IN HESC AND IPS CELLS
Tung, Po Yuan, Knoepfler, Paul
University of California, Davis School of Medicine, Sacramento, CA, USA
There are many important links between tumorigenesis and pluripotency. 
For example, the genes used to produce induced pluripotent stem cells 
(IPSC) are strongly associated with cancer and highly expressed in human 
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embryonic stem cells (hESC). hESC and IPSC both can robustly form tera-
toma as well. To test the notion that pluripotency-related genes may have 
key roles in tumorigenesis and search for stem cell-related oncogenes that 
might be important in teratoma formation, here we conducted an expres-
sion screen of a novel retroviral hESC cDNA library that we produced. When 
we transduced fibroblasts with the hESC cDNA library, we found remarkably 
robust cancer cell formation, indicating that dozens of genes that are highly 
expressed in hESC are putative oncogenes that can readily drive cellular 
transformation. All viral cDNAs from cancer colonies that we have tested, 
have been validated as powerful single-hit oncogenes. After sequencing 
to identify the cDNAs acting as oncogenes, we found known oncogenes 
but also many novel oncogenes. Gene ontology analysis indicated that 
many of these new oncogenes encode proteins that interact together in a 
functional network. Thus, from this screen we have discovered a network 
of novel stem cell-related oncogenes that control cellular metabolism and 
cell cycle. At the center of this network is a single core pluripotency-related 
transcription factor also identified in our screen, but not previously linked to 
cancer. This gene is highly expressed in germ cell tumors such as teratoma 
and in other cancers including leukemias. Strikingly the transcription factor 
it encodes regulates expression of many of the other oncogenes that we 
identified. Our findings have critical implications for understanding stem cell 
biology and tumorigenesis as well as for the development of safe regenera-
tive medicine therapies based on IPSC and hESC.
Poster Board Number: 2130
P27 TUMOR SUPPRESSOR REPRESSES SOX2 
EXPRESSION
LI, HAN1, Collado, Manuel1, Villasante, Aranzazu1, Matheu, Ander2, 
Vidal, Anxo3, Lovell-Badge, Robin2, Serrano, Manuel1
1Spanish National Cancer Centre, MADRID, Spain, 2MRC National Institute 
for Medical Research, London, United Kingdom, 3Universidad de Santiago 
de Compostela, Santiago de Compostela, Spain
p27Kip1 is an inhibitor of the cell cycle dependent kinases (Cdkn1b). Mice 
deficient for p27 develop pituitary tumors, exhibit organ hyperplasia result-
ing in increased body size, and retinal dysplasia. Decreased expression of 
p27 is linked to multiple human cancers, particularly lung cancer. On the 
other hand, Sox2 is one of the core ES transcription factors. Interestingly, 
heterozygous loss of Sox2 in mice results in reduced body size, atrophic 
retina, and hypopituitarism. More recently, overexpression of Sox2 has been 
associated with lung cancer in both mice and human. This reversed pheno-
type prompted us to further investigate the potential interplay between p27 
and Sox2 during development, cancer and reprogramming. Here, we report 
that p27 deficiency causes an increase in the expression of Sox2 and in the 
number of Sox2 positive cells in mice. Furthermore, the combination of 
p27 deficiency with Sox2 heterozygosity largely rescued all the phenotypic 
defects observed in either single p27 or Sox2 deficient mice, thus normal-
izing body size, retinal organization, and pituitary size and development. 
To further elucidate the molecular mechanisms connecting p27 and Sox2, 
we observed that during in vitro ES differentiation, p27 directly binds to 
Sox2 promoter and contributes to its transcriptional repression. Further-
more, retinoic acid-induced differentiation of p27-/- iPSCs failed to reduce 
Sox2 expression as efficiently as in wild type iPSCs. Finally, mouse embryo 
fibroblasts derived from p27-/- mice can be reprogrammed with only Klf4 
and Oct4. All together, we conclude that p27, a cell cycle regulator, directly 
regulates Sox2, a stemness gene. This regulation is important for differentia-
tion, development and cancer.
Poster Board Number: 2132
CELL REPROGRAMMING ALLEVIATES 
EXPRESSION ABERRATIONS OF SKI AND 
PRDM16 IN GASTRIC CANCER CELLS
Miller, Christine H.1, Lu, Pamela W.1, Park, Vincent I.2, Park, Hong 
Joon3, Lu, Li-Heng Hans1, Cai, Cindy X.1, Li, Valery J.1, Hampilos, 
Perry J.1, Munroe, Elizabeth S.1, Lu, Amy Q.4, Liao, Jung-Chi1
1Columbia University, New York, NY, USA, 2Great Neck South High School, 
Great Neck, NY, USA, 3Bergen County Academies, Hackensack, NJ, USA, 
4Multiple Sclerosis Research Center, New York, NY, USA
Both the origin of cancer and the reprogramming process are thought 
to involve important and widespread epigenetic changes inside cells. We 
investigated the possibility of carcinogenic pathway suppression through 
reprogramming gastric cancer cells. Two specific genes, SKI and PRDM16 
(also known as MEL1), have been shown to be aberrantly over-expressed 
in gastric cancer cells. These two genes interact with Smad3 and Smad4 
to restrict the transforming growth factor (TGF)-β signaling pathways in 
gastric cancer cells, ultimately causing malignancies. Through the process of 
induced pluripotent stem cell (iPSC) reprogramming, we have been able to 
reduce the expression of these genes, thereby reducing the cancerous traits 
of these cells. We reprogrammed a gastric cancer line MKN28 using a ret-
roviral system of the four transcription factors Oct4, Sox2, Klf4, and c-Myc. 
A unique protocol was developed to reprogram this media-sensitive cell 
type. The reprogrammed cancer cells exhibited iPSC morphology of tightly 
packed colonies composed of small cobblestone-shaped cells that possess a 
high nucleus-to-cytoplasm ratio. Immunostaining assays showed that these 
colonies expressed the pluripotency markers alkaline phosphatase, SSEA4, 
Tra-1-60, and Nanog while the parental MKN28 cells did not. Quantitative 
RT-PCR results showed the increasing endogenous expressions of Nanog, 
Cripto and the four transcription factors while the retroviral transgenes were 
silenced, indicating a reprogrammed, pluripotent state. After validating the 
pluripotency of reprogrammed MKN28 cells, we compared the expression of 
SKI and PRDM16 of the parental MKN28 gastric cancer cells to the repro-
grammed cells through quantitative RT-PCR and immunoassaying. qRT-PCR 
results showed that the reprogrammed cancer cells have a significantly 
reduced gene expression of SKI and PRDM16 when compared to MKN28 
parental cells. Our immunostaining results confirmed the qRT-PCR results, 
as they showed higher expression of SKI in MKN28 parent cells than in the 
reprogrammed cells. These results demonstrate that the iPSC reprogram-
ming process alleviates the over-expression of onco-proteins and alters 
TGF-β signaling pathways, suggesting possible effects of reprogramming on 
reducing malignant characteristics of cancer cells.
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FGF2 MEDIATES RAPID DNA REPAIR IN SP 
CARCINOMA CELLS
MARIE, Melanie, HAFNER, Sophia, MORATILLE, Sandra, VAIGOT, 
Pierre, RIGAUD, Odile, MARTIN, Michèle TI
DSV, CEA LGRK, Evry, France
Cancer stem cells can resist to anticancer therapy through various mecha-
nisms, including overexpression of endogenous factors or extracellular pro-
teins of the SC niche. The secreted form of the growth factor FGF2 can be a 
component of the tumor cell micro-environment, originating from the tumor 
stroma or from the tumor cells. This factor has also a nuclear form, whose 
function is largely unknown. As we demonstrated that the secreted form 
of FGF2 can be a regulator of DNA repair in normal epidermal stem cells 
through the canonical signaling pathway using FGF2 receptor and MEK ki-
nases, we here address such mechanisms in carcinoma cells. We isolated the 
SP and non-SP populations (NSP) from the A431 carcinoma cell line using 
flow cytometry, on the basis of Hoechst dye exclusion. This SP cells (1-2 % 
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of the total population), has been shown to be more tumorigenic than NSP 
cells. Investigations of radiation-induced DNA damage and repair using the 
alkaline comet assay revealed that the damage was repaired more rapidly in 
SP than in NSP cells. When the FGF2 signaling pathway was blocked using 
the MEK1 inhibitor UO126, the irradiated SP cells lost their capacity of rapid 
DNA repair. Moreover, addition of exogenous FGF2 in the growth medium 
of NSP before irradiation increased the repair of radiation-induced dam-
age. These data show that FGF2 can protect carcinoma cells by activating 
stress-induced DNA repair. They support the hypothesis that targeting FGF2 
signaling pathway could potentiate carcinoma radiotherapy. To better under-
stand the origin of FGF2, the expression of this cytokine was characterized 
in the two carcinoma cell populations. NSP cells expressed low levels of intra 
and extra cellular forms of FGF2, both before and after irradiation. The pos-
sible effects of FGF2 on NSP in a tumor could then rely on a stromal origin, 
and use the canonical signaling pathway through the FGF2 receptor. SP cells 
expressed constitutively more intracellular and secreted FGF2 than NSP cells, 
before irradiation. We propose that the more tumorigenic cellular fraction 
in the carcinoma cell line is primed to a more rapid response to radiation by 
this endogenous high level of FGF2. We postulate that a high content in 
the nuclear form of FGF2 plays an important role in their rapid DNA repair, 
and that downregulating endogenous FGF2 could be a way to radiosensitize 
cancer stem cells in carcinoma.
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HYPOXIA ENHANCES TUMOR STEMNESS 
OF A RARE FRACTION OF ES CELLS BY 
UPREGULATING HIF-2ALPHA
Das, Bikul1, Mokhtari, Reza Biat2, Tsui, Micky3, Lotfi, Shamim2, 
Yeger, Herman4
1Stanford University, Stanford, CA, USA, 2Hospital for Sick Children, 
Toronto, ON, Canada, 3Hospital for Sick Children, Toronto, ON, USA, 
4Hospital For Sick Children, Hospital for Sick Children, ON, USA
Background: A long-standing question in stem cell biology has been whether 
transient exposure of stem cells to the area of injury is sufficient enough for 
malignant transformation. The site of injury/inflammation is characterized 
by hypoxia and ROS (reactive oxygen species). Stem cells, when exposed 
to such stressful microenvironment may switch to an unstable but highly 
functional, highly undifferentiated state, the “enhanced stemness” state 
by upregulating HIF-2α, which in turn may upregulate Oct-4, Nanog and 
MDM2 to switch the stem cell state to a tumor stemness state. We investi-
gated this possibility by exposing hESCs to extreme hypoxia. Methods: Hu-
man ES cells (hESCs-BGO1v) were exposed to an extreme environment of in 
vitro hypoxia/oxidative stress that mimics in vivo injured microenvironment. 
FACS sorted surviving SSEA3 and ABCG2 fraction (3 days post hypoxia) was 
subjected to QPCR (real time PCR) and In-cell western blot assay to study 
the expression of enhanced stemness genes. HIF-2α was inhibited by siRNA 
knockdown. Results: FACS analysis revealed that BGO1v cells contain a rare 
fraction (about ~0.1%) expressing both SSEA3 and ABCG2. When exposed 
to hypoxia, a small fraction of cells, SSEA3+/ABCG2+, about ~4% survived 
and retained the undifferentiated state even after 3 weeks of culture, where-
as the SSEA3+/ABCG2- underwent differentiation and apoptosis. When the 
surviving SSEA3+/ABCG2+ cells were expanded for another three weeks, 
an EC like clone (resembling a Tera-2 like clone in the cell culture plate) was 
obtained. This post-hypoxia clone (denoted henceforth as ESt; t denoting 
tumor) demonstrated higher levels of Nanog, SSEA3, HIF-2α, N-MYC and 
MDM2 and ABCG2 than the parental BGO1v cells. The ESt fraction was 
characterized by significantly higher clonogenic activity than the pre-hypoxia 
SSEA3+/ABCG2+ fraction. Most importantly, the SSEA3+/ABCG2+ cells, 
FACS sorted from the Est clone, required only one fifth of the number of 
cells required to form a rapidly growing teratoma in nude mice compared to 
the pre-hypoxia SSEA3+/ABCG2+ fraction (10,000 cells versus 50,000 cells 
respectively). The dissociated teratoma obtained from the ESt clone showed 
the presence of ~1% of SSEA3+/ABCG2+ve cells, which when re-injected 
i.p. formed a rapidly growing secondary teratoma suggesting an EC like 
teratocarcinoma forming activity of the ESt cells. The siRNA knockdown 
of HIF-2α induced differentiation and apoptosis of the SSEA3+/ABCG2+ 
fraction during exposure to hypoxia. Conclusion: We conclude that only a 
rare fraction of highly undifferentiated hESCs could achieve this “enhanced 
stemness” state during exposure to hypoxia and oxidative stress, whereas 
the remaining cells either undergo apoptosis or differentiation.. Furthermore, 
on rare occasion, the “enhanced stemness” state is stabilized into a “tumor 
stemness” state.
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ISOLATION AND CHARACTERISATION OF 
LYMPHOMA INITIATING CELLS
Moti, Naushad, Turner, Suzanne D.
Division of Molecular Histopathology, Department of Pathology, University 
of Cambridge, Cambridge, United Kingdom
Haematological malignancies comprise a variety of functionally heteroge-
neous cells thought to arise from discreet cellular subsets, and are respon-
sible for tumour maintenance and metastasis. These discrete cellular subsets 
are termed Tumour-Initiating Cells (TICs) and are so called because of their 
functional likeness to tissue-specific stem cells; they are able to self-renew, 
survive for the long term and give rise to the bulk of the tissue/tumour 
population and yet are relatively quiescent. Such cells have been described 
for a number of malignancies and are deemed responsible for continued 
tumour growth and propagation as well as for disease relapse and in some 
cases metastatic growth. It has yet to be determined whether TICs exist in 
Non-Hodgkin lymphoma (NHL), a heterogeneous disease affecting the cells 
of the immune system. There are greater than 30 sub-types of NHL and our 
initial focus has been on the Anaplastic Large Cell Lymphoma (ALCL) and 
Peripheral T-cell Lymphoma-Not Otherwise Specified (PTCL-NOS) catego-
ries, both representing mature T-cell malignancies. In this study, we provide 
evidence for the presence of a distinct sub-population of cells with stem-like 
properties within the bulk tumour population. We have employed the Side 
Population (SP) technique to identify cells with enhanced drug efflux capac-
ity, an inherent property of stem cells. We show that a distinct population of 
SP cells exist in ALCL cell lines and that this population contains cells positive 
for the CD117 or c-kit (2-5%) cell surface marker commonly associated 
with haematopoietic stem cells (HSCs). Importantly, cells expressing c-kit 
are absent in the main population (MP; cells that are not detected as SP 
cells). Furthermore, in-vitro differentiation assays show that the isolated SP 
population can differentiate to give rise to more SP cells as well as the bulk 
differentiated tumour population. Conversely, the MP cells do not form 
new SP cells and fail to propagate. Real-Time quantitative PCR (qPCR) on 
SP and MP showed increased expression of ABCG2 and Oct4 transcription 
factors in SP cells contributing to its defense mechanism and self-renewal 
ability respectively. We have also identified a Verapamil-sensitive SP popula-
tion in primary human ALCL and PTCL-NOS primary patient tumours and 
furthermore we demonstrate that 2-3% of these cells likewise express c-kit 
on their surface. This primary cell population, from ALCL and PTCL-NOS 
patients, is reproduced on transplantation of whole tumour cell populations 
into immunodeficient mice and furthermore when c-kit+ cells alone are 
transplanted into mice, they propagate to produce tumours representative of 
the primary sample whereas c-kit depleted tumour cells do not. Hence, we 
propose that at least some NHL may constitute a small population of TICs. 
Specifically, ALCL constitutes a small population of c-kit-positive cells which 
display properties of TICs.
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DIFFERENTIAL EXPRESSION OF CELL 
ADHESION MOLECULES IN RETINOBLASTOMA
Seigel, Gail M.1, Geng, Yue2, King, Michael2
1University at Buffalo SUNY, Buffalo, NY, USA, 2Biomedical Engineering, 
Cornell University, Ithaca, NY, USA
Purpose: Adhesion molecules, such as MUC-1, CD24 and CD44 play 
important roles in intercellular signaling in cancer, particularly in the context 
of cancer stem cells. The purpose of this study was to examine the expres-
sion of these molecules in retinoblastoma (RB) to provide insights into cell 
adhesion and potential mechanisms of metastasis. Methods: RB143, a 
short-term, low passage human RB cell line and WERI-RB27, a long-term, 
high passage human RB cell line, were analyzed for expression of adhesion 
molecules MUC-1, CD44 and CD24 by flow cytometry. Results: WERI-RB27 
cells expressed neither CD44 nor CD24, but did contain a small percentage 
of MUC-1+ cells (13% positive). In contrast, virtually all RB143 cells were 
CD24+ (100% positive), while a small percentage of cells were MUC-1+ 
(16% positive). CD44, a major E-selectin ligand, was also not detected in 
RB143 cells. Conclusions: WERI-RB27 cells and RB143 cells differ greatly 
in the percentage of CD24+ cells, but exhibit similar numbers of MUC-1+ 
cells (13-16%). Both cell lines lack CD44 immunoreactivity. Based on these 
results and our previous studies, retinoblastoma cells appear to lack the 
CD44-E-selectin metastatic adhesion pathways and may rely on alternate 
mechanisms, such as ICAM-1 to accomplish metastatic spread and extrava-
sation into target tissues.
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ONCOGENES INDUCE STEM CELL LIKE 
PROPERTIES IN THYMOCYTE
Tremblay, Mathieu, Lemieux, Sebastien, Hoang, Trang
Universite de Montreal, Montreal, QC, Canada
Thymocytes are devoid of self-renewal activity and long term thymic output 
in T lymphocytes requires input from hematopoietic stem cells. We now 
show that DN3 thymocytes are the target cells of transformation by the 
SCL-LMO1 oncogenes in T-cell acute lymphoblastic leukemia. Furthermore, 
ectopic expression of these oncogenes induces aberrant self-renewal in DN3 
thymocytes which acquire thymic engraftment capacities when transplanted 
during the pre-leukemic phase. Remarkably, genetic manipulation of this 
stem cell-like activity during the pre-leukemic phase supports the view that 
aberrant self-renewal determines the penetrance and the aggressiveness of 
the disease. In addition, we provide genetic evidence that enhanced self-
renewal was not due to a suppression of differentiation, since oncogene-
induced aberrant self-renewal is independent of the Cd3 gene which is 
required for thymocyte differentiation. Rather, SCL-LMO1 upregulate a set 
of stem cell genes and challenge this limit in thymocytes. We therefore con-
clude that oncogene-induced aberrant self-renewal in thymocytes represent 
an important initiating event in T-ALL.
Poster Board Number: 2144
RESIDUAL EMBRYONIC CELLS AND THE 
ORIGIN OF A BARRETT’S-LIKE METAPLASIA
Wang, Xia1, Ouyang, Hong1, Yamamoto, Yusuke2, Kumar, Pooja 
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1Cell Biology, Harvard Medical School, Boston, MA, USA, 2Genome 
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Biology, A-STAR, Singapore, Singapore, 4Institut de Science et d’Ingénierie 
Supramoléculaires, University of Strasbourg, Strasbourg, France, 
5Multiclonal Therapeutics, Inc., Boston, MA, USA, 6Ludwig Cancer 
Institute, Oxford University, Cambridge, United Kingdom, 7Department of 
Pathology, Brigham and Women’s Hospital, Boston, MA, USA, 8Department 
of Medicine, Yong Loo Lin School of Medicine, National University of 
Singapore, Singapore, Singapore
Barrett’s esophagus is an intestine-like metaplasia and precursor of esopha-
geal adenocarcinoma. Triggered by gastroesophageal reflux disease, the 
origin of this metaplasia remains unknown. p63-deficient mice, which 
lack squamous epithelia, may model acid-reflux damage. We show here 
that p63 null embryos rapidly develop intestine-like metaplasia with gene 
expression profiles similar to Barrett’s metaplasia. We track its source to a 
unique embryonic epithelium that is normally undermined and replaced by 
p63-expressing cells. Significantly, we show that a discrete population of 
these embryonic cells persists in adult mice at the squamocolumnar junction, 
the source of Barrett’s metaplasia in humans. Upon programmed damage 
to the squamous epithelium, we show that these embryonic cells migrate 
towards and under adjacent, specialized squamous cells in a process that 
may recapitulate early Barrett’s. Our findings suggest that particular precan-
cerous lesions, such as Barrett’s, derive not from genetic alterations but from 
competitive interactions between cell lineages driven by opportunity.
Poster Board Number: 2146
INVESTIGATION OF SOX2 INTERACTING 
PARTNERS IN EMBRYONAL CARCINOMA STEM 
CELL LINE, NTERA2
Yousefi, Maryam, Hosseini Salekdeh, Ghasem
Molecular Systems Biology, Royan Institute for Stem Cell Biology and 
Technology, Tehran, Iran, Islamic Republic of
Much attention has been paid to embryonic and induced pluripotent stem 
cells because of their great therapeutic potential in regenerative medicine. 
Identifying underlying mechanism of their properties especially self-renewal 
and pluripotency may lead to their reliable application in therapy and 
alternative ways of reprogramming. As it has been shown, protein interac-
tion networks of transcription factors such as Oct4, Sox2 and Nanog and 
also epigenetic mechanisms are playing important role in establishment and 
maintenance of pluripotency, in this study we aim to investigate interact-
ing partners of SOX2 in NTERA-2 cell line as a convenient model pertinent 
to human pluripotent stem cells. A combination of affinity purification of 
tagged SOX2 and LC-MS/MS were used for isolation and characterization 
of interacting proteins. The presence of factors such as XRCC6, HNRNPC 
and SET links the pluripotency to DNA replication, recombination, repair 
and promoter maintenance, RNA processing and epigenetic mechanisms, 
respectively.
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CXCR6, A NEWLY DEFINED BIOMARKER OF 
TISSUE SPECIFIC STEM CELL ASYMMETRIC 
SELF RENEWAL, IDENTIFIES MORE 
AGGRESSIVE HUMAN MELANOMA CANCER 
STEM CELLS
Taghizadeh, Rouzbeh1, Sherley, James2, La Porta, Caterina AM3
1AuxoCell Laboratories, Inc, Boston, MA, USA, 2Boston Biomedical 
Research Institute, Boston, MA, USA, 3Biomolecular Science and 
Biotechnology, University of Milan, Milan, Italy
The majority of human cancer cells are the clonal progeny of an initiating 
variant tissue cell. Recent investigations of a variety of tumor types have 
shown that phenotypically identifiable and isolable subfractions of cells pos-
sess the tumor-forming ability. This feature of rare cells with tumor-forming 
potential dividing to produce cells with limited or no tumor forming poten-
tial is the basis for the cancer stem cell paradigm. Cancer stem cell research 
revived a longer-standing idea that many tumors (though not all) were likely 
to be the spawn of mutated tissue-specific stem cells. We will present the 
first phenotypic evidence to support this concept. Another important point 
that will be discussed is the identification of a more aggressive subpopula-
tion ABCG2/CXCR6+ in melanoma. CXCR6 is a new biomarker for tissue-
specific cell asymmetric self-renewal. The association of more aggressive tu-
mor phenotype with asymmetric self-renewal phenotype reveals a previously 
unrecognized aspect of tumor cell physiology. Namely, the retention of some 
tissue-specific stem cell attributes, like the ability to preserve self-phenotype, 
impacts the natural history of human tumor development. Knowledge of 
this new aspect of tumor progression may provide new targets for cancer 
prevention and treatment.
Poster Board Number: 2150
IDENTIFICATION OF ECCRINE GLAND 
MELANOCYTE STEM CELLS IN MOUSE ACRAL 
SKIN AS A POTENTIAL SOURCE OF ACRAL 
MELANOMA
Aoto, Takahiro1, Okamoto, Natsuko2, Miyachi, Yoshiki2, Nishimura, 
Emi K.1
1Department of Stem Cell Biology, Medical Research Institute, Tokyo 
Medical and Dental University, Tokyo, Japan, 2Department of Dermatology, 
Kyoto University Graduate School of Medicine, Kyoto, Japan
Acral volar skin is unique in that it contains (abundant) eccrine glands 
instead of hair follicles as the main skin appendage and is minimally exposed 
to UV sunlight. Acral melanoma is the most prevalent subtype of melanoma 
in the non-Caucasian population. The preferential proliferation of early acral 
melanoma cells along and around epidermal eccrine ducts has indicated a 
close association between early acral melanoma in situ and eccrine glands. 
However, neither the presence of melanocytic cells in the eccrine glands nor 
the precise origin of these melanoma cells has been identified to date. Here, 
we report the identification of eccrine gland melanocyte stem cells in mouse 
acral skin. We found that unpigmented melanocytic cells reside in the secre-
tory portion of eccrine glands using lineage-tagged H2B-GFP reporter mice 
and have characterized the development and maintenance of this popula-
tion in adult mouse skin. These melanoblasts are normally kept in an im-
mature and slow-cycling state but are able to self-renew and provide transit 
amplifying progeny which migrates upward toward the epidermis concurrent 
with the synthesis and deposition of melanin pigment in response to stresses 
including ionizing irradiation. These findings indicate that this population 
possesses several features consistent with adult stem cells. The existence 
of an acral melanocyte stem cell population within the eccrine gland might 
explain the preferential proliferation of early acral melanoma cells around ec-
crine glands during the process of melanomagenesis.
GERMLINE CELLS
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IMPROVED METHODS TO ISOLATE AND 
CULTURE VSEL STEM CELLS FROM HUMANS
Perkins, Diana O.1, Jeffries, Clark2, Turaga, Vandana1, Frelinger, 
Kees1
1Psychiatry, University of North Carolina, Chapel Hill, NC, USA, 2Renci, 
University of North Carolina, Chapel Hill, NC, USA
Very small embryonic-like (VSEL) stem cells have been isolated from human 
umbilical cord blood, murine and human adult peripheral blood and tis-
sues. These cells uniformly express proteins characteristic of embryonic and 
induced pluripotent stem cells, have a high nuclear to cytoplasm ratio, and 
predominance of euchromatin. Murine VESL are capable of differentiation 
into endoderm, mesoderm and ectoderm cells, and human-derived VESLs 
are at least capable of neuronal differentiation. VSEL cells do not express 
markers of hematopoietic stem cells or possess re-populating capabilities 
of hematopoietic stem cells. The function of these cells in mammals is not 
well understood, but a role in regeneration is suggested by the finding 
that in humans the peripheral blood population fraction expands following 
myocardial infarction and stroke, and enhanced cardiac recovery from MI in 
a mouse model. We will report on a method to isolate VSEL stem cells from 
human non-CSF mobilized blood that yields 4-7 cells per uL of whole blood 
with 99% purity. This yield is ~10 times higher than other published meth-
ods and indicates that VSELs are more common than previously thought. 
Methods to culture human VSEL stem cells over extended periods have not 
been described. We report a method to propagate human peripheral blood 
VESL stem cells in culture. After six months VESL stem cells cultured by our 
methods continue express a similar profile of pluripotency markers as de-
termined by a TaqMan pluripotency array and are phenotypically similar to 
VSEL stem cells harvested immediately from blood. These methods provide 
new research opportunities with VSEL stem cells.
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PROSPECTIVE ISOLATION AND ENRICHMENT 
OF HUMAN SPERMATOGONIAL STEM CELLS, 
ENDOTHELIAL PROGENITOR CELLS AND 
TESTICULAR STROMAL CELLS FROM ADULT 
TESTIS
Harichandan, Abhishek1, Sivasubramaniyan, Kavitha1, Hennenlotter, 
Joerg2, Schwentner, Christian2, Bühring, Hans-Jörg1
1Internal Medicine II, University clinic of Tuebingen, Eberhard-Karls 
University, Tuebingen, Germany, 2Department of Urology, University clinic 
of Tuebingen, Eberhard-Karls University, Tuebingen, Germany
Tissue-specific stem cells are known to possess therapeutic potential in 
regenerative medicine. Several markers are described to isolate hematopoi-
etic and mesenchymal stem cells. Little is known, however, about the marker 
profile of human spermatogonial stem cells (SSCs). The main reasons are the 
difficult availability of tissue and the small number of SSCs that is present in 
testis. Markers currently used for isolation of human SSCs like CD49f and 
CD9 are not highly specific. Recent studies have shown that SSCs express 
CD49f. In the search of additional antigens, which are co-expressed on 
subpopulations of CD49f+ cells, we prepared single cell suspensions derived 
from testicular biopsies and screened a large panel of antibodies against 
surface antigens for their reactivity with CD49f+ cells. Flow cytometry 
ISSCR 9th Annual Meeting
76
www.isscr.org
Friday Poster Abstracts
analysis revealed that antibodies against CD49a and CD144 are suitable 
to further fractionate the CD49f+ population. Multicolor cell staining and 
FACsorting of testicular cells revealed that SSCs were exclusively found in 
CD49f+CD49a-CD144- population, as determined by colony forming assays 
and real-time qPCR using BioMark Dynamic Array. In contrast, testicular 
stromal cells (TSCs) were enriched in the CD49f+CD49a+CD144- subset 
and endothelial progenitor cells (EPCs) in CD49f+CD49a+CD144+ subset, 
which was verified by the specific expression of key markers defining mes-
enchymal (CD49a, CD73, CD90, CD105, CD140b, CD166) and endothelial 
cells (CD31, CD34, CD45, CD105, CD144, CD146, CD309), respectively. In 
conclusion, we identified a novel marker combination, which is suitable for 
the simultaneous isolation of SSCs, TSCs and EPCs from adult human testis.
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CONTRIBUTION OF SPECIFIC TRANSCRIPTION 
FACTORS IN THE REPROGRAMMING 
OF MOUSE SOMATIC CELLS TOWARDS 
SPERMATOGONIAL STEM CELLS
Kellam, Lori D., Gearhart, John D.
Department of Cell and Developmental Biology, University of Pennsylvania, 
Philadelphia, PA, USA
Studies over the past 15 years have culminated in the demonstration that 
we can isolate spermatogonial stem cells (SSCs) from the testes of several 
mammalian species, culture them in vitro, and in the mouse, transplant 
them to a germ cell depleted testis where they are capable of colonizing 
and producing mature functional sperm. Though SSCs can be enriched from 
the general ‘germ stem’ (GS) population in the testis, molecular charac-
terizations that uniquely distinguish SSCs from any other stem cell type in 
the body have yet to be determined. Further, how SSCs arise from more 
primitive gonocytes remain to be fully elucidated. It is becoming clear that 
the larger GS population is characteristically and functionally heteroge-
neous and that the percentage of GS cells capable of colonizing a germ cell 
depleted testis in functional transplantation assays is very low. In an effort to 
further characterize spermatogonial stem cell differentiation we are forcing 
expression of specific SSC transcription factors to covert somatic cells to 
spermatogonial stem cells. The selected transcription factors were previously 
defined as important for SSC establishment or maintenance. cDNAs from 
a dozen factors were sub-cloned to lentiviral vectors for transduction to 
mouse embryonic fibroblasts (MEFs), and transduced and non-transduced 
MEFs were maintained in media that supports long-term culture of SSCs. 
RNA was collected from both transduced cells and non-transduced controls 
every 7 days for a period of 4 weeks to assess changes in gene expression 
by real time q-PCR. At 4 weeks, MEFs transduced with the SSC transcription 
factors showed an up-regulation in endogenous expression of stem cell spe-
cific genes such as Nanog and Pou5f1, as well as in germ cell specific genes 
including Plzf, Kit, Tex15 and Thy1 compared to non-transduced controls; 
an expression pattern consistent with that seen in SSCs in vivo. Ongoing ex-
periments to refine our list of transcription factors will help us identify novel 
factors involved in the SSC transcriptional network and to define a collection 
of transcription factors, which could reprogram a somatic cell towards an 
SSC. Successfully generating an SSC in vitro would be a major advancement 
in the treatment of male infertility, enabling the generation of patient-specif-
ic SSCs to extend treatment options for men undergoing radiation or other 
cancer treatments, which ablate the germ cell populations in the testis.
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THE INDUCTION OF DIFFERENTIATION OF 
MOUSE SPERMATOGONIAL STEM CELLS BY 
RETINOIC ACID
Sicilia, Sabrina, Zhang, Xiangfan, Nagano, Makoto
Obstetrics and Gynecology, McGill University, Montreal, QC, Canada
Spermatogonial stem cells (SSCs) are the foundation of spermatogenesis. 
SSCs self-renew for a lifetime and produce progenitor spermatogonia that 
ultimately transform into sperm. In recent years, several growth factors have 
been identified that promote SSC self-renewal and knowledge regarding the 
mechanism of self-renewal has been accumulating steadily. In contrast, the 
mechanism of SSC differentiation has remained elusive. Since the funda-
mental function of SSCs is to support sperm generation, i.e. differentiation, 
this lack of knowledge is a critical problem for understanding SSC biology 
and for the clinical use of SSCs to restore fertility. It is known that retinoids 
are crucial for spermatogenesis. Their importance is most clearly seen in 
their deficiency, which results in male infertility. Recent studies also show 
that retinoic acid (RA) induces meiotic entry of differentiating spermatogo-
nia. However it is unclear if RA can modulate the activity of primitive 
spermatogonia. In this study we assessed the effect of RA on SSCs and 
primitive spermatogonia in vitro and used spermatogonial transplantation 
to measure stem cell activity. It is now possible to culture mouse SSCs and 
primitive spermatogonia indefinitely and expand the SSC population in vitro. 
In this culture system, SSCs form aggregates of primitive spermatogonia, 
called ‘clusters’. Using this system, we assessed the effect of RA on clusters. 
When treated with RA (0.7 and 0.07 μM) for five consecutive days, clusters 
appeared to disintegrate and change their morphology. The cells of the dis-
integrating clusters formed chains of cells connected by cytoplasmic bridges, 
which is the morphology that has long been attributed to differentiating 
spermatogonia. The RA treatment increased the length of cell chains in a 
time-dependent manner up to 5 days, but no dose-dependent effects were 
observed. Using immunocytochemistry, we detected in all cluster cells the 
expression of retinoic acid receptor α, the major isoform of the RA recep-
tor in mouse testes. These results suggest that cluster cells are capable of 
responding to RA and undergoing the morphological changes observed. To 
determine the effect of RA on SSCs, we quantified SSCs by transplanting 
cluster cells into recipient testes 2 days after the RA treatment at 0.7 μM. 
We detected a significant decrease in SSCs (21-fold), suggesting that RA in-
duced SSC differentiation or death. Since all cells in clusters are known to be 
undifferentiated spermatogonia, application of RA into this culture system 
may present an effective approach to understanding the mechanism that 
underlying the loss of stem cell potential in the male germ line.
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IDENTIFYING GENES DIFFERENTIALLY 
EXPRESSED BETWEEN WNT/β-CATENIN 
SIGNALING AND NON-SIGNALING CELLS 
IN MOUSE SPERMATOGONIAL STEM CELL 
CULTURE
Yeh, Jonathan R., Zhang, Xiangfan, Nagano, Makoto C.
McGill University, Montreal, QC, Canada
Spermatogonial stem cells (SSCs) are an elusive population in the testis 
but are critical for the life-long production of sperm. Recently, we investi-
gated the involvement of canonical (Wnt/βCat) signaling in SSC fate. In a 
long-term culture, SSCs form aggregates (clusters) of SSCs and differenti-
ated cells. Using a transgenic reporter mouse-line for Wnt/βCat pathway 
activation, we found that Wnt/βCat signaling is activated in a subpopulation 
of cluster cells and that Wnt/βCat-signaling cells do not have stem cell activ-
ity suggesting that they may be early committed progenitors. Therefore, 
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in this study we examined the downstream targets differentially regulated 
in these non-SSCs. Using a global gene expression approach we identified 
137 targets upregulated at least 2-fold in Wnt/βCat signaling cluster cells. 
Gene ontology analyses classified most targets as components of extracel-
lular matrix and in cell adhesion. We noted the expression of members of 
the Notch pathway (Dlk1, Notch4, Maml2), which has known importance 
in the cell-cell communication necessary for embryo patterning, in particular 
in establishing the SSC niche in the developing Drosophila gonad. There-
fore, as a preliminary approach we added recombinant DLK1 to clusters and 
assessed its effect on SSC activity. We observed that the addition of DLK1 
significantly reduced SSC numbers without a corresponding decrease in total 
cluster cell numbers, implying that DLK1 may support differentiation. These 
results raise the possibility that differentiated germ cells may contribute to an 
SSC niche and influence SSC fate.
Poster Board Number: 2162
LIN28A REGULATES GERM CELL POOL SIZE 
AND FERTILITY
Shinoda, Gen1, Urbach, Achia1, Shah, Samar P.1, Schlosser, Kerianne 
C.1, Takeuchi, Ayumu1, Hagan, John P.2, Moss, Eric G.3, Gregory, 
Richard I.2, Daley, George Q.1
1Pediatric Hematology and Oncology, Children’s Hospital Boston, Boston, 
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USA, 3Department of Molecular Biology, University of Medicine and 
Dentistry of New Jersey, Stratford, NJ, USA
The RNA-binding protein Lin28a, which regulates the biogenesis of the 
let-7 family of tumor-suppressor microRNAs, has been implicated in ES cell 
pluripotency, somatic cell reprogramming, and tumorigenesis. Lin28a is 
expressed in primordial germ cells (PGCs) of the developing embryo and un-
differentiated spermatogonia of the postnatal testes, and is over-expressed 
in virtually all germ cell tumors. Previously we defined a molecular pathway 
whereby Lin28a influences PGC development via the let-7 target Blimp-1, 
a key regulator of PGC specification (West et al., Nature 2009). To further 
elucidate the role of Lin28a in the germ lineage, we evaluated Lin28a 
knockout mice. By flow cytometry and immunostaining we found markedly 
fewer SSEA-1+ PGCs in the genital ridges of 13.5 dpc Lin28a-null embryos 
compared to their littermate controls (4.8 +/- 0.5 % vs 7.3 +/- 0.6 %). Neo-
natal mouse testes and ovaries showed correspondingly fewer gametes, as 
defined by staining with the mouse vasa homologue Mvh, and adult Lin28a 
knockout males had reduced fertility. These data indicate that Lin28a regu-
lates germ cell pool size from an early stage in vivo, and compromises fertil-
ity while not abrogating germ cell function. In addition, we have developed 
mouse strains with conditional over-expression of Lin28a, and are currently 
testing how Lin28a hyper-function influences PGC pool size, fertility, and 
tumorigenesis.
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STEM CELLS IN ASEXUALLY REPRODUCING 
INVERTEBRATES, EMBRYONIC STEM AND 
GERMLINE CELLS SHARE COMMON, 
EVOLUTIONARY CONSERVED FEATURES
Shukalyuk, Andrey I.1, Isaeva, Valeria V.2, Akhmadieva, Anna V.2, 
Alexandrova, Yana N.2
1Institute of Biomaterials and Biomedical Engineering, University of 
Toronto, Toronto, ON, Canada, 2A.V. Zhirmunsky Institute of Marine 
Biology of the Far Eastern Branch of the Russian Academy of Sciences, 
Vladivostok, Russian Federation
In asexually reproducing invertebrates no early segregation of the germ cell 
lineage is observed; the lineage of pluripotent (traditionally referred to as 
totipotent) stem cells ensure both sexual and asexual reproduction over the 
entire life span of an individual or a colony. These pluripotent stem cells can 
differentiate into gametes and all the types (or a wide spectrum) of somatic 
cells in adult organisms. We studied such stem cells in representatives of five 
animals: archaeocytes in sponge Oscarella malakhovi (Porifera), interstitial 
cells in colonial hydroids Obelia longissima and Ectopleura crocea (Cnidaria), 
neoblasts in planarian Girardia tigrina (Platyhelmintes), stem cells in colonial 
rhizocephalans Peltogasterella gracilis and Polyascus polygenea (Arthro-
poda), and colonial ascidian Botryllus tuberatus (Chordata), compared with 
mouse embryonic stem cells (mESCs) in vitro. The morphological structure 
of studied stem cells in such diverse taxa shares common features typical for 
germline cells in other studied Metazoa: a high nucleo/cytoplasmic ratio, 
a large nucleus with diffuse chromatin and a large nucleolus, thin rim of 
undifferentiated basophilic cytoplasm including electron-dense perinuclear 
granules (nuage). All studied stem cells contain the specific electron-dense 
germinal granules or nuage - ultrastructural marker and key organelles of 
metazoan germline cells as well as of potentially gametogenic pluripotent 
stem cells. Asexually reproducing animals express evolutionary conserva-
tive germ cell markers such as products of genes related nanos, vasa and 
pl-10 (DEAD box family members), Piwi, and also high activity of alkaline 
phosphatase, PCNA and telomerase some of which were found in studied 
species: PCNA, alkaline phosphatase activity, selective expression vasa-like 
gene. We found expression of Ddx4/Vasa, Miwi/Piwi and Nanog/Nanos 
in undifferentiated mouse embryonic and induced pluripotent stem cells, 
with localization of DDX4 protein in perinuclear granules (nuage) of mESCs, 
which, along with invertebrate stem cells, are potentially gametogenic 
cells retaining pluripotency. We hypothesize that evolutionary conserved 
mechanism ensures germline specification remaining cell pluripotency. The 
data supported our hypothesis that pluripotent, potentially gametogenic 
stem cells display evolutionarily conservative features of the morphological 
and functional organization typical for cells of the germ line. In asexually 
reproducing invertebrates, from sponges and hydroids to some arthropods 
and chordates, stem cells share with cells of early embryos evolutionary 
conservative features presumably involved in maintenance of pluripotency 
(totipotency) and the gametogenic program. Such invertebrate cells capable 
of both gametogenesis and asexual reproduction (blastogenesis) are similar 
in their potential to mammalian embryonic stem cells. We propose that 
evolutionary and ontogenetically related cells of early embryos and pluripo-
tent stem cells belong to populations of cells that retain a wide or unlimited 
morphogenetic potential.
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EXPRESSION OF POSTMEIOTIC MARKERS 
DURING DIFFERENTIATION OF NONHUMAN 
PRIMATE ES CELLS IN VITRO
Takada, Tatsuyuki1, Shimozawa, Nobuhiro2, Noce, Toshiaki3, 
Suemori, Hirofumi4, Ohta, Yoshio1
1Ritsumeikan University, Kusatsu Shiga, Japan, 2Tsukuba Primate Research 
Center, Tsukuba, Japan, 3Shiga University of Medical Science, Otsu Shiga, 
Japan, 4Kyoto University, Kyoto, Japan
Primate embryonic stem (ES) cells can differentiate into pre-meiotic germ 
cells spontaneously in vitro. It has been reported that although expressions 
of several meiotic and post-meiotic marker genes become detectable during 
embryoid body (EB) differentiation from ES cells, the meiotic progression is 
inefficient for producing functional gametes. However, expression of post-
meiotic markers such as TEKT1 and GDF9, specific for spermatid and oocyte 
respectively, has been reported regardless of sex difference (XY or XX) of 
primate ES cells. To understand the expression of these post-meiotic markers 
in comparison with other germ cell markers further, we investigated sequen-
tial expression of stage-specific germ cell markers during in vitro differen-
tiation using XY and XX ES cell lines established from cynomolgus monkey 
blastocysts. Immunohistochemical analysis was also performed to identify 
cells expressing these post-meiotic markers in EBs. Several pre-meiotic germ 
cell markers (VASA, NANOS3, CXCR4) were upregulated upon the in vitro 
ISSCR 9th Annual Meeting
78
www.isscr.org
Friday Poster Abstracts
differentiation but meiotic markers were not. On the other hand, post-
meiotic markers (ACROSIN, HAPRIN, TEKT1, and GDF9) were upregulated 
in both XY and XX cell lines. Immunohistochemical analyses of EBs showed 
the existence of cells expressing TEKT1 and GDF9 protein, and co-expres-
sion of both proteins was observed in some cells. In addition, some TEKT1 
positive cells co-expressed Vasa, possibly suggesting the existence of germ 
cell lineage expressing post-meiotic genes without meiosis. Of interest, XY 
cells and XX ES cells showed similar time course of germ cell marker genes 
and appeared to be similar in the post-meiotic gene and protein expression 
profiles. These results suggested that sex difference (XY or XX) did not af-
fect the expression pattern of germ cell marker genes especially TEKT1 and 
GDF9 under in vitro differentiation.
Poster Board Number: 2168
GENE EXPRESSIONAL AND EPIGENETIC 
SIGNATURES TO DEFINE SPERMATOGENIC 
CELLS OF CALLITHRIX JACCHUS
Lin, Zachary Y.1, Imamura, Masanori1, Sano, Chiaki2, Yamadera, 
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Hideyuki1
1Physiology, Keio University, Tokyo, Japan, 2Kato Ladies clinic, Tokyo, 
Japan, 3CIEA, Kanagawa, Japan
Germ cell development is a fundamental process to produce offspring and 
sustain the species. As a result of evolutional selection, the developmental 
program of spermatogenesis seems to be quite similar across mammalian 
species. However, it becomes revealed that the program is not identical in 
detail among species. This fact prevents a simple application of rodent in-
sights to higher primates, despite accumulated knowledge on the molecular 
properties of germ cells in mouse. Thus, considering an extrapolation to 
human, it is essential to investigate the nature of primate germ cells using 
appropriate model animals. Here, we performed a molecular dissection of 
spermatogenic cells in common marmoset Callithrix jacchus. RT-PCR and 
immunostaining analyses demonstrated many similarities in gene expression 
between mouse and marmoset testes as expected. On the other hand, we 
found the exclusive signatures to distinguish both species as shown by the 
expression of pluripotency and early germ cell markers. It was also revealed 
that NANOS family and PLZF proteins changed their intracellular localiza-
tion during spermatogenesis, unlike mouse homologues. Furthermore, 
DNA methylation analyses identified a unique epigenome profile that the 
marmoset NANOG and OCT4 promoters exhibited an opposite methylation 
status to those in mouse spermatogenic cells, while the VASA and LEFTY1 
loci as well as imprinting genes displayed an evolutionarily conserved DNA 
methylation status. Because marmoset holds great advantages as not only a 
human model but also an experimental animal, the current study could be 
an important platform for primate reproductive biology including a possible 
application to human.
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IDENTIFICATION OF SPERMATOGONIAL STEM 
CELLS ISOLATED FROM TESTIS OF OCT4-EGFP 
TRANSGENIC PIGS
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Biotechnologie, Friedrich-Loeffler-Institut, Neustadt, Germany
Spermatogonial stem cells (SSCs) are essential for initiation and mainte-
nance of spermatogenesis in the testis of mammalian species. SSCs are 
unique because of their capacity for self-renewal and/or the potential for 
differentiation into spermatozoa. SSCs are rare in the testis and show only 
limited proliferation in vitro, hampering in-depth studies on their develop-
mental potential in vivo and in vitro. Up to now, only mouse SSCs have 
been successfully cultured in vitro over prolonged periods of time. However, 
domestic animals, in particular the domestic pig, are excellent large animal 
models, in which the clinical potential of stem cell therapies can be studied. 
We had previously generated and extensively characterized Oct4-EGFP 
(OG2) transgenic pigs as a novel large animal model for studying the fate of 
pluripotent cells, by monitoring of Oct4 expression using EGFP fluorescence. 
SSCs are the only adult stem cells that express Oct4; thus expression of the 
OG2 transgene can be used to isolate SSCs in OG2 transgenic pigs. In the 
present study, testes were obtained from OG2 transgenic boars at different 
ages. For derivation of SSCs the testes were enzymatically dissociated using 
two digestion steps to obtain a single-cell suspension. Fluorescence-activat-
ed cell sorting (FACS) based on Oct4-EGFP and c-KIT expression was used 
to purify the spermatogonial stem cell population. Four cell populations, i.e. 
EGFP+/c-KIT-, EGFP+/c-KIT+, EGFP-/c-KIT+ and EGFP+/c-KIT+ could be 
isolated. Fluorescence microscopy of testicular tissue isolated from transgenic 
piglets revealed a very low number of EGFP positive cells, whereas testicular 
tissue isolated from adult transgenic boars resulted in a high amount of 
EGFP fluorescent cells. FACS analysis of ejaculated spermatozoa from ma-
ture OG2 boars displayed no EGFP fluorescence. At present, we are working 
on the further characterization of these cell populations using real-time PCR 
analysis and immunohistochemistry. OG2 transgenic pigs used for isolation 
testicular cells based on both expression of Oct4-EGFP and specific surface 
markers could allow improved characterization of SSCs in pigs.
TECHNOLOGIES FOR STEM CELL RESEARCH
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A NOVEL PLATFORM UTILIZING FLOW 
CYTOMETRY ACTIVATED CELL SORTING AND 
DEFINED CULTURE SYSTEMS TO ENABLE THE 
GENERATION OF CLONALLY DERIVED HIPSCS 
WITH NAïVE STATUS
Valamehr, Bahram, Abujarour, Ramzey, Robinson, Megan, Le, Thuy, 
Robbins, David, Shoemaker, Daniel, Flynn, Peter
Fate Therapeutics, San Diego, CA, USA
Several key obstacles impede the translation of human induced pluripotent 
stem cells (hiPSCs) to clinical applications: the lack of an efficient feeder-free 
reprogramming method, a robust clonal selection strategy and a scalable 
single-cell culture technique. To this end we have developed a chemical 
platform comprising a unique combination of four small molecule inhibi-
tors of signaling pathways associated with the perturbation of stem cell 
self-renewal and survival: ROCK, TGFβ, MEK and GSK3. This small molecule 
cocktail is seen to not only augment somatic cell reprogramming but also 
supports the viability, proliferation and self-renewal of established hiPSCs in 
a defined media formulation. Using this platform, we have demonstrated 
enhanced and routine feeder-free reprogramming of various somatic cells 
using three factors (Oct4/Klf4/Sox2) and derived the previously unattain-
able feeder-free hiPSCs from IMR90 fibroblast cells. In addition, we have 
replaced the cumbersome and often impure technique of picking potential 
hiPSC colonies based on morphology with an effective flow cytometry sort-
ing and expansion strategy: capturing individual hiPSCs by unique pluripo-
tency surface markers to efficiently obtain, expand and characterize clonal 
hiPSC lines. Importantly, hiPSCs derived and maintained using this platform 
retain genomic stability over multiple passages, effectively differentiate into 
the three germlayers and are seen to have minimal requirements for extrinsic 
signaling. Furthermore, we have demonstrated that hiPSCs previously gen-
erated in conventional feeder-systems can be adapted to our feeder-free and 
single cell culture platform. hiPSCs adapted to or generated in our platform 
are more similar to human embryonic stem cells, indicated by global expres-
sion profiling, reduced Xist activity and compact and dome-like morphol-
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ogy when reintroduced on to feeder cells; all suggestive of naïve status. 
This study provides a chemical platform that not only facilitates the single 
cell and the defined culture of clonally derived feeder-free hiPSCs but also 
makes possible the generation of pharmaceutical-grade hiPSCs for regenera-
tive medicine applications.
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We have extensive experience in cGMP banking of various cell lines in 
support of human clinical trials, including various viral vector producer lines, 
human feeder lines, and transformed neural stem cell (NSC) lines. Over the 
past several years we have focused our attention on the development of 
cGMP processes for banking and differentiation of human embryonic stem 
cells (hESCs) in support of planned and anticipated clinical studies. We have 
developed an adherent hESC line suspension culture adaptation process and 
a scalable suspension culture system using defined reagents. We have dem-
onstrated that this system will support extensive passaging and expansion of 
several hESC lines. To develop the process, we assessed different serum-free, 
defined media and a broad spectrum of additive factors, including kinase 
inhibitors, cytokines, and adhesion modulators in small-scale rotary culture. 
Promising conditions were further tested in small-scale spinner culture. Our 
data shows that hESC cultured in the presence of a ROCK inhibitor and 
increased bFGF supported undifferentiated growth of hESC lines as small 
aggregates in suspension. Ultra-structural staining, immunohistochemistry, 
and confocal microscopic analyses of these cellular aggregates reveal high 
expression of pluripotent markers on the cells comprising the aggregates. 
Suspension culture parameters were further improved by assessing changes 
in agitation rate, seeding density, and passage interval to optimize cell 
growth while minimizing differentiation rates. Under optimized culture con-
ditions, we demonstrated that hESCs can be serially passaged for more than 
15 times in spinner flasks and expanded in large-scale to over 1x107 fold in-
crease. The expanded cells retained a normal karyotype, low differentiation 
as measured by SSEA-4, Tra-1-60 and Tra-1-81, and Oct-4, high viability 
(>85%), and EB forming capability. Epigenetic analysis of the suspension 
culture showed high similarity to fingerprints from hESC cultured on mouse 
embryonic fibroblasts (MEFs). The cells can be cryopreserved in serum-free 
medium and thawed into adherent or suspension cultures with high viability 
(>85%). We have successfully used this method under cGMP conditions to 
generate cell banks of 200-400 vials of the hESC lines HES-2, H1, and H9. 
Taken together, our suspension culture system provides a powerful approach 
for scale-up expansion of hESCs and is suitable for process transfer to our 
GMP facility for banking and bulk differentiation of hESC lines in support of 
clinical studies as a national resource.
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DEFINED, XENOBIOTIC-FREE MICROCARRIER 
CULTURE FOR ISOLATION OF NOVEL HUMAN 
INDUCED PLURIPOTENT STEM CELLS AND FOR 
MASS PRODUCTION
Monsma, Scott A., Marty, Andrea L., Garcia II, Bradley H.
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Current methods for creation of new human induced pluripotent stem 
cell lines (iPSC) require frequent, labor intensive culturing steps to achieve 
isolation of iPSC from the population of parental somatic cells that were 
not induced to pluripotency, and to expand the iPSC population before 
beginning differentiation. Two recent publications have reported the use of 
microcarrier based stirred-suspension bioreactors for cultivation of human 
embryonic stem cells (hESC) and iPSC. Both studies employed microcarriers 
coated with extracellular matrix extract derived from tumors grown in mice 
(BD Matrigel™). However, to fulfill the promise of iPSC as a clinical-grade 
source for regenerative and cellular therapies, xenobiotic and undefined 
materials (serum, Matrigel, conditioned media) must be excluded at all 
stages of culture, from the creation of the iPSCs through clone selection and 
propagation/expansion. It also is essential for consistency to automate as 
much of the culture process as possible, while maintaining the pluripotency 
and robust proliferation of the iPS cells. Primorigen is addressing these needs 
by developing a xenobiotic-free, feeder cell-free, scalable stirred suspension 
bioreactor culture system for mass production of iPSC lines using Primori-
gen’s proprietary stem cell attachment factor, StemAdhere XF™. StemAd-
here XF is a highly purified, xenobiotic-free recombinant human protein that 
enables calcium-dependent adhesion and proliferation of pluripotent stem 
cells. StemAdhere XF has been immobilized on a variety of porous and solid 
microcarriers, and used to expand existing iPSCs in stirred cell bioreactors.
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IN VIVO AND IN VITRO GENE INDUCTION IN 
T LINEAGE CELLS DERIVED FROM HUMAN 
EMBRYONIC STEM CELLS
Scripture Adams, Deirdre, Brown, Helen, Chen, Hongying, Zhong, 
Nianxin, Bristol, Greg, Kacena, Amelia, Zack, Jerome A., Galic, 
Zoran
University of California, Los Angeles, Los Angeles, CA, USA
Stem cell therapies which rely on transplantation of a permanently modi-
fied population of hematopoietic cells which express a gene of therapeutic 
interest lack both the safety and the increased efficacy afforded by a more 
directly regulated expression system. To address this problem, we have 
modified hESC lines such that a gene of interest can be tightly regulated by 
treatment with doxycyclin. We derived hematopoietic precursors from these 
lines, and have generated thymocytes in vivo from these precursors using 
our recently reported SCID-hu based method. We subsequently elicited ex-
pression of a gene of interest in vitro in these cells following co-stimulation, 
and have further shown that an induced external reporter protein correlates 
directly with the level of expression of a protein of interest. We can now ex-
plore in vivo gene induction using these doxycylin responsive hESC derived 
T lineage cells, and we will present preliminary data demonstrating in vivo 
induction in the SCID-hu system. We anticipate that tight regulation of ex-
pression of therapeutically important proteins will be essential to long term 
patient treatment success and safety, and we thus present here one method 
to achieve the desirable level of control.
ISSCR 9th Annual Meeting
80
www.isscr.org
Friday Poster Abstracts
Poster Board Number: 2180
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CD34(+)CD38(-) HEMATOPOIETIC STEM CELL 
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BACKGROUND: Human peripheral blood is a promising source of autolo-
gous stem-progenitor cells such as endothelial progenitor cells or he-
matopoietic stem cells However, the rarity of stem cell population and lack 
of effective method to expand or differentiate it remained a major hurdle for 
its application. Recently, Spheroid cultures of various stem-progenitor cells 
have been successfully used to expand or differentiate stem cells in embry-
onic, cardiac, neurogenic and cancer stem cells. METHODS AND RESULTS: 
Here, we described a novel method of Lin(-)CD34(+)CD38(-) hematopoi-
etic stem and progenitor cells(HSPCs) expansion using spheroid culture of 
human peripheral blood mononuclear cells (hPBMCs) without synthetic 
growth factors or artificial niche. The spheres, termed as ‘Blood-Born Hema-
tospheres (BBHS). We found that self-renewal of CD34(+) hematopoietic 
stem-progenitor cells(HSPCs) were localized inside BBHS. Flow cytometry 
analysis revealed that HSPCs exponentially increased between day 3 and day 
7 during BBHS maturation and these HSPCs were functional in vitro, colony 
forming assay and in vivo, long-term SCID repopulating cell (SRC) assay. 
Freshly isolated MNCs contained scanty amount of Lin(-)CD34(+)CD38(-) 
cells. However, at day 5 of BBHS culture, 4-6% of Lin(-) cells were CD34(+)
CD38(-). The increase of absolute Lin(-)CD34(+)CD38(-) count at day 3 
and day 5 were 5.2- and 9.4-fold, respectively. Culture of 2.0 x 107 MNCs, 
which usually corresponds to 10ml of peripheral blood from healthy donor, 
yielded 1.5 ± 0.2 x 105 Lin(-)CD34(+)CD38(-) cells at day 5 which cor-
responds to 1.6% of total cell and 7.2% of lineage-negative fraction. BBHS 
culture expands phenotypic Lin(-)CD34(+)CD38(-) cells average 10-fold 
and yields 6-fold expansion of colony forming progenitors. BBHS consists 
of heterogenous blood cells and CD14(+) cells were found to be the cellular 
component of BBHS and its exclusion disrupted the sphere formation. Fur-
thermore, BBHS provided natural extracellular matrix deposition such as Fi-
bronectin, laminin and collagen I,III, and IV for human stem-progenitor cells 
self-renewal. CONCLUSION: Here, we described a new method that high 
density suspension culture of peripheral blood mononuclear cells results in 
spontaneous formation of hematopoietic cell spheroids. The culture system, 
which we termed BBHS, potentiates the expansion of rare circulating Lin(-)
CD34(+)CD38(-) HSPCs population in the sphere. The expanded HSPCs 
remained functional in vitro and in vivo. Our novel strategy of ex vivo ex-
pansion of human stem-progenitor cells using self-organized hematopoietic 
sphere provides an innovative autologous HSPCs source and a new model to 
investigate adult stem cell niche.
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QUANTITATIVE CYTOLOGICAL FEATURE 
ANALYSIS BY MICROFLUIDIC IMAGE 
CYTOMETRY REVEALS PHENOTYPIC 
DIFFERENCES AMONG HUMAN PLURIPOTENT 
STEM CELL LINES
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Gschweng, Eric2, Witte, Owen N.2, Graeber, Thomas G.2, Nakatsuji, 
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Kyoto, Japan, 2Department of Molecular and Medical Pharmacology, 
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Human pluripotent stem cells (hPSCs), including embryonic stem (ES) and 
induced pluripotent stem (iPS) cells hold a great potential for applications 
in cell-based therapy, drug screening and regenerative medicine as well 
as developmental biology due to their unique characteristics, such as (i) 
unlimited self-renewal at undifferentiated stage with normal karyotype and 
(ii) the ability to differentiate any cell types in a human body. However, 
recently, even though hiPSCs were generated to mimic hESC characteristics, 
there have been some studies reported that assess the similarities and differ-
ences between hiPSCs and hESCs. Indeed, some of the hiPSC lines appear 
to vary morphologically and behave differently in chemically defined media 
due to variables involved in the derivation/culture methods. Moreover, 
there are the additional concerns that hPSCs generate highly heteroge-
neous populations during culture and might affect the purity of targeted 
cells during induced differentiation. Therefore, it is necessary to develop 
new methodology to systematically assess the difference individual hPSC 
characteristics to address these issues. Microfluidic image cytometry (MIC) 
is advantageous over flow cytometry for profiling cell behavior at a single 
cell level due to its capabilities of (i) well-controlled cellular environments, 
(ii) higher-throughput and multiparametric assays for individual cells and 
(iii) in situ real-time cell monitoring. In these years, we have developed MIC 
platforms for characterizing individual hPSCs cultured in chemically defined 
medium and diagnosing glioblastoma patients in vitro. While genetic and 
epigenetic approaches can provide valuable information, in this study we 
have used MIC technique to indentify an alternative way to compare and 
distinguish the current state of a particular iPSC line from another iPSC line 
or other ESC lines and determine relative status of pluripotency by analyzing 
the unique cytological features of hiPSCs at a single cell level. To begin with, 
we established the two sets of phenotypic markers that could characterize 
hPSCs based on cytological features collected at single cell level. General 
cytological features evaluated in the experiments include, but not limited to, 
the size, texture, shape and maker intensity of nucleus, cytoplasm or both 
and the distance between neighbor cells. In terms of phenotypic markers, 
the first set contains 5 markers aimed to check for cell cycling and apoptosis: 
i) DAPI for DNA contents, the size of nucleus and G1 and G2 phase in cell 
cycle, ii) phosphorylated-Histone H3 and iii) EdU for M and S phases in cell 
cycle respectively, and iv) Caspase-3/7 for apoptosis (Phenotype assay I). 
The second set includes 3 markers: i) DAPI for DNA contents, ii) OCT4 and 
iii) SSEA1 for pluripotency and differentiation, respectively (Phenotype assay 
II). Finally, we have established the multi-parametric microfluidic phenotypic 
assays combined with biostatistic analyses (i.e., common factor analysis, self-
organizing map analysis and hierarchical clustering) that provide a collection 
of cytological features. Interestingly, unsupervised hierarchical clustering 
of SOM data revealed that hESC lines and hiPSC lines were distinguished, 
and hiPSC lines was categorized into a same group with IMR90 somatic 
fibroblast cell line.
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MICROFLUIDIC CLONAL CULTURE OF HUMAN 
EMBRYONIC STEM CELLS
Sikorski, Darek1, Caron, Nicolas J.2, VanInsberghe, Michael3, 
Hansen, Carl L.3, Piret, James M.1
1Department of Chemical and Biological Engineering, University of British 
Columbia, Vancouver, BC, Canada, 2Michael Smith Laboratories, University 
of British Columbia, Vancouver, BC, Canada, 3Department of Physics and 
Astronomy, University of British Columbia, Vancouver, BC, Canada
The analysis of human embryonic stem cells (hESCs) at the single cell level 
is limited by low hESC plating efficiencies and limitations to analytical 
throughput. We have developed a sub-line of CA1 hESCs (CA1S) that can 
be passaged as suspensions of single cells with high plating efficiency (24 ± 
4% compared to 0.4 ± 0.1% for CA1 cells). The CA1S cells display normal 
karyotype, growth rates, pluripotency marker expression, differentiation 
potential and teratoma formation. For the purpose of analyzing clonal CA1S 
cell cultures, we have fabricated a microfluidic cell culture platform consist-
ing of 160 individually addressable parallel 500 x 500 um culture chambers 
adapted to perfusion culture of isolated hESC colonies, each in 25 nL. This 
device and the CA1S cell line extend the state of the art for hESC culture by 
analyzing colony growth from single-cell suspensions, precise quantification 
of cell growth by counting individual cells and observation of colony surface 
marker heterogeneity, during clonal cell maintenance or differentiation. The 
overall microfluidic device culture performance was optimized until growth 
rates in the chip (td = 23.4 ± 1.6 h, n=3) matched conventional hESC 
culture growth rates (td = 22.5 ± 2.9 h, n=3) and exhibited normal colony 
morphologies. Microfluidic immuno-staining showed that the cells cultured 
on chip remained positive for Oct4, Tra-1-60 and SSEA-3. Furthermore, cells 
recovered from the device were positive for cell surface markers associated 
with the undifferentiated state such as SSEA-3 (99.8% positive) and TRA-1-
60 (96.5% positive). This system provides live-cell imaging of many isolated 
conditions for dynamic medium change investigations and for directed dif-
ferentiation of hESCs, resolving cell-to-cell and colony-to-colony variations.
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COMPARATIVE ANALYSIS OF GENE 
EXPRESSION AND FIBROBLAST COLONY 
FORMING ABILITIES OF HUMAN ADIPOSE 
OR UMBILICAL CORD DERIVED PROGENITOR 
CELLS
Kim, Ji Hyang1, Han, Su-Youne1, Cho, Jung Ah1, Kim, Byeong Kyu1, 
Oh, Soon Nam2, Yoon, Yong-Dal3, Kim, Chul Geun3, Do, Byung-
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Mesenchymal stem cells (MSCs) from adipose tissue (AT) or umbilical cord 
(UC) are regarded to be important for the source of regenerative medicine. 
Recent studies have suggested stable expansion of cell growth and mainte-
nance of intrinsic characteristics are necessary to investigate or develops a 
cell therapy. Therefore, this study investigates the gene expression profiling 
and the frequencies of colony-forming unit-fibroblast (CFU-F) of human 
AT- or UC-MSCs. The cells were prepared by enzymatic dissociation and 
characterized by flow cytometry (CD31, CD34, CD90, CD45, and CD117). 
Gene expression was analyzed by NimbleGen Human Whole Genome 
12-plex Array and hybridization by MAUI system. Functional genes related 
signal transduction, transport, differentiation and immune response showed 
differential expression after ex vivo expansion. Of 44,049 genes, 917 genes 
significantly expressed in AT-MSCs compared to UC-MSCs. Especially, gene 
expression of inflammatory response, cell migration, growth and metastasis 
showed similar patterns (< 8 genes). After a culture period of 14 days, prolif-
eration potential of CFU-F was evaluated. Human umbilical vein endothelial 
cells (HUVECs) were used as negative control and had a disability of colony-
forming. By image analysis, results of the UC-MSCs increased more than 
55 percent the rate of AT-MSCs. Population doubling levels of both MSCs 
showed a high rate (> 35th doublings), although their value of CFU-F was 
indicated significant difference. These data indicate that AT- or UC-MSCs 
have similar gene expression profiling and high proliferation ability. Further 
studies are required to investigate the characteristics and differentiation abil-
ity of AT- or UC-MSCs in modified conditions or long-term culture.
Poster Board Number: 2188
REVERSAL OF TYPE 1 DIABETES THROUGH 
THE IMMUNE MODULATION OF HUMAN CORD 
BLOOD-DERIVED MULTIPOTENT STEM CELLS
Zhao, Yong
Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA
Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease that results 
in a shortage of pancreatic islet β cells. To date, many approaches have 
been investigated to find a cure for T1D. All in all, control of autoimmunity 
is the top priority for the prevention and treatment of T1D, followed by 
the provision of β-cell surrogates and reconstruction of functional islets. 
If unaddressed, the autoimmune cells can destroy those β-cell surrogates 
and limit their therapeutic potential. Due to the polyclonal nature of the 
autoimmune response and the global problem of immune regulation in 
T1D, approaches that individually targeting different arms of the immune 
system have been uniformly unsuccessful in T1D prevention trials. Stem cells 
hold great promise for the treatment of T1D in overcoming the shortage 
of insulin-producing cells. For a long time, most work on stem cells has 
focused on regulating their differentiation to replace a specific physiologic 
function. We identified a novel type of stem cell from human umbilical cord 
blood, designated cord blood-derived multipotent stem cells (CB-SC), which 
display embryonic stem (ES) cell characteristics and multiple potential of 
differentiations. Recently, our animal data revealed that CB-SC can function 
as an immune modulator that can lead to control of autoimmune responses, 
which could in turn be used as a new approach to overcome the autoim-
munity of T1D in patients. In vitro co-culture experiments demonstrated 
that direct suppression of CB-SC on the islet β-cell GAD-specific CD4+ T 
cell clone generated from T1D patients. The proliferation of this T cell clone 
was markedly decreased in the presence of CB-SC compared to the control 
group in the absence of CB-SC. To translate this technology into clinics, we 
invented a device Stem Cell Educator that is optimized for CB-SC culture 
and clinical treatment via connecting with Blood Cell Separator. In collabora-
tion with a medical center in China, Phase I clinical trial (n = 19, 10 males, 9 
females) has demonstrated the feasibility and safety of Stem Cell Educator 
therapy. Ongoing studies have confirmed that T1D patients (n = 9, aged 15-
48 years, diseased for 1-17 years) receiving Educator therapy experienced 
improvement of metabolic control, a marked reduction of HbA1c values, 
decreasing insulin doses, and increasing C-peptide values both at baseline 
and 2 hours post high glucose challenge. Additionally, immune characteriza-
tions have revealed the reversal of autoimmunity of T1D, the restoration of 
Th1/Th2 cytokine balance, the marked up-regulation of Foxp3+ regulatory 
T cells (Tregs) in peripheral blood. The whole procedure is simple, safe and 
very cost-effective. The Autoimmune Regulator (Aire) usually expressed in 
thymic medullary epithelial cells, plays an important role in immune toler-
ance by mediating the ectopic expression of peripheral self-antigens and the 
deletion of auto-reactive T cells. To explore molecular mechanisms underly-
ing the immune modulation of CB-SC, we found CB-SC express Aire at both 
mRNA and protein levels. Using three pairs of human Aire-specific small 
interfering RNAs (siRNA) to knockdown Aire expression, functional analysis 
demonstrated that expression of Aire in CB-SC contributes to the immune 
modulation. Thus, our findings have the potential for enormous clinical 
ISSCR 9th Annual Meeting
82
www.isscr.org
Friday Poster Abstracts
impact on T1D, by paving the way toward the development of novel Stem 
Cell Educator therapy to reverse diabetes in T1D patients.
Poster Board Number: 2190
CXCR1 MEDIATED MIGRATORY CAPACITY OF 
HUMAN UMBILICAL CORD BLOOD-DERIVED 
MESENCHYMAL STEM CELLS TOWARD 
GLIOMAS
Kim, Seong Muk1, Kim, Dal-Soo2, Jeong, Chang Hyun1, Jeun, Sin-
Soo1, Oh, Wonil2, Chang, Jong Wook2
1The Catholic University, Seoul, Korea, Republic of, 2Biomedical Research 
Institute, MEDIPOST Co., Ltd., Seoul, Korea, Republic of
The use of tumor-tropic mesenchymal stem cells (MSCs) as a delivery 
vehicle of antitumor agents is a promising approach in cancer gene therapy. 
However, achieving a sufficient number of tumor-targeted MSC may be a 
limitation of this strategy. Interleukin-8 (IL-8) released by glioma cells medi-
ate the tropism of MSC toward tumors. Here, we show that transfection of 
the IL-8 receptor, CXCR1, on human umbilical cord blood-derived MSCs 
(UCB-MSCs) enhanced the migratory capacity of MSC toward gliomas. We 
showed that UCB-MSCs have the migratory ability toward the glioma cell 
lines and primary glioma cells. IL-8 treatment increased the migration of 
UCB-MSC in a dose-dependent manner and inhibition of IL-8 by treat-
ment with the anti-IL-8 or IL-8 siRNA transfection into glioma cells blocked 
the migration capacity of UCB-MSC toward glioma cells. Furthermore, 
CXCR1-transfected UCB-MSCs (CXCR1-MSCs) showed a superior migratory 
capacity toward glioma cells compared with primary MSCs in vitro migration 
experiment, and also exhibited enhanced migration toward tumors in mice 
bearing intracranial human glioma by the histological and in vivo imaging 
analysis. Our findings indicate that overexpression of CXCR1 may be a use-
ful tool for MSC-based gene therapy to achieve desirable sufficient quantity 
of therapeutic MSC that localize within tumors.
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GENERATION OF ICM-TYPE HUMAN IPS CELL 
FROM CD34+ CORD BLOOD CELLS
Nishishita, Naoki1, Takenaka, Chiemi1, Shikamura, Masayuki2, 
Matsushima, Kentaro2, Fusaki, Noemi3, Kawamata, Shin1
1Foundation for Biomedical research and Innovation and RIKEN CDB, 
KOBE, Japan, 2Foundation for Biomedical research and Innovation, KOBE, 
Japan, 3DNAVEC Corporation and PRESTO, JST, Tsukuba, Ibaraki 300-2611, 
Japan
Mouse ES cell lines from C57BL/6N or 129Sv strain are the ICM-type stem 
cells. They can contribute to chimerism when placed into blastocyst and 
be passaged in a single cell suspension. However human ES cells or iPS 
cells cannot contribute to chimerism and retain the similar gene expression 
pattern to the mouse Epiblast. They are called the Epistem-type stem cells 
and can be passaged as cell clumps. In this study, we have reprogrammed 
CD34+ cord blood cells with Sendai virus integrating factors (Oct3/4, 
Sox2, c-myc, Klf4) and by culturing the infected cells in the ICM-type stem 
cell culture condition [N2B27 based media supplemented with LIF, GSK3 
inhibitor, MEK inhibitor and forskolin under 5% O2 hypoxic condition] for 
single cell cloning. Approximately five dome shape-like, colonies emerged 
from 1X104 freshly isolated CD34+ cord blood cells around 14 days when 
co-cultured with feeder cell line SNL. Removal of SeV construct from 
the reprogrammed cells was examined in single cell level by RT-PCR and 
immune-staining for viral construct during several passages in the ICM-
type stem cell culture. As we cannot maintain the ICM-type stem cell by 
this culture method for more than 10 passages, reprogrammed ICM-type 
stem cells were converted to EpiSCs-type by changing culture condition to 
KSR-based human ES media with bFGF in 20 % O2 condition for further ap-
praisal of differentiation potential of reprogrammed cells. Our report would 
provide the safer iPS generation method for future clinical application of iPS 
cell-derived cell therapy.
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THE ROCK INHIBITOR Y-27632 PROMOTES 
MOTOR NEURON GENESIS, MOTOR NEURON 
SURVIVAL AND NEURITE OUTGROWTH 
IN CULTURES DERIVED FROM HUMAN 
EMBRYONIC AND INDUCED PLURIPOTENT 
STEM CELLS
Lamas, Nuno J., Wichterle, Hynek, Henderson, Christopher E.
Pathology, Neurology, and Neurobiology and Behavior, Columbia 
University Medical Center, New York, New York City, NY, USA
Human Embryonic Stem Cells (hESCs) and Induced Pluripotent Stem Cells 
(iPSC) can virtually give rise to all cell types in the body, constituting an 
inexhaustible source of disease relevant cell types, which creates new excit-
ing opportunities in the study of incurable neurodegenerative disorders like 
Amyotrophic Lateral Sclerosis (ALS), where affected cell types are naturally 
hard to obtain. Conditions for patterning of hESC and iPSC cells resulting 
in specification of motor neurons (MNs) have been extensively studied and 
in general work robustly. However, less is known about the mechanisms 
that control motor neuron genesis and human motor neuron survival. Here, 
using human ES-derived MNs, we performed a medium-throughput screen 
to identify compounds that increase MN numbers and found the putative 
Rho-associated Kinase (ROCK) Inhibitor Y-27632. We demonstrate that this 
molecule increases MN numbers approximately 5-fold over 09 days treat-
ment comparatively to control conditions. We dissected the mechanisms 
and demonstrate that Y-27632 compound provides a small, but significant 
increase in motor neuron survival and neurite outgrowth - two effects previ-
ously attributed to the Y-27632 compound in other cellular contexts. Inter-
estingly, the most significant effect was on increased cell proliferation lead-
ing to the amplification of the number of progenitor cells in MN lineage and 
human motor neurons. This was also documented in MN cultures derived 
from several wild-type hESC and iPSC cell lines. In conclusion, we identified 
a reagent that increases motor neuron yields and will facilitate more efficient 
utilization of hESC or iPSC derived MNs for cell-based screening and other 
clinical applications.
Poster Board Number: 2196
DEVELOPMENT OF HIGHLY SENSITIVE ASSAYS 
TO DETECT RESIDUAL HUMAN EMBRYONIC 
STEM CELLS FROM HUMAN EMBRYONIC STEM 
CELL DERIVED CARDIOMYOCYTES
Lindquist, Jeffrey N., O’Sullivan, Christopher, Gold, Joseph, 
Natesan, Arjun
Cell Technologies, Geron Corporation, Menlo Park, CA, USA
Human embryonic stem cell (hESC) can be differentiated to pure populations 
of a variety of cell types, providing a promising source of cells for disease 
therapy. However, a major concern with hESC-derived cell therapies is the 
possibility of teratomas from residual embryonic stem cells. To address this 
concern we developed a functional assay, hESC-like colony formation, to 
detect very rare residual embryonic stem cells in embryonic stem cell-derived 
cardiomyocyte preparations. When undifferentiated hESCs are spiked as 
single cells into a lot of hESC-derived cardiomyocytes, the appearance of 
colonies is directly proportional to the input hESC cell number. Furthermore, 
we have identified the presence of very low-levels of residual cells capable 
of forming colonies in unpurified hESC-derived cardiomyocytes utilizing this 
assay. In parallel, we have developed an assay to accurately identify and 
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quantitate rare OCT4A expressing cells in a mixed population. Using an im-
munofluorescent high content analysis approach, we are able to accurately 
identify spiked hESCs in a lot of highly purified hESC-derived cardiomyo-
cytes in a linear fashion down to less than 0.0002%. We performed FACS 
to divide the cardiomyocyte preparation into sub-populations based on 
surface marker expression and discovered that the colony forming activ-
ity is restricted to cells that express a number of canonical hESC markers. 
Interestingly, we found that the number of colonies correlated with the 
levels of OCT4A expressing cells. This population of OCT4A positive cells 
is a very small fraction of the cells within this stem-cell like population. The 
remaining hESC-derived cardiomyocyte population contained no detect-
able OCT4A+ cells and no colony-forming ability. Here we demonstrate the 
ability to detect residual hESC-like cells with remarkable sensitivity using a 
functional colony-formation assay and a high content analytical screen to 
detect OCT4A expressing cells. This addresses a critical safety issue for the 
use of hESC-derived cells in cell transplant therapy.
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ESTABLISHMENT OF GENE EXPRESSING 
ARTIFICIAL CHROMOSOMES IN HUMAN 
EMBRYONIC STEM CELLS
Mandegar, Mohammad A.1, Moralli, Daniela1, Khoja, Suhail1, 
Cowley, Sally2, Chan, David YL1, Yusuf, Mohamed1, Mukherjee, 
Sayandip3, Blundell, Mike P3, Volpi, Emanuela V1, Thrasher, Adrian 
J3, James, William2, L. Monaco, Zoia1
1Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, 
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United Kingdom, 3UCL Institute of Child Health, University College 
London, London, United Kingdom
Development of efficient gene delivery platforms in human embryonic stem 
cells (hESc) is vital to realizing their full potential for basic and clinical stud-
ies. The purpose of this study was to develop an efficient, non-integrating 
gene expression system in hESc using human artificial chromosomes (HAC). 
Similar to endogenous chromosomes, HAC are capable of gene expression, 
replication and segregation during mitosis. HAC present certain advantages 
over conventional gene delivery vectors, as they do not integrate into the 
host genome and can encompass large genomic regions for the delivery of 
multiple genes. Despite the advantages HAC offer, their use has been limited 
due to low cloning and transformation efficiencies, thus only studied in im-
mortalized and tumor derived human cell lines. In this study, we utilized the 
high transduction efficiency of Herpes Simplex Type-1 (HSV-1) amplicons 
to overcome the aforementioned difficulties and subsequently delivered 
HAC vectors into hESc. Analysis of stable hESc clones showed that de novo 
gene- expressing HAC were present at high frequencies without integrat-
ing into the host genome. Established HAC contained an active centromere, 
and were stably maintained without integration or loss in the absence of 
selection for 30 passages. Stable HAC containing hESc clones retained their 
pluripotency and differentiation capabilities as demonstrated by neuronal 
differentiation, in vitro germ layer and teratoma formation assays. Our 
findings are proof of principle study that hold potential for delivering high 
capacity genomic constructs safely and efficiently into hESc for the purpose 
of genetic manipulation and ultimately, somatic gene therapy.
Poster Board Number: 2200
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Increasing the efficiency of gene targeting in human embryonic stem cells 
(hESCs) and human induced pluripotent stem cells (hiPSCs) is essential to 
improve both the experimental and therapeutic potential of these cells. 
Although gene targeting by electroporation has been routinely used in 
mouse embryonic stem cells (mESCs), its application in hESCs and hiPSCs 
has been limited. By using high-capacity helper-dependent adenoviral vector 
(HDAdV), we previously reported ~45% of relative targeting efficiencies 
at the HPRT1 locus in hESC lines. In this study, we expanded the general 
applicability of HDAdVs to both gene knock-out and knock-in at both tran-
scriptionally active (KU80, LIG1, LIG3) and inactive (motor neuron-specific 
HB9) loci in hiPSCs. At these five loci, 3 to 59% of vector chromosomal 
integration (G418-resistant colonies; G418R) were found at the target loci, 
judged by PCR analyses, indicating a strong affinity of the gene targeting 
cassettes delivered by HDAdVs with homologous chromosomal sequences. 
After detailed Southern analyses with multiple probes and enzymes, 
68-100% of these site-specific integration events were confirmed to be 
mediated by accurate homologous recombination (HR) without additional 
ectopic integrations, resulting in overall gene targeting efficiencies of 7-81% 
without detectable effects on undifferentiated state and pluripotency. As 
one example, to examine the efficiency of HDAdV-mediated gene target-
ing at transcriptionally inactive loci, reporter hESC and hiPSC lines were 
established, in which the enhanced green fluorescent protein (EGFP) gene 
was knocked into the HB9 locus by HR. HB9 is expressed selectively in mo-
tor neurons in the developing vertebrate central nervous system but not in 
ES/iPS cells. Southern analyses demonstrated that 57% of G418R/ GANCR 
colonies, originated after infection with the HB9-GFP knock-in HDAdV, had 
been accurately targeted at the locus. The HB9 locus was also targeted in 
the hiPSC line at similar efficiencies, indicating that HDAdV-mediated gene 
targeting is equally efficient regardless of the transcriptional activities of 
target loci. Subsequently, the HB9-EGFP knock-in hiPSC line was induced 
to differentiate into motor neurons. Immunofluorescence analysis revealed 
a correlation between EGFP and HB9 expression, suggesting the EGFP gene 
was precisely knocked into the target chromosomal site by HDAdV-medi-
ated gene targeting. HR has to be highly accurate for applications such as 
establishment of knock-in hESC/hiPSC lines to obtain tissue-specific expres-
sion of an inserted reporter gene. Furthermore unintended mutations during 
chromosomal manipulation are obviously not acceptable for therapeutic 
applications, such as gene repair therapy using patient-specific iPSCs. Our 
results indicate that HDAdVs would be the best suited for manipulation of 
iPSCs for clinical applications because of the highly efficient and accurate 
gene targeting with minimal cytotoxicity.
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STENCIL PATTERNING METHOD IMPROVES 
UNIFORMITY OF HUMAN PLURIPOTENT STEM 
CELL COLONIES
Myers, Frank B.1, Silver, Jason S.1, Abilez, Oscar J.2, Zarins, Chris K.3, 
Lee, Luke P.1
1Bioengineering, University of California, Berkeley, Berkeley, CA, USA, 
2Bioengineering, Stanford University, Stanford, CA, USA, 3Surgery, Stanford 
University, Stanford, CA, USA
Geometric factors including the size, shape, and density of pluripotent stem 
cell colonies, as well as the spacing between neighboring colonies, play a 
significant role in the maintenance of pluripotency and in cell fate determi-
nation. These factors are impossible to control using standard tissue culture 
methods. As such, there can be substantial batch-to-batch variability in cell 
line maintenance and differentiation yield. Not only does this variability 
pose a challenge in the laboratory setting, but it is a significant barrier to 
developing large scale cell production methods for clinical applications. We 
have developed a simple, robust technique for patterning Matrigel using 
a thin silicone stencil. We have observed that patterned arrays of Matrigel 
spots lead to human induced pluripotent stem cell (hiPSC) colonies which 
are highly uniform in growth rate, size, and shape. Patterned cell colonies 
are capable of undergoing directed differentiation into spontaneously 
beating cardiomyocyte clusters. We anticipate that this patterning method 
can improve both yield and repeatability in many stem cell differentiation 
procedures.
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FLOW CYTOMETRY TECHNIQUES FOR HUMAN 
PLURIPOTENT STEM CELLS AND THEIR 
DERIVATIVES
O’Connor, Eric, Willert, Karl
Stem Cell Department, University of California, San Diego, La Jolla, CA, 
USA
Human pluripotent stem cells (hPSCs, which encompass both embryonic and 
induced pluripotent stem cells) are evolving into a powerful model by which 
to study early human development and will likely provide many therapeutic 
interventions for currently incurable diseases. Since these cells are able to 
differentiate into all cell lineages, a major challenge has been to isolate and 
study pure cell populations. To overcome this substantial hurdle, we have 
established the UCSD Human Embryonic Stem Cell Core Facility (HESCCF) 
equipped with state-of-the-art instrumentation for flow cytometry and 
imaging. The facility houses a four laser, custom designed FACS Aria 2 cell 
sorter capable of processing and sorting four cell populations at rates up to 
20,000 cells per second, a 3 laser digital flow cytometer for high resolution 
analysis, as well as several confocal and fluorescence based imaging systems. 
In collaboration with a number of users of the HESCCF we are developing 
flow cytometry based approaches with particular emphasis on applications 
for hPSCs. Here we present three flow cytometry techniques that will prove 
to be invaluable to the greater stem cell community. First, we demonstrate 
feasibility for single cell sorting to establish clonal hPSC lines. This method is 
particularly useful for gene transduction of hPSC where transgene expres-
sion is dependent on the site of integration in the genome. Using lenti-viral 
based systems to transduce inducible shRNAs, we have isolated clonal lines 
with maximal gene knockdown. Cells of interest can then be stained and 
sorted to establish clonal cell cultures. Second, we are using fluorescence 
activated cell sorting to enrich various differentiated progenitor populations, 
including those of the neural ectodermal and endodermal lineage. Such 
methods can be used to eliminate undifferentiated cells yielding homog-
enous cell populations suitable for molecular analysis or cellular transplanta-
tion into animal models. Various approaches are employed to achieve this 
aim, and the core facility engages in ongoing collaborations with academic 
investigators and private companies to improve laboratory protocols and 
develop new reagents to characterize distinct cell populations. Along with 
traditional surface staining and sorting, new techniques such as lyoplate 
screening, fluorescent barcoding, and intracellular staining have enabled 
the core facility to assist investigators in identifying and isolating target cell 
populations. Advances in high throughput technology allow for analysis 
of a wide range of conditions including efficiency of various combinations 
of reprograming factors and the role of small molecules in determining cell 
fate. Finally, we are developing methods to detect and monitor the stages 
and efficiencies of induced pluripotent stem cell (iPSC) generation. Stable 
cultures can be established based on the detection of early reprograming 
events occurring at low frequencies allowing us to examine the effect of 
WNT developmental regulators on iPSC generation.
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ATOMIC SIGNATURE OF MOUSE AND HUMAN 
PLURIPOTENT STEM CELLS
Cardoso, Simone C.1, Stelling, Mariana P.2, Paulsen, Bruna S.2, 
Rehen, Stevens K.2
1Instituto de Física, Universidade Federal do Rio de Janeiro, Rio de Janeiro, 
Brazil, 2Laboratório Nacional de Células-Tronco Embrionárias, Universidade 
Federal do Rio de Janeiro, Rio de Janeiro, Brazil
The mechanisms underlying pluripotency in embryonic and reprogrammed 
stem cells are unclear. In this work we characterized the pluripotent towards 
differentiated state through analysis of trace elements distribution using the 
Synchrotron Radiation X-ray Fluorescence Spectroscopy. Embryoid bodies 
derived from embryonic and induced pluripotent stem cells were irradiated 
with a spatial resolution of 20 µm to make elemental maps and qualitative 
chemical analyses. Results show that these embryo-like aggregates exhibit 
self-organization at atomic level. Consistent elemental polarization pattern 
of S and P in both mouse and human pluripotent stem cells were observed, 
indicating that neural differentiation and elemental polarization are strongly 
correlated.
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THE SCALE-UP OF HUMAN EMBRYONIC STEM 
CELL CULTURE USING A HOLLOW FIBRE 
PERFUSION BIOREACTOR - THE QUANTUM 
CELL EXPANSION SYSTEM
Roberts, Iwan T.1, Moens, Nathalie1, Hernandez, Diana1, Rice, 
Brent2, Nguyen, Kim2, Janssens, Michiel3, Baila, Stefano3, Mason, 
Chris1
1Advanced Centre of Biochemical Engineering, University College London, 
London, United Kingdom, 2CaridianBCT/Beckman Coulter, Denver, CO, 
USA, 3CaridianBCT/Beckman Coulter, Brussels, Belgium
The successful translation of allogeneic stem cell therapies to treat large 
patient population indications requires the realisation of economies of scale 
to produce a consistent final product at a price point that the healthcare 
sector can afford. This goal necessitates the scale-up of cell culture, which 
traditionally takes place in the lab setting on tissue culture plastic. However, 
at larger scales, such methods demand an ever-increasing ‘footprint’ in 
expensive processing facilities. Therefore, alternative culture systems char-
acterized by high surface/volume ratios such as microcarrier or fibre based 
systems will likely need to be employed once the required cell number per 
batch rises above a critical point. Here we used the Quantum Cell Expan-
sion system (Provided by CaridianBCT and Beckman Coulter), a hollow fibre 
based perfusion bioreactor system to grow a human embryonic stem cell line 
in a co-culture system with inactivated mouse embryonic fibroblasts. The 
Quantum system is a functionally closed and temperature controlled system 
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comprised of ~10,000 hollow fibres of diameter ~200µm, generating a total 
area available for growth of 2.1m2 (21,000cm2). The machine’s physical 
dimensions are 48cm X 50cm X 58.4cm. Cells are grown on the inside of 
the fibres, where they experience a low shear environment. Oxygenation is 
provided via a gas transfer module, through which media on the outside of 
the fibres is circulated. The semi-independent flow paths on the inside and 
outside of hollow fibers enable glucose and lactate to transfer between the 
two loops, while any growth factors or proteins larger than ~15kDa remain 
on the inside loop with the adherent cells. A karyotypically abnormal hESC 
line was used in the experiments, due to its relative insensitivity to its own 
seeding density. Consequently, fewer cells are required to achieve a seeding 
density capable of supporting good proliferation on the large surface area 
of the system. Despite its abnormalities, the line still expresses pluripotency 
markers (e.g., Oct 4, TRA 1-60, SSEA-4) and will form embryoid bodies, 
which stain positive for markers representative of the three germ layers, Sox 
17, Nestin and Brachyury after re-plating. One hundred million hESC were 
seeded into the system atop two hundred and ten million mitomycin-C-
inactivated MEFs and cultured for 5 days. Flow rates were altered to control 
glucose and lactate levels to within that seen in flask culture. Data will be 
presented from the analysis of the harvested cells, detailing the expansion 
and viability (Vi-CELL Trypan Blue exclusion), maintenance of pluripotency 
marker expression from flow cytometry and PCR, and the sustained ability 
to form the three germ layers after embryoid body formation.
Poster Board Number: 2210
BFGF, TGFβ1 AND PDGF SUPPORT EXPANSION 
OF PRIMARY HUMAN MESENCHYMAL STEM 
CELLS IN SERUM-FREE CULTURE MEDIUM
Schnitzler, Aletta C., Kehoe, Daniel E., Simler, Janice L., Colman, 
Michael S.
EMD Millipore, Woburn, MA, USA
As an increasing number of stem cell therapies are explored and moved 
into early phase clinical trials, the demand rises for animal-free, chemically-
defined culture media that avoid the pathogen-safety risk and variability 
associated with animal serum. Bone marrow-derived mesenchymal stem 
cells (MSCs) are multipotent cells that can differentiate into various meso-
dermal lineage cell types and are currently being explored for the treatment 
of diseases including multiple sclerosis and graft-versus-host disease. We 
aim to develop an animal-free medium that supports rapid MSC expan-
sion in vitro, while maintaining their stem cell phenotype and multipotency. 
First, MSC growth rates were monitored using the Scepter™ cell counter in 
serum-containing medium supplemented with bFGF. We demonstrate that 
glucose level, culture density and atmospheric oxygen concentration are 
critical parameters affecting growth rates. Stem cell phenotype was deter-
mined in early, mid and late passages by RT-PCR or immunofluorescence of 
MSC markers, including Stro-1, CD44, CD90 and CD105. Adipogenic and 
osteogenic differentiation potentials were evaluated in later passages by im-
munocytochemistry. Maintenance of stem cell phenotype and differentiation 
potential was observed beyond passage ten. Next, a basal medium formula-
tion was developed for the expansion of MSCs in the absence of serum. This 
formulation was supplemented with human serum albumin (HSA) and the 
growth factors bFGF, TGFβ1 and PDGF, and supported higher growth rates 
of MSCs than did serum-containing medium. Interestingly, MSC growth 
varied significantly when different fractions of albumin, devoid of globulins, 
fatty acids or proteases, were compared. Further experimentation includes 
chemical composition analyses of serum fractions to identify molecules criti-
cal for MSC growth, as well as the examination of additional growth factors 
including BMPs and Wnt family members.
Poster Board Number: 2212
CELLFINDER: A NEW STEM CELL AND 
DEVELOPMENTAL BIOLOGY PLATFORM AND 
DATA REPOSITORY
Stachelscheid, Harald1, Damaschun, Alexander1, Lekschas, Fritz1, 
Werner, Stefanie1, Leser, Ulf2, Nguyen-Dobinsky, Trong-Nghia3, 
Kurtz, Andreas1
1Berlin Brandenburg Center for Regenerative Therapies, Charité - 
Universitaetsmedizin Berlin, Berlin, Germany, 2Institut für Informatik, 
Humboldt-Universität zu Berlin, Berlin, Germany, 3Department of 
Obstetrics, Charité - Universitaetsmedizin Berlin, Berlin, GermanyCellular 
therapies are increasingly relevant for personalized medicine, requiring 
resources informing about the complex characteristics of cells. Large 
amounts of research data on stem cells are already available, but these 
are scattered, derived by diverse technologies, not standardized and are 
not available at the necessary integration level for cellome modeling. 
Consequently, the selection of cells, e.g. for therapeutic applications, 
is based on rather incomplete information. CellFinder aims at mapping 
stem cell information to lift the cellome to an even level with the other 
‘omics’ fields to provide a basis for global understanding of cells, increase 
comparability of data and relate cells to more complex systems. To organize 
the data stored in CellFinder we have developed a novel ontology that 
allows the annotation of data from the organ down to the single cell 
level and mapping of homologous entities between species. Furthermore 
this ontology allows mapping of developmental data like cell lineage 
differentiation. Existing taxonomies such as the gene ontology (GO) or 
Foundational Model of Anatomy (FMA) are used for data annotation. Based 
on this the CellFinder platform provides the framework for comprehensive 
descriptions for all human tissues, cells and commonly used model organisms 
on molecular and functional levels, in vivo and in vitro. These descriptions 
can be attributed with state-of-the-art experimental data, images, 
references to publications, and to sources of the relevant materials. Access 
to the knowledge base is provided by means of a public web interface that 
allows browsing, searching and querying the data stored. Current work 
concentrates on the integration of existing cell biology datasets to assimilate 
the diverse dimensions of data spanning molecular, functional, anatomical 
and cyto-histological, as well as auxiliary levels. The CellFinder repository 
will aid standardization and comparability of complex datasets for each cell 
and organize these in a cellome environment by ontological description and 
technical implementation. Future development includes community and 
scientific networking applications that will allow users to store and analyse 
their own data and to explore cells and their interactions on singular and 
complex resolution levels.
3D VERSUS 2D CULTURE OF HUMAN ADIPOSE 
TISSUE DERIVED MESENCHYMAL STEM CELLS 
(MSC)
Roch, Manfred, Stachelscheid, Harald, Kurtz, Andreas
BCRT Berlin Center for Regenerative Therapies, Berlin, Germany
Mesenchymal stem cells (MSC) are multipotent stem cells, which because 
of their differentiation capacity and their stemness raise big hopes for thera-
peutic regenerative approaches. It has recently been suggested that MSC 
grown in spheres show higher potency, immunomodulatory and differentia-
tion potential than MSC grown in 2D. We generated 3D MSC spheres and 
compared these with 2D adherently grown MSC. The differentiation capac-
ity and stemness was analyzed by differentiation assays for neurogenesis, 
osteogenesis and adipogenesis. The expression of pluripotency associated 
genes such as Oct4, Sox 2 and Nanog as well as expression of specific dif-
ferentiation markers was investigated by RT-PCR. On the protein level, we 
compared the proteome patterns by high-resolution 2D gel electrophoresis 
and nLC MALDI TOF/TOF mass spectrometry. 3D cultured MSC reacted 
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faster and more effective on differentiation induction, which was proved by 
phenotypical staining. They also expressed higher RNA levels of differentia-
tion markers and pluripotency markers. By high-resolution 2D gel electro-
phoresis 356 significant differently expressed proteins were evaluated and 
identified by mass spectrometry. The different in vivo effects of the cells are 
analyzed by applying the §D MSC in a Parkinson`s rat model. The results 
suggest a higher functional capacity of spheroid grown MSC, suggesting 
that the therapeutic application of MSC can be improved by spheroid or 3D 
cultivation methods of the cells.
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DYNAMIC OPTICAL MOLECULAR IMAGING 
REVEALS INSIGHTS INTO HUMAN NK CELL-
MEDIATED CYTOTOXICITY IN VIVO
Wang, Jie Ting Tina1, Figueiredo, Carlyn A.1, Kosaka, Yoko2, Wang, 
XingHua2, Siegers, Gabrielle M.2, Viswanathan, Sowmya2, Keating, 
Armand2, DaCosta, Ralph S.1
1Ontario Cancer Institute, University Health Network, Toronto, ON, 
Canada, 2Cell Therapy Program, Princess Margaret Hospital, Toronto, ON, 
Canada
Introduction: The cytotoxic response of natural killer (NK) cells against tumor 
cells contributes to the beneficial clinical use of NK cells for the treatment 
of acute myeloid leukemia (AML). Using molecularly-specific fluorescent 
probes and a novel intravital fluorescence confocal microscopy (CFM) 
technology, our goal was to understand the spatio-temporal dynamics of NK 
mobility and tumor-targeting as well as the perforin-granzyme pathway of 
NK cell cytotoxicity in vivo. Our specific aim was to visualize effector-target 
interactions in vitro and extend this in vivo using a transparent window 
chamber (WC) tumor-bearing mouse model for real-time and non-invasive 
imaging of NK cell mobility and cytotoxicity. Methods: GFP-expressing K562 
and PKH26-labled KHYG-1 cells were used in combination with an anti-
perforin antibody delivered into the KHYG-1 cells using a ChariotTM vector 
assay. Both cell lines were co-cultured at a 10:1 effector:target ratio, and 
incubated at 37oC/ 5% CO2 . Aliquots of the mixed population were fixed 
onto microscope slides at 0, 30 min, 1, 2 and 3 h following co-culture, and 
imaged using an epifluorescence microscope (AxioObserver). In a separate 
experiment, 1Ξ106 GFP-K562 cells were injected into the fascia of female 
WC-bearing nude mice to induce tumor formation for one week. Then 
10Ξ106 PKH26-KHYG-1 cells were injected i.v. Sytox-blueTM and CD31-
APC ‘reporter’ probes were then injected i.v. to visualize dead cells and 
vasculature, respectively. Intravital confocal fluorescence microscopy (iCFM) 
images were obtained at 1, 2, 3, 4, 5 h and 1, 2, 3, and 4 days following 
injection of the reporter probes. Results: In vitro fluorescence microscopic 
imaging revealed the transfer of perforin into K562 cells from KHYG-1 
(at 30 min post co-culture) with a polarized intracellular biodistribution of 
perforin granules. Nanotubules were observed forming between target 
and effector cells at 15 min post co-culture, suggesting a spatio-temporal 
dependency between nanotubules and perforin-mediated cytotoxicity. iCFM 
imaging showed KHYG-1 cells remained primarily in the vasculature up to 
24 hrs after i.v. injection in K562 tumor-bearing mice. At later time points, 
KHYG-1 cells were observed to extravasate from the capillary network into 
the tumor stroma and migrate toward GFP-K562 cells. We focused on a 
region of interest containing a cluster of K562 cells and several KHYG-1 cells 
over 4 days and observed a dramatic reduction in GFP fluorescence signal in 
the K562 cells directly adjacent to KHYG-1 cells. Sytox-blueTM fluorescence 
(injected i.v.) at day 3 confirmed K562 cell death, indicating KHYG-1 medi-
ated lysis in vivo. Taken together, these results demonstrate that it is pos-
sible to i) optically label effector and target cells separately, ii) track them in 
real-time in vivo through tumor vasculature while they home to the targets, 
iii) obtain single-cell image resolution, and iv) visualize the spatio-temporally 
dynamic mechanisms involved in NK cell cytotoxicty. Conclusions: While 
preliminary, these results demonstrate that our unique preclinical experimen-
tal intravital imaging platform offers an unprecedented ability to study the 
dynamic mechanism(s) of NK cell cytotoxicity in tumors in vivo which may 
help enhance our knowledge and thus the clinical effectiveness of NK cells in 
the treatment of AML. This new experimental platform may also have wider 
application in related preclinical in vivo studies in regenerative medicine and 
tissue engineering.
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AN ENHANCED CHEMICALLY DEFINED 
SILAC CULTURE SYSTEM FOR QUANTITATIVE 
PROTEOMICS STUDY OF HUMAN EMBRYONIC 
STEM CELLS
Wang, Shuai, Tian, Ruijun, Li, Li, Figeys, Daniel, Wang, Lisheng
Department of Biochemistry, Microbiology and Immunology, Faculty of 
Medicine, University of Ottawa, Ottawa, ON, Canada
Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC)-based quan-
titative proteomics analysis provides an unprecedented tool for the study 
of mechanisms underlying the self-renewal and differentiation of human 
embryonic stem (hES) cells. While we recently reported a chemically defined 
SILAC culture system specific for a rare cell proteomic reactor (Mol Cell 
Proteomics. 2010 Sep 7), total hES cell yield, prolonged self-renewal capac-
ity (i.e. <12 days), and laborious procedure remain substantial hurdles for its 
conventional application in hES cell studies. Here, we devised an enhanced 
SILAC culture system consisting of a new chemically defined SILAC-medium 
and a novel culture protocol. As a result, with much less culture maneuvers, 
approximately 40-fold greater hES cells were produced than the system 
reported previously. Moreover, the enhanced SILAC culture system was 
sufficient to support the self-renewal of hES cells for >60 days and was also 
highly reproducible. As such, it provides a new platform that can be readily 
adapted by general laboratory for further comprehensive SILAC-based pro-
teomics analysis of hES cells and induced pluripotent stem cells.
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IDENTIFICATION OF HIGHLY SPECIFIC LECTIN 
BIOMARKERS FOR ISOLATION OF HUMAN 
PLURIPOTENT STEM CELLS
Wang, Yu-Chieh1, Nakagawa, Masato2, Garitaonandia, Ibon1, 
Slavin, Ileana1, Altun, Gulsah1, Lacharite, Robert M.1, Nazor, 
Kristopher L.1, Tran, Ha T.1, Leonardo, Trevor R.1, Peterson, Suzanne 
E.1, Laurent, Louise C.3, Yamanaka, Shinya2, Loring, Jeanne F.1
1Dept of Chemical Physiology, Scripps Research Institute, La Jolla, CA, USA, 
2Center for iPS Cell Research and Application (CiRA), Kyoto University, 
Kyoto, Japan, 3Dept of Reproductive Medicine, University of California, San 
Diego, La Jolla, CA, USA
Rapid and reliable methods for determining pluripotency in human pluripo-
tent stem cell (hPSC) populations are critically needed, not only for quality 
control in basic research but also for purification of differentiated hPSCs 
intended for clinical use. Antibodies targeting cell surface antigens are 
commonly used to identify pluripotent cells in preparations of viable cells. 
These pluripotency-associated antigens are often glycoproteins or glycolip-
ids, suggesting that unique glycosylation patterns potentially recognized by 
specific lectins may be a hallmark of pluripotency. Using protein microarrays 
containing 45 different lectins, we discovered unique glycosylation patterns 
and distinctive lectin-binding signatures that distinguish pluripotent cells 
from non-pluripotent cells, identified by analysis of glycoproteins extracted 
from 26 hPSC and 15 differentiated cell samples. As few as 15 lectins were 
sufficient to accurately distinguish hPSCs from non-pluripotent cell types. 
These highly specific biomarkers were shared by all 12 human embryonic 
stem cell and 14 human induced pluripotent stem cell samples examined, 
regardless of the method of derivation, the culture condition, the cell type 
of origin, and the reprogramming strategy used. We then demonstrated the 
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utility of specific lectins as tools for identification and isolation of hPSCs from 
mixed cell populations. Lectin-mediated fluorescence staining showed ex-
tremely high concordance with staining for validated pluripotency-associated 
transcription factors, such as OCT4/POU5F1. In addition, we were able to 
separate a 1:1 mixture of hPSCs:non-pluripotent cells into two cell popula-
tions that were 90% pure using lections conjugated to magnetic beads. 
Gene expression analysis using cDNA microarrays suggested the differential 
expression of fucosyltransferases and sialyltransferases may be the mecha-
nism underlying the association between pluripotency and specific patterns 
of protein glycosylation. Our results demonstrate that protein glycosylation 
differs considerably between pluripotent and non-pluripotent cells, and 
suggest that regulation of pluripotency-associated glycoproteins may be 
mediated by differential gene expression of glycosyltransferases. Specific 
lectins that recognize the pluripotency-associated glycoproteins are poten-
tially useful biomarkers that can be used to monitor pluripotency in stem cell 
populations and separate pluripotent and non-pluripotent cell populations 
for both research and therapeutic purposes.
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INSTANT REAL TIME DETECTION OF LIVE 
RODENT AND HUMAN NEURAL STEM AND 
GLIOMA-DERIVED STEM CELLS BY AN 
OLIGOTHIOPHENE DERIVATIVE
Hermanson, Ola1, Illkhanizadeh, Shirin1, Simon, Rozalyn2, Åslund, 
Andreas2, Teixeira, Ana I.3, Konradsson, Peter2, Holmberg, Johan4, 
Uhlén, Per5, Joseph, Bertrand6, Nilsson, Peter2
1Neuroscience, Karolinska Institutet, Stockholm, Sweden, 2IFM, Linköping 
University, Linköping, Sweden, 3Cell and Molecular Biology (CMB), 
Karolinska Institutet, Stockholm, Sweden, 4Cell and Molecular Biology 
(CMB)/LICR, Karolinska Institutet, Stockholm, Sweden, 5Medical 
Biochemistry and Biophysics (MBB), Karolinska Institutet, Stockholm, 
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The development of molecular probes for non-invasive live cell detection of 
specific cell types is a critical issue in cancer and stem cell biology as well as 
drug discovery. Here we report the synthesis of a luminescent conjugated 
oligothiophene (LCO), named p-HTMI, which could be used in conventional 
microscopy for near instant real-time detection of live embryonic neural 
stem cells, but not other types of physiological stem cells, differentiated 
cells, or cancer cells investigated. Interestingly, p-HTMI stained c:a 1-2 % of 
neural tumor (glioma) cells but 100% of glioma-derived stem cells, whereas 
the reverse pattern was seen with another LCO, pHTES, having an alterna-
tive side chain functionalization. Cell sorting experiments proved that neural 
and glioma-derived stem cells could be specifically detected in samples of 
mixed cell types. p-HTMI is functionalized with a methylated imidazole 
moiety resulting in a structure similar to methylated histidine/histamine and 
importantly a non-methylated analogue did not show the same character-
istics. We propose that LCOs with distinct and defined side chain function-
alities represents a novel generation of molecular probes for immediate and 
specific detection of specific stem cell types.
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R26GR: A CRE-ACTIVABLE R26 DUAL 
FLUORESCENT PROTEIN REPORTER MOUSE
Chen, You-Tzung1, Tsai, Ming-Shain2, Ku, Amy T.1, Huang, Ke-
Han1, Chou, Fu-Ju1, Yu, I-Shing3, Huang, Cheng-Yen4, Su, Kang-Yi5, 
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Shu-Wha2, Yang, Tsung-Lin7
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College of Medicine, Taipei, Taiwan, 2Department of Clinical Laboratory 
Sciences and Medical Biotechnology, National Taiwan University College 
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the National Research Program for Genomic Medicine, National Taiwan 
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the First Core Labs, National Taiwan University College of Medicine, Taipei, 
Taiwan, 5NTU Center of Genomic Medicine, National Taiwan University, 
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University Hospital and College of Medicine, Taipei, Taiwan
Green fluorescent protein (GFP) and its derivatives are the most widely used 
molecular reporters for live cell imagining. Recent development of organelle-
specific fusion fluorescent proteins improves the labeling resolution to a 
higher level. Here we generate a R26 dual fluorescent protein reporter 
mouse, activated by Cre-mediated DNA recombination, labeling target cells 
with a chromatin-specific EGFP and a plasma membrane-anchored mono-
meric cherry fluorescent protein (mCherry). This dual labeling allows the 
visualization of mitotic events, cell shapes and intracellular vesicle behaviors. 
We expect this reporter mouse to have a wide application in developmental 
biology studies as well as cancer/stem cell lineage tracing.
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TECHNOLOGY THAT IMPROVES GENE 
TARGETING EFFICIENCY IN MURINE 
EMBRYONIC STEM CELLS
Ezekiel, Uthayashanker
Geneprotech, Inc, Saint Louis, MO, USA
Gene targeting in human embryonic stem (ES) cells and somatic cells has 
important applications in areas where rodent models do not adequately 
recapitulate human biology or disease progression. However, these applica-
tions require targeting frequencies much greater than the levels achievable 
with today’s technology. In human ES cells and induced pluripotent cells 
(iPS), gene targeting is difficult and the frequencies observed are often much 
lower than those observed in murine ES cells. Currently, gene therapy relies 
heavily on viral-mediated approaches, which although successful, can also 
lead to serious complications. Whereas viral vectors provide efficient gene 
delivery, safety is a major concern, in part because random integration of the 
vector may cause inactivation or activation of endogenous genes leading to 
potentially serious side effects. Therefore, a better biological approach for 
gene therapy utilizes homologous recombination (HR), not only because it 
is inherently specific, but also because it avoids the use of viruses. Another 
technology which utilizes an engineered zinc-finger-endonuclease fusion 
protein has been shown to increase the frequency of gene targeting. How-
ever, this approach potentially can create DNA strand breaks caused by the 
fusion endonuclease at sites other than those intended which may lead to 
deleterious mutations and also create off-target nonhomologous end joining 
mutations. We have developed a gene-targeting technology that relies on 
the cell’s own homologous recombination machinery. In this technology, the 
HR frequencies are significantly increased by using targeting vectors modi-
fied so as to contain two different peptides that, in concert, function to pro-
mote HR. The first peptide consists of a nuclear localization sequence (NLS) 
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and increases the amount of tranfected DNA trafficked into the nucleus. 
The second peptide (“bait peptide”) binds and recruits RAD51 onto the 
vector DNA. RAD51 (the eukaryotic analogue of the bacterial recA protein) 
provides enzymatic functions for recognition of homology and promotion of 
DNA strand exchange. Recruitment of RAD51 promotes sequence-specific 
synapsis between the targeting DNA and homologous chromosomal se-
quences, thereby promoting HR. As a proof of concept experiment, we used 
the hypoxanthine phosphoribosyl transferase (HPRT) locus in mouse ES cells 
as a targeting site to assess the increase in homologous recombination ef-
ficiency. Our results suggest that this technology holds promise in increasing 
the efficiency of gene targeting.
Poster Board Number: 2228
SCALING-UP THE EXPANSION OF MOUSE 
EMBRYONIC STEM CELL-DERIVED NEURAL 
STEM CELLS IN STIRRED BIOREACTORS
Rodrigues, Carlos A. V., Diogo, Maria M., Lobato da Silva, Cláudia, 
Cabral, Joaquim M.S.
Department of Bioengineering, Instituto Superior Técnico, IBB - Institute 
for Biotechnology and Bioengineering, Centre for Biological and Chemical 
Engineering, Lisboa, Portugal
Neural stem (NS) cells are self-renewing multipotent cells present in the 
developing and adult mammalian CNS. They generate neuronal and glial 
cells of the developing brain and also account for the limited regenerative 
potential of the adult brain. Different protocols for NS cell expansion have 
been developed in both floating and adherent conditions. The propaga-
tion of floating cell clusters, called neurospheres, is widely used for NS cell 
expansion in vitro. However, this system shows severe limitations for cell 
culture like hetrogeneous aggregate composition, diffusion limitations of 
nutrients, waste accumulation in the cluster centre or preferential astroglial 
differentiation in vivo. The expansion of NS cells on adherent conditions 
may circumvent most of these limitations. Different sources of NS cells are 
available, such as the fetal brain, the adult brain or embryonic stem (ES) 
cells (by in vitro differentiation). The propagation of NS cells and their dif-
ferentiation into mature neuronal phenotypes allows their potential use for 
treatment of neurodegenerative diseases, neural drug screening and also 
gene therapy. Although it is anticipated that a large number of cells will be 
required for those applications, the large-scale expansion and controlled 
differentiation of ES cell-derived NS (ESNS) cells on bioreactors has not 
been addressed in detail. This work aims to solve the main biological and 
technological hurdles that limit this application using as model a cell line of 
mouse ESNS. mESNS cells are currently cultured under static conditions on 
tissue culture plastic. However these culture systems are not amenable for 
large-scale applications since they are limited by a reduced surface area/
volume ratio, have a non-homogeneous nature, resulting in concentration 
gradients (growth factors, metabolites, pH, dissolved O2), and difficult or 
impossible online monitoring and control. The first step for establishing 
a mESNS cell spinner-flask culture protocol was a screening of different 
commercially available microcarriers, to support cell adhesion. To eliminate 
animal-derived products from the culture, only xeno-free microcarriers were 
tested, as well as a serum-free culture medium. Selected microcarriers were 
tested under dynamic conditions, in the spinner-flasks. Superior performance 
was observed with polystyrene beads coated with a fibronectin fragment. 
Importantly, high cell viabilities and expression of Nestin, a marker of neural 
stem/progenitor cells, was retained when cells were cultured for up to 9 
days on the microcarriers, in the spinner-flask, confirming that these culture 
conditions are not detrimental for the cells. The subsequent steps were the 
optimization of culture parameters. A stirring speed of 60 rpm was found 
to be optimal and led to a 40-fold increase in cell number after 6 days, with 
viabilities above 95%. Culture medium feeding is also a critical parameter. 
The metabolic profile of the culture, in terms of glucose, glutamine and 
lactate concentrations over time was determined, to avoid nutrient scarcity 
or metabolite accumulation. The frequency of growth factors supply was 
also found to be crucial. Finally, microcarrier concentration is also expected 
to have an important role as it relates with the available surface area. The 
validation of this bioprocess for mESNS cell expansion will be concluded with 
the demonstration of the multipotential differentiation of the spinner-flask 
expanded cells into neuronal and glial cells.
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PLURIPOTENT STEM CELLS
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Technology Agency, Tokyo, Japan, 2Center for Genetic Analysis of Behavior, 
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Cell Therapy, Institute of Medical Science, University of Tokyo, Tokyo, 
Japan
Pluripotent stem cells (PSCs) can expand infinitely while maintaining an 
undifferentiated state and pluripotency. In rodents, PSCs injected into blas-
tocyst stage embryo can contribute to the embryonic development with chi-
mera formation. Recently, we found that PSCs can contribute to xenogenic 
embryo development resulting in interspecific chimeras between mouse and 
rat. These chimeras could survive after birth and the xenogenic PSC-derived 
cells were present in every tissue we examined. Furthermore, by injecting 
rat induced PSC (iPSCs) into Pdx1-/- mouse blastocysts, we succeeded in 
generating rat pancreas in mouse indicating that PSC-derived organ can be 
generated in xenogenic environment. To extend our findings on interspecific 
chimeras further, we attempted to generate whole rat embryos in mouse 
by tetraploid complementation method. Tetraploid embryo produced by 
electrofusion of 2-cell stage embryo can differentiate into extraembryonic 
lineages but not into embryo proper. We injected EGFP expressing rat iPSCs 
into mouse tetraploid embryos and followed up their development in mouse 
uterus. The results showed that, in gastrulating embryos, epiblast was com-
posed of entirely EGFP-positive riPSC-derived cells and was surrounded by 
EGFP negative mouse extraembryonic tissues. These embryos could develop 
until 7 days after embryo transfer (E9.5). They expressed EGFP ubiquitously 
from head to tail and some embryos reversed and curved ventrally with red 
blood cells in aortic region. Immunohistochemical and flowcytometric analy-
ses revealed that the embryos were completely derived from injected riPSCs. 
However, after E11.5, embryonic tissues were degenerated and no embryo 
survived. These data indicate that riPSC alone can develop in the mouse en-
vironment up to E9.5 but not beyond E11.5. The system described here not 
only provides a powerful experimental tool for understanding of xenogenic 
barrier in early embryonic development but also an initial step toward the 
generation of PSC-derived animal in xenogenic environment.
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HETEROGENEITY OF MURINE HEMATOPOIETIC 
STEM CELL RESPONSES REVEALED BY 
A MICROFLUIDIC PLATFORM FOR HIGH-
THROUGHPUT ANALYSIS OF SINGLE CELLS
Lecault, Véronique1, Knapp, David J.H.F.2, Wohrer, Stefan2, 
Sekulovic, Sanja2, Miller, Michelle M.2, VanInsberghe, Michael3, 
Bowden, William J.1, Humphries, R. Keith2, Eaves, Connie J.2, 
Hansen, Carl L.3, Piret, James M.1
1Michael Smith Laboratories, University of British Columbia, Vancouver, 
BC, Canada, 2Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, 
Canada, 3Centre for High-Throughput Biology, University of British 
Columbia, Vancouver, BC, Canada
The ability of hematopoietic stem cells (HSCs) to self-renew and differentiate 
into specialized blood cells is a complex process involving the integration of 
multiple external cues with the intrinsic molecular state of the cell. Recent 
in vivo analyses of the clonal behavior of cells with functional proper-
ties of HSCs (>6 months reconstitution of blood formation) have revealed 
heterogeneity in their differentiation and self-renewal patterns. To generate 
matching information and characterize differences in their in vitro response 
to defined stimuli, we monitored HSCs in microfluidic devices containing 
1,600 to 6,144 nanovolume culture chambers. These devices were devel-
oped to provide automated culture and tracking of thousands of individual 
non-attached cells over periods of several days. This technology also enables 
multiple culture conditions to be tested simultaneously, including both con-
stant or temporally varying microenvironments, with an option to perform 
live cell-surface marker staining on clones without disturbing their spatial 
position. In this study, we present 4 different applications of this technol-
ogy in the context of HSC research. First, from growth profiles obtained for 
hundreds of single NUP98-HOXD13-transduced cells, we demonstrated that 
only a minority of these cells are highly proliferative and contribute to the 
overall expansion of bulk cultures. More than 52% of the cells were either 
destined to die or unable to proliferate. Second, from analyses of the early 
division kinetics of transduced primary HSCs, we showed that lentiviral vec-
tors carrying a fluorescent reporter gene preferentially transduce and express 
in those HSCs that begin to divide most rapidly. Third, live immunostaining 
of the progeny of single HSCs stimulated to divide revealed that continued 
expression of endothelial protein C receptor (EPCR), a molecule used for 
murine HSC purification, is associated with delayed entry into cell cycle 
and longer division kinetics. Finally, we used the unique medium exchange 
feature of this system to show that the survival and subsequent proliferative 
activity of very primitive adult hematopoietic cells is independent of Steel 
factor stimulation during the first 16 h in serum-free culture. Adequate Steel 
factor stimulation becomes critical for culture times greater than 16 h, as 
the cells begin to exit their quiescent state. These results illustrate the value 
of having the combined capabilities of high-throughput live-cell imaging, 
dynamic control of medium conditions, live immunostaining and selected 
clone recovery to interrogate otherwise inaccessible mechanisms governing 
mammalian stem cell growth and fate decisions.
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OBSERVATION OF THE MOVING FRONT WHERE 
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There are a couple of methods to induce differentiation of pluripotent stem 
cells (PSCs) have been developed so far, such as via generating colonies, 
forming embryoid bodies, etc. And it has been shown that there were sev-
eral similarities between PSC’s differentiation process and in vivo phenom-
ena. Developing the technique to control the key factors of differentiation, 
such as chemical or protein factors, cell-cell interaction, matrices, physical 
stresses, etc., would contribute to the reconstruction of in vivo situation. We 
have proposed a microfluidic device for spatially controlled differentiation. 
The developed device has two compartmentalized channels separated by a 
polycarbonate porous membrane. Culture media containing differentiation 
factors are injected into the lower channel where the factors’ concentration 
can be spatially controlled by the laminar flow. Since the factors are trans-
ported to the upper channel through the membrane, the cells seeded in the 
upper channel can be exposed to the differentiation factors with the concen-
tration depending on their positions. We have succeeded in differentiating 
mouse induced pluripotent stem cells (miPSCs, iPS-MEF-Ng-20D-17 cell 
line) in a spatially controlled manner in the device by injecting the medium 
containing retinoic acid (RA) and the one containing leukemia inhibitory fac-
tor (LIF). In this study, we further use the device for spatio-temporal control 
of differentiation factors in microenvironment by changing the exposure 
time. First we injected two media, one containing RA (10-7 g / mL) and the 
other containing LIF (1000 Unit), into the device at 1 and 3 μL / min each 
to induce spatially controlled differentiation. And the cells were exposed to 
these factors with the concentration controlled by the laminar flow patterns 
for the durations of 12, 24 and 72 hours. After the exposure, the medium 
has been changed into LIF containing ones. As a result, when cells were 
exposed to the differentiation factor for 12 and 24 hours, undifferentiated 
cells proliferated over the channel. This means that 24 hours exposure was 
not enough for inducing differentiation. On the other hand, when exposed 
for 72 hours, differentiation of the cells in the whole area of the channel 
was induced. This means that 72 hours exposure was enough for inducing 
differentiation. Moreover we observed the time course of GFP fluorescence 
of the cells corresponding to the expression level of Nanog. The lateral 
position in the channel showing the maximum decrease of the fluorescence 
intensity moved from the RA side to the LIF side. This means that the cells’ 
state rapidly switched at the moving front, as if the differentiation state is 
propagating from one side to the other along the lateral axis in the channel. 
This kind of phenomena can only be observed by microfluidic formats, and 
the technique can be a useful for mimicking in vivo situation.
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ADULT PROGENITOR CELLS IN A MOUSE 
MODEL OF GRAFT-VERSUS-HOST DISEASE
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1Biomedical Engineering, Case Western Reserve University, Cleveland, OH, 
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Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is the 
only curative therapy for many patients with malignant and hematologic 
disorders. Graft-versus-host Disease (GVHD) is the most frequent and 
severe complication of allo-HSCT and limits successful outcomes. Non-he-
matopoietic stromal stem cells, including multipotent adult progenitor cells 
(MAPCs) have immuno-regulatory properties, and clinical and pre-clinical 
data suggest they then can reduce the severity of GVHD. However, the bi-
odistribution of these cells after injection and the immunologic mechanisms 
behind their protective effects remain to be fully elucidated. Using SPECT 
and cryo-imaging, we studied the biodistribution of MAPCs in mice. Using a 
well-described mouse allo-HSCT model, we characterized the biodistribution 
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of labeled MAPCs within the first 24 hours of injection. Lethally irradiated, 
inbred B2D2F1 mice received BM and purified splenic T cells from alloge-
neic, haplo-identical C57Bl/6 or syngeneic F1 donors. Human MAPCs were 
either labeled with 99mTc HMPAO (for SPECT imaging) or red quantum 
dots (Qtracker 625, for cryo-imaging). The MAPCs were then mixed to-
gether so that each mouse would receive approximately 0.57 million 99mTc 
HMPAO-labeled cells and 0.57 million Qtracker-labeled cells. Cells were co-
infused via tail vein injection on the day following HSCT. Transplanted mice 
were subsequently split into 2 groups: those to be sacrificed the same day as 
the injection (Day 1), and those to be sacrificed the day after the injection 
(Day 2). Each mouse was subjected to planar scintigraphy and SPECT imag-
ing prior to sacrifice. After the mice were sacrificed, they were frozen and 
cryo-imaged. Using microscopic resolution, whole mouse cryo-images, we 
used specialized Bayesian classification software to detect even single stem 
cells throughout the mouse. Quantitative 3D analysis of SPECT and cryo-
images of the Day 1 mice show that the vast majority of injected MAPCs 
are in the lungs. With cryo-imaging, we detected ≈476,000 of the 570,000 
injected fluorescently labeled cells, with 82.6% of detected cells in the lungs. 
Remaining cells were found in the liver (17.2%) and spleen (0.2%). Signal/
cell remained fairly constant. In SPECT images of the same mouse, the 
majority of the signal from the 99mTcHMPAO-labeled cells was found in the 
lungs and bladder. Using a calibration from an aliquot of cells, we computed 
≈43,000 cells in the lung with SPECT imaging, ≈10% of the number in the 
same mouse with cryo-imaging. At later time points, we were unable to 
detect the 99mTcHMPAO-labeled cells in SPECT images. We were, however, 
able to detect the Qtracker-labeled cells in the cryo images. In Day 2 mice, 
cryo-imaging detected ≈55,000 cells with an increased percentage in the 
spleen (83% lungs, 13% liver, and 4% spleen). At early time points, SPECT 
and cryo-imaging can both track labeled cells in the mouse. Cryo-imaging is 
better suited for tracking fluorescently labeled stem cells at later time points, 
where the 99mTc HMPAO label has radioactively decayed and detached 
from MAPC, as shown by the bladder signal. Because cryo-imaging detects 
cells, it is independent of a signal/cell calibration as with SPECT.
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19F MRI CELLULAR TRACER PRESERVES 
THE DIFFERENTIATION POTENTIAL OF 
HEMATOPOIETIC STEM CELLS
Helfer, Brooke, Balducci, Anthony, Wesa, Amy
Celsense, Inc., Pittsburgh, PA, USA
Hematopoietic stem cells (HSC) have numerous applications including 
immune reconstitution, enzyme replacement, regenerative medicine and 
immunomodulation. The trafficking and persistence of these cells after 
administration is a question fundamental to the future of alternative thera-
peutic applications of HSC. While various contrast agents have been used to 
track cellular therapeutics, the impact of cellular labels on HSC function has 
not previously been studied, independently of therapeutic outcome, in vivo. 
Here we describe the labeling of human CD34+ HSC with a novel self-de-
livering perfluorocarbon (PFC) emulsion. This magnetic resonance imaging 
(MRI) tracer agent has been found to lack mutagenicity in multiple in vitro 
studies. A comparison of unlabeled and PFC-labeled human HSC in in vitro 
colony forming assays resulted in equal numbers of total colony forming 
units (CFU), as well as individual CFU types, indicating that labeling did not 
alter multipotency. In parallel, in vivo tests of pluripotency and reconstitu-
tion studies in mice with labeled murine BM HSC resulted in equivalent 
development of CFU-spleen (a measure of HSC progenitor activity) and the 
reconstitution of both lymphoid and myeloid compartments. The lack of 
interference in these highly complex biological processes both in vitro and 
in vivo following PFC labeling, provides strong evidence that the therapeu-
tic potential of the HSC is likely to be maintained. These data support the 
safety and utility of using PFC tracers for clinical in vivo trafficking of human 
stem cells.
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The identification and modulation of proliferating cells is critical for stem 
cell research and regenerative medicine. However, current approaches to 
quantify cell proliferation are imprecise in particular in tissue types display-
ing acytokinetic mitosis and endoreduplication such as heart muscle cells. 
The only definitive proof for proliferative activity followed by cytokinesis 
in cardiac muscle is the observation of a contractile ring or a midbody prior 
to abscission. To visualize these cell cycle specific events we developed a 
new in vivo proliferation marker that indicates M-phase in great detail. This 
was achieved by fusing eGFP to the scaffolding protein Anillin, which is a 
component of the contractile ring. Anillin accumulates in the nucleus during 
late G1, S/G2-phase, translocates to the cytoplasm and cell cortex after 
dissolving of the nucleus, localizes to the contractile ring and the midbody 
after constriction and is eventually degraded by the proteasome after abscis-
sion. Transgenic murine embryonic stem cell (mESC) lines were generated 
that stably expressed the eGFP-anillin fusion protein under control of the 
ubiquitous CAG promoter. mESCs of this line displayed a high overlap of 
eGFP-anillin expression with the mitotic marker Ki-67 in immunofluorescent 
stainings (96%) and flow cytometric analysis (94-99%), respectively. Dur-
ing differentiation to embryoid bodies the rate of eGFP-anillin positive cells 
declined with the appearance of postmitotic cells. The fusion protein was 
detected exclusively in proliferating cells of all three germ layers, thereby 
demonstrating the high accuracy of this proliferation marker. Transduction 
with a CAG-eGFP-anillin lentivirus enabled us to compare cell-cycle kinetics 
of human induced pluripotent stem cells (hiPS) and hESCs via time lapse 
microscopy and we found significant differences in cell cycle duration. For 
in vivo imaging of proliferation we generated a CAG-eGFP-anillin mouse 
line which allows tracking of dividing cells during embryonic development 
and upon cardiac injury at the adult stage. In the embryonic neuroectoderm 
time lapse microscopy was used to monitor cell-divisions of apical and basal 
progenitor cells. This new system for visualization of proliferation allows the 
monitoring and quantitation of cell proliferation in vitro and in vivo even in 
tissue types prone to DNA repair, acytokinetic mitosis or endoreduplication. 
This approach will probably enable us to address open questions concerning 
the proliferation of heart muscle as well as other tissue types during devel-
opment and upon injury.
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INTRACELLULAR LABELING OF MULTIPLE 
CELL TYPES FOR MRI-BASED IN VIVO CELL 
TRACKING
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Mathias2, Schlegel, Jürgen3, Bosio, Andreas1, Eckardt, Dominik1
1Research & Development, Miltenyi Biotec GmbH, Bergisch Gladbach, 
Germany, 2Max-Planck-Institut für Neurologische Forschung, Köln, 
Germany, 3Institut für Neuropathologie, Technische Universität München, 
München, Germany
Cell transplantation is an area of intense investigation especially with respect 
to stem cell therapy and transplantation studies of embryonic stem cell 
derived cell-types for treatment of degenerative diseases like Parkinson 
or heart failure. There is a need to serially image cells after intravenous 
administration or direct injection into tissue, in order to track migration into 
the target tissue. Monitoring the location and migration of grafted (stem) 
cells is essential for understanding their interaction within the host and their 
therapeutic effects. Therefore, cell tracking is of significant importance for 
basic research, preclinical evaluation as well as monitoring of early clinical 
trials applying cell transplantation. Magnetic resonance imaging (MRI) is the 
most frequently used technique for in vivo cell tracking applications due to 
high resolution of soft tissues, which makes it especially useful for imaging 
of the brain, muscles or the heart. Detectability of transplanted cells by MRI 
depends on their contrast characteristics. In order to produce a strong con-
trast against surrounding tissue, intracellular labeling of cells with iron oxide 
particles before transplantation has been described. We have established 
a two component protocol for in vitro intracellular labeling of multiple cell 
types with superparamagnetic iron oxide (SPIO) particles. Contrast particles 
and loading reagent were optimized for proper in vitro labeling of cell lines 
(NIH-3T3, Jurkat), primary cells (granulocytes, neural progenitors) and stem 
cells (hematopoietic, mesenchymal and embryonic stem cells) from different 
species (mouse, rat, human). Highly efficient intracellular labeling of various 
cell types with contrast particles was proven by prussian blue staining and 
anti-dextran immunofluorescence analysis. Intracellular labeling neither af-
fected viability nor proliferation. Additionally, similar results with labeled and 
unlabeled hematopoietic stem cells, mesenchymal stem cells or embryonic 
stem cells were obtained in CFU assays and upon differentiation into osteo-
blasts, adipocytes and neurons, indicating biocompatibility of intracellular 
labeling with contrast particles. In order to evaluate feasibility of the newly 
developed SPIO particles for magnetic resonance imaging, we analyzed 
intracellular labeling of neural progenitors after transfection of contrast 
particles. MRI analyses revealed an in vitro detection limit of 250 labeled 
cells. After transplantation into mouse cortex, intracellular labeled cells were 
clearly identified with high field MRI scanners. In contrast, extracellular 
labeling of cells with MicroBead-conjugated antibodies failed to give similar 
signal intensities. We have developed a new method for in vitro intracellular 
labeling of multiple cell types with SPIO particles without affecting cellular 
characteristics or fates for high resolution MRI-based cell tracking.
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NEWLY DEVELOPED NANOPARTICLES 
FOR CELL TRACKING USING MAGNETIC 
RESONANCE IMAGING
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Purpose: To develop highly magnetic, biocompatible, superparamagnetic 
iron oxide (SPIO) nanoparticles suitable for in vivo tracking of human 
lymphocytes and CD34+ cells. Introduction: The utilization of magnetic 
resonance imaging (MRI) to noninvasively monitor cells using SPIO 
nanoparticles as MRI contrast agents has been one of the major research 
focuses over the past several years. In particular, the ability to use MRI to 
image longitudinally offers an invaluable opportunity to track the migration, 
persistence and distribution of cell-based therapeutics in vivo in humans 
with high resolution on tissue planes. Current approaches for cell labeling 
have focused on using commercial SPIO nanoparticles with varying success 
due to differences in size and limited magnetic properties. Therefore, there 
is a clinical need to develop SPIO nanoparticles that are non-toxic, greater 
than 50nm in diameter, and produce high MRI contrast. We have utilised 
SPIO nanoparticles with a silica coating to investigate the labeling capacity 
and contrast enhancement of blood cells including human lymphocytes and 
CD34+ expressing cells. Method: Human buffy coats were used to separate 
and collect lymphocytes and CD34+ cells. A thermal decomposition method 
was used to synthesise iron oxide silica nanoparticles analysed with transmis-
sion electron microscopy (TEM) and x-ray diffraction (XRD). Suspensions 
of these silica coated SPIO nanoparticles were incubated with isolated 
peripheral blood mononuclear cells and CD34+ purified cells at 5 µg/ml, 
10µg/ml, 50µg/ml and 100µg/ml in vitro and then imaged on a clinical 
MRI 3.0 tesla scanner. T2 relaxation, which is responsible for contrast in T2 
weighted MR images, were calculated and iron content performed using 
atomic absorption spectroscopy (AAS). A 3-(4,5-dimethylthiazol-2-yl)-5-(3 
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) based as-
say was used to measure cell cytotoxicity 24 and 48 hours post-labeling with 
SPIO silica nanoparticles. Results: Iron oxide nanoparticles coated in silica 
were made with TEM showing these as monodisperse iron oxide coated 
in a silica shell with a maximum diameter of 60 ± 7 nm. A high in vitro 
T2 relaxivity of 210.40 mM s was calculated, giving negative MRI signal 
enhancement of 15%, 45%, 50%, and 75% for concentrations of 5 µg/ml, 
10 µg/ml, 50 µg/ml and 100 µg/ml, respectively. The cell cytotoxicity assay 
showed no toxicity with SPIO silica nanoparticles for concentrations up to 
50 µg/ml. Conclusion: This pilot study showed that the newly prepared iron 
oxide silica nanoparticles can be used for safe and effective cell labeling of 
human cells. Due to a high T2 relaxivity and possible higher uptake of the 
nanoparticles, significant contrast enhancement was visualised in vitro. The 
results indicate that smaller number of cells may be needed for MRI detec-
tion. Overall, these results provide preliminary evidence that high efficiency 
biocompatible labels can improve future cell tracking using MRI and SPIO 
nanoparticles as contrast agents.
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SELF-ASSEMBLING IRON-BASED 
NANOCOMPLEXES USING THREE FDA-
APPROVED DRUGS - FERUMOXYTOL, HEPARIN 
AND PROTAMINE: IMPLICATIONS FOR STEM 
CELL LABELING AND TRACKING BY CLINICALLY 
APPLICABLE MRI
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Stem cell-based therapies have become a major focus in regenerative medi-
cine and tumor trials, along with release of cytokines and growth factors to 
diseased tissues. To further understand the relevant biological and clinical 
effects of cellular therapies so as to optimize the therapeutic regimens, it is 
important to develop clinically-applicable imaging approaches that would 
allow for the monitoring of the temporal spatial migration of stem cells 
non-invasively. Labeling stem cells with superparamagnetic iron oxide nano-
particles (SPION) allows for monitoring of transplanted or implanted cell 
behavior by MRI in vivo. We previously developed a technique that involves 
adding FDA-approved dextran coated SPION ferumoxides with protamine 
sulfate to magnetically label stem cells. However, ferumoxides is no longer 
manufactured. Currently, Ferumoxytol, a non-dextran-coated USPIO nano-
particle, has been approved for the treatment of iron deficiency anemia in 
chronic kidney disease. Ferumoxytol alone or in combination with protamine 
does not label the cells. We developed a novel and straightforward magnetic 
cell labeling approach that combines three FDA-approved drugs, ferumoxy-
tol (F) (Feraheme®) at (50-100 µg/ml), heparin sulfate (H) at (1-2 IU/ml) 
and protamine sulfate (P) at (20-60 µg/ml) in serum free media to form 
self-assembling nanocomplexes that effectively label multiple type of stem 
cells (Bone marrow stromal cells (BMSC), Neural Stem Cell (NSC) and He-
matopoietic Stem Cell (HSC)) and of immune cells (T cells and Monocytes) 
for cellular MRI. HPF nanocomplexes are incubated in serum free media with 
cells for 2 hours followed by complete media. Electron Microscopy revealed 
internalized HPF inside endosomes, confirmed by Prussian blue staining 
of labeled cells. The average iron content per cell was as follows: BMSC = 
2.12+/-0.11 picograms (pg); NSC= 2.8+/-1.19 pg; HSC = 1.33+/-0.01 pg; 
T-cells= 0.73+/-0.25 pg; and Monocytes= 2.56+/-1.1 pg. Unlabeled cells 
contained 0.0-0.5 pg/cell and the increase in iron content in the HPF labeled 
cells was statistically significant (P<0.05). There was no effect or toxicity 
on cellular physiology or function of HPF labeled cells when compared to 
controls. In vivo MRI at 3Tesla detected 1000 HPF-labeled cells implanted 
in rat brains. HPF nanocomplexes form without chemical modification to 
the parent drugs and therefore should facilitate the rapid translation of this 
labeling technique in cell therapy clinical trials.
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Cell replacement therapy and regenerative medicine hold an enormous 
potential of curing contemporarily incurable diseases such as diabetes, 
autoimmune diseases, and neurodegenerative diseases such as Parkinson’s, 
Huntington’s, and Alzheimer’s. However, one of the obstacles in making 
clinical translation is the difficulty in long term monitoring of the fate of 
grafted cells non-invasively in vivo. Magnetic resonance imaging (MRI) 
has unique advantages over the other imaging methods such as positron 
emission topography (PET) and optical imaging technology in imaging 
deep tissues with high spatial and temporal resolution. However, implanted 
cells cannot be monitored with MRI unless a contrast agent, such as cell 
labeling with magnetic nanoparticles, is used. However, the invasiveness 
or limited monitoring duration due to the dilution of the contrast agent in 
the cells has been the problem. The best approach is to develop a trans-
genic reporter that is capable of generating endogenous contrast effect for 
MRI. Here, we investigated MagA, a magnetite and magnetosome forming 
prokaryotic gene, as a novel MRI reporter gene for tracking stem cell grafts 
in vivo. The accumulation of iron as a result of MagA expression may lead 
to T2 weight MRI contrast as demonstrated previously. MagA gene under 
a doxcycline promoter was successfully expressed in the mouse embryonic 
stem cell (mES) line, and characteristics of MagA gene expressed in mES cell 
have been evaluated through cell grafting, quantitative real-time PCR, and 
histochemistry. mES cells expressing MagA were successfully grafted in nude 
mice and formed teratoma at the pace compatible with the AB 2.2 mES cell 
line. A stable expression of MagA gene was observed in grafted mES cells 
with significant induction with the doxycycline treatment. Comparing to 
the wild type, the amount of iron in the teratoma grown from the cells with 
MagA also increased as the MagA gene was induced with doxycycline by 
feeding the mouse with doxycycline. These results suggest that MagA can 
be used as a non-invasive transgenic MRI reporter to track the cell growth 
and fate after the cell grafting.
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TWO CASES OF CONGENITAL CEREBRAL 
DYSPLASIA TREATED BY AFFINITY UMBILICAL 
CORD MESENCHYMAL STEM CELLS
Wang, Liming1, Zhou, Jianjun1, Zhong, Zhanqiang1, Xie, Jiang2, Liu, 
Yongjun2, Wang, Xuejun2
1Cell Therapy Center, 323 Hospital of Chinese PLA, Xi’an City, China, 
2Institute of Hematology, Chinese Academy of Medical Science & 
Peking Union Medical College, National Key Laboratory of Experimental 
Hematology, Tianjin, China
Objective: To explore the clinical efficacy of affinity umbilical cord mesen-
chymal stem cell (AUC-MSC) in treatment of congenital cerebral dysplasia 
disease. Methods: Two patients suffering from congenital cerebral dyspla-
sia received AUC-MSC therapy, the stem cells volume is 20ml per patient 
each time (cell number was 1 × 107), 16ml of which was intravenous, 4ml 
was given a subarachnoid injection by lumbar puncture way, once per 2 
weeks, four-times for a course , each patient was treated totally 8 times for 
2 courses. One case of 5-year-old girl was congenital growth retardation 
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of motor function, speech impairment, normal muscle tension, no seizures 
and dance-like movements, brain MRI examination revealed normal cranial 
structure, mesenchymal stem cells derived from her newborn sister’s umbili-
cal cord. One case of 11-year-old boy with congenital growth retardation 
of motor function, he was born with asphyxia showing spastic disorders 
especially the lower limbs, difficulty walking, unsteady gait, normal intel-
ligence, high muscle tension; With improved the Ashwoth Standard (MAS), 
quadriceps was 4 points, gastrocnemius 3; Babinski sign, Oppenheim sign 
(+), cranial MRI revealed no abnormalities, mesenchymal stem cells derived 
from his younger brother’s umbilical cord. Results: Followed up for 22 
months, 5-year-old girl compared with the pre-treatment, got fine activities 
to improve, reduced the frequency of falling, and got up after falling herself, 
enhanced immunity, increased physical strength, speech and comprehen-
sion had a slight improvement. The 11-year-old boy was followed up for 
16 months, his lower limbs muscle tension decreased, walking got well, 
MAS score: quadriceps was 7 points, gastrocnemius 5. Conclusion: Using 
affinity UC-MSC treatment of congenital cerebral dysplasia, especially the 
performance of the motor system in patients with developmental disorders, 
according the 2 cases of clinical practice, may be one of safe and practical 
new ways and a good choice.
Poster Board Number: 2254
ADULT STEM CELL APPLICATION IN 21 CASES 
OF NERVOUS DEGENERTION DISEASE
Wang, Liming1, Zhou, Jianjun1, Zhang, Hongbing1, Xie, Jiang2, Liu, 
Yongjun2
1Cell Therapy Center, 323 Hospital of Chinese PLA, Xi’an, China, 2Institute 
of Hematology Chinese Academy of Medical Science & Peking Union 
Medical college, National Key Laboratory of Experimental Hematology, 
Tianjin, China
Background: Stem cell therapy is very useful in the field of regeneration, 
there are many reports about traumatic central nerve diseases treated by the 
therapy, but until now no good way to treat neural degenerative disease. 
Objective: To study the feasibility of umbilical cord mesenchymal stem cell 
and autologous purified CD34+ stem cells in neural degenerative disease. 
Methods: From May 2008 to May 2010, 21 patients with neural degen-
erative disease were treated with adult stem cells containing autologous 
purified CD34+ stem cells and umbilical cord mesenchymal stem cells. These 
patients included 15 cases of motor neuron disease and 6 cases of spinocer-
ebellar ataxia. The 21 patients were divided into two groups with one group 
including 14 patients received umbilical cord mesenchymal stem cells and 
the other including 7 patients received autologous stem cells. A volume of 
4 ml stem cells (>1.0×107) were administrated into subarachnoid space by 
lumbar puncture. All of them were treated with the rehabilitation. Results: 
In 15 patients of motor neuron disease, 8 cases (53%) achieved progress re-
sults, 4 cases (27%) obtained markedly effective results, 3 cases (20%) were 
null and void, and the total effective rate was 80%, before and after treat-
ment the amount of ALS table and the self-assessment questionnaire scores 
were significantly different (P <0.05); In 6 cases of spinal cerebellar ataxia, 3 
cases (50%) achieved the progress results, 1 (17%) case achieved the effect 
markedly, and 2 cases (33% ) were not valid, the total effective rate was 
77%. Four of the 21 cases had mild intracranial hypotension headache (after 
lumbar puncture). Two of the 14 patients with UC-MSC-treated had fever 
2h after treatment. The remaining patients had no significant adverse reac-
tions after treatment. Conclusion: Stem cell transplantation may be one of 
the safe and practical new ways used to treat neural degenerative disease.
Poster Board Number: 2256
AUTOMATED SYSTEM FOR DERIVATION AND 
EXPANSION OF INDUCED PLURIPOTENT STEM 
CELLS
Hsu, Lih-Tao1, Chen, Kevin1, Guu, Yeou-Bin2, Chu, Chen-Hsi3, Hsu, 
Che-Wei3, Chen, Wannhsin1
1Biomedical Technology and Device Research Laboratories, Industrial 
Technology Research Institute, Hsinchu, Taiwan, 2Mechanical and Systems 
Research Laboratories, Industrial Technology Research Institute, Hsinchu, 
Taiwan, 3Chia Sheng Technology Co., Ltd, Taichung, Taiwan
Induced pluripotent stem cells (iPSCs) are adult somatic cells that have been 
genetically reprogrammed to an embryonic stem cell-like state by being 
forced to express genes critical for maintaining the pluripotent proper-
ties of embryonic stem cells. Similar to embryonic stem cells, iPSCs can be 
expanded in vitro and differentiated into various clinical functional cell types 
for research or therapeutic application. During the process of iPSC deriva-
tion, potential colonies are picked for expansion and characterization, which 
are tedious, imprecise and contamination-prone processes. To automate 
stem cell colony passage and purification, we have developed a bench-top 
automated system equipped with an identification device, a dissection and 
transfer apparatus, laminar flow and HEPA filtering system. The system 
can identify the newly formed colonies from feeder cells and pick up the 
selected areas for transfer and expansion in a sterile environment. Using this 
system, some expanded colonies showed pluripotent stem cell characteristics 
including alkaline phosphatase activity, pluripotency marker expression and 
pluripotent differentiation ability. In addition to stem cell passage and puri-
fication, this system can also be utilized to select differentiated cells derived 
from iPSC or embryonic stem cells such as neural progenitors. By eliminat-
ing tedious manual work, the automated system can improve quantity and 
quality of iPSCs, providing a more consistent and reliable cells for research or 
clinical applications.
Poster Board Number: 2258
CLONAL TRACKING OF MESC DURING IN 
VITRO DIFFERENTIATION
Herbst, Friederike, Nowrouzi, Ali, Ball, Claudia R., Zavidij, Oksana, 
Schmidt, Manfred, von Kalle, Christof, Glimm, Hanno
National Center for Tumor Diseases (NCT) & German Cancer Res Center 
(DKFZ), Heidelberg, Germany
Embryonic stem cells are a valuable tool to investigate mammalian devel-
opment in vitro. As a model system they allow to analyse the impact of 
transgene-overexpression or down-regulation during differentiation. To eval-
uate whether mESC are composed of a heterogenic population or if every 
cell gives rise to further developmental tissue we used the unique integration 
sites of stably integrated lentiviral vectors (LV) as molecular tags for individu-
al mESC to examine the clonal composition during differentiation. Therefore, 
mESC were clonally marked using an eGFP expressing LV. Transduction of 
mESC results in 60 - 65.2% eGFP+ cells and eGFP was stably expressed for 
up to 27 passages. Differentiation of individually tagged mESC was induced 
by LIF withdrawal. Insertion site analyses by highly sensitive nrLAM (non-
restricted-Linear Amplification Mediated)-PCR coupled to next generation 
sequencing was performed to monitor the clonal composition in ESC, after 
embryoid body (EB) formation and cardiomyocyte (CM) differentiation. We 
identified a total of 295 unique integration sites (IS) in the transduced mESC 
population serving as origin for the generation of EB and CM, 352 IS in EB 
and 576 IS in differentiated CM. Comparison of IS revealed an overlap of 
101 IS in EB and mESC. In addition, 170 IS were found in differentiated CM 
as well as in mESC or EB. Mapping of IS to the murine genome revealed that 
in pluripotent mESC IS tagged genes were enriched in functional categories 
involved in cell movement, embryonic development and cell-to-cell signal-
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ing. In contrast, IS in differentiated EB and CM were preferentially detected 
in the vicinity of genes contributing to cell morphology, cellular develop-
ment and cardiovascular disease. These data demonstrate that the clonal 
contribution of individual mESC clones to differentiation can be monitored 
in vitro. Thorough investigation of clonal dynamics in mESC cultures during 
differentiation may help to identify subfractions of mESC which are prone to 
certain differentiation programs.
Poster Board Number: 2260
LABEL FREE MONITORING OF STEM CELL 
DIFFERENTIATION USING MICROTECHNOLOGY
Lu, Jente1, Do, Minjee2, Nourse, Jamison L.2, Hughes, Michael P.3, 
Lee, Abraham P.1, Flanagan, Lisa A.2
1Biomedical Engineering, University of California at Irvine, Irvine, CA, USA, 
2Pathology and Laboratory Medicine, University of California at Irvine, 
Irvine, CA, USA, 3Biomedical Engineering, University of Surrey, Guildford, 
United Kingdom
The differentiation of embryonic stem (ES) cells into specific progeny is criti-
cal for their use as potential therapeutic agents. Monitoring differentiation 
of living cells would enable the generation of precise cell lineage maps, but 
current live cell techniques are limited by insufficient markers for all potential 
ES cell progeny. Our previous results suggest dielectrophoresis (DEP) may 
provide a quantitative, label-free way to monitor the differentiation of stem 
cells. In this study, we utilized a microfluidic DEP trapping device to deter-
mine the dielectric properties of stem cells at various differentiation stages. 
We initially clarified the balance of fluidic and DEP forces in our device by 
measuring the dielectric properties of relatively homogeneous cell lines 
and found we could derive specific membrane capacitance and crossover 
frequency values for the cells. We then calculated these properties for stem 
cells spanning the developmental progression from pluripotent ES cells to 
terminally differentiated CNS cells. Our results show that specific membrane 
capacitance and crossover frequency shift as the cells differentiate from one 
cell type into the next, thus providing a quantitative measure of cell pheno-
type. This approach can be applied to any stem cell population to enable live 
cell detection of lineage-specific differentiation.
Poster Board Number: 2262
SEMANTIC WEB MODELING FOR INNOVATION 
IN TRANSLATING STEM CELL SCIENCE INTO 
REGENERATIVE MEDICINE - HARNESSING 
DATA FLOWS IN THE ICASM (INTERNET 
CLOUD, APPS, AND SOCIAL MEDIA)
Jakimo, Alan L.
Sidley Austin LLP, New York, NY, USA
The innovative power of data flows through the Internet cloud, mobile 
apps, and social media (the ICASM) extends to translating stem cell science 
into regenerative medicine (SCS-to-RM). In this respect, tens of thousands 
of web, blog and microblog posts about stem cells appear daily with the 
potential for some portion of this Amazonian flow to accelerate and advance 
the SCS-to-RM process. The great preponderance of these posts, however, 
comprises background noise. This presents two challenges to the SCS-to-RM 
community: 1) developing a means by which to filter from the noise the 
few signals with innovative power; and 2) applying this power to building 
and continually improving models of the SCS-to-RM process for purposes 
of spurring the scope, speed and safety of progress. We hypothesize that 
semantic web technology can be employed to address these two challenges. 
By semantic web technology we mean the tools - sometimes called Web 
3.0 - under development over the last two decades under the auspices of 
organizations such as the W3C Consortium and the IEEE. We test the SCS-
to-RM Semantic Web Modeling Hypothesis with an experiment consisting 
of the following four iterative steps: 1) designing a semantic web ontology 
for building and maintaining SCS-to-RM models (the SCS-to-RM Ontology); 
2) building an SCS-to-RM model from the SCS-to-RM Ontology based on 
the plethora of sources in the public domain; 3) developing and applying 
a series of algorithms for signaling the potential need to alter the SCS-to-
RM model based on input from a subsequent set of blogs, microblogs and 
Internet alerts; and 4) assessing the potential of these changes in the model 
for spurring innovation. To pursue Step 1 we have further developed the 
ontology proposed for the Stem Cell Information Technology Accelerator 
Platform (SCITAP) presented in a poster at the ISSCR 2009 Annual meeting. 
To pursue Step 3 we have further developed the text analysis algorithms 
presented in a poster at the ISSCR 2010 Annual Meeting. Preliminary 
results suggest that semantic web tools can be fruitfully applied to ICASM 
data flows in the pursuit of model building for improving the process of 
translating stem cell science into regenerative medicine. As in other fields, 
these results raise the intriguing question as to the impact of semantic web 
modeling on the evolution of the nomenclature and syntax used to describe 
the SCS-to-RM process and on further development of web-based tools 
such as clinicaltrials.gov. These results also suggest the value of forming a 
working group under the auspices of the ISSCR, the W3C Consortium, and/
or the IEEE to pursue a community-wide initiative to develop an SCS-to-RM 
Semantic Web platform.
Poster Board Number: 2264
SAFETY DATA EXCHANGE IN COLLABORATIVE 
ARRANGEMENTS FOR TRANSLATION, 
DEVELOPMENT AND IMPLEMENTATION OF 
STEM-CELL BASED REGENERATIVE MEDICINE
Jakimo, Alan L.
Sidley Austin LLP, New York, NY, USA
Under the watchful eye of government regulators, developers and provid-
ers of regulated medical products, such as drugs, biologics and medical 
devices, engage in unceasing effort to monitor and maintain the safety of 
these products. Contributing to this need for incessant attention to safety, 
each new generation of medical technology creates new demands on 
this effort. The translation of stem cell science into regenerative medicine 
and the development and implementation of regenerative medicines and 
therapies based on stem cell science and technology offer no exception to 
this rule. And with the clinical studies of stem cell-based therapies recently 
allowed by the U.S. FDA to proceed, the topic of safety in clinical trials and 
eventual worldwide implementation of regenerative medicine based on 
stem cell technology takes on added importance. As is true for regulated 
medical products in general, the safety profile of any proposed regenerative 
medicine gathers mass as it traverses the pathway from its conception and 
translation to its wide, society-wide adoption and implementation. At each 
waypoint along this traverse, various aspects of product and therapeutic 
safety must satisfy a set of increasingly complex biological, medical, cultural, 
ethical, economic, and technology and business development factors. The 
study reported here begins with the axiom that the regenerative medicine 
industry must efficiently and effectively set forth and follow a clear, well-
defined set of specifications for each of these factors against the backdrop 
of two dimensions: the safety aspects of regenerative medical products in 
general; and the safety aspects of any specific regenerative medical product 
under translation and development. In addition, the study reported here also 
sets forth as an axiom the fact that most regulated medical products traverse 
the conception-to-translation-adoption pathway as a result of the collabora-
tive efforts of several entities. These two axioms thus lead to the need for 
the regenerative medicine industry to begin to define the contours of safety 
data exchange in the context of collaborative translation, development 
and implementation of regenerative medicines. The study reported here 
focuses on defining these contours. In particular, the study explores whether 
general rules regarding safety data exchange in the context of collaborative 
development and implementation of regulated medical products need to 
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be customized for regenerative medicine. By exploring this topic this paper 
seeks to propose a library of contractual provisions that the regenerative 
medicine community can use in collaborative arrangements focused on the 
translation, development and implementation of stem cell-based regenera-
tive medicine. Among the potential benefits of such a library would be its 
contribution to the fostering of an industry-wide safety data infrastructure, 
the provision of one or more tools to support safety training, and lower 
transaction costs.
Poster Board Number: 2266
SYSTEMATIC IDENTIFICATION OF 
TRANSCRIPTION FACTORS CAPABLE OF 
INDUCING CELLS OF INTEREST
Masui, Shinji
Dept of Regenerative Medicine, National Center for Global Health and 
Medicine, Tokyo, Japan
A mammalian body consists of two hundred types of cells. The molecular 
mechanism making these differences is regulated by transcriptional network, 
which is organized by interactions between transcription factors and epige-
netic factors. Recent reports have shown that forced expression of a set of 
transcription factors can induce an intended type of cells by transdifferentia-
tion (e.g. iN and iCM cells), suggesting that some of transcription factors 
may be able to recruit epigenetic factors on a large number of gene to 
eventually organize transcriptional network. It is hoped that further identifi-
cation of such transcription factors in various types of cells will promote the 
understanding of transcriptional networks and cellular differentiation. Here 
we show the novel screening system to identify transcription factors with the 
cellular induction activity. By using this system in an example type of cells, 
we identified several transcription factors capable of inducing the cells with 
similar characteristics to that used in the screening. We hope this system to 
be useful to study how transcriptional network is organized in a cell.
Poster Board Number: 2268
EFFICIENT HOMOLOGOUS RECOMBINATION IN 
ZSCAN4C EXPRESSING CELLS
Nakatake, Yuki, Ko, Minoru S.H., Cadet, Jean S.
Laboratory of Genetics, NIA, NIH, Baltimore, MD, USA
One of the unique features of mouse ES cells is the high efficiency of homol-
ogous recombination (HR), which has been widely used to carry out gene 
targeting in mouse ES cells. In higher eukaryotes, except for a chicken DT40 
cell line derived from B lymphocytes, the HR occurs relatively infrequently. 
The mechanism by which the HR is facilitated in mouse ES cells is not well 
understood. Recently, we have reported that Zscan4 (zinc finger and SCAN 
domain containing 4) shows unique expression pattern and function in ES 
cells. Zscan4 was originally identified as late 2-cell stage specific gene, and 
also detected in undifferentiated ES cells for their spotty expression pattern 
(~5% positive cells in ES cell cultures). Zscan4-positive population in ES cells 
shows the elongation of telomeres and the suppression of genomic sister 
chromatid exchange activity, suggesting possible involvement of Zscan4 in 
DNA repair and recombination systems. These observations prompted us to 
investigate the HR events in Zscan4-positive cells. Here we show that the 
HR occurs more frequently in Zscan4+ ES cells than in Zscan4- ES cells. For 
example, using a Tamoxifen-inducible CRE-ERT2 system in ES cells carrying 
a floxed LacZ, we found 5-times enrichment of LacZ+ cells after transfec-
tion of promoter-less gene targeting vector and subsequent drug selection 
compared to cells after transfection of a random integrating vector and drug 
selection. We also found more frequent HR events in the ES cells carrying 
a Zscan4-expressing transgene. These data suggest a possibility of enhanc-
ing HR frequency by manipulating Zscan4 expression. This research was 
supported entirely by the Intramural Research Program of the NIH, National 
Institute on Aging.
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DEVELOPMENT AND OPTIMIZATION OF THE 
ON CHIP MICROCHAMBER ARRAY PCR AND 
RT-PCR FOR STEM CELL ANALYSIS
Saito, Masato, Hidari, Kentaro, Tamiya, Eiichi
Osaka University, Suita, Japan
The miniaturization of analytical devices by semiconductor microfabrication 
technique is attracting many scientists for the application to the medical 
and bioanalytical fields, such as genetic analysis, clinical diagnostics, drug 
screening, and environmental monitoring. Especially, the detection sensitiv-
ity of amplified DNA at a trace volume polymerase chain reaction (PCR), 
when compared with the normal scale, was expected to become easy. If 
the same number of DNA was amplified from the same copy template, 
DNA concentration per unit volume would be higher at the trace volume. 
These merits will be important to analyze between single cell characteristics 
and gene expression. However, miniaturized on-chip DNA amplification 
devices have serious problems, which are cross-talk contamination between 
chambers and rapid drying of the trace volume PCR solution at nano scale 
volume. Then we have developed a new method employing an oil layer on 
the microchamber instead of glass or plastic film covers. The sample DNA 
mixture to be amplified was introduced into each of mirochambers of the 
array by using nano-liter dispensing system through an oil layer. Thus, the 
feasibility of our microchamber array was further improved by using TaqMan 
fluorescence PCR. The quantification of initial DNA concentration present 
in a microchamber was achieved from 0 to 12 copies per chamber, not only 
by monitoring the real-time fluorescence intensity but also by observing the 
end point fluorescence signal. Additionally, the target specific DNA amplifi-
cation from a single chromosome was also succeeded using our microcham-
ber. In this report, we will introduce a microchamber array chip for DNA 
amplification from a single cell and showed our results of the trace volume 
PCR amplification of a target DNA in the microchamber array chip. Then we 
also applied to on-chip RNA detection by through the DNA amplification 
from mRNA (RT-PCR). We fabricated the silicon microchamber array chip, 
which had 50 nL volume of each chamber. The some kind of condition of 
PCR solutions, which contained genomic DNA as a template, specific prim-
ers and fluorescence probe, were distributed into the microchambers using 
nano-liter dispenser. After on chip PCR amplification, we found that the 
polymerase concentration was needed 10 times comparing with the normal 
condition. Other hands, we developed the novel tweezer-type probe devices 
for the manipulation of the single cell. Then, the single cell (fetal blood cell), 
of which was fixed on the slide glass, was collected using tweezer probe. 
The collected single cell was released into the microchamber. After PCR am-
plification, positive signals could be obtained from 13 microchambers (46.4 
%). The some kind of condition of RT-PCR solutions, which contained total 
RNA as a template, specific primers and fluorescence probe, were distributed 
into the microchambers using nano-liter dispenser. After on chip RT-PCR 
amplification, we found that the reverse transcriptase was needed 1 times 
normal condition, however, the polymerase concentration was needed 10 
times comparing with the normal condition to detect the difference of fluo-
rescence. In the future, it is expected that the analysis of relation between 
single cell and gene expression could become possible by the established 
method.
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TRANSGENIC EXPRESSIONS OF 
PLURIPOTENCY-RELATED TRANSCRIPTION 
FACTORS IN COMMON MARMOSET ES CELLS 
BY SITE-SPECIFIC TRANSGENESIS
Shiozawa, Seiji1, Okano, Hirotaka James1, Sasaki, Erika2, Okano, 
Hideyuki1
1Department of Physiology, Keio University, School of Medicine, Tokyo, 
Japan, 2Central Institute for Experimental Animals, Kanagawa, Japan
Non-human primate embryonic stem (ES) cells have vast promise for 
preclinical studies. Genetic modification in non-human primate ES cells is 
an essential technique for maximizing the potential of these cells. Common 
marmoset, one of the New World monkeys, has several advantages as an 
experimental primate. These include their small size (250 to 400 g), ease 
of breeding, and high reproductive efficiency (average pups/year from a 
pair, 4). These characteristics are favorable for preclinical studies. However, 
transgenesis and gene targeting in common marmoset ES (cmES) cells 
remain difficult mainly because of the obscurity of cell cultures and the low 
transfection efficiency. Also, the fact that transgenes are often silenced in 
primate ES cells is another major problem. Recombinase-mediated cassette 
exchange (RMCE), a transgenic strategy using recombinase activity, enables 
efficient site-specific integration of a transgene efficiently by inserting a 
cassette flanked by a pair of heterospecific lox sites into a genomic locus 
in advance. This method is highly advantageous relative to conventional 
transgenesis using non-homologous end joining because of its predictable, 
reproducible and stable expression from a single copy transgene. Therefore, 
this transgenic strategy is feasible for research using primate ES cells. To 
establish the site-specific transgenic system using RMCE in primate ES cells, 
we inserted the enhanced green fluorescent protein (EGFP) gene with het-
erotypic lox sites into the β-actin (ACTB) locus of the cmES cells using gene 
targeting. The resulting knock-in ES cell line, BR29, expressed EGFP stably 
under the control of the endogenous ACTB promoter. Using inserted het-
erotypic lox sites, we demonstrated Cre RMCE and successfully established a 
monomeric red fluorescent protein (mRFP) knock-in cmES cell line. Next, to 
establish various transgenic cmES cell lines by RMCE, Cre expression plasmid 
and donor plasmids that express pluripotency-related transcription factors 
NANOG, KLF2, KLF4 or KLF5 were cotransfected to BR29 by lipofection. 
After drug selection, the resistant colonies were obtained and expanded. 
These transgenic cmES cell lines showed stable expression of each trans-
genes over several passages. Therefore, this transgenic strategy is expected 
to be useful for preclinical studies and stem cell biology using transgenes in 
the common marmoset.
Poster Board Number: 2274
PREDICTIVE TOXICOLOGY APPLICATIONS OF 
HESC-DERIVED CELLS
Siegenthaler, Monica M., Nistor, Gabriel, Poole, Aleksandra, 
Airriess, Chris, Keirstead, Hans
California Stem Cell Inc, Irvine, CA, USA
Predictive toxicology is a critical step in drug development and the evalu-
ation of drug safety. Most currently available models of predictive toxicol-
ogy are insufficient in identifying toxic compounds. The use of human cells 
in predictive toxicology screening allows for better correlation of human 
responses to drug products than traditional animal models, which are limited 
due to species differences. hESCs represent a reliable and scalable source of 
differentiated human cell types, that are otherwise difficult to obtain, for cell 
based assays. California Stem Cell manufactures three high purity hESC-de-
rived cell products in 96-well and 384-well screening plates for use in predic-
tive toxicology. NeuroPlate™ contains functional live neuronal progenitors 
(NPs), MotorPlate™ contains functional live motor neuron progenitors 
(MNPs) and CardioPlate™ contains live cardiomyocyte progenitors (CPs). 
Here we demonstrate the use of these plates in predicting toxicology from 
lead compounds in development. The use of our high throughput cellular 
products during the early phases of drug development could lead to safer 
pharmaceuticals and reduced attrition, potentially saving millions in overall 
development costs.
TISSUE ENGINEERING
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ISOLATION, CLONAL EXPANSION AND 
GENETIC PROFILE OF HUMAN ADULT 
EPITHELIAL STEM CELLS FROM THE CELL 
RESTS OF MALLASSEZ
Athanassiou, Maria1, Pliakas, Maria2, Wangsawiharja, Felix3, 
Papagerakis, Silvana2, Papagerakis, Petros3
1Otolaryngology, Pediatric Dentistry, University of Michigan, Medical 
School and School of Dentistry, Ann Arbor, MI, USA, 2Otolaryngology, 
University of Michigan, Medical School, Ann Arbor, MI, USA, 3Pediatric 
Dentistry, University of Michigan, School of Dentistry, Ann Arbor, MI, USA
Precious little success has been made in the area of adult, genetically un-
modified, non-cancer-derived Human Adult Epithelial Stem Cells (hEpiSC) 
or Progenitor cells despite progress with the human mesenchyme and 
hematopoietic component or with fetal murine epithelial stem cells from 
various organs. Isolating human adult hEpiSCs and testing their pluripotency 
and progenitor capabilities is complicated by the origin of relevant tissues 
in internal organs. Tissue culture of viable, human epithelial stem cells from 
more accessible sources such as the epidermis has been hindered by anoikis, 
an apoptotic cell-death triggered by the loss of cell attachment. Conse-
quently, most tissue-specific hEpiSCs have been identified in tumors, at a 
point in which they cause cancer and are of no use to the desired end-point 
of stem cell research: therapeutic application. We report a major advance, as 
we have been able to clonally isolate, characterize and maintain in a xeno-
free, feeder-layer free tissue culture system, epithelial cells with stem-like 
pluripotency. Our cells originate in the oral cavity as a by-product of orth-
odontic removal of wisdom teeth, a procedure applied to 99% of dental pa-
tients. Our hEpiSC’s come from the Human Epithelial Cell Rests of Mallassez 
(hERM) cells, found around teeth throughout adult life and represent a po-
tential accessible homologous donor stem cell source. Our method can find 
general application in the isolation of unmodified adult epithelial stem cells. 
Human integrin-a6+ve cells as well as an Lgr5+ve subpopulation are derived 
by fluorimetric analysis (FACS). Our sorted populations can grow organoids 
and express the markers of pluripotency, oct-4, nanog and Sox2. They main-
tain the hERM growth profile in vitro. The genetic profile of Lgr5+ve cells 
shows increased expression of genes associated with an undifferentiated 
stem cell phenotype. hEpiSC can generate mineralized tissue in vivo when 
co-seeded on scaffolds with Human Dental Pulp Stem Cells (hDPSC) and 
grafted subcutaneously in the nude mouse. In grafts with co-seeded hDPSC 
and hEpisC, epithelioid organ structures appear (6-weeks post-implantation) 
followed by mineralization (ten weeks post implantation). TEM shows crystal 
mineral depositions characteristic of both cementum and enamel as well as 
profiles of cementoblast and ameloblast-like cells. hEpiSC cells alone can 
give rise to contained acinar, secretory epithelial-like structures but no min-
eralized tissue. No differentiation into columnar epithelial cells, cementoblast 
-like cells and formation of mineralized tissue is seen in hERM or hDPSC 
alone controls supporting the view that mesenchymal-epithelial signaling is 
required for mineralized dental tissue differentiation. Human origin of cells 
in grafts is verified by HuNu antibody immunofluorescence. Tooth organ re-
generation is envisioned by direct transplantation of stem cells or progenitors 
in the jaw in vivo or by implantation of the in vitro engineered tooth. More 
than cosmetic application tooth organ regeneration is needed for patients 
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of trauma and severe tooth abnormalities such as Amelogenesis Imperfecta. 
This is the first report showing regeneration of human enamel and human 
cementum in vivo and. Differentiation protocols to address the question of 
hERM in broad application as hEpiSC are being evaluated. It is conceivable 
that the same pluripotent cell used for tooth regeneration might be used for 
skin, or kidney or liver regeneration.
Poster Board Number: 2278
COMPRESSION-INDUCED ALIGNMENT OF 
HUMAN MESENCHYMAL STEM CELLS IN 
COLLAGEN CONSTRUCT
Chan, Barbara, Ho, FC, Li, CW
Medical Engineering, The University of Hong Kong, Hong Kong, China
Cell alignment is an important design parameter in tissue engineering. Using 
a micromanipulator-based loading device, we delivered compression loading 
to human bone marrow derived mesenchymal stem cells (MSCs) in collagen 
constructs and investigated the alignment response of these cells upon load-
ing. We demonstrated that hMSCs preferably aligned along the compres-
sion loading axis. Moreover, the matrix factor, particularly the collagen 
concentration, interferes with the mechanoresponse of hMSCs. Specifically, 
the compression-induced hMSCs alignment and elongation is collagen 
concentration-dependent, with moderate collagen concentrations giving the 
optimal responses. Our results also suggest the importance of integrin beta 1 
in mediating the mechanoresponses. Moreover, hMSCs respond to compres-
sion by exhibiting morphological change in actin organization. Furthermore, 
compression may induce the expression of matrix adhesions other than focal 
adhesion and may stimulate the maturation of matrix adhesions.
Poster Board Number: 2280
HUMAN FALLOPIAN TUBE MESENCHYMAL 
STEM CELLS ENHANCE BONE REGENERATION 
IN A XENOTRANSPLANTED MODEL
Jazedje, Tatiana1, Bueno, Daniela Franco1, Pimenta, Bruno1, 
Caetano, Heloisa1, Czeresnia, Carlos Eduardo2, Perin, Paulo 
Marcelo3, Evangelista, Lucila2, Nisenbaum, Marcelo Gil2, Halpern, 
Silvio2, Maluf, Mariangela3, Martins, Marília Trierveiler1, Bueno, 
Maria Rita Passos1, Zatz, Mayana1
1University of Sao Paulo, Sao Paulo, Brazil, 2Celula Mater, Sao Paulo, Brazil, 
3Centro Especializado em Reprodução Humana, Sao Paulo, Brazil
The treatment of osteoporosis, which affects about 70% of women over 
50 years of age, has been the focus of many researches. We have recently 
reported that human fallopian tubes, which are discarded during surgical 
procedures of women submitted to sterilization or hysterectomies, are a rich 
source of mesenchymal stem cells (htMSCs). It has been previously shown 
that stem cells may be useful in enhancing the speed of bone regenera-
tion. This prompted us to investigate if htMSCs may be useful in the future 
treatment of osteoporosis since they present a pronounced capacity for 
osteogenic differentiation in vitro. Based on this prior knowledge, our aim 
was to evaluate, in vivo, the osteogenic capacity of htMSCs to regenerate 
bone through an already described xenotransplantation model: nonim-
munosuppressed (NIS) rats with cranial defects. htMSCs from five 30-50 
years old and fertile heathy women were used in this experiment. They 
were characterized by flow cytometry and for their multipotenciality in vitro 
(osteogenic, chondrogenic and adipogenic differentiations) prior to the 
transplantations. Two symmetric full-thickness cranial defects (5 x 8 mm) 
on each parietal region of seven NIS rats were performed. The left side (LS) 
of six animals was covered with CellCeram (Scaffdex) only, and the right 
side (RS) with the CellCeram and htMSCs(106 cells/scaffold). In one control 
animal, the RS had CellCeram only and nothing was added at the left side 
(controls) to ensure, that the provoked cranial defect does not regenerate 
spontaneously. Animals were euthanized at 30, 60 and 90 days postopera-
tively and cranial tissue samples were taken for histological analysis. After 90 
days we observed neo-bone formation in both sides. However, in animals 
euthanized 30 and 60 days after the procedure a neo-bone formation with a 
mature bone was observed only in the right side. PCR analysis confirmed the 
presence of human DNA only at the right side of the skull. This result was 
confirmed by immunofluorescence specific for human nuclei. Our results 
show, for the first time, that htMSCs can be used successfully to enhance 
bone regeneration in vivo, opening a new field of study for future treat-
ments of osteoporosis with women autologous stem cells.
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IDENTIFICATION OF SPECIFIC POPULATION 
OF HUMAN SALIVARY ACINI AND THEIR 
PROGENITORS USING MESENCHYMAL STEM 
CELL MARKERS
Maria, Ola M.1, Maria, Ahmed M.2, Tran, Simon D.1
1Mcgill University, Montreal, QC, Canada, 2Tanta University, Tanta, Egypt
Xerostomia results from irreversible destruction of salivary parenchyma in 
patients afflicted with Sjogren’s syndrome or who received radiotherapy for 
head and neck cancer. The development of an artificial salivary gland device 
or stem cell-based therapy would benefit these patients. Accordingly, we 
need to expand acinar cells and/or their progenitors. We aim to identify and 
characterize human salivary gland (huSG) stem/progenitor cells, and to track 
them in a duct-ligated parotid gland in a rabbit model. Human salivary tissue 
(n=12) was tested for the expression of mesenchymal stem cell markers: 
Stro-1, CD146, CD106, CD44, CD166, CD90, CD105 using immunofluores-
cence technique. Moreover, CD44 expression was tracked in rabbit parotids 
after duct-ligation (n=30). In huSG tissue, 100% of serous acini expressed 
the mesenchymal adhesion-related stem/progenitor cell marker CD44, while 
100% of mucous acini expressed CD166. In rabbit controls, all serous acini 
also expressed CD44. However upon ligation, CD44 expression increased 
in both acini and ducts at day 1, 7, 14 and only in duct-like structures at 
day 30 and 60 post-ligation. These CD44 stem/progenitor cells are more 
resistant to atrophy caused by duct-ligation than the differentiated cells. 
This duct-ligation model might be used to isolate a greater number of stem/
progenitor cells while CD44/CD166 could be used either to isolate stem 
cells or differentiated serous/mucous acini from human salivary glands. The 
ability to identify and isolate huSG stem/progenitor cells would provide a 
cell-based therapy for the treatment of xerostomia.
Poster Board Number: 2284
DYNAMICALLY PRIMING HUMAN FETAL 
MESENCHYMAL STEM CELLS FOR BONE 
TISSUE ENGINEERING APPLICATION—A 
COMPARATIVE STUDY OF DIFFERENT 
BIOREACTOR SYSTEMS
Zhang, Zhiyong1, Teoh, Swee Hin2, Choolani, Mahesh3, Chan, Jerry 
K Y3
1National University of Singapore, Singapore, Singapore, 2Department 
of Mechanical Engineering, National University of Singapore, Singapore, 
Singapore, 3Department of Obstetrics & Gynaecology, National University 
of Singapore, Singapore, Singapore
Bioreactors provide dynamic culture conditions for efficient exchange of 
nutrients and the mechanical stimulus necessary for generation of effective 
tissue engineered bone grafts (TEBG). We have shown that biaxial rotat-
ing (BXR) bioreactor-matured human fetal mesenchymal stem cell (hfMSC) 
mediated-TEBG can heal rat critical sized femoral defects. However, it is 
not known whether optimal bioreactors exist for bone TE (BTE) applica-
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tions. We systematically compared this BXR bioreactor with three most 
commonly used systems: Spinner Flask (SF), Perfusion and Rotating Wall 
Vessel (RWV) bioreactors, for their application in BTE applications. The BXR 
bioreactor achieved higher levels of cellularity and confluence (1.4-2.5x, 
p<0.05) in large 785mm3 macroporous scaffolds not achieved in the other 
bioreactors operating in optimal settings. BXR bioreactor treated-scaffolds 
experienced earlier and more robust osteogenic differentiation on von 
Kossa staining, ALP induction (1.2-1.6x, p<0.01) and calcium deposition 
(1.3-2.3x, p<0.01). We developed a MicroCT quantification method which 
demonstrated homogenous growth of hfMSC in BXR bioreactor-treated 
grafts, but not with the other three. BXR bioreactor enabled superior cellular 
proliferation, spatial-distribution and osteogenic induction of hfMSC over 
other commonly used bioreactors. In addition, we developed and validated a 
non-invasive quantitative microCT-based technique for analyzing neo-tissue 
formation and its spatial distribution within scaffolds.
Poster Board Number: 2286
DESIGN OF INDUCTIVE SCAFFOLD FOR THE 
OSTEOCHONDRAL DIFFERENTIATION OF 
HUMAN MESENCHYMAL STEM CELLS
Re’em, Tali, Cohen, Smadar
Biotechnology Engineering Department, Ben Gurion University, Be’er 
Sheva, Israel
Challenge and Goals: Human mesenchymal stem cells (hMSC) differentia-
tion depends on the environment wherein the cells reside, especially on the 
spatio-temporal presentation of the differentiation-inductive factors. Herein, 
we aim to reconstruct the microenvironment promoting the osteochondral 
differentiation of MSCs, by presenting the chondro-inductive Transforming 
Growth Factor-β1 (TGF-β1), and the osteo-inductive Bone Morphogenetic 
Protein-4 (BMP-4) in a similar manner to their presentation by the extracel-
lular matrix. Thus, TGF-β1 and BMP-4 were affinity-bound to alginate-sul-
fate containing scaffold, mimicking their specific interactions with heparan 
sulfate. Methods and Results: TGF-β1 and BMP-4 were affinity bound to 
alginate-sulfate, with equilibrium binding constants similar to their bind-
ing to heparin, as assessed by Surface Plasmon Resonance (SPR) analysis. 
To create the osteochondral interface, TGF-β1 or BMP-4 were individually 
bound to two alginate-sulfate-containing macroporous alginate scaffolds, 
subsequently to be combined into bilayered osteo-chondral inducing system. 
The release pattern of the growth factors (GFs) from the scaffolds were 
analyzed by their specific ELISAs, revealing a sustained factor release for 7 
days from the affinity-binding scaffolds, in contrast to the burst release of 
the factors from unmodified scaffolds. Both factors retained their bioactivity, 
as assessed by the enhanced collagen deposition in a monolayer of primary 
rat fibroblasts, measured by Sircoll assay. HMSC were seeded into TGF-β1 
or BMP-4/affinity-bound scaffolds (300,000 cells/scaffold), and GF-induced 
activation of signal transduction pathways were tested by Western Blot. 
Prolonged and elevated phosphorylation levels of Smad2 and ERK1/2 were 
observed for up to 14 days, indicating the long-term activity of the affinity-
bound factors. Masson’s trichrome staining of the 14 days-old cell constructs 
demonstrated substantial deposition of collagenous material within the 
TGF-β1/affinity-bound layer. Additionally, the immuno-staining for col-
lagen type II indicated its increased production/secretion, and the cells had 
the round-shaped morphology, typical to committed chondrocytes. In the 
BMP-4/affinity-bound layer, elevated levels of alkaline phosphatase (ALP) 
and increased mineralized bone matrix deposition after 3 weeks indicated 
their osteogenic differentiation. Moreover, the ALP activity in the bilayered 
system was shown to be significantly greater compared to the activity in the 
only BMP-4-loaded scaffolds, suggesting a positive mutual effect of the GFs 
and their spatial arrangement within the system on the cell differentiation 
pattern and efficiency. Conclusions: These data indicate the potential use of 
the affinity-binding alginate scaffolds combined with spatial presentation of 
TGF-β1 and BMP-4 for guided differentiation of hMSCs; allowing the recon-
struction of the microenvironment for osteochondral tissue formation.
Poster Board Number: 2288
SCANNING OF BIOMATERIAL COMPOSITION 
AND MICROSTRUCTURE FOR HUMAN 
ADULT STEM CELLS ASSOCIATION AND 
OPTIMIZATION OF LARGE BONE DEFECTS 
REGENERATION
Fanganiello, Roberto D.1, Ishiy, Felipe1, Bueno, Daniela Franco1, 
Martins, Marilia T.2, Passos-Bueno, Maria Rita dos Santos1
1Genetics and Evolution, Institute of Biosciences, Sao Paulo, Brazil, 
2Stomatology Department, School of Dentistry, University of Sao Paulo, Sao 
Paulo, Brazil
Although smart biomaterials have great potential to be used in bone recon-
struction surgeries, transplantation of autologous bone is still the golden 
standard in bone regeneration procedures. An ideal scaffold to support bone 
formation must have osteoconductive and osteoinductive properties which 
may be enhanced through the association between the biomaterial and 
stem cells harboring osteogenic potential. Furthermore, there are a number 
of recent reports showing that cellular behavior can be orchestrated by 
biomaterial properties such as surface topography, macro and microstruc-
ture, composition and elasticity. In this study we screened seven biomaterials 
with different properties to evaluate its effectiveness to heal rat calvarial 
critical size defects when associated with human dental pulp adult stem cells 
(hDPSCs). The immunophenotype characterization of these cell populations 
showed that they stained positively for mesenchymal cell markers (anti-CDs 
29,73, 90 and 105) but were negative for the hematopoietic (anti-CDs 34 
and 45) and endothelial (anti-CD 31) ones. We attested and quantified 
the in vitro osteogenic potential of these populations through cell culture 
treatment with osteogenic medium and by alkaline phosphatase and alyzarin 
red staining. Cells (10e6) were associated to 4.5 mm discs of five commer-
cially available and two in-house developed biomaterials: Geistlich Bio-Oss 
Collagen (Geistlich Biomaterials), BioGen, BioGen Mix Gel, Biocollagen Gel 
(Bioteck s.l.r.), CellCeram (Scaffdex Oy), 50% hydroxyapatite (H.A.) / 50% 
βTricalcium-phosphate (β-TCP) and 100% β-TCP (developed in-house). In 
vivo ossification was accessed using a rat (Wistar) model of paired critical 
size defects. Control groups were performed transplanting the biomaterials 
free of cells. We compared experimental and control groups healing 45 days 
after surgery through histological hematoxylin / eosin staining. We observed 
a significantly enhanced osteogenesis in experimental groups belonging to 
three materials: 100% β-TCP, Biocollagen Gel and CellCeram. We detected 
differences in Osteoblastic differentiation process (first phase of the osteo-
genic differentiation) in the 100% β-TCP (300 um average pore diameter, 
70% porosity) experimental groups with formation of bone islands primor-
dia, single mature bone island formation in the Biocollagen Gel (equine 
collagen material) experimental groups and generalized mature bone 
islands formation with broad osteocyte distribution in the CellCeram (60% 
H.A./40% β-TCP, with 200-400 um of pore diameter and 80% porosity) 
experimental groups. The best regeneration in this large bone defect model 
was achieved by association of hDPSCs to CellCeram discs and quantifica-
tion of total bone island area showed that bone formation was enhanced 4 
to 7 times in experimental groups when compared to control groups. In this 
work we present data supporting successful association of human adult stem 
cells to ceramic and collagen materials with specific structure and composi-
tion to heal large calvarial bone defects. We also suggest that synthetic bio-
materials associated with stem cells are a bona fide alternative to autograft 
therapy to heal critical-size bone defects. 
CAPES /CEPID / FAPESP/ CNPq 
Pos
er W
ith
r w
n
99
Friday Poster Abstractswww.isscr.org
Friday Poster Abstracts
Poster Board Number: 2292
SELF-ASSEMBLING HYDROGELS FOR 2D AND 
3D HUMAN STEM CELL CULTURE
Tuin, Annemarie, Metselaar, Gerald A., Bulten, Erna W., De Jong, 
Menno R.
Nano-FM, Groningen, Netherlands
Introduction: Stem cells isolated from fat tissue are increasingly used in 
regenerative medicine. Their easy accessibility, differentiation potential and 
immunomodulatory properties makes them ideal cells for the restoration of 
damaged or lost tissue. Hydrogels can function as multifunctional scaffolds 
in various approaches of tissue repair (TR), either as a filler, a slow-release 
depot for growth factors or a delivery vehicle for (stem) cells. Hydrogels 
can be prepared from natural ECM proteins or synthetic materials. The 
advantage of using synthetic materials is that there are no batch-to-batch 
differences, they have a defined composition and are in general easy to ma-
nipulate. Our synthetic self-assembling gels display a nanofibrous structure 
resembling the in vivo ECM structure of collagen fibers. In addition, they 
allow for easy functionalisation with ECM peptides and cell encapsulation. 
Therefore, we aim at developing novel (stem) cell-supporting coatings and 
hydrogels for 2D and 3D cell culture in vitro and for (stem) cell-delivery in 
vivo. Materials & Methods: Coatings and hydrogels were prepared from dif-
ferent types of gelator molecules. All gelators share a common core structure 
consisting of a 1,3,5-cis cyclohexane tricarboxylic acid core. The rigid-core 
predisposes the arms towards self-assembly resulting in fiber formation and 
gelation. Gelators with different cell-adhesive properties were obtained by 
conjugating different peptidic arms to the three arms of the core structure. 
The self-assembling character of the gelators allows for easy encapsula-
tion of structures like micelles or cells. Characterization of the cells on the 
coatings and in the gels is done by assessing 1) the morphology of the cells 
by light microscopy and staining 2) the viability of the cells by staining and 
biochemical assays and 3) gene expression by PCR. Results & Discussion: 
The gelators were either applied as 2D-coatings or as 3D-hydrogel matrices 
in well-plates. The growth of human adipose-derived stem cells (ADSCs) 
on and in scaffolds of these gelators was studied. Cellular function could be 
maintained on the coatings and in the hydrogels; the ADSCs survived and 
proliferated on the coatings and in the hydrogels. In addition, our coatings 
also allowed for differentiation of ADSCs along multiple lineages, e.g. adi-
pogenic, osteogenic, chondrogenic and neuronal differentiation as shown by 
staining for cell specific markers and gene expression. These studies showed 
that our gelators are suitable materials for 2D as well as 3D cell-culturing of 
ADSCs. Conclusion: Stem cell-culturing on 2D-coatings or in 3D-hydrogels 
showed that our materials are suitable scaffolds for the growth and differen-
tiation of ADSCs. Preliminary results showed that also cardiac and neuronal 
cells derived from human ESCs were growing well on our coatings and in 
our gels. Therefore, our materials offer unique possibilities for the develop-
ment of stem cell-seeded scaffolds for the regeneration of damaged or lost 
tissue.
Poster Board Number: 2294
HUMAN STEM CELL-BASED ENGINEERING OF 
ADIPOSE TISSUE: IMPACT OF ADIPOCYTES ON 
ENDOTHELIAL CELL CAPILLARY FORMATION
Proulx, Maryse, Vincent, Caroline, Fradette, Julie
Département de Chirurgie, Université Laval, Centre LOEX de l’Université 
Laval, Génie Tissulaire et Régénération : LOEX - Centre de Recherche FRSQ 
du Centre Hospitalier Affilié Universitaire de Québec, Quebec, QC, Canada
Various adult stem cell populations are available for tissue engineering appli-
cations. Adipose-derived stem/stromal cells (ASCs) are emerging as impor-
tant multipotent cells for the reconstruction of diversified tissues. We have 
used human ASCs as building blocks for the production of tissue-engineered 
connective and adipose tissue substitutes. Considering the importance to 
achieve rapid revascularization after implantation of thick tissue grafts, we 
engineered tissues comprising an in vitro network of capillaries. We thus 
report the production of human “endothelialized” reconstructed tissues 
devoid of exogenous matrix components. The self-assembly approach of tis-
sue engineering was used in combination with ASCs to produce connective 
and adipose tissue substitutes. This method stimulates cells to organize their 
own extracellular matrix environment resulting in manipulatable connective 
sheets. By including an adipogenic differentiation step, adipose sheets can 
be produced. Thicker tissues are obtained by layering multiple cell sheets. 
Addition of human microvascular endothelial cells (HMVECs) prior to sheet 
superposition resulted in the formation of capillary-like structures within the 
connective and adipose constructs. Immunolabelings and confocal analyses 
revealed a network of PECAM-expressing capillaries only within tissues 
enriched with HMVECs. In comparison to connective tissues, adipocytes 
impacted on the percentage of PECAM+ structures featuring a well-defined 
lumen on tissue sections (2-fold increase) and a tendency towards 20% 
greater lumen diameter. This higher number of capillary-like structures was 
correlated with an increased secretion of many pro-angiogenic molecules 
from adipose constructs, namely a 15-fold increase in leptin level, 3.3 fold 
for angiopoietin-1, as well as 2.0 fold for both HGF and VEGF as assessed 
by ELISA assays. Finally, a short-term study indicated that endothelialized 
adipose constructs implanted onto nude mice may promote revascularization 
within the first 7 days after grafting. In conclusion, the use of autologous 
adult stem cells combined with endogenous human matrix elements make 
these tissue-engineered adipose tissues unique and natural substitutes for 
future clinical applications.
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INVESTIGATING THE ROLE OF VARYING 
MOLECULAR WEIGHT OF HYALURONIC 
ACID IN THE PROLIFERATION AND 
DIFFERENTIATION OF MOUSE ES CELLS, EB3 
IN VITRO
Joddar, Binata, Kitajima, Takashi, Osaki, Emi, Takahashi, Sawa, 
Kang, Jeonghwa, Ito, Yoshihiro
Nanomedical Engineeiring Laboratory, Riken, Advanced Science Institute, 
Wako-shi, Saitama, Japan
Recently there has been much focus on not just regenerative biomaterials 
alone, but also exploring their potential as components of a ‘niche’ in the 
area of stem cell research. One such biomaterial that holds promise to serve 
as a ‘niche’ material is Hyaluronic Acid (HA), which can support controlled 
self-renewal and differentiation of human ES cells. However the properties 
of HA and its effects on cellular environments can vary depending upon its 
molecular weight (4000 Da -3 million Da) as shown by us. Low MW HA is 
more angiogenic versus high MW which is non-thrombogenic. Such differ-
ences in effects due to varying MW of HA are generally mediated via HA re-
ceptors such as CD44 and RHAMM. We attempted to investigate the effects 
of varying MW of HA on mouse ES (EB3) cell proliferation and differentia-
tion in vitro. HA of high MW (3 million Da) and of low MW (6.4 KDa) was 
UV-crosslinked using the photocrosslinker 4-Azidoaniline and patterned onto 
cell culture cover slips (0.2% w/v). EB3 were seeded (10,000 cells) onto 
these micropatterned HA surfaces and control gelatin coated dishes and 
cultured upto 5 days. Immunohistochemistry was used to detect the pres-
ence of Oct3/4, CD44 receptor and HA uptake into EB3. ALP staining was 
used to assess the levels of differentiation, and WST-1 was used to measure 
cell proliferation. RT-PCR was employed to detect mRNA levels of GATA-
4 and Oct3/4 levels within samples. WB was used to assess the levels of 
phospho- and total STAT-3 proteins. To explore the role of CD44 in uptake 
and metabolism of HA by EB3, we cultured cells by adding CD44 antibod-
ies and explored the uptake of HA, and resulting effects on cell proliferation 
and differentiation when cultured on HA. Cells adhered to all wells receiv-
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ing HA, but formed flat spread out colonies only on gelatin, immobilized 
LMW HA and to some extent in wells that received soluble LMW HA. All 
colonies appeared undifferentiated as detected by ALP-1 staining. Oct3/4 
was expressed by cells grown on all substrates except immobilized HMW 
HA. WST-1 assay showed that cells proliferated to a maximum extent and 
equally on gelatin, immobilized LMW HA and in soluble LMW HA compared 
to others. Reduced GATA-4 mRNA expression in cells cultured on LMW HA 
(both immobilized and soluble), in soluble HMW HA and on gelatin controls 
confirmed the undifferentiated state of EB3 cells on these substrates. In-
creased protein expression of phospho-STAT3, which induces the expression 
of Oct-3/4 and maintains the undifferentiated state of EB3 was detected in 
cells cultured on all substrates except on immobilized HA. For the very first 
time, we demonstrated the presence of CD44 receptors on EB3, which when 
blocked by adding CD44 antibodies caused reduction in HMW HA, but not 
LMW HA uptake. This also led to decrease in cell proliferation, and increas-
ing levels of differentiation in EB3 cultured on or with HMW HA. However 
for cells cultured with LMW HA in the presence of CD44 antibodies, these 
trends were not affected. Suspecting the involvement of p42/44 MAPK in 
this HA-CD44 interaction, we blocked the CD44 receptors on EB3. In cells 
cultured on or with HMW HA, blocking CD44 lead to reduction in the levels 
of phospho-p42/44 MAPK. This was however not the case for EB3 cultured 
with CD44 antibodies on LMW HA, wherein the levels of phospho-p42/44 
MAPK remained unaffected. Probably there is another pathway, other than 
via CD44 (maybe RHAMM) which is responsible for LMW HA uptake and 
metabolism in EB3.
Poster Board Number: 2298
MOUSE EMBRYONIC STEM CELL-ENGINEERED 
TISSUE SHEETS WITH DEFINED CARDIAC CELL 
POPULATIONS AMELIORATE FUNCTION AFTER 
MYOCARDIAL INFARCTION
Masumoto, Hidetoshi1, Ikeda, Tadashi2, Sakata, Ryuzo2, Yamashita, 
Jun K.1
1Dept of Cell Growth and Differentiation, Center for iPS Cell Research and 
Application (CiRA), Kyoto University, Kyoto, Japan, 2Dept of Cardiovascular 
Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan
BACKGROUNDS: Embryonic stem (ES)/ induced pluripotent stem (iPS) cells 
hold promise for cardiac regeneration therapies. Previously, we established 
a systematic cardiovascular cell differentiation system from mouse ES/
iPS cells (Nature, 2000; Circulation 2008). In this system, cardiomyocytes 
(CMs), endothelial cells (ECs) and mural cells (MCs) can be induced from 
common progenitor, Flk1+ cells. In this study, combining our system and 
cell sheet technology using a temperature-responsive culture surface, we set 
out to reconstitute cardiac tissue by assembling ES/iPS cell-derived CMs/
ECs/MCs, and examined the effect of the cardiac tissue sheet transplanta-
tion to myocardial infarction (MI) model. METHODS & RESULTS: Three 
cardiovascular cell types (CMs/ECs/MCs) were induced from mouse ES/iPS 
cells, purified by cell sorting, and plated on temperature-responsive culture 
dishes. Whereas pure CMs failed to efficiently form a sheet structure, CM/
MC mixture successfully formed pulsatile cell sheets, suggesting a cell-
integrative function of MCs. We generated cardiac cell sheets consisting of 
CMs (43.4±6.2% of total cells), ECs (3.3±2.6%), and MCs (53.3±8.2%). 
Multichannel extracellular potential analysis revealed that the cardiac tissue 
sheets hold unidirectional and regular electrical conduction, without ectopic 
foci (MED 64 system). Tri-layered ES cell-derived cardiac sheets were trans-
planted to a MI model of athymic rat heart one week after coronary ligation. 
Four weeks after the transplantation, echocardiogram showed a significant 
improvement of systolic function of left ventricle (LV) (fractional shortening: 
36.2±7.6% vs 22.4±8.0, p<0.01, n=9) and a decrease in akinetic area in 
transplantation group. LV pressure-volume loop studies with catheter exami-
nation revealed higher values of end-systolic elastance compared to sham 
control (15.4±1.5 vs 8.8±2.2 mmHg/μl, p<0.001, n=8). Sirius red staining 
showed reduction of the infarct wall thinning (average thickness: 973±178 
vs 705±192μm, p<0.001, n=25) and fibrotic area (MI length / total length: 
24.8±7.4 vs 35.3±12.7%, p<0.001, n=25), indicating the attenuation of LV 
remodeling. Promotion of neovascularization in transplantation group was 
observed by von Willebrand factor staining. CONCLUSIONS: We succeeded 
in generating novel tissue sheets with defined cardiac cells from ES cells. 
Transplantation of cardiac tissue sheets significantly ameliorates cardiac 
function after MI. ES/iPS cell-engineered cardiac tissue may prove to be a 
promising strategy for efficient cardiac regeneration.
Poster Board Number: 2300
THE EXPANSION AND CARDIAC 
DIFFERENTIATION OF MOUSE EMBRYONIC 
STEM CELLS IN THREE-DIMENSIONAL 
BIOREACTOR SYSTEM
Matsuura, Katsuhisa1, Shimizu, Tatsuya1, Yamashita, Jun K.2, 
Okano, Teruo1
1Institue of Advanced Biomedical Engineering and Science, Tokyo Women’s 
Medical University, Tokyo, Japan, 2Kyoyo University, Kyoto, Japan
Although embryonic stem (ES) cells are known to differentiate into function-
al cardiomyocytes in vitro, current methods for inducing cardiac differentia-
tion such as hanging drop might not be suitable for large scale cultivation to 
get enough amounts of cardiomyocytes for cardiac regeneration therapy. In 
this study, we show the established cultivation methods for expansion and 
cardiac differentiation of mouse ES cells using three-dimensional bioreactor 
system. To evaluate the cardiac differentiation efficiency, we used EMG7 
mouse ES cells that expressed GFP under control of α-MHC promoter. We 
developed a robust and scalable bioprocess that allows direct embryoid 
body (EB) formation in a fully controlled, stirred 100 ml bioreactor with a 
pitched-blade-impeller following inoculation with a single cell suspension of 
mouse ES cells. Appropriate stirring conditions and dissolved oxygen resulted 
in the generation of high-density suspension cultures containing 7.0X106 
cells/mL and 1,000 EBs/mL after 10 days of differentiation. Approximately 
40% of the EBs in this process contained GFP positive cells and 10% of the 
EBs vigorously contracted, indicating robust cardiomyogenic induction. FACS 
analysis revealed that about 3% of cells expressed GFP, suggesting that 
bioreactor system might enable to expand ES-derived EBs that also contain 
cardiomyocytes. Next we tried to purify cardiomyocytes using mouse ES 
cells that expressed neomycin resistant gene under the control of α-MHC 
promoter. After 10 days in suspension culture with differentiation condi-
tion, EBs were treated with neomycin until 18 days. Almost all of remained 
cells after neomycin selection showed spontaneous beating and immuno-
cytochemical analysis revealed that 99% of cells were positive for myosin 
heavy chain, 97% of cells were positive for sarcomeric α-actinin and 85% 
of cells were positive for cardiac troponin T, suggesting that drug-based 
purification system might useful in suspension culture. Furthermore, confo-
cal microscopic analysis revealed that differentiated cardiomyocytes showed 
the fine striated pattern and some cells possessed double or triple nuclei, 
suggesting that suspension culture might enable to promote cardiomyocytes 
maturation. These findings suggest that optimized three-dimensional biore-
actor cultivation might enable us to expand ES cells to get enough amounts 
of cardiomyocytes for cardiac regeneration therapy.
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GRAPHITE OXIDE NANOPARTICLES WITH 
DIAMETER GREATER THAN 20 NM IS 
BIOCOMPATIBLE TO MOUSE EMBRYONIC 
STEM CELLS AND CAN BE USED IN A TISSUE 
ENGINEERING SYSTEM
Wang, I-Ning E.1, Robinson, Joshua T.2, Do, Grace1, Gould, Danny 
R.2, Dai, Hongjie2, Yang, Phillip1
1Medicine/Cardiovascular Medicine, Stanford University, Stanford, CA, 
USA, 2Chemistry, Stanford University, Stanford, CA, USA
Embryonic stem cells (ESCs) possess self-renewal property and robust dif-
ferentiation potential. The pre-clinical transplantation of ESCs has dem-
onstrated the ability to regenerate functional tissues. However, the clinical 
implementation of ESC therapy is hindered by limited engraftment and cell 
survival following transplantation, greatly compromising their restorative po-
tential. In order to address this issue, a three-dimensional collagen hydrogel-
based tissue engineering system has been designed to provide structural 
support and enhance cell engraftment following delivery. This platform can 
be integrated with graphite oxide nanoparticles (GO). The GO in their read-
ily synthesized form are water-soluble single-layered sheets ranging in size 
from 3 to 600 nm in diameter. They allow electrical insulation, remain highly 
economical, and provide easy fabrication. With proper functionalization, hy-
drophobic biomolecules can be loaded onto the surface through pi-pi stack-
ing, allowing controlled delivery and gradual release. Our long term goal is 
to apply tissue engineering in nanographite oxide technology to facilitate 
robust stem cell engraftment and survival. We propose to cross-link the GO 
to collagen fibers and anti-apoptotic molecule, neutrophorin 4 (NT4), and 
use this platform in conjunction with the delivery of ESC. The objective of 
this pilot study is to first optimize the size range of GO that is biocompat-
ible on mouse ESCs followed by assessment of the effects of NT4 on ESCs. 
Mouse ESC line E14 was transduced with a reporter gene over-expressing 
luciferase. In the first study, GO was synthesized using a modified Hummers’ 
method with varying levels of sonication and centrifugation to control the 
size of GO particles. We covalently conjugated branched poly(ethylene gly-
col) to the GO in order to impart biocompatibility. The mESCs were seeded 
at 25,000 cells/cm2, and GO particles of three size ranges (small: d=3-20 
nm; medium: d=20-75; large: d=125-700) were dissolved in media at 0.005 
mg/ml (low) or 0.01 mg/ml (high). For 7 days, control group received no 
GO and experimental groups received media containing GO of different size 
ranges and concentrations, resulting in a total of six groups: Small (size)/
Low (concentration), Small/High, Medium/Low, Medium/High, Large/Low, 
Large/High. In the second study, mESCs receiving 0 or 10 ng/ml of mouse 
NT4 was maintained in hypoxia (5% CO2, 5% O2) to assess its pro-survival 
effect in an environment simulating ischemia over 72 hours of culture. Cell 
growth and phenotypic responses were evaluated. Atomic Force Micros-
copy and Dynamic Light Scattering of as-synthesized GO particles clearly 
showed three different size ranges. After 24 hours of culture, cellular uptake 
of GO particles was found in all groups. All cells grew over time while cells 
receiving small GO showed less proliferation and more cell death. 0.01 mg/
ml of GO decreased cell growth compared to 0.005 mg/ml. Furthermore, 
small GO significantly decreased luciferase expression compared to all other 
sizes. No difference was found in the expressions of the pluripotency genes. 
Cells receiving NT4 showed higher cell growth, less cell death, and higher 
luciferase activity. In conclusion, GO particles larger than 20 nm in 0.005 
mg/ml are biocompatible and can be safely used for mESCs; and NT4 is able 
to promote cell survival and growth under ischemic condition. Future study 
will focus on cross-linking GO to NT4 to control the release in our tissue 
engineering system.
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MOUSE EMBRYONIC STEM CELLS ENGINEERED 
BONE AND CARTILAGE WITHIN A NOVEL 
PERFUSION BIOMIMETIC BIOREACTOR
Lee, Poh Soo1, Rancourt, Derrick1, Krawetz, Roman2
1Dept. of Biochemistry & Molecular Biology, University of Calgary, Calgary, 
AB, Canada, 2Dept. of Surgery, University of Calgary, Calgary, AB, Canada
Introduction: Research in bone and cartilage engineering for regenerative 
medicine approaches has expanded over the last decade; however, few 
methods have been clinically translated. Partially because most engineered 
constructs lack anatomical and mechanical characteristics of native tissues, 
and can be resorbed after implantation. In this study, we have generated 
an engineered bone and cartilage construct (EBCC) within a biomimetic 
bioreactor. This work has leveraged from our recent studies, which dem-
onstrated collagen 1 matrix polymerised with β-glycerol phosphate (BGP) 
as a potent inducer for osteogenesis. Cultivation of mouse and human 
embryonic stem cells (ESCs) with the matrix in vitro triggered osteogenesis. 
Furthermore, a switch to chondrogenesis can be obtained when chondroitin 
sulphate is supplemented. This data coupled with the fact that no teratomas 
or tumors were observed when the construct was transplanted into SCID 
mice sub-cutaneously is promising. However, prolonged maintenance of cell 
viability, media changes and application of mechanical stimulants that drives 
further maturation of chondrocytes in a petri-dish limits the application of 
this engineered construct. Methodologies: A perfusion bioreactor supported 
with a peristaltic pump was designed to provide a continual flow of media 
to the EBCC at constant flow rate. This design allows alternation of media 
compositions in real-time, based on the needs of the EBCC at each stage 
of differentiation. An isolated BGP polymerized collagen 1 platform was 
fabricated within the bioreactor which supports ESC differentiation. Oxygen 
and nutrients are delivered to the cells through passive diffusion across 
an agarose intermediate to mimic physiologic conditions. Nutrient and 
oxygen gradients developed within the bioreactor are based on the design 
of bioreactor and seeding density of ESCs. This gradient is exploited (with 
media supplementation) to promote both osteogenesis and chondrogenesis 
resulting in EBCC formation. Furthermore, the materials used to assemble 
the bioreactor are amenable to direct mechanical stimulation (bending and 
compression) and is applied to the developing EBCC to enhance differentia-
tion. Results: The EBCC is viable within the bioreactor for at least 30 days 
post inoculation, with cellular remodeling observed in constructs cultivated 
with active perfusion. Quantitative PCR (qPCR) analyses demonstrates a 
significant decrease in the pluripotent marker, OCT-4, after 30 days, with 
coinciding increases in osteogenic and chondrogenic markers. Conclusion: 
We have shown the capability of our bioreactor to maintain long term culti-
vation. The composition of media could be adjusted according to the needs 
of the cells at different stage of development. We will be applying mechani-
cal stimulants on the engineered construct to drive further maturation, to 
achieve constructs with similar anatomical and mechanical characteristics as 
native tissues. Further, the collagen-based platform will be segregated based 
on exposure to oxygen determined through a fiber-optic probe for a more 
comprehensive study.
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FORMULATIONS FOR CONCURRENT PROTEIN 
DELIVERY FROM MICROPARTICLES AS 
A METHOD FOR INDUCTION OF TISSUE 
REGENERATION
Qodratnama, Roozbeh
Pharmacy, University of Nottingham, Nottingham, United Kingdom
INTRODUCTION: The controlled release of proteins from microparticles 
(MP) is a key strategy in regenerative medicine. The protein may act as an 
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angiogenic factor or a growth factor to stimulate tissue formation once they 
have been release from MP in vivo or in vitro. To achieve functional tissue 
regeneration multiple protein delivery might be needed depending of the 
target tissue. On the other hand, the proteins must be presented in an active 
form within the therapeutic window for sufficient time to complete the tis-
sue formation process. In this abstract we present an approach to pre-pro-
gram protein release from poly(lactic acid-co-glycolic acid) (PLGA) MPs. This 
approach uses a surfactant to control protein release as a function of water 
penetration. MPs may or may not be loaded with cells to help regeneration 
of the damaged tissue. This information would be further used for concur-
rent or sequential delivery of growth factors that is shown to play a crucial 
rule in regenerative medicine. EXPERIMENTAL METHODS: poly(ethylene 
glycol) with (Mw 1000), DL-lactide, glycolide, stannous octoate were used 
to synthesise PLGA-PEG1000-PLGA triblock copolymer(TB IV) following a 
method described by Zentner et al. . Triblock is characterised using 1H-NMR 
and GPC. Fluorescein isothiocyanate (1 mole) was dissolved in borate buffer 
(pH 8.3 to 9) and stirred at room temperature for 48 hrs followed by addi-
tion of lysozyme (1 mole) to the FITC solution and stirred for another 48 hrs. 
Lyso-FITC solution was dialysed against borate buffer for 72 hrs to exclude 
excessive FITC. Lyso-FITC solution was then freeze-dried and degree of 
labelling was calculated. HSA/Lyso-FITC was encapsulated in MPs using 
water-in-oil-in-water emulsion method. Briefly, Lyso-FITC and HSA were 
mixed in 1:9 ratios and dissolved in water. PLGA and PLGA-PEG1000-PLGA 
triblock were dissolved in DCM in a 7:3 or 9:1 (w/w) ratio. After complete 
dissolution, protein was added to the polymer solution and homogenised for 
2 min at 4000 rpm using a Homogeniser. This was followed by addition of 
the protein-polymer mix to a 0.3% PVA bath and homogenised for second 
emulsion for 2 min at 2000 rpm. MPs were left to harden in a 0.3% PVA 
bath for 4 hrs stirring at 300 rpm. To investigate the Lyso-FITC release from 
each of formulations 50 mg pf MPs were added to a vial and 1.5 ml PBS 
was added to the top. Samples were collected as certain time points. Release 
of Lyso-FITC from HSA/Lyso-FITC loaded MPs was measured by measur-
ing fluorescent intensity. RESULTS AND DISCUSSION: The spectra obtained 
(figure 1) were similar to spectra reported previously. To obtain the number 
average molecular weight, the peaks at 5.20 ppm (CH of LA), 4.80 ppm 
(CH2 of GA), 3.65 ppm (CH2 of ethylene glycol), and 1.55 ppm (CH3 of 
LA) were used. The polydispersity indexes of the triblocks and composition 
ratios of LA/GA were determined via 1H-NMR and GPC. The release profile 
from six different formulations is shown in figure 2. In search for formula-
tions that release protein in certain period of time, foundation polymers that 
contain different amount of glycolide was used. This formulation might be 
used for drugs which their presence is required for short period of time and 
in high dosage such as VEGF and PDGF delivery. CONCLUSION: Based on 
these data, the addition of the surfactant to the particles can be used to 
modify the release kinetics of a model protein. Formulations introduce here 
might be used for concurrent or sequential delivery of multiple drug proteins 
in a pre-programmed manner.
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SCREENING FOR CELL CULTURE 
SUBSTRATE TOPOGRAPHY THAT ENHANCE 
DIFFERENTIATION OF NEURAL PROGENITOR 
CELLS INTO MATURE NEURONS
Sandy, Lim1, Aung Aung Kywe, Moe1, Soneela, Ankam2, Jason, 
Tann2, Guillaume, Marcy Thierry1, Eyleen, Goh1, Evelyn, Yim2
1Duke-NUS Graduate Medical School, Singapore, Singapore, 2National 
University of Singapore, Singapore, Singapore
Replenishing the nervous system with stem cell derived functional neurons 
may be a viable treatment for neurological diseases such as Parkinson’s 
disease. However, a major bottleneck lies in the current inability to direct 
the differentiation of stem and progenitor cells quickly and efficiently to 
the neuronal subtypes of interest, and this has to be overcome. Our group 
had shown that nano-scale extracellular matrix topography can influ-
ence cell fate decisions of stem and progenitors cells and enhance differ-
entiation. For example, human mesenchymal stem cells (hMSCs) can be 
induced to differentiate into neurons by culturing cells on nano-gratings 
on poly(dimethylsiloxan) (PDMS) substrate. Based on our observation, we 
hypothesize that topographies with various geometries and sizes can have 
different and specific effects on the stem cell fates and selection of the ap-
propriate topographical cues will enhance the neuronal differentiation into 
different sub-type of neurons. Here, we conducted a screen for cell culture 
substrate topographies that are able to direct differentiation of neural pro-
genitor cells (NPCs) isolated from the hippocampus of postnatal day 5 old 
mouse into specific neuronal subtypes of interest. Interestingly, we were able 
to find anisotopic patterns that preferentially differentiate multipotent NPCs 
into neurons over the astrocytic and oligodendrocytic lineages. We also 
found that certain topographical parameters such as the microscale pillars 
enhance the differentiation of NPCs into forebrain neurons. In conclusion, 
we have gained important insights from this screen that could be adapted 
for a more efficient derivation of mature neurons for neurological repair.
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QUANTITATIVE CELLULAR AND MOLECULAR 
SCREENING STRATEGIES FOR MYOCARDIAL 
INFARCTION REVEAL A POTENTIAL CARDIAC 
REGENERATIVE THERAPY
Song, Hannah1, Yoon, Charles1, Fluri, David1, Thravandiran, 
Nimalan1, Masse, Stephane2, Rubart, Michael3, Nanthakumar, 
Kumaraswamy2, Keller, Gordon4, Radisic, Milica1, Zandstra, Peter1
1University of Toronto, Toronto, ON, Canada, 2Toronto General Hospital, 
Toronto, ON, Canada, 3Indiana University School of Medicine, Indianapolis, 
IN, USA, 4University Health Network, Toronto, ON, Canada
Myocardial infarction (MI) is the leading cause of congestive heart failure 
and death in the world. Coronary occlusion and the resultant myocardial 
ischemia rapidly results in myocardial necrosis followed by fibrotic scar 
formation. Clinical trials for cell transplantation to treat MI have been con-
ducted mostly using bone marrow cells wherein modest (at best) improve-
ments in cardiac function have been attributed to paracrine effects. Next 
generation strategies to treat MI include transplanting cardiomyocytes (CM) 
or cardiac progenitors (CP) (either on their own or as part of ex vivo engi-
neered cardiac tissue), and endogenous cardiac tissue repair using molecules 
or genes. Developing the most suitable conditions to bring forward for 
clinical development is made signicnaflty more complicated by the lack of 
efficient and predictive strategies to screen the large numbers of parameters 
that may impact the success of these strategies. We are using cardiac tis-
sue models, engineered heart tissue (EHT), and quantitative molecular and 
electrophysiological analyses, as a test-bed to screen regenerative conditions 
for their potential to functionally integrate with the host tissue. In the area 
of cell transplantation, EHT was prepared by seeding neonatal rat CM onto 
porous collagen scaffolds and subjecting the resulting constructs to electrical 
field stimulation (biphasic pulses, 1ms duration per phase, 1Hz) for 5 days 
as described. This platform was validated by injection of contractile mouse 
neonatal (n) CM, non-contractile cardiac FB and embryonic stem cells (ESC). 
As expected, FB injection interfered with electrical signal propagation, ESC 
formed teratoma-like structures uninfluenced in their differentiation trajec-
tory by the in vitro cardiac microenvironment, and injected nCM improved 
tissue function. Interestingly ESC-derived CP (Flk+/PDGFRα+ cells), but 
not ESC-derived CM (generated using MHCα-driven antibiotic selection) 
appeared able to appropriately mature and integrate into EHT, enhancing 
the amplitude of tissue contraction, propagating electrical signals, support-
ing the viability of the host EHT and exhibiting Ca2+ transients in synchrony 
with the host EHT. Recently, using the EHT model system, we began to 
quantitatively test the impact of in situ fibroblast-to-CM reprogramming 
using regulated expression of the cardiac transcription factors MEF2c, Gata4 
and Tbx5. This reprograming strategy resulted in about 15 % cTnT + cells 
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with upregulation of other cardiac genes such as Mesp1. In addition, to 
accelerate the screening efficiency in reprogramming, we engaged a self-
organized micro tissue platform using mouse embryonic FB and CM. These 
cardiac model systems are powerful tools to rapidly and qualitatively screen 
cellular and molecular based strategies to regenerate cardiac tissue in MI-like 
scenarios.
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EFFECTS OF THE DESIGNED SELF ASSEMBLING 
PEPTIDE NANOFIBERS ON DIFFERENTIATION 
OF MARROW-DERIVED CARDIAC STEM CELLS 
AND CARDIAC REPAIR
Tan, Yu-zhen, Wang, Hai-jie, Guo, Hai-dong, Zhang, Da-yong, Wu, 
Jin-hong, Li, Zhi-hua
Department of Anatomy, Histology and Embryology,, Shanghai Medical 
School of Fudan University, Shanghai, China
Stem cell therapy is a promising therapeutic strategy for treating myocardial 
infarction. However, the efficacy of the procedure remains hampered by a 
low differentiation efficiency of the engraftment cells toward cardiomyo-
cytes. In recent years, synthesis and application of injectable nanomaterials 
have opened a brand-new research field for therapy of stem cell transplanta-
tion. In this study, a novel self-assembly peptide possessing functional motifs 
to attach cells and bind BMP-2 was used as carrier of stem cells and scaffold 
with biological and functional properties in transplantation. The functional 
self-assembly peptide can assemble spontaneously into well-ordered nano-
fiber scaffolds. Marrow-derived cardiac stem cells (MCSCs) were isolated 
from rat bone marrow by single-cell clone culture and RT-PCR analysis. 
The cells seeded in the self-assembly peptides spread well and attached 
tightly on the nanofiber scaffolds. At 3 and 7 days after incubation in the 
self-assembly peptide nanofiber (SPNF) scaffolds, survival of the cells were 
determined with AO/EB double staining. There were more survived cells in 
SPNF group than that in control group. After treatment with oxygen and 
glucose deprivation, the apoptotic and necrotic cells were less significantly in 
SPNF group than that in control group. After induction with BMP-2 for two 
weeks, the cells in SPNF showed a tendency to parallel in arrangement and 
expressed cardiac-specific troponin T (cTnT). After induction for four weeks, 
the cells displayed myotube-like structures, cTnT expression of the cells was 
increased. SPNFs have been degraded partly. After injection into rat myocar-
dial infarction models, immunogenicity of the peptides was very low. Most 
SPNFs have been degraded at four week after injection, only some SPNF 
fragments were observed between cardiomyocytes. The echocardiographic 
examination showed that EF and FS increased significantly in MCSC-SPNF 
group compared with MCSC and SPNF alone groups. Quantitative analysis 
demonstrated that collagen volume fraction in MCSC-SPNF group was 
smaller than that in MCSC and SPNF alone groups. Fluorescence in situ 
hybridization indicated that there were more Y chromosome-positive cells 
in MCSC-SPNF group at three week after transplantation. Most Y chro-
mosome-positive cells expressed cTnT and connexin 43. Connexin 43 was 
located between Y chromosome positive-cells and recipient cardiomyocytes. 
These results show that the self-assembly peptides represent a good bio-
compatibility for MCSC attachment and growth. Cytokines released slowly 
from SPNF induce MCSCs to differentiate into cardiomyocytes. Transplanta-
tion of stem cells in SPNF is a useful technique for repairing the myocardium 
and improving cardiac functions.
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HYPOXIC CONDITIONS HAVE DIFFERENTIAL 
EFFECTS ON COLONY FORMATION, 
PROLIFERATION AND IN VITRO ANGIOGENESIS 
OF ENDOTHELIAL PROGENITORS.
Wang, Zhan1, Mendelson, Jill2, Soker, Shay1
1WFIRM, Winston Salem, NC, USA, 2Rensselaer Polytechnic Institute, Troy, 
NY, USA
Introduction: Bioengineered tissue requires a vascular network in order to 
access oxygen and nutrients. Cord blood derived endothelial progenitor 
cells (CEPC) and umbilical vein endothelial cells (HUVEC) are widely used to 
facilitate neo-vascularization (1-2). However, CEPCs or HUVECs delivered 
in vivo face hypoxic conditions, and it is not completely understood how 
and to what extent hypoxic conditions affect angiogenesis resulting from 
implantation of these cells. In this study, we examined the effect of hypoxic 
conditions on the viability, clonogenic ability, proliferation and angiogenesis 
potential of both CEPCs and HUVECs . Materials and Methods: Colony 
forming assay: HUVECs and CEPCs were sorted using a BD FACSAria II and 
dispersed as single cells into individual wells of a 96-well plate. Each well 
was pre-filled with 200µL of EGM10 medium. The cells were cultured in 
normoxic and hypoxic conditions (0.1%, 3%, or 20% O2) for seven days 
and then stained with Crystal Violet. Colonies were then counted, and the 
number of cells within each colony was determined. Angiogenesis potential 
(Dynamic Tube Forming Assay): HUVECs and CEPCs were seeded on 96-
well plates containing Matrigel (BD Biosciences) at a seeding density of 5000 
cells per well. Cells were then cultured in normoxic and hypoxic conditions 
for eight days. Images were taken each day at 40X with a Zeiss Axiovert 
microscope and analyzed using the Image J plug-in NeuronJ to quantify 
tube length. MTS cell proliferation assay vascular endothelial growth factor 
(VEGF) or fibroblast growth factor (FGF) was also added to some samples 
of HUVECs and CEPCs. The MTS assay was then performed at daily time 
points in normoxic and hypoxic conditions to assay cellular proliferation. 
Results: The colony forming assay showed that about 50% of the wells 
developed colonies, and there appeared to be no difference in the colony 
forming ability of these cells at different oxygen conditions. However, at 
high oxygen levels, there was an increase in the number of larger colonies 
for both cell types. The dynamic tube forming assay demonstrated that 
in low oxygen conditions (0.1% and 3%), HUVECs and CEPCs were able 
to form and maintain complex tube networks over 7 days, while in high 
oxygen conditions (20%), the tube networks disintegrated. The proliferation 
assay showed that the proliferation of both cell types slowed under hypoxic 
conditions. However, compared to the control culture conditions (EBM2 cul-
ture medium alone), 10ng/mL bFGF or 50ng/mL of VEGF in the media were 
able to rescue the cells, and the cell number increased under hypoxic condi-
tions when these growth factors were present. Discussion and Conclusion:  
In this study, we observed that hypoxic conditions affect the proliferative 
ability and angiogenic potential of CEPCs and HUVECs, but colony forming 
ability was not altered. These findings demonstrate that hypoxic conditions 
have separate effects on colony forming, proliferation and tube forming abil-
ity, and thus, these may represent three independent biological responses to 
hypoxic stress. Overall, this study indicates that low oxygen concentrations, 
existing at the center of implanted bioengineered tissues, have a significant 
effect on the activity of endothelial cells, this may affect their ability to con-
tribute to tissue neovascularization. 
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IN SITU CARDIOMYOGENIC DIFFERENTIATION 
OF IMPLANTED BONE MARROW 
MONONUCLEAR CELLS BY HEPARIN 
CONJUGATED PLGA NANOSPHERES WITH 
TRANSFORMING GROWTH FACTOR-BETA1
Yang, Hee Seok1, Bhang, Suk Ho2, Kim, Deok-Ho1, Kim, Byung-Soo2
1Department of Bioengineering & Member, Center for Cardiovascular 
Biology, University of Washington, Seattle, WA, USA, 2School of Chemical 
and Biological Engineering, Seoul National University, Seoul, Korea, 
Republic of
Bone marrow mononuclear cells (BMMNCs) can be used to treat patients 
with myocardial infarction, since BMMNCs can differentiate in vitro toward 
cardiomyogenic lineages when treated with transforming growth factor-β1 
(TGF-β1). However, the in vitro cardiomyogenic differentiation culture 
process is costly and laborious, and the patients should wait during the 
culture period. In this study, we hypothesize that BMMNCs implanted in 
cardiomyogenically undifferentiated state to myocardial infarction site would 
differentiate cardiomyogenically in situ when exogenous TGF-β1 is delivered 
to the cell implantation site. Heparin-conjugated poly(lactic-co-glycolic acid) 
nanospheres (HCPNs) suspended in fibrin gel were used as a TGF-β1 deliv-
ery system. BMMNCs were labeled with a green fluorescent dye (PKH-67) 
and implanted into the infarction border zone of rat myocardium using fibrin 
gel containing HCPNs and TGF-β1. BMMNC implantation using fibrin gel 
and HCPNs without TGF-β1 served as a control. Four weeks after implanta-
tion, the expression of cardiomyogenic marker proteins by the implanted 
BMMNCs was dramatically greater in the TGF-β1 delivery group than in the 
control group. This method can significantly improve the stem cell therapy 
technology for myocardial regeneration, since it can remove in vitro cell 
culture step for cardiomyogenic differentiation prior to cell implantation.
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DEVELOPING A MINIMALLY-INVASIVE 
INJECTABLE HYDROGEL SYSTEM FOR CO-
DELIVERY OF ADULT RAT NEURAL STEM CELLS 
AND PLATELET-DERIVED GROWTH FACTOR-AA
Zahir, Tasneem, Donaghue, Irja E., Tam, Roger, Shoichet, Molly S.
University of Toronto, Toronto, ON, Canada
Stem cell transplantation presents a promising strategy for the treatment 
of a variety of CNS disorders. However, it is broadly recognized that there 
is poor survival of transplanted cells, even in the “immunoprivileged” CNS. 
This is primarily due to the notoriously inhibitory environment that exists 
after injury. To promote differentiation and enhance survival of transplanted 
neural stem cells (NSCs), various factors have been delivered via catheter 
and mini-pump to the intrathecal space including Epidermal growth fac-
tor (EGF), Fibroblast growth factor 2 (FGF2), and Platelet-derived growth 
factor-AA (PDGF-AA) (1). Yet the cell delivery/minipump method is invasive 
and has risks of infection. We have designed a minimally-invasive, inject-
able and biodegradable hydrogel blend of hyaluronan and methylcellulose 
(HAMC). HAMC has been shown to promote survival of retinal stem/pro-
genitor cells (2). Here we describe the development and in vitro optimiza-
tion of HAMC to enhance survival of NSCs by incorporation of cell adhesive 
peptides and growth factors. HAMC allows uniform cell distribution. Func-
tionalization of methylcellulose to incorporate reactive carboxylic groups 
allows conjugation of cell adhesive peptides to enhance cell adhesion. 
PDGF-AA treatment enhances survival and promotes differentiation of NSCs 
primarily into oligodendrocytes (70.9%), with very few astrocytes (0.9%) 
and negligible neurons (0.01%). In ongoing studies we are examining co-
delivery of PDGF-AA and cell adhesive peptides in HAMC for enhanced cell 
survival of NSCs. The long-term goal is to test the efficacy of this hydrogel 
system in enhancing in vivo survival of NSCs after transplantation to the 
injured spinal cord.
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BLADDER STRAIN INDUCED 
MICROENVIRONMENT ATTENUATES SMOOTH 
MUSCLE DIFFERENTIATION OF ADULT 
RAT SKIN DERIVED PRECURSOR CELLS: 
IMPLICATIONS FOR TISSUE REGENERATION
Tolg, Cornelia1, Dworski, Shaalee2, Ahsan, Alya1, Aitken, Karen1, 
Miller, Freda2, Bagli, Darius1
1Urology, Hospital for Sick Children, Toronto, ON, Canada, 2Stem Cell and 
Developmental Biology, Hospital for Sick Children, Toronto, ON, Canada
Smooth muscle cell containing organs such as bladder, heart and blood 
vessels are targeted by a variety of pathological conditions necessitating 
surgery or organ replacement. Currently, tissue engineering approaches 
are hampered by lack of functional smooth muscle cells. Multipotent Skin 
derived progenitor cells (SKPs) can easily be isolated from adult skin and can 
be differentiated into a variety of cell lineages. Here we describe the oppos-
ing effects of FBS and the bladder microenvironment on induction of smooth 
muscle cell differentiation in SKPs. SKPs cultured in presence of FBS strongly 
upregulate expression of smooth muscle marker such as smooth muscle 
actin, calponin, myocardin and myosin heavy chain compared to SKPs cul-
tured in EGF/FGF containing medium as demonstrated by real time PCR and 
IF. FBS treated SKPs organize smooth muscle actin into cytoskeleton actin 
cables and contract collagen I gels, two characteristics of functional smooth 
muscle cells (SMC). In vivo, bladder strain induces microenvironmental 
changes lead to de-differentiation of fully differentiated bladder SMC. To 
investigate how this strain induced bladder microenvironment modifies SMC 
differentiation of SKPs, we differentiated SKPs in presence of bladder or-
ganoids or conditioned medium derived from stretched or relaxed bladders. 
Diffusible factors released from stretched bladders decreased SMC differen-
tiation of SKPs. Inhibition of mTOR signaling using Rapamycin treatment, 
previously observed to promote SMC differentiation of fully differentiated 
bladder SMC in vivo, revealed here that FBS induced SMC differentiation 
of SKPs requires mTOR signaling. These results suggest that SKPs could be 
used as a source for SMCs in regenerative strategies for hollow organs such 
as the bladder. However, it is also apparent that organ-specific microenvi-
ronmental contexts play a significant role in modulating or even inhibiting 
stem cell phenotype, possibly explaining the variable or less than exuberant 
differentiation of stem cell constructs in in vivo settings. These observations 
must be considered in drafting any overall regeneration strategy.
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COMPARING HUMAN TROPHECTODERM WITH 
EMBRYONIC STEM CELLS: DELINEATING THE 
FIRST DEVELOPMENTAL BIFURCATION
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INSERM U1040; Université MONTPELLIER1, UFR de médecine; CHU 
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The first week of human development is characterized by the differentia-
tion of the early embryo into the inner cell mass (ICM) and trophectoderm 
(TE). Whereas the ICM, through its derivative, human embryonic stem cells 
(hESC), has been largely reported, by contrast, the human TE at blastocyst 
stage is still unelucidated. TE is of prime importance since TE not only plays 
a major role in the shaping of the blastocyst stage but also latter develop 
into placenta that will provide the nutrient support for further embryonic 
development. The aim of the present study is (i) to establish the human TE 
transcriptome by whole genome expression profiling and (ii) to compare 
with hESC transcriptome. Five TE samples were mechanically separated 
from fresh embryos issued during an in vitro fertilization program. The 
human embryos were donated to research after informed consent from the 
couples. This embryo research has received an IRB agreement. Each TE was 
individually analyzed by whole genome U133P Affymetrix (Santa Clara, 
CA) oligonucleotides microarrays. Gene enrichment is analyzed with Fatigo 
(BABELOMICS) and statistical analysis was carried out with SAM (Stanford, 
CA). Gene expression profile was illustrated by Amazonia! (http://amazonia.
transcriptome.eu/). Using SAM, we delineated a «TE signature» compris-
ing 975 probesets (PS) overexpressed in TE comparing to hESC. Through a 
gene enrichment analysis of TE signature, TE showed significantly increased 
protein synthesis activity and decreased extracellular molecules expression. 
19 genes in TE signature display unique profile in TE. Comparing with hESC, 
SAM result showed 16 common transcription factors (TF) in placenta and 
TE. With these TF, a network was built up using Ingenuity System. All TF in 
this network was shown simultaneously up-regulated in an in vitro model 
established by inducing hESC and hiPS cell lines into TE differentiation 
though BMP4 treatment. This network deserves further studies although 
a few of them have the known functions in placenta development, TE 
differentiation or maintenance. Our results show for the first time the tran-
scriptome difference between TE and pluripotent stem cells (PSC) at whole 
genome scale. TE was shown having very differed expression profile to PSC, 
just few days after the differentiation from ICM. Expression of TE-specific 
genes corresponds to its special functions. A persisting TF network was built 
up and may play key roles in the first bifurcation of cell fate in whole human 
development. (2135 characters)
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ROLES OF KLF5 IN ESC PLURIPOTENCY AND 
EARLY EMBRYONIC DEVELOPMENT
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Deptartment of Anatomy and Embryology, Institute of Basic Medical 
Sciences, Tsukuba University, Tsukuba, Japan
ES (Embryonic Stem) cells are derived from the blastocyst and have the 
potential to give rise to derivatives of each germ layer. Induced pluripo-
tent stem (iPS) cells can be derived from lineage-restricted cells, such as 
fibroblasts, by forced expression of specific transcription factors. Although 
recent studies indicate that Krüppel-like factors (Klfs) are essential for both 
maintenance of ES cell self-renewal and reprogramming of somatic cells into 
a pluripotent state, the molecular mechanism of these processes remains un-
known. Thus, understanding the molecular mechanism of ES cell self-renew-
al by Klfs would be important for the efficient generation of patient-specific 
pluripotent stem cells and for the development of regenerative medicine. 
Although we have showed that Klf5 is indispensible for blastocyst develop-
ment and the derivation of mouse ESCs from the inner cell mass (ICM), 
the molecular mechanism underlying these functions remains unknown. To 
understand the mechanism, we first addressed the precise phenotype of Klf5 
KO mouse embryos. By investigating the BrdU incorporation activity and 
the pluripotency-related and lineage-marker expressions in Klf5 knock-out 
embryos, we show that Klf5 is indispensible for normal cell-cycle progression 
of early stage of mouse embryos, which may be consistent with the previous 
our finding that Klf5 is an essential regulator for the cell-cycle process of 
mouse ESCs. We also show that comparable Cdx2 and Oct3/4 gene expres-
sions are seen in Klf5 KO embryos at morula stage. While Nanog and Cdx2 
gene expression are decreased significantly in Klf5 KO embryo at blastocyst 
stage, the development of Klf5 KO embryos is severely retarded, suggest-
ing that the reduced expression of Nanog may be due to the retardation of 
development. Members of the Klf family such as Klf2, 4 and 5 are expressed 
abundantly in the ICM and down-regulated as the cells differentiate into 
epiblasts, which suggest that the down-regulation of Klf2, 4 and 5 is 
required for correct differentiation into epiblasts. By using over-expressing 
ESCs for Klf family members, we show that Klf family members have over-
lapped and non-overlapped functions.
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BONE MARROW-DERIVED RAT MULTIPOTENT 
ADULT PROGENITOR CELLS ARISE FROM 
PROLONGED IN VITRO CULTURE AND 
ARE SIMILAR TO BLASTOCYST-DERIVED 
EXTRAEMBRYONIC ENDODERM PRECURSOR 
CELLS
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Zwijsen, An6, Verfaillie, Catherine1
1Stem Cell Institute, Leuven, Belgium, 2Division of Molecular and Life 
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Debeb et al. (2009) recently described the isolation of extraembryonic 
endoderm precursor (Xen-P) cell lines from rat blastocysts, which contrib-
ute to visceral and parietal endoderm and to trophoblast following morula 
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aggregation, and form yolk sac like tumors. Here, we demonstrate that the 
rat (r) multipotent adult progenitor cell (MAPC) lines, described by Breyer 
et al (2006) and Ulloa et al (2007), exhibit salient Xen-P-like characteristics. 
Cells with Xen-P-like features (expression of SSEA1, CD31, Oct4, Gata4, 
Gata6, Sox17, Sox7, and Foxa2) emerged after 8-12 weeks of culture of rat 
bone marrow (BM) in MAPC culture conditions. However, we were unable 
to retrospectively identify similar cells in uncultured or short time cultured rat 
BM cells by FACS, qRT-PCR and Oct4 immunohistochemistry. Unlike BM-
derived MAPC, the new Xen-P-like cell lines, we now report, were isolated 
from rat blastocysts in 2-8 days, in rMAPC medium. Moreover, established 
Xen-P clones, grown under rMAPC conditions (5% O2, 2% FBS, LIF, PDGF, 
EGF on fibronectin at ±300 cell/cm2) grew dispersed and showed a uniform 
morphology, as is typically seen for rMAPC, and expressed nearly homog-
enously SSEA1, CD31, Oct4, Gata4, Gata6, Sox17, Sox7 and Foxa2. When 
rMAPC lines were cultured under Xen-P conditions (20% O2, 15% FBS and 
LIF on rat embryonic fibroblasts) they acquired the typical morphology of 
Xen-P colonies: round cells at the border expressing SSEA1, Oct4 and Gata4 
protein, whereas the more flattened cells in the center of the colonies were 
low or negative for SSEA1 and Oct4 but remained strongly Gata4 positive. 
When comparing cells isolated under rMAPC conditions from BM, the new 
blastocyst-derived cell lines obtained under MAPC conditions, and tradi-
tional Xen-P cell lines cultured under rMAPC conditions, we did not observe 
significant differences in expression of cell surface CD31 and SSEA1, nor in 
their expressed gene profile. Consistent with the high levels of Oct4 expres-
sion, the Oct4 promoter was hypomethylated in cells isolated under MAPC 
conditions from either BM or blastocysts, and growth factor requirements 
were almost identical. In particular, LIF withdrawal resulted in complete 
growth arrest of both cell types after two passages, downregulation of Oct4 
and significant induction of the visceral/parietal endoderm transcripts Hnf4a 
and Afp and the visceral endoderm transcript Tmprss2, suggesting default 
differentiation to visceral endoderm. In vitro, the differentiation ability of 
cells isolated under rMAPC conditions from blastocysts to smooth muscle-
like, hepatocyte-like and neuroprogenitor-like cells was similar to that of 
cells isolated from BM under rMAPC conditions. In vivo, cells isolated under 
rMAPC conditions from either BM or blastocysts, as was previously shown 
for Xen-P cells, could contribute to the extraembryonic endoderm of the 
developing embryo after morula aggregation, and generated yolk-sac like 
tumors when transplanted subcutaneously or under the kidney capsule of 
immunocompromised mice. In conclusion, these studies provide a dramati-
cally improved method for isolation and culture of almost homogeneous 
Xen-P cell populations, and demonstrate that rat MAPC are most likely a 
culture-induced equivalent of Xen-P cells.
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NANOG REGULATES ENDODERM FORMATION 
THROUGH THE MXTX2-NODAL PATHWAY
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During early embryogenesis, the acquisition of pluripotency is dependent 
upon Nanog. In zebrafish, we identified the nanog ortholog, and found 
that its knockdown impaired endoderm formation. The expression of nodal 
genes that are required for endoderm induction was specifically lower in 
nanog morphants. And the endoderm defect could be rescued by restoring 
nodal, suggesting nanog regulates endoderm formation by activating nodal. 
Genome-wide transcriptional analysis revealed that nanog morphants fail to 
develop primitive endoderm. The primitive endoderm was shown to secrete 
nodal necessary for definitive endoderm induction. Recent studies have 
shown that Nanog null mouse embryos do not develop primitive endoderm, 
suggesting a conserved role of nanog in regulating primitive endoderm 
formation during vertebrate evolution. In an effort to define critical regula-
tors of primitive endoderm, we examined the genes that were differentially 
regulated by nanog deficiency, and identified the homeobox gene, mxtx2. 
mxtx2 is one of the earliest genes expressed in primitive endoderm precur-
sors, and its expression is absent in nanog morphants. Using morpholinos, 
we demonstrated that mxtx2 is required for primitive endoderm induction. 
By overexpression of mxtx2, we were able to restore the primitive endoderm 
and rescue the nodal and endoderm defects in nanog morphants. To evalu-
ate if mxtx2 is a direct target of nanog, we developed a novel method in 
zebrafish to undertake ChIP-Seq analysis. Myc tagged nanog or mxtx2 was 
injected as mRNA into 1-cell embryos, and resulting embryos at early or late 
blastula stage were subjected to chromatin immunoprecipitation assays. The 
global binding analysis found that nanog directly activates mxtx2 and mxtx2 
binds specifically to primitive endoderm genes. Our study discovered a novel 
nanog-mxtx2-nodal pathway, and established a role of nanog in regulating 
the formation of the primitive endoderm required for definitive endoderm 
induction.
HEMATOPOIETIC STEM CELLS
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It is known that “globin switching” during erythropoiesis is associated 
with the pathophysiology of sickle cell anemia, as well as an approach to 
ameliorating some hemoglobinopathies. Human pluripotent stem cells are 
attractive tools for studying the ontogeny of human erythropoiesis because 
they exhibit in vitro differentiation toward various erythrocytes with em-
bryonic (ε), fetal (γ) or adult (β) globin genes, and they are amenable to 
gene manipulation in treating diseases. However, earlier studies showed that 
erythroid differentiation from human ESCs/iPSCs (hESCs/hiPSCs) stopped 
at fetal erythrocytes. In addition, successful differential reprogramming 
through somatic cell nuclear transfer and the use of iPSCs raised to the 
possibility that the poor yield of β-globin-expressing erythrocytes may result 
from incomplete genomic methylation or deregulated epigenetic modifica-
tion. Recent studies using mouse iPSCs suggest the presence of “epigenetic 
memory” reflecting the tissue of origin. It has been also suspected that 
aberrant DNA methylation in iPSCs provides may lead to dominant differ-
entiation to the original cell lineages, however in mouse iPSCs this tendency 
was observed in less than 10 passages. Mouse iPSC are known as a ground 
state-pluripotent stem cell enabling viable chimera mouse as a result of reset 
of DNA methylation from original cells. However, the quite huge distinc-
tion between mouse and human iPSCs may also raise the idea that hiPSCs 
derived from targeted cell lineage could be a promising source for specific 
cell therapy. In that context, we attempted to establish an in vitro differen-
tiation culture system that would preferentially yield adult-type erythrocytes 
derived from hiPSCs and would enable the study of β-globin gene switch-
ing during erythrocyte ontogeny. We initially established iPSCs from human 
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dermal fibroblasts (HDFs) (f-iPSCs) or cord blood-derived CD34+/CD45+ 
cells (b-iPSCs). Gene expression analyses showed comparable patterns of 
gene clustering in f-iPSCs and b-iPSCs, suggesting that hiPSCs retain some 
memories of original cells. We then compared the hematopoietic colony 
forming capacities of 6 f-iPSC clones and 10 b-iPSC clones using a previ-
ously established culture system. The b-iPSCs produced a higher number of 
mixed-lineage or BFU-E colonies than f-iPSCs (Mixed colonies: 261±39.4 vs. 
36±13.8, p<0.01; BFU-E: 192±35.4 vs. 11.8±6.7 per 1x105 iPSCs, p<0.01). 
We selected two clones from each group to further analyze erythroid 
maturation and globin switching in erythrocytes generated from b-iPSCs 
and f-iPSCs. RT-PCR and immunochemical assays revealed limited differen-
tiation by f-iPSC-derived erythrocytes (i.e., most were at the fetal stage), 
which is consistent with previous reports (Chang, Blood 2010), but b-iPSCs 
efficiently generated adult-type erythrocytes expressing β-globin (f-iPSCs, 
27.6±15.8% vs. b-iPSCs, 79.9±11.7% β-globin+ p<0.01). Quantitative 
PCR analysis for known regulators of globin switching, such as BCL11A, 
KLF1, GATA1, and FOG1 shows no clearly difference between f-iPSCs and 
b-iPSCs. This dominant generation of adult-type erythrocytes is observed 
in human b-iPSCs independently of passage number, i.e., over 40 passages. 
These results suggest that incomplete reprogramming possibly by aberrant 
DNA methylation may promote preferential differentiation to original cell 
lineage using hiPSCs, contributing to stable supply of adult-type erythro-
cytes toward clinical applications.
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HEMANGIOBLASTS
Kimbrel, Erin A.1, Lu, Shi-Jiang1, Lanza, Robert2
1Stem Cell and Regenerative Medicine International, Marlborough, MA, 
USA, 2Advanced Cell Technology, Marlborough, MA, USA
Dendritic cells (DCs) are powerful antigen-presenting cells (APCs) of the 
adaptive immune system. Upon encountering foreign cells, DCs proteolyze 
and present pathogenic or tumor-associated peptides to induce antigen-
specific immune responses from both memory and naïve T cells as well as 
B cells, thereby protecting the body against viruses, bacteria, and can-
cer. Clinically, DCs may have potential utility in vaccine-based therapies 
against cancer and/or HIV due to their ability to stimulate specific immune 
responses from a patient’s own adaptive immune cells. Several DC-based 
vaccine therapies are currently being tested in clinical trials using autolo-
gous and allogenic DC sources, yet these procedures are quite expensive to 
perform and must be prepared on an individual basis. Human embryonic 
stem cells (hESCs) offer an alternative cell source for the derivation of DCs. 
Since hundreds of disease-associated antigenic peptides have already been 
discovered and well-characterized, hESC-derived DCs could theoretically be 
used with such peptides in cost-effective, off-the-shelf DC vaccine therapies. 
To explore this possibility, we have used a hemangioblast differentiation 
system to generate DCs from multiple hESC lines including H1, H7, H9, and 
our own single-blastomere derived MA01 hESCs. Hemangioblasts (blasts) 
serve as the precursor to both hematopoietic and vascular cell lineages and 
our lab has shown that they can be generated in large scale quantities in 
vitro. With respect to hematopoietic differentiation, our lab has previously 
shown that blasts can efficiently differentiate into megakaryocytes /eryth-
roid cells, thereby facilitating the in vitro production of mature red blood 
cells and functional megakaryocytes/platelets in large scale quantities. Here, 
we describe for the first time, the use of hESC-derived hemangioblasts for 
the production of functional myelomonocytic CD11c+ DCs. In comparison 
to previously published embryoid body based methods, our hemangioblast 
system offers comparable efficiency (2-5 DCs per starting hESC) in less time 
(20-24 versus 30-50 days) and can be performed in a serum- and feeder-
free manner, which is critical for future clinical translation. Our blast-derived 
CD11c+ DCs display morphologically distinct dendritic processes and 
express characteristic DC surface markers such as CD209, HLA-ABC (class 
I), HLA-DR (class II), CD86, CD83 and CD45. They migrate in response to 
the chemoattractant MIP3β, take-up and proteolyze antigen, and can be 
induced to secrete the Th1-directed cytokine IL12p70. Importantly, blast-
derived DCs can induce T cell proliferation in a mixed leukocyte reaction as-
say and can be used to generate antigen-specific T cell populations. Overall, 
this study further expands the utility of our hemangioblast differentiation 
system to include the production of myelomonocytic lineage cells and shows 
that large scale hemangioblast production can potentially be used for the 
development of future off-the-shelf DC-based vaccine therapies.
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S.1
1Department of Medicine and the Stem Cell Institute, University of 
Minnesota, Minneapolis, MN, USA, 2Department of Diagnostic and 
Biological Sciences, University of Minnesota, Minneapolis, MN, USA
In the present study, we sought to quantify the efficiency of induced pluri-
potent stem cell (iPSC) reprogramming and subsequent in vitro hemato-en-
dothelial differentiation potential from different human primary cells. These 
starting cell populations include neonatal human dermal fibroblasts (NH-
DFs), CD34+ umbilical cord blood cells (UCBs), and dental pulp cells (DPCs). 
iPSCs were readily generated from all of these cell sources by lentiviral 
transduction of a polycistronic cassette harboring OCT4, SOX2, KLF4, and 
cMYC. Reprogramming efficiencies were quantified by scoring putative iPSC 
colonies present at 26 days post-transduction. UCBs generated iPSC colonies 
(UCB-iPSCs) at an estimated efficiency of 0.05%, approximately 14-fold less 
than the generation of NHDF-iPSCs (F-iPSCs, 0.7%). We obtained DPCs 
from four different patients. These DPCs all had significantly greater repro-
gramming efficiencies at 2.7% to 10.6%, a rate up to 15.1-fold increase 
compared to NHDFs. The quality of putative DPC-iPSC colonies (DP-iPSCs) 
generated was quantified by immunostaining for Nanog-positive colonies. 
On average, over 90% of the colonies generated from DPCs were Nanog-
positive, compared to 64% of putative colonies from NHDFs. Interestingly, 
we were unsuccessful at generating iPSCs from genetically matched gingival 
tissue of one of our DPC samples. UCB-iPSCs, F-iPSCs, and DP-iPSCs 
all produced teratomas and had normal karyotype, phenotype and gene 
expression patterns. As inhibition of TGFβ activity can promote derivation 
of iPSCs, analysis of TGFβ activity may help prospectively assist in choosing 
optimal starting cell populations cells for reprogramming. We found expres-
sion of TGFβ receptors were significantly different between the starting cell 
populations, with DPCs having the lowest expression of TGFβ receptors. 
Next, we determined the ability of these different iPSCs to differentiate into 
hemato-endothelial cell populations. These studies using both stromal cell-
mediated differentiation and embryoid body formation demonstrated the 
DP-iPSCs were less effective in differentiation into CD34+CD31+ hemato-
endothelial cells, CD34+CD45+ hematopoietic cells or hematopoietic colony 
forming cells (CFCs), a measure of hematopoietic progenitor cells. Adding 
Wnt3a could improve hemato-endothelial cell development from DP-iPSCs. 
Taken together, although DPCs may be a robust source of adult cells to 
reprogram, DP-iPSC may have a reduced differentiation potential, making 
them less applicable for cellular therapies.
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MOLECULAR AND FUNCTIONAL 
CHARACTERIZATION OF EARLY LINEAGE 
COMMITMENT OF HUMAN HEMATOPOIETIC 
STEM CELLS
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The hematopoietic system is a highly regulated cellular hierarchy, responsible 
for the day-to-day production of mature blood cells which can be divided 
in two major lineages, myeloid and lymphoid. Hematopoietic stem cells 
(HSCs) have the unique ability to give rise to all hematopoietic cell types, by 
first generating lineage-committed progenitors which in turn will produce 
terminally differentiated cells. HSCs are characterized by their extensive 
self-renewal and differentiation capacities. While in mice the mechanisms 
underlying early HSC differentiation and lineage determination are well 
understood at the molecular level, very few transcription factors regulating 
lineage decisions have been identified in human hematopoiesis. Our group 
has recently established a novel cell sorting strategy for human HSCs and 
early lineage committed progenitors (Doulatov et al., Nature Immunology; 
Notta et al., submitted) which uncovered the existence of a novel human 
multilymphoid progenitor (MLP). MLPs give rise to all lymphoid cell types, 
as well as dendritic cells and monocytic cells. Here we report a comprehen-
sive analysis of gene expression at each developmental stage of the human 
hematopoietic hierarchy. We show that hematopoietic specification is de-
fined by a small number of global gene expression clusters that correspond 
to major biological lineages and that lineage programs in committed pro-
genitors are paired with HSC-shared priming programs. HSCs display most 
extensive priming along the lympho-myeloid branch (MLP). In contrast early 
progenitors of the megakaryocytic/erythrocytic lineage form a distinct clus-
ter, highly enriched for cell cycle genes. Upon assembly of the transcription 
factor networks underlying each major developmental expression pattern, 
we selected a few candidate genes predicted by our model to be key regula-
tors of lineage choices. As a proof of principle, we investigated the function 
of BCL11a, which expression is primed in HSCs then peaks in the newly 
discovered MLP stage. BCL11a is a C2H2 zinc finger transcriptional repres-
sor, which has been implicated in the development of B cell progenitors in 
mouse. When BCL11a is knocked down in cord blood derived hematopoi-
etic stem cells and early progenitors, we observe reduced formation of cells 
committed to the B cell fate both in vitro and in an in vivo xenograft assay. 
BCL11a knock-down resulted in a partial block of B cell maturation at the 
proB to preB cell transition that was accompanied by a decrease in the key B 
cell maturation transcription factor, Pax5. These preliminary results suggest 
that BCL11a directs B cell specification in human and that our genome-wide 
strategy allows identification of key regulators of human hematopoietic stem 
cells and of human lineage commitment.
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RGS13 NEGATIVELY REGULATES SDF-1-
DIRECTED MOTILITY IN HUMAN CORD BLOOD 
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The stromal cell-derived factor-1 (SDF-1)/chemokine C-X-C receptor 4 
(CXCR4) axis is an essential mediator of hematopoietic stem cell (HSC) hom-
ing. In a recent study, we reported the transcriptome profile of human cord 
blood CD34+ cells in response to a short-term exposure of SDF-1 (4 hours; 
Leung KT et al., Blood, 2010). From the list of differentially regulated genes, 
we found that the expression level of 3 of the R4 Regulator of G-protein 
signaling (RGS) family proteins (RGS1, RGS2 and RGS13), were upregu-
lated upon SDF-1 treatment (> 1.5-fold change; P < .05; n = 4). RGS family 
proteins are known to negatively control G-protein coupled receptor-evoked 
signal transduction through their GTPase-accelerating activity. In several 
types of hematopoietic cells, the SDF-1/CXCR4 axis is subjected to regula-
tion by members of the R4 subfamily (including RGS1, RGS13 and RGS16). 
In this study, we investigated the expression level and possible role of RGS13 
in SDF-1 induced homing-related functions of primary cord blood CD34+ 
HSC. Quantitative RT-PCR analysis revealed that enriched cord blood-
derived CD34+ cells expressed relatively high mRNA level of RGS1, RGS2 
and RGS3, and moderate level of RGS5, RGS13, RGS16 and RGS18 (n = 3). 
Expression of RGS8 was barely detectable, while RGS4 and RGS21 expres-
sion was not detectable. A short-term exposure (1-24 hours) of CD34+ cells 
to SDF-1 (100 ng/mL) slightly increased the expression of RGS1, RGS2 and 
RGS3 (≤ 1.5-fold; P < .05; n = 4). In agreement with the microarray data, a 
4-hour SDF-1 treatment significantly upregulated RGS13 expression (1.8 ± 
.06-fold; P = .04; n = 4). Preincubation of CD34+ cells with the CXCR4 an-
tagonist AMD3100 resulted in an 83.3% inhibition of SDF-1-induced RGS13 
expression, indicating that it is a CXCR4-dependent event. To investigate the 
role of RGS13 in homing-related functions, we introduced RGS13 siRNA into 
CD34+ cells by nucleofection. With over 50% reduction in RGS13 mRNA 
level, migration of RGS13 siRNA-transfected cells towards a SDF-1 gradient 
was significantly enhanced (28.2% increase, P = .02, n = 5), when com-
pared with cells transfected with control, non-targeting siRNA. Interestingly, 
the cell surface level of CXCR4 on RGS13 siRNA-transfected cells, either in 
the presence or absence of SDF-1, was not significantly different from that 
in control siRNA-transfected cells, suggesting that the enhanced migratory 
efficiency in RGS13 siRNA-transfected cells may be CXCR4-independent. 
Other homing-related functions, including SDF-1-induced actin polymeriza-
tion and calcium mobilization, were not significantly altered in cells with 
reduced RGS13 expression. Taken together, we provided the first evidence 
that RGS13 expression is subjected to regulation by the SDF-1/CXCR4 axis 
in cord blood CD34+ HSC, and RGS13 is functionally involved in modulating 
SDF-1-mediated migration. Further investigation of RGS13-transfected cells 
in the NOD/SCID mouse transplantation model is in progress.
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CHARACTERIZATION OF THE HEMATOPOIETIC 
STEM CELL NICHE.
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Introduction: Hematopoietic stem cells (HSCs) are located in the bone mar-
row (BM) in a specific microenvironment referred as the hematopoietic stem 
cell niche, which plays a pivotal role in regulating their survival, self-renewal 
and differentiation. In this specific microenvironment, HSCs interact with a 
variety of stromal cells including fibroblasts, endothelial cells, reticular cells, 
osteoblasts and adipocytes. Though several components of the stem cell 
niche have been identified, the regulatory mechanisms through which such 
components regulate the stem cell fate are still unknown. In order to address 
this issue, we investigated how mesenchymal stem cells, osteoblasts and 
adipocytes can affect the molecular and functional phenotype of HSCs and 
vice versa in a coculture system. Methods: We set up 3 different coculture 
systems: CD34+ cells purified from the Cord Blood (CB) in culture with hu-
man osteoblasts purified from the trabecular bone or with human CD146+ 
bone marrow stromal cells or with adipocytes differentiated from CD146+ 
bone marrow stromal cells. After coculture, CD34+ cells and the hematopoi-
etic cell fraction were separated from stromal cells and analyzed by gene 
expression profiling and clonogenic assay to assess how coculture could 
affect the self-renewal and differentiation capacity of HSCs. Results: Our 
preliminary results showed that coculture of CB CD34+ cells with CD146+ 
mesenchymal stem cells induces a strong increase in the clonogenic capacity 
of CD34+ cells and a five-fold expansion of the CD34+CD38- progenitor 
pool. Moreover, in the long-term culture, CD146+ stromal cells seem to 
favour the differentiation of hematopoietic cells towards the granulocytic 
lineage at the expense of the monocytic one. Osteoblasts were able to 
induce an increase in the clonogenic capacity and an expansion of primitive 
progenitors cells comparable to those induced by mesenchymal stem cells, 
but, on the other hand, clonogenic assay results showed an increase of the 
macrophage colonies and a decrease of the erythorid ones. Gene expression 
profiling analysis allowed us to study which signaling pathways were acti-
vated in the hematopoietic cell fraction and in the stromal cell compartment 
after coculture. Such analysis enabled us to identify several cytokine-recep-
tor networks and transcription factors that could be activated by coculture 
with stromal cells and could be responsible for the biological effects reported 
above. Conclusion: Our preliminary results show that human CD146+ mes-
enchymal stem cells and osteoblast are both able to increase the clonogenic 
capacity of CD34+ cells and are capable of maintaining the more primitive 
hematopoietic progenitors up to 2 weeks in culture. Moreover, human 
CD146+ stromal cells seem to favour the differentiation of hematopoietic 
cells towards the granulocytic lineage at the expense of the monocytic one, 
whereas osteoblasts are able to affect the differentiation capacity of CD34+ 
cells by favouring macrophage commitment at the expense of the erythroid 
lineage. Gene expression profiling allowed us to identify few candidate tran-
scriptions factors and signaling pathways underlying the effect exerted by 
stromal cells on HSCs. An understanding of how the niche participates in the 
maintenance of hematopoiesis offers new opportunities for the development 
of novel HSCs ex-vivo expansion protocols that allow stem cells expansion 
without loss of ‘stemness’.
Poster Board Number: 2344
SOURCING HUMAN BLOOD-DERIVED RAW 
MATERIAL: OPTIMIZATION, QUALIFICATIONS 
AND CONTROL
Bayer, Robert J.1, van der Wal, Pete C.2, Burger, Scott3, Stock, Anna2
1Regulatory Compliance, HemaCare Corporation, Van Nuys, CA, USA, 
2HemaCare Corporation, Van Nuys, CA, USA, 3Advance Cell & Gene 
therapy, LLC, Chapel Hill, NC, USA
Human cells and tissue are critical raw material for cell therapy and tissue-
engineered products, as well as ex vivo gene therapy products. Quality 
of this living cellular raw material is a major determinant of final product 
characteristics, but is complicated by the inherent heterogeneity and inter-
individual variability of living biologics. Inconsistent collection procedures 
amplify this biological variability, adversely affecting the manufacturing pro-
cess from the outset. Controlling and qualifying the cell collection step is es-
sential to minimizing operational sources of variability, and greatly increases 
the likelihood of success in manufacturing. HemaCare’s core competency is 
apheresis collection, and, building on 33 years of experience, has addressed 
this need for optimized cell collection with a program for controlling and 
qualifying its apheresis procedures and collection sites, to supply human-de-
rived blood components for development and qualification of novel cell and 
gene therapies, assays, and medical devices. HemaCare’s apheresis program 
includes comprehensive staff qualification and training, documentation that 
supports its cGMP environment and programs to monitor effectiveness 
of equipment and procedures in accordance with an established quality 
system. Donor recruitment, screening and IRB-approved consents follow the 
requirements of Good Tissue Practices (GTPs). From 2006-2010, inclusive, 
a total of 55,262 apheresis procedures were performed, including collection 
of patient and normal-donor peripheral blood mononuclear cells, mobilized 
peripheral blood progenitor cells, plateletpheresis products, and therapeutic 
apheresis. In 2010 alone, 11,646 apheresis products were collected, many 
of which supported clinical studies spanning Phase I-Phase III, preclinical 
research, and, for the first time, commercial cell therapy applications. This 
reflects the evolution of cellular therapies.
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IDENTIFICATION OF HUMAN STEM CELL 
REGULATORS THROUGH HIGH-THROUGHPUT 
FUNCTIONAL SCREENS
van Galen, Peter1, Wienholds, Erno1, Mihajlovic, Silvija2, Popescu, 
Andreea1, Dobson, Stephanie1, van Lohuizen, Maarten3, Dick, John1
1Division of Stem Cell and Developmental Biology, Campbell Family 
Institute for Cancer Research/Ontario Cancer Institute, University Health 
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As many tissues in the body, the blood system is organized as a hierarchy 
sustained by stem cells at the apex. Hematopoietic stem cells (HSCs) give 
rise to proliferative progenitors which in turn are responsible for the output 
of approximately 1E12 differentiated cells per day. The feature that distin-
guishes HSCs from their downstream progenitors is self-renewal, an essential 
asset to maintain the blood system throughout the lifetime of an individual. 
Our lab has shown that leukemia is also organized as a hierarchy, as primary 
acute myeloid leukemia cells, which are capable of generating leukemia in 
xenografts, can be purified and distinguished from those leukemia cells that 
lack this ability. However, little is known about the regulation of self-renewal 
in either HSCs or leukemia stem cells (LSCs). We developed a high-through-
put approach to functionally asses candidate stem cell regulatory genes. 
Genes were selected from expression arrays comparing primitive versus 
more differentiated cord blood and leukemia cell populations. To study these 
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candidate genes, 96 overexpression lentiviruses were created and mixed 
in pools of 8-12 lentiviruses. These pools were used to transduce human 
cord blood cells, which were then injected into immunocompromised mice 
to determine if self-renewal ability was altered. After 16 weeks of in vivo 
competition, the abundance of every gene was assessed by quantitative PCR 
and compared to the cells before injection. Several genes were significantly 
enriched including CD200, which is involved in immune evasion and has 
been reported to be a cancer stem cell marker, and MCF2L, which is known 
to become tumorigenic when activated. Currently we are carrying out a 
similar experimental strategy to assess whether the candidate genes play a 
role in a leukemic background. We will validate and analyze the function of 
10-20 genes in detail, to yield a significant advance in our understanding of 
the mechanisms that regulate the key stem cell property of self-renewal. We 
aim to get a more comprehensive understanding of self-renewal regulation 
in normal and leukemia stem cells, and to reveal genes and pathways that 
are perturbed in the initiation and progression of neoplastic growth. This 
is an important step towards the goal of finding new targets that could be 
therapeutically exploited to eradicate leukemia.
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ANTI-TUMOR ACTIVITY FROM ANTIGEN 
SPECIFIC CD8 T CELLS GENERATED IN VIVO 
FROM GENETICALLY ENGINEERED HUMAN 
HEMATOPOIETIC STEM CELLS
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Jerome A.6
1Medicine, David Geffen School of Medicine at University of California, Los 
Angeles, Los Angeles, CA, USA, 2Surgery, David Geffen School of Medicine 
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USA, 5MIMG/Pediatrics, David Geffen School of Medicine at University of 
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The goal of cancer immunotherapy is the generation of a large, efficient, 
stable and self-renewing anti-tumor T cell population. Herein we present the 
generation of functional tumor specific human T cells in vivo from geneti-
cally modified human hematopoietic stem cells (HSC) using a mouse/human 
chimera model. HSC transduced with a vector expressing an HLA-A*0201 
restricted melanoma specific T cell receptor (TcR) were introduced into BLT 
humanized mice. This resulted in the generation of a sizeable melanoma 
specific CTL population that without any additional manipulation limited and 
cleared human melanoma tumors both in vivo and ex vivo. Bone marrow 
reconstitution lasted throughout the duration of the experiment, suggesting 
a long-term repopulation capacity of transgenic HSC. This novel approach 
represents an important tool to better understand and optimize human im-
mune response to melanoma, and potentially other types of cancer.
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HUMAN ADENYLATE KINASE 2 DEFICIENCY 
INHIBITS HEMATOPOIETIC CELL 
PROLIFERATION AND DIFFERENTIATION 
ALONG THE NEUTROPHIL AND T-CELL 
LINEAGES
Lagresle-Peyrou, Chantal1, Six, Emmanuelle M.2, Demerens-de 
Chappedelaine, Corinne Demerens-de Chappedelaine2, Rieux-
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Alain2, Cavazzana-Calvo, Marina1
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Reticular dysgenesis (RD), an autosomal recessive form of human Severe 
Combined Immunodeficiency is characterized by the absence of blood 
neutrophils and T lymphocytes. This pathology is due to biallelic mutations 
in the adenylate kinase 2 (AK2) gene, resulting in the loss of AK2 protein 
expression. AK2 is a mitochondrial protein which regulates the homeosta-
sis of cellular adenine nucleotides by converting ADP into ATP and AMP. 
In order to understand the precise role of AK2 in hematopoiesis, we have 
developed a RNA interference strategy through lentiviral-mediated gene 
transfer of AK2 short hairpin RNAs (shAK2). The knock-down of AK2 in 
human or murine hematopoietic stem cells (HSC) inhibits their capacity to 
form granulocyte colonies in methylcellulose and prevents them to generate 
mature polynucleated cells in liquid culture in the presence of G-CSF. We 
also determine the ability of shAK2-transduced HSC to differentiate along 
the T lymphoid lineage after co-culture on a OP9Delta1 stroma cell line. Our 
data demonstrated that the apparition of CD4+CD8+ cells was profoundly 
reduced in the presence of shAK2. To delineate the mechanism involved 
in this defect, we also studied the neutrophil differentiation of the HL60 
promyelocytic cell line, following retinoic acid treatment. In this system, 
the absence of AK2 expression led to an arrest of neutrophil differentiation 
process, increased cell apoptosis and disrupt the mitochondrial membrane 
potential whereas AK2 defect does not inhibit monocyte differentiation. All 
these data suggest a novel mechanism regulating hematopoietic cell prolif-
eration and differentiation.
Poster Board Number: 2354
AUGMENTING THE MAINTENANCE OF HUMAN 
HEMATOPOIETIC STEM CELLS IN MICE
Cosgun, Nehir, Waskow, Claudia
University of Technology Dresden, Dresden, Germany
Comprehensive understanding of human hematopoietic stem cell (HSC) 
biology and hematopoiesis requires in vivo analysis. The generation of 
‘humanized mice’ that support the maintenance and continuous blood 
cell formation of human origin, holds the promise to be a valuable tool 
for that purpose. Mature human hematopoietic cell types are frequently 
found in the bone marrow and spleen of immunodeficient mouse strains, 
including BALB/c Rag2-/- Il2rgy/- mice after the transplantation of human 
HSCs. However, the ability to achieve stable human HSC chimerism, which 
is required for sustained hematopoiesis over a long period of time, is still 
limited in this mouse strain. To facilitate stable human HSC engraftment, 
we generated a novel recipient mouse strain with functionally defective 
endogenous HSCs in combination with immunodeficiency. In this mouse 
strain transplanted human HSCs are retained in the bone marrow for thirty 
weeks, and mainly human but not mouse hematopoietic progenitor cells 
are present in the bone marrow, suggesting a high participation of human 
donor cells to the hematopoiesis in the recipient mice. Transplanted human 
HSCs efficiently generate cells of the B lymphoid, erythroid and myeloid 
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lineages over a long period of time in primary and secondary recipient mice 
confirming the regeneration of human HSCs. Our novel recipient mice have 
a greatly enhanced ability to support human HSC maintenance in vivo, and 
may provide a very useful tool to increase our knowledge about human HSC 
biology.
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CLONAL ANALYSES REVEAL THAT THE 
AGED MOUSE HEMATOPOIETIC STEM CELL 
COMPARTMENT ACCUMULATES MYELOID-
BIASED STEM CELLS WITH MULTIPLE 
FUNCTIONAL DEFECTS
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Stem Cell Biology Laboratory, University Medical Centre Groningen, 
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Aging in the C57Bl/6 mouse is characterized by an increase in the size of the 
hematopoietic stem cell (HSC) compartment, a corresponding decrease in 
functional HSC frequency in part due to a homing defect, and a myeloid lin-
eage skewing of differentiated cell output. These functional changes in the 
aged HSC pool have been commonly attributed to cellular aging, whereby 
HSCs gradually lose function due to accumulated cellular damage. However, 
the identification of separate populations of intrinsically lineage biased HSCs 
has raised a new hypothesis, whereby the clonal composition of the HSC 
pool, rather than individual HSCs, change with age. While data exists to 
support both hypotheses, most HSC aging studies do not evaluate the func-
tional properties of individual HSCs, but rather compare populations of old 
and young HSCs, which precludes any investigation of heterogeneity within 
the HSC compartment. In this study, we set out to obtain a more complete 
and high-resolution understanding of age-related differences in the HSC 
compartment. We compared multiple functional parameters of individual 
HSCs from young and old mice, including their short-term marrow homing 
ability, in vitro proliferative activity, in vivo differentiation properties and in 
vivo self-renewal behaviour. We confirm an increase in the absolute number 
and relative frequency of myeloid-biased HSCs in old mice. However, the 
myeloid-biased HSCs from old mice were clearly different from those in 
young mice in that most had a very small output of differentiated blood cells 
when transplanted in vivo. Nevertheless, these limited-output myeloid-bi-
ased HSCs from old mice still had extensive self-renewal ability as measured 
by long-term secondary transplantation, albeit at a reduced rate compared 
to young HSCs. Additional functional differences that were observed by 
comparing purified old and young HSCs included a decrease in short-term 
in vivo homing efficiency and a reduction in clonogenic efficiency in stromal 
co-cultures. By testing these two properties sequentially on the same cells, 
we could conclude that these functional defects are not indicative of a non-
functional subset of cells that express HSC markers, rather, they appear to 
be characteristics of all old HSCs. Old HSCs also exhibited a marked delay in 
proliferative response in stromal co-cultures and a reduced blood cell output 
in secondary recipients, regardless of their initial lineage bias. Furthermore, 
we show that in vivo repopulating cells with characteristics of aged HSCs 
can be generated from young HSCs over the course of multiple serial trans-
plants with a timeframe similar to the lifespan of a mouse. In conclusion, the 
clonal composition of the aged HSC pool changes to become dominated 
by functionally defective HSCs that appear to arise from normal HSCs by a 
process of cellular aging.
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LOSS OF ARYL HYDROCARBON RECEPTOR 
PROMOTES HEMATOPOIETIC STEM CELL 
AGING AND SENESCENCE, AND SIGNS OF 
LEUKEMIA IN MICE.
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USA
The aryl hydrocarbon receptor (Ahr) is a ligand-activated basic helix-
loop-helix gene regulatory protein that belongs to the Per-Arnt-Sim (PAS) 
superfamily. However, despite extensive studies, the normal physiological 
function of the Ahr is still not known. Our earlier studies indicated that 
juvenile Ahr-null allele (KO) mice have increased numbers of hematopoietic 
stem cell (HSC) enriched Lin-Sca-1+c-kit+ (LSK) cells in bone marrow, and 
these cells have high rates of proliferation and cell division as determined by 
increased BrdU incorporation and cell cycle analysis. Progenitor cells from 
these mice also have increased growth rates in culture (Singh et al., Stem 
Cells Dev, 2011). These data are consistent with a recent report indicating 
AHR antagonists promote the expansion of human HSCs. These and other 
reports suggest that the Ahr is a negative regulator of HSC proliferation 
by promoting HSCs to remain in quiescence. Based on these findings, we 
further hypothesized HSCs in aging Ahr-KO mice may undergo premature 
senescence leading to the development of hematologic disease. We exam-
ined phenotypic and functional changes in HSCs, progenitors, and lineage 
cells in two-year old KO and WT mice. KO mice showed increases in total 
bone marrow cells. In peripheral blood, there were increased total white 
blood cells and lymphocytes, but decreased red blood cells number. Analysis 
of bone marrow demonstrated increases in stem and progenitor cell popula-
tions, as well as increases in the colony-forming assays HPP-CFC and CFU-
preB, but decreased BFU-E, CFU-E, CFU-M, and CFU-S8. Functional analysis 
of stem cells indicated a significant decrease in competitive repopulation 
units following limiting-dilution analysis. Furthermore, HSCs from KO mice 
demonstrated lower competitive repopulation ability following primary, sec-
ondary, and tertiary serial transplants suggesting compromised self-renewal 
and differentiation. Tissues from aging KO mice demonstrated abnormal 
pathological changes with substantially increased lymphocytic infiltration in 
spleen, liver, and lung. Use of pathway-specific RT-PCR arrays showed alter-
ations in spleen cell gene expression for a number of chemokines, cytokines 
and their receptors, as well as inflammatory related genes. The expression of 
several leukemia associated genes, including gata-1, S2d3C, and gfi-1 were 
down regulated in spleen cells. Ahr-KO mice also demonstrated significantly 
lower survival rates, with an approximate 6-month difference in lifespan. 
These data, in combination with our previous report, indicates that a lifetime 
of increased cycling by HSCs lacking a functional Ahr will eventually lead to 
premature HSC aging and senescence. Furthermore, loss of Ahr expression 
and altered HSC function predisposes these mice to the development of 
a significant hematopoietic disorder that is consistent with signs of leuke-
mia. These data further support our contention that the Ahr is a negative 
regulator of HSC proliferation - a novel physiological role for this transcrip-
tion factor. Ultimately, it appears that the Ahr regulates critical genes and 
signaling pathways that allow HSCs to differentially respond to signals in 
their microenvironment. However, additional work is clearly needed to 
define these relationships and the signaling pathways responsible for them. 
(Funded by NIH Grants ES04862, ES016606, Center Grant ES01247, and 
Training Grant ES07026.)
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STEM CELLS
Ishihara, Jun1, Umemoto, Terumasa1, Yamato, Masayuki1, 
Shiratsuchi, Yoshiko1, Kitamura, Toshio2, Okano, Teruo1
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Through life, the supply of all blood cells depends on sustained division of 
hematopoietic stem cells (HSCs) for self-renewal and multi-differentiation 
potency. HSCs usually reside in a specialized microenvironment termed 
“niche”, where HSC functions are regulated. Although it is generally 
proposed that cells around HSCs, such as osteoblasts or vascular (sinu-
soid) endothelial cells form their niches, the contribution to forming their 
own niche by HSCs still remains unclear. Herein, our study showed that 
HSCs-derived soluble factors (HSFs) regulated proliferation of HSCs. Firstly, 
we examined whether HSFs affect HSC functions, since our gene expres-
sion assay using whole transcriptome showed that CD34- c-kit+ Sca-1+ 
Linage marker- (CD34-KSL) HSCs enhanced expression of several soluble 
factors which was reportedly involved with HSC regulation, compared to 
CD34+KSL hematopoietic progenitors. Therefore, to examine the effect of 
HSFs on HSCs, we utilized the culture system using a cell culture insert in 
the presence of stem cell factor (SCF) and thrombopoietin (TPO). Actually, 
bone marrow transplantation (BMT) assay following the culture showed the 
positive effect of HSFs on HSC proliferation. Importantly, the conditioned 
medium obtained from cultured HSCs with stem cell factor (SCF) and throm-
bopoietin (TPO) enhanced HSC proliferation, but not that from uncultured 
fresh HSCs. These results suggest that SCF and/or TPO stimulation on HSCs 
is required for the production of HSFs which demonstrate the positive action 
for HSC proliferation. Therefore, we next examined soluble factors in which 
mRNA expression was enhanced on HSCs by the culture with SCF and TPO 
on HSCs using SOLiD sequencing, resulting in the extraction of 6 genes 
containing Nov/CCN3, which was reportedly essential for the maintenance 
of human HSCs. Actually, we also confirmed the positive effect of Nov on 
mouse HSC activity by BMT assays. Because enhanced expression of Nov on 
HSCs is observed in the presence of SCF and TPO, we tested whether SCF 
and/or TPO preferentially contribute to expression of Nov by quantitative 
Real-time RT-PCR following the culture in the presence SCF and/or TPO. 
Importantly, TPO enable to induce enhanced expression of Nov on HSCs, 
while SCF completely failed. Therefore, these results show that expression 
of Nov by HSCs is dependent on the presence of TPO, suggesting that Nov 
contributes to TPO-dependent maintenance of HSC activity. Actually, BMT 
assays demonstrated the positive action of Nov on HSC activity only in the 
presence of TPO, supporting this possibility. In addition, we found that TPO, 
but not SCF, progressed Nov binding to HSCs via undetected receptors in 
flow cytometric analysis using Alexa fluor 647-labed Nov. Thus, this may 
elucidate TPO-dependent effects of Nov on HSC activity. In summary, our 
findings show a novel mechanism of the TPO-dependent maintenance of 
HSC activity via Nov. Moreover, we also demonstrate that HSFs including 
Nov are involved with HSC regulation, which suggests the possibility that 
HSCs also contribute to forming their own niche through the production of 
effective soluble factors for HSC regulation.
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Discordant with its importance, the thymus undergoes severe involution 
with age, characterized by profound architectural disorganization and 
significant decline in thymocyte production and output. As optimal T cell de-
velopment requires a functional thymus, patients who suffer from immuno-
depleting conditions (e.g. cytoreductive therapies, HSCT, or AIDS) have poor 
immune recovery, in part due to their declining thymic function. We have 
previously found that ablation of sex steroids (SSA) restores thymic function 
and bone marrow (BM) lymphopoiesis. In the present study, we examined 
the impact of SSA on BM and thymic hematopoietic stem and progenitor 
cells (HSPC). SSA significantly enhanced the most primitive HSC population 
both quantitatively as well as functionally. This was demonstrated by their 
lymphoid-lineage potential in vitro and in vivo, as well as their self-renewal 
capacity post SSA. These findings suggest a potential involvement in the 
fundamental mechanism underlying SSA-mediated immune regeneration. 
In addition we also found that molecular changes in the BM niche make it 
more conducive for lymphoid commitment and lymphopoiesis. While there 
is considerable debate surrounding the identity of the earliest BM-derived 
T cell progenitor, it is becoming increasingly clear that several phenotypi-
cally distinct progenitors have the ability to seed the thymus and initiate 
thymopoiesis. We found that following SSA there is a quantitative increase 
across the full spectrum of BM-resident and intrathymic T-lineage progeni-
tors with their T-lineage differentiation potential also significantly enhanced. 
Moreover, in a series of short-term in vivo homing assays, we found that 
while SSA significantly increased intrathymic niche availability, non-specifi-
cally attracting both canonical and non-canonical T-lineage progenitors, SSA 
also selectively improved the ability of non-canonical T-lineage progenitors 
to enter the thymus. Together these findings provide a tantalizing glimpse 
into improving immune function - a critical step in improving clinical out-
comes from chemotherapy, HSCT, or other immune depleting therapies.
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TYPES I AND II INTERFERON COORDINATELY 
REGULATE MURINE HEMATOPOIETIC STEM 
CELLS DURING HOMEOSTASIS AND ACUTE 
VIRAL INFECTION
King, Katherine Y., Goodell, Margaret A.
Pediatrics, Baylor College of Medicine, Houston, TX, USA
The role of the hematopoietic stem cell (HSC) in the primary immune re-
sponse to infection is unknown. We have recently demonstrated that HSCs 
proliferate and mobilize to the periphery in response to systemic chronic 
Mycobacterium avium infection in mice. Interferon-gamma (IFNγ) signaling 
through the transcriptional regulator Stat1 is both necessary and sufficient 
to mediate this response. Interferon-alpha (IFNα) can mediate similar cell-
autonomous stimulatory effects on HSCs. We hypothesized that IFNα and 
IFNγ fulfill redundant roles in activating quiescent HSCs during infection. 
In order to assess the relative importance of IFNα and IFNγ, we utilized a 
mouse model of acute viral infection. Lymphochoriomeningitis virus (LCMV) 
infection generates a mixed IFNα and IFNγ response in host animals. We 
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ascertained that HSCs are activated to proliferate in response to acute LCMV 
infection. Next, we assessed the response of HSCs to LCMV infection in 
mice lacking interferon-alpha receptor 1 (Ifnar1), interferon-gamma receptor 
1 (Ifngr1), or Stat1, a transcription factor shared by both IFNα and IFNγ 
signaling pathways. In addition, we generated double knock out animals 
lacking both Ifnar1 and Ifngr1, which we predicted would show a pheno-
type similar to the Stat1-deficient mice. HSC expansion in response to viral 
infection was achieved in LCMV-infected animals lacking either Ifnar1 or 
Ifngr1, but not both. The response of HSCs from Ifnar1-/- Ifngr1-/- double 
knock-out and Stat1-/- animals was similar, as predicted. We also performed 
transplantation experiments to test the relative reconstitution potential of 
bone marrow of the mutant mice. In the absence of infection, reconstitution 
potential was maintained or improved in the marrow of Ifnar1-deficient or 
Ifngr1-deficient animals, but diminished in bone marrow of Ifnar1-/- If-
ngr1-/- double knock-out and Stat1-/- animals. These findings suggest that 
HSCs can be activated in response to both acute and chronic infections. 
Furthermore, Types I (IFNα) and II (IFNγ) interferons serve redundant func-
tions in triggering HSC stimulation in the context of LCMV infection, and 
they participate in maintenance of HSC reconstitution potential at baseline. 
These findings contribute to our growing understanding of the role of cytok-
ines in affecting HSC function. We postulate that direct stimulation of HSC 
proliferation may be important in HSC homeostasis as well as in tailoring the 
immune response during infection. Furthermore, interferon-based responses 
may contribute to syndromes of HSC malfunction in clinical contexts such as 
post-transplant engraftment, bone marrow failure syndromes, and acquired 
aplastic anemia following infection. Further study of immune regulation of 
HSCs will provide insight into these clinical syndromes as well as the long-
term effects of inflammation on bone marrow function.
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MIGRATION OF MOUSE HEMATOPOIETIC 
CELLS
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Vancouver, BC, Canada
CD34, podocalyxin and endoglycan comprise a family of cell surface sialo-
mucins with overlapping pattern of expression on hematopoietic precursors 
and vascular cells. Although CD34 has long been used in the clinic as a 
marker of hematopoietic progenitors with long-term repopulation potential, 
little is known of the functions of CD34 sialomucins in vivo. In attempts 
to define CD34-family functions, CD34-sialomucins have been shown to 
mediate pro- or anti-adhesive functions related to tissue architecture or 
cell trafficking in both hematopoietic and non-hematopoietic cell types. 
However, the molecular mechanisms underlying these putative functions 
remain enigmatic. We have found that CD34 and podocalyxin promote the 
homing of definitive, fetal hematopoietic cells to the bone marrow of recipi-
ent mice in short term homing assays. To better characterize the mechanisms 
underlying this function, we have used shRNA lentiviral vectors to stably 
knockdown podocalyxin (Podxl) expression in the IL-3 dependent mouse 
hematopoietic precursor cell line, FDC-P1. In IL-3-deprived wild type FDC-
P1 cells, podocalyxin becomes membrane-polarized in response to treatment 
with IL-3 or stem cell factor (SCF) + CXCL12. In addition, although we only 
find low levels CXCR4, a CXCL12 receptor, on the surface of FDC-P1 cells at 
steady state, CXCR4 surface expression increases rapidly in response to SCF 
+ CXCL12 treatment and CXCR4 co-polarizes with podocalyxin. Strikingly, 
Podxl-deficient FDC-P1 cells fail to upregulate surface expression of CXCR4 
in response to SCF + CXCL12 and are severely impaired in their ability to 
migrate to SCF or CXCL12. Podxl-/- fetal liver progenitors, likewise, exhibit 
an impaired ability to migrate to SCF + CXCL12 in vitro. These data suggest 
that podocalyxin enhances chemokine-dependent migration, perhaps by 
stabilizing the appropriate polarized expression of chemokine receptors on 
the cell surface. These results offer the first mechanistic explanation for the 
cell-trafficking functions associated with the CD34-family sialomucins.
Poster Board Number: 2368
A NOVEL FUNCTION OF DEVELOPING MURINE 
ENDOCARDIUM
Nakano, Haruko1, Nakashima, Yasuhiro1, Arshi, Armin2, Shin, 
Jae Ho2, van Handel, Ben1, Conway, Simon J.3, Pashmforoush, 
Mohammad4, Mikkola, Hanna AK1, Nakano, Atsushi1
1MCDB, University of California, Los Angeles, Los Angeles, CA, USA, 2 
University of California, Los Angeles, Los Angeles, CA, USA, 3Herman B 
Wells Center for Pediatric Research, Indiana University School of Medicine, 
Indianapolis, IN, USA, 4Broad Center for Regenerative Medicine and Stem 
Cell Research, University of Southern California Keck School of Medicine, 
Los Angeles, CA, USA
We have previously demonstrated that single cardiac progenitors expressing 
Flk1 Isl1, and Nkx2.5 give rise to both cardiac and endocardial/endothelial 
cell lineages during early murine cardiogenesis. Interestingly, the pool of 
Flk1+/Isl1+/Nkx2.5+ cardiac progenitors express multiple hematopoi-
etic transcription factors. Although a close relationship between cardiac, 
endocardial, and hematopoietic lineages has been suggested in Drosophila, 
zebrafish, and embryonic stem cell in vitro differentiation models, the 
significance of hematopoietic genes in the developing mammalian heart 
remains unclear. Here, we demonstrate hemogenic activity in the develop-
ing murine endocardium. A subset of developing endocardium expresses a 
hematopoietic progenitor marker, CD41, proliferates in situ, and emerges 
into the cardiac chamber. FACS-purified endocardial cells are capable of 
generating blood colonies ex vivo. In search for the molecular mechanism 
underlying hematopoiesis in endocardium, we identified Nkx2.5 as a key 
regulator. Nkx2.5 mutant heart showed almost no CD41 positive cells in the 
endocardium, and Nkx2.5 null ES cells generated significantly less blood cells 
than the control ES cells. These data, taken together, suggest that develop-
ing murine endocardial cells display hemogenic activity during cardiogenesis 
via an Nkx2.5-dependent pathway.
Poster Board Number: 2370
SLAM FAMILY MARKERS IMPROVE THE 
ABILITY TO DISTINGUISH DIFFERENT 
SUBPOPULATIONS OF MOUSE MULTIPOTENT 
HEMATOPOIETIC PROGENITORS
Oguro, Hideyuki, Morrison, Sean J.
Howard Hughes Medical Institute, Center for Stem Cell Biology, and Life 
Sciences Institute, University of Michigan, Ann Arbor, MI, USA
Various combinations of markers have been used to isolate transiently 
reconstituting multipotent hematopoietic progenitors (MPPs); however, all 
such populations remain heterogeneous, containing different subpopula-
tions of MPPs with different degrees of reconstituting capacity as well as 
restricted progenitors. Hematopoietic stem cell (HSC) and MPP purity has 
been enhanced using two SLAM family markers: CD150 and CD48. The 
Lineage-Sca-1+c-Kit+ (LSK) hematopoietic stem and progenitor fraction can 
be separated into a CD150+CD48-LSK HSC fraction, a CD150-CD48-LSK 
MPP fraction, and two downstream hematopoietic progenitor cell (HPC) 
fractions, CD150-CD48+LSK HPC-1 and CD150+CD48+LSK HPC-2. To 
elucidate a detailed functional hierarchy of HSC and MPP fractions, we 
identified additional SLAM family markers that can further subdivide primi-
tive hematopoietic progenitors: CD229 and CD244. These new markers 
can break down HSCs into two sub fractions (CD229-CD244- HSC-1 and 
CD229+CD244- HSC-2) and MPPs into three sub fractions (CD229-CD244- 
MPP-1, CD229+CD244- MPP-2, and CD229+CD244+ MPP-3). These 
two HSC fractions, three MPP fractions, and two HPC fractions possess 
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differential cell-cycle status revealed from BrdU incorporation, Ki67 staining, 
and histone H2B-GFP retaining assays. Among these fractions, HSC-1 is the 
most quiescent fraction, with HSC-2 dividing more actively than HSC-1. The 
progenitor fractions showed increasing cell cycle activity in this order: MPP-
1, MPP-2, MPP-3, HPC-1, and HPC-2. Bone marrow (BM) reconstitution as-
says with very small numbers of cells showed that both HSC fractions have 
long-term multi-lineage repopulating capacity. However, serial transplanta-
tion assays revealed that HSC-1 robustly repopulated secondary recipient 
BM, whereas HSC-2 poorly repopulated secondary recipients. Most MPPs 
gave transient multilineage reconstitution and the duration of reconstitu-
tion declined in this order: MPP-1, MPP-2, and MPP-3 (longest to shortest). 
These findings demonstrate the existence of a functional hierarchy within 
HSC and MPP fractions, and the ability to distinguish functionally distinct 
subpopulations of HSCs and MPPs using SLAM family markers.
Poster Board Number: 2372
CORRECTION OF ARTEMIS DEFICIENCY IN 
MURINE HEMATOPOIETIC STEM CELL BY 
I-SCE1 MEGANUCLEASE AND ARTEMIS 
RECOMBINATION MATRIX MEDIATED 
HOMOLOGOUS RECOMBINATION.
Rivière, Julie1, Hauer, Julia2, Poirot, Laurent3, Brochet, Julien1, 
Pâques, Frédéric4, De Villartay, Jean-Pierre1, Fischer, Alain1, 
Cavazzana-Calvo, Marina1
1INSERM, PARIS, France, 2Pediatric Hematology and Oncology, Children’s 
University Hospital, Duesseldorf, France, 3Genome surgery, Cellectis, 
Romainville, France, 4Cellectis, Romainville, France
Gene therapy allows correction of a number of monogenic diseases affecting 
the hematopoietic system. This approach can be conducted by two different 
strategies which are either semi-random integration of the therapeutical 
gene using self-inactivating (SIN) retroviral vectors or homologous recom-
bination (HR). The feasibility and efficacy of the first approach has been 
demonstrated in different forms of severe combined immunodeficiency 
(SCID) (SCID-X1 and Adenosine Deaminase) but the occurrence of a 
number of severe adverse events leads to further consider the HR approach. 
Homologous recombination (HR) is a highly specific DNA-repair mechanism, 
allowing to selectively replace a DNA sequence by another of interest. DNA 
double strand breaks (DSB) can enhance the frequency of HR. Specific DSB 
can be induced by meganucleases. These meganucleases are endonucleases 
with long DNA-recognition sites (12-30bp). They thus principally allow 
to target gene specific positions in the genome. In view of that, engineer-
ing gene specific meganucleases represents a tempting novel approach for 
gene therapy and targeting. To further develop this approach, we chose the 
Artemis deficiency model. This variant of SCID combines the phenotype of 
radio-sensitivity and lymphocyte developmental arrest at the double nega-
tive CD44-CD25+ T-progenitor and the B220+CD43+ B-progenitor stage. 
In this model, successful gene targeting can thus be assessed by reversion 
of the pathological phenotype in a number of assays used to study radio-
sensitivity, B- or T-cell development in vitro. The Artemis deficient mouse 
model was created by substitution of exon 12 of the murine Artemis gene 
by a restriction site for the I-Sce 1. The I-Sce 1 specific meganuclease would 
thus allow site specific induction of DSB at the Artemis gene. To deliver the 
I-Sce 1 meganuclease and to provide the Artemis DNA matrix we designed 
two SIN-integrase-defective lentiviral vectors (SIN-IDLV): IDLV-CMVI-Sce 
1 and IDLV-Art. SIN-IDLV were used to avoid non-specific integration and 
transgene over-expression. Transduction of bone marrow derived Sca1+ he-
matopoietic stem cells (HSC) from Art-/- mice with both vectors, IDLV-CM-
VI-Sce 1 and IDLV-Art, resulted in a transduction efficiency of about 30%. 
Reversion of the Artemis deficient phenotype indicating successful gene 
targeting of the Artemis exon 12 was observed in 2 out 10 experiments by 
means of appearance of CD4/CD8 double positive T cells after co-culture 
on the OP9-DL1 system. Site specific insertion of Artemis exon 12 by HR 
was confirmed by nested-PCR and genomic DNA sequence analysis. These 
preliminary results demonstrate that meganucleases and repair matrixes can 
induce site specific DNA-repair by HR in HSC. Even though the efficiency of 
genomic reparation needs to be further improved and its potential genotox-
icity remains to be evaluated, this new approach of gene therapies is very 
promising for the future.
Poster Board Number: 2374
THE SKP2 E3 LIGASE IS REQUIRED FOR 
MOUSE HSC REGENERATION IN RESPONSE TO 
MYELOABLATIVE STRESS AND BONE MARROW 
TRANSPLANTATION.
Rodriguez-Rodriguez, Sonia
Indiana University, Indianapolis, IN, USA
SKP2 is the F-box subunit of the ubiquitin-ligase complex SCFSKP2 that tar-
gets the cyclin-dependent kinases (CDKs) p27Kip1, p21Cip1, p57Kip2 and 
p130 for ubiquitination and degradation. SKP2 protein levels are modulated 
during cell cycle and in response to mitogenic stimuli: its expression is essen-
tial for cell cycle entry whereas its downregulation is critical for cell cycle ar-
rest. The fact that SKP2 controls the destruction of several CKIs underscores 
its central role as a cell cycle regulator. Alteration of the CKIs p21Cip1 and 
p27Kip1 levels has a significant impact on hematopoietic cells; however, the 
role of SKP2 in hematopoiesis has not been investigated, and it is not known 
whether SKP2 regulates these CKIs in distinct hematopoietic subpopula-
tions. We found that SKP2 is present in murine bone marrow (BM) HSC 
and progenitors, and that its expression is dynamically regulated in response 
to hematopoietic stress requiring rapid cell cycle entry. To better define the 
role of SKP2 in hematopoietic homeostasis, we analyzed the effects of SKP2 
deletion in the BM compartment of SKP2 null mice. At steady-state, SKP2 
deletion decreased the mitotic activity of HSC and progenitors resulting 
in enhanced HSC quiescence and increased pool size. Immunophenotypi-
cal analysis of the distinct BM subsets showed that SKP2 deletion resulted 
in a significant increase in HSC (LT-HSC and ST-HSC) both in percentages 
and absolute numbers (LSK, averages: 6.6% KO vs 3% WT vs; p<0.001). 
Conversely, the pool of highly cycling erythromyeloid progenitors were 
significantly decreased in the absence of SKP2 (GMP; averages 2.4% KO vs 
4.2% WT; p=0.03; MEP; averages 9% KO vs 14% WT; p=0.01). As antici-
pated, loss of SKP2 expression correlated with the accumulation of p27Kip1, 
p57Kip2 and p130 in SKP2 -/- HSC, and with overall reduced cell cycle, as 
determined by in vivo BrdU incorporation. Next, we determined whether 
the loss of SKP2 have a negative impact on HSC ability to enter the cell 
cycle in response to stress. Competitive repopulation assays demonstrated 
that SKP2-/- stem/progenitor cells were greatly impaired in reconstituting 
hematopoiesis at short-term (4th week CD45.2: 30% in KO vs 60% in WT 
vs; p=0.001). In agreement with these observations, SKP2-/- mice showed 
a marked slower hematopoietic regeneration following 5-FU myelosuppres-
sion, as indicated by lower WBC counts (50% less at week 2) compared 
to WT mice. As anticipated, long-term reconstitution (>20 weeks) was not 
affected or slightly improved in mice transplanted with SKP2-/- cells. Thus, 
SKP2 deficiency results in a slower cell cycle that: i) at steady-state favors 
quiescence in HSC, and results in decreased proliferative rates in progenitors; 
and ii) following stress impairs both HSC and progenitors to enter rapidly in 
the cell cycle. Taken together, these data indicate that SKP2 is a physiologic 
regulator of cell cycle progression and regeneration of HSC and progenitors 
and provide new insights on the mechanisms involved in BM recovery post-
chemotherapy and radiation and BM transplantation.
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EPIGENETIC REGULATION OF IMPRINTING 
GENE INFLUENCES THE QUIESCENT VERSUS 
ACTIVE STATE AND FUNCTION OF ADULT 
MOUSE HEMATOPOIETIC STEM CELLS
Venkatraman, Aparna1, He, Xi1, Sanchez, Rebeca1, Sugimura, Rio1, 
Bartolomei, Marisa Bartolomei2, Li, Linheng1
1Stowers Institute for Medical Research, Kansas City, MO, USA, 2University 
of Pennsylvania, Philadelphia, PA, USA
There is compelling evidence that hematopoietic stem cells (HSCs) exist in an 
active (enriched in short term HSC) and quiescent (enriched long term HSCs) 
state. Earlier studies from our laboratory revealed differential expression of 
imprinting genes in these two populations, These observations led us to 
hypothesize that the epigenetic state of imprinting genes can influence HSC 
state and its function. To test this hypothesis, we used a genetic approach 
complemented by functional analysis. Mice with a conditional deletion of 
the differential methylation region (DMD), 2kb upstream of the 5’ prime 
region of the imprinting gene H19 were employed. Since imprinting genes 
are known to be mono-allelic in expression, female & male H19fx/fx were 
crossed with Mx cre mice of the opposite gender to generate mice with ma-
ternally & paternally deleted DMD alleles (H19ΔDMD) respectively. Unlike 
deletion from the paternal allele (H19ΔDMD), that showed no difference 
in frequency of LT HSC in BM, deletion from the maternal allele resulted 
in phenotypic reduction in LT HSCs (LSK CD34-Flk2-) accompanied by an 
increase in ST HSCs (LSK CD34+Flk2-) and multi progenitor(MPP) cells(LSK 
CD34+Flk2+). The competitive repopulation assay confirmed compromised 
function of HSC in the maternal inherited H19 Δ DMD mutant mice. This 
data suggests that the epigenetic state of imprinting genes regulates stem 
cell state and function. Deletion of the DMD region was accompanied by 
a decrease in H19 gene expression and reciprocal up regulation of Igf2, 
leading to exhaustion of LT HSC as well as the LSK population by 16 weeks 
post deletion. In conclusion, using a combination of genetic and functional 
approaches our data clearly demonstrate that epigenetic regulation of 
imprinting genes regulate HSC state and function. We anticipate that this 
mechanism of regulation may also exist in other types of adult somatic stem 
cells.
Poster Board Number: 2378
IN VIVO MARKING DEMONSTRATES LONG-
TERM CONTRIBUTION OF MULTIPLE STEM 
CELL CLONES TO MURINE STEADY-STATE 
HEMATOPOIESIS
Zavidij, Oksana, Ball, Claudia R., Herbst, Friederike, Fessler, Sylvia, 
Oppel, Felix, Schmidt, Manfred, von Kalle, Christof, Glimm, Hanno
National Center for Tumor Diseases (NCT) German Cancer Research Center, 
Heidelberg, Germany
Distinct hematopoietic stem and progenitor cells are defined by their role 
in post-transplant reconstitution as the analysis of the properties of isolated 
stem cells required syngeneic or xenogeneic transplantation models. There-
fore, the clonal activity of individual hematopoietic stem and progenitor cells 
in undisturbed steady-state hematopoiesis is poorly understood. To address 
the clonal contribution of individual hematopoietic stem cells under steady-
state conditions, murine hematopoietic stem and progenitor cells were 
directly marked by intrafemoral (IF, n=10) or intravenous (IV, n=5) injection 
of GFP-expressing lentiviral vectors (LV) into eGFP-tolerant B6.Cg-Tg (Krt1-
15-EGFP) mice (Krt15). GFP expression in murine peripheral blood (PB) was 
monitored for up to 24 months after in vivo marking and myeloid and lym-
phoid blood cells were isolated by fluorescence activated cell sorting. A low 
but remarkably stable proportion of myeloid and lymphoid hematopoietic 
cells expressed GFP for up to 24 months (5-100 GFP+ cells per 20000 PB 
cells analyzed), indicating stable marking of murine steady-state hematopoi-
esis. Long-term contribution of marked cells in PB showed a comparable 
distribution into myeloid and lymphoid cell lineages. Pre-conditioning 
with 5-Fluorouracil did not influence the proportion or lineage distribution 
of marked hematopoiesis (IF: n=5; IV: n=5). Although IV-Injection of LV 
resulted in comparable percentages of marked cells as IF injection (p>0.05) 
the marking kinetics were different. While the proportion of marked cells 
remained stable for up to 2 years after IF Injection, IV-marking resulted in 
a 2-fold decline of GFP expressing cells during the first two weeks after IV-
marking indicating that IV vector administration primarily targets short-lived 
more mature cells. Monitoring of individual marked clones in sorted cell 
fractions by highly sensitive amplification of lentiviral integration sites using 
LAM-PCR demonstrated long-term contribution of marked clones to myelo-
id and lymphoid hematopoiesis. 1-10 marked clones detected by LAM-PCR 
generated only 0.01%-0.23% of all PB cells in individual mice suggesting 
that at least 750 to several thousand hematopoietic clones simultaneously 
contribute to steady-state hematopoiesis. Immunostaining of histologi-
cal sections 24 months after transplantation verified that eGFP expressing 
hematopoietic cells were located in the bone marrow. In addition, marked 
non-hematopoietic and hematopoietic cells were found in liver and spleen of 
injected mice. In summary, these data demonstrate stable long-term marking 
of undisturbed steady-state hematopoiesis for up to 24 months. We show 
that stem cell clones with myeloid and lymphoid differentiation potential sta-
bly contribute to murine steady-state hematopoiesis. These studies provide 
evidence that an unexpected high number of individual stem cell clones are 
active in murine steady-state hematopoiesis. In vivo marking further allows 
to directly analyze the influence of hematopoietic stress such as chemother-
apy to individual stem cell clones.
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STEM CELLS ENHANCE MOTOR RECOVERY 
FOLLOWING STROKE IN LONG-EVANS RATS
Mocco, J, Afzal, Aqeela, Thomas, Nagheme, Warraich, Zuha, Hoh, 
Brain, Scott, Edward, Kleim, Jeffery
Neurosurgery, University of Florida, Gainesville, FL, USA
Background: Stroke is the leading cause of disability in the Unites States 
resulting in upper extremity motor impairments. Methods: Male Long-Evans 
hooded rats (350-420g) underwent stroke surgery using Endothelin-1 
induced MCAO. Animals were housed in standard laboratory cages on a 
12 hour light/dark cycle. Animals were pretrained to familiarize them with 
the reaching accuracy task. Trained animals were then divided into 3 groups 
(controls, n=7; stroke, n=3; stroke with post-reperfusion administered 
endothelial progenitor cells (EPC’s), n=6); The EPC’s were enriched from the 
bone marrow of a separate group of donor rats using nanoparticles tagged 
with LIN negative and CD90 markers. Ten million EPC’s were injected into 
the tail vein immediately following reperfusion. Animals were assessed at 
3 and 5 weeks following the surgery for reaching task performance. All as-
sessments were performed in a blinded manner. Results: Reaching accuracy: 
Control animals scored a reaching accuracy of 41±8.1% and 46±11% at 
3 and 5 weeks, respectively. Stroke decreased this task to 12±21% and 
18±28%, respectively (p<0.05, compared to controls at both time points). 
Injection of EPC’s following reperfusion led to an increase in reaching ac-
curacy to 27±26% and 32±24%, at 3 and 5 weeks, respectively (p<0.05, 
compared to stroked non-EPC cohort at 5 weeks). Conclusions: These data 
suggest that Hematopoietic EPC’s play a significant role in the amelioration 
of stroke injury following cerebral ischemia.
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HOXB4 INDUCES MORE SELF-RENEWAL 
ACTIVITY IN CD133 POSITIVE RATHER THAN 
CD34 POSITIVE HEMATOPOIETIC STEM CELLS
Allahbakhshian Farsani, Mehdi, Forouzandeh Moghadam, Mehdi, 
Amirizadeh, Naser, Soleymani, Masoud, pourfatholah, Ali akbar
Hematology and Blood Banking, Tarbiat Modares University Tehran Iran, 
Tehran, Iran, Islamic Republic of
Background: because of several advantages of cord blood HSCs over other 
sources of HSCs, They increasingly attract attention for BM transplanta-
tion purposes. But unfortunately the number of HSCs is a limiting factor for 
BM transplantation in adult recipients. Cord blood HSCs ex vivo expansion 
of cord blood HSCs is investigated as an beneficial approach to overcome 
the problem by HSCs self-renewal induction. Meanwhile HOXB4 has been 
shown its powerful capability for HSCs self-renewal induction. In this study 
we evaluated and compared the response of CD34+ and CD133+ HSCs as 
different subpopulations of HSCs to HOXB4 self-renewal induction. 
Material and methods: HOXB4 was cloned in pLEX-MSC lentiviral vector. 
Then we produced lentiviruses containing HOXB4 and transduced cord 
blood CD34+ and CD133+ HSCs isolated with MACS column. HSCs were 
cultured in IMDM medium containing 10% FBS and early acting cytokines 
(Flt3L, SCF, Tpo) for 8 days. During ex vivo expansion period we evalu-
ate HOXB4 over Expression using QRT-PCR and thereafter HOXB4 protein 
synthesis was evaluated by western blotting. By the end of 8th day, CD133+ 
and CD34+ subpopulation of cultured cells were examined by flow cyto-
metric analysis. Finally the expanded cells were evaluated for the presence 
of early hematopoietic stem cells by LT-CIC and clonogenic assays. Results: 
our results showed that HOXB4 increase self-renewal of both CD34+ and 
CD133+ HSCs subpopulation as it was shown by flow cytometric analysis. 
Then we decided to assess the frequency of LT-CICs by LT-CIC test. We 
saw that CD133+ HSCs showed more LT-CIC frequency than CD34+ HSCs. 
Discussion: altogether our results showed that CD133+ HSCs transduced 
with HOXB4 lentivirus produced more long term initiating cells in LT-CIC test 
and it shows that CD133+ HSCs are possibly better targets for HOXB4 gene 
delivery for self-renewal induction and produces more valuable cell resources 
for BM transplantation. 
Key words: HSCs, HOXB4, LT-CIC
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DEVELOPMENT OF AN EXPANSION MODEL 
OF CD34+ UMBILICAL CORD BLOOD 
CELLS COCULTURE IN FEEDER LAYERS OF 
MESENCHYMAL CELLS AND CYTOKINES.
Becerra-Calixto, Andrea del P., Avila-Portillo, Luz M., Avila, Jeniffer 
P., Gomez, Claudia, Madero, Jose I.
Direccion Cientifica, Stem Medicina Regenerativa, Bogota, Colombia
Umbilical Cord Blood (UBC) has CD34+ Hematopoietic Stem cells (HSCs), 
which have the ability of long term bone marrow restocking. The blood 
is easily obtained and criopreserved for posterior use, which makes it a 
feasible alternative for transplant. The limited volume of obtained UCB 
yields low counts of HSCs, having a repercussion on the probability of do-
ing a short-term graft. Around the world, scientists are trying to solve this 
by increasing the number of HSCs ex vivo with human growth factors, for 
its posterior grafting. It has been proven that for the homing of the HSCs 
the expression of CXCR4 receptor is required which interacts with Stromal 
Cells Derived Factor 1 (SDF-1/CXCL12) that stimulates signal pathways for 
cellular division, proliferation and chemotaxis. This research developed a 
small scale model for the expansion of HSCs using the human recombinant 
cytokines (HRC), Stem Cell Factor (SCF), Interleukin 3(IL-3), thrombopoy-
etin (TPO) and FT3 ligand (FLT3) (Cell Genix Germany®); altogether with 
Mesenchymal Stem Cell feeding cultures obtained from protein-free animal 
supplements, which where compared with previously established models. 
Those CD34+ cells cultured with the developed model, using supplement 
processed lysate platelet-rich human plasma, showed an initial expansion 
factor of 7.7±2.2 times (p<0.05) greater compared with their initial value.
This value was higher compared with the other studied conditions, show-
ing increasing numbers after day 12 of culture (p<0.05).The expression of 
CXCR4 was significantly higher in the model when compared with other 
studied models, the obtained value was 51.324±2.436 cells (p<0.05),and 
therefore it showed a tendency for an increase in this receptor expression 
over time. However, when comparing the CD34+ cell population against 
those CD34+/CXCR4+, we obtained an expression of the CXCR4 on nearly 
70% of the cell population, considering all the conditions studied; suggest-
ing that the proposed model using mesenchymal cells as support, permits 
the necessary interaction with CD34+ cells needed not only for division 
but also for the preservation of the homing and chemotaxis molecules. 
Therefore, this study shows evidence for an efficient model of CD34+ cells 
expansion.
Poster Board Number: 2386
ENDOGLIN IS NECESSARY FOR PROPER 
HEMATOPOIETIC DEVELOPMENT
Borges, Luciene1, Iacovino, Michelina1, Mayerhofer, Tim1, Baik, 
June1, Kyba, Michael1, Letarte, Michelle2, Perlingeiro, Rita C.R.1
1Department of Medicine, University of Minnesota, Minneapolis, MN, USA, 
2Hospital for Sick Children and Department of Immunology, University of 
Toronto, Toronto, ON, Canada
Endoglin (Eng), an accessory receptor for the Transforming Growth Factor 
(TGF)-beta superfamily, plays a critical role in early development. Endoglin-
deficient mice die around 10.5 d.p.c. due primarily to vascular and cardiac 
abnormalities. Analyses of 9.5 d.p.c. Eng-/- yolk sacs (YS) revealed abnormal 
blood vessels as well as anemia. It is not clear whether the latter results from 
an indirect effect due to insufficient blood flow, or a direct effect of endoglin 
on blood development. Here we addressed this question by investigating the 
role of this receptor in vivo during early hematopoiesis. Analysis of YS from 
E9.5 Eng-/- embryos show significantly reduced numbers of hematopoietic 
colony-forming cells (CFCs), in particular GEMMs and BFU-Es, when com-
pared to both wild-type and heterozygous embryos. This is accompanied by 
decreased expression of important hematopoietic genes, including Embry-
onic Globin, Gata-1, and Scl. Based on these findings we set up experi-
ments to characterize the nature and function of endoglin-expressing cells 
in wild-type mice. Remarkably, hematopoietic activity was restricted to the 
Eng+ cell fraction at every time point (from E7.5 to E9.5) studied. Eng- cells 
failed to produce any hematopoietic colonies. Subsequently, we subfrac-
tionated these E7.5-9.5 cells into four distinctive cell fractions based on 
Eng and Flk-1 expression. The vast majority of colony-forming cells at E7.5 
reside within the Eng+ Flk-1+ fraction. This pattern changes as the embryo 
develops, and at E9.5, most of the hematopoietic activity resides within the 
Eng+ Flk-1- population. Transcriptional profiling of the 4 fractions in E7.5 
embryos reveals that the Eng+Flk-1+ fraction highly expresses endothelial 
and hematopoietic markers, such as Fli-1, VE-Cadherin, Tie-2, CD31, CD34, 
Gata-1, Gata-2, Scl, and Lmo2. Moreover, ligands, receptors type I and 
II, and target genes of the TGF-beta superfamily were found highly and 
distinctively expressed in these fractions, suggesting that endoglin plays a 
critical role in these early signaling events. Taken together, our data demon-
strate that endoglin is not only necessary for proper hematopoiesis, but also 
identifies the first wave of hematopoietic progenitors during early develop-
ment, pointing to a defined role for endoglin and the TGF-β superfamily 
signaling in early hematopoiesis.
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EMERGENCE OF EMP-DERIVED DEFINITIVE 
HEMATOPOIESIS IN THE MAMMALIAN 
EMBRYO AND EMBRYONIC STEM CELLS
McGrath, Kathleen E., Frame, Jenna, Fegan, Kate H., Koniski, Anne, 
Kingsley, Paul D., Palis, James
University of Rochester Medical Center, Rochester, NY, USA
The ontogeny of hematopoiesis in mammalian embryos is complicated 
by the requirement for functional blood cells prior to the emergence of 
hematopoietic stem cells (HSC) or the bone marrow microenvironment. In 
the murine embryo, transplantable HSC are first evident at embryonic day 
(E) 10.5 and small numbers begin to seed the fetal liver between E11.5 and 
E12.5. However, two overlapping waves of hematopoietic potential arise in 
the yolk sac before E10.5. The first “primitive” wave produces progenitors 
from E7.25 to E8.5 with primitive erythroid, megakaryocyte and mac-
rophage lineage potential. At E8.5, a second wave of hematopoiesis begins 
in the yolk sac and generates definitive erythroid, megakaryocyte, and 
multiple myeloid lineage potential that is the proposed source of hematopoi-
etic progenitors that seed the fetal liver before HSC colonization. A similar 
pattern of pre-HSC hematopoiesis has been found in human and as well as 
zebrafish embryos, where this first transient definitive wave has been termed 
“erythromyeloid progenitors” or EMP. We have determined that EMP in the 
E9.5 mouse yolk sac have a unique immunophenotype, co-expressing ckit, 
CD41, CD16/32 and endoglin. Other markers associated with HSC forma-
tion (AA4.1, ScaI) or with lymphoid potential (IL7R, Flt3) are not present 
on these cells at E9.5 while, as seen in HSC emergence, the “endothelial” 
markers VE-Cadherin and Flk1 are present. This immunophenotypically-
defined EMP population rapidly forms definitive erythroid, megakaryocyte, 
macrophage, and all forms of granulocytic cells in vitro and contains all of 
the definitive hematopoietic colony-forming cells present in the E9.5 yolk 
sac. Consistent with the lack of lymphoid markers, EMP do not generate 
(CD19+B220+) B-cells in vitro, in contrast to bone marrow-derived Lin-/
ckit+/ScaI- cells. Like CMP in the marrow, single EMP can generate both 
erythroid and granulocyte potential. The differentiation of embryonic stem 
cells (ES) and induced pluripotent stem cells (iPS) cells into mature cells types 
offers the hope of cell-based therapies. Analysis of differentiating murine 
ES cells reveals overlapping waves of primitive and definitive hematopoietic 
colony forming potential. We demonstrate this definitive potential resides 
in an EMP-like (ckit+/CD41+/FcGR+) population. Our studies support the 
concept that blood cell emergence during ES cell differentiation closely mim-
ics pre-HSC hematopoiesis in the yolk sac. Though these EMP were enriched 
at E9.5 in the yolk sac, they are also found at low levels in the fetal blood, 
embryo proper and placenta, consistent with their entrance into the circula-
tion. By E10.5, EMP were most highly enriched in the newly formed fetal 
liver. Additionally by E12.5, a time when the first few HSCs are detected in 
the fetal liver, we find active erythropoiesis and granulopoiesis in the liver 
and the first definitive red blood cells and neutrophils in the bloodstream. 
Therefore, we believe the yolk sac definitive progenitors’ fate is to populate 
the fetal liver and thus provide the first definitive erythrocytes and granulo-
cytes for the embryo.
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LOSS OF CSL-DEPENDENT NOTCH SIGNALING 
IN THE HEMATOPOIETIC MICROENVIRONMENT 
LEADS TO A LETHAL MYELOPROLIFERATIVE 
DISORDER
Wang, Lin
Pediatrics, Indiana University, Indianapolis, IN, USA
In the adult, hematopoietic stem cell (HSC) homeostasis is regulated by 
specialized niches in the bone marrow (BM). The three-dimensional structure 
of the BM microenvironment includes the extracellular matrix and differ-
ent cell types, such as fibroblasts, adipocytes, osteoblasts, endothelial and 
mesenchymal stem cells (MSC). While the role of the osteoblastic niche has 
been extensively studied, the instructive role of other cell types in providing 
homeostatic stimuli to resident HSC and multipotential progenitors needs to 
be further explored. Several molecular effectors have been implicated in the 
fine-tuned regulation of HSC functions by the BM niches, including Notch 
signaling and its ligands. Importantly, Notch signaling plays a critical role on 
hematopoiesis, endothelial cell biology, osteoblasts homeostasis and MSC 
differentiation. Although the cell-autonomous role of Notch signaling on 
hematopoietic cells has been extensively studied, to date, no studies have 
formally demonstrated whether disruption of Notch signaling on the he-
matopoietic microenvironment has an impact on hematopoietic homeosta-
sis. To investigate the role of Notch signaling in the BM microenvironment, 
we used the RBP-Jlox/loxMx1Cre mice model. Deletion of the DNA-binding 
motif of RBP-J by Cre results in the loss of CSL-dependent signaling from 
all Notch receptors. The Mx1 promoter drives Cre expression not only on 
hematopoietic cells but also on the stromal component of the hematopoietic 
organs. Effective deletion of the RBP-J exon was detected by PCR on he-
matopoietic cells, as well as on sorted BM osteoblasts, MSC and endothelial 
progenitor cells (EPC) of RBP-Jlox/lox Cre+ mice following induction by 
Poly(I)-poly(C) (pIpC). To determine the effects of Notch-defective BM 
stroma on hematopoiesis, we transplanted normal BM from CD45.1 B6/
BoyJ mice into lethally irradiated CD45.2 RBP-Jlox/loxMxCre+ (RBP-J KO) 
or RBP-Jlox/loxMxCre- (Co). At wk 8 from transplant, both groups were 
induced with pIpC. At day 50 to 70 from induction, all RBP-J KO recipi-
ents showed increased WBC, in particular neutrophils (KO 11.75±6.63 vs 
Co 5.29±1.86 k/uL) and increased Gr1+/Mac1+ cells in the bone marrow 
(KO 49.10%±4.83%, vs Co 33.93%±1.90%) spleen (KO 2.88%±0.97% 
vs Co 1.00%±0.34%) and peripheral blood (KO 19.27%±4.19% vs Co 
7.57%±1.76%), increased circulating HSC (KO 0.86%±0.32% vs Co 
0.25%±0.12%), and splenomegaly, suggesting a myeloproliferative disorder. 
Survival at 5 months was 12% for the RBPJ KO mice compared to 100% for 
the control mice. Histological analysis of BM and spleen confirmed a MPD-
like disorder and showed increased microvascular density and increased 
CD31+ EC by IHC. Also, higher frequency of the CD45-CD105+CD31+ cell 
subset, enriched in EC, was seen in the BM and spleen of RBP-J KO mice. 
Transplantation of BM cells from RBP-J KO mice with advanced disease 
did not transfer the myeloproliferative disease to secondary WT recipients. 
Transplantation of RBP-J KO BM HSC into WT mice resulted in decreased 
T-cells; increased B-cells, as previously described, but did not induce any 
obvious defect in myelopoiesis. Taken together, these data suggest that the 
alteration of the hematopoietic system in floxed RBP-J mice is driven by 
the microenvironment. Further studies are ongoing to identify whether the 
endothelium or other cellular types are involved in mediating the non-cell 
autonomous myeloproliferative disease.
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SQSTM1 (P62) EXTRINSICALLY REGULATES 
HEMATOPOIETIC STEM CELL AND 
PROGENITOR MOBILIZATION
Sengupta, Amitava1, Duran, Angeles2, Pratt, Ronald1, Dunn, Susan3, 
Ficker, Ashley1, Diaz-Meco, Maria2, Moscat, Jorge2, Cancelas, Jose1
1Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA, 
2Sanford/Burnham Medical Research Institute, La Jolla, CA, USA, 
3University of Cincinnati, Cincinnati, OH, USA
Hematopoietic stem cell and progenitor (HSC/P) mobilization is a complex 
process that involves interaction of HSC/P with hematopoietic microenviron-
ment. The molecular signatures implicated in the control of the hematopoi-
etic microenvironment on HSC/P mobilization and retention remain poorly 
understood. Using loss of function chimeric mice models, we report cell-
nonautonomous requirement of SQSTM1 (p62) in adult HSC/P mobiliza-
tion. We demonstrate that deficiency of p62 in the hematopoietic microen-
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vironment, but not in HSC/P, induces HSC/P egress. Increased circulation of 
HSC/P was associated with reduction in trabecular bone volume and archi-
tecture. Interestingly, additional deletion of Nbr1, another member in phox 
bemp1 (PB1) domain-containing proteins, in a p62-deficient background 
(p62-/-, Nbr1Δ/Δ) rescued HSC/P mobilization and reverted bone architec-
ture in vivo. Combined deficiency of p62 and Nbr1 also induced expansion 
of bone marrow mesenchymal progenitor pool and altered osteogenic dif-
ferentiation. However, loss of Erk1, which is negatively regulated by p62 to 
inhibit adipogenesis, in p62-deficient background (p62-/-; Erk1-/-) did not 
rescue increased HSC/P mobilization in vivo, suggesting HSC/P mobilization 
was independent of adipogenesis. Collectively, our studies provide genetic 
evidence that p62 and Nbr1 play cell-nonautonomous epistatic antagonism 
in bone remodeling in mammalian HSC/P mobilization in vivo.
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HEMATOPOIETIC STEM CELL ACTIVITY AND 
POLARITY ARE CONSERVED IN THE ABSENCE 
OF ATYPICAL PKCζ AND λ
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Stem cell pool is considered to be maintained by a balance between sym-
metric and asymmetric division of stem cells. Cell polarity model proposes 
that the facultative use of symmetric and asymmetric cell division is orches-
trated by a polarity complex consisting of partitioning-defective proteins: 
Par3, Par6 and atypical protein kinase C (aPKCζ and aPKCλ) which regulates 
planar symmetry of dividing stem cells with respect to the signaling microen-
vironment. However, the role of the polarity complex has been unexplored 
in mammalian adult stem cell maintenance. Here we report that, in contrast 
to accepted paradigms, activity of adult hematopoietic stem cell (HSC) does 
not depend on the polarity complex-determining kinases: aPKCζ or aPKCλ 
or both in vivo. Mice, having constitutive and hematopoietic-specific (Vav1-
Cre) deletion of aPKCζ and aPKCλ, respectively, are phenotypically normal 
and their litters follow Mendelian ratio of inheritance. Inducible genetic 
inactivation of aPKCζ and aPKCλ in HSC does not affect HSC polarization, 
self-renewal, engraftment, differentiation, steady state or G-CSF-induced 
mobilization and interaction within the bone marrow microenvironment 
either. In addition, aPKCζ and aPKCλ-deficient HSCs elicited a normal pat-
tern of hematopoietic recovery secondary to myeloablative stress. Taken 
together, expression of aPKCζ or aPKCλ or both are dispensable for primitive 
and adult HSC fate determination, in steady state and stressed hematopoie-
sis; jeopardizing the dogma of evolutionary conserved aPKCζ/λ-directed cell 
polarity in mammalian HSC fate determination and suggesting that alterna-
tive kinases can replace aPKCζ/λ in the composition of the polarity complex.
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EMBRYONIC STEM CELL-DERIVED FACTORS 
INHIBIT T EFFECTOR ACTIVATION AND INDUCE 
T REGULATORY CELLS BY MODULATING PKC-Θ 
ACTIVATION.
Mohib, Kanishka1, Al Khamees, Bodour1, Allan, David2, Wang, 
Lisheng3
1Department of Biochemistry, Microbiology and Immunology, University of 
Ottawa, Ottawa, ON, Canada, 2Regenerative Medicine Program, Ottawa 
Health Research Institute, University of Ottawa, Ottawa, ON, Canada, 
3Department of Biochemistry, Microbiology and Immunology, Ottawa 
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Embryonic stem cells (ESC) possess immune privileged properties and have 
the capacity to modulate immune activation. However, the mechanisms 
by which ESC inhibit immune activation remain mostly unknown. We have 
previously shown that ESC derived factors block dendritic cell maturation 
and thereby affect T cell activation indirectly. Our ongoing studies have 
elucidated that ESC derived factors also have a direct effect on T cell activa-
tion. In mixed lymphocyte reaction assays, ESC derived factors significantly 
down-regulated IL-2 and IFN-γ expression, while up-regulating IL-10 and 
TGF-β expression. Also, ESC derived factors suppressed the expression 
of Th1 transcription factor Tbet, while enhancing the expression of Treg 
transcription factor Foxp3. Furthermore, PBMC/purified T cells activated 
with CD3/CD28, ConA and PMA proliferated poorly in the presence of 
ESC derived factors, while proliferation in response to ionomycin was not 
affected. Western blot analysis indicated that ESC derived factors prevented 
PKC-θ phosphorylation without influencing total PKC-θ levels. Moreover, 
IκB-α degradation was abrogated, confirming absence of PKC-θ activity. 
Incubation of ESC derived factors with recombinant GST-PKC-θ resulted 
in the pull-down of four proteins. The purified proteins are currently being 
analyzed by mass spectrometry. In conclusion, ESC’s are able to directly im-
pact T cell activation and polarization, likely by negatively regulating PKC-θ 
through potentially novel factors.
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CONTROLLED GENERATION OF T CELLS FROM 
HEMATOPOIETIC PROGENITOR CELLS (HPC) 
DERIVED FROM PLURIPOTENT CELL SOURCES 
(PSC) FOR HIV TRANSPLANTATION THERAPY
Shukla, Shreya, Zandstra, Peter W.
Institute of Biomaterials and Biomedical Engineering, University of Toronto, 
Toronto, ON, Canada
Embryonic and induced PSC hold great potential for cell-based therapies due 
to their ability to differentiate into all cell types, including blood cells. Blood 
cells are the principal target of many infectious diseases, including human 
immunodeficiency virus (HIV). HIV propagates by debilitating the immune 
system; specifically CD4+ T cells that mediate resistance to opportunistic in-
fections. Developing better technologies to generate T cells from PSC, either 
in their normal state or mutated to be more resistant to HIV infection could 
provide important tools to gain new insight into this disease. Results will be 
presented comparing the differentiation kinetics of ESCs and iPSCs derived 
from mature and immature T cell subsets (T-iPSCs) to HPCs in a serum-free 
assay with defined aggregate sizes. Additionally, novel micropatterning 
techniques for immobilizing Delta-like 1 (DL1) ligand are being developed; 
these will be incorporated into T-cell assays to characterize T cell develop-
ment under defined conditions. Finally, human blood cell targets are being 
compared for their T-cell generation properties. Controlled generation of 
HIV-resistant T cells from HPCs can lead to the production of cell-based vac-
119
Friday Poster Abstractswww.isscr.org
Friday Poster Abstracts
cines on a large scale that will provide a co-ordinated immunological defense 
against HIV progression.
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TRANSGENE FREE DISEASE DERIVED-IPS 
DIFFERENTIATION INTO HEMATOPOIETIC AND 
ERYTHROID CELLS
Chang, Chan-Jung, 
Cell Biology/ Hematology, Albert Einstein College of Medicine, Bronx, NY, 
USA
Chan-Jung Chang,. 
Hematology, A. Einstein College of Medicine, Bronx, NY 10461 
Human induced pluripotent stem cells (hiPSC) have been shown to have 
differentiation potential similar to human embryonic stem cells (hESC). In 
particular, the questions of whether the source and the age of the somatic 
cells used to produce iPS have an influence on the differentiation potential 
of the iPS, has not been fully explored. From our previously study shown 
that co-culture hESC with immortalized fetal hepatocytes (FHB) yield CD34+ 
cells that can be further expanded in serum-free liquid culture to obtain 
large number of megaloblastic nucleated erythroblasts. With extending the 
liquid culture, we found that the hemoglobin composition switching from 
basophilic erythroblasts expressing Hb Gower I (22) to orthochromatic 
erythroblast hemoglobin Gower II(22). By extending the co-culture of hESC 
with FHB from 14 day to 35 day, the CD34+ obtained from extending 
culture follow expanding and differentiating by liquid culture, shown more 
developmentally mature fetal-liver like erythroblast which expressed HbF 
(22). In the current study, we have used retroviruses expressing Oct4, Sox2, 
Klf4 and c-Myc to produce iPS from embryonic and fetal mesenchymal 
cells, from adult skin fibroblasts, and hair keratinocytes, and compared them 
in details with hESC. Morphology, growth characteristics, surface antigen 
expression and mRNA expression (Affymetrix Human Gene 1.0 ST Array) 
were undistinguishable from undifferentiated H1 and H9 hESC. PCR analysis 
of pluripotency factors revealed that in most iPS clones the four exogenous 
reprogramming factors were mostly silenced except in one interesting clone, 
obtained from fetal liver which had not silenced any of the four factors. Dif-
ferentiation along the hematopoietic and erythroid lineages yielded numbers 
of CD34+ cells (2 to 10%) similar to those obtained with hESCs and red 
blood cells that undergo the same two globin switches as hESCs. Interest-
ingly, the iPS clone that did not silenced the four factors differentiated 
predominantly into CD34+ cells, yielding 10 to 20 times more CD34+ cells 
than the other iPS, although these CD34+ cells had very poor erythroid dif-
ferentiation potential. We conclude that iPS with apparently normal globin 
switching potential can be obtained from embryonic, fetal or adult somatic 
cells originating from multiple tissue sources. Aberrantly reprogrammed 
iPS with interesting differentiation potential are also obtained. Aberrant 
reprogramming can be associated with poor silencing of the reprogramming 
factors. In order to avoid the consequences caused by virus insertion, we 
reprogrammed disease fibroblasts with episome vectors. The iPS cells from 
alpha thalassemia fibroblast that has four alpha gene deletions (FIL-/SEA-), 
and the aTiPS expressed typical hESC markers. The aTiPS can form terato-
mas with injected into immuno-compromise mice, and shown no trasngene 
insertions in the PCR results. The CD34+ cells obtain from 14 days coculture 
of aTiPS with FHB, after expend and maturated by liquid culture, express 
Gower I (22) compare to the erythroblast from the hESC and other iPS from 
normal cells with the same 14 co-culture protocol that express Gower II 
(22). However, the erythroblast derived from aTiPS didn’t show microcytic or 
hypochromic features in our 14 days differentiation.
Poster Board Number: 2402
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CELLS DERIVED FROM DOWN SYNDROME 
FIBROBLASTS
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Down Syndrome (DS) children are prone to develop blood abnormalities. 
The blood disorder starts in the fetus, presenting as Transient Abnormal 
Myelopoiesis (TAM) in neonates which, in some cases, evolves into leukae-
mia, particularly Acute Megarkaryoblastic leukaemia (AMKL). In this study 
we aim to use iPS cells made from DS fibroblasts as a novel way to recreate 
the abnormal haematopoiesis in vitro. Stable iPS cell lines have been cre-
ated from normal and DS fibroblasts using two non-viral episomal vectors 
containing six reprogramming factors-OCT4, Sox2, NANOG, LIN28, c-Myc 
and KLF4. Both normal and DS iPS cell clones are free of episomal vector 
DNA and episome-derived transcripts. Cytogenetic studies confirmed the 
presence of trisomy 21 and gene expression studies showed the expression 
of pluripotency associated genes. The expression of a selection of these 
genes including SSEA-4 and TRA-1-60 was verified by flow cytometry and 
immunofluorescent staining. These iPS cells also have the ability to differ-
entiate into all three germ layers and develop teratomas in mice. Embryoid 
bodies (EBs) formed from these iPS cells were subjected to two different 
haematopoietic differentiation methods. The first is based on the co-culture 
of EBs on OP9 cells and growth factors (SCF, Flt3 ligand, FGF, TPO, BMP4, 
VEGF) for two weeks. The other method involved a 20-day culture of EBs 
on low attachment plates in the presence of high dose growth factors (SCF, 
Flt3 ligand, TPO, BMP4, VEGF). Both methods were able to generate CD34 
and CD45+ cells detected by flow cytometry yielding 4-9% CD34/CD45+ 
double positive cells. We have modified the culture method to increase the 
yield. The haematopoietic cells generated are isolated by MACs and further 
characterised using haematopoietic progenitor assays to verify the abnormal 
differentiation and proliferation characteristics of DS iPS cells likely associ-
ated with the evolution of DS into leukaemia reported in in vivo studies. 
Gene expression profiling of isolated progenitors aiming to identify abnormal 
gene expressions linked to the aberrant haematopoiesis of DS iPS cells will 
be discussed.
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OSTEOBLASTS DERIVED FROM MSC 
PROMOTE CELL CYCLE ENTRY OF CD34+ 
CELLS AND EXPANSION OF HEMATOPOIETIC 
PROGENITORS
Çelebi, Betül1, Boily, Yannick2, Pineault, Nicolas3
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2Research&Development, Hema-Quebec, Quebec, QC, Canada, 
3Research&Development, Dept Biochemistry, Microbiology, Bioinformatic, 
Hema-Quebec and Laval University, Quebec, QC, Canada
Introduction: Expansion of Umbilical cord blood (UCB) hematopoietic cells 
is of high interest to broaden their use in transplantation medicine. Indeed, 
UCB transplantation in adults is currently limited by the small amount of 
hematopoietic progenitor cells (HPCs) present in each unit. In this work, we 
aimed to increase the expansion of HPCs and megakaryocyte progenitor cell 
(MPC) by the combine use of optimized cytokine cocktails and feeder cells 
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normally present within the Bone marrow (BM) or UCB environment. Mate-
rial & Methods: Osteoblasts (OST) derived from BM Mesenchymal Stem 
Cells (MSC) and Human umbilical vein endothelial cells (HUVECs) were 
tested as feeder cells for CD34+ UCB cells. The cultures were complemented 
with the cytokine cocktails OMPC (TPO, SCF, FLT-3) and BS1 (TPO, SCF, 
IL-6, IL-9) used for MPC expansion (day 0-4) and megakaryocyte differen-
tiation (day 4-14). 4 co-culture conditions were tested; OST with (OST C) or 
without contact in trans-wells (OST WC) and, HUVECs with (HUVEC C) or 
without contact (HUVEC WC). The control conditions consisted of CD34+ 
cells grown in 24-well (CTL C) and in trans-wells (control for non-contact 
condition (CTL WC)). HPCs (CFC) and MPCs (CFU-MK) frequencies were 
measured using standard progenitor assays. 4 independent experiments 
were done for all tests. Results: First, the impact of co-culture with the 
HUVEC or OST feeder cells on the proliferation of UCB CD34+ cells was 
assessed. Total cell expansion in OST C cultures was increased by 1.6-fold 
and 1.2-fold compared to the CTL C at days 6 and 14, respectively. There 
was no differences in the frequencies of CD34+ cells between the differ-
ent co-culture conditions, though the former tended to be greater in the 
co-cultures with OST C at day-6 and OST WC at day-14 compared to the 
controls (2- and 3-fold greater, respectively). Next, the impact of the feeder 
cells on HPC expansions were investigated by colony assays. Co-culture with 
OST WC and HUVEC WC increased the expansion of myeloid HPC by 1.7 
(p<0.05) and 3.7-fold (p>0.05), and of MPC by 3.2- (p<0.01) and 2.5-fold 
(p<0.1) compared to the CTL WC at day 6, respectively. The increased 
expansion of hematopoietic cells and HPCs obtained in some co-culture 
conditions suggest that the feeder cells may have a positive impact on the 
proliferation and/or cell cycle entry. To investigate this, cell cycle and cell 
cycle entry of quiescent hematopoietic cells were analysed by cytometry 
(Ki-67 and 7AAD). The proportion of CD34+ cells still in G0 in HUVEC C 
cultures (16.3±5.0) were 5.6- (p<0.07) and 5.2-fold (p<0.04) greater than 
those in the OST C (2.9±1.3) and CTL C (3.1±0.8) cultures at day 4. Similar 
observations were made for the total nucleated cell population. In contrast, 
hematopoietic cells co-cultured with OST (C and WC) generally entered 
the G1 phase faster than those present in the control (74 ± 3 vs. 65 ± 6 
p<0.15 for contact, and 72 ± 8 vs. 63 ± 8, p< 0.01 for non contact) and 
HUVEC C (61±7, p<0.07) cultures. Conclusion: These results demonstrate 
that expansion of myeloid and megakaryocyte progenitors are significantly 
increased when CD34+ cells are co-cultured with OST without contact. The 
results also suggest that growth factors released by OST stimulate the cell 
cycle entry of quiescent CD34+ cells, while direct contact with HUVEC has 
the opposite effect. Hence, co-culture of HPCs with OST in the presence of 
optimized cytokine cocktails provides an interesting strategy to increase the 
amount of HPCs and MPCs available for transplantation.
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THE ROLE OF RETINOIC ACID SIGNALING IN 
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The emergence of the primitive erythroid lineage in the blood islands of 
the yolk sac defines the onset of hematopoiesis in the mammalian embryo. 
The primitive erythroid lineage is unique within the hematopoietic system in 
that it represents a transient developmental program that is restricted to the 
yolk. In addition to primitive erythrocytes, the early yolk sac also generates 
macrophages, megakaryocytes and progenitors of the definitive erythroid 
lineage. The transient and restricted nature of primitive erythropoiesis 
suggests that both its onset and termination are tightly controlled. Insights 
into the regulation of this early blood cell lineage have been provided by 
studies in the early embryo and the embryonic stem cell (ESC) differentia-
tion model, which have shown that primitive erythropoiesis is controlled in 
part by the VEGF/Flk-1, Wnt, Notch and activin pathways. Findings from 
recent studies suggest that retinoic acid (RA) signaling may also play a role 
in the regulation of this early hematopoietic program. When added to ES cell 
differentiation cultures, RA was found to inhibit primitive hematopoiesis. RA 
exerts its effect through three different retinoic acid receptors (RARs) alpha 
(α), beta (β), and gamma (γ). To determine if the inhibitory effect is medi-
ated specifically through one of these receptors, we treated whole mouse ES 
cell-derived embryoid body (EB) populations or Flk-1+ progenitors isolated 
from them with α (RAR-α) or γ (RAR-γ) specific agonists. When added 
at the onset of primitive erythropoiesis, RAR-α but not RAR-γ completely 
inhibited the generation of the primitive erythroid and macrophage lineages, 
characteristic of the in vitro equivalent of yolk sac hematopoiesis. All trans 
RA also inhibited this early stage of hematopoiesis. The addition of the 
RAR-α antagonist together with RAR-α or RA partially rescued the block in 
primitive hematopoietic development, indicating that the inhibitory effect 
of RA is mediated through the α receptor. The differential effects of RAR-α 
and RAR-γ on the ESC-derived primitive hematopoietic program provide 
a unique model for further dissecting the role of this signaling pathway in 
hematopoietic specification.
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Stem cell (SC) transplantation is a common treatment for haematological 
malignancies and bone marrow (BM) failure. Mobilized peripheral blood 
stem cells and BM are the most common sources for haematopoietic stem 
cell transplantation (HSCT). Currently, umbilical cord blood stem cells (CBSC) 
are also being used. CBSC have many attractive properties such as low inci-
dence and severity of graft-versus-host disease (GvHD), a strong graft-ver-
sus-leukemia (GvL) and an increased tolerance to HLA mismatch are highly 
relevant. However, there are also disadvantages; delayed recovery and 
post-transplant infections have the most important clinical considerations. 
Previous studies have reported that accessory cells, such as CD8, regula-
tory T cells (Tregs) and Natural Killer (NK) cells have a positive effect on SC 
engraftment after transplantation. On this basis, we decided to analyse the 
effect of accessory cells: NK cells, CD4+ and CD8+ on engraftment of CBSC. 
Using a humanized model, Rag2-/-IL-2Rgc-/- mice, we analyzed 4 different 
groups. The first group of mice were transplanted with CD34+ cells only, 
the second, third and fourth group received NK cells, CD4+ cells and CD8+ 
cells, respectively, in addition to the dose of CD34+ cells. After 5 weeks 
we analyzed engraftment based on the presence of CD45+ cells within the 
BM. We observed a higher level of engraftment in the group of mice that 
received SC plus NK cells compared to the other groups that received CD4+ 
and CD8+. Based on these results we decided to study the effect that NK 
cells have on the migration of CBSC, and the mechanisms of interaction 
between these two cells. We first characterised different homing receptors 
such as alpha and beta integrins, P-selectin receptor, CD47 and CXCR4. This 
characterisation was done on resting freshly isolated CBSC and NK cells and 
also on CBSC co-cultured with NK cells. Additionally, in order to analyse 
the migration capacity of CBSC in the presence of NK cells we performed 
transwell migration assays with CBSC alone and in the presence of NK cells, 
using SDF1a as a stimulus for migration at a concentration of 125ng/mL. 
Our results so far suggest that NK cells seem to play an important role in 
CBSC migration and engraftment. However we still need to propose a pos-
sible mechanism by which NK cells have an effect on CBSC migration.
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EVALUATION OF SEVEN DAY COLONY 
FORMING UNIT (CFU) ASSAY FOR THE 
ASSESSMENT OF CORD BLOOD (CB) POTENCY 
AND HEMATOPOIETIC PRECURSOR CELL (HPC) 
CONTENT
Frandberg, Sofia, Borestrom, Cecilia, Anghem, Eva, Lindahl, Anders, 
Palmqvist, Lars
The Swedish National Cord Blood Bank, Goteborg, Sweden
Background: Choosing the perfect cord blood unit (CBU) for transplanta-
tion is based on tissue typing and the stem cell potential of the unit. CBUs 
are routinely assessed at collection with regards to total nucleated cells 
and CD34+cell count. The potency of the unit to be released is assessed 
post-thaw by the 14-day CFU (colony forming units) assay. This assay has 
a disadvantage in being time-consuming, and an alternative assay with a 
shorter 7-day incubation period has been proposed (MethoCult® Express, 
Stem Cell technologies). Aim: To compare the performance of the 7-day 
CFU assay with the traditional 14-day CFU assay, using our standard CFU 
protocol with MethoCult® GF medium (7d and 14d-assay) and MethoC-
ult® Express (7d -assay). Materials and Methods: CBUs (n=58) were evalu-
ated for CFU growth and colony number post-cryopreservation. Each unit 
was cultured in MethoCult® GF with erythropoietin or MethoCult® Express 
(StemCell technologies) for 7 and 14 days respectively. The total number of 
colonies was counted manually. Results and Discussion: All CBUs showed 
colony growth in both assays. Colonies were smaller with the 7d-assay, and 
it was not possible to discriminate between different cell colony types. The 
CFU counts of the 7d and 14d assays correlated well, irrespective of which 
growth medium that was used. MethoCult® GF 7d vs 14d: R2=0,87 and 
MethoCult® Express 7d vs MethoCult® GF 14d: R2=0,89. Furthermore, the 
CFU count of the 7d MethoCult® GF and the 7d MethoCult® Express also 
correlated very well, R2=0,94. In summary, the 7-day assay is useful when 
results are needed fast, however using the more expensive culture medium 
MethoCult® Express does not seem to be necessary, as very similar results 
were obtained using the standard MethoCult® GF medium.
Poster Board Number: 2412
MICRORNA-126 MODULATES THE SENSITIVITY 
OF HEMATOPOIETIC STEM AND PROGENITOR 
CELLS TO ENVIRONMENTAL SIGNALS
Gentner, Bernhard1, Giustacchini, Alice1, Boccalatte, Francesco E.1, 
Saini, Massimo1, van Galen, Peter2, Lechman, Eric2, Dick, John E.2, 
Naldini, Luigi1
1Division of Regenerative Medicine, Stem Cells and Gene Therapy, San 
Raffaele -Telethon Institute for Gene Therapy, Milan, Italy, 2Division of Cell 
and Molecular Biology, University Health Network, Toronto, ON, Canada
We recently identified miR-126 as a hematopoietic stem cell (HSC) mi-
croRNA. Yet, little is known about its function in hematopoietic stem and 
progenitor cells (HSPC). We generated a stable miR-126 knockdown (kd) 
or forced its expression (“knock-in”, ki) in mouse HSPC using lentiviral vec-
tors. Kd or ki cells were competitively transplanted with congenic, control 
vector-transduced cells, and hematopoietic chimerism was followed for >1 
year in primary and secondary recipients. Forced expression of miR-126 
resulted in a higher myeloid and B cell contribution compared to control cells 
at week 2-4 after transplant. However, this was followed by a progressively 
decreasing contribution of miR-126 ki cells to all hematopoietic lineages 
and a nearly complete depletion of Kit+Sca+Lin- (KSL) BM cells by 6 weeks 
after transplant. At 3 weeks post-transplant, when miR-126 ki KSL cells 
could still be detected, we found an increased proliferative index in these 
cells as judged by in vivo EdU incorporation. These data suggest that 
miR-126 ki might favor HSC commitment at the cost of self-renewal. This 
phenotype was specific for miR-126 and not due to vector toxicity, as we 
demonstrate stable, long term overexpression of several control miRNAs in 
vivo. Moreover, miR-126 ki cells showed normal clonogenic activity in vitro. 
On the contrary, miR-126 kd HSPC engrafted long-term in competitive 
transplantation assays, and miR-126kd cell chimerism was >2 fold above 
control specifically in the HSC-enriched Lin-Kit+Sca+CD150+CD48- bone 
marrow (BM) compartment. We furthermore noted enhanced myeloid and/
or lymphoid contribution during the early phases of reconstitution which 
was reproducible upon serial transplantation, suggesting that miR-126 kd 
enhances hematopoiesis particularly under stress conditions, possibly by 
modulating HSC responses to environmental signals. We then optimized a 
protocol to stably knock down miR-126 in human cord blood (huCB) HSPC, 
and validated this approach by demonstrating upregulation of previously 
described miR-126 targets including the beta subunit of phosphoinositide-
3-kinase (Pi3K). Importantly, we provide evidence for increased activation of 
the Pi3K-Akt pathway in miR-126 kd huCB cells upon cytokine stimulation, 
and these cells show enhanced growth and increased CFU-C content when 
cultured in the presence of early acting cytokines. Identification of additional 
miR-126 targets is ongoing using unbiased proteomic and transcriptomic 
approaches. In summary, these data identify miR-126 as a novel HSC regu-
lator, possibly modulating the responsiveness of HSPC to growth/survival & 
differentiation signals. Further study of miR-126 will provide new insights 
into hematopoietic stem cell biology which might facilitate the usage of 
these clinically relevant cells for novel gene therapy approaches.
Poster Board Number: 2414
CAN AMNIOTIC FLUID STEM CELLS BE AN 
OPTION FOR AUTOLOGOUS CELL BASED GENE 
THERAPY IN UTERO?
Shaw, S.W. Steven1, Pipino, Caterina2, Maghsoudlou, Panagiotis2, 
Waddington, Simon N.1, David, Anna L.1, De Coppi, Paolo2
1Institute for Women’s Health, University College London, LONDON, 
United Kingdom, 2Institute of Child Health, University College London, 
LONDON, United Kingdom
Introduction: Prenatal stem cell-based gene therapy using transduced amni-
otic fluid stem (AFS) cells is a possible strategy to treat congenital diseases. 
Allogeneic cells can be rejected in immune-competent animals, even in fetal 
life. Autologous cell therapy offers an alternative option. Mouse amniotic 
fluid (AF) contains ~1% c-Kit(+)/Lin(-) AFS cells, that can differentiate into 
the three germ layers. We compared congenic (autologous) versus allogenic 
in utero transplantation of AFS cells in mice. Materials and Method: Amni-
otic fluid was collected from yellow fluorescence protein YFP(+) C57BL/6 
mice at E13.5. c-Kit(+)/Lin(-) cells were injected into the peritoneal cavity of 
every fetus from C57BL/6 (congenic transplantation) or CD1 wild type (allo-
genic transplantation) dams on E13.5. Engraftment was assessed at 1 and 3 
months of age. Results: Twelve out of 20 (60%) CD1 and 4 out of 7 (57%) 
injected C57BL/6 pups survived to term. There was significantly higher 
peripheral blood engraftment in congenic (5.15±1.40%), compared with 
allogenic (1.65±0.60%, p<0.05) models by flow cytometry at 1 months of 
age. Colony-forming cell (CFC) assays were performed by plating the bone 
marrow Lin(-) cells of transplanted animals into methylcellulose semi-solid 
medium (MethoCult, StemCell Technologies). All types of the hematopoi-
etic CFC were observed after 14 days incubation. Fluorescence microscopy 
showed small population of yellow colonies in the bone marrow of congenic 
but not allogenic injected mice. A positive YFP bands were detected by PCR 
in the liver, spleen, adrenal glands of recipient congenic mice, while only in 
the liver of allogenic one. Immunohistochemistry further confirmed the YFP 
cells engrafting in the liver of both arms at 3 month-old. Conclusion: These 
initial studies confirm that autologous cell therapy may give better engraft-
ment than allogenic.
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SHEEP AMNIOTIC FLUID DERIVED CD34+ 
STEM CELLS COULD ENGRAFT AND RESTORE 
THE HEMATOPOIETIC SYSTEM OF NSG MICE
Shaw, S.W. Steven1, David, Anna L.1, Blundell, Mike2, Resca, Elisa2, 
Ramachandra, Durrgah1, Porada, Christopher3, De Coppi, Paolo2
1Institute for Women’s Health, University College London, LONDON, 
United Kingdom, 2Institute of Child Health, University College London, 
LONDON, United Kingdom, 3Wake Forest Institute for Regenerative 
Medicine, Winston-Salem, NC, USA
Introduction: We have previously shown that human and mouse amniotic 
fluid (AF) c-Kit(+)/Lin(-) amniotic fluid stem (AFS) cells, displayed he-
matopoietic potential both in vitro and in vivo. Currently, there is no c-Kit 
antibody available for sheep cells, and the human antibody does not cross 
react with sheep. Recently a novel CD34 monoclonal antibody specific to 
sheep has been developed. In this study, we tested whether CD34+ sheep 
AFS cells have functional haematopoietic potential. Materials and Method: 
Sheep amniotic fluid was collected by ultrasound guided amniocentesis at 
59.5±4.5 days (term=145 days). A novel sheep specific CD34 monoclonal 
antibody was used to select cells in a microbeads magnetic sorting system. 
Sheep AFS CD34 + cells were cultured with StemSpan SFEM medium plus 
cytokine cocktail, and transduced using an HIV vector encoding enhanced 
green fluorescent protein (GFP, MOI=50) for 24 hours. Transduced AFS 
CD34+ cells (3x10^5 cells in 200µl PBS) were injected intravenously into 
NOD-scid gamma (NSG) mice (N=10). Engraftment of transduced cells was 
assessed after 3 months. Results: Sheep CD34+ AFS cells formed colonies 
using methylcellulose-based assay, and were positive for CD45, CD133, 
but negative for CD14, CD31, CD44, CD58 and CD166. 80% injected 
NSG mice survived up to 3 months. Flow cytometric analysis at 3 months 
showed GFP positive cells in the peripheral blood (3.38±0.92%) and bone 
marrow (12.9±1.6%). The liver, spleen, bone marrow and adrenal gland 
were positive for GFP DNA by PCR. Immunohistochemistry confirmed the 
engraftment of donor cells in liver. Conclusion: This study demonstrates the 
hematopoietic potential of CD34+ sheep AFS cells. These cells could be ap-
plied as an autologous transplantation resource into large animal models of 
disease and could correspond to early haematopoietic progenitors identified 
previously in mouse and human AF.
MESENCHYMAL CELL LINEAGE ANALYSIS
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HUMAN MENSTRUAL BLOOD DERIVED 
MESENCHYMAL CELLS EFFICIENTLY MANAGE 
OXIDATIVE STRESS
Goldenberg, Regina Coeli dos Santos, Asensi, Karina Dutra, 
Fortunato, Rodrigo Soares, de Souza, Elaine Cristina Lima, dos 
Santos, Danúbia Silva, Kasai-Brunswick, Taís Hanae, Rodrigues, 
Deivid Carvalho, de Carvalho, Antônio Carlos Campos, Carvalho, 
Denise Pires, Carvalho, Adriana Bastos
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Mesenchymal stem cells transplantation (MSCs) proves to be useful to treat 
diseases in which tissue damage is linked to oxidative stress (OS). Recently, 
it has been demonstrated that stem cells can be isolated from menstrual 
blood. This is an important new source of stem cells, since they can be easily 
obtained, do not require invasive procedures, and availability is virtually 
endless. Thus, the aim of this work was to isolate, characterize, differentiate 
menstrual blood-derived stem cells (MBMC) and evaluate whether MBMC 
can manage oxidative stress (OS). Human menstrual blood was collected 
from eleven healthy female subjects when menstrual flow initiated. Mono-
nuclear cells were obtained by Ficoll-Paque gradient and plated in culture 
dishes. Human menstrual blood-derived cells presented a subpopulation of 
adherent cells with spindle-shape morphology that were highly proliferative. 
Population doubling time was 38.07 ± 1.9 hours of women not using con-
traception while MBMC from women who use contraceptives double their 
population every 35.97 ± 1.7 hours, with no statistical difference between 
samples. After five passages, the presence of surface markers was evalu-
ated by flow cytometry. These cells were positive for the mesenchymal cell 
markers CD90 (93.3%), CD73 (85.5%); and negative for the hematopoietic 
markers CD34, CD45, CD14, CD19 and HLA-DR, the endothelial marker 
CD31, CD133 and the stem cell marker c-kit. This immunophenotypic 
profile was maintained after fifteen passages. The expression of pluripotency 
molecules was evaluated by RT-PCR and immunofluorescence. At the mRNA 
level, menstrual blood-derived cells expressed the core embryonic stem 
(ES) cell regulators Oct4, Sox2, nanog and Klf4. At the protein level, these 
cells stained positive for the pluripotency markers SSEA-4, TRA1-60 and 
TRA1-81. Moreover, when adipogenic and osteogenic differentiation was 
induced, these cells formed fat vacuoles demonstrated by Oil Red O staining 
and showed calcium deposits when stained with Alizarin Red, respectively. 
MBMC were cultured with increasing concentrations of reactive oxygen 
species (ROS; source: H2O2) and its viability was evaluated by staining 
of adherent cells with crystal violet. These cells showed high resistance 
to OS-induced death (IC50: 1.8mM). Moreover, MBMC are capable of 
producing large quantities of total H2O2 (90.6 ± 9.7 nmol H2O2 /h/mg of 
protein) and NADPHoxidase is responsible for one third of this production. 
In conclusion, menstrual blood-derived cells are highly proliferative, express 
mesenchymal stem cell surface markers and differentiate into osteocytes and 
adipocytes in vitro, indicating that they are multipotent mesenchymal cells. 
These cells express pluripotency markers, suggesting that they are a power-
ful source of progenitors and could potentially be differentiated in other 
mesodermal tissue types. Moreover, these cells presented high resistance to 
OS and might be considered a tool for cell therapy strategy aimed to treat 
patients with diseases in which onset and progression is associated with OS.
Poster Board Number: 2420
TRANSPLANTATION AND BIODISTRIBUTION OF 
HUMAN PLACENTA-DERIVED MESENCHYMAL 
STROMAL CELLS IN IMMUNOCOMPETENT 
MICE SUBMITTED TO MYOCARDIAL 
INFARCTION.
Passipieri, Juliana A., Suhett, Grazielle, Brasil, Guilherme, 
Mello, Débora B., Kasai-Brunswick, Tais H., Martins, Andreza 
B., Rodrigues, Deivid C., Christie, Beatriz B., Rocha, Nazareth, 
Carvalho, Adriana, Goldenberg, Regina, Campos de Carvalho, 
Antonio
Federal University of Rio de Janeiro, Rio de Janeiro, Brazil
Death of cardiomyocytes due to myocardial infarction (MI) causes wall 
thinning and ventricular dilatation, which diminishes the ability of the heart 
to pump blood, leading to heart failure. This study aims to evaluate the role 
of placenta-derived mesenchymal stromal cells (pMSC) in the treatment 
of cardiac failure, as well as its survival after xenogenic transplantation in 
immunocompetent mice. pMSC were obtained from the chorionic plate of 
human term placenta, after enzymatic digestion. They were characterized 
as plastic-adherent and multipotent cells. Flow citometry analysis revealed 
they did not express hematopoietic (CD45, CD34, CD14, and HLA-DR) or 
endothelial cells markers (CD31 and CD133), but expressed bone marrow 
derived MSC-associated molecules (CD90, CD105, and CD73). pMSC also 
expressed pluripotency markers OCT-4, DMNT3b and KLF4, usually associ-
ated to embryonic stem cells, suggesting that their plasticity is superior to 
that of adult stem cells. Female C57Bl/6 mice were submitted to MI through 
permanent occlusion of the anterior descending coronary artery. Two weeks 
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after MI, mice were submitted to weekly intramyocardial injections, guided 
through echocardiography, of 105 pMSC or vehicle during 3 weeks. Func-
tional parameters were evaluated weekly by echocardiogram for 40 days 
after the beginning of treatment. We did not observe significant improve-
ment in ejection fraction, end systolic volume and end diastolic volume 
in the pMSC group, when compared to the vehicle group. pMSC stably 
transduced with a viral construct expressing the luciferase gene under the 
control of MSCV promoter were used in a bioluminescence assay. Cells were 
detected only at the injection site, suggesting that the injection method is 
accurate. p-MSC remained at injection site for 3 days after de first injection, 
but the survival period was reduced after the 2nd and 3rd injection, suggest-
ing immune rejection. Our study indicates that the p-MSCs transplantation 
does not contribute to improvement in cardiac performance, probably due 
to the short survival of the cells in the xenogenic setting.
Poster Board Number: 2422
EFFECTS OF DMSO ON GROWTH HORMONE, 
DIFFERENTIATION AND PLURIPOTENCY 
MARKER EXPRESSION IN HUMAN STEM CELL 
CULTURES
Boroduskis, Martins1, Parfejevs, Vadims1, Cakstina, Inese1, Nakurte, 
Ilva1, Riekstina, Una1, Pook, Martin2, Lubenets, Dmitri2, Krustins, 
Janis3, Ancans, Janis1
1Laboratory of Bioanalytical and Biodosimetry Methods, University of 
Latvia, Riga, Latvia, 2Institute of Molecular and Cell Biology, University 
of Tartu, Tartu, Estonia, 3Latvian Center of Plastic, Reconstructive and 
Microsurgery, Riga, Latvia
Development process of advanced therapy medicinal products for clinical 
trials can include a variety of approaches to modulate or increase therapeuti-
cal potential of cells. Stem cell modification with small molecular compounds 
can substantially change expression pattern of various genes, thus poten-
tially influence cell regenerative potential and clinical applicability. The aim 
of this study was to characterize adult human skin tissue and bone marrow 
derived mesenchymal stem cell (MSC) populations from different donors 
and H9 (WA09) hESC culture and to test influences of clinical grade cryo-
protectant DMSO on the expression levels of several cytokines, growth fac-
tors, their receptors and differentiation/ pluripotency markers. Experiments 
were carried out on cells cultured in the presence of 1-3% DMSO diluted in 
media for 48 hours. Dermal and bone marrow derived MSCs were charac-
terized for surface marker expression pattern (positive for CD73, CD90 and 
CD105; negative for CD45, CD14 and HLA-DR) and differentiation capacity. 
hESC (H9) were evaluated for the expression of pluripotency markers, cells 
were passed to the Matrigel coated plates before experiments. The fol-
lowing experimental methods were applied: real time PCR, cytochemistry, 
ELISA, FACS and HPLC. HPLC analysis demonstrated that DMSO remained 
chemically stable under cell culture conditions throughout the experiment. 
We also detected that DMSO had no influence on TERT gene expression 
and did not affect MSC surface marker expression pattern. DMSO did affect 
cell differentiation marker pattern, real time PCR showed significantly in-
creased expression for two osteogenic and adipogenic differentiation mark-
ers and decreased hondrogenic marker. Flow cytometry analysis showed 
that presence of 3% DMSO in growth medium of hESC caused significant 
decrease of pluripotency markers Oct3/4 and Nanog but had minimal effect 
on SSEA-4. Cytokine panel (IL-1α, IL-2, IL-4, IL-6, IL-10, IL-12, IFNγ and 
TNFα) expression was tested by PCR. Only IL-6 and IL-12 expression was 
detected in dermal MSC and DMSO treatment had no effect on this pattern. 
Dermal MSCs expressed growth factors SDF-1, FGF-2, VEGF and receptors 
FGF-R, VEGF-R but did not express CXC-R4. Presence of DMSO increased 
expression of FGF-2 and FGF-R over 4-fold, VEGF increased more than 10-
fold, but expression of VEGF-R and SDF-1 was decreased, reaching 4-fold 
reduction for SDF-1. Expression of the same growth factors was observed 
in bone marrow derived MSC cultures, which expressed also CXC-R4, and 
DMSO had similar influence on the expression pattern, except for VEGF 
that, in contrast, had decrease of expression (4-fold). ELISA assays con-
firmed corresponding profiles for secreted SDF-1 and VEGF in both tissue 
MSC cultures. This concept study indicates that high purity DMSO can exert 
profound effect on expression of several factors which may affect cell culture 
differentiation and regenerative potential. Therefore use of DMSO and other 
common and characterized small molecular compounds can be considered 
as useful approach for design of pre-clinical investigations and clinical trials 
of adult somatic cells.
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X-FACTOR DETERMINES THE INDIVIDUAL 
VARIATIONS IN THE THERAPEUTIC EFFICACY 
OF HUMAN UMBILICAL CORD BLOOD 
DERIVED MESENCHYMAL STEM CELLS
Lee, Eun Ju, Kang, Hyun-Jae, Lee, Sae-Won, Cho, Hyun-Jai, Park, 
Myoung Hee, Park, Young-Bae, Kim, Hyo-Soo
Seoul National University Hospital, Seoul, Korea, Republic of
Objectives- This study was designated to investigate the mechanism under-
lying the variations in hUCB-MSCs and their impact on therapeutic efficacy 
in MI model.  Background- There is paucity of information whether human 
umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) from 
separate donors might have different effects on improving myocardial repair 
after myocardial infarction (MI). Moreover, the underlying mechanism re-
mains elusive. Method and Results- In this study, we established and charac-
terized 4 hUCB-MSCs from 4 different donors. All four umbilical cord blood 
-derived cells expressed typical human mesenchymal stem cells (hMSC) 
specific immunophenotypes and immunosuppressive ability in the mixed 
lymphocyte reaction test. Furthermore, they showed similar morphology, 
proliferation and differentiation potency. However, hUCB-MSCs showed 
remarkable variations in the therapeutic efficacy repairing the infarcted rat 
myocardium 8 weeks after transplantation. To find the signature of the best 
hUCB-MSC in repairing the infarcted myocardium, we screened cell surface 
genes at RNA and protein levels. X-factor was the only cell surface gene 
which was highly expressed in the most efficient hUCB-MSC at RNA and 
protein levels. Furthermore, X-factor increased VEGF expression via ERK 
activation in hUCB-MSCs. The infarcted rat heart transplanted with hUCB-
MSCs showed human VEGF-positive hUCB-MSCs, human VEGF released 
from hUCB-MSCs bound to rat endothelial cells, and the enhanced capillary 
density in peri-infarct area. Conclusions- Human hUCB-MSCs showed a 
remarkable individual variation in repairing infarcted myocardium. X-factor 
could be used as a signature molecule in selecting hUCB-MSCs having a 
good therapeutic efficacy. 
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IMMUNOLOGICAL PROPERTIES HUMAN 
ADIPOSE-DERIVED MESENCHYMAL STROMAL 
CELLS UNDIFFERENTIATED AND PREVIOUSLY 
COMMITTED TO MYOGENIC PHENOTYPE
Vieira, Natássia, Assoni, Amanda, Gomes, Juliana P., Almeida, 
Camila, Secco, Mariane, Brandalise, Vanessa, Zucconi, Eder, 
Camargo, Maristela M., Zatz, Mayana
Human Genome Research Center Biosciences Institute - University of Sao 
Paulo, São Paulo / SP, Brazil
Progressive muscular dystrophies (PMD) are a group of disorders character-
ized by progressive degeneration of skeletal muscle caused by the absence 
or defective muscular proteins. The possibility to use cell therapy for the 
treatment of PMD has been investigated by many groups. We have recently 
shown that undifferentiated human adipose-derived stem cells (hASCs) can 
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differentiate into skeletal muscle when in contact with dystrophic muscle in 
vitro and in vivo; these cells were not rejected after systemic injection even 
without immunosuppression. However, surprisingly when these cells were 
injected systemically after being cultured in myogenic induced media no 
human cells were found in the host muscles. In order to better understand 
this observation we compared the effect of undifferentiated and myogenic 
committed hASCs on the proliferative function of mouse lymphocytes as 
a measure of the immune response (mixed lymphocyte culture). We also 
evaluated if the systemic injection of undifferentiated and myogenic com-
mitted hASCs modifies the function of the mouse lymphocytes. Our results 
confirm that undifferentiated hASCs are immune modulating cells but myo-
genic committed hASCs lose these properties and cause lymphocyte growth. 
These observations suggest that allogenic and xenotransplanted hASCs will 
not cause an immune response as long as they are undifferentiated which 
may have important applications for future therapy in patients with different 
forms of PMD. Supported by FAPESP-CEPID, INCT and CNPq.
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FUNCTIONAL PROPERTIES OF BONE 
MARROW MESENCHYMAL STEM CELLS FROM 
SPONTANEOUSLY HYPERTENSIVE RATS
Oliveira, Lucas F.1, Voltarelli, Julio C.2, Dias da Silva, Valdo Jose1
1Triangulo Mineiro Federal University, Uberaba, Brazil, 2School of Medicine 
of Ribeirao Preto/USP, Ribeirao Preto, Brazil
Mesenchymal stem cells (MSC), usually extracted from bone marrow, play 
several physiological roles, including angiogenesis induction. Taking into 
consideration the defective angiogenesis and microvascular rarefaction in 
systemic arterial hypertension (SAH), it could be hypothesized that MSCs 
could participate in the pathogenesis of SAH. The aim of the present study 
was to evaluate some functional aspects of bone marrow-derived MSCs in 
spontaneously hypertensive rats (SHR) comparing with normotensive control 
Wistar-Kyoto (WKY) rats. After confirmation of arterial blood pressure levels 
in age-matched (16-24 weeks) SHR and WKY rats, MSCs were extracted, 
cultured, phenotypically characterized by flow cytometry and submitted to 
some functional assays: a) colony-forming unit-fibroblastic (CFU-F) assay, b) 
proliferation assay, c) doubling populations in vitro assay and d) differentia-
tion assay in osteogenic and adipogenic lineages. Number of CFU-F from 
SHR was similar to that from WKY. MSCs proliferation analysis shows a 
great rise in cells number with the time, which was significantly lower in 
SHR, indicating a proliferative dysfunction of MSCs in SHR. According to 
doubling-population in vitro assay, MSC from SHR were doubled 27 times in 
culture, while MSCs from WKY were doubled 42 times until acquire senes-
cent phenotype. At the end, in vitro differentiation assay revealed a lower 
ability of MSCs from SHR to differentiate in osteogenic and adipogenic 
lineages. The results showed a functional deficit of bone marrow-derived 
MSCs from SHR. The possible mechanisms and eventual consequences of 
this functional deficit for the hypertensive state are not known and deserve 
intensive future investigation.
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BONE MARROW-DERIVED MESENCHYMAL 
STEM CELLS ATTENUATE PROGRESSION OF 
LATE STAGE CHRONIC KIDNEY DISEASE IN 
RATS
Alves, Angelica C.1, Capuano, Vanessa1, Voltarelli, Julio C.2, Dias da 
Silva, Valdo Jose1
1Triangulo Mineiro Federal University, Uberaba, Brazil, 2School of Medicine 
of Ribeirao Preto/USP, Ribeirao Preto, Brazil
In recent years, cell therapy with bone marrow-derived mesenchymal stem 
cells (BM-MSC) has been intensively investigated in a pre-clinical context 
using animal models of chronic kidney disease (CKD). However, BM-MSC 
administrations are performed in the first days or weeks after lesion in these 
animal models, which are not a good surrogate of real clinical conditions. 
Therefore, our aim was to investigate the effects of BM-MSC administration 
in remnant kidney model in a late-stage of the disease. Forty eight female 
12-16 weeks old Wistar Kyoto rats were divided in three groups: two of 
them were submitted to 5/6 nephrectomy to induce CDK (groups NX-VE, 
receiving vehicle and NX-MSC, receiving BM-MSC) and one group were 
submitted to a sham surgery (SHAM-VE). BM-MSC were extracted from fe-
mur and tibiae from donor male age-matched Wistar Kyoto rats (n=10) and 
cultivated in vitro on appropriated conditions. All animals were weekly fol-
lowed taking measures of systolic arterial pressure and heart rate by means 
of tail occlusion method. After 8 weeks, plasma and 24 hours urine samples 
were collected to measure creatinine clearance and proteinuria, and then 
animals were transplanted with 5 x 106 MSCs (NX-MSCs, n=8) or vehicle 
(NX-VE, n=12), while sham animals received vehicle (SHAM-VE, n=12). 
Five weeks after transplantation, all animal were submitted to baseline 
arterial pressure recordings followed by arterial baroreflex test and pharma-
cological blockade with atropine and propranolol to calculate sympathetic 
and parasympathetic tonus. After 24 hours, all animals, under anesthesia, 
were submitted to an endothelial function study measuring endothelium-
dependent and endothelium independent vasodepressor responses. At 
the ending, animals were sacrificed and organs like remnant kidney, heart, 
lungs, aorta, spleen and skeletal muscle were collected and stored in -80oC 
freezer. Morphological and morphometrical studies of remnant kidney were 
performed to measure nephron numbers, glomerular diameter, inflammatory 
infiltrate, glomerusclerosis and interstitial fibrosis. Our results demonstrated 
that BM-MSCs expressed positive markers for CD29 and were negatives 
for CD11b, CD34, CD31, CD45 e c-kit. In addition, these cells are able to 
differentiate in adipogenic and osteogenic lineages. During all study period, 
body weights were not different among groups while systolic pressure of 
NX-VE animals was higher than SHAM-VE animals and treatment with 
BM-MSC reduced systolic pressure in NX-MSC animals. These animals also 
presented improvement in renal function measured as reduction in plasma 
levels of urea and creatinine and proteinuria, as well as increase in creatinine 
clearance. Baroreflex sensitivity and autonomic tonus did not differ among 
groups. Endothelium-dependent vasodilation mediated by acetylcholine 
was significantly improved in NX-MSC when compared to NX-VE animals. 
Regarding to remnant kidney morphology, BM-MSC played a protective role 
preventing nephron loss and hypertrophy, as well as blunting inflammatory 
infiltrate and glomerular and intersticial fibrosis. In conclusion, BM-MSC 
transplantation, even in a later stage of CKD, was able to efficiently improve 
or delay progressive renal damage, possibly via their paracrine and immu-
nomodulatory effects, promoting significant improvements in renal function 
and structure. This cell therapy with BM-MSC could represent an efficient 
alternative for the treatment of CKD in a near future.
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MYOGENIC POTENTIAL OF MURINE 
MESENCHYMAL STEM CELLS FOR THERAPY IN 
PROGRESSIVE MUSCULAR DYSTROPHIES
Onofre-Oliveira, Paula C., Martins-Machado, Poliana, Lanzotti, 
Amanda, Almeida, Camila, Nogueira, Leticia, Calyjur, Priscila, Ayub-
Guerrieri, Danielle, Vainzof, Mariz
Human Genome Research Center - Biosciences Institute - University of Sao 
Paulo, Sao Paulo, Brazil
Human muscular dystrophies (MD) are a heterogeneous group of genetic 
disorders, caused by mutations in genes coding for sarcolemmal, sarcomeric 
and citosolic muscle proteins. Deficiencies or loss of function of any of 
these proteins lead to irreversible and progressive degeneration of skeletal 
muscles, resulting in a variable degree of weakness. Since no effective 
treatment is available for MD, mouse models for these diseases are valuable 
tools for testing putative cell therapies. Murine bone-marrow mesenchymal 
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stem cells (BM-MSC) and adipose tissue mesenchymal stem cells (ASC) are 
multipotent cell populations that show immunosuppressive properties, an 
important characteristic to be considered in their use for transplantation. The 
main objective of this study was to evaluate and compare the myogenic po-
tential of mesenchymal stem cells from these two different sources in vivo, 
in three different mouse models for dystrophy: Dmdmdx (total absence of 
dystrophin, model for Duchenne MD), Lama2dy2J/J (α2-laminin deficient, 
severe phenotype, model for congenital MD type 1A) and Largemyd (defect 
in glycosylation of α-DG, severe phenotype in older animals, model for con-
genital MD type 1D). Aiming to study homing and behavior of these cells 
under non-dystrophic conditions, normal C57Black mice were also injected. 
BM-MSC and ASC were isolated from eGFP-FVB/N mice and characterized 
by flow cytometry for stem cell markers before injections. 36 animals were 
injected weekly for one month through systemic intravenous delivery as 
followed: 22 animals injected with BM-MSC - 3 C57Black, 7 Dmdmdx, 6 
Largemyd and 6 Lama2dy2J/J and 14 mice injected with ASC - 4 C57Bl, 4 
Dmdmdx, 3 Largemyd, and 3 Lama2dy2j/J. The presence of donor cells at 
the host muscle was evaluated by PCR for the DNA of the eGFP construc-
tion and dystrophin protein expression was verified by western blotting. 
We found DNA of transplanted cells in 10 out of the 22 injected animals 
with BM-MSC (1 C57Bl, 4 Dmdmdx, 1 Largemyd and 4 Lama2dy2j/J) and 
in 8 of 14 mice treated with ASC (2 C57Bl, 3 Dmdmdx, 1 Largemyd and 2 
Lama2dy2j/J). These results show a proper engraftment of the normal cells 
in the target tissue both for hostile dystrophic environment as well as for the 
normal muscle after systemic delivery. Additionally, the injected cells were 
retained despite the known differences in MHC H2 haplotype of donor and 
receiver mice. Comparing the two sources, ASC showed a slightly better 
proportion of maintenance in comparison with BM-MSC (57% of retention 
versus 45%). However, both sources could be considered for cell therapy 
targeting muscular dystrophies, regarding cell retention. At the protein 
level, we could detect a small amount of dystrophin expression in the eGFP 
positive muscles from Dmdmdx mice, mainly the ones injected with ASC, 
suggesting thus that this source possibly presents a better myogenic poten-
tial. Complementary additional studies, which are currently underway, are 
necessary to improve the amount of expressed muscle proteins leading to an 
enhanced therapeutic effect. FAPESP-CEPID, CNPq-INCT, FINEP, ABDIM.
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ROLES OF MATRIX METALLOPROTEINASE 
AND MESENCHYMAL STEM CELL THERAPY IN 
ISCHEMIC STROKE
Nam, Hyo Suk1, Lee, Bo Hyung1, Kwon, Il1, Park, Eunjeong2, Heo, Ji 
Hoe1
1Department of Neurology, Yonsei University College of Medicine, Seoul, 
Korea, Republic of, 2Computer Science and Engineering, Seoul National 
University, Seoul, Korea, Republic of
In the ischemic stroke, beneficial mechanism of mesenchymal stem cells 
(MSC) is largely unknown. Neurogenesis, angiogenesis, neuroprotection, 
and activation of endogenous neurorestorative processes had been sug-
gested. Matrix metalloproteinases (MMPs) are zinc-dependent endopep-
tidases and they can destruct extracellular matrix. Detrimental effects of 
MMPs are well known after ischemic stroke. MMPs is strongly associated 
with the hemorrhagic transformation, edema formation and thrombolytic 
failure in the ischemic stroke. Recent reports showed that MMPs have a 
role in the recovery phase after stroke. Moreover, bone marrow-derived 
cell is a major supplier of MMP and crucial for vascular endothelial growth 
factor (VEGF) induced angiogenesis. This study sought the roles of MMPs in 
MSC therapy after ischemic stroke and the best time of MSC injection. The 
experiments were conducted through two phases. In phase 1, we searched 
the appropriate injection time of human MSC (hMSC) after middle cerebral 
artery occlusion (MCAO). The injection was performed to male Sprague-
Dawley rats at three different time points (1 hr, 1 day, or 3 days). In phase 
2, the serial changes of neurological improvements, activities of MMPs and 
infarction volumes after hMSC or vehicle injections were investigated. In 
phase 1, hMSC injection at 1 hr after MCAO group showed marked neuro-
logical improvement in the rotarod tests (p = 0.023) and Longa score (p = 
0.018). The activities of MMP-2 was increased in the 1 hr hMSC injection 
group compared with control (3130 ± 1807 vs. 1087 ± 579, p = 0.028), 
whereas MMP-9 levels were not different between hMSC injection and 
control groups. In phase 2 experiments, the group of hMSC injection at 1 
hr after MCAO showed significant neurological improvement on rotarod 
test (p = 0.027) and Neurological Severity Score (p =0.001) compared with 
vehicle injection rats. In gelatin zymography, the MMP-2 activities at 1 day 
were higher in the hMSC groups than the control (828 ± 119 vs. 360 ± 203, 
p= 0.002). No difference of MMP-9 activity was detected. The Infarctions 
volumes were not different between the hMSC-treated rats and control (p 
= 0.625). In this study, a favorable neurological outcome after the hMSC 
injection was shown, particularly after earlier injection of hMSC. Higher 
MMP-2 level was noted in the 1 hr hMSC injection after MCAO. Neurologi-
cal improvements without reduction of infarction volumes may suggest that 
the beneficial effects of hMSC are related from the increased plasticity. The 
brain plasticity may be associated with earlier MMP-2 elevation after hMSC 
injection in the ischemic stroke.
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EVALUATION OF GENE TRANSFERRING 
EFFICIENCY VIA PAMAM G6 DENDRIMER AS 
A GENE PORTER TO MESENCHYMAL AND 
EMBRYONIC STEM CELLS
Pourasgari, Farzaneh1, Nomani, Alireza2, Hafizi, Maryam3, 
Soleimani, Masoud4, Massumi, Mohammad5
1Department of molecular biology and genetic engineering, Stem Cell 
Technology Research Centre, Tehran, Iran, Islamic Republic of, 2Faculty of 
Pharmacology, Tehran University of Medical Sciences, Tehran, Iran, Islamic 
Republic of, 3Department of stem cell biology, Stem Cell Technology 
Research Centre, Tehran, Iran, Islamic Republic of, 4Department of 
Hematology, Tarbiat Modares University, Tehran, Iran, Islamic Republic of, 
5Department of Tissue engineering, Tehran University of Medical Sciences, 
Tehran, Iran, Islamic Republic of
Gene transfer to stem cells is still one of the challenging issues in the field. 
Although, the best transduction efficiency is resulted from viral gene trans-
duction, but the remnant viral genome can impair the physiology of infected 
cells and in some cases it may cause mutagenesis. In the other hand, for ef-
ficient gene transfer via electroporation, the cells must be dissociated by en-
zymes which can irreversibly damage the aggregation and in turn survival of 
human embryonic and induced pluripotent stem cells. Given the mentioned 
obstacles, non-viral gene transfer by chemical vehicle, may still attend as an 
alternative approach for gene transferring to stem cells. In present study, 
the efficiency of polyamidoamine (PAMAM) G6 dendrimer, as a chemical 
gene porter, was assessed in gene transferring to mesenchymal (MSC) and 
embryonic stem cells (ES) and the efficiency was compared to lipofectamine. 
To achieve this goal, a GFP-containing plasmid was trandfected to stem cells 
using PAMAM G6 denderimer or lipofectamine. Three days after, the num-
ber of GFP positive stem cells was quantified by flow cytometry. The result 
showed PAMAM G6 has more transfection efficiency than lipofectamine 
in gene transferring to MSC, whereas in ES cells, the lipofectamine showed 
better transfection results. Cytotoxicity studies by MTT revealed that PA-
MAM G6 dendrimer has lower cytotoxicity than lipofectamine in transfected 
MSC but in contrary, it showed a higher cytotoxicity in ES cells. Taking into 
account the above results with the cheap cost of PAMAM G6 dendrimer, our 
study pointed PAMAM G6 as a promisimg carrier for gene transferring into 
mesenchymal and embryonic stem cells.
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MURINE MESENCHYMAL STEM CELLS HAVE 
A DISTINCT PROTEIN ISOFORM SIGNATURE 
FROM THAT OF NON-MULTIPOTENT STROMA.
Rosu-Myles, Michael D., She, Yi-Min, Walrond, Lisa, Muradia, 
Gauri, Cyr, Terry
Biologics and Therapeutics Directorate, Health Canada, Ottawa, ON, 
Canada
Cell function is often controlled by dynamic changes in the expression of 
different protein isoforms. In the current study, we utilized C57Bl/6 mouse 
bone marrow stromal cultures, together with quantitative mass spectrom-
etry (MS/MS), to identify protein isoforms that may play a role in regulat-
ing the proliferation, differentiation and immune suppressive functions of 
mesenchymal stem cells (MSC). Proteins isolated from the nucleus and 
cytoplasm of stem cell enriched (CD105+) and depleted (CD105-) stromal 
cells were labelled with either deuterated or non-deuterated formaldehyde 
and analyzed by liquid chromatography MS/MS. Quantitative comparison 
of 123 protein isoforms was completed between the two cell populations. 
Thirty-four isoforms were identified that were expressed at two-fold greater 
or lower levels in MSC. Where possible, proteomic analysis was verified 
by western blotting and was demonstrated to be divergent from the level 
of gene transcription detected for certain proteins. Our analysis provides a 
protein isoform signature specific to MSC and a basis for understanding the 
protein pathways involved in the regulation of these therapeutically relevant 
stem cells.
Poster Board Number: 2440
SSEA-4 IS NOT A MARKER OF MESENCHYMAL 
STEM CELLS IN CULTURE.
Rosu-Myles, Michael D., McCully, Jennifer, Mehic, Jelica
Biologics and Therapeutics Directorate, Health Canada, Ottawa, ON, 
Canada
Bone marrow derived stromal cultures contain multipotent mesenchymal 
stem cells (MSC) that can initiate tissue repair and suppress the immune sys-
tem. Consequently, the therapeutic efficacy of stromal cultures are currently 
being tested in clinical trials for a wide range of diseases and tissue damage. 
The identification of markers that discriminate MSC from non-multipotent 
stroma would provide a means for determining the efficacy of these cultures 
prior to therapeutic use. The goal of the present study was to determine 
whether SSEA-4, a known marker of MSC in vivo, is expressed on multi-
potent stromal cells in vitro. Standard and serum free stromal cultures were 
created from the bone marrow of 4 separate donors and characterized for 
SSEA-4 expression and multipotent differentiation potential. The proportion 
of SSEA-4 expressing (SSEA-4pos) cells varied from 9% to 89% in both the 
presence and absence of serum. Purified SSEA-4pos and SSEA-4 non-
expressing (SSEA-4neg) cells were each capable of differentiating into fat, 
bone and cartilage and showed no difference in proliferating potential over 
a 60 day culture period. After 7-10 days, cultures derived from either puri-
fied population consisted of a mixture of both SSEA-4pos and SSEA-4neg 
cells at proportions similar to that found in the original culture. To provide a 
quantitative comparison of MSC, clonal cultures are currently being derived 
from SSEA-4pos and SSEA-4neg cells and characterized in multipotent dif-
ferentiation assays. Our data demonstrate a divergence between the SSEA-4 
phenotype of MSC in vivo compared to in vitro, suggesting that SSEA-4 
expression will not provide a suitable marker for measuring the medicinal 
component in therapeutically relevant stromal cultures.
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STROMAL CELLS IN AMNIOTIC FLUID: 
EVIDENCE FOR DERIVATION BY EPITHELIAL TO 
MESENCHYME TRANSITION
Wilson, Patricia G.1, Winter, Allison2
1Institute for Regenerative Medicine, Wake Forest University, Winston 
Salem, NC, USA, 2Wake Forest University School of Medicine, Wake Forest 
University, Winston Salem, NC, USA
Neural damage due to trauma, disease and aging limits the quality of life for 
millions worldwide. Mesenchymal stromal cells (MSCs) have garnered sig-
nificant interest in regenerative medicine as a source of trophic support for 
self-repair and immunomodulation of the damaging effects of inflammation. 
Long lived stromal cells in amniotic fluid (AF) resemble MSCs derived from 
bone marrow (BMMSC); both cell types differentiate into connective tissues 
such as fat, bone, and cartilage and express a broad spectrum of trophic fac-
tors, cytokines, and immunomodulatory proteins. Neither the source of cells 
in AF nor the precise identity of the AF cell types responsible for BMMSC-
like activities is well established. Motivation for the current study was to 
determine 1) the source of stromal cells in AF and 2) to determine whether 
trophic activity is limited to specific clonal lineages. We first generated clonal 
lines by simple dilution (1:10 - 1:500) of 4 uncultured amniocentesis samples 
in multiwall plates; 43 independent clonal lines expanded from a single point 
source. Clonal populations were classified by phase microscopy as either 
stromal-like or epithelial-like. Selected epithelial-like clones failed to prolifer-
ate beyond 10-12 passages. While the proliferative capacity of stromal cell 
populations declined over time, representative lines could be maintained for 
15 to 30 passages before senescence. Total RNA was isolated from repre-
sentative clones of stromal cells, epithelial cells and the previously estab-
lished A1AFS cell line of MSC-like cells. A preselected set of genes encoding 
growth factors, cytokines and immunomodulatory proteins were assayed 
by ABI microfluidics gene arrays and validated by individual ABI TaqMan 
assays. Transcript profiles showed differences between lines, but all lines 
tested expressed a broadly overlapping range of factors that could promote 
self-repair. We developed a neural cell-based assay to correlate transcript 
profiles with cell-based trophic activity; proliferating cultures of neural 
progenitors were generated from our ChM5 iPS cells, a fully validated and 
vector-free line of induced pluripotent stem cells. In the absence of extrinsic 
neurotrophic factors and mitogens, neural progenitors cease proliferation 
and differentiate into neurons. Media conditioned by stromal cell clones, 
but not epithelial cell clones, improved viability of neurons in differentiating 
cultures of neural progenitors in comparison to comparably aged control 
media, suggesting that trophic support may be an activity of stromal cells. 
Given that MSCs can be generated by epithelial to mesenchmal transitions, 
this same set of stromal cell clones and BMMSCs were evaluated by iim-
munostaining for markers of stromal and epithelial cell types. Immunostain-
ing showed profiles typical of MSCs, but a subset of stromal cell clones also 
showed epithelial cell characteristics, including extensive networks of keratin 
as well vimentin and E-cadherin. Together with other studies, these findings 
raise the question of whether AF-derived populations can reflect epithelial to 
mesenchyme transitions of cells released from epithelial exposed to amniotic 
fluid. Given the results of our neural cell based assays, our results further 
suggest that the source of stromal cells may not be critical for trophic activ-
ity.
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MESENCHYMAL STEM CELL DIFFERENTIATION
Poster Board Number: 2444
HUMAN INDUCED PLURIPOTENT STEM 
CELLS DIFFERENTIATE INTO OSTEO- AND 
CHONDROGENIC PROGENITORS
Chilton, Jamie M.1, Hodges, Kathryn S.1, McCabe, Jessica A.1, 
Galland, Kimberly L.1, Mumaw, Jennifer L.2, Jordan, Erin T.2, Levey, 
Natalie H.2, West, Rachel C.2, Raines, Andrew L.3, Stice, Steven L.2
1ArunA Biomedical Inc, Athens, GA, USA, 2University of Georgia, Athens, 
GA, USA, 3Georgia Institute of Technology, Athens, GA, USA
Multipotent human mesenchymal stem cells (MSCs) have been identified 
as promising candidates for advancing drug discovery and cellular therapy 
strategies, especially for the correction of disorders of orthopedic origins. 
Characterized by fibroblast-like morphology and isolated from multiple 
sources like adult bone marrow, adipose tissue and umbilical cord blood, 
human MSCs are typically distinguished by their ability to differentiate along 
multiple pathways including osteogenic, chondrogenic and adipogenic 
lineages. Despite their broad potential, MSCs pose significant problems for 
the researcher, including: 1) surgical procedure required for initial patient 
harvest; 2) variability in starting population; 3) limited lifespan in vitro; 4) 
loss of multilineage capacity soon after continued propagation; and 5) het-
erogeneous multilineage differentiation potential depending on tissue and 
donor source. Hence, developing homogeneous cultures of mesenchymal-
like cells derived from induced pluripotent stem cells (iPSCs) will circumvent 
the drawbacks of adult MSCs and offer a theoretically limitless supply of 
genetically identical and patient-specific stem cells. Derived from repro-
grammed adult somatic cells, iPSCs are indistinguishable in their epigenetic 
state and developmental potential from blastocyst-derived embryonic stem 
cells (ESCs). However, the capacity of iPSCs to differentiate into thera-
peutically relevant and functional cell types in comparison to ESC-derived 
cell types and adult stem cell sources is largely uninvestigated. Here we 
generated human iPSCs by transducing IMR-90 human lung fibroblasts with 
lentiviral vectors encoding 6 pluripotency factors, OCT3/4, NANOG, SOX2, 
KLF4, LIN28, and c-MYC. In these studies we induced iPSCs to differentiate 
in vitro into mesenchymal-like cells and derivative phenotypes using ArunA’s 
unique culture system. Resulting progenitor cells were characterized by flow 
cytometry, real-time PCR and then assayed for differentiation potential in 
comparison to hESC-derived progenitors and bone marrow and umbili-
cal cord sources of MSCs. We found that the morphology, time frame for 
differentiation and marker expression of iPSC-derived progenitors is similar 
to hESC-derived progenitors for mesenchymal differentiation in vitro. Inter-
estingly, we also found that iPSC-derived progenitors mimic umbilical cord 
MSCs in their lineage potential, showing a greater capacity for osteogenic 
differentiation in contrast to bone marrow MSCs with higher adipogenic 
capabilities. Our results show ArunA’s culture system enables the large-scale 
production of an osteo/chondrogenic lineage-restricted cell line from iPSCs, 
capable of being maintained as robust, adherent monolayer cultures for 
multiple passages, with distinctive utility for future orthopedic regenerative 
medicine applications.
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BORTEZOMIB PROMOTES OSTEOGENIC 
DIFFERENTIATION OF HUMAN MESENCHYMAL 
STEM CELLS
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Sciences, Faculty of Medicine, Thammasat University, Pathumthani, 
Thailand, 4Division of Hematology, Department of Medicine, Faculty of 
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Human mesenchymal stem cells (hMSCs) are multipotent cells which pos-
sess the osteogenic differentiation potential that could be used for bone 
and cartilage reconstruction. During the past few years, drug targeting of 
adult stem cells has been proposed as a strategy for regenerative medicine, 
but the use of such strategy to augment the osteogenic differentiation of 
hMSCs is still poorly explored. It has evidence that the proteasome inhibitor 
Bortezomib (BZB) (a chemotherapeutic drug which is approved for treating 
patients with multiple myeloma) could induce the differentiation of mouse 
MSCs toward osteocyte lineages. In this study, we have studied the effects 
of BZB on the osteogenic differentiation process of hMSCs. The isolated hM-
SCs from bone marrow expressed typical MSC markers, being positive for 
CD105, CD90 and CD73, and negative for CD45 and CD34 and were able 
to differentiate to osteocytes and adipocytes in vitro. The results showed 
that 1-2 nM BZB promoted osteogenic differentiation of hMSCs as indicated 
by the level increasing of alkaline phosphatase (ALP) activity and the up-reg-
ulation of early osteogenic marker genes, such as runt DNA-binding domain 
transcription factor-2 (RUNX2) compared with controls. Moreover, after 28 
days, BZB could trigger the matrix mineralization processes of hMSC-derived 
osteocytes (a crucial step towards the formation of calcified extracellular 
matrix associated with functional bone) as evidence by the positive increas-
ing of Alizarin Red S staining and the up-regulation of osteocalcin (OCN) 
gene in comparison to controls. In summary, these results suggest that BZB, 
an anti-cancer drug, could induce the osteogenic differentiation of hMSCs 
and might have a potential to be used in several clinical applications, such as 
tissue engineering and cell-based therapy in the near future.
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POLYAMINES PROMOTE OSTEOGENIC 
DIFFFERENTIATION OF HUMAN BONE 
MARROW-DERIVED MESENCHYMAL STEM 
CELLS
Lee, Mon-Juan1, Huang, Yuan-Pin2, Hsu, Ja-Ruei1, Chen, Chi-Yuan1
1Department of BioScience Technology, Chang Jung Christian University, 
Tainan, Taiwan, 2Department of Chemical and Materials Engineering, 
Cheng Shiu University, Kaohsiung, Taiwan
Polyamines are organic polycations that are derived from amino acids. These 
molecules of low molecular weight are ubiquitous in all organisms, and are 
essential for cell proliferation and differentiation. Eukaryotes contain the 
three common polyamines, putrescine, spermidine, and spermine, while in 
bacteria, the principal polyamines are putrescine, cadaverine and spermidine, 
but a large range of uncommon polyamines also exists. Several early studies 
have implicated the relationship of polyamines to the growth and develop-
ment of bone and cartilage. More recently, spermine was shown to promote 
osteogenic differentiation of goat mesenchymal stem cells. Nevertheless, 
the mechanisms underlying the osteogenic potential of polyamines remain 
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unclear. In this study, we found that all three of the common eukaryotic 
polyamines, putrescine, spermidine, and spermine, were capable of promot-
ing osteogenic differentiation of human bone marrow-derived mesenchymal 
stem cells (hBMSCs). Extracellular matrix mineralization, a marker for os-
teoblast maturation, was enhanced in the presence of polyamines. Besides, 
alkaline phosphatase activity and the expression of osteogenic genes, such 
as BMP2, Runx2, osteopontin and osteocalcin, were up-regulated, suggest-
ing that polyamines may promote osteoblastogenesis of hBMSCs through 
BMP2- and Runx2-related pathways. Developing new drugs to enhance 
osteogenesis is crucial in orthopedic research. Currently, the only drug used 
clinically to stimulate bone formation is parathyroid hormone (PTH), which 
possesses the risk of inducing osteosarcoma. Studies on polyamines as novel 
osteogenic inducers not only help to explore the mechanism of their osteo-
genic activity and their efficacy in the treatment of skeletal disorders such 
as osteoporosis, but also accelerate the development of polyamine-derived 
new drugs that stimulate bone formation.
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OSTEOBLAST DIFFERENTIATION OF HUMAN 
AMNIOTIC FLUID-DERIVED STEM CELLS 
IRRADIATED WITH VISIBLE LIGHT
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Cells have been recognized to be sensitive to visible light, although most 
of research introduced light-activated channels or enzymes into the cells 
genetically for the investigation of effect of visible light on the cell func-
tion. There are also several studies that investigated the effect of light on 
the regulation of cell functions of native cells (e.g., genetically unchanged 
cells). However, there are only few studies to investigate the effect of light 
irradiation on stem cells. Here we repot effect of light irradiation of visible 
light on the expression of pluripotent genes (Oxt-4, Sox2, and Nanog) in 
human amniotic fluid-derived stem cells (hAFSCs) and on the osteogenic 
differentiation ability of hAFSCs under light irradiation from light emitting 
diode (LED) having several wavelength of light, blue (470 nm), green (525 
nm), yellow (600 nm), and red (630 nm) light at 0-2 mW/cm2. Pluripotent 
gene expression in hAFSCs was upregurated by the irradiation of visible 
light (blue, green, and yellow light) from LED more than 6 hours, while no 
enhanced expression of pluripotent genes in AFSCs under irradiation of red 
light was observed. Green light irradiation to hAFSCs upregulated the pluri-
potent genes significantly than irradiation of blue, yellow and red light. Light 
irradiation of specific wavenumber is found to be important to upregulate 
the pluripotent genes in hAFSCs.The osteogenic differentiation of hAFSCs 
was evaluated in differentiation medium of osteoblasts under irradiation of 
LED light for 0 or 48 hr to investigate the effect of light irradiation on the 
osteogenic differentiation of hAFSCs from alizarin red S staining (calcium 
deposition), alkali phosphatase activity (early osteoblast marker), and gene 
expression of osteopontin (late osteoblast marker). It was found that alkali 
phosphatase activity and alizarin red S staining area as well as the gene 
expression of osteoblast differentiation marker in hAFSCs increased when 
blue light was irradiated on AFSCs at light intensity more than 1 mW/cm2. 
Therefore, the intensity of light irradiation on AFSCs was fixed to be 1 mW/
cm2 in the following experiments. The osteogenic differentiation of hAFSCs 
was significantly facilitated by green and blue light irradiation from LED, but 
not significantly by red and yellow light. Light irradiation of specific wave-
number is found to be important to facilitate the osteogenic differentiation 
of hAFSCs. One possible mechanism for the facilitated differentiation of 
hAFSCs into osteoblasts by irradiation of visible light is mediated by reactive 
oxygen species (ROS), which have been shown to be secondary messengers 
in cell signal transduction. Therefore, we have evaluated the differentiation 
ability of hAFSCs into osteoblasts irradiated by blue light (24hr, 1 mW/cm2) 
under existence of free radical scavenger in the differentiation mediumin. 
The facilitated differentiation into osteoblasts by irradiation of visible light 
was found not to be mediated by ROS, because alkaliphosphatase activ-
ity and gene expression of osteopontin did not change significantly among 
hAFSCs in the differentiation medium with and without scavenger (vitamin 
C). The mitogen-activated protein kinase (MAPK)/extracellular signal-regu-
lated protein kinase (ERK), MAPK/ERK pathway as well as other unknown 
signal pathways should be responsible for the activation of signal pathways 
for the facilitated differentiation of hAFSCs into osteoblasts on light irradia-
tion.
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HUMAN AMNIOTIC FLUID STEM CELLS CAN 
FUNCTIONALLY DIFFERENTIATE ALONG 
SMOOTH MUSCLE LINEAGE
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Introduction - In order to create a biocompatible tissue to replace absent 
or damaged organ, the generation of a functional smooth muscle (SM) 
layer is essential. In our study we aimed to derive functional SM cells from 
human Amniotic Fluid Stem (hAFSC) cells. Materials and Method - Clonal 
lines were generated by limiting dilution from c-kit+ hAFSC. Differentiation 
towards SM lineage (SMhAFSC) was obtained using a medium conditioned 
by PDGF-BB and TGF-b1 addition. hAFSC were transduced using vectors 
encoding both ZsGreen and DsRed respectively under the aSMA and MHC 
promoter. qPCR was used to evaluate aSMA, desmin and calponin and 
smoothelin expression. Immunofluorescence was performed for a-SMA, 
desmin, smoothelin, CD31 and pancytokeratine. To better understand 
ultrastructural features, Transmission Electron Microscopy (TEM) analysis 
was also carried out. Cells were analysed by cytofluorimetry and time-lapse 
analyses under carbachol/atropine were performed to evaluate single cell 
contractility. Ultimately calcium activated potassium channels were assessed 
by patch-clamping and functionality was validated by collagen lattice assay 
(CLA). Results - SMhAFSC expressed significantly higher level of aSMA, 
desmin and calponin transcripts after selective culture condition. These 
features were confirmed by immunofluorescence, demonstrating a single 
lineage commitment. TEM confirmed increased intermediate filaments, 
dense bodies and glycogen deposits in SMhAFSC. Sequential imaging 
analyses demonstrated that SMhAFSC have a higher contractile potential 
than hAFSC. Consecutive single cell sampling showed the presence of 
voltage-dependent calcium activated potassium channels on differentiated 
SMhAFSC, which are sensitive to tetraethilammonium blockade, inhibited by 
angiotensin II and activated by carbachol (as in functional SM cells). By con-
trast undifferentiated hAFSC did not respond to mediators. Lastly SMhAFSC 
confirmed an enhanced contractility by CLA. Conclusion - hAFSC under 
selective cultural conditions are able to give rise to functional SM cells and 
transduction represents a valuable tool to select SM committed population. 
This step may eventually overcome the well-known problem of expanding 
SM progenitors, making these cells amenable to tissue engineering.
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COMPARATIVE CHARACTERIZATION OF 
MULTIPOTENT CELLS ISOLATED FROM HUMAN 
AMNIOTIC MEMBRANE AND PLACENTA
Huang, Hsing-I1, Chan, Shu-Hui2, Wu, Chung Zu1, Song, Jheng-Da1
1Chang Gung University, Kwei-Shan Tao-Yuan, Taiwan, 2Cathay General 
Hospital, Hsi-Chih Taipei, Taiwan
Fetal tissues such as placenta, cord, and amnion are temporary tissues in 
supporting fetus development during pregnancy. Recently, we isolated the 
multipotent stem cells from human term placenta (hPDMCS) and showed 
these progenitors were with plasticity in differentiating toward multiple lin-
eage cells. We were wondering whether other fetal tissues such as amniotic 
membrane contain multipotent progenitors. Trypsin-EDTA disassociated 
amnion cells were cultivated and isolated through the abilities in adhering 
to plastic surface. Some colony-forming fibroblastic cells were observed s 
on the bottom of culture vessels. Our results demonstrated these cells were 
with the differentiation abilities even after 30 passages. In this study, we 
compared the properties and differentiation potentials of placenta- and am-
niotic membrane-derived progenitors. Both progenitors were with fibroblast-
like morphologies and positively expressed CD90, CD105, SH3, SH4, CD29, 
CD44, STRO-1 and absent for CD45 and CD34. In contrast to placenta-
derived progenitors, the immunofluorescent staining results revealed that 
c-Met could not be detected on amniotic membrane-derived cells. The 
differentiation assays showed both stem cell populations were capable in 
differentiating toward adipocytes and osteocytes. However, the hepatic dif-
ferentiation experiments showed the amniotic membrane isolated progeni-
tors were able to convert to hepatocyte-like cells which could be positively 
stained by anti-Hep Par1 antibodies. According to our results, progenitors 
derived from amniotic membrane and placenta shared similarities on their 
immunophenotypes and possess comparable differentiation capabilities.
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Understanding the molecular mechanisms that regulate cellular proliferation 
and differentiation is a central theme of developmental biology. MicroRNAs 
(miRNAs) are a class of regulatory RNAs of approximately 22 nucleotides 
that post-transcriptionally regulate gene expression. Increasing evidence 
points to the potential role of miRNAs in various biological processes. Cell 
fate is likely to be controlled by an elaborate orchestration of multiple 
signaling pathways. In a previous study, we reported the development of 
cardiogenic cells from rat MSCs activated by phorbol myristate acetate 
(PMA), a PKC activator, which exhibited high expressions of cardiac-specific 
markers (cTnT, MHC, MLC) and Ca2+ homeostasis-related proteins. Here 
we confirmed that cardiogenic differentiation led to in PMA-treated human 
mesenchymal stem cells (hMSCs). We found that miR-181a down-regulates 
the expression of PKC by targeting sequences in the 3’UTR of PKC mRNA. 
The overexpression of miR-181a regulates expression of PKC which are 
involved in cellular processes linked to differentiation. To investigate the 
role of miR181a in differentiation, hMSCs were transfected with miR181a 
mimic. cTnT expression level is not exchange in miR-181a transfected cell, 
indicates that the ectopic expression of miR-133a maintains MSC properties, 
whereas the miR-181a inhibitor increase cTnT, MHC and MLC expression. 
We conclude that miR-181a has major roles in cardiac differentiation though 
direct targeting of PKCs genes.
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MicroRNAs (miRNAs) are short non-coding RNA molecules that fulfill a 
variety of biological functions by negatively regulating gene expression. 
Critical regulation of protein expression is important for controlling the 
balance between self-renewal and differentiation in stem cells and cellular 
processes are regulated by an elaborate orchestration of multiple signaling 
pathways. H-89 (PKA inhibitor) inhibit cAMP/Protein kinase A (PKA) path-
way leading to suppress phosphorylation of cAMP response element binding 
(CREB) family of transcription factors. We have shown previously that H-89 
induced the chondrogenic differentiation of rat mesenchymal stem cells 
(MSCs). Here, we confirmed the involvement of H-89 in the chondrogenic 
differentiation of hMSCs and found that miR-23b induce chondrocyte dif-
ferentiation through down-regulation of PKA signaling. To determine the 
relation of miR-23b and PKA in chondrogenic differentiation, we examined 
that miR-23b expression on H-89-treated hMSCs by real time-PCR and that 
effect of miR-23b on PKA regulation by western blot analysis. MiR-23b is 
up-regulated upon chondrogenic differentiation by H-89 and overexpression 
of this miRNA on hMSCs decreased protein levels of PKA and p-CREB. Re-
porter gene analysis was confirmed the functionality of the miR-23b target 
in the 3’-untranslated region of PKA mRNA. Finally, we detected signifi-
cantly increased chondrogenic phenotype on miR-23b transfected hMSCs 
using measuring absorbance of Alcian blue and expression of aggrecan, a 
chondrocyte marker. Also, integrin α5β1, fibronectin, and N-cadherin were 
down-regulated in miR-133a transfected hMSCs. These results indicate that 
miR-23b contributes to the regulation of chondrogenic differentiation by 
negatively inhibition of PKA signaling.
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MicroRNAs function as negative regulators of gene expression by inhibit-
ing the translation or promoting the degradation of target mRNAs, having 
major roles in cellular differentiation. Cell fate is likely to be controlled by an 
elaborate orchestration of multiple signaling pathways. We found miR-26a 
to be highly overexpressed in during differentiation. To investigate the role 
of this miRNA in differentiation, human mesenchymal stem cell (MSC) were 
transfected with miR-26a mimic. Overexpression of miR-26a led to the 
expression of CD31, an endothelial specific marker, which was similar to that 
induced by SB216763 in human MSCs. Also, SB216763 increased mRNA 
level of eNOS, VCAM-1, VE-cadherine and VEGF-R2, endothelial specific 
markers. One of the predicted downregulated miR-26a targets was glyco-
gen synthase kinase 3β (GSK-3β), target of SB216763, which is involved in 
cellular processes linked to either proliferation or differentiation. GSK-3β was 
experimentally validated as a direct target of miR-26a, and siRNA-mediated 
inhibition of this mRNA alone resulted in expression of CD31, VE-cadherine 
and VEGF-R2. Moreover, we show that miR-26a could be stabilized 
β-catenin by overexpression of this miRNA. We conclude that miR-26a has 
major roles in the process of mesenchymal stem cell differentiation through 
direct targeting of GSK-3β, which induces the downregulation of β-catenin.
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MicroRNAs (miRNAs) are known to cause translation inhibition or degrada-
tion of targeting mRNAs, as important posttranscriptional regulatory roles. 
miRNAs play essential roles in cell fate through multiple signaling pathway 
by a delicate orchestration. Among various miRNAs, we found miR-133 to 
be involved in cardiac differentiation and investigated the roles of miR-
NA-133 transfecting with miR-133 mimic to human mesenchymal stem cells 
(MSCs). The overexpression of miR-133 by transfection of mimic increased 
the mRNA expression level of a cardiac-specific markers (cardiac Toroponin 
T; cTnT, myosin light chain; MLC, myosin heavy chain; MHC, atrial natriuret-
ic peptides; ANP, brain natriuretic peptide; BNP) similar to expression level 
of human MSC-treated by compound 56 (4-[(3-Bromophenyl)amino]-6,7-
diethoxyquinazoline), a specific inhibitor of the tyrosine kinase activity of the 
epidermal growth factor receptor (EGFR). EGFR was one of predicted miR-
133 targets as the target of compound 56 which is involved in the regulation 
of several cellular modifications leading to biological activity. We confirmed 
the target of miR-133 through luciferase assay and validated that the pro-
tein expression of EGFR is mediated by miR-133 mimic. Taken together, we 
conclude that EGFR is one of miR-133 targets and miR-133 has crucial roles 
in mediation of human MSC differentiation via targeting of EGFR.
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Use of mesenchymal stem cell (MSC) has emerged as a potential new treat-
ment for therapy to myocardial infarction; however, the poor viability of 
MSCs after transplantation critically limits the efficacy of this new strategy. 
MicroRNA-210 (miR-210) is induced by hypoxia and has an important role 
in cell survival under hypoxic condition. But role of miR-210 in regulation 
of MSC survival have yet to be delineated. Prolyl hydroxylase inhibitor dim-
ethyloxalyglycine (DMOG) treatment increased hypoxia inducible factor-1 
(HIF-1) protein level and expression level of miR-210 in MSCs, respectively, 
by western blot analysis and real time-PCR. To investigate effect of miR-
210 in HIF-1 - induced MSC survival, MSCs were treated with DMOG, in 
absence or presence overexpression of miR-210 mimics. Enforced expression 
of miR-210 significantly inhibited survival of MSC and induced cell cycle 
arrest in G0/G1, compared with control miRNA. We identified an E2F family 
member E2F3 as targets of miR-210 through assessed activity luciferase 
reporter construct containing the 3’ UTR of E2F3 and expression of E2F3. 
Transcription factor E2F3 regulates the progression of cell cycle, influence on 
cell proliferation and survival. The cell transfected with siRNA against E2F3, 
cell death and cell cycle arrest was increased. These data demonstrate that 
miR-210 have important role in survival of MSCs under hypoxic response.
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Bone marrow-derived mesenchymal stem cells (MSCs) possess multi-lineage 
differentiation potentials and have the ability to repair and rebuild injured 
vessels. MicroRNAs (miRNAs) are non-coding RNA molecules that regulate 
a subset of target genes involved in cell differentiation and specific cell func-
tion through posttranscriptional modulation. A number of studies have dem-
onstrated that GSK-3β plays a critical role in several cellular processes, such 
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as differentiation, growth, and apoptosis. Here, we described a novel miRNA 
that were identified by cloning from human MSC and cancer cell. Among 
these novel miRNAs, we identified binding site of 3 novel miRNA within 
GSK-3β 3’ UTR through sequence based analysis. Using luciferase assay, we 
identified one specific novel miRNA is direct target GSK-3β. Immunoblot 
analyses indicated that GSK-3β protein expression was dramatically de-
creased in hMSCs after transfection with this miRNA. To investigate the role 
of novel miRNA in differentiation, MSCs was transfected with novel miRNA 
mimic. Overexpression of miRNA led to a differentiated phenotype that 
was similar to that induced by SB216763 in human MSCs. The transfected 
cells showed a strong increase of expression of endothelial-specific mark-
ers (CD31, eNOS, VE-cadherin, VCAM-1, and VEGF-R2) and functional 
behavior of endothelial cells such as a formation of capillary-like structure. 
The differentiation of MSCs into endothelial-like cells by the treatment novel 
miRNA mimic was associated with GSK-3β/β-catenin signaling. In conclu-
sion, these results indicate that novel miRNA regulate differentiation into 
endothelial cells by inhibition of GSK-3β/β-catenin signaling pathway. Our 
work suggests amount miRNA greatly relatives in MSCs and their differen-
tiation into various fate.
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THE INFLUENCES OF NONYLPHENOL ON 
HUMAN AMNIOTIC FLUID-DERIVED STEM 
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The aim of this study is to explore the influences of Nonylphenol (NP) on 
human amniotic fluid-derived stem cells (AFSCs). Amniotic fluid samples 
were obtained from pregnant women by amniocentesis performed between 
16 and 20 weeks of gestation for fetal karyotyping. AFSCs were isolated by 
two-stage culture protocol and then treated with NP (10, 50, 100, 200μM) 
for 24, 48, and 72 hours, respectively. The effect of NP on the prolifera-
tion of AFSCs was determined by trypan blue dye exclusion assay. The total 
number of viable cells was calculated by microscopy. RT-PCR and qPCR 
were used to assess the Oct4, Nanog, and Sox2 expressions of AFSCs. The 
viability of AFSCs decreased proportional to the increasing dosage or the 
length of incubation when they were treated with NP. In addition, the higher 
dosage of NP and the longer exposure of NP, the stronger Oct4, Nanog, and 
Sox2 gene expressions were found. When treating AFSCs with 90μM NP 
by 24 hours and 48 hours respectively, the levels of Oct4, Nanog, and Sox2 
gene expressions on AFSCs were 1.1 and 2.2 for Oct4, 1.2 and 2.6 for Sox2, 
and 1.0 and 2.4 for Nanog respectively. These results indicated that NP 
might influence the process of cellular differentiation or organgenesis during 
fetal development.
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Studies have only recently begun to evaluate the role of miRNAs in multi-
potent bone marrow stromal cells/mesenchymal stem cells (MSC). Analysis 
of deep sequencing miRNA expression profile and measurements using real 
time PCR revealed high expression of let-7 family members in MSC. How-
ever, the study on a single miRNA level is difficult due to their redundancy 
and sequence identities with mature miRNAs commonly differing in a single 
nucleotide. The pluripotency factor Lin28 is a RNA-binding protein neces-
sary and sufficient to block microprocessor-mediated cleavage of pri-let-7 
miRNAs. We indirectly studied the role of let-7 in human MSC by lentiviral-
mediated over-expression of Lin28. Similar to what has been described in 
fibroblasts, MSC engineered to over express Lin28 showed strong reduction 
of senescence in vitro as evaluated morphologically. In agreement with 
findings in embryonic stem cells, we observed that Lin28 induces a shift in 
cell cycle from S phase to G2, without affecting the percentage of quiescent 
cells (G0/G1), as compared to MSC transduced with a control lentiviral 
vector. Surprisingly however, this led to a slight, but significant decrease 
in proliferation of MSC by Lin28, dependent on the level of expression of 
the transgene. Of note, this mild reduction of proliferation mediated by 
Lin28 only occurs during 8-10 days after transduction. Thereafter, unknown 
compensatory mechanisms reestablish cell growth to control levels. When 
cultured in osteogenic medium for 14 days, MSC that over-expressed Lin28 
showed 25% more calcium precipitation. When cultured in adipogenic 
medium, MSC that over-expressed Lin28 had increased triglyceride content 
and expression of adipogenic markers ppar-gamma and fabp4, as compared 
to controls. These findings show that Lin28 enhanced the differentiation 
potential of MSCs and reduced cellular senescence.
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Introduction: Human mesenchymal stem cells (hMSCs) that have been used 
for clinical application have a limited potential of proliferation and differenti-
ation, as sub-culturing in vitro. In order to overcome these obstacles, several 
delivery systems of biological proteins have been introduced recently in the 
experimental or clinical research field, and it may have also a merit for avoid-
ing genomic manipulation that may cause tumor formation and other unex-
pected outcomes. In present study, we have applied a novel protein delivery 
system to elevate the functional potential of hMSCs through histone modi-
fication by methylation of histone arginine residues using cell-penetrating 
peptide coactivator-associated arginine methyltransferase 1 (CPP-CARM1) 
protein. Materials and Methods: Production of the CPP (R7)-CARM1 protein 
were performed by cloning using pET protein expression vector, and it was 
purified through 6x His-taq conjugated in c-terminal. This CPP-CARM1 
was treated to cultured bone marrow (BM)-, adipose (AD)-hMSCs. The 
existence of CPP-CARM1 in the nuclei was analyzed by immunocytochem-
istry using anti-6x His-taq antibody. Also, in order to confirm functional 
activity of CPP-CARM1, we performed immunocytochemistry and Western 
blot analysis using anti-Histone H3 asymmetric dimethyl R17 (H3R17di-me) 
antibody. Finally we compared the efficiency of adipogenic and osteogenic 
differentiation of hMSCs by the histone methylation wity CPP-CARM1 
protein through experiments such as Oil Red O and Alizarin Red S staining 
and realtime-RT-PCR. Results: CPP-CARM1 was localized in both cytoplasm 
and nuclei of hMSCs at 6 hr after protein treatment and remained in nuclei 
only at 12 hr. In groups treated with CPP-CARM1, di-methylation of histone 
H3R17 were more increased, compared to control group, and the higher 
levels of methylation were maintained at 12hr and 24hr after treatment. The 
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level was lowered at 48 hr. In addition, treatment of CPP-CARM1 protein 
improved the efficiency of differentiation and it was confirmed by elevating 
Oil Red O and Alizarin Red S staining as well as expression levels of each lin-
eage related genes by realtime-RT-PCR. Conclusion: We established a direct 
delivery system of CARM1 protein using cell-penetrating peptide (R7), and 
resulted in successful delivery into the nuclei of hMSC. Also, we found that 
treatment of CPP-CARM1 improved the differentiation efficiency of hMSCs 
into adipogenic, and osteogenic lineage. Therefore, our results suggest that 
this system may be a valuable tool to complement the weak point of hMSCs 
in clinical applications.
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Myocardial infarction caused by chronic atherosclerosis of the coronary 
artery could induce heart failure with high mortality. Because myocardium 
has very limited ability of regeneration, heart transplantation is currently 
considered to be the most effective treatment for severe heart failure. In 
the case of patients with some remaining heart functions, ventricular assist 
devices can be used to complement their lost functions. For severe patients 
who need to replace their heart, artificial hearts are used in order to bridge 
the time to heart transplantation for a limited period of time. However, at 
present these devices cannot be used forever and improved long-time anti-
thrombogenicity, biocompatibility, reliability and durability are needed. On 
top of that, limited number of donor for heart transplantation causes serious 
issues of this methodology. Recently, stem cell therapy is expected to be the 
alternative regenerative medicine for heart failure. In addition to pluripotent 
embryonic stem (ES) cells and induced pluripotent stem (iPS) cells, mesen-
chymal stem cells (MSCs) have been shown to differentiate into various cells 
including bone, cartridge, fat, neuron, skeletal muscle, and cardiac muscle 
lineages in vitro. Recent reports suggested that adult bone marrow-derived 
MSCs augment the recovery of cardiac function after ischemia in vivo. 
The effects induced by MSCs are generally temporary and limited. Because 
these stem cells show beneficial effects without long-time engraftment, the 
effects of these stem cells are considered due to paracrine effects of various 
cytokines secreted by injected stem cells. The successful differentiation of 
transplanted cells in vivo was mainly due to cell fusion of the injected cells 
with differentiated host cells. Thus, effective differentiation in vitro followed 
by successful engraftment is crucial for more practical application of MSCs 
for heart failure patients. In this study, we surveyed cell surface markers 
of human MSCs of which expression correlates with their cardiomyogenic 
differentiation ability. Various MSCs derived from human bone marrow 
or adipose tissues were used in this study. To analyze cardiomyogenic dif-
ferentiation ability, GFP-labeled human MSCs were co-cultured on mouse 
embryonic cardiomyocytes in vitro. After 10 days culture, GFP-positive 
beating cells differentiated from human MSCs were counted. The differenti-
ated cardiomyocytes were further evaluated by immunofluorescent staining 
with cardiomyocyte-specific antibodies against cardiac troponin T, α-actinin, 
and connexin-43. Among various cell surface markers tested, the expression 
of N-cadherin on MSCs showed good correlation with the differentiation 
abilities into beating cardiomyocytes. Our data suggested that N-cadherin 
could be a prospective cell-surface marker of human MSCs that have higher 
differentiation abilities into cardiomyocytes.
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Cardiovascular diseases are the leading cause of death in North America. 
Heart tissue has no/limited capacity to regenerate; as a result, cardiomyo-
cyte loss and the subsequent pathological remodeling of the cardiac tissue 
lead to heart failure after myocardial injury. In recent years, cell replacement 
approaches with a plethora of cell types have been investigated to mitigate 
these pathological effects and restore cardiac function in animal and pre-
clinical studies. However, the outcome of these studies is variable and gener-
ally shows modest functional improvements, which implicate the necessity 
to identify “optimal” cell type and/or factors that enhance the regenerative 
capacity of cell transplants. Mesenchymal Stromal/Stem Cells (MSCs) have 
unique properties that make them good candidates for cell-based therapies. 
Here we have investigated the effect of 3D environment (collagen scaffold) 
and cadiomyogenic priming (via co-culturing with primary cardiomyocyte) 
on biological and functional properties of bone marrow-derived human 
MSCs using an in vitro micro-engineered heart model. We have shown that 
both 3D environment and cardiogenic priming enhance proliferative activity 
of hMSC assessed by cell cycle profile and colony forming capability. Primed 
hMSCs injected onto engineered heart tissue (EHT) neither interfere with 
nor contribute to the electrical property of EHT though improve the force of 
contraction in EHT. We have shown that while 3D environment enhances 
the cardiomyogenic inductive effect of co-culture, evaluated by the expres-
sion of cardiac-specific genes by primed hMSCs, covalent immobilization 
of vascular endothelial growth factor (VEGF) and basic fibroblast growth 
factor (bFGF) on scaffolds helps primed MSCs to sustain the acquired cardiac 
lineage phenotype. The result of the latter finding may lead to the potential 
development of hMSC grafts that could be directly applied to the site of 
myocardial injury.
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Adult human mesenchymal stem cells are generally restricted in their dif-
ferentiative potential to the tissue where they reside. However, previous 
studies in our laboratory reported brain-derived neurotrophic factor (BDNF)/ 
neurotrophins (NT)/retinoic acid (RA) triggered a transdifferentiation of hu-
man mesenchymal stem cells (hMSCs) toward neuronal progenitor-like cells. 
Extracellular matrix (ECM) protein, tenscin-cytotactin (Tn-C), and Wnt-7a 
further showed a trans-differentiation and somatic plasticity phenomena 
in cell culture. The BDNF/NT/RA triggered neuronal differentiation of 
hMSCs resulting in increased mRNA expression of neuronal markers such as 
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nestin, microtubule associated protein-2 (MAP2), glial fibrially acidic protein 
(GFAP), βIII tubulin and neuron growth factor (NGF). The addition of Tn-C 
continued enhancing mRNA expression of MAP2, βIII tubulin and NGF. 
Wnt-7a found to significantly increase MAP2, βIII tubulin, NGF, and Myelin 
Basic Protein (MBP). Incorporation with Wnt-7a and lithium in culture, hM-
SCs found to express synapsin1 (Syn1). The induction of Syn1was inhibited 
after adding Wnt inhibitors. Moreover, Wnt7a triggered formation of cho-
linergic, dopaminergic, GABAergic and serotonergic neurons. In conclusion, 
ECM such as tenscin C and Wnt-7a, may play a functional role in modulat-
ing neurogenesis by MSCs. Canonical Wnt7a is crucial to synapse formation 
and neuron type determination in hMSCs. These findings suggest that the 
combined use of Tn-C, Wnt-7a, BDNF/NT/RA, and MSCs offers a novel cell 
therapy in clinic in the future. Keywords: mesenchymal stem cell, Wnt-7a, 
neurogenesis, synapsin, tenascin C, transdifferentiation
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OPTIMIZATION OF CULTURE CONDITION OF 
HUMAN UMBILICAL CORD BLOOD-DERIVED 
MESENCHYMAL STEM CELLS
Lee, Mi-Yeon
MEDIPOST, Seoul, Korea, Republic of
Mesenchymal stem cells (MSCs) have several features of pluripotency, 
paracrine effects, and immunosuppressive properties, which lead to clinical 
trial implementation. It is important to increase the proliferation rate of the 
MSCs which is essential of mass production of MSCs for clinical use. In this 
study, several factors were tested to up-regulate the proliferation and their 
several effects on MSCs were evaluated. It has been reported that several 
factors increase the proliferation rate of adherent mammalian cells. Among 
them, we selected the most effective factors on umbilical cord blood-derived 
MSCs (UCB-MSCs) and tested the effects on the proliferation. Calcium, 
hypoxia, and several extracellular matrix (ECM) proteins like fibronectin and 
thrombospondin-1 (TSP-1) were tested using proliferation assay with UCB-
MSCs. Optimal concentration of calcium was determined with concentration 
range of 0~3mM without the change of differentiation capacity. The effects 
of individual factors were different among UCB-MSC batches due to the 
lot variations. To diminish different effects of factors according to the batch 
of MSCs, their combinations were conducted and investigated to maximize 
the proliferation of MSCs. Proliferation of UCB-MSCs was increased 2-fold 
in individual treatment and maximum 6-fold in combined ones. Several 
characteristics of UCB-MSCs after treatment of factors were monitored to 
evaluate their properties. Their effects on the growth of MSCs were evalu-
ated by proliferation assay. The differentiation of UCB-MSCs into several cell 
types including osteoblasts, chondrocytes and adipocyte were tested. Also, 
the surface markers of UCB-MSCs were monitored by FACS analysis, which 
all showed no critical difference in MSC properties. In conclusion, single or 
combinations of several factors were adjusted to up-regulate the prolifera-
tion, and their effects on the properties of UCB-MSCs were evaluated.
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TRANSPLANTATION OF NEURAL PROGENITORS 
GENERATED FROM HUMAN PLACENTAL 
MESENCHYMAL STEM CELLS INCREASE 
DOPAMINE UPTAKE AND ALLEVIATE 
ASYMMETRIC MOTOR BEHAVIOR IN THE RAT 
MODEL OF PARKINSON’S DISEASE
Lee, Young-Jay1, Park, Saeyoung1, Kim, Eungpil1, Maeng, Sungho2, 
Koh, Seung-Eun3, Lim, Jinho1
1Maria Biotech, Seoul, Korea, Republic of, 2Dept. of East-West medicine, 
Kyunghee University, Seoul, Korea, Republic of, 3Dept. Rehabilitation, 
Kunkuk University, Seoul, Korea, Republic of
Parkinson’s disease (PD) is a degenerative disorder characterized by a 
progressive loss of dopaminergeic neurons in the mesencephalic substantia 
nigra. Symptoms of locomotive dysfunctions of the illness were relieved by 
pharmacological treatments but the treatments accompany side effects if 
administered for a long term. Alternatively, fetal mesencephalic tissues were 
transplanted with some success, however, the uitilization of human fetal tis-
sue caused ethical and religious debates as well as difficulties in availability. 
Recently developed stem cells are a group of cells that are capable of self- 
renewal and differentiation and thus are considered as promising candidates 
for the replacement of human tissues or organs. We previously isolated 
17 independent mesenchymal stem cells from the first trimester human 
placenta (fPMSC) and successfully differentiated the cells neural progenitor 
cells. When transplanted into the striatum of the 6-OHDA-induced PD ani-
mal models, the in vitro-differentiated neural progenitors differentiated into 
dopaminergic neurons, normalize the asymmetric rotational behavior of the 
animals, and increased the uptake of 18F-fluorodopa in the ipsilateral brain 
as determined by PET. These results suggest that the in vitro-differentiated 
neural progenitors may be as effective as the terminally differentiated cells 
for the cell replacement therapies.
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A NEW METHOD OF THE DIFFERENTIATION 
OF MESENCHYME STEM CELLS FROM HUMAN 
PLACENTA INTO NEURON-LIKE CELLS IN 
VITRO
Lijun, Ma, Fan, Heng, Wang, Libin, Liu, Ting, Ma, Xiaona, Jin, 
Yiran, Zhu, Yongzhao, Wei, Jun, Yukui, Li
The Affiliated Hospital of Ningxia Medical University, Ningxia Human Stem 
Cell Institute, Yinchuan, China., China
BACKGROUND AND AIMS. Human placenta may contain plenty of mesen-
chymal stem cells (MSCs), which can be differentiated into neuron-like cells. 
At present, it is always used conditional medium containing some specific 
growth factors to induce MSCs. This study was aimed to explore a new way 
to the differentiation of MSCs from human placenta into neuron-like cells in 
vitro. METHODS. MSCs from human placenta were isolated and purified by 
cell culture. The third passage of MSCs was incubated with DMEM contain-
ing 20%FBS for 24 hours. Then add Diff-1 medium supplemented with 
0.2%FBS, bFGF and EGF. Continue culture for 24 hours. Replace medium 
with fresh Diff-1 medium supplemented with 0.2%FBS,200ug/ml (protein) 
of CNS tissue extracts. Continue culture for 6 days. Replace medium and 
add to RA and Shh .Continue culture for 3 days. Finally, replace medium 
with fresh Diff-1 supplemented with 10%FBS and add BDNF, GDNF 
and IGF-II for 7 days. Cell morphology was observed. Nerve cell mark-
ers were detected by immunohistochemistry and ELISA assays. RESULTS. 
The adhesive cells gradually formed flat monolayer cells, parallel arranged 
or whirlpool grew, with uniform morphology after 2 passages. Compared 
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with control, the cells expressed CD90, CD44, CD73, CD29, et al. But not 
expressed CD45 and CD34. After induce culture, NSE,Nestin,GFAP,NF-M, 
GAP-43 could be expressed by immunohistochemical staining test. NT3 
,NT4 and BDNF were expressed in the supernatant by ELISA kit analysis. 
CONCLUSION. The result demonstrated that MSCs from human placeta 
can differentiate into neuron-like cells, which add the protein of CNS tissue 
extracts to medium.
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Background: Multi-potent mesenchymal stromal cells (MSCs) are self-
renewing cells with the ability to differentiate into osteocytes, chondrocytes, 
adipocytes, myocytes and also neuron-like cells and hepatocytes. Because of 
their multi-potency and low immunogenicity, MSCs are considered a poten-
tial candidate for clinical applications including cartilage reconstitution, and 
the therapy of inherited diseases such as osteogenesis imperfecta. Tradition-
ally, MSCs are isolated from primary tissue based on their capacity to adhere 
to a plastic surface. This isolation procedure is hampered by the unpredict-
able influence of co-cultured hematopoietic and other contaminating cells. 
To circumvent these limitations, several surface markers have been identified 
to facilitate the prospective isolation of MSCs. Results: Here we provide 
a high quality method using flow cytometry to isolate a pure population 
of clonogenic human MSCs based on the expression of low-affinity nerve 
growth factor receptor (LNGFR) and Thy-1. Multicolor cell sorting and CFU-
F assays showed that mesenchymal stem cells were ~33,000-fold enriched in 
the LNGFR+Thy-1+ fraction. The LNGFR+Thy-1+ cells contained CFU-Fs at 
the frequency of one per six cells. Clonogenic assays of these cells revealed 
3 distinct sub-populations within we have designated rapidly proliferating 
clone (RPC), moderately proliferating clone (MPC) and slowly proliferating 
clone (SPC). RPCs demonstrated robust multi-lineage differentiation and 
self-renewal potency. In order to validate these results we established 145 
clonally derived LNGFR+Thy-1+ MSC populations. From the 46 RPC, 37 
(80%) clones gave rise to all adipogenic, chondrogenic and osteogenic lin-
eages. In contrast, only 6 (13%) clones of SPC demonstrated tri-lineage dif-
ferentiation capacity. Surprisingly, 16 out of 51 SPC (31%) were only able to 
differentiate to bone or unable to differentiate at all. Additionally we noted 
the responsiveness of each clone type to adipogenic differentiation appears 
to be linked to its proliferative capacity and therefore growth kinetics may 
predict the stem-like potential hMSCs. From our data so far we concluded 
that RPC contained cells with most stem like qualities. In order to determine 
if any additional surface markers could distinguish between RPC, MPC and 
SPC we looked for a difference in expression of hMSCs markers between 
these different cell types. The most marked difference that we noted was 
moderate expression of CD106 in RPC following 6 weeks in culture (54.9%) 
compared to absent expression in MPC and SPC. To examine and define the 
phenotype among the CD106-positive cells, we perform secondary single 
cell sorting in CD106-positive and CD106-negative cells. Interestingly, the 
CD106-positive cells yielded high colony forming capacity. These results 
indicating that MSC compartment are a heterogeneous population that may 
be sub-divided into RPC, MPC and SPC based on growth kinetics. Conclu-
sions: We describe a method to prospectively isolate a pure population of 
potent MSCs based surface expression of LNGFR and Thy-1. This population 
is composed of sub-populations which differ in their replicative ability and 
plasticity. We provide strong evidence for biological heterogeneity within an 
MSC population.
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NEUROPROTECTIVE EFFECTS OF HUMAN 
UMBILICAL CORD MESENCHYMAL 
STEM CELLS IN AN ANIMAL MODEL OF 
PARKINSON’S DISEASE
Mathieu, Patricia, Roca, Valeria, Pitossi, Fernando
Institute Leloir, Buenos Aires, Argentina
Human mesenchymal stem cells (hMSCs) are reported to possess immuno-
modulatory properties and secrete various neurotrophic factors. We have 
demonstrated that inflammation plays a crucial role in Parkinson´s Disease 
(PD) progression. In this study, we evaluated whether the transplantation 
of hMSC obtained from umbilical cord (UC) has a neuroprotective effect 
in a rat PD model. To address the neuroprotective effect of these cells, we 
implanted undifferentiated hMSCs into the sustantia nigra pars compacta 
(SNc) of rats bearing a lesion of the nigrostriatal pathway induced by the 
intrastriatal injection of 6-hydroxydopamine (6-OHDA), a widely recognized 
rodent model of PD. The hMSCs were transplanted 7 days after 6-OHDA 
injection and animals were sacrificed 14 days later. Umbilical cord hMSC 
expressed markers characteristic of mesenchymal stem cells: CD 90 (+), CD 
73 (+), CD 105 (+), CD 44 (+), CD 34 (-), HLA-DR (-), CD 14 (-) and CD 45 
(-). Our results revealed that rats receiving hMSCs transplantation displayed 
significant preservation in the number of dopaminergic neurons in the SNc 
compared to control rats. However, rats receiving hMSC transplantation did 
not show a significant behavioural amelioration in a cylinder test compared 
with the control groups at the experimental time points analysed. Even 
though the animals did not receive an immunosuppressive treatment the in-
flammatory response against human transplanted cells was restricted to the 
implantation area. This results suggest that grafted hMSCs exert neuropro-
tective effects on dopaminergic neurons against the degeneration induced 
by 6-OHDA. The mechanisms underlying this effect remain to be clarified, 
although we favour the hypothesis that hMSCs have a neuroprotective ef-
fect through anti-inflammatory actions.
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EFFICIENT LABELING OF HUMAN 
MESENCHYMAL STEM CELL WITH IRON OXIDE 
NANO PARTICLE FOR IN VIVO TRACKING
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Transplantation of adult Mesenchymal stem cells (MSCs) has shown promise 
for the treatment of several degenerative diseases. However, the inability of 
present strategies, to non-invasively track these cells after in vivo adminis-
tration has been a significant roadblock to the clinical acceptance of many 
cellular therapies. This has motivated the development of non-invasive im-
aging techniques to track the transplanted cells. In this study, we sought to 
determine if bone marrow derived MSCs, labeled with in-house Iron Oxide 
Nano Particle (IONP) can retain their phenotype, proliferation and differenti-
ation potential. This study was initiated after IRB clearance. Iron oxide nano 
particles of 7-10 nm size were prepared and were characterized for size, 
chemical composition using various techniques like Transmission Electron 
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Microscopy, X-ray diffraction, Attenuated Total Reflection Fourier Transform 
Infrared and Dynamic light scattering. MSCs were isolated and expanded 
from human bone marrow, by using established protocols. At confluence, 
cells were labeled with IONPs. These IONP labeled cells were stained with 
Prussian blue stain to estimate the labeling efficiency and further passaged 
to determine cell proliferation and IONP retentions during expansion. After 
successful labeling of MSCs with IONP, the cells were investigated for any 
change in the surface marker expression by flow-cytometry; CD29, CD90, 
CD73, CD105, HLA I & II. The labeled cells were induced to differentiate 
into various cell lineages including osteoblasts, chondrocytes, adipocytes, 
cardiomyocytes and neurons. During induction, cells were observed carefully 
to see the change in phenotype i.e. cell morphology, matrix mineralization 
and cytoplasmic lipid vesicles formation. At the end of induction period, 
differentiated cells were characterized at transcript and protein levels by 
RT-PCR and immunofluoresence. Unlabelled MSCs served as controls in all 
the experiments. IONPs labeled cells were also investigated for their tracking 
ability using non-invasive technique i.e. MRI. Labeled MSCs were injected 
into rat models of Myocardial infarction by tail vein as well as direct in the 
infarct tissue. After injection MRI was done after 24 hrs and 3 weeks to 
track the IONP labeled cells. IONPs labeling did not alter the surface marker 
profile, proliferation rate, differentiation potential of MSCs. IONPs were re-
tained in the MSCs till 4th passage. in vivo study also revealed the tracking 
efficiency of IONPs labeled MSCs for long duration up to three weeks in the 
infracted myocardial tissue. This study revealed that MSCs can be labeled 
efficiently with this novel IONP without any change in stemness, expansion 
and differentiation potential. This in-house developed IONP may be a useful 
tool for non-invasive tracking of transplanted MSCs.
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CORD BLOOD PLATELET GEL FOR GMP 
PRODUCTION OF HUMAN MESENCHYMAL 
STEM CELL: AN INNOVATIVE, SAFE AND 
ANIMAL-FREE SUBSTITUTE FOR CLINICAL 
APPLICATIONS
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Human mesenchymal stem cells (MSC) are used in clinical trials for their 
immunomodulation ability and more recently for their tissue regeneration 
properties. Their production has to be done under GMP conditions and cru-
cial is the definition of the optimal cell culture components that could impact 
on cell yield and differentiation. Routinely, fetal bovine serum (FBS) is used 
for MSC culture but its associated risks (e.g. disease transmission and bovine 
protein sensitization) are well known. An interesting and safe alternative 
component is cord blood (CB) platelet gel (PG) that we have recently pro-
duced, validated and patented. This CB-PG contains higher concentration of 
some growth factors such as VEGF in comparison with its peripheral blood 
counterpart (1803.5 ± 788.5 pg/mL vs 250 ± 120 pg/mL, respectively) 
and lower levels of some other factors including TGFbeta1 (6865.6±2668.5 
pg/mL vs 11250 ± 6796). In order to test the ability of CB-PG releasate to 
replace FBS, adipose MSC were cultured in standard conditions in the pres-
ence of 20% CB-PG batroxobin-induced releasate or 20% FBS. During and 
after the culture, adipose MSC in the presence of CB-PG show a higher cell 
expansion rate compared to FBS cultures. In addition, adipose MSC cultured 
in CB-PG releasate were more prone to differentiate toward chondrogenic, 
adipogenic and osteogenic cell lineages. Moreover, adipose MSC showed a 
higher rate of CFU-F. The telomerase activity was normal when compared 
to the HELA cells. These interesting findings prompted us to investigate the 
proteomic profile of CB-PG using four different approaches: ELISA (6 fac-
tors; R&D Systems, Minneapolis, MN, USA), multi-analyte profiling platform 
(189 factors; RBM, Austin, TX, USA), SELDI-ToF-MS (Surface Enhanced 
Laser Desorption/Ionization-Time of Flight-Mass Spectometry) and Reverse 
Phase HPLC coupled with SDS PAGE. Some analyses are still ongoing but 
the preliminary results show that CB-PG can be a valid alternative to FBS 
when MSC have to be produced for angiogenic-mediated tissue repair. This 
peculiarity could be explained by extending the properties of CB stem cells 
as part of perivascular/endothelial compartment to CB-PG.
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SOX2 CONTROLS THE DIFFERENTIATION 
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DERIVED MESENCHYMAL STEM CELLS BY 
DIRECT REGULATION OF DKK1 AND GSK3-β 
PHOSPHORYLATION
Park, Sang-Bum, Seo, Kwang-Won, So, Ah-Young, Seo, Min-Soo, 
Yu, Kyung-Rok, Yang, Se-Ran, Seo, Yoo-Jin, Shin, Ji-Hee, Kang, 
Kyung-Sun
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SOX2 is a well-known core transcription factor in embryonic stem cells 
(ESCs) and one of the reprogramming factors to make induced pluripotent 
stem (iPS) cells. The function of SOX2 has been researched mainly in neural 
stem cells. Recently, SOX2 expression in human umbilical cord blood-derived 
mesenchymal stem cells (hUCB-MSCs) has been reported by us and others. 
However, the mechanism of SOX2 in stem cells has not been known well. To 
identify the molecular mechanism of SOX2, inhibition study was performed 
in hUCB-MSCs. SOX2-inhibited hUCB-MSCs showed severe prolifera-
tion defects. Additionally, the adipogenic differentiation of SOX2-inhibited 
hUCB-MSCs decreased. In contrast, the osteogenic and chondrogenic differ-
entiation increased. After SOX2 inhibition, the phosphorylation of GSK3-β at 
serine 9 increased as a consequence of DKK1 depression in SOX2-inhibited 
hMSCs. SOX2 bound to the promoter region of DKK1 and has a posi-
tive regulatory role in DKK1 transcription. Ectopic treatment of DKK1 in 
SOX2-inhibited hUCB-MSCs recovered the differentiation deformities but 
could not abrogate the cell proliferation defect. These results show that 
SOX2 directly regulates DKK1 expression and, as a consequence, regulates 
phosphorylation of GSK3-β during differentiation of hUCB-MSCs. Taken 
together, SOX2 is critical to the differentiation of stem cells was evaluated.
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MESENCHYMAL CELLS AS A CELL SOURCE 
FOR RAPID AND EFFICIENT NUCLEAR 
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Leandro1, Azevedo-Pereira, Ricardo Luiz1, Silva, Rosane1, Rondinelli, 
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1Biophysical Institute Carlos Chagas Filho, Federal University of Rio de 
Janeiro, Rio de Janeiro, Brazil, 2Departamento de Clínica Médica, Federal 
University of Rio de Janeiro, Rio de Janeiro, Brazil, 3National Institute of 
Cardiology, Rio de Janeiro, Brazil
Induced pluripotent stem cells (iPSC) were originally generated by forced 
ectopic expression of four transcription factors - Oct4, Klf4, Sox2 and c-myc 
- in adult fibroblasts. However, the efficiency of iPSC recovery is extremely 
low, varying from 0.01 - 0.1%, and the nuclear reprogramming takes about 
20 days to be accomplished. We reasoned that adult cells showing basal 
expression of core embryonic stem (ES) cell regulator genes, such as Oct4, 
Sox2, Klf4 or Nanog, could be a better cell source for reprogramming. Men-
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strual blood-derived mesenchymal cells (MBMC) are multipotent cells that 
show detectable transcripts and protein levels of some of the core ES regula-
tors, such as Oct4, Sox2 and Klf4. The aim of this study was to determine 
whether reprogramming efficiency could be increased by using MBMCs as 
a cell source to generate iPSC. In order to reprogram these cells, two rounds 
of transduction were made using a mixture of 3 recombinant retroviruses 
expressing the coding region of Oct4, Sox2 and Klf4 genes. Twenty-four 
hours after the second round of transduction, MBMCs were plated on Mito-
micin C-inactivated mouse embryonic fibroblasts (iMEF). Nuclear reprogram-
ming was detected as early as 5 days post-transduction by the appearance 
of cells with high nucleus/cytoplasm ratio, and colonies begun to appear 
after 7 days. At day 15, colonies were picked-up and expanded for charac-
terization. Most of the clones were morphologically identical to ES cells and 
positive for alkaline phosphatase (AP). Some of the clones expressed the 
cell surface pluripotency marker SSEA-4 and TRA-1-60 and the transcription 
factors Nanog and Oct4. RT-PCR analysis detected the transcripts of the 
pluripotency marker genes Oct4, Sox2, Klf4, Nanog, Dnmt3b, Nodal, Tdgf 
and hTert and qRT-PCR assays confirmed robust expression levels. They 
are capable of forming embryoid bodies and to differentiate in vitro into 
cells of the three germ cell layers. Nonetheless, our results showed that the 
reprogramming was faster and with efficiency around 2 - 5%, even in the 
absence of c-myc. To date, this is the first study showing MBMCs as a cell 
source for nuclear reprogramming.
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Mesenchymal stromal cells (MSCs) are adult multipotent cells able to differ-
entiate toward mature mesodermal lineages. Despite years of investigation, 
little is known about the molecular mechanisms underlying the stemness 
state in these cells. The Pou domain-containing transcription factor Oct4 is 
a well established master regulator of pluripotency in the inner cell mass of 
the embryo as well as in embryonic stem cells. While it has been shown that 
the Oct4 gene is inactivated through a series of epigenetic modifications fol-
lowing embryonic development, recent studies have detected Oct4 mRNA 
and protein in a number of somatic stem cells, mesenchymal stromal cells 
and tumor cells. These observations suggest that Oct4 may have a function 
in maintaining self-renewal and stemness in these cells. We employed an 
RNA interference approach to determine whether Oct4 gene expression is 
important for maintaining stemness and self-renewal in the placenta-derived 
mesenchymal cells. Using lentiviral constructs which constitutively give rise 
to siRNAs targeted against Oct4 mRNA, about 80-90% knock-down of 
the Oct4 transcript levels were obtained. These cells showed a significant 
reduction in proliferation as verified by Ki67 immunoassays (about 25%) 
and by Brdu incorporation assays (23.5%). When these cells were induced 
to differentiate into osteocytes and adipocytes, they showed a delayed ki-
netics and reduced efficiency as compared to wild-type cells. The molecular 
mechanisms underlying the reduced proliferation and reduced differentiation 
efficiency are currently being investigated. These results suggest that Oct4 
may have a function in stemness and self-renewal of mesenchymal stromal 
cells derived from the placenta.
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Progressive muscular dystrophies are a group of disorders characterized by 
progressive and irreversible muscle degeneration for which there is no thera-
py. Human umbilical cord tissue has been considered as an important source 
of stromal stem cells (SSC), which are able to differentiate into distinct cell 
types. However, there is limited information concerning favorable conditions 
that induce differentiation of SSC into muscle cells. It has been demon-
strated that insulin-like growth factor-1 (IGF-1) promotes survival, prolifera-
tion, migration and myogenic differentiation of muscle progenitor cells, but 
its effects on stem cells has not been reported. Here we investigated, for 
the first time, if IGF-1 is capable of inducing the proliferation and myogenic 
differentiation of SSC from human umbilical cord tissue in vitro. Our results 
showed that IGF-1 induces SSC proliferation. Moreover, we observed that 
SSC undergo activation of myogenic regulatory factors (MRFs), followed by 
extensive muscle differentiation with a transient increase of MyHC expres-
sion when exposed to IGF-1. In summary, our data indicate that IGF-1 in-
creases proliferation and myogenic differentiation of SSC. These results may 
have important applications for future therapies in patients with different 
forms of muscular dystrophies. Supported by CEPID, INCT and CNPq.
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Dopaminergic transcription and neurotrophic factors support dopamine 
signaling in embryonic development and have shown their potential to 
accelerate differentiation of appropriate cell sources toward dopaminergic 
fate. Here, we report the synergistic effects of Nurr1 transcription factor and 
GDNF neurotrophic factor on neuronal differentiation of human umbili-
cal cord matrix stem cells. We isolated these mesenchymal stem cells from 
human Wharton’s Jelly and cultured in DMEM supplemented with serum 
and insulin-transferin-selenium (ITS) for a week before characterizing them 
for expression of stem cell markers. The cells largely expressed CD29, CD44 
and SH2 whereas CD34 and CD45 expression could not be detected. Next, 
we transduced these cells using recombinant lentivirus vectors harbor-
ing either Nurr1/GFP (pLV-Nurr1-GFP), or GDNF/Jred coding sequences 
(pLV-GDNF-Jred). Following RT-PCR detection of transgene overexpression 
in transduced cell populations, we cultured the cells in defined medium 
supplemented with sonic hedgehog and FGF8. Compared to control cells 
transduced with empty vectors, the test cells displayed neuronal morphol-
ogy with distinct neurite formation. Furthermore, we detected expression of 
dopamine synthesizing enzymes TH and AADC in the transduced test cells. 
However, the cell group that was transduced with both recombinant virus 
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stocks and so co-expressed Nurr1/GDNF subsequently expressed higher 
levels of TH and AADC compared to when either virus stock was applied. 
Our data suggest that Nurr1 and GDNF synergize to accelerate dopamine 
signaling pathways and that their strong co-presence can direct a substantial 
proportion of the transduced test cells toward dopaminergic fate.
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Objective: Native periodontal ligament-derived cells (PDLCs) constantly 
express both osteogenesis and tendongenesis-related genes, but when 
passaged in culture, PDLCs have a tendency of de-differentiation. Al-
though it is well known that dexamethasone or BMP2 can induce/enhance 
osteogenic characteristics of PDLCs, little is known about effective factors 
that can induce/enhance tendongenic characteristics of PDLCs. In this 
study, we examined whether GDFs can enhance or maintain tendongenic 
characteristics of human PDLCs being expanded in culture during several 
passages for potential use as a cell source for tissue engineering of tendons 
and ligaments. Methods: Human PDLCs were obtained from extracted 
teeth, digested with collagenase, and the isolated cells subcultured until 
passage 6 for experiments herein. PDLCs from passages 3-6 were cultured 
until 70% confluency and subsequently placed in serum-free media with 
or without various concentrations of recombinant human GDF5 (100 ng/
ml) and/or GDF7 (1-200ng/ml). Then, these treated cells were evaluated 
using cell proliferation (WST8), alkaline phosphatase (ALP) activity, reverse 
transcription -polymerase chain reaction (RT-PCR) and quantitative real-time 
PCR to determine the expression of tendongenic- and osteogenic-related 
genes. Human mesenchymal stem cells (MSCs) and dental pulp-derived cells 
(DPCs) were used as controls. Results: GDFs reduced ALP activity in cultured 
PDLCs, but its effect was reduced during passages. In contrast, ALP levels in 
MSCs and DPCs were increased by treatment with GDF5. Consistent with 
this result, the expression of osteogenic-related genes was down-regulated 
in GDFs-treated PDLCs, while its expression was up-regulated in MSCs or 
DPCs. On the other hand, the expression of tendongenic-related genes was 
up-regulated in GDFs-treated PDLCs. In particular, tenomodulin expression 
(a late marker of tendongenesis) was maintained in GDFs-treated PDLCs 
even at passage 6, contrasting with its disappearance in non-treated PDLCs. 
This suggests that GDFs stimulation rescued tendongenic characteristics in 
de-differentiated PDLCs. We are currently investigating additional inducible 
tendongenesis characteristics by GDFs in cultured PDLCs.
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NOVEL POPULATION OF NESTIN POSITIVE 
PROGENITORS IN RAT ADULT PROSTATE 
DIFFERENTIATES INTO INSULIN PRODUCING 
CELLS FROM SGL1: A BIOACTIVE COMPONENT 
OF ENICOSTEMMA LITTORALE
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Akhilesh2, Singh, Anubha2, Soni, Sanket2, Gupta, Sharad3, Bhonde, 
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1M.S University, Vadodara, India, 2Biochemistry, M.S University, Vadodara, 
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By 2010 the number of people with Diabetes Mellitus has reached upto 350 
million worldwide. Major hurdles in treatment of diabetes are the current 
treatment of exogenous insulin supply which is not fully capable of achiev-
ing tight control over glucose regulation, leading to long-term complica-
tions. Recent success in islet transplantation-based therapies for diabetes 
mellitus and storage of pancreatic islets have motivated sprouting efforts to 
develop renewable sources of islet replacement tissue. A major impediment 
to our understanding of the biology of stem cells is the inability to distin-
guish them from their homing niche and multipotent differentiating property 
which makes them usable for islet replacement therapy. We made efforts to 
make use of association of stem cells with adult prostate to isolate a novel 
population of prostatic stem/ progenitors that express higher levels of nes-
tin, a neuroendocrine protein and vimentin, mesenchymal stem cell marker, 
enabling a transformative link for endocrine cell differentiation. Enicostemma 
littorale, an antidiabetic medicinal Indian herb recently reported from our lab 
to have islet neogenic potential from various multipotent stem/ progentiors. 
In present study we analyzed selected population from prostate tissue which 
has a basal phenotype of fibroblastic mesenchymal with high proliferative 
and mulitpotential nature, as determined by expression of Nestin, Vimentin, 
SMA proteins by confocal microscopy and has a greater ability to form islet 
like clusters in-vitro upon differentiation with SGL-1 bioactive component 
from Enicostemma littorale. Furthermore the presence of dithizone staining 
and immunopositivity for islet hormones in post differentiated prostate 
progenitors suggests that these cells share common regulating pathways 
with pancreatic stem cells during developmental fate in organogenesis. Our 
study provides an evidence for distinct source for neuroendocrine progeni-
tors which can be isolated and used for diabetic patients who are undergo-
ing prostectomy
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FGF2 BUT NOT WNT3A OR BMP2 INHIBIT 
MOUSE MESENCHYMAL STEM CELL 
DIFFERENTIATION BY INDUCING TWIST2 
AND SPRY4 AND BLOCKING ACTIVATION OF 
EXTRACELLULAR REGULATED KINASE
Krishnappa, Veena1, Lai, Wen-Tzu2, Phinney, Donald G.1
1Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL, USA, 
2National Institute of Health, Bethesda, MD, USA
Cell signaling pathways that regulate adipogenic, chondrogenic, and osteo-
genic differentiation of mesenchymal stem cells (MSCs) are well described 
but those that maintain cells in an undifferentiated state remain largely 
unexplored. Previously we reported that FGF2 reversibly inhibited multi-
lineage differentiation of primary mouse MSCs. Herein we identify a unique 
compliment of signaling proteins expressed in MSCs that are dynamically 
regulated by FGF2 and contribute directly to its inhibitory effect on cell 
differentiation. FGF2 significantly induced expression of Twist2, Sprouty4 
(Spry4) and Cyclin D1 (Ccnd1) in MSCs and down regulated expression of 
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soluble frizzled related receptor 2 (Sfrp2), runt-related transcription factor 2 
(Runx2), and peroxisome proliferation activated receptor gamma (Pparg). In 
contrast, WNT3A induced expression of Twist but not Twist2 or Spry4 and 
bone morphogenetic protein 2 (BMP2) failed to alter expression of these 
mRNAs. Consistent with these findings, pre-treatment of MSCs with FGF2 
blocked osteogenic and chondrogenic differentiation whereas WNT3A had 
only a partial inhibitory effect and BMP2 augmented osteogenic differ-
entiation. Moreover, FGF2-induced changes in Spry4 mRNA and protein 
expression levels in MSCs were inversely correlated with the extent of 
extracellular regulated kinase 1 and 2 (ERK1/2) activation. Finally, immuno-
staining demonstrated that Twist proteins and Spry4 were co-expressed in a 
small subpopulation of MSCs and that FGF2 enriched for this subpopulation 
and also altered the sub cellular localization of both proteins. Collectively, 
these studies demonstrate that FGF2 modulates differentiation of MSCs by 
modulating expression levels of Twist2 and Spry4, the latter of which inhibits 
ERK1/2 activity.
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DEVELOPMENT OF CARDIAC FIBROSIS IN 
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Paylor, Ben, Natarajan, Anuradha, Rossi, Fabio
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Abstract: Fibrosis is defined by excess deposition of extracellular matrix 
components including collagen, and is associated with a wide variety of 
pathological states in numerous different tissues. The functional implications 
of the development of fibrosis are well documented, but a thorough under-
standing of the cellular and molecular mechanisms underlying its progression 
is still lacking. Recent studies in skeletal muscle have identified a population 
of fibro/adipogenic progenitors (FAPs) and demonstrated their vital role 
in regulating both muscle regeneration and formation of fibrosis following 
muscle damage. Further data has supported the notion that of FAPs (CD31-
:CD45-:alpha7-:Sca1+:PDGFRa+) are activated during regeneration in other 
tissues, including (but not limited to) adipose, skin, lung and bladder. We hy-
pothesize that FAPs are present in the heart and may play an important role 
in development of cardiac fibrosis. Following enzymatic digestion of murine 
hearts, FAPs were isolated from the heart and expanded in culture. These 
cells possessed similar surface phenotypes to populations previously isolated 
from skeletal muscle. Following in vitro expansion we were successfully able 
to differentiate these cells toward adipogenic and fibrogenic lineages, as 
evidenced by Oil Red O and fibroblast marker staining (respectively), thus 
confirming them as FAPs. Using PDGRa-EGFP transgenic mice, we visualized 
the cardiac tissue distribution of these cells. We investigated the genetic pro-
file of freshly sorted cardiac FAPS and found them to significantly upregulate 
several ECM-producing genes as compared to Lin-Sca1+PDGFRa-, Lin-Sca-, 
and Lin+ cell populations. We induced cardiac fibrosis in PDGFR-EGFP mice 
by injecting isoproterenol (100mg/kg/d) subcutaneously for 5 days, and 
isolated the heart 10 days later. ECM-producing genes were significantly up-
regulated as compared to FAPs from undamaged hearts. FAPs from muscle 
have been shown to express high levels of IL-6, which has been proposed 
as a potential mediator of their trophic role in regulating skeletal muscle 
regeneration. IL-6 has been suggested as an important signaling molecule 
mediating FAPs paracrine effect on tissue regeneration. Experiments on 
IL-6 KO mice demonstrated an increased HW/BW ratio as well as cardiac 
fibrosis at 6-weeks of age. Following isoproterenol-induced cardiac fibrosis, 
we observed increased fibrosis as compared to WT-controls, and significant 
proliferation of the FAP population evidenced by increased PDGFRa staining 
in heart sections. These results highlight FAPs important role in reparative 
processes following cardiac injury, and suggest they may be a key compo-
nent for any strategies intended to augment cardiac regeneration.
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ACTIVATION OF P130 AND E2F4 IS 
ASSOCIATED WITH INDUCTION OF WNT/Β-
CATENIN SIGNALING AND FORMATION OF THE 
P130/GSK3Β/Β-CATENIN COMPLEX IN MOUSE 
MESENCHYMAL STEM CELLS
Petrov, Nikolay, Zhidkova, Olga, Zenin, Valery, Popov, Boris
Institute of Cytology of the Russian Academy of Sciences, Saint Petersburg, 
Russian Federation
Signaling pathways, which regulate cell differentiation and self-renewal, 
function in cell cycle context. Proteins p130 and E2f4, members of the 
retinoblastoma protein (pRb) family/E2F transcription factor family, are the 
key elements in regulation of cell cycle and differentiation for majority of cell 
lines however their roles in somatic stem cells are still obscure. We demon-
strate here that activation of the Wnt/β-catenin pathway in mesenchymal 
stem cells (MSC) by co-culture with A-549 cells or by lithium ions was as-
sociated with accumulation of active forms of the β-catenin, p130 and E2f4 
but did not result in inhibition of cell cycle progression. The levels and phos-
phorylation patterns of p130, E2f4 and β-catenin in MSC did not change 
during cell cycle progression in contrast to control T98G glyoblastoma cells 
which accumulated differently phosphorylated forms of the p130 in quies-
cence and under active proliferation. During G0/G1 and S cell cycle phases 
in MSC E2f4 retained the ability to interact with p130, p130 and β-catenin 
physically bound each other, while Gsk3β bound and coprecipitated both 
p130 and β-catenin. Our results indicate that Wnt/β-catenin and pRb signal 
pathways may interact in MSC to form the p130/β-catenin/Gsk3β complex. 
Physiological relevance of such a complex may be associated with coupling 
cell cycle and differentiation in MSC related to their wide differentiation 
potential.
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IMPLANTATION INTO EXPERIMENTAL MOTOR 
CORTEX INJURIES
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It has been widely described that mesenchymal stem cells (MSC) secrete 
inflammatory mediators exerting an immunomodulatory function when 
transplanted into an injured tissue or organ. These secreted factors with 
immunomodulatory activity have been implicated in the promotion of tissue 
regeneration by stimulating proliferation, migration and differentiation of 
endogenous stem cells or tissue specific progenitor cells. In the brain, the 
main class of neuroinflamatory response molecules secreted at an injury 
site are the cytokines. Among these cytokines is the chemokine CXCL12, 
a chemoattractor for CXCR4+ cells, such as endogenous neural stem cells. 
Previous results from our lab showed that bone marrow-derived MSC (BM-
MSC) transplanted at an injury site in the motor cortex of mice modulate 
the expression of the anti-inflammatory cytokines IL-4 and IL10, and the 
pro-inflammatory IL-6 and TNF-α. These results suggest that transplantation 
of MSC could have a positive effect on different CNS pathologies, such as 
traumatic injury, ischemia and neurodegenerative disorders. Although the 
presence of MSC can be beneficial to the regenerative process, in another 
set of experiments we observed that transplanted bone marrow-derived 
mononucleated cells did not remain at the lesion site and migrated towards 
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the lateral ventricles, thus decreasing the period of time that they remained 
at the injury site. Increased permanence of transplanted cells at an injury 
site would likely increase their immunomodulatory effects, such as chemoat-
tration of neuroblasts from the subventricular zone to the lesion. Based on 
that we aimed to develop a process to retain MSC at an injury site and use 
the immobilized cells as a localized source of secreted factors. In order to 
achieve this objective we have immobilized mouse BM-MSC imbedded in 
a collagen net. This system is often used in the treatment of skin burns and 
utilizes fibroblasts to form discs called dermal equivalents (DE). In this study 
we present the MSC version of DE, which we named DiMe (mesenchymal 
discs). DiMe was prepared with MSC obtained from adult C57BL/6-Tg-
eGFP mouse femurs alone (pure DiMe) or in combination with human gingi-
val fibroblasts (mixed DiMe). Pure DiMe was prepared by immobilizing MSC 
in a collagen net, and mixed DiMe was prepared by overlaying MSC on top 
of premade DE at different periods of time: i) during DE preparation or ii) 2, 
7 or 10 days after DE was formed. After that, we analyzed the dynamics of 
disc formation as well as maintenance of MSC markers in the formed discs. 
Fixed and sectioned discs were immunostained for CD29, CD34, CD44, 
CD73 and nestin. We observed that the dynamics of pure and mixed DiMe 
contraction was similar to the dynamics of fibroblast DE contraction. Cells 
present in pure DiMe were positive for CD29, CD44, CD73, nestin and were 
negative for CD34, indicating that MSC markers were maintained after im-
mobilization. Our results suggest that MSC immobilization might be an ef-
fective tool to be used as a form of cell based therapy for CNS pathologies.
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THERAPEUTIC CAPACITY OF TYPE 2 
DIABETIC BONE MARROW DERIVED MOUSE 
MESENCHYMAL STEM CELLS IN WOUND 
HEALING
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Wound healing is the result of a series of well-orchestrated events involving 
a sequence of inflammation, proliferation and remodeling. A systemic condi-
tion such as type 2 diabetes often disrupts the ability of the body to initiate 
these phases due to a loss of blood flow and defective signaling of cellular 
activity and growth factors. These wounds persist and often lead to amputa-
tions. Bone marrow-derived mesenchymal stem cell (MSCs) therapies are 
seen as a promising new avenue for repair and regenerating tissue. Native 
MSCs exhibit the ability to contribute to a wide variety of endogenous organ 
tissue repair. We have observed acceleration in closure with the engraft-
ment of healthy non-diabetic MSCs in a slow healing type 2 diabetic mouse 
wound model. Recent studies have shown that grafted exogenous MSCs 
initiate repair but disappear long before healing is complete, suggesting 
significant host involvement in the repair process. This project focuses on the 
capacity and contribution of endogenous diabetic MSCs in the repair pro-
cess. Type 2 diabetic animals (db/db) have been utilized extensively to study 
the pathophysiology of impaired wound healing. The characterization of 
stem cells, however, in a type 2 diabetic context is still largely unknown. We 
have derived MSCs from the db/db animal and have characterized using in 
vitro and in vivo assays. We evaluated proliferative capacity using BrdU, dif-
ferentiation with induction media, and their therapeutic potential in-vivo by 
engrafting diabetic MSCs into an excisional splint wound on a diabetic and 
wild type mouse. Our results show that MSCs derived from diabetic animals 
are markedly impaired relative to their non-diabetic counterparts. The type 
2 diabetic animals have fewer endogenous MSCs but this host population 
can be expanded over time and passage in culture. The MSCs from diabetic 
animals also initially exhibited efficiency problems meaning fewer proliferat-
ing cells and greater cell death compared to their non-diabetic counterparts. 
After multiple passages, however, a subpopulation of better performing 
cells demonstrated a 4-fold increase in the percentage of proliferating cells 
and a 3-fold increase in the number of viable cells after each passage. 
These higher performing cells at passage 4 were selected and used in vivo 
to test the therapeutic capacity in accelerating wound closure. The diabetic 
MSCs were able to accelerate closure in diabetic animals suggesting a latent 
ability to stimulate signaling required for healing. They were not able to 
accelerate closure in wild type animals, an end point that the MSCs from a 
non-diabetic mouse were able to achieve. Despite these in vitro manipula-
tions diabetic MSCS still were unable to achieve the same levels of efficiency 
and therapeutic capacity as their non-diabetic counterparts suggesting an 
underlying impairment in the endogenous MSC population within the type 
2 diabetic animals. These deficiencies in this stem cell population may have 
a widespread impact throughout the body and may contribute to impaired 
tissue maintenance, wound healing, and immune system complications.
Poster Board Number: 2518
ISOLATION OF THE STROMAL/VASCULAR 
FRACTION OF MURINE BONE MARROW 
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Bone marrow (BM) stromal cells have been ascribed two key functions, 
namely as stem cells for non-hematopoietic tissues (mesenchymal stem cells, 
MSC) and secondly, as components of the stem cell niche that provides 
exogenous support for hematopoietic stem cells (HSC) in the BM. Cur-
rent approaches to the study of the stromal cell system in the mouse are 
complicated by the low yield of clonogenic progenitors (CFU-F) reported by 
many investigators. Given the perivascular location of MSC in BM reported 
in multiple publications, we developed an alternative methodology to 
isolate MSC from mouse BM which is based upon maintaining the structural 
integrity of the stromal vascular fraction of the BM. In brief, an intact ‘plug’ 
of bone marrow is expelled from bones treated with 3 sequential rounds of 
enzymatic digestion to yield a single cell suspension. The recovery of CFU-F 
obtained by pooling the product of each digestion (1917.95+/-199) repro-
ducibly exceeds that obtained using the standard BM flushing technique 
(14.32+/-1.9) by at least 2 orders of magnitude (P<0.001; N = 8) with 
an accompanying 196-fold enrichment of CFU-F frequency. Purified BM 
stromal cell populations devoid of hematopoietic contamination are readily 
obtained by FACS at P0 and demonstrate robust multilineage differentia-
tion in vitro and in vivo into bone, adipose and chondrogenic progeny. A 
detailed immunophenotypic analysis of P0 cultures identified PDGFRab+ 
stromal cell subpopulations distinguished by their expression of CD105, 
reflecting the existence of phenotypically identical subpopulations in freshly 
isolated BM cell suspensions prepared by enzyme-mediated disaggregation. 
Analysis of serially passaged PDGFRab+/CD105+ and CD105- fractions 
demonstrated that both subpopulations retained their original phenotype of 
CD105 expression. To determine whether these stromal populations also dif-
fer in their capacity to support long-term multi-lineage reconstituting HSCs, 
we fractionated P0 cultures of BM stromal cells into either the PDGFRab+/
CD105+ and PDGFRab+/CD105-phenotypes and tested their capacity to 
support LT-HSC by co-culturing each population with 10 LSKSLAM HSCs for 
10 days. Following the 10 day co-culture period, the entire contents of each 
well was collected and transplanted into a lethally irradiated Ly5.1/Ly5.2 F1 
chimeric mice along with 300,000 F1 WBM as competitor cells. Although 
both populations supported short-term repopulating HSC at 6 weeks, only 
the PDGFRab+/CD105- population was able to support long-term multi-
lineage reconstituting HSCs at 16 weeks with all recipient mice demonstrat-
ing high level donor repopulation with an average of 61% chimerism in the 
peripheral blood and 51.8% donor chimerism in the bone marrow. These 
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results demonstrate that the PDGFRab+/CD105- stromal cell subpopulation 
is distinguished by a unique capacity to support long-term reconstituting 
HSCs in vitro. In conclusion, we describe a simple and robust methodology 
that, for the first time, allows the simultaneous isolation of both the stromal 
and vascular components of mouse BM. Secondly, this technique reveals 
a level of stromal cell heterogeneity not apparent in previous analyses of 
mouse BM-derived MSC that reflects the likely complexity of stromal cell 
populations in vivo. These studies will facilitate experimental strategies 
designed to analyze the identity, anatomic location and functional properties 
of phenotypically defined subpopulations of stromal cells in mouse BM.
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BUILDING A BETTER FAT CELL IN VITRO: 
TRANSCRIPTIONAL AND EPIGENETIC ANALYSIS 
OF STEM CELL DERIVED ADIPOCYTES VERSUS 
PRIMARY ADIPOCYTES
Camahort, Raymond, Deo, Rahul, Bernstein, Bradley, Cowan, Chad
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Over the past several years it has been increasingly recognized that obesity 
is a strong contributing factor to a number of human diseases, including 
cardiovascular disease, type 2 diabetes, and cancer. In the United States, 
as the number of obese individuals has reached epidemic proportions, the 
incidence of obesity-related illness has greatly increased. In order to better 
understand the role obesity is playing in these disease states, it is imperative 
to better understand the biology of adipocytes. A well-established model of 
in vitro adipocyte function is based on the use of cultured adipose derived 
mesenchymal stem cells (ADMSCs). It has been shown that these adult 
ADMSCs can be physically transitioned from a fibroblast-like state to an 
adipocyte-like state using hormones and mitogens. Unfortunately, in vitro 
derived adipocytes do not accurately recapitulate many of the functional 
aspects of mature fat cells found in vivo. Unlike mature primary adipocytes, 
in vitro derived adipocytes do not readily form monocular lipid droplets, do 
not express high levels of the hormone Leptin, and exhibit insulin resis-
tance. Because of these deficiencies, in vitro differentiated ADSMCs do not 
represent an ideal model for understanding fat cell biology in the context 
of in vivo functionality. It is our goal to better understand the differences 
between in vitro derived adipocytes and in vivo isolated primary adipocytes, 
with the hopes of identifying novel mechanisms which may contribute to 
recapitulating the “mature” adipocyte function in vitro. To this end we 
have devised a large-scale genome-wide approach to study histone H3 
post-translational modifications and whole genome transcriptional profiles 
of both primary adipocytes and donor matched ADSMCs (undifferentiatied 
and differentiated). Using this technique we have identified several novel 
transcription factors which may play a role in fat cell development in vivo 
and contribute to achieving a more “mature” fat cell phenotype in ADMSCs 
derived in vitro.
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Cha, Byung Hyun, Kim, Jin Soo, Kang, Sun-Woong, Park, Sang 
Gyu, Lee, Soo-Hong
Biomedical science, CHA Univercity, Seoul, Korea, Republic of
Human adipose-derived stromal cells (ASCs) are a heterogeneous group of 
multipotent progenitor cells that are possible to differentiate into various 
types of cells such as adipocyte, chondrocyte, osteoblast etc. Tauroursode-
oxycholic acid (TUDCA) is a bile acid derivative that has been used in many 
countries to treat cholestatic liver disease and cholelithiasis. Recently, it has 
been reported that TUDCA not only has the ability to decrease endoplas-
mic recticulum (ER) stress, also plays a role as leptin-sensitizing agents in 
obese mice and human. In this study, we examined whether TUDCA affects 
adipogenic, chondrogenic and osteogenic differentiation of ASCs that were 
evaluated through RT-PCR, histological staining and so on. TUDCA signifi-
cantly decreased adipogenic differentiation of ASCs, while it did not affect 
osteogenic and chondrogenic differentiation. These finding demonstrates 
TUDCA treatment on stem cells would be useful as a supplemental strategy 
for anti-adipogenic differentiation without changing other lineage differen-
tiation.
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Myocardial infarction (MI) is a life threatening disease that, despite recent 
advances in its prevention and treatment, causes significant mortality. There-
fore, approaches based on adult stem cells represent a promising alterna-
tive to conventional therapies for MI. We followed a concept to engineer 
Mesenchymal Stem Cells (MSCs) which represent self renewing multipotent 
cells that can be isolated from multiple tissues towards cardiomyocyte 
progenitors. At an undifferentiated stage, MSCs have been shown to harbor 
capacity for cardiac repair and contributing to angiogenesis by paracrine 
signaling, yet so far failed to incorporate into newly forming tissue. To derive 
progenitors from MSCs which harbor cardiac differentiation and tissue inte-
gration potential, we exposed human MSCs to growth factors and cytokines 
which are known to induce the formation of early mesodermal cells in em-
bryonic stem cells. Our data show that differentiation induction of hMSCs 
towards cardiomyocytes (CMs) may be possible via stimulation through 
Activin A or PDGF-AB, leading to expression of early cardiac or pluripoten-
cy-associated markers. Flow cytometric analysis of hMSC at 7 and 10 days 
post-differentiation revealed a relatively high expression of Oct4 (60% and 
37% respectively), and the putative cardiac progenitor marker c-kit CD117 
(14% and 18%, respectively). Strikingly, expression of cardiac transcription 
factor GATA4 and pluripotency marker SOX2 were also detected. Forced 
expression of known cardiac master regulators, Baf60c, Nkx2.5 and Tbx 
5 in cells exposed to Activin A and BMP-4 further induced upregulation 
of early mesodermal cell markers T-brachyury (2 fold) and early cardiac 
marker GATA-4 (6 fold), but failed to induce transcription of mature cardiac 
markers such as troponin T and alpha-sarcomeric actin. When MSCs were 
maintained in 3D culture systems under these conditions, we observed the 
additional formation of large cell aggregates, and emergence of spontane-
ously structures beating at a frequency of 45-60/min. In summary, our data 
demonstrate that differentiation of MSCs via PDGF-AB or TGF-β, additional 
forced expression of early cardiac transcriptional regulators and 3D culture 
systems contribute to generating cells with a pre-cardiomyocyte phenotype.
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ANTI-INFLAMMATORY AND ANGIOGENIC 
EFFECTS OF ADIPOSE TISSUE DERIVED 
MESENCHYMAL STEM CELLS CULTURED IN 3D 
SPHEROIDS
Park, Su-Jin, Roch, Manfred, Stachelscheid, Harald, Kurtz, Andreas
Berlin-Brandenburg Center for Regenerative Therapies, Charite - 
Universitätsmedizin Berlin, Berlin, Germany
Mesenchymal stem cells (MSC) have been reported to possess immunomod-
ulatory properties. We investigated whether the anti-inflammatory effects 
of MSC impact endothelial cells and modulate angiogenesis. In addition, we 
compared the immunomodulatory and angiogenic effects of MSC derived 
from adipose tissue that were cultured as 3D spheroids with that of MSC 
grown in conventional adherent 2D cultures. We measured cytokine levels 
after co-cultivation of 3D spheroids in a mixed lymphocyte reaction (MLR) 
assay. For determination of the combined effect on angiogenesis and inflam-
mation a co-culture of MSC with endothelial cells and inflammatory cells 
was analyzed in a boyden chamber system regarding the effect of the MSC 
on angiogenesis. Previous reports suggested that culture as 3D aggregates 
or as spheroids can increase the therapeutic potential of the adult stem/pro-
genitor cells. Also, MSC show induction of vasculogenesis in an inflamma-
tory environment in vivo. The interaction between MSC, inflammation and 
angiogenesis on the cellular level is not understood. We suggest that MSC 
3D spheroids derived from adipose tissue show direct anti-inflammatory 
effects. Furthermore, we suggest that the anti-inflammatory effects are at 
least partially mediated by endothelial cells. Finally, we provide data that 
the effect of MSC on endothelial cells is modified by the inflammatory and 
cellular environment.
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Pre-clinical studies have supported the use of mesenchymal stem cells (MSC) 
to treat highly prevalent neurodegenerative diseases such as Parkinson’s 
disease (PD) but preliminary clinical trials have reported controversial results. 
We first observed that transplantation of human umbilical cord-derived MSC 
(hUC-MSC) in a rat model of PD induced by MPTP neurotoxin resulted in 
clinical improvement. However, surprisingly, intracerebral administration of 
fibroblasts as a xenotransplantation control was highly detrimental, causing 
significant degeneration of SN neurons and motor deficits independently of 
MPTP. This observation prompted us to further investigate the consequences 
of transplanting a heterogeneous hUC-MSC preparation, simulating con-
tamination with human fibroblasts which is plausible since they also express 
typical MSC markers. Here we show for the first time, using the same exper-
imental model and protocol, that while transplantation of hUC-MSC resulted 
in clinical benefit, co-transplantation with fibroblasts reverted therapeutic ef-
ficacy and caused opposite damaging effects. Engraftment and intracerebral 
distribution after intrastriatal administration were similar for both hUC-MSC 
and fibroblasts. MPTP induced significant loss of dopaminergic neurons in 
the substantia nigra (SN) ensuing motor deficits in sham rats. Transplanta-
tion of hUC-MSC early after MPTP injury caused a significant bilateral pres-
ervation of SN neurons and prevented later manifestation of motor deficits 
typically observed in PD such as hypokinesia, catalepsy, and bradykinesia. 
However, administration of hUC-MSC preparations deliberately contaminat-
ed with fibroblasts was not able to ameliorate the neurotoxic and behavioral 
effects of MPTP and further enhanced neurodegeneration in both control 
and MPTP-exposed rats. These findings suggest that, while hUC-MSC may 
induce potent neuroprotective adjustments in the brain, contamination with 
fibroblasts, another type of mesenchymal cell without stem cell properties, 
may cause opposite effects accelerating neurodegeneration. These findings 
might also explain discrepant results reported by different groups and indi-
cate that purity of MSC preparations must be carefully considered in clinical 
trials. In addition, our pre-clinical study provides a rationale for testing MSC 
transplantation in early phases of PD, aiming at delaying disease progression 
and intensification of motor deficits.
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MESENCHYMAL STROMAL CELLS FROM THE 
CHORIONIC VILLI OF TERM PLACENTA ARE 
MULTIPOTENT. HAVE EMBRYONIC FEATURES 
AND ARE OF MATERNAL ORIGIN
Saadatzadeh, Mohammad R., Bhavsar, Janak, Rapp, Brian, Jester, 
Andrea, Grimes, Brenda R., March, Keith L., Murphy, Michael P.
Indiana University School of Medicine, Indianapolis, IN, USA
Objective. Mesenchymal stromal cells (MSC) possess unique biological 
characteristics that present significant potential for regenerative therapies. 
MSCs were originally isolated from adult bone marrow (BM); however, 
adipose tissue, umbilical cord blood and matrix, and decidua of placenta are 
all sources of MSCs. The origin of MSCs is believed to be pericytes located 
in the stromal fraction of blood vessels. Thus, we hypothesized that the cho-
rionic villi, a microvascular bed that constitutes the majority of the decidual 
plate, would be a rich source of placenta derived MSCs (PMSC) that may 
possess embryonic features and pluripotentiality. Methods. The vascular 
lobules of term human placenta were dissected, debrided mechanically to 
expose the terminal villius, then minced and digested with trypsin and colla-
genase. The homogenate was washed in phosphate buffered saline and cells 
plated on plastic with Mesocult medium for 14 days. Expanding colonies 
were detached and replated for purity. Cells were analyzed using fluores-
cent assisted cell sorting (FACS), permissive differentiation culture assays, 
and fluorescent in situ hybridization (FISH) with sex chromosome probes. 
Results. Placenta cells plated on plastic produced rapidly expanding colonies 
exhibiting MSC morphology. FACS demonstrated that pMSCs express CD 
13, 29, H-CAM (CD44), 73, THY-1 (CD90), 105, 140b and did not express 
CDs: 14, 31, 34, 45, 133, 140a, 144 and HLA-DR, a phenotype consistent 
with MSCs. PMSCs express the embryonic markers Oct-4, Nanog, SSEA-3 
and SSEA-4. In permissive culture assays, PMSCs were shown to differenti-
ate into adipocytes, osteoclasts, myocytes and neurons. Using FISH analysis 
with Y-chromosome probes, we found that 85.6 + 1.2% PMSCs were found 
to be of female origin. Conclusions. PMSCs derived from the chorionic villi 
express the surface antigen phenotype characteristics of MSCs and uniquely 
possess embryonic markers. These PMSCs are capable of differentiating into 
multiple mesenchymal lineages demonstrating their pluripotency. PMSCs 
are of maternal origin; thus, there exists chimeric tolerance of fetal and 
endometrial vascular cells in the chorionic villi which may translate into im-
munotolerance with transplantation into mother or child. Most importantly, 
PMSCs represent a novel source of mesenchymal stem cells that may have 
utility in the treatment of homozygous recessive diseases such as Duchene’s 
muscular dystrophy.
ISSCR 9th Annual Meeting
142
www.isscr.org
Friday Poster Abstracts
Poster Board Number: 2532
FASL-INDUCED KILLING TARGETS 
MESENCHYMAL STEM CELLS 
DIFFERENTIATING INTO BONE MORE THAN 
DIFFERENTIATING ADIPOCYTES
Rodrigues, Melanie1, Griffith, Linda2, Wells, Alan1
1Department of Pathology, University of Pittsburgh, Pittsburgh, PA, 
USA, 2Department of Biological Engineering, Massachusetts Institute of 
Technology, Cambridge, MA, USA
Mesenchymal stem cells (MSC) or multipotential stromal cells have been 
proposed for the regeneration of cranio-facial injuries and lesions in long 
bones due to their ability to form osteoblasts. However a major hindrance 
encountered during MSC transplantation is the initial loss of cells follow-
ing implantation. This cell death is likely due, at least in part to ubiquitous 
non-specific inflammatory signals like those of FasL and TRAIL generated 
in response to the wound environment into which these cells are delivered. 
Our group previously found that epidermal growth factor (EGF) signaling 
promotes stem cell expansion while not inducing differentiation. Further, we 
also showed that tethering EGF (tEGF) to a biomaterial substratum protects 
MSC from FasL-induced cell death. These findings suggested that EGF 
could be used both to expand the MSC and protect them in the wound site. 
However, we needed to determine whether the sensitivity to inflammatory 
signals is altered as MSC differentiate. On subjecting MSC to differentiation, 
we found that MSC readily differentiated into both osteoblasts and adipo-
cytes. However, these MSC-derived pre-osteoblasts became more suscepti-
ble to FasL-induced cell death, while differentiating adipocytes became more 
resistant to FasL-induced death. This coincided with receptor levels for FasL 
increasing in osteogenic cells and decreasing in adipogenic cells. Receptors 
for EGFR also increased in osteoblasts and decreased in adipocytes. tEGF did 
not alter the reduced cell death observed in FasL treated adipocytes. We are 
currently testing for survival using tEGF in differentiating osteoblasts treated 
with FasL. Preliminary tests with Tenascin-C a low affinity but high avidity 
EGFR ligand, which like tEGF also signals from the cell surface has shown to 
protect MSC from FasL induced cell death. Taken together, our results sug-
gest that both MSC and differentiating osteoblasts need protective signals 
to survive in the implanted bone wound milieu to help regenerate bone and 
prevent fat formation, and that tethered EGF would serve this function.
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MESENCHYMAL STEM CELLS STIMULATE 
THEIR OWN DEATH IN THE PRESENCE OF 
FASL BY PRODUCTION OF REACTIVE OXYGEN 
SPECIES
Rodrigues, Melanie1, Turner, Omari2, Stolz, Donna B.3, Griffith, 
Linda G.4, Wells, Alan1
1Department of Pathology, University of Pittsburgh, Pittsburgh, PA, USA, 
2Meharry Medical College, Nashville, TN, USA, 3Department of Cell 
Biology, University of Pittsburgh, Pittsburgh, PA, USA, 4Department of 
Biological Engineering, Massachusetts Institute of Technology, Pittsburgh, 
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Multipotential stromal cells/mesenchymal stem cells (MSC) can be differenti-
ated into osteoblasts and chondrocytes, making these cells candidates to 
regenerate cranio-facial injuries and lesions in long bones. A major problem 
with MSC replacement therapy however is the loss of transplanted cells at 
the site of the graft. Studies done in vitro show that one of the main reasons 
behind this MSC death is by paracrine reactive oxygen species (ROS) signal-
ing and effects of pro-death cytokines such as FasL and TRAIL, generated 
in the wound milieu. We hypothesized that MSC themselves produce ROS 
under cytokine challenge. To test our hypothesis, MSC were treated with 
FasL alone or FasL and the protein synthesis inhibitor cycloheximide. We 
observed ROS generation within two hours of FasL treatment that the anti-
oxidant n-acetyl cysteine was able to curtail. Addition of epidermal growth 
factor (EGF), a cell survival factor was also able to protect MSC from FasL 
induced ROS production initially; however the protective effect waned with 
continued FasL exposure. Along with increased ROS, FasL induced upregula-
tion of the uncoupling protein UCP2, the main uncoupling protein in MSC, 
known to reduce mitochondrially generated ROS. The increase in UCP2 
seems to be a compensatory mechanism to moderate increased ROS; how-
ever the FasL treated MSC ended in apoptotic cell death. These data suggest 
that MSC participate in their own demise due to non-specific inflammation, 
holding implications for replacement therapies.
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DERIVATION OF ISLET LIKE CELLS FROM 
MESENCHYMAL STEM CELLS USING PDX1-
TRANDUCING LENTIVIRUSES
Talebi, Samira1, Aleyasin, Ahmad1, Massumi, Mohammad1, 
Soleimani, Masoud2
1Medical Genetic, Natianal Institute of Genetic Engineering and 
Biotechnology, Tehran, Iran, Islamic Republic of, 2Medical, Tarbiat Modares 
University, Tehran, Iran, Islamic Republic of
Type1 diabetes is generally caused by insulin deficiency because of destruc-
tion of islet beta cells and differentiated mesenchymal stem cells (MSCs) can 
be therapeutic source for the cure of type 1 diabetes. The aim of current 
experiment is to explore the possibility of derivation of insulin producing 
cells from bone marrow mesenchymal stem cells in vitro by overexpres-
sion of pdx1 transcription factor. In this study rat MSCs were isolated and 
differentiated into adipocyte and osteocyte by differentiating medium to 
confirm of their multipotency. Pdx1-harboring lentiviruses were generated 
by transfection of three necessary plasmids (psPAX2, pMD2G, LV-105_pdx-
1) into HEK293 cells. Then MSCs were transduced by pdx1-lentiviruses and 
pdx1-expressing cells were puromycin (2500ng/ml). The appropriate expres-
sion of exogenous pdx1 was confirmed in the level of mRNA and protein us-
ing RT-PCR and immunofluorescent analysis. The immunoflurescent showed 
a nuclear localization in pdx1-expressing cells. Also expression of ngn3, 
glucagon, insulin1, insulin2 as specific markers of β-cells was investigated 
by quantitative RT-PCR. These differentiated cells also expressed glucoki-
nase (GK) and glucose transporter 2 (Glut2), indicating that the differenti-
ated cells had the glucose-sensing ability. MSCs and pdx1-infected MSCs 
expressed detectable level of the mentioned genes with the exception of 
gapdh gene. In conclusion, MSCs as an easy and available resource can have 
impacted in cell based gene therapy of type1 diabetes.
Poster Board Number: 2538
EXPRESSION OF PDX1 PROMOTE DERIVATION 
OF BETA CELLS FROM MESENCHYMAL STEM 
CELLS
Talebi, Samira1, Aleyasin, Ahmad1, Soleimani, Masud2, Massumi, 
Mohammad1
1Medical Genetic, Natianal Institute of Genetic Engineering and 
Biotechnology, Tehran, Iran, Islamic Republic of, 2Medical, Tarbiyat 
Modares University, Tehran, Iran, Islamic Republic of
The transplantation of pancreatic cells is a promising approach for treat-
ment of type1 diabetes that generally caused by insulin deficiency because 
of destruction of beta cells; however, lack of suitable donors limits the ap-
plication. Therefore, differentiated mesenchymal stem cells (MSCs) can be 
therapeutic source for the cure of type 1 diabetes. The aim of current experi-
ment is to explore the possibility of derivation of insulin producing cells from 
bone marrow mesenchymal stem cells in vitro by overexpression of pdx1 
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transcription factor. In this study rat MSCs were isolated and identified by 
flow cytometry that showed high level of CD29, CD90 and not detect-
able level of CD45 which proved the lack of hematopoietic contamination. 
Pdx1-harboring lentiviruses were generated. Then, MSCs were transduced 
by pdx1-lentiviruses and pdx1-expressing cells were selected by puromycin. 
The appropriate expression of exogenous pdx1 was confirmed in the level of 
mRNA and protein using RT-PCR and immunofluorescent analyses. In addi-
tion to ectopic expression of pdx-1 gene, differentiating medium contain-
ing nicotinamid and beta mercaptoethanol (Nico/betaME) used to efficient 
differentiation of rat mesenchymal stem cells into beta like cells. Then, the 
expression of islet specific markers was investigated by quantitative RT-PCR. 
The immunoflurescent showed a nuclear localization pdx1. Pdx1-expressing 
MSCs transcribed specific pancreatic endocrine markers such as endogenous 
Pdx1, Ngn3, Glucagon and insulin regardless to using Nico/betaME, but the 
quantitative RT-PCR showed an high increase in all markers except insulin, 
in Nico/betaME treated cells compared to non-treated cells. The beta like 
cells derived from MSCs also expressed glucokinase and glucose transporter 
2 (Glut2) indicating that these cells have the glucose sensing ability. In 
contrast, treated MSCs didn’t express P48, one of the exocrine markers; it 
implies that these cells have been committed to endocrine linage. In conclu-
sion, MSCs as an easy and available resource can have impacted in cell 
based gene therapy of type1 diabetes.
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SIGNIFICANCE OF TOPOGRAPHY AND 
EXTRACELLULAR MATRIX COMPONENTS IN 
STEM CELL DIFFERENTIATION
Teo, Benjamin, Kim Kiat1, Yap, Chong Hao2, Yim, Evelyn K F3
1Mechanobiology Institute Singapore, Division of Bioengineering, National 
University of Singapore, Singapore, Singapore, 2Mechanobiology Institute 
Singapore, National University of Singapore, Singapore, Singapore, 
3Division of Bioengineering, Mechanobiology Institute Singapore, 
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Singapore
When stem cells are removed from the in vivo stem cell niche, they can dif-
ferentiate spontaneously in vitro but this differentiation process is inefficient, 
uncontrolled and often results in highly heterogeneous cell population. A 
crucial strategy of regenerative medicine is to understand how to control the 
microenvironment surrounding the cells to restore the niche equilibrium cru-
cial for dictating stem cell fate. A typical strategy is to enrich the biochemical 
environment in the in vitro culture medium with a combination of soluble 
growth factors, cytokines and /or serum protein, in order to induce the stem 
cells to differentiate preferentially into a particular lineage. Interestingly, 
stem cells that were cultured on physical topographical patterns were also 
directed to preferential lineage, showing the importance of the physical geo-
metrical environment in the stem cell niche. In this study, we investigated 
the significance of both extracellular matrixes (ECM) and topography in di-
recting the differentiation of mesenchymal stem cells (MSCs). We hypothe-
size that topography is able to preferentially direct stem cell lineage through 
mechanotransduction while ECM components are able to synergistically 
direct stem cell fate. Fibronectin, vitronectin, Collagen I, Laminin and Poly-
L-Lysine were coated on polydimethylsiloxane (PDMS) patterned substrates 
culturing MSCs on these differently coated PDMS patterned substrates using 
a defined medium. Immunostaining of the hMSCs demonstrated a vastly dif-
ferent morphology across the different ECMs, with or without the presence 
of physical topographical patterns. This suggests that both ECM and topo-
graphical patterns play a role in dictating the cellular morphology of MSCs. 
Gene expression analysis of the hMSCs however, suggests that the effect of 
physical topography is stronger than the constituents of the ECM coating, 
with a possible synergistic effect for laminin. The results provide insights to 
the significance of ECM and topography in directing stem cell fate.
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AUTOLOGOUS CHONDROCYTES PROMOTE IN-
VITRO CHONDROGENIC DIFFERENTIATION OF 
BOVINE MESENCHYMAL STEM CELLS
Yang, Yueh-Hsun, Barabino, Gilda A.
Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA, USA
Tissue engineering approaches to articular cartilage regeneration hold 
promise, yet the complexities in incorporating appropriate cell sources in bio-
processing conditions that optimize the development of tissue-engineered 
constructs remain a challenge. Although articular chondrocytes have been 
widely used in cartilage tissue engineering, several limitations have been 
identified, for example, the invasive surgical procedures for chondrocyte 
extraction and the limited ability of harvested cells to grow and proliferate. 
Due to multipotency and self-renewal capacity, adult mesenchymal stem 
cells (MSCs) have been considered a substitute for chondrocytes. However, 
one of the major challenges of MSC applications in tissue engineering is to 
precisely control their differentiation into a desired lineage. Some groups 
have utilized chondroinductive molecules, such as transforming growth 
factor-β family, to successfully induce a certain level of MSC chondrogenic 
differentiation in vitro, yet the engineered tissue fails to meet the functional 
criteria achieved by chondrocyte constructs. A possible explanation is that 
the addition of single or multiple inductive factors to the culture systems is 
not sufficient to induce complete MSC differentiation. Clinically, although 
MSC transplantation has been utilized in cartilage repair, the mechanisms 
that promote MSC differentiation is not fully understood. The present study 
aims to evaluate the feasibility of chondrocyte-MSC co-culture approaches 
to the regeneration of clinically relevant cartilage replacements by studying 
the paracrine regulation of the two populations in a simple model that mim-
ics clinical MSC transplantation. We hypothesized that synergism between 
chondrocyte-generated signals can trigger and stimulate complete chon-
drogenic differentiation of MSCs that coexist in the system. To eliminate the 
interference with cell differentiation caused by medium supplements, the 
co-culture system was established by cultivating bovine chondrocyte pellets 
and autologous MSC monolayers with a serum-free, growth factor-free 
medium in the different compartments separated by a transmembrane film 
with 0.4-µm pores for 15 days. The intensity of chondrocyte-secreted signals 
was regulated by altering the ratios between the two populations. Har-
vested monolayer cells were characterized based on gene expression, matrix 
secretion, and morphology.  Our data demonstrate that higher chondrocyte 
proportion is required for the monolayer cells to exhibit chondrocyte-specific 
gene expression profile. For example, elevated mRNA expression of type II 
collagen was detected in the groups where the initial chondrocyte-to-MSC 
ratio was at least 30. The immunofluorescent and histological staining fur-
ther revealed that type II collagen and proteoglycan were highly expressed 
by the differentiated cells in these groups. Morphologically, the monolayer 
cells co-cultured with massive chondrocytes (60-fold greater in population) 
began forming the structure of cell clusters or aggregates after 15 days in 
culture. This evidence substantiates that primary chondrocytes provide es-
sential inductive factors that are required to promote MSC chondrogenic dif-
ferentiation and that the differentiated cells can mimic chondrocyte behavior 
and phenotype. Further development of the present model will be necessary 
to identify these inductive molecules and to incorporate this approach with 
tissue engineering strategies.
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PROTEOMIC COMPARISON OF BETA CELLS 
OBTAINED FROM MESENCHYMAL STEM-LIKE 
CELLS DERIVED FROM PANCREATIC ISLETS 
AND BONE MARROW MESENCHYMAL STEM 
CELLS
Zanini, Cristina1, Baci, Denisa1, Mandili, Giorgia2, Bruno, Stefania1, 
Forni, Marco1, Izzi, Leo3
1Department of Molecolar Biotechnology Centre (MBC), University of 
Turin, Turin, Italy, 2Research Centre for Experimental Medicine (CeRMS), 
University of Turin, Turin, Italy, 3EuroClone S.p.A., Pero (Mi), Italy
In the present work we report a proteomic study comparing stem cells of dif-
ferent sources isolated by research teams of the collaborative PISTEM project 
of the Piemonte Region. Human islet-mesenchymal stem cells (HI-MSC) 
and bone marrow mesenchymal stem cells (BM-MSC) were conditioned in 
custom-made serum free culture media in order to induce differentiation 
toward pancreatic β cells. HI-MSC and BW-MSC (courtesy of Prof. Camussi, 
MBC, University of Turin) were phenotyped by flow cytometry for specific 
antigens including CD105, CD29, CD73, CD166, CD146, CD44, CD90, 
vimentin, and nestin. HI-MSC and BW-MSC were differentiated into β cells 
with a medium containing: DMEM low glucose, platelet lysate, retinoic acid, 
activin A, GLPI-1 (glucagon like peptide 1), EGF (epidermal growth factor), 
FGF (fibroblast growth factor), betacellulin, nicotinamide and glutamine. In 
order to demonstrate β-cell induction, indirect immunofluorescence was per-
formed on differentiated cells with antibodies against the following proteins: 
PDX1 (pancreatic duodenal homeobox gene-1), insulin, and C peptide. 
Ultrastructural analysis revealed secretory granules. An ELISA test indicated 
that the cells began to secrete insulin into the culture medium after differen-
tiation. Proteomic techniques were applied to HI-MSC and BM-MSC before 
conditioning to study differences in protein expression inherent to stem cells 
from different origins, and after conditioning to evaluate modifications of 
the proteomic profile after in vitro differentiation into pancreatic β cells. HI-
MSC, BM-MSC and their derived β cells were analyzed by two-dimensional 
gel electrophoresis and characterized by matrix-assisted laser desorption/
ionization time of flight (MALDI-TOF) mass spectrometry analysis. All cell 
lines showed different proteomics patterns with few overlaps: only 11 pro-
teins were in present in all cells. HI-MSC contained 19 unique proteins, while 
BM-MSC had 37. The two populations of mesenchymal stem cells expressed 
proteins with known functions in embryonic and postnatal growth such as 
STK36 hedgehog signalling pathway protein, enzymes, chaperonins and 
anti-oxidant proteins. β cells from different MSC origins showed a drastic 
decrease of the total number of proteins. Only one protein, apolipoprotein I, 
was induced by conditioning in β cells derived from HI-MSC and BM-MSC. 
A limited number of proteins were present in β cells and the original con-
trols: PDIA1, PDIA3, GPR78, vimentin, CH60 and triphosphates isomerase. 
The differentiated cells maintained a proteomic profile restricted to the cell 
type of origin and expressed a specific set of new proteins. In conclusion 
the proteomic analysis give new insights in the process of differentiation: a) 
the differences in proteomic profile between HI-MSC and BM-MSC, b) the 
reduction of the number of proteins after differentiation into β cells, and c) 
the generation of a different repertoire of proteins upon differentiation of 
two MSC populations into β cells with the identical conditioning process.
PRE-CLINICAL AND CLINICAL APPLICATIONS OF 
MESENCHYMAL CELLS
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HUMAN MESENCHYMAL STEM CELLS 
TRANSPLANTATION PROTECTS AGAINST 
SOCIAL DEFICIT EXHIBITED BY THE SUBACUTE 
PHENCYCLIDINE MOUSE MODEL OF 
SCHIZOPHRENIA
Barzilay, Ran, Ben-Zur, Tali, Sadan, Ofer, Bren, Ziv, Tarasenko, Igor, 
Uzan, Ravit, Lev, Nirit, Taler, Michal, Gil-Ad, Irit, Melamed, Eldad, 
Weizman, Abraham, Offen, Daniel
Felsenstein Medical Research Center, Tel Aviv University, Petach-Tikva, 
Israel
Background: Stem cell based regenerative therapy is considered a promis-
ing cellular therapeutic approach, bringing hope for patients affected with 
incurable brain diseases. Mesenchymal stem cells (MSCs) represent an 
attractive cell source for regenerative medicine strategies for the treatment 
of neurodegeneration. Previous studies have shown that these cells are 
efficient in treating animal models of Parkinson’s and Huntington’s disease. 
Schizophrenia (Sz) is a devastating brain disease with poor prognosis. 
Beside a neurodevelopmental element, the pathophysiology underlying 
Sz involves neurodegeneration, impaired neurogenesis and alterations in 
neurotrophic factors availability. In the current study, we sought to explore 
the prospect of intracerebral MSCs transplantation for treating the social 
impairment endophenotype displayed by a mouse Schizophrenia model. 
Methods: Phencyclidine (PCP) was administered subcutaneously to C57bl 
mice (10mg/kg daily for 2 weeks). Adult Human Mesenchymal Stem Cell 
transplantation into the prefrontal cortex was conducted on the day of first 
PCP administration. Social preference test was conducted 10 days follow-
ing the last PCP administration. Results: The results show that human MSCs 
transplantation into the prefrontal cortex results in a significant reduction in 
the impairment in social preference induced by the PCP insult, as observed 
by the social preference test. Importantly, no reduction of the social impair-
ment was observed upon daily clozapine treatment. Immunohistochemical 
analysis of the mice brains revealed that the human cells survived in the 
mice brain throughout the course of the experiment (24 days). ELISA of the 
cortices revealed significantly higher BDNF levels in the stem cell treated 
group. Furthermore, Western blot analysis has shown that MSCs transplan-
tation to the cortex prevented the significant reduction in Akt phosphoryla-
tion following the PCP treatment. Conclusion: Delivery of MSCs to distinct 
brain regions involved in the pathophysiology of schizophrenia is beneficial 
in attenuating the behavioral deficits exerted by the PCP insult. We hereby 
present a novel therapeutic approach for the treatment of Schizophrenia 
negative symptoms.
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DEVELOPMENT OF A SERUM-FREE HUMAN 
BONE MARROW MESENCHYMAL STEM CELL 
EXPANSION SYSTEM SUPPORTS SUPERIOR 
GROWTH PERFORMANCE AND RETENTION OF 
MULTIPOTENCY AND IMMUNOPHENOTYPE
Blaesius, Rainer1, Crapnell, Kirsten1, Hastings, Abel1, Gottlieb, 
Megan1, Lennon, Donald P.2, Bruder, Scott P.3, Caplan, Arnold I.4
1Cell and Tissues, BD Technologies, Research Triangle Park, NC, USA, 
2Skeletal Research Center, Case Western Reserve University, Cleveland, OH, 
USA, 3BD, Franklin Lakes, NJ, USA, 4Biology and General Medical Sciences 
(Oncology), Case Western Reserve University, Cleveland, OH, USA
Fulfilling the clinical promise of mesenchymal stem cells (MSCs) in cell thera-
py and tissue engineering will require solutions to reliably expand and manu-
facture these primary cells. MSC expansion has traditionally employed serum 
supplementation of growth media, but serum presents challenges due to its 
lot-to-lot variation, chemically undefined nature, and potential for transmis-
sion of infectious agents. A novel serum-free MSC expansion medium, BD 
MOSAIC™ , yields proliferation in culture significantly exceeding that of 
cells in conventional serum-containing medium through multiple passages. 
Cells expanded in this serum-free medium maintained their multipotency in 
in vitro adipogenic, chondrogenic and osteogenic differentiation protocols 
as measured by lipid accumulation, glycosaminoglycan accumulation, and 
alkaline phosphatase induction, respectively. Serum free-expanded cells 
also maintained the consensus MSC immunophenotype (positive for CD73, 
CD90, CD105; negative for CD14, CD34, CD79a, HLA-DR). The immu-
nomodulatory ability of serum free-expanded cells was likewise equivalent 
to that of serum-expanded cells in an in vitro T-cell proliferation assay. This 
chemically defined medium, developed through the application of bioinfor-
matic and screening principles, may thus assist in the progress of MSCs from 
the laboratory bench to the clinic.
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THERAPEUTIC APPLICATION OF HUMAN 
MULTIPOTENT MESENCHYMAL STROMAL 
CELLS FROM VARIOUS TISSUES IN ALLERGIC 
ASTHMA
Heng, Tracy SP, Mathias, Louisa J., Boyd, Richard L.
Monash Immunology and Stem Cell Laboratories, Monash University, 
Clayton, Australia
Multipotent mesenchymal stromal cells (MSCs) are fibroblastic cells from 
the bone marrow with the ability to expand in culture and differentiate into 
bone, cartilage and fat in vitro. MSCs can home to sites of tissue injury and 
produce soluble factors to alleviate inflammation and aid in tissue repair. 
Clinical experience has shown MSC administration is safe and can promote 
haematopoietic engraftment and control graft-versus-host disease. We 
have investigated alternative human tissue sources of MSCs and found that 
their immunosuppressive capacity is highly comparable, if not superior, to 
bone marrow MSCs. As systemically infused MSCs are rapidly cleared from 
the blood and travel to the lungs where they can exert anti-inflammatory 
effects, we utilised a mouse model of allergic asthma to test the efficacy 
of MSC treatment. Asthma is a serious and common condition, and for 
many sufferers there is only limited control and rarely resolution. We found 
that administration of MSCs decreases eosinophilic infiltration and T cell 
responsiveness to antigen restimulation, including proliferation, IL-5 and 
IL-13 production. The inhibitory effects of MSCs are crucially dependent on 
the number of injections and timing of treatment. Our results have clinical 
implications in the therapeutic application of MSCs in asthma and other 
inflammatory diseases of the lungs and airways.
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Hepatocellular carcinoma (HCC) is the fifth most common malignancy and 
the third cause of cancer-related death worldwide. Unfortunately, the inci-
dence and mortality associated with HCC is increasing steadily. In the major-
ity of patients HCC is associated with advanced fibrosis or cirrhosis. Several 
proinflammatory cytokines, chemokines and growth factors are produced 
by tumor stroma and also by cirrhotic livers. It is known that mesenchy-
mal stromal cells (MSCs) have the ability to migrate to sites of injury or to 
remodeling tissues after in vivo administration. The aim of this work was to 
study the mechanisms involved in human MSCs (hMSCs) migration and an-
chorage to HCC in order to use them for delivery of therapeutic genes. For 
that purpose, in vitro migration was studied by modified Boyden chambers, 
observing that MSC displayed a high migration towards conditioned me-
dium (CM) derived from human HCC cell lines (Hep3B, HuH7, PLC/PRF/5, 
HC-PT-5), from human tumor samples and also from human hepatic stellate 
cells (LX-2 cell line), but not to components of the stroma such as fibroblast 
or endothelial cells. We also observed that CM obtained from monolayer 
tumor cells induced higher migration in hMSCs than CM obtained from ex 
vivo tumors and also from multicellular spheroids composed by tumor cells, 
endothelial cells and activated hepatic stellate cells. Adhesion of hMSCs was 
observed at 5 min after exposure to tumor CM to fibronectin and collagen 
and at 30 min to endothelial cells. To further characterize the effect of HCC 
CM on hMSCs, invasion assays were performed observing that CM from 
HCC cell lines and LX-2 induced hMSC invasion to fibronectin and collagen 
and also increased metalloproteinase activity (MMP-2). In order to evaluate 
hMSC in vivo migration, HCC cell line HuH7 was subcutaneously inoculated 
in BALB/c nude mice and then CMDiI-DiR-labeled hMSCs were intrave-
nously injected. Biodistribution of hMSCs was monitored by biolumines-
cence imaging using the Xenogen In Vivo Imaging System. Within the first 
hour, hMSCs located into the lungs; after 24 hours cells were observed also 
in the liver and spleen and around 7 days hMSCs were identified within the 
tumors. However, CM derived from tumors but not from spleen, liver or 
lungs induced hMSC migration in vitro. Mice were sacrificed and the pres-
ence of hMSCs was confirmed by visualization of CMDiI positive cells in the 
isolated organs. Our results indicate that factors produced by HCC and acti-
vated stellate cells induced hMSC migration, adhesion to extracellular matrix 
components and invasion capacity. Our results also demonstrate that CM 
obtained from monolayers cultures induced higher levels of hMSC migration 
in comparison with CM obtained from fresh tumors, indicating the relevance 
of studying hMSC migration in “a real system”. A proper understanding of 
hMSC migratory mechanisms to the tumor sites could have important impli-
cations for effective cellular delivery of therapeutic agents in HCC therapies.
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TRANSPLANTATION OF HUMAN ADIPOSE 
TISSUE-DERIVED MULTILINEAGE PROGENITOR 
CELLS REDUCES SERUM CHOLESTEROL 
AND THE EFFECTS COULD BE AUGMENTED 
BY HMG-COA REDUCTASE INHIBITOR IN 
HYPERLIPIDEMIC WATANABE RABBITS.
Saga, Ayami1, Okura, Hanayuki1, Soeda, Mayumi1, Tani, Junnko1, 
Moriyama, Mariko1, Moriyama, Hiroyuki2, Yamashita, Shizuya3, 
Ichinose, Akihiro4, Tahara, Shinya4, Hayakawa, Takao2, Matsuyama, 
Akifumi1
1Foundation for biomedical research and innovation, Kobe, Japan, 
2Pharmaceutical Research and Technology Institute, Kinki University, Osaka, 
Japan, 3Osaka University Graduate School of Medicine, Osaka, Japan, 
4Kobe University Hospital, Kobe, Japan
Familial hypercholesterolemia (FH) is an autosomal codominant disease 
characterized by high concentrations of proatherogenic lipoproteins and 
premature atherosclerosis secondary to low-density lipoprotein (LDL) 
receptor deficiency. We have supposed that human adipose tissuederived 
multilineage progenitor cells (hADMPCs) localized in the portal triad after 
transplantation via portal vein, subsequently integrated into the hepatic 
parenchyma and showed hepatocytic differentiation in vivo and lowered 
serum cholesterol in the WHHL rabbits, indicationg that hADMPCs-trans-
plantation via portal vein might be a novel cell therapy strategy for the 
treatment of FH in the Watanabe heritable hyperlipidemic (WHHL) rabbit, 
an animal model for homozygous FH. Here we examined whether HMG-
CoA reductase inhibitor pravastatin, which could correct the metabolic 
defects of heterogeneous FH via LDL receptor up-regulation, could augment 
the effect of serum cholesterol reduction onto immunosuppressed WHHL 
rabbit transplanted hADMPCs via portal vein. Transplantation of hADMPCs 
via portal vein resulted in significant reductions in total cholesterol, and the 
reductions maintained for 12 weeks. Then the WHHL rabbits were received 
HMG-CoA reductase inhibitor pravastatin i.m. or not. Four weeks after 
administration of HMG-CoA reductase inhibitor, the lipid profilings were 
examined. Total cholesterol levels and LDL-cholesterol levels of HMG-CoA 
reductase inhibitor treated WHHL rabbits were significantly lower than those 
of placebo-treated ones. On the other hand, high-density lipoprotein (HDL)-
cholesterol levels of HMG-CoA reductase inhibitor treated group were 
higher than those of placedo-treated. To confirm the HMG-CoA reductase 
up-regulated LDL-receptor on hADMPCs-derived hepatocytes, we exam-
ined LDL turnover studies using 125I-labelled LDL. 125I-LDL turnover study 
showed that the 24 hour clearance rate of LDL was significantly higher and 
LDL half life was significantly shorter in the hADMPCs transplanted-WHHL 
rabbits treated with HMG-CoA reductase inhibitor than those of non-treat-
ed. Previously reported that hepatocytes of WHHL rabbit could not express 
functional LDL-receptor, and no significant effects could be observed by 
MHG-CoA reductase inhibitor. Our results suggested that transplantation of 
hADMPCs reduces serum cholesterol and the effects could be augmented 
by HMG-CoA reductase inhibitor in hyperlipidemic Watanabe rabbits. These 
results indicated the in situ stem cell therapy in coordination with drugs, as 
novel strategy for regenerative medicine.
Poster Board Number: 2558
TRANSPLANTATION OF HUMAN ADIPOSE 
TISSUE-DERIVED MULTILINEAGE PROGENITOR 
CELLS BUT NOT ADIPOSE TISSUE-DERIVED 
STROMAL STEM CELLS REDUCES SERUM 
CHOLESTEROL IN HYPERLIPIDEMIC WATANABE 
RABBITS.
Soeda, Mayumi1, Okura, Hanayuki1, Saga, Ayami1, Tani, Junnko1, 
Moriyama, Mariko1, Moriyama, Hiroyuki2, Yamashita, Shizuya3, 
Ichinose, Akihiro4, Tahara, Shinya4, Hayakawa, Takao2, Matsuyama, 
Akifumi1
1Foundation for Biomedical Research and Innovation, Kobe, Japan, 
2Pharmaceutical Research and Technology Institute, Kinki University, Osaka, 
Japan, 3Osaka University Graduate School of Medicine., Osaka, Japan, 
4Kobe University Hospital, Kobe, Japan
Familial hypercholesterolemia (FH) is an autosomal codominant disease 
characterized by high concentrations of proatherogenic lipoproteins and 
premature atherosclerosis secondary to low-density lipoprotein (LDL) 
receptor deficiency. We have supposed that human adipose tissuederived 
multilineage progenitor cells (hADMPCs, which were reported by Okura et 
al. Abstract presented at the ISSCR Meeting, Philadelphia, PA, Abstract no. 
167, 2008.) localized in the portal triad after transplantation via portal vein, 
subsequently integrated into the hepatic parenchyma and showed hepa-
tocytic differentiation in vivo and lowered serum cholesterol in the WHHL 
rabbits, indicationg that hADMPCs-transplantation via portal vein might be 
a novel cell therapy strategy for the treatment of FH in the Watanabe heri-
table hyperlipidemic (WHHL) rabbit, an animal model for homozygous FH. 
Here we showed that transplantation of hADMPCs but not human adipose 
tissue-derived stromal/stem cells (ADSCs, which were reported by Zuk et 
al.), could correct the metabolic defects of WHHL rabbit. To compare the 
effect of hADMPCs and ADSCs, human adipose tissue as excess obtained 
from plastic surgery was first digested in Hank’s balanced salt solution 
containing collagenase in a shaking water bath at 37°C for 1 h. After red 
blood cells were excluded, mononuclear cells were collected as stromal 
vascular fraction. The stromal vascular fraction was divided into two aliquots 
and one was treated as previously reported by Zuk et al. (Mol Biol Cell 13, 
4279, 2002.) to obtain hADSCs, and the other by Okura et al. (Tissue Eng 
Part C Methods 16,417, 2010.) to obtain hADMPCs, in brief the stromal 
vascular fractions were seeded, and 24h later the attached cells were treated 
with EDTA and the supernatant was collected and cultured as hADMPCs. 
Transplantation of hADMPCs via portal vein resulted in significant reduc-
tions in total cholesterol, and the reductions maintained for 12 weeks. On 
the other hand, the total cholesterol levels of hADSCs-transplanted group 
showed no significant difference to those of saline control group. To confirm 
transplantation of hADMPCs but not hADSCs reduces serum cholesterol in 
hyperlipidemic Watanabe rabbits, we examined LDL turnover studies using 
125I-labelled LDL. 125I-LDL turnover study showed that the 24 hour clear-
ance rate of LDL was significantly higher and LDL half life was significantly 
shorter in the hADMPCs transplanted-WHHL rabbits than those of saline 
control group. There was no significant difference on the 125I-LDL turnover 
study between hADSCs-transplanted group and saline control one. These 
results indicated that ransplantation of hADMPCs but not hADSCs could 
correct the metabolic defect of the WHHL rabbit and be a novel therapy for 
inherited liver diseases.
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HUMAN UMBILICAL CORD BLOOD-DERIVED 
MESENCHYMAL STEM CELLS PROTECT 
DIABETIC KIDNEY THROUGH SECRETION OF 
HUMORAL FACTORS
Park, Jong Hee1, Hwang, Inah1, Hwang, Soo Han2, Han, Hoon2, Ha, 
Hunjoo1
1Department of Bioinspired Science, Division of Life & Pharmaceutical 
Sciences, College of Pharmacy, Ewha Womans University, Seoul, Korea, 
Republic of, 2Seoul Cord Blood Bank, Seoul, Korea, Republic of
Introduction: Excessive accumulation of extracellular matrix (ECM) and 
epithelial to mesenchymal transition (EMT) contribute to renal fibrosis that is 
associated with diabetic nephropathy, the leading cause of end-stage renal 
disease worldwide. Current therapy including tight control of blood glucose 
and pressure and inhibition of angiotensin II may delay but does not stop 
the development and progression of renal injury in diabetes, underscoring 
the need for new and more effective treatment for diabetic nephropathy. 
The present study examined the therapeutic mechanism as well as effect of 
human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSC) 
on renal fibrosis induced by diabetes or transforming growth factor-β1 
(TGF-β1). TGF-β1 is the major mediator of renal fibrosis including diabetic 
nephropathy. Methods: Experimental diabetes was induced by i.p. injection 
of streptozotocin (STZ) 50 mg/kg into 6-week-old male Sprague-Dawley 
rats. hUCB was harvested from deliveries with the mother’s consent. MSC 
obtained from hUCB were administered through tail vein at the time of the 
induction of diabetes (2 days after the injection of STZ). To examine whether 
secreted humoral factors from hUCB-MSC mediate renal protection, 
growth-arrested and synchronized normal rat kidney tubular epithelial cells 
(NRK-52E) were treated with 10 ng/ml of recombinant human TGF-β1 in 
the presence of different concentrations of hUCB-MSC conditioned media. 
Results: At 4 weeks after the injection of STZ, diabetic rats showed signifi-
cantly increased urinary protein excretion, renal and glomerular hypertrophy, 
fractional mesangial area, and renal expression of TGF-β1 and α-smooth 
muscle actin (α-SMA) but decreased renal E-cadherin and BMP-7 expres-
sion, confirming diabetic renal injury. Intravenously administered hUCB-MSC 
at dose above 1x105 cells/rat effectively prevented renal injury without 
significant effect on blood glucose. Engraftment of hUCB-MSC in diabetic 
kidneys was confirmed by CM-DiI-labeled hUCB-MSC or positive staining 
of human nuclei antigen (PKsc). In TGF-β1 treated NRK-52E cells, we found 
that hUCB-MSC conditioned media decreased mRNA and protein expres-
sion of ECM components and prevented EMT. Conclusion: The present data 
suggest that hUCB-MSC effectively prevented the development of ECM 
accumulation and EMT in diabetic kidney through secretion of humoral fac-
tors. Further investigations are required to characterize the humoral factors 
that are important for mediating renal protection. (Supported by HPEB-
A090289 and BK21)
Poster Board Number: 2562
REGULATION OF MIGRATION 
CHARACTERISTICS OF HUMAN MESENCHYMAL 
STEM CELLS BY ENCAPSULATION IN 
COLLAGEN MATRIX
Wong, Mei Yi1, Wong, Carrie1, Diao, Huajia1, Wong, Natalie1, 
Chan, Barbara P.1, Chan, Godfrey2
1Dept of Mechanical Engineering, Univ of Hong Kong, Hong Kong, Hong 
Kong, 2Dept of Paediatrics & Adolescent Medicine, University of Hong 
Kong, Hong Kong, Hong Kong
Stem cell based therapies are therapeutic approaches with promising poten-
tials in regenerative medicine. However, the success of stem cell therapy is 
greatly limited by the engraftment at the target tissue. In this study, we have 
investigated the in vitro migration properties and the in vivo engraftment 
rate of human mesenchymal stem cells (hMSCs) migrated through a col-
lagen barrier. Specifically, hMSCs were subjected to a self selection process 
via collagen microencapsulation followed by plating onto culture dish, cells 
transmigrated out from the collagen barrier were characterized for their in 
vitro migration properties using transwell migration assay and in vivo en-
graftment rate using a partial hepatectomy model in NOD/SCID mice. Flow 
cytometry showed that the immunophenotypes of these selected hMSCs 
were unaltered compared with hMSCs derived from monolayer cultures. 
These cells also preserved their multi-potent differentiating potential and self 
renewing capacity, suggesting that they retain their stem cell characteristics. 
Upon transwell migration assay using serum free medium and chemotactic 
factors including SDF-1 and Fractalkine, hMSCs from both bone marrow 
and adipose tissue sources showed significantly higher migration efficiency 
than those maintained in monolayer cultures. To investigate the in vivo en-
graftment efficiency of these selected hMSCs, intravenous injection of one 
million hMSCs immediately after partial hepatectomy in NOD/SCID mice 
was performed. The remaining liver lobe was analyzed for the percentage of 
cells expressing human cell surface marker HLA-ABC using flow cytometry 
at 48 hours, 1 week and 1 month post-injection. The selected hMSCs have 
shown a significant increase in the engraftment efficiency comparing with 
those derived from monolayer cultures. These results suggest that selection 
through microencapsulation in collagen gel may be a possible method to 
enhance the engraftment efficiency of MSCs.
Poster Board Number: 2564
CHARACTERIZATION OF HUMAN 
MESENCHYMAL STEM CELL- NEURAL 
PROGENITORS (MSC-NP) DERIVED FROM 
PATIENTS WITH MULTIPLE SCLEROSIS
Vyshkina, Tamara, Harris, Violaine K., Faroqui, Raihan, Sadiq, Saud 
A.
MS Research Center of New York, New York, NY, USA
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of 
the central nervous system (CNS), with highly variable clinical course, as-
sociated with irreversible disability in a significant proportion of patients. The 
currently approved treatments for MS are disease-modifying agents, which 
only reduce the attack rate and delay progression in some patients, and no 
treatment is available to stop or reverse the progression of the disease. Mes-
enchymal stem cell (MSC)-based therapies offer an autologous source of 
stem cells with potential for treatment of progressive forms of MS. We have 
investigated bone marrow mesenchymal stem cell-derived neural progeni-
tors (MSC-NP) as a subpopulation of MSCs which are optimized for CNS 
applications due to their neural progenitor, immunoregulatory and trophic 
properties, as well as a reduced capacity for mesodermal differentiation. 
Preclinical testing has demonstrated efficacy of MSC-NPs in experimental 
animal models of MS. The aim of this study was to characterize MSC-NPs 
obtained from bone marrow aspirates from a panel of healthy and MS 
donors. MSCs were isolated and expanded from three healthy donors, one 
spinal cord atrophy patient, and ten patients with secondary progressive 
form of MS (SPMS). To obtain MSC-NPs, MSCs were cultured for 3 weeks 
in a serum-free neural progenitor maintenance media. MSC-NPs consist of 
a subpopulation of MSCs and exhibit characteristic neurosphere morphol-
ogy. Gene expression changes in MSC-NPs compared to the MSCs from 
which they were derived was determined by quantitative real-time PCR. 
We analyzed a panel of genes consisting of stem cell markers, markers of 
neural or mesenchymal lineage potential, and genes potentially involved 
in the immunoregulatory and trophic properties of MSCs and MSC-NPs. 
Neural lineage markers Nestin (neural stem cell marker), medium neurofila-
ment (neuronal marker), GFAP (glial and neural stem cell marker) were all 
upregulated 5 to 10 fold in MSC-NPs compared to MSCs, confirming the 
neural lineage potential of MSC-NPs. In addition, C-X-C chemokine receptor 
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type 4 (CXCR4, stem cell marker) was upregulated approximately 100 fold. 
Conversely, MSC-NPs expressed decreased mRNA levels of MSC markers 
CD90 and smooth muscle isoform of alpha-actin (SMA) with a 0.5 to 0.1 
fold change compared to MSCs. Time course experiments demonstrated 
that gene expression changes were maximal after one week of MSC-NP 
induction and sustained for up to 3 weeks. In addition to neural markers, a 
number of immunoregulatory markers such as IDO1, TGF-β, TLR2, TLR3, 
TLR4, IL-10, CXCL-10, and IL-6 and potential trophic mediators such as 
GDNF, HGF, IGF, IL-11, VEGF-A, CNTF, and BDNF were also upregulated in 
MSC-NPs compared to MSCs. Changes in gene expression were confirmed 
by protein analysis. There were no differences in gene expression changes 
in MSC-NPs between control or MS patients. The observed gene expression 
changes in MSC-NPs give insight into the potential therapeutic mechanisms 
by which MSC-NPs may influence CNS repair in vivo. Furthermore, these 
data contribute to the preclinical characterization and identification of MSC-
NPs for future therapeutic use in MS.
Poster Board Number: 2566
VEGF PRODUCTION IN RESPONSE TO TNFA IN 
HUMAN MSCS GROWN IN AMBIENT OXYGEN 
AND HYPOXIA
Muralidhar, M. G., Kharazi, Ludmila, Kharazi, Alex
R & D, Stemedica Cell Technologies, San Diego, CA, USA
VEGF production in response to TNFa in human MSCs grown in ambient 
oxygen and hypoxia. Abstract: Human MSCs upregulate production/secre-
tion of paracrine factors with appropriate stimuli, such as when challenged 
with TNFa, LPS, hypoxia. We determined the secretion of VEGF in response 
to increasing amounts of TNFa in MSC grown in either ambient oxygen or 
hypoxic conditions. Our results suggest that in hypoxic cells VEGF produc-
tion continues to increase with higher TNFa levels in contrast to normoxic 
cells which reach the maximum VEGF secretion at lower concentrations of 
TNFa. Background: Human mesenchymal stem cells are promising thera-
peutic agents for diseases due to their ability to home towards and repair 
injured tissues, at least in part due to their release of paracrine factors, such 
as VEGF, FGF2, IGF-1 and HGF. In vitro stimulation by TNFa and TGFa 
results in increased production of VEGF, as do other stimuli such as LPS and 
acute hypoxia. In this paper we compared production of VEGF in response 
to TNFa by MSC grown in ambient and low O2 conditions. Methods: Hu-
man MSCs were purchased from Lonza and expanded in tissue culture in 
DMEM containing 15% bovine growth serum and 10 ng/ml bFGF at 370C, 
5% CO2 either in ambient oxygen (normoxic) or low (5%) oxygen. MSC at 
passage 4 were seeded on tissue culture dishes and incubated in appropriate 
conditions till they reach about 70% confluence. DMEM without bFGF but 
with or without TNFa was added to the plates and collected 24 hrs later for 
determination of secreted VEGF by ELISA. Results: When cells were stimu-
lated with various concentrations of TNFa, there was an increase in VEGF 
production. The increase reached plateau in cells grown in ambient oxygen. 
Interestingly, cells grown in hypoxic environment showed a continued 
increase in the levels of VEGF produced. Legend: Controls are cells grown in 
ambient and 5% oxygen without TNFa (RC & LC); TNFa stimulation at 25 
ngs/ml (RT25 and LT25), 50 ngs/ml (RT50 & LT50) and 100 ngs/ml (RT100 
and LT100) Conclusion: MSC grown in low O2, in contrast to normoxic 
cells, showed continuously increased production of VEGF at higher TNFa 
concentrations. This finding may have important implications for therapeutic 
efficacy of MSC.
Poster Board Number: 2568
NEW AND EFFICIENCT METHOD FOR SCALING 
UP HUMAN MESENCHYMAL STEM CELLS
Sanyal, Suparna1, Slater, Katie1, Abraham, Elizabeth J.1, Flaherty, 
Paula1, Medlin, Tony2, Hastings, Abel2
1R&D, BD Biosciences, Bedford, MA, USA, 2Cell and Tissue Technologies, 
BD Technologies, Research Triangle Park, NC, USA
The use of single layer T-flasks can prove to be time consuming, cumber-
some and labor intensive for cell culture applications requiring large numbers 
of cells. Yet, caution needs to be exercised while scaling up cells using multi-
layer vessels as potential differences in culture environment within vessels 
can lead to subtle changes that can affect yield, homogeneity and perfor-
mance of cell populations. In the current study we compared the growth of 
human mesenchymal stem cells (hMSCs) in single layer BD T-175 flasks with 
those grown in BD Falcon Multi-flasks (3-layer). hMSCs were grown in me-
dia with and without serum. For serum free culture, vessels were pre-coated 
with attachment factors. Cells could be thawed directly into the multi-layer 
vessels obviating the need for step-wise scale up. Overall, cell yield from 
both single and multi-layer vessels were comparable when normalized for 
cells/cm2. Cell proliferation profile of hMSC populations were uniform 
following scale-up in multi-flasks and comparable to those grown in single 
layer T-175 flasks. Data regarding comparability of cell multipotency and im-
munophenotype maintenance between cells cultured in single and multi-lay-
ered vessels will be presented. In addition to the hMSCs, diverse established 
and primary cell lines have also been cultured in the BD Multi-layer vessels 
with equivalent performance to T-175 flasks. This study demonstrates a new 
and efficient way to scale-up stem cells without the need for re-optimizing 
existing cell culture conditions or compromising the quality, performance 
and homogeneity of cell populations.
Poster Board Number: 2570
GENES ASSOCIATED WITH ISCHEMIA-INDUCED 
VEGF SECRETION OF HUMAN BONE MARROW 
MESENCHYMAL STEM CELLS
Sato, Yoji1, Atsuki, Haruka1, Satoh, Mitsutoshi2, Tanabe, Shihori3, 
Yamaguchi, Teruhide4, Hayakawa, Takao5, Suzuki, Kazuhiro1
1Division of Cellular & Gene Therapy Products, National Institute of Health 
Sciences, Tokyo, Japan, 2Department of Toxicology & Pharmacolohy, 
Faculty of Pharmaceutical Sciences, Toho University, Tokyo, Japan, 
3Division of Safety Information on Drug, Food & Chemicals, National 
Institute of Health Sciences, Tokyo, Japan, 4Division of Biological Chemistry 
& Biologicals, National Institute of Health Sciences, Tokyo, Japan, 
5Pharmaceutical Research & Technology Institute, Kinki University, Osaka, 
Japan
Secretion of vascular endothelial growth factor (VEGF) is known as one of 
the important mechanisms of ischemic damage repair mediated by human 
mesenchymal stem cells (hMSCs). Therefore, we attempted to identify 
candidate genes that can serve as markers to predict VEGF secretional level 
of hMSCs under ischemic condition. Six lots of bone marrow-derived hMSCs 
were cultured under normal or ischemic condition. The cell culture media 
were collected 24hrs after the exposure to the ischemic stress, and their 
VEGF levels were measured by ELISA. Then, we analyzed the correlation 
between their gene expression profiles under the normal condition (Affyme-
trix HG-U133Plus2.0) and their VEGF secretion after the exposure to the 
ischemic stress. Seventeen genes showed positive correlations in all combi-
nations of pre-ischemic gene expression (passage 7 or 9) and post-ischemic 
VEGF level (amount or %change) (p<0.01, Spearman’s rank correlation 
coefficient). Furthermore, RNAi against 2 of the 17 genes reduced VEGF 
secretion in response to the ischemic stress (p<0.05). These findings indicate 
that the 17 genes may be useful to assess quality and efficacy of hMSCs 
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under ischemic environment. In addition, it is suggested that the 2 genes, 
knockdown of which decreased the VEGF response, are functionally coupled 
to the ischemia-induced VEGF secretion of hMSCs.
Poster Board Number: 2572
INTRACEREBRAL TRANSPLANTATION OF 
HUMAN PLACENTA-DERIVED MESENCHYMAL 
STEM CELLS FOR THE NEUROREGENERATION 
IN A RAT PERINATAL BRAIN INJURY MODEL
Schoeberlein, Andreina1, Reinhart, Ursula1, Sager, Ruth1, Messerli, 
Marianne1, Müller, Martin2, Surbek, Daniel V.2
1Laboratory for Prenatal Medicine, Department of Clinical Research, 
University of Bern, Bern, Switzerland, 2University Women’s Hospital, 
Obstetrics & Feto-Maternal Medicine, University Hospital Bern, Bern, 
Switzerland
Objective: Peripartal brain injury in the premature infant leads to a large 
spectrum of clinical problems. There is no established therapy available. 
Stem cell transplantation has been proposed as a therapy for neurodegen-
erative diseases. The aim of this study is to assess the therapeutic potential 
of human stem cell treatment in an animal model of perinatal brain damage. 
Methods: Perinatal brain injury was induced in newborn (postnatal days 2-7) 
Wistar rats by the administration of LPS (0.1 mg/kg BW, i.p.), followed by 
the ligation of the left carotid artery and hypoxia (8% O2, 80 min). Injured 
and sham-treated animals were transplanted 24h, 1 week or 4 week post 
injury. Newborn anesthetized rats were fixed in a stereotaxic frame (Kopf) 
and mesenchymal stem cells (MSC) derived from human placenta (chorion) 
or umbilical cord Wharton’s jelly (250’000 cells in 5 µl) were injected into the 
left lateral ventricle using a 32-gauge needle at a very low speed (Lab Ani-
mal Studies Injector, Hamilton). The animals were sacrificed 3-4h, 1 week, 
2 and 4 weeks after transplantation. In brain sections, donor human MSC 
were detected by immunohistochemistry using a mouse anti-human HLA 
Class 1 ABC antibody. Co-labeling using antibodies against neurons, astro-
cytes and oligodendrocytes are used to detect donor cell differentiation into 
the neural lineages Results: Single donor-derived cells detected in the brains 
of healthy rats shortly (1-2h) after transplantation showed an unaltered 
morphology. After 4h, donor cells had started migrating throughout the 
ventricular system. A few cells had already migrated into the parenchyma. 
Two weeks after transplantation, 84% of the uninjured pups had survived 
the transplantation procedure. The first 24h after transplantation were 
crucial for the survival. Single cells were found in the solid tissue around the 
ventricles. Conclusion: Human stem cells were successfully delivered into 
the lateral ventricle of neonatal rat brains. Donor cells were detected in the 
hosts’ brains up to four weeks after transplantation. Longer term studies will 
be done to analyze the proliferation, the long-term survival and engraft-
ment of the donor cells. The co-expression of lineage-specific proteins 
and human-specific markers will give information about the fate of the 
transplanted human cells in the brains of both injured and control rats. As a 
proof of principle, stem cell-treated and non-treated rats will be subjected to 
behavioral tests to assess the improvement of motor and memory deficits.
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NEURAL DIFFERENTIATION POTENTIAL OF 
HUMAN UMBILICAL CORD WHARTONS JELLY-
DERIVED CELLS
Messerli, Marianne1, Schoeberlein, Andreina1, Wagner, Anna-
Margaretha2, Sager, Ruth1, Surbek, Daniel V.2
1Laboratory for Prenatal Medicine, Department of Clinical Research, 
University of Bern, Bern, Switzerland, 2University Women’s Hospital, 
Obstetrics & Feto-Maternal Medicine, University Hospital Bern, Bern, 
Switzerland
OBJECTIVE: Perinatal brain damage accounts for the major part of the 
clinical problems in surviving premature infants. A considerable therapeu-
tic potential has been ascribed to mesenchymal stem cells. The umbilical 
cord connective tissue (Wharton’s jelly) represents a promising source of 
mesenchymal stem cells. Thus, the aim of this study is to characterize the 
phenotype of human Wharton’s jelly-derived cells and to assess their neural 
differentiation potential. STUDY DESIGN: Wharton’s jelly cells from umbilical 
cord tissues of term (gestational age ≥ 37 weeks) and pre-term (gestational 
age: 27 - 36 weeks) pregnancies were evaluated. The expression of the 
membrane markers for mesenchymal stem cells defined by the Interna-
tional Society for Cellular Therapy (ISCT) was measured by flow cytom-
etry. Accordingly, mesenchymal stem cells have to be ≥ 95% positive for 
CD105, CD90 and CD73, but negative for CD45, CD34, CD19, CD14 and 
HLA-DR. Adaptations of previously published multistep protocols were used 
to produce neural progenitors and, subsequently, induce terminal neural 
differentiation. Analysis of neural differentiation markers was performed by 
real-time PCR, flow cytometry and immunocytochemistry. RESULTS: Isolated 
umbilical cord Wharton’s jelly cells were plastic adherent and highly posi-
tive for CD105, CD73, CD90, but negative for CD45, CD34, CD14, CD19 
and HLA-DR, independent of gestational age. A subset of Wharton’s jelly 
cells displayed the neural progenitor cell marker nestin, whose protein and 
gene expression was increasing during neurogenic pre-induction into neural 
progenitor cells, the so-called neurospheres. In addition, mRNA levels of the 
neural progenitor cell markers PAX6, musashi-1 and nanog were elevated 
in neurospheres relative to undifferentiated Wharton’s jelly-derived cells. 
Conclusion: Wharton’s jelly cells meet the criteria for the phenotypic charac-
terization of mesenchymal stem cells. The up-regulated expression of neural 
progenitor cell markers in neurospheres compared to undifferentiated cells 
strongly indicates that neural precursor cells can be obtained from Whar-
ton‘s jelly-derived mesenchymal stem cells. Terminal differentiation into the 
neural subtypes is currently tested.
Poster Board Number: 2576
DISTRIBUTION OF TRANSPLANTED 
HUMAN MESENCHYMAL STEM CELLS 
DURING EXPERIMENTAL AUTOIMMUNE 
ENCEPHALOMYELITIS
Siatskas, Christopher1, Payne, Natalie1, Sun, Guizhi1, Moussa, 
Leon1, Emerson-Webber, Ashley1, Price, John2, Bernard, Claude C.1
1Monash Immunology and Stem Cell Laboratories, Monash University, 
Clayton, Australia, 2Biochemistry and Molecular Biology, Monash 
University, Clayton, Australia
Mesenchymal stem cells (MSCs) are promising vehicles for the treatment of 
neurodegenerative diseases such as multiple sclerosis (MS). This is in part 
due to their broad immunomodulatory properties and their reported abil-
ity to home to sites of tissue inflammation and injury. We have previously 
demonstrated that human mesenchymal stem cells (MSCs) derived from 
the bone marrow (BM-MSCs), adipose tissue (Ad-MSCs) or umbilical cord 
Wharton’s jelly (UC-MSCs) were capable of suppressing the in vitro prolif-
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eration of lymphocytes stimulated by either non-specific or specific mito-
gens, even in the absence of cell-to-cell contact. Transplantation of all three 
types of MSCs suppressed the clinical and pathological signs of disease in 
mice with either chronic progressive (CP) or relapsing-remitting (RR) forms 
of the MS-like disease termed experimental autoimmune encephalomyelitis 
(EAE). Given these results, mechanisms focusing on the fate and homing 
of systemically administered MSC to the central nervous system (CNS) or 
secondary peripheral lymphoid organs have not been clearly defined. In the 
current investigation we analysed the expression of molecules involved in 
cellular trafficking from the blood into tissues and tracked gene-modified 
MSCs in normal and immunodeficient mice. We have further analysed the 
post-transplant fate of MSCs in mice with CP- and RR-EAE. FACS analysis 
of integrins, selectins, members of the immunoglobulin superfamily and 
tetraspanins, which are involved in cellular adhesion, revealed that all three 
MSC groups expressed a broad range of cell surface molecules including 
CD29, CD44, CD49b, CD49c, CD49e, CD63, CD81, CD106, CD151 and 
CD166. RT-PCR analysis also confirmed the expression of the chemokine 
receptors CCR6, CCR7, CCR11, CXCR3, CXCR6 and CXCR7. Interestingly, 
Ad-MSCs and UC-MSC expressed a number of common markers such 
as CD9, CD49a, CD51, CD54, CD61, CCR9, CCR10 and CXCR2, whilst 
BM-MSCs did not. Significantly, exposure to INFg did not result in the 
upregulation of these chemokine receptors. In vivo bioluminescent tracking 
of transplanted MSCs engineered to over express luciferase in immunocom-
petent Balb/c mice or immunocompromised NOD/SCID mice revealed that 
after intravenous infusion, most cells were trapped as emboli in the lung that 
persisted for approximately 3 to 4 weeks. We next examined the distribution 
of human BM-MSCs expressing eGFP in CP-EAE. In this model, C57Bl/6 
mice were immunized with recombinant myelin oligodendrocyte glycopro-
tein (rMOG) and twelve days later, during the onset of disease signs, BM-
MSCs were infused. Lymph nodes, spleen, CNS, heart, liver, gut and lung 
tissues were excised and examined for the presence of MSCs. PCR analysis 
of extracted DNA from these tissues using eGFP-specific primers revealed 
that donor-derived cells were only transiently located in the lung or spleen. 
On-going studies characterizing the distribution of gene-modified MSCs into 
NOD/Lt mice immunized with rMOG, which manifest a RR-form of EAE, are 
currently underway. In summary, these results suggest that a low number 
of persisting MSCs, which were below the detection of methods used in 
this study, can elicit long-lasting anti-inflammatory effects were they limit 
the number of lesions, reduce axonal loss and preserve myelin structure. 
Future mechanistic studies will investigate the gene expression patterns of 
transplanted MSCs, particularly with cells that have lodged in the pulmonary 
vasculature.
Poster Board Number: 2580
EFFECTS OF SYSTEMIC TRANSPLANTATION OF 
AUTOLOGOUS MESENCHYMAL STEM CELLS 
ON THE REGENERATION OF RAT NERVOUS 
TISSUE AFTER CLOSED CRANIOCEREBRAL 
TRAUMA
Konoplyannikov, Anatoly G.1, Yuzhakov, Vadim V.1, 
Konoplyannikov, Mikhail A.2
1Department of Cell Therapy and Experimental Radiation Therapy, Medical 
Radiological Research Center, Obninsk, Russian Federation, 2Department of 
Medical Nanobiotechnologies, Russian State Medical University, Moscow, 
Russian Federation
We studied effects of transplanted mesenchymal stem cells (MSC) from 
Wistar rat bone marrow on the functional morphology of neurons and 
reparative processes in the nervous tissue of rats after closed craniocerebral 
trauma. The brain trauma was modeled by a free falling weight (impact 
area 0.5 cm2). Survived animals (about 50 from 100) were divided into the 
comparison groups. Group 1 included rats with the injury without treatment. 
Group 2 included rats with the injury receiving basic therapy (antiedema-
tous, antihypoxic, and anti-inflammatory drugs). Group 3 consisted of rats 
who received a single i/v injection of 2 x 106 MSC 24 h after the injury. 
Group 4 involved rats who received a combined treatment: basic therapy 
and the MSC injection. The control group consisted of sham-injured rats. 
The rats were euthanized in 1 h, 1 day, 3 days, or 14 days after the injury. 
The brains were isolated, fixed and then cut into two sagittal blocks or 
4 frontal fragments at the level of the rostral compartment of the lateral 
ventricles, hippocampus, midbrain, and cerebellum. Sections were stained 
using Nissl method. PCNA immunostaining was used for the cell prolifera-
tion analysis. Histotopographic mapping of the damaged areas and precise 
determination of the levels of coronary sections were carried out using a 
stereotaxic atlas of the rat brain. We have found that closed craniocerebral 
trauma causes diffuse damage of the rat brain. The primary injury is associ-
ated with the vascular disorders and traumatic edema peaking on the 1st 
day. The edema leads to ischemic damage of the cortical and brain stem 
neurons. The reactive and compensatory-regeneratory mechanisms along 
with cell proliferation in the zones of neurogenesis are triggered during the 
earliest periods after the injury. For Group 2, the effect on the proliferative 
activity of cells in vascular plexuses, microglia, and particularly, ependymal 
and subepedymal layers appeared only on the 3rd day after the trauma. 
After 2 weeks, despite recovery of the neuron morphology, there were still 
some local foci of cell proliferation and elevated activity of neurogenesis 
zones in the cortex, corpus callosum, and diencephalons. The therapeutic 
effect in Group 3 was observed visually on the 2nd day after intravenous 
injection of MSC. The neuroprotective effects of MSC on the diffuse brain 
injury included not only stimulation of general reparative processes during 
the regeneration phase (rapid restoration of Nissl substance in neurons, ac-
celeration of gliogenesis and angiogenesis), but also, presumably, activation 
of the germinative zones of neurogenesis. Systemic transplantation of MSC 
activated other cells additionally expressing growth factors in the brain such 
as glial cells expressing neurotrophic factors to promote the neurons’ survival 
and recovery. Thus, systemic injection of MSC in a syngeneic organism 
produced proliferotropic, angiogenic and presumably neurotrophic effects. In 
Group 4, the activating effect of MSC was augmented by the basic therapy. 
We found the combined treatment including metabolic support and i/v MSC 
injection to create prerequisites for activation of the mechanisms of compen-
satory adaptive processes during the reparative regeneration period and for 
improvement of nervous tissue trophics, essential for the restoration of the 
functional morphology of damaged neurons. These morphological results 
are consistent with the additional results on the dynamics of psychophysi-
ological tests of rats from the same groups.
Poster Board Number: 2582
ENGRAFTED DENTAL PULP STEM CELLS 
PROMOTED FUNCTIONAL RECOVERY OF 
COMPLETELY TRANSECTED RAT SPINAL CORD
Sakai, Kiyoshi, Yamamoto, Akihito, Matsubara, Kouki, Hibi, 
Hideharu, Ueda, Minoru
Department of Oral and Maxillofacial Surgery, Nagoya University, Nagoya, 
Japan
Adult spinal cord injury (SCI) often leads to persistent functional deficits 
due to insufficient neuropoiesis and limited axonal regeneration of injured 
CNS: no effective treatment to cure the SCI has been established. We 
report here that dental pulp stem cells from human exfoliated deciduous 
(SHEDs) and adult permanent teeth (DPSCs), when transplanted into the 
acute phase of completely transected rat spinal cord, significantly recovered 
hind-limb locomotors functions. SHEDs strongly suppressed apoptosis of 
neurons, astrocytes and oligodendrocytes, and preserved neuronal filaments 
and myelin sheaths after complete transection. SHEDs regenerated both 
corticospinal tract (CST) and raphe spinal serotonergic (5-HT) axons beyond 
the epicenter. Interestingly, before transplantation, more than ninety-five 
percent of both SHEDs and DPSCs uniquely co-expressed variety neuronal 
markers being expressed by neural stem cells, neuroblasts, early neurons, 
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astrocytes and oligodendrocyte progenitors. We found that, after eight 
weeks from transplantation, SHEDs specifically differentiated into the mature 
oligodendrocytes expressing myelin basic protein and APC; concomitantly 
abolished expressions of neurofilaments and astrocytes. Taken together our 
data demonstrate significant benefits of SHEDs and DPSCs-based regenera-
tion therapy for treatment of SCI. In the acute phase, factors secreted from 
SHEDs would protect injured spinal cord from severe neural damages in 
none-cell autonomous manner; subsequently, specifically self-differentiated 
SHEDs into the oligodendorocytes contributed functional recovery by pro-
moting re-myelination of damaged axons in cell autonomous manner. Thus 
both none-cell and cell autonomous neuro-regenerative activates of tooth 
derive stem cells play important role in functional recovery of SCI.
Poster Board Number: 2584
HUMAN IMMATURE DENTAL PULP STEM 
CELLS (HIDPSC) IN CHRONIC DOG SPINAL 
CORD INJURY - PRELIMINARY RESULTS
Feitosa, Matheus LT, Sarmento, Carlos AP, Russo, Fabiele B., 
Fernandes, Isabela R., Pignatari, Graciela C., Beltrão-Braga, Patrícia 
CB, Miglino, Maria A., Ambrósio, Carlos E.
University of São Paulo - USP, São Paulo, Brazil
The regenerative process of a injured area of the central nervous system 
(CNS), particularly the spinal cord, has some limiting factors, such as the 
limited capacity of the CNS to restore damaged cells. Despite several 
therapeutic attempts have been made the results remain unsatisfactory, even 
using human models. This study aims to evaluate the clinical outcomes of 
transplanted human immature dental pulp stem cells (h-IDPSC) in dogs with 
different degrees of chronic spinal cord injury, unresponsive to conservative 
treatments. Magnetic resonance imaging (MRI) and the Olby et al. (2001) 
behavioral scale were used to analyze and classify each animal response to 
treatment. In this experiment there were used five animals. Those whose 
chronicity of the injury prevented the surgical treatment, compounded the 
experimental group. All animals included in the research protocol were 
evaluated by preoperative MRI. The findings of MRI from the first clini-
cal case indicated the presence of myelopathy with mild extradural cranial 
hydromyelia caused by ventral disc material in the right side of T12-13. A 
corpectomy associated with pediculectomy was performed under general 
anesthesia, and 1 x 106 h-IDPSC were injected by intramedular route. After 
this procedure, the animal was submitted to veterinary physiotherapy for 
muscular tonicity and proprioceptive reflexes increase. It was possible to ob-
serve a gradual and progressive improvement in the patient behavior, mea-
sured with the method proposed by Olby (2001). After 15 days of surgery, it 
could be classified with a score around 4 or 5, and this rank reached 7 after 
30 days. Postoperative MRI showed the resolution of the initial hydromyelia 
process, leading to an apparent improvement of pre-existing condition. 
These findings lead us to believe the h-IDPSC helped in the process of 
regeneration of the spinal cord.
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CELL THERAPY IN ADULT DOGS WITH 
CHRONIC SPINAL CORD INJURY USING BONE 
MARROW STEM CELLS DERIVED FROM DOG 
FETUSES - PRELIMINARY RESULTS
Sarmento, Carlos A., Tajra, Matheus Levi, Russo, Fabiele, Fernades, 
Isabella, Abreu, Dilayla, Pignatari, Graciela, Beltrao Braga, Patricia 
Cristina, Wenceslau, Cristiane, Ambrosio, Carlos Eduardo, Miglino, 
Maria Angelica
Anatomy, University of Sao Paulo, Sao Paulo, Brazil
Spinal cord injury is one of the most devastating damage, especially when 
installed abruptly, with aspects physicals and psychologicals, confronting the 
medicine with multiple challenges. The regenerative process of the central 
nervous system (CNS), and particularly in spinal cord, has some limiting 
factors, such as the limited capacity of the CNS to restore the damaged cells. 
Moreover, considering all the problems and difficulty in finding satisfactory 
treatment, the cell therapy emerges as a possible tool for the treatment 
of such injuries. Our group proposes fetuses bone marrow stem cell as a 
promising source of cells to treat spinal cord injury. So, in our work we use 
magnetic resonance imaging for effective diagnosis of spinal cord injury and 
implant bone marrow stem cells derived from fetal dogs in the lesion focus 
through surgery. The dogs treated with the cells were undergoing physical 
therapy, and their performance was recorded and evaluated by a veterinary 
physiotherapist, using also a behavioral test (Test of Olby). Special attention 
was done to look for evolution in the march and in urodynamic function. 
Until the present moment two animals were submitted to the treatment and 
both of them showed an improvement in the Olby score and in the urody-
namic function. These findings lead us to believe that the stem cells from fe-
tuses bone marrow helped in the process of regeneration in the spinal cord.
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ANTITUMOR EFFECTS OF GM-CSF 
OVEREXPRESSING CANINE ADIPOSE TISSUE 
DERIVED MESENCHYMAL STEM CELLS IN A 
MOUSE MELANOMA MODEL
Ahn, Jin-ok1, Coh, Ye-rin1, Park, Chong-Woo1, Chae, Ji-sang1, Seo, 
Kyoung-won1, Bae, Bo-kyoung1, Lee, Hee-Woo2, Youn, Hwa-
young1
1Department of Veterinary Internal Medicine, Seoul National University, 
Seoul, Korea, Republic of, 2Research Institute for Veterinary Science, Seoul 
National University, Seoul, Korea, Republic of
Cell-based therapy is a promising strategy to treat cancer. Among cell types 
that can be used for this purpose, mesenchymal stem cells (MSCs) appear 
to hold great advantage for reasons including easier propagation in culture, 
possible genetic modification to express therapeutic proteins and homing 
to sites of cancer growth upon in vivo. Accordingly, the primary objec-
tive of the present study is to investigate the preventive and therapeutic 
potential of canine AT-MSCs against B16F10 melanoma in a mouse model. 
Secondary, this study examines the preventive antitumor effects of GM-CSF 
overexpressing cAT-MSCs in experimental melanoma model. C57BL/6 
mice (six to eight-week-old, female) from the Charles River Laboratories 
(Wilmington, MD) were immunized with 2 x 105 unengineered cAT-MSCs 
(antigen-pulsed/unpulsed) or GM-CSF-secreting cAT-MSCs (antigen-pulsed/
unpulsed) on day -13, -10, -7, before the challenge with 2 x 105 tumor cells 
on day 0. In all experimental design, mice were monitored for the formation 
of palpable tumors twice weekly and tumors were measured three times a 
week. The present study shows that cAT-MSCs have the potential to inhibit 
the proliferation of B16F10 melanoma in vitro and to attenuate rapidly 
growing tumor cells in a mouse melanoma model. In addition, cAT-MSCs 
were able to perform cross-presentation of B16 antigen and inhibit the 
growth of the B16 melanoma cells in vivo. Mice injected with unpulsed cAT-
MSCs developed tumors that reach a mean tumor volume of 1552 mm3. 
In contrast, a mean tumor volume of mice injected with the B16 antigen-
pulsed cAT-MSCs reached only 566 mm3 (P < 0.05) at 22-day time point. 
Mice injected with the unpulse mGM-CSF overexpressing cAT-MSCs de-
velop tumors that reach a mean tumor volume of 2801 mm3 at day 22 after 
tumor cell injection, as determined with 4 mice. Mice injected with the B16 
antigen-pulsed mGM-CSF overexpressing cAT-MSCs develop tumors that 
reach a mean volume of 1511 mm3 at this 22-day time point. GM-CSF has 
been found to be more potent in generating a long-lived, specific, systemic 
antitumor response than any other single cytokine examined if GM-CSF 
production is above 35 ng per 106 cells per 24 hours. However, the GM-CSF 
dose released by cAT-MSCs in this study (1969.8 pg per 106 cells per 24 
h) was insufficient to have anti-tumor activity that appears to be related to 
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stimulation of the immune system. In conclusion, the present study indicates 
that AT-MSCs remarkably attenuate the growth of B16F10 melanoma cells 
in vivo and in vitro. Also AT-MSCs can cross-present B16F10 antigen induce 
an effective immune response, a property that could be a useful tool for 
cancer cytotherapy.
Poster Board Number: 2590
NEURONAL INDUCTION OF WHARTON’S 
JELLY-DERIVED MESENCHYMAL STROMAL 
CELLS USING ROCK INHIBITOR IMPROVES 
THERAPEUTIC EFFECT IN INTRACEREBRAL 
HEMORRHAGE STROKE MODEL
Joe, Young Ae, Lee, Hyun-Sun, Kim, Kwang S., Choi, Mo Ran, Ahn, 
Hyun-Young, Shin, Jong-Chul
Department of Medical Lifescience, The Catholic University of Korea, 
Seoul, Korea, Republic of
Mesenchymal stromal cells (MSCs) are known to differentiate into meso-
dermal lineage cells and neuronal cells in specific conditions. Rho-kinase 
(ROCK) inhibitors have therapeutic effects in animal models of CNS disor-
ders and co-treaement of ROCK inhibitor and CoCl2 has been reported to 
stimulate neuronal differentiation of murine bone marrow MSCs. Here, we 
isolated human MSCs from Wharton’s jelly in umbilical cord (WJ-MSC) and 
demonstrated neuronal differentiation by combination treatment of ROCK 
inhibitor and CoCl2 and promoted therapeutic effect of ROCK inhibitor-
primed MSCs in brain ischemia The combination treatment of ROCK 
inhibitor and CoCl2 in WJ-MSCs in a special induction medium provoked 
morphological changes into neuron-like cells and increased expression of 
neuronal markers such as Tuj-1, NSE, and NF-H. Accordingly, ROCK knock-
down by ROCKI, II specific siRNAs also resulted in induced axonal process 
and upregulated MAP2 expression in WJ-MSCs. In order to confirm the 
therapeutic effect of neuronal induction of WJ-MSCs by ROCK inhibitor in 
neuro-degenerative disease, induced- or none induced WJ-MSCs cultured in 
the presence or absence of ROCK inhibitor were transplanted into rat intrac-
erebral hemorrhage (ICH) model. Behavior of the transplanted animals was 
evaluated for period up to 8 weeks using modified Rotarod test and limb 
placement test. The induced WJ-MSC transplanted group showed mark-
edly improved functional performance compared with the PBS group after 
3 weeks and compared with the none-induced WJ-MSC transplanted group 
after 7 weeks on Rotarod test. In addition, the engrafted WJ-MSCs were de-
tected by immunostaining with anti-human mitochondria specific antibody 
and anti- MAP2, NF-H or GFAP antibody. In the induced WJ-MSC group, 
52.29% of the grafted cells were MAP2 positive in contrast to 3.17% of 
the none-induced WJ-MSC group. Interestingly, the induced WJ-MSC 
represented strong expression of GDNF in the tissue of ICH region. Accord-
ingly, WJ-MSCs secreted higher level of GDNF upon treatment of ROCK 
inhibitor in vitro. Altogether, these results suggest that neuronal induction of 
WJ-MSCs by ROCK inhibition is a possible application for cell replacement 
therapy of ICH and other neurological disorder diseases. NRF fund from the 
MEST (2009-0079656)
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PRECLINICAL CELLULAR THERAPEUTIC SAFETY 
STUDY DESIGN CONSIDERATIONS
Jackman, Shawna M.1, Schriver, Mary V.1, Black, Lauren E.2, Learn, 
Doug B.1, Hoberman, Alan M.1
1Charles River Laboratories, Horsham, PA, USA, 2Charles River Laboratories, 
Laurel, MD, USA
Safety evaluations of cell-based therapies present unique challenges in 
preclinical study design and execution. Preclinical studies must be specifi-
cally designed for each cell product and indication to provide the developer 
valuable information for assessment of potential clinical risks and address 
the regulatory hurdles to be overcome to bring the therapy to market. In 
these studies, a well characterized cellular product must be assessed for 
cell survival, differentiation (anticipated or unanticipated), distribution, and 
neoplastic potential in an appropriate preclinical model. These design consid-
erations include selection of the appropriate test system (including relevant 
surgical animal models), extent of cell characterization both before and after 
administration, study duration, critical toxicological endpoints, and required 
cell detection criteria to evaluate deposition, distribution and cell fate. These 
properly incorporated study design components, implemented by GLP-
compliant laboratories with the required cell and animal model capabilities 
and reported by experienced preclinical scientists, constitute a complete ex-
perimental program. These comprehensive preclinical evaluations, conducted 
with respect to the most current understanding of the regulatory climate in 
which this work is evaluated, are essential for success in meeting the safety 
and regulatory expectations.
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CELL THERAPIES FOR INFLAMMATORY 
DISEASES: BIOLOGICAL BASIS FOR NEW 
CLINICAL PROTOCOLS
Zanotti, Lucia1, Sarukhan, Adelaida1, D’Amico, Giovanna2, Arato, 
Iva3, Falabella, Giulia3, Viola, Antonella1
1Istituto clinico Humanitas, Rozzano, Milano, Italy, 2Centro Ricerca “M. 
Tettamanti,” Clinica Pediatrica Università degli Studi di Milano Bicocca, 
Monza, Italy, 3Department of Internal Medicine University of Perugia, 
Perugia, Italy
Chronic inflammation is involved in the pathogenesis of several human dis-
eases, such as cancer, atherosclerosis, allergy, inflammatory bowel diseases 
and autoimmune diseases. Several anti-inflammatory pharmacological drugs 
are currently available but with limited efficacy and deleterious long-term 
consequences. Long lasting tolerance induction may represent a safe and ef-
fective resolution for these diseases and scientists have become interested in 
therapies based on cells with immunomodulatory activity. It has been widely 
demonstrated that Mesenchymal Stem Cells (MSCs) exert potent immuno-
suppressive effect both in vitro and in vivo, although the results of clinical 
trials are still disappointing. This can be due to several reasons including the 
fact that MSCs display a low ability to home to inflamed tissue. In addition, 
the biological mechanisms responsible for MSC-induced immunomodulation 
are still not clear. Our project aims at a deeper understanding of the MSC bi-
ology, tolerogenic properties and homing. In particular we have transplanted 
alginate-encapsulated MSCs in order to determine whether their therapeutic 
effect is dependent on migration capacity and cell to cell contacts. Us-
ing TCR transgenic mice, we have found that encapsulated MSCs hamper 
recruitment of leukocytes and dendritic cells into inflamed lymph nodes and 
antigen-specific CD4+ T cell proliferation in vivo. This immunomodulation 
is thus independent of MSC homing to specific tissues and likely due to a 
direct effect on endothelial activation and permeability. 
Furthermore, we found that the administration of encapsulated MSCs was 
more effective than their intra venous administration, with the advantage of 
being safer and removable. These results suggest that the efficacy of MSC 
administration in clinical protocols aimed at treating inflammatory diseases 
can be greatly improved.
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SAFETY AND EFFECTS OF ALLOGENIC BONE 
MARROW MESENCHYMAL STEM CELL 
TRANSPLANTATION IN SYSTEMIC LUPUS 
ERYTHEMATOSUS
Quintero, Lida Osmarla, Lucena, Carolina Lucena, Gonzalez, 
Leonardo, Estrada, Esteban, Lucena, Andres
Stem Cell, Cecolfes, Bogota, Colombia
Systemic Lupus erythematosus (SLE) is a multisystem autoimmune disease. 
Despite the advances in immunosuppressive medical therapies, SLE remains 
fatal in some patients. In this case report we used allogenic bone marrow 
mesenchymal cells (BM-MSC´s) based on studies that shows that MSCs from 
some patients with lupus may have abnormalities in phenotype, prolifera-
tion, differentiation and senescence. In addition the cells lose their immuno-
modulatory functions. To evaluate the feasibility, safety, and immunological 
effects of BM-MSC´s, we compare the growth characteristics, cell membrane 
markers (CD34-, CD105 +, CD144 +, CD90 +, HLADR-), cell differentiation 
to adipogenic, osteoblastic and chondrogenic lineages, and karyotype in 
one patient and in one healthy donor. One female, 28 years old fulfilling the 
2002 American College of Rheumatology (ACR) criteria for SLE in mild stage 
was infused with allogenic BM-MSC´s. We evaluated the suppressive effect 
of these cells in vitro and changes in CD3+, CD4+, CD8+, CD25 +, FoxP3 
+ in regulatory T cells from the patient and proinflammatory cytokines 
before and after treatment. Allogenic BM-MSC´s transplantation is a safety 
treatment with no adverse effects in the patient. These cells are capable of 
reverse multiorgan dysfunction resulting in amelioration of disease activity 
and stabilization of proinflamatory cytokines according to the clinical trials 
conducted by Dr. Sun, with a decrease in the proliferative responses of lym-
phocytes. Our case report point out in the same direction. Results from the 
patient´s 3 months evolution post- transplantation will be presented.
Poster Board Number: 2598
GENE THERAPY AS A NEW APPROACH 
TO MITIGATE CUTANEOUS RADIATION 
SYNDROME: HYPE OR REALITY
RICCOBONO, Diane R.1, FORCHERON, Fabien1, GARRIGOU, 
Philippe1, SCHERTHAN, Harry2, VIVIER, Mylène1, Meineke, Viktor2, 
AGAY, Diane1, DROUET, Michel1
1Radiobiology department, IRBA-La Tronche, LA TRONCHE Cedex, France, 
2Institut für Radiobiologie der Bundeswehr- Universität Ulm, München, 
Germany
Cutaneous radiation syndrome (CRS) caused by accidental or therapeutic 
irradiations is characterized by iterative inflammatory waves, incomplete 
wound healing and poor revascularization. Local injection of Bone marrow-
Mesenchymal Stem Cells (MSCs) or Adipocyte derived Stem Cells (ASCs) 
has been recently demonstrated to favour wound healing in animal models 
of CRS and in few patients. Paracrine processes are thought to be crucial 
in this context. Thus grafting modified MSCs/ASCs in order to transiently 
produce and secrete ad hoc factors may represent a pertinent strategy. 
Based on the literature, we chose to evaluate Sonic Hedgehog (Shh) as a 
first candidate. Shh is a morphogen involved in embryonic development. It 
codes for a protein which can induce proliferation of a variety of cell types 
including keratinocytes, neuronal precursor stem cells, hematopoïetic stem 
cells and also involved in angiogenesis. In a first step we set up an in vitro 
study model to evaluate the response of irradiated fibroblasts to conditioned 
media (CM) from ASCs secreting or not Shh. ASCs were electroporated 
(Amaxa®) with a plasmid coding for Shh and then were cultured in minimal 
essential medium with 10% fetal calf serum and fibroblast growth factor 
(2ng/mL) at 37°C in air with 5% CO2 for 7 days. At the end of the culture 
the different culture media were harvested. Minipig fibroblasts were in 
vitro irradiated at the dose of 25Gy gamma (1.5 Gy/min) and incubated 
within 10 min in the different CM. Fibroblasts were harvested at different 
times (30min, 6h, 24h and 48h post irradiation) and analyzed for apoptosis 
(Annexin V staining n=9 for each condition) and gene expression using 
RT-qPCR (n=3 for each gene). Globally, Shh significantly improve fibroblasts 
survival : apoptosis rate decreased in presence of Shh-ASC CM from 6 
hours post irradiation to 24h (p<0.05). In addition we observed a sustained 
production of proangiogenic factors such as VEGF and ANGPT1 (at 24h post 
irradiation). Secondly we evaluated the biologic activity of Shh-ASCs in a 
NOD/SCID mice model. Shh-ASCs and ASCs were injected in BD Matrigel® 
“growth factor reduced”. Then BD Matrigel® loaded or not with cells were 
subcutaneously injected in NOD/SCID mice (n=10 for each group). One 
week post implantation, mice were euthanized and BD Matrigel® were 
dissolved in 1ml of Drabkin lysis buffer. After homogenization, haemoglobin 
was quantified by spectrophotometry at 540nm. Interestingly the amount 
of haemoglobin was twice higher in Shh-ASCs-BD Matrigel® than in ASCs 
only BD Matrigel® (p<0.05). Work is going on to characterize the Shh-ASCs 
activity upon keratinocytes and determine in minipig model whether Shh 
transient gene therapy may represent a useful strategy to mitigate CRS (Exp. 
Hematol. 2010;38:945-956).
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COMPARISON OF VITROGROWTM 
MESENCHYMAL STEM CELL MEDIA TO 
COMPETITORS
Musick, Jim R.
Vitro Diagnostics, Inc, Golden, CO, USA
Mesenchymal stem cells are adult stem cells with multipotent differentia-
tion capacity that have clinical applications in several conditions such as 
articular injury/disease, autoimmune, cardiovascular, renal and possibly other 
diseases. This study compares commercial low serum media available for 
MSC growth/self-renewal including VitroGrow™ (Vitro Diagnostics, Inc.) 
MesenPRO-RT® (InVitrogen, Inc.), MesenCult® (Stem Cell Technologies, 
Inc.), Lonza MSC-GM and MSCM (Science Cell Laboratories). The end-
points measured from culture of human cord blood-derived MSCs included 
doubling time, number of cells recovered, cell diameter and Lumenesc assay 
for MSC quality and potency which were determined in direct comparison 
during successive passages. These data showed superior MSC growth, qual-
ity, potency and cellular recovery in VitroGrow™ compared to other media, 
while cell diameter decreased in Lonza MSC medium, initially increased in 
Mesencult and MesenPRO-RT and thereafter was comparable to MSCs cul-
tured in VitroGrow™. Also, since the MSC niche is hypoxic, we compared 
endpoints at both 5% and 20% O2. Following an initial adaptation in two 
successive passages, VitroGrow™ was also superior with regard to growth 
rates, cell recovery and cell quality by Lumenesc assay at 20% O2 as well as 
5% O2. Additional studies were performed to determine real time stability 
of low serum VitroGrow™. Growth rates of MSC cultured in VitroGrow™ 
were stable during 12 months of storage at 2 to 8 o C and thereafter de-
creased indicating instability, while MSCM medium (Science Cell Laborato-
ries, Inc.) showed decreased growth rate after 3-months storage. Other low 
serum MSC media manufactured by InVitrogen, Inc, Lonza, Inc. and Stem 
Cell Technologies, Inc. is provided with written recommended usage periods 
of 2 to 4 weeks following preparation of complete medium. Also, we show 
that recovery of MSC growth rates and Lumenesc assay of ATP content 
were not significantly different following freezing of low serum VitroGrow™ 
medium, which will further extend the useful lifespan beyond 12 months.
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HUMAN STEM CELLS FROM EARLY FETAL 
BLOOD, CHORION AND AMNIOTIC FLUID 
DIFFERENTIATE INTO PODOCYTES AND 
IMPROVE RENAL GLOMERULOPATHY IN 
ALPORT MICE.
Moschidou, Dafni1, Patsia, Maria1, Bou-Gharios, George1, Pusey, 
Charles D.1, Fisk, Nick M.2, Cook, Terence H.1, De Coppi, Paolo3, 
Guillot, Pascale V.1
1Imperial College London, London, United Kingdom, 2University of 
Queensland, Brisbane, Australia, 3University College London, London, 
United Kingdom
Alport Syndrome (AS) is a hereditary glomerulopathy, in which a mutation 
in COLIVA3, A4 or A5 chain genes impairs glomerular podocyte function, 
leading to compromised filtration and progressive glomerulosclerosis. AS 
patients experience hematuria, proteinuria and progress to end stage renal 
failure by the age of 20 to 40. Currently there is no cure, only the empiric 
treatments of renal dialysis or transplantation. To ameliorate AS, stem cells 
have been proposed as vehicles for gene or protein delivery because of their 
ability to expand, differentiate and repopulate a host in vivo. We investigat-
ed the potential of human fetal stem cells found in 1st trimester fetal blood 
and chorionic villi samples (CVS) and 2nd trimester amniotic fluid (AF), to 
differentiate into podocytes and improve renal glomerulopathy in a mouse 
model of AS. We first investigated the podocyte differentiation potential 
of the cells in vitro, either cultured on ColIV or co-cultured with wild type 
mouse glomeruli for 2 weeks. In both protocols, we found a significant up-
regulation of the podocyte genes CR1, CD2AP, SYNAPTOPODIN, PODO-
CIN, NEPHRIN and VEGF along with a down-regulation of the progenitor 
genes CD24, CD133 and BMI-1. We next analysed the migration capacity 
of the cells towards Alport and wild type glomeruli using in vitro chemotaxis 
assays; cells from all sources migrated significantly more towards the Alport 
than control glomeruli in vitro. Finally, cells were transplanted into 7 week-
old Alport or wild type mice and their engraftment and therapeutic effect 
assessed 2 weeks later. We observed that cells from all sources engrafted 
significantly more in Alport glomeruli, consistent with cell homing being 
enhanced in the presence of tissue injury. We also observed that transplant-
ed Alport mice (n=10) maintained their weight for two weeks while 63% 
of non-transplanted control animals (n=10) dropped their weight below a 
20% endpoint. In addition, transplanted Alport mice showed significantly 
lower blood urea levels compared to untreated animals (20.4±3.3, 27.5±1.0 
mmol/l respectively, P<0.01). We conclude that early human fetal stem cells 
from fetal blood, chorion and amniotic fluid differentiate into podocytes and 
improve renal glomerulopathy in Alport mice.
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Placenta trophoblast stem (TS) cells differentiate into the cytotrophoblast 
and syntiotrophoblast in terminal villi, or become extravillous trophoblasts 
which invade the maternal decidua and remodel maternal terminal arteries. 
Abnormal placental cell differentiation and function in early pregnancy have 
been implicated with the development of preeclampsia and intrauterine 
growth retardation later in pregnancy. Currently, the in vitro study of hu-
man first trimester placenta development is limited by availability of primary 
trophoblast cultures and fidelity of immortalized trophoblast and chorio-
carcinoma cell lines. To address this need, we established human induced 
trophoblast stem (iTS) like cells by reprogramming somatic cells with a pool 
of transcription factors. iTS like cells similar as mouse TS cells form flat iso-
lated colonies after passaged more than 60 days. In the study we reported 
here, we have analyzed genome-wide gene expression, epigenetic signature, 
and invasion capacity of these iTS like cells. First, iTS like cell and its somatic 
donor cell trancriptome was determined using Agilent human DNA array. 
3953 genes are significantly up-regulated (more than 2 fold) in iTS like cells 
vs. donor fibroblast cells. Among these transcipts the stem cell renewal 
genes: TERT, Sall4, Klf5 etc; and TS related genes, such as Tead4 and Cdx2. 
The up-regulated genes suggested that the cell identity transformed from 
somatic cell into self-renewal trophoblast lineage. Secondly, we determined 
epigenetic signature of TS gene, ELF5, in iTS like cells by detecting DNA 
methylation status and mRNA. We found that in iTS like cells, Elf5 was DNA 
hypermethylated, whereas Elf5 mRNA was still expressed. These results 
suggest that Elf5 gene regulation by other mechanisms than DNA methyla-
tion. Thirdly, we have further examined differentiation ability of iTS like cells 
by studying their invasive capabilities (the character of EVT) and formation 
of multi nucleated cells (the character of ST). After 7 days differentiation, 
HLA-G positive cells and multinucleated cells sporadically stained (5 to 
10%). The invasion capability of iTS like cells was determined by culturing 
cells on matrigel-coated transfer chambers and after 20~22hrs, the invasion 
percentage of iTS like cells vs. fibroblast was 44% vs. 26%. In conclusion, 
these results provide evidences that human iTS like cells harbor similar TS 
self-renewal and lineage specific transcripts. Further, iTS like cells have the 
capability to differentiate into invasive trophoblast like cells and form multi-
nucleated giant cells.
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Placenta-derived multipotent cells (PDMCs) are multipotent mesenchy-
mal stromal cells (MMSC) isolated from human term placenta. These cells 
express bone marrow MMSC markers, are able to differentiate into cell 
types of all three germ layers in vitro, and are highly immunomodulatory. 
Moreover, being isolated from the placenta, PDMCs provide an easily acces-
sible source of multipotent cells without ethical problems. However, similar 
to many adult stem cells (ASCs), PDMCs will senesce after a period of in 
vitro culture, which limits prevalent use of these versatile cells. We therefore 
focus on studying the mechanisms of PDMC senescence. Proliferation was 
attenuated after approximately 25 population doublings (PDs), and staining 
for β-galactosidase, a marker of senescence, was positive in late-passage 
PDMCs. Reactive oxygen species (ROS) detection revealed that the level 
of H2O2 was increased in late-passage PDMCs, presumably caused by 
up-regulation of the manganese superoxide dismutase (MnSOD). The 
cyclin dependent kinase (CDK) inhibitor p21 was found to be elevated in 
late-passage PDMCs accompanied with cell cycle arrest at G0/G1 phase. 
However, inhibition of H2O2 had no effect on p21 expression or cell cycle 
arrest. The tumor suppressor p53 is known to regulate the expression of 
p21, but p53 expression is decreased in late-passage PDMCs, and inhibition 
of p53 by the p53 inhibitor PFT-α did not alter the accumulation of p21. 
These findings suggest that p53 is not involved in the senescence of PD-
MCs. It has been reported that MAPK and protein kinase C (PKC) activation 
play important roles in p53-independent cell senescence mechanisms. We 
found that in late-passage PDMCs, phosphorylation of ERK was elevated. 
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Inhibition of ERK attenuated the H2O2 level in late-passage PDMCs, how-
ever, the p21 level was not reduced by ERK inhibition. Expression of the PKC 
family member PKC-α was found to be elevated in late-passage PDMCs, 
and inhibition of PKC-α attenuated the accumulation of p21 in late-passage 
PDMCs. Furthermore, cell cycle arrest was also reversed by PKC-α inhibition. 
Our data shows that PDMC senescence involves the up-regulation of p21 
and leads to cell cycle arrest. These events also involve PKC-α regulation in a 
p53- and ERK-independent pathway. The role of ERK activation and H2O2 
accumulation in late-passage PDMCs is still unclear and consulting further 
investigation
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Mesenchymal stem cells derived from umbilical cord (UC-MSCs) and 
placenta (PL-MSCs) are considered to be adult stem cells that can be easily 
obtained in large quantities by a less invasive method in comparison to bone 
marrow-derived MSCs (BM-MSCs). However, the biological and immuno-
regulatory properties of UC-MSCs and PL-MSCs are still poorly character-
ized. Particularly; the underlying mechanisms of this immunomodulation 
remain undefined. Recent research demonstrated that BM-MSCs express 
the tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase (IDO), 
known to suppress T-cell responses. This study was designed to address 
whether IDO contributes to the immunoregulatory functions of UC-MSCs 
and PL-MSCs in vitro. To isolate UC-MSCs and PL-MSCs, umbilical cord 
and placenta were digested with collagenase and cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine 
serum. The expression profiles of several MSC markers were examined by 
flow cytometry. UC-MSCs and PL-MSCs from passage 3-5 were used for 
in vitro adipogenic and osteogenic differentiation assays by culturing in 
appropriate induction media. The results demonstrated that UC-MSCs and 
PL-MSCs were easily expanded to 18-20 passages while maintaining the un-
differentiated state and exhibiting MSC markers CD73, CD90, and CD105 
but do not express the hematopoietic markers CD34 and CD45. Similar to 
BM-MSCs, UC-MSCs and PL-MSCs were able to differentiate to several 
mesodermal-lineages including adipocytes and osteoblasts. Fascinatingly, im-
munomodulating properties of UC-MSCs and PL-MSCs were not difference 
from BM MSCs. In addidition, IDO secreted by UC-MSCs and PL-MSCs was 
responsible, at least in part, for induction of immunosuppressive activities 
in the same manner as BM-MSCs. This study supports the clinical applica-
tion of UC-MSCs and PL-MSCs as therapeutic tool not only for regenerative 
medicine, but also for the treatment of GvHD after bone marrow transplan-
tation.
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Human pluripotent stem cells (hPSCs), due to their capacity to differentiate 
into any cell type found in the body, have enormous potential for cell-based 
regenerative therapies. However, the realization of this potential remains 
hampered by many unanswered questions regarding the pathways that 
regulate self-renewal, survival, and differentiation of these cells. hPSCs, 
including human embryonic stem cells (hESCs) and human induced pluripo-
tent stem cells (hiPSCs), exhibit poor survival upon dissociation, hindering 
the ability to generate scalable cultures and perform genetic manipulation 
on these cells. In a previous high-content screen for small molecules the 
modulate hESC survival we identified an inhibitor of Rho kinase (ROCK) that 
significantly enhances the survival of dissociated hPSCs. Recent literature has 
demonstrated that upon dissociation, hPSCs experience a ROCK-mediated 
terminal overactivation of the actin-myosin cytoskeleton, leading to a loss 
of cell integrity and apoptosis. While the cellular phenotypes associated with 
this apoptosis have been described, it is still unclear what signals are altered 
in hPSCs during dissociation that lead to actin-myosin hyperactivation. To 
examine this we have taken two approaches: evaluation of the extrinsic 
and intrinsic signals that are modified by dissociation, and a high content 
screening approach to identify novel small molecules capable of regulating 
hPSC survival. In the first approach, we have found that cell-cell signaling 
via E-cadherin is important for the survival of dissociated hPSCs as loss of 
E-Cadherin signals results in decreased survival upon dissociation. One key 
event after hPSC dissociation is relocation of E-cadherin away from the 
surface leading to loss of cell-cell junctions and subsequent cell blebbing 
and apoptosis. We hypothesize that dissociation of hPSCs leads to greater 
apoptosis due to internalization of and loss of signals from cell-cell junction 
proteins. One means to improve hPSC survival would then be via regulating 
endocytosis in order to control the cellular localization of cell-cell junction 
proteins including E-cadherin and integrins. This could reduce ROCK activa-
tion as a result of dissociation and subsequent cell death. In our second 
approach, we are continuing to screen libraries of known and novel small 
molecules to find additional regulators of hPSC survival. Novel molecules 
will be used to better characterize how hPSC survival can be regulated in 
response to dissociation. Improving our understanding of signals regulating 
hPSC survival will improve our ability to stably culture hPSCs and improve 
our ability to manipulate them for potential therapeutic use.
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Microbial growth in damp indoor environment has been correlated with 
health risk. Although genotoxicity and cytotoxicity of some microbial volatile 
organic compounds (VOCs) including 1-octen-3-ol on lung epithelial cell 
line A549 has been reported, however; the toxicity of fungal VOCs on hu-
man embryonic stem cell lines has not been explored. This study was aimed 
to determine the cytotoxicity of 1-octen-3-ol, a major fungal volatile organic 
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compound associated with mushroom and mold odors, on human embryon-
ic stem cells (hESCs) in an attempt to determine the developmental toxicity 
of 1-octen-3-ol on growing embryo. 1-octen-3-ol exists as enantiomers, 
(R)-(-)-1-octen-3-ol and (S)-(+)-1-octen-3-ol, which exhibit identical physi-
cal and chemical properties but different three-dimensional orientation. We 
performed cytotoxic assays by exposing hESCS to racemic 1-octen-3-ol 
and its enantiomers, (R)-(-)-1-octen-3-ol and (S)-(+)-1-octen-3-ol using 
an airborne exposure technique assuming inhalation as the prime mode of 
delivery of 1-octen-3-ol in people residing in moldy buildings. Racemic and 
(S)-(+)-1-octen-3-ol exhibited greater cytotoxicity to hESCs than (R)-(-)-1-
octen-3-ol. The Inhibition concentration 50 (IC50) values for these fungal 
VOCs were 40 to 80-fold lower than that of vapor phase toluene, an indus-
trial chemical used as a positive control in this study. Our report pioneers 
modeling of human embryonic stem cells as an in vitro approach to screen 
the developmental toxicity of fungal VOCs associated with building-related 
illness and indicates that in the vapor phase, the fungal natural product 
1-octen-3-ol and its enantiomers are more toxic than toluene to hESCs.
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The differentiation method from pluripotent stem cells, such as embryonic 
stem cells (ESCs) and induced pluripotent stem cells (iPSCs), into kidney 
lineage remains to be developed. Kidney is derived from one of early em-
bryonic germ layers, intermediate mesoderm (IM), and directing pluripotent 
stem cells into IM lineage is a crucial step for kidney regeneration. Here we 
have efficiently generated human iPSC lines that contain an allele of OSR1 
gene, a marker for IM, into which a green fluorescence protein (GFP) gene 
was knocked-in by homologous recombination. We have also established 
an induction protocol using combinational treatment of growth factors, in 
which differentiation of human iPSCs produced cultures consisting of more 
than 40 % OSR1+ cells. Furthermore, the cells expressed other IM marker 
genes, and could differentiate into multiple cell types included in IM deriva-
tive organs, such as kidney, gonad and adrenal cortex in vitro. These results 
suggest that our differentiation protocol can induce human pluripotent stem 
cells into IM cells with similar developmental potential to that in embryos, 
supplying systems for understanding the developmental mechanisms of IM 
lineage and cell sources for the regeneration of mature IM derivatives.
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Factors that drive migration and trafficking of bone marrow-derived 
multipotent stromal cells (MSCs) in vivo are still poorly understood, yet 
it is desirable to control these behaviors for therapeutic applications. We 
and others have reported that ligands of the EGFR family can control the 
migration, proliferation, and trafficking of bone marrow-derived multipotent 
stromal cells (MSCs), processes important for therapeutic applications. Hu-
man MSCs express three members of the epidermal growth factor receptor 
(EGFR) family -- EGFR/HER1, HER2, and HER3 - that are implicated in bone 
development, homeostasis, and healing in vivo, and that regulate cell migra-
tion and motility in several cell types. In particular, Neuregulin (NRG) has 
been shown to have a protective effect against hypoxia conditions in mouse 
derived MSCs, but to our knowledge there are no studies that seek to 
understand the role of NRG/HER-3 signaling axis in human MSC migration. 
Therefore, in this study we investigate whether motility of human MSCs is 
regulated by EGF or Neuregulin (NRG) activation of EGFR family members, 
and whether subpopulations within the MSC culture differentially respond to 
these ligands. We analyzed behavior of primary human MSCs migrating on 
a defined fibronectin-coated glass in the basal and EGF or NRG stimulated 
states, using time-lapse video microscopy of individual cells. The 12-hr 
migratory tracks of individual cells were generated using a Brownian motion 
tracking algorithm. Means and associated standard errors were calculated 
from individual cells’ speed, total migratory path length, and net displace-
ment for a given experimental condition. Cell morphological parameters 
were determined and correlated with a cell’s migration statistics to derive 
population distributions. Basal cell motility and sensitivity to growth factor 
stimulation were correlated with cell projected area, and evidence of EGFR 
family autocrine stimulation in the motility response was observed.
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Each year, 600,000 patients are diagnosed worldwide with head and 
neck cancers, and will be treated with a combination of (chemo) radiation 
therapy. A large proportion of these patients will develop severe xerostomia 
(‘dry mouth syndrome’), as a consequence of salivary gland ablation. In 
mice, we showed previously that transplantation of c-Kit+ stem/progenitor 
cells (SSCs) isolated from cultured salivary gland samples, rescued irradiated 
mice from xerostomia(1). We currently aim to characterise putative stem 
cells residing within the human gland, as a possible therapeutic avenue for 
the treatment of radiation-induced xerostomia in humans. We initially show 
by immunohistochemistry that cells expressing c-kit can be localized to the 
larger ducts within the intact biopsy-derived human salivary gland. Sali-
spheres cultured from human salivary gland tissue also express c-kit and cy-
tokeratin-5, proposed salivary gland stem cell markers. When dispersed and 
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analysed by flow cytometry, 0.10 % (± 0.08 % S.D.) of salisphere-derived 
cells were c-kit+. Salisphere-derived cells also express the established adult 
stem cell marker proteins CD24, CD49f and CD133 at differing frequen-
cies (CD24: 19.65 % ± 21.70 S.D.; CD49f: 16.92 % ± 20.22 S.D.; CD133 
17.98 % ± 18.28 % S.D.), suggesting that the cultures potentially contain 
stem cell populations, and may be therapeutically useful. In order to become 
useful in the clinical environment, putative salivary gland stem cells must 
demonstrate an ability to differentiate into functional cells of the salivary 
gland. During in vitro culture, salispheres originally negative for differentia-
tion markers gradually obtained expression of the salivary-gland associated 
proteins α-amylase, aquaporin-5 and mucin-5, as shown by immuno-
histochemistry and PCR. The ability of the cells to proliferate and differenti-
ate in an in vivo setting will also be determined. After a period of eight 
weeks, kidney capsules of immune-compromised mice engrafted with whole 
spheres, dispersed cells and c-kit+ cells showed morphological resemblance 
to human salivary gland tissue. In addition, amylase and Muc-5 positivity 
was observed by immunohistochemistry, suggesting that salivary stem cells 
(SSC) have an innate potential for differentiation into saliva-producing cells. 
Finally, we correlated our in vitro tissue culture findings with donor age, and 
found that donor tissue from patients older than 50 yielded significantly less 
salispheres in culture. Interestingly, earlier data of ours indicated that greater 
patient age at time of radiotherapy is positively correlated with the likeli-
hood of xerostomia development. Considered together, the present clinical 
and in vitro data suggest that a causal relationship exists between the qual-
ity or quantity of SSCs and presentation in the clinic of xerostomia. The data 
also imply that these SSCs, if manipulated correctly in vitro, could provide a 
future strategy for the largely unmet clinical need for xerostomia therapy.
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Salivary glands are often exposed to radiation, during radiotherapy for head 
and neck cancers. This may result in life-long salivary gland impairment, 
severely reducing the quality of post-treatment life of patients. Stem cell 
therapy may be an option to prevent radiation-hyposalivation. In mice, we 
recently showed that transplantation of salisphere-derived c-Kit+ stem/
progenitor cells (SSCs) rescued the salivary glands from radiation damage. 
The aim of current study is to characterise the exact stem cells in the salivary 
glands of rodents, which can regenerate the radiation damaged salivary 
gland. To obtain putative stem cells dissociated salivary glands of mice and 
rats were cultured to form three-dimensional aggregates of cells termed sali-
spheres. To investigate the ability of these rat and mouse spheres to differ-
entiate into cells/structures of their respective salivary gland cells in vitro, we 
plated single spheres in collagen matrigel matrix. When supplemented with 
different growth factors, such as R-spondin with insulin, keratinocyte growth 
factor (KGF) and the rock inhibitor, the spheres developed into duct like 
structures, which stained immunohistochemically positive for duct cell mark-
ers, such as CK14, and CK18. Furthermore, the matrix stained positive for 
Periodic Acid Schiff (PAS) indicating secretion of acinar cell derived salivary 
gland mucins. In matrigel without supplements, salisphere derived single 
cells were able to regrow spheres for at least 10 passages. These results pro-
vide evidence that the salispheres may contain stem cells, with self-renewal 
potential and able to form the structures of the salivary gland. To charac-
terize the exact stem cells in mice salispheres derived from submandibular 
tissue cells, single cells from the trypsinised salispheres were stained with 
flourochrome labelled antibodies specific for certain known stem cell mark-
ers. Flow cytometrical analysis showed that these salispheres contain, 0.65% 
±0.93 c-Kit+, 56.12%±9.40 CD24+, 80.04% CD29+, 55.2%±15.8 CD49f+, 
and 5.42%±3.62 CD133+ cells. Moreover, 0.02%±0.02 of all cells are 
double positive for CD24/c-kit, 32.71%±12 for CD24/CD49f, 55.46±11.45 
for CD24+/CD29+, but surprisingly no overlap was found between CD133 
and c-Kit-positive cells. To investigate the regenerative potential of the cells, 
we transplanted salisphere derived, CD133+ or CD24+/CD29+ or CD24+/c-
kit+ cells, intraglandularly into the locally irradiated (15 Gy) salivary gland 
of mice. To investigate potential salivary gland specific genes, microarray 
studies on 4d salispheres were performed, revealed upregulation of, MyoD, 
BMP7, Cdh1, Cdh13, Notch1 and CD44 in comparison with mouse salivary 
glands and fibroblats. Confirmation of their upregulation and importance in 
salisphere stem cells is in progress. Conclusion - Salispheres do contain cells 
with stem cell activity, as determined by prolonged in vitro growth, in vitro 
differentiation and in vivo regeneration. Further investigation of subpopula-
tions of double and triple stem cell marker positive cells may reveal the true 
identity of the salivary gland stem cell in rodents.
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Background: Stem cells have been vastly investigated for treatment of kid-
ney failure during the recent years and promising results have been obtained 
with different sources such as bone marrow derived cells, embryonic cells, 
and tissue specific stem cells. However, in spite of protective effects on other 
disease models, the renoprotective potential of human umbilical cord unre-
stricted somatic stem cells (USSC), have not been examined so far. Methods: 
In the present study, acute kidney failure was induced in female nude mice 
by subcutaneous injection of 14 mg/Kg cisplatin (day 0). After 24 hours, 
the mice received either 0.5 ml phosphate buffered solution (PBS) contain-
ing 105 USSC or 0.5 ml PBS alone. The mice were sacrificed in day 4 and 
serum and kidney samples were obtained for assessment of urea, creatinine, 
and histopathologic state. Results: The serum urea level of USSC group was 
higher than the control group (268.8±59.1 and 99.3±13.6, respectively; p-
value<0.05) and histopathologic examinations revealed that the severity of 
tissue damage was higher in USSC-receiving mice in comparison to control 
mice (138.9±8.7 and 112.6±7.0 respectively; p-value<0.05) In addition, 
the number of hyaline casts per high power field was more in USSC group 
(16.5±8.5 and 8.8±1.2 respectively; p-value<0.05). Conclusion: Unexpect-
edly, our results indicate that, transplantation of USSC following cisplatin 
induced nephropathy, has a negative effect on kidney function and structure 
and probably USSC is not a suitable source for cell therapy of acute kidney 
injury.
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Background: Mutations in the survival of motor neuron gene (SMN1) 
are responsible for spinal muscular atrophy (SMA), a fatal neuromuscular 
disorder. Using a Cre-LoxP system, mice carrying a homozygous deletion 
of Smn exon 7 directed to skeletal muscle (HSA-Cre, SmnF7/F7 mice) pres-
ent the main clinical features of human progressive muscular dystrophies. 
Cell−mediated therapies are still limited by the inefficiency of progenitors 
suitable to functional muscle regeneration. We have investigated whether 
amniotic fluid stem (AFS) cells are able to functionally restore muscle tis-
sue. Methods: Freshly isolated and expanded mouse AFS cells GFP+ were 
injected via tail vein in 3 months old HSA-Cre, SmnF7/F7 mice. Long term 
(15 months) morphological analyses and secondary transplantation were 
performed to demonstrate the restoration of satellite cell niche. Results: 
Muscle tissue of surviving AFS cells treated animals was analyzed 15 months 
after cell injection. Morphological analyses demonstrated that treated muscle 
tissue was compact, with few central nucleated fibres (<1%), comparable to 
WT mice. Moreover, 58% of myofibres were GFP+ in AFS cells treated mice. 
PCR analyses of GFP expression performed 15 months after transplantation 
on three different muscles (gastrocnemius, tibialis anterior and diaphragm) 
confirmed that the AFS cells had spread throughout the body engrafting 
in various skeletal muscle tissues. Finally, freshly isolated satellite cells from 
muscles of AFS cells transplanted primary hosts were injected into muscles 
of HSA-Cre, SmnF7/F7 secondary hosts. One month after secondary 
transplantation, all the mice in the AFS cell group had GFP+ fibres (31%). 
Conclusions: This is the first study demonstrating the functional integration 
of non-muscle and non-embryonic stem-derived cells into the satellite cell 
niche. The AFS cells’ ability to replenish the skeletal muscle stem cell niche 
could make them a promising treatment option for muscular dystrophy.
Poster Board Number: 3028
LINEAGE SPECIFIC DISTRIBUTION 
OF HIGH LEVELS OF GENOMIC 
5-HYDROXYMETHYLCYTOSINE IN 
MAMMALIAN DEVELOPMENT.
De Sousa, Paul A.1, Ruzov, Alexey2, Fletcher, Judy2, Serio, Andrea3, 
Tsenkina, Yanina2, Mjoseng, Heidi2, Pells, Steve2, Sullivan, Gareth2, 
Chandran, Siddharthan3, Hay, David2, Wilmut, Ian2, Bradley, Mark4
1University of Edinburgh, Edinburgh, United Kingdom, 2MRC Centre 
for Regenerative Medicine, University of Edinburgh, Edinburgh, United 
Kingdom, 3Centre for Neuroregeneration, University of Edinburgh, 
Edinburgh, United Kingdom, 4School of Chemistry, University of Edinburgh, 
Edinburgh, United Kingdom
Methylation of cytosine is a DNA modification associated with gene repres-
sion. Recently, a novel cytosine modification, 5-hydroxymethylcytosine 
(5-hmC) has been discovered. Here we examine 5-hmC distribution during 
mammalian development, adult tissues and derivative cellular systems com-
mencing with lineage specification at the blastocyst stage. We show that 
the developmental dynamics of 5-hmC are different from those of 5-mC; 
in particular 5-hmC is enriched in embryonic contexts compared to adult 
tissues. Levels of 5-hydroxymethylcytosine are high in cells of the inner 
cell mass (ICM) in blastocysts, and co-localise with nestin-expressing cell 
populations in mouse post- implantation embryos. Compared to other adult 
mammalian organs, 5-hmC is strongly enriched in bone marrow and brain, 
wherein a high 5-hmC content is a feature of both neuronal progenitors and 
in contrast with other contexts, postmitotic neurons. We show that high 
levels of 5-hmC are not only present in mouse and human embryonic stem 
cells (ESCs) and lost during differentiation, as it has been reported previously 
but also reappear during the generation of induced pluripotent stem cells 
(iPSC); thus 5-hmC enrichment correlates with a pluripotent cell state. Our 
findings suggest that apart from the cells of neuronal lineages, high levels of 
genomic 5-hmC are an epigenetic feature of embryonic cell populations and 
cellular pluri- and multi-lineage potency. To our knowledge, 5-hmC repre-
sents the first epigenetic modification of DNA discovered whose enrichment 
is so cell-type specific.
Poster Board Number: 3030
A ROLE FOR GATA3 IN CYCLING 
HEMATOPOIETIC STEM CELLS
Frelin, Catherine1, Herrington, Robert1, Benveniste, Patricia1, 
Janmohamed, Salima1, Barbara, Mary1, Penttilä, Pier-Andrée1, 
Souabni, Abdallah2, Busslinger, Meinrad2, Iscove, Norman1
1Ontario Cancer Institute, University Health Network, Toronto, ON, 
Canada, 2Research Institute of Molecular Pathology, Vienna, Austria
Gata3 is a zinc finger transcription factor known to play multiple roles in 
development and in the specification of various adult tissues including skin, 
hair follicle and mammary gland. Although Gata3 transcript expression has 
been described in highly purified fractions of hematopoietic stem cells (HSC), 
neither protein-level expression nor evidence for any functional role have 
been reported. We analysed Gata3 protein expression in highly purified pop-
ulations of Long-Term (LT)-HSC by immunofluorescence microscopy. Gata3 
protein was detected in 30% of RholoKit+Sca+Lin-CD49blo (RKSLCD49blo) 
and 50% of Kit+Sca+Lin-CD150+CD48b- (KSLCD150+CD48-) cells, but not 
in the newly described Intermediate-Term-HSC fraction (RholoKit+Sca+Lin-
CD49bhi). Interestingly, RKSLCD49blo and KSLCD150+CD48- fractions 
contain 30% and 50% of biologically active LT-HSC respectively. Confocal 
microscopy localized Gata3 in the cytoplasm of quiescent LT-HSC. However, 
after culture with cytokines, Gata3 had relocated entirely to the nucleus. 
This finding predicted that a functional role for Gata3 might be demonstra-
ble only in cycling HSC. In order to show conclusively that Gata3 expres-
sion was restricted to LT-HSC rather than other contaminating cell types 
present in the RKSLCD49blo and KSLCD150+CD48- fractions, we made use 
of a Gata3 mutant mouse in which GFP is expressed under control of the 
endogenous Gata3 promoter. When marrow from these mice was fraction-
ated according to GFP fluorescence and tested in recipient mice, long term 
engraftment was obtained only from the GFP+ fraction, while all transient 
engraftment activity remained in the GFP- fraction. To analyse Gata3 func-
tion we used a conditional Gata3 deletant mouse strain crossed to Mx1-Cre 
deleter mice. Gata3 excision had no effect on steady-state hematopoiesis 
and did not affect the frequency of phenotypic (RKSLCD49blo) HSC. 
However, when Gata3-deleted cells were transplanted into irradiated hosts 
where they would be induced to cycle, their reconstituting capacity was dra-
matically enhanced relative to wild-type competitors. When cultured with 
cytokines, Gata3-/- LT-HSC entered active cell cycle with expected kinetics 
but thereafter cycled more slowly than Gata3+/+ cells. After 7 - 14 days in 
culture, the long-term competitive in vivo repopulating activity of Gata3+/+ 
cells was lost as expected. In striking contrast, the reconstituting activity 
of cultured Gata3-/- cells increased beyond the activity initially placed into 
culture. These results are the first to implicate Gata3 in regulating key HSC 
properties, demonstrating a suppressive role in self-renewal of dividing HSC, 
presumably in favour of differentiation. Endogenous Gata3 is thus identified 
as a significant modulator of the outcome of cell divisions uniquely in the 
HSC subset capable of long-term maintenance of the self-renewal function.
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CONJUNCTIVAL POLYPLOID CELLS AND 
DONOR-DERIVED MYOFIBROBLASTS IN 
OCULAR GRAFT-VERSUS-HOST DISEASE
Hallberg, David M.1, Stenberg, Kristina2, Hanson, Charles3, Stenevi, 
Ulf4, Brune, Mats1
1Hematology & Coagulation, Sahlgrenska University Hospital, Gothenburg, 
Sweden, 2Opthalmology, Sahlgrenska University Hospital, Gothenburg, 
Sweden, 3Obstetrics and Gynecology, Sahlgrenska University Hospital, 
Gothenburg, Sweden, 4Ophthalmology, Sahlgrenska University Hospital, 
Gothenburg, Sweden
Purpose: After allogeneic hematopoietic stem cell transplantation (allo-SCT), 
ocular graft-versus-host disease (GvHD) is a common complication, typically 
symptoms being dry eye syndrome with features of fibrosis. In this study, 
we have identified and quantified two cell types - myofibroblasts (MFB) and 
polyploid cells - in the conjunctival surface of allo-SCT patients (pts), and 
have explored their kinetics and association with local and systemic GvHD. 
Methods: Imprint cytologies were obtained by pressing the conjunctival 
surface with a sterile, non-abrasive cellulose acetate filter (Millipore). After 
retraction, typically a monolayer of the outermost cells of the epithelium 
were retrieved. MFB were identified by immunofluorescent (IF) staining for 
alpha-smooth muscle protein (αSMA). Polyploid (PP) cells were detected 
by aberrant chromosome content analyzed via X/Y-FISH. In female pts with 
a male donor (M→F group), donor genotype were be identified by sex 
chromosome detection using FISH methodology. IF and FISH methods were 
applied in situ on the same filter, and amounts of MFB and PP cells are ex-
pressed as percent of all cells on the filter. In all, seventy samples from 46 pts 
were obtained 1-122 months after allo-SCT. Results: The total myofibroblast 
density (MFBTOT) was higher in allo-SCT pts compared to healthy controls, 
and increased by time elapsed since transplantation (p<0.001). In M→F 
recipients this increase proved to due to a significant (p<0.001 ) gradual 
elevation of donor-derived MFB (MFBXY), whereas recipient-derived MFB 
(MFBXX) did not vary over time. Clinical ocular GvHD correlated with MF-
BXY/MFBTOT ratio (p=0.034). No association between MFBTOT or MFBXY 
and systemic or ocular GvHD was observed. In the MtF group (n=25), 28 
of 37 imprints (76%) both MFBXY and MFBXX were detected. In pts >36 
months post-transplant, 11/12 imprints, a median of 9.4% (1.4-39) MFBXY 
and 3.6% (0-11) MFBXX was found. In one patient, 1.6% MFBXY were de-
tected at three weeks post-transplant. Polyploid cells (6-24n), exclusively of 
recipient origin, were found to a median of 0.6 (0-37)%. The PP cell density 
differed significantly (p<0,001) between time intervals with a maximum, 8.9 
(0-35)% of all cells, at 3-12 months. No correlation between polyploid cells 
and GvHD (ocular or systemic) was observed. ConclusionS: The MFB has 
been indicated as a culprit in chronic inflammation and fibrosis. The observa-
tions that (i) MFBTOT and time after transplantation; and (ii) MFBXY/MF-
BTOT ratio, correlated with ocular GvHD, suggest a role of MFB in GvHD 
pathogenesis. The constant finding of recipient-derived MFBXX cells many 
years after transplant in pts with 100% donor hematopoiesis, indicates that 
there is a non-hematopoietic differentiation route to MFB. The origin and 
role of polyploid cells after allo-SCT remains obscure.
Poster Board Number: 3034
WDHD1 MODULATES THE POST-
TRANSCRIPTIONAL STEP OF THE 
CENTROMERIC SILENCING PATHWAY
Hsieh, Chia-Ling1, Lin, Chih-Li2, Liu, Hsuan2, Shih, Chii-Jiun2, 
Chang, Yao-Jen2, Lee, Sheng-Chung1, Tan, Chin-Ming2
1Institute of Molecular Medicine, College of Medicine, National Taiwan 
University, Taipei, Taiwan, 2Department of Biomedical Sciences and 
Graduate Institute of Biomedical Sciences, College of Medicine, Chang 
Gung University, Kwei-San, Tao-Yuan, Taiwan, Taipei, Taiwan
The centromere is a highly specialized chromosomal element that is essential 
for chromosome segregation during mitosis. Centromere integrity must 
therefore be properly preserved and is strictly dependent upon the establish-
ment and maintenance of surrounding chromatin structure. Here we identify 
WDHD1, a WD40-domain and HMG-domain containing protein, as a key 
regulator of centromere function. We show that WDHD1 associates with 
centromeres in a cell cycle-dependent manner, coinciding with mid-to-
late S phase. WDHD1 downregulation compromises HP1α localization to 
pericentric heterochromatin and leads to altered expression of epigenetic 
markers associated with this chromatin region. As a consequence, such 
reduced epigenetic silencing is manifested in disrupted heterochromatic state 
of the centromere and a defective mitosis. Moreover, we demonstrate that a 
possible underlying mechanism of WDHD1’s involvement lies in the proper 
generation of the small non-coding RNAs encoded by the centromeric 
satellite repeats. This role is mediated at the post-transcriptional level and 
likely through stabilizing Dicer association with centromeric RNA. Collec-
tively, these findings suggest that WDHD1 may be a critical component of 
the RNA-dependent epigenetic control mechanism that sustains centromere 
integrity and genomic stability.
Poster Board Number: 3036
DETECTION AND QUANTIFICATION OF MRNA 
TRANSCRIPTS IN SINGLE EMBRYONIC STEM 
CELLS BY OPENARRAY® AND DIGITAL PCR
Kolling, Fred W.
Molecular and Cell Biology, University of Connecticut, Storrs, CT, USA
There is increasing evidence that pluripotent embryonic stem cell cultures 
(ESCs), once thought to be a uniform cell type, are in fact highly heteroge-
neous, especially in terms of RNA expression. Until recently, understanding 
the dynamics of both miRNA and mRNA expression within a cell population 
has been severely limited by the lack of an efficient and effective means 
to assay gene expression within individual cells. Here we demonstrate our 
success using the Taqman™ chemistry on Open Array platform (Life Tech-
nologies, Inc) to easily and robustly analyze miRNA and mRNA expression 
in single embryonic stem cells. Open Array results are consistent with our 
established single cell analysis platform, confirming the robust reproducibil-
ity of the Open Array system, and establishing the technology required for 
high throughput single cell profiling experiments. In our most recent studies 
we confirm highly heterogeneous expression of key developmental control 
genes in ESC and demonstrate heterogeneous expression of several miRNAs, 
adding a new dimension to our understanding of cell type complexity in ESC 
cultures. In addition, we utilized cutting-edge digital PCR (dPCR) technol-
ogy to quantify the number of transcripts present in each cell, providing an 
unprecedented level of resolution to single cell transcript analysis. Single 
mouse embryonic stem cells (mESCs) were collected via FACS sorting into 96 
well plates containing Single Cell-to-Ct® Lysis Buffer with subsequent DNA 
treatment, RT and preamplification performed using either gene-specific or 
miRNA Megaplex® primers and samples were sent to Life Technologies for 
analysis. In total we analyzed the expression of 64 mRNA transcripts in 48 
single cells and 61 miRNAs in 27 cells using the Open Array® platform. For 
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dPCR, cells were lysed following FACS and sent to Life Technologies where 
RNA was reversed transcribed and the entire RT reaction was applied to the 
Open Array®. dPCR was used to quantify Nanog and Gapdh transcripts for 
pools containing between 1-20 cells and per-cell transcript levels were con-
sistent across all samples. Our experience with the Open Array® platform 
and its dPCR capability has dramatically increased our throughput, providing 
a flexible and cost-effective means of analyzing gene expression in single 
cells without compromising the reliability and sensitivity of our assay.
Poster Board Number: 3038
ENHANCED STEMNESS DUE TO EMBRYONIC 
MICRORNA
Langroudi, Lida1, Jamshidi, Fatemeh1, Arefian, Ehsan1, Ahmadbeigi, 
Naser2, Soleimani, Masoud2
1Molecular Biology and Genetic Engineering, Stem Cell Technology 
Research Center, Tehran, Iran, Islamic Republic of, 2Stem Cell Biology and 
Tissue Engineering, Stem Cell Technology Research Center, Tehran, Iran, 
Islamic Republic of
Stem cells hold promise as an unlimited source for various clinical and 
biotechnological applications. Speculating the regulatory mechanism in Stem 
cells will greatly enhance the understanding of stem cells as well as their ap-
plications. Recent advances in small RNA research have implicated microR-
NAs (miRNAs) as important regulators of development and differentiation. 
miRNAs constitute a large family of non-coding small RNAs of approximate-
ly 22 nucleotides (nt) in length which interfere in gene expression either by 
inhibiting translation or RISC mediated mRNA degradation. The expressions 
of miRNAs are often regulated in tissue specific and developmental stage 
manners. Studies have shown that a group of microRNAs are expressed 
only in hES cells including mir371 cluster. The mir-372 microRNA (miRNA) 
is expressed specifically in human embryonic stem (ES) cells, and quickly 
decreases after cell differentiation and proliferation. Therefore, mir-372 was 
investigated as one of the key factors essential for maintenance of ES cell 
renewal and pluripotency in this study. The lenti-viral based miRNA expres-
sion system was used to transgenically transduce the mir-372 into human 
mesenchymal stem cells (MSCs). The mir-372 - transducted cells expressed 
exceptional key ES cell markers, Nanog and Rex1. Cell proliferation assay 
and other findings will need to be further explored and will be announced 
later. At this stage we can conclude that mir-372 not only functions to main-
tain the pluripotent state of human embryonic stem cells but also function 
to manage the same in Mesenchymal stem cells (MSCs) which may offer a 
great chance for therapeutic intervention.
Poster Board Number: 3040
WNT β-CATENIN SIGNALING INDUCES AGING 
OF BONE MARROW MESENCHYMAL STEM 
CELLS THROUGH DNA DAMAGE AND P53 P21 
PATHWAY
Zhang, Da-yong, Tan, Yu-zhen, Wang, Hai-jie
Shanghai Medical School of Fudan University, Shanghai, China
Recent studies have demonstrated importance of cellular extrinsic factors 
in aging of adult stem cells. This study examined effects of the aged serum 
on aging of bone marrow mesenchymal stem cells (MSCs) and explored 
mechanisms of aging of MSCs mediated by Wnt/β-catenin signaling. 10% 
serum from young (3 ~ 4 weeks) or old (64 ~ 72 weeks) SD rats was added 
into the culture medium for MSCs. Senescence-associated changes of the 
cells were examined with SA-β-galactosidase staining and ROS staining. The 
proliferating ability was detected in MTT assay. The survived and apoptotic 
cells were determined by AO/EB staining and Hochest 33342 staining. Old 
rat serum (ORS) promoted MSC senescence and reduced proliferation and 
survival of the cells. The expression of β-catenin and GSK-3β were detected 
by immunofluorescence and western blotting. The results showed that 
the Wnt/β-catenin signaling of the cells was activated after ORS treat-
ment. In order to evaluate roles of Wnt/β-catenin signaling on MSC aging, 
we examined aging, proliferation and survival of MSCs after modulating 
Wnt/β-catenin signaling. The results indicated that continuous exposure to 
100ng/ml Wnt 3a induce senescence and dysfunction of MSCs incubated 
with young rat serum (YRS). Senescence and dysfunction of MSCs in the 
medium contained ORS could be reversed by Wnt/β-catenin signaling 
inhibitor DKK1 or β-catenin siRNA. For further exploring mechanisms of 
Wnt/β-catenin signaling on the MSC aging, we detected expression of 
γ-H2A.X, a molecular marker of DNA damage response, p16INK4a, p53 
and p21 by reverse transcription-PCR, immunofluorescence and western 
blotting. The results showed the expression of γ-H2A.X, p16INK4a, p53 and 
p21 increased in senescent MSCs induced with ORS or following a Wnt 3a 
exposure in YRS. This study indicates that Wnt/β-catenin signaling pathway 
may play a critical role in MSC aging induced by serum of the aged animals 
and suggests that the DNA damage response and p53/p21 pathway may be 
main mediators of MSC aging induced by excessive activation of Wnt/β-
catenin signaling.
Poster Board Number: 3042
A GENOME-WIDE PROFILING OF SILENCED 
INSERTS TARGETED BY PIGGYBAC, TOL2, AND 
SLEEPING BEAUTY TRANSPOSONS IN HEK293
Meir, James, Kan, Chih Yen, Wu, Chiung-yuan
Chang Gung University, Kwei-Shan Tao-Yuan, Taiwan
Most of the advanced gene trap systems currently available are retrovirus-
based gene trap vectors that favor inserting into active genes. Consequently, 
the inactive chromosomal regions are either hard or unable to be targeted 
by these vectors, leading to the targeting profile of retrovirus-based gene 
trap vectors biases toward the active gene category in undifferentiated ES 
cells. To overcome the aforementioned obstacles encountered by current 
gene trap vector systems, a novel gene trap system, enabling to target both 
active and silenced regions in mammalian genome in an effective and ran-
dom manner is urgently needed. Unlike retrovirus-based vectors, preferably 
targeting to the active gene regions, DNA transposons, such as piggyBac, 
Tol2, and Sleeping Beauty display a relatively random targeting profile. In 
this study, we aim to explore the potential of developing a DNA transposon-
based gene trap system enabling to target both active and epigenetically 
silenced genes in the mammalian genome. To this end, here we conducted 
a side-by-side genome-wide target profiling of piggyBac, Tol2, and Sleeping 
Beauty with focuses on the targets located in silenced regions of the HEK293 
genome. We observed that the chromosomal integration rate of piggyBac 
and Tol2 are 94% and 95%, respectively, once they are delivered into cells. 
And the transgene in 19% of piggyBac and 24% of Tol2 targeted HEK 293 
clones are silenced. Furthermore, except for the 19% silenced clones, most 
of the piggyBac targeting clones expressed transgene (hygromycin resistant 
gene) at a moderate to high level. On the contrary, only about one half of 
Tol2 targeted clones expressed sufficient hygromycin resistant gene product 
for drug selection. Plasmid rescue experiments are now undergoing to 
retrieve the chromosomal sequences flanking the piggyBac and Tol2 silenced 
targets. The similar evaluation on Sleeping Beauty is also undergoing.
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IDENTIFICATION OF TISSUE SPECIFIC STEM / 
PROGENITOR CELLS IN AUDITORY PATHWAY
Ooka, Hisashi1, Kanda, Seiji1, Nishiyama, Toshimasa1, Tomoda, 
Koichi2, Okazaki, Haruka1
1Regeneration Research Center for Intractable Diseases, Kansai Medical 
University, Moriguchi, Osaka, Japan, 2Otorhinolaryngology, Kansai Medical 
School, Osaka, Japan
Objects: Recently, in the region of regenerative medicine, it focused on 
the tissue specific stem/progenitor cells such as neural stem cells in adult 
brain that has multipotency and identified these cells in various organs. The 
treatment for the deaf patients that have the auditory damages has been 
tried, however it was difficult to heal completely. In this research, in order 
to find out the keys of treatments for these patients by using regenerative 
medicine, we tried to isolate stem cells from auditory pathway and identify 
the cell characterization and gene expressions. Methods and Results: 3 days 
age of mice were injected BrdU to the hypodermic at 2 times/day for 3 days 
continuously, and sacrificed after 16 weeks to identify the slow-cycling cells 
suggesting the possibility of stem cells. The results of immunohistochemis-
try showed that a few cells were identified as BrdU+ and ABCG2+ double 
positive cells in the section of cochlear nuclei in auditory pathway. Further-
more, we assumed that it was possible to purify stem cells as side popula-
tion (SP) cells. Cochlear nuclei cells were isolated from 6 weeks age of mice 
and stained with Hoechst 33342. After staining, SP cells were sorted as a 
negative fraction. The population of SP cells was about 4% of total cells of 
cochlear nuclei. Furthermore, we analyzed the gene expression of SP cells by 
RT-PCR. The results showed that some specific markers of stem/progenitor 
cells, such as Oct-3/4, Sox2 and ABCG2, were over-expressed in SP cells 
compared with main population (MP) cells. Cell suspension from CN were 
cultured in the conditioned medium, sphere formation was found. Now 
we are going to study whether these cells have the multipotency as stem/
progenitor cells, and analyze the specific gene function that identified by 
microarray analysis.
Poster Board Number: 3046
DEVELOPMENT OF POTENTIAL BIOMARKERS 
FOR TUMORIGENESIS IN EMBRYONIC STEM 
CELL BASED THERAPY
Park, Ki Dae
National Institute of Food and Drug Safety Evaluation, Cheongwon-gun, 
Korea, Republic of
Embryonic stem cells (ESCs) give rise to the possibility that stem cell therapy. 
However, before cell replacement therapies can be used, the problems with 
the tumorigenicity of ESCs must be solved. In the present study, we attempt 
to find biomarkers related with tumor formation of ESCs. We induced 
neuronal differentiation from H9, a hESCs, using a five-stage method and 
performed characterization of hESCs in each developing stages. We decided 
stage 3 as the step of cell sorting and performed separating cells on SSEA3 
and CD133 using the MACS. In the results of in vivo assay with each sorted 
cells, CD133 positive and negative cells were not related with tumorigenesis. 
But groups injected the SSEA3 positive cells showed high levels of tumor 
forming rate as 100%, otherwise the group injected SSEA3 negative cells 
not detected tumorigenesis during periods of study. In these results, we rec-
ognized that SSEA3 related with undifferentiated status has important role in 
reduction of tumor formation on hESCs tumorigenesis, suggesting that these 
appears to be a useful biomarker for the assessment of the safety of stem 
cell-based therapies using hESCs.
Poster Board Number: 3048
INVESTIGATING THE EFFECT OF HIGH GLUCOSE 
ON BONE MARROW-DERIVED MESENCHYMAL 
STEM CELLS TOXICITY: ROLE OF APOPTOSIS
Sharifi, Ali M., Tekiyehmaroof, Neda, Ghazanfari, Roshanak, Sharifi, 
Mohammad Amin
Pharmacology, Tehran University of Medical Sciences, Tehran, Iran, Islamic 
Republic of
Hyperglycemia which occurs under the diabetic condition induces a number 
of serious complications such as cell death in various types of cells. Mesen-
chymal stem cells (MSCs) are population of cells with ability to differentiate 
into various cell types. Despite of intensive investigation on effect of high 
glucose poisoning on many cell types, there is no report on high glucose-
induced toxic effect on MSCs. The goal of this study was to investigate the 
cytotoxic effect of high glucose on rat bone marrow derived MSCs toxicity 
and also to examine the involvement of Bax, pro-apoptotic, Bcl-2, anti-
apoptotic, and caspase-3, the executioner of apoptosis, protein expres-
sion, during high glucose-induced apoptosis in MSCs. The cell viability was 
measured by MTT assy. Exposure to high glucose significantly decreased the 
level of cell proliferation in a dose-dependent manner. The expression of 
pro-apoptotic Bax and anti-apoptotic Bcl2 and caspase-3 protein expres-
sions were measured by western blotting analysis. High glucose at 60 mg/
ml enhanced over expression of pro-apoptotic Bax, as well as caspase 3- 
protein compared to the controls, while the expression of Bcl-2 protein did 
not change significantly. The Bax/Bcl2 ratio significantly increased in high 
glucose-treated cells. Finally, it may be concluded that high glucose could 
cause toxicity of MSCs, in which apoptosis by mitochondrial pathway plays 
an important role.
CHROMATIN IN STEM CELLS
Poster Board Number: 3050
TEMPORAL CHANGES OF HISTONE 
MODIFICATIONS DURING DIFFERENTIATION 
OF MOUSE EMBRYONIC STEM CELLS
Xiao, Shu, Yu, Pengfei, Musselman, Meagan, Zhong, Sheng
Institute for Genomic Biology, University of Illinois at Urbana-Champaign, 
Urbana, IL, USA
Embryonic Stem (ES) Cell differentiation is accompanied by overall changes 
in chromatin accessibility regulated in epigenomic layers. To follow this 
dynamic process, we differentiated mouse embryonic stem (mES) cells into 
mesendoderm cells (precursors of endoderm and mesoderm) using a serum 
free medium with Activin A. Analysis of the expression of 10 lineage-specific 
marker genes showed strong enrichment of mesendoderm population after 
6 days of differentiation. Changes of epigenomic states were assayed with 
chromatin immunoprecipitation followed by DNA sequencing (ChIP-Seq) in 
three time points (day 0, 4 and 6). We found the distribution of the histone 
modification H3K27me3 was temporally altered upon differentiation. In 
mES cells, H3K27me3 was highly enriched in the genomic neighborhood of 
lineage-specific developmental regulatory genes and depleted near pluripo-
tency regulatory genes. During differentiation, the enrichment near some 
lineage markers was gradually lost, and it was enhanced near pluripotency 
regulatory genes.
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CELL FATE SPECIFICATION OF CARDIAC 
PROGENITOR CELLS AND STEM CELLS BY 
DEFINED FACTORS IN MICE
Takeuchi, Jun K.1, Kwon, Chulan2, Koshiba-Takeuchi, Kazuko1
1Institute of Molecular and Cellular Biosciences, the University of Tokyo, 
Tokyo, Japan, 2Division of Cardiology, Johns Hopkins University, Baltimore, 
MD, USA
Congenital heart defects (CHDs) are the most common birth defects in hu-
man, occurring in approximately 1% of all live births, and heart disease re-
mains a leading cause of death globally. For patients with extensive damage 
to heart muscle, treatment options are very limited and there is no therapy 
available to reverse the damage once it has occurred. Recently, therapies 
based on cardiac progenitor/stem cells have emerged as promising potential 
cardiac therapeutics. This offers a new approach to treat patients with 
heart disease, including the potential to differentiate into new heart muscle 
and thus reverse dysfunction. However, to take advantage of regenerative 
therapy, we need to develop efficient and reliable ways to induce and dif-
ferentiate cardiac projenitor/stem cells. Our strategy is to directly induce/dif-
ferentiate Isl1+/Wt1+ embryonic cardiac progenitors and Sca1+/c-Kit+ adult 
stem cells by identifying and manipulating their master regulators. Recently, 
I discovered key epigenetic factors that act as master regulators for cardio-
myocyte induction in a mammalian system (Takeuchi & Bruneau 2009). In-
terestingly, additional epigenetic genes belonged to the family of the factors 
had a specific function in heart cell specification. Based on these findings, 
we profiled epigenetic genes expressed in cardiac progenitor/stem cells. We 
identified 15 genes that are highly enriched in these cells and investigated 
their function in mice. Strikingly, a gene deletion caused loss of outflow 
tract formation as in Islet1-deleted mouse embryos. Flow cytomety revealed 
that cells positive for the deleted genes were also positive for Isl1 (50%), 
cKit (40%) and Sca1 (10%). This suggests that these genes may potentiate 
induction/differentiation of cardiac progenitor/stem cells. These candidate 
genes were co-expressed with cKit/Sca1 in the adult heart. Importantly, their 
overexpression resulted in ectopic expression of cardiac progenitor genes in 
vivo. Our study will elucidate the fundamental mechanisms by which cardiac 
progenitor/stem cells are induced and differentiated into specific lineages, 
which will be applicable for future cell-mediated heart therapeutics.
Poster Board Number: 3054
EED-DEPENDENT GLOBAL AND LOCAL 
CHROMATIN STATES IN PLURIPOTENT AND 
DIFFERENTIATING MOUSE EMBRYONIC STEM 
CELLS
Obier, Nadine, Hornich, Vroni, Becker, Matthias, Müller, Albrecht 
M.
Zemm, University of Wuerzburg, Wuerzburg, Germany
The molecular programs determining pluripotency and differentiation of 
embryonic stem (ES) cells underlie epigenetic regulation. The chromatin of 
ES cells is characterized by a hyperdynamic state, open conformation, overall 
elevated gene expression levels and bivalent domains, which are defined by 
the concomitant presence of activating histone H3K4 tri-methylation (me3) 
and repressive histone H3K27me3 marks. Bivalently modified chromatin is 
thought to keep genes in a transcriptionally poised state. While Trithorax 
group proteins are involved in H3K4 methylation, the methylation of H3K27 
is catalyzed by the Polycomb repressive complex 2 (PRC2), consisting of 
the core subunits EZH2, SUZ12 and EED. The deletion of EED leads to the 
loss of EZH2 and SUZ12 protein expression and thus results in a global loss 
of H3K27 methylation. EED knockout (KO) ES cells are reported to express 
bivalently regulated genes at higher levels than wildtype (wt) ES cells while 
the non-bivalently marked pluripotency-associated genes are expressed 
at levels comparable to wt ES cells. We aim to understand the role of EED 
in the organization of global nuclear chromatin architecture. Further we 
study the role of PRC2 during in vitro ES cell differentiation. By micrococ-
cal nuclease digestion we observed similar chromatin accessibility in wt and 
EED KO ES cells, indicating that the absence of the H3K27 methylation does 
not result in a global opening of ES cell chromatin structure. In agreement 
with this, FRAP analyses revealed similar linker histone dynamics in wt and 
EED KO ES cell nuclei. By fluorescence microscopy we could, however, show 
that DAPI-/H3K9me3-positive heterochromatic foci were more defined, 
larger in size and less frequent in EED KO ES cells as compared to wt ES cells. 
Further, global H3K9me3 levels were slightly decreased, pointing towards a 
PRC2-mediated crosstalk between H3K9 and H3K27 methylation, and the 
enzymes that set or read these marks. Currently performed genome-wide 
H3K9me3 ChIP-seq analyses using wt and EED KO ES cell chromatin prepa-
rations will provide further information on the genomic regions affected by 
PRC2-dependent H3K9 methylation. To investigate the role of PRC2 during 
ES cell differentiation, we induced cardiomyocytic differentiation in wt and 
EED KO ES cells. The data revealed severe defects in EED KO ES cell dif-
ferentiation as they failed to form contracting cardiomyocytes and retained 
more cells with colony formation potential after an extendend period of 
time under differentiation culture conditions. In comparison to wt cells the 
expression of pluripotency-associated genes remained high in EED KO cells 
during this period. Together, we report that the nuclear H3K9me3-enriched 
heterochromatin is reorganized in EED KO ES cells and that pluripotency-
associated genes require PRC2-mediated silencing upon in vitro differentia-
tion.
Poster Board Number: 3056
THE ROLE OF CHROMATIN MODIFYING 
ENZYMES IN CHROMATIN RE-ORGANIZATION 
DURING MOUSE EMBRYONIC STEM CELL 
DIFFERENTIATION
Hassan-Zadeh, Vahideh, Rugg-Gunn, Peter, Fussner, Eden, Bazett-
Jones, David
Hospital for Sick Children, Toronto, ON, Canada
In Embryonic Stem cells (ES) derived from the E3.5 embryo, the chromatin 
is uniformly and widely dispersed whereas in Epiblast Stem Cells (EpiSCs) 
derived from the E5.5 embryo, compact chromatin domains are observed. 
ES and EpiSCs are both pluripotent stem cells but unlike ES cells, EpiSCs are 
primed-for-differentiation and unable to produce a chimera mouse. ES and 
EpiSCs are reversibly convertible in vitro. Following differentiation of ES 
cells, the global chromatin architecture is extensively re-organized includ-
ing the formation of large compact chromatin domains. These observations 
led to our hypothesis that an open chromatin structure is required for stem 
cell pluripotency and that chromatin re-organization is critical in the early 
differentiation program. The question we wish to address is what is the 
mechanism responsible for global chromatin changes observed upon the 
reversible conversion between ES and EpiSCs and in ES cell differentiation? 
In other words, what change in chromatin organization is inherent in lineage 
commitment? For this purpose, we have obtained a number of ES cell lines 
that are null mutants including a component of the nucleosome remodel-
ling and histone deacetylation complex NuRD, the DNA methyltransferases 
3a/b and a histone methyltransferase. We convert these mutant ES cells to 
EpiSCs and take advantage of a transmission electron microscopy technique, 
called electron spectroscopic imaging, which allows us to observe a change 
in the global chromatin configuration with high resolution and contrast. 
The absence of epigenetic modifiers crucial in establishing heterochromatin 
domains in early development leads to defects in chromatin reconfiguration 
in ES/EpiSC conversion.
163
Friday Poster Abstractswww.isscr.org
Friday Poster Abstracts
Poster Board Number: 3058
CULTURE-INDUCED DNA DEMETHYLATION 
OF THE EPIGENOME OF HUMAN EMBRYONIC 
STEM CELLS
Chung, Tung-Liang, Wolvetang, Ernst
Australian Institute for Bioengineering and Nanotechnology, The University 
of Queensland, Brisbane, Australia
The genetic and epigenetic integrity of human embryonic stem cells (hESCs) 
is critical to their future application in research and medicine. hESCs cultured 
in serum free media can accumulate point mutations, aneuploidy, and 
progressive epigenetic changes over prolonged culture in vitro. For the first 
time, we previously identified ascorbate as the only molecule in the very 
widely used Knock-out serum replacement medium that is sufficient to 
induce widespread and remarkably specific and consistent DNA demethyla-
tion of 1,847 genes in both HES2 and HES3 cells, including CD30, a member 
of the tumour necrosis factor receptor superfamily and a biomarker for 
embryonal carcinoma cells. The underlying biochemistry and the upstream 
molecular mechanism of ascorbate-induced DNA demethylation remain to 
be determined. We speculate that ascrobate directly changes DNA topology 
by affecting the activity of histone demethylases and thus modifying the 
accessibility of DNA methylases and/or demethylases. Our preliminary data 
show that ascorbate leads to increased global histone acetylation, decreased 
H3K9-methylation as well as increased expression of Jumonji histone dem-
ethylase JMJD2 in hECSs. Notably, JMJD2 (2A, 2B, 2C, 2D) demethylate 
H3K9 me3/me2, which is required for the binding of the repressive protein 
HP1 and is associated with heterochromatin formation and transcriptional 
repression in a variety of species. We propose that addition of ascorbate 
in culture media triggers JMJD2-mediated H3K9 me3/me2 demethyla-
tion, subsequently leading to genome wide DNA demethylation in hESC 
epigenome. Using CD30 as a marker, we are currently assessing the effect 
of enforced overexpression of JMJD2B and JMJD2C on CD30 expression in 
hESCs.
Poster Board Number: 3060
NON-HISTONE CHROMATIN PROTEINS AND 
PROTOONCOGENES HMGA1 AND HMGA2 ARE 
GUARDIANS OF HUMAN EMBRYONIC STEM 
AND TUMOR CELL GENOMES
Yu, Haojie, Nathan, Priya, Droge, Peter
Nanyang Technological University, Singapore, Singapore
Background: Besides critical roles for high mobility group AT-hook (HMGA) 
proteins in early mouse and human development, clinicians have known for 
some time that high HMGA levels are associated with most malignant hu-
man neoplasias such as breast cancer, sarcomas, pancreas and lung cancer. 
In fact, HMGA genes are the only known proto-oncogenes coding for DNA 
architectural chromosomal proteins consistently over-expressed in nearly all 
types of naturally occurring cancers. Their expression level correlates directly 
with the degree of malignancy and metastatic potential. In line with these 
observations, recent microarray analyses showed that both HMGA genes 
belong to a small class of genes whose expression is critical to the cancer 
phenotype in cells that carry two key oncogenic mutations in p53 and Ras. 
Intriguingly, HMGA2 is also found in rare tumor-inducing cells (cancer stem 
cells) which are resistant to chemotherapy. Findings and Conclusions: We re-
cently demonstrated that HMGA1 and HMGA2 possess intrinsic abasic (AP) 
and dRP site DNA cleavage activities. By employing a variety of cell-based 
assays, we provided evidence that HMGA2 promotes cellular resistance 
against DNA damage that is targeted by base excision repair pathways, and 
that this protection directly correlates with the level of HMGA2 expression. 
We demonstrate here that HMGA2 has an additional DNA-stabilizing role at 
stalled replication forks in human ES and cancer cells, thus substantially in-
creasing genome stability after spontaneous or induced DNA damage. These 
observations reveal another unexpected and crucial function for HMGA2 in 
genome stability in human ES and cancer (stem) cells. Funded, in part, by 
BMRC Singapore.
Poster Board Number: 3062
CHROMATIN DYNAMICS DURING 
CARDIOVASCULAR DIFFERENTIATION FROM 
HUMAN EMBRYONIC STEM CELLS
Paige, Sharon L.1, Thomas, Sean2, Wang, Hao2, Canfield, 
Theresa2, Sandstrom, Richard2, Pabon, Lil1, Reinecke, Hans1, 
Stamatoyannopoulos, John2, Murry, Charles E.1
1Pathology, University of Washington, Seattle, WA, USA, 2Genome 
Sciences, University of Washington, Seattle, WA, USA
Directed differentiation of human embryonic stem cells (hESCs) into defini-
tive cardiovascular cells provides a model system for studying the molecu-
lar mechanisms of human cardiovascular development. In this study, we 
analyzed cells undergoing cardiovascular directed differentiation at five key 
developmental stages: pluripotency, mesoderm, tripotential cardiovascular 
progenitor (KDR+/PDGFRα+), cardiac committed and definitive cardiovas-
cular cells. We performed whole-transcriptome analysis using traditional 
microarray to monitor changes in gene expression over the course of dif-
ferentiation. To gain insight into the mechanisms of gene regulation during 
cardiovascular differentiation, we sought to examine chromatin dynamics 
over time. We performed chromatin immunoprecipitation followed by deep 
sequencing (ChIP-seq) for histone H3 lysine 4 trimethylation (H3K4me3), 
H3K27me3 and H3K36me3, an activating modification, a repressive 
modification and a surrogate for RNA polymerase, respectively. In addi-
tion, we utilized DNase hypersensitivity analysis to identify cis-regulatory 
elements genome-wide. Many known cardiac transcription factors, including 
NKX2.5 and TBX5, had high levels of H3K27me3 early in differentiation 
that decreased over time, concurrent with increasingly levels of H3K4me3, 
H3K36me3 and RNA expression. This highlights the importance of repress-
ing expression of transcription factors until the precise time when their activ-
ity is developmentally appropriate. In contrast, structural proteins involved in 
cardiac muscle contraction, such as alpha myosin heavy chain (MYH6) and 
cardiac troponin T (TNNT2), were not marked with H3K27me3 at any stage 
of development, but showed the same increase in H3K4me3, H3K36me3 
and RNA expression as cardiac transcription factors. Of note, several cardiac 
transcription factors showed the highest levels of H3K4me3, H3K36me3 and 
RNA expression at the tripotential cardiovascular progenitor stage of dif-
ferentiation. These include the closely-related forkhead transcription factors 
FOXC1 and FOXC2, which have been implicated in cardiovascular defects in 
both mice and humans, and are thought to be involved in second heart field 
development. Thus, our data can be used to identify the specific stage(s) of 
differentiation regulated by known cardiac transcription factors. In addition, 
we have identified several transcription factors with a less well-defined role 
in cardiogenesis that have similar chromatin patterns to transcription fac-
tors known to be critical to cardiac development. These include zinc finger 
proteins, homeobox-containing transcription factors and nuclear receptors. 
Thus, our results show that genome-wide chromatin state profiles facilitate 
the discovery of novel regulators of key developmental processes. Our 
ongoing work is focused on knocking down these genes during cardiovas-
cular directed differentiation from hESCs and zebrafish embryogenesis to 
characterize their role in heart development.
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CHROMATIN PROTEOMICS IN EMBRYONIC 
STEM CELLS REVEALS A ROLE FOR 
CHROMATIN REMODELERS IN STEM CELL 
IDENTITY
Alajem, Adi1, Gerbasi, Vincent R.2, Golden, Dan3, Datta, Arnab4, 
Kwan, Sze Siu4, Meshorer, Eran1
1Genetics, Hebrew University, Jerusalem, Israel, 2University of Chicago, 
Chicago, IL, USA, 3Northwestern University, Chicago, IL, USA, 4Nanyang 
Technological University, Nanyang, Singapore
Chromatin in ES cells has an open structure that is permissive to the 
transcriptional machinery. Upon differentiation, chromatin is reorganized 
into a more closed, restrictive structure. In order to identify the proteins 
that regulate chromatin biology in ES cells, we developed an assay (DCAP: 
Differential Chromatin Associated Proteins), which enables us to reveal ES 
cell-specific chromatin associated proteins by Multidimensional Protein Iden-
tification Technology (MudPIT). We identified several chromatin remodeling 
proteins which are exclusively associated with chromatin in undifferenti-
ated ES cells, including Smarcd1. Reduced levels of Smarcd1 in ES cells lead 
to elevated levels of acetylated histone H3 (H3ac) and reduced levels of 
heterochromatin protein 1 alpha (HP1α), implying a transition to a hyper-
active chromatin state. Smarcd1 Knock-Down (KD) derived embryoid bodies 
(EBs) display elevated levels of Oct4, suggesting delayed differentiation. The 
formation of neuronal progenitor cells (NPCs) from Smarcd1-KD cells is per-
turbed, indicating the importance of Smarcd1 for neuronal differentiation. 
Taken together, these results show that Smarcd1 acts to restrict chromatin in 
differentiating ES cells, reducing pluripotency during early differentiation.
Poster Board Number: 3066
LOSS OF HISTONE DEMETHYLASE LSD1 NON-
AUTONOMOUSLY CAUSES GERMLINE STEM 
CELL TUMORS IN THE DROSOPHILA OVARY
Eliazer, Susan, Shalaby, Nevine, Buszczak, Michael
Molecular Biology, University of Texas Southwestern Medical Center, 
Dallas, TX, USA
Specialized microenvironments called niches keep stem cells in an undif-
ferentiated and self-renewing state. Dedicated stromal cells form niches 
by producing a variety of factors that act directly upon stem cells. The size 
and signaling output of niches must be finely tuned to ensure proper tissue 
homeostasis. While advances have been made in identifying factors that 
promote niche cell fate, the mechanisms that restrict niche cell formation 
during development and limit niche signaling output in adults remain poorly 
understood. Here we show that the histone demethylase Lsd1 regulates the 
size of the germline stem cell (GSC) niche in Drosophila ovaries. GSC main-
tenance depends on BMP signals produced by a small cluster of cap cells 
located at the anterior tip of the germarium. Lsd1 null mutant ovaries carry 
small germline tumors, containing an expanded number of GSC-like cells 
that display ectopic BMP signal responsiveness away from the normal niche. 
Clonal analysis and cell-type specific rescue experiments demonstrate that 
Lsd1 functions within the escort cells (ECs) that reside immediately adjacent 
to cap cells and prevents them from ectopically producing niche specific sig-
nals. Temporally restricted gene knock-down experiments suggest that Lsd1 
functions both during development, to specify EC fate, and in adulthood, 
to prevent ECs from forming ectopic niches independent of changes in cell 
fate. Further analysis shows that Lsd1 functions to repress dpp expression in 
adult germaria. The role of Lsd1 in regulating niche specific signals may have 
important implications for understanding how disruption of its mammalian 
homolog contributes to cancer and metastasis.
Poster Board Number: 3068
THE ROLE OF KAP1 IN NEURAL STEM CELLS
Fasching, Liana, König-Walles, John, Jakobsson, Johan
Molecular Neurogenetics, Lund University, Lund, Sweden
Epigenetics is becoming an important puzzle piece to gain a better under-
standing for several diseases. It is characterized by the interplay of genetic 
background, environmental influences and aging. Epigenetics enables the 
ability of adjusting to the environment and being flexible without inter-
vening DNA. Kap1 (also nown as TIF1β or TRIM28) is a KRAB-associated 
protein and shows the ability of being a universal co-repressor of gene-
transcription. By using a NestinCre - loxP approach we have generated mice 
with a CNS-specific Kap1 deletion. We have found that Kap1-NestinCre 
knockout mice die before or around birth. To clarify this finding we have 
generated neurospheres derived from KAP1-deficent embryos and found 
that the lack of Kap1 has no influence on neural stem cell proliferation and 
self-renewal. Furthermore the Kap1 knockout neurospheres showed the 
ability to differentiate into neurons and astrocytes. The result of histochemi-
cal staining showed that the brain morphology of Kap1 knockout embryos 
at E13.5 does not differ compared to wild type controls. In summary we 
have found that although Kap1 knockout embryos do not show any anoma-
lies in development until E 13.5, Kap1-NestinCre knockout mice either die 
before or after birth. We are currently further investigating the mechanisms 
behind this lethality.
Poster Board Number: 3070
THE D4Z4 INSULATOR PROTECTS RETROVIRUS 
TRANSGENES FROM SILENCING IN 
PLURIPOTENT STEM CELLS
Gervier, Sylvie1, LO, Mandy Y.M.1, Barsyte-Lovejoy, Dalia2, Pasceri, 
Peter1, Jin, Jian3, Arrowsmith, Cheryl H.2, Ellis, James1
1Developmental & Stem Cell Biology, Hospital For Sick Children, Toronto, 
ON, Canada, 2Campbell Family Cancer Research Institute and Department 
of Medical Biophysics, Ontario Cancer Institute, Toronto, ON, Canada, 
3University of North Carolina at Chapel Hill, Center for Integrative 
Chemical Biology and Drug Discovery, Chapel Hill, NC, USA
A challenge for genetic manipulation of pluripotent stem cells is to maintain 
long-term expression of transgenes. Indeed, many transgene vectors, retro-
viral vectors included, are often silenced in transgenic animals, stem cells and 
also in induced pluripotent stem cells (iPS). It has been shown that silencing 
of the reprogramming factors delivered by retroviral vectors is required dur-
ing reprogramming, and is one of the critical criteria to distinguish fully and 
partially reprogrammed clones. In addition, transcriptional silencing of retro-
virus vectors in cells is a major obstacle to current gene therapy approaches. 
Insulator elements can overcome this problem by protecting transgenes 
from position effects. The best studied insulator, the chicken ß-globin locus 
(HS4) insulator, has to date had limited effectiveness in viral vectors. A novel 
insulator has been discovered within the D4Z4 repeat sequence that is in-
volved in human Facio-scapulo-humeral dystrophy (FSHD). Protection from 
silencing is dependent on CTCF and A-type lamin binding at the 5’ end of 
D4Z4. We investigate here whether D4Z4 is able to protect retrovirus vector 
transgenes from silencing in mouse embryonic stem cells and induced pluri-
potent stem cells. We analyze the expression from self-inactivating retroviral 
vectors (HSC1) bearing an EF1α-EGFP-ires-puro reporter over 5 months 
of culture. We observed that the unprotected vector is silenced over time 
(30% of cells are GFP positive without selection pressure versus 99% under 
puromycin selection). We were able to remove this expression extinction by 
inhibiting G9a activity to decrease di-methylated H3K9 levels on the proviral 
DNA. The HS4 insulator partially protects the HSC1 retrovirus (70% versus 
30% eGFP positive cells with or without HS4 respectively), but silencing still 
occurs. We compared these vector versions (unprotected vector or insulated 
by cHS4 insulator in the LTRs) to retroviral vectors with D4Z4 subfragments 
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cloned between gag and the EF1α promoter. We observed that the 3’ D4Z4 
subfragment protects provirus from silencing in all cells, while the 5’ D4Z4 
subfragment does not although it decreases the variability of fluorescence 
intensity in those cells that do express. Only by combining the 3’ D4Z4 
element with HS4, is silencing prevented and consistent levels of expression 
maintained. Bisulfite sequencing 150 days after infection shows proviral 
DNA is hypomethylated when it contains D4Z4, which correlates with a 
higher frequency of expression. Our results demonstrate that D4Z4 is the 
first insulator capable of maintaining long-term, stable expression of retrovi-
rus vectors in pluripotent stem cells. We propose that D4Z4 may induce an 
active chromatin structure on the provirus independent of the integration 
site. We are comparing provirus expression at identical integration sites in 
the absence and presence of D4Z4. We are also evaluating the ability of 
D4Z4 retroviral vectors to maintain expression of transgenes designed for 
cell marking and suicide vector delivery in iPS cells.
Poster Board Number: 3072
MECHANISMS REGULATING CHROMATIN 
PROTEIN DYNAMICS IN EMBRYONIC STEM 
CELLS
Melcer, Shai1, Hezroni, Hadas1, Rand, Eyal2, Skoultchi, Arthur3, 
Stewart, Colin4, Bustin, Michael2, Meshorer, Eran1
1Genetics Dept., Life Sciences Institute, The Hebrew University of 
Jerusalem, Jerusalem, Israel, 2National Cancer Institute, National Institutes 
of Health, Bethesda, MD, USA, 3Albert Einstein College of Medicine, Bronx, 
New York, NY, USA, 4Institute of Medical Biology, Singapore, Singapore
Embryonic stem cells (ESCs) are characterized by unique epigenetic features 
including decondensed chromatin, hyperdynamic association of proteins 
with chromatin and a permissive transcriptional program. Here we investi-
gate the mechanisms that regulate chromatin plasticity in ESCs. Using epi-
genetic drugs and mutant ESCs lacking various chromatin binding proteins, 
we find that histone acetylation enhances chromatin dynamics specifically 
in euchromatin, while histone H3 lysine 9 (H3K9) methylation and lamin A 
expression restrict chromatin dynamics exclusively in heterochromatin. In 
contrast, we find that DNA methylation and nucleosome repeat length have 
little or no effect on the dynamics of chromatin-binding proteins in ESCs. Al-
tered chromatin dynamics was associated with perturbed ESC differentiation. 
Together, these data delineate the mechanisms responsible for chromatin 
plasticity in ESCs, and indicate that the epigenetic state of the genome 
modulates chromatin plasticity and the differentiation potential of ESCs.
iPS CELLS
Poster Board Number: 3074
COMPARISON OF THE PHENOTYPES OF 
DIFFERENTIATION AND MOLECULAR 
SIGNATURES IN HUMAN EMBRYONIC STEM 
AND INDUCED PLURIPOTENT STEM CELLS
Koyanagi, Michiyo, Takahashi, Kazutoshi, Ichikawa, Ayumi, 
Ohnuki, Mari, Okita, Keisuke, Yamanaka, Shinya
Center for iPS Cell Research and Application, Kyoto, Japan
Human embryonic stem (ES) cells show some variation in differentiation 
propensity, and induced pluripotent stem (iPS) cells may also. To apply ES/
iPS cells for any purposes such as drug discovery, studies on disease mecha-
nism and cell therapy, we need to select the clones which can differentiate 
into target cells completely with no remaining of undifferentiated cells as 
early as possible. To characterize the clones, we established iPS clones from 
fibroblasts derived from people with various age and sex and performed 
colony formation assay and neural differentiation by modified serum-free 
floating culture of embryoid body-like aggregates (SFEBq) methods. To 
explore the factors which are related to the differentiation propensity, we 
compared gene/miRNA expression and methylation status between these 
clones. These data indicate that molecular signatures of ES cells and iPS cells 
are very similar and to predict the differentiation propensity by molecular 
signatures is difficult.
Poster Board Number: 3076
HUMAN IPS CELLS PRODUCED USING 
GMP-COMPLIANT METHODS PRODUCE 
FUNCTIONAL NEURONS
Karumbayaram, Saravanan1, Azghadi, Soheila1, Lee, Peiyee2, 
Lindgren, Anne2, Patterson, Michaela2, Nelson, Stanley3, Byrne, 
James4, Pyle, April5, Kohn, Donald5, Clark, Amander2, Plath, 
Kathrin6, Zack, Jerome5, Lowry, William2
1Broad Stem Cell Research Center, University of California (UCLA), Los 
Angeles, CA, USA, 2Department of Molecular, Cell and Developmental 
Biology, University of California (UCLA), Los Angeles, CA, USA, 3Center 
for Neurobehavioral Genetics, University of California (UCLA), Los 
Angeles, CA, USA, 4Molecular & Medical Pharmacology, University of 
California (UCLA), Los Angeles, CA, USA, 5Microbiology, Immunology, & 
Molecular Genetics, University of California (UCLA), Los Angeles, CA, USA, 
6Biological Chemistry, University of California (UCLA), Los Angeles, CA, 
USA
Induced pluripotent stem cells (iPSCs) have an enormous potential for the 
treatment of a wide range of diseases and injuries. But there is an excep-
tional regulatory challenge for stem cell derived products as they represent 
complex biological materials. One of the challenges is the derivation and 
differentiation of human iPSCs without the use of xenogeneic materials 
(xeno-free) under current good manufacturing practice (cGMP) protocols. 
Undefined components in the media formulation lead to difficulty in quality 
control and may cause lot-to-lot variability. We have established a cGMP 
compliant laboratory and established protocols and cGMP compliant stan-
dard operating procedures (SOPs) for the derivation of xeno-free somatic 
cells from human tissues and have used them to reprogram the somatic cells 
into iPS cells under xeno-free and feeder-free conditions. The iPS cells de-
rived were karyotyped, characterized using standard immunocytochemistry 
markers, and studied for their tri-lineage potential. We found that they are 
with normal karyotype; express cell surface markers Nanog, Tra 1-81 and 
SSEA-1 and are capable of multi-lineage differentiation in vivo as teratomas. 
Furthermore, we differentiated the GMP iPSCs into neuronal precursor cells 
and neurons under xeno-free conditions. To our knowledge, this is the first 
description of the generation of xeno-free terminally differentiated neurons 
proceeding from patient biopsies through pluripotent intermediates. These 
protocols and SOPs will serve as a platform for further advancement of the 
iPS technology for clinical translation and may aid to establish norms for cel-
lular therapy using iPS cells.
Poster Board Number: 3078
EPIGENETIC DIFFERENCES BETWEEN HUMAN 
PLURIPOTENT STEM CELL LINES
Kim, Hyemin, Kim, Dongkyu, Jang, Mi-Jin, Han, Yong-Mahn
Kaist, Daejeon, Korea, Republic of
Pluripotent stem cells (PSCs) have unique transcriptional regulatory net-
works and epigenetic state to maintain their pluripotency. This study was 
carried out to test epigenetic variations between human PSC lines such as 
embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs). For 
that, gene expression and histone modifications were examined between 
two hESC lines and four hiPSC lines by real-time PCR and chromatin im-
munoprecipitation (ChIP) analysis, respectively. Transcriptional levels of pluri-
ISSCR 9th Annual Meeting
166
www.isscr.org
Friday Poster Abstracts
potency marker genes (OCT4, SOX2, NANOG, and REX1), iPSC-inducible 
factor genes (cMYC and KLF4), and developmental genes (SOX17, T, and 
NESTIN) varied between respective hESC and hiPSC lines. Regardless of the 
expression level of those genes, their promoter regions represented different 
patterns of permissive (H3K4me3 and H3K9ac) and repressive histone modi-
fications (H3K27me3, H3K9me2, and H3K9me3) between human PSC lines. 
Bivalent histone modifications retained in promoters of developmental genes 
in both hESC and hiPSC lines. These results indicate that respective PSC 
lines may have a distinct epigenetic signature to regulate the transcriptional 
network for pluripotency.
Poster Board Number: 3080
PRE-EVALUATED SAFE HUMAN IPS CLONE 
DERIVED NEURAL STEM CELLS PROMOTED 
FUNCTIONAL RECOVERY AFTER SPINAL CORD 
INJURY WITHOUT TUMORIGENECITY IN ADULT 
COMMON MARMOSETS
Kobayashi, Yoshiomi1, Okada, Yohei2, Iwai, Hiroki1, Nishimura, 
Soraya1, Nori, Satoshi1, Konomi, Tsunehiko1, Fujiyoshi, Kanehiro1, 
Tsuji, Osahiko1, Toyama, Yoshiaki1, Yamanaka, Shinya3, Nakamura, 
Masaya1, Okano, Hideyuki2
1Orthopedic Surgery, Keio University, Tokyo, Japan, 2Physiology, Keio 
University, Tokyo, Japan, 3Center for Induced Pluripotent Stem Cell 
Research and Application, Kyoto University, Kyoto, Japan
Recently, we have reported the effectiveness of transplantation of mouse 
as well as human iPS derived neural stem cells (NSCs) for spinal cord injury 
(SCI) in rodents. The purpose of this study is to determine the effectiveness 
and safeness of transplantation of human iPS derived NSCs (human iPS-
NSCs) into the injured spinal cord in non-human primates, as a final stage of 
pre-clinical research. We used a pre-evaluated safe iPS clone, and induced 
their differentiation into NSCs using original protocol. A moderate contu-
sive SCI was induced at the C5 level in adult common marmosets using a 
weight-drop device as described previously. 9 days after the injury, human 
iPS-NSCs at a density of 1000000 cells/5μl in medium without growth 
factors were transplanted into the injured spinal cord. Behavioral analyses 
were performed according to previous reports (original open field scoring 
scale (MIKY score), bar grip test, cage climbing test) until 12 weeks after 
SCI. Axial sections of spinal cords were subjected to histological analyses to 
determine the effects of transplantation. Grafted human iPS-NSCs that were 
survived and differentiated into NeuN positive neurons and GFAP positive 
astrocytes. It was noteworthy there was no tumor formation at least for 3 
months after transplantation. LFB staining showed a significant decrease in 
demyelinated areas at the epicenter in the transplantation group compared 
to the vehicle-control group. Furthermore, quantitative analysis of the 
CaMK-IIα positive areas that there was a significant difference in CaMK-
IIα positive areas at the epicenter between the transplantation and vehicle 
control groups. All of the examined behavioral tests also revealed that hu-
man iPS-NSCs promoted the functional recovery after SCI in adult common 
marmosets. Taken together, pre-evaluated safe human iPS clone derived 
NSCs could be a potential cell source for SCI in clinic.
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DELAYED POST-STROKE RECOVERY BY 
EPIDURAL TRANSPLANTATION OF LATE-
STAGE NEURAL PROGENITORS FROM HUMAN 
INDUCED PLURIPOTENT STEM CELLS VIA A 
UNIQUE SECRETOME
Lee, I-Hui1, Liao, Ko-Hsun1, Chuang, Ching-Yu2, Huang, Shiang-
Suo3, Chuang, Chai-Chi1, Lin, Hung-Jui4, Hsieh, Jui-Yu4, Su, Yu-
Shih5, Su, Shu-Han4, Lee, Oscar Kuang-Sheng6, Kuo, Hung-Chih2, 
Wang, Hsei-Wei4
1Department of Neurology, Taipei Veterans General Hospital, Taipei, 
Taiwan, 2Institute of Cellular and Organismic Biology and Genomics 
Research Center, Academia Sinica, Taipei, Taiwan, 3Department of 
Pharmacology and Institute of Medicine, Chung-Shan Medical University, 
Taichung, Taiwan, 4Institute of Microbiology and Immunology, National 
Yang-Ming University, Taipei, Taiwan, 5Institute of Brain Science, National 
Yang-Ming University, Taipei, Taiwan, 6Institute of Clinical Medicine, 
National Yang-Ming University, Taipei, Taiwan
Induced pluripotent stem cells (iPSCs) from over-expression of transcription 
factors in adult fibroblasts are promising source for tailor-made cell therapy 
in devastating stroke beyond therapeutic time window. However, risk of 
tumorigenesis is a major obstacle to iPSCs translational implantation. Here 
we show therapeutic potential of human iPSCs-derived late-stage neural 
progenitor/precursor cells (iPSC-NPCs) in murine stroke models through 
bystander effects after delayed extra-cerebral epidural engraftment. We first 
compared neuroprotective effects of different human stem cell types utiliz-
ing a trans-membranous co-culture system with rat cortical cells subjected to 
oxygen-glucose deprivation (OGD). In contrast to mesenchymal stem cells 
(MSCs) from bone marrow or umbilical cord Wharton’s jelly, iPSC-NPCs and 
iPSCs preferentially enhanced neuronal survival and axonal growth as well 
as mitigated reactive astrocytosis. Notably, the gene and protein expression 
profiles of iPSC-NPCs and iPSCs showed a unique secretome from which we 
identified five enriched neuroprotective cytokines (BMP7, CXCL14, FGF8, 
FGF9, and IGFBP2) in the OGD model. Neutralization of the five cytokines 
significantly abolished neuroprotective effects in the iPSC-NPCs co-cultures. 
Moreover, we investigated one week-delayed iPSC-NPCs transplantation via 
epidural fibrin glue upon the infarct neocortex after permanent middle ce-
rebral artery occlusion (MCAO) in adult rats. From 10 days post-transplan-
tation onwards, the cell-transplanted rats showed significant sensorimotor 
improvement of the paretic forelimb as compared to the vehicle-transplant-
ed rats. At four weeks after MCAO, the cell-transplanted rats had markedly 
reduced infarct size associated with ameliorated microglial infiltration and 
astrogliosis, while increased peri-infarct cortical angiogenesis and subcortical 
myelination preservation as compared to the controls. Very few iPSC-NPCs 
migrated across the dura and survived at the peri-infarct cortex while 
persistent functional recovery, suggesting beneficial paracrine effects from 
the grafted iPSC-NPCs. There was no tumor formation in any transplanted 
rat until four weeks post-MCAO. The results suggest that delayed epidural 
engraftment of iPSC-NPCs via topical fibrin glue can safely induce potent 
neuroprotection and functionally regenerative response in adult peri-infarct 
cortex through paracrine effects.
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TRANSPLANTATION OF HUMAN IPS CELL-
DERIVED NEUROSPHERES FOR THE 
TREATMENT OF SPINAL CORD INJURY IN NOD-
SCID MICE
Nori, Satoshi1, Okada, Yohei2, Yasuda, Akimasa1, Tsuji, Osahiko1, 
Takahashi, Yuichiro1, Kobayashi, Yoshiomi1, Fujiyoshi, Kanehiro1, 
Toyama, Yoshiaki1, Yamanaka, Shinya3, Nakamura, Masaya1, 
Okano, Hideyuki2
1Orthopaedic Surgery, Keio University School of Medicine, Tokyo, Japan, 
2Physiology, Keio University School of Medicine, Tokyo, Japan, 3Center 
for iPS Cell Research and Application (CiRA), Kyoto University School of 
Medicine, Kyoto, Japan
Induced pluripotent stem (iPS) cells have the potential to resolve the ethical 
issues and immunological rejection associated with embryonic stem (ES) 
cells. Recently, we have reported the effectiveness of transplantation of 
mouse iPS cell-derived neurospheres (iPS-NS) for spinal cord injury (SCI) in 
mice. In the present study, we performed the transplantation of human iPS-
NS into injured spinal cord of NOD-scid mice to examine their therapeutic 
potential and safeness as a cell source of transplantation for SCI. 
We established the directed neural differentiation of human iPS cells, using 
the cell line generated from adult human dermal fibroblast by retroviral 
transduction of four transcription factors (Oct3/4, Sox2, Klf4 and c-Myc) 
(Takahashi et al., 2007). Human iPS-NS were mainly differentiated into 
neurons in vitro. Adult female NOD-scid mice were used in this study. After 
laminectomy, contusive SCI was induced at Th10 level using IH impactor. 
Nine days after injury, the mice were to receive randomized human iPS-NS 
(n=28) or PBS (n=26). Motor functions in the hindlimbs had been assessed 
until 56 days after SCI by BMS, Rotarod test and Treadmill gait analysis us-
ing DigiGait system. Motor-evoked potential (MEP) was performed to evalu-
ate the functional recovery in the mice after each intervention electrophysi-
ologically. Grafted human iPS-NS survived and differentiated into neurons, 
astrocytes and oligodendrocytes in the injured spinal cord. We found that 
the most of human iPS cell-derived neurons were GABAergic neurons, 
and also found the synapse formation between human iPS cell-derived 
neurons and host neurons. We also observed human iPS-NS promoted 
axonal regrowth, which was demonstrated by the quantitative analyses of 
Neurofilament (NF-H), 5-hydrosytryptamine (5-HT) and growth-associated 
protein-43 (GAP43) positive fibers. Moreover, 5-HT positive fibers extended 
along with the human iPS cell-derived astrocytes. It is known that angio-
genesis has the positive effect for tissue repair in the injured spinal cord, and 
we observed the transplantation of human iPS-NS promoted angiogenesis. 
We found that the human iPS cell-derived astrocytes secreted VEGF, and 
considered it was the reason for promotion of angiogenesis observed in the 
human iPS-NS group. As a result of these positive effects, the human iPS-NS 
group exhibited significantly better functional recovery than the control 
group. Consistently, MEP waves were detected in most of the iPS-NS group, 
whereas they were not detected in the control group. It is important to 
address safety issues about transplantation of human iPS-NS. To investigate 
the long-term safeness about the grafted iPS-NS, we extended follow-up 
period up to 112 days after SCI. Human iPS-NS grafted mice maintained 
their functional recovery and none of iPS-NS grafted mice showed teratoma 
or other tumor formation. The present study demonstrates the human iPS-
NS could have potential benefits for SCI.
Poster Board Number: 3086
IMPACT OF VIRAL TRANSGENE EXPRESSIONS 
ON THE DIFFERENTIATION OF HUMAN IPS 
CELLS
Li, Ming, Zhu, John, Abai, Anna, Chen, Christine, Noble, Amy, Chu, 
Vi
EMD Millipore, Temecula, CA, USA
Induced pluripotent stem (iPS) cells can be generated from somatic cells 
by ectopic over-expression of four transcription factors, Oct4, Klf4, Sox2 
and c-Myc. Recent findings suggest that factor-induced reprogramming 
primarily generates an undifferentiated intermediate cell state that is not 
completely pluripotent. These partially reprogrammed cells are characterized 
by the continued expression of viral transgenes, the incomplete expression 
of pluripotent genes and down-regulation of somatic cell marker genes. To 
quickly determine whether an iPS clone is a fully reprogrammed colony or 
a partially reprogrammed intermediate, a multiplex real-time RT-PCR assay 
was developed to detect the expressions of the viral Oct-4 transgene and 
the endogenous ES/iPS cell pluripotent gene, Nanog. Using this assay, the 
kinetics of viral transgene expression during cell differentiation was also 
monitored. Somatic cell reprogramming of human foreskin fibroblasts was 
accomplished using a polycistronic cre-excisable lentivirus expressing all four 
transcription factors. Because the four transgenes are transcribed as a single 
mRNA molecule, a single transgene analysis of viral Oct4 would represent 
the gene expression level of the whole cassette. Using this assay, we show 
that the viral transgenes were silenced upon the creation of human iPS cells, 
indicating full reprogramming. However, upon differentiation into either 
mesenchymal or neural stem cell progenitors, the viral transgenes were 
reactivated and viral expression levels remained high even after a two week 
differentiation protocol into specific cell lineages such as osteocytes. The 
efficiency of differentiation was significantly reduced in human iPS (hiPS) 
compared with human ES cells undergoing identical differentiation protocols, 
suggesting that the effects may primarily be due to conflicting pluripotency 
and differentiation signals rather than differences in genetic backgrounds 
and epigenetic stages. We are currently exploring ways to remove the trans-
genes using cre-excision and analyzing whether removal of the viral trans-
genes would restore the differentiation potential of post-excised hiPS cells to 
levels similar to those observed in human ES cells. The dynamic state of viral 
transgene expressions in hiPS and their differentiated progenies underscore 
the need for assays to quantitatively monitor gene expressions along with 
tools for the excision of the viral transgenes.
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INDUCED PLURIPOTENT STEM CELLS A 
SLIPPERY SLOPE FOR NEURODEGENERATIVE 
DISEASE MODELING?
Sidhu, Kuldip S.
Faculty of Medicine, University of New South Wales, Sydney, Australia
The recent breakthrough in reprogramming somatic cells has invigorated 
the prospect that disease mechanisms that underpin various human diseases 
particularly the neurodegenerative disorders could be unraveled by using the 
disease-specific pluripotent stem cells. A number of studies have demon-
strated that such disease-specific induced pluripotent stem cell (iPSC) could 
be generated relatively easy. Some recent studies have substantiated the 
utility of this technology in describing the initial characterization of neurode-
generative patient-derived iPSC as a proof of concept. However, as it is be-
coming evident now that the cell type of origin influences the molecular and 
functional properties of derived iPSC. The indications that reprogramming 
may erase the cell memory also raises the question if the disease phenotype 
may not be correctly represented or also erased in iPSC unless coaxed by 
further perturbation in vitro culture conditions. Other associated difficul-
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ties in iPSC research such as culture variability, selective adaptation of such 
cultures and the lack of robust protocols to generate homogeneous popula-
tion of desired cell type may have compounding affects in the use of these 
cells in disease modelling. We have generated the human induced pluri-
potent stem cells (iPSCs) from a sporadic female patient with clear clinical 
symptoms of Alzheimer’s disease (AD). Phenotypically, the fibroblasts and 
AD-iPSCs are indistinguishable from control fibroblasts, iPSCs and hESCs, 
however genome-wide transcriptomic analysis revealed a small number of 
genes that were significantly and differentially (Fold change > 1.5) expressed 
between control and disease populations of fibroblasts but the same were 
reset to ground state after reprogramming. Further analysis of differentially 
expressed genes in disease fibroblasts/Ad-iPSCs revealed biological functions 
that were related to neurogenesis, neuronal maturation, nervous system de-
velopment etc. as determined by gene ontology (GO) enrichment. This may 
suggest that altered neuro-biological activities during their development into 
neurons. There seem no differences in AD-iPSCs and controls in neurosphere 
production and gene and protein expressions, further studies are in progress. 
While generation of AD-iPSCs, may serve as a potential in vitro model for 
the study of Alzheimer’s disease, but issue of epigenetic modifications during 
reprogramming may remain an issue to be resolved. Unless this and other 
issues as above are addressed properly the prospects of iPSC in disease 
modelling may remain a slippery slope. Key Words: induced pluripotent cells. 
Neurodegenerative diseases. Disease modeling. 
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HUMAN INDUCED PLURIPOTENT STEM CELLS 
DERIVED FROM ALZHEIMER’S PATIENT 
SHOW ABERRATIONS OF LATE NEURAL 
DEVELOPMENT
Lie, Khun H.1, Sachdev, Perminder S.2, Sidhu, Kuldip S.3
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Alzheimer’s disease (AD) manifests clinically as a loss of cognition includ-
ing memory and other cognitive functions. The pathological characteristics 
of AD include neuronal and synaptic loss, activated microglia, gliosis and 
the pathognomonic entities - intraneuronal neurofibrillary tangles and the 
extracellular neuritic plaques. Currently, the study of AD is limited by a lack 
of model systems that can reproduce the precise sequence and timing of cel-
lular and molecular events. Animal models offer reasonable phenocopies of 
AD, but suffer because comparative genomic and anatomical differences are 
prominent in relation to the human brain. Human induced pluripotent cells 
(hiPSCs) that now can be derived from somatic cells have the inherent ability 
to recapitulate human development in vitro. hiPSCs generated from indi-
viduals with AD arguably contain the genetic predisposition to AD that could 
provide valuable insights into the pathophysiology of that disease. We pro-
duced hiPSCs from a skin sample of a patient with early-onset AD and from 
a control subject, and also used hESC in this study. First, we demonstrated 
a stepwise differentiation process that mimicked the early stages of neural 
development in humans to promote the generation of neuroprogenitors. 
Both the hESCs and hiPSCs were initially cultured in an optimized feeder-free 
condition, which offered an efficient formation of cell aggregates. To initi-
ate neuroectodermal specification, cell aggregates were differentiated in a 
defined neural induction medium to develop into neuroepithelia and neural 
rosettes-like structures that resembled the radial arrangements of columnar 
cells in the neural tube. It is of interest that there were no morphological 
differences observed between the AD-hiPSCs, hiPSCs-control and hESCs in 
the formation of neuroprogenitors. Quantitative real-time PCR analysis be-
tween these cells further indicated no differences in the expression levels of 
PAX6 and SOX1 genes, suggesting similar neural-differentiation efficiency. 
Subsequently, neural rosette structures were dispersed to form free-floating 
neurosphere-like structures, which can be propagated further or differenti-
ated to mature neuronal subtypes. The adherent neurospheres on laminin-
coated surface were direct differentiated to midbrain and forebrain lineage 
commitment using defined morphogens (FGF8, SHH, cAMP, ascorbic acid 
and IGF) and neurotrophins (BDNF and GDNF). Early differentiation dem-
onstrated clear morphological differences between AD-hiPSCs and controls 
with former consistently producing poor neurons-like outgrowths in cultures. 
Further molecular and immuno staining studies are in progress to confirm 
whether AD-hiPSCs-derived neurospheres are capable of developing into 
mature functional neurons. 
Poster Board Number: 3092
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SHOW AN INTRINSIC PROPENSITY TO REVERT 
TO PLURIPOTENCY AFTER DIFFERENTIATION.
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Several studies have established that human induced pluripotent stem 
cells (iPSC) exhibit strong similarities with human embryonic stem cells 
(hESC), with regard to morphology, expression of pluripotency markers 
and functional properties such as embryoid body or teratoma formation. 
However, more detailed examinations of directed differentiation into specific 
lineages using several iPSC lines have shown that iPSCs responded to a 
lesser degree and with marked variability to chemical inducers of differen-
tiation compared with hESC. Moreover, epigenetic memory of the donor 
tissue has been shown to influence iPSC differentiation potential, causing a 
differentiation bias towards lineages related to the donor cells. In addition, 
transplantation of differentiated iPSC into mice demonstrates a propensity 
of these cells to form teratomas, by unknown mechanisms that do not 
involve transgene reactivation. These differences between iPSC and hESC 
may be problematic for the clinical application of iPSC technologies. Here 
we report that human iPSC, compared with hESC, exhibit a propensity to 
revert to a pluripotent phenotype after spontaneous or directed differentia-
tion. Initially, we used our published method to obtain sub-fractions of iPSC 
and hESC by fluorescence activated cell sorting (FACS), based on expression 
of the cell surface markers TG30 (CD9) and GCTM-2. Our previous findings 
demonstrated that the TG30Hi-GCTM-2Hi (P7) sub-fraction contains the 
highest proportion of pluripotent cells, whereas the TG30Neg-GCTM-2Neg 
(P4) sub-fraction contains a very high proportion of differentiated cell types. 
Continuing with the characterization of P4 and P7 cell sub-fractions, we 
found that spontaneously differentiated cells (TG30Neg-GCTM-2Neg) col-
lected and cultured post-FACS from multiple human iPSC lines were able to 
re-acquire immunoreactivity to TG30 and GCTM-2, formed stem cell-like 
colonies and robustly formed both embryoid bodies and teratomas. In con-
trast, spontaneously differentiated TG30Neg-GCTM-2Neg hESC, processed 
in an identical fashion, did not re-acquire immunoreactivity to TG30 and 
GCTM-2, formed negligible stem cell-like colonies and did not form terato-
mas. We also found that this reversion was stable and reproducible even in 
late-passage (>40 weekly passages) iPSC lines, without signs of attenuation. 
Finally, the propensity to revert to a pluripotent phenotype was also seen in 
human iPS cell lines following a 28 day neural differentiation protocol and 
FACS for polysialyated NCAM positive cells. We are currently investigating 
the mechanism(s) responsible for this iPSC phenomenon in multiple human 
iPS cell lines derived from various somatic cell sources and made using both 
genome integrative and non-integrative technologies. 
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INVESTIGATION FOR DIFFERENTIAITON-
RESISTANCE IN HUMAN INDUCED 
PLURIPOTENT STEM CELLS
Ohnuki, Mari, Koyanagi, Michiyo, Takahashi, Kazutoshi, Yokura, 
Midori, Narita, Megumi, Miyashita, Ito, Yamanaka, Shinya
Kyoto University, Center for iPS cell Research and Application, Kyoto, Japan
Embryonic stem (ES) cells are capable of unlimited proliferation and differen-
tiation into all cell lineages. Induced pluripotent stem (iPS) cells were estab-
lished from somatic cells with introducing defind factors and have a similar 
character to ES cells. Although one of most expected use of the iPS cells is 
cell therapy, residual undifferentiated cells can develop teratomas after in 
vivo transplantation if not all cells are induced differentiation. Here, we un-
covered abnormal iPS clones persisting undifferentiated state after induction 
of neural differentiation and investigated their difference from nomal ES and 
iPS cells. First, we found there were some differentiation-resistant human 
iPS cell clones when human ES and iPS cells cultured with inhibitor of BMP 
and TGFβ/Actin/Nodal signal formed neurospheres (SFEBq). Flowcytometry 
analysis showed 4 clones, including 1 cord blood-derived clone, 1 trans-
gene-free clone and 1 clone established without c-MYC, remained OCT3/4 
expressing cells, whereas the other clones were highly differentiated into 
PSA-NCAM+ neural cells after 14 days SFEBq differentiation. Next, we 
performed gene expression and miRNA microarray analysis for comparing 
normal and abnormal clone groups. However, no significant candidate gene 
was shown. We investigate the possibility that only a part of all population 
of abnormal clone might represent differentiation-resistance. Subclones 
established from single cells of each abnormal clone were performed with 
SFEBq, and some of them were well-differentiated without remaining TRA-
1-60+ undifferentiated cells. Moreover, we isolated TRA-1-60+ cells from 
abnormal clone-derived neurospheres (NSTPs). Using such subclones and 
NSTPs, more effective comparable analysis was performed with microarray. 
As a result, we found 6 candidate genes significantly different expressing 
between normal and abnormal subclones. For the future, the functional rela-
tion between abnormality and these 6 genes would be studied.
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COMPARISON OF GENETICALLY IDENTICAL 
HUMAN EMBRYONIC STEM CELL (HESC) AND 
INDUCED PLURIPOTENT STEM (HIPS) CELL 
LINES
Shutova, Maria V., Lagarkova, Maria A., Vassina, Ekaterina M., 
Chestkov, Ilya V., Bogomazova, Alexandra N., Kiselev, Sergey L.
Vavilov Institute of General Genetics, Russian Academy of Science, 
Moscow, Russian Federation
Since the discovery of methods to derive human induced pluripotent stem 
cells (hiPSCs) from somatic cells, numerous studies were published. hiPSCs 
provide a valuable tool for understanding disease mechanisms, model 
for human development, and for drug discovery. iPS cells share similar 
features with hESCs and for many aspects are identical to them. However, 
the comparison of hESC and iPSCs is obstructed by their different genetic 
backgrounds. The aim of our study was to establish and compare genetically 
identical hESCs and iPS cell lines. In our study we established hESC line from 
hESM05 line with Dox-inducible lentiviral insertion of 5 transcription factors 
(Oct3/4, Sox2, KLF4, c-Myc, Nanog). This line designated as hESM05neo2 
was tested for pluripotency and further differentiated into pure population 
of neural cells. Then, Dox-system was activated in hESM05neo2-derived 
neural cells by doxycycline, and first iPS clones were picked up at day 16 
after induction. Reprogramming efficiency was about 10%, iPS clones were 
characterized by RT-PCR analysis, karyotype analysis and immunocytochem-
istry. The clones were able to differentiate into cells of three germ layers. 
We demonstrate the results of transriptome and methylome comparison of 
neural-derived hiPS clones, hESC clone, and hESC-derived neural cells.
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DISSECTING THE CELLULAR PATHOGENESIS OF 
HERPES SIMPLEX ENCEPHALITIS IN NEURONS 
AND GLIA DERIVED FROM PATIENT-SPECIFIC 
UNC-93B-DEFICIENT IPS CELLS.
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Childhood Herpes Simplex Encephalitis (HSE) results, in at least some cases, 
from inborn errors of UNC-93B-dependent, TLR3 immunity. In primary 
and SV40-transformed dermal fibroblasts from the patients with molecu-
larly defined HSE, impaired TLR3-dependent induction of IFN-α/β and -λ 
results in enhanced HSV-1 replication and increased cell death. To test the 
hypothesis that a similar process operates in the Central Nervous System 
(CNS), we derived induced Pluripotent Stem Cells (iPSCs) from UNC-93B-
deficient and normal human primary dermal fibroblasts. These iPSCs were 
successfully differentiated into purified CNS populations of Neural Stem Cells 
(NSCs), neurons, oligodendrocytes and astrocytes. In all UNC-93B-deficient 
cell types, there was impaired induction of IFN-β and/or -λ upon TLR3 
stimulation. Moreover, consistent with impaired IFN-β or -λ induction upon 
HSV-1 infection, UNC-93B-deficient neurons and oligodendrocytes, but 
not astrocytes, showed higher vulnerability to HSV-1 infection as compared 
to healthy control cells. This is the first study to provide a tissue-specific 
molecular and cellular basis for childhood HSE, a devastating viral disease, 
by demonstrating impaired TLR3-dependent IFN-α/β and -λ immunity to 
HSV-1 in UNC-93B-deficient CNS neurons and oligodendrocytes.
Poster Board Number: 3100
GENERATION OF HUMAN DISEASE-SPECIFIC 
INDUCED PLURIPOTENT STEM CELLS
Sun, Danqiong, Lu, Bill, Razvi, Enal, Li, Gang
System Biosciences, Mountain View, CA, USA
The epigenome of differentiated somatic cells can be reprogrammed to a 
pluripotent state by overexpression of defined transcription factors. This 
new approach greatly simplifies the generation of pluripotent stem cells, 
bypassing many technical and ethical hurdles. The derivation of pluripotent 
stem cells from somatic tissues has provided researchers with a renewable 
source of patient-specific stem cells. Potentially, it offers a new paradigm 
for modeling human disease and for individualizing drug testing. Here we 
reported that a series of disease-specific induced pluripotent stem (iPS) 
cells were generated by transducing reprogramming factors into human 
dermal fibroblasts from disease patients isolated via informed consent, which 
include diabetes type 1, amyotrophic lateral sclerosis (ALS), metachromatic 
leukodystrophy (MLD), and Krabbe disease.
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GENERATION OF DISEASE-SPECIFIC 
INDUCED PLURIPOTENT STEM CELLS AND 
DIFFERENTIATION INTO DISEASE-SPECIFIC 
CELL TYPES
Lee, Jeong-ah1, Yoo, Jeong-eun1, Jang, Jiho2, Kim, Ji Young1, Huh, 
Yong Jun1, Kim, Dong-Wook2
1Brain Korea 21 Project for Medical Science, Yonsei University College of 
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Induced pluripotent stem cells (iPSCs) derived from patients possess the 
same genetic information as patients. These cells would provide critical 
evidences for determining mechanisms of disease pathogenesis. Here, we 
report that iPSCs are generated using adult fibroblasts taken from patients 
with diverse disease backgrounds including Alzheimer’s disease (AD), 
Adenoleudodystrophy (ALD), Parkinson’s disease (PD), Duchenne type mus-
cular dystrophy (DMD), Juvenile-onset, and type I diabetes mellitus (JDM). 
These skin fibroblasts were transduced with retroviral vectors containing the 
4 reprogramming genes (OCT4, SOX2, KLF4, and c-MYC). After 4 weeks 
of viral transduction, ES-like colonies were obtained, respectively. These cells 
were successfully expanded by mechanical passaging. All of them showed 
intense alkaline phosphatase activity, exhibited characteristics of human 
embryonic stem cell (hESC) morphology, expressed pluripotent markers 
including OCT4, NANOG, SOX2, SSEA4, TRA1-60, and TRA1-81. DNA 
fingerprinting analyses for microsatellite markers verified that iPSC lines 
were indeed derived from their parental skin fibroblasts. RT-PCR revealed 
that the endogenous pluripotency-associated genes, OCT4, SOX2, NANOG, 
hTERT, REX1, and GDF3, were robustly expressed in the iPSCs as in hESCs, 
while the expression of retrovirus-delivered transgenes was barely detectable 
in the iPSC lines. Furthermore, the iPSC lines were able to spontaneously 
differentiate into the three embryonic germ layers (ectoderm, endoderm, 
and mesoderm). Taken together, our results demonstrated that disease-
specific iPSCs closely resembled hESCs and retained the capability to dif-
ferentiate into all cell types of human body. With the patient-specific iPSCs, 
we induced differentiation and obtained disease related cell types such as 
oligodendrocytes and neurons. We are now studying for discovering disease 
mechanisms and screening new drug compounds with the differentiated 
cells. Our results will be announced on the poster. This research was sup-
ported by grants from the Stem Cell Research Center of the 21th Century 
Frontier Research Program funded by the Ministry of Education, Science and 
Technology, Republic of Korea (SC1110) and from Korean Health Technol-
ogy R&D Project, Ministry for Health, Welfare & Family Affairs (A100694).
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University School of Public Health, Kyoto, Japan, Kyoto, Japan
Autosomal dominant polycystic kidney disease (ADPKD) is the most preva-
lent, potentially lethal, monogenic disorder, characterized by the develop-
ment of multiple renal cysts and various extrarenal manifestations. Cardio-
vascular complications are the main cause of death in patients with ADPKD, 
including hypertension, intracranial aneurysms and dolichoectasias, thoracic 
aortic and cervicocephalic artery dissections, coronary artery aneurysms and 
valvular heart abnormalities. The pathogenesis of cardiovascular lesions as 
well as renal cyst formation remains largely unknown, and no therapeutic 
strategies have been established. Here we report the derivation of induced 
pluripotent stem cells (iPSCs) from skin fibroblast samples from seven pa-
tients with ADPKD. These cells expanded robustly in culture and differentiat-
ed into vascular endothelia and mural cells in vitro. Using this differentiation 
system, we have identified several molecules whose expression levels were 
upregulated or downregulated in vascular cells differentiated from ADPKD-
iPSCs as compared to those from normal Japanese iPSCs. These results 
suggest that disease modeling using patient-specific iPSCs can be used for 
studying the mechanisms of vascular complications associated with ADPKD.
Poster Board Number: 3106
INTRODUCTION OF THREE NOVEL IPS DISEASE 
MODELS, AND A REPOSITORY FOR THE 
PRESERVATION AND DISTRIBUTION OF IPS 
LINES
Yin, Dezhong, Strubzcewski, Noelle, Tokuyama, Yukari, Zhang, 
Chengkang, Rust, William
ATCC, Gaithersburg, MD, USA
The ability to reprogram a somatic cell to the induced Pluripotent Stem 
Cell (iPS) state enables the creation of in vitro models of human disease. 
The impact these models will have on the discovery and testing of novel 
therapies will be largely determined by two parameters: the breadth and 
genetic diversity of the models created; and the accessibility of those models 
to medical researchers around the world. To address the issue of iPS cell di-
versity, we strived to achieve the establishment of an efficient method of iPS 
cell reprogramming that could be routinely used to generate iPS lines from 
tissue samples harboring mutations of developmental disease. We report 
here the creation and characterization of three novel iPS lines reprogrammed 
from fibroblasts donated by patients with osteogenesis imperfecta, Down’s 
syndrome, and cystic fibrosis. All lines, and a wild type control line, were 
created by transient expression of the reprogramming genes Oct4, Sox2, 
Klf4 and Myc and harbor no gene insertion events or residual expression of 
reprogramming genes. All lines are characterized for expression of pluri-
potency markers, ability to differentiate, and presence of disease-specific 
genetic mutations. To address the issue of accessibility, we created the 
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ATCC® iPS Cell Repository. This Repository continues the ATCC mission to 
make relevant models of human disease accessible to medical researchers 
worldwide. These and other iPS lines, the origin fibroblasts, and fibroblasts 
from relatives and control lines will be available from the Repository through 
the ATCC catalog.
Poster Board Number: 3108
GENERATION OF HUMAN INDUCED 
PLURIPOTENT STEM CELLS FROM PATIENTS 
WITH EARLY-ONSET CARDIOVASCULAR 
DISEASE
Maiwald, Stephanie1, Sivapalaratnam, Suthesh1, Vallier, Ludovic2, 
Ouwehand, Willem H.3, Trip, Mieke D.1
1Vascular Medicine, University of Amsterdam, Amsterdam, Netherlands, 
2Laboratory for Regenerative Medicine, University of Cambridge, 
Cambridge, United Kingdom, 3Department of Haematology, University of 
Cambridge, Cambridge, United Kingdom
Myocardial infarction is a leading cause of mortality and morbidity world-
wide. In addition to traditional risk factors, several studies have confirmed 
that a family history of cardiovascular disease (CVD) is an independent risk 
factor. Myocardial infarctions in younger individuals have been associated 
with substantially greater heritability. Thus, early-onset myocardial infarc-
tion with confirmed family history is a promising phenotype for mapping 
genetic risk factors for CVD. At the Academic Medical Centre (AMC) in 
Amsterdam we have identified pedigrees with several cases of premature 
atherosclerosis (PAS). It is tempting to speculate that novel, high-penetrance 
mutation segregates in these pedigrees. We aim to identify these sequence 
variations and determine how these may result in CVD by studying the 
effect on cell phenotype by using human induced pluripotent stem cells 
(hiPSCs). We isolated human fibroblast cell lines from skin biopsy of PAS 
patients. The affected fibroblasts were reprogrammed with four lentiviral 
vectors encoding for the pluripotent transcription factors c-Myc, Sox-2, Klf 
4 and Oct-4. Six weeks later, the first fully reprogrammed colonies were 
detected. The PAS-hiPSCs were morphologically analyzed and evaluated 
for the positivity for the pluripotent marker. Furthermore the differentiation 
potential into the three germ layers in vitro was analyzed. We successfully 
reprogrammed hiPSCs from four patients. The characterization revealed their 
efficient functionality and their use for further applications. We are focused 
to differentiation the PAS-hiPSCs into different lineages mainly part of the 
vascular system (i. e. endothelial cells, smooth muscle cells) in order to study 
the disease mechanisms.
Poster Board Number: 3110
IPS CELLS: A NOVEL CELLULAR SOURCE FOR 
MUCOPOLYSACCHARIDOSIS TYPE I
Gatto, Francesca
M. Tettamanti Research Center, Monza, Italy
MPS I is an autosomal recessive disease, belonging to lysosomal storage 
disorders and it is caused by mutations in the IDUA gene, resulting in the 
deficiency of α-L-iduronidase enzyme. The intra-cellular accumulation of its 
substrates in all body tissues causes progressive deterioration and abnormal 
function of multiple organs. Recently, a new kind of pluripotent stem cells, 
named induced Pluripotent Stem cells (iPS), were isolated through the re-
programming of adult somatic cells with the over-expression of four defined 
transcription factors. Once established, iPS cells are transcriptionally and epi-
genetically similar to embryonic stem (ES) cells and they normally maintain 
the developmental potential to differentiate into derivatives of all the three 
primary germ layers. We aim to use iPS cells as a tool to elucidate MPS-I 
mechanisms, with a particular focus on the skeletal and neural abnormalities. 
We isolated human fibroblast cell lines from skin biopsy of MPS-I patients. 
Subsequently, we reprogrammed the affected fibroblasts with four lentiviral 
vectors encoding for the pluripotent factors c-Myc, Sox2, Klf 4 and Oct-4. 
Four weeks later, the first fully reprogrammed colonies arose in the culture; 
we selected and then characterized few iPS cell lines. To fully characterize 
MPS-I iPS, the cells were morphologically analyzed and the isolation effi-
ciency was determined. We then evaluated the positivity for the pluripotent 
markers and the content of endogenous and exogenous expression of the 
transduced genes through real time PCR. We also assessed viral integration 
copy number. Furthermore, we tested their differentiation potential into the 
three germ layer in vitro and finally, we injected iPS into immunodeficient 
mice for teratoma induction. We successfully isolated several iPS cell lines 
from two MPS-I patients; the complete characterization revealed their effi-
cient functionality and their possible use for further applications. Indeed, our 
ongoing studies are focused to assess the differentiation potential of MPS-I 
iPS cell lines into different lineages mainly affected by the disease (i.e. bone, 
cartilage and neurons). 
Poster Board Number: 3112
MODELING HUMAN PROTEIN-INDUCED 
DISEASES LINKED TO DESMIN-RELATED 
CARDIOMYOPATHY WITH INDUCED 
PLURIPOTENT STEM CELLS
Limphong, Pattraranee1, Zhang, Huali1, Liu, Qiang1, Riedel, 
Michael1, Ivey, Kathryn2, Cheng, Paul2, Arnold, Josh2, Conklin, 
Bruce2, Winge, Dennis3, Srivastava, Deepak2, Benjamin, Ivor1
1Division of Cardiology, University of Utah School of Medicine, Salt Lake 
City, UT, USA, 2Gladstone Institute of Cardiovascular disease, San Francisco, 
CA, USA, 3University of Utah Health Sciences Center, Salt Lake City, UT, 
USA
Chronic conditions such as heart failure and Alzheimer’s are characterized by 
protein misfolding states for which the underlying mechanism(s) and effec-
tive therapies remain poorly defined and elusive goals, respectively. Direct 
reprogramming of somatic cells into induced pluripotent stem cells (iPSC) 
using defined transcription factors provides a robust platform for studies 
of pathophysiology, enables the development of patient-specific model 
systems, and opens a gateway for screening novel disease-specific therapies 
for personalized medicine. Missense mutation of the small MW heat shock 
protein CryAB causes an inheritable multisystem disorder characterized by 
cataracts, proximal muscle weakness, cardiomyopathy, and sudden cardiac 
death in humans. Our laboratory has challenged the existing paradigm of 
oxidative stress by demonstrating that mouse hearts exhibiting protein-
folding cardiomyopathy found in humans are under ‘reductive stress’ from 
an over-active antioxidative system. Decreasing the function of glucose-6-
phosphate dehydrogenase (G6PD), which generates the reductant NADPH, 
“cures” the disease in mice by ameliorating reductive stress, aggresome 
formation, hypertrophy, heart failure and death. To further understand 
the molecular mechanisms, we have harvested dermal fibroblasts from 
transgenic mice harboring wild type and transgenic R120G CryAB under the 
control of alpha-MHC promoter for generation of iPSC containing both hu-
man wild type and R120G mutant CryAB proteins. From several clones after 
four-factor reprogramming (OCT4, SOX2, KLF4, and C-MYC) that showed 
typical size and morphology of pluripotent stem cells, we have begun initial 
characterization after differentiation of iPSCs into cardiomyocytes containing 
protein aggregates. In Preliminary Studies, we will report on our progress to 
define their metabolic profiles using GC-MS and LC-MS. In addition, we will 
determine whether distinct molecular signatures at the post-transcriptional 
levels using Micro-RNA arrays accompany these metabolic perturbations. 
In summary, our study will illustrate whether iPSC technology will be robust 
platform that recapitulates certain cellular, molecular and biochemical prop-
erties of protein-induced diseases found in humans.
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EFFECTIVE DIFFERENTIATION INTO 
CARDIOMYOCYTE FROM XENO-FREE 
CONDITION CULTURED HUMAN IPS CELLS
Miki, Kenji1, Saito, Atsuhiro2, Higuchi, Takahiro1, Yu, Tao1, 
Miyagawa, Shigeru1, Sawa, Yoshiki1
1Department of Surgery, Division of Cardiovascular Surgery, Osaka 
University Graduate School of Medicine, Suita, Osaka, Japan, 2Medical 
Center for Translational Research, Osaka University Hospital, Suita, Osaka, 
Japan
Background: Cell therapy for myocardial repair after myocardial infarction 
is a promising strategy. Human Induced pluripotent stem (hiPS) cell-derived 
cardiomyocytes hold significant promise for clinical applications. However, 
in most of protocols for not only maintaining undifferentiated state but 
also differentiation induction, the animal derived products are used such as 
feeder cells and medium containing FBS or serum replacement, which might 
adversely affect in clinical situation. We believe it is better to use as much 
of xeno-free condition protocols as possible. In this study, we investigated 
whether hiPS cells in xeno-free conditions can differentiated into cardio-
myocyte effectively. Methods & Results: hiPS cells were maintained both on 
synthemax surface in xeno-free medium and on MEF feeder cells in defined 
medium including 20%KSR. For differentiation into cardiomyocytes, hiPS 
cells were floating-cultured and induced by WNT signaling molecules. The 
efficiency of cardiac differentiation was determined by the number of beat-
ing conies, immunostaining and RT-PCR. Using hiPS cells in xeno-free condi-
tions, the number of beating colonies in WNT signaling molecules treated 
group was more than 30-fold higher than that in WNT signaling molecules 
untreated group. Moreover, the number of beating colonies from hiPS cells 
in xeno-free conditions was higher than that from hiPS cells in MEF feeder 
cells-conditions (1.37±0.11-fold; p<0.01). Conclusion: These data dem-
onstrate that WNT signaling molecules can effectively differentiated into 
cardiomyocyte from hiPS cells in xeno-free conditions and suggest that hiPS 
cells in xeno-free conditions have more potential for cardiac differentiation 
than in MEF feeder cells-conditions. This protocol from maintenance of hiPS 
cells to cardiac differentiation can be able to scale up easily and it might 
solve some questions in regard to clinical application of hiPS cells for cell 
therapy of myocardial repair.
Poster Board Number: 3116
TRACKING THE GENOMIC STABILITY OF 
HUMAN INDUCED PLURIPOTENT STEM 
CELLS BY BOTH KARYOTYPING AND HIGH-
RESOLUTION ARRAY-BASED COMPARATIVE 
GENOMIC HYBRIDIZATION
Martins-Taylor, Kristen1, Nisler, Benjamin S.2, Taapken, Seth M.2, 
Compton, Tiwanna1, Crandall, Leann1, Montgomery, Karen Dyer2, 
Lalande, Marc1, Xu, Ren-He1
1University of Connecticut Stem Cell Institute, Department of Genetics 
& Developmental Biology, University of Connecticut Health Center, 
Farmington, CT, USA, 2WiCell Cytogenetics Laboratory, WiCell Research 
Institute, Madison, WI, USA
Genomic stability of human induced pluripotent stem cells (hiPSCs) is essen-
tial to safeguard their value for research and therapeutic applications. Here 
we monitored the genomic stability of 32 hiPSC lines by G-banded karyo-
typing and high-resolution array-based comparative genomic hybridization 
(aCGH) analysis. Few aneuploidies were detected in hiPSCs by karyotyping, 
following extended periods in culture. Using aCGH, we identified unique 
copy number variation (CNV) signatures for hiPSC lines derived from specific 
sources of parental fibroblasts, including CNVs shared between high and low 
passages and CNVs acquired specifically by hiPSCs during culture. Recurrent 
CNVs at 1q31.3 and 17q21.1 were shared by > 25% of hiPSCs. Further-
more, the loss of 8q24.3 was unique to hiPSCs. Additional recurring CNVs at 
2p11.2 and 20q11.21 were acquired by both hESCs and hiPSCs. Our results 
suggest that both karyotyping and aCGH are required for the analysis of the 
genomic stability of hiPSC lines.
Poster Board Number: 3118
MAINTENANCE OF HUMAN IPS CELLS ON 
DENDRIMER SURFACE WITH D-GLUCOSE-
DISPLAYING
Mee-Hae, KIM, Masahiro, KINO-OKA
Osaka University, Osaka, Japan
Introduction: The culture technique for maintenance of human induced 
pluripotent stem (iPS) cells is not sophisticated owing to extremely high cost 
and tedious labor, leading to developing issues for the culture environment 
(ex. feeder-free medium and artificial substrate to remove feeder cells and 
nature materials, respectively) and the operation (automation system). In the 
present study, we develop a novel artificial substrate for maintaining undif-
ferentiated state of iPS cells by using the dendrimer surface with D-glucose-
displaying. Materials and Methods: The cultures of iPS cells (clone 201B7 
provided from RIKEN Bioresource Center in Japan) were conducted in me-
dium of ReproStem (ReproCELL, Japan) on the substrates (conventional tis-
sue culture plastic surface with gelatin coat and the dendrimer surface with 
d-glucose-displaying) with feeder layer of Mitomycin C-treated SNL76/7 
cells (ECACC, UK). Here, the dendrimer surface was prepared according to 
the procedure as described elsewhere. To evaluate cell shape and function, 
immunostaining was performed using the standard protocol. Results and 
Discussion: The dendrimer surface was applied to prepare the feeder layer 
with feeder cells. The feeder cells exhibited the active migration with peri-
odic change in cell morphology (round- and stretch-shapes), compared with 
that on gelatin-coated surface, suggesting the high potency of substrate for 
the maintenance of iPS cells due to the enrichment of extracellular matrix 
on the surface. The maintenance cultures were performed on the dendrimer 
surface and gelatin-coated surface and the undifferentiated state of iPS cells 
were estimated. The iPS cells on the dendrimer surface made packed colony 
with its defined edge. Analyses of alkaline phosphatase activity and immu-
nofluorescence staining (OCT4, Nanog and SSEA-4) revealed that iPS cells 
in the colony on the dendrimer surface at 5 days maintained the character-
istics of undifferentiated state, similarly to those on a gelatin-coated surface. 
Thus, the dendrimer surface is suggested to become an alternative substrate 
for iPS cells due to the activation of feeder cells. 
Poster Board Number: 3120
REGULATED ECTOPIC EXPRESSION OF 
THE PLURIPOTENCY FACTORS SOX-2 AND 
OCT-4: A NOVEL APPROACH TO INSTALL 
REPROGRAMMING FACTORS IN HUMAN CELLS
Greve, Tobias, Jochum, Marianne, Neth, Peter
Division of Clinical Chemistry and Clinical Biochemistry, Ludwig-
Maximilians-University, Munich, Germany
Transcription-factor-based reprogramming triggers dedifferentiation of 
adult (stem) cells back to an embryonic state. The obtained cell entities are 
called induced pluripotent stem cells (iPSC). They are able to generate all 
tissues across the three germ layers. Although the benefits of these cells 
are obvious, they remain far from clinical application. One major obstacle is 
the low efficiency of transcription-factor-based reprogramming. Beside the 
fact that reprogramming efficiency is strongly dependent on the respective 
cell type, it has been shown that minimal fluctuations of pluripotency factor 
concentration can induce cell fate decisions of embryonic stem cells. This 
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led us to the hypothesis that defined levels of pluripotency factor expression 
might favor reprogramming in terminally differentiated cells as well as in 
adult stem cells. In order to check this hypothesis, we developed a method 
to overexpress defined quantities of the crucial pluripotency factors Sox-2 
and Oct-4 and to track their intranuclear activity over the entire time period 
of the reprogramming process. In detail, the regulated gene expression is 
mediated by a non-viral plasmid vector system which has recently been de-
veloped in our laboratory (p2in1-Sox-2-IRES-Oct-4). It harbors a doxycy-
cline-inducible promoter, regulating the expression of both a transactivator 
and the reprogramming factors Sox-2 and Oct-4. This vector was shown to 
promote adjustable gene expression in close correlation to the corresponding 
inductor concentrations. With the aim of detecting the functional expression 
of the reprogramming factors, we established an activity-based reporter-
gene assay, capable of quantifying the functional levels of Sox-2 and 
Oct-4 in living cells using a Sox-2-Oct-4-dependent reporter gene plasmid 
(pN3-OSR). Due to secretion of the reporter protein (Gaussia luciferase), 
the intranuclear activity of the reprogramming factors can be quantified in 
the supernatant. This technique circumvents cell lysis and therefore allows 
continuous analysis of reprogramming factor activity. In summary, the two 
vector systems provide a powerful tool for a fine-tuned ectopic expres-
sion of the reprogramming factors Sox-2 and Oct-4 in combination with a 
simultaneous quantification of their intracellular activities during the entire 
reprogramming period.
Poster Board Number: 3122
GENERATION OF HUMAN INDUCED 
PLURIPOTENT STEM CELLS UNDER FEEDER 
AND SERUM FREE DEFINED CONDITIONS
Chan, T1, Hayashi, Y1, Warashina, M2, Ariizumi, T1, Okabayashi, 
K1, Takayama, N1, Otsu, M1, Eto, K1, Furue, M K.3, Michiue, T1, 
Ohnuma, K4, Nakauchi, H1, Asashima, M1
1University of Tokyo, Tokyo, Japan, 2Wako Pure Chemical, Hyogo, Japan, 
3NIBIO, Osaka, Japan, 4Nagaoka UT, Niigata, Japan
The successful establishment of human induced pluripotent stem cells (hiP-
SCs) has increased the possible applications of stem cell research in biology 
and medicine. However, one of the major obstacles to uses for hiPSCs is the 
risk of contamination from undefined pathogens in conventional culture 
conditions that use serum replacement and mouse embryonic fibroblasts 
as feeder cells. Here we report a simple method for generating hiPSCs 
under feeder- and serum-free defined culture conditions that we developed 
previously for human embryonic stem cells. The defined culture condition 
comprises a basal medium with a minimal number of defined components 
including five highly purified proteins and fibronectin as a substrate. We suc-
cessfully generated hiPSCs using adult dermal fibroblast under the defined 
culture conditions from the reprogramming step. For a long term culture, 
the generated cells also had the property of self renewal and pluripotency, 
they carried a normal karyotype. Moreover, levels of nonhuman N-glycolyl-
neuraminic acid (Neu5Gc), which is a xenoantigenic indicator of pathogen 
contamination in human iPS cell cultures, were markedly decreased in the 
generated hiPSCs. This study suggested that generation or adaption cultur-
ing under defined culture conditions can eliminate the risk posed by unde-
fined pathogens. This success in generating hiPSCs using adult fibroblast 
would be beneficial for clinical application.
Poster Board Number: 3124
HUMAN INDUCED PLURIPOTENT STEM 
CELLS FROM AN AUTISTIC INDIVIDUAL WITH 
MICRODELETION OF PTCHD1
Ross, P. Joel1, Vaags, Andrea K.2, Cheung, Aaron Y.L.1, Scherer, 
Stephen W.2, Ellis, James1
1Developmental & Stem Cell Biology Program, The Hospital for Sick 
Children, Toronto, ON, Canada, 2Genetics and Genome Biology Program, 
The Hospital for Sick Children, Toronto, ON, Canada
The study of neuropsychiatric diseases and the development of effective 
treatments have been limited by a lack of appropriate models. Induced 
pluripotent stem (iPS) cells represent a potentially limitless supply of patient-
specific cells for the study of neuropsychiatric disorders. Here we describe 
the generation of iPS cells derived from an autistic male with an X-linked 
genomic copy number variation (CNV) that encompasses the promoter 
and first exon of the patched domain containing 1 (PTCHD1) gene, which 
encodes a patched homologue that has been implicated in regulation of the 
hedgehog signaling pathway. We also derived iPS cells from the proband’s 
unaffected mother, who encodes both the wild type PTCHD1 allele and 
the CNV inherited by the proband. Skin fibroblasts were reprogrammed by 
retrovirus-mediated expression of OCT4, SOX2, KLF4, and CMYC. Success-
fully reprogrammed cells exhibited retroviral silencing, activation of endog-
enous reprogramming factors, and expression of pluripotency-associated 
genes including REX1, DNMT3b, and ABCG2. iPS cells derived from the 
proband’s mother exhibited clonal, line-specific X chromosome inactivation. 
This has resulted in the generation of isogenic iPS cell lines that differ only 
with regards to their X chromosome inactivation status - and therefore - 
expression of the autism-associated PTCHD1 locus. Finally, we found that 
PTCHD1 is expressed in human embryonic stem cell-derived glutamatergic 
forebrain-like neurons, a cell type whose dysfunction has been implicated 
in the development of autism. Our future experiments will be focused upon 
directed-differentiation of proband and isogenic “control” and “mutant” 
maternal lines into (i) forebrain-like glutamatergic neurons and (ii) cerebellar 
granule cell-like neurons for characterization of gene expression and synapse 
formation, with the goal of identifying neuronal phenotypes that may 
underlie the development of autism. The cells described herein represent 
a potential model system for the elucidation of the molecular and cellular 
underpinnings of autism, and for understanding the role of PTCHD1 and the 
hedgehog signaling pathway in neuronal function and dysfunction.
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FRAGILE X SUBJECT-DERIVED IPS CELLS AS 
A SOURCE FOR HUMAN NEURONS WITH 
CLINICALLY-RELEVANT FMR1 MUTATIONS
Sidhu, Harpreet K.1, Ethell, Iryna M.2, Berry-Kravis, Elizabeth3, 
Ethell, Douglas W.1
1Molecular Neurobiology Group, Western University of Health Sciences, 
Pomona, CA, USA, 2Biomedical Sciences and Neuroscience, University of 
California, Riverside, Riverside, CA, USA, 3Pediatrics, Biochemistry and 
Psychiatry, Rush University, Chicago, IL, USA
Fragile X Syndrome (FXS) is an inherited neurodevelopmental disorder that 
causes mental retardation and autistic features in 1/5000 births, from every 
racial and socio-economic group. FXS is caused by expansions in the number 
of CGG repeats (>200) in the 5’ untranslated region (UTR) of the FMR1 
gene, which results in gene silencing and loss of the FMR protein (FMRP) 
- an RNA binding protein known to bind to and regulate the translation of 
a variety of mRNA species. This condition exhibits variable penetrance due 
to individual differences in CGG repeat length, methylation patterns of the 
FMR1 promoter and mosaicism - the locus is carried on the X chromosome. 
Although the Fmr1 KO mouse model displays dendritic spine abnormali-
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ties that are similar to those in FXS subjects, this animal model does not 
address the variable penetrance exhibited in humans as those mice are 
completely deficient for FMRP. We are developing an in vitro system to 
study the effects of clinically-relevant FMR1 mutations on synaptogenesis in 
large pyramidal neurons. Using primary fibroblast lines (12 lines) obtained 
from FXS subject skin biopsies, we have generated induced-pluripotent 
stem (FXS-iPS) cells using a 4-factor virus that forces expression of OCT-4, 
SOX-2, KLF-4 and c-MYC. The clones were grown 4 weeks before colonies 
with hESC-like morphologies were picked to generate FXS-iPS cell lines. 
The lines were expanded and characterized for the expression of SSEA-3/4, 
Alkaline phosphatase and OCT-4 expression. To produce the large pyramidal 
neurons required for this project, we developed a differentiation protocol 
using H9 human embryonic stem cells (hESC). The mixed neuron cultures 
obtained included large neurons with mature dendritic spines that stained 
for glutamatergic synapse markers. We are currently characterizing synapses 
and dendritic spine formation in FXS-iPS derived neurons, to determine if 
there are correlations between the gene methylation patterns, and dendritic 
spine dynamics. This approach will provide a disease-in-a-dish model to 
test the effects of new drugs on spiny neurons that carry clinically-relevant 
FMR1 mutations. Funding provided by FRAXA foundation and the California 
Institute for Regenerative Medicine.
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BANKING HUMAN IPS CELLS GENERATED 
FROM ADIPOSE TISSUE-DERIVED 
MESENCHYMAL STEM CELLS
Lim, Susan1,3, Stanton, Lawrence W.2, Lim, Kerrie1, Aksoy, Irene2, 
Ma, Feng Juan3, Karuppasamy, Jayavani1, Divakar, Ushashree1, 
Remulla, Sherwin Jade3
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Singapore, 3Stem Cell Technologies (i), Singapore, Singapore
Induced pluripotent stem (iPS) cells were originally derived by reprogram-
ming of human dermal fibroblasts through ectopic expression of pluripo-
tency-associated transcription factors. A limitation to the use of dermal 
fibroblasts as the starting cell type for reprogramming is that it usually takes 
weeks to expand cells from a single biopsy, and the efficiency of the process 
is very low. In contrast to human dermal fibroblasts or terminally differenti-
ated cell sources, a large number of adipose-derived mesenchymal stem 
cells (Ad-MSCs) can be easily obtained from human fat tissue, without the 
time-consuming steps of cell expansion. The successful reprogramming of 
Ad-MSCs into iPS cells may provide an ideal autologous source of cells for 
generating individual-specific iPS cells. Patient-specific iPS cells will facilitate 
our basic understanding of specific disease mechanisms. More importantly, 
the generation of patient-specific and disease-specific iPS cells has the 
potential to greatly impact regenerative medicine, and facilitate drug and 
vaccine development. The aim of this study is to generate a bank of human 
iPS derived from Ad-MSCs. The starting point is the derivation of Ad-MSCs 
from human adipose tissue obtained from liposuction or discarded fat from 
surgical procedures. The Ad-MSCs were then used to generate iPS cells by 
ectopic expression of “Yamanaka’s cocktail” containing OCT4, SOX2, KLF4 
and c-MYC. The success rate is very high compare to iPS cells generated 
from human dermal fibroblasts, almost all Ad-MSCs cell lines can be repro-
grammed into iPS cells. These cells present the same characteristics as skin 
fibroblasts-derived iPS cells and human ES cells in their morphology, gene 
expression profile and differentiation capacities. We are now optimizing this 
approach and making it more clinically useful by adopting an integration-
free method to deliver the reprogramming factors.
Poster Board Number: 3130
GLOBAL ANALYSIS OF PARENTAL IMPRINTING 
IN 
HUMAN PARTHENOGENETIC INDUCED 
PLURIPOTENT STEM CELLS
Stelzer, Yonatan, Yanuka, Ofra, Benvenisty, Nissim
Genetics, The Hebrew University, Jerusalem, Israel
Parental imprinting is a phenomenon affecting human development and dis-
ease. In order to analyze the role of parental imprinting in human embryo-
genesis, we generated parthenogenetic human induced pluripotent stem 
cells (PgHiPSCs), by genetic manipulation of parthenogenetic ovarian tera-
tomas. PgHiPSCs show typical characteristics of pluripotent cells and have 
a homozygote diploid karyotype. Global gene expression analysis of the 
parthenogenetic cell lines correctly identified most of the known paternally 
expressed genes. In addition, genome-wide DNA methylation analysis of 
the parthenogenetic cells demonstrated differential methylation in imprinted 
loci. We could demonstrate that a variant of the U5 RNA component of 
the spliceosome (U5d), which is highly enriched in pluripotent stem cells, 
is a novel imprinted gene, as it is down regulated in the parthenogenetic 
cells, and expressed in a monoallelic fashion in the wild type cells. Introduc-
tion of the U5d gene to the parthenogenetic cells corrected the expression 
of several of the aberrantly expressed genes. Our analysis also uncovered 
multiple miRNAs as novel imprinted clustered transcripts, and studied their 
putative targets. In order to study the consequences of parthenogenesis on 
human development, we differentiated the PgHiPSCs in vitro and in vivo, 
demonstrating marked effects on the differentiation of the extra-embryonic 
trophectoderm, and of the embryonic liver and muscle tissues. This analysis 
provides a global view on human imprinting, and suggests a significant 
involvement of distinct regulatory imprinted small RNAs and their targets in 
human development.
Poster Board Number: 3132
SMALL MOLECULES IN INDUCING 
PLURIPOTENCY OF HUMAN FIBROBLASTS 
THROUGH CHEMICAL GENOMICS
Tom, Susan, Leng, Song, Vaisberg, Eugeni, Strulovici, Berta, Wang, 
Weidong
iPierian, Inc, South San Francisco, CA, USA
Human induced pluripotent stem (iPS) cells offer great potential for cell-
based therapies, in vitro disease modeling, drug discovery and toxicology. 
To realize the full potential of iPS cell technology, two major hurdles must 
be addressed: the reliance on viral vectors to deliver reprogramming fac-
tors, and the inefficiency of the process when applied to human cells. Small 
molecules could potentially replace the virally delivered reprogramming 
factor(s) or enhance reprogramming efficiency. Indeed, iPSCs have recently 
been generated from primary somatic cells with only one gene OCT4 and 
chemical compounds, although the efficiency leaves much to be desired. We 
have established a screening assay for reprogramming, in which stable hu-
man fibroblast cell lines were established to express 2 sets of 3 factors (Sox2, 
Klf4 and c-Myc, and Oct4, Sox2 and Klf4) under the control of Tetracycline 
(Tet) and hence can be used to screen for small molecules that function in 
the place of the missing factor when other 3 factors are induced in the pres-
ence of Tet. With this assay system, we are carrying out 2 parallel screens 
of 100,000 compounds for their ability for reprogramming. A few dozens 
of primary hits have been identified, and further confirmatory and second-
ary assays measuring molecular markers of pluripotency (e.g., AP, Tra-1-60, 
SSEA4, NANOG) are being employed to validate these hits. Mechanistic 
studies of the confirmed hits will likely identify novel genes / pathways 
involved in reprogramming and shed light on the mechanisms of cellular 
reprogramming in human cells.
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Poster Board Number: 3134
THE AUTOMATED CELL PROCESSING OF 
HUMAN INDUCED PLURIPOTENT STEM 
CELLS (HIPS CELLS) IN LARGE AMOUNT FOR 
INDUSTRIAL USE.
Watakabe, Keizo1, Sakurai, Takashi1, Akutsu, Hidenori2, Toyoda, 
Masashi3, Umezawa, Akihiro2, Asashima, Makoto4, Nakashima, 
Katsumi1
1MD Project Section, System Technology Development Center, Corporate 
Technology Division, Kawasaki Heavy Industries Ltd., Kobe, Japan, 
2Department of Reproductive Biology and Pathology, National Center for 
Child Health and Development, Tokyo, Japan, 3Research Team for Geriatric 
Medicine, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan, 
4Division of Reproductive Technology Department of Reproductive Biology 
and Pathology, National Institute of Advanced Industrial Science and 
Technology, Tsukuba, Japan
Kawasaki Heavy Industries, LTD. (KHI), National Institute of Advanced 
Industrial Science and Technology(AIST), and National Center for Child 
Health and Development(NCH) have succeeded in culturing human induced 
pluripotent stem cells (hiPS) automatically for about 4 months continuously 
by using the automated cell processing machine which KHI has developed. 
HiPS cells can be established from mature somatic cells, so it can clear the 
ethical problems easily compared to hES cells, which require to destroy 
a fertilized ovum to be obtained. Therefore, hiPS cells are expected to 
become common in the field of regenerative medicines or drug discovery. 
To accelerate the industrial use of hiPS cells, it is necessary to supply cells 
in large amount stably. The automated cell processing machine which can 
deal with hiPS cells can be the best solutions. It is important to keep the 
cells undifferentiated (pluripotency) during the culture for the further use. 
However, processing hiPS cells is difficult compared to established cell lines, 
and the special technique of the skilled technician is required. The KHI’s 
cell processing machine can duplicate the manual handling of the techni-
cians by using clean robot and the other special equipments to automate 
the process of cell culture. Since they can move in programmed way, they 
will not make careless mistakes, and they can repeat the same movement 
completely with high reproducibility. On the other hand, culture parameters 
can be modified by users for every operation according to the condition of 
cultured cells. The clean robot carry out culture operations inside the chassis 
where the clean class is kept virtually 0, so there is no risk to contaminate. 
The automated processing of hiPS cells have tried by applying these features 
of the machine. In this trial, the hiPS cell line derived from MRC5 cell line 
(established by NCH) was cultured automatically using commercially avail-
able dishes. During the trial, passage cultures were executed once a week 
and medium replacement were executed everyday automatically for about 4 
months. The cultured hiPS cells were observed by phase-contrast micro-
graph to check the morphology of cultured hiPS colonies. As the marker 
of undifferentiated hiPS cells, expression of Oct3/4, Nanog, Sox2, SSEA4 
and Tra-1-60 were verified by immunostaining. Also expression of alkaline 
phosphatase was confirmed to check all colonies in the dishes. As a result, 
more than 90% of colonies showed positive reaction by ALP staining. In ad-
dition, the cultured hiPS cells were transplanted to immunodeficient mouse 
to check the pluriopotency. After 2 months, tumor formation was confirmed 
and tissues from endoderm, mesoderm, and ectoderm were observed by HE 
staining. The karyotype of cultured hiPS cells were also tested and verified 
that they were kept normal after 15 passages. For the next step, culture of 
more number of hiPS cell lines, automated colony screening by using the 
image processing technology in the machine will be tested. This machine 
will be able to apply for the regenerative medicine in the future because KHI 
has already developed another version of cell processing machine which can 
adapt GMP standard. This machine can contribute the industrial use of hiPS 
cells significantly.
Poster Board Number: 3136
HETEROGENEITY IN EARLY HUMAN INDUCED 
PLURIPOTENT STEM CELL COLONIES
Weltner, Jere, Trokovic, Ras, Mikkola, Milla, Otonkoski, Timo
Biomedicum Stem Cell Center, University of Helsinki, Helsinki, Finland
Somatic cells can be reprogrammed to pluripotent state by ectopic ex-
pression of defined transcription factors. The acquisition of a pluripotent 
phenotype is a stochastic process with intermediate cell states resulting in 
only part of the cells reaching pluripotency during the induction. To distin-
guish partially from fully reprogrammed cells, several features associated 
with pluripotent cells can be monitored live in early forming iPS cells. These 
properties include for example typical morphology, silencing of retrovirally 
delivered transgenic factors and expression of specific cell surface anti-
gens. To decipher how the pluripotent state is acquired in human cells, we 
have monitored transgene silencing and surface marker expression by live 
imaging during the generation of iPS cells. Human foreskin fibroblasts were 
transduced with retroviruses encoding Oct4, Sox2, Klf4 and c-Myc coupled 
to EGFP with self cleaving 2A sequences. Cells were split on day 3 post 
transduction on either mitotically inactivated mouse embryonic feeder cells 
(MEF) or matrigel, and cultured in reprogramming medium since day 6. Cells 
were monitored for GFP and Tra-1-60 expression under fluorescent micro-
scope or in an automated live cell imaging system (Cell-IQ ®). iPSC colonies 
were plated either on MEFs using conventional hES medium or on Matrigel 
using StemPro medium. Majority of the colonies turned GFP negative early 
on during reprogramming, indicating the silencing of transgenes. However, 
a subset of the forming colonies showed heterogeneous GFP positive cell 
populations within colonies that otherwise showed morphological properties 
and Tra-1-60 positivity typical to bona fide iPS colonies. Automated live cell 
monitoring revealed that some of the heterogeneously fluorescent colonies 
were formed by fusion of multiple smaller colonies originating from separate 
reprogramming events.GFP expression diminished significantly during the 
first passage, faster in cells cultured on Matrigel than on MEFs. Our results 
show that pluripotent reprogramming of human somatic cells can lead to 
heterogeneous cell populations measured by transgene silencing. Our data 
also proposes that culture conditions after colony formation might affect the 
outcome of the reprogramming process and quality of the iPS clones.
Poster Board Number: 3138
COMPARATIVE ANALYSIS OF THE ROLE OF 
USP44 IN HUMAN EMBRYONIC STEM CELLS, 
RETROVIRAL AND mRNA-DERIVED AMNIOTIC 
FLUID INDUCED PLURIPOTENT STEM CELLS
Wolfrum, Katharina1, Tavernier, Geertrui2, Rejman, Joanna2, Adjaye, 
James1
1Vertebrate Genomics, Max Planck Institute for Molecular Genetics, Berlin, 
Germany, 2Laboratory of General Biochemistry and Physical Pharmacy, 
Ghent University, Ghent, Belgium
Human amniotic fluid cells (AFCs) have gained increasing appreciation in the 
biomedical field over the last decade. Due to the presence of fetal stem cells 
within this heterogenic mixture of cells, which have multipotent capacities 
and possess putative immune privilege characteristics, primary human AFCs 
are believed to be valuable for conducting disease modeling, pharmaceutical 
and toxicological studies and even cell-based regenerative therapies in the 
future. Adding even greater value to AFCs, we and others demonstrated 
very recently that amniotic fluid cells enable fast and efficient induction 
of pluripotency, whereby senescence of primary human AFC cultures is 
bypassed and their differentiation potential enhanced. We extensively 
characterized several retrovirally generated human amniotic fluid-derived 
induced pluripotent stem cell (AFiPSC) lines and work with these established 
AFiPSC lines in different follow-up studies. We will present the current status 
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of two of our ongoing AFiPSC-based projects: (I) We focus on the optimi-
zation of an improved non-viral, synthetic mRNA-based reprogramming 
technique. As our retroviral-derived AFiPSC lines harbour several integration 
events within their genomes with yet unknown effects on the transcriptome 
it is our goal to generate integration-free AFiPSC lines. We anticipate that 
the stem cell-like cells present in bulk primary AFC cultures facilitate the real-
ization of this otherwise rather complex, inefficient mRNA reprogramming 
approach. This will give us the opportunity to compare the transcriptomes 
and differentiation potential of our retroviral and mRNA-derived induced 
pluripotent stem cell (iPSC) lines harbouring identical genetic background. 
(II) We aim to compare the downstream effects of knocking down a gene in 
the AFiPSC lines and embryonic stem cells (ESCs). For this purpose we chose 
to knock down the gene encoding the deubiquitinating enzyme USP44. This 
enzyme is a critical regulator of the spindle checkpoint during cell cycle. It 
has been shown to prevent premature activation of the anaphase promoting 
complex. Using an OCT4 ChIP-on-chip approach, we and others identified 
USP44 as a positively regulated OCT4 target gene in various human pluri-
potent cell lines. We also demonstrated that the USP44 proximal promoter 
harbours an evolutionary conserved OCT4 binding site and we were able to 
confirm OCT4 binding by ChIP-real-time-PCR. Yet, the exact role of USP44 
in the maintenance of self-renewal and pluripotency is unknown. Therefore, 
utilizing our AFiPSC lines as well as the ESC lines H1 and H9, we will aim at 
deciphering its function. As a result of these studies we expect to be able 
to attain the following: (I) unveil similarities and differences between viral 
and in vitro mRNA-based reprogramming methods on the transcriptome, 
long-term stability and differentiation capabilities of iPSC lines derived from 
the same genetic background. (II) unravel the role of the pluripotency-asso-
ciated gene USP44 on self-renewal and the maintenance of pluripotency in 
human ESCs and iPSCs.
Poster Board Number: 3140
REVEALING THE ONCOGENIC RISK OF HUMAN 
INDUCED PLURIPOTENT STEM CELLS USING IN 
VITRO CARTILAGE TISSUE ENGINEERING.
Yamashita, Akihiro1, Thomas, Bradley1, Meng, Guoliang1, Hotta, 
Akitsu2, Ellis, James3, Rancourt, Derrick E.1
1University of Calgary, Calgary, AB, Canada, 2Kyoto University, Kyoto, 
Japan, 3The Hospital for Sick Children, Toronto, ON, Canada
Induced pluripotent stem cells (iPSCs) are attractive cells for regenerative 
medicine. However, iPSCs may have the risk of oncogenic transformation 
due to the use of proto-oncogenes in reprogramming, in addition to the 
use of viral vectors and random genomic integrations. Indeed, an incident 
of tumor formation was observed in mouse iPSC-derived chimeras. In this 
regard, chimera formation is a useful indicator for oncogenic potential in 
mouse iPSCs. Unfortunately, this risk remains unclear for human iPSCs, as 
a useful indicator has been lacking. What is needed is a useful indicator for 
evaluating the risk of oncogenic transformation in human iPSCs. Here, we 
demonstrate how we have discovered a new way to reveal the oncogenic 
risk of human iPSCs using in vitro cartilage tissue engineering. Follow-
ing micro-mass chondrogenic differentiation, both human ESCs and iPSCs 
displayed similar cell morphology. Although cartilage specific histological 
staining is present in cartilage derived from both cell types after 6-8 weeks 
of differentiation culture, upon closer inspection we observed the pres-
ence of mucous glands or adenocarcinoma-like cysts within iPSC-derived 
cartilage based on morphology, lack of cartilage matrix, proteoglycan, and 
the expression of tumor markers, CEA and CA19-9. Non-cartilage specific 
genes, such as the pro-oncogenic/pluripotency c-Myc and Lin28B were also 
up-regulated in pro-oncogenic iPSC lines. The penetrance of this adenocar-
cinoma phenotype could be modulated down by the p53 agonist, Nutlin-3, 
or up by the antagonist α-pifithrin. Nutlin-3 suppresses tumor formation by 
activating the p53 pathway, which resulted in apoptosis or cell cycle arrest of 
cartilage differentiated iPSCs cultures. This adenocarcinoma-like phenotype 
was observed in two of three human iPSC lines, which we have studied thus 
far. These results indicate that certain human iPSCs may have pro-oncogen-
ic/adenocarcinoma potential and reveal their risks following differentiation 
into cartilage. Considering the aforementioned observations, cartilage tissue 
engineering may be an excellent tool for screening human iPSCs in vitro, 
without the need for transplantation into animals. This system also shows 
the potential to identify the key regulators of oncogenic transformation of 
pro-oncogenic human iPSCs and to adapt similar approaches to the study of 
cancer stem cells. There are several variations between iPSC lines owing to 
genomic insertional mutagenesis. Since safety is a foremost issue in human 
iPSC application, cartilage tissue engineering may provide a useful safety 
evaluation approach.
Poster Board Number: 3142
DIRECT DIFFERENTIATION OF SUSPENDED 
SPHEROID FORM OF HIPSCS TO ENDODERM 
PROGENY
Vosough, Massoud1, Omidinia, E1, Kadivar, M1, Shokrgozar, MA1, 
Aghdami, N2, Pournasr Khakbaz, B3, Baharvand, H3
1Biochemistry Department, Pasteur Institute, Tehran, Iran, Islamic Republic 
of, 2Department of Regenerative medicine, Royan Institute, Tehran, Iran, 
Islamic Republic of, 3Department of Stem Cell and Developmental Biology, 
Royan Institute, Tehran, Iran, Islamic Republic of
Definitive Endoderm (DE) and particularly foregut is the primary origin of 
functional cells in parenchyma of liver and pancreas. Many studies have 
been conducted to produce hepatocytes and beta cells from pluripotent 
cells, however the acceptable functionality and adequate quantity of 
generated cells are two main challenging issues that have been remained 
undisclosed yet. Simulation of the specific niche of cells during development 
and application of appropriate growth factors are the basic considerations in 
direct differentiation protocols of stem cells into favorite mature cells. Static 
culture of cells in plates in two dimensional (2D) forms and their differentia-
tion in experimental scale through expensive growth factors cannot product 
adequate cells for therapeutic application. Suspension culture of pluripotent 
cells in spheroid form has enabled researchers to handle the culture of enor-
mous amount of stem cells in limited space and helped them to save their 
time and budget. The replacement of expensive growth factors with suitable 
chemicals will be the second solution for cell production in therapeutic 
scale. In this study we performed direct differentiation of human induced 
pluripotent stem cell lines in the suspended condition to DE in different 
groups. We demonstrated that lower concentrations of ActivinA (50ngr/ml) 
in correlation with small amounts of Rapamycin can stimulate the expression 
of specific genes of DE such as SOX17 and FOXA2. This increase in gene 
expression in some groups is even higher than control group with 100ngr/
ml ActivinA. Treatment of pluripotent cells by different concentrations of 
Rapamycin during the first day of induction can accelerate the differentia-
tion trend of cells into DE. This treatment can cause remarkable decrease in 
expression of stemness genes like Oct4. Immunochemistry staining of sec-
tions of spheres confirmed the expression of SOX17 and FOXA2 proteins. 
This approach can inspire researchers to launch a new insight in practical 
cell-based therapies.
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MODELLING PROTEIN AGGREGATION IN 
MACHADO JOSEPH DISEASE USING PATIENT 
SPECIFIC IPS CELLS
Koch, Philipp1, Breuer, Peter2, Peitz, Michael1, Jungverdorben, 
Johannes1, Kesavan, Jaideep1, Poppe, Daniel1, Ladewig, Julia1, Evert, 
Bernd2, Tütting, Thomas3, Wüllner, Ullrich2, Klockgether, Thomas2, 
Brüstle, Oliver1
1Dept Reconstructive Neurobiology, University of Bonn, Bonn, Germany, 
2Department of Neurology, University of Bonn, Bonn, Germany, 
3Department of Dermatology, University of Bonn, Bonn, Germany
Machado-Joseph Disease (MJD; syn. spinocerebellar ataxia type 3; SCA3) 
is a dominantly inherited late-onset neurodegenerative disorder caused by 
expansion of polyglutamine (polyQ)-encoding CAG repeats in the MJD1 
gene. Proteolytic cleavage of the MJD1 gene product, ataxin-3 (ATXN3), is 
believed to trigger the formation of ATXN3-containing aggregates, the neu-
ropathological hallmark of MJD. Here we report the generation of induced 
pluripotent stem (iPS) cell-derived neurons from a patient with MJD and his 
non-affected sibling. We demonstrate that L-glutamate-induced excitation 
of MJD neurons is sufficient to initiate cleavage of ATXN3 and the formation 
of SDS-insoluble aggregates. Aggregate formation was efficiently blocked 
by the calpain inhibitors N-acetyl-Leu-Leu-norleucinal (ALLN) and calpeptin 
but not by caspase inhibition, indicating that excitation-induced activation of 
calpains is sufficient to generate aggregation-competent proteolytic polyQ 
fragments. Thus, our study illustrates the powerful potential of iPSC-derived 
cellular models to identify fundamental pathophysiological processes in hu-
man neurodegenerative disorders.
Poster Board Number: 3146
REDUCED LEVELS OF VAPB IN MOTOR 
NEURONS FROM ALS8 PATIENTS FOLLOWING 
IPSC FIBROBLASTS REPROGRAMMING
Mitne Neto, Miguel1, Machado-Costa, Marcela2, Marchetto, Maria 
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4Scripps Research Institute, La Jolla, CA, USA, 5Federal University of São 
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ALS is a devastating and incurable neuromuscular disease that leads to a 
profound loss of life quality. Around 10% of the ALS cases are inherited. 
ALS8 is an autosomal dominant form of familial ALS, which is caused by 
mutations in the VAPB gene. It was first described in Brazilian patients and 
identified in other countries such as Germany, Japan and UK. The VAPB 
protein affects many cellular processes and likely contributes to the patho-
genesis in many other forms of ALS besides ALS8. A substantial number of 
successful drug tests in ALS animal models could not be translated to hu-
mans demonstrating the need to develop other ALS model systems. Induced 
pluripotent stem-cells (iPSC) technology brings new hope in this area since 
it can be used to model and investigate diseases in vitro. Here we present a 
new ALS model based on ALS8-iPSC. Fibroblasts from 7 individuals, 4 pa-
tients and 3 non affected siblings from two ALS8 families, were successfully 
reprogrammed to a pluripotent state, accessed by the expression of embry-
onic stem cell markers. When injected into nude mice, these cells generated 
teratomas containing tissues from the three embryonic germ layers, showing 
that these arebona fide iPSC. We show, for the first time, that the VAPB 
protein is present in iPSC and in two different human embryonic stem cell 
lineages. Additionally, this is the first description that VAPB is reduced in fi-
broblasts, iPSC and differentiated motor neurons derived from ALS8 samples 
when compared to controls obtained from the normal siblings. We suggest 
that with aging the levels of VAPB may be crucial for motor neuron viability, 
supporting previous studies showing that VAPB is diminished in postmortem 
sporadic ALS samples. Besides helping in the understanding of motor neuron 
diseases, iPSC modeling will probably become a useful tool to answer why 
proteins expressed early in development cause late onset diseases.
Poster Board Number: 3148
INDUCED PLURIPOTENT STEM CELLS 
(IPS CELLS) - DERIVED HEPATOCYTES 
TRANSPLANTATION AS A THERAPEUTIC 
STRATEGY FOR GENETIC LIVER DISEASE
Wu, Yao-Ming, Huang, Yu-Jen, Kao, Chung-Yang, Lin, Shu-Wha, 
Lee, Po-Huang, Lee, Hsuan-Shu
National Taiwan University Hospital, Taipei, Taiwan
Background: Recently, hepatocyte transplantation has been demonstrated 
as an effective therapeutic strategy for different kinds of liver diseases 
in animals and clinical trials, including metabolic liver disease, acute liver 
failure, and chronic liver cirrhosis. But the shortage of donor cells is still a big 
problem to overcome before the wide application of cell transplantation. The 
iPS cells have the potential to expand the donor cell source of hepatocyte 
transplantation for liver diseases. We will identify in this study whether the 
iPS cells - derived hepatocytes transplantation can be an effective therapeu-
tic strategy for genetic liver diseases - hemophilia B as an example. Meth-
ods: In this study we plan to identify if the iPS cells can be a new source of 
donor cells. The iPS cells were provided kindly by Prof. YamanaKa S. Firstly, 
we will identify the capacity of iPS cells to differentiate into functional 
hepatyocytes. We applied the modified three steps protocol to differentiate 
the iPS cells into hepatocytes. The morphology and functional characteris-
tics of iPS cells -- derived hepatocytes will analyze by microscope, RTPCR 
for hepatocytes-related genes (α-FP, factorIX, CK18, G6P, TAT, alb, HNF4, 
cyp2b, cyp7a, etc) expression, ELISA for hepatocytes-related protein secre-
tion (albumin), cytochrome P 450 enzyme activity and ICG uptake test. The 
fate of iPS cells- derived hepatocytes also evaluated at different time points 
after differentiation (3, 7, 10, 14, 21, and 28 days). Secondly, we studied 
the in vivo therapeutic efficiency of these iPS cells- derived hepatocytes. 
We transplanted intrasplenically the iPS cells- derived hepatocytes (1million 
cells/mice) into FIX knock-out mice. The blood samples were taken at day 
5, 10, 15, and 20 to measure the clotting activity and ELISA for factor IX. 
The engraftments of transplanted hepatocytes were evaluated by labeling 
the transplanted cells with Quantum dots before cell transplantation and 
quantitative PCR. The hemostatic functional studies were evaluated by the 
thromboelastography (TEG). We also performed 2nd transplantation 7 days 
after the 1st transplantation to determine whether this approach increased 
the therapeutic efficiency. Results: The iPS cells - derived hepatocytes 
showed typical morphology of primary isolated hepatocytes under micro-
scope. These iPS cells-derived hepatocytes also expressed the hepatocytes-
-related gene. We can detect the increased albumin secretion up to 6ng/
ml after differentiation. The ICG uptake test, the cytochrome P450 enzyme 
activity test, and the PAS staining for glycogen storage disclosed in advance 
the functional characteristics of these iPS cells-derived hepatocytes. The re-
cipients (n = 8-10) transplanted with these iPS cells-derived hepatocytes ex-
hibited 1.75%, 1.59%, 1.10%, and 1.46% of FIX clotting activity at day 5, 
10, 15, and 20, which is compatible with those (n = 2-4) transplanted with 
primary isolated hepatocytes from wild type mice (1.63%, 1.20%, 0.93%, 
and 1.22% of FIX clotting activity respectively). Conclusion: These studies 
demonstrated that hepatocytes transplantation is an effective therapeutic 
strategy for genetic liver diseases. And the iPS cells can be an alternative 
source for hepatocytes transplantation to overcome the problem of organ 
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shortage. These results will help us to develop the therapeutic strategy of 
cells transplantation for genetic liver diseases.
Poster Board Number: 3150
PATIENT-DERIVED IPS CELLS WITH A H137L 
MUTATION IN RP9 GENE MODEL RETINITIS 
PIGMENTOSA
Jin, Zi-Bing1, Okamoto, Satoshi2, Qu, Jia1, Takahashi, Masayo2
1Wenzhou Medical College, Wenzhou, China, 2Lab. for Retinal 
Regeneration, RIKEN Center for Developmental Biology, Kobe, Japan
Retinitis pigmentosa (RP) is the most common inherited human eye disease 
resulting in night blindness and visual defects. RP encompasses a number of 
genetic subtypes, which overlap in both etiology and phenotype. Retinitis 
pigmentosa-9 is caused by an autosomal dominant mutation in RP9 (PAP-1) 
gene. The mechanism whereby the mutation in ubiquitously expressed RP9 
gene merely leads to retinal degeneration remains unknown. We obtained 
from two familiar patients with a H137L mutation in the RP9 gene and 
generated induced pluripotent stem (iPS) cells. We differentiated them into 
rod photoreceptor cells by using a sophisticated protocol and found that 
differentiated rod photoreceptor cells showed immunocytochemical features 
and electrophysiological properties. Cell number of the patient-derived rod 
cells with distinct mutation underwent loss in vitro. We showed the cells de-
rived from patients expressed markers of oxidative stress and were rescued 
by vitamin E. In conclusion, RP9 patient-derived rod cells recapitulated the 
disease phenotype. Using patient-derived iPS cell technology, our results 
provide insights for elucidation of pathogenic mechanisms caused by RP9 
H137L mutation.
Poster Board Number: 3152
HUMAN EYE STROMAL CELLS AS NEW 
RESOURCES TO GENERATE HUMAN INDUCED 
PLURIPOTENT STEM CELLS (HIPSCS)
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Nadri, Samad2, Soudi, Sara2, Hashemi, Mahmood Masiha2, 
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Technologies, Tehran University of Medical Sciences, Tehran, Iran, Islamic 
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Research Center, Tehran, Iran, Islamic Republic of, 3Molecaular Biology 
and Genetic Engineering Department, Stem Cell Technology Research 
center, Tehran, Iran, Islamic Republic of, 4Faculty of Pharmacology, 
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of, 
5Hematology Department, Faculty of Medical Science, Tarbiat Modares 
University, Tehran, Iran, Islamic Republic of
The iPS cells have been seriously attended in last five years for therapeutic 
implications because of potentially surmounting of two important problems 
related to hES cells: 1) potency of immune rejection after transplantation, 2) 
ethical issues in terms of embryo destruction. Many investigations showed 
efficient establishment of iPS from different cells such as Fibroblast, stromal- 
and adult stem cells originated from different tissues. Here, we evaluate the 
possibility and efficiency of iPS derivation from human eye stromal cells. To 
end that, stromal segments of conjunctiva and trabecular meshwork biopsies 
were cultured and fibroblast-like stromal cells, which can be differenti-
ated toward the osteogenic, adipogenic, chondrogenic, and neurogenic 
lineages, were isolated. Then the Eye-derived stromal cells were directly 
reprogrammed by either constitutive or doxycycline inducible lentiviral 
systems overexpressing four (Oct4, Sox2, Klf4 and c-Myc) or three (Oct4, 
Sox2, Klf4) key transcription factors. After three weeks, ES-like colonies 
were picked up and subcultured on MEF cells and were analyzed by PCR for 
stemness markers, immunocytochemistry for ES markers such as Nanog, Tra-
1-60 and SSEA4, EB formation and Karyotyping. The pluripotency of ES-Like 
colonies was confirmed in vitro and in vivo by differentiation to all three 
germ layers lineages and teratoma formation in nude mice, respectively. In 
conclusion, we demonstrated that human eye-stromal cells, which can be 
obtained in ophthalmic surgery, can directly be reprogrammed to induced 
pluripotent stem cells like fibroblasts by either constitutive or inducible 
systems and interestingly the efficiency was the same (0.01%) as fibroblasts. 
As iPS derived from human eye-stromal cells may have maintained their ge-
nome imprinting, the cells may efficiently re-program to different cell types 
of eye tissue and provide unique resources for eye tissue regeneration.
Poster Board Number: 3154
COMBINED INFLUENCES OF MATRIGEL 
AND ELECTROSPUN PLGA NANOFIBROUS 
SCAFFOLDS ON DIFFERENTIATION OF 
PLURIPOTENT MOUSE EMBRYONIC STEM 
CELLS
Massumi, Mohammad1, Tarraf, Pania1, Babaloo, Hamideh1, Safi, 
Mojtaba1, Abasi, Mozhgan1, Divsalar, Adele2, Saeed, Mahdi3, Barzin, 
Jalal3
1Department of Animal and Marine Biotechnology, National Institute of 
Genetic Engineering and Biotechnology, Tehran, Iran, Islamic Republic of, 
2Department of Biological Sciences, Tarbiat Moallem University, Tehran, 
Iran, Islamic Republic of, 3Biomaterials Department, Iran Polymer and 
Petrochemical Institute, Tehran, Iran, Islamic Republic of
In this study, we analyzed the effect of a natural Extra Celluar Matrix, 
Matrigel, in combination with synthetic/biodegradable electrospun PLGA-
nanofibrous scaffolds on differentiation program of the stem cells. To end 
that, a GFP-expressing mouse embryonic stem (GFP-ES) cell line were 
generated by lentiviral gene transduction system and was used to study 
of all possible cell programming fats as well as monitoring of the attach-
ment, growth and behavior of the cells on the scaffolds. The GFP-ES cells 
were characterized by RT-PCR, and immunocytochemistry for pluripotency 
markers such as Oct4 and Nanog. The PLGA nanofibrous scaffolds were 
fabricated by different parameters and characterized by SEM, FTIR-ATR and 
Atomic Force Microscopy (AFM). Then, ES- differentiating cells were seeded 
on PLGA scaffolds and the Matrigel was added as On-top embedding. The 
transcriptome of the differentiated cells was analyzed for expression of early 
developmental markers for endoderm, mesoderm and ectoderm and their 
late derivates such as specific marker for neuron, cardiomyocyte, hepato-
cyte, endothelia, adipocyte, muscle etc. as well as germ and ES cell markers 
using quantitative RT-PCR for more than fifty tissue-specific transcription 
factor/marker. The attachment, infiltration and morphological changes were 
monitored by SEM and IF microscopy. In conclusion we found that combina-
tion of Matrigel with PLGA scaffolds decrease the endodermal cell lineages 
programming whereas it promotes significantly mesodermal and germ cell 
lineages programming. The pluripotency status of the cells was maintained 
more in Matrigel/ PLGA combination condition compared to the cells 
cultured on scaffolds alone. The ectodermal programming of ES cells was 
more influenced by the roughness and alignments of scaffolds mats than 
combination with Matrigel.
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REPROGRAMMING OF MOUSE AND HUMAN 
SOMATIC CELLS BY HIGH PERFORMANCE 
ENGINEERED FACTORS
Xu, Guoliang
Institute of Biochemistry and Cell Biology, Shanghai, China
Reprogramming somatic cells to induced pluripotent stem (iPS) cells by 
defined factors represents a major breakthrough in biology and medicine, 
yet remains inefficient and poorly understood at this stage. We therefore 
devised synthetic factors by fusing the VP16 transactivation domain to 
Oct4 (also known as Pou5f1), Nanog and Sox2 respectively. These synthetic 
factors could reprogram both mouse and human fibroblasts with enhanced 
efficiency and accelerated kinetics. Remarkably, Oct4-VP16 alone could re-
program mouse embryonic fibroblasts (MEFs) efficiently into germline-com-
petent iPS cells. Furthermore, episomally- delivered synthetic factors could 
generate integration-free iPS cells from MEFs reproducibly with enhanced 
efficiency. Our results not only demonstrate the feasibility of engineering 
more potent reprogramming factors, but also suggest that transcriptional 
reactivation of Oct4 target genes might be a rate-limiting step in the conver-
sion of somatic cells to pluripotent ones. Synthetic factor-based reprogram-
ming may lead to a paradigm shift in reprogramming research.
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EFFICIENT DERIVATION OF MOUSE INDUCED 
PLURIPOTENT STEM CELLS IN STIRRED 
SUSPENSION BIOREACTORS
Shafa, Mehdi, Krawetz, Roman, Day, Brad, Yamashita, Akihiro, 
Meng, Guoliang, Liu, Shying, Rancourt, Derrick E.
Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, 
Canada
The generation of induced pluripotent stem cells (iPSCs) is an inefficient 
process, which requires several weeks before a cell line is established. Here, 
we report that iPSCs can be generated more quickly and efficiently in stirred 
suspension bioreactors (SSBs). We have previously shown that SSBs provide 
a homogenous and dynamic environment, suitable for expanding mouse 
and human embryonic stem cells (ESCs). Our work suggests that SSBs 
favour the maintenance of pluripotency over differentiation. In this study, 
we examined whether SSB culture presents a selective advantage in iPSC 
derivation. We transduced mouse embryonic fibroblasts (MEFs) with retrovi-
ral vectors of the four reprogramming genes (Oct4, Sox2, klf4 and c-Myc). 
Two days after transferring to a 100mL SSB at 100RPM, the MEFs formed 
aggregates, which were morphologically similar to ESC aggregates. These 
bioreactor-derived iPSC (BiPSC) aggregates expressed alkaline phosphatase 
(ALP) only 5 days post-transfection, whereas ALP expression was totally 
absent in the control static culture condition. We observed the de novo ex-
pression of major pluripotency markers such as Oct4, Nanog, SSEA1, Rex1, 
Dax1 and E-Ras on day 10. We were able to expand the culture to more 
than 50 million cells in less than 10 days, which is an outstanding differ-
ence, compared to conventional static culture methods.We observed about 
2.5×105 ALP+ aggregates (i.e. iPSC colony equivalents) from an input of 
5×105 original fibroblasts, suggesting an efficiency of 50%. This number is 
substantiated by our observation that approximately 50% of the cells in the 
bioreactor were ALP+ on day 12. BiPSCs from day 12 were karyotypically 
normal and could spontaneously differentiate into all three germ layers both 
in vitro and in vivo. We have recently generated several high percentage 
chimeras using BiPSCs and are awaiting the results of germline transmission. 
Our results suggest that liquid shear stress plays an important mechanistic 
role in bioreactor induced pluripotency. When we examined the nuclear 
translocation of β-catenin in ESCs, using the TCF/LEF GFP reporter system, 
we observed that considerably more β-catenin resides in the nucleus of cells 
undergoing liquid shear stress. We suggest that suspension cultures provide 
a selective advantage in enhancing iPSC generation partly by inducing nu-
clear β-catenin activation. Our results show for the first time that fibroblasts 
can be efficiently reprogrammed in SSBs. Combined with new methods of 
reprogramming that only use epigenetic reprogramming factors, our BiPSC 
technology has the potential to accelerate and standardize iPSC research, 
bringing it to clinical application more quickly.
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ECTOPIC REPROGRAMMING FACTOR 
EXPRESSION AFFECTS THE EPIGENETIC 
STATUS OF THE IMPRINTED DLK1-DIO3 GENE 
CLUSTER IN MOUSE IPSCS
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Recent studies indicate that the epigenetic status of a single imprinted 
region, the Dlk1-Dio3 gene cluster, is sufficient to predict the developmental 
potential of induced pluripotent stem cells (iPSCs). For example, iPSC clones 
exhibiting epigenetic silencing of Gtl2, a member of the Dlk1-Dio3 cluster 
normally expressed from the maternally inherited allele, contribute poorly to 
chimeras and fail to produce viable mice through tetraploid complementa-
tion. To date, it has not been clear whether aberrant Gtl2 silencing in iPSCs 
results from the selection of a subset of previously mis-imprinted parental 
fibroblasts or occurs at some point during the reprogramming process. We 
have mapped the ontogeny of the epigenetic state of this locus, exemplified 
by the methylation state of CpG islands in the Gtl2 ‘intergenic differen-
tially methylated region’ (IG-DMR) in parental fibroblasts and in their iPSC 
progeny before vs after withdrawal of exogenous reprogramming factors 
(OKSM). Similar to tail tip fibroblasts (TTF) that exhibit ~50% methylation 
of the IG-DMR, in iPSCs reprogrammed with a single lentiviral copy of the 
STEMCCA-loxP vector, which combines all 4 factors in a single polycistronic 
transcript, we found 10 out of 10 TTF-derived iPSC clones (passage ~12-
16) to be normally methylated at this locus (40-50%) in the presence of 
continued over-expression of OKSM. Following Cre-mediated excision of 
STEMCCA-loxP, resulting in withdrawal of exogenous OKSM, the majority 
of iPSC clones maintained a normal ESC-like methylated IG-DMR state, and 
2 out 10 became aberrantly imprinted (hypermethylated). To further evalu-
ate the global molecular changes associated with withdrawal of exogenous 
OKSM, gene expression profiling was performed on these 10 iPSC clones 
both before and after STEMCCA-loxP vector excision. Hierarchical cluster-
ing and PCA analyses indicated that after removal of exogenous factors, 
the global gene expression program of all 10 iPSC clones clustered more 
closely to control ESCs. Remarkably, no significant differences (FDR-adjusted 
p<0.01) were found between iPSCs reprogrammed with three factors (OKS; 
5 clones) vs. four factors (OKSM; 5 clones). Our findings provide insights 
into the molecular events that occur during reprogramming and suggest that 
normal vs aberrant imprinting of the Dlk1-Dio3 domain in iPSCs occurs fol-
lowing the withdrawal of exogenous reprogramming factors.
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IMPLICATION OF INFLAMMATORY SIGNALING 
IN SOMATIC CELL REPROGRAMMING IN 
MOUSE
Sung, Hoon-Ki, Park, Jin Gyoon, Lotito, Vito, Tonge, Pete D., Knut, 
Woltjen, Wrana, Jeffrey L., Nagy, Andras
Samuel Lunenfeld Research Institute, Toronto, ON, Canada
Achievement of pluripotency through somatic cell reprogramming with de-
fined factors provides not only source of regenerative medicine but also tool 
to investigate the developmental cues for ontogeny of various cell types. 
Despite success of induced pluripotent stem cells (iPSCs) establishment, 
the molecular processes associated with somatic cell reprogramming are 
still poorly understood. Our laboratory has established iPSCs by combining 
piggyBac transposons for delivery of the reprogramming transgenes with 
the doxycycline inducible system. A unique feature of these iPSC lines is that 
their differentiated derivatives (2º MEFs) can be sent back to a pluripotent 
state in a population manner through reactivation of the reprogramming 
transgenes by administration of doxycycline. Transcriptome profiling during 
the three-week course of the reprogramming process revealed 1) mesen-
chymal to epithelial transition (MET) reflected by gradual down regulation 
of mesenchymal and up regulation of epithelial markers, and 2) a temporal 
increase in the expression of interferon (IFN) response genes. Here we pres-
ent evidence that IFN related inflammatory signaling is implicated in somatic 
cell reprogramming, and its pharmacological activation or inhibition result 
in enhanced or reduced colony formation, respectively. This study provides 
comprehensive data on the potential involvement of the inflammation-
response pathway driving reprogramming of somatic cells, broadening our 
understanding on molecular basis of pluripotency and development, and 
facilitating safe and personalized regenerative medicine.
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The nonobese diabetic (NOD) mouse strain has been widely used to inves-
tigate the pathology and genetic susceptibility for type 1-diabetes. Induced 
pluripotent stem cells (iPSCs) derived from this unique mouse strain would 
enable novel strategies for investigating T1D pathogenesis and potential 
therapeutic targets. The objective of this study was to determine if somatic 
fibroblasts from NOD mice could be reprogrammed to iPSCs. Adult tail-tip 
fibroblasts from male NOD mice were reprogrammed by retroviral transduc-
tion of the coding sequences of three transcription factors, OCT4, SOX2 
and KLF4, in combination with a histone deacetylase inhibitor, valproic acid 
(VPA). Three of the 18 NOD iPSC lines generated were characterized and 
exhibited silencing of the reprogramming transgenes and reactivation of 
endogenous pluripotent markers (OCT4, SOX2, NANOG, REX1 and SSEA1). 
The iPSCs readily differentiated in vitro to form embryoid bodies, and in 
vivo by teratoma formation in immuno-deficient mice. Moreover, the cells 
were successfully transfected with a reporter transgene, and were capable 
of contributing to the inner cell mass of recipient blastocysts, leading to the 
generation of a chimeric mouse. In conclusion adult tail-tip fibroblasts from 
NOD mice can be reprogrammed, without constitutive ectopic expression of 
transcription factors, to produce pluripotent iPSCs, which can be maintained 
and propagated under normal ESC culture conditions to produce genetically 
altered cell lines, differentiated cells and chimeric mice.
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The long-term goal of induced pluripotent stem (iPS) cell technology is to 
generate patient specific donor cells for transplantation, which can be ex-
panded and differentiated to multiple directions, and also genetically modi-
fied for gene therapy purposes. The scientific aim of this study is to further 
develop techniques for generation therapeutically safe iPS cells. For genera-
tion of iPS cells we used a novel polycistronic lentiviral gene delivery system 
to minimize the risk of insertional mutagenesis caused by multiple insertion 
sites. We also inserted a LoxP site in our expression construct to make the 
integrated transgenes removable from the genome. To test if our construct 
is able to reprogram embryonic fibroblast cells from different genetic back-
grounds we tested it on two inbred (C57BL/6 and C57BL/6xDBA/2J) and 
one outbred (CD1) mouse strain. The lentiviral delivery was optimized for 
low copy integration. The iPS cell lines were characterized by morphology, 
RT-PCR and immunostaining (IHC) for pluripotency markers, such as alkaline 
phosphatase, Pou5f1/Oct4, Nanog and SSEA-1. We differentiated the cells 
in vitro into cardiac and neural lineages. The number of viral integrations 
was determined by quantitative PCR. The reprogramming efficiency was 
approximately 0.01%. We found that the morphology of our iPS lines were 
very similar to normal embryonic stem (ES) cells and also the iPS cells ex-
pressed all examined pluripotency markers. The iPS clones after Cre-excision 
were able to differentiate into beating cardiomyocytes (70±10%) in vitro. 
Also, the reprogramming factor free clones differentiated to neural lineage, 
which was confirmed by IHC for neural progenitor cells (nestin) and for 
mature neural markers (βIII-tubulin). In both in vitro differentiation assays 
we found that the iPS clones before Cre-excision have weak differentiation 
ability, while after removing the reprogramming factors they were able to 
differentiate comparable to standard ES cells. The in vivo chimera-formation 
experiments from the reprogramming factor free cell lines are in progress. 
In conclusion, we have successfully derived iPS cells from different genetic 
backgrounds. After deletion of all reprogramming factors, the iPS lines main-
tained their pluripotency and showed characteristics more similar to normal 
ES cells than the iPS lines containing the transgenes. The generation of iPS 
cells with an excisable lentiviral construct represents a promising technology 
and their in vitro differentiation to different cell types provide a good oppor-
tunity for studies on cell replacement therapy and pharmacological testing.
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C-MYC PLAYS A CRUCIAL ROLE IN 
GENERATING FULL DEVELOPMENTAL 
POTENTIAL OF IPSCS
Hoki-Fujimori, Yuko, Araki, Ryoko, Jincho, Yuko, Uda, Masahiro, 
Nakamura, Miki, Ando, Shunsuke, Sunayama, Misato, Kasama, 
Yasuji, Abe, Masumi
Transcriptome Research Group, National Institute of Radiological Sciences, 
Chiba, Japan
iPSC was initially generated by the introduction of four transcription-
regulation factors, OSKC, into mouse embryonic fibroblasts with retrovirus 
gene transduction system, and dispensability of c-Myc for the generation 
was subsequently shown. Therefore, it has been believed that there is no 
significant differences between iPSCs generated using the 4 factors and the 
3 factors excluding c-Myc. Here we carefully investigated two types of iPSCs 
focusing on their differences. To exclude the effects of their genetic back-
grounds and of the possible aberrations caused by the integration of vectors 
we used genome integration-free iPSCs generated from an inbred strain, 
C57BL/6J. As reported, few significant differences were observed when 
we conducted molecular biological analyses on transcripts, DNA methyla-
tion state, genes products. Test for the teratoma formation also showed no 
difference between the two types of iPSCs. Subsequently, we conducted an 
aggregation test for evaluating their developmental abilities. Experiments us-
ing three of 4FiPSC clones and five of 3FiPSC clones revealed that although 
4FiPSCs developed to highly chimeric mice efficiently and showed frequent 
germline transmission, few 3FiPSCs could develop to highly chimeric mice, 
indicating that 4FiPSC clones have full developmental potential compared 
to 3FiPSC clones. Similar incompleteness was also observed in the 3FiPSCs 
generated by another procedure, with retrovirus gene transduction system, 
and by using another mouse, Nanog-TG mouse, that has been frequently 
used for iPSC studies thus far. Interestingly, even if highly chimeric mice 
were born from the embryos aggregated with 3FiPSCs, they died soon 
after their birth. In addition, we also found a difference in the implantation 
frequency of the aggregated blastocysts between the two types of iPSCs. 
Therefore, we directly investigated the aggregation steps using GFP-labeled 
iPSCs with time-lapse system and then revealed a defect in aggregation 
process of 3FiPSCs. The observation suggested that the molecular difference 
could be detected during in vitro blastocysts development. We therefore 
performed comprehensive analyses of these iPSCs for transcriptome and 
methylome. While no significant difference was shown in R-value between 
4F and 3FiPSC clones, several transcripts and CpG sites that exhibited dif-
ference between them, were identified. Currently we are investigating these 
transcripts and genetic regions.
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Somatic cell reprogramming have generated an enormous interest after 
the first report by Yamanaka and coworkers on the generation of induced 
pluripotent stem cells from mouse fibroblasts by expressing four defined 
transcription factors (Klf4, Oct4, Sox2 and c-Myc). To address the safety is-
sues arose from harboring integrated exogenous sequences in the target cell 
genome, a number of methods have been developed and produced iPSCs 
with potentially reduced risks. Here we report the generation of stable in-
duced pluripotent stem cells (iPSC) from mouse fibroblasts by treating them 
with purified proteins (Klf4, Oct4, Sox2 and c-Myc) carrying the GST tag for 
purification and the TAT-NLS polypeptide to facilitate membrane penetration 
and nuclear localization. We performed the reprogramming procedure on 
embryonic fibroblasts from two different genetic backgrounds: one inbred 
(C57BL/6xDBA/2J) and one outbred (ICR). The cells were treated four 
times with the purified proteins at an interval of 48 hrs between treatments. 
Following the treatment the cells were transferred onto mytomycin treated 
MEF and kept in complete medium until colonies formed. The reprogram-
ming was successful just for the fibroblasts from the outbred strain. The 
newly generated iPSC have similar morphology to the mouse embryonic 
stem cells (ESCs) they can be sustained undifferentiated for over 20 pas-
sages. The cells were checked for the typical pluripotency markers (Nanog, 
Oct4, Sox2, Klf4, cMyc, APS) by immunocytochemistry. The RT-PCR analysis 
confirmed endogenous gene expression of a number of pluripotency genes. 
To verify the developmental potential of the protein IPS cells we performed 
standard in vitro differentiation by embryoid body (EB) formation, and 
in vivo chimerism assays. The pIPS cells formed EBs in suspension and 
subsequently differentiated towards cardiac and neural lineages. The pIPSC 
differentiated into cardiomyocytes started to beat on day 6 of differentia-
tion. On day 7 almost all cardiomyocytes (more than 80%) were beating. 
These EBs were cardiac Troponin T and Troponin I (marker of contracting 
muscle) positive. The pIPS were also positive for Nestin (early neural marker) 
and Tuj1 (neuron specific class III beta Tubulin, mature neural marker). Ap-
proximately 40% of the cells seeded differentiated into neural precursor cells 
(NPC). Importantly the pIPS cells could incorporate into the blastocyst and 
led to high degree of chimerism in new born mice. These data show that 
the recombinant purified cell-penetrating proteins are capable to reprogram 
mouse embryonic fibroblasts to iPSC showing similar morphology and func-
tional behavior as the bona fide ESC.
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Cellular reprogramming is a promising approach to deriving specific neuronal 
populations lost due to disease or injury-related neurodegeneration. Unfor-
tunately, the full extent of genomic and epigenomic changes that occur dur-
ing the reprogramming process are poorly understood. Thus far, the capacity 
of mouse and human iPSC lines to differentiate into neurons has been highly 
variable, prompting the need for a reliable means of assessing the differen-
tiation capacity of newly derived cell lines. Extended passaging is emerging 
as a method of ensuring faithful reprogramming. We adapted an established 
and efficient embryonic stem cell (ESC) neuronal induction protocol to test 
whether iPSCs (1) have the competence to give rise to functional neurons 
with similar efficiency as ESCs and (2) whether the extent of neuronal dif-
ferentiation could be altered or enhanced by extended time in culture prior 
to differentiation. Our initial gene expression and morphological analyses 
revealed that neuronal conversion was temporally delayed in iPSC lines 
and some iPSC lines did not properly form embryoid bodies during the first 
stage of differentiation. Notably, these deficits were corrected by continual 
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passaging in an iPSC clone. Late-passage iPSCs expressed higher mRNA 
levels of pluripotency markers and formed larger embryoid bodies than the 
early-passage iPSCs. Moreover, late-passage iPSCs expressed neural marker 
genes several days in advance of early-passage iPSCs after the start of 
neural induction. Furthermore, late-passage iPSC-derived neurons exhibited 
notably greater excitability and more mature membrane properties than 
early-passage iPSC-derived neurons, although these cells were morphologi-
cally indistinguishable. These findings demonstrate that highly efficient 
neuronal conversion is critically dependent on the complete reprogramming 
of iPSCs via extensive passaging.
Poster Board Number: 3174
MOUSE DEFINITIVE NEURAL STEM CELLS 
GENERATION FROM PIGGYBAC TRANSPOSON 
INDUCED PLURIPOTENT STEM CELLS CAN BE 
ENHANCED BY INDUCTION OF THE NOTCH 
SIGNALING PATHWAY.
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INTRODUCTION: Despite advances in medical and surgical care, current 
clinical therapies for spinal cord injury (SCI) have limited effectiveness. Cell-
based therapies using neural stem cells (NSC) animal models of SCI have 
shown positive outcomes. Although, efforts are currently underway to trans-
late the use of NSC derived from embryonic stem (ES) cells for SCI, the clini-
cal application of these technologies have been limited by a number of po-
tential concerns. The discovery of induced pluripotent stem (iPS) cells holds 
the promise to revolutionize the field of regenerative medicine by addressing 
many of these caveats, including the host immune response to allogeneic 
cells and availability. However, in light of recent developments on the inher-
ent differences between ES and IPS cells, particular in terms of epigenetics, 
detailed characterization of the iPS-derived NSCs will be require before 
translation experiments can be performed. METHODS: Murine embryonic 
fibroblast are transfected with a piggyBac transposon plasmid contain all of 
the reprogramming factors (Oct4, Sox2, Klf4, c-myc). Following induction of 
pluripotency the reprogramming factors are seamlessly excised. The PB-iPS 
cells were clonally expanded along the default pathway of neutralization to 
generating NSCs initially with serum free media (SFM) containing LIF (primi-
tive NSC; pNSC) and followed by SFM with FGF (definitive NSC; dNSC). ES 
cells (R1) were used a control cell line for comparison. RESULTS: Primitive 
and definitive neursosphere were successfully generated using the default 
pathway condition with the iPS cell qualitatively similar to the ES cell. The 
iPS-derived dNSCs showed increases in neural specific marker (Pax6, Nestin, 
Olig2, Map2). However, the iPS-dNSC express significantly higher levels 
of pluripotency (Oct4, Nanog, lin28) and non-ectoderm lineages (Gata4, 
Gata6, Afp) genes compared to equivalent ES-dNSCs. Furthermore, in vitro 
differentiation of the ES-dNSC show a restricted neural fate, while only a 
subset of the differentiated iPS-dNSC stained for neural cell markers. The 
neuralization of the PB-iPS cells can be improved by reinforcing the default 
conditions. The addition of Noggin (a BMP antagonist) to the culture media 
significantly increase primary neurosphere generation in the iPS cell lines. 
Also, the induction of the NOTCH signaling pathway by Delta-like ligand 
4 (DLL4) improved the transition from primitive (LIF-dependant) NSCs the 
definitive (FGF-dependant) state. CONCLUSION: This study suggests that 
intrinsic differences between ES and iPS cell can affect their ability to acquire 
a dNSC fate. However by manipulating critical stages of the neuralization 
with recombinant proteins, the IPS cells can be forced to a restricted neural 
identity. Given the increasing recognition of key differences between ES and 
iPS cells, the development of methods that can overcome these differences 
will be required to realize the full potential of iPS cells.
Poster Board Number: 3176
DIFFERENTIATED RETT SYNDROME MOUSE 
INDUCED PLURIPOTENT STEM CELLS REVEAL 
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Induced pluripotent stem (iPS) cells hold great promise for studying central 
nervous system disorders in vitro, whereby neuronal differentiation of 
patient-specific iPS cells creates a limitless supply of defective neurons for 
disease study. Rett Syndrome (RTT) is a neurodevelopmental autism spec-
trum disorder primarily caused by mutations in the methyl CpG-binding pro-
tein 2 (MECP2) gene. Due to the inaccessibility of patient neurons, most of 
what is known about underlying RTT phenotypes has been described using 
mouse models. Here we describe the characterization and neuronal differen-
tiation of mouse RTT iPS cell lines. Wild-type and heterozygous iPS cell lines 
express endogenous pluripotency markers, reactivate the X-chromosome, 
and differentiate into the three germ layers. Directed differentiation of the 
lines produced neurons which formed functional synapses that generate 
action potentials and miniature excitatory postsynaptic currents (mEP-
SCs). Consistent with previous reports in MeCP2-null mouse brain slices, 
neurons derived from MeCP2-deficient iPS cells reproduce defects in the 
generation of evoked action potentials and mEPSC frequency. Further, they 
exhibit novel phenotypes when compared to wild-type iPS-derived neurons, 
specifically, diminished peak inward and outward currents, higher average 
input resistances, and more depolarized resting membrane potentials. Taken 
together, these results indicate that MeCP2-deficient iPS-derived neurons 
recapitulate previously described defects observed in MeCP2-null mouse 
neurons and exhibit novel immature neuron electrophysiology with minimal 
variability between lines. These newly identified phenotypes are consistent 
with the hypothesized role of MeCP2 in modulating neuronal maturity, and 
provide additional maturation deficiencies that reveal novel insight into RTT 
pathogenesis.
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NT AND PARTHENOGENESIS EMBRYO 
CHIMERA BECOMES A CRITERION FOR 
IDENTIFYING THE NATURE OF PIG INDUCED 
PLURIPOTENT STEM CELLS
Cheng, De, Li, Zhen, Gao, Xing, Wang, Huayan
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Without pig embryonic stem (ES) cells highly restricted the usage of pig as 
an ideal model in medical research and the production of transgenic animals. 
Reprogramming of somatic cells into iPS cells in vitro had been achieved 
through over expression of defined transcription factors in 2006. Then, pig 
iPS cells were established in 2009. However, pig iPS cells generated from 
the different labs have showed the different characteristics, and were not 
yet obtain the germline transmission chimera. In this study, we generated 
pig iPS cells by the retrovirus system using pMXs vectors containing mouse 
4F (Oct4\Sox2\KLF4\c-Myc). Four established cell lines can grow stably on 
MEF feeder in Knock-out DMEM with 15% FBS plus both LIF and bFGF at 
38.5°C, 5% CO2 atmosphere, and have been continually cultured for over 
30 passages without changing the karyotype. The morphology of isolated 
piPS cells is more like mouse ES cells rather than human ES cells. The piPSs 
express Oct4, Sox2, Nanog, TERT and ES cells specific markers (SSEA1, 
SSEA4, Tra-1-60 and Tra-1-81) and show the activity of alkaline phos-
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phatase (AP). Meanwhile, the ES cell specific signal receptors LIFR, bFGFR 
and SCFR were s also significantly reactivated. However, we found that the 
expression of 4 exogenous factors in these piPS cell lines were not silenced, 
similar to the results reported in the other labs. To evaluate the pluripotency 
of piPS cells, the nuclear transfer (NT) embryo and parthenogenesis embryo 
chimera were applied for the determination of developmental potential of 
pips cell lines. The result showed that the high expression of 4 exogenous 
factors could seriously block NT embryo development, which was mostly 
stopped in 4-8 cell stage, and barely to develop into blastocytes. We have 
injected 1-2 piPS cells (labeled with red fluorescent protein) into partheno-
genesis embryo to detect the chimeric potential of piPS. The results showed 
that piPS cell line with the normal karyotype and lower expression of exog-
enous factors could create the chimeric embryo.
Poster Board Number: 3180
EVALUATION OF REPROGRAMMING EVENTS 
IN A SINGLE PORCINE INDUCED PLURIPOTENT 
STEM CELL-LIKE LINE.
Hall, Vanessa J.1, Kristensen, Marianne1, Ujhelly, Olga2, Dinnyes, 
Andras2, Hyttel, Poul1
1Dept of Basic Animal & Veterinary Science Life, Copenhagen University, 
Fredriksberg C, Denmark, 2Biotalentum, Godollo, Hungary
Previous research in production of porcine induced pluripotent stem cells 
(piPSC) reveals that transgenes are unable to be appropriately silenced in 
this species. Despite this revelation, differentiation of piPSC can be achieved. 
This lack of transgene silencing is an interesting phenomena and should be 
further investigated. In this study, we closely analyzed both exogenous and 
endogenous gene expression of OCT4, NANOG, SOX2, KLF4 and cMYC in 
a putative porcine induced pluripotent stem cell line during extended in-vitro 
culture. An inducible expression system of piPSCs was produced by lentivirus 
transduction using the human reprogramming factors (OSMN*K) (*NANOG 
pseudogene P8) as obtained from Addgene. A single colony was isolated 7 
days following transduction and sub-cultured in KO-DMEM + 15% KSR, 1 
x NEAA, 1x pen/strep 0.1mM beta-mercaptoethanol, 20ng/ml human re-
combinant bFGF and either 1ug/ml doxycycline or 4ug/ml doxycycline. Cells 
were maintained on mitomycin c-treated mouse embryonic fibroblasts and 
mechanically passaged every 4-5 days. Colonies were isolated at Passage 5, 
10, 15 and 20 and RNA was isolated using the Qiagen RNeasy mini kit and 
cDNA amplified using the Quantitech whole transcriptome kit respective. 
Semi-quantitative RT-PCR was performed to analyze endogenous and ex-
ogenous gene expression of OCT4, NANOG, SOX2, KLF4 and cMYC using 
customized primer sets. Protein expression of OCT4, NANOG, SOX2, KLF4 
and cMYC was also analyzed by immunocytochemistry, in early passage 
cells. Results indicated that all transgenes could be detected with the excep-
tion of SOX2. Interestingly, protein expression revealed SOX2 was present 
at Passage 1 and 3. Endogenous SOX2 could also be detected in cells grown 
using 1ug/ml doxycycline, but not 4ug/ml doxycycline. Genomic PCR 
confirmed the lack of the human SOX2 transgene. The endogenous SOX2 
expression was inhibited when cultured in 4ug/ml doxycycline. In addition, 
endogenous gene expression did occur for NANOG KLF4 and cMYC, but 
was delayed until passage 10 in the high doxycycline cell cultures. Evalua-
tion of OCT4 endogenous expression was ambigious. We observed a single 
band of incorrect size in our piPSC-like cells, which when sequenced did not 
correspond to OCT4. This was not observed in our control tissues (porcine 
epiblast). This primer set is designed to amplify the stem-cell specific isoform 
OCT4A, and we wonder if unknown splicing may interfere in amplification 
of this gene. This piPSC-like line could not be maintained in an undifferenti-
ated state in the absence of doxycycline. Further this cell line could readily 
form embryoid bodies in-vitro, but only in the presence of doxycycline. 
Better quality and larger embryoid bodies formed in 4ug/ml doxycycline. 
In conclusion, endogenous expression of porcine NANOG, SOX2, KLF4 
and cMYC could not replace human transgenes and sustain proliferation 
in-vitro. Endogenous expression of porcine OCT4 was lacking and may be 
crucial for reprogramming. The level of doxycycline expression also appears 
to be important for in-vitro culture and reprogramming. Further molecular 
analyses are required in order to understand the reprogramming events oc-
curring in piPSC lines. This work was financed by EU FP7 grants (PartnErS, 
PIAP-GA-2008-218205 and PluriSyS, 223485).
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EXPRESSION OF A NON-VIRAL POLY-
PROMOTER VECTOR INDUCES PLURIPOTENCY 
IN QUIESCENT BOVINE CELLS UNDER 
CHEMICALLY DEFINED CONDITIONS
HUANG, BEN, Li, Tong, Alonso-Gonzalez, Lucia, Gorre, Ruben, 
Keatley, Sarah, Green, Andria, Turner, Pavla, Kumar, Prasanna, 
Verma, Vinod, Oback, Björn
Agresearch, Hamilton, New Zealand
Induced pluripotent stem cells (iPSCs), capable of giving rise to all cell types 
of an adult animal, are only available in mouse. Here, we report the first 
generation of bovine iPSC-like cells following transfection with a novel non-
viral poly-promoter vector. This vector contains the bovine cDNAs for OCT4, 
SOX2, KLF4 and c-MYC, each controlled by its own constitutive promoter. 
Following transfection, bovine fibroblasts were cultured without feeders in 
a chemically-defined medium containing leukaemia inhibitory factor and 
inhibitors of Erk 1/2 signalling (PD0325901) and glycogen synthase kinase-3 
(CHIR99021). Non-invasive real-time kinetic profiling revealed a differ-
ent response of bovine vs human and mouse cells to culture in PD/CHIR-
supplemented media. Only in bovine, PD/CHIR was necessary and sufficient 
to induce the appearance of tightly packed alkaline phosphatase-positive 
iPSC-like colonies. These colonies formed in the absence of DNA synthesis 
and did not expand in 2i/Lif after passaging. Non-proliferative primary 
colonies expressed discriminatory markers of ground state pluripotency, 
including endogenous iPS factors, NANOG, SALL4, DPPA3, telomerase 
activity, Tra-1-60/1-81 and SSEA-3/4, but not SSEA-1. This indicates that 
they had initiated a self-sustaining pluripotency programme. Bovine iPSC-
like cells maintained a normal karyotype and differentiated into derivatives 
of all three germ layers in vitro and in teratomas. Our study demonstrates 
that conversion into induced pluripotency can occur in quiescent cells, fol-
lowing a previously undescribed route of direct cell reprogramming. This 
identifies a major species-specific barrier for generating iPSCs and provides a 
chemically-defined screening platform for factors that maintain proliferation 
and pluripotency of embryo-derived pluripotent stem cells in livestock.
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SAFEGUARDING NONHUMAN PRIMATE IPS 
CELLS WITH SUICIDE GENES
Zhong, Bonan, Watts, Korashon L., Wohlfahrt, Martin E., Adair, 
Jennifer E., Enssle, Joerg, Kiem, Hans-Peter
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
The development of technology to generate induced pluripotent stem (iPS) 
cells constitutes one of the most exciting scientific breakthroughs because 
of the enormous potential for regenerative medicine. However, the safety of 
iPS cell-related products is a major concern for clinical translation. Insertional 
mutagenesis, possible oncogenic transformation of iPS cells or their deriva-
tives, or the contamination of differentiated iPS cells with undifferentiated 
cells, resulting in the formation of teratomas, have remained considerable 
obstacles. Here, we demonstrate the utility of suicide genes to safeguard iPS 
cells and their derivatives. We found suicide genes can control the cell fate 
of iPS cells in vitro and in vivo without interfering with their pluripotency 
and self-renewal capacity. This study will be useful to evaluate the safety 
of iPS cell technology in a clinically highly relevant, large animal model and 
further benefit the clinical use of human iPS cells.
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PRE-CLINICAL EVALUATION OF PLURIPOTENT/
MULTIPOTENT STEM CELL BASED THERAPIES 
IN NON HUMAN PRIMATES.
Hong, Sogun1, Winkler, Thomas1, Wu, Chuanfeng1, Donahue, 
Robert E.1, Metzger, Mark1, Kilts, Tina2, Kuznetsov, Sergei A.2, 
Robey, Pamela G.2, Dunbar, Cynthia E.1
1NIH/NHLBI, Bethesda, MD, USA, 2NIH/NIDCR, Bethesda, MD, USA
The transplantation of pluripotent and multipotent stem cells or their dif-
ferentiated derivatives is a promising treatment strategy for degenerative 
diseases as well as other diseases requiring tissue replacement. To date, all 
experimental data on the safety and efficacy of cells derived from hu-
man ES/iPS cells in vivo derivatives is necessarily limited to xenotransplant 
models, specifically immunocompromised mice. The profoundly immuno-
deficient xenotransplant setting does not reflect clinical reality, and there 
are numerous physiological differences between humans and mice that limit 
the predictive value of this model. Unlike many rodent based models, the 
rhesus macaque (Macaca mulatta) is developmentally and physiologically 
closely related to humans and therefore represents a highly desirable model 
develop clinical applications for ES/iPSCs. Our study focuses on the produc-
tion of bone from bone marrow mesenchymal stromal cells (BM-MSCs) 
and rhesus macaque induced pluripotent stem cells (rhiPSc) in vivo. Despite 
their clinical potential, the use of BM-MSCs is limited by their availability, 
restricted proliferation capacity and phenotypic heterogeneity. An alterna-
tive to BM-MSCs could be the use of autologous iPSc-derived MSCs. It has 
been shown that human BM-MSCs are able to form mature bone organs 
when injected along with a matrix consisting of hydroxyapatite/tricalcium 
phosphate (HA/TCP) particles in immunocompromised mice. In order to 
investigate if autologous and allogeneic rhesus BM-MSCs are also able to 
form bone structures in the rhesus macaque, we cultured marrow stromal 
cells derived from BM for 1-3 passages. Flow cytometric analysis demon-
strated positive staining for CD105, CD166, CD73, CD90 and CD44, but 
as expected, the cells were negative for CD45 and CD34. Autologous and 
allogeneic BM-MSCs were incubated with 40 mg of HA/TCP particles for 90 
minutes at 37C and transplanted into recipient animals subcutaneously. Af-
ter 8-16 weeks, the organoids were harvested and histologically analyzed for 
signs of bone formation. Viable bone was observed within the autologous 
but not the allogeneic implants. To produce rhesus iPSCs, adult BM-MSCs 
were isolated, passaged four times and transduced with retroviral vectors 
carrying species-specific reprogramming transcription factors OCT4, SOX2, 
KLF4 and C-MYC. On Day 4, cells were plated onto mouse embryonic 
fibroblast feeder layers (mEFs) and cultured in ESC culture medium under 
5% oxygen (KO-DMEM supplemented with 20% ES-defined FBS, 1% 
nonessential amino acids, 2 mM L-glutamine, 0.1 mM β-mercaptoethanol 
and 20 ng/ml bFGF). ES-like colonies were picked approximately 21 days 
after transduction and expanded for further characterization. Generated 
rhiPSc lines morphologically resembled rhesus ES-cells (ORMES-22), stained 
positive for alkaline phosphatase, expressed endogenous pluripotency 
markers (Oct-4, Nanog, SSEA4, Tra1-60), and silenced viral reprogramming 
factors. Furthermore, rhiPSc spontaneously differentiated into derivatives of 
the three embryonic germ layers in vitro, and formed tumors in NSG mice. 
We differentiated the rhiPSc in the presence of bFGF, PDGF and EGF toward 
mesenchymal lineages. Similar to BM-MSCs, the derived cells stained posi-
tive for the surface markers CD105, CD166, CD73 and CD90 and negative 
for CD45 and CD34. Further in vitro characterizations as well as in vivo 
studies are ongoing and results will be discussed in the presentation.
Poster Board Number: 3188
GENERATION OF GERMLINE COMPETENT RAT 
INDUCED PLURIPOTENT STEM CELLS
Hamanaka, Sanae1, Yamaguchi, Tomoyuki1, Kobayashi, Toshihiro1, 
Kto-Itoh, Megumi1, Yamasaki, Satoshi1, Hirabayashi, Masumi2, 
Nakauchi, Hiromitsu3
1Nakauchi Stem Cell and Organ Regeneration Project, Japan Science and 
Technology Agent, ERATO, Minato-ku, Tokyo, Japan, 2Center for Genetic 
Analysis of Behavior, National Institute for Physiological Sciences, Okazaki, 
Aichi, Japan, 3Division of Stem Cell Therapy, Center for Stem Cell Biology 
and Regenerative Medicine, Institute of Medical Science, University of 
Tokyo, Minato-ku, Tokyo, Japan
Recent report showed that rat ES cells (rESCs) were established under the 
condition of using two or three kinds of kinase inhibitors including GSK3 
inhibitor, MEK inhibitor and FGF receptor tyrosine kinase inhibitor in the 
culture medium and these rESCs possess an ability of generating chimeric 
rats and germline transmission. Soon after this report, establishment of rat 
induced pluripotent stem cells (riPSCs) that could contribute to chimera 
formation was reported. However, germline competency of riPSCs has not 
yet been reported. Here, we report for the first time, a successful genera-
tion of germline competent riPSCs and these riPSCs were able to generate 
interspecific germline chimera. Rat embryonic fibroblast cells (REFs) were 
infected with a lentiviral vector carrying mouse reprogramming factors 
(Oct4, Klf4 and Sox2) under tetracycline regulatory element and Ubc pro-
moter driven EGFP as a marker. Infected REFs were seeded on mitomycin-C 
treated mouse embryonic fibroblasts (MEFs) and medium was changed to 
serum free medium (N2B27/F12) containing Dox and rLIF. MEK inhibitor 
(PD0325901) and GSK3 inhibitor (CHIR99025) (2i) or 2i and FGF receptor 
inhibitor (SU5409) (3i) were added to medium on day7. EGFP expressing 
mouse ES cell-like colonies appeared from day10 and independent colonies 
were picked. Picked riPSCs were expressing pluripotent marker genes at 
quantities comparable to those in rESCs and their ability to differentiate 
into three germ layers was confirmed by teratoma formation. To generate 
chimeric rats, we injected riPSCs into blastocysts from Wister (WI) rats and 
determined the formation of chimera by expression of EGFP in embryos or 
neonates. As a result, we obtained 11 chimeras (61 %) from riPSCs T1-3 
(WI) and 7 chimeras (54 %) from riPSCs T3-11(WI) respectively. To address 
whether these riPSCs possess the ability of germiline transmission, gener-
ated male chimeraic rats were mated with wild type female WI/WI rats. 
We obtained three embryos (E15.5) and eight pups which express EGFP 
from three chimeric rats derived from riPSCs T1-3 or T3-11. Furthermore, 
we generated rat-mouse interspecific chimera and analyzed the expres-
sion of EGFP in embryonic fibroblasts. As a result, embryos derived from 16 
out of 17 riPSCs clones had EGFP positive fibroblasts indicating that most 
riPSCs clones possess the ability to form interspecific chimera. Furthermore 
we analyzed to see whether riPSCs (T1-3) possess an ability to generate 
interspecific germline chimera by immunostaining of testis from mouse-rat 
interspecific chimera with antibody against mouse versa homolog (MVH) 
and the result showed that EGFP and MVH double positive germ cells were 
found in testis. These data provide conclusive evidence that rat embryonic 
fibroblasts can be reprogrammed into ground state pluripotent stem cells by 
three mouse reprogramming factors (Oct4, Klf4 and Sox2) and these riPSCs 
can differentiate into germ cells even in xenogenic mouse environment.
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GENERATION OF CANINE IPS CELLS AND 
THEIR CHARACTERISTICS
Kazuo, Hayakawa
Department of Cell Growth and Differentiation, Center for iPS Cell 
Research and Application, Kyoto University, Kyoto, Japan
For the clinical application of induced pluripotent stem cells (iPSCs) to regen-
erative medicine, there are many issues to be overcome. One of them is to 
establish appropriate non-rodent animal models for preclinical experiments, 
in which the efficacy and the safety of the iPSCs-based treatments can be 
monitored. For this purpose, dog is a suitable animal because of its long life 
and anatomical and physiological similarities with human. In addition, dog 
and human share some pathological conditions with identical genetic cause 
such as muscular dystrophy. We are currently working on the generation of 
canine iPSCs from somatic cells to take those advantages. As the cell source 
for generating iPSCs, embryonic fibroblasts were used. We have cloned ca-
nine Yamanaka’s factors and other reprogramming factors, and constructed 
retroviral vectors expressing each factor. These factors were introduced 
canine embryonic fibroblasts, which demonstrated iPSC-like colonies after 
two to three weeks. We have attempted a series of culture conditions, and 
finally established an appropriate one for maintaining iPSC-like morphology 
of clones. Gene expression profiles of each clone showed clonal differences, 
but were basically similar to those of human and mice pluripotent stem cells. 
Characterization of each clone in terms of its differentiation property in vivo 
and in vitro is currently ongoing.
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INVESTIGATION OF OPTIMIZED CONDITIONS 
FOR RNA BASED CELLULAR REPROGRAMMING
Shimada, Hidenori1, Hashimoto, Yoshiya2, Nakada, Akira1, Shigeno, 
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Induced pluripotent stem (iPS) cells have been generated from somatic cells 
by forced ectopic expression of a set of pluripotency-associated transcription 
factors. They can grow indefinitely while maintaining pluripotency and dif-
ferentiate into all three germ layers except for extra-embryonic tissues. This 
technology opened new ways to use individual-specific stem cells for regen-
erative medicine, avoiding ethical issues and immune rejections that human 
embryonic stem (ES) cells face. In terms of clinical application, generation of 
iPS cells using non-integrating methods which avoid the risk of insertional 
mutagenesis or genome modification are essential for therapeutic purposes. 
RNA-based cellular reprogramming is one of the most promising strategies 
to generate safe iPS cells, but cytosolic delivery of non-self RNAs coding 
for reprogramming factors induces innate antiviral responses with the rapid 
production of a range of cytotoxic cytokines such as interferons, resulting 
apoptosis of transfected cells. Here we investigated methodologies to opti-
mize protocols to generate iPS cells with RNA-based cellular reprogramming, 
minimizing activation of cytoplasmic RNA sensors. We started with human 
adipose-derived stromal cells (ADS) cells and transfected in vitro transcribed 
RNAs coding for Yamanaka factors (Oct3/4, Sox2, Klf4, and c-Myc) into 
ADS cells using nucleofection. In order to minimize activation of cytoplasmic 
RNA sensors and maximize translation efficiency, reprogramming RNAs were 
synthesized with modified nucleotides, capped with Anti-Reverse Cap Ana-
log (ARCA) at the 5’ end, and polyadenylated at the 3’ end. Silencing of cy-
toplasmic RNA sensors with small interfering RNAs (siRNAs) was employed 
as adjuvants to suppress residual antiviral activity. We shall report progress 
of our research, mainly focusing on assay results. Our current progress will 
provide insight on the development of RNA-based cellular reprogramming 
and facilitate to establish safe iPS cells for clinical applications in regenerative 
medicine.
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LIN28 ACCELERATES THE GROWTH OF 
REPROGRAMMING CELLS DURING IPS CELL 
INDUCTION
Tanabe, Koji, Okada, Aki, Narita, Megumi, Ichisaka, Tomoko, 
Ohnuki, Mari, Takahashi, Kazutoshi, Yamanaka, Shinya
Center for IPS Cell Research & Application (CiRA) Kyoto University, Kyoto, 
Japan
Human induced pluripotent stem cells (iPSC) were established with OCT3/4, 
SOX2, KLF4, C-MYC (OSKM) or OCT3/4, SOX2, NANOG, LIN28 (OSNL). 
We found that OSKML generated 2~10 fold more iPS cell colonies than 
OSKM. LIN28 has 2 RNA binding domains, cold shock protein domain 
(CSD) and zinc finger protein domain (Zinc). Several reports indicated LIN28 
regulated the stability of micro RNA through these domains. We made CSD 
or ZINC deletion mutants LIN28 and induced iPSC by introducing OSKM 
with those mutants. CSD deletion mutant increased the efficiency of iPSC 
induction. However, Zinc deletion mutant did not. These data suggested 
that LIN28 regulated the micro RNA through ZINC to increase the efficiency 
of iPSC induction. Moreover we focused on another phenomenon. The size 
of iPSC colonies made with OSKML was bigger than OSKM. There were 
2 possibilities. One of them was that LIN28 brought forward the timing of 
generating iPSC. Another possibility was that LIN28 accelerated the growth 
of reprogramming cells. We carried out time laps imaging during iPS induc-
tion to test these possibility. The timing of arising iPSC colonies was not 
different between OSKML and OSKM. However growth of iPSC colonies 
with OSKML was faster than with OSKM. These data indicated that LIN28 
accelerated the growth of reprogramming cells to increase the efficiency of 
iPSC induction. We are studying about the function of LIN28 during iPSC 
induction in detail.
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SIRTUIN 1 IS INVOLVED IN THE GENERATION 
OF INDUCED PLURIPOTENT STEM CELLS
Lee, Yin Lau1, Fong, Sze-Wan1, Peng, Qian1, Lee, Kai-Fai1, Nagy, 
Andras2, Ng, Ernest H.Y.1, Yeung, William S.B.1
1University of Hong Kong, Hong Kong, China, 2Samuel Lunenfeld Research 
Institute, Toronto, ON, Canada
Somatic cells can be reprogrammed into induced pluripotent stem cells 
(iPSC) by forced-expression of 4 transcription factors. Recent studies show 
that the reprogramming efficiency can be improved by inclusion of small 
molecules that modulate epigenetic enzyme activities. We report here that 
sirtuin 1 (SIRT1), a member of the sirtuin family of NAD+-dependent protein 
deacetylases, is involved in iPSC formation. Our data indicated that Sirt1 
protein levels in human and mouse embryonic stem cells (ESCs) decreased 
upon differentiation, while that of mouse fibroblasts increased during 
reprogramming. By using an efficient mouse fibroblasts reprogramming 
system using doxycycline (DOX) inducible Yamanaka’s transcription factors 
delivered by piggyBac (PB) transposition, we further showed that Sirt1 was 
involved in reprogramming. Suppression of Sirt1 level decreased the effi-
ciency of iPSC formation and increased the level of acetylated p53, a known 
substrate of Sirt1, during reprogramming. Conversely, resveratrol (RSV), an 
activator of Sirt1, increased the efficiency of iPSC formation. Consistently, 
the stimulatory activity of RSV on Sirt1 was associated with a reduction of 
acetylated p53. Furthermore, RSV and Sirt1 siRNA were applied at different 
periods during reprogramming. They were most effective in influencing the 
number of iPSC colonies formation in the initiation phase of reprogramming. 
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The results in this study provide support on the possible use of epigenetic 
regulatory molecules in improving the efficiency of iPSC production.
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BUTYLIDENEPHTHALIDE MAINTAINED THE 
PLURIPOTENCY OF INDUCED PLURIPOTENT 
STEM CELLS BY ACTIVATING JAK/STAT3 
PATHWAY
Liu, Shih-Ping1, Chien, Ying-Jiun2, Hsu, Chien-Yu2, Fu, Ru-Huei3, 
Harn, Horng-Jyh4, Huang, Yu-Chuen5, Chen, Shih-Yin5, Lin, Shinn-
Zong6, Shyu, Woei-Cherng6
1Center for Neuropsychiatry, Graduate Institute of Basic Medical Science, 
China Medical University and Hospital, Taichung, Taiwan, 2Graduate 
Institute of Basic Medical Science, China Medical University, Taichung, 
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Induced pluripotent stem (iPS) cells were generated from somatic cells via 
introducing of four transcriptional factors: Oct4, Sox2, c-Myc and Klf4 by 
virus system in 2006. Although there were many ways to generate iPS cells, 
low efficiency was still a big hurdle need to overcome. In addition, as same 
as embryonic stem (ES) cells, iPS cells need to maintain the pluripotency 
by treating with leukemia induced factor (LIF), an expansive reagent. The 
aim of this study was to find the pure compound extracted from traditional 
Chinese medicine that not only could maintain the pluripotency in the ES 
cells and iPS cells, but also could increase the efficiency of iPS cells genera-
tion in the future. In this study, we showed that the gene expression levels 
of Oct4 and Sox2 in MEF cells up-regulated after treated with 10ug/ml 
N-Butylidenephthalide (BP), the extract from Angelica sinensis. Interesting, 
this effect was lower when the concentration higher (20ug/ml and 40ug/
ml). We used the MTT assay to test whether these concentrations made 
the cell apoptosis and this data shown not. We also used iPS cells treated 
with different concentration of BP (replaced LIF in the culture medium) to 
test whether it was useful to maintain the pluripotency of iPS cells. The data 
showed that the expression levels of several stem cell markers in BP-treated 
iPS cells higher than LIF-out control, including alkaline phosphatase, SSEA1 
and Nanog. This data determined that BP could maintain the pluripotency 
of iPS cells. In addition, we used the microarray analysis to find the major BP 
regulatory pathway. Microarray analysis showed that the top three deregu-
lated pathway were PPAR, ECM and Jak-STAT pathway. We determined that 
phospholation-JAK2 and phospholation-STAT3 protein level was increase 
after BP treatment. In conclusion, our data demonstrated that BP could 
maintain the pluripotency of iPS cells though the Jak-STAT pathway. BP will 
become a health food to activate the stem cells. It is also useful to increase 
the efficiency to generate the novel iPS cells in the future.
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POTENTIAL ROLE OF TCL1A IN THE 
PLURIPOTENT REPROGRAMMING OF 
FIBROBLASTS
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Induced pluripotent stem cells (iPS) derivation is an inefficient process and 
the reprogramming mechanisms are largely unknown. The main reason of 
the difficulty is that iPS phenomenon may occur in a stochastic manner. As 
iPS might be similar to embryonic stem cells (ESC) and offer novel therapeu-
tic strategy to generate patient-specific stem cell lines, it would be important 
to elucidate the mechanisms and to improve the efficiency. With this in 
mind, the aim of this study was to analyze the global expression profile of 
TSM, a reprogrammed human fibroblast generated with forced expression 
of TCL1A, SOX2 and C-MYC, and to compare with the donor fibroblast 
cell line and with ESCs in order to identify genes that could modulate the 
reprogramming process. Moreover, we established cell lines with overex-
pression of TCL1A individually in order to find out its contribution to the 
reprogramming process, as this transcription factor had never been used for 
reprogramming before. We used a microarray platform composed by 44,000 
human genes to perform the gene expression profile. We further validated 
some gene transcripts levels by quantitative PCR (qPCR). First, we inves-
tigated if the fibroblast specific genes were correctly silenced in the TSM 
cells, since this is the first step in the reprogramming process. To illustrate 
the change toward an embryonic stem-like transcriptome, using bioinfor-
matic tools we selected a group of fibroblast signature genes and analyzed 
their microarray expression in the TSM cells. The results showed that the 
introduction of TCL1A, C-MYC and SOX2 into the TSM cells successfully 
silenced the fibroblast specific genes. THY1 and PLAU genes, which are 
markers of fibroblast lineage, were down-regulated in TSM cells compare to 
the donor fibroblast. Then, we examined genes involved with the mesen-
chymal-epithelial transition (MET), since this process had been suggested to 
be critical in the initial of mouse iPS derivation. We searched for 44 genes 
in the microarray libraries and found that these genes had been modulated 
after the induction and have a similar pattern of expression to the ESCs. 
We identified that important epithelial markers were activated in the TSM 
cells, including CDH1. Moreover, COL1A2 and CDH2, which are mesenchy-
mal markers, were downregulated in the TSM cells. We also detected that 
SNAI1, TWIST1, and TGFB1, that are inhibitors of MET, were downmodu-
lated in TSM cells. We next investigated if the pluripotent genes had been 
properly activated in TSM cells. We identified a core of pluripotent genes 
that had low expression levels compared to ESCs, such as POU5F1, NANOG 
and GDF3, indicating that they had not been correctly turned on. The qPCR 
results were in agreement with the microarray data. Finally, we analyzed the 
individual contribution of TCL1A, for which we expressed this gene in the fi-
broblast and compared with the donor cell and with ESCs. Intriguingly, qPCR 
analysis revealed that TCL1A alone was able to induce OCT4, LIN28, CDH1 
and MMP9 mRNA expression and also to downregulate the MET repres-
sors SNAI1, TWIST1 and TGFB1. In summary, the analysis revealed that the 
TSM cells presented an intermediary profile between the donor fibroblast 
and the ESCs, but the pattern of gene expression seems to move toward the 
embryonic-state. Moreover, TCL1A may contribute to the initial steps of hu-
man reprogramming through downmodulation of MET repressors.
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INDUCED PLURIPOTENT STEM CELLS DERIVED 
FROM TWO MESODERM CELL LINEAGES 
IMPART DIFFERENT EFFICIENCIES OF 
HEMATOPOIETIC STEM/PROGENITOR CELL 
GENERATION
Moraghebi, Roksana1, Rönn, Roger1, Parker, Aaron2, Lutz, 
Margaret3, Berggren, Travis3, Woods, Niels-Bjarne1
1Molecular Medicine and Gene Therapy, Lund University, Lund, Sweden, 
2Laboratory of Genetics, Salk Institute for Biological Studies, San Diego, CA, 
USA, 3Stem Cell Core, Salk Institute for Biological Studies, San Diego, CA, 
USA
The ability to generate hematopoietic stem cells (HSC’s) from patient derived 
induced pluripotent stem (iPS) cells, would enable the generation of an 
unlimited supply of HLA matched transplantable cells for the treatment of 
hematological disorders and malignancies. It has been proposed that the 
cellular starting material used to generate novel iPS cell lines imparts an 
epigenetic memory which in turn influences the differentiation capacity and 
efficiency of the iPS cells towards certain developmental lineages. Because 
the hematopoietic system is derived from the mesoderm germ layer during 
development, we decided to test the efficiency of blood cell generation from 
iPS cell lines derived from two human neonatal cell types with mesodermal 
origin; umbilical cord blood derived endothelial cells and amniotic fluid 
derived mesenchymal stem cells. With the ultimate goal of determining 
novel regulatory genes that can help direct ES/iPS cell differentiation to-
wards blood lineages, we generated multiple iPS cell lines from the two cell 
sources, and evaluated the blood cell lineage differentiation capacity of the 
iPS lines using our state-of-the-art ES/iPS-to-blood differentiation protocol. 
Our optimized blood differentiation protocol allows for the generation of 
comparable numbers of hematopoietic progenitors from numerous iPS lines 
to those found in umbilical cord blood mononuclear cells isolates. From 
the 8 cord blood derived iPS lines we tested, the efficiency of hematopoi-
etic cell generation ranged from 9.8 to 65.8% CD45+ hematopoietic 
cells (mean=34.6+/- 21.2% of which 5.8+/- 4% were CD45+CD34+ 
hematopoietic progenitors), while from the 9 amniotic fluid derived iPS 
lines, the efficiency ranged from 1.6 to 26.3% CD45+ hematopoietic cells 
(mean=14.2+/- 9% of which 2.9+/- 1.9% were CD45+CD34+ hematopoi-
etic progenitors). The difference in the efficiency of hematopoietic cell 
generation between the cord blood and amniotic fluid derived iPS lines sug-
gests that iPS reprogramming to a pluripotent state is not complete and that 
significant gene expression differences exist between the lines. Moreover, 
these differences can be determined and then exploited for more efficient 
blood cell production. To address these issues further investigation into the 
gene expression and epigenetic status of these lines is being performed.
Poster Board Number: 3204
PURIFIED MESENCHYMAL STEM CELLS ARE 
AN EFFICIENT CELL SOURCE FOR IPS CELLS 
INDUCTION
Niibe, Kunimichi1, Kawamura, Yoshimi2, Morikawa, Satoru1, 
Mabuchi, Yo2, Araki, Daisuke1, Nakagawa, Taneaki1, Okano, 
Hideyuki2, Matsuzaki, Yumi2
1Dentistry & Oral Surgery, Keio University, Tokyo, Japan, 2Physiology, Keio 
University, Tokyo, Japan
Purpose: The iPS cell is ES like versatile cell induced by introducing several 
kinds of genes into somatic cells. It has been gained attention as a new 
cell source in the field of regenerative medicine. However, the induction 
efficiency was very low, and it is uncertain that which cell type should be 
responsible for the iPS cells induction. In addition, it has been known that it 
was difficult to produce germ-line competent iPS cells from adult tisuue. The 
purpose of this study is, therefore, to establish a higher quality of iPS cell 
from adult tissue. The cell source for the iPS induction is mainly fibroblast 
that represents heterogeneous population. Therefore, we assumed a possi-
bility that only a very small amount of stem cell included in mixed popula-
tion acquired the pluripotency by the gene introduction. Then we hypoth-
esized that reprogramming efficiency of the stem cell is quicker than that of 
the differentiating cells. In this project, we performed comparative study of 
the induction efficiency by using adult mouse tail tip fibroblast (TTF), Os-
teoblast (OB) and high purity mesenchymal stem cells (MSCs). Method: We 
isolated enriched fraction of MSCs (PαS: CD45-/Ter119-/PDGFRa+/ Sca-1+ 
fraction) based on the specific cell surface markers expression by flowcy-
tomery from Nanog-EGFP-IRES-Puror mouse. PαS represents 120,000 fold 
enriched fraction of MSCs compared with the conventional adhesion culture 
separation. The three or four Yamanaka factors were induced into PαS cells. 
We examined the introduction efficiency and the quality by comparing the 
numbers of colony formation and the gene expression, etc. Result: Compare 
to OB and TTF, the numbers of PαS derived iPS colonies were significantly 
increased. When five GFP+ colonies were picked from each cell sources ran-
domly and analyzed with RT-PCR, all PαS-iPS clones expressed most ES cell 
marker genes. Silencing of the transgene was also observed with all PαS-iPS 
clones. DNA microarray analyses confirmed that PαS-iPS cells had ES cell like 
gene expressions. Compare to OB and TTF, PαS cells improved reprogram-
ming efficiency and iPS quality. Moreover, iPS cells from PαS cells generated 
similar ratio of germ-line chimera as from ES. Germline-competent iPS cells 
express spermatogenesis related genes from DNA microarray analysis.
Poster Board Number: 3206
TRANSPOSON BASED SCREEN TO IDENTIFY 
OCT4 REPLACEMENTS IN REPROGRAMMING
Ooi, Jolene1, Wang, Wei1, Liu, Hui1, Jenkins, Nancy A.2, Copeland, 
Neal G.2, Liu, Pentao1
1Wellcome Trust Sanger Institute, Cambridge, United Kingdom, 2Institute of 
Molecular and Cell Biology, Singapore, Singapore
Reprogramming of somatic cells to iPSCs involves the over-expression of 
four transcription factors, Oct4, c-Myc, Klf4 and Sox2. Although this phe-
nomenon has been demonstrated to be reproducible in a spectrum of cell 
types and animal species, we are only beginning to elucidate the molecular 
mechanisms of this dedifferentiation process. Molecular pathways involved 
in chromatin remodelling and mesenchymal-to-epithelial transition have 
been suggested to play significant roles. Genetic analyses have revealed 
factors replacing or enhancing the initial defined set of four genes. Comple-
mentary to this, chemicals which are able to promote reprogramming have 
also been discovered. These pieces of information enable us take a mecha-
nistic peek at the reprogramming process and provide clues to decipher the 
pathways behind the plasticity of cellular pluripotency. To identify additional 
factors, we plan to perform a genetic screen in mouse fibroblast cells to 
replace the function of Oct4 in the reprogramming process. We expect to 
uncover factors that could be (i) direct upstream regulators of Oct4, (ii) main 
downstream targets of Oct4 and (iii) participants of alternative pathways 
regulating gene targets of Oct4. These gene targets may shed light on the 
intricacies behind the molecular circuitry involving Oct4 and perhaps un-
cover novel pathways in the maintenance of pluripotency, hence deepening 
our understanding of the reprogramming process.
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ADIPOGENIC DIFFERENTIATION 
AND EXPRESSION OF INTEGRINS IN 
REPROGRAMMED NIH3T3 CELLS
Rohani, Leili1, Keyhani, Sarva2, Talaie, Tahereh1, Mostafavipour, 
Zohreh2
1Anatomy, Shiraz University of Medical Sciences, Shiraz, Iran, Islamic 
Republic of, 2Biochemistry, Shiraz University of Medical Sciences, Shiraz, 
Iran, Islamic Republic of
Introduction: Dedifferentiation of adult somatic cells into multipotent cells 
may provide an attractive source of stem cells for regenerative medicine. 
Interaction between the matrix proteins and integrin adjust many cells’ func-
tion such as adhesion, migration, cell cycle and self renewal in stem cells. In 
the present study, NIH3T3 cells were de-differentiated by mouse embryonic 
stem cell (mESC) extract. The expression of pluripotency markers as well as 
α2, α5 and α6 integrin subunits were determined in reprogrammed NIH3T3 
cells. Adipogenic differentiation was performed to determine the potency 
of reprogrammed NIH3T3 cells. Material & methods: NIH3T3 cells were 
cultured in DMEM medium and permeabilized with streptolycin O, then 
exposed to embryonic stem cell extract. To prepare the extract, mESCs were 
treated with lysis buffer containing protease inhibitor. After permeabilization, 
the reprogrammed cells were cultured on inactivated feeders and were pas-
saged every 2 days until 10 days. To check the ESC markers, enzyme assay, 
immunocytochemistry and RT-PCR were assessed by Alkalin phosphatase 
kit, Sox2 and Nanog antibodies, and Oct3/4 primer respectively. To assess 
the expression of integrins in reprogrammed cells, RT-PCR techniques 
was done for α2, α5 and α6 primers. The adipogenic differentiation was 
performed to determine the potency of reprogrammed NIH3T3 cells. Cell 
aggregates from the third passage were removed and cultured in adipogenic 
medium for 12 days, then were stained with Oil red. Results: NIH3T3 cells 
treated with mESC extracts showed noticeable changes in cell morphology 
as early as day 2 post-treatment forming colonies similar to typical mESC 
morphology by day 8, after three passages. The results of Alkaline phos-
phatase assay and immunocytochemistry staining indicated that these colo-
nies showed the alkaline phosphatase activity and they expressed Sox2 and 
Nanog antibodies. RT-PCR revealed that the colonies also express Oct3/4. 
NIH3T3 cells, ESCs and reprogrammed cells expressed α2 integrin. α5 integ-
rin expression was greatest in reprogrammed cells followed by the expres-
sion of this integrin in NIH3T3 which in turn was more than in ESCs. α6A 
integrin was expressed in NIH3T3 cells while α6B integrin was expressed in 
ESCs and in very low quantity was expressed in reprogrammed cells. The 
reprogrammed NIH3T3-derived EB like structures were differentiated into 
adipocytes by culturing in appropriate induction media. The intercellular lipid 
vacuoles and adipose droplet were stained with oil red. Concusion: These 
data provide evidence for the generation of ES like cells from differentiated 
somatic cells by mESC extract also expression profile of integrins after de-
differentiation by ESC extract. Cytoplasmic lipid accumulation and the ex-
pression of oil red show the potency of reprogrammed NIH3T3 into different 
cell types. Our observations demonstrating that mESC protein extracts can 
reprogram somatic cells toward multipotency would argue that multipotent 
epigenome could be activated in somatic cells without fusion and forced 
expression of nucleic acids.
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AN INDUCED PLURIPOTENT STEM CELL 
MODEL FOR LONG QT SYNDROME
Schaniel, Christoph1, D’Souza, Sunita L.1, Fabris, Frank J.1, 
Terrenoire, Cecile2, Wang, George K.2, Gong, Quiming3, Stump, 
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Kass, Robert S.4, Lemischka, Ihor R.1, Adler, Eric D.3
1Mount Sinai School of Medicine, New York, NY, USA, 2Columbia 
University, New York, NY, USA, 3Oregon Health and Science University, 
Portland, OR, USA, 4Columbia Unviersity, New York, NY, USA
The recent breakthrough to generate patient-specific induced pluripotent 
stem cells (iPSCs) offers a new approach to model human disorders and 
could facilitate the development of novel therapeutic interventions. Long 
QT syndromes (LQTS) are genetic arrhythmogenic disorders characterized 
by abnormal ion channel function resulting in prolonged QT intervals on 
an electrocardiogram. A reduction of the rapidly activating delayed rectifier 
potassium channel current (IKr) caused by LQTS-associated mutations in the 
KCNH2/hERG gene can induce ventricular arrhythmia and cause sudden 
cardiac death. Here we report the development of disease-specific human 
iPSC lines from patients with type-2 LQTS caused by a splice site mutation 
in the KCNH2/hERG gene. The specific mutation disrupts the consensus 
sequence of the donor splice site of intron 9 and leads to the activation of 
a cryptic splice site 54 bp downstream. The cryptic splicing results in a full-
length KCNH2/hERG protein with an insertion of 18 amino acids, causing 
a trafficking defect of the mutant channel. This was confirmed by KCNH2/
hERG immunostaining in cardiomyocytes differentiated from established 
LQT2-iPSC lines, thereby providing the first trafficking defect studies with 
patient-specific iPSC lines. Electrophysiological measurements revealed 
prolonged action-potential-duration in LQT2 hiPSC lines when compared 
to healthy control lines. Ongoing single-cell patch clamp studies should 
confirm that the prolongation in action-potential-duration stems from a 
specific decrease in IKr. Furthermore, we are in the process of rescuing the 
phenotype in our LQT2-hIPSC lines by depleting the mutant KCHN2/hERG 
mRNA using short-hairpin RNA that targets the 54 bp insertion in combina-
tion with inducible overexpression of wild-type KCHN2/hERG. Our work 
demonstrates the opportunity of hiPSC technology to study human diseases 
in a dish, in our case, the abnormal functional phenotype of an inherited 
cardiac disorder.
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TGF-β AND BMP SIGNALS LIMIT 
REPROGRAMMING OF AGING FIBROBLASTS 
FROM DYSTROPHIN-DEFICIENT MDX MUSCLE
Wang, Bo1, Ito, Naoki2, Ono, Yusuke1, Miyagoe-Suzuki, Yuko1, 
Takeda, Shin’ichi1
1Molecular Therapy, National Institue of Neuroscience, Tokyo, Japan, 
2Department of Biological Information, Tokyo Institute of Technology, 
Tokyo, Japan
Duchenne muscular dystrophy (DMD) is a severe muscle wasting disorder. 
There is currently no effective therapy, but induced pluripotent stem cells 
(iPSCs) hold promise as a potential treatment for DMD. Since muscle biopsy 
is routinely performed to diagnose muscle dystrophy, cells derived from 
muscle tissue are a good candidate source for iPSCs generation. Further-
more, to determine the impact of the donor’s age on reprogramming, we 
generated iPSCs from muscle derived fibroblasts (MuFs) of mdx mice aged 
6 weeks, 6 months, and 14 months. MuFs from 14-month-old mdx mice 
showed lower proliferative activity and lower reprogramming efficiency, 
compared with those from younger mdx mice, and were refractory to full 
reprogramming by retroviral expression of Oct4, Klf4, Sox2, and c-Myc. 
Moreover, all iPSCs derived from 14-month-old mdx mice (14m-iPSCs) 
189
Friday Poster Abstractswww.isscr.org
Friday Poster Abstracts
gradually lost Nanog expression, and regressed in conventional ES medium 
during passages. Interestingly, 14m-iPSCs exhibited higher expression levels 
of TGF-β family receptors (BMPR2, TGF-βR2, Acvr2a, Acvr1(ALK-2)) than 
embryonic stem cells or iPSCs derived from younger mice, and short-term 
treatment with inhibitors of TGF-β signaling (SB431542) or BMP signaling 
(Noggin) dramatically stabilized Nanog expression and promoted their self-
renewal.
Poster Board Number: 3216
MOLECULAR INSIGHTS INTO INDUCED 
PLURIPOTENCY MEDIATED BY THE OCT4, 
SOX2, KLF4 AND C-MYC GENE REGULATORY 
NETWORK
Wang, Ying1, Mah, Nancy2, Liao, Mei-Chih1, Prigione, Alessandro1, 
Jozefczuk, Justyna1, Lichtner, Björn1, Wolfrum, Katharina1, 
Haltmeier, Manuela3, Schaefer, Martin2, Hahn, Alexander3, 
Andrade-Navarro, Miguel A.2, Adjaye, James1
1Max Planck Institute for Molecular Genetics, Berlin, Germany, 2Max 
Delbrück Center for Molecular Medicine, Berlin, Germany, 3Genomatix 
Software GmbH, München, Germany
Induced pluripotent stem cells (iPS) can be derived from somatic cells by 
viral transduction of four defined transcription factors, including OCT4, 
SOX2, KLF4 and c-MYC (OSKM). Although previous studies have shown 
that epigenetic changes, suppression of p53, mesenchymal-to-epithelial 
transition (MET) and metabolic shift are key events for successful repro-
gramming, our understanding of cellular reprogramming is incomplete. 
Here, we have profiled genome-wide transcription levels using Illumina 
microarrays in the donor cells (human foreskin fibroblast-HFF1 cell line) and 
at three time points post OSKM transduction (24 h, 48 h, 72 h), as well as 
two iPS cell lines (iPS2, iPS4) and ES cell lines (H1, H9). We find that dif-
ferentially regulated transcripts (relative to HFF1 cells), are enriched in genes 
associated with viral responses, as well as response to physiological oxygen, 
cellular morphological changes, apoptosis, cell proliferation, cell cycle and 
aging. Expression profiles suggest that full activation/depression of tran-
scripts involved in epigenetic modifications, MET or metabolic shift had not 
occured within 72h of transduction. To find pathways associated with the 
induction and maintenance of pluripotency, we constructed a gene network 
from interactions available in the literature and identified relevant network 
paths within the context of regulated genes from the time series. Using this 
approach, we further describe molecular mechanisms involving GSK3B and 
FGF2 in the context of reprogramming.
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THE ROLE OF DNMT3B IN REGULATING DNA 
METHYLATION PATTERNS DURING CELL 
REPROGRAMMING
Yu, Juehua1, Huang, Kevin1, Wu, Zhuorui1, Kim, Kee-pyo1, Le, 
Thuc1, Gennery, Andrew2, Pellegrini, Matteo3, Fan, Guoping1
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Immunodeficiency, Centromeric instability and Facial anomalies (ICF) 
syndrome is a recessive autosomal disorder linked to mutations in the DNA 
de novo methyltransferase DNMT3B. The loss of DNMT3B activity in cells 
from affected patients is closely associated with loss of DNA methylation at 
specific repeat regions and several gene promoters related to neurogenesis, 
development, and immune function. However, the roles of DNMT3B in 
regulating DNA methylation patterns during development and ICF patho-
genesis remain to be fully understood. Using somatic cell reprogramming 
technology, we have generated iPSCs carrying DNMT3B mutation from 
fibroblasts of affected ICF syndrome patients. Next, we carried out unbiased 
genome-wide bisulfite sequencing to examine DNA methylation patterns 
in ICF fibroblasts and iPSCs. Our results show global demethylation in both 
CpG as well as CHG/CHH methylation sites in ICF iPSCs. Interestingly, while 
control and ICF fibroblasts show virtually no difference and minimal levels 
of CHG/CHH methylation, ICF iPSCs exhibited a significant hypomethyla-
tion in CHG/CHH methylation when compared to BJ control iPSCs. These 
results implicate that DNMT3B is partially involved in CHG/CHH methyla-
tion during somatic cell reprogramming. In addition, we have compared 
gene expression profiles in ICF fibroblasts and iPSCs. We found that ICF 
iPSCs exhibit much more deregulated genes when compared to fibroblasts, 
particularly in the category of embryonic development and morphogenesis, 
consistent with the important role for DNMT3B in pluripotent stem cells. 
The generation of ICF iPSCs will provide us great opportunities to investigate 
the pathogenic mechanisms of ICF Syndrome in development.
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TAP63 AND ΔNP63 AFFECTS INDUCED 
PLURIPOTENT STEM CELL (IPSC) GENERATION 
THROUGH DICER, DGCR8 AND MIRNAS
Zhai, Yuxin, Flores, Elsa R., Barton, Michelle C.
University of Texas, MD Anderson Cancer Center, Houston, TX, USA
p63, along with p73 and p53, belongs to the extended p53 family. The 
three proteins share functional domains, including an N-terminal transactiva-
tion domain (22% identity), a central DNA-binding domain (60% identity) 
and a C-terminal oligomerization domain (35% identity), and have multiple 
isoforms due to alternative splicing and alternate promotor usage. Despite 
of the similarities in structure, these proteins have distinct functions in tumor 
suppression and development. The work of our laboratory and others sup-
ports a role for p53 in differentiation of embryonic stem cells and opposing 
stem cell formation during generation of induced pluripotent stem cells (iP-
SCs). p53-null and -mutant mouse embryonic fibroblasts (MEFs) have a sig-
nificantly higher efficiency in iPSC generation. We chose to use this system 
to test whether p63 may likewise play roles in iPSC generation, and weather 
the specific isoforms of p63 exhibited similar or differing functions in this 
process. We used retroviruses carrying the genes of the four pluripotent 
factors (Oct4, Klf4, Sox2 and c-Myc) to infect primary MEFs and generate 
iPSCs. The full-length, trans-activating (TA) p63-/- MEFs show higher iPSCs 
generation efficiency compared to wild type MEFs, while the N-terminal 
deleted (ΔN) p63 MEFs showed lower iPSCs generation efficiency compared 
to wild type. This suggests that TAp63, like p53, might act as an anti-pluri-
potency factor, while ΔNp63 might act as a pluripotency promoting factor. 
Further analysis shows that the ΔNp63 level increased more than 10 folds 
during the process of iPSC generation in wild type MEFs. All together our 
data suggest that TAp63 and ΔNp63 might affect pluripotency by regulating 
miRNAs and/or cell cycle.
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A PROPOSED PSYCHOSOCIAL EDUCATION 
AND TREATMENT SCHEME, NECESSARY AND 
SPECIFIC FOR FUTURE THERAPIES BASED ON 
INDUCED PLURIPOTENT STEM (IPS) CELLS.
Salazar, Ophelia E.1, Doherty, Jason M.2
1Social Work, Saint Louis University, St. Louis, MO, USA, 2Private, St. Louis, 
MO, USA
With the advent of findings and research regarding induced, pluripotent 
stem (iPS) cells, it is predictable that, in the near future, treatments for a 
variety of degenerative diseases will emerge based on this technology. Even 
ISSCR 9th Annual Meeting
190
www.isscr.org
Friday Poster Abstracts
with the wonderful results in animal models, the efficacy, lasting-potential, 
and acceptance of such new technologies is still undetermined. Within this 
space, there will be a bioethical need for patients and families to understand 
iPS cells, their purpose in treatment, and the social effect of, as yet, an unde-
termined range of outcomes. We propose the development of a scheme of 
social work interventions, including psycho-education within presenting in-
formed consent and assisting clients in making an informed decision. In ad-
dition, we propose borrowing techniques applied to other medical diseases 
and treatments (Motivational Interviewing, Cognitive-Behavioral Therapy, 
etc.) to serve patients and their families in any given stage of action. This 
approach also would be essential for the medical community to acquire, sus-
tain, and build a client base for iPS cell-based procedures. With the tailored 
application of interventions, clients and their families will be better able to 
accept and understand these new treatments, and to understand and honor 
their own personal feelings pre-, during, and post-procedures.
REGENERATION MECHANISMS
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REGULATION OF OSTEOBLASTS AND 
OSTEOCLASTS BY HUMAN UMBILICAL CORD 
BLOOD DERIVED CD34 STEM CELLS IN 
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Osteoporosis is a diseased condition of bone developed due to low mineral 
density and loss of bone microarchitecture. A delicate balance of bone 
formation and bone degradation regulates the strength of bone. Osteoblasts 
and osteoclasts are two most important cells play critical roles in maintaining 
homeostasis of bone. Increased osteoclast activity and decreased osteo-
blast activity result in osteoporosis. Anabolic therapies and osteoinductive 
implants combined with change in lifestyle offer minimal improvements with 
complicated side effects. Stem cell therapies are being currently investi-
gated for osteoporosis, however, their success is yet to be established. We 
have developed a nanofiber based ex-vivo expansion technology for the 
CD133+/CD34+ stem cells derived from human umbilical cord blood to 
provide essential number of functional therapeutic stem cells. To verify the 
in-vitro differentiation potential of nanofiber-expanded stem cell toward 
osteoblastic lineage, we induced differentiation using conditional media 
containing ascorbic acid and ß-glycerophosphate. To verify in vivo effective-
ness, nanofiber-expanded stem cells were injected via intra-cardio ventricular 
route to osteoporotic animals (immunocompromised NOD/SCID mice) de-
veloped by injecting dexamethasone. After four weeks of stem cell injection, 
femurs were harvested and bone micro-architecture and bone remodelling 
was evaluated using micro-computed tomography (microCT), immunohis-
tochemistry, morphometry and serum markers for bone remodeling. Bone 
marrow was also harvested from osteoporotic animals that received stem cell 
therapy and sham treated controls to evaluate osteoclast differentiation and 
functionality. Herein we show that nanofiber-expanded stem cells could be 
differentiated in vitro towards osteoblastic lineage. The osteoblastic differen-
tiation was confirmed by using RT-PCR, immunocytochemistry, western blot 
and calcium specific staining (Alizarin Red S) for osteoblast related-gene and 
protein expressions. In vivo, stem cell therapy significantly improved bone 
mineral density, bone-remodeling and bone micro-architecture in osteo-
porotic mice compare to the sham treated controls evaluated by micro CT 
analyses, histomorphometry and in vivo immuno-labeling of bones. These 
improvements correlated with the elevated serum levels of osteocalcin, IL-
1α, IL-10 and GM-CSF. Concurrently impaired differentiation and reduced 
activity of osteoclasts were observed in mice, which received stem cell 
therapy. Taken together, these data support an effective stem cell therapy 
for osteoporosis.
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INFLUENCE OF HUMAN UMBILICAL CORD 
DERIVED MESENCHYMAL STEM CELLS 
(UCMSC) ON MONOCYTE/MACROPHAGE 
DIFFERENTIATION AND ACTIVATION IN 
MONOCYTE / UCMSC CO-CULTURES: 
IMPLICATIONS IN INJURY RESOLUTION
Prasanna, Jyothi, Vasandan, Anoop Babu
Adult Stem Cells, Manipal Institute of Regenerative Medicine, Bangalore, 
India
Mesenchymal stem/stromal cells (MSCs) have been implicated to mediate 
regeneration and tissue repair in both in vitro and in vivo models of tissue/
cell injury and inflammation. One of the initial events in an injury response is 
recruitment and differentiation of monocytes. Monocytes differentiated into 
cells of dendritic/macrophage lineage, facilitate maintenance of a microbe 
free environment and co-ordinate inflammatory responses at the sight of 
injury. Thus studying MSC interactions with monocytes is imperative to the 
understanding of how MSCs aid in tissue homeostasis post injury. In this 
study prototypic human monocytic cells lines, THP-1 and U937 and primary 
human monocytes have been activated with PMA to achieve monocyte 
differentiation and further activation was established in the presence of LPS 
and IFNγ. The influence of UCMSCs on monocyte differentiation and activa-
tion was studied in UCMSC-monocyte co-cultures or UCMSC macrophage 
co-cultures at different levels of activation or in presence of conditioned 
media obtained from proliferating UCMSCs. Monocyte differentiation and 
activation was scored through expression of surface markers CD14, CD11b, 
HLA-DR, co-stimulatory ligands and expression of scavenger receptors. 
Further phagocytosis capacity, cytokine release profiles, up-regulation of co-
stimulatory molecules and oxidative status of the activated monocytes was 
studied to check the maturation status of activated monocytes in co-cultures 
with UCMSCs. Results indicate that though UCMSCs do not majorly influ-
ence monocyte differentiation per se it does skew the activation status of 
monocytes. Activated monocytes exposed to secretory factors from UCM-
SCs exhibit a more immature phenotype with higher phagocytosis capacity 
and reduction in Reactive nitrite intermediates (RNI). However, the antigen 
presentation capacity of macrophages cultured in the presence of UCMSCs 
is compromised thus indirectly controlling inflammation through attenu-
ation of effector T cell responses. We thus speculate that UCMSCs might 
facilitate injury recovery by acting at monocyte activation at multiple levels 
without compromising on their anti-microbicidal functions but skewing them 
towards a more anti-inflammatory phenotype.
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THE EFFECT OF INTERLEUKIN (IL)-1β ON 
HUMAN ENDOMETRIAL AND ENDOMETRIOTIC 
STROMAL STEM/PROGENITOR CELLS
Chan, Yat Yan, Chan, Rachel, W.S., Yeung, William, S.B.
Obstetrics and Gynaecology, University of Hong Kong, Hong Kong, Hong 
Kong
The human endometrium is a highly regenerative tissue with remarkable 
proliferative and differentiation capacity. Endometrial stem/progenitor cells 
have been identified in human. Endometriosis is a common gynaecologi-
cal disease affecting 5-10% of women. It is postulated to be related to 
the reflux of endometrial tissue during menstruation. Recently, clonogenic 
cells which exhibit somatic stem cell properties from ovarian endometriosis 
have also been reported. As chronic inflammatory responses can be found 
in patients with endometriosis, the effect of pro-inflammatory cytokine, 
interleukin (IL)-1β on endometrial and endometriotic stromal stem/pro-
genitor cells was examined. Using functional clonogenic assay by seed-
ing cells at very low density (500 cells/cm2), large colony forming units 
(CFUs) corresponding to colonies derived from stem/progenitor cells were 
observed. Treatment with IL-1β did not affect the formation of CFUs in 
normal endometrial stromal cells (NSCs, 0.048%±0.016%, n=16) and 
endometriotic stromal cells (ESCs, 0.062%±0.020%, n=16) when compared 
to the untreated controls. The effect of IL-1β on proliferative capacity of 
the clonogenic endometrial and endometriotic CFUs was examined by 
total cell output. With continuous treatment of IL-1β, the yield of a single 
CFU from NSCs (1.04±1.03x1016, n=3) was similar when compared to the 
control (7.52±6.62x1015, n=3). This suggests that IL-1β did not promote 
cellular senescence of endometrial stem/progenitor cells. Interestingly, the 
yield of a single CFU from IL-1β treated ESCs was about 30-fold higher 
than that of the control group (3.51±3.51x1010, n=3). There was signifi-
cant difference (P<0.05) in the proliferative potential of individual CFUs of 
NSCs (1.04±1.03x1016) and ESCs (3.51±3.51x1010), demonstrating that 
microenvironment in which these stem/progenitor cells reside can influ-
ence their proliferation capacity. Expression of IL-1RI and IL-1RII mRNA 
was detected in all passaged cell types. It was assumed that each CFU was 
derived from 1 single stem/progenitor cell. The effect of IL-1β on self-re-
newal of ESCs was studied by subcloning (P1) of 5% of cells from individual 
primary (P0) IL-1β treated CFUs of ESCs (n=4) in an environment without 
the cytokine. Thus, a change in the number of CFUs in P1 would be due 
to the modulatory action IL-1β on self-renewal of clonogenic cells in P0. 
Results showed that cells from IL-1β treated CFUs produced more colonies 
(54.38±30.73) when compared to the untreated control (21.75±6.48) in 
P1. In summary, IL-1β does not affect the clonogenicity of NCCs. However, 
it increases the self-renewal capacity of ESCs, which may account for the 
increase in total cell yield per CFU. The results suggest differential response 
of NSCs and ESCs to IL-1β. Further studies will provide a better understand-
ing on the aetiology of endometriosis.
Poster Board Number: 3230
REGULATORY MECHANISMS OF HUMAN 
ENDOMETRIAL STEM/PROGENITOR CELL-IN 
VITRO AND IN VIVO
Xiang, Lina, Chan, Rachel.W.S, Yeung, William. S.B
University of Hong Kong, Hong Kong, Hong Kong
Human endometrium exhibits unique properties of cyclical regeneration 
and tissue breakdown throughout a woman’s reproductive life. Within this 
highly regenerative tissue, it has been suggested that stem cells may be 
responsible for the cyclic growth of the endometrium. Human endometrial 
clonogenic cells as candidate somatic stem/progenitor cell have been identi-
fied, however little is known about the regulation of these cells. The aim of 
this study is to examine the key stem cell properties of human endometrial 
clonogenic cells in vitro and in vivo. Using the functional clonogenic assay, 
endometrial large (initiated by stem/progenitor cells) and small (initiated by 
transit amplifying cells) CFUs (colony forming units) were identified. The 
differentiation capacity of the large CFUs in vivo was studied by xenograft 
experiment. A mixture of endometrial epithelial/stromal cells derived from 
large CFUs was embedded in collagen I clots and transplanted beneath the 
kidney capsule of NOD-SCID (n=15). After 12 weeks, occasional proliferat-
ing cells (Ki67+) were detected within the xenograft. Smooth muscle-like 
structure (α-SMA+) and some newly formed vessels (VWF+) of human 
origin were also detected. The total cloning efficiency (CE) of epithelial 
cells was 0.06%±0.01% (n=13) at the proliferative phase and 0.09% ± 
0.03% (n=9) at the secretory phase. The corresponding values for stromal 
cells was 0.27% ± 0.06%, (n=13) and 0.17% ± 0.06% (n=9), respectively. 
Individual large CFUs of epithelial and stromal cells had substantial self-
renewal activity, being able to serial subclone 3.1 ± 0.1 (n=10) and 2.65 ± 
0.3 (n=5) times, respectively. Whereas, small CFUs of both cell types could 
only self-renewal 2.0 times. After menses, the lower basalis give rise to 
the upper functionalis layer. During endometrial repair, we postulated that 
residual epithelial cells and stromal cells of the previous cycle stimulated the 
proliferation of endometrial stem/progenitor cells. Therefore, the importance 
of epithelial and stromal interaction was examined by a co-culture system 
using endometrial aspirate samples obtained on day 2 of the menstrual 
cycle. Epithelial and stromal cells were isolated from the aspirate and placed 
in a culture insert for coculture with epithelial cells or stromal cells collected 
from the basalis and seeded at cloning density. The total CE of endometrial 
stromal cells when co-cultured with day 2 epithelial cells was significantly 
higher (0.51% ±0.12 %, n=6) when compared to control (0.12% ± 0.05%, 
n=6, P<0.05). The increase was mainly due to the increase of small CFUs. 
The total CE of epithelial CFUs when co-culture with day 2 stromal cells 
(0.15% ± 0.06%, n=6) was similar to the control (0.17% ± 0.07%, n=6). 
In conclusion, the large CFUs are capable of differentiation into different 
lineages in vivo, supporting that their derivation from stem/progenitor cells. 
The clonogenic activity of endometrial cells was similar at different menstrual 
stages. Endometrial cells from day 2 of the menstrual cycle stimulated only 
the proliferation of the transit amplifying cells (small CFUs), indicating that 
the endometrial stem/progenitor cells (large CFUs) respond differently from 
its progenies. These findings contribute to a better understanding on the 
role of endometrial stem cells during the reproductive cycle. 
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IN VIVO BONE MARROW NICHE PROPENSITY 
REVEALS FUNCTIONAL HETEROGENEITY OF 
THE HUMAN HEMATOPOIETIC STEM CELL 
COMPARTMENT
Guezguez, Borhane1, Campbell, Clinton J.V.1, Karanu, Francis1, 
Schnerch, Angelique1, Smith, Mary-Jo2, Levadoux-Martin, 
Marilyne1, Bhatia, Mickie1
1Biochemistry, McMaster Stem Cell and Cancer Research Institute, 
McMaster University, Hamilton, ON, Canada, 2Pathology and Molecular 
Medicine, McMaster University, Hamilton, ON, Canada
In vivo transplantation studies of prospectively isolated cells have uncovered 
significant phenotypic heterogeneity within the compartment of reconstitut-
ing human hematopoietic stem cells (HSCs). Despite the dependence on in 
vivo reconstitution of recipient bone marrow microenvironment, HSC het-
erogeneity has yet to be examined in situ. Here using an in vivo approach, 
we reveal that human NOD/SCID Repopulating Cells (SRCs) are heteroge-
neous for functional reconstituting ability. SRC in the trabecular bone area 
(TBA) of recipient immune deficient mice possessed superior self-renewal 
and regenerative capacity to those in long bone area (LBA). These niche fea-
tures were consistent using mouse HSCs suggesting a conservation of this 
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mode of HSC regulation. Molecular signatures of purified TBA-SRC uniquely 
indicated distinct Notch pathway regulation in contrast to SRC found in the 
LBA, and were physically identified to be exclusively associated with TBA 
bone endosteum expressing the Notch ligand Jagged-1. This in vivo niche 
affinity allowed independent de novo enrichment of human SRC based on 
direct Notch ligand binding. Our study demonstrates that heterogeneity of 
human HSCs can be functionally defined by the combination of specific BM 
niche occupancy and active in situ molecular interactions that define in vivo 
HSC capacity. This work was funded by a research grant from the Canadian 
Institutes of Health Research (CIHR).
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IMPROVING LIVER REPOPULATION WITH 
MOUSE EMBRYONIC STEM CELL-DERIVED 
HEPATIC CELLS
Bourdon, Alice1, Han, Songyan1, Dziedzic, Noelle1, Sommer, Cesar2, 
Mostoslavsky, Gustavo2, Kotton, Darrell3, Gouon-Evans, Valerie1
1Mount Sinai School of Medicine, New York, NY, USA, 2Section of 
Gastroenterology, Boston University School of Medicine, Boston, MA, USA, 
3Center for Regenerative Medicine (CReM), Boston University School of 
Medicine, Boston, MA, USA
The shortage of liver donors is currently a major drawback hindering 
the treatment of liver diseased patients. One alternative to a whole liver 
transplantation protocol is the transplantation of hepatocytes. The ability 
of embryonic stem (ES) cell-derived hepatic cells to repopulate diseased 
livers remains inefficient. Published studies that generated ES cell-derived 
hepatic cells showed very little repopulation potential of those cells fol-
lowing transplantation in injured liver mouse models. Therefore our work 
focused on understanding the repopulation process in a step-wise manner 
and subsequently the identification of the limiting step to achieve successful 
transplantation with ES cell-derived hepatic cells. Fah-/-, Rag2-/-, IL2Rγ-/- 
(FRG) mice constitute an excellent model to follow diseased liver regenera-
tion as the liver deficiency can be reverted by treating the FRG mice with a 
drug NTBC. Hepatic cells are transplanted while NTBC is removed to allow a 
growth advantage compared to the surrounding deficient hepatocytes. 
Using a reporter ES cell line expressing CD4 cDNA from the Foxa2 locus 
and CD25 cDNA from the Foxa3 locus (Foxa2-CD4, Foxa3-CD25), we have 
previously demonstrated an efficient and reproducible induction and hepatic 
specification of Foxa2+/Foxa3+ definitive endoderm population in the 
presence of BMP4 and ß-FGF. More recently, we demonstrated that mouse 
endothelial cells coordinate the hepatic specification of the Foxa2+/Foxa3+ 
definitive endoderm population through dual repression of Wnt and Notch 
signaling. Here we show that in a co-culture setting, human umbilical vein 
endothelial cells (Huvec) also highly induce Foxa2+/Foxa3+ definitive en-
doderm specification in the presence of Dkk1 (Wnt pathway inhibitor) and 
gamma secretase inhibitor (Notch pathway inhibitor) as mRNA levels of AFP 
and Albumin are increased 22-fold following 6 days of induction. We are 
now in the process of analyzing the regenerative ability of these hepatic cells 
using the FRG mice. However a growing literature indicated that the regen-
erative ability of ES cell-derived hepatic cells remains poor. Therefore, we will 
in parallel identify genes that are essential for successful liver repopulation 
by comparing the gene expression profile of Dlk+ hepatoblasts from embry-
onic 13.5 fetal livers (capable of successful repopulation) with that from ES 
cell-derived hepatic cells from day 12 of differentiation cultures. The gene 
signature characteristic of successful repopulation will be further discussed 
at the meeting. In parallel, these regeneration studies will be also performed 
using mouse iPS cell-derived hepatic cells. Our preliminary studies aimed to 
evaluate the relative ability to generate hepatic cells from mouse iPS lines 
compared with syngenic ES cell lines. Monitoring cell number and endoderm 
markers (cKit and CXCR4, ENDM1) expression by flow cytometry until day 
6 of differentiation showed that iPS lines display a very similar prolifera-
tion rate, embryoid body morphology and endoderm emergence kinetic 
compared to the syngenic ES cell line. iPS cells and ES cells display a similar 
functional capacity to form definitive endoderm. Altogether, this study will 
define the limiting step of liver regeneration with ES cell-derived hepatic cells 
and identify key gene candidates for successful liver regeneration process.
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SYSTEMIC ADMINISTRATION OF MULTIPOTENT 
MESENCHYMAL STROMAL CELLS INTO TYPE 
1 DIABETIC MICE RESTORES THE BALANCE 
BETWEEN ANTI-INFLAMMATORY AND 
PROINFLAMMATORY CELLS, ALLOWING THE 
REGENERATION OF PANCREATIC ISLETS
Ezquer, Fernando, Ezquer, Marcelo, Simon, Valeska, Contador, 
David, Conget, Paulette
Instituto de Ciencias, Facultad de Medicina, Universidad del Desarrollo, 
Santiago, Chile
Type 1 diabetes mellitus (T1D) results from a cell-mediated autoimmune 
destruction of pancreatic beta-cells. Any available treatment allows patient 
cure. Previously, we demonstrated that the intravenous administration of 
a single dose of bone marrow-derived multipotent mesenchymal stromal 
cells (MSC) into mice with T1D reverted hyperglycemia, reduced glycated-
hemoglobin level and increased insulinemia. This phenotypic reversion 
correlated with the recovery of the number, morphology and function of 
pancreatic islets. Our next aim was to evaluate whether transplanted MSC 
modify the imbalance between anti-inflammatory and proinflammatory 
cells characteristic of individuals with T1D. By flow cytometry and immu-
nohistofluorescence, we studied the biodistribution of donor MSC in mice 
with T1D. Donor cells were isolated from isogenic mice that express GFP 
(MSCGFP) and intravenously administered into mice with T1D. Seven days 
post-administration, MSCGFP were mainly found in Peyer’s patches and in 
minor degree in inguinal and pancreatic lymph nodes and bone marrow. 
Sixty-five days post-administration, MSCGFP were present almost exclusive-
ly in Peyer´s patches. At days 7 and 65, transplanted MSC were scarcely de-
tected in the pancreas parenchyma. By flow cytometry, we determined the 
abundance of regulatory (CD4, CD25, Foxp3) and autoreactive (CD4low, 
CD40high) T cells in blood, spleen, bone marrow and pancreatic lymph 
nodes of mice with T1D transplanted or not with MSC. Seven and 65 days 
post-administration, in MSC-treated mice we found more regulatory and 
less autoreactive T cells, when compared with untreated mice. Furthermore, 
we observed that T cells isolated from MSC-treated mice were less prone to 
produce proinflammatory cytokines [IL2, INFgamma, TNFalpha] compared 
with cells isolated from untreated mice. By qRT-PCR, we assessed the ex-
pression level of anti-inflammatory/cytoprotective [IL4, IL5, IL10 and IL13] 
and proinflammatory [IL1beta, IL18, TNFalpha, TGFbeta, INFgamma, MCP1 
and ICAM1] markers in the pancreas of mice with T1D transplanted or not 
with MSC. At day 7 post-administration, in the MSC-treated mice IL1beta, 
IL18, TNFalpha and MCP1 were expressed at basal levels, while in untreated 
mice all proinflamatory markers were overexpressed. At day 65, IL4, IL5 and 
IL13 were expressed at basal levels in the pancreas of MSC-treated diabetic 
mice, while in untreated mice those cytoprotective factors were downregu-
lated. Our results show that in mice with T1D, MSC administered systemi-
cally mainly home into secondary lymphoid organs, induce the generation of 
regulatory T cells, reduce the number and the activity of autoreactive T cells 
and recover the expression of pancreatic cytoprotective factors. Hence, the 
transplantation of MSC restores the balance between anti-inflammatory and 
proinflammatory cells, resulting in a decline of the destruction of pancreatic 
beta-cells newly generated from endogenous progenitors. 
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MOUSE KIDNEY PROGENITOR CELLS 
ACCELERATE RENAL REGENERATION VIA 
DIFFERENTIATION-INDEPENDENT PATHWAY
LEE, PO-TSANG, Chou, Kang-Ju, Fang, Hua-Chang, Chen, Chien-
Liang, Hsu, Chih-Yang, Huang, Wei-Chieh
Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
Acute tubular necrosis is followed by regeneration of damaged renal tubular 
epithelial cells. Renal progenitor cells are supposed to be one of the sources. 
The purpose of the study is to unravel the possible mechanism of how 
renal progenitor cells accelerate renal regeneration after injury. A unique 
population of cells that behave in a manner consistent with renal progenitor 
cells was isolated from Myh9 targeted mutant mice, namely mouse kidney 
progenitor cells. Mouse kidney progenitor cells rescued renal damage as 
manifested decreases in peak serum urea nitrogen and the infarct zone 
when these cells were injected into the kidney of SCID mice after ischemic 
injury. By flow analyses, GFP-positive cells of the kidney increased from 
3.4% on day 2 to 6.7% on day 30 after injury. It is interesting that condi-
tioned medium of renal progenitor cells also rescued renal damage. In vitro, 
renal progenitor cells as well as conditioned medium not only accelerated 
primary proximal tubular cells proliferation but also decreased apoptosis 
after ischemic injury. Our results indicate that renal progenitor cells might 
accelerate renal regeneration after ischemic injury via paracrine effects.
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ALLOGRAFT OF MOUSE UMBILICAL CORD-
DERIVED MESENCHYMAL STEM CELLS INTO 
ISCHEMIC BRAIN ENHANCED THE GENERATION 
OF NEURAL CELLS FROM BONE MARROW- 
AND SVZ-DERIVED CELLS
Li, Wen-Wen1, Li, Hung2, Wei, Yau-Huei1, Lin, Teng-Nan3
1National Yang-Ming University, Taipei, Taiwan, 2Institute of Molecular 
Biology, Academia Sinica, Taipei, Taiwan, 3Institute of Biomedical Sciences, 
Academia Sinica, Taipei, Taiwan
Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) have 
recently been identified as a promising candidate for cell-based therapy in 
various preclinical experimental models, such as Parkinson’s disease, cerebral 
ischemia, spinal cord injury, and liver fibrosis. In addition, the induced pluri-
potent stem cells from hUC-MSCs have been successfully generated and 
shown higher efficiency than induced from fibroblasts (<0.01% vs. 0.4%). 
However, there is a growing concern on rejection and alteration of genetic 
code of this xenotransplant approach. In this study, a novel mouse UC-
MSCs (mUC-MSCs) derived from wild-type and GFP transgenic mice have 
been successfully isolated, expanded, characterized, and differentiated into 
cells that distinct from its origin in vitro. We have administrated mUC-MSCs 
in several animal models, including hematopoietic reconstitution, murine 
focal cerebral ischemia, and acute liver failure, to explore their therapeutic 
effects. Our results indicated that post-irradiated intravenous infusion of 
mUC-MSCs could increase survival rate of γ-irradiated mice. And mUC-
MSCs can differentiate into hematopoietic lineage cells in peripheral blood. 
Intracerebral administration of mUC-MSCs into ischemic brain significantly 
reduced infarct volume (63% vs. 47%), improved neurological behavior (a 
1.6-fold increase in gait swing speed), and increased homing of BM-derived 
cells to ischemic cortex by up-regulation of SDF-1α. These BM-derived 
GFP+ cells were co-localizated with markers for microglia, endothelial 
cells, and to a less extend neuronal cells, but not astrocytes. Furthermore, 
semiquantitative RT-PCR revealed that mUC-MSCs expressed the mRNA of 
VEGF, GDNF, and SDF-1, but not FGF2 and BDNF. Intriguingly, hUC-MSCs 
do express VEGF, GDNF, BDNF, but not SDF-1. In summary, allograft of 
mUC-MSCs into various murine disease models might shed more light on 
the mechanism underlying the beneficial effects of cell therapy.
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UMBILICAL CORD BLOOD DERIVED 
ENDOTHELIAL CELLS AND SMOOTH MUSCLE 
CELLS CAN REPAIR HIND LIMB ISCHEMIA IN 
MICE.
Whiteley, Jennifer, Chua, Shawn, Li, Mira, Rogers, Ian
Samuel Lunenfeld Research Institute, Toronto, ON, Canada
Peripheral vascular disease (PVD) is a condition that affects the vascula-
ture outside of the heart and brain, causing an acute or chronic ischemia. 
It is also commonly referred to as peripheral arterial disease (PAD). The 
risk of suffering from PVD is significantly higher in diabetic patients and 
is a major complication of type 2 diabetes. While it is seen in 15% of the 
general population over 55 years old, the risk is increased up to four times 
in diabetic patients. Currently there are only two approaches for PVD 
management, surgery and medication. Therapies to improve blood flow, 
which include bypass surgery, stent or angioplasty, only target larger ves-
sels and are not generally applicable for smaller vessels. The lack of proper 
treatment can result in amputation of the affected limb. Current treatments 
target slowing the progress of the disease but our aim is to reverse tissue 
damage, improve blood flow and repair damaged muscle. We have previ-
ously demonstrated that CD45+ human umbilical cord blood cells or bone 
marrow cells are capable of generating non-blood cell types after culture in 
FGF4, SCF and Flt3-ligand. When the post cultured cells are injected into the 
ischemic muscle they engraft and differentiate into new blood vessels as well 
as contribute to the enlargement of existing vessels. Sections were stained 
for human muscle actin and CD31 to identify human smooth muscle actin 
and endothelial cells respectively. The animals that received cells had high 
levels of vasculo- and arteriogenesis and a 75% normal return of blood flow. 
Our cells, referred to as multi-potential stem cells (MPSC) have proven to 
have higher levels of engraftment and repair than current products in clinical 
development (CD34+ cells).
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MOUSE GERM PLASM-LIKE DOT CELLS 
TRANSFORM INTO EPITHELIAL AND 
HAIR FOLLICLE STEM CELLS IN TISSUE 
REGENERATION.
Kong, Wuyi1, Li, Shaowei2
1Hongtai Medicine, Beijing, China, 2Stanford University, Palo Alto, CA, USA
Recent evidences suggest that skin epithelial stem cells are tissue specific. 
Therefore, we asked if there is a pre-stem cell population that gives rise to 
all cell types including epithelial cells. We have found, in the mouse blood, 
a group of E-cadherin-positive bodies (germ plasm-like Dot cells) that have 
strong regenerative activities. Immuno-electron microscopy confirms that 
these small bodies are not eukaryotic cells. They are about 1 μm, contain 
nuclear acid, and do not have nuclear membrane or intracellular organelles. 
Germ plasm-like Dot cells transform into small stem cells through a process 
including aggregation, fusion, and nuclear programming when they are in 
eukaryotic microenvironments. Results from in vivo transplantation demon-
strate that germ plasm-like Dot cells-derived stem cells regenerate interfolli-
cular epithelium via mesenchymal-epidermal transition; germ plasm-like Dot 
cells-derived hair bulb stem cells regenerate entire hair follicles. Our data 
provide evidence that germ plasm-like Dot cells transform into skin specific 
stem cells, which further divide symmetrically to regenerate different types 
of skin structures.
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ENHANCED RESISTANCE OF EPCS DERIVED 
FROM HESC AGAINST OXIDATIVE STRESS 
THAN CB EPCS DUE TO UPREGULATED 
ANTIOXIDANT MOLECULE EXPRESSION
Kim, Hye Eun1, Kim, Jumi1, Chae, Jung Il I.2, Lee, Min Ji1, Lee, 
Kyung Il1, Kim, Hee Jeong1, Chung, Hyung-Min1
1CHA Stem Cell Institute, Seoul, Korea, Republic of, 2Department of Oral 
Pharmacology, Chonbuk National University, Jeonju, Korea, Republic of
Endothelial progenitor cells (EPCs), which can obtained from umbilical cord, 
peripheral blood, bone marrow and placenta play an important role in tissue 
regeneration and vascular repair, but there still have obstructions, includ-
ing limited proliferative capacity and low engraft efficiency, to use in clinical 
field. As these reasons, we derived EPC like cell population from hESCs 
(hESC-EPCs), to overcome therapeutic cellular source limitation, on the basis 
of unlimited proliferation capacity and pluripotency of hESCs. In this study, 
hESC-EPCs were sorted by endothelial cell marker CD133+/ KDR+, and we 
confirmed that hESC-EPCs were functionally equal to cord blood derived 
EPCs (CB-EPCs) by characterization test through RT-PCR, FACs analysis, ac-
LDL uptake and tubule forming assay, in vitro. Also, to define fundamental 
characteristics of hESC-EPCs at molecular level, we performed proteomic 
analysis using 2-DE and LC-M/MS protein identification method. As a result, 
specific up-regulated protein expression profile, which involved in vascular 
structure reconstruction, anti-oxidant/ anti-apoptosis and migration, were 
verified in hESC-EPCs. To investigate whether anti-oxidant related proteins, 
which up-regulated in hESC-EPCs, are functionally contributed on defense 
mechanism against oxidative stress, we compared anti-oxidant ability of 
hESC-EPCs and CB-EPCs using in vitro wound healing assay, hypoxia culture 
and H2O2 treatment. Consistently with proteomic result, up-regulated ex-
pression pattern was sustained and hESC-EPCs were shown more resistant in 
oxidative stress. More interestingly, anti-oxidant related proteins expressed 
in hESC-EPCs were more up-regulated in oxidative stressful condition than 
normal culture condition. Also, in hindlimb ischemic disease model mice, the 
therapeutic effect of hESC-EPCs also confirmed. As same as our expectation, 
up-regulated antioxidant molecule expression in hESC-EPCs was equipped 
with an antioxidative defense, to provide resistance against oxidative stress 
than CB-EPCs. Taken together, the data shown in this study suggested 
that hESC-EPCs will be more optimized cellular source on several ischemic 
diseases due to their resistant effect on oxidative stress and this combina-
tional approach using stem cell and proteomics could give us clue to solve 
therapeutic mechanism.
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ORIGINS OF THE NUCLEUS PULPOSUS: 
IMPLICATIONS FOR STEM CELL THERAPY OF 
DEVELOPMENTAL DISC DISEASE.
McCann, Matthew R.1, Tamplin, Owen J.2, Rossant, Janet3, Séguin, 
Cheryle A.1
1Physiology and Pharmacology, The University of Western Ontario, London, 
ON, Canada, 2Department of Pediatrics, Harvard University, Boston, MA, 
USA, 3The Hospital for Sick Children, Toronto, ON, Canada
Background: Low back pain is the most common musculoskeletal problem 
with a lifetime prevalence of 82%. A significant proportion of lower back 
pain is attributed to degeneration of the intervertebral disc (IVD) and more 
specifically the nucleus pulposus. To reverse the pathological process of disc 
degeneration, cell viability and cellular phenotype in the nucleus pulposus 
should be targeted; an approach that requires first characterization of the 
developmental origins of cell types within the nucleus pulposus. 
Methods: We have generated a novel notochord-specific Cre knock-in 
mouse in which Cre recombinase has been targeted to the Noto locus, a 
gene that is expressed exclusively in the node and developing notochord. 
Upon mating the NotoCre/+ mouse with a ROSA26 conditional LacZ 
reporter mouse, we have performed lineage-tracing experiments throughout 
development. Results: Fate mapping studies have shown the notochord 
gives rise to the nucleus pulposus in the mature mouse. This is achieved by 
β-galactosidase staining, which is present throughout the majority of the 
spinal column. Cellular localization of β-galactosidase demonstrates that 
both notochord cells and chondrocyte-like are derived from the embryonic 
notochord. This indicates that the notochord exclusively gives rise to the 
nucleus pulposus and that notochord cells act as embryonic predecessors of 
all the cells found within the nucleus pulposus. Conclusions: The ultimate 
goal of this study was to determine the fate and function of notochord cells 
during spinal skeletogenesis. These experiments show that nucleus pulposus 
is exclusively derived from the notochord and that all cells within are derived 
of the embryonic notochord. This study provides evidence that notochord 
cells are tissue specific stem cells for the nucleus pulposus and therefore has 
the potential for future tissue engineering strategies.
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PLEIOTROPHIN IS A NICHE FACTOR 
WHICH REGULATES ENGRAFTMENT OF 
HEMATOPOIETIC STEM CELLS
Istvanffy, Rouzanna, Kröger, Monika, Eckl, Christina, Vilne, Baiba, 
Gitzelmann, Sylke, Bock, Franziska, Keller, Ulrich, Peschel, Christian, 
Oostendorp, Robert A.J.
Technical University Munich, Munchen, Germany
Hematopoietc stem cells (HSC) are maintained at a quiescent state during 
steady-state hematopiesis. HSC are charachterized by their ability to respond 
quickly to hematopoietic stress in vivo, as well as in culture, by increas-
ing proliferation and inducing early lineage commitment. It is likely that 
secreted niche factors are involved in this transition from quiscence towards 
activation. We here show that knockdown of the secreted factor pleiotro-
phin (Ptn-KD) in stromal cells increases proliferation as well as production 
of hematopoietic progenitors as well as HSC activity in co-cultures with 
lineage-negative (Lin-) hematopoietic cells. Moreover, engraftment of cells 
co cultured with PtnKD stromal cells is associated with increased numbers of 
Cd34- Lin- Sca+ Kit+ (LSK) cells and dominant myeloid regeneration. De-
spite clear effects of Ptn deficiency in co-cultures, steady-state hematopoi-
esis is not altered in Ptn knockout (Ptn-/-) mice. This suggests that Ptn May 
be involved in regulating HSC quiscence. Indeed, engraftment of wild-type 
HSC in lethally irradiated Ptn-/- mice mirrors the cultures on PtnKD stromal 
cells in that engraftment is increased in serial transplantations with progres-
sive myeloid skewing and accumulation of CD34- LSK donor cells. On a mo-
lecular level, steady state Ptn-/- LSK cells express decreased levels of cyclin 
D1, but an increased expression of the myeloid master-regulator C/EBPα. In 
contrast, the observed increase in hematopoietic regeneration in co-cultures 
on PtnKD stromal cells is associated with UPregulation of cyclin D1 (Ccnd1), 
whereas again C/EBPα was also increased. Thus, the difference between 
steady-state quiscence and activated engraftment appears to lie in strict 
regulation of cyclin D1 through Ptn. Since neither in steady state Ptn-/- cells, 
nor in wild-type LSK cells cultured on PtnKD stroma, the transcript or protein 
levels of β-catenin were influenced. The regulation of cyclin D1 through Ptn 
appears to be independent of canonical Wnt signaling. In conclusion, our 
results point to different regulatory mechanisms in normal hemostasis and 
in hematopoietic regeneration. Moreover, our results support the idea that 
microenvironmental Ptn mainly regulates cyclin D1-dependent hematopoi-
etic regeneration.
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HEDGEHOG/WNT FEEDBACK SUPPORTS 
REGENERATIVE PROLIFERATION OF 
EPITHELIAL STEM CELLS IN BLADDER
Shin, Kunyoo
Stem Cell Institute, Stanford University, Stanford, CA, USA
Epithelial integrity in metazoan organs is maintained through the regulated 
proliferation and differentiation of organ-specific stem and progenitor cells. 
Although the epithelia of organs such as the intestine regenerate constantly 
and thus remain continuously proliferative, other organs, such as the mam-
malian urinary bladder, shift from near-quiescence to a highly proliferative 
state in response to epithelial injury. The cellular and molecular mechanisms 
underlying this injury-induced mode of regenerative response are poorly de-
fined. Here we show that the proliferative response to bacterial infection or 
chemical injury within the bladder is regulated by signal feedback between 
basal cells of the urothelium and the stromal cells that underlie them. We 
demonstrate that these basal cells include stem cells capable of regenerat-
ing all cell types within the urothelium, and are marked by expression of the 
secreted protein signal, Sonic hedgehog (Shh). Upon injury, Shh expression 
in these basal cells increases and elicits increased stromal expression of Wnt 
protein signals, which in turn stimulate the proliferation of both urothelial 
and stromal cells. The heightened activity of this signal feedback circuit and 
the associated increase in cell proliferation appear to be required for restora-
tion of urothelial function and, in the case of bacterial injury, may help clear 
and prevent further spread of infection. Our findings provide a conceptual 
framework for injury-induced epithelial regeneration in endodermal organs, 
and may provide a basis for understanding the roles of signaling pathways in 
cancer growth and metastasis.
Poster Board Number: 3256
INHIBITION OF CXCR4 RECEPTOR 
ENDOCYTOSIS INDUCES CXCR4 SURFACE 
EXPRESSION AND ENHANCES MIGRATION OF 
FETAL MESENCHYMAL STEM/STROMAL CELLS
Ting, Michael J., Ryan, Jennifer M., Fisk, Nicholas M.
University of Queensland, Brisbane, Australia
Both adult and fetal mesenchymal stem/stromal cells (MSC) preferentially 
home to sites of tissue injury but the underlying processes are poorly un-
derstood, limiting ability to target MSC to regions of tissue damage. The CX-
CR4-SDF-1 axis is active in MSC, which migrate toward SDF-1 in vitro, but 
has not been studied in fetal MSC, which have translationally advantageous 
properties over adult MSC. Only a subset of adult MSC express surface 
CXCR4, and up-regulation of CXCR4 by viral transduction increases MSC 
homing to injury sites. CXCR4 like other G-protein receptors undergoes both 
ligand-dependent & ligand-independent endocytosis, and its trafficking in 
turn should determine the outcome of CXCR4 signalling. We investigated 
surface & cytoplasmic expression of CXCR4 on human fetal bone marrow 
MSC. As in adult MSC, CXCR4 surface expression in fMSC is low (3-4%), 
with most CXCR4 protein sequestered intracellularly (>90%). Using immu-
nofluorescence microscopy, we showed that CXCR4 is colocalized with Rab5 
& Rab11, markers associated with early & recycling endosomes respectively. 
CXCR4 also colocalized albeit to a lesser extent with the lysosomal marker, 
Lamp-1. Using a neutralizing antibody against SDF-1, we demonstrate that 
endocytosis of CXCR4 is independent of endogenously produced SDF-1. 
Treatment of fMSC with blebbistatin & dynasore, inhibitors of endocytosis, 
increased the surface expression of CXCR4 more than 5 fold (untreated 
mean fluorescence intensity 3.8±0.25 vs blebbistatin 33.4±11.3 dynasore 
25.6±5.4 respectively, p<0.05) relative to untreated cells. Migration of fMSC 
to SDF-1 was increased by both inhibitors in in vitro chemotaxis assays 
(blebbistatin 2.8±0.21, dynasore 2.6±0.22, fold more than untreated cells, 
p<0.01). These data implicate constitutive endocytosis in the regulation of 
CXCR4 membrane expression on fetal MSC, & suggest pharmacological 
strategies to enhance migration of systemically-transplanted cells. Improving 
homing would be advantageous not only to increase the therapeutic effect 
but also to reduce potential harm posed by inappropriate uptake of MSC in 
healthy tissues.
Poster Board Number: 3258
BMP AND WNT PATHWAY REGULATION 
OF LINEAGE-SPECIFIC GENE PROGRAMS 
UNDERLIE HEMATOPOIETIC REGENERATION
Trompouki, Eirini1, Bowman, Teresa V.1, Lawton, Lee N.2, Peng Fan, 
Zi2, Wu, Dai-Chen3, DiBiase, Anthony1, Martin, Corey S.1, Cech, 
Jennifer N.1, Sessa, Anna K.1, Leblanc, Jocelyn L.1, Li, Pulin1, Heffner, 
Garrett C.1, Daley, George Q.1, Paulson, Robert F.4, Young, Richard 
A.2, Zon, Leonard I.1
1Hematology/Oncology, Children’s Hospital Boston, Boston, MA, USA, 
2Whitehead Institute for Biomedical Research, Cambridge, MA, USA, 
3Veterinary and Biomedical Sciences, Penn State University, University 
Park, PA, USA, 4Veterinary and Biomedical Sciences, Penn State University, 
University Park, PA, USA
BMP and Wnt signaling pathways play key roles in hematopoietic develop-
ment. Here we describe the effect of these pathways during stress-induced 
hematopoietic regeneration. Using heat-shock inducible transgenic fish lines 
that overexpress BMP2 or WNT8, we demonstrated accelerated marrow re-
covery following irradiation. Irradiation recovery was blunted by heat shock 
induced overexpression of the respective inhibitors Chordin and DKK1. Simi-
lar to the zebrafish regeneration results, competitive transplants with mouse 
bone marrow treated with the WNT agonist BIO led to enhanced chimerism. 
Inhibition of BMP diminished peripheral blood contribution in the presence 
of WNT stimulation, suggesting a conserved and cell intrinsic interaction 
for these signaling pathways in adult stress hematopoiesis. To examine 
potential target genes of these pathways that could account for the effects 
during irradiation recovery, we performed chromatin immunoprecipitation 
coupled with sequencing (ChIP-seq) with SMAD1 and TCF7L2, mediators 
of the BMP and Wnt pathways respectively, in erythrocytic and monocytic 
leukemias. Surprisingly, the Wnt and BMP co-localization in each cell type 
occurred at well-known lineage-specific genes associated with erythroid 
lineage in K562 cells, and with myeloid lineage in U937 cells. These data 
indicate cell type selective binding of TCF7L2 and SMAD1 at distinct 
hematopoietic genes according to cell lineage. Comparison of the ChIP-seq 
results with previously published GATA1/2 ChIP-seq results in K562 and C/
EBPα in U937 showed that more than 70% of TCF7L2 and SMAD1 targets 
co-localize with these cell-specific factors. These data suggest selective 
binding of TCF7L2 and SMAD1 signaling-directed transcription factors in 
concert with cell specific master regulators at lineage distinctive genes. This 
specific binding occurs also in primary human hematopoietic progenitor 
cells (CD34+ cells) and in erythroid cells derived from CD34+ cells. A shift 
in binding of BMP and Wnt transcriptional regulators to erythroid specific 
genes upon directed differentiation was observed suggesting interplay 
between lineage restricted transcription factors and the signaling regulators. 
We demonstrated the biological significance of this type of interaction in 
flexed tail mutant mice with defective BMP dependent stress erythropoiesis 
due to a dominant negative mutation in SMAD5. In these mice, forced 
expression of lineage-specific transcription factors GATA2 or SCL restored 
the regeneration defect in SMAD-deficient erythroid progenitors. Our data 
support a model in which the BMP and Wnt pathways act on cell-specific 
gene targets and are guided by lineage-specific master regulators. Although 
dispensable for steady state hematopoiesis the BMP and Wnt pathways 
regulate tissue regeneration. Our data imply that an underlying mechanism 
of regeneration and self-renewal is the control of the entire hematopoietic 
program. The BMP and Wnt signaling transcription factors associate with 
master regulators of multiple hematopoietic cell types, providing a mecha-
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nism to stimulate the intrinsic hematopoietic program during differentiation 
and regeneration. The two first authors contributed equally to this work
Poster Board Number: 3260
CHANGES IN THE EXPRESSION OF MARKERS 
OF STEM /PROGENITOR CELLS LINKED TO 
FLUCTUATION IN LACTOTROPH POPULATION
Vaca, Alicia M.1, Sosa, Liliana1, Petiti, Juan P.1, Mukdsi, Jorge H.1, 
Alvarez, Clara2, Torres, Alicia I.1
1Medical School, Electron Microscopy Center, Córdoba, Argentina, 2Medical 
School, Fisiology, Santiago de Compostela, Spain
The pituitary gland shows dynamic adjustments in response to hormonal 
fluctuations such as puberty, pregnancy and lactation. The adaptation of this 
gland at different physiological requirements may be due to the recruit-
ment and differentiation of stem/progenitor cells (S/P).These cells was 
located in the marginal zone that limits the pituitary cleft. In previous work 
we demonstrated that lactotroph population exhibit significant changes 
during lactation. The aim of this study was to identify pituitary S/P cells and 
quantify pluripotency markers: Sox2 and Oct-4, evaluating possible changes 
during lactation and estrous cycle. We used adult Wistar female rats in 
oestrus and diestrus II phase of estrous cycle and active lactancy. The pitu-
itary gland were processed for ultrastructural immunocytochemistry, which 
allowed us to determine the topographic location of S/P cells by detection 
of differentiation markers: ß-catenin and vimentin at the subcellular level 
and to identify markers associated with S/P cell phenotype, the membrane 
receptor GFRa2 and transcription factors Sox2 and Oct-4. Morphomet-
ric quantification was carried out immunostaining of Sox2 and Oct-4 by 
electron microscopy using software Image J. Statistics: ANOVA-Fisher. Cilli-
ated cells of the marginal zone were negative for ß-catenin, while vimentin 
positive cells were localized around those like as they were supporting cells. 
The GFRa2 receptor was expressed in cells that limit the pituitary cleft. The 
transcription factors Sox2 and Oct-4 is expressed in marginal zone cells with 
an increase (p <0.05) during active lactation and oestrus phase compared to 
diestrus II phase of estrous cycle. These findings would seem to indicate the 
involvement of stem/progenitor cells in lactotroph population fluctuations 
on physiological conditions of high hormonal demand.
Poster Board Number: 3262
A BATF DEPENDENT DIFFERENTIATION 
CHECKPOINT LIMITS SELF RENEWAL AND 
FUNCTION OF HEMATOPOIETIC STEM CELLS IN 
RESPONSE TO DNA DAMAGE
Wang, Jianwei1, Rudolph, K. Lenhard2
1Institute of Molecular Medicine and Max-Planck Research Department on 
Stem Cell Aging, University of Ulm, Ulm, Germany, 2Max-Planck Research 
Department on Stem Cell Aging, Ulm University, Ulm, Germany
There is growing evidence that the accumulation of DNA damage and 
telomere dysfunction contributes to declines in stem cell function and tissue 
maintenance during aging and in response to chronic disease. Checkpoint 
responses that mediate the decline in stem cell function in response to DNA 
damage remain yet to be delineated. Here we conducted a functional ge-
nomic in vivo screen to identify genes impairing the function of hematopoi-
etic stem cells in the context of chronic DNA damage induced by telomere 
dysfunction. Screening of an shRNA library of 1000 cancer related genes re-
vealed that the shRNA mediated knock down of the transcription factor Batf 
was most potent to rescue the function of telomere dysfunctional stem cells. 
Specifically, Batf knockdown was 500fold enriched in telomere dysfunctional 
HSCs compared to wildtype HSCs when transplanted into lethally irradiated 
recipients. Our study shows that Batf is strongly upregulated in HSCs in 
response to telomere dysfunction or gamma-irradiation induced DNA dam-
age and during mouse aging. Upregulation of Batf in HSCs in response to 
DNA damage was G-CSF/Stat3 dependent. shRNA-mediated knockdown of 
Batf rescued the repopulation capacity of telomere dysfunctional stem cells 
in transplanted recipients. This rescue in HSC function was associated with 
impaired induction of lymphocyte differentiation markers, cell cycle inhibi-
tors (p53, p21, p16), and apoptosis in telomere dysfunctional or gamma-
irradiated HSCs. Irradiation experiments revealed that lymphoid competent 
HSCs (CD150low CD34- KSL) were most sensitive to DNA damage induced 
stem cell depletion, which was rescued by shRNA mediated knockdown of 
Batf. Together, this study provides the first experimental evidence that DNA 
damage leads to induction of a Batf-dependent differentiation checkpoint 
limiting the repopulation capacity of HSCs and the self-renewal of lymphoid 
competent HSCs. It is conceivable that this molecular circuit contributes to 
the age-dependent skewing of HSC characterized by impairments in lym-
phopoiesis and increases myelopoiesis.
Poster Board Number: 3264
MODULATION OF THE LIN28/LET-7 PATHWAY 
ENHANCES WOUND HEALING AND 
REGENERATION.
Shyh-Chang, Ng, Zhu, Hao, Shah, Samar P., Einhorn, William S., 
Takeuchi, Ayumu, Viswanathan, Srinivas R., Daley, George Q.
Hematology/Oncology, Children’s Hospital of Boston, Boston, MA, USA
Planaria, zebrafish and newts are capable of epimorphic regeneration, the 
regrowth of anatomically complex organs after injury or amputation. In 
contrast, mammals lack the ability to regenerate injured limbs, hearts and 
spinal cords. In studies of the RNA-binding proteins Lin28a and Lin28b, 
which block the processing of let-7 microRNA family members to promote 
pluripotency in embryonic stem cells and to enhance somatic cell reprogram-
ming, we have noted a surprising regeneration phenotype in several injury 
models. First, we found that Lin28a transgenic (Tg) mice have a markedly 
enhanced capacity to regrow hair after shaving in both 4 and 10 week old 
mice, reflecting rapid re-entry into anagen after a prolonged telogen phase. 
Second, Lin28a Tg mice show improved capacity for wound healing after 1 
or 2mm ear hole punching, with decreased wound size at day 5, 8, and 25, 
and shorter time to full hole closure. In contrast, induction of let-7g in con-
ditional transgenic mice delayed wound healing and resulted in incomplete 
wound closure. Third, Lin28a transgenic mice displayed enhanced soft tissue 
and bone regeneration after neonatal digit amputation, even when normal-
ized for differences in animal size. Expression analysis in regenerating digits 
revealed upregulation of canonical let-7 target mRNAs including Lin28a, 
Hmga1/2, Igf2bp1-3, Igf1 and Igf1r. To determine if Lin28a Tg mice mani-
fest enhanced regeneration via the same pathways as do MRL mice, a well-
known regenerative strain, we performed epistasis experiments. Surprisingly, 
even in the MRL background Lin28a overexpression produced enhanced 
regeneration following digit amputation, suggesting non-overlapping, syn-
ergistic mechanisms of enhanced regeneration. We are currently exploring 
the cellular and molecular bases for these phenomena. In summary, we have 
demonstrated that mammalian regeneration and wound healing can be 
augmented by genetic modulation of the Lin28/let-7 pathway, which may 
be exploited therapeutically.
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Poster Board Number: 3266
DIRECT CONVERSION OF HUMAN 
FIBROBLASTS TO DOPAMINERGIC NEURONS
Pfisterer, Ulrich1, Kirkeby, Agnete1, Torper, Olof1, Wood, James2, 
Nelander, Jenny1, Dufour, Audrey1, Björklund, Anders3, Lindvall, 
Olle2, Jakobsson, Johan4, Parmar, Malin1
1Developmental Neurobiology, Lund University, Lund, Sweden, 2Laboratory 
of Neurogenesis and Cell Therapy, Lund University, Lund, Sweden, 
3Neurobiology, Lund University, Lund, Sweden, 4Molecular Neurogenetics, 
Lund University, Lund, Sweden
Recent studies revealed that overexpression of defined factors enables direct 
conversion of somatic mouse cells into other mature cell types, such as 
cardiomyocytes, neurons or insulin-secreting beta cells. We show that the 
same three factors that convert mouse fibroblasts into neurons (Ascl1, Myt1l 
and Brn2) can be used to directly convert human fibroblasts into functional 
neurons, termed human induced neural (hiN) cells. The neuronal properties 
of the hiN cells were verified based on morphology, expression of neuronal 
markers (beta-III-tubulin, MAP2 and Synaptophysin), and electrophysiologi-
cal characteristics of neurons. In the presence of the three conversion factors 
(Ascl1, Myt1l and Brn2), only few hiN cells expressed GABA or glutamate 
and no hiN expressed markers of dopaminergic or serotonergic neurons. 
We hypothesize that additional factors are needed to program hiN cells into 
subtype-specific neurons. Therefore, we performed direct neural conversion 
of human fibroblasts in the presence of two additional factors known to be 
important for dopamine fate specification. Under these conditions, hiN cells 
expressing TH, AADC and Nurr1 are formed. This study provides evidence 
that human fibroblasts can be directly converted into functional neurons. 
The ability to further direct the converted cells towards specific subtypes 
of neurons, exemplified here by dopamine neurons, offers exciting future 
possibilities to generate patient-specific neurons for disease modelling and 
brain repair.
Poster Board Number: 3268
DIRECT CONVERSION OF HUMAN SOMATIC 
CELLS INTO NEURONS BY DEFINED 
TRANSCRIPTION FACTORS
Pang, Zhiping P, Yang, Nan, Vierbuchen, Thomas, Südhof, Thomas 
C, Wernig, Marius
Stanford University, Palo Alto, CA, USA
Cell-lineage fates are considered stable once determined during embryonic 
development. However, experimental manipulations such as somatic cell 
nuclear transfer, cell fusion, or expression of lineage-specific factors can 
induce cell-fate changes in diverse somatic cell types. We recently observed 
that forced expression of a combination of three transcription factors, Brn2 
(also known as Pou3f2), Ascl1, and Myt1l rapidly and efficiently convert 
mouse fibroblasts into functional neuron-like cells termed induced neuronal 
(iN) cells. Here, we asked whether iN cell reprogramming factors could 
also generate neurons from human cells. We show that a very similar ap-
proach yields iN cells from fetal or postnatal human fibroblasts. The human 
iN cells displayed typical complex neuronal morphologies, expressed an 
array of pan-neuronal as well as subtype-specific neuronal markers, and 
were stable after downregulation of the exogenous transcription factors. 
Importantly, the vast majority of human iN cells were able to generate action 
potentials, and many matured sufficiently to receive synaptic contacts from 
primary mouse cortical neurons. Our data provide a proof-of-principle that 
non-neural human somatic cells can be directly converted into neurons by 
lineage-determining transcription factors. We are currently optimizing the 
reprogramming factor combination and culture condition to improve the 
efficiency of generating functional human iN cells. These methods may al-
low robust generation of patient-specific human neurons for in vitro disease 
modeling or future applications in regenerative medicine.
Poster Board Number: 3270
DIRECT REPROGRAMMING OF HUMAN 
FIBROBLASTS INTO CARDIOMYOCYTE-LIKE 
CELLS BY DEFINED FACTORS
Fu, Jidong1, Qian, Li1, Hayashi, Yohei1, Spencer, Ian1, Ieda, Masaki2, 
Srivastava, Deepak1
1J David Gladstone Institute, San Francisco, CA, USA, 2Keio University 
School of Medicine, Tokyo, Japan
Recently, we reported that mouse cardiac and dermal fibroblasts can be 
directly reprogrammed into cardiomyocyte-like cells by three defined 
transcription factors (e.g., Gata4, Mef2c, Tbx5), and we termed these cells 
induced cardiomyocytes (iCMs). 50% of cells in the human heart are fibro-
blasts, providing a vast pool of potential cells that could be reprogrammed 
into cardiomyocytes if an analogous cocktail of factors could be identified. In 
the current study, we found that a combination of seven defined transcrip-
tion factors rapidly and efficiently reprogrammed human ES cell-derived 
fibroblasts or adult human dermal fibroblasts into cardiomyocyte-like cells. 
30% of fibroblasts transduced with the human cardiac reprogramming 
factors expressed cardiac troponin T within 2-weeks. These cells expressed 
cardiac-specific markers and had a global gene expression profile similar to 
that of cardiomyocytes. These findings demonstrate that human fibroblasts 
can be directly reprogrammed into cardiomyocyte-like by defined factors. 
Reprogramming cardiomyocytes from patient-specific fibroblasts might pro-
vide a viable cell source for regenerative medicine and for modeling cardiac 
disease.
Poster Board Number: 3272
ELECTROPHYSIOLOGICAL PROPERTIES OF 
FUNCTIONAL NEURONS DIRECTLY CONVERTED 
FROM HUMAN FIBROBLASTS
Wood, James C.1, Kirkeby, Agnete2, Pfisterer, Ulrich2, Torper, Olof2, 
Nelander, Jenny2, Dufour, Audrey2, Bjorklund, Anders2, Lindvall, 
Olle1, Jakobsson, Johan2, Parmar, Malin2
1Department of Clinical Sciences, Lund University, Lund, Sweden, 
2Department of Experimental Medical Science, Lund University, Lund, 
Sweden
Recent reports have shown that mouse somatic cells can be directly 
converted to functional neurons using the combined expression of de-
fined factors. We have now shown that the same strategy can be applied 
to human embryonic and postnatal fibroblasts by over-expression of the 
transcription factors Ascl1, Brn2, and Myt1l. Here we demonstrate using 
whole-cell patch-clamp recordings that the human fibroblasts are converted 
to functional neurons. These cells, at 30-32 days in vitro, exhibited passive 
and active membrane properties (e.g., input resistance, resting membrane 
potential, whole-cell currents, action potential threshold, amplitude, and 
duration) comparable to functional neurons. Depolarizing current injection 
elicited trains of TTX-sensitive action potentials. The converted cells could 
be directed towards a specific neuronal subtype when two genes involved 
in dopamine neuron generation, Lmx1a and FoxA2, were provided together 
with the three conversion factors. At 28 days in vitro, these cells showed 
passive and active membrane properties characteristic of mature neurons, 
and a proportion exhibited spontaneous action potentials and properties re-
sembling those of midbrain dopamine neurons in vitro. Our results indicate 
that human embryonic and postnatal fibroblasts can be directly converted to 
functional neurons of specific subtypes.
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CENTRIOLE DEACETYLATION IS A 
CYTOPLASMIC EVENT VITAL FOR 
REPROGRAMMING HUMAN CELLS BY 
INDUCED PLURIPOTENCY
Simerly, Calvin, Easley IV, Charles, Ben-Yehudah, Ahmi, Oliver, 
Stacie, Redinger, Carrie J., McFarland, Dave, Schatten, Gerald
Obstetrics-Gynecology-Reproductive Sciences, University of Pittsburgh, 
Pittsburgh, PA, USA
Centriole Deacetylation is a Cytoplasmic Event Vital for Reprogramming 
Human Cells by Induced Pluripotency. Calvin Simerly1,2, Charles Easley IV1, 
Ahmi Ben-Yehudah1, Stacie Oliver1, Carrie J Redinger1, Dave McFarland1 
and Gerald Schatten1,2,3. 1Division of Developmental and Regenerative 
Medicine, Department of Obstetrics, Gynecology, and Reproductive Sci-
ences; 2Department of Cell Biology-Physiology; 3Department of Bioengi-
neering; University of Pittsburgh, Pittsburgh, PA 15213, USA 
Induced pluripotency (iPS) has revolutionized human stem cell biology 
since patient-specific, disease-bearing pluripotent cell lines can readily be 
generated for fundamental and translational investigations, and yet the 
underlying molecular mechanisms responsible for iPS have not been fully 
elucidated. While great strides have been made in understanding the roles 
of transcription factors and epigenetic chromatin modifications, our research 
focuses on the cytoplasmic mediators of reprogramming. Specifically, we 
have discovered that the microtubules which comprise the centrioles in the 
poles of the mitotic spindles of human pluripotent stem cells (hPSCs) are 
post-translationally modified. -Tubulin is acetylated at lysine 40 in centri-
oles found in human somatic and pluripotent stem cells (PSCs) at mitosis, 
with only weak localization in spindle pole microtubules. This centriole 
localization pattern persists in some early in vitro differentiation colonies 
and following cold depolymerization of microtubules. Interestingly, rescue 
of cold-treated PSCs demonstrates that the first dynamic microtubules to 
reassemble from the centrosomes are not acetylated. Between 30-60sec 
post-cold recovery in interphase cells, acetylated microtubule cables appear 
which are detached from the centrosome where dynamic microtubules 
are reassembling. Acetylated--tubulin is lost from centrioles after exposure 
to HDAC inhibitors (HDACi), especially inhibitors to HDAC6, which may 
well serve as a cytoplasmic Tubulin Deacetylase (TubDAC). We found that 
Tubastatin-A, Scriptaid, Trichostatin-A, and SAHA, but not Oxamflatin, 
induces a loss of centriole acetylation and a concomitant increase in spindle 
microtubule acetylation in human pluripotent hESCs and iPS cell lines. Like-
wise, HDACi treated cells exposed to cold followed by microtubule rescue 
for 2 min showed no centriole acetylation, but increased spindle microtubule 
acetylation. We also investigated if the HDAC6 inhibitor Tubastatin-A would 
prevent iPS reprogramming— Neither PSC colony formation nor of the PSC 
pluripotency marker expression (SSEA-4) are found. Tubastatin-A induces 
differentiation of hPSCs but without apparent effects on histone acetylation 
levels in pluripotent cells as well as in cells undergoing iPS reprogramming. 
These investigations focus on the role of the cytoplasm and cytoskeleton 
in mediating the events of nuclear reprogramming, and demonstrate 
tight cooperation between nuclear dynamics and cytoskeletal plasticity. In 
summary, this research demonstrates that post-translational modifications 
of microtubules, in addition to transcriptional regulation, are essential for 
both differentiation as well as reprogramming by iPS in human cells. We 
conclude that microtubule deacetylation in mitotic centrioles is required for 
reprogramming Human iPS cells. This then represents A Novel Cytoplasmic 
Example of ‘Centriole Reprogramming.’ Sponsored by the National Institutes 
of Health.
Poster Board Number: 3276
HUMAN IPS GENERATED WITH FUSION 
PROTEINS. FINE TUNING OF THE PROCESS 
WITH SMALL MOLECULES
Cailleret, Michel, Chose, Olivier, Brenot, Marion, Itier, Valerie, 
Dumay, Vinciane, Polentes, Jerome, Onteniente, Brigitte
INSERM UMR861/UEVE/CECS, I-STEM, Evry, France
The possibility to directly reprogram somatic cells into iPS cells with recom-
binant proteins has been described from 2009 by several groups. Totally 
devoid of viral sequences, protein-based iPS might represent the ideal stem 
cell (SC) source for a number of applications, particularly in a therapeutic 
perspective. Generalization of this approach is linked to the optimization 
of a number of steps that include protein production and purification on 
one hand, and protein concentrations and timing of application on the 
other hand. An additional and crucial parameter is the application of small 
molecules to improve the reprogramming process. The coding sequences 
of human OCT4, NANOG, KLF4, SOX2, LIN28 and C-MYC were fused 
to the protein transduction domain of the HIV1-TAT. TAT recombinant 
proteins were produced in human embryonic kidney (HEK293) cells, to allow 
post-transcriptional modifications, and were purified with FPLC (Akta, GE 
Healthcare) using either a STREP or a 6-His tag. The purity and concentra-
tions of TAT-proteins were assessed with Western blot and ELISA. Sox2 or 
Nanog promoter reporter lines were constructed with human fetal lung 
fibroblasts (IMR90, ATCC). Reporter IMR90 were cultured in fibroblast me-
dium in 24-well plates at a density of 10.000 cells per well and were treated 
at 80% confluency with combinations of TAT-proteins and the following 
small molecules: CHIR99021 (3µM), PD0325901 (, BIX01294, SB31542 (25 
µM), valproic acid (0.5 µM), sodium butyrate (1 mM), ascorbic acid (1 mM), 
5-azacytidine and E-616452 (2.5-25 µM). Cells were treated daily for 5 days 
with the proteins and for 10 days with the molecules. At day 15, they were 
replated in hESC medium on mouse embryonic feeders (MEF). E-616452 at 
2.5 µM was added after 5 days for 10 days. Controls received either: TAT-
proteins only, small molecules only, or the culture medium only. Morpho-
logical changes were observed from day 5 and day 10 in wells treated with 
TAT-OKSL in the presence of CHIR99021+PD0325901+E-616452 and in the 
presence of VPA+SB431542+E-616452 (2.5 µM), respectively. Cell clusters 
formed from day 15 in both conditions and evolved into colony-like struc-
tures in 3 weeks. The efficacy of reprogramming was of 0.001% in both 
conditions. Adding TAT-c-Myc had no further effects. Other combinations 
resulted in either death of fibroblasts after plating in hESC conditions or for-
mation of non-viable clusters of varying sizes. Strong fibroblasts death was 
observed in control wells with small molecules in the absence of TAT-pro-
teins. The expression of pNANOG-GFP and pSOX2-GFP was concomitant 
to morphological changes, confirming rapid cell transduction and biological 
efficacy of the proteins, and was maintained for the whole duration of the 
experiments, suggesting accurate reprogramming. The analysis of the colo-
nies is in progress, as is the validation of the process on other cell sources.
Poster Board Number: 3278
IDENTIFICATION OF A SET OF TRANSCRIPTION 
FACTORS FOR DIRECT REPROGRAMMING 
OF HUMAN SOMATIC CELLS INTO 
HEMATOPOIETIC STEM CELLS/PROGENITORS
Sandler, Vladislav M., Bouhassira, Eric E.
Medicine/Hematology, Albert Einstein College of Medicine, Bronx, NY, 
USA
Modern methods of treatment of numerous malignant (e.g. leukemia and 
lymphoma), and genetic (e.g. immunodeficiencies, hemoglobinopathies, 
and Fanconi’s Anemia) blood diseases rely on hematopoietic stem cell (HSC) 
transplantation. While it is possible to prospectively isolate HSCs/ progeni-
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tors from patient’s blood and bone marrow to use for transplantations, they 
neither can be reliably maintained and expanded in undifferentiated state 
in culture nor manipulated to eliminate genetic cause of a disease. In order 
to overcome this problem we have attempted to rationally identify a set of 
transcription factors necessary for reprogramming human somatic cells into 
HSCs. During development the first definitive HSCs are found in the dorsal 
aorta within the aorta-gonad-mesonephros (AGM) region, in two arteries 
that connect the dorsal aorta with the yolk sac, and the vitelline and umbili-
cal arteries. Mouse as well as human placentas and placental vasculature are 
considered to be potent hematopoietic sites from midgestation to birth. We 
have compared a transcription profile of human HSCs and human umbilical 
arterial endothelial cells (HUAECs). We have identified a set of transcrip-
tion factors and micro RNAs that are differentially expressed in these two 
cell type. Over-expression of a subset of these factors in human embryonic 
fibroblasts converted them into CD45+ cells. In a methyl-cellulose colony 
forming assay CD45+ fibroblasts were able to generate CD11b+, CD16+, 
and CD71+ cells.
Poster Board Number: 3282
CHEMICAL AND GENETIC PLATFORMS FOR 
THE GENERATION OF PHARMACEUTICAL-
GRADE, TRANSGENE-FREE HUMAN INDUCED 
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The generation of induced pluripotent stem (iPS) cells by forced expression 
of reprogramming factors has overcome the ethical and technical hurdles 
that are associated with the use of embryonic stem cells. However, the use 
of iPS cells in scientific and clinical applications is hindered by the very low 
reprogramming efficiency, the use of viruses and oncogenic transcription 
factors to generate iPS cells, the incomplete silencing of the trangenes or 
their re-activation, and the use of animal products including serum and 
feeder cells. To overcome these obstacles and generate “pharmaceutical-
grade” human iPS cells, we established an enhanced protocol for the 
generation, selection, and maintenance of iPS cells. Human fibroblasts were 
isolated and cultivated from donor-consented adult tissue (skin biopsy) 
or neonatal foreskin tissue, and infected with a single lentivirus carrying a 
Cre recombinase-excisable polycistronic cassette expressing three or four 
reprogramming factors (Oct4, Sox2, and Klf4, with or without c-Myc) 
connected with 2A self-cleaving peptides and internal ribosome entry site 
(IRES). The use of the polycistronic lentivirus reduced the number of viral 
integrations required for the reprogramming process, and thus reducing the 
risk of insertional mutagenesis. We achieved significant enhancement in 
reprogramming efficiency (more than 50 fold) by using a cocktail of 4 small 
molecule inhibitors of signaling pathways (TGFβ, MEK, GSK3β, and ROCK) 
that regulate stem cell differentiation and self-renewal. The small molecule 
cocktail enabled efficient generation of iPS cells in feeder-free culture and 
defined media, culture conditions that are required if iPS cells are to be used 
for pharmaceutical or clinical applications. In addition, instead of relying 
on morphology only for picking iPS cell colonies, we have improved on the 
selection process by using fluorescence-activated cell sorting for the isolation 
of SSEA4- and Tra-1-81 double positive iPS cells. To eliminate any residual 
expression of the transgenes or the risk of reactivation, established iPS cell-
lines were transfected with the Cre recombinase to excise the polycistronic 
cassette (contains a loxP site) and transgene-free clones were selected and 
characterized. Thus, our chemical and genetic platforms enabled robust 
generation of feeder-free, transgene-free “pharmaceutical-grade” iPS cells 
that can be used in pharmaceutical screening applications, and ultimately 
cell therapy applications.
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Kim, Janghwan1, Efe, Jem A.1, Zhu, Saiyong1, Talantova, Maria2, 
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The simple yet powerful technique of induced pluripotency may eventu-
ally supply a wide range of differentiated cells for cell therapy and drug 
development. However, making the appropriate cells via induced pluripotent 
stem cells (iPSCs) requires reprogramming of somatic cells and subsequent 
re-differentiation. Given how arduous and lengthy this process can be, we 
sought to determine whether it might be possible to convert somatic cells 
into lineage-specific stem/progenitor cells of another germ layer in one step, 
bypassing the intermediate pluripotent stage. Here we show that transient 
induction of the four reprogramming factors (Oct4, Sox2, Klf4, and c-Myc) 
can efficiently transdifferentiate fibroblasts into functional neural stem/
progenitor cells (NPCs) with appropriate signalling inputs. Compared to 
“iN cells”, transdifferentiated NPCs have the distinct advantage of being 
expandable in vitro and retaining the ability to give rise to multiple neuronal 
subtypes and glial cells. Our results provide a new paradigm for iPSCfactor-
based reprogramming by demonstrating that it can be readily modified to 
serve as a platform for transdifferentiation.
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1Department of Pharmacology and Toxicology, Dresden University of 
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Center for Regenerative Therapies, Dresden University of Technology, 
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Introduction of iPSCs was beyond doubt a major breakthrough. Neverthe-
less direct conversion of one cell type into another without passing through 
the intermediate pluripotent stage is highly desirable for regenerative 
medicine. Recent success in direct lineage reprogramming in the pancreatic 
and neuronal field encouraged us to establish a project on direct lineage 
reprogramming into cardiomyocytes. We cloned 9 cardiac transcription 
factors (Nkx2.5, Gata4, Gata5, Tbx5, Tbx20, Mef2c, Myocd, Mesp1, Srf) 
and the chromatin remodeling factor Baf60c into lentiviral backbones. All 
possible 120 combinations of 3 factors out of this pool of factors were 
screened on E13.5 mouse embryonic fibroblasts (Mefs). As readout Q-PCR 
for the cardiac contractile apparatus genes Myh6, Myl2, Actc1 the transcrip-
tion factor Nkx2.5 and the cardiac sodium channel gene Scn5a was applied. 
Upregulation of all 5 cardiac markers was considered as indication for a 
positive reprogramming event. The combination of Tbx5, Mef2c, Gata4 
which was recently shown to result in beating cardiomyocytes by direct 
reprogramming of fibroblasts only caused upregulation of Myh6 and Actc1 
whereas expression of Myl2, Nkx2.5 and Scn5a was unchanged in our ex-
periments. In contrast we identified one alternative combination resulting in 
at least five times upregulation of all tested cardiac genes. Antibody staining 
against cardiac alpha-actinin was positive for both combinations but did not 
show organized striation. Also no spontaneous beating cells were observed. 
We reasoned that the starting cell type might be important for reprogram-
ming into functional cells. Therefore a transgenic mouse model express-
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ing dtTomato under the control of the cardiac alpha-myosin heavy chain 
promoter (Myh6) was established. This enabled us to isolate and purify 
neonatal cardiac fibroblasts and furthermore to in vitro trace the induction 
of the cardiac program by the expression of dtTomato. As starting popula-
tion cardiac fibroblasts were isolated from heart pieces and FACS sorted for 
Myh6 negative, Thy1 (CD90) positive cells. No dtTomato positive cells were 
detected in the cultures directly after sorting. Application of Tbx5, Mef2c, 
Gata4 resulted in 0.5% dtTomato positive cells 14 days post infection. With 
the combination identified in our screen we obtained 2% dtTomato positive 
cells. Antibody stainings against cardiac alpha-actinin 14 days post infection 
showed beginning of cross striation and therefore indicated the establish-
ment of a contractile apparatus. Further analyses are necessary to figure 
out whether functional cardiomyocytes can be obtained with this method. 
Currently we are investigating the electrophysiological properties of the dt-
Tomato positive cells.
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Introduction: Induced pluripotent stem cells (iPSCs) can be generated by 
ectopic overexpression of the four transcription factors Oct4, Sox2, Klf4 and 
c-Myc. Even though re-activation of the pluripotency-related transcriptional 
network during reprogramming is well studied, only limited information is 
available on the role of microRNAs (miRNAs), which support induction of 
pluripotency in somatic cells. Here, conducting a full miRNA library screen 
during the early phase of iPSC generation, we investigated if particular 
miRNAs can improve reprogramming and sought to elucidate further 
molecular pathways involved in the induction of pluripotency. Materials/
Methods: We transduced murine embryonic fibroblasts (MEFs) from OG2 
mice (Oct4 promoter-driven GFP expression) with a polycistronic lentiviral 
construct expressing Oct4, Klf4 and Sox2 from a spleen focus forming virus 
(SFFV)-derived promoter/enhancer. Twenty-four hours after transduction, 
we individually transfected murine miRNAs from a Pre-miR miRNA Precursor 
Library-Mouse V3 containing 379 miRNAs (Ambion) into these MEFs. At 
day 7 to 10 after transduction, GFP-positive colonies were counted. 
Results: Applying a threshold of 4-fold induction of reprogramming events 
over the controls, we could identify miRNAs previously demonstrated to im-
prove reprogramming, such as the mir-290 and mir-302 clusters. In addition, 
we were able to find twelve hitherto unpublished miRNAs profoundly en-
hancing iPSC generation. Interestingly, we identified a miRNA family target-
ing the same downstream mRNAs. Based on in-silico predictions (Targetscan 
and miRBase), we investigated the putative miRNA targets BMPRII, Mier1, 
Mecp2, Meox2, phospho-Erk1/2 and Pten by western blot and luciferase 
assays. Indeed, one of these factors was directly regulated by this miRNA 
family. Further validation reveals that ectopic overexpression of the protein 
from a lentiviral construct significantly decreased reprogramming events, but 
specific siRNA-mediated knockdown of this factor enhanced reprogramming 
efficiencies comparable to the miRNA-mediated effects. Conclusion: Ap-
plying a full library miRNA screen, we were able to identify further miRNAs 
that significantly increase the induction of pluripotency in MEFs. Indeed, a 
newly characterized miRNA family specifically targets one protein, whose 
knockdown facilitates and whose lentiviral overexpression blocked repro-
gramming. Further studies aim at elucidating downstream effectors of the 
transcription factor identified.
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Adult spermatogonial stem cells (SSCs) maintain spermatogenesis in males 
and also transmit genetic information to the next generation. Despite their 
lineage commitment, these cells are capable of achieving pluripotency 
spontaneously, forming embryonic stem cell-like cells (referred to as multi-
potent adult spermatogonial-derived stem cells or MASCs), which in turn 
can produce a repertoire of tissues. Therefore, it is important to understand 
the genetic and/or environmental conditions that predispose these cells to 
acquire pluripotency without any prior manipulations. Identified by GPR125 
expression, SSCs can either remain quiescent, self renew, undergo pro-
grammed cell death or form MASCs. Based on our established protocols to 
maintain SSCs in vitro, we hypothesize that the microenvironment created 
by the combination of SSCs and CD34+ mouse testis stromal cells, employed 
as feeders, determines the fate of SSCs. To address this hypothesis, we have 
utilized SSCs derived from transgenic reporter mice to monitor change in 
GFP expression, as an indicator of pluripotency gene promoter activity. Our 
study revealed a progressive increase in transcriptional activity of promoters 
associated with pluripotency in SSCs maintained in long term culture; this 
increase can be disrupted by passaging the cells and is highly dependent on 
initial plating conditions. These findings concur with prior observations that 
SSCs require uninterrupted maintenance in culture in order to acquire pluri-
potency. In order to understand the biology of the SSCs in normal culture 
conditions along with change in potency, we have investigated the change 
in cell cycle, cell proliferation and differentiation undergone by the SSCs. 
We have adopted three different approaches to define the niche-derived 
signals, as well as identify the molecular changes induced by these signals, 
that influence SSCs to form MASCs, a) altering culture conditions to influ-
ence cellular properties of SSCs, such as colony and monolayer formation, 
b) manipulating expression of candidate genes in SSCs and c) a chemical 
genetic approach. Our data suggest that the extracellular milieu strongly 
influences the SSC phenotype in vitro. Since the factors essential to support 
self-renewal of SSCs may be conserved among mammalian species, a deeper 
understanding of the biology of the SSCs could reveal alternative pathways 
to induce cells to become pluripotent, which would be of general impor-
tance in the field of stem cell biology and regenerative medicine
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GENERATION OF A ZERO-FOOTPRINT AND 
XENO FREE INDUCED PLURIPOTENT STEM 
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The generation of induced pluripotent stem cells from fibroblasts or other 
somatic cells enables the possibility of providing unprecedented access 
to patient-specific iPS cells for drug screening, disease modeling, and cell 
therapy applications. Animal models of human disease have shown that 
these cells have a potential to treat conditions developed by ageing, birth 
defects and injury. However, one major obstacle to the use of iPS cells for 
therapeutic applications is the viral-based delivery of reprogramming factors 
that result in multiple proviral integrations that pose the danger of insertion-
al mutagenesis. Second, the current reprogramming protocols involve the 
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use of products of animal origin, making them unsuitable for the generation 
of clinical grade iPSCs. Here we report the generation of a zero-footprint 
iPSCs in a Xeno-free condition. We derived human foreskin fibroblasts 
under Xeno-free conditions, reprogrammed with non-integrating mRNA 
method, and expanded iPSCs under XF-human feeders and conditions. The 
iPSCs generated in this system are able to proliferate, maintain and displays 
pluripotent markers. Further these cells are able to give rise to EBs that can 
differentiate to all the three lineages - ectoderm, endoderm and mesoderm. 
We also demonstrate that these iPSCs are free of genomic integration of 
exogenous genes by ICC staining and PCR. Generation of a footprint free 
iPSCs under Xeno free conditions should facilitate the safe clinical translation 
of iPSC-based therapies
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STEM CELLS WITH NON INTEGRATIVE VIRUS
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To date, a large number of reports have described reprogramming of many 
somatic cell types into induced pluripotent stem (iPS) cells, using different 
numbers of transcription factors and devising alternate methods of introduc-
ing the transcription factor genes or proteins into the somatic cells. However, 
one of the limitations of traditional reprogramming is that it leads to iPS cells 
that have integrated into their genome the viral genomes used for repro-
gramming, thus acquiring a mutagenic potential. Experiments leading to 
integration-free reprogramming of human somatic cells provided the proof 
of principle that transient expression of the four classical reprogramming 
factors is indeed sufficient to induce pluripotency in somatic cells. Neverthe-
less reprogramming efficiencies with current non integrating methods are 
several orders of magnitude lower (~0.001%) than those achieved with 
integrating vectors (0.1%-1%), most likely because factor expression is not 
maintained for a sufficient length of time to allow complete epigenetic re-
modelling. Here, we describe a method using mutated lentivirus which does 
not integrate into in the genome. The goal of our project is the validation 
of non-integrative vectors for iPS cell reprogramming. We are developping 
a new vectorology tool based on lentiviral transduction, but this time not 
integrative. Non-integrative lentiviral vectors (NILV) have been developed 
by several European teams and studies show they can be used as tools for 
effective transitive gene transfer. They retain their ability to penetrate effec-
tively into the target cells while losing their capacity of integration into the 
host genome. In fact, mutations are introduced directly into the gene coding 
for the virus integrase. The transgene expression is obtained from episomal 
forms of viral genome that are gradually diluted during cell divisions. We 
are currently testing different ways to transduce somatic cells with the NILV 
and we use integrative virus as a control. For now, these tests are performed 
with a GFP reporter gene and we could determine an accurate” M.O.I (Mul-
tiplicity Of Infection) for transduction. This M.O.I leads to a level of intensity 
of non-integrated GFP expression similar to that observed with integrated 
GFP. For the reprogramming experiments we will use a polycistronic vector 
containing OCT4, SOX2, KFL4 and c-MYC in fibroblasts. If this method 
allows us to obtain iPS cells free of any genome injury these cells and their 
in vitro differentiation into defined cell lineages should have an even greater 
impact as model systems for human diseases. The long-term goal of iPS cell 
technology is to provide a source of stem cell-derived allogeneic or autolo-
gous cell grafts for regenerative medicine approaches.
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Introduction: The groundbreaking work of Yamanaka’s group (2006) proved 
the possibility to reprogram mouse embryonic fibroblasts into stem cell-like 
cells (induced pluripotent stem cells or iPS) by viral introduction of 4 types 
of plasmid DNA, each encoding a defined factor (Oct4, Sox2, Klf4, cMyc). 
Since then, laboratories all over the world tried to improve the efficiency or 
safety, among others by using other (e.g. Nanog, Lin28) and/or less factors, 
by using other transfection methods (e.g. non-integrating vectors, protein-
based reprogramming). In the past decade, it became clear that mRNA, 
however always believed to be too unstable, can indeed transfect cells ef-
ficiently. Because mRNA does not integrate into the host genome, it is a per-
fect candidate to safely introduce the factors into somatic cells. Results: Our 
group has elaborate experience in mRNA transfection by non-viral means. 
Because mRNA induced protein expression is in situ transient, it is impera-
tive that expression of the 4 factors lasts long enough to induce reprogram-
ming. Therefore, we introduced mRNA encoding luciferase (by complex-
ation with liposomes) in two cell lines (HeLa and MSCs) and ensured that 
luciferase levels were detectable up to 9 days post transfection. Then, we 
subjected fibroblasts to either a single, double or triple transfection with 4 
different mRNAs, each encoding a factor (Oct4, Sox2, Klf4, cMyc). Flow 
cytometry following immunostaining proved successful transfection of all 
introduced factors, moreover, also expression of other transcription factors 
typically upregulated during the reprogramming process (such as Nanog) 
was significantly increased. Preliminary results, based on morphology and 
immunohistochemistry, indicate that iPS colonies have indeed been formed. 
Conclusion: mRNA not only has the potential to introduce the 4 above-
mentioned factors in somatic cells and thereby induce their reprogramming, 
it also has several advantages, such as no risk of insertional mutagenesis and 
lower immunogenicity (no CpG motifs). Preliminary results are very promis-
ing with regard to iPS colony formation, the final proof by means of embroid 
body and teratoma formation is currently being performed.
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The majority of the methodologies used to reprogram somatic cells into 
Induced Pluripotent Stem Cells (IPSCs) rely on genetic modification via viral 
vector. There is a great interest to elucidate a highly efficient economical and 
bio-safe non-genetic modifying method in order to move the IPSC field from 
bench to bedside providing a therapeutic source of stem cells to treat human 
disease or injury. In this study, we compared the reprogramming of human 
fibroblastic cells using two different methods; lentiviral which modifies the 
genome, and a hybrid BacMAM system that leaves the cell unmodified. The 
latter system can be considered a potentially therapeutic mode to reprogram 
cells. We used the CMV promoter combined with the beta globin intron in 
both systems to drive the expression of four factors; Oct4, Sox2, KLF, and 
L-Myc. To help track viral transduction Oct4 was combined with FMDV 2A 
splicing domain fused to a novel RFP-Blasticidin S-Deaminase fusion protein 
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(Oct4-2A-RB). In addition, we prepared a polycistronic counterpart combin-
ing Oct4, Sox2, KLF4 together with the 2A-RB domain, allowing visual 
tracking of transduction efficiency. Transduction of lentiviral four factors 
yielded greater than 80% infection rate, similar to that observed with Bac-
MAM. As the polycistronic lentiviral vector was difficult to package, we were 
unable to efficiently infect the cells. However, BacMAM polycistronic virus 
was as efficient as the four factor mix at transduction. Following transduc-
tion and 5-7 day treatment with VPA, the cells were passaged from a serum 
containing fibroblast media into mTeSR1/Matrigel with 3 small molecules 
to enhance reprogramming. After 7 days, the majority of the BacMAM 
infected cells were either dead, or no longer fluorescent, whereas the four 
factor lentiviral infected cells showed early signs of colony formation. After 
30 days, we observed distinct colonies, which were picked and expanded 
in mTeSR1 on Matirgel coated plastic. Current work is aimed at character-
izing the new IPSC line, and solving the massive cell death observed after 
BacMAM infection by addressing the role of interferon pathways activated 
via innate immune response to viral infection.
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Parkinson’s disease (PD) is a neurodegenerative disease affecting predomi-
nantly older people and is characterized by loss of movement control. The 
symptoms are caused by the degeneration of midbrain dopaminergic neu-
rons of the substantia nigra pars compacta which are involved in the control 
of voluntary movement. Studies have shown that dopamine neurons can 
be derived from ES cells and iPS cells and successfully integrated into animal 
models of PD to improve Parkinsonian behavior. Previously, our lab has 
shown the direct conversion of fibroblasts to neurons with 3 transcription 
factors Brn2, Ascl1 and Myt1L. Here, we aim to generate DA neurons of the 
A9 group from mouse embryonic fibroblasts (MEFs) using defined factors. 
By screening known transcription factors implicated in determination of 
dopaminergic fate, we have identified factors that not only convert MEFs to 
cells with neuronal characteristics, but with unique dopaminergic markers as 
well. Electrophysiological studies and functional transplantation into animal 
models will be used to characterize these cells. Our results suggest a promis-
ing future for these cells in cell replacement therapy of Parkinson’s disease. 
This strategy can also be used to generate specific subtypes of neurons that 
are involved in other diseases.
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REPROGRAMMING IN PORCINE NUCLEAR 
TRANSFER DERIVED EMBRYOS
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Efficiency of reproductive cloning derived from nuclear transfer using undif-
ferentiated status cells, i.e. embryonic stem cells has been known higher 
than differentiated ones in mice. It is believed that early embryonic genes 
(Oct4, Sox2 and Nanog, etc) may have beneficial influence on its nucleus 
reprogramming to produce cloned offspring. In this study, we hypothesized 
that ectopic expression of an early embryonic gene, oct4 in neonate skin 
fibroblasts will have affect early nuclear transfer embryonic development in 
pig. For this study, coding domain region of porcine oct4 from pig ovarian 
cDNA by PCR was cloned, sequenced and ligated to pCMV-IRES-DsRED 
express II vector (Clontech, USA). The linearized DNA was transfected to 
neonate ear skin fibroblasts and then after 48 hours 1mg/mL, neomycin 
was added in culture medium for around two weeks. Oct4 expression was 
observed in nucleus after immune-staining in selected fibroblasts, changed 
the morphology of the cells, and increased cell proliferation without viability 
decrease. Expression of related other genes (Sox2, c-Myc and Nanog) 
was not changed. Nuclear transfer was carried out using transfected (oct4 
expressed) or non-transfected cells as followed to our previous established 
protocol. Cleavage rate of cloned embryos from oct4 expressing cell line was 
higher than control group. Interestingly, first blastocyst formation time is one 
day faster than control group. In conclusion, this study demonstrated that 
porcine oct4, which was cloned and sequenced for the first time, had not 
only affected the morphology and proliferation of neonate skin fibroblasts, 
but also accelerated nuclear reprogramming to produce nuclear transfer 
embryos. In the future, we will find out which mechanism may be con-
nected in increase of speed of nuclear transfer embryonic development. This 
study was supported by grants from MKE (#2009-67-10033839, #2009-
67-10033805), IPET (#109023-05-1-CG000), NRF (#M10625030005-
10N250300510), and BK21 program.
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The present study showed the rhesus monkey (Macaca mulatta ) partheno-
genetic embryonic stem cells (rpESCs) lines were derived from parthenoge-
netic blastocysts in serum-free medium. These two novel rpESCs have typical 
primates ESCs morphology including clear clones boundary, high nuclear-
cytoplasm ratio and significant nucleolus. The rpESCs are positive for alkaline 
phosphatase and are immunoreactive for octamer-binding transcription fac-
tor 4 (Oct-4), Nanog, tumor rejection antigen 1-60 (TRA 1-60), tumor rejec-
tion antigen 1-81 (TRA 1-81), stage-specific embryonic antigen 4 (SSEA-4); 
The cells also were detected Sox-2 and Rex-1 by RT-PCR. The two novel 
rpESCs could spontaneously differentiate into cell lineages representative 
of all three embryonic germ layers by embryonic body (EB) formation and 
teratoma. Detailed G-banding analysis revealed that all of the two ESC lines 
were karyotypically normal, with a diploid set of 40+XX chromosomes, even 
after long time cultivation in vitro and repeat freezing. Several imprinted 
genes were tested and results suggested that both of the rpESCs expressed 
maternally imprinted genes including H19 and UBE3A. However, paternally 
expressed imprinted genes have a variable expression pattern, such as both 
of the rpESCs expressed PEG3 and SGCE, whereas, PEG10, ZIM2, and MEST 
were detectable only in one of the rpESCs. In addition, SNPRN, NDN and 
MAGEL2 were absent in both of rpESC but expressed in control biparental 
ESCs. These results suggest that reactivation of paternally imprinted genes in 
parthenogenesis was a stochastic process.
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Induced pluripotent stem (iPS) cells are generated from somatic cells by 
introducing a small number of transcription factors. Many iPS cell clones 
203
Friday Poster Abstractswww.isscr.org
Friday Poster Abstracts
have been generated using different tissues. We previously generated iPS 
cells from bimaternal parthenogenetic neural stem cells (pNSCs). Here we 
show the epigenetic status of imprinted genes influenced their gene expres-
sion during the generation and differentiation of parthenogenetic iPS cells. 
As expected, there was no the difference between NSC and pNSC on the 
expression of paternal imprinting genes. However we found that maternal 
imprinting genes exhibited remarkably higher expression in NSC, whereas 
they were expressed in pNSC at lower levels than in NSC through heat map 
of imprinting genes. In addition, parthenogenetic iPS cells exhibited a global 
gene profile clustering and an imprinting gene profile clustering closer to 
pESCs clustering and that was clearly distinct from that of pNSC. Interest-
ingly, pNSCs lost the parthenogenetic imprinting patterns during pluripo-
tential reprogramming. Parthenogenetic iPS cells had not reverted to the 
parthenogenetic imprinting patterns during differentiation. We explored the 
correlation between expression and methylation of PWS-related imprinted 
genes during reprogramming and differentiation. These results indicate 
that parthenogenetic iPS cells may be a useful tool to study Prader-Willy 
syndrome and other genetic imprinting diseases.
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We recently show that mouse fibroblasts can be directly reprogrammed into 
induced neuronal (iN) cells by the three transcription factors Ascl1, Brn2 
(Pou3f2), and Myt1l. This suggests that direct cell fate conversions are pos-
sible even between distantly related somatic cell types. However, this study 
left the important question open, what the differentiation stage and exact 
nature of the donor cells were. Primary fibroblast cultures are a heteroge-
neous mixture of various, presumably mesenchymal progenitors potentially 
including neural crest-derived lineages. We therefore asked whether iN cells 
can be generated from a better defined, terminally differentiated cell type. 
Here, we show that the same transcription factors can also convert albumin-
expressing hepatocytes into neuronal cells (Hep-iN cells). This provides 
unequivocal proof for direct lineage conversion between somatic cell types 
representing different germ layers.
Poster Board Number: 3310
MOLECULAR MECHANISMS OF ASTROGLIA-
TO-NEURON CONVERSION BY FORCED 
EXPRESSION OF NEUROG2
Masserdotti, Giacomo1, Gillotin, Sebastien2, Guillemot, Francois2, 
Berninger, Benedikt3, Götz, Magdalena1
1Institute of Stem Cell Research, Helmholtz Zentrum München, Munich, 
Germany, 2Molecular Neurobiology, National Institute for Medical 
Research, Mill Hill London, United Kingdom, 3Physiological Genomics, 
Ludwig Maximilians University Munich, Munich, Germany
Direct conversion of endogenous glia into neurons could provide an alter-
native for cell-based therapies of neurodegenerative diseases. One glial 
population meeting the requirement of widespread distribution throughout 
the mammalian brain consists of astroglial cells. Astroglial cells may be 
particularly suitable for attempts of direct conversion into neurons as they 
are lineage-related to neurons through common radial glia ancestors, they 
share molecular properties with astro/radial glial stem cells in the develop-
ing and adult brain and can acquire hallmarks of stem cells following injury 
and isolation in vitro. We have recently shown that retrovirus-mediated 
expression of the proneural genes Neurog2 or Mash1 (also referred to as 
achaete-scute complex homolog 1[Ascl1]) can directly convert astroglia of 
the postnatal mouse cerebral cortex into fully functional neurons. In order 
to gain insight into the molecular mechanisms of proneural gene-mediated 
direct astroglia-to-neuron conversion, we took advantage of an induc-
ible system in which the Neurog2 coding sequence is fused to a modi-
fied estrogen receptor (ERT2)-binding domain (Neurog2ERT2), rendering 
Neurog2 activity dependent on tamoxifen treatment. We could show that 
this system is tight in that Neurog2 activity can only be observed following 
stimulation with tamoxifen. Moreover, several days of tamoxifen treatment 
is capable of inducing neurogenesis from astroglia to a similar extent as 
forced expression of the wild type Neurog2. Using this system, which allows 
for a more precise timing of Neurog2 activity, we are currently examining 
which genes are activated during the course of direct astroglia-to-neuron 
conversion. Using this inducible system we also observed that, in contrast to 
an immediate onset of Neurog2 activity, delayed induction of Neurog2ERT2 
by tamoxifen failed to convert postnatal astroglia into neurons. This loss of 
susceptibility to Neurog2-induced reprogramming may be due to progres-
sive astroglial maturation, as reflected by a massive up-regulation of GFAP 
expression, providing a model system to study the dependence of proneural 
gene-mediated reprogramming on the maturation state. Morerover it allows 
for examining the possibility to overcome the loss of plasticity by forced 
expression of additional transcription factors.
Poster Board Number: 3312
INHIBITION AND ENHANCEMENT OF 
REPROGRAMMING BY CHROMATIN 
MODIFYING ENZYMES
Onder, Tamer T., Daley, George Q.
Hematology / Oncology, Children’s Hospital Boston, Boston, MA, USA
Generation of induced pluripotent stem (iPS) cells from differentiated cell 
types by somatic cell reprogramming involves complete resetting of epige-
netic states. A number of proteins are known to play a role in regulating 
the chromatin marks associated with these distinct epigenetic changes, 
but how such epigenetic modifiers influence the reprogramming process 
remains largely unknown. To address this question, we generated a shRNA 
mini-library targeting genes in DNA and histone methylation pathways, 
and screened for positive and negative regulators of iPS cell generation. 
Knock-down of the H3K27 histone methyl-transferase Ezh2 and partner 
components of the polycomb repressive complex inhibited reprogramming, 
while knockdown of three genes markedly increased reprogramming effi-
ciency. Reduced expression of one such gene, the H3K79 histone methyl-
transferase Dot1L, not only significantly increased the yield of iPS colonies, 
but could also substitute for the reprogramming factors Klf4 and Myc. iPS 
cells generated with only Oct4 and Sox2 in the presence of Dot1L inhibition 
differentiated into all 3 three germ layers in teratoma analyses, indicative 
of their pluripotency. We have established that Dot1L inhibition functions 
early in the reprogramming process, when gene expression analyses reveals 
a marked induction of the two alternative reprogramming factors Nanog 
and Lin28. By loss-of-function experiments, we showed that Nanog and 
Lin28 play essential functional roles in the enhancement of reprogramming 
by Dot1L inhibition. Our findings implicate select epigenetic modifiers in 
somatic cell reprogramming. Modulation of these genes can be exploited 
to generate iPS cells more efficiently and with fewer exogenous transcrip-
tion factors, and to understand the epigenetic mechanisms at play during 
reprogramming.
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REPROGRAMMING OF LINEAGE MARKED 
DIFFERENTIATED MUSCLE TO THEIR 
PROGENITOR CELLS BY SMALL MOLECULE 
INHIBITORS
Paliwal, Preeti, Conboy, Irina M.
University of California, Berkeley, Berkeley, CA, USA
Reprogramming of terminally differentiated cells to their progenitors can 
serve as powerful source of tissue specific stem cells. Skeletal muscle is a 
classic example of differentiation which involves activation and proliferation 
of adult muscle stem cells that give rise to precursor cells (myoblasts) which 
exit cell cycle and fuse to form terminally differentiated multinucleated 
myotubes. In order to study muscle reprogramming in culture conditions, 
we developed a novel technique to preferentially label myotubes by using 
Cre-Lox method which unequivocally distinguished mononucleated cells 
(reserve cells) from multinucleated myotubes. A significant percentage of 
these lineage marked multinucleated myotubes then de-differentiated into 
proliferating myoblasts in the presence of a tyrosine phosphatase and a 
general caspase inhibitor. The reprogrammed mononucleated proliferating 
cells down-regulated muscle differentiation markers, such as myogenin and 
embryonic myosin heavy chain, decreased expression of cdk inhibitor p21 
and up-regulated muscle progenitor markers such as Pax7 and MyoD1. 
These reprogrammed cells retain their full competence to form de-novo 
myotubes and contribute to in vivo muscle regeneration in immuno-defi-
cient NOD- SCID mice. This de-differentiation of lineage marked myotubes 
into reprogrammed myoblasts by small molecules has broad implications in 
understanding adult tissue regeneration and can be translated towards novel 
therapeutic approaches aimed to enhance muscle repair.
EMBRYONIC STEM CELLS CLINICAL APPLICATION
Poster Board Number: 3316
SCALABLE CULTURING AND DOWNSTREAM 
PROCESSING FOR THE PRODUCTION OF 
HUMAN EMBRYONIC STEM CELLS
Nie, Ying, Pattasseril, Jacob, Misleh, Elizabeth, Woo, Tsung Liang, 
Rowley, Jon
Cell Therapy R&D, Lonza Walkersville Inc, Walkersville, MD, USA
As demonstrated by the FDA approval of two clinical trials, human embry-
onic stem cell (hESC)-based cell therapies are progressing from bench to 
clinic. However, current plate and T-flask-based culture platforms and open 
centrifugation processes severely limit the scalability of hESCs production to 
commercially relevant lot sizes at reasonable cost of goods. The Lonza cell 
therapy R&D team set out to develop a closed and scalable hESC manufac-
turing process. This process design includes culturing hESCs in multilayer cell 
factories, the culture platform widely used in current cell therapy manufac-
turing, automatically washing and concentrating cell harvest using scalable 
downstream processing technology. Traditionally, hESCs are harvested and 
passaged as colony fragments with enzymatic treatment followed by labor 
intensive mechanical scraping. Single-cell passaging and harvesting is not 
desirable due to the low post-passaging and cryopreservation recovery and 
the increased risk of abnormal karyotype associated with low cloning effi-
ciency of hESCs. However, mechanical scraping cannot be directly applied in 
closed system and multilayer cell factories. To overcome this hurdle, we have 
optimized a process of expanding and passaging hESCs from T-flasks into 
multilayer cell factories with a novel non-enzymatic cell passaging method, 
followed by downstream processing with continuous counter-flow centrifu-
gation technology. The post-detachment cell viability was 93.0% with our 
non-enzymatic passaging method, compared with 52.7% cell viability of 
hESC colony fragments generated with the conventional hESC enzymatic 
and scraping passaging method. This greater viability results in improved 
post-passaging attachment and recovery, which enables higher passage 
ratio, and thus leads to greater process efficiencies and a more rapid scale-
up to harvests of billions of healthy, viable cells. The hESCs harvested from 
multilayer cell factories were characterized with flow cytometry and over 
90% of these cells were expressing pluripotency markers including OCT4, 
SSEA4, Tra-1-60 and Tra-1-81. The final cell harvest was concentrated over 
14 times after automated downstream processing, with only 2% drop in cell 
viability. Our study shows that hESC culture can be brought into scalable 
manufacturing platforms while maintaining the important quality param-
eters of viability and pluripotency markers. The culturing and downstream 
processing system we have developed has a great potential to be translated 
into cGMP compliant hESC production.
Poster Board Number: 3318
METHOD OF IMPROVING VIABILITY AND 
PURITY OF HESC-DERIVED NEURAL CELLS FOR 
CLINICAL TRANSPLANTATION
Nistor, Gabriel I., Siegenthaler, Monica, Poole, Aleksandra J., 
Airriess, Chris, Keirstead, Hans
California Stem Cell Inc., Irvine, CA, USA
The viability and purity of a human embryonic stem cell (hESC)-derived 
therapeutic product intended for clinical transplantation are important safety 
considerations. Neural cultures typically undergo some form of dissociation 
when being prepared for clinical transplantation. Neurons cultured in-vitro 
are especially sensitive to enzymatic dissociation and mechanical manipu-
lations. Following such disruptions, immediate viability is 75% to 90%. 
Additional cell death occurs a few hours following dissociation, resulting a 
drop in viability to 60 to 80%. Therefore, it can be anticipated that trans-
plantation of the dissociated population will include 10% to 40% nonviable 
cells, which is undesirable. In addition, hESC-derived neural populations for 
clinical use have the potential risk of containing unintended undifferenti-
ated stem cells, which can present tumorigenic risk. Methods to purify hESC 
neural derivates, including FACS or other labeling methods, can introduce 
undesirable components in the transplant or more often results in a drop 
of viability. Here we present an inherent aggregation-based method that 
ensures the purification of neural cells by elimination of nonviable cells and 
viable cells outside of the neural lineage, including that of undifferentiated 
stem cells, without the use of labeling techniques. Following this method 
of purification and improved viability, the final transplant population has a 
viability of 99% to100%. This method provides advantages over other cur-
rently used methods for purification and improvement of viability of hESC-
derived neural cell populations in development for clinical application.
Poster Board Number: 3320
DERIVATION OF A HUMAN EMBRYONIC STEM 
CELL LINE IN XENO-FREE CULTURE SYSTEM
Kim, Hee-Sun1, Oh, Sun Kyung2, Yoon, Bo Ae2, Seol, Hye Won2, 
Baek, Jin Ah2, Ku, Seung-Yup3, Kim, Seok Hyun3, Choi, Young Min3, 
Moon, Shin Yong3
1Seoul National University Hospital, IVF laboratory, Dept of Obstetrics & 
Gynecology, Seoul, Korea, Republic of, 2Seoul National University College 
of Medicine, Institute of Reproductive Medicine & Population, Medical 
Research Center, Seoul, Korea, Republic of, 3Seoul National University 
College of Medicine, Dept of Obstetrics & Gynecology, Seoul, Korea, 
Republic of
INTRODUCTION: Derivation and culture of human embryonic stem cells 
(hESCs) without animal material would be optimal for future application 
of hESCs in clinical cell therapy. Here, we set out to develop a protocol to 
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derivation and maintain human embryonic stem cells that would be xeno-
free condition. METHODS: We used post-natal, commercially available 
human foreskin fibroblasts (HFFs) as feeder cells. Thawed human embryos 
which survived and developed up to the blastocyst stage were cultured on a 
confluent layer of mitomycin C inactivated HFFs in G-1/G-2 embryo culture 
media in 4-well plates. On day 6, embryos developed into blastocysts with a 
cavity, zona pellucida was removed after a short incubation in acid Tyrode’s 
solution. We developed a practical mechanical isolation method for the 
inner cell mass (ICM). Two glass pipettes with sharpened tips were used to 
device trophectoderm and ICM under a stereomicroscope. Isolated ICMs 
were cultured in xeno-free culture systems that replaced other reagents of 
animal origin (gelatin, Knockout SR, mouse fibroblast) with their recombi-
nant equivalents (humanized CELLstartTM, Knockout SR xeno-free, HFFs). 
RESULTS: Cryopreserved human embryos (n=40) were donated to this study 
upon informed consent by couples. From these embryos, 9 blastocysts (2 
early blastocysts, 2 mid blastocysts and 5 expanded blastocysts) were used 
for derivation of new clinical-grade hESC line. Three ICM outgrowths were 
mechanically passaged, and one hESC lines was derived (mid blastocyst). 
One xeno-free hESC line, which could be continuously passage in xeno-free 
conditions and maintained characteristics indistinguishable from previously 
established hESCs, including colony morphology and growth behavior, ex-
pression of pluripotency-associated markers, normal karyotype (46,XY) and 
pluripotent differentiation ability in vitro. CONCLUSION: Overall, the results 
presented here demonstrate that hESCs can be generated and maintained 
under xeno-free conditions that should be facilitated the clinical translation 
of hESCs-based therapies. This work was supported by the Stem Cell Re-
search Center of the 21st Century Frontier Research Program funded by the 
Ministry of Education, Science and Technology, Republic of Korea (SC1150).
Poster Board Number: 3322
HIGH QUALITY EPISOMAL HUMAN IPSC LINES 
DERIVED FROM CORD BLOOD WITH A ZERO 
VIRAL FOOTPRINT: APPLICATIONS IN SERUM 
FREE AND XENO FREE CULTURE SYSTEMS
Pal, Shruthi1, Kaur, Jasmeet2, MacArthur, Chad3, Peters, Ann4, Park, 
Tea Soon5, Yuan, Xuan6, Burridge, Paul6, Kolkundkar, Udaykumar1, 
Zambidis, Elias6, Vemuri, Mohan2
1Primary and Stem Cell System, Life Technologies, Bangalore, India, 
2Primary and Stem Cell System, Life Technologies, Frederick, MD, USA, 
3Primary and Stem Cell System, Life Technologies, Carlsbad, CA, USA, 
4Stem Cell Program, Johns Hopkins, Baltimore, MD, USA, 5Stem Cell 
Biology, Johns Hopkins, Baltimore, MD, USA, 6Johns Hopkins, Baltimore, 
MD, USA
Nonviral, non-integrated human induced pluripotent stem cell (hiPSC) lines 
were generated using cord blood-derived CD34+ progenitors with seven 
episomal expressed factors (OCT4, SOX2, KLF4, MYC, NANOG, LIN28, 
SV40 T) expressed with the pCEP4 plasmid system. Zero foot print iPSC 
lines were derived first on feeders and subsequently adapted to feeder free 
conditions in serum free and xeno-free culture conditions. In all three culture 
conditions, the iPSC lines showed robust proliferation with normal karyotype 
and expressed a panel of pluripotency markers Oct4, Sox2 and Nanog by 
RT-PCR and Oct4, SSEA4, TRA-1-60 and TRA-1-81 by ICC. Whole genome 
expression and epigenetic profiling analyses demonstrated that these lines 
were of extremely high quality and molecularly indistinguishable from hu-
man embryonic stem cell lines. In a directed differentiation and teratoma 
analysis, the lines retained potential to the three germ layers, ectoderm, en-
doderm and mesodermal lineages. This report presents an optimized culture 
system for nonintegrated human iPSC in a feeder -free, serum - free and 
Xeno-free conditions, that enable the use of iPSC line as a positive control in 
reprogramming methods for iPSC generation. In addition, viral free vascular, 
hematopoietic, neural and cardiac lineages were derived with robust ef-
ficiencies that support cell therapy applications.
Poster Board Number: 3326
DERIVATION OF A CLINICAL GRADE HUMAN 
EMBRYONIC STEM CELL LINE IN A NOVEL BIO-
PROCESSING UNIT
Prathalingam, Nilendran S.1, Ferguson, Linda2, Lamont, Alison3, 
Murdoch, Alison3, Herbert, Mary1
1Institute for Aging and Health, Newcastle University, Newcastle upon Tyne, 
United Kingdom, 2Institute of Cellular Medicine, Newcastle University, 
Newcastle upon Tyne, United Kingdom, 3Newcastle Fertility Centre, 
Newcastle upon Tyne, United Kingdom
The ongoing development of human embryonic stem cell (hESC)-based 
therapies will require deriving and expanding hESC lines under the control 
of Good Manufacturing Practice (GMP). However, implementation of GMP 
standards incurs enormous cost and can be detrimental to the viability of 
cells and embryos. To address this we developed an enclosed cell culture 
cabinet with integrated incubators. The system is designed to deliver grade 
A (ISO Class 5) air quality whilst maintaining a stable physiological environ-
ment with controlled temperature, O2, and CO2 during culture and open 
manipulations. To test the efficacy of the system for hESC derivation, we 
isolated the inner cell mass (ICM) of human blastocysts (n=9) and plated 
them on a CELLstart™ matrix with in-house derived, inactivated GMP grade 
fibroblasts (NclFed1A) in culture medium containing KnockOut™ Serum Re-
placement. Five of the ICM’s (56%) formed outgrowths, 3 of which formed 
hESC colonies. We next used the same culture conditions to derive a new 
hESC line in full compliance with GMP. A pre-seed bank was produced at 
Passage 5 (P5) and a master cell bank at P9. Analysis of the line has shown 
a normal female karyotype and cells express the pluripotency markers Oct4 
and Nanog, and readily differentiate into embryoid bodies. We propose that 
protection of hESC lines from ambient conditions during derivation and cul-
ture is likely to increase stability and reproducibility, which is a cornerstone 
of GMP. In addition the culture systems we have developed significantly 
reduce the cost of hESC derivation and scale up compared to the use of a 
conventional clean-room.
Poster Board Number: 3328
COMPARATIVE PROTEOMICS OF 
KARYOTYPICALLY ABNORMAL AND NORMAL 
HUMAN EMBRYONIC STEM CELLS
Sun, Yi1, Lin, Ge1, Yang, Yi Xuan2, Lu, Guang Xiu1
1Institute of Reproductive and Stem Cell Engineering, Central South 
University and National Engineering and Research Center of Human Stem 
Cells, Changsha, China, 2Key Laboratory of Molecular Biology for Infectious 
Diseases of Ministry of Education of China, The Second Affiliated Hospital, 
Chongqing Medical University, Chongqing, China
Previous reports indicated that during long term culture, the human embry-
onic stem cells (hESCs) acquired genomic alterations and the transformation 
hESCs had a tendency to progression to malignant cells, which raise con-
cerns about the safety of future clinical use of the cultured hESCs, but which 
may be an excellent model for characterizing the initial stages that deter-
mine the transition of embryonic stem cells into cancer stem cells. In this 
study, ITRAQ-based tandem mass spectrometry was employed to quantify 
proteins of normal and aberrant karyotypic hESCs from simple to complex 
karyotype abnormalities. Over 2600 proteins were identified and quanti-
tated, among which are proteins associated with pluripotency such as LIN28 
and THY1 and development as well as FGF signaling and EGF receptor path-
way. The expression levels of 313 proteins representing at least 24 molecular 
function groups including chaperone, kinases, proteases, ligase, calcium 
binding, nucleic acid binding and cytoskeletal proteins were found to be 
significantly different between normal and abnormal hESCs. Examples of 
some early developmental markers high in normal karyotypic hESCs include 
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NES, GRB2, RBM14 and HNRPA3. Several proteins related to hyperprolifera-
tion and suppression of apoptosis such as HDAC2 were highly expressed 
in abnormal hESCs, but genes associated with apoptosis such as HNRNPK, 
DFFA and TKT were down-regulated in the karyotypically abnormal hESCs. 
In addition, several proteins that were highly expressed in abnormal hESCs 
such as DNMT3B, RAP2B, CTNNB1, CSNK2A1, PRDX1, EEF1A1, VDAC2, 
ANXA2 and YWHAZ have also been attributed to malignancy in other 
systems. Furthermore, 15 differential proteins were verified by real-time 
PCR and Western blot analysis was used to validate the proteomic analyses 
for a subset of the proteins including DNMT3B, NES, CTNNB1, EIF3B and 
DNMT1. In summary, this is the first large-scale quantitative proteomic 
analysis of normal and aberrant karyotypic hESCs, and the information 
generated by this study should serve as a useful reference that malignant 
transformation process of aberrant karyotypic hESCs has close relationship 
with the changes of DNA methylation, cell cycle and apoptosis, WNT, P53 
and FAS signaling pathways, which may mirror those of oncogenesis and tu-
mor progression. Also, dysregulation of DNMT3B, NES, and CTNNB1 could 
be detected as early as the pre-neoplastic stage.
Poster Board Number: 3330
HUMAN AMNIOTIC FLUID CELLS SUPPORT 
EXPANSION OF HUMAN EMBRYONIC STEM 
CELLS IN XENO-FREE CULTURE CONDITIONS
Jung, Juwon1, Yoon, Bo Ae1, Seol, Hye won1, Baek, Jin Ah1, Seo, 
Jin1, Oh, Sun Kyung1, Ku, Seung-Yup2, Kim, Seok Hyun2, Moon, 
Shin Yong2, Choi, Young Min2
1Institute of Reproductive Medicine and Population, Medical Research 
Center , Seoul National University, Seoul, Korea, Republic of, 2Dept. of 
Obstetrics & Gynecology, Seoul National University College of Medicine, 
Seoul, Korea, Republic of
Human embryonic stem cells (hESCs) have been routinely cultured on mouse 
embryonic fibroblast (MEF or STO) feeder layers with a medium containing 
animal products. However, for clinical application of hESCs, animal-derived 
materials from the animal feeder cells, animal substrates such as gelatin or 
Matrigel and medium containing animal serum are essential to be eliminated 
in the current culture system. In this study, we performed that hES cell lines, 
SNUhES4, SNUhES31 and H1 were cultured on human amniotic fluid cells 
(hAFCs) derived feeder layer with Knockout SR XenoFree as serum replace-
ment and a humanized CELLstart as cell substrate. All of hESCs were able 
to propagate up to 10 passages on hAFCs feeders with xeno-free condi-
tions. These hESCs were conserved normal karyotype and were expressed 
pluripotent stem cell markers, alkaline phosphatase (ALP), SSEA-4, TRA-
1-60, TRA-1-81, Oct-4, and Nanog like hESCs cultured on STO or human 
foreskin fibroblast (HFF) feeders. In addition, we observed the expression of 
nonhuman N-glycolylneuraminic acid (Neu5GC) by flow cytometery, which 
was xenoantigenic components of contamination in hESCs cultures, was not 
detected in xeno-free condition. In conclusion, we demonstrated that hESCs 
could be successfully prolonged on hAFCs and excluded animal compo-
nents for humanized culture conditions. It will be aided in the progression 
toward clinical-grade hESCs culture. This research was supported by grants 
(SC1150) from the Stem Cell Research Center of the 21st Century Frontier 
Research Program funded by the Ministry of Science and Technology.
Poster Board Number: 3332
MAINTENANCE AND PROPAGATION OF 
HUMAN INDUCED PLURIPOTENT STEM CELLS 
USING STEMADHERE XF™, A DEFINED AND 
XENOBIOTIC-FREE HUMAN RECOMBINANT 
PROTEIN
Garcia II, Bradley H., Marty, Andrea L., Monsma, Scott A.
Primorigen Biosciences Inc., Madison, WI, USA
In order to establish clinically adaptable methods for therapeutic applications 
of stem cells, there is increasing interest in completely defined and xenobi-
otic-free methods for stem cell expansion and differentiation. Nagaoka et 
al. have previously shown that E-Cadherin fused to mouse IgG Fc domain 
is an excellent substrate for maintenance and expansion of human embry-
onic (hES) and induced pluripotent (hiPS) stem cells. Extending this work, 
Primorigen has developed StemAdhere XF™, a defined and xenobiotic-free 
substrate useful for routine maintenance and expansion of hES and hiPS 
cells. StemAdhere XF™ can be handled at room temperature, is compatible 
with gentle, non-enzymatic passaging methods and works well with many 
defined and xenobiotic-free stem cell media. Here we present comparative 
data demonstrating StemAdhere XF™ as a robust substrate for maintenance 
and expansion of pluripotent stem cells in defined and xenobiotic-free 
culturing conditions.
Poster Board Number: 3334
ECTOPIC PREGNANCY CONCEPTUS AS A 
NOVEL SOURCE OF FETAL STEM CELL 
RESEARCH AND THERAPY 
Arjmand, Babak1, Aghayan, Hamid - Reza1, Larijani, Bagher2, 
Maanavi, Seyed Majid3
1Clinical Grade Cell Manufacturing Facility, Endocrinology and Metabolism 
Research Institute, Tehran University of Medical Sciences, Tehran, Iran, 
Islamic Republic of, 2Endocrinology and Metabolism Research Institute, 
Tehran University of Medical Sciences, Tehran, Iran, Islamic Republic of, 
3bioscience Department, Iran Presidency Technology Cooperation Ofﬁce, 
Tehran, Iran, Islamic Republic of
Introduction: Regenerative medicine as a background of stem cell research 
and therapy, has a long history. Several diseases including Parkinson’s 
disease, heart diseases, multiple sclerosis, spinal cord injury, diabetes mellitus 
and etc; are candidates to treat by different types of stem cell. Several sourc-
es of stem cell have been described such as bone marrow, umbilical cord, 
peripheral blood, germ cells and the embryo / fetus. Despite the potential 
benefit of human embryonic / fetal stem cells in cell therapy, the utiliza-
tion of this source of stem cell remains controversial because abortion and 
termination of pregnancy under a normal condition is forbidden by nearly all 
the major world religions such as Islam and laws in most of Muslim countries 
permit termination of pregnancy and abortion only when the life of the 
mother is severely threatened or when continuing pregnancy may lead to 
the birth of a mentally retarded, genetically or anatomically malformed child. 
According to the mentioned rules and conditions in Islamic countries, finding 
a viable source for embryonic / fetal stem cell will be too difficult. On the 
one had Muslim scientists have an ideal as the finding a genetically and ana-
tomically normal embryo / fetus as a source for stem cell research and thera-
py, but on the other hand, they should adhere to the law and related rules in 
all parts of stem cell research and therapy. Our purpose is that Ectopic Preg-
nancy (EP) conceptus can meet these major priorities. Ectopic Pregnancy: 
The incidence of Ectopic pregnancy (EP) is around 2% in all pregnancies. EP 
occurs when the conceptus implants and matures outside the endometrial 
cavity that is the cause of 10% of all pregnancy-related deaths because of 
the potential for tubal rupture and serious maternal mortality and morbidity. 
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So EP has to be terminated because of maternal life saving. There are several 
well-known factors that are associated with risk of ectopic pregnancy such 
as Pelvic inflammatory disease (PID), a history of previous EP, tubal ligation, 
tubal surgery, intrauterine devices, ovulation induction, in vitro fertilization 
(IVF), Smoking and maternal age (more than 35 year - old). Our hypothesis 
is that when an ectopic conceptus has a chromosomal abnormality that 
is lethal in origin, the EP will regress spontaneously without the necessity 
of surgical intervention. As we described, EP is a valuable source because 
there are no cytogenetic or other etiologies that could affect the material 
and results of research and therapy. Conclusion: The authors suggest that 
using of EP material as a source of stem cell research and therapy has some 
advantages. Termination of an ectopic pregnancy is accepted by nearly all of 
Islamic laws because of maternal life saving, and also EP conceptus is a novel 
and valuable source for stem cell research and therapy. 
Poster Board Number: 3336
BANKING CLINICAL GRADE HESC LINES: 
GOVERNANCE, REGULATORY AND ETHICAL 
ISSUES
Isasi, Rosario1, Knoppers, Bartha M.1, Stacey, Glyn2, Lomax, 
Geoffrey3
1Dept of Human Genetics, Centre of Genomics and Policy, McGill 
University, Montreal, QC, Canada, 2NIBSC, UK Stem Cell Bank, Potters 
Bar, United Kingdom, 3California Institute for Regenerative Medicine, San 
Francisco, CA, USA
Stem cell research is steadily entering clinical translation with the launch-
ing of the first clinical trial (Phase I) testing a hESC- derived cell therapy by 
Geron and a second trial by Advanced Cell Technology Inc’s recently ap-
proved by the FDA. Stem cell banks are increasingly seen as an essential re-
source of biological materials for both basic and translational research. They 
also support international access to authenticated, quality-controlled and 
ethically sourced stem cell lines. In short, clinical grade hESC banks are vital 
to the advancement of translational efforts. While regulatory frameworks for 
stem cell translation are being refined, regulatory uncertainty could create 
barriers to not only the availability of lines and their commercialization but 
also to the clinical development of cell therapies, thereby stressing the need 
for clear and harmonized definitions of key concepts and terms. Stem cell 
banks can only be effective if the lines they curate have undergone rigorous 
screening, derivation and manufacturing processes together with robust eth-
ical provenance. Given the aforesaid consideration, the International Stem 
Cell Banking Initiative sponsored by the International Stem Cell Forum, is 
currently elaborating global best practices for the development of banks for 
clinical grade stem cell lines. The overall objectives are to enable the global 
sharing of hESC lines of high scientific quality and to foster compliance with 
regulatory and ethical requirements across heterogeneous legal and ethical 
frameworks. This presentation will focus on the results of the International 
Stem Cell Banking Inititiative’s (ISCBI) survey of the policy, regulatory and 
governance frameworks related to clinical grade hESC in 16 jurisdictions. 
To that end, convergence and divergence in issues surrounding determi-
nation of compliance (i.e., provenance, access, ethics review, oversight), 
informed consent (i.e., withdrawal and re-consent requirements) as well as 
mechanisms for the sharing of samples and data will be analyzed. Finally, 
we will report on the governance and policy recommendations adopted by 
the ISCBI in its “Points to Consider in the Development of Banks for Clinical 
Grade hESC lines”).
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EXPRESSION OF EMBRYONIC STEM CELLS 
MARKERS IN INFANTILE HEMANGIOMA
Itinteang, Tinte1, Brasch, Helen D.2, Vishvanath, Anasuya1, Steel, 
Ryan1, Best, Heather A.1, Tan, Swee T.2, Day, Darren J.1
1School of Biological Sciences, Victoria University of Wellington, NZ, 
Wellington, New Zealand, 2Gillies McIndoe Research Institute, Wellington, 
New Zealand
Background: Infantile hemangioma (IH), the most common tumor of in-
fancy, is a tumor of the microvasculature. It typically undergoes rapid prolif-
eration during infancy, followed by spontaneous involution. We have shown 
proliferating IH consists of a primitive mesoderm-derived hemogenic en-
dothelium, with the presence of mesenchymal and hematopoietic stem cells. 
Primitive mesoderm-derived hemogenic endothelium is derived develop-
mentally from embryonic stem cells (ESCs) during early fetal development. 
Aims & Objectives: To investigate the expression of ESC-associated proteins 
in proliferating IH, and to determine their ability to form teratomas in vivo. 
Methods: Proliferating IH biopsies from 6 patients were (i) processed for IHC 
staining for ESC-associated proteins Oct-4, SSEA-4, Nanog and STAT-3; (ii) 
used to determine the relative expression of Oct-4 & Nanog transcripts by 
qRT-PCR; and (iii) grown as explants prior to being injected into SCID/NOD 
mice. Results & Observations: IHC showed that the endothelial layer of 
proliferating IH expressed Oct-4, SSEA-4 and STAT-3. Cells within the inter-
stitium, away from the endothelium, expressed Nanog. qRT-PCR confirmed 
the expression of mRNA transcripts for both Oct-4 and Nanog. All injected 
SCID/NOD mice formed tumors, but no teratomas were seen. Conclusion 
& Discussion: The mRNA and protein expression of ESC-associated markers 
in proliferating IH supports the developmental anomaly origin of IH. The 
expression of OCT-4, SSEA-4 and STAT-3 on the capillary endothelium and 
the expression of more downstream ESC marker, Nanog, on the interstitial 
cells, infer an ESC-like origin of IH. The novel demonstration of ESC markers 
on 2 distinct populations in proliferating IH and their inability to form tera-
tomas in vivo suggests that IH are possibly derived from cells downstream 
of ESC phenotypes. The 10% prevalence of IH in the Caucasian population 
provides a novel extra-utero phenotype downstream of ESC for studying 
human developmental and regenerative medicine.
EMBRYONIC STEM CELL DIFFERENTIATION
Poster Board Number: 3342
IDENTIFICATION OF MICRORNAS REGULATING 
DIFFERENTIATION OF HUMAN NEURAL STEM 
CELLS
Muertz, Laura1, Borghese, Lodovica1, Roese-Koerner, Beate1, 
Weinhold, Sandra2, Koch, Philipp1, Wernet, Peter2, Uhrberg, 
Markus2, Bruestle, Oliver1
1Institute of Reconstructive Neurobiology, Bonn, Germany, 2Institute for 
Transplantation Diagnostics and Cell Therapeutics, Düsseldorf, Germany
MicroRNAs (miRNAs) are a class of small non-coding RNAs that act as post-
transcriptional regulators of gene expression. Studies in model organisms 
have demonstrated critical roles for a number of microRNAs in neuronal de-
velopment; however data on microRNA functions in the context of human 
neural development and neural stem cell biology are still scarce. We assessed 
microRNA signatures of human ES cells (hESC, I3 line), of derived long-term 
self-renewing neural epithelial stem cells (lt-NES®) and of further differenti-
ated neuronal cultures (ND15, ND30) using a quantitative real-time PCR 
multiplex assay. We validated the identified expression patterns of several 
microRNAs by Northern blot analysis in two independent hES cell lines (I3 
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and H9.2) indicating the reliability of our approach. Furthermore, we were 
able to confirm previous assignments of ES cell-specific and brain-specific 
microRNAs. In addition to the known neurogenesis-associated microRNAs 
(i.e. miR-124 and miR-125), we identified novel microRNAs as up-regulated 
during human neural stem cell differentiation. Stable over-expression of a 
many of these newly identified microRNAs, just like the over-expression of 
miR-124 and miR-125, resulted in an increased rate of neuronal differentia-
tion. This work shows that our human embryonic stem cell based neural 
differentiation protocol provides a useful paradigm for the analysis of mi-
croRNA profiles in human pluripotent and multipotent stem cells and for the 
identification and functional characterization of novel microRNAs associated 
with neuronal differentiation.
Poster Board Number: 3344
DISSECTION OF THE EARLY CARDIAC 
DEVELOPMENTAL PROCESS FROM 
HUMAN EMBRYONIC STEM CELLS USING A 
MODEL SYSTEM THAT RECAPITULATES THE 
EMBRYOGENESIS
Yamauchi, Kaori1, Nakatsuji, Norio2, Suemori, Hirofumi1
1Laboratory of Embryonic Stem Cell Research, Stem Cell Research Center, 
Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan, 
2Institute for Integrated Cell-Material Sciences (iCeMS), Kyoto University, 
Kyoto, Japan
Human embryonic stem cells (hESCs) are expected to be a valuable model to 
study the embryonic development including cardiogenesis in culture. This is 
because the hESCs potentially have ability to differentiate into specific tissue 
cells along the in vivo embryonic developmental process, when cultured un-
der the condition mimicking the embryonic environment. We have recently 
shown that cardiomyocytes developed from anterior primitive streak (PS) 
populations induced by synergistic activation of β-catenin using a glycogen 
synthase kinase (GSK) 3 inhibitor and blockage of bone morphogenetic 
protein (BMP) signaling by Noggin in hESCs. Now, we are mainly focusing 
on the following two topics. First, identifying the origin of cardiomyocytes 
is one of the important steps to understand the cardiac developmental 
process, but the lack of specific and suitable cell surface markers hampers 
identifying the origin of the heart-forming cells. To address the issue, we 
investigated the expression of cell surface proteins at different stages of 
cardiac development by flow cytometry analysis. We found that some mark-
ers, such as KDR, PDGFRα, PDGFRβ, CD56, CXCR4, and Integrinα6, may 
be useful to define the anterior PS populations that include the cells having 
cardiac potential. Second, recently, many researches reveal the existence of 
cardiovascular progenitors that can undergo bipotential or tripotential dif-
ferentiation toward cardiomyocyte, smooth muscle, or endothelial lineages 
in vitro and in vivo. To examine the multipotentiality of the cells induced by 
our method, we established a single cell lineage tracing system that enables 
monitoring the differentiation from a single cell by the observation of the 
continued expression of GFP protein. Using this system, we found that one 
GFP-marked cell isolated from the anterior PS populations contributed to 
cardiomyocytes and other differentiated cells, suggesting that the cells at the 
stage of the PS formation are not yet completely committed toward the car-
diac lineage in hESCs. Taken together, these findings would provide valuable 
opportunities to discuss the cellular and molecular mechanisms of the early 
cardiac developmental process in humans.
Poster Board Number: 3346
MICRORNA SIGNATURES IN SMALL MOLECULE 
INDUCED CARDIAC AND NEURAL LINEAGE-
SPECIFICATION DIRECT FROM PLURIPOTENT 
HUMAN EMBRYONIC STEM CELLS
Parsons, Xuejun H.
San Diego Regenerative Medicine Institute, San Diego, CA, USA
The human embryonic stem cells (hESCs), derived from the inner cell mass 
(ICM) or epiblast of human blastocyst, are genetically stable with unlim-
ited expansion ability and unrestricted plasticity, proffering a pluripotent 
reservoir for in vitro derivation of a large supply of disease-targeted human 
somatic cells that are restricted to the lineage in need of repair. One of the 
major challenges for both developmental studies and clinical translation 
has been how to channel the broad differentiation potential of pluripo-
tent human stem cells to a desired phenotype efficiently and predictably. 
Although such cells can differentiate spontaneously in vitro into cells of 
all germ layers by going through a multi-lineage aggregate stage, only a 
small fraction of germ-layer-induced cells pursue a given lineage. In those 
hESC-derived aggregates, the simultaneous appearance of a substantial 
amount of widely divergent undesired cell types that may reside in three 
embryonic germ layers often makes the emergence of desired phenotypes 
not only inefficient, but uncontrollable and unreliable as well, hence, a 
high risk of tumorigenicity. To overcome these obstacles, in our study, we 
resolved the elements of a defined culture system necessary and sufficient 
for sustaining the epiblast pluripotence of hESCs, serving as a platform for 
de novo derivation of therapeutically-suitable pluripotent hESCs and ef-
fectively directing such hESCs uniformly towards clinically-relevant lineages 
by simple provision of small molecules. Employing the defined platform, we 
found that nicotinamide (NAM) and retinoic acid (RA) induced respective 
cardiac- and neural-lineage commitment direct from pluripotent hESCs that 
further progressed to beating cardiomyocytes and ventral neurons with dras-
tic increases in efficiency. MicroRNAs (miRNAs) are emerging as important 
regulators of stem cell pluripotence and differentiation. To uncover key 
regulators, genome-scale miRNA profiling was used to identify novel sets of 
development-initiating small miRNAs upon small-molecule-induced cardiac- 
and neural-specification direct from the pluripotent stage. A unique set of 
pluripotence-associated miRNAs was down-regulated, while novel sets of 
distinct cardiac- and neural-driving miRNAs were up-regulated upon the 
induction of lineage specific differentiation from hESCs, including silenc-
ing of hsa-miR-302 family and a drastic expression increase of Hox miRNA 
hsa-miR-10 family upon RA exposure. Our study opens new dimensions of 
small molecule-mediated direct control and modulation of hESC fate when 
deriving an unlimited supply of clinically-relevant lineages from pluripotent 
cells for regenerative therapies.
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IN-DEPTH PROTEOMIC AND 
PHOSPHOPROTEOMIC PROFILING AND 
COMPARATIVE SYSTEMS BIOLOGY ANALYSIS 
OF HUMAN PLURIPOTENCY AND NEURAL 
MULTIPOTENCY
Singec, Ilyas, Brill, Laurence, Crain, Andrew, Tobe, Brian, Hou, 
Junjie, Snyder, Evan
Sanford-Burnham Medical Research Institute, La Jolla, CA, USA
Defining ‘stemness’ in pluripotent and multipotent stem cells is crucial for 
comprehensive cell type characterization during early human development. 
Here, we demonstrate that human embryonic stem cells (hESCs) can be 
rapidly and completely converted into neural stem cells (NSCs) under feeder-
free conditions by inhibition of TGF-β superfamily and WNT signaling. These 
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pure populations of NSCs (97% PAX6+) were differentiated into various 
neuronal and glial phenotypes confirming their multipotent potential. By fo-
cusing on the transition from pluripotency to neuroectodermal multipotency, 
we delineated comparative (phospho)proteomic profiles from undifferentiat-
ed hESCs (OCT4+/PAX6-) vs. the earliest definitive human neural stem cells 
(NSCs; OCT4-/PAX6+) identifying a total of 12,904 proteins, 76.4% (9,964) 
of which were phosphorylated on a total of 59,680 sites. This is the largest 
comparative (phospho)proteomic dataset generated to date, allowing us to 
reveal numerous novel characteristics of pluripotent and multipotent stem 
cells: 1. Although the total (phospho)proteome overlap was 75.9% between 
these stem cell populations, only 25.7% of the localized phosphorylation 
sites were identified in both ESCs and NSCs suggesting that both stem cell 
states are predominantly defined by unique signatures on the posttrans-
lational level, thus not detectable with commonly used microarray-based 
transcriptomic analysis. 2. Among the 27,964 precisely localized phospho-
sites, 55% were on serine (S) residues, 32% were on threonine (T) residues, 
and 13% were on tyrosine (Y) residues. These values were essentially the 
same in hESCs and NSCs; however, an unusually high percentage of Y phos-
phorylation sites was detected in stem cells relative to many other biological 
systems (typically ~1% Y). 3. We performed an unbiased and quantitative 
analysis of dynamic changes of proteins associated with pluripotency and 
epigenetic modifications (e.g. OCT4, SOX2, NANOG, c-MYC, Polycomb 
Group proteins, SWI/SNF chromatin remodeling complex, REST, DNMT3B, 
CTCF) including the identification of numerous novel phosphorylation sites. 
4. Large-scale precision proteomics allowed comparative global pathway 
analyses of TGF-β superfamily and WNT signaling. 5. We detected surpris-
ingly early expression and phosphorylation of proteins associated with later-
stage neuronal function and neurological diseases (e.g. α-synuclein, amyloid 
precursor protein). A protein cluster map for Parkinson’s disease, Alzheimer’s 
disease, and Huntington’s disease was generated as a resource for novel 
biochemical assays. Together, our findings shed new light on the proteome 
of human pluripotency and neural multipotency on the systems biology level 
and should facilitate the scalable production of defined neural phenotypes 
for developmental studies, disease modeling, and drug discovery.
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DIRECTED DIFFERENTIATION OF HUMAN 
EMBRYONIC STEM CELLS TOWARDS NEURAL 
ECTODERM USING SMALL MOLECULES
Surmacz, Beata, Lubitz, Sandra, Whiting, Paul
Regenerative Medicine, Pfizer Regenerative Medicine, Cambridge, United 
Kingdom
Human embryonic stem (hES) cells have the potential to differentiate in 
vitro into cells and tissues of the three primary germ layers: endoderm, 
mesoderm and ectoderm. Therefore hES cells offer a great promise for cell 
replacement therapies. The molecular pathways and mechanisms underlying 
the differentiation of hES cells however have not been well understood. We 
have focused on the induction of hES cells to ectoderm, in particular anterior 
neural ectoderm (ANE). ANE cells have the potential to differentiate in vitro 
into cells of the brain, spinal cord, pituitary and eye. Based on knowledge 
from the early embryo development, where ANE development is regulated 
by native inhibitors of bone morphogenic protein (BMP) and Nodal/Activin 
signalling, most published protocols are demonstrating a crucial role SMAD 
signalling in the neural induction. The drawbacks of such protocols include 
the use of an embryoid body culture step (leading to a higher than desirable 
variability), as well as use of polypeptide secreted factors which are both 
expensive and have significant challenges in terms of GMP compliancy. 
To increase the efficiency and reproducibility, as well as to understand the 
pathways and mechanisms involved in ANE induction, we have developed 
a monolayer cell culture methodology using xeno-free media to derive ANE 
cells from hES cells. In order to investigate the role of SMAD signalling in 
the neural induction we have tested a group of small molecules that are 
both selective and non selective Activin-receptor-like kinases (ALK) inhibi-
tors. We have developed a protocol that requires only two small molecules 
LDN193189 (a BMP inhibitor) and SB431542 (ALK 4/5/7 inhibitor) for the 
efficient induction of ANE fate. This protocol enables the reproducible and 
efficient conversion of monolayer hES cells to ANE cells without the require-
ment of serum or polypeptide signalling factors in the culture medium.
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LONG TERM NEUROEPITHELIAL STEM CELLS 
CAPTURED DIRECTLY FROM THE DEVELOPING 
HUMAN BRAIN
Tailor, Jignesh1, Falk, Anna2, Smith, Austin1
1Wellcome Trust Centre for Stem Cell Research, University of Cambridge, 
Cambridge, United Kingdom, 2Karolinska Institute, Karolinska, Sweden
Introduction: Stably expandable neural stem cells in culture provide the 
unique opportunity to model neurodevelopment and human diseases that 
may involve neural progenitors in the developing brain such as congenital 
malformations and paediatric brain tumours. Recently, long term propagat-
ing stem cells that appear to represent neuroepithelial progenitors were 
derived from embryonic stem cells in vitro. We explored the possibility 
of deriving this neuroepithelial stem cell (NES) intermediate directly from 
human foetal brain as a first step towards elucidating the true relationship 
between NES cells and normal progenitors in the developing brain. Meth-
ods: The developing hindbrain was surgically dissected from Carnegie stage 
14-23 (week 5 to 9) aborted human foetuses and dissociated into a cell 
suspension. Cells were cultured in monolayer with DMEM/F12 media with 
N2, B27, epidermal growth factor (EGF) and fibroblast growth factor (FGF2) 
supplements as previously described. Results: We found that neuroepithelial-
like stem (NES) cells can be derived from dissected hindbrain tissue samples 
with reasonably high efficiency (7 out of 13 samples). All foetal NES cells 
were derived from Carnegie 14-18 (week 5-7) foetuses. Cells from older, 
Carnegie stage 19-23 (week 8-9) fetuses (2 samples) were reminiscent of 
more mature, radia-glia like neural stem (NS) cells. In similar fashion to pluri-
potent cell derived NES cells, the foetal derived NES cells exhibit rosette-like 
architectures in culture, express early neuroepithelial markers (Sox1, Pax6) 
and genes specific to neural rosette cells derived from embryonic stem cells 
(PLZF, Dach1). They can be passaged for more than 40 generations and 
retain the capacity to differentiate into neural and glial lineages. Foetal NES 
cells were found to retain expression of hindbrain regional identity markers 
(Gbx2, Krox20) after long term passaging, and display a gene expression 
profile that correlates with pluripotent cell derived NES cells. Conclusion 
and future directions: These findings suggest that NES cells are a common 
entity that can be derived from both pluripotent cells and the developing 
foetal hindbrain. With the advent of cell programming and the generation of 
patient-specific induced pluripotent stem cells (iPS cell), it is now possible to 
develop patient-specific NES cell models of neuroepithelial precursors. The 
generation of foetal derived NES cells provides evidence for a relationship 
between pluripotent cell-derived NES cells and neuroepithelial progenitors in 
the developing human brain, and provides an important benchmark for the 
future derivation of patient-specific iPS cell-derived NES cells. Future experi-
ments will involve the in utero transplantation of foetal derived NES cells 
into foetal rat brain to determine if NES cells retain the capacity to integrate 
into the developing brain.
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PREDICTING TOXICITY ON DEVELOPING 
NEURAL CELLS BY USING THE HUMAN 
EMBRYONIC STEM CELL LINE H9
Vojnits, Kinga, Ensenat-Waser, Roberto, Bremer, Susanne
Institute for Health and Consumer Protection, European Joint Research 
Centre, Ispra, Italy
Animal models used to predict prenatal toxicity often do not correlate to 
human response since the concordance between species is unsatisfying. 
Therefore it is urgent to develop more predictive tools in order to optimize 
the process of risk identification and characterisation. Human Embryonic 
Stem Cells (hESC) and their derivatives are currently scientifically discussed 
as the basis for toxicological tests including assays that aim to detect effects 
on early embryogenesis. For the detection of toxic effects on the develop-
ing nervous system, cells of the H9 cell line were differentiated into early 
neural precursor. Effects of nine toxicologically well defined compounds on 
this differentiation process were analyzed. In an initial step, the cytotoxic-
ity of 6-Aminonicotinamide, 5-Fluorouracile, Lead acetate, Methylmercury, 
Methotrexate, Toluene, Retinoic acid, Valproic acid and Warfarin were 
defined. Resulting dose-response curves were used to determine critical dos-
ages levels like the IC50 and the lowest non-cytotoxic concentration. These 
concentrations have been further analysed to assess changes of the gene 
expression profile after chemical treatments. The chemicals were clustered 
according to their toxicological responses in the differentiating cultures. The 
quality and reproducibility of the obtained data were ensured by the estab-
lishment of acceptance criteria defining successful independent experiments. 
In the present study we succeeded to develop an embryonic stem cell based 
test system that allows the detection of toxicological effects on differentiat-
ing embryonic stem cells. A first set of data deriving from a training set of 
chemicals allowed suggesting a prediction model which can be used to get 
a better understanding of effects of unknown compounds. Further work will 
be needed to refine this model and challenge it with additional xenobiotics 
to fully evaluate its predictive capacity.
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PRODUCTION OF HIGH PURITY NEURONAL 
AND OLIGODENDROCYTE PROGENITOR 
CELL POPULATIONS FROM HUMAN IPS AND 
BLASTOCYST-DERIVED HES CELL LINES
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Background: The discovery that human somatic cells can be reprogrammed 
to induced pluripotent stem cells (hiPSCs) which closely resemble human 
embryonic stem cells (hESCs) garnered tremendous excitement. While 
iPS lines pass gross tests of pluripotency, more stringent characterization 
indicates that most lines are partially rather than completely reprogrammed. 
The objective of our work was to, 1) determine the degree of equivalence 
between three human iPS and two blastocyst-derived human ESC lines 
and 2) determine whether differences have functional implications for the 
ability of lines to produce neuronal and oligodendrocyte progenitor lines 
via clinically relevant high purity differentiation protocols. Methodology/
Principal Findings: Two blastocyst-derived hESC lines (H7 and CSC-14) and 
three hiPSC lines derived from adult human dermal fibroblasts were exposed 
to identical expansion conditions followed by differentiation into neuronal 
and oligodendrocyte progenitor cells. Proliferation rates and gross morphol-
ogy were recorded during expansion. During stem cell expansion, all lines 
had similar rates of proliferation and gross morphology. Yield and purity of 
differentiated products were determined via cell counts and ICC profiling. 
ICC profiling indicated that both hESC lines and two of the three hiPSC lines 
produced differentiated products with a low percentage of contaminating 
cell populations. These two iPS lines matured faster than the hESCs. The 
third iPS line produced a very low yield of differentiated product, consisting 
primarily of undifferentiated neural cells. Despite the recently published dif-
ferences between hiPSCs and hESCs, properly screened iPS lines are capable 
of producing differentiated products of purity sufficient for clinical applica-
tions and should be tested in vivo to determine if differentiated products 
have functional equivalence to those produced from hESC lines.
Poster Board Number: 3358
DIRECTING HUMAN EMBRYONIC STEM CELLS 
TO FUNCTIONAL HEPATOCYTE-LIKE CELLS 
USING CONDITIONED MEDIA FROM A HUMAN 
HEPATOMA CELL LINE
Mandal, Arundhati, Srivastava, Gunjan, Ravindran, Geeta, 
Viswanathan, Chandra
Regenerative Medicine, Reliance Life Sciences Pvt Ltd, Navi Mumbai, India
Hepatocytes derived from human embryonic stem cells (hESC) promises to 
address issues in drug discovery and treatment of liver diseases. We have 
developed a novel method to efficiently differentiate three different hESC 
lines; BG01, Relicell®hES1 and Relicell®hES2 into functional hepatocytes. 
To establish the protocol, we reasoned that conditioned media of HepG2, a 
human hepatoma cell line, may contain pro-hepatic factors and priming the 
hESCs with this media in the early stages can initiate hepatic commitment. 
Here we have attempted to recapitulate the in vivo liver development by 
using conditioned media from HepG2 cell line, supplemented with specific 
growth factors involved in liver development such as aFGF, HGF, oncosta-
tin, dexamethasone and EGF for stage specific hepatic differentiation. For 
further maturation the differentiated hepatocytes were cultured in a defined 
hepatocyte maintenance media. The differentiated cells generated by this 
protocol exhibited the typical polygonal morphology of hepatocytes and ex-
pressed genes such as HNF4a, AFP and ALBUMIN as seen by real time PCR. 
Importantly these cells also expressed Phase I (CYP3A4) and Phase II (GST 
A1) drug metabolism enzymes which are responsible for metabolizing most 
of the chemical compounds. The expression of markers involved in the vari-
ous stages of hepatocyte development was examined by immunofluores-
cence and FACS. In the final stage, 70% of the differentiated cells expressed 
hepatic lineage markers like albumin, CK8/18 and EpCAM. Furthermore, the 
functional assays confirmed that the differentiated cells were able to carry 
out hepatocyte functions such as production of urea and glycogen storage. 
These results suggest that our unique protocol is successful in generating 
functional hepatocytes and is also efficient as shown with three genetically 
different hESC lines. These differentiated cells can provide in vitro drug 
toxicity testing platform in the future.
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EFFICIENT GENERATION OF FUNCTIONAL 
HEPATOCYTES FROM HUMAN EMBRYONIC 
STEM CELLS AND INDUCED PLURIPOTENT 
STEM CELLS BY HNF4α TRANSDUCTION
Takayama, Kazuo1, Inamura, Mitsuru1, Kawabata, Kenji2, Katayama, 
Kazufumi1, Tashiro, Katsuhisa2, Sakurai, Fuminori1, Furue, Miho 
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1Department of Biochemistry and Molecular Biology, Graduate School of 
Pharmaceutical Sciences, Osaka University, Osaka, Japan, 2Laboratory of 
Stem Cell Regulation, National Institute of Biomedical Innovation, Osaka, 
Japan, 3JCRB Cell Bank, Division of Bioresources National, National 
Institute of Biomedical Innovation, Osaka, Japan
Induced hepatocytes from human embryonic stem cells (ESCs) and induced 
pluripotent stem cells (iPSCs) are expected to be utilized as a tool for screen-
ing for cytotoxicity in the early phase of pharmaceutical development. 
Although conventional methods such as growth factor-mediated hepatic dif-
ferentiation are performed, they only lead to generation of a heterogeneous 
hepatocyte population. To improve this, transduction of transcription factors 
is performed to promote hepatic differentiation by using adenovirus (Ad) 
vectors. We have recently reported that hepatic commitment is promoted by 
transduction of SOX17 and HEX gene, although these induced hepatocytes 
were not enough matured for drug screening. To promote hepatic matura-
tion, we utilized transduction of the hepatocyte nuclear factor 4α (HNF4α) 
gene, which is known as a master regulator of liver-specific gene expression, 
in addition to transduction of SOX17 and HEX gene. Overexpression of 
HNF4α in hepatoblasts resulted in the upregulation of the gene expression 
level of the epithelial markers and the mature hepatic markers related to 
drug metabolism including cytochrome P450 enzymes. The flow cytometry 
analysis showed that HNF4α transduction led to almost homogeneous hepa-
tocyte population; the differentiation efficacy based on the CYPs, ASGR1, or 
ALB expression levels was approximately 80%. The Ad-HNF4α-transduced 
cells exhibited an abundant characteristics of hepatocytes; uptake of LDL, 
uptake and excretion of ICG, and storage of glycogen. Furthermore, in-
duced hepatocytes could catalyze the toxication of several compounds such 
as Troglitazone, Acetaminophen, Cyclophosphamide, and Carbamazepine. 
We also found that HNF4α overexpression in hepatoblasts promoted hepatic 
differentiation by activating mesenchymal to epithelial transition (MET). 
In summary, the findings described here demonstrate that transduction of 
HNF4α could promote hepatic differentiation from human ESC-derived 
hepatoblasts by activating MET. In the present study, both human ESCs and 
iPSCs (3 lines) were used and all cell lines showed efficient hepatic matura-
tion, indicating that our protocol would be a universal tool for cell line-
independent differentiation into functional hepatocytes. Moreover, human 
ESC- or iPSC-derived hepatocytes would a valuable tool to predict drug 
toxicity because induced hepatocytes have ability to catalyze the toxication 
of several compounds as primary human hepatocytes.
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EFFECT OF FGF7 TO DIRECTED 
DIFFERENTIATION OF HUMAN ESCS INTO 
AMYLASE-POSITIVE CELLS
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University School of Medicine, Matsumoto, Japan
The pancreatic exocrine cells secrete digestive enzymes, which comprise 
major enzymes involved in the digestion of foodstuffs. However, cultivation 
of functional pancreatic cells isolated from adult mammalian pancreas re-
mains difficult to achieve. Recently, embryonic stem (ES) cells have received 
much attention as the resource of cells to evaluate activity of drug and food 
as well as cell transplantation therapy. In addition, it was reported that the 
effect of cholecystokinin, the most important mediator of postprandial pan-
creatic exocrine enzyme output is species-specific on pancreas. Therefore, it 
is significant to use human cells to prediction experiment of human digestive 
reaction in vitro. The goal of our study is to construct digestive system with 
human ES cell-derived pancreatic cells which could imitate normal human 
tissues in vitro. In this study, we investigated whether human ES cells can be 
induced into pancreatic exocrine cells without embryoid body (EB) forma-
tion. Initially, undifferentiated human ES cells (KhES-3) were cultured with 
Activin A and Wnt3a for the differentiation of definitive endoderm. Then, 
the cells were treated with retinoic acid for 3 days, followed by treatment 
with FGF7, GLP-1 and Nicotinamide. As a result, amylase-positive cells were 
effectively induced by FGF7, and PDX1-positive cells, a marker for pancre-
atic progenitor, were localized in proximity to amylase-positive population. 
Additionally the expression levels of pancreatic endodermal markers such 
as Foxa2 and Pdx1 were up-regulated in previous step and these amylase-
positive cells were double-positive with carboxypeptidase A. All these results 
suggested that the ESC-derived amylase-positive cells were regarded as 
pancreatic exocrine cells. The present study indicates reproducible induction 
of pancreatic exocrine cells from human ES cells. Our induction protocol for 
pancreatic exocrine cells provides an insight into the use of human ES cells 
for imitating digestive systems in drug and food development. The physi-
ological analysis of the differentiated pancreatic exocrine cells and improve-
ment of differentiation efficiency is now ongoing. (Yoshie, Mogi and Sasaki, 
who had been permitted to culture human ES cells by the government, 
performed all steps of culturing of human ES cells.)
Poster Board Number: 3364
CHARACTERISATION OF PANCREATIC 
PROGENITORS AND GUT ENDODERM 
DERIVATIVES DERIVED FROM HUMAN 
EMBRYONIC STEM CELLS
Teo, Adrian K. K., Dunn, Ray
Institute of Medical Biology, Singapore, Singapore
The directed differentiation of human embryonic stem cells (HESCs) into 
functional pancreatic beta cells has attracted much interest as a potential 
treatment for diabetes. Several groups have demonstrated the efficient in 
vitro production of pancreatic progenitor cells or immature beta cells from 
HESCs. However, to date, no published report has described the production 
of these cell types to homogeneity. Here, we describe a simple, chemically-
defined protocol that yields ~ 60 % HESC-derived PDX1+ pancreatic 
progenitors in adherent culture. This protocol is reliant upon the synergistic 
activity of combined Activin A and BMP4 treatment between days 0 and 
3 of differentiation, which results in rapid downregulation of pluripotency 
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genes and robust formation of both definitive endoderm (DE) and PDX1+ 
cells. Q-PCR, immunostaining and western blot analyses show that many 
of the signature pancreatic endoderm genes in addition to PDX1 such as 
HNF6, NGN3, NEUROD and NKX2.2 are increasingly expressed between 
days 12 and 17. Similar to the highly cited study from Novocell / ViaCyte, 
we have initiated transplantation experiments into immuno-deficient mice 
to characterise whether PDX1+ progenitors derived under these conditions 
develop into functional beta cells in vivo and maintain euglycemia. We also 
investigated the identity of the remaining ~ 40 % cells by marker gene anal-
ysis assuming that this population likely contains other DE derivatives. Not 
surprisingly, we detect expression of stomach (RAE1 and HOXA3), liver (AFP 
and ALB) as well as the small intestine (DPP4, CDX2, HOXA4 and HOXA5) 
marker genes. Microarray experiments at selected time points confirm the 
upregulation of numerous genes involved in gut endoderm formation. We 
are extending these observations by FACS and immunohistochemistry. 
Overall, our HESC-derived PDX1+ pancreatic progenitors develop with other 
gut endoderm derivatives and are thus developmentally relevant. Future 
work includes the use of this robust differentiation protocol to study the role 
of novel pancreatic genes.
Poster Board Number: 3366
DEVELOPMENT OF 3D CULTURE METHODS 
FOR THE HEPATOCYTIC DIFFERENTIATION OF 
HUMAN PLURIPOTENT STEM CELLS
Toivonen, Sanna C.1, Lundin, Karolina1, Ustinov, Jarkko1, Palgi, 
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Hepatocytes derived from human pluripotent stem cells (hPSC) could 
provide a defined and renewable source of human cells relevant for cell 
replacement therapies and toxicology studies. Moreover, patient cell-derived 
iPS cells contain the genotype responsible for the human disease and so 
provide a possibility for experimental disease modeling and therapeutic ex-
ploration. Differentiation of definitive endoderm (DE) is a crucial first step in 
generating hepatocytes. 3D matrices are expected to provide a more natural 
microenvironment for the maturation of the differentiating DE cells as com-
pared with 2D culture. We have established a modified method for efficient 
induction of DE from hPSCs. We routinely observe up to 95% FOXA2/
Sox17/CXCR4 positive cells. The DE- cells were further differentiated into 
hepatic progenitors in the presence of DMSO and then matured for 7 days 
with HGF and Oncostatin M into hepatocyte like cells. The cell population 
generated in this culture condition showed a morphological resemblance to 
human hepatocytes and expressed hepatocyte specific markers at RNA and 
protein level. The cells were also able to secrete albumin. In order to identify 
the optimal niche for differentiation, we next studied the effect of various 
purified ECM proteins. Based on immunocytochemistry and albumin secre-
tion, collagen III and fibronectin showed the best capacity to support matu-
ration of DE-cells towards hepatocyte like cells. According to this, collagen 
III and fibronectin are candidates as supporting components in otherwise 
inert 3D-culture matrix. Several commercial matrices intended for 3D culture 
were tested, of which HydroMatrix (Sigma), HyStem-C (Sigma) and ExtraCel 
(TebuBio) have been studied in more detail. DE-cells differentiated most 
efficiently into hepatocyte like cells in ExtraCel based on highest albumin 
secretion, highest relative albumin gene expression and strongest Cyp3A4 
and albumin immunoreactivity. However, during a 21-day differentiation 
protocol, the overall level of hepatocytic differentiation was not significantly 
higher in 3D than in standard 2D culture. Longer maturation times are likely 
needed to obtain a higher degree of differentiation in the 3D environment.
Poster Board Number: 3368
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LIKE CELLS FROM HUMAN PLURIPOTENT 
STEM CELLS
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Human embryonic and induced pluripotent stem cells represent novel 
sources of human hepatocytes for transplantation, for drug toxicity screens 
and for basic developmental biology studies. Although several studies 
have already demonstrated that it is possible to direct the differentiation 
of human pluripotent stem cells (hPSCs) to the hepatic lineage, generating 
functionally differentiated hepatocytes remains a major challenge. To be 
able to efficiently and reproducibly generate hepatic lineage from hPSCs, 
it is essential to recapitulate the critical induction events of liver develop-
ment in vitro, including endoderm induction, hepatic specification and 
hepatocyte maturation. Efficient endoderm induction is the first key step 
in generating cells of the hepatic lineage from hPSCs. We have found that 
the combination of activin A, Wnt3A and bFGF is required to induce an 
embryoid body (EB) population that consists of greater than 90% endoderm 
as measured by expression of the cell surface markers as c-KIT and CXCR-4 
and the transcription factor SOX17+. For hepatic specification, the EB cells 
are dissociated and plated as a monolayer in the presence of activin for an 
additional 2 days and then in the presence of BMP-4 and bFGF for 6 days. 
Sustained activin-induction is important for efficient hepatic development 
and the optimal timing of this step varies among different hPSCs. Following 
hepatic induction, the population is maintained as a monolayer in the pres-
ence of HGF, Dex and OSM for 12 days to generate a hepatoblast popula-
tion characterized by expression of AFP, ALB and CK19. To induce hepatic 
maturation, the hepatoblast stage cells are harvested and cultured for an 
additional 18 days as aggregates. Beyond 40 days of differentiation, the ag-
gregates consist of greater than 90% albumin+ cells, 60 % Asialoglycopro-
tein receptor-1 positive cells and express levels of albumin, G6Pase, and TAT 
comparable to those of found in the adult liver. Analyses of the aggregate 
cells for CYP1A2 and UGT activity revealed levels similar to those found in 
primary human hepatocytes. Taken together, these findings show that ef-
ficient endoderm induction of hPSCs following by appropriate specification 
and maturation cues results in the emergence of hepatocyte-like populations 
that display characteristics of primary human hepatocytes.
Poster Board Number: 3370
TEMPORAL REGULATION OF HNF4α OVER-
EXPRESSION ALTERS ANTERIOR-POSTERIOR 
FATE DURING HUMAN EMBRYONIC STEM CELL 
(HESC) DIFFERENTIATION
McDonald, Angela C. H.1, Ogawa, Shinichiro2, Stanford, William 
L.3, Keller, Gordon2, Rossant, Janet1
1Developmental and Stem Cell Biology, The Hospital for Sick Children, 
Toronto, ON, Canada, 2McEwen Centre for Regenerative Medicine, 
University Health Network, Toronto, ON, Canada, 3Institute of Biomaterials 
and Biomedical Engineering, University of Toronto, Toronto, ON, Canada
hESC-derived definitive endoderm (DE) tissues such as liver and intestine are 
of great interest in regenerative medicine however, DE differentiation path-
ways are poorly understood. We have previously demonstrated that SOX17 
over-expression in hESCs results in an anterior DE progenitor population pro-
viding an in vitro model to elucidate the molecular mechanisms that specify 
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DE. In vivo, the developing embryo undergoes morphological changes as 
the DE differentiates into the primitive gut tube. The primitive gut tube is 
divided into organ domains marked by organ-specific transcription factor ex-
pression. The nuclear receptor transcription factor HNF4α is expressed in the 
intestine, liver, pancreas and stomach throughout organogenesis and is im-
portant for differentiation and maturation of these cell types. In fibroblasts, 
HNF4α over-expression induces intestinal gene expression. The aim of this 
work is to use HNF4α-hESCs as a tool to investigate the molecular regula-
tion of primitive gut tube development and differentiation. To generate 
HNF4α-hESCs, HES2 hESCs were transfected with a PiggyBac transposon 
containing HNF4α under the control of the tetO2 tetracycline/doxycycline 
inducible promoter. Following 48 hours of HNF4α over-expression, HNF4α-
hESCs undergo morphological changes resulting in a flattened morphology 
and a high cytoplasm to nucleus ratio. Gene and protein expression profil-
ing of HNF4α-hESCs reveals an induction of the HNF4α intestinal target 
CDX2 as well as PDX1 and SOX2, consistent with posterior gut identity 
in vivo. HNF4α over-expression downregulates pluripotency genes OCT4 
and NANOG and does not induce expression of extraembryonic endoderm 
genes SOX7, LAMB1 and AFP. To determine whether the temporal over-
expression of HNF4α can induce liver specific function during hESC differ-
entiation, HNF4α was induced at three stages of hepatocyte differentiation, 
DE specification, hepatic specification and hepatic maturation. Induction of 
HNF4α following DE specification produced inefficient hepatic differentiation 
and induction of the posterior DE marker CDX2. However, when HNF4α is 
induced following hepatic specification or maturation, hepatic differentia-
tion is more efficient compared to non-induced controls as demonstrated 
by CYP1A2 and CYP3A7 expression. Additionally, the posterior DE gene 
CDX2 was not induced. These preliminary experiments demonstrate that the 
temporal regulation of HNF4α during hESC differentiation can alter anterior-
posterior DE fate.
Poster Board Number: 3372
THE GENERATION AND ISOLATION OF NKX2.1 
EXPRESSING POPULATIONS FROM HUMAN 
PLURIPOTENT STEM CELLS, AND THEIR 
ABILITY TO PRODUCE LUNG EPITHELIUM.
Pilquil, Carlos S., Roth-Albin, Ivana, Marilyne, Levadoux-Martin, 
Fazzari, Jennifer, Collins, Tony, Draper, Jon S.
McMaster University SCCRI, Hamilton, ON, Canada
Although hPSCs are maintained in vitro, they still respond to the core devel-
opmental programs identified in the mouse embryo that control gastrula-
tion, the generation of definitive endoderm (DE) and subsequent differentia-
tion into the gut tube. Foregut endoderm is the precursor tissue that gives 
rise to the lung buds, which in turn are delineated by the expression of 
Nkx2.1. Work in our lab has examined the correlation of expression of the 
human orthologs of genes known to be important for the specification of 
the DE (i.e. EOMES, SOX17, FOXA2) using Wnt3a, high activin A, and low 
serum. We have found that NKX2.1 is expressed early during the induction 
of DE, and co-expressed with other transcription factors (TFs) important for 
DE and subsequent foregut specification, including FOXA2. We have made 
a fluorescent reporter for NKX2.1 that enables us to detect and isolate cells 
expressing NKX2.1 after DE-induction, and have confirmed these popula-
tions are enriched for genes expressed in the DE. We have also utilized TF 
gain of function to further evaluate the role of NKX2.1 in the specification 
of foregut and lung progenitors. We have combined these tools with an in 
vitro air-liquid interface culture system to investigate the role of NKX2.1 in 
the generation of human lung progenitors. Our study provides insight into 
the efficient generation of lung progenitors from hPSCs for future use in 
tissue replacement therapies and drug discovery.
Poster Board Number: 3374
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ENDODERM
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Definitive endoderm (DE) formation is the most important stage that all 
endodermal organs pass through during their development. So, in vitro 
production of definitive endoderm is one of the important issues in stem cell 
related differentiation studies. Introducing more defined and efficient meth-
ods for differentiation of human embryonic stem cells (hESCs) to the DE can 
help to produce more efficient endoderm derivatives for therapeutic applica-
tions. We selected chemicals Rapamycin, Stauprimide, CHIR, NSC-308848, 
LY294002, Cymarin and IDE1 and also growth factor Activin A. During the 
differentiation induction different combinations of these inducers applied on 
hESCs and then DE specific markers investigated in both RNA and protein 
expression levels. The control group was Wnt and Activin A for the 1st day 
and activin A for the next 3 days. According to the real time RT-PCR results, 
one of our inductive groups composed of Rapamycin (200 nM, 1st day) 
and Activin A (50 ng/ml, the next 3 days) increased the SOX17 and FOXA2 
expression levels significantly more than our control group. The flowcyto-
metric and immunofluorescent staining results were also in agreement with 
the gene expression results. These findings may help to design more efficient 
chemically defined protocols for DE induction of hESCs and also may lead 
to better understanding of the different signaling networks involve in DE 
differentiation.
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TRANSLATING CELL BIOLOGY INTO RATIONAL 
BIOPROCESS DESIGN: EFFICIENT, SCALABLE 
PRODUCTION OF DEFINITIVE ENDODERM 
FROM HUMAN PLURIPOTENT STEM CELLS AS 
VALIDATION OF A NOVEL STRATEGY
Ungrin, Mark D.1, Clarke, Geoff1, Yin, Ting1, Niebrugge, Sylvia1, 
Nostro, M. Cristina2, Sarangi, Farida2, Wood, Geoffrey3, Keller, 
Gordon2, Zandstra, Peter W.1
1Institute of Biomaterials and Biomedical Engineering, University of 
Toronto, Toronto, ON, Canada, 2McEwen Centre for Regenerative 
Medicine, University Health Network, Toronto, ON, Canada, 3Ontario 
Veterinary College, Pathobiology, University of Guelph, Guelph, ON, 
Canada
Capitalizing on the therapeutic potential of human pluripotent stem cells 
(hPSC) will require translation of bench-scale proof-of-concept experiments 
to robust and scalable production bioprocesses. Few such technologies 
are currently available, and rational bioprocess design strategies required 
to develop them are under-explored. We will present the application of 
a predictive strategy employing cell- and molecular-level analysis of rate 
limiting steps to produce definitive endoderm (DE) progenitors in scalable, 
microwell-aggregation-based directed differentiation technologies. We have 
defined a bioprocess optimization parameter (L; targeted cell Loss) and, with 
quantitative cell division tracking and fate monitoring of hPSC expansion 
and differentiation to DE, identify and overcome key suspension bioprocess 
bottlenecks. Targeting these parameters in a cell-line specific manner en-
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abled adherent-equivalent growth rates of hPSCs in feeder- and matrix-free 
defined-medium suspension culture. Taking these suspension expanded 
cells we then demonstrated that predominantly instructive (as opposed to 
selective) differentiation mechanisms underlied a subsequent 18-fold expan-
sion of cells during directed hPSC differentiation to high-purity DE (C-KIT+/
CXCR4+/CD31- by flow cytometry with significantly upregulated transcrip-
tion of SOX17, FOXA2, Cerberus and GATA3 but not PDGFRA, KDR, SOX7, 
FOXA3 or SOX1;) competent for further differentiation towards pancreatic 
(INS, PDX-1, SOX9-expressing) and hepatic (AFP, Albumin, Cyp3A4-ex-
pressing) fates. Our coupled expansion and differentiation systems employ 
only defined culture components, and permit the generation of over 109 
CKIT+ CXCR4+ double positive cells from 1.5 x 104 input cells in 22 days, 
employing only 4,000 cm2 of combined culture surface (the area of a circle 
roughly the size of a bicycle wheel, less than a single 10-deck cell factory), 
providing a solid foundation for future preclinical and clinical studies. The 
aggregates themselves are confined to unit cells with dimensions 400 x 
400 x 283 microns, giving final densities exceeding 8 x 106 cells per mL. To 
facilitate the rapid incorporation of additional future process and culture im-
provements, we focused on scale-independent solutions and “open-access” 
approaches that are easily replicated, improved, and extended upon without 
requiring unconventional technical capabilities. By quantitatively assessing 
such key, cell-line specific parameters as cycling rate and initial survival we 
are able to prospectively specify optimal induction conditions to guide the 
optimized production of target cells from other cell lines in our scale-free 
directed differentiation system. To our knowledge, this is the first application 
of this approach to the production of differentiated cells from hPSC, and 
provides a generally applicable template for the translation of bench-scale 
experimental work into robust cell production for industrial, preclinical and 
clinical applications.
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DERIVATION OF STROMAL (MESENCHYMAL) 
STEM-LIKE CELLS FROM HUMAN EMBRYONIC 
STEM CELLS IN SERUM FREE ENVIRONMENT
Mahmood, Amer1, Aldahmash, Abdullah1, Kassem, Moustapha2
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Derivation of bone forming cells from human embryonic stem cells (hESC) 
is a potentially useful tool for clinical applications. However, there is no 
standard protocol for differentiating of hESC into osteoblastic cells. In addi-
tion, when implanted in vivo as undifferentiated cells, hESC forms teratomas 
with a mixture of various mesodermal, endodermal and ectodermal tissues 
and thus limiting their clinical use. The aim of this study was to design a 
protocol for directing the differentiation of hESC into osteoblastic cells and 
test the ability to form bone in vivo. We cultured hESC in absence of serum 
and mouse feeder layer and in suspension as 3D-embryoid bodies (hEB) 
aggregates. During a time course of 20 days, the hEBs became enriched for 
cells expressing mesenchymal stem cell (MSC) markers: CD29, CD44, CD63, 
CD56, CD71, CD73, CD105, CD106 and CD166 as revealed by immuno-
histochemistry and the number of positive cells increased with time during 
20 day period. In order to test the functional ability of hESC-derived MSC, 
we implanted day 20 hEBs mixed with hydroxyapatite/tricalcium phos-
phate (HA/TCP) as an osteoconductive scaffold, subcutaneously in immune 
deficient mice. Bone and cartilage as well as fibrous tissue were detectable, 
after 8 weeks of implantation. There was no evidence for differentiation to 
other non-mesodermal tissues. This is in contrast to undifferentiated hESC 
that formed a teratoma with a mixture of endodermal, mesodermal and 
ectodermal tissues. Also, hEB implanted in absence of HA/TCP formed cysts 
containing glandular, fibrous and muscle-like tissues. Our study demon-
strates the feasibility of enriching EBs for osteogenic cells under serum-free 
culture conditions.
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Experiments in model organisms and embryonic stem cells have shown 
that differentiation is associated with a lengthening of the cell cycle. We 
hypothesise that passage through the cell cycle, in addition to its gradual 
lengthening, is required for efficient transcription of early differentiation-
associated transcription factors. Here we focus on mesoderm as a model for 
differentiation and examine the role of the cell cycle in the induction of the 
early mesoderm-associated transcription factor Brachyury (T). Mesoderm 
is an embryonic germ layer from which tissues such as bone, blood vessels, 
the spleen, the kidneys, cardiac and skeletal muscle are formed. Therefore 
there is a high demand for efficient in vitro protocols to induce human 
embryonic stem cells (hESCs) to form mesoderm. Upon mesoderm induction 
with a combination of FGF2, an inhibitor of PI3K (LY294002) and BMP4 
(collectively known as the FLyB protocol), H9 hESCs cease proliferation but 
still differentiate efficiently. In contrast, using another mesoderm induction 
protocol comprising an inhibitor of GSK3b (CHIR99021), FGF2 and BMP4 
(also known as the ChFB protocol), hESCs continue to both proliferate and 
differentiate. We then exposed asynchronous H9 hESCs to FLyB and ChFB 
for various lengths of time within one ES cell cycle, sorted them by DNA 
content and performed quantitative real-time PCR to examine T transcript 
accumulation by cell cycle phase. Interestingly, there was a statistically 
significant cell cycle-associated accumulation of T transcript at 12h using the 
FLyB protocol. Other mesoderm-associated, pluripotency and housekeep-
ing genes did not show the same expression pattern. Disrupting cell cycle 
progression using aphidicolin blocked the accumulation of T using the FLyB 
protocol but not with the ChFB protocol. Paradoxically, these findings imply 
that passage through S phase is responsible for the bulk of T transcription 
using the FLyB protocol, but not ChFB. Our results indicate that induction 
of hESCs into early mesoderm progenitors using FlyB increases T expression 
but that the cell cycle is a major barrier to the long-term maintenance of 
differentiated cells.
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EMBRYONIC STEM CELLS
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The in vitro differentiation of human embryonic stem cells (hESCs) reca-
pitulates aspects of embryonic development, whereby cells destined to 
differentiate into mesoderm or endoderm pass through a primitive steak-like 
stage. We have used gene targeting by homologous recombination to gen-
erate a hESC line that expresses a GFP reporter gene from the MIXL1 locus 
(MIXL1GFP/W), which results in transient GFP expression in differentiating 
mesendodermal cells that will later adopt mesoderm or endoderm fates. We 
have utilized transcriptional profiling of differentiating MIXL1 GFP/W hESCs 
to identify genes expressed during early mesoderm differentiation from 
hESCs. Transcriptional profiling of flow sorted mesendodermal cell popula-
tions revealed that MIXL1-GFP+ cells transiently expressed high levels of the 
AGTRL1 (hAPJ receptor) gene. Prior literature has linked hAPJ and its ligand, 
Apelin, to cardiovascular development and angiogenesis. In the light of its 
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expression in early primitive streak-like cells, we have examined the role of 
Apelin/APJ signaling on hematopoietic differentiation in vitro. We identified 
a reproducible augmentation in hematopoietic colony formation following 
the supplementation of the culture with a bioactive Apelin peptide during 
mesodermal differentiation and during hematopoietic blast colony forma-
tion. With the use of a synthesized fluorescein conjugated Apelin peptide 
we were able to isolate APJ+ population after primitive streak induction 
and confirmed the enrichment of hematopoietic colony forming cells within 
the APJ+ population. Transcriptional profiling of mesoderm differentiation 
culture revealed an increase in fetal globulin genes following day2 treatment 
of Apelin peptide as well as the accelerated upregulation of other develop-
mental gene groups. Apelin peptide, together with VEGF also synergistically 
enhanced the proliferation and hematopoietic colony frequency of KDR+/
CD34+ endothelial progenitors in vitro.
Poster Board Number: 3384
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The generation of megakaryocytes from human embryonic stem cells 
(hESCs) and induced pluripotent stem cells (iPSCs) provides a model system 
for studying the earliest stages of lineage commitment in vitro as well as 
supplying an unlimited source of cells for functional applications. With an 
embryoid body (EB)-based protocol, in serum-free media we are able to 
generate hematopoietic populations with megakaryocyte potential from 
hESC and iPSC lines. We utilized a three step EB-based protocol that in-
volves the formation of a primitive-streak-like (PS) population, the induction 
and specification of mesoderm, and the expansion of the megakaryocyte 
lineage. As shown by Kennedy et al. (Blood 109:2679, 2007), the primitive 
erythroid and macrophage lineages are generated within the developing 
EBs following the establishment of the hemangioblast and are detected in a 
population that co-expresses KDR and CD31. By using BMP-4, VEGF, bFGF, 
and hematopoietic cytokines, kinetic analyses of this population of cells 
shows that KDR expression diminishes over time followed by the emergence 
of a KDR-CD31+ population. This population co-expresses CD41 (αIIb) and 
CD235 (glycophorin A), markers on megakaryocyte-erythroid progenitor 
(MEP) cells. Between days 8 and 10 of differentiation, this MEP population is 
released from the EBs as single cells resulting in a homogenous population of 
MEPs that does not require cell sorting and results in a yield of one MEP per 
input hESC or iPSC. Co-culture of this MEP population on the stromal cell 
line OP9 for 3-7 days in the presence of cytokines, including TPO, promotes 
further maturation toward the megakaryocyte lineage as defined by the 
surface expression of CD42b (GPIbα) and CD42a (GPIX) expression, the ap-
pearance of multinucleated cells, the upregulation of the expression of genes 
associated with megakaryocyte commitment including PF4, and functional 
properties including PAC-1 and soluble fibrinogen binding following agonist 
stimulation. Ploidy analyses show that this CD41+CD42+ population is pre-
dominantly 2N. Various conditions are being tested to increase ploidy levels 
in these cells followed by analyses of platelet production in vitro and in vivo. 
These studies demonstrate the power of using hESC and iPSC for the study 
of hematopoiesis, especially for megakaryocytes which are an extremely rare 
and a difficult cell type to study.
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Although myocyte cell transplantation studies have suggested a promis-
ing therapeutic potential for myocardial infarction, a major obstacle to the 
development of clinical therapies for myocardial repair is the difficulties 
associated with obtaining relatively homogeneous ventricular myocytes for 
transplantation. Human embryonic stem cells (hESCs) are a promising source 
of cardiomyocytes. Our previous study demonstrated that retinoid signalling 
regulates the fate specification of atrial versus ventricular myocytes during 
cardiac differentiation of hESCs. We found that both Noggin and the pan-
retinoic acid receptor antagonist BMS-189453 (RAi) significantly increased 
the cardiac differentiation efficiency of hESCs. Our results showed that the 
expression levels of the ventricular-specific gene IRX-4 were radically el-
evated in Noggin+RAi-treated cultures. MLC-2v, another ventricular-specific 
marker, was expressed in the majority of the cardiomyocytes in Noggin+RAi-
treated cultures, but not in the cardiomyocytes of Noggin+RA-treated 
cultures. Flow cytometry analysis and electrophysiological studies indicated 
that with 64.7±0.88% (mean ±s.e.m) cardiac differentiation efficiency, 
83% of the cardiomyocytes in Noggin+RAi-treated cultures had embryonic 
ventricular-like action potentials (APs). With 50.7±1.76% cardiac differentia-
tion efficiency, 94% of the cardiomyocytes in Noggin+RA-treated cultures 
had embryonic atrial-like APs which demonstrate that retinoid signalling 
specifies the atrial versus ventricular differentiation of hESCs. Currently, we 
are investigating the underline mechanisms that retinoid signalling regulat-
ing atrial vs. ventricular myocytes specification with high though put genetic 
analysis approaches.
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Human embryonic stem (hES) cell derived hematopoietic progenitors rep-
resent a renewable source of material for use in screening and evaluation 
assays in the search for novel therapeutic and regenerative drugs. Here we 
describe the discovery of novel serum-free feeder-free protocols that direct 
differentiation of hES cells to functionally active megakaryocytes and plate-
lets. Additionally these protocols feature the replacement of commonly used 
cytokines with small molecule bioactives. Novel differentiation protocols 
were discovered using a high throughput screen called CombiCultTM (Com-
binatorial Cell Culture) that is capable of multiplexing very large numbers 
of cell differentiation protocols to identify critical combinations that result in 
high efficiency differentiation to a given phenotype. Human ES cells were 
grown on microcarriers and shuffled randomly through 40 different culture 
conditions, with concomitant labeling of the beads using nanomaterial tags. 
Ten thousand distinct protocols were sampled in one experiment. Follow-
ing screening to identify beads bearing cells positive for the megakaryocyte 
specific marker cd41a and analysis of the tags to deduce cell culture history, 
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90 novel protocols were identified. In a number of protocols efficient dif-
ferentiation of hES cells into megakaryocytes and platelets was achieved 
through the use of small molecule bioactives such as the TPO receptor 
agonist eltrombopag, replacing lineage specific cytokines at different stages 
of differentiation and platelet formation. Cell populations produced by eight 
highly efficient protocols were further characterized for surface marker 
expression and functional properties.
Poster Board Number: 3390
ENHANCED INDUCTION OF HUMAN 
PLURIPOTENT STEM CELLS INTO 
PROLIFERATIVE AND FUNCTIONAL 
CYTOTROPHOBLAST
Sullivan, Stephen1, Li, Yingchun1, Moretto Zita, Matteo1, Wolfe, 
Lynlee2, Nazor, Kristopher2, Laurent, Louise2, Parast, Mana M.1
1Dept of Pathology, University of California, San Diego, La Jolla, CA, USA, 
2Dept of Reproductive Medicine, University of California, San Diego, La 
Jolla, CA, USA
During early human embryonic development, the trophectoderm (outer 
layer of the blastocyst) develops into extraembryonic ectoderm, which sub-
sequently forms the epithelial compartment of the placenta, the trophoblast. 
The placenta broadly consists of two types of trophoblast: (a) villous tropho-
blast, including the multinucleated, βhCG-secreting, syncytiotrophoblast, 
and (b) extravillous trophoblast, an invasive tissue found at the maternal-
fetal interface, which express cell surface marker HLA-G. It has been 
postulated that villous and extravillous trophoblast arise from a common 
precursor termed the ‘Trophoblast Stem’ (TS) cell, which resides within the 
proliferative cytotrophoblast compartment. Cytotrophoblast forms a con-
tinuous layer in placenta during the first trimester, but, as gestation proceeds 
this layer becomes fragmented, possibly due to depletion of endogenous 
TS cells. In chorionic villi, cytotrophoblast cells fuse to form the syncytiotro-
phoblast. Independently in anchoring villi at the maternal-fetal interface, the 
cell column of cytotrophoblast gives rise to invasive extravillous trophoblast. 
Development of an in vitro model for human trophoblast differentiation has 
met with several challenges. While BMP4 treatment of human pluripotent 
stem cells (both hES and hiPS cells) induces trophoblast differentiation within 
days, a stable self-renewing population has yet to be isolated. Instead cul-
tures terminally differentiate with a bias toward syncytiotrophoblast, based 
on morphology and βhCG secretion. Here, we use a novel set of prolifera-
tive trophoblast markers, including CDX2 and TP63, to establish culture con-
ditions for formation and maintenance of putative human TS cells. We find 
that presence of basic Fibroblast Growth Factor (bFGF) and physiologic oxy-
gen tension (5% O2) enhance expression of trophoblast markers between 
3-5 days in BMP4-supplemented media. Additionally, we compare such in 
vitro-derived trophoblast cultures to primary cytotrophoblast representative 
of first, second, or third trimester placenta, and find that the established 
culture based system most closely resembles first trimester cytotrophoblast 
- both in terms of global gene expression profile and functionality. We are 
currently in the process of identifying surface markers for culture-derived 
proliferative trophoblast and plan to use these markers to further enrich and 
optimize culture conditions for these cells. Our ultimate goal is to develop in 
vitro models useful in interrogating early placental development and related 
pregnancy disorders and to produce a novel platform for drug testing and 
other in utero therapeutics.
Poster Board Number: 3392
OPTIMIZING HEMATOPOIETIC 
DIFFERENTIATION FROM HUMAN EMBRYONIC 
STEM CELLS USING A HIGH-THROUGHPUT 
SCREENING ASSAY
Outten, Joel T.1, Gadue, Paul2, French, Deborah L.2, Diamond, Scott 
L.1
1Bioengineering, University of Pennsylvania, Philadelphia, PA, USA, 
2Pathology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA
The differentiation of pluripotent stem cells to derivative cell types is of 
great interest for both basic science research and for the development of 
cell replacement therapies. We have developed a 96-well plate, 4-color 
flow cytometry based screening system to optimize embryoid body (EB) 
serum-free differentiation of human embryonic stem cells (hESCs) to desired 
lineages. We induced efficient differentiation to the three primary germ lin-
eages (endoderm, mesoderm, and ectoderm) and successfully distinguished 
cell types by using specified combinations of four surface markers. Endo-
derm (CXCR4+KDR-), mesoderm (KDR+SSEA-3-), and ectoderm (SSEA-
3+NCAM+) differentiation yields for H9 cells were 80 ± 11%, 78 ± 7%, and 
41 ± 9%, respectively. Additionally, we screened for the effect of manipu-
lating concentrations of four cytokines upon hematopoietic differentiation. 
In sequential screens, the concentrations of BMP4, VEGF, bFGF, and FLT3 
ligand were varied at specified time points over six days of EB differentia-
tion of H9 hESCs. Initially, EBs were seeded at day 0 and supplemented 
with specified concentrations of BMP4 (0-50 ng/mL) and VEGF (0-100 
ng/mL). At day 3, cells were given medium containing bFGF and VEGF 
with no BMP4. At day 6, cells were harvested and analyzed using 96-well 
flow cytometry. VEGF induced proportional increases in both CD34 and 
CD31 expression, with 100 ng/mL inducing CD34 and CD31 expression in 
30-40% of cells. 70-90% of cells consistently expressed KDR, with greater 
concentrations of BMP4 inducing moderately increased KDR expression. 
Based off of this data, EBs were seeded at day 0 and supplemented with 10 
ng/mL BMP4 and 50 ng/mL VEGF. At day 2, EBs were supplemented with 
medium containing 50 ng/mL VEGF, bFGF (0-10 ng/mL), and FLT3 ligand 
(0-40 ng/mL). Flow cytometry was performed at days 4 and 6. Mid-range 
FLT3 ligand concentrations induced the greatest expression of the he-
matopoietic markers CD34, CD43, and CD31 after 6 days of differentiation. 
CD235 and CD41 expression were not detected throughout differentiation 
day 6. Increasing concentrations of bFGF induced slight trends of increasing 
CD31 and KDR expression. Overall, these data indicate that maximal yields 
of CD31+CD34+CD43+KDR+ cells at day 6 are obtained with mid-range 
BMP4 concentrations (10-20 ng/ml) during early differentiation, high VEGF 
concentrations (50-100 ng/ml) throughout differentiation, and mid-range 
bFGF (5-10 ng/ml) and FLT3 ligand (25 ng/ml) concentrations during late 
differentiation. Higher concentrations of cytokines displayed no significant 
increase in yields. We aim to utilize this system progressively to optimize the 
differentiation of target hematopoietic cells.
Poster Board Number: 3394
EFFICIENT AND RAPID DOPAMINERGIC 
DIFFERENTIATION OF HUMAN PLURIPOTENT 
STEM CELLS BY CO-CULTURE OF EZ SPHERES 
WITH PA6 STROMAL CELLS
Moon, Jung-Il, Kim, Dohoon, Kim, Kwang-Soo
Molecular Neurobiology Laboratory, McLean Hospital, Harvard Medical 
School, Belmont, MA, USA
At present, in vitro differentiation of human pluripotent stem cells (e.g., 
embryonic stem (hES) cells and induced pluripotent stem (hiPS) cells) into 
subtype neural lineages is inefficient and time-consuming. Recently, various 
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approaches including the application of specific chemical compounds inhibit-
ing other cell lineage differentiation, have been reported to improve this 
process. Here, we report an efficient procedure for in vitro differentiation of 
human pluripotent stem cells to neural precursor cells and then to dopamin-
ergic neurons by combining EZ spheres with PA6 stromal feeders. This novel 
method provides both fast and efficient generation of neural precursor cells 
and dopaminergic neurons from human pluripotent stem cells, compared to 
other currently available methods. We found that EZ spheres derived from 
hES cells or hiPS cells robustly formed tubular rosettes-like structures as early 
as 3 days, upon co-culturing with PA6 stromal feeders. Neural precursor 
cells were generated from rosettes-like structures and were dramatically 
expanded without losing neuronal differentiation potentials. Subsequently, 
tyrosine hydroxylase-positive dopaminergic neurons were efficiently and 
rapidly generated from these expanded neural precursor cells. Taken to-
gether, our efficient and rapid method will serve as useful platforms to study 
neuronal differentiation mechanisms and associated brain disorders using 
human pluripotent stem cells.
Poster Board Number: 3396
FUNCTIONAL TENDON REGENERATION WITH 
DIFFERENTIATING HUMAN EMBRYONIC STEM 
CELLS
Chen, Xiao1, Zou, Xiao-hui2, Yin, Zi1, Chen, Jia-lin1, Shen, Wei-
liang1, Liu, Huan-huan1, Tang, Qiao-mei1, Fang, Zhi1, Heng, Boon 
Chin1, Lu, Lin-rong1, Ouyang, Hong-wei1
1Center for Stem Cell and Tissue Engineering, School of Medicine ,Zhejiang 
University, Hangzhou, Zhejiang, China, 2Center for Stem Cell and Tissue 
Engineering and Women’s Hospital, School of Medicine ,Zhejiang 
University, Hangzhou, Zhejiang, China
Aim: Activation and repression of lineage-specific genes determine the dif-
ferentiation fate of embryonic stem (ES) cells. To date, optimal induction of 
hESC for tendon regeneration has not yet been achieved. Here, we are the 
first to show that the combination of mechanical stress and transcription 
factor scleraxis (SCX) is efficient committed the teno-lineage differentia-
tion of hESC. Methods: Human ESCs were first induced to differentiate into 
mesenchymal stem cells (MSCs). The immuno-phenotype of hESC-derived 
MSCs (hESC-MSCs) was identified by flow cytometry. Then the hESC-MSCs 
were transfer with the tendon-lineage specific transcription factor scleraxis. 
hESC-MSCs formed cell sheet after 14 days culture and engineered tendon 
were formed in vitro. The engineered tendon was subjected to a dynamic 
mechanical stress of 1HZ for 2h/day. Then the regeneration potential of the 
engineered tendon tissues was evaluated in both an in vitro tissue engineer-
ing model and an in-situ rat patellar tendon window repair model. Results: 
Scleraxis overexpression increased the expression of tendon ECM genes col-
lagen I, XIV.. It was found that SCX can improve the teno-lineage differen-
tiation of hESC-MSC, when working with mechanical stress. SCX has syner-
gistical effect on teno-lineage differentiation but inhibit other mesenchymal 
lineage differentiation induced by mechanical stress. Also it was demon-
strated that combining SCX with mechanical stimulation was able to drive 
tendon regeneration in vivo. Further analysis revealed that enhanced tendon 
differentiation and regeneration is due to the modulation of BMP signaling 
by SCX and mechanical stress. Conclusion: Our results demonstrated that 
functional tendon regeneration can be achieved by hESC-MSC engineered 
with SCX and mechanical stress. These findings not only contribute to a bet-
ter understanding of the mechanisms underlying tendon differentiation but 
also provide new insights in developing novel therapeutic approaches for 
tendon regeneration using hESC.
Poster Board Number: 3398
CYTOKINE DIRECTED DIFFERENTIATION AND 
IN VITRO SELECTION OF HEPATIC HIPSC AND 
HESC DERIVATIVES
Sgodda, Malte1, Schambach, Axel2, Ott, Michael3, Vogel, Arndt4, 
Schöler, Hans R.5, Cantz, Tobias1
1JRG Stem Cell Biology, Hannover Medical School, Hannover, Germany, 
2JRG Hematopoietic Cell Therapy, Hannover Medical School, Hannover, 
Germany, 3Centre of Experimental and Clinical Infection Research, 
Hannover Medical School, Hannover, Germany, 4Dept. Gastroenterology, 
Hepatology, and Endocrinology, Hannover Medical School, Hannover, 
Germany, 5Dept of Cell and Developmental Biology, Max Planck Institute 
for Molecular Biomedicine, Muenster, Germany
Human embryonic stem cells (hESCs) and human induced pluripotent stem 
cells (hIPSCs) hold great promise in regenerative medicine. Due to their 
merely unlimited self-renewal capacity and their ability to differentiate into 
derivatives of all three germ layers, these cells might serve as hepatic trans-
plants for metabolic or acute liver diseases. So far, hepatic differentiation ef-
ficiencies of hiPSCs and hESCs are well studied, but enrichment of functional 
active hepatic derivatives for transplantation purposes need further atten-
tion. In our study, we aimed for an efficient hepatic differentiation protocol 
that is applicable for both, hESCs and hiPSCs. We were using a cytokine and 
small molecule based protocol for direct differentiation of hESC and hiPS 
cells into hepatic cells. Furthermore, we select the hepatic differentiated cells 
during differentiation using a hepatic promoter driven G418 resistance. Due 
to an IRES dependent eGFP reporter expression we were able to track the 
hepatic differentiated cells and evaluated the most efficient time-frame for 
G418 selection. The status of the hepatogenic differentiation was deter-
mined by qRT-PCR comparing the expression of hepatic markers as AFP, 
ALB, PCK, SOX17, Cyp1A1 and HNF4 to hepatic cell lines and the loss of 
pluripotency markers (Oct4, Sox2 and Nanog) to undifferentiated parental 
cells. Functional analyses of the hepatic phenotype were obtained by mea-
surements of secreted albumin and by analyses of cytochrome P450 type 
1A1 activity (EROD). The percentages of differentiated cells were quantified 
by FACS analyses. Finally, hESC-derived hepatic cells were transplanted into 
immunodeficient FAH-/- mice. Preliminary data indicate engraftment of 
transplanted cells into the host liver parenchyma and functional contribution 
to albumin synthesis. In conclusion, the modified protocol shows that both 
pluripotent cell sources (hESC and hiPSC) can be differentiated in vitro into 
hepatic cells with similar efficiencies. Further analyses need to reveal the re-
population efficiency of stem cell derived hepatic cells in relation to different 
pluripotent cell sources and improved differentiation protocols.
Poster Board Number: 3400
A MYOGENIC MEDIUM COMBINED WITH AN 
ADENOVIRUS EXPRESSING MYOD INDUCE THE 
MYOGENESIS OF HUMAN EMBRYONIC STEM 
CELLS.
Goudenege, Sebastien, Lebel, Carl, Dufour, Christine, Rousseau, 
Joel, Tremblay, Jacques P.
Génétique Humaine, CHUQ, Quebec, QC, Canada
Human embryonic stem cells (hESC) have an endless self-renewal capacity 
and can differentiate into all types of cells found in the body. For this reason, 
they represent an unlimited source of cells for cell therapy of degenerative 
diseases, such as Duchenne muscular dystrophy. Due to the considerable 
amount of myogenic cells required in this kind of cell-based therapy, hESC 
represents a promising avenue for the elaboration of such treatment. How-
ever, at the moment the use of hESC is compromise by the small amount 
of efficient specific lineage differentiation protocols published. In the case 
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of myogenic differentiation, Barberi & al developed a stroma-free induction 
system to derive engraftable skeletal myoblasts from hESC. However, this 
technique had a low conversion rate and was time consuming. Since this 
work, no major break advance has emerged. We developed a new protocol 
to differentiate hESC into skeletal muscle combining an adenovirus express-
ing MyoD and a myogenic culture medium (MB1). The fusion potential of 
these cells was established by the formation of multinucleated myotubes 
i.e 60% of the nuclei were located in myotubes stained positive for myosin 
heavy chain. Our results indicate that the combination of MB1 medium and 
adenovirus is an interesting protocol for hESC differentiation into skeletal 
muscle cells. The potential of these cells to fuse with muscle fibers in vivo is 
currently under investigation. Our findings are the first step to use hESCs or 
induced pluripotent stem cells (IPS) as an alternative source of cells for basic 
applications and for preclinical studies in muscle repair.
Poster Board Number: 3402
RETINOIC ACID ENHANCES SKELETAL 
MYOGENESIS IN HUMAN EMBRYONIC STEM 
CELLS BY EXPANDING THE PREMYOGENIC 
PROGENITOR POPULATION
Skerjanc, Ilona S., Ryan, Tammy, Liu, Jun, Chu, Alphonse, Wang, 
Lisheng, Blais, Alexander
Biochemistry, Microbiology, and Immunology, University of Ottawa, 
Ottawa, ON, Canada
Human embryonic stem cells (hESCs) are a potential source of cells for 
cell therapy of muscle diseases. To date, it has proven difficult to gener-
ate skeletal muscle from hESCs in high yields and within a reasonable 
timeframe. Further, a human ES-derived Pax3/7-positive skeletal muscle 
progenitor population has not yet been described. Previous studies have 
shown that Pax3/7-positive progenitor cells can repopulate the satellite cell 
niche, indicating the importance of this population for therapy. We sought 
to optimize the differentiation of hESCs into skeletal muscle with a view to 
identifying distinct stages of myogenesis and shortening the time course. We 
treated hESCs with retinoic acid (RA) and found that skeletal myogenesis, 
and the expression of the myogenic regulatory factors (MRFs) Myf5, MyoD 
and myogenin were enhanced. Furthermore, we found that RA treatment 
expanded the muscle progenitor pool, which occurred as a distinct Pax3+ve/
Meox1+ve population prior to MRF expression. Non-skeletal muscle tissue 
types, known to be enhanced by RA, were not greatly affected. We have 
identified a differentiation pathway in hESCs that provides a skeletal muscle 
progenitor population and a shorter time course of myogenesis. We propose 
that RA could fit into a directed culture method for deriving skeletal muscle 
from hESCs.
Poster Board Number: 3404
DISTINCT ENERGY METABOLISM IN 
HUMAN PLURIPOTENT STEM CELLS AND 
DIFFERENTIATED CELLS REGULATED BY UCP2
Zhang, Jin
University of California, Los Angeles, Los Angeles, CA, USA
It has been assumed, based largely on morphologic evidence, that human 
pluripotent stem cells (hPSCs) contain underdeveloped, bioenergetically 
inactive mitochondria, while differentiated cells harbor a fused, branch-
ing mitochondrial network, with oxidative phosphorylation (OXPHOS) 
as the main energy source. A role for mitochondria in hPSC bioenergetics 
therefore remains uncertain. Here we show that hPSCs have functional 
respiratory complexes that consume O2 at maximal capacity. Despite this, 
ATP generation in hPSCs is mainly by glycolysis. To help maintain hPSC 
mitochondrial membrane potential, cell proliferation, and viability, glycolytic 
ATP is hydrolyzed by the mitochondrial F1F0ATP synthase. Uncoupling 
protein 2 (UCP2) regulates this unique pattern of hPSC energy metabolism 
while suppressing reactive oxygen species. Upon differentiation, UCP2 is 
repressed and cells shift from glycolysis and fatty acid oxidation to glucose 
oxidation dependency. Ectopic UCP2 expression during differentiation blocks 
this metabolic transition, and it blocks induction of differentiation genes and 
proper embryoid body formation. Combined, our data show that hPSC have 
distinct bioenergetics regulated by UCP2 and repression of UCP2 is required 
for metabolic reprogramming and proper differentiation. This is to our 
knowledge the first report on a energy metabolism-related molecule regulat-
ing differentiation in hPSCs.
Poster Board Number: 3406
GENERATION AND CHARACTERIZATION OF 
INDUCED PLURIPOTENT STEM CELLS FROM 
HUMAN SARCOMA CELL LINES
Zhang, Xi, Matushansky, Igor
Columbia University, New York, NY, USA
Induced pluripotent stem cells (iPSCs) are defined as somatic cells that have 
been reprogrammed (using either the four transcriptional factors Oct4, 
Sox2, Klf4 and c-Myc or Oct4, Sox2, Nanog and Lin28) to exhibit embry-
onic stem cell-like pluripotent differentiation properties. The generation of 
iPSCs was a great achievement for the field of cell transplantation and tissue 
engineering. More recently multiple cancer cell lines (e.g, leukemia cells, 
melanoma cells & gastric cancer cell) have been successfully reprogrammed 
to the iPSC-state, at least as defined by (1) expression of genes specific to 
undifferentiated embryonic stem cells; and (2) pluripotency as defined by 
embryoid body formation in vitro and early markers of commitment to vari-
ous differentiation lineages. However, the question that remains unanswered 
is: can the cancer derived iPSCs complete maturation along a given lineage, 
be it the lineage from which it was derived (i.e., originally prematurely 
blocked) or an alternative lineage? If the former were demonstrated it would 
in essence answer the question of whether global changes in chromatin 
architecture or epigenetics can supersede the specific genetic changes (i.e., 
mutation) in DNA that resulted in the lineage specific differentiation block 
and subsequent tumorigenesis. To attempt to answer these questions we 
generated iPSC-cancer cells from sarcoma cell lines representing undif-
ferentiated sarcomas, osteosarcoma cells, liposarcoma cells, and sarcomas 
of unknown lineage. While the original sarcoma cell lines could not be dif-
ferentiated into multiple mature connective tissue cells, their iPSC-counter-
parts readily differentiated into multiple mature connective tissue lineages. 
Furthermore, assessment of proliferation indicated that acquisition of the 
mature phenotype was concurrent with cessation of proliferation; and thus 
abrogation of tumorigenicity. We are currently(1) performing gene expres-
sion, microRNA, and global DNA promoter methylation profiling in order to 
assess the mechanism by which iPSC-based reprogramming of cancer cells 
overrides the inherent genetic mutation in these cells and restores the capac-
ity for terminal differentiation and (2) extending our work to carcinomas.
Poster Board Number: 3408
DIRECTING HUMAN EMBRYONIC STEM CELL 
DIFFERENTIATION BY NON-VIRAL DELIVERY 
OF SIRNA IN 3D CULTURE
Zoldan, Janet, Laytton-Jean, Abigail K., Karagiannis, Emmanuel D., 
Deiorio-Haggar, Kaila, Bellan, Leon, Langer, Robert S., Anderson, 
Daniel G.
Massachusetts Institute of Technology, Cambridge, MA, USA
Human embryonic stem cells (hESCs) hold great potential as a resource for 
regenerative medicine. Before achieving therapeutic relevancy, methods 
must be developed to control stem cell differentiation. It is clear that stem 
cells can respond to genetic signals, such as those imparted by nucleic acids, 
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to promote lineage-specific differentiation. However, the major barrier 
preventing the use of nucleic acids from influencing differentiation is the 
lack of safe and efficient delivery methods. The majority of current delivery 
methods utilize modified viruses. While viruses are an effective means of 
transferring nucleic acids to stem cells, they have limited loading capacity 
and questionable safety. Here we have developed an efficient system for 
delivering siRNA to hESCs in a 3D cultured matrix. We show that effi-
cient siRNA delivery can be used to coordinate hESC differentiation. Using 
siRNA to silence either the KDR or the androgen receptor gene, we achieve 
concurrent down regulation in genes representative of the endoderm germ 
layer and significant upregulation of genes representative of the mesoderm 
germ layer. We also identify that integrins play a significant role in the siRNA 
delivery and activity. This is the first demonstration that siRNA can direct 
stem cell differentiation by blocking one of the germ layers.
Poster Board Number: 3410
COMPARISON OF VENTRAL PROSENCEPHALIC 
PROGENITORS GENERATED FROM HUMAN 
AND MOUSE EMBRYONIC STEM CELLS THAT 
GIVE RISE TO MATURE CORTICAL NEURONS
Maroof, Asif M.1, Anderson, Stewart2, Studer, Lorenz1
1Developmental Biology, Memorial Sloan Kettering Cancer Center, New 
York, NY, USA, 2Psychiatry, Weill Cornell Medical College, New York, NY, 
USA
The developing prosencephalon gives rise to cortical, limbic, and hypotha-
lamic structures in the brain, which in the human are the regions that under-
lie complex cognitive processes, including movement, memory, and execu-
tive decision-making. While some mechanisms to generate this vast diversity 
of cell types are conserved between mammalian species, several processes 
have already been described in humans to be evolutionarily divergent. By 
comparing the mouse and human prosencephalon during embryonic devel-
opment, we have identified the molecular signatures that are common and 
unique to humans. In this study, we seek to elucidate the signaling pathways 
involved in patterning the ventral prosencephalon through the use of human 
and mouse embryonic stem cells (ESCs). By directing their patterning at the 
pluripotent stage, we can direct these cells towards various diencephalic and 
telencephalic progenitors within two to three weeks through a novel rapid 
induction protocol. Using ESCs that express GFP regulated by the NKX2.1 
promoter, we can isolate ventral prosencephalic progeny through fluorescent 
activated cell sorting (FACS). When FACS-sorted and placed into a cortical 
environment, either in vivo or in vitro, these GFP-expressing progenitors 
give rise to GABA-expressing neurons that receive inputs and can fire action 
potentials reminiscent of cortical interneurons. Therefore, this work demon-
strates the use of human ESCs to model human development. By generating 
a plethora of specified human ventral prosencephalic progenitors, this work 
can be applied to the study of distinct and novel neural populations.
Poster Board Number: 3412
GENESIS OF RETINAL PIGMENT EPITHELIUM 
CELLS DURING MONOLAYER DIFFERENTIATION 
OF HUMAN PLURIPOTENT STEM CELLS
Maruotti, Julien, Wahlin, Karl, Zack, Donald
Johns Hopkins University, Baltimore, MD, USA
Age-related macular degeneration (AMD) is the most common cause of 
irreversible visual loss in the elderly in the Western world. It is a devastating 
disease of the retina that can lead to central blindness. It affects the retinal 
pigment epithelium (RPE) - the layer of cells that surrounds and nourishes 
the neurosensory retina. When RPE cells do not function properly, photo-
receptor cells begin to die and vision is lost. Currently, there are few if any 
available option to treat or replace diseased RPE. Cell-based transplanta-
tion strategies offer the promise of being able to restore RPE cells, thus 
potentially limiting vision loss. Therefore, establishing an abundant and 
quality source of donor cells is of utmost importance. Human pluripotent 
stem cells (hPSCs) may prove suitable for this purpose: significant advances 
have recently been made in inducing the differentiation of hPSCs toward an 
RPE-like cell fate. Nevertheless, the length and efficiency of these methods 
are still not optimal. Current RPE differentiation protocols are based on 
embryoid body or cell monolayer-based differentiation approaches. The rela-
tive simplicity of the latter approach makes it a preferred alternative for high 
throughput screening campaigns aimed at finding small molecules that could 
improve RPE differentiation efficiency. However, RPE generation from hPSC 
is a lengthy process (up to several months). Therefore, it would be most 
useful to first gain a precise understanding of the time frame and efficiency 
of the different steps involved in RPE differentiation, in order to adapt high 
throughput screening strategies. Since very little is known regarding the 
different steps of RPE genesis during hPSC monolayer differentiation, we 
decided to start studying these, with a view to establishing a small mol-
ecule screen for compounds that promote RPE differentiation and survival. 
Following a simple and scalable monolayer differentiation protocol with 
serum-free and feeder-free conditions, we were able to obtain RPE-like cells 
from human embryonic stem cells, as well as from induced pluripotent stem 
cells. hPSC derived RPE cells formed a pigmented monolayer, and expression 
of specific markers such as Mitf, Otx2, CRALBP and Best1 was confirmed at 
the mRNA and protein levels. On the functional level, pigmented RPE sheets 
were able to phagocytose pHrodo labeled bioparticles. Since pigmented cell 
clusters started to appear after 25-30 days of in vitro differentiation, we 
next sought to follow the expression of key transcription factors involved in 
RPE differentiation during this time window. Preliminary results indicate that 
after a surge in the number of RPE precursor cells (Mitf+/Otx2+) at 5 days 
of differentiation, significant cell loss is observed 5 days later. Therefore, the 
first 10 days of differentiation might constitute a window of opportunity to 
screen for small molecules able to promote survival and proliferation of RPE 
precursors.
Poster Board Number: 3414
LINKING DIFFERENTIATION AND CELL CYCLE 
WITHDRAWAL IN HUMAN EMBRYONIC STEM 
CELLS
Moore, Jennifer C., Fremed, Michael A., Toro-Ramos, Alana J., 
Swerdel, Mavis, Davila, Jonathan, Hart, Ronald P.
Cell Biology and Neuroscience, Rutgers University, Piscataway, NJ, USA
During the earliest stages of development nearly all cells in an embryo un-
dergo continuous cell division to increase the total cellular mass of the em-
bryo. As development progresses cell specialization occurs and an increasing 
number of cells begin to withdraw from the cell cycle and differentiate 
into multiple cell types. One of the unanswered questions in this process is 
whether differentiation initiates cell cycle withdrawal or whether cell cycle 
withdrawal enables differentiation. The differentiation of human embryonic 
stem cells is an excellent system with which to model this process. We and 
others have shown that nearly all pluripotent hESC remain in the cell cycle 
and that their cell cycle consists of very short G1 phases and long S phases. 
However, as these cells begin to differentiate, an increasing number of cells 
withdraw from the cell cycle and the length of S phase decreases with a 
corresponding increase in the length of the G1 phase. Concomitantly with 
lengthening of the G1 phase, negative regulators of the cell cycle such as 
p21/WAF1 and p27/KIP1 increase. We hypothesize that cell cycle with-
drawal is necessary for a cell to undergo differentiation and are using this 
model system to investigate the mechanisms that link the differentiation of 
cells to their withdrawal from the cell cycle.
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CANONICAL WNT SIGNALING INHIBITS 
MEGAKARYOCYTE-ERYTHROID PROGENITOR 
FORMATION FROM HUMAN EMBRYONIC STEM 
CELLS
Paluru, Prasuna C., Cheng, Xin, Disimone, Aline M., French, 
Deborah L., Gadue, Paul
Center for Cellular and Molecular Therapeutics, Children’s Hospital of 
Philadelphia, Philadelphia, PA, USA
The Wnt gene family consists of structurally related genes encoding secreted 
signaling molecules that have been implicated in many developmental pro-
cesses, including regulation of cell fate and patterning during embryogen-
esis. We have previously found that Wnt signaling enhances primitive eryth-
rocyte development and its inhibition results in a loss of primitive erythrocyte 
development when given to mouse ES cell-derived mesoderm. Here, we 
examine the effect of Wnt signaling on the formation of early hematopoi-
etic progenitors derived from human ES cells. The first hematopoietic cells 
co-express CD41 and CD235, typical markers of megakaryocytes and eryth-
rocytes, respectively. We find that canonical Wnt signaling is inhibitory both 
to the development of this hematopoietic population from mesoderm and to 
its maintenance. Specifically, treatment of mesodermal cells with Wnt3a led 
to an almost complete loss in the development of colony-forming cells while 
inhibition of canonical Wnt signaling with DKK1 led to a 4-fold increase 
in erythroid colony formation. Culturing CD41+CD235+ cells with Wnt3a 
led to a 10-fold decrease in the number of CD41+CD42+ megakaryocytes 
and CD235+CD41- erythroid cells. Addition of the non-canonical Wnt5a 
has a similar effect as DKK1 treatment in that it increased the generation 
of CD41+CD235+ progenitors. In addition, we demonstrate that this effect 
is specific to primitive erythrocyte-megakaryocyte progenitors, as myeloid 
development is less affected by Wnt3a treatment. This finding is in stark 
contrast to the role of Wnt signaling during mouse ES cell differentiation. 
These studies demonstrate the utility of the ES cell system in the study of cell 
fate decisions and highlight the importance of working with human ES cells 
as there are some species- specific differences in development that will need 
to be addressed before applying findings from the mouse model system.
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DEFINING TRANSCRIPTIONAL LANDMARKS OF 
EARLY HUMAN DEVELOPMENT WITH HUMAN 
PLURIPOTENT STEM CELLS
Patterson, Michaela
University of California, Los Angeles, Los Angeles, CA, USA
Human pluripotent stem cells (hPSCs) have the capacity to differentiate to 
all cell types of the human body making them very attractive for regenera-
tive medicine purposes. It is not known, however, if in vitro differentiation 
of hPSCs mirrors in vivo development, nor if the differentiated progeny of 
hPSCs are truly analogous to their tissue-derived counterpart. To answer 
these questions, we have differentiated two sources of hPSCs, human 
embryonic stem cells and human induced pluripotent stem cells, to cell types 
representing all three germ layers: a neural progenitor cell (ectoderm), a 
hepatocyte (endoderm), and fibroblasts (mesoderm). We performed large 
scale transcriptome profiling comparing PSC progeny to their tissue-derived 
counterparts and identified a significant list of genes that is differentially ex-
pressed between the PSC derivatives and their natural counterparts regard-
less of germ layer produced. The observed differences include many genes 
expressed in the early embryo that fail to turn off during in vitro differentia-
tion. These data and evidence from expression patterns in early human fetal 
tissue (3-16 weeks of development) suggests that the differentiated progeny 
of human PSCs are more reflective of very early human development (<6 
weeks gestation) rather than later time points. These findings validate the 
idea that human pluripotent stem cells can serve as useful models of very 
early development, but also underscore the need to consider the maturity of 
hPSC derivatives for regenerative medicine purposes.
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DERIVATION OF ASTROCYTES FROM HUMAN 
EMBRYONIC STEM CELLS FOR SPINAL CORD 
INJURY THERAPY
Shih, Chung-Hsuan, Cooney, Michelle, Noble, Mark, Pröschel, 
Christoph
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Every year about 300,000 patients in the U.S. suffer traumatic injury of the 
brain or spinal cord requiring hospitalization, of which 250,000 survive. Due 
to the limited regenerative capability of adult central nervous system (CNS), 
these patients are facing the debilitating consequence of their injuries. Tak-
ing advantage of the neuroregeneration promoting properties of glial cells, 
we have developed a cell therapy for SCI using a specific type of astrocyte. 
Previously we have shown that transplantation of BMP-induced astrocytes 
(GDAsBMP) derived from either rat or human embryonic glial-restricted 
precursor (GRPs) cells promotes extensive neuronal survival, axonal regen-
eration, and functional recovery in a rat spinal cord lesion model. With the 
recent advances in human embryonic stem cell (hESC) technology, we hy-
pothesize that hESCs can be used as a source for generating astrocyte popu-
lations with therapeutic potential. Using step-wise differentiation through 
an intermediate neural progenitor stage, we have derived distinct types of 
human astrocytes from hESCs. Our data indicate that these hESC-derived 
astrocytes recapitulate characteristics of rodent precursor-derived astrocytes 
with respect to cell morphology and expression of glial specific genes. We 
have also developed a high-throughput in vitro neuronal survival and axonal 
outgrowth assay using the Cyntellect Celigo adherent cell cytometer. Our 
Celigo results show that astrocytes derived from hESC by BMP induction 
selectively support the survival and axonal growth of embryonic cortical 
and dorsal root ganglion neurons. These results set the stage for testing 
the therapeutic potential of hESC-derived astrocytes for spinal cord injury 
regeneration in vivo.
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A REPORTER HUMAN EMBRYONIC STEM 
CELL LINE THAT FACILITATES IDENTIFICATION 
OF THYMIC EPITHELIAL CELLS DURING 
DIFFERENTIATION
Soh, Chew-Li1, Giudice, Antonietta1, Micallef, Suzanne1, 
Hatzistavrou, Tanya1, Seach, Natalie1, Trounson, Alan2, Boyd, 
Richard1, Elefanty, Andrew1, Stanley, Ed1
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Thymic epithelial cells (TECs) form the main constituent of the thymus 
microenvironment and play an essential role in thymocyte development 
and T-cell repertoire selection. The ability to produce a replacement source 
of TECs from human embryonic stem cells (hESCs) would significantly 
enhance research efforts into the mechanisms that govern immunity, and 
may enable the restoration of thymus function in aged or diseased states. 
Furthermore, hESC-derived TECs could theoretically be combined with 
host-derived haematopoietic stem cells (HSCs) to create a chimeric thymus, 
which in turn might be used to establish antigen-specific tolerance induction 
in vivo. In order to facilitate analysis of directed thymic differentiation, we 
have developed a hESC (FOXN1GFP/w) line in which the green fluorescent 
protein (GFP) gene has been inserted into the locus encoding the forkhead-
box transcription factor, FOXN1. Expressed in all epithelial cells of the early 
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thymic rudiment, FOXN1 is an essential gene for TEC differentiation into 
mature cortical and medullary epithelial cells. Correct gene targeting was 
confirmed using a PCR-based approach in conjunction with southern blot 
hybridisation. FOXN1GFP/w lines are karyotypically normal, retain expres-
sion of pluripotency markers and form multi-lineage teratomas in immuno-
deficient mice. We have used our FOXN1GFP/w hESCs in conjunction with 
a serum-free spin embryoid body (EB) differentiation system to develop a 
robust and reproducible protocol for the generation of FOXN1+ endodermal 
progenitors. Analysis of this population confirms that FOXN1 expression is 
confined to the GFP+ fraction and that these cells express a suite of markers 
consistent with early foregut endoderm. Current experiments are focused on 
further characterising purified differentiated FOXN1+ cells via transcriptional 
profiling, functional assays and transplantation experiments.
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Implantation of in vitro differentiated human embryonic stem cells (hESC) 
derivatives constitutes promising therapy of multiple serious diseases. 
Survival of grafted cells is influenced by several factors, expression of death 
receptors and their pathway components being an important one. In living 
organism expression of death receptors functions to eliminate transformed 
cells. Elevated expression of TRAIL receptors DR4 and DR5 sensitizes these 
cells to TRAIL-induced apoptosis engaging caspase 8. Expression of death 
receptors, constituency of downstream signalling and its functionality in 
undifferentiated hESCs and their differentiated derivatives has not been ex-
plored yet. We determined expression of death receptors during the course 
of differentiation of hESCs into neural precursor cells line (NPC), expression 
of caspase 8 and response to TRAIL. Quantities of death receptors (DR4, 
DR5, DcR1, DcR2, TNFR1, Fas) were determined by flow cytometry. We 
found that expression profile of death receptors changed with differentia-
tion. Whereas quantity of DR4 during differentiation decreases, DR5 and Fas 
increases. TRAIL decoy receptors DcR1, DcR2 are not significantly expressed 
in none of investigated cell types. Both undifferentiated hESCs and NPCs 
express caspase 8, essential for execution of TRAIL induced apoptosis. Inter-
estingly, treatment with soluble recombinant TRAIL (0-1000ng/mL, 24h) did 
not induce apoptosis either in hESCs or NPCs, but cells were sensitized by 
chemical inhibition of proteasome (1μM MG132, 24h). Our work describes 
presence of selected components of death receptor apoptotic pathway in 
undifferentiated human embyonic stem cells and its differentiating deriva-
tives - neural precursor cells. However, presence of these components 
themselves is not sufficient to mediate apoptosis upon TRAIL treatment. Our 
current research effort focuses on detailed understanding of mechanism of 
resistance to TRAIL induced apoptosis.
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FROM EACH OF THE PRIMARY GERM LAYERS.
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Human embryonic stem cells (hESCs) hold promise to treat diseases such 
as Parkinson’s and type I diabetes, which are caused by the destruction of 
specific cell types. In order to achieve the promise these pluripotent cells 
hold, precise control of hESC fate and differentiation must be established. 
Here we have employed a modular and defined set of peptide surfaces to 
support undifferentiated hESCs and hESC-derived progenitor cells from each 
germ layer. Significant research is dedicated to creating completely defined 
culture conditions, which are important to reduce experimental variability 
and to prevent exposure of cells to pathogens or xenobiotics. Research-
ers have access to commercial chemically defined media, but developing a 
completely defined matrix has proven more difficult. Recently, we discovered 
that surfaces displaying the peptide GKKQRFRHRNRKG derived from the 
heparin-binding domain of vitronectin are capable of supporting long term 
undifferentiated hESC culture. The surfaces consist of biotinylated pep-
tides bound to streptavidin-coated polystyrene. Moreover the surfaces are 
modular in that by mixing different peptide conjugates together, they can 
display multiple peptides or peptides in various densities. Surfaces displaying 
GKKQRFRHRNRKG alone support hESCs in the presence of Y-27632 ROCK 
inhibitor while surfaces presenting an equal mixture of GKKQRFRHRNRKG 
and a cyclic RGD peptide require ROCK inhibition only during initial cell 
plating. Further, hESCs cultured long term under these defined conditions 
retain the ability to respond to directed differentiation protocols to ecto-
derm, endoderm, and mesoderm. Because most adherent directed differen-
tiation protocols rely on undefined matrix components such as Matrigel or 
gelatin, this aspect of the project instigated research into designing tailored 
synthetic niches for hESC-derived progenitor cells from each germ layer. We 
have shown that hESCs grown on GKKQRFRHRNRKG in the presence of 
Y-27632 can differentiate into PAX6+ ectoderm when treated with Noggin 
and SB-431542 for 6 days, SOX17+ definitive endoderm when treated with 
Activin A for 6 days, and FOXF1+ mesoderm when treated with Activin A 
for 1 day and BMP4 for 5 days. All of the differentiation conditions involved 
the defined matrix and serum-free media. However, unlike undifferentiated 
hESCs, the combination of GKKQRFRHRNRKG and cyclic RGD does not 
support differentiation toward the ectoderm in the absence of ROCK inhibi-
tor. In order to address this issue, we have compared the expression of cell 
adhesion receptors and extracellular matrix (ECM) proteins of hESC-derived 
PAX6+ OCT4- neural precursor cells to undifferentiated hESCs. We plan to 
design surfaces that display ligands to differentially expressed cell adhesion 
receptors or that mimic bioactive regions of differentially expressed ECM 
proteins. In conclusion, we show that surfaces displaying the peptide GK-
KQRFRHRNRKG can serve as a defined matrix for hESC directed differentia-
tion protocols to each germ layer when ROCK is inhibited. Additionally we 
are developing surfaces that present ligands to differentially expressed cell 
adhesion receptors in order to improve directed differentiation protocols in 
terms of cell viability, yield of the desired cell type, and independence from 
soluble molecules such as ROCK inhibitor. These surfaces offer modular, 
simple and accessible defined culture matrices for hESCs and hESC-derived 
progenitor cells from each germ layer.
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DIFFERENTIATION OF HESCS INTO CARDIAC 
LINEAGE BY MODULATION OF BOTH ALK/
SMAD AND BFGF SIGNAL PATHWAY
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of Bio and Brain Engineering, KAIST, Daejeon, Korea, Republic of, 4Dept of 
Biological Sciences, KAIST, Daejeon, Korea, Republic of
The TGFβ/BMP-activated Smad signaling pathway plays a complicated 
role in the maintenance of human embryonic stem cell (hESC) pluripotency 
and in the cell fate decision of hESCs. To better understand the specific 
role of the TGFβ/BMP signaling pathway in hESC function, we examined 
the effects of a pharmacological ALK4/5/7 inhibitor, which blocks type I 
receptor-mediated Smad signaling, on in vitro hESC differentiation under 
various culture conditions with or without bFGF stimulation. Here, we report 
that sustained inhibition of the TGFβ type I receptor (also termed activin re-
ceptor-like kinase or ALK) using a chemical inhibitor selective for ALK4/5/7 
(ALKi) leads to the cardiac differentiation of hESCs under feeder-free and 
serum-free conditions. Treatment with ALKi reduced Smad2/3 phospho-
rylation and increased Smad1/5/8 phosphorylation in hESCs, suggesting a 
requirement for active Smad1/5/8 signaling for cardiac induction in these 
cells when ALK/Smad2/3 is inhibited. Importantly, active bFGF signaling 
was also required for ALKi-mediated cardiac differentiation of monolayer-
cultured hESCs. The FGFR inhibitor SU5402 blocked ALKi-mediated cardiac 
induction in hESCs, while BMP4 enhanced the ALKi-induced increase in 
phospho-Smad1/5/8 levels but failed to induce the cardiac differentia-
tion of hESCs, and instead promoted trophoblastic differentiation. We also 
confirmed that ALKi potentially enhanced the cardiac differentiation of hEBs, 
as determined by expression of cardiac specific markers, increased beating 
areas, and action potential recorded from beating areas. Our results demon-
strate that ALKi could serve as a potent cardiogenic inducer of hESCs, and 
coordinated Smad-dependent signaling and FGF-dependent signaling play 
an important role in the differentiation of hESCs into the cardiac lineage. 
Acknowledgements: The study was supported by grants of the NRF grant 
[2010-0020272(3)] and the KRCF/KRIBB research initiative program.
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HEPATIC DIFFERENTIATION OF MOUSE AND 
HUMAN ES CELLS AND IPS CELLS IN VITRO
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Stem Cell Biology, Institute of Molecular Embryology and Genetics, 
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In drug discovery, many researchers often use primary cultures of hepato-
cytes for toxicity tests. However, primary hepatocytes are short-lived and 
cannot be maintained in long term cultures. In addition, there are consider-
able donor dependent variations. Embryonic stem (ES) cells are pluripotent 
cells derived from the inner cell mass of the blastocyst. Lines of evidence 
have shown that ES cells recapitulate normal developmental processes, and 
suggest that ES cells provide an attractive source for routine access to large 
numbers of cells that enable the development of new drug-screening strate-
gies. We previously reported that culturing ES cells on a mesonephric cell 
line, M15, with the addition of specific growth factors resulted in a selective 
induction of hepatic differentiation of ES cells at a high efficiency. Here, we 
established a novel hepatic differentiation method using synthetic nanofiber 
(NF) as a cell culture scaffold. First, we performed endoderm differentiation 
of mouse ES (mES) cells using NF based methods in comparison with several 
substrata, such as gelatin, fibronectin, collagen I, and MHS gel. Similar to 
collagen I and MHS gel, ES cells cultured on NF methods gave rise to Sox 17 
positive endodermal cells efficiently. Using these three substrata, we cultured 
further for 20 days until ES cell became mature. Time dependent Albumin 
expressions and secretions were analyzed by RT-PCR and ELISA, respec-
tively. On differentiation day 24, functional assays for hepatocyte were also 
carried out. In these assays, PAS- assaying glycogen storage, and indocyanin 
green (ICG) test for hepatocyte detoxification function, and cytochrome 
P450 activities and their induction responding to inducers were analyzed. 
All these assays revealed that ES cells cultured on NF were potentiated for 
hepatic differentiation. Moreover, differentiated ES cell-derived hepatocytes 
uptook ICG and were maintained for more 100 days on NF. These results 
indicate that NF is a suitable scaffold that not only promotes ES differentia-
tion into hepatocytes, but also maintains the differentiated functions of the 
hepatocytes. Finally, we checked whether NF method was applicable to hu-
man ES cells and human induced pluripotent stem (iPS) cells. As a result, NF 
is similarly effective in supporting the hepatic differentiation of hES cells as 
compared to M15 cells. As this NF method is a serum-free and feeder-free 
system, it would be useful for Xeno-free culture of human ES/iPS cells. This 
novel procedure will be useful for the elucidation of molecular mechanisms 
that underlie lineage decision, and could represent a key milestone for a 
surrogate cell source not only for regenerative medicine but also for pharma-
ceutical studies such as toxicology.
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ENHANCE MOUSE CARDIOVASCULAR 
PROGENITOR CELLS IN VITRO
Hagvall, Sepideh, Gluck, Jessica M., Ehsani, Nazanin, Shemin, 
Richard J.
Surgery, University of California, Los Angeles, Los Angeles, CA, USA
Tissue engineered structures are fast becoming a viable solution for not only 
the treatment of heart disease by replacing diseased cardiovascular tissue, 
but also as a means to further understand the complex nature of cardiovas-
cular tissue development. We have previously seen that common extracellu-
lar matrix (ECM) proteins have varying effects on the terminal differentiation 
of murine embryonic stem (ES) cells. It has also been previously thought that 
three-dimensional (3D) cell culture environments more closely mimic the in 
vivo native environment. In an effort to elucidate the mechanism through 
which the complex ECM 3D microenvironment enhances cardiovascular dif-
ferentiation of ES cells, we have examined the partially differentiated cardiac 
progenitor cells (CPCs) in different 2D and 3D conditions. Co-axial bicompo-
nent electrospun scaffolds were created from a core of 5% polyurethane 
(PU) and a sheath of a hybrid mix of 10% polycaprolactone- 10%gelatin. 
Briefly, the solutions were loaded into a double syringe system with a 25G 
blunt edge needle for the core solution and an 18G needle for the sheath 
solution. An applied voltage of 30kV was used with a flow rate of 70μL/min 
and a grounded collection plate 16.5cm away. The following protein coat-
ings were applied to a standard 24-well culture dish as well as 3D electro-
spun scaffolds: gelatin, collagen IV, laminin, fibronectin, and vitronectin. mES 
cells were expanded in a feeder free cell culture conditions using ESGRO 
medium. Cells were kept in an undifferentiated state until ready for seeding. 
Each 2D or 3D condition was seeded with 500,000/cm2 undifferentiated 
mES cells. Once seeded, the cells were maintained in differentiation media, 
α-MEM media supplemented with 10% FBS. Initial cytotoxicity assays 
confirm the biocompatible nature of the protein coatings and electrospun 
nanofibrous scaffolds. These studies have also confirmed the prolonged 
presence of the protein coatings for the duration of the current study, up to 
9 days of culture. FACS analysis shows a gradual decrease in CPC population 
(Flk-1+) when exposed to collagen IV in 2D vs. 3D conditions. However, 
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collagen IV in 2D conditions do exhibit high levels of Flk-1+. Laminin and 
vitronectin 3D conditions support higher number of Flk-1+ as compared to 
their 2D counterparts. As previously reported CPCs as identified by Flk-1 
have shown greater differentiation potential when exposed to various 
ECM proteins. Additionally, a 3D microenvironment further enhances this 
differentiation potential. In order to determine the mechanism by which 
a 3D microenvironment enhances a cellular response, we have combined 
both the 3D microenvironment of the electrospun nanofibrous scaffolds 
with various ECM proteins we have identified as influential. We have seen 
that the 3D microenvironment has the ability to enhance the number of 
CPCs present after at least 4 days in differentiation conditions. Further study 
will be required to determine the appropriate in vitro microenvironment to 
fully recapitulate the cardiovascular stem cell niche present in the heart and 
understand the specific cellular mechanisms of how these ECM proteins are 
able to enhance CPC populations.
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Embryonic stem (ES) cells have the ability to differentiate into a variety of 
tissue types such as cardiac myocytes and, therefore, offer great thera-
peutic potential. Identifying the role of transcription factors important for 
cardiomyogenesis could be instrumental in developing heart muscle stem 
cell therapies. Our lab has previously shown that the overexpression of 
Glioma associated factor 2 (Gli2) induces cardiomyogenesis in P19 embryo-
nal carcinoma (EC) cells, a well-established model of ES cells. Alternatively, 
disrupting Gli2 expression in P19 EC cells delayed cardiomyogenesis. We 
hypothesize that Gli2 has a similar role in the transcriptional regulation of 
cardiomyogenesis in murine ES cells. Murine ES cells, stably overexpress-
ing Gli2, were grown in vitro under optimal cardiomyogenesis committing 
conditions. Quantitative polymerase chain reaction (qPCR) indicated that 
Nkx2.5 and Tbx5, markers of cardiomyogenesis; MEF2C, a gene expressed 
during cardiomyogenesis; and MHC6, a cardiac muscle specific myosin 
heavy chain, were upregulated in cells containing stably overexpressed 
Gli2, while mesoderm markers, Mesp1 and Brachyury T, were unaffected. 
Our data suggests that the overexpression of Gli2 in murine ES cells has a 
positive effect on cardiomyogenesis, in accordance with previous studies 
performed in P19 EC cells.
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Parkinson disease (PD) is a neurodegenerative disorders in which dop-
aminergic (DAergic) neurons in substantia negra region are degenerated. 
Cell replacement therapy can surmount the obstacles related to current PD 
chemotherapy. Here, for the first time the effect of Beta-Boswellic acid (BBA) 
as major component of Boswellia serrate gum on DAergic differentiation of 
mouse embryonic stem (mES) cells has been investigated. We already dem-
onstrated the enhancement effect of BBA on neurites growth of neurons 
isolated from hippocampus. To end that, we used two R1 and CGR8 cell 
lines, feeder dependent and independent mES, respectively. The cells were 
subjected to EB formation in medium contains 3% serum replacement for 
one week. Then the ES-differentiating cells were embedded by Matrigel as 
a natural extra cellular matrix and plated on Matrigel coated plates. Several 
concentration of BBA (10-50nm) used in the step three of gold standard 
protocol for DAergic differentiation. Then the efficiency was analyzed by 
Real-time RT-PCR, Immunocytochemistry for expression of neuroectermal, 
mesencephalic or DAergic neuron-related markers expression such as Nestin, 
Pax2, Pax5, Wnt, En, Nurr1 and TH. As a positive control SY5Y, a neuro-
blastoma dopamine-synthesizing cell line was used for our analyses. The 
synthesis and secretion of dopamine will be analyzed by reverse HPLC in 
supernatant of differentiated cells. The result showed that embedding and 
plating of EBs regardless to BBA concentrations on Matrigel, increase the 
survivals of the differentiated cells, and expression of transcripts related to 
mesencephalic and DAergic neurons. The results showed the high DAergic 
differentiation is achieved in medium contains 30 nM BBA; however the 
expression of mesencephalic markers such as Pax2 and Pax5 in 10nM BBA 
was more than 30nM. In conclusion, BBA can promote DAergic differentia-
tion of mES cells that this effect can be synergized by presence of Matrigel. 
The mechanism of DAergic programme promotion by BBA in ES is under 
investigation. The result of this study may have impact on future cell therapy 
of PD by ES or induced pluripotent stem cells (iPS).
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With the ability to generate spinal motor neurons (MNs) from stem cells in 
culture, great hope has been placed on using stem cell-derived MNs to treat 
neurodegenerative disease by both replacing damaged neurons and creat-
ing in vitro models to study disease pathogenesis. However, the methods 
currently used to generate MNs from embryonic stem cells (ESCs) typically 
produce a limited subset of the MN subtypes that exist in vivo. We hypoth-
esized that the forced expression of different MN fate determinants could 
efficiently direct the formation of specific MN classes. Specifically, we tested 
whether misexpression of the transcription factor Foxp1 in mouse ESCs was 
sufficient to generate limb and sympathetic nervous system-innervating 
MN populations. Transgenic mice expressing Foxp1 in all spinal MNs show 
increased numbers of limb-innervating MNs and reduced MN axonal projec-
tions to axial muscles, specifically the rhomboideus muscle. We derived 
mouse ESC lines that express Foxp1 under the MN-specific promoter Hb9, 
and upon differentiation of these lines we are able to generate MNs (with 
≤30% efficiency), of which 80% express Foxp1. Of these Foxp1+ MNs, 
58% and 42% express molecular profiles characteristic of dorsal (Lhx1+) 
and ventral (Isl1+) limb-innervating MNs, respectively. The Foxp1+ MNs 
express HoxA5 and HoxC6, which indicates a rostral forelimb identity. In 
addition, the Foxp1+ MNs also express the EphA4 receptor, which is highly 
expressed by dorsal limb-innervating axons in vivo. Upon transplantation 
of the Foxp1+ MNs into developing chick embryos, they project axons to 
both the dorsal and ventral limb. Lastly, the Foxp1+ MNs are physiologically 
active and form synapses when cultured with muscle. These results provide 
important insights into whether different types of MNs can be generated in 
culture simply by altering expression of specific MN fate determinants.
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The neural crest is a stem cell-like population that arises at the boundary 
between the neural and non-neural ectoderm. Neural crest (NC) cells give 
rise to a vast range of cells. However, the molecular mechanisms of NC 
induction during early development remain poorly understood. Embryonic 
stem (ES) cells could be used for an in vitro model of mammalian develop-
ment. Although conventional differentiation methods using ES cells usually 
involve forming embryoid bodies and culturing in medium that contains 
undefined components. Therefore, these methods have hardly enabled us to 
follow up the process of cell status change during differentiation. We previ-
ously developed a growth factor defined serum-free medium for culturing 
mouse ES (mES) cells without feeders. Under this defined culture condition, 
the effects of additive factors on ES cells are expected to be clearly assessed. 
In this report, we establish a NC induction system from mES cells in a growth 
factor defined serum-free monolayer culture condition. We assessed the 
effects of extracellular matrix components and found that laminin matrix 
is effective for the differentiation of mES cells into neural cell lineages. We 
found that FGF-2 upregulated expression of primitive ectodermal genes and 
subsequently elevated expression of neuroectodermal genes. We also found 
that BMP-4 upregulated expression of NC genes in FGF-2 treated cells. 
These results indicate that adding BMP-4 together with FGF-2 promotes 
mES cells differentiation into the NC through lineage-specific defferentia-
tion. Our data also showed that these FGF-2/BMP-4 treated cells have the 
potential to differentiate into NC derivatives such as peripheral neurons, 
Schwann cells, smooth muscle cells, adipocytes, chondrocytes, and osteo-
cytes. Furthermore, we have established a cell line designated as P0-6 that is 
derived from the blastocysts of P0-Cre/Floxed-EGFP mice expressing EGFP 
in an NC-lineage-specific manner. P0-6 cells cultured using this culture sys-
tem expressed EGFP. Taken together, this growth factor defined serum-free 
NC induction system could be useful tool for studying the mechanism of by 
which cells differentiate into the NC and for developing stem cell therapies.
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IMMUNOMAGNETIC ENRICHMENT OF MOUSE 
EMBRYONIC STEM CELL DERIVED NEURONAL 
PRECURSORS PRIOR GRAFTING INCREASES 
THE NUMBER OF IN VIVO DIFFERENTIATED 
NEURONS
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Several protocols for differentiation of mouse pluripotent stem cells (mESC, 
iPSC) into specific neural subpopulations were developed by use of specific 
signaling factors. Nevertheless, such protocols are not able yet to synchro-
nize the generation and development of specific neural subpopulations, 
except for nestin+ neural progenitors, arising to cellular heterogeneity that 
hampers experimental and clinical improvement in the use of pluripotent 
stem cells. In order to generate a clearly defined population of neuronal 
precursor cells, we characterized the expression of cell surface markers of 
actin-eGFP mESC differentiated into neuronal subpopulations. We observed 
the presence of PSA-NCAM positive neuronal precursors and developed a 
method for isolation of mESC derived PSA-NCAM positive cells by immuno-
magnetic sorting. PSA-NCAM, as neural surface marker, plays a role in neu-
ral plasticity from embryonic to adult nervous system (axonal growth, cell 
migration, synaptic plasticity, and embryonic and adult neurogenesis). For 
functional characterization, we enriched the in vitro derived PSA-NCAM+ 
cells with magnetic beads and compared their in vivo behavior to unsorted 
mESC derived nestin+ cells by injecting both cell populations stereotactically 
into the forebrain of adult mice. Analysis for several neuronal and glia mark-
ers (PSA-NCAM, TUJ1, NeuN, MAP2, GAFP, Olig2, GLAST) after 10 or 40 
days post graft, showed a distinct differentiation pattern of the two grafted 
populations. PSA-NCAM+ actin-eGFP derived neuronal precursors retained 
their ability of migration and the majority differentiated in NeuN (marker for 
mature neurons) positive cells. On the other hand, actin-eGFP mESC derived 
nestin+ cells differentiated only rarely into NeuN positive cells but gave rise 
to a mixed population of cells expressing markers for neuronal precursors 
and young neurons such as PSA-NCAM and TUJ1, respectively. Moreover, 
a higher number of actin-eGFP PSA-NCAM expressing cells migrated along 
the rostral migratory stream (RMS) in those animals where the PSA-NCAM+ 
actin-eGFP enriched population was grafted. Taken together, these results 
show that a straight forward in vitro enrichment of functional ES cell derived 
neuronal precursor cells can be used to streamline the in vivo differentiation 
towards neurons and increase the number of target cells after grafting.
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THYROID HORMONE PROMOTES NEURONAL 
DIFFERENTIATION AND INHIBITS THE 
PROLIFERATION AND MAITENANCE OF 
MOUSE EMBRYONIC NEURAL STEM CELLS 
THROUGH THYRIOD HORMONE RECEPTOR 
ALPHA AND STAT3 SIGNALLING
Chunhai, Chen, Zhou, Zhou, Li, Maoquan, Zhong, Min, Zhang, 
Yanwen, Yu, Zhengping
Dept of Occupational Health, Third Military Medical University, 
Chongqing, China
Thyroid hormones are essential for brain development, especially during the 
embryonic phase. However, the effects of thyroid hormone on the develop-
ment of embryonic neural stem cells and the underlying mechanisms are 
poorly understood. Here, we found that insufficient of thyroid hormones 
during pregnancy inhibits telencephalon neurogenesis in mouse during 
embryonic phase, and destroys the learning and memory function. In our in 
vitro investigations, we treated embryonic day 13.5 mouse neural stem cells 
with physiological level of 3, 5, 3’-L-triiodothyronine. We found that 3, 5, 
3’-L-triiodothyronine inhibits neural stem cell proliferation and maintenance, 
meanwhile promotes neuronal differentiation. In addition, thyroid hormone 
alpha was found expressing in embryonic neural stem cells both in vivo 
and in vitro and it is essential for the effects of 3, 5, 3’-L-triiodothyronine. 
Further studies found that 3, 5, 3’-L-triiodothyronine decreases tyrosine 
phosphorylation of STAT3 and subsequently inhibits STAT3-DNA binding 
activity. Over-expression of STAT3 can antagonize the effects of 3, 5, 3’-L-
triiodothyronine. We also found the effects of thyroid hormone have no 
association with the ERK1/2 and Akt signallings, which are closely related to 
embryonic neural stem cell proliferation and differentiation. Taken together, 
these results suggest that thyroid hormone inhibits the proliferation and 
maintenance of embryonic neural stem cells and promotes neuronal dif-
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ferentiation through thyroid hormone receptor alpha and STAT3 signalling. 
These findings emphasize the importance of thyroid hormone functions dur-
ing early brain development and suggest that embryonic neural stem cells 
are one of the major cellular targets of thyroid hormones.
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INDUCTION EFFICIENCY OF SONIC HEDGEHOG 
ON DIFFERENTIATION OF MOUSE EMBRYONIC 
STEM CELLS INTO NEURAL PRECURSOR CELLS 
WITH RNA EXPRESSION ANALYSIS
Jahanbakht, Hedieh1, Akhondi, Mohammad Mahdi2, Heidari, 
Mohammad Hassan3, Gholamhoseini, Banafshe4
1Biological science and Breeding Dept, Veterinary College, Azad Islamic 
University, Karaj, Iran, Islamic Republic of, 2Reproductive Biotechnology 
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School ,Shahid Beheshti Medical University, Tehran, Iran, Islamic Republic 
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Pluripotent embryonic stem cells (ESC) are capable to giving rise to de-
rivatives of each of the three germ layer cells because of their ability to 
self-renew and differentiate into functional cells including neural cells. A 
major challenge at ESC researches is to develop novel processes for efficient 
in vitro cell type differentiation of ESC for analysis of gene function, and 
the therapeutic potential of using stem cells. Growth factors and cytokines 
promote in vitro differentiation and survival of ESC. If the in vitro differ-
entiation processes of cells follows the development of neuroectodermal in 
vivo, we can expect to generate neural precursor cells can differentiate into 
both neural and glial cells. Sonic hedgehog (Shh) is a morphogenic protein 
that effects on ventral neuron induction and neural tube formation in early 
embryonic stages. We investigated enhancing neural differentiation of 
mouse ESC and inducing specific neural genes expression that control CNS 
development upon treatment with different concentrations of Shh. More-
over, for studying on differentiation efficiency of basic Fibroblastic Growth 
Factor (bFGF) we compared the effects of bFGF and Shh at the same time. 
Methods: Mouse ESC line was co-cultured on inactivated mouse embryonic 
fibroblasts and the resulting embryoid bodies were transplanted on culture 
plates that covered by poly- L- lysine. Shh was added to specific neural 
precursor cells by different concentrations, 300 and 500 nano molar (nM).
Nestin (marker of neuroepithlial cells), Nkx2.2 (ventral neurons in spinal cord 
andV3 neurons), nurr1 (primary dopaminergic neurons), S100 (Astrocysts), 
Olig-2(oligodentrocytes and primary motor neurons), were selected to study 
the differentiation efficiency. Expression of these specific neural genes were 
assessed by RT-PCR and densitometry.In addition, the formation of dendrites 
and soma in neurons was assessed through immunocytochemistry assay on 
Microtubule Association Protein 2 (MAP2). Results: The expression of Nestin 
and Nkx2.2 showed Shh caused neural induction and ventral neurons in spi-
nal cord differentiation. Nkx2.2 positive cells became more induction by 300 
nm concentration of Shh. Moreover, bFGF 20 nM was added to the EBs cul-
ture and it showed synergic and special effects with Shh on neural induction 
and oligodendrocytes differentiation and the primary dopaminergic neuron 
formation that express nurr1 gene. Some of ES cells under treatment with 
Shh express Olig2 and were accordingly proved to be oligodendrocytes. 
However expression of s100 was not demonstrated and consequently no 
differentiation into astrocystes had happened. Immunocytochemistry assay 
of MAP-2 confirmed the formation dendrites and neurons. Conclusion: Our 
results suggest that Shh as a morphogenic protein induced in vitro neural 
gene expression and consequently it has positive effects on enhancing 
neural differentiation of ESC that could be employed in both neural develop-
ment studies and may be future studied used for clinical trials.
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CYSTEINE CATHEPSINS INDUCES THE 
DIFFERENTIATION OF MOUSE EMBRYONIC 
STEM CELLS INTO NEURONS
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Embryonic stem (ES) cells are used as a model to understand the role of 
different molecules in embryonic development. Cystatin C (CysC), an 
endogenous inhibitor of cysteine cathepsins, was shown to induce the dif-
ferentiation of mouse ES (mES) to neural stem cells. However, it is unclear 
whether CysC is acting as a cathepsin inhibitor or as a co-factor of bFGF. 
We investigated the possible role of cysteine proteases (CP) in neural dif-
ferentiation by treating embryoid bodies (EB) from mES cells with: i) E64; 
an inhibitor of papain-like CPs and of calpains; ii) an inhibitor to cathepsin 
L; iii) an inhibitor to calpains; or iv) with cystatins, and assessed their ability 
to differentiate into neurons. After 24h treatment, E64 induced an increase 
in Pax6 expression in EBs. The inhibition of cysteine cathepsins, but not 
of calpains, led to a significant increase in the numbers of nestin-positive 
cells, three days later, indicating the induction of EB differentiation into 
neural progenitor cells (NPC). Glycosylated mouse CysC (mCysC), but not 
unglycosylated egg white cystatin (eCys), also increased the numbers of 
NPC. However, this effect was independent of CP inactivation. Neutralizing 
antibodies to bFGF blocked the induction of NPC only in mCysC-treated 
EBs, suggesting that bFGF is required for mCysC induced neural differentia-
tion. Addition of bFGF increased the numbers of NPC in cultures derived 
from untreated EBs, or from eCys-treated EBs, but not from mCysC-treated 
EBs. Next, we followed cell differentiation for additional 24 days. In 14 days, 
we observed increased numbers of β-3-tubulin positive cells in populations 
derived from E64-treated EBs, showing greater percentage of immature 
neurons, a feature that persisted up to 24 days. At this stage, we verified the 
presence of functional neurons by performing electrophysiological records 
to detect Na+ channels. All cell populations displayed voltage-gated inward 
and outward currents when stimulated with depolarizing voltage steps. In 
cell populations originated from E64-treated EBs, we observed a significantly 
higher percentage of functional neurons (60%; n=10) as compared to 
untreated controls (20%; n=20). We propose that the inhibition of cysteine 
cathepsins induces the differentiation of mES cells into neurons, through a 
mechanism that is distinct from CysC-induced neuronal differentiation. This 
work was supported by: Edital CT-Biotecnologia/MCT/CNPq/MS/SCTIE/
DECIT, CAPES, FAPERJ e INCT.
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MESODERM AND ENDODERM 
DIFFERENTIATION DEFECTS OF PORCUPINE 
HOMOLOG MUTANT MOUSE EMBRYONIC 
STEM CELLS AND EMBRYOS
Biechele, Steffen, Cox, Brian J., Rossant, Janet
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In mammals, 19 Wnt ligands activate canonical and non-canonical 
pathways, which play important roles in development and disease. While 
research efforts have focused on the cells that receive Wnt signal, the Wnt 
secreting cells have not been extensively studied. Conserved from worms to 
human, the X-chromosomal gene porcupine homolog (Porcn) is a mem-
ber of the membrane bound O-acyl transferase (MBOAT) superfamily. 
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Biochemical evidence shows that Porcn is required for lipid modification of 
several, if not all Wnt ligands, which is essential for Wnt secretion or func-
tion. Embryonic lethality of several single Wnt mutants suggests a require-
ment for Porcn in mouse embryonic development. Using mouse embryonic 
stem (ES) cells carrying a genetrap null allele as well as a mouse line carrying 
a conditional allele, we present in vivo and in vitro evidence for the require-
ment of Porcn and Wnt signaling in early embryonic development and ES 
cell differentiation. Autocrine Tcf/Lef-Luciferase reporter assays show that 
Porcn null cells overexpressing Wnt3a exhibit defects in the secretion of 
functional Wnt3a ligand and absence of canonical Wnt signaling response. 
Further, paracrine reporter assays show that Porcn is exclusively required in 
the Wnt3a secreting cell, but not in Wnt signal receiving cells. In vitro differ-
entiation of ES cells as embryoid bodies (EBs) in serum-free conditions dem-
onstrates a requirement for Porcn in the generation of Flk1+ mesoderm and 
CXCR4+ endoderm after 4 days of differentiation. Quantitative real-time 
PCR analysis of EBs at 0, 2 and 4 days of differentiation suggests successful 
epiblast transition of Porcn null cells and confirms defects in the generation 
of mesodermal and endodermal tissues, based on the strongly reduced ex-
pression of Brachyury, Tbx6, Mixl, Sox17 and Cer1. Canonical Wnt signaling 
targets Axin2 and c-Myc were also significantly downregulated. Pluripotency 
and neural marker genes remain largely unchanged. Similar to the in vitro 
phenotype, aggregation of Porcn null ES cells with wildtype morula embryos 
as well as zygotic deletion of Porcn is lethal due to gastrulation defects in 
vivo. Using in situ hybridization at embryonic day 7.5 and 8.5, we detected 
prolonged expression of epiblast markers Oct4 and Otx2 throughout the 
embryo proper and a strong reduction or absence of anterior and poste-
rior marker genes, as well as canonical Wnt signaling targets. These gene 
expression patterns as well as the embryonic morphology is reminiscent of 
the earliest single Wnt knock-out phenotype (Wnt3) and suggests a role for 
Porcn in the function of Wnt3, but does not exclude a role for other Wnts. 
Our data demonstrate a critical role for Porcn in canonical Wnt signaling, ES 
cell differentiation and mouse embryonic development.
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SITE-SPECIFIC DIFFERENTIATION OF 
MURINE EMBRYONIC STEM CELL-DERIVED 
VASCULAR PROGENITORS BY IMMOBILIZED 
GROWTH FACTORS FOR VASCULAR TISSUE 
ENGINEERING
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Engineered tissue patches have the potential to repair and replace damaged 
and diseased tissues. However, mass transfer limitations require embedding 
engineered blood vessels in the tissue to achieve physiologically-relevant 
tissue thickness. Vascular progenitor cells can be differentiated into vascular 
endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) in a site-
specific manner by manipulating adhesion substrates and growth factor 
concentrations on a surface. We showed previously that vascular endothelial 
growth factor (VEGF), when covalently immobilized onto CollagenIV (ColIV) 
using EDC chemistry, was capable of differentiating murine embryonic 
stem cell (mESC) derived Flk1+ vascular progenitors toward a CD31+ EC 
phenotype, on both patterned and uniform surfaces. However, we have not 
elucidated the effects of PDGF, and whether having the two growth factors 
on the same surface would elicit differential responses in differentiation. 
In addition, the immobilization techniques used could potentially release 
growth factors in soluble form due to substrate degradation. Growth factors 
immobilized on a non-degradable surface would be necessary to ascertain 
that the differentiation was due to the immobilized growth factor and 
not due to degradative release. Here, we demonstrated that not only did 
these Flk1+ vascular progenitors yield primarily CD31+ ECs when cultured 
on surfaces with immobilized or soluble VEGF, they yielded mostly SMA+ 
VSMCs when cultured on surfaces with PDGF (immobilized or soluble) or 
ColIV alone. The immobilized growth factors had a dose-responsive effect 
on differentiation. Decreases in VEGF concentration resulted in correspond-
ing decreases in EC differentiation, whereas decreases in PDGF concentra-
tion resulted in increases in EC differentiation. Differential responses could 
be observed when both growth factors were immobilized onto the same 
surface. ECs were observed on the VEGF-immobilized area, whereas VSMCs 
were found on the PDGF-immobilized area. In addition, Flk1+ progenitors 
seeded onto non-degradable surfaces with GMBS-immobilized VEGF and 
PDGF showed similar responses to soluble controls and EDC-immobilized 
conditions. Quantitative PCR analysis showed significant down-regulation of 
Oct4 and up-regulation of Flk1. EC and VSMC markers were differentially 
expressed in VEGF and PDGF conditions. CD31 expression was higher in 
VEGF conditions while SMA and Calponin expression were higher in PDGF 
conditions. Together, these results demonstrated that differentiation is attrib-
uted largely to immobilized growth factors, not the degradative release of 
growth factors into media. ECs and VSMCs can be reproducibly generated 
from a common progenitor by immobilizing and patterning growth factors 
to direct differentiation in a site-specific manner. Ongoing and future work 
will focus on human ESC-derived cardiovascular progenitors.
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NOTCH SIGNALING DEFINES TWO DISTINCT 
HEMATOPOIETIC PROGRAMS IN MOUSE 
EMBRYONIC STEM CELL DIFFERENTIATION 
CULTURES
Ditadi, Andrea, Clarke, Raedun, Keller, Gordon
McEwen Centre for Regenerative Medicine, Toronto, ON, Canada
The requirement for Notch signaling is one characteristic that distinguishes 
yolk sac from para-arotic splanchnopleura (P-Sp)/aorta-gonad-mesonephros 
(AGM) hematopoiesis in the mouse embryo. Whereas this signaling path-
way is dispensable for generation of the yolk sac blood cell lineages, it is 
essential for establishment of the intraembryonic P-Sp/AGM hematopoietic 
program and the formation of the first hematopoietic stem cells (HSCs). We 
have recently identified two temporally distinct Flk1+ hematopoietic popula-
tions in mouse embryonic stem cell (ESC) differentiation cultures that display 
characteristics of yolk sac and P-Sp/AGM hematopoiesis. When induced 
with the combination of activin A, BMP-4 and VEGF in an embryoid body 
(EB) format, mESCs generate a Flk-1+ population within 72 hours of dif-
ferentiation that displays the capacity to give rise to primitive erythrocytes. 
This early Flk-1 population has little T-cell potential. When cultured for an 
additional 48 hours, the day 3.0 EB cells give rise a second Flk-1+ popula-
tion that shows diminished primitive erythroid potential and enhanced 
capacity to generate T-lymphocytes compared to the early population. To 
determine if Notch signaling distinguishes these two waves of hematopoiesis 
in the mESC cultures, we analyzed the hematopoietic potential of the two 
Flk-1 populations generated from RBP-Jk null cells that are unable to signal 
through this pathway. As expected from previous studies, the hematopoietic 
potential of the early arising Flk-1+ population is enhanced showing an in-
crease in the frequency of primitive erythroid progenitors compared to con-
trols. In contrast, the second Flk-1+ population derived from the RBP-Jk null 
cells showed dramatically reduced hematopoietic potential. Taken together, 
these findings demonstrate that the two ESC-derived hematopoietic popula-
tions differ in their requirement for Notch signaling and as such, provide 
strong support for the hypothesis that they represent the in vitro equivalent 
of the yolk sac and P-Sp/AGM-derived hematopoietic programs.
227
Friday Poster Abstractswww.isscr.org
Friday Poster Abstracts
Poster Board Number: 3456
THE NOTCH SIGNALING PATHWAY, AN 
IMPORTANT REGULATOR IN MOUSE 
EMBRYONIC STEM CELLS DERIVED 
HAEMATOPOIESIS IN VITRO
Huang, Caoxin1, Jackson, Melany1, Kyba, Michael2, Iacovino, 
Michelina2, Lowell, Sally1, Forrester, Lesley M.1
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Mouse Embryonic Stem Cells (mESCs) are able to differentiate into many 
cell lineages in vitro, including all haematopoietic cell types. The aorta-
gonad- mesonephros (AGM) region is the first site in the embryo where 
haematopoietic stem cells (HSCs) are generated and is likely to be rich of 
haematopoietic inductive signals. We have demonstrated previously that the 
production of haematopoietic progenitors (HPCs) from both mouse and hu-
man ES cells is significantly enhanced when co-cultured with primary AGM 
and AGM-derived stromal cell lines (AM), which supplied a powerful plat-
form for investigation the molecular mechanisms of haematopoiesis in vitro. 
We demonstrated that the haematopoietic enhancing effects of the ES/
AGM-derived stromal cell co-culture system was significantly reduced when 
inhibition of the Notch signaling pathway was applied with γ-Secretase 
Inhibitor(GSI) after the formation of mesoderm. To further clarify the role 
of the Notch signaling pathway during haematopoietic differentiation of 
mESCs, we have assessed the activity of the Notch pathway throughout 
the AGM stromal/ES cell co-culture period and have established both 
gain- and loss-of-function tools. We have shown that the Notch pathway 
is active in ES cells when they are co-cultured with AGM-derived stromal 
cell lines but that the level of Notch activity did not correlate with the level 
of haematopoietic induction displayed by the different stromal cell lines. 
In a gain of function strategy we have used a ES cell line in which Notch 
Intracellular Domain (Notch-IC) expressing cells can be selected by flow 
cytometry: tamoxifen-induced CRE-mediated excision results in expression 
of both Notch-IC and the cell surface marker CD2. We have also generated 
a novel loss-of-function strategy to down-regulate Notch activity in mESCs 
by inserting a dominant-negative MAML (DNMAL)-EGFP fusion protein into 
the doxycycline-inducible A2loxCre system. The DNMAL protein inhibits 
Notch activity by inactivation of the RBP-Jκ complex. This inducible system 
will allow us to elucidate role of Notch in the mESCs at different time points 
during the co-culture period. To date, the expression of the DNMAL-EGFP 
fusion protein has been validated by Western blotting and flow cytomtery 
and we have used the 12xRBP-Jk-luciferase reporter (12xRBP-Jκ-Luc) to 
confirm that the DNMAL-GFP fusion protein was able to inhibit Notch 
activity upon addition of doxycycline. We are currently assessing the effects 
of NOTCH-IC and DNMAL expression on the production of haematopoietic 
progenitors from FLK1+ cells using methylcelluose assays and surface marker 
expression (CD41, c-kit and CD45).
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Haematopoietic differentiation of mouse embryonic stem (ES) cells in vitro 
is a powerful tool to model early blood cell development and to generate 
cells for regenerative medicine. A number of strategies have been used to 
increase the production of haematopoietic cells from ES cells and to enhance 
the functional properties of the haematopoietic progenitors that are gener-
ated. These include co-culture on a variety of stromal cell lines and over-
expression of homeobox transcription factors such as HOXB4. To more fully 
understand the mechanism of action of HOXB4 we established ES cell lines 
carrying a HOXB4-ERT2 fusion protein that allows the activation of HOXB4 
at defined time points during the differentiation process. We demonstrate 
that the activation of HOXB4 prior to the emergence of haematopoietic 
progenitors results in an increase in haematopoietic differentiation suggest-
ing that HOXB4 acts on the pre-haematopoietic mesoderm. An increase 
in haematopoietic differentiation was observed when GFP+ ES cells were 
cultured in the presence of HOXB4-ERT2-expressing ES cells indicating that 
HOXB4 activation has a paracrine, as well as a cell autonomous, effect on 
haematopoietic differentiation. This hypothesis was supported by expression 
profiling of HOXB4 target genes at early stage of ES cell differentiation that 
identified a number of genes associated with paraxial mesoderm that gives 
rise to the haematopoietic niche. We provide evidence that this paracrine 
effect may, in part, be mediated by modulation of the Wnt pathway.
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MOUSE EMBRYONIC STEM CELLS
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The capacity of embryonic stem cells (ESCs) to generate differentiated 
progeny provides a model system for studying mammalian development 
as well as a source of cells for pharmaceutical and therapeutic applications. 
Within this context, the generation of hematopoietic stem cells (HSCs) is 
of particular interest, as the derivation of these cells would provide a novel 
source of stem cells for transplantation and for modeling hematologi-
cal diseases in vitro. To achieve this goal, it is necessary to recapitulate 
embryonic hematopoiesis in stem cell cultures. Embryonic hematopoiesis is 
temporally and spatially regulated; the first wave of primitive hematopoiesis 
occurs in the yolk sac (YS) followed by definitive hematopoiesis and the 
emergence of the HSC in the para-aortic splanchnopleura (P-Sp). Lineage 
tracing studies have shown that both hematopoietic programs develop from 
Flk-1+ progenitors cells. To recapitulate YS and P-Sp hematopoiesis in ES cell 
cultures we identified two temporally distinct Flk-1+ hematopoietic progeni-
tor populations that showed different developmental potential. The earliest 
Flk-1+ population contained large numbers of primitive erythroid precursors 
and few lymphoid precursors whereas the later arising Flk-1+ population 
displayed lymphoid potential and diminished primitive erythroid potential. 
We hypothesized that these Flk-1+ progenitors represent the equivalent of 
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the yolk sac and P-Sp progenitors respectively. Further analysis of the Flk-1+ 
P-Sp population revealed the expression of Sox17 enriches for lymphoid 
potential and that VEGF and TGFβ signaling are required for Sox17 expres-
sion. Additionally, analysis of E9.0 mouse embyros confirmed that Sox17 
expression is enriched in Flk-1+ cells. Enforced expression of Sox17 in Flk-1+ 
cells induced an endothelial cell type that maintains hematopoietic poten-
tial suggesting that Sox17 may play a role in the generation of hemogenic 
endothelium. Taken together these findings suggest that Sox17 plays a role 
in the generation of definitive hematopoietic progenitors in ES cell cultures.
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POLYCOMB GROUP PROTEIN BMI1 PROMOTES 
HEMATOPOIETIC CELL DEVELOPMENT FROM 
MOUSE ES CELLS
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Bmi1 is a component of the Polycomb-repressive complexes (PRC) and 
essential for maintaining the pool of adult stem cells. PRC are key regula-
tors for embryonic development by modifying chromatin architecture and 
maintaining gene repression. To assess the role of Bmi1 in pluripotent stem 
cells and upon exit from pluripotency during differentiation, we studied 
forced Bmi1 expression in mouse embryonic stem cells (ESC). We found 
that ESC do not express detectable levels of Bmi1 RNA and protein and 
that forced Bmi1 expression had no obvious influence on ESC self-renewal. 
However, upon ESC differentiation Bmi1 effectively enhanced development 
of hematopoietic cells. Global transcriptional profiling identified a large array 
of genes that were differentially regulated during ESC differentiation by 
Bmi1. Importantly, we found that Bmi1 induced a prominent up-regulation 
of Gata2, a zinc finger transcription factor, which is essential for primitive 
hematopoietic cell generation from mesoderm. In addition, Bmi1 caused 
sustained growth and a more than 100-fold expansion of ESC-derived 
hematopoietic stem/progenitor cells within 2-3 weeks of culture. The en-
hanced proliferative capacity was associated with reduced Ink4a/Arf expres-
sion in Bmi1-transduced cells. Taken together, our experiments demonstrate 
distinct activities of Bmi1 in ESC and ESC-derived hematopoietic progenitor 
cells. In addition, Bmi1 enhances the propensity of ESC in differentiating 
towards the hematopoietic lineage. Thus, Bmi1 could be a candidate gene 
for engineered adult stem cell derivation from ESC.
Poster Board Number: 3464
A COLLAGEN-BASED MATRIX THAT ENHANCES 
CARDIAC AND SKELETAL MYOGENESIS IN 
MOUSE EMBRYONIC STEM CELLS
Ebadi, Diba1, Kuraitis, Drew2, Al-Madhoun, Ashraf1, Suuronen, Erik 
J.2, Skerjanc, Ilona S.1
1Biochemistry,Microbiology,Immunology, University of Ottawa, Ottawa, 
ON, Canada, 2Cellular and Molecular Medicine, University of Ottawa Heart 
Institute, Ottawa, ON, Canada
Statement of Purpose: It has been shown previously that a collagen matrix 
containing sialyl Lewis X (sLex), an L-selectin ligand found on CPCs, can 
enhance the regeneration of ischemic muscle1, and accelerate the dif-
ferentiation of C2C12 myoblasts. In this study, we tested whether or not 
these matrices would also support the formation of a myogenic progenitor 
population from mouse embryonic stem cells (ES). This population should 
replenish the satellite cell niche when engrafted into muscle. Considering the 
difficulty of grafting stem cells in vivo, a matrix that can support the forma-
tion of myogenic progenitor cells would be valuable as a potential method 
of delivery for future cell therapy approaches. The effects of a collagen 
matrix, with and without sLex, were evaluated during skeletal and cardiac 
myogenesis in mouse ES cells. Results: Skeletal muscle: Immunofluorescent 
staining identified skeletal myocytes on the collagen surface with a higher 
number of nuclei compared to the control surface, indicating enhanced cell 
fusion. This was confirmed by Q-PCR analysis of a skeletal muscle-specific 
fusion marker, nfatc3. Q-PCR analysis of skeletal muscle precursor markers 
showed a significantly higher expression of Pax3 and Pax7 in the cells differ-
entiating on the collagen and sLex compared to control tissue culture plates, 
indicating enhanced myogenic progenitor formation. Furthermore expres-
sion of myogenic regulatory factors, Myf5 and Myogenin was significantly 
higher on both surfaces, indicating enhanced myoblast/myotube formation. 
Expression of the final differentiation marker MHC3 was also significantly 
higher for the matrix-cultured compared to the control. Cardiac muscle: 
It was observed that a greater number of cells differentiated into cardiac 
muscle on the sLex surface, as judged by the number of beating foci. When 
compared to the control surface, the beating of the cells on the sLex surface 
was more synchronized. Expression of the cardiomyogenic genes GATA4 
and Nkx2.5 and the cardiac muscle-specific peptide, ANF, was significantly 
higher on the sLex surface, indicating enhanced cardiomyogenesis. Conclu-
sions: These results demonstrate that the collagen matrix enhanced skeletal 
myogenesis, indicated by increased numbers of multinucleated myotubes 
and upregulation of skeletal muscle markers. The sLex -modification of the 
collagen matrix enhanced cardiomyogenesis in mouse ES cells, shown by 
increased beating and upregulation of cardiogenic genes. Thus we have 
identified biomaterials that could serve a two-fold purpose of providing an 
injectable substrate for delivery of stem cells and enhancing the progenitor 
population of both cardiac and skeletal muscles.
Poster Board Number: 3466
CELL-SECRETED SOLUBLE FACTORS INDUCE 
ENHANCED DIFFERENTIATION OF MOUSE 
EMBRYONIC STEM CELLS TOWARDS 
MESODERM AND ENDODERM IN A 
MEMBRANE-BASED MICRO-BIOREACTOR 
CULTURE
Chowdhury, Mohammad Mahfuz, Fujii, Teruo, Sakai, Yasuyuki
The University of Tokyo, Tokyo, Japan
Mimicking in vivo situation in vitro enables better understanding and con-
trol on embryonic stem cell fate choice. At the initial stage of development, 
pluripotent stem cells in the embryo change their fate under the influence 
of autocrine/paracrine signaling in a diffusion dominant microenvironment. 
However, in the static open macro-scale culture (for example, Petri dish) 
systems, cell secreted soluble factors swept away from cell neighborhood 
through spontaneous convection as well as become diluted in large volumes 
as compared to the enclosed micro-scale culture systems. Therefore, we 
utilized a membrane-based two-chambered micro-bioreactor (MB) to dif-
ferentiate mouse embryonic stem cells (mESCs) in a diffusion dominant 
microenvironment. Common techniques of micro-fabrication were used to 
fabricate the MB. Both chambers heights and volumes were 500 μm and 
114 µL, respectively. Chambers were kept separated by the semipermeable 
membrane. mESCs were differentiated for 8 days on the membrane side fac-
ing upper chamber of the MB in static condition. Culture medium containing 
Knockout Serum (KSR, Gibco),Knock-out DMEM (Gibco), and other basic 
constituents was used for the differentiation. Two operation conditions 
were used to differentiate mESCs in the MB: culture medium from 1) both 
chambers (MB1), and 2) only the lower chamber (MB2) was exchanged 
after every 2 days. In the MB1, differentiated cells at day 8 formed an 
epithelial sheet-like morphology. Differentiated cells in the MB2 also formed 
epithelial sheet-like morphology; however, it was not extensive as MB1. In 
contrast to the MBs, differentiated cells in the 6-Well plate (6-WP) formed 
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spherical colonies. Some of these colonies had neural extension spreading 
out from them. Genes related to pluripotency and different germ layers also 
showed different expression level in the culture systems. Expression level 
of pluripotency markers showed that, loss of pluripotency in the MB1 was 
higher whereas it was lower in the MB2 as compared to the 6-WP. Expres-
sion level of ectoderm related genes showed no difference among culture 
systems. However, expression levels of mesoderm and endoderm related 
genes were higher in the MB1 and MB2 than the 6-WP. Notably, meso-
derm related gene expression was highest in the MB1 than MB2 though 
endoderm related genes showed no significant difference between the two. 
Between the soluble factors Fgf4 and Bmp4, Fgf4 expression was lower in 
the MB1 than both 6-WP and MB2. However, Bmp4 expression was higher 
both in the MB1 and MB2 than the 6-WP. Presumably, differential effects of 
Fgf4 and Bmp4 in the MB1 and MB2 might have influenced the differentia-
tion behavior of mESCs. Currently, we are investigating the effects of these 
soluble factors through their inhibition experiments in the MB1 and MB2. 
Our study demonstrated that, mESCs differentiated more extensively in the 
MB1 than conventional macro-scale culture. In addition, medium exchange 
from the chambers (influencing the accumulation of the soluble factors) had 
also affected the mESC differentiation profile. The study also showed that, in 
the absence of any exogenous soluble factors, mESCs can differentiate not 
only towards ectoderm but also towards mesoderm and endoderm through 
the autocrine effects of soluble factors in an environment provided by the 
micro-bioreactor. Therefore, the microbioreactor can be utilized to derive 
mesodermal or endodermal cells which derivations from mESCs are not 
straight forward as neural cells.
Poster Board Number: 3468
IDENTIFICATION OF MOUSE EMBRYONIC STEM 
CELL FATE DETERMINANTS
Fortier, Simon, MacRae, Tara, Sauvageau, Guy
Institute for Research in Immunology and Cancer (IRIC), Montreal, QC, 
Canada
We have developed a viral based Cre/LoxP strategy that efficiently creates 
chromosomal deletions in mouse embryonic stem (ES) cells. Using this 
method, we generated a collection (named DelES) of more than 1000 clones 
carrying a chromosomal deletion. An in vitro embryoid body (EB) formation 
screen was conducted with DelES clones to assess differentiation problems 
throughout our collection. Our aim is to complement these phenotypes 
by reinserting DNA fragments into the deleted clones, thus potentially 
identifying new determinants of ES cell fate. Complementation studies of 
DelES family 9 showed that only one BAC was able to rescue the in vitro EB 
formation phenotype caused by a 4.3Mb deletion. Additional experiments 
identified the ribosomal protein S14 (Rps14) coding gene as being haploin-
sufficient for EB formation. Altered ribosomal proteins expression has been 
shown to induce a “nucleolar stress” which results in increased levels of the 
p53 protein. Western blot analyses revealed that p53 was more abundant in 
family 9 clones. Interestingly, an shRNA against p53 was able to rescue the 
differentiation defect of clone 9-37. This result suggests that Rps14 is essen-
tial for EB formation and that its deletion leads to a p53-related block of dif-
ferentiation. Our latest studies on ribosomal proteins confirmed that a p53 
block of differentiation was common in at least one other family of clones. 
Future studies will focus on the molecular events that are responsible for the 
differentiation phenotype seen upon ribosomal protein defects. Moreover, 
about 30 ribosomal protein genes are deleted in different DelES families. 
It will therefore be interesting to compare the role of different ribosomal 
proteins in ES cells differentiation.
Poster Board Number: 3470
“RESIDUAL POTENTIAL”, THE NEW 
CHARACTERISTIC OF MOUSE EMBRYONIC 
STEM CELLS
Fu, Wei, Zhang, Wen Jie, Pi, Qing Meng, Wang, Shu Jun, Zhou, 
Guang Dong, Liu, Wei, Cao, Yilin
Shanghai 9th People’s Hospital, Shanghai Jiao Tong University School of 
Medicine, Shanghai, China
Embryonic stem (ES) cells are a potential cell source for regenerative 
medicine. However, the residual undifferentiated embryonic stem (rES) 
cells after in vitro differentiation are tumorigenic during transplantation. 
These cells are thought to be genetically mutated cells due to long-term 
culture. Here, we proposed that generating rES cells during differentiation 
might be a unique characteristic of ES cells which could protect themselves. 
To prove this hypothesis, an in vitro and an in vivo ES cell differentiation 
system were utilized to characterize the residual cells during differentiation. 
We demonstrated that rES cells existed in both embryoid bodies (EBs) and 
teratomas and were indistinguishable from their parental cells. The rES cells 
could be re-differentiated to form EBs in vitro and form teratomas in vivo, 
and importantly, could participate in normal mouse development following 
blastocyst injection, indicating that they are normal pluripotent cells rather 
than mutant cells. Further more, we proved that the primary cultured ES 
cells were heterogeneous, with few cells having the “residual potential” 
that could generate rES cells during differentiation, and the rES cells were 
enriched in the PECAM-1 and Oct-4 double positive population in long-
term EBs and teratomas. This is the first study to demonstrate that a small 
number of normal mouse ES cells could be maintained in a pluripotent state 
during differentiation. This new characteristic of mouse ES cells prompts us 
to reconsider the strategies for solving the tumorigenic problem of stem cells 
during cell therapies.
Poster Board Number: 3472
EXPRESSION OF HAEMATOPOIETIC STEM CELL 
MARKERS C-KIT AND SCA-1 RELATES TO CELL 
CYCLE STATUS
Abeyewickreme, Anil, Thrasher, Adrian, Kinnon, Christine
Institute of Child Health, University College London, London, United 
Kingdom
INTRODUCTION: Previous studies have investigated whether levels of 
expression of the haematopoietic stem cell (HSC) marker C-kit relates to 
cell cycle status in sorted populations enriched for HSCs. These studies have 
found no link although C-kit deletion mutant mice do show significantly 
reduced HSC numbers. Sca-1 deficient mice have a reduction in immature 
haematopoietic progenitors and HSCs show impaired repopulating ability. 
METHOD: We investigated haematopoietic stem cell marker expression in 
unsorted cell populations at different developmental stages including dif-
ferentiating ES cells, foetal liver cells and adult bone marrow cells. Flow cy-
tometry studies were performed to determine expression of C-kit, Sca-1 and 
other HSC markers in these different populations. Bone marrow populations 
were then sorted based on expression of C-kit or Sca-1 and analysed for cell 
cycle status. RESULTS: We find higher levels of C-kit expressing cells in day 
6 ES cells and foetal liver cells than in bone marrow cells (P<0.05). How-
ever there are higher levels of Sca-1 expressing cells in bone marrow cells 
compared with foetal liver cells (P<0.05). In development many more cells 
are dividing and we hypothesised that expression of C-kit is related to cell 
division. Given higher levels of Sca1 expression in the adult we hypothesised 
that Sca-1 expression is related to quiescence. Further experiments reveal 
that in the bone marrow 83% of Sca-1 expressing cells are in G1/0 resting 
phase of the cell cycle (P<0.05). However in the bone marrow derived C-kit 
population 60% of cells were in G2/M or S phase (P<0.05). CONCLUSION: 
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This initial data indicates that C-kit is expressed on dividing cells and Sca-1 
is expressed on cells that are quiescent. We propose that previous experi-
ments have not demonstrated this as they have focused on levels of marker 
expression and cell cycle status in specific HSC populations that may select 
out cells in a particular stage of the cell cycle.
Poster Board Number: 3474
NEW PHYSIOLOGICAL DIFFERENTIATION 
SYSTEM TO DERIVE HIGH-PURITY DEFINITIVE 
ENDODERM LINEAGES UNCONTAMINATED BY 
UNDIFFERENTIATED CELLS
Agapova, Larissa1, Jeffrey, Fair2, West, Richard A.3, Ostrowska, 
Alina1, Semechkin, Ruslan1, Agapov, Vladimir1, Turovets, Irina1, 
Kochetkova, Olga1, Semechkin, Andrey1, Turovets, Nikolay1
1International Stem Cell Corporation, Oceanside, CA, USA, 2Cedars Sinai 
Medical Center, Los Angeles, CA, USA, 3Western Michigan University, 
Kalamazoo, MI, USA
Derivation of differentiated cells uncontaminated by undifferentiated 
cells that may evolve into tumors is one of a major objective of stem cell 
research. We report here a novel physiological approach to derive from 
various human pluripotent stem cell types, a high-purity definitive endoderm 
(DE) and DE lineages uncontaminated by undifferentiated cells. Our new 
differentiation culture system reproduces in vitro the conditions encountered 
by cells during gastrulation and differentiation into functional cell types 
in vivo. Detailed description of the new culture system will be presented. 
Our observations indicate that the cell type derived in new differentiation 
system by the end of DE-stimulation step of the differentiation protocol is an 
authentic DE. Marker analysis at the protein and RNA levels was consis-
tent with the formation of DE. Flow cytometry data analysis indicated the 
extremely high purity of these cultures and no undifferentiated cells were 
detected in the created DE. Reverse transcriptase (RT) real-time quantita-
tive PCR revealed a lack of distinct expression of mesoderm, ectoderm, 
trofectoderm as well as extraembryonic endoderm markers. Further direct 
differentiation of cells toward hepatocytes within our differentiation system 
produced cells manifesting the same cubical shape as mature hepatocytes, 
and expressing a variety of genes and proteins, typical for functional mature 
hepatocytes. Comparative analysis of hepatocyte-like cells derived in our dif-
ferentiation system from human pluripotent stem cells, and mature human 
hepatocytes was based on RT real-time quantitative PCR gene detection. To 
determine whether the test cells express metabolic functions characteristic 
of normal human hepatocytes, we examined the activities of several phase 
I (CYPP450) and phase II drug-metabolizing enzymes by using reversed-
phase HPLC; expression of the appropriate drug-methabolizing enzymes 
was additionally confirmed by RT real-time quantitative PCR. The purity of 
derived hepatocytes was determined by FACS analysis. Obtained data will 
be presented and discussed. The efficacy of this method was demonstrated 
for both human embryonic and human parthenogenetic stem cells. The 
latter cell type holds a great promise as a source of pluripotent stem cells 
for cell-based transplantation therapy due to the ethical method of deriva-
tion, as well as the enhanced capacity for immune-matching with signifi-
cant segments of human population. Thus, we postulate that, if culture of 
pluripotent stem cells can respond to direct differentiation signaling and 
can produce DE lineages, our system will be an effective new approach to 
isolate a high-purity population of DE lineages. The ability to work with a 
wide range of cell lines may also facilitate and promote cell transplantation 
based on stem cells derived from the patient or histocompatible donors. 
The method described here represents a significant step toward the efficient 
generation of high purity hepatocytes and pancreatic endocrine cells for use 
in regenerative medicine and drug discovery.
Poster Board Number: 3476
SKELETAL MYOSIN LIGHT CHAIN KINASE 
REGULATES SKELETAL MYOGENESIS BY 
PHOSPHORYLATION OF MEF2C
Al Madhoun, Ashraf, Skerjanc, Ilona
BMI, University of Ottawa, Ottawa, ON, Canada
The MEF2 transcription factors play an important regulatory role in several 
lineages. In skeletal myogenesis, MEF2 factors amplify and synergize with 
MyoD, establishing myoblast formation. While phosphorylation is known 
to regulate MEF2 function, lineage-specific regulation is unknown. Here, 
we show that a novel phosphorylation of MEF2C on T80 by skeletal myosin 
light chain kinase (skMLCK) enhances skeletal and not cardiac myogen-
esis. A phosphorylation-deficient MEF2C mutant (MEFT80A) was able to 
enhance cardiac, but not skeletal myogenesis in P19 stem cells. Further, 
MEFT80A was deficient in recruitment of p300 to skeletal but not cardiac 
muscle promoters. In gain-of-function studies, skMLCK enhanced skeletal 
myogenesis in P19 cells and myogenic conversion assays. In loss-of-func-
tion studies, MLCK was essential for efficient myogenesis in P19, mouse 
embryonic stem (ES) and mouse progenitors cells. Our findings define a 
novel function for skMLCK in regulating myoblast formation, by control-
ling the MEF2C-dependent recruitment of histone acetyltransferases (HATs) 
to skeletal muscle promoters, going beyond the known role of skMLCK in 
muscle contraction. Finally, we identify the first kinase that regulates skeletal 
myogenesis in ES cells.
Poster Board Number: 3478
STUDIES OF MESP1 IN EARLY DEVELOPMENT 
OF MESODERMAL LINEAGES
Cai, Mi1, Gill, Jennifer G.1, Murphy, Theresa L.1, Murphy, Kenneth 
M.2
1Pathology and Immunology, Washington University School of Medicine, 
Saint Louis, MO, USA, 2Pathology and Immunology, Howard Hughes 
Medical Institute, Washington University School of Medicine, Saint Louis, 
MO, USA
Recently we and others identified the gene mesoderm posterior 1 (Mesp1) 
as an important regulator of early cardiovascular fate specification during 
differentiation of murine embryonic stem cells (ESCs). We observed that 
induction of Mesp1 during early ESC differentiation could drive a program 
of epithelial-mesenchymal transition (EMT) that was independent of Wnt 
signaling, in contrast to spontaneous EMT which required Wnt signaling. 
To identify how Mesp1 directs EMT, we sought to identify its direct targets 
during ESC differentiation. Microarray analysis identified PDGFRα, being 
increased 14-fold within 6 hours of Mesp1 induction in differentiating ESCs. 
PDGFRα induction by Mesp1 may be important, since PDGFR signaling 
plays a role in normal gastrulation, the survival of mesodermal cells and the 
induction of mesoderm during embryogenesis. We tested whether PDGFRα 
is a direct target of Mesp1, and the possibility that it mediates Mesp1’s 
functions during ESC differentiation. Here we report that Mesp1 directly 
binds to the PDGFRα promoter in differentiating ESCs by EMSA. In addition, 
by inducing Mesp1, but blocking PDGFRα signaling through use of specific 
PDGFR inhibitors, we show that PDGFRα signaling is also necessary for 
Mesp1’s effects in cell survival, EMT and mesodermal cell fate specification. 
Another unanswered question is how Mesp1 functions in the specification of 
cardiovascular lineages. In examining ESC differentiation, we found that lin-
eage segregation between endothelial and mesenchymal progenitors, which 
generate smooth muscle cells (SMC) and cardiomyocytes, occurred as early 
as 2 days after Mesp1 induction. Factors that are differentially expressed 
between these endothelial and mesenchymal progenitors at this early stage 
may interact with Mesp1 to specify individual cardiovascular cell lineage. To 
identify such potential factors, we isolated purified populations of differen-
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tiating ESCs that that appear to be endothelial progenitors (Flk1hiTie2+) or 
mesenchymal progenitors (Flk1medPDGFRα+Tie2-) from Mesp1-induced 
ESCs and compared their gene expression by global microarray analysis. The 
transcription factors Erg and Fli-1 were enriched in endothelial progenitors. 
We show that these factors promote endothelial differentiation in differ-
entiating ESCs. Fli-1 also partially inhibited smooth muscle differentiation. 
In contrast, Baf60c, a subunit of the Swi/Snf-like BRG1-associated factors 
(BAF) complex, was enriched in mesenchymal progenitors. Knockdown 
of Baf60c in differentiating ESCs reduced induction of cardiac troponin T 
(cTnT) by Mesp1, suggesting that Mesp1 requires Baf60c to induce cardiac 
lineages. Our studies further elucidate the mechanisms by which Mesp1 
regulates EMT and early cardiovascular specification, which is important for 
understanding cardiac development and eventual applications to regenera-
tive therapy.
Poster Board Number: 3480
SCREENING SMALL MOLECULES FOR 
INDUCERS OF CARDIOMYOCYTE CELL 
LINEAGE FATE
Gonzalez, Rodolfo
Chemistry, The Scripps Research Institute, La Jolla, CA, USA
Chemical genetics has become an increasingly robust and general paradigm 
for addressing difficult biological questions. This approach has been ap-
plied in the field of regenerative medicine leading to the identification of a 
number of small molecules used to control stem cell fate. Our current focus 
is on identifying and characterizing small molecules that can induce human 
pluripotent cells to differentiate into cardiomyocytes. Because kinases are 
likely to play an important role in cell signaling processes that regulate stem 
cell proliferation and differentiation, a combinatorial library designed around 
kinase-directed molecular scaffolds was screened to identify members that 
differentiate human embryonic stem cells (hESCs) into cardiomyoctes. We 
are currently characterizing the mechanism of the identified compounds by 
determining the target(s) using affinity based approaches and investigating 
the signaling pathways using genetic and biological methods.
Poster Board Number: 3482
FBXO25 ACTS AS AN E3 LIGASE TO TARGET 
TBX5 AND HAS A PROFOUND EFFECT ON 
CARDIOMYOCYTE DIFFERENTIATION IN 
EMBRYONIC STEM CELLS
Jang, Jae-Woo, Lee, Won-Young, Habib, Omer, Kim, Chang-Hoon, 
Chung, Hyung-Min
CHA Stem Cell Institute, Seoul, Korea, Republic of
Fbxo25 is a subunit of functional ubiquitin ligase complex containing Skp1, 
Cul1, and Rbx1. Tbx5 is one of transcription factors which regulate forma-
tion of embryonic heart. Mutations in this gene have been known to associ-
ate with Holt-Oram syndrome, a developmental disorder affecting the heart 
and upper limbs. Here we show that Fbxo25 bound to Tbx5 and promoted 
Tbx5 degradation. Tbx5 associated with N-terminal domain in Fbxo25. 
Fbxo25 bound to T-box domain of Tbx5. Tbx5 degradation was triggered 
by ubiquitination through SCF complex with Fbxo25. In addition, Tbx5 
increased the activities of atrial natriuretic peptide (ANP)-luciferase reporter, 
but Fbxo25 decreased the effects of Tbx5 on ANP-luciferase in parallel with 
degradation of Tbx5 proteins. We performed cardiomyocyte differentiation 
assays using embryonic stem cells (ESCs) expressing wild type or dominant 
negative Fbxo25 mutants. As a result, the ratios of cardiomyocyte differ-
entiation were dramatically compromised compared to control ESCs. The 
expression of Fbxo25 using Fbxo25 lenti-viruses decreased Tbx5 expression 
in the regions of myocardiac infarction. These results indicated that Fbxo25 
has an important role in cardiac development and differentiation through 
Tbx5 degradation.
Poster Board Number: 3484
EMBRYONIC STEM CELL-DERIVED RENEWABLE 
AND FUNCTIONAL MIDBRAIN DOPAMINERGIC 
PROGENITORS
Chung, Sangmi1, Leung, Amanda1, Aldrich, Daniel1, Kitayama, Yui1, 
Lamonerie, Thomas2, Kim, Kwang-Soo1
1Mclean Hospital/Harvard Medical School, Belmont, MA, USA, 2IBDC, 
UMR CNRS 6543, Université de Nice - Sophia Antipolis, Nice, France
During early development, midbrain dopaminergic (mDA) neuronal precur-
sors (NPs) arise from the ventral mesencephalic area by the combined 
actions of secreted factors (e.g., Shh and Wnt 1) and their downstream 
key transcription factors. These mDA NPs proliferate, migrate to their final 
destinations, and develop into mature mDA neurons in the substantia nigra 
and in the ventral tegmental area. Here, we show that such authentic mDA 
NPs can be efficiently isolated from in vitro differentiated mouse embryonic 
stem cells (ESCs) using a fluorescent activated cell sorting (FACS) method 
combining two-markers, Otx2 and Corin. Purified Otx2+ Corin+ cells 
coexpressed other mDA NP markers such as FoxA2, Lmx1b and Glast. Us-
ing our optimized in vitro culture conditions these mDA NPs continuously 
proliferated for at least up to 4 weeks with almost 1,000-fold expansion 
without significant changes in their phenotype and developmental potential. 
Furthermore, upon neuronal differentiation, Otx2+ Corin+ cells efficiently 
generated mDA neurons, as evidenced by coexpression of mDA neuronal 
markers (e.g., TH, Pitx3, Nurr1 and Lmx1b) and physiological functions 
(e.g., efficient DA secretion and uptake). Notably, these mDA NPs differenti-
ated into a relatively homogenous population containing high DA neurons 
but very few serotonergic neurons. When transplanted into a mouse model 
of PD, aphakia mice, they differentiated into mDA neurons in vivo and 
generated well-integrated grafts with enriched DA neurons, resulting in 
significant improvement of motor dysfunctions without tumor formation. 
Furthermore, grafted Otx2+ Corin+ cells exhibited significant migratory 
function in the host striatum, reaching up to >3.3mm length in the entire 
striatum. We propose that functional and expandable mDA NPs can be ef-
ficiently isolated by this novel double sorting strategy and will serve as useful 
platforms in regenerative medicine, bioassay, and drug screening for DA 
neuron-related biology and diseases.
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SURFACEOME PROFILING REVEALS NOVEL 
REGULATORS OF NEURAL STEM CELL 
FUNCTION
DeVeale, Brian1, Bausch-Fluck, Damaris2, Seaberg, Raewyn3, 
Runciman, Susan1, Akbarian, Vahe4, Karpowicz, Phillip5, Yoon, 
Charles4, Song, Hannah4, Leeder, Rachel1, Zandstra, Peter4, 
Wollscheid, Bernd2, van der Kooy, Derek1
1Molecular Genetics, University of Toronto, Toronto, ON, Canada, 2Institute 
of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland, 3Institute of 
Medical Science, University of Toronto, Toronto, ON, Canada, 4Institute of 
Biomaterials and Biomedical Engineering, University of Toronto, Toronto, 
ON, Canada, 5Dept of Genetics, Harvard Medical School, Boston, MA, USA
The composition of cell-surface proteins changes during lineage specifica-
tion, altering cellular responses to their milieu. Cell-autonomous proper-
ties arise including distinct adhesive profiles that facilitate morphogenetic 
movements, boundary formation towards organization of tissues as well 
as cell-intrinsic lineage programs which restrict the range and output of 
morphogen responsiveness. The prevailing model of neural induction posits 
that epidermis is induced from ectoderm by BMP-induced signaling, while 
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neural tissue is segregated from ectoderm by release of BMP antagonists 
such as Noggin and Chordin from anterior visceral endoderm at E7.5 of 
murine development; BMP antagonism effectively relieves repression of 
neural fate, as factors downstream of BMPs including SMADs and IDs inhibit 
the neural program. These events in development can be modeled using 
pluripotent Embryonic Stem Cells that self-renew when cultured in serum-
free media supplemented with BMP4 and Lif, but undergo neural induction 
to form Primitive Neural Stem Cells (pNSCs) when placed at low density 
in serum free media with Lif but without exogenous BMPs, and Definitive 
(dNSCs) when pNSCs are passaged into FGF-containing media without 
Lif. The changes that characterize maturation of early NSCs remain poorly 
understood, and improved characterization would help elucidate the regula-
tors of critical NSC properties. We reasoned that an unbiased approach to 
examining the cell-surface constituents of each cell in the lineage of early 
NSCs would provide direct insight into molecules that functionally dictate 
the unique identity of each cell type. Here we use Mass-Spectrometry based 
Cell Surface Capture technology to profile the cell surface of early NSCs and 
find many molecules enriched on the cell surface of one of ES cells, pNSCs 
or dNSCs, and not on the other two cell types. Moreover, we demonstrate 
functional requirements for several of the enriched molecules selectively on 
each of the two NSC types. Specifically, we demonstrate that Neural-cad-
herin is the predominant determinant of dNSC compartmentalization, c-kit 
signaling promotes pNSC quiescence, signaling through EphA4 is required 
for viability of both NSC populations and that Erbb2 signaling is required 
for the proliferation of pNSCs. This work elucidates several key mediators of 
NSC function whose relevance then is confirmed on forebrain-derived popu-
lations and identifies a host of other candidates that may regulate NSCs.
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OLIGODENDROCYTES AND MOTONEURON 
PROGENITORS DERIVED FROM HESC RESCUE 
LOCOMOTOR FUNCTION IN RATS WITH 
COMPLETELY TRANSECTED SPINAL CORD
Erceg, Slaven1, Stojkovic, Miodrag2, Bhattacharya, Shomi S1
1Centro Andaluz de Biología Molecular y Medicina Regenerativa 
(CABIMER), Medical Genome Project, Seville, Spain, 2Spebo Medical, 
Leskovac, Serbia
Human embryonic stem cells (hESC) hold great promise in the treatment of 
many neurodegenerative human diseases particularly those arising from cell 
loss or neural dysfunction what is the case of spinal cord injury (SCI). This 
study is designed to evaluate the therapeutic effects on axonal remyelination 
and functional recovery of complete transacted spinal cord of transplanted 
hESC-derived oligodendrocytes (OPC) and/or motoneuron progenitors 
(MP). Adult female rats were subjected to the model of complete transec-
tion SCI and hESC- derived OPC and/or MP were grafted into the site of 
injury in the acute phase. Immunohistochemical data provide evidence dif-
ferentiation of hESC derived OPCs and MPs into several neural phenotypes 
including neurons and oligodendrocytes. Recovery of hind limb locomotor 
function was also significantly enhanced in the rats treated with a single cell 
type (OPC or MP) or combination of these two cell types compared with 
the control lesioned rat treated with vehicle only, based on Basso-Beattie-
Bresnahan (BBB) scores assessed during the 4 months after transplantation. 
We demonstrate that OPC and MP, when transplanted into the spinal cord 
immediately after complete transection survive and differentiate into mature 
oligodendrocytes and neurons and improve locomotor function. These re-
sults show that OPC and MP derived from hESC could be a useful therapeu-
tic strategy to repair the injured spinal cord.
Poster Board Number: 3490
EXPRESSION AND FUNCTION OF A TYPE II 
TRANSMEMBRANE SERINE PROTEASE IN 
NEURAL PROGENITOR CELLS
Fang, Jung-Da
National Health Research Institute, Zhunan Town, Miaoli County, Taiwan
Recent studies show that the type II transmembrane serine proteases play 
important roles in diverse cellular activities and pathological processes 
through interaction with cell surface proteins, soluble proteins, proteins on 
adjacent cells and matrix components. Their expression and functions in 
central nervous system, however, are largely unexplored. In this study, we 
show that one such member, matriptase (MTP), is expressed in neural stem/
progenitor (NS/P) cells and in neurons, but little or none in brain endothe-
lial cells, astrocytes or microglial cells. MTP is crucial to NS/P cell mobility. 
Blocking of MTP expression or MTP activity impaired while overexpression 
of MTP promoted NS/P cell to traverse reconstituted basement membranes. 
Silencing of MTP impairs vascular endothelial growth factor and hepatocyte 
growth factor induced NS/P cell mobilization. MTP acts upstream of matrix 
metalloproteinases in promoting NS/P cell migration. In embryonic stem cell 
to neural differentiation, MTP has no effect on neural lineage entry by em-
bryonic stem cell; high MTP protein or activity, however, shift the population 
between NS/P cells and neurons to favor neuronal differentiation. This is the 
first report to demonstrate the expression and function of type II transmem-
brane serine protease in NS/P cells
Poster Board Number: 3492
CONTRARY EFFECTS OF VALPROIC ACID ON 
THE DIFFERENTIATION OF STEM CELLS AT 
DIFFERENT STAGES OF DEVELOPMENT
Lau, Shong, Tsang, Kam Sze Kent, Ng, Ho Keung
Anatomical and Cellular Pathology, Chinese University of Hong Kong, 
Shatin, Hong Kong
Valproic acid (VPA) is commonly used as a mood stabilizer and anticonvul-
sant. Despite the clinical relevance to neural disorders, the roles of this small 
molecule in neurogenesis are not well understood. The recent discovery of 
the inhibitory effect of VPA on histone deacetylase has led to studies on its 
potential application in manipulating differentiation of stem cells for therapy 
and regenerative medicine. We used an in vitro culture system to elucidate 
the biological effects of VPA on mouse embryonic stem (ES) cells D3 and 
E14Tg2a, primary neural stem (pNS) cells and neural precursor cell line 
C17.2. The morphological study in C17.2 differentiation suggested that sev-
en-day treatment with VPA enhanced the neuronal development as evident 
of more extensive dendritic protrusions. On the contrary, embryoid bodies 
(EB) derived from VPA-treated ES cells for 14 days were reluctant to yield 
dendritic protrusions, as compared to the control group. Immunohistochemi-
cal staining demonstrated that the numbers (mean ± SD) of β-tubulin+ cells 
derived from both VPA-treated pNS cells and C17.2 cells were signifi-
cantly higher than those of the control groups (pNS cells: VPA-treated vs. 
untreated; 13.2% ± 0.9% vs. 5.8% ± 0.6%; n=3; p<0.01, C17.2: VPA-
treated vs. untreated; 37.8% ± 0.7% vs. 17.8% ± 0.6%; n=3; p<0.01), 
suggesting the differentiating effect of VPA on neural stem and progenitor 
cells. Besides, the numbers of 14-day VPA-treated D3 and E14Tg2a-derived 
EB with dendritic protrusions were comparatively lower than those of the 
untreated counterparts (D3: VPA-treated vs. untreated: 0% ± 0% vs. 32.6% 
± 4.1%; n=3; p<0.01, E14Tg2a: VPA-treated vs. untreated: 0% ± 0% vs. 
66.9% ± 5.1%; n=3; p<0.01), implying the inhibitory effect of VPA on the 
differentiation of ES cells. Using two-stage neural induction cultures, VPA 
treatment of D3 and E14Tg2a at an early stage (VN) elicited a significantly 
lower percentage of cell foci with β-tubulin+ protrusions compared to that 
with no treatment (NN, D3: VN vs. NN; 3.1% ± 0.8% vs. 32.6% ± 4.1%; 
233
Friday Poster Abstractswww.isscr.org
Friday Poster Abstracts
n=3; p<0.01, E14Tg2a: VN vs. NN; 7.5% ± 4.3% vs. 66.9% ± 5.1%; VV 
vs. NV; 0% ± 0% vs. 92.0% ± 3.2%; n=3; p<0.01). On the contrary, VPA 
treatment at late stage (NV) yielded an elevated percentage of β-tubulin+ 
cell foci in E14Tg2a, implicating a late acting effect on neural commitment. 
Real-time PCR revealed two- to six-fold increases in the expression of 
Notch-1 and Notch-2, and the downstream targets, hes1 and hes3, in the 
VPA-treated ES cells E14. The up-regulation of the Notch signalling pathway 
might be attributable to the inhibitory effect of VPA on neural induction of 
ES cells. Taken together, the readouts imply the double-edged effect of VPA 
on the neural fate of stem cells at different stages of maturation.
Poster Board Number: 3494
MORPHOGENESIS, PATTERNING, AND 
DIFFERENTIATION OF ESC-DERIVED NEURAL 
ROSETTES
Germain, Noelle D., Banda, Erin, Grabel, Laura
Biology, Wesleyan University, Middletown, CT, USA
Embryonic stem cell (ESC) in vitro neurogenesis resembles the develop-
ment of the central nervous system in the early mammalian embryo. Using 
a well-defined monolayer protocol that utilizes the BMP-antagonist Noggin, 
we observe formation of neural rosettes, in which differentiating neural stem 
cells (NSCs) are radially arranged around a lumen and exhibit interkinetic 
nuclear migration. N-cadherin and Numb are localized at the apical luminal 
surface, suggesting the emergence of a polarized epithelial layer, reminiscent 
of radial glia in the embryonic neural tube. Rosettes also appear to have 
regional identities, for example expressing the ventral marker Nkx2.1 in 
one half of the rosette. In addition, our RT-PCR analysis shows that during 
differentiation, cells express markers of both dorsal (Pax7) and ventral neural 
populations (Mash1, Nkx2.1 and Dlx2). One goal of our work is to use this 
in vitro system to generate an enriched population of GABAergic interneu-
rons that could be used to treat neurodegenerative diseases like Temporal 
Lobe Epilepsy (TLE), characterized by the loss of inhibitory GABAergic in-
terneurons. We now demonstrate that further differentiation of hESC-NSCs 
efficiently produces mature GABAergic neurons.
Poster Board Number: 3496
LOCALIZED INDUCTION OF EARLY EMBRYONIC 
STEM CELL DIFFERENTIATION IN A NOVEL 
THREE DIMENSIONAL SYSTEM
Fine, Amir, Chen-Konak, Limor, Tzchori, Itai, Levenberg, Shulamit
Biomedical Engineering, Technion, Haifa, Israel
Embryonic stem cells (ESC) and induced pluripotent stem (iPS) cells are at-
tractive cell sources for diverse clinical applications in regenerative medicine 
due to their ability to both undergo self renewal and to differentiate into 
specialized cell types of the adult body. Before the cell-based therapeutic po-
tential of ESC can be implemented, a better understanding of the pathways 
regulating lineage-specific differentiation is required. This understanding will 
enable the development of better selective differentiation methods. Current 
studies suggest that similar pathways that are required for gastrulation and 
germ layer induction in the embryo are also essential for differentiation of 
ESC in culture. However, these pathways are still not fully understood. In 
order to investigate the mechanisms that control ESC differentiation and 
the cues that determine germ layer differentiation, a novel approach for 
controlled differentiation of ESC was developed. We formed embryoid bod-
ies (EBs), from Brachyury:GFP mouse ES cells which serves as a kinetic me-
sodermal marker. Bmp-4 coated micro particles implanted in the EBs enable 
us to monitor the kinetics and localization of mesodermal differentiation by 
following GFP expressing cells proximal to the attached-beads along the dif-
ferentiation process. In order to identify the early factors involved in ESC dif-
ferentiation patterns by gene expression analysis, induced and non induced 
EBs were dissociated in to single cells and positive and negative populations 
of GFP were isolated using flow cytometry on various days of differentiation. 
Overall, our results demonstrate the ability to locally direct and control the 
differentiation of mouse ESC in a three dimensional system. Ongoing experi-
ments are currently underway to further examine the differentiation process 
and the ability of different factors to locally induce or inhibit differentiation.
Poster Board Number: 3498
REGULATION OF ENDODERM COMMITMENT 
IN EMBRYONIC STEM CELLS BY FIBRILLAR 
FIBRONECTIN AND ADHESION STRENGTH
Fuhrmann, Alexander, Taylor-Weiner, Hermes, Engler, Adam J.
Bioengineering, University of California, San Diego, San Diego, CA, USA
Fibronectin (FN) is an extracellular matrix protein that assembles to a fibrillar 
network surrounding stem cells and significantly regulates morphogen-
esis, i.e. fibronectin null embryos are arrested at gastrulation. Here we also 
suggest that FN may also regulate embryonic stem cell (ESC) fate via its 
intrinsic properties, e.g. structure and stiffness. ESCs were found to have a 
spatiotemporal correlation between expression of FN and GATA4, an endo-
derm gene. Initial endoderm commitment depended on FN ligation of α5β1 
integrins followed downstream by Src and Rho kinases, which was enhanced 
in ESCs cultured on stiff fibrillar FN matrix. To assess to what degree adhe-
sion was required for this process, ESCs were exposed to high, radially-de-
pendent shear force over a 6 day time course. The shear to detach 50% of 
the cells (τ50) did not change between 12 hr and 6 days, though it differed 
significantly between the matrices with different structure, i.e. τ50 of FN-
coated substrates was 5-fold higher than fibrillar FN matrix. The formation 
and uniform distribution of small focal contacts observed throughout cells 
on fibrillar FN was found to correlate with higher adhesion strength and en-
doderm differentiation, e.g. the ratio of GATA4 positive to negative cells in 
areas of high shear forces increased ~50 times. Together these data suggest 
that the matrix ligand, structure, and stiffness are all important in endoderm 
commitment, and that a uniform distribution of labile adhesions is required 
to maintain firm adhesion characteristic of endoderm.
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A NOVEL ROLE FOR ANKRD11 IN THE 
DEVELOPING CEREBRAL CORTEX
Gallagher, Denis1, Burns, Sarah1, Paquin, Annie1, Bramall, Alexa1, 
Neilsen, Paul2, Scherer, Stephen3, Keller, Gordon4, Kaplan, David1, 
Miller, Freda1
1Developmental and Stem Cell Biology, The Hospital for Sick Children, 
Toronto, ON, Canada, 2Breast Cancer Genetics, Hanson Institute, Adelaide, 
Australia, 3The Hospital for Sick Children, Toronto, ON, Canada, 4McEwen 
Centre for Regenerative Medicine, Toronto, ON, Canada
Increasing evidence suggests that perturbations in cell genesis during the de-
velopment of the nervous system may underlie cognitive dysfunction associ-
ated with neurodevelopmental disorders. In that regard, we have identified 
a novel role for a recently identified autism-associated gene, ankyrin repeat 
domain-containing protein 11 (Ankrd11), in the development of the cerebral 
cortex. We show that Ankrd11 is expressed in both embryonic cortical 
precursors and in newly-born cortical neurons. We demonstrate that genetic 
knockdown of Ankrd11 inhibits neurogenesis in cultured cortical precur-
sors. Embryonic neurogenesis was similarly perturbed after acute shRNA-
mediated knockdown of Ankrd11 in vivo using in utero electroporation. 
Furthermore, we have developed a method for generating neural precursors 
from human embryonic stem cells (hESCs) and human induced pluripotent 
stem cells (hiPSCs), based on inhibition of BMP signalling. Precursors gener-
ated using this method express markers consistent with a forebrain precursor 
identity and subsequently differentiate into glutamatergic neurons. We have 
employed this method to study the role of Ankrd11 in human neurogenesis.
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MASS TRANSFER LIMITATIONS IN EMBRYONIC 
STEM CELL DERIVED EMBRYOID BODIES 
DURING DIFFERENTIATION
Van Winkle, Allison1, Hunt, Megan M.1, Gates, Ian2, Kallos, 
Michael2
1Pharmaceutical Production Research Facility, Schulich School of 
Engineering, University of Calgary, Calgary, AB, Canada, 2Dept of Chemical 
and Petroleum Engineering, Schulich School of Engineering, University of 
Calgary, Calgary, AB, Canada
Human embryonic stem cells (ESCs) readily proliferate, self-renew and can 
be driven to differentiate into cell types from all three germ layers making 
them a source with tremendous potential in the treatment of debilitat-
ing diseases and injuries. Typically in vitro differentiation of these cells is 
induced via embryoid body formation to mimic in vivo conditions of embryo 
development. However, the use of hESC-derived cells in clinical applications 
will require culture protocols which are well defined, in a controlled environ-
ment, and fully reproducible to successfully scale up production to clinically 
relevant numbers. The ability to accurately direct the differentiation of 
these cells is required to minimize the risk of tumour formation. As such, we 
have developed a transient mass diffusion model to elucidate the effect of 
nutrient transfer and embryoid body size on subsequent cell differentiation. 
The results of this model indicate that oxygen levels at the centre of large 
embryoid (400μm) bodies are significantly lower than in small embryoid 
bodies (200μm) which helps substantiate experimental observations by oth-
ers indicating that embryoid body size influences differentiation trajectories. 
The glucose concentration profile was modeled and resulted in a profile 
which did not depend on embryoid body size. As such, glucose concentra-
tion was not shown to be a major contributor to hESC differentiation. A 
comparison of the model results with published experimental data reveals 
a correlation between the fraction of cells exposed to different oxygen and 
cytokine concentrations and the fraction of cells observed to be differentiat-
ing into a specific lineage. A better understanding of diffusive mass transfer 
within the embryoid body is an important step in the development of robust 
differentiation protocols required to produce functioning cell types for tissue 
engineering applications. The model was validated against experimental 
data with from mouse and human ESCs.
Poster Board Number: 3504
ASTROCYTIC DIFFERENTIATION OF EMBRYONIC 
STEM CELL-DERIVED OLIG2 POSITIVE GLIAL 
PROGENITOR CELLS
Jiang, Peng1, Chen, Chen1, Liu, Ying2, Deng, Wenbin1
1University of California, Davis, Sacramento, CA, USA, 2University of 
California, San Diego, San Diego, CA, USA
Astrocytes are the major glial cells in the central nervous system (CNS). 
Previous studies have demonstrated that brain-derived immature but not 
mature astrocytes have the ability to promote axon growth. Moreover, 
transplanted immature astrocytes are motile, interact with blood vessels and 
suppress glial scar formation, while transplanted mature astrocytes do not. 
Given these potential beneficial effects, immature astrocytes may be used 
as cell therapy for CNS injury or diseases. Embryonic stem cells (ESCs) are 
capable of self-renewal and can give rise to neural lineage cells, proving 
the promise of using ESC-derivates as cell replacement therapies for CNS 
disorders. To date, very few studies have examined astrocyte differentiation 
from ESCs. Astrocyte differentiation has often been reported merely as a by-
product in directed differentiation of ESCs into neurons or oligodendrocytes. 
The Olig2-GFP human (h) and mouse (m) ESCs are genetically labeled ES 
reporter cell lines, in which GFP is inserted into the Olig2 gene locus so that 
ES-derived cells that express Olig2 also express GFP. Our previous studies 
have shown that using small molecule-based methods (Jiang et al. 2010 and 
Xue et al., 2009), both Olig2-hESCs and Olig2-mESCs can be coaxed into 
either Olig2+/GFP+ motor neuron precursors or glial progenitor cells (GPCs) 
that can then give rise to oligodendrocytes. Here, we studied the fate of the 
Olig2+/GFP+ GPCs cultured in the presence of the astrogliogenesis inducer 
bone morphogenetic protein-4 (BMP-4). Although the GFP expression was 
terminated once the ESC-derivates stopped expressing Olig2, the cells that 
once expressed GFP protein could be identified using anti-GFP antibody 
even 5 days after culturing in the presence of BMP-4. Thus, we used anti-
GFP staining to track down the fate of Olig2+/GFP+ cells after exposure 
to BMP-4. Interestingly, the mESC-derived Olig2+/GFP+ GPCs could be 
efficiently differentiated into GFAP+ astrocytes in the presence of BMP-4. 
The majority of the differentiated cells was GFAP+/A2B5- type-1 astrocytes 
and a small population of them was GFAP+/A2B5+ type-2 astrocytes. We 
are studying whether these ESC-derived astrocytes have similar properties 
of brain-derived immature astrocytes to promote neurite growth when co-
cultured with brain- or ESC-derived neurons in vitro and to promote axon 
outgrowth and suppress scar formation in CNS lesions after transplantation 
in vivo.
Poster Board Number: 3506
COMPARATIVE ANALYSIS OF BRANCHING 
EPITHELIUM DERIVED FROM EMBRYONIC 
PDX1+ PANCREAS AND DIFFERENTIATED 
EMBRYONIC STEM CELLS
Lim, Sue Mei, Micallef, Suzanne J., Li, Xueling, Stanley, Edouard G., 
Elefanty, Andrew G.
School of Biomedical Sciences, Monash University, Monash Immunology 
and Stem Cell Laboratories, Melbourne, Australia
We have generated an embryonic stem cell (ESC) line in which sequences 
encoding green fluorescent protein (GFP) were targeted to the locus 
of the pancreatic-duodenal homeobox gene (Pdx1). Using the reporter 
Pdx1GFP/w ESC line, we have utilised a serum-free based approach to 
induce the formation of Pdx1+ endoderm through the sequential addition of 
BMP4 (5 ng/ml) from day (d) 0 to d4, and subsequently a pulse of retinoic 
acid from d4 to d5. Under these conditions, GFP+ cells formed well-defined 
tube-like structures (termed GFPdull structures) within d12 embryoid bodies 
(EBs) that were connected to GFP bright (GFPbr) buds. These GFPbr cells 
from partially disaggregated d12 EBs, formed epithelial ring-like structures 
when cultured in matrigel. After several days in culture, these rings undergo 
a process resembling branching morphogenesis, similar to that seen during 
pancreatic development of the mid-gestation embryo. Indeed, when pan-
creatic buds from E12.5-E13.5 Pdx1GFP/w embryos were dissociated and 
cultured under identical conditions, a virtually indistinguishable process of 
proliferation and branching morphogenesis of epithelial rings was observed. 
Furthermore, immunohistochemical analysis of both embryonic Pdx1GFP/w 
branching pancreatic epithelium and d12 GFPbr branching organoids, 
revealed that they expressed a suite of markers that were representative 
of epithelial (EpCAM, E-Cadherin), ductal (MUC1), exocrine (Amylase and 
Carboxypeptidase 1A) and endocrine cell types (Glucagon, Somatostatin). 
In summary, ESCs can be directed to differentiate into pancreatic endoderm 
in vitro. It is hoped that these studies will assist in the understanding of 
pancreatic cell fate in the mammalian embryo, and further efforts towards 
discovering therapeutic applications in the treatment of Type 1 Diabetes.
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EMBRYONIC STEM CELL PLURIPOTENCY
Poster Board Number: 3510
OXYGEN-REGULATED TRANSCRIPTIONAL 
NETWORKS CONTROLLING HUMAN 
EMBRYONIC STEM CELL PLURIPOTENCY
Pursiheimo, Juha-Pekka1, Närvä, Elisa M.1, Laiho, Asta1, Laurila, 
Kirsti2, Lund, Riikka1, Lähdesmäki, Harri2, Jaakkola, Panu3, 
Lahesmaa, Riitta1
1Centre for Biotechnology, Turku University, Turku, Finland, 2Dept of Signal 
Processing, Tampere University, Tampere, Finland, 3Dept of Oncology and 
Radiotherapy, Turku University Hospital, Turku, Finland
The pluripotent human embryonic stem cells (hESC) are isolated from the in-
ner cell mass (ICM) of blastocyst stage embryos. These embryos receive me-
tabolites and oxygen from the uterine fluid containing 2% - 5% of dissolved 
oxygen. Early embryo develops in low oxygen environment suggesting that 
hypoxic growth conditions would be physiological for hESC cultures. Indeed, 
hypoxic growth conditions (1% - 4% O2) reduce spontaneous differentia-
tion and enhance hESC self-renewal indicating that the processes mediating 
spontaneous differentiation are suppressed under low oxygen. However, 
how hypoxia contributes to pluripotency and self-renewal is not completely 
understood. To study the mechanisms involved in oxygen-regulated pluripo-
tency and self-renewal, three different hES cell lines (HS401, H9 and HS360) 
were plated on Matrigel® and cultured in 4% (hypoxia) or in ambient oxy-
gen concentration for fixed time intervals. Consistent with the hypothesis of 
hypoxia supporting pluripotency, the data from Western and Flow Cytom-
etry analyses revealed that in response to low oxygen environment, hES 
cells activate canonical hypoxia responses and inhibit the down regulation 
of the pluripotency markers. To identify the hES cell specific transcriptional 
programs regulated by oxygen, RNA was extracted from all the time points 
for which microarray analysis, using the Affymetrix Human Exon 1.0 ST ar-
ray platform. Data analysis revealed that hypoxic culture induced differential 
expression of over 200 genes, affecting various biological processes regulat-
ing hESC pluripotency and differentiation.
Poster Board Number: 3512
DEVELOPMENT OF A DEFINED SERUM FREE 
AND XENO FREE MEDIUM COMPOSED OF 
MINIMAL COMPONENTS FOR CULTURING 
HUMAN ES/IPS CELLS
Tateyama, Daiki, Kinehara, Masaki, Hirata, Mitsuhi, Matsumura, 
Hiroko, Inoue, Shin-Ichi, Furue, Miho K.
Dept of Disease Bioresources Research, National Institute of Biomedical 
Innovation, Osaka, Japan
Previously, we developed a serum-free growth factor defined culture me-
dium, hESF9, for culturing human ES cells without feeders. However, it con-
tained non-human origin components. Here we report a modified version of 
hESF9 that is completely xeno-free and composed of minimal components. 
Many other xeno-free media contain large quantity of albumin and growth 
factor cocktail to aid the maintenance and proliferation of pluripotent cells, 
but at the same time, they mask minute reactions of cells. On the contrary, 
this xeno-free culture medium is composed of only 3 growth factors and 
it is with the lowest quantity of human albumin. Thus cells cultured in this 
medium would yield more sensitive reaction to signals caused by chemical 
compounds of interest. So the use of this media in research hold promise 
for establishment of not only safe clinical application but also assured drug 
screening. Using this medium, we performed long-term (>10 passages) 
culture of human ES/iPS cells and confirmed their maintenance of an undif-
ferentiated state. Human ES/iPS cells cultured in this medium maintained 
a normal karyotype and expression of pluripotency markers which were 
assayed by FACS, PCR and immunofluorescence analysis. Furthermore, 
we confirmed multilineage differentiation potential of these cells by the 
embryoid body assay.
Poster Board Number: 3514
ACELLULAR XENO-FREE LAMININ 511 
RICH CULTURE MATRIX SUPPORTS HUMAN 
EMBRYONIC STEM CELLS
Vuoristo, Sanna, Tuuri, Timo, Otonkoski, Timo
Biomedicum Stem Cell Center, University of Helsinki, Helsinki, Finland
Several recent papers, including our own, have illustrated that laminin 511 
(Lm-511) coating alone supports maintenance of undifferentiated human 
pluripotent stem cells (hPSC) in defined culture conditions. Therefore, either 
purified or recombinant Lm-511 seems to be an optimal extracellular matrix 
coating for hPSCs. However, the difficulty and high cost of purification or 
recombinant production of Lm-511 limits its use in large-scale use. We have 
taken an alternative approach in order to develop an optimal and cost-effec-
tive human derived culture matrix for the hPSC cultures. This is based on the 
use of an acellular culture matrix (AMX) derived by alkaline lysis of a human 
chorioncarcinoma cell line that produces large amounts of laminins -511 and 
-111, the only two laminin isoforms also synthesized by hESCs. The hESC 
line FES 29 was passaged on AMX coated plates in defined medium (Stem-
Pro). Flow cytometry analysis after 15 passages showed that 86% and 87% 
of the cells cultured on AMX were positive for the surface markers SSEA3 
and Tra 1-60, respectively, while the corresponding numbers for the control 
cells cultured on Matrigel were 89% and 91%. The AMX-cultured cells also 
exhibited a strong reactivity for Nanog, Oct4 and E-cadherin antigens in im-
munocytochemistry. The cells differentiated into all three germ layers in em-
bryoid body assay. This acellular matrix has many advantages. It is derived 
from human cells and it is easy and cheap to prepare as compared with most 
commercial matrices. Furthermore, there is no batch to batch variation when 
equal numbers of cells are plated each time when preparing the plates. We 
assume that out of the two laminin isoforms produced by the chorioncar-
cinoma cell line, Lm-511 is the one supporting the undifferentiated hPSCs. 
To demonstrate it we decided to knock down the laminin alpha 5 subunit in 
the chorioncarcinoma cells and to prepare culture matrices that contain no 
laminin alpha-5 protein. We’re currently proceeding with these and several 
other strategies to investigate the role of Lm-511 in the biology of hPSCs.
Poster Board Number: 3516
INVESTIGATING THE EFFECTS OF 
EXTRACELLULAR MATRIX COMPONENTS ON 
THE REGULATION OF PLURIPOTENCY
Iskender, Banu, Soteriou, Despina, Byron, Adam, Humphries, 
Jonathan, Humphries, Martin, Kimber, Sue
The University of Manchester, Manchester, United Kingdom
Human embryonic stem cells are pluripotent cells that have indefinite 
replicative potential and ability to differentiate into derivatives of all three 
germ layers. HESCs are conventionally grown on mitotically inactivated 
mouse embryonic fibroblasts and some alternative feeder types of human 
origin have been used to culture hESCs while trying to prevent cross-species 
contamination. Understanding the mechanisms that drive these cells to pro-
liferate and specialize into certain lineages is important to our understanding 
of pluripotency and for controlling their behaviours in vitro. The trophic 
factors that are secreted by the feeders have been found to be important 
for long-term pluripotency of hESCs. However, there are also supportive 
culture systems for hESCs lacking feeder cells and in these the substrate has 
been shown to be important, suggesting that extracellular matrix-stem cell 
interactions might contribute to the regulation of self-renewal or differen-
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tiation. Extracellular matrix components are known to form an important 
component of the microenvironment of the niche for other types of stem 
cells but have been relatively little investigated for ESCs. Therefore we 
used mass spectrometry for analyzing the niche of hES cell lines grown on 
different feeder cells, to reveal the functional components of the extracel-
lular matrix which might take part in the regulation of self-renewal. The aim 
of our study is to investigate ECM components which might have a role in 
the maintenance of hESCs by comparing matrices from human placental 
stromal fibroblasts and mouse embryonic fibroblasts. hPSFs were shown 
to support long-term pluripotency of hESC for at least 12 passages and 
the matrix laid down by immortalized placental fibroblasts was found to 
be supportive for hESC growth and pluripotency in the absence of the cell 
layer. We used a proteomics approach to identify ECM proteins released by 
mouse and human feeders in order to characterise the range of extracellular 
matrix components that support the growth of self-renewing hESCs. We 
aimed to determine both similarities and differences between supportive and 
unsupportive feeder and so to dissect important and novel components of 
the matrix, which conducive with the pluripotent self-renewing state. We 
found that many ECM proteins are expressed by both mouse and human 
feeders. However some candidate proteins are only expressed by supportive 
matrices and might play a role in the maintenance of pluripotency. Quantita-
tive differences were also identified between supportive and unsupportive 
matrices. We tested candidate extracellular matrix molecules as substrates 
for feeder-free growth of hESCs including HSPG, fibulin-2, collagen VI and 
tenascin C. Our results show that some of the molecules can support attach-
ment and self-renewal of hESCs alone or in combination with fibronectin in 
the absence of feeders. Thus this study further illuminates the role that ECM 
interactions play in the hESCs phenotype which has until recently been a 
neglected area of hESCs biology.
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THE CORNING® SYNTHEMAX™ SURFACE: A 
SYNTHETIC, XENO-FREE SURFACE FOR LONG-
TERM SELF-RENEWAL OF HUMAN EMBRYONIC 
STEM CELLS IN DEFINED MEDIA.
Weber, Jennifer1, Melkoumian, Zara1, Yang, Jiwei2, Qiu, Liqun2, 
Dolley-Sonneville, Paula1, Kelley, Jessica1, Li, Yan2, Gautam, Archna2, 
Priest, Catherine2, Brandenberger, Ralph2
1Corning Incorporated, Corning, NY, USA, 2Geron Corporation, Menlo Park, 
CA, USA
Scalable, reproducible, low cost and regulatory-friendly technologies must 
be developed to enable clinical use of human embryonic stem cell (hESC)-
based therapeutics. hESC culture methods use complex, animal-derived 
products, such as mouse feeder layers, Matrigel™, murine laminin or 
human-derived biological substances as surfaces to which the hESCs attach. 
Most of these materials are costly, of limited scalability, have batch to batch 
variability and are a potential source of adventitious agents. For clinical ap-
plication of hESC-based therapeutics it is highly desirable to have defined, 
scalable culture systems for production of cells suitable for clinical use. In 
this study we describe a fully synthetic, xeno-free surface for the culture of 
undifferentiated hESC. A peptide sequence derived from the active domain 
of the vitronectin protein was covalently linked to a synthetic acrylate 
polymer surface to mimic biological ligands for cell adhesion. Self-renewal 
and pluripotency of multiple hESC lines (H7, H1, H9, and BG01v) cultured 
on Synthemax Surface was compared to cells grown on Matrigel control 
surfaces under various defined media conditions (StemPro®, NutriStem™, 
mTeSR®1, and XVIVO™ 10). Our results demonstrate efficient adhesion 
and self-renewal of H7, H1, H9 and BG01v/hOG hESCs on Synthemax 
Surface for up to 20 serial passages in defined media. Importantly, stable 
proliferation rate, expression of stem cell specific markers (Oct-4, TRA 
1-60, SSEA-4), in vitro and in vivo pluripotency and normal karyotype were 
retained throughout multiple passages on Synthemax Surface. Further, we 
demonstrated successful scale-up of Synthemax Surface to large culture ves-
sel formats to accommodate the clinical scale production of therapeutic cells. 
To our knowledge, Synthemax Surface is the only commercially available, 
synthetic, non-biological surface that supports the long-term, multi-passage 
expansion of undifferentiated hESC in chemically-defined, xeno-free media. 
We believe Synthemax Surface will be applicable for both research purposes 
and scalable manufacturing of hESC-derived cellular therapeutics.
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Human embryonic stem cell culture environments have generally relied on 
provision of recombinant or purified extracellular protein matrices to support 
attachment and growth. Here we report the screening of synthetic polymer 
hydrogels as a chemically defined and protein-free alternative to purified or 
recombinant extracellular matrix molecules for hESC attachment, mainte-
nance and enzyme free passaging. Specifically we report the identification 
of two hydrogel polymers which maintain undifferentiated hESC marker and 
endoderm, mesoderm and ectoderm lineage potential in a defined medium, 
mTESR, for over 20 passages in the absence of enzyme-mediated passaging, 
a capacity confirmed in independent cell lines. These substrates constitute 
a paradigm shift in stem cell culture technology, obviating reliance on both 
animal sourced or recombinant protein substrates and enzymatic dissociation 
for passaging.
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LOCALIZATION AND FUNCTION OF SURVIVIN 
SPLICE VARIANTS IN HUMAN EMBRYONIC 
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Meinzer, Amber, Klar, Amanda, Navara, Christopher
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The BIRC5 gene encodes the dual function protein Survivin as well as four 
additional splice variants (Survivin, Survivin ΔEx3, Survivin 2B, Survivin 3B 
and Survivin 2α). Previous results from our lab and others have demonstrat-
ed that Survivin is expressed at high levels in embryonic stem cells and that 
inhibition of Survivin function in these cells results in apoptosis, however 
these previous studies did not investigate the other four splice variants. In 
this study, we examined the expression, subcellular localization and function 
of the other variants. Consistent with previous results studying Survivin, all 
five splice variants are expressed in human embryonic stem (hES) cells and 
all five variants were expressed at levels significantly higher than both hES 
derived differentiated cells and somatic cells. Survivin and Survivin ΔEx3 
are the two most common variants expressed, accounting for 90% of the 
expression from the Birc5 gene. Survivin functions as both a necessary 
member of the chromosomal passenger protein complex and as a member 
of the inhibitor of apoptosis (IAP) family based on its’ single baculovirus 
IAP repeat. The functions of the other four variants are not well understood 
but a very small number of studies suggest they may be important in dif-
ferentiation. For this reason, we quantitated mRNA expression following 
differentiation with retinoic acid. Differentiation resulted in a rapid reduction 
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of all expression levels over a short timecourse but did not demonstrably 
change the ratio of splice variants to each other. We also examined the 
subcellular localization of three of the variants. Survivin displayed canoni-
cal chromosomal passenger protein (CPP) localization to the centromeres 
during prophase, moving to the inner centromeric region during metaphase 
and onto the interzonal microtubules at telophase. During interphase it was 
cytoplasmic due to a nuclear export signal. In contrast, Survivin ΔEx3 cannot 
function as a CPP and has no well defined function. It has a bipartite nuclear 
localization signal and was found constitutively in the nucleus. When we 
examined Survivin 2B localization we found that this variant also does not 
localize as a CPP and instead was distributed along the chromosomes during 
mitosis and also to the mitotic spindle poles. These disparate localizations 
suggest alternative functions for the splice variants from those commonly 
described for Survivin. Previous studies have demonstrated that inhibition 
of Survivin function in hES cells through siRNA or expression of a dominant 
negative mutant resulted in increased cell death and reduction in the ability 
to form teratomas. We sought to repeat these studies with an inducible 
shRNA system to elucidate any pleiotropic effects of Survivin inhibition 
masked by the apoptosis caused by unregulated inhibition. Reduction of 
Survivin and Survivin ΔEx3 mRNA expression by approx. 50% resulted 
in a corresponding reduction in Oct-4 expression. Together these results 
have led to the hypothesis that Survivin has functions in embryonic stem 
cells in addition to those canonically described and these functions may be 
dependent on the splice variants. Additionally, embryonic stem cells are the 
perfect cell type for examining Survivin function as all variants are expressed 
at detectable levels unlike most cell types and ES cells can be differentiated 
into multiple lineages to determine changes in splice variant expression and 
function during development.
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With the advent of human pluripotent stem cells (hPSCs) there has been a 
great interest in understanding the regulation of stem cell fate in order to 
further our knowledge of human development and to enable drug develop-
ment and cell therapy. Currently, assays do not account for the complex 
microenvironments, or “niches”, in which the hPSCs reside. As in the 
embryo, these niches have heterogeneous spatial organization and multiple 
populations of factor secreting cells. These microenvironmental heterogene-
ities confound results, reduce assay robustness, and limit our ability to gain 
mechanistic insight into stem cell fate processes. Micro-contact printing of 
hPSCs into colonies of specified shape, size, and colony-to-colony separa-
tion distance can be used to engineer the microenvironment and mitigate 
the heterogeneous response and obfuscating endogenous signalling in hPSC 
culture. We have developed a robust and scalable micro-contact printing 
based HTP (µCP-HTP) platform, consisting of hPSC colonies arrayed in 96-
well plates and we have optimized colony size, colony spacing, cell density, 
media composition, and the substrate for optimal signal to noise ratio. 
Single cell protein expression profiling of 20+ transcription factors and cell 
surface receptors across a diverse set of conditions revealed rapid induc-
tion of neurectoderm and primitive streak/mesendoderm lineages within 
48 hours, in addition to maintenance of pluripotency. Using hierarchical 
clustering of these protein expression profiles, we determined dual staining 
of Oct4 and Sox2 can allow discrimination between pluripotent, neurecto-
derm, extraembryonic, and primitive streak subpopulations, allowing the 
simultaneous tracking of these subpopulations as screen readouts. We have 
completed an initial screen using the human embryonic stem cell (hESC) H9 
cell line, obtaining results which link 300+ combinations of ligands and their 
small molecules inhibitors to hESC fate. We have elucidated the mechanistic 
role of individual signalling factors in stem cell fate decisions, identifying 
synergistic and antagonistic relationships between factors, and developed 
optimized conditions for both stem cell expansion and directed differentia-
tion. Dose curves of single factors reveal a common bimodal response of 
stem cells to ligands, where subpopulations have dramatically different 
responses to ligands at different concentrations, particularly FGF2, Activin A, 
and BMP4, necessitating careful dosing of ligands. Several small molecules 
have been identified that induce neurectoderm and primitive streak. The 
dual gain and loss of function screen design has also enabled functional 
assessment of endogenous signalling, indicating generally low levels of most 
endogenous signalling in this platform with the exception of high intracrine 
FGF2. Lastly, the µCP-HTP platform will enable the generation of quantita-
tive and mechanistic systems-level models of fate decisions in specific hPSC 
cell lines and their derivatives, allowing cell-line comparative studies and 
step-wise optimization of differentiation.
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Pluripotency is a transient developmental state in the early embryo defined 
by the capacity to generate all cell types comprising an adult organism. In 
humans, this unique developmental potential can be stabilized through 
establishment of embryonic stem cell (ESC) lines and can be induced in 
somatic cells (induced pluripotent stem cells; iPSCs) via transcription fac-
tor mediated epigenetic reprogramming or fusion with ESCs. The unique 
combination of unlimited growth and an extensive differentiation repertoire 
makes human pluripotent stem cells (hPSCs) attractive tools for modeling 
human developmental and degenerative processes. However, these studies 
have been complicated by an indisputable heterogeneity in the behavior of 
hPSCs. Further, that pluripotency can be both readily acquired via epigenetic 
reprogramming and silenced via differentiation demonstrates the context-
dependent dominance of pluripotency networks. Collectively, these observa-
tions highlight the complexity of pluripotency networks and necessitate a 
more thorough understanding of the underlying dynamics. To this end, we 
developed a systems biology approach based on genome-wide SNP, mRNA, 
miRNA and DNA methylation data from more than 300 hPSC samples and 
200 somatic cell lines and tissue samples. We find that while the hPSCs are 
all clearly distinct from differentiated cells, a broad spectrum of differing 
molecular profiles exists among them. Analysis of the expression profiles 
showed that all hPSCs share invariant pluripotency-associated molecular 
networks, and indicated that secondary networks underlie the variation in 
molecular profiles. Our results show that pluripotency has tolerance for con-
siderable variation within the distinct boundaries that separate all pluripotent 
cells from all non-pluripotent cells. We are investigating how pluripotent 
sub-states are maintained and why some specification factors are tolerated 
in hPSCs while others are silenced in iPSC generation.
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Properties of human embryonic stem cells (hESCs) such as pluripotency and 
differentiation are regulated by a complex network of interacting pathways. 
The subcellular localization of these pathway proteins and their relative 
abundance within a pathway dictate the influence of the pathway on hESC 
fate.. Further, the pool of endogeneously secreted extracellular cytokines 
also dictates activation/repression of various pathways. Here we describe an 
effort to uncover these regulatory mechanisms in hESCs through compre-
hensive characterization of the hESC proteome at subcellular resolution. We 
developed a discontinuous sucrose gradient-based protocol for simultaneous 
isolation of the nuclear, membrane and cytosolic subcellular fractions for 
studying differential localization of proteins inside the cell, and of the endo-
plasmic reticulum (ER) to study localization of proteins in the extracellular 
space (the secretome); secreted proteins are synthesized in the (ER). Further, 
we also used the method of spectral counting to estimate the relative 
abundance of all proteins identified in the cytosolic and ER fractions. The 
relative abundance data sheds light on dominant mechanisms regulating a 
particular pathway. The integration of protein identifications with subcellular 
localization data and estimates of protein abundance allowed us to uncover 
several potential mechanisms pertaining regulating hESC pluripotency and 
differentiation. We first studied the pluripotent hESC state and identified 
several chromatin modifying proteins to be experimentally sequestered in 
the cytosol. Our data suggests that the activity of the SIN3A chromatin 
remodeling complex and several p300/CBP containing transcription fac-
tor complexes may be regulated through cytosolic sequestration. Several 
negative regulators of the SMAD2/3 pathway are expressed in the cytosol, 
suggesting that the SMAD2/3 pathway is highly regulated in undifferenti-
ated hESCs. We also studied the secretome of hESCs grown in conditioned 
medium (CM), to elucidate the endogenous signaling present in the hESC 
microenvironment. Relative quantification for these secreted proteins allows 
us to identify the dominant signaling pathways present, as well as mecha-
nisms of their regulation. We coupled this data with relative quantification 
of mouse embryonic fibroblast (MEF)-secreted proteins present in CM, to 
understand the regulation of endogenous signaling pathways by exogenous 
MEF factors in CM. Finally, we studied the differentiation of hESCs towards 
trophectodermal lineages by inhibition of Activin/Nodal pathway and identi-
fied various regulatory feedback loops that control SMAD signaling when 
differentiation is triggered. Taken together, our data enables us to obtain 
a comprehensive understanding of the signaling networks operational in 
hESCs and the mechanisms that regulate them, at subcellular resolution.
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Multipotent neural stem cells (NSC) derived from human embryonic stem 
(hES) cells, fetal/adult tissues, or reprogrammed somatic cells (induced 
pluriopotent stem cells, hiPS) can differentiate into all central nervous 
system CNS) cell types. As we have shown, human fetal NSC prospec-
tively sorted for a CD133+/CD34- population differentiated primarily into 
oligodendrocytes and neurons, and promoted functional recovery when 
transplanted 9 or 30 days post-spinal cord injury (SCI) (PMID: PMC1216836 
& PMC2923623); these cells exhibited no evidence of tumorigenesis in 
vivo. However, the properties of hNSC derived from hES and hiPS cells, 
including their fate and tumorigenesis potential, and potential for efficacy in 
the treatment of neurological disease/injury are unclear, particularly given 
that hES and hiPS exhibit high levels of heterogeneity between lines and 
following differentiation. Experiments with hESC have shown that selection 
for CD133+ cells yields a population of neuroectoderm and differentiation 
committed cells, suggesting that not all cells in hESC cultures are pluripo-
tent. We hypothesize that the differentiation of pluripotent hESC or hiPSC 
to multipotent NSC, followed by selection via magnetic bead activated cell 
(MAC) sorting to select for CD133+ cells, will yield a population of fully 
neural lineage restricted NSC, reducing the tumorigenesis potential of the 
pluripotent starter population. Additional selection for CD34- cells is hypoth-
esized to limit hematopoietic cells in culture and further reduce heterogene-
ity. Here, we demonstrate that this sorting protocol can efficiently select a 
sustainable hES-derived NSC population (~96.4% CD133+) as assessed by 
flow cytometric analysis after 4 passages (P4) post-sorting, compared to the 
unsorted cell population (~50.0% CD133+). NSC purity was sustained up 
to P12 (~92.7% CD133+). Furthermore, sorted NSC had significantly less 
hematopoietic contaminants (CD133+/CD34+) than unsorted NSC at P4. 
However, this CD133+/CD34+ population increased slightly after P11, sug-
gesting that negative selection for hematopoietic contaminants may not be 
sustained at passages greater than P11. Preliminary fate analysis after 10DIV 
under differentiating conditions showed that both cell populations (un-
sorted and sorted) had minimal GFAP+ cell number, while sorted cells had a 
significant (~50%) reduction of β-tubulin III+ cells. Furthermore, sorted cell 
populations expressed markers suggestive of early neuronal development 
that included nestin, β-tubulin III, and the radial glial marker Brain Lipid 
Binding Protein (BLBP). Preliminary data for cell proliferation was assessed 
by EdU incorporation as well as q-PCR, showing low to no difference in the 
proliferation rate between sorted and unsorted populations, suggesting low 
tumorigenesis potential in both cases. Currently, we are validating this MAC 
sorting protocol using other hES-NSC and hiPS-NSC lines, and characterizing 
their neural developmental stage and lineage potentials. Teratoma formation 
assays are in progress to characterize the effect of CD133+/CD34- sorting 
on tumorigenesis potential. These data may have implications for the gen-
eration of hES and iPS-derived NSC lines with improved safety and efficacy 
profiles for pre-clinical testing in neurological disease/injury indications.
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In vitro culturing of human embryonic stem cells (hESC) is a promising tool 
to explore the possibilities of using pluripotent cells for future medicine. The 
characterization and maintenance of cell pluripotency is of utmost impor-
tance during cultivation of cells and performing experiments. The hetero-
geneity of hESC culture due to spontaneous differentiation is a well-known 
fact, which can only be quantified at the level of single cell analysis. Here 
we used multicolor flow cytometry to detect simultaneously up to three 
pluripotency marker proteins in individual human embryonic stem cells. 
Fluorescence minus one (FMO) controls are widely suggested to use for 
multicolor experiments. We suggest to use an alternative control, where 
the specific isotype control antibody is added to the FMO control sample 
(FMOi). This type of control should be used in cases, when non-specific and 
specific antibody stainings show partially overlapping fluorescence signals. 
Nonpluripotent cells present within a pluripotent cell population can be also 
used as a negative control for antibodies to detect markers for pluripotency. 
In addition we also suggest an alternative gating approach to combine 
fluorescence intensities for a cell cycle marker (DNA stained with DAPI) 
and negative control for pluripotency marker on density-plot graphs. This 
enabled us to show, how nonspecific staining and autofluorescence increase 
as the cell cycle proceeds. To clarify the result, we used an “aslant” gating 
system for detecting antibody reaction adequately without counting possible 
false events in G1 or G2/M phases. We conclude that nonspecific binding 
should be carefully and critically controlled, when immunostaining of human 
embryonic stem cells is carried out.
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The extracellular matrix (ECM) protein Vitronectin is a promising candidate 
for creation of defined surfaces that support human embryonic stem cell 
(hESC) growth and maintenance. Vitronectin is a 75kDa ECM molecule that 
promotes cell spreading and adhesion through interactions with cell surface 
integrins. We have recently shown that hESC lines MEL1, MEL2 and HES3 
can be supported for greater than 10 passages on tissue culture plastic 
surfaces coated with a recombinantly produced VN fragment consisting of 
the somatomedin B domain and integrin associating RGD motif. HESC sup-
port on the VN fragment was equivalent in pluripotency marker expression, 
proliferation and differentiation potential compared to controls grown on 
the current ECM standard derived from an Engel-Breth-Holm Swarm mouse 
tumour (GeltrexTM). VN, through interactions with its known integrin 
binding partners (αVβ1, αVβ3, αVβ5, αVβ6, αVβ8, αIIbβ3) is known to 
influence differentiation, proliferation and cell survival in a variety of differ-
ent cell types however the downstream signaling pathways of VN in hESC 
have not yet been elucidated. For this paper, we initially screened changes in 
intracellular phosphorylated protein signaling between hESC grown on a re-
combinant VN fragment versus the less defined current standard GeltrexTM 
(Invitrogen). It was discovered in this initial screen that phosphorylation 
of tumour suppressor protein p53, was down regulated at three different 
locations, S15, S46 and S392 in cultures grown on VN. Here we report some 
preliminary investigations into changes in p53 phosphorylation on VN and 
the concomitant effects on cell survival and pluripotency. This research will 
have significant impact on optimization of defined culture processes result-
ing in effective scale-up of hESC for therapeutic applications.
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Small noncoding RNA molecules have emerged as a key post-translational 
regulator of gene expression in diverse species. In particular, microRNAs 
have been demonstrated to play an integral role as regulators of stem cell 
pluripotency, proliferation and differentiation. Novel technologies such as 
deep sequencing have enabled identification of 500-1000 novel microRNAs 
that may have regulatory roles in stem cell function. In mouse cells, mutant 
ESC lacking microRNAs have been utilized to link microRNAs with specific 
cellular responses. In this study we utilize a similar approach to create knock-
down of DGCR8, a key component in the microRNA biosynthesis pathway. 
The DGCR8 RNAi with a GFP cassette to aid visualization of transfected/
transduced cells was developed. Two gene delivery platforms were utilized: 
BacMam, an insect-based nonintegrating viral method known to achieve 
efficient gene delivery for transient expression into hard-to-transfect primary 
and stem cells and episomal vectors, EBV-based nonintegrating vectors that 
aids in rapid creation of pooled stable clones. DGCR8 RNAi was tested in 
Ntera2 human embryonal carcinoma cells, human embryonic stem cells 
(hESC) and human adipose derived mesenchymal stem cells (AdSC). Prelimi-
nary results indicated a decrease in endogenous levels of the DGCR8 level 
with RNAi expression in all the cells types. In the case of hESC and AdSC, 
distinct cellular phenotypes were noted in DGCR8 RNAi treated cells relative 
to control. Further analysis of global gene expression analysis together with 
miRNA expression patterns will allow confirmation of large numbers of mi-
croRNAs while linking the role of microRNAs to specific processes involved 
in stem cell maintenance and differentiation.
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Several markers for human embryonic stem cells (hESCs) have been identi-
fied. However, the function and molecular mechanisms underlying the 
unique properties of hESC are still poorly understood. The aim of our study 
is to elucidate the regulation of self-renewal and early differentiation of 
hESCs. For this purpose we have analyzed unpublished and published tran-
scriptome data on hESCs and their differentiated derivatives from altogether 
21 hESC lines. From this data we have identified the genes rapidly down-
regulated or induced during the early differentiation of different hESC lines. 
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Two novel candidate genes have been chosen for further functional studies 
to examine their importance in the hESC pluripotency maintenance.
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We have recently shown that laminin-511 alone can support long-term 
self-renewal of pluripotent human embryonic and iPS (hES/iPS) cells in a 
xeno-free cell culture environment. However, laminin-511 failed to permit 
stable survival of the cells after replating from single cell suspension. In the 
present study, we have produced recombinant human laminin-521, another 
laminin isoform expressed by pluripotent hES cells and a part of their natural 
niche. Laminin-521 was also shown to support self-renewal of hES cells in 
a completely defined, feeder-free and xeno-free cell culture system using 
TeSR2TM medium. Importantly, however, this laminin isoform allowed clonal 
survival of pluripotent hES cells after plating from single cell suspension, and 
subsequent long-term self-renewal at a stable rate higher than that of cells 
grown on Matrigel. The cells were passed every 10-12 days in 1:20-1:30 
ratios, cultured as monolayers for over 4 months exhibiting stable expres-
sion levels of pluripotency markers (Oct-4 and Nanog), after which the cells 
could develop teratomas in nude mice, containing cell lineages of all three 
germ layers. Pluripotency of the cells was also confirmed by embryoid body 
formation with subsequent immunofluorescence study. The pluripotent cell 
clonal survival was mediated via interaction with alpha6/beta1 integrin. This 
new chemically defined and xeno-free human pluripotent stem cell culture 
system may be particularly useful for producing large quantity of human 
stem cells for cell therapy. The method is also advantageous both timewise 
and laborwise, it is cost-effective and can be automated, and, thus, may 
provide significant economical benefits.
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Human embryonic stem cells (hESCs) possess the unique characteristic of 
indefinite self-renewal while retaining an undifferentiated state. The reasons 
for this may include the ability to preserve genomic integrity to a higher 
degree than somatic cells. Maintaining genomic integrity is vital for stem 
cells and their function as a primary progenitor, since mutations will severely 
compromise all derived cell lineages. The pathways controlled by the ataxia 
telangiectasia-mutated (ATM) and ATM-related (ATR) proteins represent the 
principal pathways by which cells react to DNA damage in somatic cells. The 
mechanisms that protect the genome in proliferating hESCs are minimally 
understood. Here, we investigated how WA09 hESC line react to replication 
mediated double-strand DNA breaks induced by camptothecin (CPT). Com-
ponents of the ATM/p53/p21 pathway were studied. Immunofluorescence 
microscopy revealed the presence of phosphorylated ATM and gamma-
H2AX in CPT treated hESCs. A significant decrease in gamma-H2AX foci 
was observed by treatment with PI3KK inhibitors (caffeine and KU55933). A 
marked induction of p21WAF1 mRNA levels was determined by qRT-PCR, 
while p27Kip1 and p57Kip2 transcripts abundance remained unaffected. 
Importantly, the mRNA levels of Skp2, a member of the SKP1/CUL1/F-box 
protein complex involved in ubiquitination and proteasomal degradation of 
p21WAF1, p27Kip1 and p57Kip2 , were reduced upon CPT induced DNA 
damage. Collectively, our findings demonstrate that the ATM checkpoint 
signaling cascade is intact in pluripotent hESCs and provide insights into 
pathways that are activated in human embryonic stem cells upon DNA insult 
to support development and tissue regeneration.
Poster Board Number: 3544
NUCLEOTIDE-LEVEL RESOLUTION OF LIN28 
RNA BINDING SITES REVEALS A NETWORK OF 
POST-TRANSCRIPTIONAL CONTROL IN HUMAN 
EMBRYONIC STEM CELLS
Wilbert, Melissa L., Liang, Tiffany Y., Vu, Anthony Q., Chen, Stella 
X., Massirer, Katlin B., Yeo, Gene W.
Biomedical Sciences, University of California, San Diego, La Jolla, CA, USA
Post-transcriptional control of gene expression is increasingly recognized 
as critical in the maintenance of pluripotency and differentiation of human 
embryonic stem cells (hESCs). The RNA binding protein LIN28 is important 
for the survival and growth of pluripotent cells and increases the efficiency 
of reprogramming of somatic cells into induced pluripotent stem cells. Ad-
ditionally, LIN28 has been shown to be overrepresented in primary tumors 
and cancer cell lines. However, the mechanism by which LIN28 exerts these 
effects remains unknown. Recent studies using standard immunoprecipita-
tion techniques have shown LIN28 to associate with hundreds of RNA tran-
scripts, and yet the impact of this binding on translation has been validated 
for fewer than a dozen genes. We hypothesize that revealing the direct RNA 
targets of LIN28 at nucleotide-level resolution, coupled with high-through-
put functional assays to reveal the consequences of this binding, will lead 
to a greater understanding of the molecular function of this protein. Using 
UV cross-linking and immunoprecipitation of the LIN28 protein followed 
by high-throughput sequencing (CLIP-seq) we have identified direct LIN28 
binding regions on thousands of target RNAs in hESCs. Strikingly, despite 
differences in cell types, we can recapitulate our CLIP-seq results using an 
antibody against the V5 tag of a LIN28-v5 fusion protein stably expressed in 
human 293FRT cells. We demonstrate that LIN28 preferentially binds coding 
exons and 3’ untranslated regions (3’ UTRs) within target genes. Gene on-
tology analyses have revealed that LIN28 targets are enriched for compo-
nents of the translational machinery and RNA binding proteins, in particular, 
factors that control alternative splicing. To elucidate the downstream impact 
of LIN28 modulation on alternative splicing, we are using custom-designed 
splicing-sensitive microarrays. To confirm the impact of LIN28 on identified 
RNA binding targets, we are applying RNA-seq, ribosomal profiling and 
proteomics techniques. This work represents the first combination of these 
approaches for the study of an RNA binding protein. We expect that the 
results of these experiments will reveal the global effect of LIN28 binding 
on transcript stability and translational state of target mRNAs. Our findings 
will provide insight for the improvement of reprogramming and the role of 
LIN28 in cancer.
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NPR-C IS REQUIRED FOR SURVIVAL OF 
MURINE EMBRYONIC STEM CELLS
Abdelalim, Essam M., Tooyama, Ikuo
Molecular Neuroscience Research Center, Shiga University of Medical 
Science, Otsu, Japan
Growth of embryonic stem (ES) cells as a pluripotent population requires a 
balance between survival, proliferation and self-renewal signals. Recently, 
we found that natriuretic peptides are expressed in ES cells and they play 
important roles in ES cell self-renewal. Here we report a novel role for 
natriuretic peptide receptor-C (NPR-C) in the survival of murine ES cells. We 
found that NPR-C was expressed in undifferentiated ES cells and down-
regulated precisely during ES cell differentiation at both mRNA and protein 
levels. Furthermore, NPR-C was co-expressed with Oct-4 in the blastocyst 
inner cell mass (ICM). A small interfering RNA (siRNA)-based technique was 
employed to specifically knockdown NPR-C gene in the undifferentiated ES 
cells that were maintained in a feeder-free culture. Abrogation of NPR-C 
signaling had no effect on the undifferentiated status of the ES cells, as 
determined by morphologic examination and confirmed by measurements 
of alkaline phosphatase activity and the expression of the pluripotent ES 
cell markers (Oct-4 and nanog). However, knockdown of NPR-C resulted in 
apoptotic cell death, and induction of p53. Conversely, chemical inhibition 
of p53 significantly reduced apoptosis in NPR-C-deficient cells. Treatment 
of murine ES cells with a selective NPR-C ligand, prior to H2O2 exposure 
conferred protective effect against oxidative stress-induced apoptosis in dose 
dependent manner. Activation of p53 by DNA damaging agents results in 
suppression of Nanog expression, which was blocked by the pretreatment 
with NPR-C agonist. These findings establish the presence of functional 
NPR-C in ES cells maintaining their survival through regulation of p53 levels. 
Thus, NPR-C is required to control DNA damage-induced p53 levels for 
sustainable ES cell self-renewal.
Poster Board Number: 3548
MODELLING MOUSE EMBRYONIC STEM CELL 
SELF-RENEWAL AT DIFFERENT O2 LEVELS 
USING A FACTORIAL DESIGN APPROACH
Barbosa, Hélder S C, Fernandes, Tiago G., Diogo, Maria M., Cabral, 
Joaquim M S
Dept of Bioengineering, Institute for Biotechnology and Bioengineering 
(IBB), Centre for Biological and Chemical Engineering, Instituto Superior 
Técnico, Lisboa, Portugal
Mouse embryonic stem (mES) cells can self-renewal in feeder-free culture 
conditions via activation of STAT3 signalling by the leukemia inhibitor factor 
(LIF) and via Smad pathway activation by the bone morphogenetic protein 
(BMP-4). Alternatively, undifferentiated mES cells can be expanded indepen-
dently of the activation of the STAT3/Smad signalling via the inhibition of 
the mitogen-activated protein kinase (MAPK, MEK/ERK signaling pathway) 
and inhibition of the glycogen synthase kinase 3β (GSK-3β) using the small 
molecules PD0325901 and CHIR99021, respectively. 
Work previously performed in our group showed that culturing mES cells 
under different oxygen tensions gave origin to different cell proliferation 
patterns and commitment stages dependent on which signalling pathways 
are activated/inhibited to support mES cells self-renewal. These results show 
that mES cell self-renewal and pluripotency, can be differently influenced 
by the O2 tension levels according to the effect exerted by this culture 
parameter towards the different signalling pathways. To further investigate 
these effects more systematically, the sole and interactive influence of each 
one of the small molecules used for the inhibition of MEK/ERK pathway 
(PD0325901, at 0, 0.4 and 0.8 μM), activation of Wnt/β-Catenin path-
way through the inhibition of GSK-3β (CHIR99021, at 0, 3 and 6 μM) and 
activation of the STAT3 signalling (LIF, at 0, 500 and 1000 U/mL), was 
statistically evaluated for the ex vivo expansion of 46C mES cells. Both the 
cumulative fold increase (CUM_FI) after 5 consecutive passages (10 days) 
and the colony forming efficiency were used as the read-out for this system-
atic study. A two-level face-centered cube design experiment was performed 
at 2 and 20% oxygen levels using as basal medium the knockout Dulbecco’s 
modified eagle’s medium (DMEM; Gibco) supplemented with 15% (v/v) 
knockout serum-replacement. Our results reinforce that LIF/STAT3 signaling 
pathway has a central role in maintaining mES cell proliferation at normoxic 
conditions. Hypoxia reduces significantly the cumulative fold increase of 
these cells, which accomplish its maximum CUM_Fi at 2% O2 when the 
Wnt/β-Catenin pathway is activated in the presence of LIF. In addition, we 
showed that we could propagate mES cells with complete bypass of the 
MEK signaling pathway. Our study also suggests that mES cells pluripotency 
is maximized, as evaluated by the clonal efficiency assay, only when either 
the MEK signaling or the Wnt/β-Catenin pathway are activated in normoxia 
in the presence of LIF. This suggests that the MEK /ERK signaling inhibition 
might interact upon the activation of Wnt/β-Catenin pathway promoting 
the improvement of mouse ES cell pluripotency in normoxia. At lower O2 
tensions, however, STAT3 signaling and Wnt/β-Catenin are the two main 
and indispensable signaling pathways required for mES cell self-renewal 
and pluripotency. Collectively, the present data adds new insights into the 
mechanisms by which the oxygen tension influences mES cell self-renewal 
and pluripotency while distinct pathways are activated/inhibited. Wnt/β-
Catenin, in particular, has an important reported role towards maintenance 
of both mouse and human ES cell pluripotency, which increases the possibil-
ity of translating these findings to human pluripotent stem cells envisaging 
the maximization of cell yield.
Poster Board Number: 3550
FOLLISTATIN ISOFORMS REGULATE MOUSE 
EMBRYONIC STEM CELL SELF-RENEWAL
Lin, Shyr-Yeu1, Chiou, Chih-Yung2, Wei, Cheng-Hung2, Chiu, Yu-
Tien2, Peng, Jia-Chi2, Wang, Shih-Chung2
1Stem Cell Lab, Dept of Medical Research; Dept of Obstetrics and 
Gynecology, Mackay Memorial Hospital, Taipei, Taiwan, 2Stem Cell Lab, 
Dept of Medical Research, Mackay Memorial Hospital, Taipei, Taiwan
Introduction: Follistatin (fst) is a protein that is able to bind and antagonize 
members of TGF-β superfamily, including activins and bone morphogenetic 
proteins (BMP). As activins and BMPs play an important role in embryonic 
stem (ES) cell self-renewal and pluripotency, it is likely that follistatin is also 
involved in these important characteristics of ES cells. Follistatin isoforms 
arise from alternative pre-mRNA splicing and proteolytic cleavage and exist 
as three isoforms (i.e., fst288, fst303 and fst315) differing in length at the 
C terminus. In this work, we try to delineate the roles of follistatin isoforms 
in mouse ES cell self-renewal and pluripotency. Methods: We constructed 
four fst isoform-specific transgenes (fst288, fst303, fst315 and fst-myc), 
which are drived by the EF1 promoter and can consistently overexpress fol-
listatin isoform 288, 303 and 315, respectively. The fst-myc was fst315 with 
a myc-tag linked at its C terminus, which design may be able to prevent 
fst315 from proteolysis into fst303 in vivo. Mouse ES cells were transfected 
with these four transgenes individually by electroporation, and then stable 
clones were screened. To test the influence of follistatin isoforms on self-
renewal, mouse ES cell clones were cultivated in various conditions with 
different growth factors. During cultivation, the percentage of Oct4 positive 
ES cells was determined by flow cytometry. In the meanwhile, expression 
levels of self-renewal marker genes (Oct4, Nanog, Rex1, Sox2 and alkaline 
phosphatase) were evaluated by qRT-PCR. Passage survival of different 
ES cell clones under various conditions was also observed. Assessments of 
cell proliferation and apoptosis were performed by flow cytometry for cell 
counting, BrdU incorporation, Annexin V-7 ADD staining and TUNEL. To 
determine the effect of follistatin isoforms on pluripotency, embryoid body 
(EB) differentiation (day 0, 3, 9, 15 21 and 27) was made. The samples were 
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then used for analyses of early and late endodermal, mesodermal and ecto-
dermal markers by qRT-PCR and immunostaining. Studies into the potential 
interaction of follistatin isoforms with specific signalings (LIF, BMP, Act, 
PI3K/Akt and Wnt) were conducted by Western blots. Results: In the pres-
ence of LIF but without feeders, fst288, fst303, fst315 and fst315myc can 
be propagated for 4 passages, compared with mES that can be propagated 
for at least 6 passages. Follistatin isoforms assume different effects on prolif-
eration. Follistatin isoforms appear to reduce apoptosis of mouse ES cells in 
absence of LIF and serum. Follistatin isoforms did not block the endodermal, 
mesodermal, or ectodermal commitments, however, with different extents 
of diverse gene expressions during EB differentiation. Conclusions: Follistatin 
isoforms regulate mouse ES cell self-renewal and pluripotency with distinct 
responses to different culture conditions.
Poster Board Number: 3552
A GENOME-SCALE SIRNA SCREEN IDENTIFIES 
NOVEL REGULATORS OF PLURIPOTENCY AND 
DIFFERENTIATION IN NANOG-REPORTER 
MOUSE EMBRYONIC STEM CELLS UNDER 
DIFFERENTIATION CONDITIONS
Gingold, Julian A., Lee, Dung-Fang, Lau, Wingshan, Zhou, 
Hongwei, Felsenfeld, Dan, Schaniel, Christoph, Lemischka, Ihor
Mount Sinai School of Medicine, New York, NY, USA
In order to better understand the molecular basis of stem cell pluripotency 
while using an unbiased and comprehensive approach, we used a genome-
scale siRNA library to screen for genetic pathways critical for maintaining 
pluripotency and differentiation in mouse embryonic stem (ES) cells. Because 
of its critical role in regulating and maintaining pluripotency and the lack of 
genome-scale studies on modulators of the particular gatekeeper Nanog, we 
utilized a Nanog-promoter GFP-reporter transgenic mouse ES cell line. In or-
der to permit a two-way readout to screen for pathways that either enhance 
or block differentiation, we carried out our siRNA screen in the presence of 
mild differentiation conditions containing low concentrations of the mor-
phogen retinoic acid, permitting primarily neuronal cell fates. We utilize a 
novel cell-level analysis to explain the effect of an siRNA pool targeting one 
specific gene of the distribution of fluorescence. Our principal-component-
based analyses directly identify novel genes which affect ES cell pluripotency 
characteristics in the Nanog reporter system as well as genes which might 
affect the distribution of fluorescence without affecting the average level in 
a population of cells. Our screen results correlate well with published work 
and identify numerous previously characterized pluripotency mediators as 
well as novel regulators. We are in the process of validating these hits, first 
by assaying the candidate hit genes in a demultiplexed arrayed plate with 
one siRNA targeting each gene in our existing reporter, followed by im-
munostaining for additional pluripotency regulators and lineage markers. In 
parallel, we are constructing inducible shRNAmir lentiviruses to downregu-
late candidate genes as well as inducible overexpression systems, focusing 
on related genes with strong and opposite effects on the reporter in the 
primary screen or genes with differential expression or promoter occupancy 
in the differentiated versus undifferentiated state. Collectively, such systems 
will allow us to characterize the genetic and epigenetic profile of an ES cell in 
response to multiple mediators of differentiation and inform our understand-
ing of embryonic development and the regulation of pluripotency.
Poster Board Number: 3554
INVESTIGATION OF STEM CELL SPECIFIC 
MIRNA EXPRESSION IN MOUSE AND RABBIT 
EMBRYONIC STEM CELLS
Gocza, Elen, Lichner, Zsuzsanna, Maraghechi, Pouneh, Hiripi, 
Laszlo, Toth, Gabor, Bosze, Zsuzsanna
Agricultural Biotechnology Center, Godollo, Hungary
miRNAs are emerging regulators of gene expression, predicted to target 
about one third of all human genes. Structurally, miRNAs are short, 22-26 nt 
single stranded RNA molecules. Though they have been described to regu-
late gene expression at multiple levels, in mammalian cells they mainly act 
by blocking the translation of mRNAs (targets) with partially complementer 
recognition sequences in their 3’ UTR. Embryonic stem (ES) cell-specific 
miRNAs are abundant in the pluripotent stem cells, but rapidly disappear 
during differentiation. Using conditional knock-out ES cell lines, disrupted 
in miRNA biogenesis (Dicer and DGCR8 knock-out ES cell lines), it is now 
evident that miRNA pathway is a compulsory regulator of pluripotency. 
miRNAs are inevitable for the maintenance of high proliferation and the cell 
cycle phase distribution, characteristic to pluripotent ES cells. Moreover, it 
is now clear that ES-specific miRNA promoters are regulated by common 
stem cell markers, such as Oct4, Sox2 and Nanog. On the other hand, ESC-
specific miRNAs can directly target these transcription factors, establishing a 
complete negative feedback loop, which is a key regulator of pluripotency 
maintenance. The best studied ES cell-specific miRNAs are: miR302-367, 
miR-371-373 and miR-512-519 family in human ESCs; and miR-290-295 
family in mice. Initially, our experiments focused on the functional charac-
terization of miR-290-295 cluster. We provide evidence that mouse ES cell 
lines, stably overexpressing miR-290-295 cluster, have increased rate of 
cell proliferation and colony formation. We have also shown that miR-290-
295 overexpression interferes with early differentiation events. Our results 
suggest that the cluster regulates cell cycle at multiple steps (G1-S transition 
and G2-M transition), by directly inhibiting the translation of at least two 
cell cycle regulators: Fbxl5 and Wee1. In summary, we suggest that miR-
290-295 cluster is an important regulator of pluripotency maintenance and 
exerts its effect by directly inhibiting several cell cycle suppressors. Lately 
we extended our research interest towards rabbit derived ESCs and early 
embryos. Rabbit ESCs present high expression of a miR-302a, miR-302b 
and miR-367 while miR-294 expression is somewhat lower. We could not 
detect mature miR-290, miR-295, miR-371 or miR-373 miRNAs, using the 
primers optimized for mouse of human sequences, probably because of the 
inadequate sequence similarities. The SOLiD Sequencing System allowed us 
to identify numerous miRNAs that are specific for rabbit ES cells. The newly 
described miRNAs have already been validated on rabbit embryos and ES 
cells. We anticipate that knowing the miRNA signature of rabbit ES cells will 
explain and solve the problem of ES cell isolation from different species. To 
this end, we will also explore the stemness related targets of miR-302-367 
and miR-290-295 families; including in silico analysis and target validation 
with luciferase assay and at protein level via Western blot analysis or ELISA.
Poster Board Number: 3556
WNT/β-CATENIN SIGNALING NEGATIVELY 
REGULATES ERK PATHWAY IN MOUSE 
EMBRYONIC STEM CELLS
Hirano, Kazumi, Sasaki, Norihiko, Nishihara, Shoko
Dept of Bioinformatics, Soka University, Tokyo, Japan
Several signaling cascades as well as the expression of intrinsic factors, such 
as Oct3/4 and Nanog, maintain self-renewal and pluripotency of embryonic 
stem cell (ESC). The signaling cascades are activated by extrinsic factors, 
such as LIF, BMP and Wnt. Heparan sulfate (HS) is a ubiquitous component 
of proteoglycans in the extracellular matrix and on the cell surface. HS 
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polysaccharide chains are attached covalently to Ser residues in core proteins 
through the linkage tetrasaccharides, GlcAβ1-3Galβ1-3Galβ1-4Xyl. HS are 
synthesized in the Golgi apparatus by several enzymes, including members 
of the EXT protein family, which elongate HS chain by adding repeat-
ing disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine, 
(-4GlcAb1-4GlcNAcα1-)n. These repeating units are then modified by sul-
fates and are known to play crucial roles in regulating several signaling cas-
cades. Previously, we have demonstrated that Wnt signaling was reduced by 
knockdown of EXT1 in mouse ESCs (mESCs) and that, subsequently, spon-
taneous differentiation into extraembryonic endoderm was induced. FGF4 
signaling has been reported to trigger the induction to the differentiation 
in mESCs. To clarify the mechanism of spontaneous differentiation in EXT1 
knockdown cells, we analyzed the responsivity of EXT1 knockdown cells to 
exogenous FGF4 and found that their responses to FGF4 stimulation did not 
change as compared with that of control cells. Surprisingly, internal activa-
tion of ERK was higher in EXT1 knockdown cells than control cells. There-
fore, we hypothesized that the activation of ERK in EXT1 knockdown cells 
induces spontaneous differentiation. To test this hypothesis, we added the 
MEK inhibitor to EXT1 knockdown cells and made their ERK phosphorylation 
decrease. Then self-renewal of EXT1 knockdown cells was restored. These 
results indicated that spontaneous differentiation was caused by activation 
of ERK pathway. The only Wnt/β-catenin signaling was down-regulated in 
EXT1 knockdown cells. Hence, ERK pathway was activated and spontane-
ous differentiation was induced because of the reduction of Wnt/β-catenin 
signaling. We propose that Wnt/β-catenin signaling negatively regulates 
ERK pathway in mESCs and HS chains are involved in this regulation.
Poster Board Number: 3558
SHEAR STRESS IN STIRRED SUSPENSION 
BIOREACTORS INFLUENCES PLURIPOTENCY OF 
MURINE EMBRYONIC STEM CELLS
Gareau, Tia1, Lara, Giovanna2, Shepherd, Robert D.2, Krawetz, 
Roman3, Rancourt, Derrick3, Rinker, Kristina D.2, Kallos, Michael S.1
1Pharmaceutical Production Research Facility (PPRF), University of Calgary, 
Calgary, AB, Canada, 2Cellular and Molecular Bioengineering Research 
Laboratory (CMBRL), University of Calgary, Calgary, AB, Canada, 3Dept of 
Biochemistry and Molecular Biology, University of Calgary, Calgary, AB, 
Canada
Pluripotent embryonic stem cells (ESCs) have been used increasingly in re-
search as primary material for various tissue engineering applications. Pluri-
potency, or the ability to give rise to any cells of the body, is an important 
characteristic of ESCs. Traditional methods use leukemia inhibitory factor 
(LIF) to maintain murine ESC (mESC) pluripotency in static and bioreactor 
cultures. When LIF is removed from mESCs in static culture, pluripotency 
genes are down-regulated and the cultures will spontaneously differentiate. 
However, recently, we showed that shear forces experienced by mESCs in 
suspension bioreactors may influence pluripotency. Experiments conducted 
within suspension bioreactors indicated that pluripotency gene expression 
was maintained during differentiation experiments in the absence of LIF. This 
is undesired in a differentiation experiment where the goal is down-regula-
tion of pluripotency gene expression and up-regulation of gene expression 
characteristic to the differentiation. Thus, the objective of this study was 
to examine how effectively different levels of shear (6 dyne/cm2, 3 dyne/
cm2) maintained and rescued mESC pluripotency in suspension bioreactors. 
Pluripotency markers, Oct-4, Nanog, Sox-2, and Rex-1, were assessed using 
gene expression profiles and flow cytometry analysis and showed that shear 
does maintain and rescue the gene expression of certain pluripotency mark-
ers. For example, in the shear maintenance experiment derived from static 
cultures, the gene expression of Rex-1, and Sox-2 were effectively main-
tained by both levels of shear stress. Overall, this study provides a better un-
derstanding of the environmental conditions within suspension bioreactors, 
and specifically how different levels of shear affect the pluripotency of ESCs.
Poster Board Number: 3560
COOPERATION OF PKA/RHOA AND EPAC/
RAP1 SIGNALING IN 8-BROMO CAMP-
INDUCED CX43 PHOSPHORYLATION IN MOUSE 
EMBRYONIC STEM CELLS
Kim, Mi Ok, Park, Jae Hong, Yun, Seung Pil, Seo, Bit Na, Park, Su 
Shin, Jeon, Ji Hoon, Han, Ho Jae
College of Veterinary Medicine, Chonnam National University, Gwangju, 
Korea, Republic of
Gap junctions play multiple essential roles in cell homeostasis and connexin 
(Cx) phosphorylation affects both the structure and function of Cx43 and 
leads to changes in localization, interacting protein partners and chan-
nel selectivity in response to many different kinases. However, the impact 
signaling in response to cAMP stimuli is less well understood in embryonic 
stem (ES) cells. Thus, we examined effect of 8-Bromo (8-Br) cAMP on 
Cx43 phosphorylation of ES cells and its related signaling pathways. 8-Br 
cAMP increased Cx43 phosphorylation and decreased Cx43 protein level in 
plasma membrane compartment. Moreover, 8-Br cAMP inhibited transfer 
of Lucifer yellow to neighboring cells in a scrape loading/dye transfer (SL/
DT) assay. Thus, we further examined the molecular mechanisms respon-
sible for the phosphorylation of Cx43 by 8-Br cAMP. 8-Br cAMP stimulated 
PKA/Rho A and Epac/Rap1 signaling pathways, respectively. Moreover, 
inhibition of either Rho A or Rap1 signaling pathway partially blocked 
8-Br cAMP-induced Cx43 phosphorylation and decrease of Cx43 protein 
level in membrane compartment, but both inhibition completely blocked. 
Furthermore, 8-Br cAMP-induced Cx43 phosphorylation and Cx43 protein 
endocytosis disrupted interaction of Cx43 with tight junctional proteins 
such as occludin, claudin, and Zo-1 or adherent junctional proteins such 
as catenin and E-cadherin in plasma membrane compartment, which were 
mediated by Rho A and Rap1 signaling pathways. This suggests that Cx43 
structural changes are contributed to cell adhesion formation. In conclusion, 
8-Br cAMP stimulated Cx43 phosphorylation via PKA/Rho A and Epac/Rap1 
signaling pathways, which regulated ES cell adhesion.
Poster Board Number: 3562
MAINTENANCE OF GENOMIC IMPRINTING IN 
MOUSE EMBRYONIC STEM CELLS
Li, Xiajun
Developmental and Regenerative Biology, Mount Sinai School of Medicine, 
New York, NY, USA
Zfp57 is highly expressed in undifferentiated ES cells and down-regulated 
during ES cell differentiation. It encodes a KRAB zinc finger protein and is 
conserved between mouse and human. Previously, we found that Zfp57 is 
a maternal-zygotic effect gene and is required for the maintenance of DNA 
methylation imprints in mouse embryos. Interestingly, ZFP57 was shown to 
be associated with an imprinted domain in ES cells in a chromatin immuno-
precipitation (ChIP) assay. Indeed, our recent data indicate that loss of Zfp57 
in ES cells results in loss of DNA methylation genomic imprints at a large 
subset of imprinted regions, including the Dlk1-Dio3 imprinted domain. 
Zfp57 is also required for the maintenance of genomic imprinting in mouse 
ES cells directly derived from blastocysts. Our results have confirmed that 
Zfp57 is an important regulator of genomic imprinting in ES cells. Intriguing-
ly, improper expression of the imprinted genes at the Dlk1-Dio3 imprinted 
domain is the notable epigenetic defect present in a majority of mouse 
iPS cell lines. We are developing several different strategies to examine if 
genomic imprinting can be manipulated in ES cells and iPS cells via Zfp57-
mediated regulation.
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A PANORAMIC VIEW OF NON-
POLYADENYLATED TRANSCRIPTION IN MOUSE 
ESC AND NPC REVEALS NOVEL NON-CODING 
RNA RELATED TO PLURIPOTENCY AND 
DIFFERENTIATION
Livyatan, Ilana1, Duttagupta, Radha2, Gingeras, Thomas R.3, 
Meshorer, Eran1
1Hebrew University of Jerusalem, Jerusalem, Israel, 2Affymetrix Inc., Santa 
Clara, CA, USA, 3Cold Spring Harbor Laboratory, New York, NY, USA
Hypertranscription in ESCs is a characteristic underlying the pluripotent 
nature of these cells. Yet, this characterization results mainly from the 
examination of the polyadenylated fraction of cellular RNA, while the non-
polyadenylated (NPA) fraction remains largely unexplored. However, the 
NPA RNA superfamily, which is mainly comprised of fundamental compo-
nents of the RNA translational machinery, the RNA splicing machinery, and 
RNA-RNA or RNA-DNA interacting complexes, has every potential to par-
ticipate in the regulation of pluripotency and stem cell fate. We conducted 
a comprehensive analysis of the transcriptive nature of NPA RNA in murine 
ESCs and ESC-derived Neural Progenitor Cells (NPCs) using a combination 
of whole genome tiling arrays and Next Generation Sequencing technolo-
gies. This strategy allowed for the transcriptional characterization of already 
well-defined NPA RNA subclasses in this unique biological context as well as 
the identification of many new members of these functional ncRNA classes. 
In addition, many novel, conserved, and differentially expressed NPA RNAs 
were detected, providing the first evidence of a novel group of potentially 
functional ncRNAs involved in the regulation of pluripotency and stem cell 
fate.
Poster Board Number: 3566
LACDINAC CARBOHYDRATE STRUCTURE 
CONTRIBUTES TO SELF RENEWAL OF MOUSE 
EMBRYONIC STEM CELLS BY REGULATING LIF/
STAT3 SIGNALING
Sasaki, Norihiko, Hirano, Kazumi, Nishihara, Shoko
Bioinformatics, Soka University, Hachioji, Japan
Self-renewal of mouse embryonic stem cells (mESCs) is maintained by leu-
kemia inhibitory factor (LIF)/STAT3 signaling. However, this signaling control 
does not function in mouse epiblast stem cells (mEpiSCs) or human ESCs 
(hESCs), including human induced pluripotent stem cells (hiPSCs). The un-
derlying molecular mechanisms that determine this differential LIF-respon-
siveness have not been clarified yet. Several types of glycan are expressed 
on the cell surface and contribute to biologically important functions such 
as the regulation of signaling pathways. The expression patterns of several 
cell surface glycans have now been described in undifferentiated and dif-
ferentiated mESCs and hESCs. However, their functional roles have not been 
demonstrated with the exception of heparan sulfate. Therefore, to identify 
glycans that were essential for ESC self-renewal, we performed an RNA 
interference (RNAi) screen using short hairpin RNAs (shRNAs) that targeted 
specific glycan-related genes in mESCs by evaluation of alkaline phosphatase 
activity. Then we found that the cell surface glycan LacdiNAc (GalNAcβ1-
4GlcNAc) is required for LIF/STAT3 signaling. LacdiNAc is frequently present 
on glycoproteins and glycolipids in invertebrates but is only present on a 
limited number of glycoproteins and glycolipids, such as glycoprotein hor-
mones, in vertebrates. The roles of LacdiNAc in mammalian cells have not 
been fully understood. Undifferentiated state mESCs expressed LacdiNAc at 
a higher level than differentiated state cells. Knockdown of β4GalNAc-T3 
reduced LacdiNAc expression and caused a decrease in LIF/STAT3 signal-
ing that lessened the rate of self-renewal of mESCs. A biochemical analysis 
showed that LacdiNAc expression on LIFR and gp130 was required for the 
stable localization of the receptors with lipid raft/caveolar components, such 
as caveolin-1. This localization is required for transduction of a sufficiently 
strong LIF/STAT3 signal. In primed state pluripotent stem cells, such as 
hiPSCs and mEpiSC-like cells produced from mESCs, LacdiNAc expression 
on LIFR and gp130 was extremely weak and the level of localization of 
these receptors on rafts/caveolae was also low. Furthermore, knockdown 
of β4GalNAc-T3 decreased LacdiNAc expression and reduced the efficiency 
of reversion of primed state mEpiSC-like cells into naïve state mESCs. These 
findings demonstrate that the different LIF-responsiveness of naïve state 
(mESCs) and primed state (mEpiSCs, hESCs, hiPSCs) cells is dependent upon 
the expression of LacdiNAc on LIFR and gp130 and that this expression is 
required for the induction and maintenance of the naïve state.
Poster Board Number: 3568
RAD21 COOPERATES WITH PLURIPOTENCY 
TRANSCRIPTION FACTORS IN THE 
MAINTENANCE OF EMBRYONIC STEM CELL 
IDENTITY.
Nitzsche, Anja1, Paszkowski-Rogacz, Maciej1, Stunnenberg, Hendrik 
G.2, Buchholz, Frank1
1Buchholz, Max Planck Institute CBG, Dresden, Germany, 2Molecular 
Biology, Nijmegen Centre for Molecular Life Sciences, Nijmegen, 
Netherlands
For self-renewal, embryonic stem cells (ESCs) require the expression of 
specific transcription factors accompanied by a particular chromosome 
organization to maintain a balance between pluripotency and the capacity 
for rapid differentiation. However, how transcriptional regulation is linked 
to chromosome organization in ESCs is not well understood. We show that 
the cohesin component RAD21 exhibits a functional role in maintaining ESC 
identity through association with the pluripotency transcriptional network. 
ChIP-seq analyses of RAD21 reveal an ESC specific cohesin binding pattern 
that is characterized by CTCF independent co-localization of cohesin with 
pluripotency related transcription factors Oct4, Nanog, Sox2, Esrrb and Klf4. 
Upon ESC differentiation, most of these binding sites disappear and instead 
new CTCF independent RAD21 binding sites emerge, which are enriched for 
binding sites of transcription factors implicated in early differentiation. Fur-
thermore, knock-down of RAD21 causes expression changes that are similar 
to expression changes after Nanog depletion, demonstrating the functional 
relevance of the RAD21 - pluripotency transcriptional network association. 
Finally, we show that Nanog physically interacts with the cohesin or cohesin 
interacting proteins STAG1 and WAPL further substantiating this association. 
Based on these findings we propose that a dynamic placement of cohesin by 
pluripotency transcription factors contributes to a chromosome organization 
supporting the ESC expression program.
Poster Board Number: 3570
REVERSION OF MOUSE EPIBLAST STEM 
CELLS TO NAIVE PLURIPOTENT CELLS BY 
EXOGENOUS REACTIVATION OF DOWN-
REGULATED SIGNALING PATHWAYS
Onishi, Kento1, Tonge, Peter D.2, Nagy, Andras2, Zandstra, Peter 
W.1
1Institute of Biomaterials and Biomedical Engineering, University of 
Toronto, Toronto, ON, Canada, 2Samuel Lunenfeld Research Institute, 
Toronto, ON, Canada
Mouse embryonic stem cells (mESCs) and mouse epiblast stem cells (EpiSCs) 
are pluripotent stem cells that are derived from developmentally related 
tissues in the early mouse blastocyst. In vitro, mESCs and EpiSCs are capable 
of transitioning bidirectionally. Going forward, mESCs can readily differenti-
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ate into culture derived EpiSCs (CDEs) upon mimicking in vivo conditions 
(i.e. 3D structure + FGF signaling) and subsequent culture in EpiSC-specific 
media (Activin A + bFGF or AF media). Reprogramming EpiSCs to mESCs-
like cells, however, requires overexpression of transgenes. Alternatively, 
transgene-free reprogramming of EpiSCs can occur on a layer of feeder cells 
where JAK-STAT signaling plays an important role. However the mecha-
nisms facilitating this rare reprogramming event remain obscure. We have 
previously demonstrated that the JAK-STAT pathway in mESCs functions 
as a feed-forward autoregulatory loop. Interestingly, upon differentiation 
to CDEs, mESCs lose responsiveness to leukemia inhibitory factor (LIF) due 
primarily to downregulation of its receptors, LIF-R and gp130 (10-fold and 
3-fold respective decrease by qRT-PCR), and subsequent degradation of 
activated (i.e. phosphorylated) STAT3 (pSTAT3). We hypothesized that re-
activation of STAT3 by bypassing its dependence on LIF-R would enable re-
programming of EpiSCs to naïve mESC-like cells. Indeed, bypassing LIF-R by 
using IL-6 along with its soluble receptor, sIL-6Rα, increased pSTAT3 levels 
in regions of high local cell density. We were also able to obtain, from this 
pre-treatment, reverted colonies at low frequency (1 for every 75,000 cells 
seeded) when placed in defined feeder-free naïve mESC media (2i + LIF me-
dia). We further hypothesized that an increase in local cell density leads to a 
concomitant increase in both the proportion of LIF responsive cells and the 
frequency of reversion. Consistent with this, we observed increased local cell 
density, LIF responsiveness, and reversion frequencies in CDEs cultured on 
feeders (MEFs). We next controlled local cell density by micropatterning (μP) 
CDEs in the absence of feeders and observed an increase in LIF responsive-
ness and importantly, in frequency of reversion (3 colonies for every 10,000 
cells seeded), demonstrating the ability to recapitulate conditions seen on 
MEFs. The reverted cells displayed gene expression profiles and protein lev-
els comparable to mESCs but not CDEs, and were able to generate chimeras 
when injected into host blastocysts. The increase in local cell density leads 
to an increase in LIF responsiveness in part due to accumulation of local 
gp130 ligands, as inhibition of JAK-STAT signaling on μP colonies abolishes 
LIF responsiveness. Our findings suggest controlling local cell density, and 
its resultant autocrine and paracrine signaling, facilitates reprogramming of 
EpiSCs through reactivation of suppressed JAK-STAT signaling, demonstrat-
ing for the first time efficient feeder and transgene-free reversion. More 
generally, these results demonstrate that transitions between closely related 
cell types may be accessible via exogenous reactivation of differentiation-
induced downregulation of signaling pathways.
Poster Board Number: 3572
FIBRONECTIN STIMULATES CELL MIGRATION 
THROUGH NHE-1 ACTIVATION VIA CAVIN-1 
AND CALMODULIN COMPLEX IN MOUSE 
EMBRYONIC STEM CELLS
Park, Jae Hong, Seo, Bit Na, Jeon, Ji Hoon, Park, Su Shin, Han, Ho 
Jae
Dept of Veterinary Physiology, Biotherapy Human Resources Center (BK21), 
College of Veterinary, Gwangju, Korea, Republic of
Recent works have focused on the possible role of Na+/H+ exchanger iso-
form 1 (NHE-1) as a signaling complex, due to its function of anchoring for 
cytoskeleton and scaffolding for signaling protein; however a lot remains to 
be evaluated regarding role of NHE-1 in the control of embryonic stem (ES) 
cell migration. Thus, this study has examined the effect of fibronectin (FN) 
on NHE-1 and its relationship to migration of mouse ES cells. FN including 
other ECM components (laminin, fibrinogen, or collagen type I) increased 
Na+ uptake, but their effects were less than FN. Co-immunoprecipitation 
(Co-IP) studies demonstrated that FN induced formation of complexes 
between cavin-1 and calmodulin (CaM), as well as between CaM and NHE-
1. These results revealed that there was a marked increase in the amount 
of cavin-1 and NHE-1 in CaM immunoprecipitates after FN treatment in a 
time- dependent manner, which were blocked by integrin β1 neutralizing 
antibody, integrin β1 siRNA, methyl-β-cyclodextrin (MβCD, lipid raft disrup-
tor), or cavin-1 siRNA. In addition, pretreatment of these inhibitors blocked 
the FN-induced increase of Na+ uptake. FN increased Ca2+ influx and PKC 
activation and Co-IP levels of PKC and CaM, which were also contributed 
to FN-induced NHE-1 activation. Finally, FN significantly increases RhoA 
expression in a time (≥ 12 h)- dependent manner, which was blocked by 
amolide (NHE inhibitor) and transfection of NHE-1 siRNA. We further identi-
fied that FN stimulated ES cell migration via increase of MMP-2 and F-actin 
expression levels. These effects were inhibited by GGTI-286 (RhoA inhibitor) 
or Y-27632 (ROCK inhibitor). In conclusion, FN stimulated ES cell migration 
through NHE-1 activation via cavin-1/camodulin complex formation.
Poster Board Number: 3574
ENHANCING HOMOLOGOUS RECOMBINATION 
BY ALTERING CULTURE CONDITIONS IN MOUSE 
ES CELLS
Prabhakar, Chandra Shekhar, Dhawan, Jyotsna
Stem Cell and Regenerative Biology Group, Institute for Stem Cell Biology 
and Regenerative Medicine, Bangalore, India
Embryonic stem cells are characterized by their unique properties of self-re-
newal and pluripotency. Also these cells exhibit relatively higher frequencies 
of homologous recombination in comparison to the primary somatic cells. 
One of the promising therapeutic potential of ES cells to treatment of some 
of the genetic disorders by correcting the mutation in ES cells and then using 
these ES cells for stem cell therapy. Though ES cells show relative higher 
frequencies of homologous recombination. The process is still inefficient and 
laborious. We have used various culture conditions to study the efficiency 
of homologous recombination in Hprt locus in mouse ES cells. The condi-
tions included commercially available media, conditioned media and small 
molecules. We have few identified conditions in which, the frequency of 
homologous recombination was enhanced by 5-10 times relative to the ES 
cells cultured in regular ES cells medium containing 15% ES cell tested FBS. 
Our results show that the culture conditions can influence the frequency of 
homologous recombination and the frequency can be improved under ap-
propriate culture conditions. We are performing experiment with targeting 
vectors targeting other loci in mouse genome to ensure that this phenom-
enon is not specific to Hprt locus.
Poster Board Number: 3576
EXTRACELLULAR MATRIX-BASED SIGNALING 
PROMPTS AN EXIT FROM THE NAÏVE 
PLURIPOTENT MOUSE STEM CELL STATE IN 
THE ABSENCE OF CELL-SECRETED SIGNALS
Przybyla, Laralynne1, Voldman, Joel2
1Biology, Massachusetts Institute of Technology, Cambridge, MA, USA, 
2Electrical Engineering and Computer Science, Massachusetts Institute of 
Technology, Cambridge, MA, USA
Cell-secreted signals are an integral part of the extracellular environment of 
embryonic stem cells, but their precise contributions to cell phenotype are 
often difficult to define. While it is known that cell-secreted factors play a 
role in embryonic stem cell (ESC) growth, self-renewal, and differentiation, 
the role of such signals in these processes is only starting to be uncovered. 
Here, we present a microfluidic perfusion method that continuously removes 
soluble cell-secreted proteins. We use this method to show that soluble 
signaling is required for self-renewal of mouse ESCs, and that without this 
signaling the cells exit their self-renewing state and enter a more epiblast-
like, primed pluripotent state. Upon removal of soluble signals under 
perfusion, ESCs enter a defined lineage in which cells downregulate the ESC 
markers Rex1 and Klf4 and upregulate the EpiSC markers Fgf5, Brachyury, 
and Dnmt3b. These epiblast-like cells are dependent on Activin for Nanog 
expression, as they are refractory to LIF signaling, and they can be propa-
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gated in defined epiblast stem cell media. This state change is surprising 
given the fact that LIF and BMP4 are still present in the culture media of the 
cells grown under perfusion, factors which together have been thought to 
be sufficient for maintenance of ESC self-renewal. Thus, our results show 
that LIF and BMP4 are not sufficient to maintain the self-renewal of mESCs 
in the absence of soluble signaling and thus that cell-secreted factors play 
a critical role in self-renewal. Removal of soluble cell-secreted factors by 
perfusion also uncovers the function of non-diffusive factors, including 
many components of the extracellular matrix. We show that the continued 
presence of functional ECM is responsible for the exit from the ESC state, 
as disruption of the ECM by attenuation of heparan sulfate proteoglycan 
function mitigates the state change. Intriguingly, the major contribution of 
the ECM that drives cells toward an epiblast-like fate is not Fgf4 signal-
ing through ERK, as inhibition of this signaling pathway under perfusion 
does not halt the phenotypic change. Since our results suggest that ECM 
remodeling is critical for mESC self-renewal, we investigated the role of 
matrix metalloproteinases (MMPs) in this process. MMPs are the major class 
of cell-secreted proteins responsible for curating the ECM, and thus are 
appealing candidates for the cell-secreted molecules being removed under 
perfusion. We first assessed whether MMP downregulation by inhibition in 
static culture would also cause a differentiation phenotype, and indeed we 
show that when MMPs are inhibited, mESCs are unable to self-renew for 
more than two passages. Conversely, MMP addition helps to maintain ESC 
self-renewal, further showing the importance of large-scale ECM remodel-
ing in the self-renewal process. Thus, we are able to uncover a previously 
undescribed level of extracellular regulation that is involved in maintenance 
of mESC self-renewal.
Poster Board Number: 3578
L-THREONINE REGULATES CYCLINS OF MOUSE 
EMBRYONIC STEM CELLS THROUGH PI3K/AKT, 
MAPKS, AND MTORC PATHWAYS
Ryu, Jung Min, Lee, Yu Jin, Kim, Mi Ok, Park, Jae Hong, Suh, Han 
Na, Yun, Seung Pil, Jang, Min Woo, Seo, Bit Na, Park, Su Shin, 
Jeon, Ji Hoon, Han, Ho Jae
Dept of Veterinary Physiology, College of Veterinary Medicine, Chonnam 
National University, Gwang-ju, Korea, Republic of
Amino acids are able to control many physiological functions and are 
involved in regulating early embryonic development. In addition, it is now 
widely accepted that amino acids can stimulate signal transduction and 
function as signal molecules regulating many embryonic stem cell (ESC) 
functions. Nevertheless, amino acid-dependent regulation of ESC function 
and related signal pathways has not been described. Thus, we investigated 
the effect of L-threonine on regulation of mouse (m)ESC self-renewal and 
related signaling pathways. Depletion of L-threonine decreased the expres-
sion of undifferentiation marker genes (Oct4, nanog, FOXD3, Rex1, and 
Sox2) and proliferation (cyclins D1/CDK4 and cyclin E/CDK2) of mESC, 
which were restored by L-threonine addition. Disruption of the lipid raft/
caveolae microdomain through treatment with methyl-β-cyclodextrin or 
transfection with caveolin-1 specific small interfering RNA blocked L-
threonine-induced proliferation of mESCs Addition of L-threonine induced 
phosphorylation of Akt, ERK, p38, JNK/SAPK, and mTOR in a time-depen-
dent manner. This activity was blocked by LY 294002, wortmannin, or an 
Akt inhibitor. L-threonine-induced activation of mTOR, p70S6K, and 4E-BP1 
as well as cyclins and Oct4 were blocked by PD 98059, SB 203580 or SP 
600125. Furthermore, L-threonine induced phosphorylation of raptor and 
rictor binding to mTOR was completely inhibited by 24 hr treatment with 
rapamycin; however, a 10 min treatment with rapamycin only partially inhib-
ited rictor phosphorylation. L-threonine induced translocation of rictor from 
the membrane to the cytosol/nuclear, which blocked by pretreatment with 
rapamycin. In addition, rapamycin blocked L-threonine-induced increases in 
mESC proliferation. In conclusion, L-threonine stimulated ESC G1/S transi-
tion as well as maintenance of undifferentiated states through lipid raft/
caveolae-dependent PI3K/Akt, mTOR, and p70S6K signaling pathways
Poster Board Number: 3580
NOVEL E3 UBIQUITIN LIGASE RNF12 
REGULATES FEMALE X-CHROMOSOME 
INACTIVATION BY DEGRADATION OF OCT4
Lee, Won-Young1, Jang, Jae-Woo1, Habib, Omer1, Kim, Chang-
Hoon1, Song, Hyuk2, Chung, Hyung-Min1
1CHA Stem Cell Institute, Seoul, Korea, Republic of, 2Animal Science, 
College of Natural Science, Konkuk University, Chung-ju, Korea, Republic 
of
Embryonic stem cells (ESCs) are maintained by defined transcription factors 
including Oct4, Nanog and other stemnness factors. During the differentia-
tion, X-chromosome inactivation (XCI) was appeared in female ESCs for 
equalization of X-chromosome-linked gene dosage. XCI is regulated by ho-
mologous X-chromosome pairing and counting, and random X-chromosome 
inactivation. Pluripotency factor Oct4 interacts with Ctcf and then controls 
XCI by their association. Recent report shows that XCI is determined by 
Rnf12 expression in a female-dependent manner. Rnf12, an E3 ubiquitin li-
gase known as Rlim, locates to several killobase near the Xist RNA in X-chro-
mosome and contains ring domain as an E3 activity. Here we demonstrate 
that Rnf12 functions as E3 ligase for Oct4 and regulates XCI. We found that 
Rnf12 and Oct4 co-localized to the nuclei in ESCs and Rnf12 targeted Oct4 
by ubiquitination in a dose-dependent manner. Rnf12 and Oct4 formed 
complexes in vitro and in vivo, especially homeo domain of Oct4 was ubiq-
uitinated by Rnf12 and required for the association with Rnf12. Oct4 was 
elevated significantly when Rnf12 was disrupted by loss-of-function such as 
expressions of shRNA and dominant negative mutants. Furthermore, Rnf12 
determined XCI by Oct4 degradation. Remarkably, gain-of-functions of 
Rnf12 activated XCI, but loss-of-functions of Rnf12 decreased XCI. In addi-
tion, Rnf12 regulated the stemness and ES differentiation of ESCs by protein 
levels of Oct4 in wild type or dominant negative Rnf12-expressing ESCs. In 
conclusion, our findings identify that Rnf12 initiates XCI by degradation of 
negative XCI regulator Oct4 and activates ES differentiation.
Poster Board Number: 3582
A SHRNA FUNCTIONAL SCREENING OF KINASE 
AND PHOPHATASE IN ESC RENEWAL
Wang, Chia-Hui, Wu, Cheng-Chung, Lin, Yu-Tsen, Lu, Jean
Academia Sinica, Taipei, Taiwan
ESCs provide a prominent model for studying cell renewal, oncogenicity, and 
pluripotency. Kinases and phosphatases are well-recognized for their impor-
tance in cell-fate determination. However, their roles in ESCs remain elusive. 
To address this issue, we used 4801 shRNAs against 929 kinases and phos-
phatases to simultaneously identify the pivotal genes for ESC renewal and 
pluripotency. Alkaline phosphatase activity (ALP) was chosen as the marker 
used for the primary screening. Based on the result of ALP assay, among 
the 4801 shRNAs that target 929 genes, 377 shRNAs which recognized 143 
genes were identified as the potential targets . Since ESCs undergo morpho-
logical change upon differentiation, thirty-one genes which were targeted 
by 70 shRNAs were selected based on morphological change. Among them, 
we further demonstrated that two of the candidate genes, Nme6 (non-
metastatic cells 6, protein expressed in nucleoside-diphosphate kinase) and 
Nme7 (non-metastatic cells 7, protein expressed in nucleoside-diphosphate 
kinase), are essential for ESC renewal and pluripotency. Interestingly, Oct3/4 
and Klf4 were reduced in both Nme6- and Nme7- knockdown ESCs. The 
differentiation markers of ectoderm, endoderm, and mesoderm are also 
activated upon the depletion of Nme6 or Nme7. This suggests the pivotal 
roles for Nme6 and Nme7 in ESC renewal.
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DELINEATING THE ROLE OF TCF3 IN 
EMBRYONIC STEM CELL SELF-RENEWAL AND 
DIFFERENTIATION
Ng, Deborah, Kelly, Kevin, Doble, Bradley
McMaster University, Hamilton, ON, Canada
In addition to its roles in developmental and cancer related processes, 
emerging evidence suggests that the canonical Wnt/β-catenin/TCF pathway 
is also involved in regulating stem cell self-renewal and differentiation. The 
ubiquitous serine/threonine kinase, Glycogen Synthase Kinase-3 (GSK-3) 
acts as a negative regulator in the Wnt/β-catenin/TCF pathway. Genetic 
ablation of both GSK3 α and β (referred to as DKO, for double knockout) 
in mouse embryonic stem cells (ESCs), renders them incapable of efficiently 
differentiating into the three germ layers. In an attempt to rescue this dif-
ferentiation blockade of DKO ESCs, we expressed dominant negative forms 
of the TCFs (TCF1, LEF1, TCF3 and TCF4), the final effector molecules of 
this pathway. Surprisingly, although the expression of TCF1, LEF1 or TCF4 
was tolerated and resulted in attenuated expression of β-catenin/TCF target 
gene expression, the expression of dominant negative TCF3 (TCF3DN) 
resulted in premature cell differentiation/death. Thus, TCF3 appears to play 
a unique role in the regulation of ESC properties. To clarify the underlying 
mechanism of TCF3 action in ESCs, we are examining the effects of express-
ing a dominant negative TCF3 (TCF3DN) in DKO cells using an inducible 
doxycycline regulated system. Gene expression analyses of DKO-TCF3DN 
ESCs, relative to DKO and DKO-TCF4DN ESCs, suggests that TCF3DN dif-
ferentially regulates a specific subset of genes. In addition, the differentiation 
capabilities of DKO-TCF3DN cells were assessed by using embryoid body 
and teratoma assays. Furthermore, to more fully understand the mechanism 
by which TCF3 regulates stem cell properties, we have used an unbiased 
quantitative proteomic approach to identify proteins that interact with TCF3. 
The information obtained from these studies provides new insights into the 
mechanisms through which TCF3 regulates stem cell self-renewal and dif-
ferentiation.
Poster Board Number: 3586
MYC ACTIVITY CAN BE ELIMINATED IN ES 
CELLS UNDER 2I CONDITION WITHOUT 
AFFECTING THEIR INDEFINITE SELF-RENEWAL 
PROPENSITY
Okuda, Akihiko, Hishida, Tomoaki
Saitama Medical School Research Center for Genomic Medicine, Saitama, 
Japan
Indefinite self-renewal is one of the most prominent features of ES cells 
in which a number of transcription factors are known to be involved in 
the establishment and the maintenance of this important property. c-Myc 
protein has been shown to be crucially involved in this task as one of major 
downstream regulators of LIF-Stat3 signaling cascade. However, it is known 
that expression levels of c-Myc in inner cell mass cells in blastocysts and ES 
cells cultured under the ground state condition using specific kinase inhibi-
tors (2i condition) are extremely low, implicating that these cells maintain 
their prominent features through a c-Myc independent mechanism. To 
address this question directly, we generated null-ES cells for Max gene which 
encodes a best characterized partner for all of Myc family proteins compris-
ing of c-Myc, N-Myc and L-Myc. Our analyses reveal that Myc activity can 
be deprived completely without affecting their ES cell-specific prominent 
features, although loss of Max gene expression leads to loss of pluripotency 
and cell viability when the cells are under the conventional culture condition. 
Thus, these results indicate that, unlike Oct3/4, Myc is not an absolute, but 
is a context dependent regulator of ES cell status and the crucial requirement 
is rather restricted to ES cells under empirical culture condition using LIF and 
serum.
Poster Board Number: 3588
FROM EMBRYONIC STEM CELL TO EPIBLAST
Primich, Daniel, Banda, Erin, Grabel, Laura
Wesleyan University, Middletown, CT, USA
A series of pluripotent cell types characterizes early mammalian develop-
ment: the zygote, the inner cell mass, and finally epiblast. Epiblast is a 
pluripotent cell type, able to generate ectoderm, mesoderm, and endoderm, 
but has lost the ability to generate most extraembryonic tissues. We are 
interested in understanding the molecular events that restrict the pluripoten-
tial state and promote epiblast differentiation, and will use embryonic stem 
cells (ESCs) as an easily manipulated in vitro model. We hypothesize that 
an FGF5+ epiblast intermediate will be observed during the differentiation 
of ESCs toward the neural lineage. FGF5 is an established epiblast marker. 
qRT-PCR and immunocytochemistry analysis of ESCs undergoing neural 
differentiation suggest a transient FGF5+ epiblast population is present at 
around 3-4 days. We aim to isolate ESC-derived epiblast and determine its 
developmental potential. FGF5 cannot be used for this purpose because it 
is a secreted ligand and very little is known about the regulatory sequences 
driving expression of FGF5 in epiblast. We are currently screening for genes 
that display a similar temporal expression pattern to FGF5, with the hope 
of identifying cell surface markers or genes that can be used to generate a 
reporter cell line. Preliminary deep sequencing data verifies the expected 
temporal pattern of FGF5 expression. Once we are able to isolate ESC-
derived epiblast, we will begin to investigate the molecular events regulat-
ing transition to epiblast. We hypothesize roles for the FGF, Notch, and Hh 
signaling pathways. A better understanding of this molecular regulation will 
aid in efficiently generating ESC-derived material for cell-based therapies.
Poster Board Number: 3590
RONIN’S TRANSCRIPTIONAL CONTROL OF 
DNA REPAIR IN EMBRYONIC STEM CELLS
Seifert, Bryce A., Dejosez, Marion, Zwaka, Thomas
Baylor College of Medicine, Houston, TX, USA
Embryonic stem cells (ES cells) provide a potentially powerful tool for regen-
erative medicine due to two unique properties. Self-renewal allows them 
to divide continuously in culture without differentiating, while pluripotency 
enables them to differentiate into all three germ layers. ES cells also possess 
a low spontaneous mutation rate that is 100 times lower than that of many 
differentiated cells. However, the mechanism responsible for this low muta-
tion rate remains to be defined. Recently, we have identified a transcription 
factor named Ronin that is essential to ES cell self-renewal by transcription-
ally regulating its targets via direct recruitment of chromatin modifying 
enzymes through its interaction with Host cell factor 1 (Hcf1). Here we 
show Ronin controls a transcriptional program specific to ES cell DNA repair. 
Mapping promoter binding sites for Ronin in ES cells (using ChIP-Seq tech-
nology) indicate it to bind genes involved in multiple DNA repair pathways 
including nucleotide excision repair, post-replication repair, and homologous 
recombination. Conditional loss of Ronin in ES cells results in increased 
sensitivity to DNA damage as well as defects in repair of DNA strand breaks. 
In contrast, constitutive overexpression of Ronin results in enhanced DNA 
repair and enhanced survival after DNA damage. Our data suggest Ronin to 
regulate transcription of its bound DNA repair genes. We propose this regu-
lation to be one component of the mechanism underlying the low mutation 
rate in ES cells. Ultimately, our studies may give insight into the spontaneous 
mutation rate of adult stem cell populations and the mutation rate within 
the developing embryo.
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PRINCIPAL COMPONENTS OF EMBRYONIC 
STEM CELL PLURIPOTENCY
Sharov, Alexei A.1, Nishiyama, Akira2, Piao, Yulan1, Binder, Bernard3, 
Tapnio, Richard4, Malinou, Justin1, Correa-Cerro, Lina1, Yu, Hong1, 
Xin, Li5, Amano, Misa1, Qian, Yong1, Dudekula, Dawood1, Ko, 
Minoru S.H.1
1Genetics Laboratory, National Institute on Aging, Baltimore, MD, USA, 
2Yokohama City University, Yokohama, Japan, 3University of California, 
Davis, CA, USA, 4University of Medicine and Dentistry, New Jersey, New 
Brunswick, NJ, USA, 5Victor Chang Cardiac Research Institute, Sydney, 
Australia
To decipher gene regulatory networks, we used systematic knockdown 
of 97 transcription factors (TFs) and 7 other genes with shRNA in mouse 
embryonic stem (ES) cells, followed by global gene expression profiling 
with microarrays. Meta-analysis of these data together with the earlier data 
obtained by the induction of 50 TFs and the existing genome-wide data 
on TF binding sites identified the sets of target genes regulated by 23 TFs. 
Target genes were identified based on their over-representation (Parametric 
Analysis of Gene Set Enrichment, PAGE) in sets of upregulated or downreg-
ulated genes after manipulation of the TF. Most of these TFs (Pou5f1, Sox2, 
Nanog, Esrrb, Sall4, Btbd14b, Zfp281, Nr0b1, Tcfcp2l1, Stat3, Myc, Trp53, 
Eed, Phc1, Suz12, Klf4, Cdx2, Eomes, and Gata3) tend to positively regulate 
the expression of their targets, and only 4 TFs (Rest, Jarid2, Tcf3, and Nr5a2) 
have predominantly negative effects on their targets. Even well-known re-
pressors, such as Polycomb TFs - Eed, Phc1, and Suz12, positively regulate a 
large number of their targets. Positive regulation of target genes by Pou5f1, 
Sox2, Nr0b1, Eed, and Suz12 in normal conditions is reverted to negative 
regulation when these TFs are over-expressed; a phenomenon previously 
described as “bell-shaped” response. Gene Ontology (GO) analysis of target 
genes elucidated the key function of each TF. For example, targets regulated 
by Rest, Esrrb, Klf4, and Trp53 are enriched in synapse, glycolysis, cytoskel-
eton, and apoptosis functions, respectively. Principal component analysis 
shows two main directions of ES cells state change after manipulation of TFs: 
(1) knockdown of Pou5f1 or Sox2 (“Pou5f1 regulatory module”), or induc-
tion of Esx1, Cdx2, Gata3, Sox9, or Tcf3 initiates cell differentiation towards 
trophectoderm, and (2) knockdown of Esrrb, Sall4, Nanog, Gbx2, Grhl2, 
Mtf2, Aff1, Tcfap4, or Cdc5l (“Esrrb regulatory module”), or induction of 
Nrip1 initiates cell differentiation towards epiblast lineage. Differentiation 
towards trophectoderm is associated with a strong downregulation of target 
genes of core pluripotency factors Pou5f1 and Sox2, whereas differentiation 
to epiblast is associated with downregulation of targets of Esrrb and upregu-
lation of targets of Trp53 and polycomb TFs. These findings indicate that the 
Pou5f1 regulatory module prevents trophectoderm differentiation and Esrrb 
module prevents epiblast differentiation. Esrrb module is downstream of 
Pou5f1; thus, active Pou5f1 module is a necessary (but not sufficient) condi-
tion for Esrrb activity. Pou5f1 module is independent from Esrrb: Pou5f1 
remains active after the repression of Esrrb module and is required for ES cell 
differentiation towards epiblast.
Poster Board Number: 3594
DISSECTING SELF RENEWAL CIRCUITRY 
USING PHOSPHO-PROTEOMICS AND SMALL 
MOLECULE MODULATION OF SIGNALING 
PATHWAYS
Singh, Harvir, Brivanlou, Ali H.
Rockefeller University, New York, NY, USA
The maintenance of human embryonic stem cell (hESC) pluripotency re-
quires an intricate balance of signaling factors that promote self renewal and 
inhibit differentiation inducing signals. Although canonical TGF-β, FGF, and 
Wnt signals synergize to maintain pluripotency at the transcriptional level, 
the complex crosstalk between these pathways immediately downstream 
of receptor activation has remained unexplored. Here we demonstrate that 
TGF-β activated kinase 1 (TAK1) acts as a central node integrating signals 
between the TGF-β, MAP kinase, and BMP pathways. Inhibition of TAK1 
results in the rapid loss of pluripotency and the highly efficient induction 
of trophoblast differentiation of hESCs. Furthermore this phenotype is 
completely dependent on the activity of BMP signals. Using a phospho-
proteomic strategy, we show that TAK1 prevents differentiation by positively 
regulating downstream effectors MEK, p38, and JNK to inhibit autocrine 
BMP signaling. Surprisingly, TAK1 also positively mediates Smad 2/3 activa-
tion, and is necessary for receptor induced phosphorylation of Smad 2/3 
by TGF-β. Thus TAK1 functions as a central hub in pathway crosstalk to 
maintain self renewal and inhibit differentiation inducing signals. Our results 
highlight the multilayered complexity of self renewal signaling circuitry and 
implicate TAK1 as a central mediator of the pluripotent state.
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X-INACTIVATION STATUS IN FEMALE MONKEY 
EMBRYOS AND EMBRYONIC STEM CELLS
Tachibana, Masahito1, Ma, Hong1, Sparman, Michelle1, 
Masterson, Keith1, Lee, Hyo-Sang1, Ramsey, Cathy1, Wolff, Erin1, 
Tuohetahuntila, Maidina1, Mitalipov, Shoukhrat2
1Oregon National Primate Research Center, Oregon Health & Science 
University, Beaverton, OR, USA, 2Oregon National Primate Research 
Center, Oregon Stem Cell Center and Dept of Obstetrictics & Gynecology 
and Molecular & Medical Genetics, Oregon Health & Science University, 
Beaverton, OR, USA
X chromosome inactivation (XCI) is believed to be essential mechanism 
compensating expression levels of X-linked genes between females (XX) 
and males (XY). In preimplantation mouse embryos, paternal X chromosome 
is selectively inactivated in the extraembryonic lineage while the inner cell 
mass (ICM) lineage maintains two active chromosomes (XaXa). Embryonic 
Stem Cells (ESCs) derived from mouse ICMs retain this unique epigenetic 
feature. Random XCI takes place in the female ICM lineage after implanta-
tion or in ESCs upon in vitro differentiation. In contrast, XCI status in human 
ESCs is not uniform, with majority of analyzed female ESCs displaying non-
random XCI. It remains unclear whether human ESCs represent develop-
mentally more advanced stages than their mouse counterparts or human 
ESCs simply inherit XCI status present in the parental ICMs. To date, XCI 
status of human preimplantation embryos, particularly in the ICM lineage 
remains unknown. Here we demonstrate detailed XCI analysis in preimplan-
tation embryos and ESCs in clinically relevant nonhuman primate model. 
We generated heterozygous rhesus monkey (Macaca Mulatta) embryos 
carrying single nucleotide polymorphisms (SNPs) within transcribed regions 
of XIST and several other X-linked genes. Allele-specific expression analysis 
in isolated whole ICMs revealed that XIST and several other analyzed genes 
are transcribed from both parental alleles suggesting either XaXa or mixture 
of cells with random XCI. However, detailed bisulfite sequencing analysis 
indicated that promoters of these genes were not methylated in the ICM 
while is somatic cells these CpG sites were heavily methylated on one 
X-chromosome. These results suggest that monkey ICM cells maintain two 
active X chromosomes. In contrast, majority of monkey ESC lines expressed 
XIST and other X-linked genes exclusively from one X chromosome suggest-
ing non-random XCI or clonal selection during derivation and culture. ESCs 
also exhibited methylation of XIST and X-linked genes on one X chromo-
some similar that seen in somatic cells. These observations are consistent 
with conclusion that in contrast to pluripotent ICMs, which maintain two ac-
tive X chromosomes, primate ESCs have already undergone X chromosome 
inactivation. Moreover, most primate ESC lines display non-random XCI with 
expression from only one of the parental X chromosomes.
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KDM5B-MEDIATED HISTONE DEMETHYLATION 
REGULATES EMBRYONIC STEM CELL SELF-
RENEWAL AND SAFEGUARDS PRODUCTIVE 
TRANSCRIPTIONAL ELONGATION
Xie, Liangqi
Oregon Stem Cell Center, Oregon Health & Science University, Portland, 
OR, USA
KDM5B-mediated histone demethylation regulates embryonic stem cell 
self-renewal and safeguards productive transcriptional elongation ChIP-
Seq and RNA-Seq analysis identified that the histone H3 trimethyl lysine 4 
(H3K4me3) demethylase KDM5B as a direct downstream target of Oct4 and 
Nanog in murine and human embryonic stem cells (mESCs). KDM5B expres-
sion is highly enriched in the inner cell mass of preimplantation blastocysts 
and largely restricted to pluripotent cells. Ablation of Oct4 or Nanog mark-
edly reduced KDM5B expression in mESCs. Both loss- and gain-of-function 
studies have implicated KDM5B as a critical regulator of mESC self-renewal. 
Knockdown of KDM5B in mESCs displayed compromised proliferation and a 
predisposition towards differentiation. Forced expression of KDM5B support-
ed clonal expansion of mESC in the absence of LIF. Although KDM5B is be-
lieved to function as a promoter-bound repressor, RNA-Seq analysis showed 
that it paradoxically functions as an activator of a gene network associated 
with self-renewal. ChIP-Seq revealed that KDM5B is predominantly targeted 
to intragenic regions and that it is significantly correlated with H3K36me3, 
a histone modification that marks actively transcribed chromatin. KDM5B is 
recruited to H3K36me3 via an interaction with the chromodomain protein 
MRG15 and ChIP-Seq analysis shows high degree of MRG15 colocaliza-
tion with KDM5B. MRG15 is an ortholog of Eaf3, a component of the yeast 
Rpd3S complex which functions to repress cryptic intragenic transcription 
in yeast. In mammals H3K4me3 has been proposed to serve as a nucleation 
site for the PolII initiation complex. We show that PolII interacts with core 
subunits of the H3K4 methyltransferase and that inhibition of PolII elonga-
tion reduces intragenic H3K4me3 deposition. KDM5B knockdown induced a 
marked increase in H3K4me3 at intragenic target sites, stimulated loading of 
PolII, and increased cryptic intragenic transcription. We propose a model in 
which KDM5B activates a unique self-renewal-associated gene network by 
repressing intragenic cryptic initiation and maintaining an H3K4me3 gradi-
ent important for productive transcriptional elongation.
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MAINTENANCE OF GENOMIC STABILITY BY 
ZSCAN4
Zalzman, Michal, Sharova, Lioudmila V., Stagg, Carole A., Ko, 
Minoru S.H.
Laboratory of Genetics, National Institutes of Health, Baltimore, MD, USA
Current advances in tissue stem cells and iPS technologies as potential 
source for therapies have emphasized the need for methods to stabilize and 
prevent cancerous transformation of cultured cells. Mouse ES cells retain 
their genomic integrity following long-term cultures and portray diminutive 
amounts of chromosomal abnormalities compared to other pluripotent stem 
cell lines, such as embryonal carcinoma (EC) cells and some human ES cells. 
However, the mechanism for this characteristic remains to be elucidated. Te-
lomeres are repetitive DNA sequences accompanied by proteins that cap and 
protect chromosome integrity. Telomere shortening may lead to cancerous 
transformation through contribution to genomic instability, and has been 
associated with aging and cellular senescence. By using ES cells we have 
identified a novel telomere regulation and genomic stabilization mechanism 
induced by Zscan4 activity. We have further shown that Zscan4 is essential 
for immortality and long-term culture of mouse ES cells. Although telom-
erase, the enzyme involved in telomere maintenance, is active in ES cells, we 
found Zscan4 activates a telomerase independent mechanism for telomere 
length regulation. Our current study indicates further involvement of Zscan4 
in genome stability of mouse ES cells. Zscan4 seems to have a protective 
effect from DNA damage and moreover, its expression is upregulated, fol-
lowing cells’ exposure to genotoxic stress. Taken together, our data reveal a 
unique mode of genome maintenance in undifferentiated ES cells.
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